-- phpMyAdmin SQL Dump
-- version 4.2.11
-- http://www.phpmyadmin.net
--
-- Host: 127.0.0.1
-- Generation Time: Apr 09, 2024 at 01:13 PM
-- Server version: 5.6.21
-- PHP Version: 5.6.3

SET SQL_MODE = "NO_AUTO_VALUE_ON_ZERO";
SET time_zone = "+00:00";


/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8 */;

--
-- Database: `kombat`
--

-- --------------------------------------------------------

--
-- Table structure for table `all_data`
--

CREATE TABLE IF NOT EXISTS `all_data` (
  `THEME` varchar(100) NOT NULL,
  `ENTITY` varchar(500) NOT NULL,
  `EVIDENCE` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `all_data`
--

INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Peptide', 'Antimicrobial peptide KLKLLLLLKLK-NH2 and its D-enantiomer', 'Significant chemotherapeutic activity in MRSA-infected mice', '', 'Chemotherapeutic activity of synthetic antimicrobial peptides: correlation between chemotherapeutic activity and neutrophil-activating activity', 9326370),
('Antibacterial Peptide', 'Protegrin-1', '', '', 'CONCLUSIONS: This study shows that protegrin-1 potentially may be used as an alternative or adjunct therapy to standard agents used to treat wound infections.', 11445704),
('Antibacterial Peptide', 'Brevinin-2 peptides from the skin of the Hokkaido frog, Rana pirica', 'The most abundant peptide, brevinin-2PRa (680 nmol/g weight of dry skin) showed high potency [minimal inhibitory concentration (MIC) values between 6 and 12 microM] against a range of clinical isolates of P. aeruginosa.', '', 'A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Nine peptides displaying varying degrees of antimicrobial activity were extracted from the skin of the Hokkaido frog, Rana pirica.', 15003829),
('Antibacterial Peptide', 'Antimicrobial peptide, human lactoferrin 1-11 (hLF1-11)', '', '', 'The hLF1-11-treated group also had a significantly lower radiological score compared to the gentamicin-treated group. This study demonstrates the efficacy of hLF1-11 incorporated into Ca-P bone cement as a possible therapeutic strategy for the treatment of osteomyelitis, showing efficacy comparable to that of gentamicin.', 15917544),
('Antibacterial Peptide', '[fMLF]PMBN and [fMLF]PMEN', '', '', 'Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria', 16048913),
('Antibacterial Peptide', 'Phenothiazinium', 'We used MDR-deficient mutants of Staphylococcus aureus (NorA), Escherichia coli (TolC), and Pseudomonas aeruginosa (MexAB) and found 2 to 4 logs more killing than seen with wild-type strains by use of three different phenothiazinium PSs and red light.: Mutants that overexpress MDRs were protected from killing compared to the wild type.', 'Antimicrobial photodynamic therapy (PDT) combines a nontoxic photoactivatable dye, or photosensitizer (PS), with harmless visible light to generate singlet oxygen and free radicals that kill microbial cells.', 'Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrobial photodynamic therapy (PDT) combines a nontoxic photoactivatable dye, or photosensitizer (PS), with harmless visible light to generate singlet oxygen and free radicals that kill microbial cells.', 16377686),
('Antibacterial Peptide', 'Natural toxins and animal venoms (snakes, scorpions and honey bee venoms)', 'Antimicrobial activity against Burkholderia pseudomallei', '', 'In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei', 16784542),
('Antibacterial Peptide', 'Antimicrobial peptides (AMPs), UBI 1-59 and synthetic fragments comprising amino acids 31-38', 'In vitro killing of MRSA by synthetic peptides derived from the alpha-helix or beta-sheet domains of the human cationic peptide ubiquicidin (UBI 1-59), allowed selection of AMPs for possible treatment of MRSA infections. The strongest antibacterial activity was observed for the entire peptide UBI 1-59 and for synthetic fragments comprising amino acids 31-38.', '', 'The availability, chemical synthesis opportunities, and size of these small peptides, combined with their strong antimicrobial activity towards MRSA make these compounds promising candidates for antimicrobial therapy and detection of infections in man. ', 16814900),
('Antibacterial Peptide', 'Hyaluronic acid binding peptides', 'Effective in experimental surgical wound infections caused by S. aureus', '', 'Treatment with these peptides was highly efficacious in reducing the number of S. aureus cells at the wound site and ameliorated the inflammatory host response associated with these infections.', 17065624),
('Antibacterial Peptide', 'Defr1, covalent dimer species of beta-defensin', 'Antimicrobial activity against Pseudomonas aeruginosa PAO1 and an extended panel of multidrug-resistant nosocomial pathogens', '', 'Covalent dimer species of beta-defensin Defr1 display potent antimicrobial activity against multidrug-resistant bacterial pathogens. Beta defensins comprise a family of cationic, cysteine-rich antimicrobial peptides, predominantly expressed at epithelial surfaces.', 17353239),
('Antibacterial Peptide', 'Lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin', 'Vancomycin combined to Pal-Lys-Lys-NH(2) exerted the strongest anti-staphylococcal efficacies. The in vitro studies showed, that MIC and MBC values for vancomycin were lower in presence of lipopeptides. They reduce the bacterial load and to enhance the effect of vancomycin in the prevention of vascular graft staphylococcal infections.', '', 'The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.', 17537542),
('Antibacterial Peptide', 'Antimicrobial peptide thionin Thi2.1', 'Growth inhibition of S. aureus isolates was dose-dependent, showing a total inhibition at concentrations higher than 3.12 microg/ml.', '', 'Antibacterial activity of thionin Thi2.1 from Arabidopsis thaliana expressed by bovine endothelial cells against Staphylococcus aureus isolates from bovine mastitis. Bovine mastitis is mainly caused by Staphylococcus aureus and antimicrobial therapy, commonly used for its control, has resulted in an increase in the frequency of resistant staphylococci in recent years.', 17961938),
('Antibacterial Peptide', 'AP-CECT7121 (an antimicrobial peptide isolated from an environmental strain of Enterococcus faecalis CECT7121)', 'Activity against Enterococcus faecium, Enterococcus faecalis,Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Clostridium perfringens and Clostridium difficile', '', 'CONCLUSIONS: AP-CECT7121 may provide a novel strategy for treating potentially fatal clinical infections in hospitalized patients.', 19494489),
('Antibacterial Peptide', 'Arminin', 'Minimal bactericidal concentration, 0.4 microM to 0.8 microM against multiresistant human pathogenic strains, such as methicillin-resistant Staphylococcus aureus (MRSA) strains', '', 'Activity of the novel peptide arminin against multiresistant human pathogens shows the considerable potential of phylogenetically ancient organisms as drug sources', 19770277),
('Antibacterial Peptide', 'Laterocidin and its analogues [3 (Asp(1)-->Asn(1), Phe(4)-->Tyr(4) and d-Tyr(6)-->d-Phe(6))]', 'Antimicrobial properties, against clinical Methicillin-resistant Staphylococcus aureus (L-MRSA) and the gram-negative extended-spectrum beta-lactamases-producing Escherichia coli (ESBLs E. coli) and L-E.coli.', '', 'Solid-phase synthesis and antibiotic activities of cyclodecapeptides on the scaffold of naturally occurring Laterocidin', 19932962),
('Antibacterial Peptide', 'longicornsin', 'Strong antimicrobial ability against drug-resistant microorganisms and Helicobacter pylori', '', 'A novel defensin-like peptide from salivary glands of the hard tick, Haemaphysalis longicornis', 20027626),
('Antibacterial Peptide', 'Alyteserin-1c (GLKEIFKAGLGSLVKGIAAHVAS?NH(2)) and its analogues', 'Alyteserin-1c displayed MIC=5-10 micro M; minimum bactericidal concentration, MBC=5-10 microM), increasing the cationicity of alyteserin-1c by the substitution Glu(4)->Lys enhanced the potency (MIC=1.25-5 micro M; MBC=1.25-5 micro M) against MDRAB', 'alyteserin-1c (LD(50)=220 ?M)and its catonic analogues (HC(50)>400 ?M) has low hemolytic activity against human erythrocytes , and.', 'Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii', 20603168),
('Antibacterial Peptide', 'Hominicin (DmIle-Dhb-Pro-Ala-Dhb-Pro-Phe-Dhb-Pro-Ala-Ile-Thr-Glu-Ile-Dhb-Ala-Ala-Val-Ile-Ala -Dmp)', 'Potent activity against Staphylococcus aureus ATCC 25923, methicillin-resistant S. aureus (MRSA) ATCC 11435 and vancomycin-intermediate S. aureus (VISA) CCARM 3501', '', 'Characterization and structure identification of an antimicrobial peptide, hominicin, produced by Staphylococcus hominis MBBL 2-9.', 20654578),
('Antibacterial Peptide', 'Acyldepsipeptide 4 (ADEP 4) analog in which the pipecolate was replaced by 4-methyl pipecolate', 'in vitro antibacterial activity against Enterococci that was fourfold higher than the parent compound ADEP 4', '', 'Diversity-oriented synthesis of cyclic acyldepsipeptides leads to the discovery of a potent antibacterial agent.', 20833054),
('Antibacterial Peptide', 'PTP-7, lytic peptide', 'Anti-biofilm activity, potent to Gram-positive bacteria and is able to kill antibiotic sensitive and resistant Staphylococcus aureus', '', 'The activity of a small lytic peptide PTP-7 on Staphylococcus aureus biofilms', 21887652),
('Antibacterial Peptide', 'C(12)K-2?(12), oligo-acyl-lysyl (OAK) antimicrobial peptidomimetic', 'A dual mode of action against the H. pylori membrane and cytoplasmic components', '', 'The oligo-acyl lysyl antimicrobial peptide C(12)K-2?(12) exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori', 22064541),
('Antibacterial Peptide', 'Epidermicin NI01', 'Potent antimicrobial activity toward a wide range of pathogenic Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA), enterococci, and biofilm-forming S. epidermidis strains', '', 'Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci.', 22155816),
('Antibacterial Peptide', 'CPF-AM1, PGLa-AM1, B2RP-ERa, [E4K]alyteserin-1c, [D4K]B2RP and [G4K]XT-7', 'Overall colistin-susceptibleminimum inhibitory concentration against colistin-susceptible (MIC) ? 2 micro g/mL] and colistin-resistant (MIC ? 64 micro g/mL) clinical isolates of multidrug-resistant strains of Acinetobacter baumannii and Acinetobacter nosocomialis, with most potent peptides being [D4K]B2RP and [E4K]alyteserin-1c (MIC=4-16 micro g/mL)', 'low haemolytic activity against human erythrocytes.', 'Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group', 22326566),
('Antibacterial Peptide', 'OH-CATH30 and its analog OH-CM6', 'The MICs of OH-CATH30 and OH-CM6 ranged from 1.56 to 12.5 micro g/ml against drug-resistant clinical isolates of several pathogenic species, including Escherichia coli, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus.', 'relatively low toxicity and potent efficacy in mouse models', 'Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models.', 22491685),
('Antibacterial Peptide', 'Dimeric PpIX-YI13WF (photosensitizer protophophyrin IX - YI13WF (YVLWKRKRKFCFI-Amide)) conjugate', '(MIC) values of dimeric PpIX-YI13WF conjugate itself observed for E. coli DH5a (~4 times), S. enterica (~8 times), and other Gram-negative strains including antibiotic-resistant E. coli BL21 (~8 times) and K. pneumoniae (~16 times).', 'Dimeric PpIX-YI13WF conjugate could selectively recognize bacterial strains over mammalian cells and generate less photo damage to mammalian cells.', 'Lipopolysaccharide neutralizing peptide-porphyrin conjugates for effective photoinactivation and intracellular imaging of gram-negative bacteria strains. A simple and specific strategy based on the bioconjugation of a photosensitizer protophophyrin IX (PpIX) with a lipopolysaccharide (LPS) binding antimicrobial peptide YI13WF (YVLWKRKRKFCFI-Amide) has been developed for the effective fluorescent imaging and photodynamic inactivation of Gram-negative bacterial strains.', 22769015),
('Antibacterial Peptide', 'Peptide conjugated phosphorodiamidate morpholino oligomers', 'Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis. ', '', 'Targeting bacterial essential genes using antisense phosphorodiamidate morpholino oligomers (PMOs) represents an important strategy in the development of novel antibacterial therapeutics.', 22978365),
('Antibacterial Peptide', 'PEP6R (VKVRVRVRV(D)PPTRVRVRVKV)', 'High potency against bacteria', 'cytocompatible toward human erythrocytes as well as mammalian mesenchymal stem cells', 'Arginine-rich self-assembling peptides as potent antibacterial gels.', 22995710),
('Antibacterial Peptide', 'PXL150', 'In vitro a broad spectrum microbicidal action against both Gram-positive and Gram-negative bacteria, including resistant strains', '', 'The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections.', 23053090),
('Antibacterial Peptide', 'NK-18', 'Two targets, acts on bacterial membrane and DNA in the cytoplasm', '', 'The double targets of NK-18 make it difficult for bacteria to generate resistance, which may present a new strategy to defend against multidrug-resistant bacteria and provide a new lead in the design of potent antimicrobial peptides with therapeutic application in the presence of increasing resistance to conventional antibiotics.', 23089755),
('Antibacterial Peptide', 'LL-37', 'Effective in killing extracellular S. aureus at nanomolar concentrations', '', 'Therefore, LL-37 was shown to be very potent and prompt in eliminating both extra- and intracellular S. aureus and was more effective in killing extra- and intracellular S. aureus than commonly used conventional antibiotics.', 23274662),
('Antibacterial Peptide', 'TSG-8-1, WWSYVRRWRSR-amide', 'Antimicrobial activity against E. coli and S. aureus', 'Very little hemolytic activity in human erythrocytes t high dose level', 'Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide', 23570790),
('Antibacterial Peptide', 'S-thanatin', 'High activity of S-thanatin against K. pneumoniae in vitro with MIC between 4 and 8 micro g/ml.?', '', 'All above implied that S-thanatin, as an alternative, may provide a novel strategy for treating K. pneumoniae infection and other infections due to multidrug-resistant bacteria.', 23643614),
('Antibacterial Peptide', 'Peptidomimetics (Short histidine-derived antimicrobial peptides (SAMPs))', 'High antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA)', 'No hemolytic activity', 'Non hemolytic short peptidomimetics as a new class of potent and broad-spectrum antimicrobial agents.', 23816372),
('Antibacterial Peptide', 'R-thanatin', 'Potent in vitro activity against coagulase-negative staphylococci, such as S. epidermidis, S. haemolyticus, and S. hominis, and inhibited biofilm formation at subinhibitory concentrations', '', 'R-thanatin inhibits growth and biofilm formation of methicillin-resistant Staphylococcus epidermidis in vivo and in vitro', 23917310),
('Antibacterial Peptide', 'C5a-derived immunobiotic peptide EP67', 'EP67 inhibits GBS growth in vitro and in vivo and that antibacterial activity was specific to Streptococcus species.', '', 'We have employed a host-directed immunomodulatory therapy using a novel peptide, known as EP67, derived from the C-terminal region of human complement component C5a.', 23979760),
('Antibacterial Peptide', 'Hymenochirin-1B (IKLSPETKDN(10)LKKVLKGAIK(20)GAIAVAKMV.NH2) analogue in which the Pro(5), Glu(6) and Asp(9) on the hydrophilic face of the ?-helix are substituted by one or more l-lysine or d-lysine residues', '[E6k,D9k]hymenochirin-1B has MIC in the range 0.8-3.1 micro M against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) and a range of Gram-negative bacteria, including multidrug-resistant strains of Acinetobacter baumannii and Stenotrophomonas maltophilia, MIC in the range 3.1-6.25 micro M against NDM-1 carbapenemase-producing clinical isolates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae and Citrobacter freundii.,', 'low hemolytic activity (LC50=302 ?M) of [E6k,D9k]hymenochirin-1B', 'An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties', 24172540),
('Antibacterial Peptide', 'BmKn2 scorpion venom peptide and its derivatives', 'Bactericidal, potent activity against N. gonorrhoeae with MIC50 values of 6.9-27.6 ?M', '', 'Potent and rapid antigonococcal activity of the venom peptide BmKn2 and its derivatives against different Maldi biotype of multidrug-resistant Neisseria gonorrhoeae.', 24184420),
('Antibacterial Peptide', 'His-derived antimicrobial peptides (HDAMPs)', 'Promising dual antimicrobial and anti-inflammatory activities, as well as anti-methicillin-resistant Staphylococcus aureus (MRSA) activity', '', 'CONCLUSION/SIGNIFICANCE: The combination of the ultra-short size, high-prokaryotic selectivity, potent anti-MRSA activity, anti-inflammatory activity, and proteolytic resistance of the designed HDAMP-1, -3, -5, and -6 makes these molecules promising candidates for future antimicrobial therapeutics.', 24302996),
('Antibacterial Peptide', 'Temporin-SHa (FLSGIVGMLGKLF amide)', 'Broad-spectrum activity against Gram-positive and Gram-negative bacteria, yeasts and parasites', '', 'Temporin-SHa (FLSGIVGMLGKLF amide) is a small hydrophobic and low cationic antimicrobial peptide with potent and very broad-spectrum activity against Gram-positive and Gram-negative bacteria, yeasts and parasites.', 24919960),
('Antibacterial Peptide', 'Pandinin 2 variants', 'Antimicrobial activity against E. coli, S. aureus, and M. tuberculosis', 'Pin2 [14] presented only 25% of hemolysis toward human erythrocytes at concentrations as high as 100 ?M, while the peptide Pin2 [17] did not show any hemolytic effect at the same concentration', 'Therefore, Pin2 [14] and Pin2 [17] have the potential to be used as an alternative antibiotics and anti-tuberculosis agents with reduced hemolytic effects.', 25019413),
('Antibacterial Peptide', 'Peptides human beta-defensin-3 (hBD-3) and cathelicidin (LL-37)', 'Non-cytotoxic concentrations of hBD-3 (10 and 20 micro M) and LL-37 (0.1 and 0.2 micro M)', '', 'This combination of antimicrobial peptides thus shows promising potential as an adjunctive therapy for treating inflammatory periodontitis.', 25187958),
('Antibacterial Peptide', 'l isomer of lycosin-I (l-lycosin-I), d isomer of lycosin-I (d-lycosin-I), l- and d-amino acid residues of RKGWFKAMKSIAKFIAKEKLKEHL', 'The MICs of the three isomers of lycosin-I and several other clinical drugs were determined through the broth microdilution method in accordance with the CLSI protocol', '', 'These two compounds displayed high antibacterial activities and rapid bactericidal effects against MDRAB. Moreover, the compounds retained their activity even at high salt (Mg(2+) or Ca(2+)) concentrations.', 25199777),
('Antibacterial Peptide', 'G(IIKK)(3)I-NH(2)', 'Effective against ESBL-producing bacterial infection', 'multidrug resistant ESBL-producing bacteria do not develop resistance and low toxicity toward mammalian hosts', 'High cell selectivity and low-level antibacterial resistance of designed amphiphilic peptide G(IIKK)(3)I-NH(2). On the basis of cell cultures involving bacterial strains (Escherichia coli 5? and Bacillus subtilis 168) and a mammalian cell line (NIH 3T3), the potent antibacterial activity and distinct selectivity from designed amphiphilic peptides G(IIKK)nI-NH2 (n = 2-4) have been demonstrated.', 25210781),
('Antibacterial Peptide', 'Antimicrobial peptides (AMPs) GPPPQGGRPQG and RFGYGYGPYQPVPEQPLYPQ', 'Antibacterial effect in S. aureus', '', 'These showed to exert an antibacterial effect in Staphylococcus aureus. This report validates the prospection of mammal''s saliva to find new alternatives to antibiotics.BIOLOGICAL SIGNIFICANCE: With the growing problem of antibiotic resistance, the identification of new routes in antibiotic therapy is on the scientific agenda worldwide.', 25534884),
('Antibacterial Peptide', 'VRV-PL-V (Vipera russellii venom phospholipase A2 fraction V) of Daboia russellii pulchella venom', 'Antibacterial activity with MIC values ranging from 13 to 24 micro g/ml', '', 'VRV-PL-V demonstrated a potent antibacterial activity against all the human pathogenic strains tested.', 25540009),
('Antibacterial Peptide', 'Tilapia piscidin antimicrobial peptides TP3 (H-FIHHIIGGLFSVGKHIHSLIHGH-OH), TP4 (H-FIHHIIGGLFSAGKAIHRLIRRRRR-OH)', 'TP4 MIC against K. pneumonia and A. baumannii in the range < 1.56 microg/mL - 3.125 microg/mL. TP3 MIC against K. pneumonia and A. baumannii in the range < 1.56 microg/mL - 25 microg/mL', '', 'TP3 and TP4 are able at potentiate anti-Acinetobacter baumannii or anti-Klebsiella pneumonia drug activity, reduce bacterial load, and prevent drug resistance, indicating their potential for use in combating multidrug-resistant bacteria.', 25874924),
('Antibacterial Peptide', 'VG16KRKP', 'Antimicrobial activity against Gram-negative E. coli and plant pathogens X. oryzae and X. campestris, as well as against human fungal pathogens C. albicans and C. grubii.', '', 'The de novo design of VG16KRKP provides valuable insights into the development of more potent antibacterial and antiendotoxic peptides for the treatment of human and plant infections.', 26144972),
('Antibacterial Peptide', 'Synthetic peptides based on LF11( LF11-215 (FWRIRIRR), LF11-227 (FWRRFWRR), DI-MB-LF11-322 (2,2-dimethylbutanoyl-PFWRIRIRR) and DI-MB-LF11-215)', 'Potent anti-biofilm activity against Pseudomonas aeruginosa', '', 'Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms', 26149536),
('Antibacterial Peptide', 'NLF20 (NLFRKLTHRLFRRNFGYTLR)', 'Potent antimicrobial effects against the Gram-negative bacteria Escherichia coli and P. aeruginosa, the Gram-positive Bacillus subtilis and Staphylococcus aureus and the fungi Candida albicans and Candida parapsilosis', '', 'NLF20: an antimicrobial peptide with therapeutic potential against invasive Pseudomonas aeruginosa infection', 26503666),
('Antibacterial Peptide', 'K1K8: an Hp1404-derived antibacterial peptide', 'Decreased methicillin-resistant Staphylococcus aureus (MRSA) bacterial counts in the wounded region in a mouse skin infection model', 'Low hemolytic activity', 'K1K8: an Hp1404-derived antibacterial peptide. As an alternative class of antimicrobial agents used to overcome drug-resistant infections, antimicrobial peptides (AMPs) have recently gained significant attention.', 26952110),
('Antibacterial Peptide', 'D-L91 (SEFAYGSFVRTVSLPVGADE)', 'Enhancement of IFN-gamma(+)TNF-alpha(+) polyfunctional Th1 cells and IL-17A(+)IFN-gamma(+) Th17 cells, enduring memory CD4 T cells and downregulation of PD-1', '', 'The adjunct therapy using drugs and L91 (D-L91) significantly declined the bacterial load in Mtb infected animals.', 27052185),
('Antibacterial Peptide', 'CSpK14 , antimicrobial peptide', 'MICs reduced by 8- to 64-fold and 2- to 16-fold in combination wth oxacillin and ampicillin respectively', '', 'CSpK14 was simple to purify, had low molecular mass, was stable over a wide pH range or tested chemicals, had broad inhibitory spectrum, and possessed potent synergistic antimicrobial-antibiofilm properties.', 27787755),
('Antibacterial Peptide', 'Series of side-chain hybrid dimer peptides J-AA (Anoplin-Anoplin), J-RR (RW-RW), and J-AR (Anoplin-RW) based on the wasp peptide Anoplin and the arginine- and tryptophan-rich hexapeptide', '', '', 'Design of novel antimicrobial peptide dimer analogues with enhanced antimicrobial activity in vitro and in vivo by intermolecular triazole bridge strategy.', 28040477),
('Antibacterial Peptide', 'Thiazomycin, nocathiacin and analogs', 'Activity against drug resistant Mycobacterium tuberculosis with different MICs', '', 'Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis. Thiazolyl peptides are a class of natural products with potent Gram-positive antibacterial activities.', 28096545),
('Antibacterial Peptide', 'Heterofunctionalized poly(ethylene glycol) with different lengths (methacrylate-PEGn-tosyl, n=10/45/90) conjugated with polypeptides to form diblock amphiphiles', 'Antimicrobial activity against several pathogenic bacteria like Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and effectively prevent biofilm formation', '', 'Thus, this facilely synthesized PEGylated AMP bottlebrush coating is a feasible method to prevent biomedical devices-associated infections.', 28131941),
('Antibacterial Peptide', '[K3]SHa', '[K3]SHa emerged as a highly potent compound active against a wide range of bacteria, yeasts/fungi, and trypanosomatids (Leishmania and Trypanosoma), with leishmanicidal intramacrophagic activity and efficiency toward antibiotic-resistant strains of S. aureus and antimony-resistant L. infantum.', '', 'To improve activity, we designed analogs of SHa and compared the antibacterial and antiparasitic mechanisms. [K3]SHa emerged as a highly potent compound active against a wide range of bacteria, yeasts/fungi, and trypanosomatids (Leishmania and Trypanosoma), with leishmanicidal intramacrophagic activity and efficiency toward antibiotic-resistant strains of S. aureus and antimony-resistant L. infantum.', 28319176),
('Antibacterial Peptide', 'Cecropin A2', 'Synergistic Efficacy in combination with Tetracycline against Pseudomonas aeruginosa', '', 'Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa.', 28483966),
('Antibacterial Peptide', 'Sph12-38', 'MIC 3 micro M against Staphylococcus aureus, Corynebacterium glutamicum, Micrococcus lysodeikticus Fleming, Bacillus subtilis, Pseudomonas fluorescens, Aeromonas hydrophila and A. sobria', '', 'Taken together, the synthetic peptide of Sph12-38 had a potent antimicrobial activity against bacteria.', 28600196),
('Antibacterial Peptide', 'Free or anchored antimicrobial peptides like  the cathelicidins BMAP-27 and BMAP-28, their (1-18) fragments and the rationally designed, artificial P19(9/G7) peptide', 'Effective at micromolar concentrations against 22 Staphylococcus and Streptococcus isolates from orthopaedic infections,  BMAP-28 and to a lesser extent BMAP-27 were active against Enterococcus faecalis', 'Negligible toxicity towards osteoblasts', 'Alpha-helical antimicrobial peptides (AMPs) may be promising candidates in this respect due to their potent and broad-spectrum antimicrobial activity, their low tendency to elicit resistance and possible retention of efficacy in the immobilized state.', 28707817),
('Antibacterial Peptide', 'NZ2114 and MP1102', 'The minimal inhibitory concentration and minimal bactericidal concentration of NZ2114 and MP1102 against resistant C. perfringens type A strain CVCC 46 were 0.91 micro M', '', 'Mode of action of plectasin-derived peptides against gas gangrene-associated Clostridium perfringens type A. .', 28934314),
('Antibacterial Peptide', 'Antimicrobial peptide Brevinin-2Ta (GILDTLKNLAKTAGKGILKSLVNTASCKLSGQC)', 'MIC of B-2Ta against S. aureus 64 mg/L, E. coli 32 mg/L, C. albicans 64 mg/L.', '', 'Assessment of antimicrobial and wound healing effects of Brevinin-2Ta against the bacterium Klebsiella pneumoniae in dermally-wounded rats. Antimicrobial peptides (AMPs) are regarded as promising alternatives for antibiotics due to their inherent capacity to prevent microbial drug resistance. Amphibians are rich source of bioactive molecules, which provide numerous AMPs with various structures as drug candidates.', 29340060),
('Antibacterial Peptide', 'Histone H5 purified from chicken erythrocytes', 'Active against Gram-positive and Gram-negative planktonic bacteria (MIC range: 1.9 +- 1.8 to 4.9 +- 1.5 micro g/mL)', '', 'Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides. Modern medicine is challenged continuously by the increasing prevalence of antibiotic resistant bacteria.', 29402952),
('Antibacterial Peptide', 'OH-CATH30 (L and D)', 'highest bactericidal activity against Acinetobacter spp., including multi-drug-resistant Acinetobacter baumannii (MRAB) and methicillin-resistant Staphylococcus aureus (MRSA)', '', 'King cobra peptide OH-CATH30 as a potential candidate drug through clinic drug-resistant isolates. Cationic antimicrobial peptides (AMPs) are considered as important candidate therapeutic agents, which exert potent microbicidal properties against bacteria, fungi and some viruses.', 29515090),
('Antibacterial Peptide', 'Pituitary adenylate cyclase-activating polypeptide (PACAP)', 'Antimicrobial activity against Escherichia coli and Staphylococcus aureus', '', 'Pituitary adenylate cyclase-activating polypeptide (PACAP) is a naturally occurring cationic peptide with potent immunosuppressant and cytoprotective activities.', 29654809),
('Antibacterial Peptide', 'Myristoylation of Human alpha-Defensin 5', '', '', 'Our strategy involves the myristoylation of human alpha-defensin 5 (HD5) as a therapeutic target and subsequent self-assembly in aqueous media in the absence of exogenous excipients.', 29856606),
('Antibacterial Peptide', 'Antimicrobial peptide N10 and NB2', 'Both peptides were effective against A. baumannii and showed antibacterial activities (minimum inhibitory concentration (MIC) 500 micro g/ml). In the biofilm inhibition assay, NB2 reduced biofilm more efficiently (75%) than N10 (50%).', '', 'The selected peptides showed significant binding to A. baumannii rather than to the human cell line Caco-2. Both peptides were effective against A. baumannii and showed antibacterial activities', 29859290),
('Antibacterial Peptide', 'Marcin-18 (FFGHLFKLATKIIPSLFR), Meucin-18 (FFGHLFKLATKIIPSLFQ) and Megicin-18 (FFGALFKLATKIIPSLFR)', 'Showed highly potent inhibitory activity against Gram-positive bacteria (MIC 1.5 to > 48.3 microM), including some clinical antibiotic-resistant strains. Importantly, in a mouse acute peritonitis model, these peptides significantly decreased the bacterial load in ascites and rescued nearly all mice heavily infected with clinical methicillin-resistant Staphylococcus aureus from lethal bacteremia.', '', 'In vitro, chemically synthetic marcin-18 and its homologs (meucin-18 and megicin-18) showed highly potent inhibitory activity against Gram-positive bacteria, including some clinical antibiotic-resistant strains.', 29896190),
('Antibacterial Peptide', 'Oligo-lipidated arginyl peptide (OLAP11)', 'antimicrobial actions against MRSA infections', 'low in vitro toxicity', 'Our results showed that OLAP-11 exhibits potent antimicrobial activity against Gram-positive bacteria with improved physico-chemical activity in various physiological conditions.', 30066172),
('Antibacterial Peptide', 'LTX21', 'Role on host-pathogen interplay,', '', 'Targeting bacterial virulence or the human host immune system to increase host defence are important strategies in the search for novel antimicrobial drugs.', 30916807),
('Antibacterial Peptide', 'Melittin', 'Potency in eradication of extensively drug-resistant (XDR) Acinetobacter spp., killed all examined XDR isolates at 4 microg/mL up to 3 h, significant activity at the minimum dose of 0.062 microg/m', 'No toxixity observed on injured or healthy derma, as well as circulating Red Blood Cells (RBCs) in the examined mice', 'Potent promising antibacterial activity of melittin and the lack of toxicity at the therapeutic dose can clarify that melittin can be implemented as a topical drug lead in a preclinical trial of third degree burn infections.', 30513367),
('Antibacterial Peptide', 'MAP-0403 (J-1, J-2, and J-3)', 'MIC reported as, J-1: 5 microM, J-2 : 2.5 microM, J-3: 10 microM', 'J-2 showed significantly reduced hemolytic effect (3.4%), while J-1 and J-3 showed slightly decreased hemolytic effect (46.2%, 55.6%, respectively', 'Design, synthesis, and antimicrobial activities of novel functional peptides against Gram-positive and Gram-negative bacteria', 31059203),
('Antibacterial Peptide', 'N-terminal fatty acid modified-antimicrobial peptide', 'Displayed synergistic effects when used together with the antibiotics rifampicin and polymyxin B, had strong membrane permeabilization and depolarization, could damage the integrity of the bacterial membrane and could bind to bacterial DNA', '', 'Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.', 31466017),
('Antibacterial Peptide', 'Sphaeropsidin A', 'MIC= 6.25 microgram/mL to 12.5 microgram/mL, methicillin-resistant S. aureus (MRSA)', '', 'Sphaeropsidin A activity appears noteworthy for its ability to inhibit biofilm formation, preventing a growth mode that results in particular resistance to antibiotic treatment.', 32650496),
('Antibacterial Peptide', 'Anoplin analogues: Ano-1beta and Ano-8beta', 'Multidrug-resistant P. aeruginosa', '', 'The new peptides Ano-1beta and Ano-8beta might be promising antimicrobial candidates in combating the increasing antibiotic-resistant bacteria.', 32654770),
('Antibacterial Peptide', 'Tridecaptin M', 'Tridecaptin M reduced the MIC of vancomycin and rifampicin against A. baumannii by 16-fold', 'Tridecaptin M and rifampicin combination killed the bacteria completely in 4 h in an ex vivo blood infection model and was superior to rifampicin monotherapy', 'This study reports the in vitro potential of an antimicrobial peptide tridecaptin M in combination with other antibiotics against different strains of A. baumannii.', 32708842),
('Antibacterial Peptide', 'cCATH-2 (a chicken-derived antimicrobial peptide)', 'All tested concentrations of cCATH-2 (1/32-1/2MIC) significantly reduced the biomass at the biofilm formation stage', '', 'Inhibitory effect of a novel chicken-derived anti-biofilm peptide on P. aeruginosa biofilms and virulence factors.', 32976967),
('Antibacterial Peptide', 'PBDM1: YKWFAHLIKGLC and PBDM2: YKWFRHLIKKLC', 'The MIC value of PBDM1 was found to be as 10 microgram/mL against S. aureus, MRSA, and E. coli. Whereas, in case of E. faecalis, VRSA and VRE the MIC was found to be 30, 15, and 20 microgram/mL. But, the MIC value for PBDM2 was 10 microgram/mL when tested against S. aureus, MRSA, VRSA, VRE, and E. coli. Whereas, in case of E. faecalis the MIC was found to be 20 microgram/mL', 'in vitro study with human epithelial cells showed no significant cytotoxic effects with high biocompatibility and good hemocompatibility', 'In conclusion, PBDM peptides displayed significant antibacterial activity against certain drug resistant bacteria which cause infections in human beings', 32983007),
('Antibacterial Peptide', 'L1G, L7A, and L1GA5K : Mastoparan-C (MP-C) analogs', 'The newly designed peptides showed synergy or additive effects against Gram-negative bacteria, when they combined with conventional antibiotics gentamicin, rifampin, and polymyxin B.', '', 'Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.', 33285267),
('Antibacterial Peptide', 'Astucin from A. tubingensis A01.', 'The MIC of the purified polypeptide was 32 m/L and 128 microgram/mL and the MBIC was 2 and 8 microgram/mL against Staphylococcus aureus and MRSA, respectively', 'The results demonstrated that the antimicrobial and antibiofilm activity of astucin, together with its lack of cytotoxicity, makes it an alternative for application in medicine.', 'This protein shows antimicrobial and antibiofilm activity against S. aureus.', 33309927),
('Antibacterial Peptide', 'F12, Lysostaphin', 'F12 possesses high potency and rapid onset of action, it has narrow selectivity against pathogenic staphylococci, and it manifests synergy with numerous SOC antibiotics.', '', 'These results suggest that combinations of F12 and SOC antibiotics are a promising new approach to treating refractory S. aureus infections.', 33318001),
('Antibacterial Peptide', 'Nisin and P10', 'Nisin + colistin and P10+ceftazidime/doripenem were effective on XDR A. baumannii . The MIC value of Nisin and P10 against studied pathogens were 64-256 and 8-32 microgram/ml, respectively.', '', 'Combination therapy and using antimicrobial peptides are two strategies with high potential to solve this issue.', 33346078),
('Antibacterial Peptide', 'C14-R1 (C14-RWW-NH2) and C12-R2 (C12-RRW-NH2)', 'C14-R1 and C12-R2 showed high antimicrobial potential for gram-positive bacteria.', 'Among them, the new lipopeptides C14-R1 (C14-RWW-NH2) and C12-R2 (C12-RRW-NH2) presented higher selectivity to bacterial membranes over mammalian membranes and low cytotoxicity, which also maintained better antimicrobial activity in the presence of physiological salts or serum.', 'Most of the new lipopeptides exhibited preferable antimicrobial potential against gram-positive bacteria, including MRSA clinical isolates.', 33422980),
('Antibacterial Peptide', 'Fungal peptide, NZX', 'We further observed that this peptide was effective against nontuberculous mycobacteria (NTM), such as M. avium and M. abscessus, and several Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus.', 'In vivo, the peptide remained stable in circulation and preserved lung structure better than ethambutol alone', 'Alternative ways to prevent and treat infectious diseases are needed.', 33603037),
('Antibacterial Peptide', 'Peptide-Based Antibiotics', 'In both cases, optimization of the N-terminal lipid tails led to the identification of analogues with potent activity toward Escherichia coli and Pseudomonas aeruginosa.', '', 'Peptide natural products stand as promising candidates to meet this need as bacterial resistance is typically slow in response to their unique modes of action.', 33750106),
('Antibacterial Peptide', 'Dilipid ultrashort cationic lipopeptides (dUSCLs)', 'Can indirectly disrupt active efflux of chloramphenicol in P. aeruginosa', '', 'Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria', 30392097),
('Antibacterial Peptide', 'Microencapsulated-Host Defense Peptides (HDP ) ;Ub2-MS, K4-MS, and Aurein1.2-MS', 'HDP-MS exhibited up to ?3.02 and ?3.41-log decrease in Mycobacterium tuberculosis CFU as compared to blank-MS (drug free) and untreated control group in 96 h', '', 'Mycobactericidal activity of some micro-encapsulated synthetic Host Defense Peptides (HDP) by expediting the permeation of antibiotic: A new paradigm of drug delivery for tuberculosis.', 30630076),
('Antibacterial Peptide', 'Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles', 'The most potent, broad-spectrum peptidomimetic showed activity against Gram-positive (methicillin-resistant Staphylococcus aureus - MIC = 2 microg/mL) and Gram-negative (Escherichia coli - MIC = 4 microg/mL) pathogenic bacteria.', '', 'Synthetic small molecular antimicrobial peptidomimetics represent a promising new class of potential antibiotics due to their membrane-disrupting ability and their decreased propensity for bacterial resistance.', 30831407),
('Antibacterial Peptide', 'alpha-Peptide/beta-Peptoid Lysine-Based Peptidomimetics', 'High potency against clinical drug-resistant P. aeruginosa strains', '', 'Emergence of bacterial resistance renders existing antibiotics inefficient, and therefore discovery of new antimicrobial agents is highly warranted.', 30842761),
('Antibacterial Peptide', 'Cationic Antimicrobial Peptides (CAMPs) : LL-37: human cathelicidin, CAMA: cecropin(1-7)-melittin A(2-9) amide, magainin-II and nisin', 'activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa', '', 'This study showed the potent and rapid antibacterial activity of CAMPs on both laboratory and clinical isolates of S. aureus and P. aeruginosa either susceptible or resistant to antibiotics.', 30849936),
('Antibacterial Peptide', 'Peptide dendrimers G3KL and TNS18', 'Can destroy the Pseudomonas aeruginosa biofilm morphological structure and thickness', '', 'Potent activity on planktonic cells and biofilms of P. aeruginosa suggests that peptide dendrimers G3KL and TNS18 are promising candidates of clinical development for treating infections.', 31101943),
('Antibacterial Peptide', 'Hybrid antimicrobial peptide (B1) from helical parts taken from the parent peptides: LL-37 and BMAP-27', 'Broad-spectrum activities, the concentration against planktonic cells ranged between 10 and 20 microM, 40-60 microM were needed to eradicate the biofilm', 'Reduced toxicity toward mammalian cells with minimal hemolysis risk', 'Results: The new peptide B1 exhibited broad-spectrum activities against all tested strains.', 31118709),
('Antibacterial Peptide', 'Bac1, Bac2 and Bac3', 'Inhibit the growth of Leuconostoc mesenteroides and affect sperm motility', '', 'Bacteriocins, which are bacterially-derived antimicrobial peptides, may fulfill some of the criteria for these new agents.', 31244418),
('Antibacterial Peptide', 'vancomycin derivatives carrying LPS binding peptides, vancomycin-LPS binding peptide conjugates (VPCs).', 'were screened against VISA/VRE and Gram-negative strains', '', 'VPCs exhibited enhanced activity against vancomycin resistant bacteria and obtained the activity against Gram-negative bacteria in vitro, providing a novel strategy for vancomycin modification and glycopeptide antibiotics synthesis.', 34015504),
('Antibacterial Peptide', 'Activated caseinolytic protease P (ClpP)', 'an antibacterial assessment demonstrated that ONC212 displays excellent activity against Xoo and prevents rice bacterial leaf blight in vivo.', '', 'Additionally, an antibacterial assessment demonstrated that ONC212 displays excellent activity against Xoo and prevents rice bacterial leaf blight in vivo.', 34218658),
('Antibacterial Peptide', 'a chimeric peptide-G6, a N6NH2 analog', 'Showed MIC value: 16 microgram/mL and could curb N6NH2-resistant mutants by stronger inhibition of biofilm formation, stronger affinity with LPS, and stronger membrane permeability and depolarization than that of N6NH2.', '', 'Antimicrobial peptides (AMPs) are regarded as the potentially effective therapy.', 34889983),
('Antibacterial Peptide', 'AMPR-22 (antimicrobial peptide derived from Romo1)', 'It showed broad-spectrum antimicrobial activity against 17 sepsis-causing bacteria, including MDR strains, by inducing membrane permeabilization.', 'Moreover, treatment with AMPR-22 enabled a remarkable survival rate in mice injected with MDR bacteria in a murine model of sepsis.', 'Based on these results, we suggest that AMPR-22 could be prescribed as a first-line therapy (prior to bacterial identification) for patients diagnosed with sepsis.', 34361008),
('Antibacterial Peptide', 'glucose-dependent insulinotropic polypeptide (GIP)', 'While GIP was devoid of direct antimicrobial activity, it has a potent membrane depolarizing effect, and at low concentrations, it significantly potentiated the activity of eight antibiotics and bile salt by reducing MICs by 4-8-fold in E. coli TG1 and 4-20-fold in E. amylovora 1189.', '', 'GIP can thus be regarded as an antimicrobial adjuvant with potential for augmenting the available antibiotic arsenal. © 2020 Walter de Gruyter GmbH, Berlin/Boston.', 33938181),
('Antibacterial Peptide', 'beta-defensin-derived peptide', 'The MIC values ranged from 2 to 4?8 microM for all the microorganisms tested, with the exception of the P. aeruginosa MDR strain 1 and A. baumannii strain 1 that are resistant up to a concentration of 32?64 microM of both peptide forms', 'it has great stability in human serum thereby enhancing its antibacterial presence and activity without cytotoxicity in human cells.', 'Currently, the race is on to identify pharmaceutical molecules or combinations of molecules able to prevent or reduce the insurgence and/or progression of infectivity.', 34818435),
('Antibacterial Peptide', 'PHNX peptides', 'PHNX-1 demonstrated antibacterial activity (under high and low-salt conditions) against antibiotic resistant and susceptible strains of Gram-positive and Gram-negative bacteria and PHNX-4 to -8 demonstrated low-salt antibacterial activity only.', '', 'Development of new antibiotics has slowed in recent years and novel therapeutics (like AMPs) with a focus against Gram-negative bacteria are needed.', 34867843),
('Antibacterial Peptide', 'cationic antimicrobial peptides (AMPs)', 'In contrast, it showed minimum inhibitory concentration values (MICs) lower than reported for several AMPs and other synthetic cationic compounds on Acinetobacter genus (3.2-12.7 microM).', '', 'New therapeutic possibilities are, therefore, urgently needed to circumvent this important problem.', 34298891),
('Antibacterial Peptide', 'Synthetic beta-hairpin antimicrobial peptides', 'mutations of only 2 to 4 amino acids at the turn region could impart a wide range of antimicrobial profiles among synthetic beta-hairpin AMPs. BTT2-4 and BTT6 displayed selective potency against Gram-negative bacteria, with minimum inhibitory concentrations (MICs) of 4-8 microM.', 'Our peptides were also determined to be non-cytotoxic against a human cell line.', 'Synthetic β-hairpin antimicrobial peptides (AMPs) offer a useful source for the development of novel antimicrobial agents. β-hairpin peptides generally consist of two side strands bridged by a reverse turn.', 34506975),
('Antibacterial Peptide', 'dipicolylamine-containing carbazole amphiphiles with strong Zn2+', 'antimicrobial candidate. 16 combined with 12.5 microgram/mL Zn2+ exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria (MICs = 0.78-3.125 microgram/mL), weak hemolytic activity, and low cytotoxicity.', 'antimicrobial candidate. 16 combined with 12.5 microgram/mL Zn2+ exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria (MICs = 0.78-3.125 microgram/mL), weak hemolytic activity, and low cytotoxicity.', 'Effective broad-spectrum 16 combined with 12.5 μg/mL Zn2+ was identified as the most promising antimicrobial candidate. 16 combined with 12.5 μg/mL Zn2+ exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria (MICs = 0.78-3.125 μg/mL), weak hemolytic activity, and low cytotoxicity.', 34235929),
('Antibacterial Peptide', 'cathelicidin-related (CR-) peptides- PepBiotics', 'A relatively small number of PepBiotics remained highly antibacterial against CF-related respiratory pathogens Pseudomonas aeruginosa and Staphylococcus aureus, at high ionic strength and low pH. I', 'Finally, interaction of CR-163 with bacterial-type anionic membranes but not with mammalian-type (zwitterionic lipid) membranes was confirmed using ITC and 31P solid state NMR.', 'Interestingly, these PepBiotics also prevented LPS/LTA induced activation of macrophages and was shown to be non-toxic to primary human nasal epithelial cells.', 34147544),
('Antibacterial Peptide', 'Temporin A and the short lipopeptides (C10)2-KKKK-NH2 and (C12)2-KKKK-NH2', '', '', 'The results of the performed experiments suggest that the potential application of peptides as adjuvant agents in the treatment of biofilm-associated infections should be studied further.', 32887236),
('Antibacterial Peptide', 'CB6-C', 'effective antimicrobial activity against gram-positive bacteria (in particular, the MIC for MRSA was 16 Microgram/mL)', '', 'In conclusion, this protein CB6-C is a newly discovered antibacterial protein and has the potential to become an effective antibacterial agent due to its high therapeutic index, safety, nontoxicity and great stability.', 34983528),
('Antibacterial Peptide', 'Lactoferricin B-Mutant (M4)', 'Among the potent AMP mutants, a Lactoferricin B-Mutant (M4) possessed uniformly high affinity with SHV1, OXA48, NDM1, and AmpC having energies -842.0Kcal/mol, -774.8Kcal/mol, -1103.3Kcal/mol, and -858.8Kcal/mol respectively. Highest affinity of Lactoferricin B_M4 was found with NDM1 due to H-bonds, salt-bridges, and hydrophobic interactions with the metallo-beta-lactamase domain including crucial active-site residue Asp124.', '', 'Molecular dynamics simulation further confirmed the stability of Lactoferricin B_M4-NDM1 complex having low residue-level root-mean square deviations (RMSD), atomic-level fluctuations, and radius of gyration (Rg). The study encourages experimental validations and similar methods to identify potential AMPs against drug-resistant pathogens.', 35188617),
('Antibacterial Peptide', 'PaP1', 'TSP showed lytic spectrum of ~ 75%, suggesting its activity against various MRSA and MSSA isolates from different clinical samples. The phage efficiently inhibited bacterial growth for up to 12 h at MOI of 1 and 10. TSP phage showed activity against various isolates of MRSA and MSSA, isolated from different clinical samples, with variable antibiotic susceptibility patterns.', '', 'Despite the necessity for additional preclinical drug development, the collective data from our study support PaP1 as a potential broad-spectrum monotherapy or adjunctive therapy for the topical treatment of polymicrobial infections and provide a foundation for engineering future lysin-derived peptides with improved antibacterial properties.', 35369520);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Peptide', 'two-peptide lantibiotic produced by Vagococcus fluvialis LMGT 4216', 'The combination of the two peptides resulted in a 1,200-fold increase in potency, confirming the two-peptide nature of the bacteriocin, named vagococcin T. The bacteriocin was demonstrated to kill sensitive cells by the formation of pores in the cell membrane, and its inhibition spectrum covers most Gram-positive bacteria, including multiresistant pathogens.', '', 'The novel lantibiotic showed a broad spectrum of inhibition of Gram-positive strains, including vancomycin-resistant Enterococcus faecium, demonstrating its therapeutic potential.', 35730941),
('Antibacterial Peptide', 'two CAMPs (LL-37 and CAMA)', 'We observed a greater bactericidal effect when IB3-1 cells were pretreated with sub-minimum bactericidal concentrations (Sub-MBCs) of the CAMPs prior to infection. These findings suggest that CAMPs induce the production of factors by IB3-1 cells that improve their bactericidal action. LL-37 induced a weak inflammatory response in the cells without being toxic.', 'The two CAMPs exerted different effects on PA survival depending on the timing of their administration. However, we observed no bactericidal effect when supra-minimum bactericidal concentrations (Supra-MBCs) of the CAMPs were added to IB3-1 cells at the same time or after infection.', 'In conclusion, our findings suggest a potential prophylactic action of CAMPs. The bactericidal effects were low when the CAMPs were added after cell infection, likely due to degradation of CAMPs by bacterial or epithelial cell proteases and/or due to adherence of CAMPs to cells becoming less available for direct bacterial killing.', 34954126),
('Antibacterial Peptide', 'series of AMPs with linear and star-shape (using n-hexylamine and amine-terminated polyamidoamine dendrimers (Gx-PAMAM, x = 1-2) as initiators)', 'The star-shaped AMPs exhibited enhanced bactericidal activity against Gram-negative E. coli and similar bactericidal activity against Gram-positive S. aureus when compared with the linear AMPs. It is worth mentioning that star-shaped AMPs demonstrated a significantly faster bactericidal efficiency (completely killed bacteria within 5 min at a concentration of 2 ', '', 'In addition, both the surfaces grafted with AMPs of different topologies demonstrated favorable biocompatibility in vitro.', 35005755),
('Antibacterial Peptide', 'metronidazole (MDZ), clindamycin (CLI), and PM-477', 'Determination of the MIC indicated that 60% of a panel of 22 Gardnerella isolates of four different species were resistant to MDZ, while all strains were highly susceptible to CLI and to the endolysin PM-477. All strains were susceptible to PM-477 when grown as preformed biofilms, at minimum biofilm eradication concentrations (MBECs) in the range of 1 to 4 microg/mL.', '', 'Therefore, the high efficacy of PM-477 in eliminating Gardnerella in in vitro biofilms, as well as its high resilience to resistance formation, makes PM-477 a promising potential alternative for the treatment of bacterial vaginosis, especially in patients with frequent recurrence.', 35416708),
('Antibacterial Peptide', 'cationic antimicrobial peptides (CAMPs)', 'In this study, the interaction of a CAMP derived from cecropin D-like (?M2) with model membranes mimicking bacterial biomembranes of wild-type (WTPa) strains of P. aeruginosa and CRPa was evaluated through in vitro and in silico approaches.', '', 'This work provides clues for elucidating the membrane-associated mechanism of action of ?M2 against colistin-susceptible and -resistant strains of Pseudomonas aeruginosa. Accordingly, cationic antimicrobial peptides (CAMPs) have emerged as promising alternatives to control resistant bacteria.', 35745820),
('Antibacterial Peptide', 'Temporin-PKE', 'Temporin-PKE is a novel peptide extracted from the skin secretion of Pelophylax kl. esculentus and it displays a strong activity against Gram-positive bacteria, with an extreme cytotoxicity. The transformation of the chirality of Ile could reduce haemolytic activity, and an analogue with appropriate D-isoforms could maintain antimicrobial activity and stability. The substitution of hydrophobic residues could bring about more potent and broad-spectrum antimicrobial activities.', 'The analogues with Lys were less harmful to the normal cells and their stabilities remained at similarly high levels compared to temporin-PKE.', 'Temporin-PKE-3K exerted dually efficient functions includingstrong antimicrobial and anticancer activity. This analogue showed a reduced possibility for inducing resistance in MRSA and Klebsiella pneumoniae, a rather strong antimicrobial activity in vivo, and it exhibited the highest therapeutic index such that temporin-PKE-3K has the potential to be developed as a clinical drug.', 35740884),
('Antibacterial Peptide', 'Pediocin-like bacteriocins (class IIa bacteriocins)', 'They act on the cytoplasmic membrane of Gram-positive cells by dissipating the transmembrane electrical potential through pore formation with the mannose phosphotransferase system (man-PTS) as the target/receptor. Bacteriocin-producing strains also synthesize a cognate immunity protein that protects them against their own bacteriocins.', 'Pediocin-like bacteriocins, ribosomally synthesized antimicrobial peptides, are generally co-expressed with cognate immunity proteins to protect the bacteriocin-producing strain from its own bacteriocin.', 'Bacteriocins are considered potential alternatives to conventional antibiotics in the context of the bacterial resistance crisis, but the immunity mechanism is unclear. This study uncovered the mechanisms of action and immunity of class IIa bacteriocins.', 35703550),
('Antibacterial Peptide', 'Antimicrobial Peptides CATH-1, CATH-3, and PMAP-36 With Erythromycin', 'The results showed that the minimum bactericidal concentration (MBC) of CATH-1,-3 and PMAP-36 was lower than 10 microM, indicating that these three AMPs had good bacterial activity against S. aureus, S. enteritidis, and E. coli. The results showed that the FBCI of AMPs (CATH-1,-3 and PMAP-36) and erythromycin was lower than 0.5 against bacterial pathogens, demonstrating that they had a synergistic bactericidal effect. Furthermore, the time-killing kinetics of AMPs (CATH-1,-3 and PMAP-36) in combination with erythromycin showed that they had a continuous killing effect on bacteria within 3 h. Notably, the combination showed lower hemolytic activity and cytotoxicity to mammal cells compared to erythromycin and peptide alone treatment. In addition, the antibacterial mechanism of CATH-1 and erythromycin combination against E. coli was studied. The results of the scanning electron microscope showed that CATH-1 enhanced the antibacterial activity of erythromycin by increasing the permeability of bacterial cell membrane. Moreover, the results of bacterial migration movement showed that the combination of CATH-1 and erythromycin significantly inhibits the migration of E. coli. Finally, drug resistance analysis was performed and the results showed that CATH-1 delayed the emergence of E. coli resistance to erythromycin.', '', 'In conclusion, the combination of CATH-1 and erythromycin has synergistic antibacterial activity and reduces the emergence of bacterial drug resistance. Our study provides valuable information to develop AMPs as potential substitutes or adjuvants for traditional antibiotics.', 35910608),
('Antibacterial Peptide', 'beta-Hairpin Peptide Z-d14CFR or recombinant Zophobas atratus (Z. atratus) defensin', 'Our results showed that Z-d14CFR (RGCRCNSKSFCVCR-NH2) exhibited a broad-spectrum antimicrobial activity to both Gram-positive bacteria and Gram-negative bacteria, including multidrug-resistant bacteria.', 'It possessed less than 5% hemolysis and 10% cytotoxicity, even at a high concentration of 1 mg/mL.', 'Our findings suggest that Z-d14CFR could be a promising candidate against multidrug-resistant bacteria.', 35563007),
('Antibacterial Peptide', 'cell-penetrating peptide fused endolysin', 'Bacteriophage encoded endolysin as an alternative antibiotics is a peptidoglycan degrading enzyme with a low rate of resistance. This engineered endolysin, DS-PA90, completely killed A. baumannii at 0.25 microM, at which concentration PA90 could only eliminate less than one log in CFU/ml. Additionally, DS-PA90 has tolerance to NaCl, where the ?50% of activity could be maintained in the presence of 150 mM NaCl, and stable activity was also observed with changes in pH or temperature. Even MDR A. baumannii strains were highly susceptible to DS-PA90 treatment: five out of nine strains were entirely killed and four strains were reduced by 3-4 log in CFU/ml. Consequently, DS-PA90 could protect waxworm from A. baumannii-induced death by ?70% for ATCC 17978 or ?44% for MDR strain 1656-2 infection.', '', 'Collectively, our data suggest that CPP-fused endolysin can be an effective antibacterial agent against Gram-negative pathogens regardless of antibiotics resistance mechanisms.', 35614377),
('Antibacterial Peptide', 'tetrameric cell penetrating antimicrobial peptoids', 'Short tetrameric Rhodamine B-labeled peptoids composed of a balance of aromatic and lipophilic residues have potent selective antimicrobial activity against a range of microorganisms. The most potent candidates were active against drug-resistant S. aureus isolates as well as mycobacterial strains, with cell penetrating capabilities reported in HeLa and RAW 264.7 macrophage cells.', '', 'Conclusions: These data suggest that peptoids with novel dual functionalities may potentially be an interesting class of therapeutics and/or molecular delivery agents for anti-infective purposes.', 35227007),
('Antibacterial Peptide', 'Human neutrophil peptide-1 (HNP-1)', 'HNP-1 induces bacterial apoptosis and prevents its SOS repair pathway from binding to the RecA protein, which may be a new antibacterial mechanism. In addition, we showed that HNP-1 encapsulated in liposomes inhibits the growth of methicillin-resistant Staphylococcus aureus (MRSA) and meropenem-resistant Pseudomonas aeruginosa (MRPA).', '', 'These results indicated that recombinant protein expression may be a simple and cost-effective solution to produce HNP-1 and that RecA inhibition via HNP-1 may serve as an alternative strategy to counteract antibiotic resistance.', 35019682),
('Antibacterial Peptide', 'RPMs : FK20 (L-Phenylalanine-L-Lysine, 20-mer), FdK (L-Phenylalanine-D-Lysine, 20-mer), dFdK (D-Phenylalanine-D-Lysine, 20-mer), and LK20 (L-Leucine-L-Lysine, 20-mer)', 'RPMs rapidly and efficiently kill different strains of A. baumannii, inhibit biofilm formation, and disrupt mature biofilms. Importantly, RPMs attenuated bacterial burden in mouse models of acute pneumonia and soft tissue infection and significantly reduced mouse mortality during sepsis.', '', 'Collectively, our results demonstrate RPMs have the potential to be used as powerful therapeutics against antibiotic-resistant A. baumannii.', 35326876),
('Antibacterial Peptide', 'beta-hairpin structure with the template (XY)2RRRF(YX)2-NH2 (X: hydrophobic amino acids; Y: cationic amino acids)', 'Almost all of the new peptides have strong antibacterial activity and negligible hemolytic toxicity. Particularly, the therapeutic index (TI) values of F(RI)2R and F(KW)2K reached up to 115.9 and 70.7, respectively. In addition, they did not show induced drug resistance and inhibited the development of antibiotic resistance when combined and used with traditional antibiotics.', '', 'Moreover, the new peptides F(RI)2R and F(KW)2K showed excellent performance in the pulmonary bacterial infection model and low toxicity in mice. In conclusion, F(RI)2R and F(KW)2K are considered new antimicrobial alternatives to address the antimicrobial-resistance crisis.', 35311294),
('Antibacterial Peptide', 'Black Soldier Fly ( Hermetia Illucens) : Hill-Cec1 and Hill-Cec10', 'Hill-Cec1 and Hill-Cec10 also showed high activity against other bacterial species, including Klebsiella pneumoniae and multi-drug resistant P. aeruginosa. Both AMPs are bactericidal and have a rapid onset of action with membrane-permeabilizing effects.', 'Hill-Cec1 and Hill-Cec10 were also able to prevent P. aeruginosa biofilm formation, but no relevant effect was seen on biofilm eradication.', 'Overall, Hill-Cec1 and Hill-Cec10 are promising leads for new antimicrobial development to treat critical infections caused by Gram-negative pathogens such as P. aeruginosa.', 34985302),
('Antibacterial Peptide', 'Cathelicidin-Mimetic Antimicrobial Peptoids', 'These peptoids also show efficient and fast (<30 min) killing of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) at low micromolar concentrations without having apparent cytotoxic side effects in vivo. One cationic 12mer, Peptoid 1, shows great promise, as it could prevent formation of and detach biofilms at concentrations as low as 1.6 microM.', 'The use of a bioluminescent S. aureus murine incision wound model demonstrated clearance of infection in peptoid-treated mice within 8 days, conveying another advantage these peptoids have over conventional antibiotics.', 'These results provide clear evidence of the potential for antimicrobial peptoids for the treatment of S. aureus wound infections.', 35467395),
('Antibacterial Peptide', 'cell adhesion peptide (CAPs) nanocoatings', 'The two leading nanocoatings upregulated integrin-mediated hemidesmosomes, selectively increased keratinocyte proliferation compared to fibroblasts, which cannot form hemidesmosomes, and expression of junctional epithelium adhesive markers. CAP nanocoatings displayed marked durability under simulated clinical conditions and the top performer CAP nanocoating was validated in a percutaneous implant murine model. Basement membrane CAP nanocoatings, inspired by the tooth and junctional epithelium, may provide an alternative anti-infective strategy for percutaneous devices to mitigate the worldwide threat of antimicrobial resistance.', '', 'Application of cell adhesion peptide nanocoatings may provide an alternative to preventing, rather that necessarily treating, medical device infection across a range of device indications, like dental implants.', 34971784),
('Antibacterial Peptide', 'Peptides ASU2056, ASU2060', 'Overall, six peptides inhibited the M. abscessus smooth morphotype (IC50 = 1.7 microM for all peptides) and had reduced activity against the M. abscessus rough morphotype (IC50 range: 13-82 microM). Peptides ASU2056 and ASU2060 had minimum inhibitory concentration values of 32 and 8 microM, respectively, against the M. abscessus smooth morphotype. Additionally, ASU2060 (8 microM) was active against Escherichia coli, including multidrug-resistant E. coli clinical isolates, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus. ASU2056 and ASU2060 exhibited no significant hemolytic activity at biologically relevant concentrations, further supporting these peptides as promising therapeutic candidates. Moreover, ASU2060 retained antibacterial activity after preincubation in human serum for 24 h.', '', 'With antimicrobial resistance on the rise, methods such as those presented here will streamline the peptide discovery process for targeted antimicrobial peptides.', 35847280),
('Antibacterial Peptide', 'Purified arasin-likeSp', 'The ELP-intein self-cleavage system was used to produce antimicrobial peptide arasin-likeSp in Escherichia coli. The final yield of arasin-likeSp was about 3.56 mg/L. Purified arasin-likeSp exhibited significant antibacterial activities against the Gram-positive Bacillus subtilis and Gram-negative Vibrio harveyi bacteria.', '', 'Collectively, these data suggest that arasin-likeSp is a candidate AMP for effective inhibition of Vibrio harveyi, a significant bacterial pathogen infecting marine fish and invertebrates. The ELP-intein self-cleavage system described here is a low-cost, simple and potential method for producing antimicrobial peptides, which lays foundations for the large-scale production of antimicrobial peptides in the future.', 35240202),
('Antibacterial Peptide', 'hepcidin gene from the fish, Catla catla (Cc-Hep)', 'Sequence analysis revealed that Cc-Hep shared sequence similarity with hepcidin from Sorsogona tuberculata. Sequence analysis revealed that Cc-Hep shared sequence similarity with hepcidin from Sorsogona tuberculata.', '', 'Conclusion: Functional characterization predicted antibacterial, antioxidant, and anticancer potential of Cc-Hep, which can be explored in aquaculture or human health care.', 35344090),
('Antibacterial Peptide', 'd,l-K6L9 peptides', 'd,l-K6L9 peptides are stable and resistant to degradation by CF sputum proteases and maintain their activity in a CF sputum environment. Additionally, the d,l-K6L9 peptides do not induce bacterial resistance.', '', 'Overall, these findings should assist in the future development of alternative treatments against resistant bacterial biofilms.', 35759644),
('Antibacterial Peptide', 'Lycosin-II isolated from spiders Lycosa singoriensis', 'Lycosin-II showed strong antibacterial activity and biofilm inhibition effects against gram-positive and gram-negative bacteria including oxacillin-resistant Staphylococcus aureus (S. aureus) and meropenem-resistant Pseudomonas aeruginosa (P. aeruginosa) isolated from patients.', 'Lycosin-II was not cytotoxic against human foreskin fibroblast Hs27 or hemolytic against sheep red blood cells at the concentration of which exerted antibacterial activity.', 'Moreover, Lycosin-II showed anti-inflammatory effects by inhibiting the expression of pro-inflammatory cytokines that are increased during bacterial infection in Hs27 cells. These results suggest that Lycosin-II can serve as a therapeutic agent against infections with multidrug-resistant strains.', 34506798),
('Antibacterial Peptide', 'WLBU2 (also known as PLG0206)', 'Populations that survived WLBU2 treatment acquired a minimum of two mutations, making the acquisition of resistance more difficult than for most antibiotics, which can be tolerated by mutation of a single target. Major targets of resistance to WLBU2 included the orfN and pmrB genes, previously described to confer resistance to other cationic peptides. More surprisingly, mutations that increase aggregation such as the wsp pathway were also selected despite the ability of WLBU2 to kill cells growing in a biofilm.', '', 'Conclusions and implications: The results show how experimental evolution and WGS can identify genetic targets and actions of new antimicrobial compounds and predict pathways to resistance of new antibiotics in clinical practice.', 35712084),
('Antibacterial Peptide', 'insect metallopeptidase inhibitor (IMPI)', 'designed a cohort of 12 single and multiple point mutants, the best of which (I57F) inhibited aureolysin with an estimated inhibition constant (K i) of 346 nM.', '', 'Given that animals lack thermolysins, our strategy may facilitate the development of safe TPs against staphylococcal infections, including strains resistant to conventional antibiotics.', 35465156),
('Antibacterial Peptide', 'LcC CL28-25 (Larimichthys crocea), Derived from Piscine Chemokine', 'lcCCL28-25 was capable of rapidly destroying the integrity and permeability of the bacterial cell membrane', '', 'Additionally, the efficacy of lcCCL28-25 in in vivo antibacterial activity in a mammalian model revealed that this compound could be a promising agent for the development of peptide-based antibacterial therapeutics. The novel peptide lcCCL28-25 may prove to be an effective antibacterial agent.', 35616397),
('Antibacterial Peptide', 'anti-inhA peptide nucleic acids (PNAs)', 'The antibacterial efficacy of anti-inhA PNA is enhanced when it is combined with permeabilizing drugs, particularly ethambutol. This indicates that the addition of even small concentrations of anti-inhA PNA to the current TB regimen could potentiate their therapeutic efficiency. We hypothesize that this system would also overcome isoniazid resistance, since the resistance mutations lie outside the designed anti-inhA PNA target site.', '', 'We therefore propose that anti-inhA PNA could improve therapy even when applied in minute doses as an addition to the current anti-tuberculosis drug regimen.', 35171048),
('Antibacterial Peptide', 'pH-responsive antimicrobial peptides (F5: FLEHLIPHVIHGLVHAIHH-NH2)', 'efficient bacterial killing activity at pH 6.5 and inactivity at pH 7.4. Among the peptides, F5 exhibited outstanding pH-responsive antimicrobial activity and low toxicity. Fluorescence spectroscopy and electron microscopy illustrated that F5 killed bacteria via a membrane-disruptive mechanism at acidic pH values.', 'Mouse cutaneous abscesses revealed that F5 was equipped with excellent therapeutic ability to reduce the bacterial load and cytokines without causing skin toxicity.', 'In summary, this study reveals a strategy for selectively killing bacteria under the pathologic conditions of abscess sites while avoiding the elimination of commensal bacteria under normal physiological pH levels.', 35294199),
('Antibacterial Peptide', 'BF15-a1 (lysine-stapled CAMPs)', 'CAMPs with a better amphiphilic structure were inclined to exhibit improved antimicrobial activity, protease stability, and biocompatibility after lysine-stapling. One of the stapled analogues of BF15-a1 was found to have extended half-life in plasma, enhanced antimicrobial activity against clinically isolated MDR ESKAPE pathogens, and remained highly effective in combating MRSA infection in a mouse model.', '', 'Cationic antimicrobial peptides (CAMPs) are promising for treatment of multidrug-resistant (MDR) bacteria-caused infections.', 34968054),
('Antibacterial Peptide', 'ZN-5 and ZN-6 (Oreoch-2 analogues)', 'were identified to be broad-spectrum effective analogues, which were superior to their parent peptide Oreoch-2. good stability to the physiological environment, and much higher selectivity to bacterial cells than to mammalian cells. Were typical bactericidal agents and quickly eliminated bacteria in a bactericidal mode by disrupting bacterial cell membrane. Moreover, ZN-5 and ZN-6 could inhibit biofilm formation of Staphylococcus aureus ATCC25923.', 'Compared with their parent peptide Oreoch-2, ZN-5 and ZN-6 not only possessed shortened peptide chains, but also showed slightly improved antibacterial activity and greatly reduced hemolysis.', 'This indicates that they are ideal lead compounds of antimicrobial peptides, which can be developed as substitutes for traditional antibiotics.', 34971943),
('Antibacterial Peptide', 'human ApoB-derived antimicrobial peptide r(P)ApoBLAla in combination with low concentrations of conventional antibiotics', 'to treat ureteral catheter-colonizing bacterial communities on clinically isolated bacteria', '', 'The results suggest that combinations of conventional antibiotics and human antimicrobial peptides might synergistically counteract biofilm growth on ureteral catheters, suggesting novel avenues for preventing catheter-associated infections in patients who have undergone radical cystectomy and ureterocutaneostomy.', 35743833),
('Antibacterial Peptide', 'P-MtrE1', 'Cotreatment of bacteria with subinhibitory concentrations of the peptide led to 2- to 64-fold increases in susceptibility to erythromycin, azithromycin, ciprofloxacin, and/or ceftriaxone in N. gonorrhoeae strains FA1090, WHO K, WHO P, and WHO X. The cotreatment experiments with peptides P-MtrC1 and P-MtrE1 resulted in increased susceptibilities of WHO P and WHO X to azithromycin, ciprofloxacin, and ceftriaxone that were of the same magnitude seen in MtrCDE mutants.', '', 'Data presented here demonstrate that these peptides may be developed for use as a dual treatment with existing antibiotics to treat multidrug-resistant gonococcal infections.', 34633841),
('Antibacterial Peptide', 'caposomes', 'capsosomes selectively deliver their cargo in the presence of bacteria, producing a bactericidal effect to protect the host organism', '', 'Thus, the capsosomes serve as a versatile multidrug, subcompartmentalized microparticle system for preventing antibiotic-resistant bacterial infections, with potential applications to protect wounds or medical device implants from infections.', 35481905),
('Antibacterial Peptide', 'DCD-1L', 'The bacterial adhesion and biofilm formation in all A. baumannii isolates were inhibited at 2 ', '', 'Results of this study demonstrated that DCD-1L can inhibit bacterial attachment and biofilm formation and prevent the onset of infection. Taking these properties together, DCD-1L appears as a promising candidate for antimicrobial and anti-biofilm drug development.', 35026999),
('Antibacterial Peptide', 'RWWWR (central motif) plus arginine (R) end-tagging', 'great potential in combating Escherichia coli bacteremia and the Staphylococcus aureus skin burn infection model, which induces a 62-90% reduction in bacterial burden, Pep 6 exhibited robust biofilm-inhibiting activity and eliminated 61.33% of the mature methicillin-resistant Staphylococcus aureus (MRSA) biofilm', '', 'These results suggest that the RWWWR motif and binding of arginine end-tagging could be harnessed as a new agent for combating multidrug-resistant bacteria.', 34964342),
('Antibacterial Peptide', 'R23F, R23DI, and R23EI hybrid peptides', 'against Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Pseudomonas aeruginosa, Escherichia coli, and Bacillus cereus', '', 'R23F, R23DI, and R23EI can be used as antimicrobial peptides against Gram-positive and Gram-negative bacteria resistant to traditional antibiotics.', 35008951),
('Antibacterial Peptide', 'Temporin-1CEc analogs 2K2L and 2K4L', 'against sensitive and multidrug-resistant bacteria, effectively killing the tested multidrug resistant strain Staphylococcus epidermidis (MRSE1208), inhibited the formation of MRSE1208 biofilms at concentrations below its MIC value', '', 'Collectively, these results suggest that 2K2L and 2K4L could be effective antibiotics against multidrug-resistant bacterial strains.', 34953322),
('Antibacterial Peptide', 'PEP-38 and PEP-137 peptides', 'active in vitro against carbapenem-resistant isolates of Klebsiella aerogenes and K. pneumoniae. PEP-137 was also active against Pseudomonas aeruginosa.', '', 'The data obtained can be used to develop new antibacterial peptide drugs to combat antibiotic resistance.', 35326874),
('Antibacterial Peptide', 'VicBac (Proline-Rich Cathelicidin from the Alpaca Vicugna pacos)', 'Potency to Combat Antibiotic-Resistant Bacteria', '', 'The pronounced antibacterial activity of VicBac, along with its moderate adverse effects on mammalian cells, make this molecule a promising scaffold for the development of peptide antibiotics.', 35629841),
('Antibacterial Peptide', 'NZX and P2, fungal defensin-derived peptides', 'MIC values (NZX: 0.11 MicroM, P2: 0.91 MicroM) and MPC (NZX: 1.82 MicroM) against Streptococcus agalactiae', '', 'Conclusion: NZX and P2 are promising antimicrobial agents for streptococcicosis treatment.', 35630326),
('Antibacterial Peptide', 'WAM-1', 'MICs of 2-4 mg/L and MBCs of 4-8 mg/L against carbapenem-resistant Klebsiella pneumoniae', '', 'Conclusions: WAM-1 has good antibacterial effect and potential anti-inflammatory effect on infection caused by CRKP.', 35474013),
('Antibacterial Peptide', 'RP557 alone or in combination with several clinically effective antibiotics, including clarithromycin, amikacin, cefoxitin and imipenem', 'increases the antibiotic sensitivity of Mycobacterium abscessus by inhibiting biofilm formation', '', 'As such, RP557 is a potential candidate to include in novel strategies to treat M. abscessus infections.', 34813807),
('Antibacterial Peptide', 'hyaluronic-acid-based hydrogel', 'The peptidomimetic was found to exhibit antimicrobial and anti-biofilm properties at concentration values ranging from 2.5 to 20 micromol L-1, to be biocompatible toward human skin cell lines, and to protect human keratinocytes from bacterial infections being able to induce a reduction of bacterial units by two or even four orders of magnitude with respect to untreated samples.', '', 'The developed hydrogel-based system represents a promising, effective therapeutic option by combining the mechanical properties of the hyaluronic acid polymer with the anti-infective activity of the antimicrobial peptidomimetic, thus opening novel perspectives in the treatment of skin infections.', 35740323),
('Antibacterial Peptide', 'CHRG01, KSR, and KLR', 'active against gram positive as well as gram negative bacteria and kill bacteria by forming membrane pores', '', 'Understanding the molecular level interaction of individual amino acids with the lipid bilayer will greatly help in the design of more efficient antimicrobial peptides.', 34838874),
('Antibacterial Peptide', 'guanidinium-functionalized poly(l-lysine) (PLL22 -Gua)', 'kills MRSA with low resistance frequency (<3.3 ', '', 'These promising results show the excellent potential of PLL22 -Gua as an antimicrobial agent against multidrug-resistant infection in vivo.', 34846807),
('Antibacterial Peptide', 'peptidomimetic antibiotic 10 (human alpha-defensin 5)', 'potent killing of multiple drug-resistant gram-negative bacteria isolated from patients', '', 'By engaging multiple bacterial targets, the lead compound is efficacious in vitro and in vivo against bacteria with highly inducible antibiotic resistance, promising a useful therapeutic agent for the treatment of infections caused by antibiotic-resistant bacteria.', 35238683),
('Antibacterial Peptide', 'Anisaxins', 'potent bactericidal agents in vitro, selectively active against Gram-negative bacteria, including multi-drug resistant strains, at sub-micromolar concentrations', '', 'This membranolytic antibacterial activity does not translate to cytotoxicity towards human peripheral blood mononuclear cells (HPBMCs), which was minimal at well above bactericidal concentrations, making anisaxins promising candidates for further drug development.', 35470073),
('Antibacterial Peptide', 'Epinecidin-1 and Beta-Defesin-3', 'showed antibacterial activity in vitro in a concentration of 2 to 32 mg/L', '', 'For K. pneumoniae-sepsis, hBD-3 was shown to be a promising option in overcoming the resistance of Klebsiella spp. to carbapenems, though more research is needed. In the P. aeruginosa-sepsis model, the addition of Epi-1 to hBD-3 was found to have a slightly reduced mortality rate compared to hBD-3 monotherapy.', 35052952),
('Antibacterial Peptide', 'Alpha-MSH (melanocyte stimulating hormone) based cationic peptides', 'most cationic analogue, KKK-MSH with a + 5 charge, demonstrated successful eradication of 105 CFU/mL of E. coli cells within 15 min at a concentration as low as 1 MicroM', '', 'Here, we propose alpha-MSH based cationic peptides as promising future agents with broad-spectrum antibacterial efficacy against both Gram-negative and Gram-positive pathogens.', 35132082),
('Antibacterial Peptide', 'Nigrocin-PN (Pelophylax nigromaculatus)', 'Nigrocin-PN and ampicillin could delay Staphylococcus aureus antibiotic resistance acquisition', '', 'Conclusions: A broad-spectrum antimicrobial peptide Nigrocin-PN was discovered from the skin secretion of Pelophylax nigromaculatus. Structurally, "Rana box" played a crucial role in reducing toxicities without compromising antibacterial abilities, and Nigrocin-PN could be a desired therapeutic candidate.', 35606468),
('Antibacterial Peptide', 'GHaR6R, GHaR7R, GHaR8R and GHaR9W', 'show potent antimicrobial activities against methicillin-resistant (MRSA)', 'GHaR6R, GHaR8R and GHaR9W show less toxicity toward normal cells HL-7702 and hFOB1.19.', 'These results suggest that the GHa-derived peptides may be promising antimicrobial candidates against MRSA infections.', 35538042),
('Antibacterial Peptide', 'combination of hydrocarbon stapled to L8 (KRIVQRIKKWLR) and L6 (RRLFRRILRWL) peptides and antibiotics (Vancomycin)', 'different hydrocarbon staples to two previously described peptides shown to act on the outer membrane, L6 and L8, and tested their activity in a zebrafish embryo infection model using a clinical isolate of Acinetobacter baumannii as a pathogen improves its in vivo potentiating activity on antibiotic treatment, without increasing its in vivo antimicrobial activity, toxicity or hemolytic activity', '', 'We show here that combinations of stapled peptide L8S1 and vancomycin may provide an attractive novel therapeutic strategy against nosocomial A. baumannii infection.', 35203875),
('Antibacterial Peptide', 'lichenicidin', 'presence of the two mature peptides, Blialpha and Blibeta, is necessary for full activity against target bacteria, both peptides exhibit synergistic activity in their interaction with the target membranes', '', 'Based on this information, we propose a mechanism of action of lichenicidin.', 34973602),
('Antibacterial Peptide', '"Picturins" (PTR) and "Pictuseptins" (PTS)', 'PTR displayed moderate activity against Escherichia coli (MIC 24.80 to 48.95 MicroM), while PTS showed a broad antimicrobial and antifungal effect. PTS-1 was the most active peptide against E. coli (6.8 microM) followed by PTS-3 (11.7 MicroM) and PTS-2 (14.24 MicroM).', '', 'Overall, new unique non-hemolytic and cationic peptide sequences were characterized that could be valuable for the next-generation of anti-infective drugs. Future functional studies should explore the pharmacological potential of Boanins to include them as antimicrobial scaffolds.', 35640793),
('Antibacterial Peptide', 'Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin', 'against Cystic Fibrosis Pseudomonas aeruginosa', '', 'Our findings demonstrate that glatiramer acetate is a strong candidate for repurposing as an antibiotic resistance breaker of pathogenic P. aeruginosa.', 35727066),
('Antibacterial Peptide', 'h-Lf1-11, MSI-78, LL-37 and magainin-2', 'against Escherichia coli, methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, carbapenem-resistant Klebsiella pneumoniae, and Acinetobacter baumannii. The MSI-78 showed potent bactericidal activity with MIC range of 1.25-40 mg/L against all bacterial strains. The h-Lf1-11, magainin-2, and LL-37 exhibited moderate activity (MIC range of 40-160, 80-160, and 40-160 mg/L, respectively)', '', 'These results revealed that MSI-78, h-Lf1-11, magainin-2, and LL-37 have great potential as antibacterial agents and their activity deserves to be more explored in further studies for the treatment of antibiotic-resistant bacteria.', 34735710),
('Antibacterial Peptide', 'temporin B and temporin L with the addition of buforin II, a histone H2A fragment', 'less potent temporin B enhances the cooperativity of the in vitro antibacterial activity of the more potent temporin L against EMRSA-15 and that this may be associated with an altered interaction with the bacterial plasma membrane, a feature critical for the antibacterial activity of most AMPs. Addition of buforin II, a histone H2A fragment, can further increase the cooperativity.', '', 'Exploration of the mechanism of synergy between AMPs isolated from the same organism may therefore yield antibiotic combinations with advantageous pharmacodynamic properties.', 35609188),
('Antibacterial Peptide', 'amyloid-beta inspired biocompatible short peptide amphiphile (sPA) molecule-AgNPs', 'potential therapeutic value for the treatment of microbiota triggered progression of neurodegenerative diseases', '', 'Such sPA-AgNPs hybrid structures can be further used to develop antibacterial materials to combat emerging bacterial resistance.', 35684988),
('Antibacterial Peptide', 'brevinin-2KP', 'weakly active towards the tested Gram-positive and Gram-negative bacteria as well as fungi due to its membranolytic action', 'brevinin-2KP inhibits the proliferation of several mammal cells with IC50 values ranging from 3.27 to 59.75 microM', 'Conclusion: This is the first report on AMP identified from the skin of K. pulchra. Brevinin-2KP adopts a typical amphipathic alpha-helix conformation in membrane mimic environment and shows antimicrobial and antitumor activities by potential membranolytic mechanism. In addition, brevinin-2KP can promote degranulation and histamine release of mast cells. Brevinin-2KP is expected to become a good drug temple molecule.', 35249479),
('Antibacterial Peptide', 'L-Chg10-Teixobactin', 'The MIC and MBC values of L-Chg10-teixobactin against both strains of Enterococcus faecalis were 0.8 Microg/mL.', '', 'Conclusions:L-Chg10-teixobactin demonstrated potent antibacterial and antibiofilm effects against E. faecalis, suggesting its potential role an effective antibacterial and antibiofilm agent in endodontic treatment.', 35744616),
('Antibacterial Peptide', 'r(P)ApoBLPro, r(P)ApoBSPro, and r(P)ApoBLAla derived from the human apolipoprotein B (residues 887-922)', 'exhibited potent antimicrobial activity against drug-resistant Klebsiella pneumoniae, Acinetobacter baumannii, and Staphylococci both in vitro and in an animal model', '', 'Our results provide a link between human plasma and innate immunity and point to the blood as a source of much-needed antimicrobials.', 35112568),
('Antibacterial Peptide', 'Star-Peptide Polymers', 'preferentially target and kill Gram-positive pathogens including MRSA', '', 'These results highlight the potential utility of peptide/polymers to fabricate materials for therapeutic development against MDR Gram-positive bacterial infections.', 35500245),
('Antibacterial Peptide', 'Human Cryptic Host Defence Peptide GVF27', 'Exhibits Anti-Infective Properties against Biofilm Forming Members of the Burkholderia multivorans and Burkholderia cenocepacia', '', 'Overall, all these findings contribute to the elucidation of the main features that a good therapeutic agent directed against these extremely leathery biofilm-forming bacteria should possess.', 35215373),
('Antibacterial Peptide', 'Liposome-Encapsulated Tobramycin and IDR-1018 Peptide', 'Biofilm Disruption and Enhanced Antimicrobial Activity against Pseudomonas aeruginosa, the biofilm formation was significantly reduced (p &lt; 0.05) at concentrations of ?4 Microg/mL and ?32 Microg/mL for PA01 and ?32 Microg/mL for MDR 7067 when loading tobramycin into liposomes, with or without the anti-biofilm peptide compared to the free antibiotic, empty liposomes, and IDR-1018-loaded liposomes', '', 'Tobramycin-loaded liposomes could be a potential candidate for treating lung-infected animal models owing to the high therapeutic efficacy and safety profile of this system compared to the free administration of the antibiotic.', 35631547),
('Antibacterial Peptide', 'cholic acid analogues 17c and 17d', 'analogues containing lysine-like residues showed the highest antibacterial potency against Gram-positive S. aureus. All di-substituted analogues possess high antimicrobial activity against both Gram-positive S. aureus as well as Gram-negative E. coli and P. aeruginosa.', '', 'These compounds were able to depolarise the bacterial membrane, suggesting that they are potential antimicrobial pore forming agents.', 35563014),
('Antibacterial Peptide', 'Mucosal pentraxin 2 (Mptx2)', 'against peritoneal infection by methicillin-resistant staphylococcus aureus', '', 'Mptx2 has bactericidal activity against MRSA both in vitro and in vivo, which may shed light on the discovery and development of novel strategies for MRSA-infected peritonitis.', 35609377),
('Antibacterial Peptide', 'symbah-1', 'macrocyclic beta-hairpin peptide antibiotic', '', 'The method of discovery and subsequent characterization of symbah-1 suggests large synthetic peptide libraries bias toward macrocyclic beta-hairpin structure could be designed and screened to rapidly expand and better understand this rare peptide antibiotic class.', 35005555),
('Antibacterial Peptide', 'isolate (WUL10) in the Brevibacillus genus', 'MIC of the purified substance was 1 microg/mL against S. aureus TISTR 517 and MRSA strains. This substance showed the bactericidal effect at the concentration of 1-2 Microg/mL against these bacterial indicators.', '', 'This novel AMP would provide an advantage for further development of anti-MRSA substances to manage the situation of antibiotic resistance.', 35736972),
('Antibacterial Peptide', '(SAAP)-148 and Halicin', 'equally effective against antimicrobial-resistant (AMR) Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus bacteria residing in immature and mature biofilms', '', 'Together, combinations of these two novel antimicrobial agents hold promise as an innovative treatment for infections not effectively treatable with current antibiotics.', 35625317),
('Antibacterial Peptide', 'Chicken cathelicidins CATH-1(RVKRVWPLVIRTVIAGYNLYAIKKK,), CATH-3(RVKRFWPLVPVAINTVAAGINLYKAIRRK, ) and porcine; PMAP-36(GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG) in combination with conventional antibiotics containing ampicillin tetracycline, gentamicin, and erythromycin', 'FBCIs of only CATH-1 + tetracycline were higher than 0.5 against S. aureus, FBCIs of other combinations (CATH-1,?3 and PMAP-36 with ampicillin, tetracycline, gentamicin, and erythromycin) were lower 0.5. FBCIs of CATH-1,?3 and PMAP-36 combination with erythromycin were lower 0.5 against S. enteritidis and E. coli . FBCIs of other combinations (CATH-1,?3 and PMAP-36 with ampicillin, tetracycline, and gentamicin) were higher than 0.5 or even higher than 1.0 against S. enteritidis and E. coli.', 'mice erythrocytes and macrophages and PK-15 cells were used to determine hemolytic activity and cytotoxicity, respectively. The results showed that CATH-1,?3 and PMAP-36 alone at MBC showed low hemolysis (<20%), and erythromycin alone at MBC showed high hemolysis (>95%). However, AMPs (CATH-1,?3 and PMAP-36) combined with erythromycin at sub-MBC showed lower hemolytic activity (<3%)', 'Hence result show that the combination of CATH-1 and erythromycin has synergistic antibacterial activity and reduces the emergence of bacterial drug resistance.', 35910608),
('Antibacterial Peptide', 'TAT-RasGAP317-326 peptide with antibiotics', 'synergistic combinations towards all three bacteria and demonstrated that these combinations had an increased bactericidal effect compared to individual drugs.', '', 'combination of TAT-RasGAP317-326 and meropenem had a promising antibiofilm effect towards A. baumannii.', 36270448),
('Antibacterial Peptide', 'The antimicrobial peptide GL13K was derived from the salivary protein BPIFA2.', 'Klebsiella pneumoniae (MICs 16-32 microgram/ml) and Acinetobacter baumannii (MICs 8-32 microgram/ml).', '', 'DGL13K displayed in vitro activity against extended-spectrum beta-lactamase (ESBL)-producing and Klebsiella pneumoniae carbapenemase, P. aeruginosa and Acinetobacter baumannii carrying metallo-beta-lactamases. P. aeruginosa showed low inherent resistance to DGL13K', 36006947),
('Antibacterial Peptide', 'Antimicrobial Peptides SAAP-148 and OP-145', 'The concentration of the peptides necessary to kill 99.9% of E. coli and E. hirae cells within 5 min of incubation period was found to be 1.6 microM and 0.4 microM for SAAP-148 and 6.4 microM versus 3.2 microM for OP-145 when tested in NaPi buffer for 1 ', 'The 99.9% lethal concentration (LC99.9%) implies antimicrobial activity and constitutes the lowest peptide concentration that killed ?99.9% of bacteria', 'these peptides immediately bind to negatively charged components and neutralize the surface of Gram-negative bacteria. Then, they insert into the fatty acyl chain region of the outer membrane, inducing higher outer membrane permeability. The increased membrane permeability for small ions will be sufficient to result in cell death.', 36139091),
('Antibacterial Peptide', 'Novel antimicrobial peptide Intestinalin (P30), which is derived from the LysC enzyme of Clostridium intestinale strain URNW', 'Intestinalin showed MIC values ranging from 7.8 to >124 microM. The highest MICs (> 124 microM) were observed for S. aureus KPD 740, S. aureus KPD 425, E. cloacae KPD 297, E. coli KPD 217, and K. pneumoniae KPD 298. The lowest MICs (7.8 microM) were against three of four A. baumannii strains tested, as well as for S. hominis KPD 910 and S. pettenkoferi KPD 741.', 'The results showed that Intestinalin was not toxic to HaCaT cells at concentrations up to 100 microM', 'Experimental data showed that Intestinalin interacts with negatively charged lipoteichoic acid (logK based on isothermal titration calorimetry, 7.45 ', 36094301),
('Antibacterial Peptide', 'AMP human beta-defensin-2 (HBD-2)', 'the data showed an almost total reduction in the invasive ability of EIEC in transfected cells (> 99%). Enteroinvasive E. coli (EIEC) that is responsible for the bacillary dysentery that causes severe diarrheal symptoms in both children and adults.', '', 'The results showed that HBD-2 is able to significantly reduce the expression of the proinflammatory cytokines by intestinal epithelial cells, the invasiveness ability of enteroinvasive E. coli (EIEC) and the expression of invasion-associated genes.', 36310877),
('Antibacterial Peptide', 'Phage Lysin-Derived Peptide P87', 'The MIC values for P88 (20', 'One of the drawbacks usually adduced for the therapeutic application of AMPs is their possible cytotoxic effect against eukaryotic cells.', 'A peptide, P87 from phage lysin Pae87 has been tested as a source for efficient, alternative antimicrobials. To improve its antimicrobial efficacy, a derivative peptide, termed P88, with increased hydrophobic moment and net charge has been designed and proven to possess an enhanced bactericidal and antibiofilm activity.', 36290106),
('Antibacterial Peptide', 'new lipopeptide-like pentamer, decanoyl-bis.diaminobutyrate-aminododecanoyl-diaminobutyrate-amide (C10BBc12B)', 'minimal inhibitory concentrations (MIC ? 50 microM) against E.coli, P. aeroginosa, K. pneumoniae, A. baumanni', 'no cytotoxicity towards cell-lines was observed at-least up to 50 microM.', 'action mechanism implicating the pentamer''s de-facto capacity to hijack bacterial efflux pumps for boosting its adjuvant activity through repetitive steps including outer-membrane adhesion, translocation and subsequent expulsion.', 36271103),
('Antibacterial Peptide', 'two peptides LP-23 and SA4, as well as their mimetic peptoids DP-23 and SPO were selected. Synergistic effects of short peptides and antibiotics', 'Based on the fraction inhibitory concentration: FICI ? 0.5 synergistic value , LP-23, DP-23, and SPO demonstrated synergy in combination with gentamicin against a gentamicin-resistant clinical isolate of Escherichia coli. For Staphylococcus aureus, Escherichia coli, and Salmonella typhimurium, seven combinations exhibited synergistic effects between peptide/peptoids and the tested antibiotics.', 'These peptides were also evaluated for its cytotoxicity against human embryonic normal kidney cells (HEK 293) and pancreatic cancer cells (MIA PaCa-2) using MTT assay. The average cell survival rate for all peptides in HEK cells was 90% at 100 microg ml?1 and 68% at 500 microg ml?1. In MIA PaCa-2, about 15% cells was compromised at high concentration of 500 microg ml?1', 'Synergy obtained between LP-23, SA4 and their mimetic peptoids DP-23 and SPO with antibiotics have the potential to be used as a combination therapy against microbial infections. These combinations may be helpful in lowering the drug dose and creating better results, which can be applied in future against various MDR strains.', 35931657),
('Antibacterial Peptide', 'pentapeptide-4" (PP4, with amino acid sequence KTTKS)', 'peptide effective against Gram-positive (S. aureus, Enterococcus faecalis) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa) bacteria.', '', 'These constructs have potent wide-spectrum antimicrobial action, including against multidrug-resistant Gram-positive and Gram-negative bacteria, and fungi.', 35950860),
('Antibacterial Peptide', 'Novel Alligator Cathelicidin As-CATH8', 'MIC of As-CATH8 for S. aureus (0.5 microM) and A. baumannii (0.25 microM) respectively. As-CATH8 demonstrated strong antibacterial effects in a murine abscess model of high-density bacterial infections against clinical isolates of S. aureus and Acinetobacter baumannii,', 'As-CATH8 were moderately cytotoxic against human bronchial epithelial (HBE) cells and peripheral blood mononuclear cells', 'Result declare that As-CATH8 peptide, which has substantial therapeutic promise for treatment of S. aureus and A. baumannii skin infections, two of the most prevalent bacterial species causing SSTIs worldwide.', 36421248),
('Antibacterial Peptide', 'designed the (WRX)n hydrophobic tryptophan (W) residues and hydrophilic charged arginine (R) (where X = hydrophilic uncharged amino residues; n = number of repeat units) series engineered peptides with high cell selectivity by introducing hydrophilic uncharged threonine (T), serine (S), glutamine (Q) or asparagine (N) residues into the minimalist design of W- and R-rich AMPs.', 'T6 exhibited potent antibacterial and antiinflammatory capabilities in vivo in a mouse peritonitis-sepsis model infected with Escherichia coli.', '', 'The results showed that the introduction of these hydrophilic uncharged amino residues, especially T residues, significantly improved the cell selectivity of the W- and R-rich engineered peptides. It has potent antibacterial activity, good biocompatibility, high selectivity index, strong tolerance, rapid and efficient time-kill kinetics, and no tendency of resistance. Studies on antibacterial mechanism show that T6 exert antibacterial activity mainly by disrupting bacterial cell membrane and inducing the accumulation of reactive oxygen species in bacterial cells.', 36115654);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Peptide', 'two designed, cationic antimicrobial-derived peptides: Mt6, and its dextroisomer D-Mt6, belonging to the analogs of MAF-1, which is isolated from the instar larvae of houseflies.', 'Mt6 and D-Mt6 showed different degrees of inhibitory activity against Gram-positive bacteria (S. aureus and B. subtilis) and Gram-negative bacteria (E. coli, K. pneumoniae, P. aeruginosa, A. baumannii).', '', 'Both Mt6 and D-Mt6 showed broad-spectrum antimicrobial activity, especially against A. baumannii, by damaging membrane integrity. Moreover, D-Mt6 showed better immunoregulatory activity against LPS induced inflammation through its LPS-neutralizing and suppression on MAPK signaling. This study suggested that D-Mt6 is a promising candidate drug as a derived peptide against A. baumannii.', 36190276),
('Antibacterial Peptide', 'rhamnolipid and linezolid', 'Four S.aureus (One ATCC 29213 strain and three methicillin-resistant strains) were used in the study. The minimum inhibitory concentration of the resistant strain decreased from 16 to 4 microg/mL with a four-fold decrease.', '', 'The G.mellonella larval model demonstrated that combined therapy was more effective than monotherapy by survival function tests and CFU determination. RML/LNZ combination improved survival compared to monotherapy and decreased the bacterial burden.', 36526037),
('Antibacterial Peptide', 'antimicrobial peptides (AMPs)', 'Anti-microbial Peptides against Methicillin-resistant Staphylococcus aureus', '', 'Anti-microbial peptides could be the next-generation solution to combat drug resistance among Superbugs. New approaches like antimicrobial peptides (AMPs) play a vital role and are more efficacious, economical, time, and energy saviours.', 36529917),
('Antibacterial Peptide', 'Innate defense regulator (IDR) peptides', 'he minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of KSL Peptide for C. albicans was determined at the level of 0.78 microg/mL. he MIC of KSL for Staphylococcus aureus and Pseudomonas aeruginosa was 0.78 microg/mL and 1.56 microg/mL, respectively. Bac2A peptide derivative show MICs between 2 and 32 microg/mL for Gram-negative bacteria, and between 0.25 and 16 microg/mL for Gram-positive bacteria. other peptide drive fro naturally occurring molecules as cNK-2, Clavanin-MO, Ac-ApoE, KSLW, SET-M33, GW-A2, AWRK6', '', 'Many studies have shown that the activity of AMPs is mostly associated with bacterial membrane destabilization. However, their activity expressed as MIC is often much lower than that of conventional antibiotics', 36009931),
('Antibacterial Peptide', 'novel strategy that combines the human antimicrobial peptide (AMP) LL37 with different antibiotics( vancomycin, azithromycin, polymyxin B, and colistin)', 'For PA103, the MIC of polymyxin B, colistin, and gentamicin decreased twofold to fourfold, but the MIC of vancomycin and azithromycin was still >512 microg/ml, which was the highest concentration tested. The antibacterial inhibitive effects of Ca2+ and Mg2+ ions were also observed for colistin; our preliminary data showed that the MIC of colistin is 0.5 microg/ml when PAO1 was cultured in the MHB medium, but it increased to 1 microg/ml in a cation-adjusted MHB medium.', '', 'Zeta potentials for P. aeruginosa strains PAO1 and PA103 were -40.9 and -10.9 mV, respectively. With the addition of LL37, negative zeta potentials were gradually neutralized. this process of neutralization is believed to have contributed to the increase in outer membrane permeability help to uptake of antibiotics. LL37-vancomycin combination showed a synergistic inhibitory effect to PAO1, as well as a synergistic bactericidal effect to both PAO1 and PA103. Vancomycin can target lipid II, which is embedded in the inner membrane and is also an important molecule needed for the synthesis of the bacterial cell wall', 35922283),
('Antibacterial Peptide', 'Antimicrobial peptide named P4 with sequence RTKLWEMLVELGNMDKAVKLWRKLKR that was constructed from influenza virus protein M1 and containing two cholesterol-recognizing amino-acid consensus (CRAC) motifs.', 'peptide P4 inhibits the growth of E. coli and B. subtilis strains at concentrations that are significantly lower than the cytotoxic concentration that was found for macrophages. The half-maximal inhibitory concentration (IC50) for B. subtilis and E. coli cells were 0.07 ', '', 'the toxic action of peptide P4 is based on membrane permeabilization through the interaction of the peptide cationic domain and anionic lipids of the bacterial membrane. They report antimicrobial activity of the peptide P4 against the representatives of Gram-positive (B. subtilis) and Gram-negative (E. coli) bacteria.', 36013956),
('Antibacterial Peptide', 'Synthetic antimicrobial peptide', 'This 6 peptides (ASU2001, ASU2009, ASU2019, ASU2056, ASU2059, and ASU2060) inhibited the M. abscessus smooth morphotype (IC50 = 1.7 microM for all peptides) and had reduced activity against the M. abscessus rough morphotype (IC50 range: 13-82 microM). Peptides ASU2056 and ASU2060 had minimum inhibitory concentration values of 32 and 8 microM, respectively, against the M. abscessus smooth morphotype. Additionally, ASU2060 (8 microM) was active against Escherichia coli, including multidrug-resistant E. coli clinical isolates, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus.', 'The two most potent peptides, ASU2056 and ASU2060, were tested for red blood cell toxicity and neither exhibited significant hRBC hemolytic activity even after prolonged incubation (18 h). ASU2060 was tested for serum stability and retained antibacterial activity after preincubation in human serum for 24 h.', 'The peptides (ASU2001, ASU2009, ASU2019, ASU2056, ASU2059, and ASU2060) were further screened against both Mabs smooth and rough morphotypes to determine the impact of cell wall glycopeptidolipids (GPLs) on activity. All six peptides displayed increased activity against the Mabs smooth morphotype, suggesting that interactions with cell wall GPLs are important for antibacterial activity. Additionally, all peptides exhibited increased inhibition in the presence of EDTA, further suggesting that sequestering divalent metal cations enhances peptide interactions with Mabs.', 35847280),
('Antibacterial Peptide', 'Temporins modeified version of brevinin-1GHa (BR-1GHa) from frog skin peptide', 'BR-1GHa-3, in which two alanine residues in the truncated version of BR-1GHa were replaced with leucine, exhibited significantly improved antimicrobial activity against Gram-positive bacterial strains (e.g., S. aureus ATCC 29213 and E. casseliflavus ATCC 700327) with lower hemolytic activity compared to the BR-1GHa peptide. BR-1GHa-4 analogue, in which Gly3 was replaced with Pro, did not show any hemolytic activity except for highest (128 microM) concentration tested and have a strong antimicrobial effect on Gram-positive bacteria (e.g., E. faecalis ATCC 51299 and B. cereus ATCC 13061).', '', 'To enhance the antimicrobial activity of this peptide and to reduce its hemolytic activity, they designed five new temporin like analogues and examined their bioactivities. Temporins are another class of frog skin peptides without hemolytic activity and shorter than brevinins. This show antimicrobial activity', 35852614),
('Antibacterial Peptide', 'designed PLP-3, a novel synthetic (protegrin-1 ) PG-1-like peptide', 'Antimicrobial activity screening showed MIC90 values of 2 mg/L for A. baumannii, 16 mg/L for K. pneumoniae and 8 mg/L for P. aeruginosa. The haemolysis IC50 value was 48.53 mg/L', 'Cytotoxicity against human HeLa and A549 cells showed values of ca. 200 mg/L in both cell lines resulting in a 100-fold selectivity window for bacterial over human cells.', 'PLP-3 has potent antimicrobial activity, especially against A. baumannii, while maintaining low haemolysis and toxicity against human cell lines at antimicrobial concentrations. These characteristics make PLP-3 a promising peptide with an interesting therapeutic window.', 35972429),
('Antibacterial Peptide', 'plantaricin A an antimicrobial peptide derived from Lactobacillus plantarum, had a synergistic effect with ciprofloxacin (CIP)', 'lantaricin A (PlnA), reducing the IC90 of CIP by eight times and kill Multidrug-resistant Staphylococcus aureus', 'which has low cytotoxicity and haemolysis and powerful inhibitory activity on efflux pumps.', 'The present study showed a new efflux pump inhibitors EPI (plantaricin A) produced by Lactobacillus plantarum, changes in membrane permeability, membrane potential, and reactive oxygen species (ROS) were determined. Therefore, it helps the design of new EPIs and controls the infection of multidrug-resistant Staphylococcus aureus', 36254863),
('Antibacterial Peptide', 'Lugdunin (cyclic peptide-1), a nonribosomal cyclic peptide', 'cyclic peptide-1 and its analogues cyclic peptide-11 and cyclic peptide-14 have the ability to disperse mature Methicillin-resistant Staphylococcus aureus (MRSA) biofilms and show anti-clinical MRSA activity, including MRSA persister cells', 'these three cyclic peptide compounds have non-toxicity, lower hemolytic activity and lack of resistance development.', 'Our results indicate that cyclic peptide-1, cyclic peptide-11, and cyclic peptide-14 have great potential as new antimicrobial drug candidates for the treatment of clinical Methicillin-resistant Staphylococcus aureus (MRSA) infections.', 35887376),
('Antibacterial Peptide', 'a series of Temporin-PE (T-PE) analogues were designed and synthesized by glutamic acid', '', 'E11K4K10 exhibited slight toxicity to the spleen with slight edema observed in the spleen, but its toxicity was less severe than that of polymyxin B.', 'E11K4K10, the optimized T-PE and the relatively safe AMP, could overcome drug resistance which was expected to be a new antimicrobial agent against clinical resistant bacteria.', 36148510),
('Antibacterial Peptide', 'Nv-CATH peptide from the skin of the frog Nanorana ventripunctata', 'S. haemolyticus 13A13770 displayed the highest sensitivity to Nv-CATH (MIC = 3.125 microg/mL), followed by S. aureus ATCC25923 and A. junii 13A15578 (MIC = 12.5 microg/mL).', '100 microg/mL Nv-CATH did not exhibit cytotoxicity toward mouse peritoneal macrophage (MPMs) and bone-marrow-derived neutrophils (BMDNs), and 300 microg/mL Nv-CATH also had no hemolytic activity on rabbit erythrocytes.', 'Nv-CATH inhibited bacterial invasion of target organs via direct bactericidal ability. Nv-CATH selectively promoted CCL and CXCL chemokines', 36378028),
('Antibacterial Peptide', 'human beta-defensin 130 (hBD130)', 'hBD130 demonstrated efficient antimicrobial activities, with MICs ranging from 10 to 45 microg/mL. Of note, hBD130 exhibited significant growth inhibition effects against E. coli ATCC 25,922 (10 microg/mL), ETEC BNCC 125,783 (10 microg/mL), L. monocytogenes ATCC 221,633 (25 microg/mL), and S. typhimurium ATCC 14,028 (15 microg/mL). The MICs for hBD130 against gram-negative bacteria, including E. coli and S. typhimurium, were 10', 'hBD130 showed a low hemolytic effect and nearly no cytotoxicity to mammalian cells with a dosage of 400 microg/Ml', 'bactericidal effect of hBD130 showed that hBD130 is a promising antimicrobial agent to treat foodborne bacterial infections and inflammation.', 35720462),
('Antibacterial Peptide', 'develop chimeric peptides with dual cell-penetrating and antimicrobial functions by conjugating Cell-penetrating peptides with AMPs', '', '', 'AMPs are regarded as an ideal alternative to antibiotics due to their powerful antimicrobial potential, rapid killing effects, and low propensity to develop resistance. the combination of CPP and AMP gives it a dual function of cell penetration and antimicrobial activity, which may be a feasible method to treat intracellular infections.', 36503077),
('Antibacterial Peptide', 'Three novel peptide families ', 'PTR displayed moderate activity against Escherichia coli (MIC 24.80 to 48.95 microM), TS-1 was the most active peptide against E. coli (6.8 microM) followed by PTS-3 (11.7 microM) and PTS-2 (14.24 microM)', '', 'Hence, Frog skin peptides are excellent examples of the biomedical potential of naturally evolved molecules for specific targets, including multi-resistant bacteria.', 35640793),
('Antibacterial Peptide', 'Peptide PN5 derived from Pinus densiflora (pine needle)', 'PN5 displayed antimicrobial activity against both Gram-negative and Gram-positive bacteria, with MICs of 2 to 16 microM (2.65 to 21.22 microg mL?1)', '', 'PN5 showed immunomodulatory properties of neutralizing LPS in a mouse septic model. These results indicate that PN5 could be a new and promising therapeutic agent for bacterial infectious disease caused by antibiotic-resistant strains.', 36129300),
('Antibacterial Peptide', 'Antimicrobial peptide (AMP) IDR-1018 derived D-amino acids substitution peptides (D1018 and D1018M) were synthesized', 'MIC of IDR-1018, 1018M and D1018 against E. coli ATCC25922 was 8 microg/ mL while that of D1018M was 4 microg/ mL. D1018M owned stronger potential antibacterial activity against E. coli ATCC25922. However, the antimicrobial activity of peptides was not so good as that of polymyxin (MIC = 1.56 microg/mL).', 'he results indicated that peptides IDR-1018, 1018M and 1018M basically had no cytotoxicity against murine macrophage cells, when the concentration was up to 16 times of MIC. However, for D1018M, the safe concentration of murine macrophage cells was only 4 times of MIC.', 'This peptides could interact with E. coli cell wall and cytoplasmic membrane, penetrate the membrane, cause leakage of contents, and disrupt genomic DNA. Among them, D1018 is the most prominent one. these data demonstrate that D1018 is a promising peptide candidate for the treatment of E. coli infection.', 36532445),
('Antibacterial Peptide', 'peptide Spgillcin177-189 derived from the amino acid sequence of Spgillcin', 'Spgillcin177-189 also showed rapid bactericidal kinetics for S. aureus and Pseudomonas aeruginosand maintained its antimicrobial activity in different conditions with a range of minimum inhibitory concentrations from 1.5 to 48 microM.', 'did not display any cytotoxicity to mammalian cells( human hepatic cell line (L02), mouse liver cell line (AML12), hepatocellular carcinoma cell line (Hep G2), and non-small-cell lung carcinoma (NSCLC) cell line (NCI-H460)', 'Spgillcin177-189 was mainly involved in the disruption of cell membrane integrity and cause the accumulation of intracellular reactive oxygen species. Spgillcin177-189 exerted a strong anti-biofilm activity by inhibiting biofilm formation and was also effective at killing extracellular S. aureus in the cultural supernatant of RAW 264.7 cells. Taken together, Spgillcin177-189 has strong potential as a substitute for antibiotics in future aquaculture and medical applications.', 36061863),
('Antibacterial Peptide', 'Antisense peptide nucleic acids (PNAs)', 'Concentration-dependent bactericidal activity was investigated by treatment of S. pneumoniae TIGR4 in a CPP-antisense PNA conjugate concentration range of 2.5 to 20 microM', '', 'CPP-antisense PNA treatment increased the survival rate of infected Galleria mellonella larvae in vivo. Based on these results, we believe that efficient antisense PNAs can be developed for the treatment of S. pneumoniae infections.', 36321914),
('Antibacterial Peptide', 'hydrogel scaffold containing genipin crosslinked HF-18 peptide', 'It was observed that HF-18-loaded OPT (P-OPT) was able to release HF-18 peptide both in acidic and neutral conditions. Antimicrobial activity assessments demonstrated that P-OPT was effectively bactericidal on Staphylococcus aureus and methicillin-resistant S. aureus.', '', 'the optimized scaffold has a composition of 90 mg Ch, 0.25 mg HA, and 0.25 mg CS and is crosslinked with 0.5 mg genipin. This scaffold was found to have highly interconnected pores and high bactericidal activity. It was claimed that HF-18 showed a strong bactericidal effect on MRSA and biocompatibility against L929 cells. As a novel approach, for the first time, HF-18 loaded polymeric scaffold was tested for wound healing. the scaffold OPT was considered a suitable and promising polymeric carrier for AMPs in terms of wound healing.', 36377395),
('Antibacterial Peptide', 'novel synthetic antimicrobial peptide, GK-19, derived fromAndroctonus amoreuxi Antimicrobial Peptide 1 ( AamAP1 ) and its derivatives', 'GK-19 exhibited potent antibacterial activity against three Gram-positive and two Gram-negative bacteria with much lower minimal inhibitory concentration (MIC) values ranging between 3 and 10 microM (E. coli (3 microM), K. pneumoniae (5 microM), P. aeruginosa (5 microM), E. faecalis (3 microM), and MRSA (5 microM)) in comparison to that of AamAP1 (>20 microM).', 'GK-19 showed negligible toxicity to mammalian cells, low hemolytic activity and high stability in plasma.', 'GK-19 showed significant antimicrobial and healing effects. Overall, it was demonstrated that GK-19 might be a promising drug candidate in the battle against drug-resistant bacterial and fungal infections.', 36145681),
('Antibacterial Peptide', 'Two novel antibacterial peptides were isolated from Alcalase-hydrolyzed chicken plasma', 'VSDH inhibited both S. aureus and B. cereus, while CCCPKAF only showed antibacterial activity toward B. cereus. The MIC values of VSDH and CCCPKAF against B. cereus were 0.5 mM and 0.25 mM, respectively. In addition, the MIC of VSDH against S. aureus was 0.5 mM. Both peptides showed weak inhibition towards S. typhimirium and L. monocytogenes with MIC > 8 mM. They did not inhibit E. coli.', '', '', 36429156),
('Antibacterial Peptide', 'scorpion venom peptide ctry2459 was modified to CT-K3K7', 'It can kill S. aureus strain MIC= 2.64 Micro Mol and P. aeruginosa strain PA01 MIC = 10.56 Micro Mol and P. aeruginosa strain ATCC9027 rapidly, and reduce the production of biofilm', 'lower hemolytic activity', 'peptide ctry2459 was modified to CT-K3K7 by lysine substitutions at the 3rd and 7th positions to increase the cationic properties. We discovered that the modified peptides CT-K3K7 had improved antibacterial activity, higher thermal stability, as well as lower hemolytic activity. CT-K3K7 has also been demonstrated to decrease bacterial counts. Hence, the modified peptide CT-K3K7 can be a novel antimicrobial agent candidate for the treatment of infections by S. aureus and P. aeruginosa.', 36113685),
('Antibacterial Peptide', 'lead peptide LI14', 'LI14 showed broad-spectrum and strong antibacterial activity against all MDR pathogens with MIC values ranging from 1 to 64 microg/mL, involving methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), carbapenem-resistant Enterobacteriaceae (CRE), MCR-positive E. coli (MCRPEC) and tigecycline-resistant pathogen, which was comparable to that of some antibiotics used clinically.', '', 'In animal models of infection, LI14 or combined with antibiotics are effective against drug-resistant pathogens. These findings suggest that LI14 is a promising antibiotic candidate to tackle MDR bacterial infections.', 36071151),
('Antibacterial Peptide', 'antimicrobial peptide conjugated poly (glycolic acid-co-caprolactone) (PGCL) sutures', '(PGCL) sutures were investigated against P. aeruginosa and methicillin-resistant S. aureus (MRSA) strains by using antimicrobial peptide sequences of KRFRIRVRV-NH2, RWRWRWRW-NH2 and their dual combination (1:1)', '', 'Our results indicated that antimicrobial peptide modified sutures could be a potential novel medical device to overcome surgical site infections by the superior acceleration of wound healing.', 36510770),
('Antibacterial Peptide', 'Synergistic effect of - Synthetic antimicrobial peptides (SAMPs-Mo-CBP3-PepI, Mo-CBP3-PepII, Mo-CBP3-PepIII, RcAlb-PepI, RcAlb-PepII, RcAlb-PepIII, PepGAT ,and Pep KAA ) with antibiotics', 'combination made by Mo-CBP3-PepIII (6.2 microg mL?1) and ciprofloxacin (0.2 microg mL?1) induced pore formation of biofilm cells of S. aureus. combination with RcAlb-PepI (0.04 microg mL?1) and ciprofloxacin (25 microg mL?1) was it possible to induce pore formation on the membrane of S. aureus in biofilm and RcAlb-PepIII alone at 50 microg mL?1 induce biofilm.', 'synthetic peptides are not toxic to human red blood cells (HRBC). Additionally, it has been shown that during synergistic action, peptides, besides enhancing drugs', 'The mechanism of the combined effect is possible by increasing the cytoplasmatic concentration of ciprofloxacin supported by pores on the membrane of S. aureus cells. Additionally, peptides reduced the toxicity of ciprofloxacin to HRBC. Considering all these findings, it is possible to suggest that the peptides studied are a considerable option to surpass the resistance of S. aureus strains to antibiotics such as ciprofloxacin.', 36145427),
('Antibacterial Peptide', 'antimicrobial peptides (AMPs) from marine parasites, Anisakis spp', 'These peptides are potent bactericidal agents in vitro, selectively active against Gram-negative bacteria, including multi-drug resistant strains, at sub-micromolar concentrations.', 'Their toxicity towards host cells is negligible,', 'Anisaxins are membrane-active peptides essential for future design of such biomaterials.', 35470073),
('Antibacterial Peptide', 'antimicrobial peptides centered on "RRR" labeled with hydrophobic amino acids at both ends- LWWR (LWWRRRWWL-NH2)', 'Show bactericidal activity against E. coli and S. aureus', '', 'LWWR (LWWRRRWWL-NH2) presented broad-spectrum antibacterial activity both in vitro and in vivo due to its multiple mechanisms and good stability. The findings of this study will provide some inspiration for the design and development of potential antibacterial agents, and contribute to the elimination of bacterial infections worldwide as soon as possible.', 36241015),
('Antibacterial Peptide', 'The Antimicrobial Peptide 1018-K6', 'this AMP was seen to be able to kill resistant Gram-positive and Gram-negative microorganisms (5 ', '', 'The AMP 1018-K6 is a candidate to prevent (food preservation) or treat (antibiotic use) infections caused by certain pathogenic bacteria, especially some that are resistant to current antibiotics for three prokaryotic species studied: Salmonella Typhimurium2GN, Escherichia coli3GN, and Staphylococcus aureus3', 36293249),
('Antibacterial Peptide', 'Temporin-GHa (GHa) obtained from Hylarana guenther Derived Peptide - GHa4R', 'peptide GHa4R had stronger antibacterial activity and bactericidal efficacy against S. aureus. GHa4R presented antibacterial activity against methicillin-resistant S. aureus (MRSA).', '', 'It was barely affected by temperature, pH, and storage period, showing high stability. it increased the permeability of the cell membrane and damaged the membrane integrity, leading to cell death. The mentioned characteristics make GHa4R a promising candidate for the treatment of S. aureus infections.', 36476441),
('Antibacterial Peptide', 'PEGylation at the C-terminal of T9W (CT9W1000) peptide', 'CT9W1000 micelles exhibited good biocompatibility in vitro and in vivo, resulting in highly effective treatment in a mouse acute lung injury model induced by P. aeruginosa PAO1 without drug resistance.', '', 'These advances may profoundly accelerate the clinical transformation of T9W and promote the development of a combination of peptide-based antibiotics and PEGylated nanotechnology.', 36577517),
('Antibacterial Peptide', 'lipopeptide', 'against Multidrug-Resistant Pseudomonas aeruginosa', '', 'discovery of lipopeptides against bacterial "superbugs"', 35786900),
('Antibacterial Peptide', 'HAZ, a novel peptide', 'HAZ revealed significant antimicrobial activity, with MIC values of 15 ', 'HAZ efficacy was accompanied with minimal hemolytic toxicity on human erythrocytes.', 'HAZ-antibiotics combinations exhibited a synergistic action mode that led to dramatic decrease in the MIC values for both HAZ peptide and the antibiotic. HAZ peptide is a broad-spectrum AMP, and a promising candidate for antimicrobial and anticancer drug development.', 36465844),
('Antibacterial Peptide', 'synthetic peptide CD4-PP', 'CD4-PP was active against both clinical and type strains in low concentrations between 0.78 and 1.56 microM. The MIC for E. coli CFT073 and the ESBL strain (CCUG 55971) were 0.78 microM. Klebsiella pneumoniae (ATCC 25955), MDR K. pneumoniae (CCUG 58547), Pseudomonas aeruginosa (ATCC 27853) had MICs of 1.56 microM.', '', 'By developing a peptide with a cyclic backbone, they intended to increase the proteolytic stability and antimicrobial activity of the novel synthetic AMP. they observed that CD4-PP displayed enhanced stability against bacterial protease. CD4-PP was tested against a range of the most clinically important uropathogens indicating a promising clinical application.', 35821354),
('Antibacterial Peptide', 'cell-penetrating peptide (CPP) fused endolysin PA90', 'This engineered endolysin, DS-PA90, completely killed A. baumannii at 0.25 microM,', '', 'Hence concluded MDR A. baumannii strains were highly susceptible to DS-PA90 treatment: five out of nine strains were entirely killed and four strains were reduced by 3', 35614377),
('Antibacterial Peptide', 'Modified the antimicrobial peptide Cec4 (41 amino acids) and obtained the derived peptide C9 (16 amino acids)', 'Derived peptide C9 (16 amino acids) showing better antimicrobial activity against S. epidermidis with an MIC value of 8 microg/mL.', 'The median lethal dose of C9 in mice was more than 128 mg/kg, and the intraperitoneal administration of 64 mg/kg was less toxic to the liver and kidneys of mice.', 'C9 peptide has rapid bactericidal activity without detectable high-level resistance, showing certain inhibition and eradication ability on S. epidermidis biofilms. In addition, C9 altered the S. epidermidis cell membrane permeability, depolarization levels, fluidity, and reactive oxygen species (ROS) accumulation and possessed the ability to bind genomic DNA.', 36453944),
('Antibacterial Peptide', 'melittin-pexiganan combination, combination of temporin-pexiganan, temporin-melittin combination peptides', 'result found that S. aureus went extinct more rapidly when treated with a mixture of two antimicrobial peptides', '', 'These results are consistent with the fact that AMP combinations that contain pexiganan were more effective for delaying resistance evolution', 35862981),
('Antibacterial Peptide', 'Novel D-form of hybrid peptide (D-AP19)', 'Geometric mean (MIC) of gram negative : GMb (Gr.? strains) = 7.16 microg/ml and geometric mean for gram positive GMd (Gr. + strains) = 5.86 microg/ml', 'AP-19 show minimal hemolytic and cytotoxic activities in mammalian cells.', 'D-AP19 displayed rapid killing via membrane disruption and leakage of intracellular contents. Additionally, it showed a low tendency to induce bacterial resistance. Among the peptides, AP19 demonstrated the best combination of broad-spectrum antibacterial activity including toward Acinetobacter baumannii', 36151303),
('Antibacterial Peptide', 'Host defense peptides (HDPs)- design the amphiphilic peptoid polymers', 'The optimal cyclic peptoid polymer, poly(Naeg0.7Npfbg0.3)20, displays strong antibacterial activities against drug-resistant bacteria.', 'low hemolysis and cytotoxicity', 'we design the amphiphilic peptoid polymers by mimicking the positively charged and hydrophobic structures of HDPs and synthesize a series of cyclic peptoid polymers efficiently via the polymerization on alpha-amino acid N-substituted glycine N-carboxyanhydrides (alpha-NNCAs) using 1,8-diazabicycloundec-7-ene (DBU) as the initiator.', 35788576),
('Antibacterial Peptide', 'AMP called Pleurocidin (Ple) and its C-terminal-amidated derivative Pleurocidin-amide (Ple-a)', 'Our results indicated that both Ple and Ple-a exhibited significant antibacterial activity against a broad spectrum of Gram-positive and Gram-negative bacteria, especially marine pathogens, with MIC values ranging from 0.25 to 32 microg/mL.', 'Ple and Ple-a also showed notable cytotoxicity toward various cancer cell lines, with IC50 values ranging from 11 to 340 microM, while normal mouse fibroblast 3T3 cells were less susceptible to these peptides.', 'Our results indicated that both Ple and Ple-a exhibited significant antibacterial activity against a broad spectrum of Gram-positive and Gram-negative bacteria, especially marine pathogens. Our findings provided support for the future application of Ple-a as potential therapeutic agent for bacterial infections.', 36005521),
('Antibacterial Peptide', 'ApoE mimetic peptide, COG1410', 'In the case of Gram-positive strains, COG1410 inhibited the growth of Bacillus subtilis, vancomycin-resistant Enterococcus faecalis and Enterococcus faecium, and Mycobacterium smegmatis with MICs ranging from 1 to 32 microg/ml. As for Gram-negative bacteria, COG1410 showed antimicrobial activity against Enterobacter cloacae, Escherichia coli, Citrobacter freundii, and even anaerobe, Porphyromonas gingivalis, with MICs ranging from 16 to 64 microg/ml.', 'The minimal concentration that caused the lysis of half of the red blood cells (EC50) was 441 microg/ml. COG1410 exhibited low hemolytic activity and medium cytotoxicity.', 'COG1410 easily entered bacterial cytoplasm and bound to DNA nonspecifically, the major mechanism of COG1410 killing was to disrupt the integrity of cell membrane and lead to leakage of cytoplasmic contents', 36081797),
('Antibacterial Peptide', 'Natural Peptide from Vespa mandarinia Venom and Its Synthetic Analogues', 'VM-3K produced a 90% survival of S. aureus-infected waxworms at a concentration of 5.656 mg/kg, at which concentration the natural template peptide only achieved 50% survival. VM-3G also displayed anti-microbial ability against Gram-negative bacteria and had bactericidal effects on E. coli and P. aeruginosa but not on K. pneumoniae', 'VM-3W exhibited haemolysis at a low concentration.', 'peptide VM-3K could be a promising broad-spectrum antimicrobial candidate for addressing the current antibiotic-resistant infection crisis. It is worth mentioning that this investigation on the relationship between peptide structure and mechanism of action could become an important aspect of drug research on short peptides.', 36138742),
('Antibacterial Peptide', 'KDEON WK-11: A short antipseudomonal peptide', 'identified its most potent effect, against Pseudomonas aeruginosa with an MIC value of 3.12 microM', '', 'KDEON WK-11 had a broad range of antimicrobial activity and specific capabilities to fight Pseudomonas aeruginosa with low in vitro cytotoxicity and promising potential to express anti-lipopolysaccharide qualities, which could be exploited to expand its properties into an anti-sepsis agent.', 36465859),
('Antibacterial Peptide', 'Amino Acid-Rich Antimicrobial Peptides', 'found 138 Leu-rich AMPs active against Staphylococcus aureus and 81 against Escherichia coli. Likewise, there were 39 Pro-rich peptides against E. coli and 15 against S. aureus in the current database.', '', 'no natural AMPs are simultaneously rich in leucine and lysine, while proline, tryptophan, and cysteine-rich peptides can simultaneously be rich in arginine. These findings can be utilized to guide peptide design. Since multiple candidates are potent against antibiotic-resistant bacteria, rich AMPs stand out as promising future antibiotics.', 36361660),
('Antibacterial Peptide', 'tachplesin I analogue peptide (TP11A) and tachplesin I', 'Both inhibited C. albicans monomicrobial, S. aureus monomicrobial, and C. albicans-S. aureus polymicrobial biofilms quite well. TP11A suppressed the biofilm- and virulence-related genes of C. albicans (hwp 1) and S. aureus (ica A, fnb B, agr A, hla, nor A, and sig B) in the mixed biofilm,', '', '', 35998684),
('Antibacterial Peptide', 'antimicrobial peptidomimetics called peptoids (sequence-specific oligo-N-substituted glycines) the sequence-specific pentamer TM5', 'the MIC values for TM5 against Pseudomonas aeruginosa (PAO1) and Staphylococcus aureus (SA25923) are 8 microg/mL and 16 microg/mL, respectively.', 'determined the cytotoxicity of TM5 against A549 lung epithelial cells to identify a non-cytotoxic concentration. A549 cell exposure to 50 microg/mL of TM5 for 24 h exposure did not cause cytotoxicity . TM5 has been shown to be safe on 3D human primary cultures of epithelial cells', 'demonstrated that TM5 is a multi-functional platform that can be used to eradicate biofilms and mitigate LPS-induced cytokine production. Future studies will explore the in vivo anti-persister cell activity of TM5 using a chronic biofilm infection animal model. Furthermore, the antimicrobial molecular mechanisms of TM5 seems to prevent resistance development. Although our resistance study showed that resistance development against TM5 is unlikely.', 36018039),
('Antibacterial Peptide', 'arenicins, antimicrobial peptides from the lugworm Arenicola marina', 'Peptide AA139, like other arenicins, exhibited an inhibitory effect on complement at a concentration of 160 microg/Ml', '', 'our results suggest that the effect on the complement system should be taken into account in the development of antibiotics based on arenicins.', 36286436),
('Antibacterial Peptide', 'Stable isotope analysis with antimicrobial random peptide mixtures (RPMs). The RPMs used in this study consisted of 20-mer peptide composed of either L-phenylalanine and L-lysine (FK20) or phenylalanine with D-lysine (FdK20) in 1:1 molar ratio', 'FK20 induced a reduction of the MIC of four bacteria (i.e. X. campestris, X. perforans, C. michiganensis and P. syringae) to between 4 and 21% of the corresponding untreated control samples (> 200 microg/mL). Two pathogenic bacteria, S. scabies and A. citrulli, were not affected by the treatment with FK20. Effects of FdK20 on the bacteria were very similar with the exception of P. syringae which was not affected by FdK20', '', 'Stable carbon isotope analysis invariably verified the changes in the FA groups of bacteria caused by treatment with FK20 and FdK20. Also, growth inhibition of bacteria by FK20 and FdK20 was generally associated with changes in the FA groups except for FdK20 in the case of C. michiganensis. The approach used in this study could be helpful in the search not only of novel antimicrobial RPMs but also other antibiotics such as polymyxin B.', 35789165),
('Antibacterial Peptide', 'Antimicrobial potential of a ponericin-like peptide', 'Results showed that Bm-ponericin-L1, at 4 ppm, inhibited biofilm formation by > 85% (P. aeruginosa) and > 90% (K. pneumoniae), after 24 h of incubation', '', 'Study revealed that infection with P. aeruginosa triggers the humoral response in B. mori larvae. The purified peptide fraction screened from the infected silkoworm found to be active against E. faecium , S. aureus , K. pneumoniae, A. baumannii , P. aeruginosa, and E. agglomerans, belonging to the ESKAPE group. This is the first report regarding the production and isolation of a ponericin in B. mori hemolymph upon P. aeruginosa infection. Bm-ponericin-L1was found to be highly specific towards bacterial cells suggesting its cell selectivity.', 36109567),
('Antibacterial Peptide', 'cross-linked lyotropic liquid crystals, formed by the self-assembly of the block copolymer Pluronic F-127.', 'The liquid crystal particles were shown to have antibacterial effect corresponding to a 4 log reduction against Staphylococcus aureus.', '', 'The bonding to the particles gave the AMPs improved stability in serum, as they retained almost all of the antibacterial potency for 2 days compared to free AMPs, which lost all of its antibacterial potency within a day.', 36152992),
('Antibacterial Peptide', 'florfenicol-polyarginine conjugates', 'These conjugates also showed excellent activity against drug-resistant strains such as methicillin-resistant S. aureus (MRSA) and florfenicol resistant Escherichia coli strains (2017XJ30, 2019XJ20), one of which as E6 had a minimum inhibitory concentration of 12.5 micromol/L.', '', 'Polyarginine peptides are widely used as CPPs and shown to inhibit bacteria by entering certain microbial cell membranes. This suggested that conjugating arginine to florfenicol succinate effectively modulated the properties of prodrugs. These new conjugates may provide useful insights for expanding the pool of antibiotics.', 35844651),
('Antibacterial Peptide', 'three peptides (LS-AMP-E1, LS-AMP-F1, and LS-AMP-G1) from Chinese Wolf Spider Lycosa sinensis', 'LS-AMP-E1 and LS-AMP-F1 exhibited similar antibacterial effects towards tested microbes. The MIC values of LS-AMP-E1 and LS-AMP-F1 against 6 tested strands ranged between 50 and 6.25 microM, except for P. vulgaris and S. aureus (not detected within 50 microM). LS-AMP-G1, on the other hand, had no discernible effect on the growth of any one of the reference strains. (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species)', '', 'In terms of antimicrobial mechanisms, LS-AMP-E1 and LS-AMP-F1 destroyed the integrity of bacterial cell membranes in a short period of time and completely inhibited bacterial growth within 10 min of action. Meanwhile, high concentrations of Mg2+ effectively reduced the antibacterial activity of LS-AMP-E1 and LS-AMP-F1. Together, it suggested that the two peptides interact directly on bacterial cell membranes.', 36432731),
('Antibacterial Peptide', 'Parietin (PTN) or physcion', 'Complexation of PTN increased the aqueous solubility 28-fold and the photostability compared to free PTN. PTN/HP-beta-CD complexes reduce the bacterial viability of Staphylococcus saprophyticus and Escherichia coli by > 4.8 log and > 1.0 log after irradiation, respectively.', '', 'As an alternative therapeutic option, antimicrobial photodynamic therapy (aPDT) can successfully eradicate antibiotic-resistant bacteria with a lower probability of developing resistance or systemic toxicity commonly associated with the standard antibiotic treatment.', 35214089),
('Antibacterial Photodynamic Therapy', 'Polycationic photosensitizer conjugate between poly-L-lysine and chlorin(e6)', 'polycationic photosensitizer penetreted with 660 nm laser light rapidly killed Escherichia coli infecting excisional wounds in mice', '', 'Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. The worldwide rise in antibiotic resistance necessitates the development of novel antimicrobial strategies.', 11837327),
('Antibacterial Photodynamic Therapy', 'Poly-L-lysine chlorin e6 conjugate or free chlorin e6 with red light from a diode laser', 'activity against Staphylococcus aureus', '', 'Targeted photodynamic therapy of established soft-tissue infections in mice. The worldwide rise in antibiotic resistance necessitates the development of novel antimicrobial strategies.', 15122362),
('Antibacterial Photodynamic Therapy', 'Photosensitizers PS (a polylysine-chlorin(e6) conjugate, pL-c(e6), and methylene blue [MB]) and an anionic molecule, free c(e6), and subsequent exposure to 665-nm light at 0 to 40 J/cm(2)', '', '', 'These data suggest that slime production and stationary phase can be obstacles against PDI for gram-positive bacteria but that these obstacles can be overcome by using cationic PS.', 15155218),
('Antibacterial Photodynamic Therapy', 'UV', 'Methicillin-resistant Staphylococcus aureus was found to be sensitive to both germicidal (ultraviolet C) and solar (ultraviolet A and B) ultraviolet radiation (ultraviolet C substantially more lethal).', '', 'The experiments reveal that medium composition (sodium chloride concentration) exerts a substantial effect on methicillin-resistant Staphylococcus aureus ultraviolet resistance and that this species lacks photoreactivation capacity.', 15695834),
('Antibacterial Photodynamic Therapy', 'XF porphyrin derivatives', 'Phototoxicity against methicillin-resistant and sensitive Staphylococcus aureus strains, methicillin-resistant Staphylococcus epidermidis strain, Escherichia coli strain', 'No harm against eukaryotic cells', 'Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. The worldwide rise in the rates of antibiotic resistance of bacteria underlines the need for alternative antibacterial agents.', 15793136),
('Antibacterial Photodynamic Therapy', '5-[4-(1-dodecanoylpyridinium)]-10,15,20-triphenyl-porphyrin', '', '', 'Efficient photoinactivation of methicillin-resistant Staphylococcus aureus by a novel porphyrin incorporated into a poly-cationic liposome. Antimicrobial photodynamic therapy is emerging as a promising therapeutic modality for bacterial infections.', 17387034),
('Antibacterial Photodynamic Therapy', 'Photodynamic effect of protoporphyrin diarginate (PPArg2)', 'Incubation with 10 microM followed by illumination yielded a 3.6 log(10)-unit reduction in the viable count for Staphylococcus aureus.', 'At the same experimental conditions, only 22.5% of the fibroblasts were photoinactivated.', 'Photodynamic effect of protoporphyrin diarginate (PPArg2) on methicillin-resistant Staphylococcus aureus and human dermal fibroblasts. The worldwide rise in the antibiotic resistance of bacteria forces the development of alternative antimicrobial treatments.', 18217106),
('Antibacterial Photodynamic Therapy', 'Porphyrin-mediated photodynamic antimicrobial chemotherapy', 'A Staphylococcus aureus suspension was exposed to a light emitting diode (LED) emitting at 628 nm, 14.6 mW/cm(2), and energy density of 20 J/cm(2), 40 J/cm(2), or 60 J/cm(2) in the presence of different porphyrin concentrations (Photogem). Three drug concentrations were employed: 12 microl/ml, 25 microl/ml, and 50 microl/ml.', 'Data suggest that PDT has the potential to eliminate Staphylococcus aureus in suspension', 'Susceptibility of Staphylococcus aureus to porphyrin-mediated photodynamic antimicrobial chemotherapy: an in vitro study.', 19585079),
('Antibacterial Photodynamic Therapy', 'RLP068/Cl is a novel Zn(II) phthalocyanine proposed as a photosensitizer', 'Inhibition concentration S. aureus strain 26A7 : 16ng/nl, and for S. aureus strain 28C65: 8 ng/ml, P. aeruginosa: 1.65 to 26.4 ?g/ml', '', 'RLP068/Cl is a novel Zn(II) phthalocyanine proposed as a photosensitizer suitable for antimicrobial photodynamic therapy (APDT) for localized infections.', 20008782),
('Antibacterial Photodynamic Therapy', 'Antimicrobial photodynamic therapy using 5,10,15-tris(1-Methylpyridinium-4-yl)-20-(pentafluorophenyl)-porphyrin triiodide (Tri-Py(+)-Me-PF) as photosensitizer and irradiated with white light (40 W m(-2)) for 270 minutes.', 'Tested against Vibrio fischeri and recombinant Escherichia coli', '', 'aPDT using Tri-Py(+)-Me-PF represents a promising approach to efficiently destroy bacteria since after a single treatment these microorganisms do not recover their viability and after ten generations of partially photosensitized cells neither of the bacteria develop resistance to the photodynamic process', 20161973),
('Antibacterial Photodynamic Therapy', 'Chemiluminescent reaction of luminol to excite the photosensitizer - chemiluminescent photodynamic antimicrobial therapy (CPAT)', 'Effect of free and liposome-encapsulated PS (methylene blue or toluidine blue) on bacteria under excitation by either white external light or chemiluminescence emitted by free or liposome-enclosed luminol.', '', 'One alternative to traditional antibiotic therapy is photodynamic antimicrobial chemotherapy (PACT) which is based on the use of a photosensitizer (PS), activated by illumination with visible light.', 20880227),
('Antibacterial Photodynamic Therapy', 'Methylene blue and a low power laser', 'The mean reduction in bacterial counts of the strains submitted to PDT ranged from 4.89 to 6.83 CFU (log10)/mL', '', 'Effect of photodynamic therapy on clinical isolates of Staphylococcus spp.', 21359491),
('Antibacterial Photodynamic Therapy', 'Rose Bengal and photosensitizing for 30 min using a halogen lamp.', 'Further, mesocosm experiments with V. harveyi and Artemia nauplii demonstrated that in 30 min, the aPDT could kill 78.9% and 91.2% of heterotrophic bacterial and Vibrio population respectively.', '', 'Reducing Vibrio load in Artemia nauplii using antimicrobial photodynamic therapy: a promising strategy to reduce antibiotic application in shrimp larviculture. We propose antimicrobial photodynamic therapy (aPDT) as an alternative strategy to reduce the use of antibiotics in shrimp larviculture systems.', 21951316),
('Antibacterial Photodynamic Therapy', 'Porphyrin-cellulose nanocrystals (CNC-Por (1))', 'Excellent efficacy toward the photodynamic inactivation of Acinetobacter baumannii, multidrug-resistant Acinetobacter baumannii (MDRAB) and methicillin-resistant Staphylococcus aureus (MRSA), with the best results achieving 5-6 log units reduction in colony forming units (CFUs) upon illumination with visible light (400-700 nm; 118 J cm(-2))', '', 'Porphyrin-cellulose nanocrystals: a photobactericidal material that exhibits broad spectrum antimicrobial activity. T', 22360680),
('Antibacterial Photodynamic Therapy', 'Cationic PS meso-tetra-4-N-methyl pyridyl porphine', 'Analyses revealed that PDT treatments delayed the growth and considerably reduced the glucose consumption capacity of S. aureus cells.', '', 'Molecular targets of antimicrobial photodynamic therapy identified by a proteomic approach.', 23000218),
('Antibacterial Photodynamic Therapy', 'Methylene blue (MB) injection followed by photodynamic therapy', 'In the study of antimicrobial PDT, we verified that methylene blue (MB) injected into the insect followed by whole body illumination prolonged the caterpillar survival (P = 0.0192). Interestingly, combination therapy of larvae infected with vancomycin-resistant E. faecium, with antimicrobial PDT followed by vancomycin, significantly prolonged the survival of the caterpillars when compared to either antimicrobial PDT (P = 0.0095) or vancomycin treatment alone (P = 0.0025), suggesting that the aPDT made the vancomycin resistant E. faecium strain more susceptible to vancomycin action.', '', 'Antimicrobial photodynamic therapy (aPDT) is an alternative therapeutic platform that is currently under investigation for the control and treatment of infections.', 23457486),
('Antibacterial Photodynamic Therapy', 'Methylene blue derivatives', 'In suspensions with both, gram-positive and gram-negative bacteria, some derivatives were highly active upon illumination to inactivate S. aureus and E. coli up to 7 log10 steps (99.99999%)?', 'No inherent toxicities in the nonirradiated state', 'Hydrogen bond acceptors and additional cationic charges in methylene blue derivatives: photophysics and antimicrobial efficiency. Photodynamic inactivation of bacteria (PIB) by efficient singlet oxygen photosensitizers might be a beneficial alternative to antibiotics in the struggle against multiresistant bacteria.', 23509728),
('Antibacterial Photodynamic Therapy', 'antimicrobial PDT (aPDT): photosensitizers TMPyP and ZnTPPS4', 'We tested these two porphyrins on two cell lines and two bacterial strains to compare effectiveness. In addition, we applied photosensitizers bound in the complex created with hp-?-cyclodextrin. The light-emitting diodes were used at the doses 0, 1, 5, 10 J/cm(2) for cells and 0, 150 J/cm(2) for bacteria. Tested concentrations for cells and microbes were from 0.5 to 50 ?M and from 0.78 to 100 ?M, respectively.', 'TMPyP is a promising compound both in aPDT and in PDT, particularly in contrast to ZnTPPS4, which was efficient only in PDT. Furthermore, the eradication of gram-positive bacteria is possible only with higher concentrations of ZnTPPS4.', 'In this work, the photosensitizers TMPyP and ZnTPPS4 are investigated for photodynamic and antimicrobial photodynamic therapy.', 23899404),
('Antibacterial Photodynamic Therapy', 'Ruthenium(II) based photosensitising material (PSM) covalently bound to micrometric glass beads', 'Activity against Helicobacter pylori, a  99.99999% decrease was detected in the number of colonies', '', 'Helicobacter pylori inactivation and virulence gene damage using a supported sensitiser for photodynamic therapy.', 23988411),
('Antibacterial Photodynamic Therapy', 'Photodynamic antimicrobial chemotherapy with ?-D-galactopyranosyl zinc phthalocyanines', 'Activity against methicillin-resistant Staphylococcus aureus', '', 'Susceptibility of methicillin-resistant Staphylococcus aureus to photodynamic antimicrobial chemotherapy with ?-D-galactopyranosyl zinc phthalocyanines: in vitro study. The incidence of methicillin-resistant strains of Staphylococcus aureus (MRSA) is increasing globally, making urgent the discovery of novel alternative therapies for infections.', 24249355),
('Antibacterial Photodynamic Therapy', 'Ru(II)-based photosensitizers', 'Bacterial samples were dosed with a range of photosensitizer concentrations (0.3-12 micro M) and exposed to 530 nm light (90J cm(-2)) in normoxic conditions (ambient atmosphere) and in hypoxic conditions (0.5% O2', '', 'The intrinsic positive charge of the Ru(II) metal combined with the oxygen independent activity demonstrated by this class of photosensitizers presents a new strategy for eradicating both gram-positive and gram-negative bacteria regardless of oxygenation level.', 24284119),
('Antibacterial Photodynamic Therapy', 'Photosensitizer safranine O with that of chlorhexidine (0.2% CHX)', '', '', 'In this context, antimicrobial photodynamic therapy (aPDT) may play a crucial part in the future.', 24473989);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Photodynamic Therapy', 'Hypericin', 'Preincubation with HYP (5 min) plus light exposure (10 min) showed bactericidal effect against planktonic methicillin-susceptible S. aureus and methicillin-resistant S. aureus.', '', 'Antimicrobial photodynamic activity of hypericin against methicillin-susceptible and resistant Staphylococcus aureus biofilms.', 25812458),
('Antibacterial Photodynamic Therapy', 'PDT using curcumin (C) as a photosensitizing agent irradiated with an LED (L) in the blue wavelength as a light source', 'Suspensions of both strains of Streptococcus mutans , were divided into 4 groups as follows: absence of C and L (control group: C-L-), with C and without L (C group: C+L-), absence of C with L (L group: C-L+) and presence of C and L (PDT group: C+L+). Three different concentrations of curcumin (0.75 mg/ml, 1.5 mg/ml and 3 mg/ml) and three light fluences of studied light source (24, 48 and 72 J cm(-2)) were tested. Aliquots of each studied group was plated in BHI agar and submitted to colony forming units counting (CFU/ml) and the data transformed into logarithmical scale.', 'A high photoinactivation rate of more than 70% was verified to standard S. mutans strain submitted to PDT whereas the clinical isolate showed a lower sensitivity to all the associations of curcumin and LED. A slight bacterial reduction was verified to C+L- and C-L+, demonstrating no toxic effects to the isolated application of light and photosensitizer to both S. mutans strains tested', 'Photodynamic therapy using a combination of curcumin and blue LED presented a substantial antimicrobial effect on S. mutans standard strain in a planktonic suspension model with a less pronounced effect on its clinical isolate counterparts due to resistance to this alternative approach.', 25876942),
('Antibacterial Photodynamic Therapy', 'In vitro PDT (photodynamic therapy) of UVA and TC (Tetracycline) as a PS (photosensitizer) before in vivo study. chitosan as booster.', 'At 1mg/mL of TC, chitosan treatment combined with PDT, increased the bactericidal effect by >10,000-fold of the effect of PDT alone.', '', 'The present study showed that PDT using a combination of TC and chitosan is an effective method for killing C. difficile.', 26386640),
('Antibacterial Photodynamic Therapy', 'Lysine-porphyrin conjugate (4i)', 'potent photosensitive antibacterial effect on Methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, and Pseudomonas aeruginosa.', '', 'Mechanism and In Vivo Evaluation: Photodynamic Antibacterial Chemotherapy of Lysine-Porphyrin Conjugate.', 26973620),
('Antibacterial Photodynamic Therapy', 'Photosensitizer 5,10,15,20-tetrakis(1-methylpyridinium-4-yl)porphyrin tetra-iodide (Tetra-Py(+)-Me)', 'Activity against Staphylococcus aureus', '', 'PDI, contrarily to traditional antibiotics, inhibited the expression of virulence factors, efficiently inactivating either highly virulent strains and low virulent S. aureus strains, inactivating also antibiotic susceptible and resistant strains, without development of photoresistance after at least 10 consecutive cycles of treatment, and so this therapy may become a strong promising alternative to antibiotics to control pathogenic microorganisms.', 27014198),
('Antibacterial Photodynamic Therapy', 'Benzylidene cyclopentanone based PSs modified by polyethylene glycol (PEG), carboxylate anionic or pyridyl cationic agents', 'In vitro and in vivo activity against methicillin-resistant Staphylococcus aureus (MRSA)', '', 'Water-soluble benzylidene cyclopentanone based photosensitizers for in vitro and in vivo antimicrobial photodynamic therapy.', 27323899),
('Antibacterial Photodynamic Therapy', 'Photodynamic Therapy (photosensitizer, Rhodamine 6G (R6G) in stealth liposomes)', 'The higher photoefficacies and production of more reactive oxygen species', '', 'The antimicrobial photodynamic therapy is an alternative method for killing bacterial cells in view of the rising problem of antibiotic resistance microorganisms.', 27371913),
('Antibacterial Photodynamic Therapy', 'DSPE-PEG-Pheo A (DPP) transfersome', 'For enhanced selectivity and skin penetration efficiency, DPP transfersomes are prepared from 1,2?distearoyl?sn?glycero?3?phosphoethanolamine?N?[amino(polyethylene glycol)?2000], pheophorbide A (Pheo A), cholesterol, and Tween?80. Incorporation of Tween?80 as an edge activator increases the deformability of DPP transfersomes, enhancing skin penetration efficiency to four times that of free Pheo A.', '', 'These results demonstrate that DPP transfersome-mediated photodynamic therapy can be used as an alternative method to treat bacterial skin infections. ? 2016 WILEY-VCH Verlag GmbH & Co.', 27863184),
('Antibacterial Photodynamic Therapy', 'Photosensitizer ZnPc(TAP)4n+, n = 0, 4, 8, 12', 'IC50 value of 59 nM at a light dosage of 5? J/cm2 toward E. coli.', 'negligible toxicity against human erythocytes', 'ZnPc(TAP)4n+ are highly potent, rapid-acting and non-toxic photosensitizers capable of inactivating bacteria.', 28251266),
('Antibacterial Photodynamic Therapy', 'cationic amino acid-porphyrin conjugate 4I with four lysine groups', 'At 3.9 ?M and 7.8 ?M, PACT induced 6 log units of inactivation of sensitive and multidrug resistant strains.', '', 'These results imply that 4I-mediated PACT (Photodynamic antimicrobial chemotherapy) therapy is an effective and safe alternative to conventional antibiotic therapy and has clinical potential for superficial drug-resistant bacterial infections. DOI: 10.1371/journal.pone.0176529 PMCID: PMC5426629', 28493985),
('Antibacterial Photodynamic Therapy', 'Antimicrobial blue light (aBL)', '', 'Much less genotoxic to host cells than ultraviolet-C (UVC) irradiation, which directly causes DNA damage in host cells', 'Unlike another light-based antimicrobial approach, antimicrobial photodynamic therapy (aPDT), aBL therapy does not require the involvement of an exogenous photosensitizer.', 28518072),
('Antibacterial Photodynamic Therapy', 'Photosensitizing agents rose bengal (RB) or methylene blue (MB), alone or combined with the antibiotics mupirocin (MU) or linezolid (LN).', 'By contrast, RB-aPDT and MB-aPDT effectively inactivated S. aureus, as evidenced by a 6 log10 reduction in bacterial growth', '', 'Antimicrobial photodynamic therapy (aPDT) could constitute an alternative therapy.', 28626456),
('Antibacterial Photodynamic Therapy', 'Boronic Acid Functionalized Photosensitizers', 'Treating planktonic cultures and biofilms of Gram-negative E. coli', '', 'This study investigated a new and innovative strategy for targeting polysaccharides found on the bacterial cell envelope and the biofilm matrix using the boronic acid functionalized and highly effective photosensitizer (PS) silicon(IV) phthalocyanine.', 28675648),
('Antibacterial Photodynamic Therapy', 'Methylene blue (MB)-mediated Antimicrobial photodynamic therapy (APDT)', 'MB (0.01%) was applied on the lesions and after 5min they were irradiated using a red laser (wavelength=660nm), fluence of 280J/cm2, 8J and 80s per point, 100mW, spot size 0.028cm2 and fluence rate of 3.5W/cm2', '', 'These results show that APDT can be used to treat infectious stomatitis in snakes.', 29037910),
('Antibacterial Photodynamic Therapy', 'Photosensitizer rose bengal (RB), combined or uncombined with gentamicin (GN)', 'Different concentrations of RB (ranging from 0.03 to 64 micro g/ml) were added to S. aureus in water suspensions or forming biofilms in the absence or presence of GN (1-40 micro g/ml) and the samples were irradiated (18 or 37 J/cm2).', '', '. Antimicrobial photodynamic therapy (aPDT) could constitute an alternative therapy to antibiotics especially against superficial infections caused by bacteria involved in multidrug resistance processes.', 29196246),
('Antibacterial Photodynamic Therapy', 'Methylene blue', 'The CFU/ml count demonstrated significant reduction (p less than or equal to 0.01) at the average 5.0 logs comparing with control group for the two species in all the tested concentrations.', '', 'Photodynamic therapy emerges as an alternative in microbial inactivation, due to its selectivity and to decreasing or dismissing antibiotic use.', 29454901),
('Antibacterial Photodynamic Therapy', 'The photosensitizer (PS) curcumin and the light source LED at 450nm)', 'The highest microbial inactivation was observed with 70% biofilm reduction in conditions 1.25 mg/mL curcumin, 2 h of PS incubation and 50 J/cm2.', '', 'Photodynamic therapy (PDT) is an alternative for microbial inactivation noninvasive without stimule of microbial resistance.', 29788897),
('Antibacterial Photodynamic Therapy', 'Photosensitizer indocyanine green (ICG) and ethylenediamine tetraacetate (EDTA)', 'In vitro activity against drug resistant Staphylococcus aureus and Pseudomonas aeruginosa,', '', 'Antimicrobial Photodynamic therapy(A-PDT) or Photodynamic antimicrobial chemotherapy (PACT) has been proposed as an alternative approach for inactivating bacteria, especially resistant bacterial biofilms.', 30633998),
('Antibacterial Photodynamic Therapy', 'Methylene blue and a low-level laser with a wavelength of 660 nm and fluence of 39.5 J/cm2 (energy of 15 J and time of 428 s)', 'Activity against clinical isolates of carbapenem-susceptible and carbapenem-resistant Acinetobacter baumannii', '', 'Antimicrobial photodynamic therapy against clinical isolates of carbapenem-susceptible and carbapenem-resistant Acinetobacter baumannii.', 30891656),
('Antibacterial Photodynamic Therapy', 'aBL (antimicrobial blue light) at 405- and 470-nm wavelengths', 'About 3.12-log10 reduction of bacterial colony forming units (CFU) was achieved by 27 J/cm 2 exposure at 405 nm, while about 3.70-log10 reduction of bacterial CFU was achieved by 234 J/cm2 exposure at 470 nm', '', 'Antimicrobial Blue Light Inactivation of Neisseria gonorrhoeae: Roles of Wavelength, Endogenous Photosensitizer, Oxygen, and Reactive Oxygen Species', 31157931),
('Antibacterial Photodynamic Therapy', 'Gallium aluminium arsenide (GaAlAs) laser', 'Reduction in colony count of P. intermedia after being exposed to GaAlAs diode laser for 1 minute from 369-229, 134 and 41; decrease in colony count of P. gingivalis after being exposed to GaAlAs diode laser for 1 minute from 286.52-197, 94 and 39,', '', 'Photodynamic therapy (PDT) kills the bacteria and also leads to the detoxification of endotoxins.', 31235678),
('Antibacterial Photodynamic Therapy', 'PDT with polyurethane (PUR) surfaces were coated with hypericin nanoformulations', '4.3 log10 reduction in bacterial growth in vitro', '', 'Synergistic effects of ultrasound and photodynamic therapy leading to biofilm eradication on polyurethane catheter surfaces modified with hypericin nanoformulations.', 31349520),
('Antibacterial Photodynamic Therapy', 'indium phosphide quantum dots (InP QDs)', 'We show that the superoxide generated by InP QDs is able to effectively kill drug-resistant bacteria in vivo to reduce subcutaneous abscess infection in mice without being toxic to the animal.', 'We show that the superoxide generated by InP QDs is able to effectively kill drug-resistant bacteria in vivo to reduce subcutaneous abscess infection in mice without being toxic to the animal.', 'These InP QDs thus provide a promising alternative to traditional small-molecule antibiotics, with the potential to be applied to a wide variety of infection types, including wound, respiratory, and urinary tract infections.', 34156817),
('Antibacterial Photodynamic Therapy', 'Methylene Blue antimicrobial photodynamic therapy (aPDT) (MB-aPDT)', '', '', 'Antimicrobial photodynamic therapy (aPDT) is a new therapeutic approach for infections, but it also improves healing in many wound models.', 34113639),
('Antibacterial Photodynamic Therapy', 'Curcumin and silver nanoparticles (AgNPs)', '', '', 'Antimicrobial photodynamic therapy (aPDT) is a non-invasive strategy against antibiotic-resistant bacteria. aPDT contains the combination of non-toxic dyes with harmless visible light to create reactive oxygen species (ROS) that selectively lead to microbial cell death.', 34379214),
('Antibacterial Photodynamic Therapy', 'benzylidene cyclopentanone (BCP) photosensitizers (Y1, P1 and P3)', 'The ex vivo experiments showed that P3 mediated aPDT resulted in 82.4% to 100% reduction of H. pylori CFU without damaging the gastric mucosa.', 'The ex vivo experiments showed that P3 mediated aPDT resulted in 82.4% to 100% reduction of H. pylori CFU without damaging the gastric mucosa.', 'Antimicrobial photodynamic therapy (aPDT) is a promising non-pharmacological antibacterial technology.', 34454316),
('Antibacterial Photodynamic Therapy', 'Zeolitic imidazolate framework (ZIF-8) NMOF nanocrystals are attached postsynthetically with SQ (designated as ZIF8-SQ)', 'ZIF8-SQ provides unparalleled aPDT action against methicillin-resistant Staphylococcus aureus (MRSA) and leads to complete loss of adherence of structurally robust bacterial biofilms.', '', 'Antimicrobial photodynamic therapy (aPDT) offers alternative modalities to combat the growing MDR typically by means of targeted cellular internalization of a photosensitizer (PS) capable of producing photoinduced reactive oxygen species (ROS).', 35026912),
('Antibacterial Photodynamic Therapy', 'VU0038882 and conjugated anti-Isd MAbs', 'Staphylococcus aureus', '', 'Antimicrobial photodynamic therapy is an effective alternative to antibiotics; therefore we developed an approach to simultaneously expose S. aureus to intracellular and extracellular photosensitizers.', 34516248),
('Antibacterial Photodynamic Therapy', 'Riboflavin', 'E.coli and MRSA', '', 'Riboflavin, as a photosensitizer to target mono and dual species bacterial biofilm of MDR E. coli and MRSA.', 32916327),
('Antibacterial Photodynamic Therapy', 'antimicrobial blue light and methylene blue', 'antimicrobial blue light and methylene blue-antimicrobial photodynamic therapy led to a significant reduction in the hydrolysis of nitrocefin (81-98 %).', '', 'Antimicrobial blue light and photodynamic therapy inhibit clinically relevant β-lactamases with extended-spectrum (ESBL) and carbapenemase activity.', 33157328),
('Antibacterial Photodynamic Therapy', 'Brominated carbon nanodots (BrCND)', 'BrCND demonstrate both type I and type II photosensitization under UV-A irradiation, and furthermore are shown to have significant antimicrobial effects against both Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus and Listeria monocytogenes as well.', '', 'The results described present the BrCND structure as a competitive new antimicrobial agent for controllable sterilization of bacteria.', 33211048),
('Antibacterial Photodynamic Therapy', '5-aminolevulinic acid derivatives; ALA-methyl ester, ALA-hexyl ester, and ALA-13A', 'In vivo studies revealed that ALA-methyl ester, ALA-hexyl ester, and ALA-13A are potent photosensitizers.', '', 'CONCLUSION: Photodynamic therapy is increasingly used to treat different types of skin infections caused by bacterial strains.', 33404073),
('Antibacterial Photodynamic Therapy', 'methylene blue (MB)-PDT', 'MB-PDT led to complete inhibition of all isolates at geometric mean concentrations of 1-16 mg/L.', '', 'Terbinafine resistant and susceptible strains are equally susceptible to MB-PDT', 33497815),
('Antibacterial Photodynamic Therapy', 'curcumin-aPDT', 'The MIC value of curcumin-aPDT for VRSA was found to be 156.25 microgram/ml whereas sub-MIC (1/2 of MIC) was found to be 78 microgram/ml', 'The test concentration of curcumin (78 ?g/ml) with light treatment (20 J/cm2 = 52 s) was found nontoxic to THP1 cell line.', 'Antimicrobial and antibiofilm photodynamic therapy against vancomycin resistant Staphylococcus aureus (VRSA) induced infection in vitro and in vivo.', 33508436),
('Antibacterial Photodynamic Therapy', 'phenothiazinium-based derivatives,', 'these compounds were able to eliminate various types of microorganisms, including Gram-(+) Staphylococcus aureus (S. aureus), Gram-(-) Escherichia coli, multidrug-resistant S. aureus, and their associated biofilms, at low drug and light dosages (e.g., 0.21 ng/mL in vitro and 1.63 ng/cm2 in vivo to eradicate S. aureus at 30 J/cm2).', 'The cytotoxicities of these synthesized pyridophenothiaziniums toward human normal fibroblast cells (WI38 cells) were assessed by using the standard MTT assay, and the results showed that all compounds except 3 displayed negligible cytotoxicity under studied conditions', 'In Vitro and In Vivo Demonstration of Ultraefficient and Broad-Spectrum Antibacterial Agents for Photodynamic Antibacterial Chemotherapy.', 33656316),
('Antibacterial Photodynamic Therapy', 'cationic photosensitizer (NB) and bacteriophage (ABP)-based photodynamic antimicrobial agent (APNB)', 'Both in vitro and in vivo experiments prove that APNB can efficiently treat A. baumannii infection.', '', 'Photodynamic antibacterial chemotherapy (PACT) has great potential to solve serious bacterial resistance, but it suffers from the inefficient generation of ROS and the lack of bacterial targeting ability.', 34163871),
('Antibacterial Photodynamic Therapy', 'oligo-thiophene-ethynylene (OTE)', 'the neutral OTEs exhibited better antibacterial activity in most cases, and OTEs bearing cyclic amino groups exhibited better antibacterial activity than those bearing acyclic ones in most cases.', '', 'Photodynamic therapy (PDT) is a potential approach to resolve antibiotic resistance, and phenylene/thiophene-ethynylene oligomers have been widely studied as effective antibacterial reagents.', 34410119),
('Antibacterial Photodynamic Therapy', 'fluorinated boron dipyrromethene (BODIPY)-based glycomimetics.', '', '', 'Photodynamic therapy is a promising strategy to reduce bacterial antibiotic resistance and employs photosensitizers, excitation light sources, and sufficient oxygen to generate toxic reactive oxygen species (ROS).', 34254513),
('Antibacterial Photodynamic Therapy', 'Tripterygium wilfordii Hook. f.', '', 'The in vitro APDT effects were also evaluated in the model animal Caenorhabditis elegans.', 'Natural photosensitizers from Tripterygium wilfordii and their antimicrobial photodynamic therapeutic effects in a Caenorhabditis elegans model.', 33848804),
('Antibacterial Photodynamic Therapy', 'buforin II-[Ru(bpy)3]2+ bioconjugate', 'The submicromolar activity of 1 against the multidrug-resistant strains Escherichia coli AR 0114 and Acinetobacter baumannii Naval-17 indicates strong synergy between the ruthenium complex and buforin II.', '', 'Antimicrobial photodynamic therapy (APDT) has gained increased attention because of its broad spectrum activity and lower likelihood to elicit bacterial resistance.', 32993282),
('Antibacterial Photodynamic Therapy', 'Cold atmospheric plasma (CAP)', 'We demonstrate that CAP treatment increases intracellular concentrations of reactive oxygen species (ROS) and nitric oxide and promotes the elimination of both antibiotic-sensitive and antibiotic-resistant S. aureus by RAW 264.7 cells.', '', 'Our study shows that CAP has beneficial effects on macrophage defense mechanisms and may potentially be useful in adjuvant antimicrobial therapies.', 34133202),
('Antibacterial Photodynamic Therapy', 'ZnTCPP/Ti3 C2 TX', 'a visible light responsive organic-inorganic hybrid of ZnTCPP/Ti3 C2 TX is designed and fabricated to treat bacterial infection with antibacterial efficiency of 99.86% and 99.92% within 10 min against Staphylococcus aureus and Escherichia coli, respectively. The porphyrin-metal complex, ZnTCPP, is assembled on the surface of Ti3 C2 TX MXene to capture bacteria electrostatically and the Schottky junction formed between Ti3 C2 TX and ZnTCPP promotes visible light utilization, accelerates charge separation, and enhances the mobility of photogenerated charges, and finally increases the photocatalytic activity.', 'Supporting Information, even if the concentration is increased from 200 to 400 Microgram mL-1, only ZnTCPP shows some cytotoxicity and ZnTCPP/Ti3C2TX still exhibits excellent cytocompatibility.', 'As a result of the excellent bacteria capturing ability and photocatalytic antibacterial effects, ZnTCPP/Ti3 C2 TX exposed to visible light has excellent antibacterial properties in vitro and in vivo. Therefore, organic-inorganic materials that have been demonstrated to possess good biocompatibility and enhance wound healing have large potential in bio-photocatalysis, antibacterial therapy, as well as antibiotics-free treatment of wounds.', 35657068),
('Antibacterial Photodynamic Therapy', 'Boron-dipyrromethene (BODIPY) is a type of photosensitizer (PSs)- BODIPY derivatives (BDP1-BDP6) modified', 'The results indicated that BDP3, which had 2, 6-diiodo and 8-phenyl substitution, was the best PS candidate with the highest reactive oxygen species (ROS) generation efficacy. BDP3 and BDP5 could rapidly kill Staphylococcus aureus (S. aureus) with the minimum inhibitory concentration (MIC) of 10 nM upon illumination.', 'the biosafety evaluation toward the mouse fibroblasts (L929 cells) suggested BDP3 had good cytocompatibility.', 'BDP3 destroyed the cell membrane structure of bacteria by generating ROS, which ultimately led to bacterial lysis and death. This work exhibits the great potential of rational designs of PS for aPDT applications.', 35561846),
('Antibacterial Photodynamic Therapy', 'two porphyrin-based photosensitizers (TMPyP and THPTS)', 'Using this method, we could confirm the susceptibility of several bacterial strains to photodynamic treatment, including extensively drug-resistant pathogens (XDR).', '', 'We recommend this luminometric method for high-throughput tasks requiring measurements of bacterial viability in the context of photodynamic treatment approaches.', 35630394),
('Antibacterial Photodynamic Therapy', 'TiO2 nanotube arrays (TNTs) decorated with Ag/SnO2-Sb nanoparticles (TNTs-Ag/SnO2-Sb) as the anode and Ti-Pd/SnO2-Sb as the cathode to construct an efficient photoelectrocatalytic (PEC) system', 'In this system, 99.9% of ARB was inactivated in 20 min, meanwhile, ARGs was removed within 30 min, and antibiotics were almost completely degraded within 1 h. Furthermore, the effects of system parameters on the removals of antibiotics, ARB and ARGs were also studied. The redox performance of the system was verified by adding persulfate. Escherichia coli, as a representative microorganism in aquatic environments, was used to evaluate the ecotoxicity of PEC treated chloramphenicol (CAP) solution. The ecotoxicity of CAP solution was significantly reduced after being treated by PEC.', '', 'This study could provide a potential alternative method for controlling antibiotic resistance and protecting the quality of reclaimed water.', 34736195),
('Antibacterial Photodynamic Therapy', 'photosensitizer LD4 in photodynamic antimicrobial chemotherapy (PACT), both alone and in combination with an antibiotic, on osteomyelitis', 'In a rabbit tibial osteomyelitis model, a reduction in bacterial numbers of more than 99.9% was recorded in the PACT group and the PACT + antibiotic group 5 weeks after treatment (p < 0.01). In histological analysis, repair of the damaged bone tissue was observed in the PACT group, and bone repair in the PACT + antibiotic group was even more significant. In radiological analysis, the X-ray Norden score showed that the severity of bone tissue defects or destruction followed the pattern: PACT + antibiotic group < PACT group < antibiotic group < control group.', '', 'Photodynamic antibacterial chemotherapy has attracted increasing attention as a potential alternative treatment. Its advantages are a broad antibacterial spectrum, lack of drug resistance, and lack of toxic side effects.', 35531297),
('Antibacterial Photodynamic Therapy', 'label-free surface-enhanced Raman spectroscopy (SERS) technology', 'The typical Raman peak intensities of I734/I867 showed a negative and non-linear correlation with the minimum inhibitory concentration (MIC). The correlation coefficient reached above 0.9. The target sites of oxacillin/cefazolin on S. aureus clearly reflected on SERS profiles.', '', 'This study indicates that SERS technology provides a rapid and flexible alternative to current drug susceptibility testing, laying a foundation for qualitative and quantitative evaluation of drug resistance in clinical detection.', 35231762),
('Antibacterial Photodynamic Therapy', 'electrochemical disinfection (ED) process assisted by molybdenum carbide (Mo2C) electrodes', 'The established ED process was proved to effectively inactivate multi-resistant ARB (i.e. Escherichia coli K-12 LE392 with resistance to kanamycin, ampicillin, and tetracycline) and to degrade ARGs (including tetA and blaTEM in the form of both intracellular (iARGs) and extracellular ARGs (eARGs)). Specifically, within 15 min treatment by the Mo2C-assisted ED under 2.0 V, a 5-log ARB removal was realized, without any ARB regrowth observed, indicating a permanent inactivation of ARB by the process. Moreover, degradation of the iARGs (0.4-log reduction of the blaTEM and 3.1-log reduction of the tetA) and the eARGs (4.2-log reduction of the blaTEM and 1.1-log reduction of the tetA) were achieved within 60 min, further underpinning the viability of the Mo2C-based ED. While e-, H2O2, and ', '', 'Collectively, the Mo2C-assisted ED demonstrated in the present study represents an attractive alternative to the traditional disinfection methods in combating the spread of antibiotic resistance.', 35334270),
('Antibacterial Photodynamic Therapy', 'electrochemical oxidation', 'Disinfection of polymicrobial urines by electrochemical oxidation. 4-6 logs bacterial removal were achieved for every bacterium tested when working with a microfluidic flow-through reactor after 180 min (0.423 Ah dm-3). The MIKROZON', '', 'This electro-ozonizer could be considered as a suitable alternative to reduce the risk of antibiotic resistance spread. Hence, this study provides an insight into different electrochemical reactors for the disinfection of complex hospital urine matrices and contributes to reduce the spread of antibiotic resistance through the elimination of ARGs.', 34923384),
('Antibacterial Photodynamic Therapy', 'effects of activated sludge and UV irradiation', 'Significant differences (p < 0.05) in the proportion of pathogens were observed between APT and the other samples, suggesting that the secondary treatment reduced its abundance. The MAS achieved 64.0-99.7% average removal efficiency for total (THB) and resistant heterotrophic bacteria, although the proportions of ARB/THB have increased for sulfamethoxazole, cephalexin, ciprofloxacin, and tetracycline. A total of 107 copies/mL of intI1 gene remained in the final effluent, suggesting that the treatment did not significantly remove this gene and possibly other ARGs.', '', 'In conclusion, disinfected effluents are still a potential source for ARB and ARGs, which highlights the importance to investigate ways to mitigate their release into the environment.', 35060061),
('Antibacterial Photodynamic Therapy', 'iridium oxide (IrOx)', 'Research results show that near-infrared light can enhance the peroxidase catalytic activity of IrOx and generate highly toxic hydroxyl radicals (', 'Importantly, IrOx has no obvious cellular and in vivo toxicity.', 'Accordingly, the novel photothermal nanozyme is expected to be applied to bacterial infectious diseases, such as wound healing, sepsis, and implant-related infections. Herein, we synthesized a new type of iridium oxide (IrOx) as an alternative to antibiotics.', 35469514),
('Antibacterial Photodynamic Therapy', 'Antimicrobial photodynamic therapy with curcumin', 'The strains were induced to form biofilm and incubated with curcumin for 20 min, irradiated with LED (Light Emitting Diode) 450 nm, at 110 mW/cm2, 50 J/cm2 for 455 s, subsequently counting the Colony Forming Units, Scanning Electron Microscopy (SEM) micrographs, Confocal Microscopy images, Resazurin dye test, ROS quantification to assess the effect of PDT on biofilm. The results show that PDT with curcumin reduced the biofilm growth of the MRSA strain. In addition, confocal microscopy showed that curcumin was internalized by S. aureus in the cells at the concentration used, and when isolated, curcumin and the irradiation parameter did not show cytotoxicity.', '', 'The study demonstrated that the PDT in the established parameters reduced the growth of the MRSA strain biofilm, making it a relevant alternative possibility for the inactivation of this strain.', 35041982),
('Antibacterial Photodynamic Therapy', 'light (? = 635 nm) in the presence of MB as a photosensitizer', 'The lethal dose of laser light (cell mortality about 99.9%) was 9.54 J cm-2, which corresponds to 30 min of irradiation. After a 15-fold phototherapy cycle, the tolerance to aPDT decreased, resulting in a decrease in the number of viable cells by 2.15 and 3.23 log10 CFU/ml units with the use of sub-lethal and lethal light doses, respectively. Multiple photosensitizations decreased the biofilm formation efficiency by 25 ', '', 'Many significant changes in the levels of the metabolites were detected demonstrating the response of A. baumannii to oxidative stress.', 35115588),
('Antibacterial Photodynamic Therapy', 'zinc phthalocyanine (ZnPcMe)', 'Palladium phthalocyanines (PdPcs) with methylpyridiloxy groups linked peripherally (pPdPc) or non-peripherally (nPdPc) were studied with full photodynamic inactivation for 5.0 microM nPdPc toward both F. hydatis, R and S strains (6 log), but with a half of this value (3 log) for 5.0 microM pPdPc and only for F. hydatis, S.', '', 'ZnPcMe showed optimal photocytotoxicity for inactivation of both F. hydatis R and S. The present study is encouraging for a further development of aPDT with phthalocyanines as an alternative method to antibiotic medication to keep under control the harmful pathogens in aquacultures'' farms.', 35678662),
('Antibacterial Photodynamic Therapy', 'organic photo-antimicrobial near-infrared (NIR) AIEgen BDPTV', 'DQVTA and DPTVN, upon photoirradiation of AIEgen BDPTV, the generation of abundant and highly toxic reactive oxygen species (ROS) irreversibly destroys MDR gram-positive bacteria through photodynamic therapy, which is better than commercial photosensitizers (including methylene blue, chlorin e6, and protoporphyrin IX) and antibiotic (cefoxitin). methicillin-resistant Staphylococcus aureus (MRSA) were completely killed. apable of successfully combating MRSA-infected wounds of mice, but not Escherichia coli (E. coli)-infected wounds.', '', 'We hope that this strategy could provide a new method to design powerful AIEgens to avoid the overuse and misuse of antibiotics.', 35635895),
('Antibacterial Photodynamic Therapy', 'series of photosensitizer-polypeptide conjugate (PPa-cP)', 'to realize the synergistic antibacterial effects on Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus (MRSA) under light irradiation. Among the synthesized PPa-cP, PPa-cP5 with the degree of polymerization of 37 and modified with a 1-methylimidazole side group exhibits the best antibacterial activity with a minimum inhibitory concentration value of 2 microm without light irradiation and 0.25 microm with light irradiation.', '', 'Overall, the present study establishes an efficient strategy for the treatment of S. aureus and S. aureus biofilm infections.', 35526119),
('Antibacterial Photodynamic Therapy', 'methylene blue (MB)-mediated aPDT', 'Pure MB-mediated aPDT significantly reduced the numbers of bacteria with biofilms on the wound surface and in the epidermis compared with those for the control tissue (saline only). However, there were many bacteria in the deeper region of the tissue. In contrast, MB/EDTA/ethanol/DMSO-mediated aPDT minimized the numbers of bacteria in the broad depth region of the tissue.', 'Still, a limited number of bacteria was observed in the subcutaneous tissue.', 'Conclusions: The depthwise analysis of bacteria demonstrated the efficacy of the MB-mediated aPDT with the addition of EDTA, ethanol, and DMSO in controlling burn wound infections. However, further improvement of the therapy is needed to suppress bacterial migration into the deep tissue completely.', 35088588),
('Antibacterial Photodynamic Therapy', 'Peripheral Pd(II)-and Zn(II)-Phthalocyanines', 'The photoinactivation results showed a full effect with 8 microM pPdPc for S strain and with 5 microM ZnPcMe for both A.hydrophila R and S strains.', '', 'Comparison between both new isolates of A.hydrophila (S and R) suggests that the uptakes and more likely photoinactivation efficacy of the applied phthalocyanines are independent of the drug sensitivity of the studied strains.', 35203593),
('Antibacterial Photodynamic Therapy', 'microwave (MW) irradiation', 'ARGs removal efficiency (85.5%)', '', 'Microwave is a promising technology for disinfecting airborne microbes and preventing the spread of antibiotic resistance.', 35410010),
('Antibacterial Photodynamic Therapy', 'heterogeneous photocatalytic oxidation (UVA-TiO2 system)', 'bacterial survival and higher conjugative transfer frequency than E. coli DH5alpha resistant to nalidixic acid and rifampicin', '', 'This new perspective provides detailed information on the practical application of photocatalytic oxidation for inactivating ARB and hampering the spreading of ARGs in the aquatic environment.', 35453030),
('Antibacterial Photodynamic Therapy', 'Ti3C2Tx MXene loaded with indocyanine green', 'great anti-MRSA activity of ICG-MXene under NIR was attributed to the combination of photothermal effect of MXene (high temperature) and photodynamic effect of ICG (high level of reactive oxygen species)', '', 'Our findings indicate that MXene can be used as both the photothermal agent and the carrier of photosensitizers to achieve the synergistic PTT/PDT therapy for bacterial infections.', 35785716),
('Antibacterial Photodynamic Therapy', '5-aminolevulinic acid (ALA) Photodynamic therapy', 'significant killing effect on M. abscessus at ALA concentrations greater than 50 Microg/ml and the effect increased with increasing photosensitizer concentrations. ALA-PDT also showed a notable scavenging effect on M. abscessus biofilm, which was also enhanced with increasing ALA concentrations', '', 'Conclusions: ALA-PDT has a significant killing effect on M. abscessus and can increase its antibiotic susceptibility.', 35297368),
('Antibacterial Photodynamic Therapy', 'red & blue LED effects', 'Blue LED light inhibited MRSA, ESBLs-Eco, and MDR-Pae in vitro study. In vivo, RBLL accelerated wound healing, reduced levels of pathogenic bacteria on the wound surface while increasing the blood supply to the wound surface and inhibiting the excessive inflammatory response.', 'This study is aimed to evaluate and compare the therapeutic effect of RBLL light on different multi-drug resistant (MDR) bacteria in vitro and male Sprague-Dawley (SD) rat refractory MDR infection wound model in vivo.', 'Conclusion: RBLL showed a great potential gain for the treatment of MDR bacterial infected wounds, suggesting PBM therapy is an inexpensive, convenient, pain-free, and safe therapeutic intervention for refractory MDR infection wounds.', 34989417),
('Antibacterial Photodynamic Therapy', 'silver nanoparticles attached to methylene blue', 'effective photodynamic therapy agent used to deactivate the Gram-negative bacteria, E. coli, and Gram-positive bacteria, S. aureus', '', 'Ag NPs/ MB combination has potential to be used in PDT where standard photosensitizers have limitations.', 35545200),
('Antibacterial Photodynamic Therapy', 'ALA-PDT', 'treatment of diabetic foot ulcer with infection, All patients'' wounds were firstly irradiated with 20% ALA-PDT (635 nm, 100 J/cm2, 80 mW/cm2) using the red LED to control the infection.', '', 'Conclusions: ALA-PDT treatment for DFUs with infection show successful outcomes and might ultimately avoid amputation.', 35331957),
('Antibacterial Photodynamic Therapy', 'Photothermal and photodynamic inactivation of using conjugated polymers', 'These platforms have demonstrated to be a reliable, rapid, and efficient alternative to eliminate tenacious pathogens while avoiding the emergence of resistance mechanisms. showing antimicrobial activity triggered by light, conjugated polymers (CPs) have risen as the most promising option to tackle this complex situation.', 'low cytotoxicity', 'conjugated polymers with applications in photodynamic inactivation and photothermal therapy towards bacteria elimination', 36049287),
('Antibacterial Photodynamic Therapy', 'Iridium oxide also has photothermal properties', 'Research results show that near-infrared light can enhance the peroxidase catalytic activity of IrOx and generate highly toxic hydroxyl radicals (', 'IrOx has no obvious cellular and in vivo toxicity.', 'novel photothermal nanozyme is expected to be applied to bacterial infectious diseases, such as wound healing, sepsis, and implant-related infections.', 35469514),
('Antibacterial Photodynamic Therapy', 'Photodynamic Inactivation (PDI) at 450 nm wavelength, 40 mW/cm2, with a 5 to 80 J/cm2 light dose.', 'survival of S. aureus in PDI as a function of light dose and fixed concentration of curcumin. No microbial toxicity was observed with the curcumin use in the dark', '', 'Different combination protocols of both therapies exert synergistic or antagonistic effects. The ROS produced by PDI can weaken the cell, facilitating the action of antibiotics, or degrade the antimicrobials, decreasing their efficiency. Moreover, the antibiotic and photosensitizer interaction may compromise photodynamic efficiency.', 36476814),
('Antibacterial Photodynamic Therapy', 'new Donor-p-Acceptor (D-p-A ) type luminogen TTTh', 'the bacterial burden of wounds in TTTh group decreased by more than 99.9 % upon infection of S. aureus', 'TTTh treatment did not affect the weight of mice, suggesting acceptable biosafety of TTTh', 'TTTh killed the extracellular MRSA by disrupting the membrane integrity and inducing ROS accumulation in bacteria. TTTh significantly reduced the number of intracellular S. aureus by potentiating the lysosomal acidification and maturation of macrophages.', 36176034),
('Antibacterial Photodynamic Therapy', 'photodynamic inactivation (PDI) using violet-blue (VB) light', 'Exposure to 405-nm light resulted in a dose-dependent increase in fluorescence in both C. jejuni and E. coli, suggesting a photoexcitation-induced ROS increase', '', 'VB light increases intracellular reactive oxygen species (ROS) to high levels. They also show that VB light causes rapid inactivation of both pyruvate and 2-oxoglutarate oxidoreductases, thus interrupting the citric acid cycle. They confirmed that C. jejuni is highly susceptible to VB light.', 35924857),
('Antibacterial Photodynamic Therapy', 'Combining antimicrobial photodynamic and antibiotic', 'Performing aPDT with the photosensitizer methylene blue (maximum molar absorptivity of 85,000 M-1 cm-1 at 664 nm) in combination with antibiotics chloramphenicol and tetracycline results in significant reductions in resistance for two methicillin-resistant Staphylococcus aureus (MRSA) strains, USA300 and RN4220. the maximum aPDT treatment on S. aureus USA300 altered both Chl and Tet tolerance designations from resistant to susceptible. For RN4220, mean Chl MIC decreased from 29.3 to 6.70 microg/mL (i.e., >4.37-fold), and mean Tet MIC decreased from 1.50 to 0.377 microg/mL (i.e., >3.97-fold).', '', 'these results suggest that concurrent aPDT consistently decreases S. aureus resistance by improving susceptibility to antibiotic treatment.', 36037346),
('Antibacterial Photodynamic Therapy', 'organic photo-antimicrobial near-infrared (NIR) AIEgen BDPTV equipped with a phenylboronic acid moiety,', 'in vitro experimental results showed that methicillin-resistant Staphylococcus aureus (MRSA) were completely killed using AIEgen BDPTV', '', 'the generation of abundant and highly toxic reactive oxygen species (ROS) irreversibly destroys MDR gram-positive bacteria through photodynamic therapy, which is better than commercial photosensitizers. More importantly, AIEgen BDPTV was capable of successfully combating MRSA-infected wounds of mice, but not Escherichia coli (E. coli)-infected wounds. We hope that this strategy could provide a new method to design powerful AIEgens to avoid the overuse and misuse of antibiotics.', 35635895),
('Antibacterial Photodynamic Therapy', 'Nanomaterials-based photothermal therapy (PTT) and photodynamic therapy (PDT): loaded indocyanine green (ICG) on the Ti3C2Tx MXene nanosheets (454 nm)', 'Under NIR, however, the viability loss of MRSA remarkably increased to 45% for MXene, 66% for ICG and 100% for ICG-Mxene activity against methicillin-resistant Staphylococcus aureus (MRSA).', '', 'We further found that the great anti-MRSA activity of ICG-MXene under NIR was attributed to the combination of photothermal effect of MXene (high temperature) and photodynamic effect of ICG (high level of reactive oxygen species). Our findings indicate that MXene can be used as both the photothermal agent and the carrier of photosensitizers to achieve the synergistic PTT/PDT therapy for bacterial infections.', 35785716),
('Antibacterial Photodynamic Therapy', 'water-soluble NIR fluorescence emission rhodamine-based photosensitizer with aggregation-inducing emission (AIE) effects, referred to as CS-2I', 'CS-2I achieves complete inhibition of methicillin-resistant Staphylococcus aureus (MRSA) at an extremely low concentration (0.5 microm) and light dosage (6 J cm-2 ).', '', 'In summary, we developed a new rhodamine-based NIR PS (CS-2I) with AIE effects and the excellent ability for selective discrimination and ablation of drug-resistant Gram-positive bacteria via PDT. CS-2I was mixed with Carbomer 940 to obtain an antibacterial hydrogel dressing (CS-2I@gel), and in vivo results demonstrated that CS-2I@gel not only provided extraordinary photodynamic bactericidal ability, but also promoted the healing of MRSA-infected wounds in mice due to the adhesiveness and moisture of the hydrogel.', 35750469),
('Antibacterial Photodynamic Therapy', 'photosensitizer (pyropheophorbide a, PPa)-conjugated cationic polypeptide (PPa-cP)', 'The developed PPa-cP exhibited excellent antibacterial properties against S. aureus and MRSA under light irradiation. PPa-cP5 modified with methyl imidazole effectively inhibited the growth of S. aureus with a concentration of 0.25 microm under light irradiation, indicating its excellent antibacterial activity.', '', 'Pa-cP exhibited enhanced antibacterial activity and synergistic antibacterial effects under light irradiation. Among these PPa-cP, PPa-cP5 showed the best antibacterial activity and the highest synergistic effect. PPa-cP5 could target the bacterial membrane and destroy the bacterial cell membrane. The hemolysis test revealed that PPa-cP5 showed good biocompatibility. Finally, PPa-cP5 achieved an effective biofilm penetration and eradication by taking advantage of their positive charge. Overall, this study establishes a promising strategy to treat bacterial infections.', 35526119),
('Antibacterial Photodynamic Therapy', 'combination of amoxicillin and light-activated methylene blue', 'Amoxicillin and light-activated MB can mutually boost each other''s uptake in S. aureus, producing up to 8 logs of reduction of MRSA infections when they are co-administrated. It can lead to more than 99% of reduction of S. aureus infections', '', 'his simple combination of light-activated MB and amoxicillin can ultimately reform our treatment against MDR S. aureus pathogens including MRSA, significantly alleviating the health and economic burden of S. aureus infections across the world.', 36099788),
('Antibacterial Photodynamic Therapy', 'novel palladium nanoparticles decorated bismuth oxybromide (Pd/BiOBr) nanostructures', 'The photocatalytic antibacterial efficiency of Pd/BiOBr was evaluated against some common pathogenic strains of Gram-positive and Gram-negative bacteria (Pseudomonas fluorescens, Pseudomonas aeruginosa, Escherichia coli, Aeromonas salmonicida, Salmonella typhimurium, Klebsiella pneumoniae, Bacillus subtilis). Pd/BiOBr showed excellent photocatalytic disinfection efficacy with > 99.9% bacterial inactivation. A very low concentration of Pd/BiOBr (0.5 microg/mL) effectively inhibited the bacterial growth in response to just 2 h of visible light irradiation, while 1 microg/mL of Pd/BiOBr completely killed all the tested bacterial strains', '', 'The developed materials with exceptional antibacterial broad range efficiency can be used in different photocatalytic disinfection systems including water purification systems, biofilm exclusion and combating differential antibiotic resistance.', 35752021),
('Antibacterial Photodynamic Therapy', 'Photothermal Nanozyme-Based Microneedle', '95% bacterial biofilm infections (BBIs) elimination can be achieved by combining heat stress-triggered iron interference with iron-nutrient immune reactivation.', '', 'photothermal microneedle patch (FGO@MN) is synthesized by the growth of Fe3 O4 nanoparticles on graphene oxide nanosheets and then encapsulated in methacrylated hyaluronic acid needle tips.', 36239263),
('Antibacterial Photodynamic Therapy', 'cationic aggregation-induced emission luminogens named with triphenylamine thiophen pyridinium (TTPy)', 'S. aureus was killed effectively with nearly no surviving colony in the presence of 0.05 ', 'toxicity was significantly observed at 1.0 ', 'This study exhibits an efficient photodynamic antibacterial treatment to BE, which induces an early intraocular immune response and saves useful vision, endowing TTPy a promising potential for clinical application of ocular infections. TTPy induces innate immune response at an early stage of infection, limiting subsequent robust inflammation and protecting retina from bacterial toxins and inflammation-induced bystander damage.', 35794437),
('Antibacterial Photodynamic Therapy', 'a visible light responsive organic-inorganic hybrid of ZnTCPP/Ti3 C2 TX is designed', 'treat bacterial infection with antibacterial efficiency of 99.86% and 99.92% within 10 min against Staphylococcus aureus and Escherichia coli, respectively.', '', 'As a result of the excellent bacteria capturing ability and photocatalytic antibacterial effects, ZnTCPP/Ti3 C2 TX exposed to visible light has excellent antibacterial properties in vitro and in vivo. Therefore, organic-inorganic materials that have been demonstrated to possess good biocompatibility and enhance wound healing have large potential in bio-photocatalysis, antibacterial therapy, as well as antibiotics-free treatment of wounds.', 35657068),
('Antibacterial Photodynamic Therapy', '265 nm UVC', 'Significant P. aeruginosa growth inhibition in the in vitro infection model was achieved with UVC, that resulted in a >3.5 log10 reduction of bacteria in a subsequent ex vivo keratitis model (p < 0.05).', '', 'In vitro and ex vivo testing confirmed therapeutic potential of 15 s UVC, proved effective in treating murine bacterial keratitis.', 35568373),
('Antibacterial Photodynamic Therapy', 'Photosensitizers with aggregation-induced far-red/near-infrared emission- AIE-active PSs (TBTPy and TBTCy)', 'Antimicrobial mechanism is found to be changing osmotic pressure of cytoplasm in E. coli, causing cell deformation and destruction of S. aureus and C. albicans', '', 'In vivo anti-infection experiment demonstrated AIE PSs can accelerate the healing process of the burned wounds on rats infected by methicillin-resistant S. aureus (MRSA) or E. coli, indicating their potential to treat tertiary burns in clinical application. Therefore, the attained AIE PSs hold great promise as antimicrobial candidates in infective therapeutic application.', 36563423),
('Antibacterial Photodynamic Therapy', 'blue light administered at continuous low-irradiance phototherapy (CLIP)', 'CLIP exposure utilizing irradiances as low as 2.78 mW/cm2 delivered over 24 h resulted in a >3.0-log (>99.9%) and >2.0-log (>99.0%) microbial load reduction when organisms were grown in planktonic and biofilm-encapsulated conditions, respectively. ( 405 nm irradiation)', 'Human fibroblast viability and proliferation were unaffected by CLIP.', 'This is the first report demonstrating the antimicrobial efficacy of CLIP for MDROs found in infected wounds. CLIP did not compromise cultured human fibroblast growth and survival. This study demonstrated that very low fluence rates (irradiances) delivered over extended periods are potently antimicrobial.', 36126289),
('Antibacterial Photodynamic Therapy', 'Photoactivated chromophore for keratitis-corneal crosslinking (PACK-CXL)', '365 nm UVA light source for 30 min at 3mW/cm2 (standard protocol) or for 5 min at 18mW/cm2, PACK-CXL treatment protocol delivering the same energy dose (5.4 J/cm2) for keratitis', '', 'PACK-CXL protocols demonstrated a significant bactericidal effect on all tested isolates. The accelerated PACK-CXL protocol can be recommended for empirical use in the treatment of bacterial corneal infections in veterinary patients while awaiting culture results. This will facilitate immediate treatment', 35978428),
('Antibacterial Photodynamic Therapy', 'Photothermal nanofibrillar membrane based on hyaluronic acid and graphene oxide', 'In vitro antibacterial activity studies performed on Staphylococcus aureus and Pseudomonas aeruginosa revealed that such electrospun membranes reduce the viability.', '', 'Specific in vitro experiment demonstrated also that is possible to disrupt, through laser irradiation, the biofilms formed onto the membrane.', 35760161),
('Antibacterial Photodynamic Therapy', 'Photon-driven advanced oxidation processes (AOPs)', 'Effective against Escherichia coli and Micrococcus flavus', '', '', 35359212);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Photodynamic Therapy', 'pore-forming toxin (PFT)-responsive biomimetic nanobubble is designed', '', '', '(PFT)-responsive biomimetic nanobubble is designed, which is constructed by co-encapsulating a perfluorocarbon nanoemulsion and a photosensitizer within the red blood cell membrane. It is shown that PFTs derived from three pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), group A Streptococcus (GAS), and Listeria monocytogenes (LM), can be effectively absorbed by the nanobubble. In three skin infection models, treatment with the nanobubbles results in significantly decreased lesion formation and reduced inflammation.', 35836329),
('Antibacterial Photodynamic Therapy', 'photodynamic therapy (wavelength of 660nm, 400mW/cm2, 300 seconds, methylene blue 0.01%)', 'Photodynamic therapy is a feasible approach to treating nasal carriage of S aureus.', '', 'Randomized controlled pilot study show effective strategy', 36396084),
('Antibacterial Photodynamic Therapy', 'methylene blue (MB)-mediated Apdt (photodynamic)', 'The MDR bacterial count decreased immediately after aPDT', '', 'aPDT can be used to treat subgingival MDR bacterial infections, but the long-term effects of treatment need to be further studied.', 36351563),
('Antibacterial Photodynamic Therapy', 'photodynamic therapy (aPDT) using two water-soluble tetra-cationic porphyrins (3-H2TMeP and 4-H2TMeP)', 'aPDT against the monoculture using a non-cytotoxic concentration of 3-H2TMeP and 4-H2TMeP porphyrins (40 microM), with 30 min of light irradiation in Gram-positive and 90 min for Gram-negative bacteria. The aPDT using the 4-H2TMeP porphyrin was also tested against five different polycultures (Coagulase positive Staphylococcus (CPS) and Pseudomonas sp.; E. coli and Proteus sp.; Pseudomonas sp. and Proteus sp.; CPS and E. coli; and CPS and Proteus sp.) for 90 min.', '', 'Only the 4-H2TMeP porphyrin had antibacterial activity against MDR bacteria in monoculture, especially S. pseudointermedius and P. aeruginosa. In polyculture, the 4-H2TMeP porphyrin reduced bacterial concentrations (p < 0.05) in the associations of E. coli and S. pseudointermedius, P. aeruginosa and S. pseudointermedius, and P. aeruginosa and P. mirabilis. These results showed that aPDT using 4-H2TMeP is a good option for future associations of aPDT and other therapies or in vivo research.', 36334907),
('Antibacterial Photodynamic Therapy', 'Photobiomodulation (PBM) detriments of lasers, Red & Blue LED light (RBLL)', 'Methicillin-resistant Staphylococcus aureus (MRSA), Extended-spectrum beta-lactamases -producing Escherichia coli (ESBLs-Eco), and the MDR Pseudomonas aeruginosa (MDR-Pae) were employed to evaluate the antibacterial effects of the Blue LED light in vitro.', 'safe therapeutic intervention', 'RBLL showed a great potential gain for the treatment of MDR bacterial infected wounds, suggesting PBM therapy is an inexpensive, convenient, pain-free, and safe therapeutic intervention for refractory MDR infection wounds.', 34989417),
('Antibacterial Photodynamic Therapy', 'metal oxide samarium orthovanadate (SmVO4) with nanorod structure, coupled with UiO-66-NH2 for the photocatalytic degradation.', 'The integration of UiO-66-NH2 with SmVO4 enhanced the light absorption, recombination resistance, carrier lifetime (from 0.382 to 0.411 ns) and specific surface area (from 67.17 to 246 m2/g) of the composite system as confirmed from multiple analyses. The obtained results further indicated that SmVO4/UiO-66-NH2Nanocomposites could form a direct Z-scheme based heterojunction.', '', 'mechanism of charge transfer leads to the effective degradation of tetracycline hydrochloride- TCH molecules up to 50% in 90 min under solar light, while it is degraded only 30% in the case of bare-SmVO4 nanorods. the incorporation of UiO-66-NH2 positively influences photoelectrochemical properties and improves the overall photoredox properties of SmVO4 for the degradation of complex compounds like antibiotic TCH molecules.', 35584713),
('Antibacterial Photodynamic Therapy', 'photosensitizer, prepared by the coupling of commercial IR820 and d-propargylglycine (a type of d-amino acid, DAA)', 'The laser energy at 808 nm could make IR820-DAA a synergistic photothermal/photodynamic agent for efficient antibacterial therapy and wound healing. Furthermore, IR820-DAA exhibits good water solubility and biological safety for clinical translation and even possesses biofilm degradation activity toward methicillin-resistant Staphylococcus aureus (MRSA)', '', 'the proposed IR820-DAA holds great promise as a nonantibiotic tool for the treatment of bacteria-related diseases and offers a blueprint for building the precise synergistic antibacterial therapeutic platform.', 36198018),
('Antibacterial Photodynamic Therapy', 'CuS nanospheres with predominant VCuSCu and VCuSS vacancy (abbreviated as CuS and CuS-T150, respectively) by synergistic effect of photodynamic and photothermal therapy.', 'The combination of experimental and theoretical calculation results demonstrates that CuS-T150 exhibits excellent antibacterial, achieving bactericidal rates of 99.9% against to Escherichia coli (E. coli) under 808 nm laser irradiation.', '', 'Compared with CuS, the superior antimicrobial activity of CuS-T150 is mainly attributed to its stronger ability to adsorb oxygen molecules, more easily bind with surface of E. coli, and higher photothermal conversion efficiency (PTCE). This work provides a deeper understanding of nanomaterials with vacancy modulated the antibacterial efficiency by synergistic effect of photodynamic and photothermal therapy.', 36303519),
('Antibacterial Photodynamic Therapy', 'Sonoantimicrobial chemotherapy (SACT) is a novel therapy of low-frequency and low-intensity ultrasound (LFLIU) combined with a sonosensitizer (Emodin )', 'Methicillin-sensitive S. aureus (MSSA) was treated with different intensities of S-LFLIU for 15 min. The survival rates of MSSA were evaluated using the value for optical density at 600 nm (OD600) after 6 h and 24 h of incubation. Based on these results, ultrasonic irradiation at 1 W/cm2 may provide favorable conditions for bacterial growth inhibition', '', 'LFLIU could produce a large amount of reactive oxygen species (ROS), destroy the integrity of the bacterial membrane and cell wall, and downregulate the expression of genes involved in oxidative stress, membrane wall synthesis, and bacterial virulence, as well as that of other related genes (agrB, pbp3, sgtB, gmk, zwf, and msrA).', 36069576),
('Antibacterial Photodynamic Therapy', 'infrared (NIR) photosensitizer (T780T-Gu) by combining positively-charged guanidinium (Gu)', 'The proposed molecule T780T-Gu exhibits synergistic photothermal therapy/photodynamic therapy effect against both H. pylori biofilms and multidrug-resistant (MDR) clinical strains.', '', 'the phototherapy mechanism of T780T-Gu acquired by the RNA-seq analysis indicates that structural deficiency as well as a decrease in metabolism and defense activity are the possible reasons for the efficient H. pylori phototherapy.', 36417577),
('Antibacterial Photodynamic Therapy', 'Visible light-regulated cationic polymer coupled with photodynamic', 'E. coli bacteria multiplied for 20 generations under the continuous stimulation of Ce6-TPP-PEI with light irradiation (630 nm, 30 mW/cm2, 5 min), the MIC value against this bacterium was 1.911 microg/mL', '', 'The combination of photodynamic therapy and cationic polymer exerted significant anti-pathogen and biofilm ablation effects. Finally, hemolysis assay demonstrated that the photosensitizer chlorin e6-loaded polyethyleneimine-based micelle Ce6-TPP-PEI exhibited good biocompatibility, ultra-efficient, anti-drug resistance, and biocompatible multifunctional antibacterial system.', 36424663),
('Antibacterial Photodynamic Therapy', 'The combination of algae lipids with innovative strategies, such as antibacterial photodynamic therapy (aPDT)', 'The results revealed that the total extracts of algae promote S. aureus inhibition after light irradiation, with a decrease of ca. 6 log10 (CFU/mL) after 15 min of treatment with both extracts of algae. The polar lipid fractions, composed by phospholipids, glycolipids and betaine lipids, from C. tomentosum and C. vulgaris also revealed antibacterial potential in combination with aPDT, but a decrease of ca. 6 log10 (CFU/mL) was reached at 60 min of treatment', '', 'Lipids isolated from algae have been recognized for their broad-spectrum antimicrobial activities and are considered a promising natural alternative to help control pathogenic microbial infections. These results unveil algae lipids as antibacterial compounds in combination with aPDT displaying an alternative from natural origin to tackle pathogen resistance.', 36181961),
('Antibacterial Photodynamic Therapy', 'Antimicrobial blue light (aBL) therapy', 'out of gram positive and negative bacteria, only some bacterial strains were susceptible to 475 nm blue light, which was associated with the lack of RecA, i.e., a fully functional DNA repair mechanism', '', 'It is demonstrated that the insertion of the gene recA reduced the susceptibility, indicating a protective mechanism conveyed by the bacterial SOS response. However, mitigating this pathway via three known RecA inhibiting molecules (ZnAc, curcumin, and Fe(III)-PcTs) did not result in an increase in bactericidal action. Hence, creating synergistic effects by combining a multitarget therapy, such as aBL, with an RecA targeting treatment could be a promising strategy to overcome the dilemma of antibiotic resistance in the future.', 36294934),
('Antibacterial Photodynamic Therapy', 'photo-sequencing batch reactor (PSBR)', 'PSBR has similar nutrient removal rate and a 30% higher antibiotics removal rate due to the corporation of microalgae (Chlorella) and bacteria, and the absolute abundance of ARGs decreased by 78% in PSBR. Further investigation showed that PSBR had certain advantages in removing quinolones and the corresponding removal rate could reach up to 90%.', '', 'As concluded photo-sequencing batch reactor (PSBR) in removing multiple antibiotics and nutrients from aquaculture wastewater as well as the antibiotic resistance genes (ARGs) proliferation were firstly investigated. This study provides an alternative and effective method to aquaculture wastewater treatment, which present high nutrients and antibiotics removal efficiencies and low ARGs transmission.', 34006208),
('Antibacterial Photodynamic Therapy', 'methylene blue (MB) as an effective photosensitizer was conjugated with carbon quantum dots (CQDs),', 'Combined with 808 nm and 660 nm laser irradiation, the minimum bactericidal concentration of CQDs-MB towards S. aureus and E. coli was 5 microm.', '', 'this study provides a potential candidate material based on CQDs for clinical applications.', 35879646),
('Antibacterial Photodynamic Therapy', 'photodynamic nanoagent, composed of chlorin e6 (Ce6)-loaded water-soluble chitosan-coated iron oxide nanoparticles (named Ce6@WCS-IONP)', 'In vitro studies verified that Ce6@WCS-IONP has superior photodynamic bactericidal effect against planktonic MRSA.', 'The fabricated Ce6@WCS-IONP has negligible toxicity to mammalian cells', 'Ce6@WCS-IONP could effectively penetrate into MRSA biofilm, photosensitizer-loaded cationic IONP with effective biofilm penetration and photodynamic eradication potential might be a promising nano platform in fighting against antibiotic-resistant microbial pathogen and biofilm.', 35760234),
('Antibacterial Photodynamic Therapy', 'gallium protoporphyrin liquid crystalline lipid nanoparticles (GaPP-LCNP) as a photosensitizer', 'LCNP significantly enhanced the performance of GaPP as photosensitizer by two-fold, which was correlated with higher antibacterial activity, reducing the viability of planktonic P. aeruginosa by 7 log10 using 0.8 microM GaPP-LCNP and a light dose of 17 J.cm-2. GaPP-LCNP also reduced the viability of biofilms by 6 log10 at relatively low light dose of 34.2 J.cm-2 using only 3 microM GaPP-LCNP.', '', 'The high antibiofilm activity of GaPP-LCNP at low GaPP-LCNP dose indicated the high efficiency and safety profile of GaPP-LCNP as a promising platform for photodynamic inactivation of recalcitrant infections.', 36297559),
('Antibacterial Photodynamic Therapy', 'conjugation of the cell-binding domain (CBD3) of a Staphylococcus aureus phage endolysin to a photoactivatable silicon phthalocyanine (IRDye 700DX)', 'We show that, upon red-light activation, the resulting CBD3-700DX conjugate generates reactive oxygen species that effectively kill high loads of planktonic and biofilm-resident staphylococci, including MRSA. Furthermore, CBD3-700DX is readily internalized by mammalian cells, where it allows the targeted killing of intracellular MRSA upon photoactivation. Intriguingly, aPDT with CBD3-700DX also affects mammalian cells with internalized MRSA, but it has no detectable side effects on uninfected cells. Altogether, we conclude that CBD3 represents an attractive targeting agent for Staphylococcus-specific aPDT, irrespective of planktonic, biofilm-embedded, or intracellular states of the bacterium.', '', 'aPDT with the resulting conjugate shows high target specificity toward MRSA with minimal side effects.', 35196798),
('Antibacterial Phytochemical', 'Totarol: diterpenoids isolated from the bark of Podocarpus nagi (Podocarpaceae)', 'The synergistic activity of anacardic acid caused the minimum bactericidal concentration (MBC) of totarol to be lowered from 1.56 to 0.2 micrograms/ml.', '', 'Totarol [1], the most abundant compound among the six, exhibited potent bactericidal activity only against Gram-positive bacteria, among which Propionibacterium acnes was the most sensitive bacterium.', 1453180),
('Antibacterial Phytochemical', 'Phytoalexin isolate 5,7,2'',6''-tetrahydroxy-6-isoprenyl-8-lavandulyl-4''-methox yflavanone (exiguaflavanone D)and 5, 2'',6''-trihydroxy-8-lavandulyl-7-methoxy-flavanone (exiguaflavanone B)', 'Exiguaflavanone D inhibited MRSA 1.56-6.25 micro g/ml, and Exiguaflavanone B inhibited at 50 micro g/ml concentration', '', 'Flavanones with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. With the therapeutic concept of using the defensive ability of plants against microbial infections, phytoalexin, an antimicrobial phytochemical was studied for its ability to inhibit the growth of methicillin-resistant Staphylococcus aureus (MRSA).', 7897594),
('Antibacterial Phytochemical', 'A sesquiterpene lactone, identified as [3aR-(3a alpha, 7 beta,8a beta)]-3,3a,4,7,8,8a-hexahydro-7- methyl-3-methylene-6-(3-oxo-1-butenyl)-2H-cyclohepta[b]furan-2-one, or xanthatin, isolated from leaves of an annual herb, Xanthium sibiricum Patr er Widd', 'Active against methicillin-resistant Staphylococcus aureus', '', 'By monitoring antibacterial activity against MRSA strains, it was shown that a sesquiterpene lactone, identified as [3aR-(3a alpha, 7 beta,8a beta)]-3,3a,4,7,8,8a-hexahydro-7- methyl-3-methylene-6-(3-oxo-1-butenyl)-2H-cyclohepta[b]furan-2-one, or xanthatin, isolated from leaves of the herb, had outstandingly potent activity against S. aureus species, including MRSA; its activity against MRSA and MSSA strains was similar.', 9364417),
('Antibacterial Phytochemical', 'Natural abietanes: 6,7-dehydroferruginol methyl ether (3), ferruginol (5), 11-hydroxy-12-oxo-7,9(11) ,13-abietatriene (7), royleanone (9), demethyl cryptojaponol (12), salvinolone (14), sugiol methyl ether (16), sugiol (17), 5,6-dehydrosugiol methyl ether (19), 5,6-dehydrosugiol (20), 6beta-hydroxyferruginol (23), and taxodione (25)', 'Phenols (12-hydroxyabieta-8,11,13-trien-6-one 22 and 23), catechols (12 and 14) and taxodione 25 has MIC 4-10 microg/mL against MRSA and 4-16 microg/mL of MIC against VRE, Quinone methide had MIC 0.5-1 microg/mL of against both MRSA and VRE.', '', 'Synthesis of variously oxidized abietane diterpenes and their antibacterial activities against MRSA and VRE.', 11249127),
('Antibacterial Phytochemical', '2'',4''-dihydroxy-8-gamma,gamma-dimethylallyl-2",2"-dimethylpyrano[5",6":6,7]isofla vanone (bidwillon B)', '(MICs) of 3.13-6.25mg/l against MRSA strains', '', 'Bidwillon B may prove to be a potent phytotherapeutic and/or combination agent with mupirocin in the elimination of nasal and skin carriage of MRSA.', 15325427),
('Antibacterial Phytochemical', 'Vaccinium macrocarpon (cranberry) capsules', 'Twelve hours after consumption of cranberry or placebo hard capsules, the first urine of the morning was collected. Different Escherichia coli strains were cultured in the urine samples. Urinary antibacterial adhesion activity was measured in vitro using the human T24 epithelial cell-line, and in vivo using the Caenorhabditis elegans killing model. With the in-vitro model, 108 mg of cranberry induced a significant reduction in bacterial adherence to T24 cells as compared with placebo (p <0.001).', '', 'Overall, these in-vivo and in-vitro studies suggested that consumption of cranberry juice represents an interesting new strategy to prevent recurrent urinary tract infection.', 18190583),
('Antibacterial Phytochemical', 'Tea tree oil and terpinen-4-ol', 'Antimicrobial activity of terpinen-4-ol and tea tree oil (TTO) against clinical skin isolates of meticillin-resistant Staphylococcus aureus (MRSA) and coagulase-negative staphylococci (CoNS)', 'No cytotoxicity against human fibroblasts', 'CONCLUSIONS: Terpinen-4-ol is a more potent antibacterial agent against MRSA and CoNS isolates than TTO with neither agent exhibiting toxicity to fibroblast cells at the concentrations tested.', 18298453),
('Antibacterial Phytochemical', 'Cannabinoids from Cannabis sativa (cannabidiol, cannabichromene, cannabigerol, Delta (9)-tetrahydrocannabinol, and cannabinol)', 'Activity against a variety of methicillin-resistant Staphylococcus aureus (MRSA) strains of current clinical relevance.', '', 'Antibacterial cannabinoids from Cannabis sativa: a structure-activity study', 18681481),
('Antibacterial Phytochemical', 'Aqueous and ethanol extracts of roselle calyx and protocatechuic acid', 'MIC 112-144 microg/mL(aqueous), 72-96 microg/mL(ethanol), and 24-44 microg/mL (protocatechuic acid) against food spoilage bacteria Salmonella typhimurium DT104, Escherichia coli O157:H7, Listeria monocytogenes, Staphylococcus aureus, and Bacillus cereus', '', 'These data suggest that roselle calyx ethanol extract and protocatechuic acid might be potent agents as food additives to prevent contamination from these bacteria.', 19099360),
('Antibacterial Phytochemical', 'Quercus infectoria Olivier', 'Ethanol extract, an ethyl acetate fraction I, gallic acid and tannic acid could inhibit the growth of clinically isolated MRSA strains with minimum inhibitory concentration values between 63 and 250 microg ml(-1). ', '', 'Detailed studies on Quercus infectoria Olivier (nutgalls) as an alternative treatment for methicillin-resistant Staphylococcus aureus infections.', 19120622),
('Antibacterial Phytochemical', 'Vaccinium berries', '', '', 'Antiadhesion therapy is a promising approach to the fight against pathogens. The results suggest Vaccinium berries as possible sources of antiadhesives against bacterial infections.', 19610031),
('Antibacterial Phytochemical', 'Tualang honey', 'Potential alternative therapeutic agent against certain microorganisms, particularly A. baumannii and S. maltophilia.', '', 'This result suggests that tualang honey could potentially be used as an alternative therapeutic agent against certain microorganisms, particularly A. baumannii and S. maltophilia.', 19754926),
('Antibacterial Phytochemical', 'Diterpenes (Abietane 5 and its 6,12-dibenzoyl, 12-methoxybenzoyl, 12-chlorobenzoyl, and 12-nitrobenzoyl esters)', 'Potent activities against the MDR strain with MIC values between 3.12 and 0.39 microg/ml.', '', 'Antimycobacterial metabolites from Plectranthus: royleanone derivatives against Mycobacterium tuberculosis strains', 20397225),
('Antibacterial Phytochemical', 'Plant-derived terpenes', '', '', 'Induction of fatty acid composition modifications and tolerance to biocides in Salmonella enterica serovar Typhimurium by plant-derived terpenes. To enhance food safety and stability, the food industry tends to use natural antimicrobials such as plant-derived compounds as an attractive alternative to chemical preservatives.', 21131520),
('Antibacterial Phytochemical', 'Ethanolic extracts of Canadian botanicals (Arctostaphylos uva ursi (kinnikinnick or bearberry), Hydrastis canadensis (goldenseal), Prunus serotina (black cherry), and Rhodiola rosea (roseroot))', 'Extracts of Arctostaphylos uva ursi (kinnikinnick or bearberry), Hydrastis canadensis (goldenseal), Prunus serotina (black cherry), and Rhodiola rosea (roseroot) inhibited the growth of all Ng isolates with minimum inhibitory concentrations of 32 micro g/mL, 4 to 32 micro g/mL, 16 to >32 micro g/mL, and 32 to 64 micro g/mL, respectively.', '', 'Extracts of Canadian first nations medicinal plants, used as natural products, inhibit neisseria gonorrhoeae isolates with different antibiotic resistance profiles.', 21301385),
('Antibacterial Phytochemical', 'Capparis spinosa', 'At 2 mg/mL, this extract inhibited the biofilm formation to 79, 75, 73, 70% and EPS production to 58, 46, 66 and 67% in S. marcescens, PAO1, E. coli and P. mirabilis, respectively', '', 'Antiquorum sensing and antibiofilm potential of Capparis spinosa.', 22222491),
('Antibacterial Phytochemical', 'Curtisia dentata', 'Activity against Escherichia coli and Acinetobacter spp., ethanol root bark extracts consistently showed the highest DPPH radical scavenging activity (62.43%), total phenol content (TPH) (57.62 26 mg GAE/g) and reducing power (RP) (41.32%), followed by those of the stem bark and leaf extracts with the respective values of 54.68%, 37.77 mg GAE/g and 21.83%.', '', 'CONCLUSION: Curtisia dentata is a very effective source of antioxidant and a possible alternative to sourcing antiverotoxic antibiotics with novel mechanism of action.', 22504170),
('Antibacterial Phytochemical', 'Aframomum melegueta seed extract (diketone 6-gingerdione (2) and its enolic tautomers, methyl-6-gingerol (5) and rac-6-dihydroparadol (7), 6-Paradol (3), 8-gingerol (6),)', 'moderate to weak antimycobacterial activities, and the best modulators induced a 4- to 16-fold decrease of the MICs of EtBr and rifampicin as well as a reduction of the MIC of isoniazid', '', 'Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta', 22789014),
('Antibacterial Phytochemical', 'Alpha-Mangostin', 'Most potent among them against Gram-positive pathogens (MIC=0.78-1.56 ?g/mL)', '', 'Rapid bactericidal action of alpha-mangostin against MRSA as an outcome of membrane targeting', 22982495),
('Antibacterial Phytochemical', 'Medihoney and rifampicin', 'Methylglyoxal (MGO), believed to be the major antibacterial compound in manuka honey, did not act synergistically with rifampicin and is therefore not the sole factor responsible for the synergistic effect of manuka honey with rifampicin.', '', 'Our findings support the idea that a combination of honey and antibiotics may be an effective new antimicrobial therapy for chronic wound infections', 23469049),
('Antibacterial Phytochemical', 'Oregano essential oil', 'Inhibited the growth of Escherichia coli and Pseudomonas aeruginosa clinical strains with different patters of resistance', '', 'CONCLUSIONS: The obtained outcomes will enable further investigations using oregano essential oil obtained from Origanum heracleoticum L. as alternative antibacterial remedies enhancing healing process in bacterial infections and as an effective means for the prevention of antibiotic-resistant strain development.', 23484421),
('Antibacterial Phytochemical', 'Tea tree oil (TTO) and silver ions (Ag(+) )', 'Antimicrobial efficacy against Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans', '', '\\The activity of alternative antimicrobial agents such as tea tree oil (TTO) and silver ions (Ag(+) ) with multiple target sites impedes the development of antibacterial resistance and might be useful in improving the current treatment strategies for various chronic wound infections.', 23581401),
('Antibacterial Phytochemical', 'Vitex negundo leaf extract (Water and methanol)', 'Methanol extract had MIC: 200-3200 ?g/mL and MBC, 200-400 ?g/mL', '', 'In vitro and in vivo bactericidal activity of Vitex negundo leaf extract against diverse multidrug resistant enteric bacterial pathogens', 23608373),
('Antibacterial Phytochemical', 'Ellagic acid in Rosa rugosa; norwogonin in Scutellaria baicalensis; and chebulagic acid, chebulinic acid, corilagin, and terchebulin in Terminalia chebula', 'The potent compound norwogoninhad a minimum inhibitory concentration of 128 microg/mL, and minimum bactericidal concentration of 256 microg/mL against clinically relevant strains of A. baumannii', '', 'Isolation and characterization of antimicrobial compounds in plant extracts against multidrug-resistant Acinetobacter baumannii', 23630600),
('Antibacterial Phytochemical', 'Leptospermum scoparium (Manuka) oil', 'Inhibitor of S. pseudintermedius biofilm formation, and the majority of bacteria decreased by >50%', '', 'In vitro efficacy of the essential oil from Leptospermum scoparium (manuka) on antimicrobial susceptibility and biofilm formation in Staphylococcus pseudintermedius isolates from dogs', 23772881),
('Antibacterial Phytochemical', 'Propolis extract GH2002', 'MICs in the range of 0.03 to 2 mg/ml against S. pyogenes, S. aureus, E. faecium and Candida. ', '', 'These results suggest that the special propolis extract GH2002 might be used in the development of alternative products for therapy of microbial infections.', 24020127),
('Antibacterial Phytochemical', 'Tabernaemontana alternifolia (Roxb) stem bark aqueous extracts', 'The minimum inhibitory concentration (MIC) of extract against the isolates ranged from 600-800 ?g/ml.', 'The extract did not exhibit cytotoxic activity against Vero cells even at the concentration of 4 mg/ml.', 'CONCLUSION: Our results offer a scientific basis for the traditional use of T. alternifolia in the treatment of skin infections, showing that the plant extract has an enormous potential as a prospective alternative therapy against MRSA skin infections.', 24066905),
('Antibacterial Phytochemical', 'Amphypterygium adstringens anacardic acid mixture', 'anti-quorum sensing activity in P. aeruginosa 94% of inhibition violecin production at 166 micro g/mL, 86% inhibition of pyocyanin at 200 micro g/mL) and 91% inhibition of rhamnolipid production 500 micro g/mL)  and decrease the elastase (75% at 500 ?g/mL) activity', '', 'The aim of this study was to evaluate the anti-quorum sensing (anti-QS) potential of an anacardic acids mixture isolated from Amphipterygium adstringens, a medicinal plant known as "cuachalalate", to prevent the onset of bacterial infections as an alternate to antibiotics.', 24126126),
('Antibacterial Phytochemical', 'essential oils from the leaves of L. gracilis (EOLG)', 'has 38 chemical constituents with thymol (44.4%), carvacrol (22.2%), p-cymene (6.2%) and ?-pinene (5.6%) as major constituents.', '', 'These results demonstrate that natural substances present in EOLG have the capacity to modulate bacterial resistance and can be used as an adjuvant therapy against multi-resistant microorganisms such as S. aureus, Escherichia coli and P. aeruginosa.', 24479735),
('Antibacterial Phytochemical', 'Aloe vera inner gel', 'The inhibitory concentrations of A. vera inner gel were ranging from 6.25 to 800 mg ml(-1) .50% of the detected strains (14 clinical strains and one reference strain of H. pylori), independently of their susceptibility profile, were inhibited in their growth at 100 mg ml(-1) .', 'NA', 'The study demonstrates that the Aloe vera inner gel expresses antibacterial properties against both susceptible and resistant Helicobacter pylori strains.', 24597562),
('Antibacterial Phytochemical', 'Flavonoids [demethylglycyrol (31) and 5,7-di-O-methylluteone (32)] and licorice phenolics [3-arylcoumarins such as licoarylcoumarin (9) and glycycoumarin (26), and 2-arylcoumarones such as gancaonin I (17)]', 'Activity against vancomycin-resistant Enterococcus species', '', 'Structures of two new flavonoids and effects of licorice phenolics on vancomycin-resistant Enterococcus species', 24686577),
('Antibacterial Phytochemical', 'Aspergillomarasmine A (AMA)', 'potent inhibitor of the NDM-1 enzyme and another clinically relevant MBL, VIM-2 etc', '', 'Here we have identified a fungal natural product, aspergillomarasmine A (AMA), that is a rapid and potent inhibitor of the NDM-1 enzyme and another clinically relevant MBL, VIM-2.', 24965651),
('Antibacterial Phytochemical', 'Different extracts from Olea europaea, mastic gum, and Inula viscosa', 'Activity against bacteria and fungi, O. europaea presented MIC and MBC ranges of 0.07-10.00 mg mL(-1) and 0.60-10.00 mg mL(-1), respectively, mean MBC values for mastic gum and I. viscosa were 0.07-10.00 mg mL(-1) and 0.15-10.00 mg mL(-1), respectively', '', 'Ethyl acetate I. viscosa extract and total mastic extract showed considerable antimicrobial activity against oral microorganisms and could therefore be considered as alternative natural anti-infectious agents.', 25054150),
('Antibacterial Phytochemical', 'Essential oil was extracted from leaves of Hyptis martiusii Benth. ? -3-carene, 1, 8-cineole, trans-caryophyllene, Cariophyllene oxide and bicyclogermacrene were important components.', 'Essential oil inhibited growth of bcteria (MIC < 512 ?g/mL) except S. aureus (SA358) multidrug resistant (MRSA) by direct contact. S. aureus ATCC 12692, S. aureus 358 (SA358),Bacillus cereus ATCC, E. coli ATCC 25922, E. coli 27 (EC27), P. aeruginosa (ATCC).', 'NA', 'CONCLUSIONS: These results show that this oil influences the activity of the antibiotic and may be used as an adjuvant in the antibiotic therapy of respiratory tract bacterial pathogens.', 25237640),
('Antibacterial Phytochemical', ' (-)-Epigallocatehin-3-Gallate (EGCG) and Green Tea Extracts (GTE)', 'EGCG inhibited the growth of P. aeruginosa at a MIC level of 200~400 ?g/ml. The MIC of GTE was a 1 : 16 dilution for P. aeruginosa. EGCG showed antimicrobial activity against E. coli at a MIC of 400 ?g/ml. In the case of GTE, the MIC was a dilution between 1:8 and 1:4 for E. coli.', '', 'CONCLUSION: EGCG and GTE showed potential as alternative or adjunct topical antimicrobial agents for infections that are resistant to traditional antibiotic therapy.', 25324647),
('Antibacterial Phytochemical', 'Vanilla, patchouli and ylang ylang essential oils stabilized by iron oxide@C14 nanostructures', 'Vanilla essential oil loaded nanoparticles pelliculised on the catheter samples surface strongly inhibited both the initial adherence of S. aureus cells (quantified at 24 h) and the development of the mature biofilm quantified at 48 h. Patchouli and ylang-ylang essential oils inhibited mostly the initial adherence phase of S. aureus biofilm development. In the case of K. pneumoniae, all tested nanosystems exhibited similar efficiency, being active mostly against the adherence K. pneumoniae cells to the tested catheter specimens.', '', 'Efficiency of vanilla, patchouli and ylang ylang essential oils stabilized by iron oxide@C14 nanostructures against bacterial adherence and biofilms formed by Staphylococcus aureus and Klebsiella pneumoniae clinical strains.', 25375335),
('Antibacterial Phytochemical', 'Coumarin', 'Quorum sensing inhibitor, active against short, medium and long chain N-acyl-homoserine lactones and also inhibited biofilm', '', 'In this study, we identified coumarin, a natural plant phenolic compound, as a novel QS inhibitor, with potent anti-virulence activity in a broad spectrum of pathogens.', 25672848),
('Antibacterial Phytochemical', 'Organic extracts from Indigofera suffruticosa leaves (diethyl ether, chloroform and acetone)', 'The acetone extract was the most potent inhibitor of S. aureus (MIC and MBC of 0.78 and 3.12 mg/mL), followed by the chloroform extract (MIC and MBC of 3.12 and 6.25 mg/mL).', '', 'Organic extracts from Indigofera suffruticosa leaves have antimicrobial and synergic actions with erythromycin against Staphylococcus aureus', 25699022),
('Antibacterial Phytochemical', '6, 6''-dihydroxythiobinupharidine from Nuphar japonicum', 'MIC was 1-4 ?g/mL against various MRSA and VRE strains, also inhibited DNA topoisomerase IV (IC50 was 10-15 ?M)', '', 'These results suggest that 6,6''-dihydroxythiobinupharidine may be a potent candidate or seed for novel antibacterial agents.', 25731981),
('Antibacterial Phytochemical', 'Cranberry proanthocyanidin', 'The minimal concentration at which significant inhibitiont occurred was 250 ?g/mL.', '', 'CONCLUSION: Cranberry proanthocyanidins exhibit potent effects on growth, adhesion, and virulence of oropharyngeal and lung isolates of E. coli, suggesting that cranberry proanthocyanidin could be of clinical interest to reduce oropharyngeal colonization and prevent lung infection.', 25803655),
('Antibacterial Phytochemical', 'Essential oils (EOs) from Salvia fruticosa, Salvia officinalis and Salvia sclarea', 'Inhibition the Tet(K) efflux pump of tetracycline resistant Staphylococcus epidermidis', '', 'Our data from molecular and functional analyses of inhibitory effect of Salvia''s essential oils, namely from S. fruticosa, on Tet(K) pump of Staphylococcus epidermidis and from modulatory studies may be the starting point for consecutive study of pharmacokinetic and pharmacodynamic parameters and their perspective use in combination therapy.', 25846244),
('Antibacterial Phytochemical', 'Pomegranate fruit constituents:  caffeic acid, ellagic acid, epigallocatechin-3-gallate (EGCG) and quercetin', 'The peel extracts exhibited greater antimycobacterial activity (MIC 64-1024 ?g/mL) than the potable juice (MIC 256 - > 1024 ?g/mL). EGCG and quercetin exhibited higher antitubercular (MIC 32-256 ?g/mL) and antibacterial (MIC 64-56 ?g/mL) potencies than caffeic acid and ellagic acid (MIC 64-512 ?g/mL).', '', 'Antimicrobial activity of pomegranate fruit constituents against drug-resistant Mycobacterium tuberculosis and beta-lactamase producing Klebsiella pneumoniae. CONTEXT: The global surge in multi-drug resistant bacteria and the imminence of tuberculosis pandemic necessitate alternative therapeutic approaches to augment the existing medications.', 25858784),
('Antibacterial Phytochemical', 'Nasutitermes corniger (Motschulsky, 1855) extract', 'Despite having no significant antimicrobial activity (MIC ? 1000 ?g mL(-1)), the extract showed additive activity to the antibiotic efficacy, significantly reducing its MIC.', '', 'These results suggest that N. corniger and its nest are promising natural products for use in antimicrobial therapy.', 26150745),
('Antibacterial Phytochemical', 'Pectinatella magnifica extract (acetone, methanol )', 'acetone extract had (MIC) 0.004-0.350 mg/mL and MBC 0.007-0.500 mg/mL), while methanol extract had (MIC 0.03-0.12 mg/mL and MFC 0.06-0.25 mg/mL)', '', 'According to the experimental data obtained, P. magnifica methanol extract may be considered as a good resource of novel natural products with potent antibiofilm activity against the bacterium well known for its resistance.', 26252786),
('Antibacterial Phytochemical', 'Chebulinic acid (CA)', 'M. tuberculosis DNA gyrase inhibitor', '', 'Identification of chebulinic acid as potent natural inhibitor of M. tuberculosis DNA gyrase and molecular insights into its binding mode of action.', 26410242),
('Antibacterial Phytochemical', 'Crude ethanolic extract (CEE), ethyl acetate fraction (EAF), and methanolic fraction (MF) from Anacardium microcarpum', 'However, addition of CEE, EAF, and MF to the growth medium at the subinhibitory concentration (MIC/8=64 ?g/mL) significantly modulated amikacin- and gentamicin-resistant E. coli', '', 'A. microcarpum is a natural resource with resistance-modifying antibacterial activity that needs to be further investigated to overcome the present resistant-infection problem.', 26604695),
('Antibacterial Phytochemical', 'Piper betle L.', 'This study revealed the bactericidal activities of all the P. betle leaf crude extracts on methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), extended spectrum ?-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and metallo-?-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii, with minimum bactericidal concentrations that ranged from 19 micro g/ml to 1250 micro g/ml.', '', 'Antimicrobial Activities of Methanol, Ethanol and Supercritical CO2 Extracts of Philippine Piper betle L. on Clinical Isolates of Gram Positive and Gram Negative Bacteria with Transferable Multiple Drug Resistance. Piper betle L. has traditionally been used in alternative medicine in different countries for various therapeutic purposes, including as an anti-infective agent.', 26741962),
('Antibacterial Phytochemical', 'Kisameet Clay', 'Antimicrobial activity against ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species)', '', 'Here, we report the broad-spectrum and potent antibacterial activity of Kisameet clay, a natural clay mineral from British Columbia, Canada, against a group of multidrug-resistant ESKAPE strains.', 26814180),
('Antibacterial Phytochemical', 'Poncirus trifoliata ethyl extract', 'Strong anti-MRSA activity, antibacterial activity with MIC value of 256 micro g ml(-1)', '', 'Studies on antimicrobial activity of Poncirus trifoliata ethyl extract fraction against methicillin-resistant Staphylococcus aureus and to elucidate its antibacterial mechanism.', 26930870),
('Antibacterial Phytochemical', 'Epigallocatachin gallate (EGCG)', 'E. coli LB226692, serotype O104:H4, O104:H4 strain 55989, EDL933, serotype O157:H7, matrix production of all strains was virtually eliminated by EGCG or green tea at 28?C and 37?C', 'NA', 'These findings highlight EGCG as a potential adjuvant for antibiotic therapy of biofilm-associated infections.', 26992034),
('Antibacterial Phytochemical', 'Ginger (Zingiber officinale)', 'The minimum inhibitory concentrations (MICs) of ginger extract for evaluated strains were 40, 40, 20, 20, 20, 20, 10, and 5 mg/mL for Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Bacillus cereus, Acinetobacter baumannii, C. albicans, and C. krusei, respectively.', '', 'Ginger extract has good antifungal and antibiofilm formation by fungi against C. albicans and C. Krusei.', 27127591),
('Antibacterial Phytochemical', 'Petroleum ether extract of seed of Nigella sativa, oil extract from mature ripe fruit husk of Aframomum corrorima and mature unripe fruit of A. corrorima', 'Petroleum ether extract of seed of Nigella sativa: Bacillus cereus [inhibition zone (IZ), 44 ? 0.31 mm] and B. cereus ATCC 10987 (IZ, 40 ? 2.33 mm); oil extract from mature ripe fruit husk of Aframomum corrorima and mature unripe fruit of A. corrorima revealed promising activities against Candida albicans ATCC 90028 (IZ, 35 ? 1.52 mm) and Staphylococcus aureus DSM 346 (IZ, 25 ? 1.32 mm), respectively.', '', 'Antimicrobial and anti-Quorum Sensing activities of selected medicinal plants of Ethiopia: Implication for development of potent antimicrobial agents. BACKGROUND: Traditional medicinal plants have been used as an alternative medicine in many parts of the world, including Ethiopia.', 27400878),
('Antibacterial Phytochemical', 'Ludwigia leptocarpa extracts ( 2?-hydroxyoleanolic acid, (2R,3S,2''''S)-3'''''',4'',4'''''',5,5'''',7,7''''-heptahydroxy-3,8"-biflavanone, and luteolin-8-C-glucoside)', 'Active against Gram-positive bacterium, Staphylococcus aureus, Gram-negative multi-drug-resistant bacteria, Vibrio cholerae and Shigella flexneri (a cause of shigellosis', '', 'Overall, the present results show that L. leptocarpa has the potential to be a natural source of anti-diarrheal and antioxidant products, so further investigation is warranted.', 27431270),
('Antibacterial Phytochemical', 'Monoterpenes nerol', 'Inhibit NorA efflux pump of multi-drug resistant S. aureus strains', '', 'This result shows that bioactives tested, especially the nerol, are able to inhibit NorA efflux pump indicating a potential use as adjuvants of norfloxacin for therapy of infections caused by multi-drug resistant S. aureus strains.', 27565089),
('Antibacterial Phytochemical', 'Tordylium persicum Boiss. & Hausskn extract', 'The results showed that Streptococcus pyogenes was the most susceptible to the methanolic extract (MIC = 25.9 ? 0.0 ?g/mL), while Proteus vulgaris was the most resistant strain (MIC = 295.3 ? 0.0 ?g/mL) among all bacteria evaluated.?', '', 'Tordylium persicum Boiss. & Hausskn extract: A possible alternative for treatment of pediatric infectious diseases. Antimicrobial herbal compounds are one of the important medical resources, and in order to help alleviate the spread of the pediatric infectious diseases, identification of additional bioactive phytochemicals and herbal extracts will be practical in treating illnesses.', 27585257),
('Antibacterial Phytochemical', 'AN(Acacia nilotica) + MKL Sprengel (Murraya koenigii (Linn.)) + Euca (Eucalyptus) + PS (Psidium guajava), AN + MKL Sprengel + Euca', 'All the triple and quadruple combinations of the plant extracts offered antimicrobial benefits either superior or comparable to 0.2% chlorhexidine against S. mutans, S. sanguis, and S. salivarius.', '', 'Antimicrobial efficacy of the combinations of Acacia nilotica,Murrayakoenigii (Linn.) Sprengel, Eucalyptus, and Psidiumguajava on primary plaque colonizers: An in vitro study. BACKGROUND: The rise in disease incidence, increased resistance of pathogenic bacteria to currently used antibiotics and chemotherapeutics, opportunistic infections in immunocompromised individuals, and financial considerations in developing countries necessitates alternate preventive and treatment strategies for oral diseases.', 27723640),
('Antibacterial Phytochemical', 'Ethanolic extract of propolis', 'Combinations of cefixime and propolis gave significant results', '', 'Propolis acted synergistically with cefixime and enhanced the efficacy of antibiotic and reduced its effective dose in combined therapy.', 27887651),
('Antibacterial Phytochemical', 'Pistacia atlantica methanolic extract', 'Active aginst Helicobacter pylori', '', 'The assay demonstrated the thiourea and the extract to be potent urease inhibitors, with the extract having strong bacteriostatic activity against clinical isolates of H. pylori, including such with antibiotic resistance.', 27923651),
('Antibacterial Phytochemical', 'Combination of Oleoresin from Copaifera multijuga Hayne and Biogenic Silver Nanoparticles', 'Bactericidal activity against planktonic Streptococcus agalactiae (group B Streptococcus - GBS) ', '', 'CONCLUSION: These results indicate the potential of copaiba oil, alone or in combination with AgNPbio, for the development of new alternative strategies for controlling GBS infections.', 27978809),
('Antibacterial Phytochemical', 'Cassia alata', '50% inhibition of violacein production in C. violaceum at 0?05 mg ml-1 concentration of fraction rich in flavonoids (F-AF)', '', 'A medicinal herb Cassia alata attenuates quorum sensing in Chromobacterium violaceum and Pseudomonas aeruginosa.', 28035685),
('Antibacterial Phytochemical', 'Combretum zeyheri alkaloid extracts', 'antimycobacterial effects with an MIC value of 125 microg/ml', '', 'Alkaloid extracts from the most potent plant species, Combretum zeyheri were further investigated for time-kill dependency effects on drug transport in Mycobacterium smegmatis.', 28228097),
('Antibacterial Phytochemical', 'Nigella Sativa extract', '', '', 'In conclusion, our literature survey revealed potent antimicrobial properties of N. sativa against MDR strains in vitro that should be further investigated in order to develop novel therapeutic perspectives for combating infectious diseases particularly caused by MDR strains.', 28386474),
('Antibacterial Phytochemical', 'Marine sponge extracts', 'MIC values of the sponge extracts ranged from 0.039 to 1.25mg/mL, best antibacterial profile was observed by its ethyl acetate extract against Staphylococcus aureus and Bacillus cereus with MIC and MBC values of 0.039mg/mL and 0.078mg/mL, respectively. ', '', 'These findings suggest that the antibacterial properties of the tested marine sponge extracts may provide an alternative and complementary strategy to manage bacterial infections.', 28392375),
('Antibacterial Phytochemical', 'Methanolic fruit extract of S. persica L.', 'Methanolic fruit extract of S. persica L. showed a high degree of anti-biofilm formation on PMMA (polymethylmetacrylate) and on violacein (pigment production in Chromobacterium violaceum) inhibition with a percentage of reduction equal to 90% when MIC value (20 mg/ml) was used.', '', 'The aim of this study was to evaluate the antiquorum sensing (anti-QS) and antibiofilm potential of Salvadora persica L. methanolic extracts to prevent the infections due to Staphylococcus as an alternate to antibiotics.', 28552808),
('Antibacterial Phytochemical', 'Puupehenone-like molecules, marine natural product', 'Active against dormant Mtb', '', 'In conclusion, we have identified and characterized antimycobacterial compounds from marine organisms with novel activity profiles which appear to target M. tuberculosis pathways that are conditionally essential for dormancy survival.', 28607021),
('Antibacterial Phytochemical', 'Phenolic Compounds: tannic acid, epigallocatechin gallate, rutin, and eugenol', '', 'Long-term treatment with several conventional antibiotics can cause harmful side effects', 'Phenolic Compounds in Antimicrobial Therapy. Long-term treatment with several conventional antibiotics can cause harmful side effects that can be alleviated by antioxidant therapy.', 28661772),
('Antibacterial Phytochemical', 'Extract of A. deliciosa', 'Activity against Acinetobacter baumannii', '', 'Therefore, it can be concluded that polar extract of A.?deliciosa can be used to find suitable alternative therapeutic to control biofilm formation by carbapenem resistant strain of Acinetobacter baumannii.', 28705748),
('Antibacterial Phytochemical', 'Naphtho[1,2-b]furan-4,5-dione', 'Minimum inhibitory concentration of N12D against MRSA was 4.9-9.8?M', '', 'Naphtho[1,2-b]furan-4,5-dione is a potent anti-MRSA agent against planktonic, biofilm and intracellular bacteria. AIM: Naphtho[1,2-b]furan-4,5-dione (N12D) and naphtho[2,3-b]furan-4,9-dione (N23D) are furanonaphthoquinone derivatives from natural resources.', 28799789),
('Antibacterial Phytochemical', 'Plectranthus amboinicus essential oil (PAEO)', 'The lowest MIC (0.25 mg mL-1) and MBC (0.5 mg mL-1) values were observed when carvacrol was used against OVRSA. When a 0.5 mg mL-1?concentration of PAEO and carvacrol was used, no viable cells were found on S. aureus biofilm.', '', 'Plectranthus amboinicus essential oil and carvacrol bioactive against planktonic and biofilm of oxacillin- and vancomycin-resistant Staphylococcus aureus. BACKGROUND: The emergence of multidrug-resistant bacteria is a worldwide concern and in order to find an alternative to this problem, the occurrence of antimicrobial compounds in Plectranthus amboinicus essential oil was investigated.', 28915875),
('Antibacterial Phytochemical', 'Fennel essential oil', 'Activity in combination with antibiotics against Staphylococcus aureus strains', '', 'Our research showed that the fennel essential oil in combination with mupirocin may be considered as a natural alternative in eradication of S. aureus with iMLSB, cMLSB, MSB resistant phenotypes and is able to decrease the growth rate of antibiotic resistance.', 28917968),
('Antibacterial Phytochemical', 'Manuka honey', 'MIC and MBC against K. pneumoniae ST11 of Manuka honey was 30% (v/v) and (>1 log) reduction was observed in mice.', '', 'CONCLUSION: Manuka honey can be used as an alternate therapeutic approach for management of New Delhi metallo-?-lactamase-producing pathogens.', 29226698),
('Antibacterial Phytochemical', 'Origanum onites essential oil (EO) ', 'Activity against ESBL positive E. coli isolates.', '', 'According to our results, O. onites EO may be an alternative to synthetic drug, used in combination with other antibiotics for treatment of infection caused by multidrug resistant bacteria after testing toxic effects and irritation at preferred doses on human.', 29262709),
('Antibacterial Phytochemical', 'Apple fruit juice', 'Antimicrobial effect against Enterococcus fecalis and Streptococcus mutans', '', 'However, preclinical and clinical trials are needed to evaluate biocompatibility & safety before apple can conclusively be recommended in endodontic therapy, but in vitro observation of apple effectiveness appears promising.', 29284967),
('Antibacterial Phytochemical', 'Passiflora cincinnata Mast', 'Enhances antibiotic activity against Staphylococcus aureus?and?Escherichia coli', '', 'Potentiation of antibiotic activity by Passiflora cincinnata Mast. front of strains Staphylococcus aureus and Escherichia coli. The development of new drugs from plants is an interesting alternative approach to overcoming microbial resistance.', 29379354),
('Antibacterial Phytochemical', 'MCFA lauric acid', 'Inhibitor of?Clostridium difficile?Growth?in Vitro', '', 'Our combined results suggest that the naturally occurring MCFA lauric acid is a novel C. difficile inhibitor and is useful in the development of an alternative or adjunctive treatment for CDI.', 29387044);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Phytochemical', 'Curcuma longa (Zingiberaceae) rhizomes', 'Tested against Escherichia coli strains, Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus sp', '', 'The results indicated that the ethanolic extract and essential oil of C. longa rhizomes have active compounds with antibacterial properties that could be used in future research as a therapeutic alternative for the treatment of infections caused by nosocomial pathogens.', 29462537),
('Antibacterial Phytochemical', 'Melipona beecheii honey (Cuba)', 'Antimicrobial and antibiofilm activity on Staphylococcus aureus and Pseudomonas aeruginosa cells', '', 'The antibiofilm activity of honeys was tested by assessing their ability to inhibit biofilm formation and to disrupt preformed biofilms.', 29988499),
('Antibacterial Phytochemical', 'Phytochemical flavanones: 2'',4''- or \n2'',6''-dihydroxylation of the B ring and 5,7-dihydroxylation of the A \nring in the flavanone structure', 'Differently substituted flavanones were isolated from Leguminosae.', '', 'The present hydroxyflavanones would be useful in the phytotherapeutic strategy against MRSA infections.', 8778504),
('Antibacterial Phytochemical', 'Mycobacteriolytic preparation (stazyme) from the Staphylococcus strain Clavelis', '', '', 'Stazyme, a mycobacteriolytic preparation from a Staphylococcus strain, is able to break the permeability barrier in multiple drug resistant Mycobacterium avium. As a strategy to augment the potential of existing drugs against Mycobacterium avium we investigated a mycobacteriolytic preparation (stazyme) from the Staphylococcus strain Clavelis, which results in significant mycobacterial growth inhibition.', 9537755),
('Antibacterial Phytochemical', 'Hot aqueous and methanolic extracts prepared from six plants (Terminallia chebula, Terminallia bellerica, Phyllanthus emblica, Punica granatum, Lawsonia alba and Mikania micrantha)', 'Antimicrobial activity against Staphylococcus aureus MTCC 2940, Bacillus subtilis MTCC 441, Escherichia coli MTCC 739, Proteus vulgaris MTCC 426 and Enterobacter aerogenes MTCC 111', '', 'Antibacterial activity of some medicinal plant extracts', 18404337),
('Antibacterial Phytochemical', 'Abrus precatorius extracts from leaves, stem and the seed oil', 'At the different concentrations of the extracts used (512 microg/ml - 4 microg/ml), Staphylococcus aureus was the most sensitive organism with an MIC of 8 ug/ml for the leaf extract', '', 'The in-vitro antimicrobial activity of Abrus precatorius (L) fabaceae extract on some clinical pathogens', 18408781),
('Antibacterial Phytochemical', 'Artemisia douglasiana extract and its active compound, dehydroleucodine.', 'The results showed that both dehydroleucodine and Artemisia douglasiana extract had activity against the microorganism with MICs between 1-8 and 60-120 mg/L, respectively.', '', 'CONCLUSIONS: Artemisia douglasiana may be a useful alternative treatment strategy principally in eradication of metronidazole and clarithromycin-resistant strain.', 19422904),
('Antibacterial Phytochemical', 'Polyphenol-rich extracts from NS (Natural almond skins)', 'MIC (50-90) 64 - 128 microg/mL', 'NA', 'CONCLUSIONS: Polyphenols from almond skins were effective in vitro against H. pylori, irrespective of genotype status and could therefore be used in combination with antibiotics as a novel strategy for antibiotic resistance.', 23659287),
('Antibacterial Phytochemical', 'essential oils and extracts of medicinal and culinary herbs (coriander, lemon balm and spearmint leaves)', 'Antibacterial activity against Esherichia coli', '', 'RESULTS: Most of the oils exhibited antibacterial activity in all three assays, however peppermint, lemon balm and coriander seed oils were most potent, with peppermint and coriander seed oils being more potent than the antibiotic rifaximin in the disc diffusion assay.', 24283351),
('Antibacterial Phytochemical', 'Grape pomace of Cabernet Sauvignon', 'grape pomace extract combined with ?-lactam, quinolone, fluoroquinolone, tetracycline and amphenicol act in synergy in all S. aureus and E. coli strains. (MIC) was reduced 4 to 75 times. quercetin, gallic acid, protocatechuic acid and luteolin with relative abundance of 26.3, 24.4, 16.7 and 11.4%, respectively.', 'It was also shown that combinations of grape pomace extract with antibiotics are not toxic for the HeLa cell line at concentrations in which the synergistic effect was observed (47 micro g/mL of extract and 0.6-375 micro g/mL antibiotics)', 'Synergistic interactions between phenolic compounds identified in grape pomace extract with antibiotics of different classes against Staphylococcus aureus and Escherichia coli. Synergy could be an effective strategy to potentiate and recover antibiotics nowadays useless in clinical treatments against multi-resistant bacteria.', 28235054),
('Antibacterial Phytochemical', 'Totarol: diterpenoids isolated from the bark of Podocarpus nagi (Podocarpaceae)', 'The synergistic activity of anacardic acid caused the minimum bactericidal concentration (MBC) of totarol to be lowered from 1.56 to 0.2 micrograms/ml.', '', 'Totarol [1], the most abundant compound among the six, exhibited potent bactericidal activity only against Gram-positive bacteria, among which Propionibacterium acnes was the most sensitive bacterium.', 1453180),
('Antibacterial Phytochemical', 'Phytoalexin isolate 5,7,2'',6''-tetrahydroxy-6-isoprenyl-8-lavandulyl-4''-methox yflavanone (exiguaflavanone D)and 5, 2'',6''-trihydroxy-8-lavandulyl-7-methoxy-flavanone (exiguaflavanone B)', 'Exiguaflavanone D inhibited MRSA 1.56-6.25 micro g/ml, and Exiguaflavanone B inhibited at 50 micro g/ml concentration', '', 'Flavanones with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. With the therapeutic concept of using the defensive ability of plants against microbial infections, phytoalexin, an antimicrobial phytochemical was studied for its ability to inhibit the growth of methicillin-resistant Staphylococcus aureus (MRSA).', 7897594),
('Antibacterial Phytochemical', 'A sesquiterpene lactone, identified as [3aR-(3a alpha, 7 beta,8a beta)]-3,3a,4,7,8,8a-hexahydro-7- methyl-3-methylene-6-(3-oxo-1-butenyl)-2H-cyclohepta[b]furan-2-one, or xanthatin, isolated from leaves of an annual herb, Xanthium sibiricum Patr er Widd', 'Active against methicillin-resistant Staphylococcus aureus', '', 'By monitoring antibacterial activity against MRSA strains, it was shown that a sesquiterpene lactone, identified as [3aR-(3a alpha, 7 beta,8a beta)]-3,3a,4,7,8,8a-hexahydro-7- methyl-3-methylene-6-(3-oxo-1-butenyl)-2H-cyclohepta[b]furan-2-one, or xanthatin, isolated from leaves of the herb, had outstandingly potent activity against S. aureus species, including MRSA; its activity against MRSA and MSSA strains was similar.', 9364417),
('Antibacterial Phytochemical', 'Natural abietanes: 6,7-dehydroferruginol methyl ether (3), ferruginol (5), 11-hydroxy-12-oxo-7,9(11) ,13-abietatriene (7), royleanone (9), demethyl cryptojaponol (12), salvinolone (14), sugiol methyl ether (16), sugiol (17), 5,6-dehydrosugiol methyl ether (19), 5,6-dehydrosugiol (20), 6beta-hydroxyferruginol (23), and taxodione (25)', 'Phenols (12-hydroxyabieta-8,11,13-trien-6-one 22 and 23), catechols (12 and 14) and taxodione 25 has MIC 4-10 microg/mL against MRSA and 4-16 microg/mL of MIC against VRE, Quinone methide had MIC 0.5-1 microg/mL of against both MRSA and VRE.', '', 'Synthesis of variously oxidized abietane diterpenes and their antibacterial activities against MRSA and VRE.', 11249127),
('Antibacterial Phytochemical', '2'',4''-dihydroxy-8-gamma,gamma-dimethylallyl-2",2"-dimethylpyrano[5",6":6,7]isofla vanone (bidwillon B)', '(MICs) of 3.13-6.25mg/l against MRSA strains', '', 'Bidwillon B may prove to be a potent phytotherapeutic and/or combination agent with mupirocin in the elimination of nasal and skin carriage of MRSA.', 15325427),
('Antibacterial Phytochemical', 'Vaccinium macrocarpon (cranberry) capsules', 'Twelve hours after consumption of cranberry or placebo hard capsules, the first urine of the morning was collected. Different Escherichia coli strains were cultured in the urine samples. Urinary antibacterial adhesion activity was measured in vitro using the human T24 epithelial cell-line, and in vivo using the Caenorhabditis elegans killing model. With the in-vitro model, 108 mg of cranberry induced a significant reduction in bacterial adherence to T24 cells as compared with placebo (p <0.001).', '', 'Overall, these in-vivo and in-vitro studies suggested that consumption of cranberry juice represents an interesting new strategy to prevent recurrent urinary tract infection.', 18190583),
('Antibacterial Phytochemical', 'Tea tree oil and terpinen-4-ol', 'Antimicrobial activity of terpinen-4-ol and tea tree oil (TTO) against clinical skin isolates of meticillin-resistant Staphylococcus aureus (MRSA) and coagulase-negative staphylococci (CoNS)', 'No cytotoxicity against human fibroblasts', 'CONCLUSIONS: Terpinen-4-ol is a more potent antibacterial agent against MRSA and CoNS isolates than TTO with neither agent exhibiting toxicity to fibroblast cells at the concentrations tested.', 18298453),
('Antibacterial Phytochemical', 'Cannabinoids from Cannabis sativa (cannabidiol, cannabichromene, cannabigerol, Delta (9)-tetrahydrocannabinol, and cannabinol)', 'Activity against a variety of methicillin-resistant Staphylococcus aureus (MRSA) strains of current clinical relevance.', '', 'Antibacterial cannabinoids from Cannabis sativa: a structure-activity study', 18681481),
('Antibacterial Phytochemical', 'Aqueous and ethanol extracts of roselle calyx and protocatechuic acid', 'MIC 112-144 microg/mL(aqueous), 72-96 microg/mL(ethanol), and 24-44 microg/mL (protocatechuic acid) against food spoilage bacteria Salmonella typhimurium DT104, Escherichia coli O157:H7, Listeria monocytogenes, Staphylococcus aureus, and Bacillus cereus', '', 'These data suggest that roselle calyx ethanol extract and protocatechuic acid might be potent agents as food additives to prevent contamination from these bacteria.', 19099360),
('Antibacterial Phytochemical', 'Quercus infectoria Olivier', 'Ethanol extract, an ethyl acetate fraction I, gallic acid and tannic acid could inhibit the growth of clinically isolated MRSA strains with minimum inhibitory concentration values between 63 and 250 microg ml(-1). ', '', 'Detailed studies on Quercus infectoria Olivier (nutgalls) as an alternative treatment for methicillin-resistant Staphylococcus aureus infections.', 19120622),
('Antibacterial Phytochemical', 'Vaccinium berries', '', '', 'Antiadhesion therapy is a promising approach to the fight against pathogens. The results suggest Vaccinium berries as possible sources of antiadhesives against bacterial infections.', 19610031),
('Antibacterial Phytochemical', 'Tualang honey', 'Potential alternative therapeutic agent against certain microorganisms, particularly A. baumannii and S. maltophilia.', '', 'This result suggests that tualang honey could potentially be used as an alternative therapeutic agent against certain microorganisms, particularly A. baumannii and S. maltophilia.', 19754926),
('Antibacterial Phytochemical', 'Diterpenes (Abietane 5 and its 6,12-dibenzoyl, 12-methoxybenzoyl, 12-chlorobenzoyl, and 12-nitrobenzoyl esters)', 'Potent activities against the MDR strain with MIC values between 3.12 and 0.39 microg/ml.', '', 'Antimycobacterial metabolites from Plectranthus: royleanone derivatives against Mycobacterium tuberculosis strains', 20397225),
('Antibacterial Phytochemical', 'Plant-derived terpenes', '', '', 'Induction of fatty acid composition modifications and tolerance to biocides in Salmonella enterica serovar Typhimurium by plant-derived terpenes. To enhance food safety and stability, the food industry tends to use natural antimicrobials such as plant-derived compounds as an attractive alternative to chemical preservatives.', 21131520),
('Antibacterial Phytochemical', 'Ethanolic extracts of Canadian botanicals (Arctostaphylos uva ursi (kinnikinnick or bearberry), Hydrastis canadensis (goldenseal), Prunus serotina (black cherry), and Rhodiola rosea (roseroot))', 'Extracts of Arctostaphylos uva ursi (kinnikinnick or bearberry), Hydrastis canadensis (goldenseal), Prunus serotina (black cherry), and Rhodiola rosea (roseroot) inhibited the growth of all Ng isolates with minimum inhibitory concentrations of 32 micro g/mL, 4 to 32 micro g/mL, 16 to >32 micro g/mL, and 32 to 64 micro g/mL, respectively.', '', 'Extracts of Canadian first nations medicinal plants, used as natural products, inhibit neisseria gonorrhoeae isolates with different antibiotic resistance profiles.', 21301385),
('Antibacterial Phytochemical', 'Capparis spinosa', 'At 2 mg/mL, this extract inhibited the biofilm formation to 79, 75, 73, 70% and EPS production to 58, 46, 66 and 67% in S. marcescens, PAO1, E. coli and P. mirabilis, respectively', '', 'Antiquorum sensing and antibiofilm potential of Capparis spinosa.', 22222491),
('Antibacterial Phytochemical', 'Curtisia dentata', 'Activity against Escherichia coli and Acinetobacter spp., ethanol root bark extracts consistently showed the highest DPPH radical scavenging activity (62.43%), total phenol content (TPH) (57.62 26 mg GAE/g) and reducing power (RP) (41.32%), followed by those of the stem bark and leaf extracts with the respective values of 54.68%, 37.77 mg GAE/g and 21.83%.', '', 'CONCLUSION: Curtisia dentata is a very effective source of antioxidant and a possible alternative to sourcing antiverotoxic antibiotics with novel mechanism of action.', 22504170),
('Antibacterial Phytochemical', 'Aframomum melegueta seed extract (diketone 6-gingerdione (2) and its enolic tautomers, methyl-6-gingerol (5) and rac-6-dihydroparadol (7), 6-Paradol (3), 8-gingerol (6),)', 'moderate to weak antimycobacterial activities, and the best modulators induced a 4- to 16-fold decrease of the MICs of EtBr and rifampicin as well as a reduction of the MIC of isoniazid', '', 'Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta', 22789014),
('Antibacterial Phytochemical', 'Alpha-Mangostin', 'Most potent among them against Gram-positive pathogens (MIC=0.78-1.56 ?g/mL)', '', 'Rapid bactericidal action of alpha-mangostin against MRSA as an outcome of membrane targeting', 22982495),
('Antibacterial Phytochemical', 'Medihoney and rifampicin', 'Methylglyoxal (MGO), believed to be the major antibacterial compound in manuka honey, did not act synergistically with rifampicin and is therefore not the sole factor responsible for the synergistic effect of manuka honey with rifampicin.', '', 'Our findings support the idea that a combination of honey and antibiotics may be an effective new antimicrobial therapy for chronic wound infections', 23469049),
('Antibacterial Phytochemical', 'Oregano essential oil', 'Inhibited the growth of Escherichia coli and Pseudomonas aeruginosa clinical strains with different patters of resistance', '', 'CONCLUSIONS: The obtained outcomes will enable further investigations using oregano essential oil obtained from Origanum heracleoticum L. as alternative antibacterial remedies enhancing healing process in bacterial infections and as an effective means for the prevention of antibiotic-resistant strain development.', 23484421),
('Antibacterial Phytochemical', 'Tea tree oil (TTO) and silver ions (Ag(+) )', 'Antimicrobial efficacy against Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans', '', '\\The activity of alternative antimicrobial agents such as tea tree oil (TTO) and silver ions (Ag(+) ) with multiple target sites impedes the development of antibacterial resistance and might be useful in improving the current treatment strategies for various chronic wound infections.', 23581401),
('Antibacterial Phytochemical', 'Vitex negundo leaf extract (Water and methanol)', 'Methanol extract had MIC: 200-3200 ?g/mL and MBC, 200-400 ?g/mL', '', 'In vitro and in vivo bactericidal activity of Vitex negundo leaf extract against diverse multidrug resistant enteric bacterial pathogens', 23608373),
('Antibacterial Phytochemical', 'Ellagic acid in Rosa rugosa; norwogonin in Scutellaria baicalensis; and chebulagic acid, chebulinic acid, corilagin, and terchebulin in Terminalia chebula', 'The potent compound norwogoninhad a minimum inhibitory concentration of 128 microg/mL, and minimum bactericidal concentration of 256 microg/mL against clinically relevant strains of A. baumannii', '', 'Isolation and characterization of antimicrobial compounds in plant extracts against multidrug-resistant Acinetobacter baumannii', 23630600),
('Antibacterial Phytochemical', 'Leptospermum scoparium (Manuka) oil', 'Inhibitor of S. pseudintermedius biofilm formation, and the majority of bacteria decreased by >50%', '', 'In vitro efficacy of the essential oil from Leptospermum scoparium (manuka) on antimicrobial susceptibility and biofilm formation in Staphylococcus pseudintermedius isolates from dogs', 23772881),
('Antibacterial Phytochemical', 'Propolis extract GH2002', 'MICs in the range of 0.03 to 2 mg/ml against S. pyogenes, S. aureus, E. faecium and Candida. ', '', 'These results suggest that the special propolis extract GH2002 might be used in the development of alternative products for therapy of microbial infections.', 24020127),
('Antibacterial Phytochemical', 'Tabernaemontana alternifolia (Roxb) stem bark aqueous extracts', 'The minimum inhibitory concentration (MIC) of extract against the isolates ranged from 600-800 ?g/ml.', 'The extract did not exhibit cytotoxic activity against Vero cells even at the concentration of 4 mg/ml.', 'CONCLUSION: Our results offer a scientific basis for the traditional use of T. alternifolia in the treatment of skin infections, showing that the plant extract has an enormous potential as a prospective alternative therapy against MRSA skin infections.', 24066905),
('Antibacterial Phytochemical', 'Amphypterygium adstringens anacardic acid mixture', 'anti-quorum sensing activity in P. aeruginosa 94% of inhibition violecin production at 166 micro g/mL, 86% inhibition of pyocyanin at 200 micro g/mL) and 91% inhibition of rhamnolipid production 500 micro g/mL)  and decrease the elastase (75% at 500 ?g/mL) activity', '', 'The aim of this study was to evaluate the anti-quorum sensing (anti-QS) potential of an anacardic acids mixture isolated from Amphipterygium adstringens, a medicinal plant known as "cuachalalate", to prevent the onset of bacterial infections as an alternate to antibiotics.', 24126126),
('Antibacterial Phytochemical', 'essential oils from the leaves of L. gracilis (EOLG)', 'has 38 chemical constituents with thymol (44.4%), carvacrol (22.2%), p-cymene (6.2%) and ?-pinene (5.6%) as major constituents.', '', 'These results demonstrate that natural substances present in EOLG have the capacity to modulate bacterial resistance and can be used as an adjuvant therapy against multi-resistant microorganisms such as S. aureus, Escherichia coli and P. aeruginosa.', 24479735),
('Antibacterial Phytochemical', 'Aloe vera inner gel', 'The inhibitory concentrations of A. vera inner gel were ranging from 6.25 to 800 mg ml(-1) .50% of the detected strains (14 clinical strains and one reference strain of H. pylori), independently of their susceptibility profile, were inhibited in their growth at 100 mg ml(-1) .', 'NA', 'The study demonstrates that the Aloe vera inner gel expresses antibacterial properties against both susceptible and resistant Helicobacter pylori strains.', 24597562),
('Antibacterial Phytochemical', 'Flavonoids [demethylglycyrol (31) and 5,7-di-O-methylluteone (32)] and licorice phenolics [3-arylcoumarins such as licoarylcoumarin (9) and glycycoumarin (26), and 2-arylcoumarones such as gancaonin I (17)]', 'Activity against vancomycin-resistant Enterococcus species', '', 'Structures of two new flavonoids and effects of licorice phenolics on vancomycin-resistant Enterococcus species', 24686577),
('Antibacterial Phytochemical', 'Aspergillomarasmine A (AMA)', 'potent inhibitor of the NDM-1 enzyme and another clinically relevant MBL, VIM-2 etc', '', 'Here we have identified a fungal natural product, aspergillomarasmine A (AMA), that is a rapid and potent inhibitor of the NDM-1 enzyme and another clinically relevant MBL, VIM-2.', 24965651),
('Antibacterial Phytochemical', 'Different extracts from Olea europaea, mastic gum, and Inula viscosa', 'Activity against bacteria and fungi, O. europaea presented MIC and MBC ranges of 0.07-10.00 mg mL(-1) and 0.60-10.00 mg mL(-1), respectively, mean MBC values for mastic gum and I. viscosa were 0.07-10.00 mg mL(-1) and 0.15-10.00 mg mL(-1), respectively', '', 'Ethyl acetate I. viscosa extract and total mastic extract showed considerable antimicrobial activity against oral microorganisms and could therefore be considered as alternative natural anti-infectious agents.', 25054150),
('Antibacterial Phytochemical', 'Essential oil was extracted from leaves of Hyptis martiusii Benth. ? -3-carene, 1, 8-cineole, trans-caryophyllene, Cariophyllene oxide and bicyclogermacrene were important components.', 'Essential oil inhibited growth of bcteria (MIC < 512 ?g/mL) except S. aureus (SA358) multidrug resistant (MRSA) by direct contact. S. aureus ATCC 12692, S. aureus 358 (SA358),Bacillus cereus ATCC, E. coli ATCC 25922, E. coli 27 (EC27), P. aeruginosa (ATCC).', 'NA', 'CONCLUSIONS: These results show that this oil influences the activity of the antibiotic and may be used as an adjuvant in the antibiotic therapy of respiratory tract bacterial pathogens.', 25237640),
('Antibacterial Phytochemical', ' (-)-Epigallocatehin-3-Gallate (EGCG) and Green Tea Extracts (GTE)', 'EGCG inhibited the growth of P. aeruginosa at a MIC level of 200~400 ?g/ml. The MIC of GTE was a 1 : 16 dilution for P. aeruginosa. EGCG showed antimicrobial activity against E. coli at a MIC of 400 ?g/ml. In the case of GTE, the MIC was a dilution between 1:8 and 1:4 for E. coli.', '', 'CONCLUSION: EGCG and GTE showed potential as alternative or adjunct topical antimicrobial agents for infections that are resistant to traditional antibiotic therapy.', 25324647),
('Antibacterial Phytochemical', 'Vanilla, patchouli and ylang ylang essential oils stabilized by iron oxide@C14 nanostructures', 'Vanilla essential oil loaded nanoparticles pelliculised on the catheter samples surface strongly inhibited both the initial adherence of S. aureus cells (quantified at 24 h) and the development of the mature biofilm quantified at 48 h. Patchouli and ylang-ylang essential oils inhibited mostly the initial adherence phase of S. aureus biofilm development. In the case of K. pneumoniae, all tested nanosystems exhibited similar efficiency, being active mostly against the adherence K. pneumoniae cells to the tested catheter specimens.', '', 'Efficiency of vanilla, patchouli and ylang ylang essential oils stabilized by iron oxide@C14 nanostructures against bacterial adherence and biofilms formed by Staphylococcus aureus and Klebsiella pneumoniae clinical strains.', 25375335),
('Antibacterial Phytochemical', 'Coumarin', 'Quorum sensing inhibitor, active against short, medium and long chain N-acyl-homoserine lactones and also inhibited biofilm', '', 'In this study, we identified coumarin, a natural plant phenolic compound, as a novel QS inhibitor, with potent anti-virulence activity in a broad spectrum of pathogens.', 25672848),
('Antibacterial Phytochemical', 'Organic extracts from Indigofera suffruticosa leaves (diethyl ether, chloroform and acetone)', 'The acetone extract was the most potent inhibitor of S. aureus (MIC and MBC of 0.78 and 3.12 mg/mL), followed by the chloroform extract (MIC and MBC of 3.12 and 6.25 mg/mL).', '', 'Organic extracts from Indigofera suffruticosa leaves have antimicrobial and synergic actions with erythromycin against Staphylococcus aureus', 25699022),
('Antibacterial Phytochemical', '6, 6''-dihydroxythiobinupharidine from Nuphar japonicum', 'MIC was 1-4 ?g/mL against various MRSA and VRE strains, also inhibited DNA topoisomerase IV (IC50 was 10-15 ?M)', '', 'These results suggest that 6,6''-dihydroxythiobinupharidine may be a potent candidate or seed for novel antibacterial agents.', 25731981),
('Antibacterial Phytochemical', 'Cranberry proanthocyanidin', 'The minimal concentration at which significant inhibitiont occurred was 250 ?g/mL.', '', 'CONCLUSION: Cranberry proanthocyanidins exhibit potent effects on growth, adhesion, and virulence of oropharyngeal and lung isolates of E. coli, suggesting that cranberry proanthocyanidin could be of clinical interest to reduce oropharyngeal colonization and prevent lung infection.', 25803655),
('Antibacterial Phytochemical', 'Essential oils (EOs) from Salvia fruticosa, Salvia officinalis and Salvia sclarea', 'Inhibition the Tet(K) efflux pump of tetracycline resistant Staphylococcus epidermidis', '', 'Our data from molecular and functional analyses of inhibitory effect of Salvia''s essential oils, namely from S. fruticosa, on Tet(K) pump of Staphylococcus epidermidis and from modulatory studies may be the starting point for consecutive study of pharmacokinetic and pharmacodynamic parameters and their perspective use in combination therapy.', 25846244),
('Antibacterial Phytochemical', 'Pomegranate fruit constituents:  caffeic acid, ellagic acid, epigallocatechin-3-gallate (EGCG) and quercetin', 'The peel extracts exhibited greater antimycobacterial activity (MIC 64-1024 ?g/mL) than the potable juice (MIC 256 - > 1024 ?g/mL). EGCG and quercetin exhibited higher antitubercular (MIC 32-256 ?g/mL) and antibacterial (MIC 64-56 ?g/mL) potencies than caffeic acid and ellagic acid (MIC 64-512 ?g/mL).', '', 'Antimicrobial activity of pomegranate fruit constituents against drug-resistant Mycobacterium tuberculosis and beta-lactamase producing Klebsiella pneumoniae. CONTEXT: The global surge in multi-drug resistant bacteria and the imminence of tuberculosis pandemic necessitate alternative therapeutic approaches to augment the existing medications.', 25858784),
('Antibacterial Phytochemical', 'Nasutitermes corniger (Motschulsky, 1855) extract', 'Despite having no significant antimicrobial activity (MIC ? 1000 ?g mL(-1)), the extract showed additive activity to the antibiotic efficacy, significantly reducing its MIC.', '', 'These results suggest that N. corniger and its nest are promising natural products for use in antimicrobial therapy.', 26150745),
('Antibacterial Phytochemical', 'Pectinatella magnifica extract (acetone, methanol )', 'acetone extract had (MIC) 0.004-0.350 mg/mL and MBC 0.007-0.500 mg/mL), while methanol extract had (MIC 0.03-0.12 mg/mL and MFC 0.06-0.25 mg/mL)', '', 'According to the experimental data obtained, P. magnifica methanol extract may be considered as a good resource of novel natural products with potent antibiofilm activity against the bacterium well known for its resistance.', 26252786),
('Antibacterial Phytochemical', 'Chebulinic acid (CA)', 'M. tuberculosis DNA gyrase inhibitor', '', 'Identification of chebulinic acid as potent natural inhibitor of M. tuberculosis DNA gyrase and molecular insights into its binding mode of action.', 26410242),
('Antibacterial Phytochemical', 'Crude ethanolic extract (CEE), ethyl acetate fraction (EAF), and methanolic fraction (MF) from Anacardium microcarpum', 'However, addition of CEE, EAF, and MF to the growth medium at the subinhibitory concentration (MIC/8=64 ?g/mL) significantly modulated amikacin- and gentamicin-resistant E. coli', '', 'A. microcarpum is a natural resource with resistance-modifying antibacterial activity that needs to be further investigated to overcome the present resistant-infection problem.', 26604695),
('Antibacterial Phytochemical', 'Piper betle L.', 'This study revealed the bactericidal activities of all the P. betle leaf crude extracts on methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), extended spectrum ?-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and metallo-?-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii, with minimum bactericidal concentrations that ranged from 19 micro g/ml to 1250 micro g/ml.', '', 'Antimicrobial Activities of Methanol, Ethanol and Supercritical CO2 Extracts of Philippine Piper betle L. on Clinical Isolates of Gram Positive and Gram Negative Bacteria with Transferable Multiple Drug Resistance. Piper betle L. has traditionally been used in alternative medicine in different countries for various therapeutic purposes, including as an anti-infective agent.', 26741962),
('Antibacterial Phytochemical', 'Kisameet Clay', 'Antimicrobial activity against ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species)', '', 'Here, we report the broad-spectrum and potent antibacterial activity of Kisameet clay, a natural clay mineral from British Columbia, Canada, against a group of multidrug-resistant ESKAPE strains.', 26814180),
('Antibacterial Phytochemical', 'Poncirus trifoliata ethyl extract', 'Strong anti-MRSA activity, antibacterial activity with MIC value of 256 micro g ml(-1)', '', 'Studies on antimicrobial activity of Poncirus trifoliata ethyl extract fraction against methicillin-resistant Staphylococcus aureus and to elucidate its antibacterial mechanism.', 26930870),
('Antibacterial Phytochemical', 'Epigallocatachin gallate (EGCG)', 'E. coli LB226692, serotype O104:H4, O104:H4 strain 55989, EDL933, serotype O157:H7, matrix production of all strains was virtually eliminated by EGCG or green tea at 28?C and 37?C', 'NA', 'These findings highlight EGCG as a potential adjuvant for antibiotic therapy of biofilm-associated infections.', 26992034),
('Antibacterial Phytochemical', 'Ginger (Zingiber officinale)', 'The minimum inhibitory concentrations (MICs) of ginger extract for evaluated strains were 40, 40, 20, 20, 20, 20, 10, and 5 mg/mL for Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Bacillus cereus, Acinetobacter baumannii, C. albicans, and C. krusei, respectively.', '', 'Ginger extract has good antifungal and antibiofilm formation by fungi against C. albicans and C. Krusei.', 27127591),
('Antibacterial Phytochemical', 'Petroleum ether extract of seed of Nigella sativa, oil extract from mature ripe fruit husk of Aframomum corrorima and mature unripe fruit of A. corrorima', 'Petroleum ether extract of seed of Nigella sativa: Bacillus cereus [inhibition zone (IZ), 44 ? 0.31 mm] and B. cereus ATCC 10987 (IZ, 40 ? 2.33 mm); oil extract from mature ripe fruit husk of Aframomum corrorima and mature unripe fruit of A. corrorima revealed promising activities against Candida albicans ATCC 90028 (IZ, 35 ? 1.52 mm) and Staphylococcus aureus DSM 346 (IZ, 25 ? 1.32 mm), respectively.', '', 'Antimicrobial and anti-Quorum Sensing activities of selected medicinal plants of Ethiopia: Implication for development of potent antimicrobial agents. BACKGROUND: Traditional medicinal plants have been used as an alternative medicine in many parts of the world, including Ethiopia.', 27400878),
('Antibacterial Phytochemical', 'Ludwigia leptocarpa extracts ( 2?-hydroxyoleanolic acid, (2R,3S,2''''S)-3'''''',4'',4'''''',5,5'''',7,7''''-heptahydroxy-3,8"-biflavanone, and luteolin-8-C-glucoside)', 'Active against Gram-positive bacterium, Staphylococcus aureus, Gram-negative multi-drug-resistant bacteria, Vibrio cholerae and Shigella flexneri (a cause of shigellosis', '', 'Overall, the present results show that L. leptocarpa has the potential to be a natural source of anti-diarrheal and antioxidant products, so further investigation is warranted.', 27431270),
('Antibacterial Phytochemical', 'Monoterpenes nerol', 'Inhibit NorA efflux pump of multi-drug resistant S. aureus strains', '', 'This result shows that bioactives tested, especially the nerol, are able to inhibit NorA efflux pump indicating a potential use as adjuvants of norfloxacin for therapy of infections caused by multi-drug resistant S. aureus strains.', 27565089),
('Antibacterial Phytochemical', 'Tordylium persicum Boiss. & Hausskn extract', 'The results showed that Streptococcus pyogenes was the most susceptible to the methanolic extract (MIC = 25.9 ? 0.0 ?g/mL), while Proteus vulgaris was the most resistant strain (MIC = 295.3 ? 0.0 ?g/mL) among all bacteria evaluated.?', '', 'Tordylium persicum Boiss. & Hausskn extract: A possible alternative for treatment of pediatric infectious diseases. Antimicrobial herbal compounds are one of the important medical resources, and in order to help alleviate the spread of the pediatric infectious diseases, identification of additional bioactive phytochemicals and herbal extracts will be practical in treating illnesses.', 27585257),
('Antibacterial Phytochemical', 'AN(Acacia nilotica) + MKL Sprengel (Murraya koenigii (Linn.)) + Euca (Eucalyptus) + PS (Psidium guajava), AN + MKL Sprengel + Euca', 'All the triple and quadruple combinations of the plant extracts offered antimicrobial benefits either superior or comparable to 0.2% chlorhexidine against S. mutans, S. sanguis, and S. salivarius.', '', 'Antimicrobial efficacy of the combinations of Acacia nilotica,Murrayakoenigii (Linn.) Sprengel, Eucalyptus, and Psidiumguajava on primary plaque colonizers: An in vitro study. BACKGROUND: The rise in disease incidence, increased resistance of pathogenic bacteria to currently used antibiotics and chemotherapeutics, opportunistic infections in immunocompromised individuals, and financial considerations in developing countries necessitates alternate preventive and treatment strategies for oral diseases.', 27723640),
('Antibacterial Phytochemical', 'Ethanolic extract of propolis', 'Combinations of cefixime and propolis gave significant results', '', 'Propolis acted synergistically with cefixime and enhanced the efficacy of antibiotic and reduced its effective dose in combined therapy.', 27887651),
('Antibacterial Phytochemical', 'Pistacia atlantica methanolic extract', 'Active aginst Helicobacter pylori', '', 'The assay demonstrated the thiourea and the extract to be potent urease inhibitors, with the extract having strong bacteriostatic activity against clinical isolates of H. pylori, including such with antibiotic resistance.', 27923651),
('Antibacterial Phytochemical', 'Combination of Oleoresin from Copaifera multijuga Hayne and Biogenic Silver Nanoparticles', 'Bactericidal activity against planktonic Streptococcus agalactiae (group B Streptococcus - GBS) ', '', 'CONCLUSION: These results indicate the potential of copaiba oil, alone or in combination with AgNPbio, for the development of new alternative strategies for controlling GBS infections.', 27978809),
('Antibacterial Phytochemical', 'Cassia alata', '50% inhibition of violacein production in C. violaceum at 0?05 mg ml-1 concentration of fraction rich in flavonoids (F-AF)', '', 'A medicinal herb Cassia alata attenuates quorum sensing in Chromobacterium violaceum and Pseudomonas aeruginosa.', 28035685),
('Antibacterial Phytochemical', 'Combretum zeyheri alkaloid extracts', 'antimycobacterial effects with an MIC value of 125 microg/ml', '', 'Alkaloid extracts from the most potent plant species, Combretum zeyheri were further investigated for time-kill dependency effects on drug transport in Mycobacterium smegmatis.', 28228097),
('Antibacterial Phytochemical', 'Nigella Sativa extract', '', '', 'In conclusion, our literature survey revealed potent antimicrobial properties of N. sativa against MDR strains in vitro that should be further investigated in order to develop novel therapeutic perspectives for combating infectious diseases particularly caused by MDR strains.', 28386474),
('Antibacterial Phytochemical', 'Marine sponge extracts', 'MIC values of the sponge extracts ranged from 0.039 to 1.25mg/mL, best antibacterial profile was observed by its ethyl acetate extract against Staphylococcus aureus and Bacillus cereus with MIC and MBC values of 0.039mg/mL and 0.078mg/mL, respectively. ', '', 'These findings suggest that the antibacterial properties of the tested marine sponge extracts may provide an alternative and complementary strategy to manage bacterial infections.', 28392375),
('Antibacterial Phytochemical', 'Methanolic fruit extract of S. persica L.', 'Methanolic fruit extract of S. persica L. showed a high degree of anti-biofilm formation on PMMA (polymethylmetacrylate) and on violacein (pigment production in Chromobacterium violaceum) inhibition with a percentage of reduction equal to 90% when MIC value (20 mg/ml) was used.', '', 'The aim of this study was to evaluate the antiquorum sensing (anti-QS) and antibiofilm potential of Salvadora persica L. methanolic extracts to prevent the infections due to Staphylococcus as an alternate to antibiotics.', 28552808),
('Antibacterial Phytochemical', 'Puupehenone-like molecules, marine natural product', 'Active against dormant Mtb', '', 'In conclusion, we have identified and characterized antimycobacterial compounds from marine organisms with novel activity profiles which appear to target M. tuberculosis pathways that are conditionally essential for dormancy survival.', 28607021),
('Antibacterial Phytochemical', 'Phenolic Compounds: tannic acid, epigallocatechin gallate, rutin, and eugenol', '', 'Long-term treatment with several conventional antibiotics can cause harmful side effects', 'Phenolic Compounds in Antimicrobial Therapy. Long-term treatment with several conventional antibiotics can cause harmful side effects that can be alleviated by antioxidant therapy.', 28661772),
('Antibacterial Phytochemical', 'Extract of A. deliciosa', 'Activity against Acinetobacter baumannii', '', 'Therefore, it can be concluded that polar extract of A.?deliciosa can be used to find suitable alternative therapeutic to control biofilm formation by carbapenem resistant strain of Acinetobacter baumannii.', 28705748),
('Antibacterial Phytochemical', 'Naphtho[1,2-b]furan-4,5-dione', 'Minimum inhibitory concentration of N12D against MRSA was 4.9-9.8?M', '', 'Naphtho[1,2-b]furan-4,5-dione is a potent anti-MRSA agent against planktonic, biofilm and intracellular bacteria. AIM: Naphtho[1,2-b]furan-4,5-dione (N12D) and naphtho[2,3-b]furan-4,9-dione (N23D) are furanonaphthoquinone derivatives from natural resources.', 28799789),
('Antibacterial Phytochemical', 'Plectranthus amboinicus essential oil (PAEO)', 'The lowest MIC (0.25 mg mL-1) and MBC (0.5 mg mL-1) values were observed when carvacrol was used against OVRSA. When a 0.5 mg mL-1?concentration of PAEO and carvacrol was used, no viable cells were found on S. aureus biofilm.', '', 'Plectranthus amboinicus essential oil and carvacrol bioactive against planktonic and biofilm of oxacillin- and vancomycin-resistant Staphylococcus aureus. BACKGROUND: The emergence of multidrug-resistant bacteria is a worldwide concern and in order to find an alternative to this problem, the occurrence of antimicrobial compounds in Plectranthus amboinicus essential oil was investigated.', 28915875),
('Antibacterial Phytochemical', 'Fennel essential oil', 'Activity in combination with antibiotics against Staphylococcus aureus strains', '', 'Our research showed that the fennel essential oil in combination with mupirocin may be considered as a natural alternative in eradication of S. aureus with iMLSB, cMLSB, MSB resistant phenotypes and is able to decrease the growth rate of antibiotic resistance.', 28917968),
('Antibacterial Phytochemical', 'Manuka honey', 'MIC and MBC against K. pneumoniae ST11 of Manuka honey was 30% (v/v) and (>1 log) reduction was observed in mice.', '', 'CONCLUSION: Manuka honey can be used as an alternate therapeutic approach for management of New Delhi metallo-?-lactamase-producing pathogens.', 29226698),
('Antibacterial Phytochemical', 'Origanum onites essential oil (EO) ', 'Activity against ESBL positive E. coli isolates.', '', 'According to our results, O. onites EO may be an alternative to synthetic drug, used in combination with other antibiotics for treatment of infection caused by multidrug resistant bacteria after testing toxic effects and irritation at preferred doses on human.', 29262709),
('Antibacterial Phytochemical', 'Apple fruit juice', 'Antimicrobial effect against Enterococcus fecalis and Streptococcus mutans', '', 'However, preclinical and clinical trials are needed to evaluate biocompatibility & safety before apple can conclusively be recommended in endodontic therapy, but in vitro observation of apple effectiveness appears promising.', 29284967),
('Antibacterial Phytochemical', 'Passiflora cincinnata Mast', 'Enhances antibiotic activity against Staphylococcus aureus?and?Escherichia coli', '', 'Potentiation of antibiotic activity by Passiflora cincinnata Mast. front of strains Staphylococcus aureus and Escherichia coli. The development of new drugs from plants is an interesting alternative approach to overcoming microbial resistance.', 29379354),
('Antibacterial Phytochemical', 'MCFA lauric acid', 'Inhibitor of?Clostridium difficile?Growth?in Vitro', '', 'Our combined results suggest that the naturally occurring MCFA lauric acid is a novel C. difficile inhibitor and is useful in the development of an alternative or adjunctive treatment for CDI.', 29387044),
('Antibacterial Phytochemical', 'Curcuma longa (Zingiberaceae) rhizomes', 'Tested against Escherichia coli strains, Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus sp', '', 'The results indicated that the ethanolic extract and essential oil of C. longa rhizomes have active compounds with antibacterial properties that could be used in future research as a therapeutic alternative for the treatment of infections caused by nosocomial pathogens.', 29462537),
('Antibacterial Phytochemical', 'Melipona beecheii honey (Cuba)', 'Antimicrobial and antibiofilm activity on Staphylococcus aureus and Pseudomonas aeruginosa cells', '', 'The antibiofilm activity of honeys was tested by assessing their ability to inhibit biofilm formation and to disrupt preformed biofilms.', 29988499),
('Antibacterial Phytochemical', 'Phytochemical flavanones: 2'',4''- or \n2'',6''-dihydroxylation of the B ring and 5,7-dihydroxylation of the A \nring in the flavanone structure', 'Differently substituted flavanones were isolated from Leguminosae.', '', 'The present hydroxyflavanones would be useful in the phytotherapeutic strategy against MRSA infections.', 8778504),
('Antibacterial Phytochemical', 'Mycobacteriolytic preparation (stazyme) from the Staphylococcus strain Clavelis', '', '', 'Stazyme, a mycobacteriolytic preparation from a Staphylococcus strain, is able to break the permeability barrier in multiple drug resistant Mycobacterium avium. As a strategy to augment the potential of existing drugs against Mycobacterium avium we investigated a mycobacteriolytic preparation (stazyme) from the Staphylococcus strain Clavelis, which results in significant mycobacterial growth inhibition.', 9537755),
('Antibacterial Phytochemical', 'Hot aqueous and methanolic extracts prepared from six plants (Terminallia chebula, Terminallia bellerica, Phyllanthus emblica, Punica granatum, Lawsonia alba and Mikania micrantha)', 'Antimicrobial activity against Staphylococcus aureus MTCC 2940, Bacillus subtilis MTCC 441, Escherichia coli MTCC 739, Proteus vulgaris MTCC 426 and Enterobacter aerogenes MTCC 111', '', 'Antibacterial activity of some medicinal plant extracts', 18404337),
('Antibacterial Phytochemical', 'Abrus precatorius extracts from leaves, stem and the seed oil', 'At the different concentrations of the extracts used (512 microg/ml - 4 microg/ml), Staphylococcus aureus was the most sensitive organism with an MIC of 8 ug/ml for the leaf extract', '', 'The in-vitro antimicrobial activity of Abrus precatorius (L) fabaceae extract on some clinical pathogens', 18408781),
('Antibacterial Phytochemical', 'Artemisia douglasiana extract and its active compound, dehydroleucodine.', 'The results showed that both dehydroleucodine and Artemisia douglasiana extract had activity against the microorganism with MICs between 1-8 and 60-120 mg/L, respectively.', '', 'CONCLUSIONS: Artemisia douglasiana may be a useful alternative treatment strategy principally in eradication of metronidazole and clarithromycin-resistant strain.', 19422904),
('Antibacterial Phytochemical', 'Polyphenol-rich extracts from NS (Natural almond skins)', 'MIC (50-90) 64 - 128 microg/mL', 'NA', 'CONCLUSIONS: Polyphenols from almond skins were effective in vitro against H. pylori, irrespective of genotype status and could therefore be used in combination with antibiotics as a novel strategy for antibiotic resistance.', 23659287),
('Antibacterial Phytochemical', 'essential oils and extracts of medicinal and culinary herbs (coriander, lemon balm and spearmint leaves)', 'Antibacterial activity against Esherichia coli', '', 'RESULTS: Most of the oils exhibited antibacterial activity in all three assays, however peppermint, lemon balm and coriander seed oils were most potent, with peppermint and coriander seed oils being more potent than the antibiotic rifaximin in the disc diffusion assay.', 24283351),
('Antibacterial Phytochemical', 'Grape pomace of Cabernet Sauvignon', 'grape pomace extract combined with ?-lactam, quinolone, fluoroquinolone, tetracycline and amphenicol act in synergy in all S. aureus and E. coli strains. (MIC) was reduced 4 to 75 times. quercetin, gallic acid, protocatechuic acid and luteolin with relative abundance of 26.3, 24.4, 16.7 and 11.4%, respectively.', 'It was also shown that combinations of grape pomace extract with antibiotics are not toxic for the HeLa cell line at concentrations in which the synergistic effect was observed (47 micro g/mL of extract and 0.6-375 micro g/mL antibiotics)', 'Synergistic interactions between phenolic compounds identified in grape pomace extract with antibiotics of different classes against Staphylococcus aureus and Escherichia coli. Synergy could be an effective strategy to potentiate and recover antibiotics nowadays useless in clinical treatments against multi-resistant bacteria.', 28235054),
('Antibacterial Phytochemical', 'Dipicolinic Acid extracted from endophytic Paenibacillus amylolyticus KMCLE06', 'Antibacterial activity against both gram-positive and gram-negative pathogens, MIC ranged from 62.5 to 125 microg/ml and MBC from 208 to 250 microg/ml', '', 'Bioactive natural compounds play pivotal roles in drug discovery and the emergence of multi-drug resistance pathogens demands the development of better/new drugs.', 30498942),
('Antibacterial Phytochemical', 'Cinnamon bark (Cinnamomum verum J. Presl) essential oil', 'Disruption of carbapenemase (KPC) producing Klebsiella pneumoniae membrane', '', 'Natural products such as essential oils are a promising source due to their complex composition.', 30939149),
('Antibacterial Phytochemical', 'Methanolic extracts of Oxalis corniculata, Artemisia vulgaris, Cinnamomum tamala, and Ageratina adenophora', 'The highest potential was observed in the extract of O. corniculata against Escherichia coli, Salmonella Typhi, MDR Salmonella Typhi, Klebsiella pneumoniae, and Citrobacter koseri with zone of inhibition (ZOI) of 17 mm, 13 mm, 16 mm, 11 mm, and 12 mm, respectively. Oxalis corniculata also showed the highest MIC against test organisms. The methanolic extract of Artemisia vulgaris, Cinnamomum tamala, and Ageratina adenophora showed efficacy against Staphylococcus aureus. Ageratina adenophora also showed antifungal activity against Rhizopus spp.', '', 'Effective treatment of a disease entails the development of new pharmaceuticals or some potential source of novel drugs.', 31065287),
('Antibacterial Phytochemical', 'Analogues of accramycins (1-13)', 'Compounds 1-13 inhibited the Gram-positive pathogens (Staphylococcus aureus, Enterococcus faecalis) and clinical isolates Enterococcus faecium (K59-68 and K60-39) and Staphylococcus haemolyticus with minimal inhibitory concentration (MIC) values in the range of 1.5-12.5 microgram/mL.', '', 'Remarkably, compounds 1-13 displayed superior activity against K60-39 (MIC = 3.1-6.3 ?microgram/mL) compared to ampicillin (MIC = 25 microgram/mL), and offered promising potential for the development of accramycin-based antibiotics that target multidrug-resistant Enterococcus clinical isolates.', 33092156),
('Antibacterial Phytochemical', 'Chromomycin A9 (1), chromomycin Ap (2), chromomycin A2 (3), and chromomycin A3 (4),', 'During a passage experiment, minimum inhibitory concentration (MIC) values for compounds 1-4 showed no more than a 4-fold increase from the starting MIC value, indicating that no resistance was detected over the 21 passages.', '', 'Compounds 1-4 showed potent antibacterial activities against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA).', 33096696),
('Antibacterial Phytochemical', 'Pathogen-derived enzyme (PelAh) from engineered lactic acid bacteria', 'show that our best performing engineered LAB, secreting a pathogen-derived enzyme (PelAh), degrades up to 85% of P. aeruginosa biofilm.', '', 'In this work, we developed a new antimicrobial treatment modality using engineered lactic acid bacteria (LAB)', 33127888),
('Antibacterial Phytochemical', 'Rutin', '', '', 'In this study, we investigated the effect of rutin as a flavonoid compound on photodynamic inactivation by MB on Pseudomonas aeruginosa and Staphylococcus aureus.', 33137496);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Phytochemical', 'oregano essential oil (OEO)', 'OEO showed antibacterial effect against all Ab-MDR tested, with minimum inhibitory concentrations (MIC) ranging from 1.75 to 3.50 mg mL-1', '', 'The results presented here indicate that the OEO used alone or in combination with polymyxin B in the treatment of Ab-MDR infections is promising.', 33190200),
('Antibacterial Phytochemical', 'Van D, a curcumin mimics', 'The best candidate Van D, a curcumin mimics reduced the MIC of tetracycline (TET) up to 16 folds against multidrug resistant clinical isolates.', 'In acute oral toxicity study, this derivative was well tolerated and found to be safe up to 1000 mg/kg dose.', 'To the best of our knowledge, this is the first report on curcumin mimics as synergistic agent via inhibition of efflux pump.', 33213895),
('Antibacterial Phytochemical', 'Magallana bilineata', 'M. bilineata potentially inhibited the bacterial growth with minimal inhibitory concentration (0.75-20 microgram/ml) and fungal pathogens (0.75-5 microgram/ml) as compared to ciprofloxacin and miconazole.', '', 'Therefore, the oysters surviving in the pollution stress modulate the physiological and immune response may exploit to develop potential antibiotics.', 33271318),
('Antibacterial Phytochemical', 'Napabucasin', 'Napabucasin exhibited good antimicrobial activity against oral streptococcal planktonic cultures and biofilms but with lessened cytotoxicity as compared to chlorhexidine. Napabucasin reduced the cariogenic S. mutans and increased the proportion of the commensal S. gordonii in the multispecies biofilms.', '', 'Napabucasin shows lessened cytotoxicity and comparable antimicrobial effects to chlorhexidine.', 33274224),
('Antibacterial Phytochemical', 'Apple cider vinegar (ACV)', 'The MIC for ACV tablets was 200 microgram/mL for both MRSA and rE. coli respectively', '', 'Therapy involves multiple rounds of ineffective antibiotics alongside unwanted side effects, alternative treatments are crucial.', 33473148),
('Antibacterial Phytochemical', '"Yellow-brown resins" from Larrea divaricata Cav (LdRe) and L. nitida Cav (LnRe)', 'A strong antimicrobial activity was displayed by both resins against methicillin-sensitive Staphylococcus aureus ATCC 25923(MSSA) and methicillin-resistant S. aureus ATCC 43300(MRSA) (MICs = 16-32 microgram resin/mL).', '', 'Additionally, the combination of LdRe or LnRe with the antibiotic cefotaxime showed an indifferent effect (FICI values = 1-1.25), however, this combinationcould be a potential strategy to reduce the drug doses, and in this way can be a potential alternative to reduce bacterial resistance.', 33525584),
('Antibacterial Phytochemical', 'Essential oils (EOs) of three Moroccan lavender species (Lavandula pedunculata, LP; Lavandula angustifolia, LA; and Lavandula maroccana, LM)', 'EOs alone or combined showed a remarkable antimicrobial activity against the tested bacteria with minimum inhibitory concentrations (MICs) ranging from 3?53 to 15?96 mg ml-1 .', '', 'Chemical composition and synergistic effect of three Moroccan lavender EOs with ciprofloxacin against foodborne bacteria: a promising approach to modulate antimicrobial resistance.', 33570805),
('Antibacterial Phytochemical', 'water-soluble monocarbonyl curcuminoids, curcumin derivatives', 'All compounds exhibited good to moderate anti-TB activity with MIC99 in the range of 3.12-25.0 microM, out of which 7c and 7p were found the most potent compounds with MIC99 in the range of 3.12-6.25 microM.', 'Furthermore, these compounds were observed to be nonhaemolytic, nontoxic, and stable under both physiological as well as reducing conditions.', 'a series of 17 water-soluble monocarbonyl curcuminoids was synthesized and evaluated for antimycobacterial activity.', 33751730),
('Antibacterial Phytochemical', 'Armeniaspirol A, isolated from Streptomyces armeniacus,', 'we found that armeniaspirol A (ARM1) exhibited potent antibacterial activity against H. pylori, including multidrug-resistant strains, with MIC range values of 4-16 microgram ml-1 .', '', 'Thus, these findings demonstrated that ARM1 is a novel potent anti-H. pylori agent, which can be developed as a promising drug lead for treatment of H. pylori infections.', 33780131),
('Antibacterial Phytochemical', 'Coriander essential oil and linalool', 'Increase in antibiotic susceptibility and reversal of antibiotic resistance in Methicillin-resistant Staphylococcus aureus (MRSA), methicillin-susceptible S. aureus, S. epidermidis and Gram-negative bacteria (Pseudomonas aeruginosa, Escherichia coli)', '', 'Combinations of coriander essential oil/linalool and antibiotics are thus very promising for the development of novel antibacterials.', 30471142),
('Antibacterial Phytochemical', '3-O-methyl-alkylgallates (3-O-methyl-butyl-, 3-O-methyl-hexylgallate, and 3-O-methyl-octylgallate) isolated from the Nigerian mistletoe Loranthus micranthus', 'Growth inhibition in vitro against M. tuberculosis, with a MIC of 6.25 ?M', 'Devoid of cytotoxicity against various human cell lines', 'In the quest for new antibacterial lead structures, activity screening against Mycobacterium tuberculosis identified antitubercular effects of gallic acid derivatives isolated from the Nigerian mistletoe Loranthus micranthus Structure-activity relationship studies indicated that 3-O-methyl-alkylgallates comprising aliphatic ester chains with four to eight carbon atoms showed the strongest growth inhibition in vitro against M. tuberculosis, with a MIC of 6.25 μM.', 31209015),
('Antibacterial Phytochemical', '4-Hexylresorcinol (4-HR)', '50% of the minimal inhibitory concentration (MIC) of 4-HR caused an up to 50-fold decrease in the MIC of antibiotics of various classes. Using an in vivo mouse model of K. pneumoniae-induced sepsis, we could demonstrate that the combination of 4-HR and polymyxin was highly effective.', '', 'It was therefore the aim of the present study to test whether alkylresorcinols, a class of phenolic lipids, can be used as adjuvants to potentiate the effect of various classes of antibiotics.', 32960928),
('Antibacterial Phytochemical', 'Kisameet clay (KC)', 'The antimicrobial assays presented in this study confirm the potent inhibitory activity of KC against a variety of bacterial strains, including M. marinum as a model for M. ulcerans, as well as against two fungal pathogens, C. albicans and C. neoformans, which are pathogenic fungi mostly causing infections in immunocompromised patients', '', 'Natural clay minerals have a long history of therapeutic and biomedical applications and have lately received specific attention for their potent antimicrobial properties.', 33024043),
('Antibacterial Phytochemical', 'Pimenta Oil', 'Both P. diocia and P. racemosa leaf E.Os showed a bactericidal action against A. baumanii within 6h at 2.08 microgram?mL-1.', '', 'Our finding suggests the potential antimicrobial activity of Pimenta leaf E.O against MDR A. baumannii wound infections and their underlying mechanism and to be further tested clinically as treatment for MDR A. baumannii infections.', 33036456),
('Antibacterial Phytochemical', 'Dolastane diterpenes: (4R,7R,14S)-4alpha,7alpha-diacetoxy-10-one-14alpha-hydroxydolasta-1(15),8-diene, (4R,7R,14S)-4alpha,7alpha-diacetoxy-14alpha-hydroxydolasta-1(15),8-diene, (4R,14S)-4alpha,14alpha-dihydroxydolasta-1(15),8-diene, (4S,9R,14S)-4alpha-acetoxy-9?,14alpha-dihydroxydolasta-1(15),7-diene, 4-acetoxy-14-hydroxydolasta-1(15),7,9-triene and isolinearol', 'Decreases MIC of antibiotics norfloxacin, tetracycline and erythromycin by 4-256 fold', '', 'The results indicate that seaweed extracts and diterpenes are potential sources of antibiotic adjuvant, acting as potential inhibitors of efflux pump.', 29733689),
('Antibacterial Phytochemical', 'p-Coumaric acid', 'Inhibits the Listeria monocytogenes RecA protein', '', 'These findings revealed that p-Coumaric acid is a potent RecA inhibitor, and can be used as an adjuvant to the existing antibiotics which not only enhance the shelf-life but also slow down the emergence of antibiotic resistance in bacteria.', 31416617),
('Antibacterial Phytochemical', 'Melatonin', 'we uncovered that melatonin disrupted bacterial proton motive force (PMF), which is an essential bacterial energy metabolism substance and is important for conjugative process.', '', '', 34813930),
('Antibacterial Phytochemical', 'Leaf Extract from Musa spp. (AAB Group, Silk Subgroup), cv. "Manzano"', 'Minimum Inhibitory Concentration of 12.5 and 6.25 microgram/mL against susceptible and drug-resistant strains of Mycobacterium tuberculosis', '', 'Our results demonstrate the efficiency and selectivity of Musa spp. AAB, cv. "Manzano" against MTB strains and support its traditional use as remedy against tuberculosis in Maya traditional medicine.', 31268391),
('Antibacterial Phytochemical', 'essential oil from Piper caldense (EOPC)', 'The oil showed activity against C. albicans ATCC 10231 (? 512 microgram/mL) and was able to inhibit hyphae formation, an important mechanism of virulence of C. albicans. On the other hand, EOPC was inactive against all bacterial strains tested (? 1,024 microgram mL). However, when combined with Norfloxacin at subinhibitory concentration EOPC reduced the Norfloxacin and Ethidium bromide MIC values against S. aureus strains SA1199B, K2068 and K4100.', '', 'Chemical composition and potentiating action of Norfloxacin mediated by the essential oil of Piper caldense C.D.C. against Staphylococcus aureus strains overexpressing efflux pump genes.', 34052872),
('Antibacterial Phytochemical', 'Fusaricidins cyclic lipopeptides (CLP), CLP 2605-4 and CLP 2612-8.1', 'Both CLPs were able to reduce bacterial counts by approximately 3 log CFU/g by the last assessment day.', '', 'New treatment strategies are needed that will help in both stimulating the wound healing process, as well as preventing and eliminating bacterial wound infections.', 34367114),
('Antibacterial Phytochemical', 'Lactophoricin-I (LPcin-I), found in the proteose peptone component-3 (PP3; lactophorin) of bovine milk', 'shows the minimal inhibitory concentration (MIC) value of YK5. against L. innocua, S. aureus, P. aeruginosa, S. typhimurium, and E. coli in the range of 5.0-12.0 microM.', '', 'Naturally derived antibacterial peptides exhibit excellent pharmacological action without the risk of resistance, suggesting a potential role as biologicals.', 33918526),
('Antibacterial Phytochemical', 'tyrocidine A (Tyrc A) and gramicidin S (GS)', 'Intriguingly, antibacterial mechanism studies revealed that, rather than the ''pore forming'' model that possessed by Tyrc A, peptide 8 likely diffuses membrane in a ''detergent-like'' manner.', '', 'Naturally occurring cyclic antimicrobial peptides (AMPs) such as tyrocidine A (Tyrc A) and gramicidin S (GS) are appealing targets for the development of novel antibiotics.', 33991963),
('Antibacterial Phytochemical', 'berberine-derived azolyl ethanols', 'Preliminary mechanistic explorations suggested that the excellent antibacterial potential of molecules 4d and 18b might be attributed to their ability to disintegrate membrane, accelerate ROS accumulation, reduce bacterial metabolism, and intercalate into DNA groove.', '', 'Natural berberine-derived azolyl ethanols as new structural antibacterial agents were designed and synthesized for fighting with dreadful bacterial resistance.', 34964345),
('Antibacterial Phytochemical', 'Natural berberine-hybridized benzimidazoles', 'Preliminary mechanism studies revealed that the active molecule 7d could damage the membrane integrity, stimulate ROS generation, and bind with DNA as well as S. aureus sortase A, thus exerting powerful antibacterial ability.', '', 'Natural berberine-hybridized benzimidazoles as potential antibacterial agents were constructed to treat Staphylococcus aureus infection in the livestock industry.', 34228443),
('Antibacterial Phytochemical', '4-methoxybenzoic acid from Seagrass Halodule pinifolia (Miki) Hartog', 'It showed an effective inhibition of bacterial growth and was considered as a lead molecule with minimum inhibitory concentration (MIC) of 62.5 microgram/mL) against Pseudomonas aeruginosa', '', 'The present findings suggests that seagrasses may act as a newer source for the marine based drug discovery and the lead compound 4-MBA derived from H. pinifolia may act as anti-infective agent against P. aeruginosa as it controls the QS-mediated virulence production.', 32711114),
('Antibacterial Phytochemical', 'Water soluble Curcumin', 'The MIC of sCur against Gram-positive and Gram-negative MDR isolates was 32 and 64 microgram/ml', '', 'This work shows that the soluble curcumin can be used to enhance the action of existing antimicrobials against both Gram-positive and Gram-negative bacteria', 32848171),
('Antibacterial Phytochemical', 'Pentagalloyl glucose (PGG) from Schinus terebinthifolia', 'PGG inhibited growth of both carbapenem-resistant Acinetobacter baumannii and susceptible A. baumannii (MIC 64-256 microgram/mL), and also exhibited activity against Pseudomonas aeruginosa (MIC 16 microgram/mL) and Staphylococcus aureus (MIC 64 microgram/mL).', 'A mammalian cytotoxicity assay with human keratinocytes (HaCaTs) yielded an IC50 for PGG of 256 microgram/mL.', 'Pentagalloyl glucose from Schinus terebinthifolia inhibits growth of carbapenem-resistant Acinetobacter baumannii', 32948818),
('Antibacterial Phytochemical', 'Eleutheroside K (ETSK) from Acanthopanax henryi (Oliv.)', 'The MIC values of ETSK against eight clinical S. aureus strains were all 50 microgram ml-1 . At sub-inhibitory concentrations, a synergistic effect between oxacillin (OXA) and ETSK was confirmed.', '', 'Results based on our study verified that ETSK significantly suppressed MRSA infections and emphasized the potential application of ETSK as a novel anti-MRSA natural drug.', 32955753),
('Antibacterial Phytochemical', 'baicalin from Scutellariae radix', 'The results show that baicalin diminished a plenty of important virulence factors in P. aeruginosa, including the Type III secretion system (T3SS).', 'Baicalin treatment reduced the cellular toxicity of P. aeruginosa on the mammalian cells and attenuated in vivo pathogenicity in a Drosophila melanogaster infection model.', 'Therapeutics that target the virulence of pathogens rather than their viability offer a promising alternative for treating infectious diseases and circumventing antibiotic resistance.', 33801847),
('Antibacterial Phytochemical', 'sorafenib derivative, SC5005', '', 'no significant haemolysis or release of LDH from human HT-29 cells was detected.', 'SC5005 is a promising lead compound for developing new therapies for biofilm-related infections caused by S. aureus.', 33855344),
('Antibacterial Phytochemical', '5% maltodextrin, 1% sodium chloride, 42% citric acid, 18% sodium citrate, 10% silica, 12% malic acid, 9% citrus extract and 3% olive extract', 'Minimum sub-inhibitory concentrations were determined for Campylobacter jejuni (0.25%), Salmonella enterica (0.50%) and Clostridium perfringens (0.50%) required for the in vitro infection assays with MDCK cells.', '', 'The present study describes for the first time that mixtures of natural antimicrobials can prevent the formation of substrates used by bacterial pathogens to grow and survive in anaerobic environments', 34099034),
('Antibacterial Phytochemical', 'quaternary ammonium chitosan derivative, N,N,N-trimethyl chitosan chloride (TMC) with inherent bactericidal property was synthesized and complexed with povidone?iodine (PVP-I)', 'TMC5/PVP-I was significantly effective against multidrug-resistant bacteria S. aureus compared with PVP-I alone. TMC/PVP-I solutions also showed fungicidal property against C. albicans', '', 'with no cytotoxic effects when tested against human fibroblast cells cultured in vitro.', 34051260),
('Antibacterial Phytochemical', 'water-soluble curcumin derivative (Curaq)', 'Only nine (9.4%) Klebsiella isolates were sensitive to meropenem; however, after synergising with Curaq (8 microgram/mL), 85 (88.54%) hvKP isolates became sensitive to the drug.', '', 'A water-soluble curcumin derivative (Curaq) was synthesised, employing a Cu (I) catalysed 1, 3-cyclo addition reaction; it has been evaluated as a potential treatment for multidrug-resistant isolates and as an antibiotic adjuvant for meropenem against hypervirulent multidrug-resistant Klebsiella pneumoniae isolates.', 33916608),
('Antibacterial Phytochemical', 'epicarp extracts of the Malaysian cultivar of yellow rambutan fruit (Nephelium lappaceum L.)', 'Among a series of solvent extracts, fractions of ethyl acetate and acetone have revealed significant activity towards six pathogens tested namely, Bacillus subtilis, methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pyogenes, Pseudomonas aeruginosa, Klebsiella pneumoniae and Salmonella enterica. .', '', 'Chemical profiling of these fractions, via HPLC, LC-MS and GC-MS, has generated a library of potentially bioactive compounds.', 34226594),
('Antibacterial Phytochemical', 'Onosma chitralicum (EtoAc fraction )', 'Compounds 1 (4'',8-dimethoxy-7-hydroxyisoflavone), 6 (5,3'',3-trihydroxy-7,4''-dimethoxyflavanone), and 7 (5'',7,8-trihydroxy-6,3'',4''-trimethoxyflavanone) were found to be more active against Staphylococcus aureus and Salmonella Typhi. Compound 1 inhibited S. typhi and S. aureus to 10 ? 0.21 mm and 10 ? 0.45 mm, whereas compound 6 showed inhibition to 10 ? 0.77 mm and 9 ? 0.20 mm, respectively. Compound 7 inhibited S. aureus to 6 ? 0.36 mm.', '', 'Compounds 6 and 7 showed significant antibacterial potential, and the structure-activity relationship also justifies their binding to the bacterial enzymes, i.e., beta-hydroxyacyl dehydratase (HadAB complex) and tyrosyl-tRNA synthetase.', 33918531),
('Antibacterial Phytochemical', 'Brazilian green and red propolis', 'ERP was more effective by displaying MIC and MBC values <100 microgram mL-1 . Compounds 8 and 9 displayed the lowest MIC values (0.98 to 31.25 microgram mL-1 ) against all tested Gram-positive MDRB. They also inhibited the biofilm formation of S. aureus (ATCC 43300 and clinical isolate) and S. epidermidis (ATCC 14990 and clinical isolate), with MICB50 values between 1.56 and 6.25 microgram mL-1', '', 'Compounds 8 and 9 have great antimicrobial potential. © 2021 Wiley-VHCA AG, Zurich, Switzerland.', 34086414),
('Antibacterial Phytochemical', 'Elaiophylin, derived from Streptomyces hygroscopicus', 'Elaiophylin presented a MIC of 0.5 microgram/mL against the SA-1199 (wild-type) and SA-1199B (NorA over-expressed) strains', '', 'Compounds capable of inhibiting the efflux pump mechanism are a promising alternative against bacterial resistance because, when combined with antibiotics, they can increase the effectiveness of these drugs by inhibiting active efflux.', 34425202),
('Antibacterial Phytochemical', 'silver nanoparticles (AgNPs) from an aqueous extract of Juniperus excelsa', 'The minimum inhibitory concentrations (MICs) of the AgNPs against the tested MDR bacteria ranged from 48 to 56 microgram/ml, while the minimum bactericidal concentrations (MBCs) of the AgNPs against the tested strains ranged from 72 to 96 microgram/ml.', '', 'Consequently, we can use AgNPs with Cefaclor, Cefoxitin, and Erythromycin antibiotics as alternative antimicrobial agents, and they could be utilized in wound dressing to prevent microbial infections. © King Abdulaziz City for Science and Technology 2021.', 33987072),
('Antibacterial Phytochemical', 'Loxostylis alata leaf extract', 'Extracts had low to moderate MIC values from 0.04 to 2.5 mg/mL.', 'Cytotoxicity values ranged from 0.02 to 0.47 mg/mL, while tested extracts were not genotoxic.', 'Extracts of L. alata are promising candidates for development of antimicrobial preparations or food additives against microbial contamination.', 33849505),
('Antibacterial Phytochemical', 'Rumex abyssinicus Jacq. (Polygonaceae)', 'MIC = 8-256 microgram/mL', '', 'Graham is a consultant for RedHill Biopharma and Phathom Pharmaceuticals regarding novel H. pylori therapies and was the PI on the clinical trial from which the data were derived.', 34090405),
('Antibacterial Phytochemical', 'Peucedanum ostruthium extracts', 'The extracts H and E show the same effect on both the M. smegmatis wild type and ?lfrA mutant (MIC of 31.25 mg/L).', '', 'Natural compounds have the potential to increase antibiotic effectiveness due to their resistance modulatory and antimicrobial effects.', 34572657),
('Antibacterial Phytochemical', '29 plant essential oils', 'We found that 25 essential oils possessed antibacterial activity against Escherichia Coli ATCC 25922 and methicillin-resistant Staphylococcus aureus (MRSA) 43300 with MICs that ranged from 0.01% to 2.5% v/v.', '', 'Synergistic combinations for antimicrobial therapies can be a good strategy for the treatment of multidrug resistant infections.', 33923861),
('Antibacterial Phytochemical', 'gamma-glutamyl-S-allyl-cysteine (fraction 18), gamma-glutamyl-phenylalanine (fraction 20), and the two stereoisomers (E and Z) of ajoene FROM gARLIC', 'The MICs of these fractions were 5.41 mg/ml, 4.60 mg/ml, and 0.16 mg/ml, respectively, against Streptococcus agalactiae', '', 'The strategy recommended by the Centers for Disease Control to reduce neonatal GBS infection is the culture-based screening of all pregnant women at 35 to 37 weeks of gestation and intrapartum antibiotic prophylaxis (IAP).', 34817207),
('Antibacterial Phytochemical', 'Solanum granuloso-leprosum (Dunal)', 'All the strains tested were susceptible to granulosain I with MIC from 156.25 to 312.5 microgram/mL and MBC from 312.5 to 625 microgram/mL, respectively against Helicobacter pylori.', 'Besides, granulosain I and RAP did not show toxicological effects at the concentrations studied.', 'Treatment of H. pylori infection includes antibiotics and proton pump inhibitors, but the increasing antibiotic resistance promotes the research of novel, more effective, and natural antibacterial compounds.', 34977105),
('Antibacterial Phytochemical', 'Essential oil from Cerrado plants', 'MIC of 7.80 microgram?mL?1 against multi?resistant Staphylococcus sp. 841', '', 'The essential oil from Cerrado plants proved active against resistant Gram-positive and Gram-negative bacteria, revealing their potentialities for the development of new alternative agents to prevent the spreading of resistant bacterial contamination.', 32708062),
('Antibacterial Phytochemical', 'Azadirachta indica, Moringa oleifera, Murraya koenigii, and Psidium guajava extracts', 'The preliminary antimicrobial study showed pet. ether extract of A. indica and ethanolic extract of P. guajava showed a MIC value of 125 microgram/mL and MBC value of 500 microgram/mL.', 'These extracts showed biofilm inhibition in the range of 60.0-83.9 % and did not possess any hemolytic activity to the human erythrocytes.', 'Our present study, Azadirachta indica, Moringa oleifera, Murraya koenigii, and Psidium guajava extracts were investigated against MRSA.', 32995315),
('Antibacterial Phytochemical', 'Cannabidiol from cannabis', 'It shows a strikingly consistent MIC of 1?4 microgram mL?1 against a diverse range of over 20 types of Gram-positive bacteria, including multiple strains of the key pathogens MRSA, multidrug-resistant (MDR) Streptococcus pneumoniae, Enterococcus faecalis, and the anaerobic bacteria Clostridioides (previously Clostridium) difficile and Cutibacterium (previously Propionibacterium) acnes', '', 'Structure-activity relationship studies demonstrate the potential to advance cannabidiol analogs as a much-needed new class of antibiotics.', 33469147),
('Antibacterial Phytochemical', 'Spirulina (Arthrospira) platensi and sucrose ester SP 70', '', 'Formulations containing SP 70 surfactant with TC showed the most favorable dissolution profiles and were found to be nontoxic.', 'Natural products used in the treatment of acne vulgaris may be promising alternative therapies with fewer side effects and without antibiotic resistance.', 33096785),
('Antibacterial Phytochemical', 'Essential Oil of Acritopappus confertus', 'it was verified that the A. confertus oil did not present direct antibacterial activity against most of the standard and multidrug-resistant strains tested, presenting a MIC above 512 microg/mL. However, an exception was observed against the standard strain S. aureus ATCC 25923, where the oil had a MIC of 256 microg/mL.', '', 'It can be concluded that the essential oil of A. confertus has potential against pathogenic fungi and bacteria, making it a target for the development of an antimicrobial drug.', 36297389),
('Antibacterial Phytochemical', 'two naturally small molecules gallic acid (GA) and diammonium glycyrrhizinate (DG) - GAD hydrogel', 'GAD hydrogel promoting Staphylococcus aureus (S. aureus)-infected wound healing.', '', 'GAD hydrogel had broad antibacterial efficiency against both Gram-positive and Gram-negative bacteria. Taken together, GAD hydrogel is a promising dressing to accelerate bacterial-infected wound healing through reconstructing an intact and thick epidermis without antibiotics or cytokines.', 36442387),
('Antibacterial Phytochemical', 'Novel two-peptide lantibiotic produced by Vagococcus fluvialis LMGT 4216 isolated from fermented maize.', 'The increased tolerance to vagococcin T of four randomly selected spontaneous mutants of E. faecium was tested and showed a 64- to 256-fold increase in the MIC compared to that for the wild type', 'GRAS (generally regarded as safe) status and have high potency and low toxicity', 'Vagococcin T is the first bacteriocin characterized from the genus Vagococcus. Bacteriocins are a promising alternative to traditional antibiotics, as they display activity against antibiotic-resistant pathogens (Enterococcus faecium) and have many desirable properties for the control of microorganisms.', 35730941),
('Antibacterial Phytochemical', 'Anatolian honey bee venom (HBV)', 'The results of MIC values were varied from 3.06 microg/mL to 50 microg/mL for the tested microorganisms. It was found that Mycobacterium smegmatis and Streptococcus pyogenes were the most susceptible bacteria (3.06 microg/mL), followed by Vibrio sp., Aeromonas sobria, Enterococcus faecalis, Listeria monocytogenes, Staphylococcus aureus (MRSA) and B. subtilis with a MIC concentration of 6.125 microg/mL.', '', 'The activity of the Anatolian HBV sample against these microorganisms was determined by the agar well diffusion method, then their zones were measured. These findings strongly suggest that Anatolian HBV will be developed as a new antibacterial-antifungal drug against Gram-positive, Gram negative and antibiotic-resistant bacteria and yeast-like fungi.', 35421436),
('Antibacterial Phytochemical', 'Indonesian Mangrove Sonneratia caseolaris Leaves Ethanol Extract ( Other species- Sonneratia caseolaris, Avicennia marina, Rhizophora mucronata, and Rhizophora apiculata)', 'An antioxidant activity assay showed comparable activity when compared to ascorbic acid, with an IC50 value of 4.2499 ', 'Based on the toxicity criterion, all extracts demonstrated non-lethality with LC50 of >1500 ppm, which might indicate the degradation of phytochemicals over time', 'Further research is needed to elucidate the interaction of the main compounds in S. caseolaris leaves extract in order to confirm their potential either as single or two or more compounds that synergistically function as a nontoxic antioxidant and antibacterial against MRSA.', 36500458),
('Antibacterial Phytochemical', 'silver and gold NPs (SNPs and GNPs, respectively)', 'The MIC values (microg/ml) of the 10-nm SNPs and 20-nm GNPs against B. melitensis were 22.43 ', 'SNPs and GNPs at doses below 2 mg/kg were not harmful to rat tissue according to organ histopathological examinations. However, a greater dose of NPs (2 mg/kg) harmed all of the tissues studied.', 'The bactericidal properties of NPs are demonstrated in this work. Brucella strains develop similar resistance to SNPs and GNPs, and at low dosages, neither SNPs nor GNPs were hazardous to rats.', 35834538),
('Antibacterial Phytochemical', 'The extracts of olive leaf (E1= highly hydrophilic compounds such as hydroxytyrosol and hydroxytyrosol glucosides (14,708 mg/100 g) and E2= moderately hydrophilic compounds, with oleuropein (20,471 mg/100 g) )', '. MIC values for E1 ranged between 1', '', 'Hydroxytyrosol was the main compound responsible, causing the inhibition of growth of Campylobacter strains at low concentrations (0.1-0.25 mg/mL). E2 demonstrated a lower antibacterial effect than E1, reducing growth from 0.52 to 2.49 log CFU/mL. The results of this study suggest that the optimization of the composition of olive-leaf extracts can provide improved treatment results against Campylobacter strains.', 36671227),
('Antibacterial Phytochemical', 'antimicrobial activity of Polyalthia longifolia plants harvested from Cameroon', 'Our results revealed that the tested extracts possess important antimicrobial activities, notably against Gram positive bacteria (MICs as low as 0.039 mg/mL). The extracts showed a synergistic antibacterial activity in combination with penicillin against a MRSA clinical isolate and significantly inhibited S. aureus biofilm formation.', '', 'The mechanism of action is related to the impairment of cell membrane integrity and cell lysis. All these findings suggest that P. longifolia could be an important source of reliable compounds used to develop new antimicrobials.', 36296219),
('Antibacterial Phytochemical', 'novel conjugated ultrashort antimicrobial peptide. The peptide named naprolyginine', 'Naprolyginine managed to inhibit the growth of gram-positive reference S. aureus and MRSA at MIC values of 8 and 15 microM, respectively. Naprolyginine managed to inhibit gram-negative E. coli (ATCC 25922) and ESBL E. coli (ATCC BAA-3054) with MIC values of 18 microM and 25 microM, respectively.', 'the peptide was evaluated for its hemolytic activity against human red blood cells and displayed negligible toxicity.', 'Our results displayed that the peptide exhibits potent synergistic antimicrobial activity against resistant strains of gram-positive and gram-negative bacteria when combined with individual antibiotics. Naprolyginine could prove to be a promising candidate for antimicrobial drug development.', 36704429),
('Antibacterial Phytochemical', 'Use of Vitex doniana (black plum) and Abutilon hirtum (Florida keys) extracts as an integral part of phytomedicine', 'Activity was detected from both plant extracts with MICs of extracted fractions ranging from 150 - 300 microg/mL. Interestingly both plants produced extracts with bactericidal activity from 300 - 600 microg/mL. V. doniana exhibited better activity against the resistant Salmonella strains in terms of greater inhibition zones, but A. hirtum extracts were more consistently active against all isolates.', '', 'Nigeria needs better anti-salmonella products and these results represent a starting point for antibiotic drug discovery.', 36099376),
('Antibacterial Phytochemical', 'Unique coumarin aminophosphonates', '3-hydroxylphenyl aminophosphonate 6f show excellent anti S. aureus activity with MIC = 0.001 Mm', '', 'Molecule * 6f exerted low toxicity, no obvious resistance and good bioavailability. Compound 6f could disturb the membrane integrity and lead to the leakage of intracellular materials and Compound 6f could induce oxidative damage and restrain metabolism.', 36343412),
('Antibacterial Phytochemical', 'synergy between a combination of terpinen-4-ol and alpha-terpineol (10:1)', 'alpha-terpineol was slightly more efficient than terpinen-4-ol on the Gram-negative Escherichia coli, with respective MICs of 0.15', '', 'our data demonstrate that the combination of terpinen-4-ol and alpha-terpineol might be a precious weapon to address ESKAPE pathogens.', 36364298),
('Antibacterial Phytochemical', 'ocotillol-derived lactone compound', 'ocotillol-derived lactone Compound 6d, which exhibited broad antibacterial spectrum, was found to be the most active with minimum inhibitory concentrations (MICs) of 1', 'compound 6d was membrane active and low toxic against mammalian cells', 'ADME- absorption, distribution, metabolism, and excretion properties of this type of compounds have shown drug-likeness with good oral absorption and moderate blood', 34661800),
('Antibacterial Phytochemical', 'protocatechualdehyde (PCA) extracted from the roots of Salvia miltiorrhiza', 'The MICs and MBCs of PCA against tested Y. enterocolitica strains have, MICs ranged from 0.30 to 0.60 mg/mL. It was noting that PCA at 2.40 mg/mL visibly exerted the potent bactericidal action against all strains of Y. enterocolitica', 'Toxic oral dose of 500 mg/kg in mice is known to cause depletion of glutathione in liver and kidney but no mortality. Due to low absorption by oral route, PCA is a nontoxic and a relatively safe compound for oral administration', 'PCA could significantly reduce biofilm formation and suppress the swarming motility of R. solanacearum. the bacteriostatic mechanisms of PCA were evaluated by monitoring changes in membrane potential, intracellular ATP, membrane integrity, intracellular reactive oxygen species and bacterial morphology', 36371064),
('Antibacterial Phytochemical', 'modifying the structural parameters of a natural chickpea-derived AMP-Leg2, termed "functionalized chickpea-derived Leg2 antimicrobial peptides" (FCLAPs)', 'FCLAPs showed potent broad-spectrum antibacterial activity, with MICs in the range of 2.5', '', 'Among the FCLAPs, KTA (RIKTATWRLALRWLKL) and KTR (RIKTRTWRLALRWLKL) showed superior antibacterial potency both in vitro and in vivo. Their findings suggest that KTA and KTR represent promising sources of antibacterial candidates that could aid efforts to fill the drug discovery pipeline as a defense against Gram-negative foodborne bacteria.', 36563134),
('Antibacterial Phytochemical', 'Diosgenin is a naturally occurring steroidal saponin', 'the antimicrobial activity of diosgenin against the standard and multidrug-resistant bacteria of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus,', '', 'Antimicrobial activity against efflux pump-bearing strains revealed that saponin did not interfere with the efflux pump mechanism or intervened antagonistically. Thus, saponin has shown to be very promising against bacterial resistance in association with aminoglycoside, fluoroquinolones and beta-lactam,', 36122765),
('Antibacterial Phytochemical', 'combination of paeoniflorin and norfloxacin', 'FIC results showed that paeoniflorin and norfloxacin exert a synergistic bactericidal effect. Evidence was brought that paeoniflorin reduces the Streptococcus suis', '', 'paeoniflorin can inhibit biofilm formation, thereby promoting the ability of norfloxacin to kill S. suis. Finally, we showed in a mouse model that paeoniflorin in association with norfloxacin is effective to treat S. suis infections.', 36173390),
('Antibacterial Phytochemical', 'endophytic actinobacteria were isolated from Citrullus colocynthis plant', 'had antagonist activity against S. aureus, P. aeruginosa, and E. coli.', '', 'This study reveals the future of new antibiotic developments looks bright against multi-drug resistance', 36217205),
('Antibacterial Phytochemical', 'novel amphiphilic xanthohumol derivative derived from the hop plant, Humulus lupulus L. (Cannabaceae)', 'reported to possess good antibacterial activity [minimum inhibitory concentration (MIC) against S. aureus strains: range 15.6', '', 'Bioactivity evaluation showed that amphiphilic xanthohumol derivative IV15 not only displayed remarkable antibacterial activity against both S. aureus ATCC 29213 and clinical MRSA strains (MICs: 1', 36584344),
('Antibacterial Phytochemical', 'lignin extracted from sugarcane and sorghum bagasse', 'These analyses showed that lignin damages the S. aureus cell membrane, causes increased cell clustering, and inhibits growth synergistically with tunicamycin, a teichoic acid synthesis inhibitor.', 'Although lignin displayed no measurable cytotoxicity against human epidermal keratinocyte (HEK) cells at the concentrations used in these experiments', 'future studies investigating the use of lignin as a topically applied antibiotic adjuvant for treatment of S. aureus skin and soft tissue infections, potentially also in livestock.', 35852361),
('Antibacterial Phytochemical', 'Conjugated alkyne oligomers (e. g., polyynes, polyacetylenes) are widely represented within natural products (NPs) as diynes, triynes, tetraynes, and even polycyclic compounds.3', 'Dodeca-2,4-diyn-1-ol 2dA, the non-specific compound between E. coli and P. fluorescens had a greater efficacy than the specific 2aC, again demonstrating compound specificity.', '', 'the implementation of a mixed synthetic approach utilizing both solid-supported and solution-based chemistries allowed for the rapid synthesis of a series of diyne compounds and their consequent screening for antibiotic activity', 36194525),
('Antibacterial Phytochemical', 'novel BRICHOS-related beta-hairpin antimicrobial peptides were identified in transcriptomes of marine polychaeta species. Two of them-abarenicin from Abarenicola pacifica and UuBRI-21 from Urechis unicinctus-possess', 'Rational design based on individual hydrophobic amino acid substitutions in the structure of abarenicin-1 led us to Ap9 (Y8A, M9R) and Ap11 (Y8A, M9R, V13A) analogs with an enhanced bacterial cell selectivity. Ap9 demonstrated a promising efficacy in E. coli infection in vivo models', '', 'In summary, the abarenicin analog Ap9 is a new attractive drug candidate treatment of diseases caused by Gram-negative bacterial pathogens.', 36005520),
('Antibacterial Phytochemical', 'Penicilazaphilone C (PAC), was isolated from a marine-derived fungus.', 'time-kill assays verified that PAC is a fast and efficient bactericidal agent. PAC significantly influences over 898 proteins in Escherichia coli. It has displayed broad bactericidal activities against Gram-negative and Gram-positive bacteria.', '', 'the mode of PAC action against E. coli was to block respiration, inhibit assimilatory nitrate reduction and dissimilar sulfur reduction, facilitate assimilatory sulfate reduction, suppress cysteine and methionine biosynthesis, down-regulate antioxidant protein expression and induced intracellular ROS accumulation, weaken bacterial chemotaxis, destroy flagellar assembly, etc., and finally cause the bacteria''s death. There findings suggest that PAC could have a multi-target regulatory effect on E. coli and could be used as a new antibiotic in medicine.', 36179970),
('Antibacterial Phytochemical', 'Cinnamomum verum Essential Oil with Sertraline', 'Enterococcus faecalis ATCC 29212 and Enterococcus faecalis MIC value of sertraline was found to decrease from 16.0 (MICo) to 0.5 (MICc) microg/mL (FICI = 0.08) and from 32.0 (MICo) to 1 (MICc) microg/mL (FICI = 0.08), respectively. Furthermore, a promising result was also obtained against Acinetobacter baumannii ATCC 19606, a Gram-negative bacillus resistant to treatment with different antibiotics. In this case, a 32-fold reduction in sertraline MIC (FICI = 0.08) was observed when used in combination with EO too. The strong synergy observed between sertraline and the EO against the Gram-negative Pseudomonas aeruginosa ATCC 27853 (FICI = 0.11) and Klebsiella pneumoniae ATCC 19833 (FICI = 0.43)', '', 'he data reported in this study underline that in vitro CEO possesses a decisive and strong action towards a large panel of bacteria in association with sertraline, a selective serotonin reuptake inhibitor whose antibacterial activity has been successfully confirmed. The sertraline-CEO association resulted in a very strong synergistic mode of action for all Gram-positive and Gram-negative strains tested', 36421261),
('Antibacterial Phytochemical', 'natural marine fungus extracted compounds.', 'The most superior compound was elipyrone A with six hydrogen bonds, -8.5 of binding affinity, and preferable results in the SWISS-ADME examination against Neisseria gonorrhoeae bacteria', '', 'our effort to predict a new natural compound to overcome the resistance of this bacteria.', 36091725),
('Antibacterial Phytochemical', 'Andrographolide and 4-Phenylbutyric Acid', 'Andrographolide and 4-Phenylbutyric Acid Administration Increase the Expression of Antimicrobial Peptides Beta-Defensin-1 and Cathelicidin and Reduce Mortality in Murine Sepsis', '', 'They have shown that these compounds reduce mortality in a murine model of sepsis caused by a carbapenem-resistant Klebsiella aerogenes isolate. From our point of view, these small molecules are promising candidates for further study as potent AMP inducers. The data obtained allow the development of new strategies to combat antibiotic resistance and infectious diseases.', 36421273),
('Antibacterial Phytochemical', 'carvacrol (CAR), a phenolic compound of essential oils', 'MIC values for S. mutans and for S. sanguinis were found both visually and spectrometrically in the concentration 0.1% (93.4 microg/mL), while the MBC value corresponded to 0.39% (373.4 microg/mL). The essential oils that contain CAR have shown antimicrobial activity against both Gram-positive and Gram-negative bacteria . The MIC ranges found for CAR vary between 250 and 2500 microg/mL depending on the microorganism and the experimental conditions', '', 'CAR as an excellent alternative agent to safely prevent periodontal diseases. Thus, CAR could be used preventively in mouthwashes or biomaterials, or in treatments to avoid existing antibiotic resistance.', 36557293),
('Antibacterial Phytochemical', 'conventional antibiotics and plant-derived compounds (Selective Combinatory Effect of Ciprofloxacin with Nitroxoline, Sanguinarine, and Zinc Pyrithione)', 'For the combination of ciprofloxacin with nitroxoline, several synergistic interactions were observed for all five standard diarrheagenic bacteria tested, with FICI values ranging from 0.094 to 0.477. The strongest synergy (FICI, 0.094) was obtained against L. monocytogenes at a nitroxoline concentration of 0.25 microg/mL, when a 13-fold ciprofloxacin MIC decrease was achieved (from 1.333 to 0.104 microg/mL). the highest ciprofloxacin MIC reduction was observed for V. parahaemolyticus, where the nitroxoline concentration of 1 microg/mL caused a 16-fold reduction of ciprofloxacin MIC from 0.125 to 0.008 microg/mL, with a FICI of 0.313. The combination of ciprofloxacin-sanguinarine exerted a growth-inhibitory interaction against the five diarrhea-causing pathogens tested, with the synergistic effect ranging between FICI values of 0.134 and 0.5. combination of ciprofloxacin with zinc pyrithione produced a synergistic antimicrobial effect (FICI ranging from 0.071 to 0.5) against all the pathogenic bacteria. The strongest synergistic activity with a FICI value of 0.071 was achieved against S. flexneri at a zinc pyrithione concentration of 0.125 microg/mL, when a 17-fold ciprofloxacin MIC decrease was attained (from 0.083 to 0.005 microg/mL)', '', 'Metal ion cofactors (e.g., magnesium ion) are known to substantially affect the biological properties of topoisomerases. sanguinarine may also enhance the intracellular penetration of ciprofloxacin because it has been observed that the permeability of the bacterial cell membrane increases in the presence of this alkaloid. In summary, the present study has demonstrated that combinations of ciprofloxacin with nitroxoline, sanguinarine, and zinc pyrithione produce an antibacterial synergistic effect against diarrhea-causing bacteria, namely, B. cereus, E. faecalis, L. monocytogenes, S. flexneri, and V. parahaemolyticus, and, simultaneously, has showed antagonistic action toward gut beneficial strains of bifidobacteria, such as B. adolescentis, B. animalis subsp. Lactis, and B. breve.', 35972279),
('Antibacterial Phytochemical', 'Ginkgo biloba exocarp extract (GBEE)', 'GBEE supernatant liquid inhibited the growth of S. epidermidis, S. haemolyticus, and E. faecium at shallow concentrations with minimum inhibitory concentrations (MICs) of 2 microg/ml, 4 microg/ml and 8 microg/ml, respectively.', '', 'Ginkgo biloba exocarp extract (GBEE) has the functions of unblocking blood vessels and improving brain function, as well as antitumour activity and antibacterial activity. GBEE has an excellent antibacterial effect on gram-positive bacteria and also inhibits the growth of gram-negative bacteria, such as A. baumannii (carbapenem-resistant Acinetobacter baumannii) CRABA and S. maltophilia. GBEE inhibits the biofilm formation of S. haemolyticus by altering the regulation and biofilm material-related genes, including the release of eDNA and cell-surface binding proteins.', 36030030),
('Antibacterial Phytochemical', 'Extracts of Plant Used in Mexican Traditional Medicine( selected plants are rosemary, estafiate, rue, epazote, mint, toloache, ajenjo, and thyme)', 'Our results demonstrate that rosemary MIC 0.13 mg/mL, mint MIC 0.46 mg/mL, and estafiate extracts significantly inhibit C. difficile strains, comparable with vancomycin. All the extracts decreased the motility of bacteria by 40%, but the thyme MMIC 0.49 mg/mL and ajenjo MIC 0.48 mg/mL extracts were the best extracts to block the adherence of bacteria. The rue MIC 0.5 mg/mL extract is the best extract to inhibit the sporulation of strains.', '', 'We found that thyme, ajenjo, and mint were the most effective against the isolates. We identified that the extracts affected protein synthesis. In addition, the extracts affect the strains'' motility, and some, such as thyme extract, affect adherence, whereas rue extract affects sporulation. These results led to the identification of new compounds beneficial to CDI treatment. However, none of the extracts affected germination.', 35890019),
('Antibacterial Phytochemical', 'Novel Fusidic Acid Cream Containing Metal Ions and Natural Products', 'numbers (9.5%) of fusidic-acid-resistant Staphylococcus aureus (FRSA) isolates possessed a high resistance pattern with MIC = 128 microg/mL. In contrast, most tested FRSA isolates (90.5%) had a low resistance pattern with MIC = 8 microg/mL.', '', 'In conclusion, the F2 cream made with fusidic acid, oleuropein, thyme oil, zinc sulfate, and copper sulfate in the right amounts has stable physical and chemical properties and has potential against FRSA as an antimicrobial agent.', 36015264),
('Antibacterial Phytochemical', 'a marine actinomycete Nocardiopsis sp. HB-J378', 'Nocardiopsistin D (Compound 1 C21H13O6Br) was found to have potent activity against two strains of vancomycin-resistant S. aureus (VRSA; 170 and 522) with MICs of 0.031 microg/mL against each strain. 1 also exhibited potent activity against Enterococcus faecium and Bacillus cereus with MICs of 0.031 and 0.063 microg/mL, respectively, compared to >50 and 12.5 microg/mL for nocardiopsistin A', '', 'The single bromination in Nocardiopsistin D - 1 drastically enhanced the anti-MRSA activity by 128-fold without altering cell toxicity and acquired new activities against the bacterial pathogens vancomycin-resistant S. aureus (VRSA), Enterococcus faecium, and Bacillus cereus.', 36269561),
('Antibacterial Phytochemical', 'polyphenolic glycosides, including thirteen new derivatives isolated from the stems of Caesalpinia cucullata,', 'Derivative effectively reduce the dose of ceftiofur in combination in vitro with fractional inhibitory concentration index (FICI) ranging from 0.188 to 0.375 effect on methicillin-resistant Staphylococcus aureus, which meant polyphenolic glycosides have got antibacterial activity with different ways.', '', 'The results indicated that polyphenolic glycosides could be used as promising therapeutic agents to prevent resistance development for S. aureus infections. All compounds exhibited weak to moderate SrtA inhibitory activity. Molecular docking revealed the interactions of active compounds with SrtA enzyme.', 36242982),
('Antibacterial Phytochemical', 'colistin/resveratrol combination', 'The MICs of colistin for the 8 P. aeruginosa strains were measured at 8 to 64 microg/mL, and 75% (6/8) of these strains exhibited MDR phenotypes ans alone resveratrol displayed no antimicrobial activity against these colistin-resistant P. aeruginosa strains (MIC >512 microg/mL) but in combination MIC of colistin exhibited a significant (8 to 16-fold) decrease in the presence of resveratrol, and the FICI of the 8 P. aeruginosa ranged from 0.25 to 0.38 (synergy).', 'the combination of colistin (2 microg/mL) and resveratrol (16, 32 microg/mL) showed a high survival rate at 90 to 100% within 168 h, it was significantly higher than that of the control group and the monotherapy group therapy (P < 0.05) in G. mellonella model', 'In conclusion, our results may provide an efficient alternative pathway against colistin-resistant P. aeruginosa infections. Resveratrol, a naturally occurring polyphenolic antioxidant, can effectively slow down or avoid the occurrence and development of bacterial resistance. In this study, colistin/resveratrol combination could synergistically damage the bacterial cell membrane, thereby inducing cell lysis while addressing the emergence of drug resistance. Moreover, this combination therapy may provide an efficient alternative pathway to combat the colistin-resistant P. aeruginosa in clinical practice.', 36475724);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Phytochemical', 'loaded plant essential oils (PEOs) into lab-made CaSO4 beads', 'All of the PEOs tested demonstrated significant growth inhibitory activity against planktonic S. aureus when comparing zones of inhibition ZOIs to a null hypothesis of 6 mm (disk size and LOD), except for neroli and wintergreen. Most notably, cilantro PEO exhibited full growth inhibition of S. aureus in all replicates', '', 'six of the significantly active PEO-beads had relatively/consistently high activity compared to all others, including arborvitae (17.4 mm), balsam fir (19.2 mm), cassia (21.8 mm), cinnamon bark (20.7 mm), grapefruit (17.6 mm), and oregano (15.28 mm), and these may represent the best candidates for additional study and optimization for use in beads. To the best of knowledge, this is the first time in which a large set of single plant PEOs have been demonstrated to exhibit growth inhibition of S. aureus in vitro when infused in CaSO4 beads.', 35802739),
('Antibacterial Phytochemical', 'extract of B. monnieri leaves and its bioactive molecules', 'the methanolic extract of B. monnieri had the highest inhibition zone against both microorganisms (K. pneumoniae and P. mirabilis). Oroxindin was considered as a potential bioactive molecule, it is a flavone or a type of phenolic of B. monnieri, is a potent inhibitor of UTIs, establishing pathogens such as K. pneumoniae and P. mirabilis', '', 'The overall results suggest that Oroxindin from B. monnieri can be a potent inhibitor for the effective killing of K. pneumoniae and P. mirabilis. Additionally, its safety has been established, indicating its potential for future drug discovery and development in the treatment for UTIs.', 35956923),
('Antibacterial Phytochemical', 'Polygonum chinense L.aqueous extract', 'Polygonum chinense L.aqueous extract against S. aureus displayed minimum inhibitory concentration (MIC) of 4 mg/mL and minimum biofilm inhibitory concentration (MBIC) of 16 mg/mL against S. aureus.', '', 'Polygonum chinense L.aqueous extract exerts a potent destruction of the cell wall of S. aureus and a significant inhibitory effect on the formation of S. aureus biofilm. In addition, flow cytometry showed the ability of Polygonum chinense L.aqueous extract to promote apoptosis by disrupting cell membranes of S. aureus. These results suggested that Polygonum chinense L.aqueous is a promising alternative antibacterial and anti-biofilm agent for combating infections caused by planktonic and biofilm cells of S. aureus.', 36539472),
('Antibacterial Phytochemical', 'silver nanoparticles (AgNPs) from Withania somnifera and Fagonia indica', 'AgNPs showed statistically highly significant results against S. pneumonia (AgNPs, 14; crude, 8.33 mm). Crude extract showed significant inhibition against two bacterial strains, P. aeruginosa (crude, 21; AgNPs, 11.67 mm) and K. pneumonia (crude, 11.33; AgNPs, 8 mm)', '', 'In phytotoxic results, crude extracts of both tested plants are more effective as compared to AgNPs. The present study has provided a base for the researcher in the field of nanomedicine to synthesize and check the biological activities of nanoparticles and isolated compounds from other medicinal plants against other microorganisms. New antibiotics and therapeutics in nanoform should be made from these natural products and replaced with those showing resistance to microorganisms.', 36440367),
('Antibacterial Phytochemical', 'Synergistic antibacterial activity of baicalin and EDTA in combination with colistin', 'the combination of baicalin and EDTA also showed a stronger synergistic effect on colistin, reversing the colistin resistance of all Salmonella strains.', '', 'Analysis revealed that baicalin and EDTA enhanced colistin activity through multiple pathways, including accelerating the tricarboxylic acid cycle (TCA cycle), inhibiting the bacterial antioxidant system and lipopolysaccharide (LPS) modification, depriving multidrug efflux pump functions and attenuating bacterial virulence. In conclusion, our study indicates that the combination of baicalin and EDTA as a novel colistin adjuvant can provide a reliable basis for formulating the therapeutic regimen for colistin resistant bacterial infection.', 36493546),
('Antibacterial Phytochemical', 'novel pleuromutilin derivatives with a scaffold of 4(3H)-quinazolinone', 'their in vitro activity against Staphylococcus aureus and Staphylococcus epidermidis as well as Gram-negative bacteria (Escherichia coli and Salmonella enterica subsp. enterica serovar pullorum). . Among this series of pleuromutilin analogues, compound 23 with a structure of 2-mercapto-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one displayed the best in vitro antibacterial activity against MRSA (MIC = 0.063 microg/mL)', 'low cytotoxicity to RAW 264.7 cells (IC50>100 microM)', 'Pleuromutilin, a naturally occurring product with moderate antibacterial activity, has a unique structure that has attracted great efforts to modify its scaffold to obtain lead compounds. Hence this was demonstrated to inhibit MRSA ( methicillin-resistant Staphylococcus aureus) effectively in a mouse thigh infection model', 36462445),
('Antibacterial Phytochemical', 'effect of Gentian violet a triarylmethane dye and Safranin', 'Gentian violet dye has been shown to be 100% sensitive to both Gram-positive and Gram-negative bacterial isolates. Although safranin also had high sensitivity (100%) to S. aureus isolates, its sensitivity to P. aeruginosa was only 20%. Staphylococcus aureus was more resistant to iodine (40% sensitivity) compared to P. aeruginosa, which was 100% sensitive to iodine.', '', 'Gentian violet had good antibacterial activity against both Gram-positive and Gram-negative bacteria, making it useful for treating bacterial skin pathogens such as S. aureus and P. aeruginosa especially for MDR bacteria. While safranin has good efficacy against Gram-positive bacteria (S. aureus), its effect against Gram-negative bacteria (e.g. P. aeruginosa) is poor.', 35921487),
('Antibacterial Phytochemical', 'sulforaphane (SFN)', 'results showed that the SFN against M. tuberculosis H37Ra exhibited bactericidal activity in a time and dose-dependent manner', '', 'SFN promoted the bactericidal effect of macrophages on intracellular bacteria in a dose-dependent manner, mediated by increasing intracellular mitochondrial ROS levels and decreasing cytoplasmic ROS levels. studies focusing on the mechanism of SFN in macrophages against M. tuberculosis are essential for developing new host-directed therapeutic approaches against TB.', 36048328),
('Antibacterial Phytochemical', 'synergistic effect of CUR with imipenem (IMP) and Colistin (CST)', 'In this study, IMP MIC values were significantly reduced (two to eight-fold decrease) in the presence of CUR, and partial synergy was observed. For CST, this value decreased two-fold against Pseudomonas aeruginosa.', '', 'It was concluded CUR-antibiotic combinations can provide an alternative approach in the treatment of infections with MDR bacteria.', 35882691),
('Antibacterial Phytochemical', 'Galloylglucoses', 'They showed minimum inhibitory concentration (MIC) values in the range of 2-256 microg/mL across tested bacterial strains active against different MDR strains of Escherichia coli and Klebsiella pneumoniae.', '', 'These findings have added to the number of known galloylglucoses from P. officinalis and highlight their potential against MDR Gram-negative bacteria. The observed antibacterial activities of galloylglucoses are related to their previously reported ability to interact with proteins, carbohydrates, lipids, and metal ions . The compounds characteristically bind to different macromolecules through hydrophobic interactions, as well as via hydrogen, covalent, and ionic or electrostatic bonds', 35956993),
('Antibacterial Phytochemical', 'Pecan (Carya illinoinensis) and Chestnut (Castanea sativa) flowers', 'Anti-quorum sensing (anti-QS), anti-biofilm, and anti-swarming (SW) activities were also studied against Chromobacterium violaceum ATCC 31532, Chromobacterium violaceum ATCC 12472, and Pseudomonas aeruginosa PA01, respectively. . Both extracts were rich in ellagic acid and gallic acid and exhibited similar antioxidant properties.', '', 'Both flower extracts exhibited high antimicrobial and antifungal activities as well as anti-biofilm, anti-QS, and anti-SW activities.', 36053379),
('Antibacterial Phytochemical', 'chrysin is a component of honey in combination with colistin', 'Our results revealed that chrysin and colistin exerted synergistic effects against A. baumannii by damaging the extracellular membrane', '', 'Synergistic effect damage the extracellular membrane and modifying the bacterial membrane potential. The chrysin/colistin combination group demonstrated an inhibitory effect on biofilm formation. In conclusion, it is expected that the synergy between these drugs can allow the use of a lower concentration of colistin for the treatment of A. baumannii infections, thereby reducing dose-dependent side effects. Thus, a combination therapy of chrysin/colistin may provide a new therapeutic option for controlling A. baumannii infections.', 36386691),
('Antibacterial Phytochemical', 'combined effect of blue LED Irradiation and berberine (an alkaloid compound)', 'the combined effect of blue LED Irradiation and berberine on Pseudomonas aeruginosa (Gram-negatives) and Staphylococcus aureus (Gram-positive) and also their effect on human dermal fibroblast (HDF) cells', '', 'This compound destroys bacterial cells by producing reactive oxygen species (ROS). These compounds also prevented the formation of biofilms and were able to destroy the created biofilms.', 36253652),
('Antibacterial Phytochemical', 'Helichrysum italicum (Roth) G. Don essential oil (EO) and hydrosol.', 'The highest antimicrobial effect was shown in the case of C. jejuni strains (12.5% (V/V)), followed by E. coli and P. aeruginosa, both inhibited by 100% V/V and S. aureus showing resistance to the undiluted H. italicum hydrosol.', 'The cytotoxicity of the EO was higher when compared to hydrosol for all cell lines( immortalized cell lines Caco-2 and A375, primary epidermal melanocytes (PEM) and CCD112CoN primary colon fibroblasts). at the tested concentration of 0.084% (V/V) EO, the highest sensitivity was shown for PEM with no viability detected, followed by Caco-2 (approx. 30% viability) and A375 (approx. 75% viability), while CCD112CoN cells were not tested at this concentration due to the higher sensitivity', '', 36009886),
('Antibacterial Phytochemical', 'Crotoxin from Crotalus durissus terrificus (Crotoxin is a beta-neurotoxin from the venom)', 'Crotoxin showed only bacteriostatic activity with a MIC of 46 microM, while the CB subunit acted as both a bacteriostatic and bactericidal agent with a MIC = MBC = 0.21 microm gainst Micrococcus luteus ATCC 10240. Both toxins reduced bacteria viability at the MIC by 72% and 85% for crotoxin- and CB-treated bacteria, respectively', 'Neither crotoxin nor the CB subunit showed any cytotoxic properties to human fibroblasts at the MIC during the three-day incubation.', 'crotoxin leading to the inhibition of bacterial growth. The membrane permeability increased approximately three times within the first hour of incubation with toxins; afterwards, either no significant changes or a decrease of membrane permeability', 36431827),
('Antibacterial Phytochemical', 'Combination of Poly(e-Caprolactone) Biomaterials and Essential Oils', 'PCL-based 3D scaffold was successfully loaded with two different EOs, eugenol and cinnamon oil, at increasing concentrations (from 30 to 50%) to achieve anti-adhesive and anti-biofilm properties against three pathogens involved in biomaterial associated infections, which are S. aureus, S. epidermidis and E. coli.', 'PCL-based biomaterials were not toxic for eukaryotic Saos-2 cells only when the lowest EO concentration (30% eugenol or 30% cinnamon oil) was added to the polymer.', 'The biodegradability and biocompatibility of the PCL together with bioactive natural compounds (EOs) make these 3D scaffolds as eco-friendly anti-adhesive/anti-biofilm constructs, granting the targeted delivery of the EOs into the site of infection where bacteria are allocated, and might have great potential applications in the regenerative medicine field.', 36145620),
('Antibacterial Phytochemical', 'Synergy between Piceatannol (PIC) (natural stilbene extracted from grape skins) and Ciprofloxacin', 'We found that PIC had an inhibitory effect against Staphylococcus aureus (S. aureus); its minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were 128 microg/mL and 256 microg/ Ml. The results showed that when PIC and ciprofloxacin (CIP) were combined, they displayed a synergistic effect against S. aureus.', 'PIC exhibited slight hemolytic activity on mammalian erythrocytes. the hemolysis rate was about 10.2% with a concentration of 1024 microg/ mL', 'PIC also inhibited bacterial adenosine triphosphate (ATP) synthesis and was less likely to induce bacterial resistance. the combination of PIC and CIP is expected to become a new drug combination to combat S. aureus. when using PIC, we should prioritize topical medication and strictly control the dosage within 128 microg/mL to avoid hemolysis', 36499677),
('Antibacterial Phytochemical', 'Dimer stilbene, a resveratrol analogue exhibits synergy with antibiotics', 'structural determinants of stilbenes that could aid in better antibacterial activity and identified Dimer stilbene (DS) as a potent inhibitor of S. aureus. DS exhibited synergy with the aminoglycoside kanamycin and additive effect with tetracycline.', '', 'Our recent work identified important structural determinants of stilbenes that could aid in better antibacterial activity. Synergy with kanamycin was also observed in other stilbenes apart from DS. Thus our study reveals stilbenes could be exploited towards combating S. aureus infections either as standalone drugs or in combination with existing antibiotics.', 35772578),
('Antibacterial Phytochemical', 'natural compound schisandraone', 'In vivo studies further suggested that schisandrone combined with antibiotic ceftiofur exhibited a significant therapeutic effect on S. aureus infection.', '', 'We also found that the addition of schisandrone could down-regulate the transcriptional levels of the alpha-hemolysin hla, agrA and RNAIII and significantly alleviated Hla-mediated injury of A549 cells co-cultured with S. aureus. These findings revealed the role of schisandrone in inhibiting the activity of Hla and we believe that it is a promising anti-virulence candidate to combat MRSA pneumonia.', 36344903),
('Antibacterial Phytochemical', 'Saussurea lappa Extract', '', '', 'Our findings suggest that the S. lappa extract exhibits an immunomodulatory effect with potential to reduce and cure systemic infections by both opaque and translucent colony variants of A. baumannii.', 36188613),
('Antibacterial Phytochemical', 'Mimosa pudica of Nepalese Terai Region', 'The extract showed a potent free radical scavenging activity with an IC50 value of 158.95 ', '', 'The findings of the current study suggest that Mimosa pudica from the Terai region of Nepal is rich in phenolic and flavonoid compounds, has a significant impact on bacterial growth inhibition, and has a notable potential to scavenge free radicals (DPPH). According to the in silico analysis, L-mimosine is a potent antibacterial compound that might be utilised to discover novel antibacterial drugs to combat antibiotic resistance.', 36248409),
('Antibacterial Phytochemical', 'kaempferol glycosides and quercetin', 'the presence of kaempferol-3,7-dirhamnoside (125 and 250 microg/mL) and quercetin (15.63 microg/mL) reduced each other', '', 'a proper compatibility of kaempferol glycosides and quercetin is beneficial to the mutual promotion of their antibacterial activities. Furthermore, GE-EE in combination with penicillin G was found to synergistically inhibit the growth of S. aureus strains BWSA11, BWSA15, and ATCC 43300 with FICs of <0.19, <0.5, and <0.16, respectively', 36354319),
('Antibacterial Phytochemical', 'hydro-ethanolic extract and protoberberine alkaloids from the stem bark of Enantia chlorantha', 'The crude extract (ECB) inhibited the growth of all the tested MDR bacteria, with the minimal inhibitory concentration (MIC) values below 100 microg/mL obtained against Escherichia coli ATCC 10536, AG 102, Enterobacter aerogenes EA 27, Klebsiella pneumoniae ATCC 11296 and KP 55, Providencia stuartii NEA 16, and Staphylococcus aureus MRSA3 and MRSA6. *Compound 1 had the best antibacterial effects with MIC values ranging from 16 to 64 microg/mL.', '', 'The crude extract (ECB) and its isolated compounds 1-6 are potential antibacterial products from Enantia chlorantha. They could be explored more to develop the antibacterial agents that could be used alone or in combination with antibiotics to overcome MDR phenotypes.', 35788039),
('Antibacterial Phytochemical', 'Cinnamomum camphora essential oil', 'The results show that the main components of the essential oil (EO) from the leaves of C. camphora were Eucalyptol. The EO had good antibacterial activity against eight clinical antibiotic-resistant pathogens, namely, Pseudomonas aeruginosa, Acinetobacter baumannii (two strains), Klebsiella pneumonia (two strains), Escherichia coli (one strain), Staphylococcus aureus (two strains).', '', 'These findings may lead to a more complete knowledge of this aromatic plant''s antibacterial action against antibiotic-resistant pathogens (in vitro).', 35993631),
('Antibacterial Phytochemical', 'lemongrass (Cymbopogon citratus) extract', 'MRSA growth inhibition (zones of inhibition) was greatest for the lemongrass oil at concentrations of 1, 2, 5, 10 and 20 % (wt/vol). The MIC for lemongrass oil was 0.5 mg/mL, while it was 4 mg/mL for both the aqueous and ethanol extracts.', '', 'The ethanol extract enhanced the activity of tetracycline and ampicillin, while the aqueous extract only increased the activity of tetracycline against MRSA. It also demonstrates that lemongrass oil potentiates the activities of three antibiotics against the biofilm-forming MRSA. This biocidal, anti-biofilm disruption and antibiotic potentiating abilities are mainly attributable, further evidence of lemongrass oil as a very useful source of phytochemicals, especially citral for the fight against antibiotic resistance.', 36026557),
('Antibacterial Phytochemical', 'Daphnetin (DAP), a coumarin derivative', 'DAP at concentrations of 0.445-1.781 mg/mL and 0.89-1.781 mg/mL can effectively inhibit biofilm formation and eradicate the formed biofilm of P. aeruginosa, respectively.', 'Daphnetin (DAP), a coumarin derivative, is a safe, non-toxic', 'In conclusion, our results support the conclusion that DAP can effectively eradicate formed biofilm and inhibit biofilm formation, bacterial motility, and pyocyanin production of P. aeruginosa and may represent a natural anti-biofilm therapeutic agent.', 36467736),
('Antibacterial Phytochemical', 'effects of cinnamon, oregano, and thyme essential oils', 'Show MIC against Escherichia coli and Trueperella pyogenes, which were isolated from dairy cows with clinical endometritis.', '', 'This study demonstrated a promising antimicrobial activity of cinnamon''s essential oil, indicating that it has excellent potential to be explored as a possible alternative in the treatment of clinical endometritis in dairy cows.', 36413866),
('Antibacterial Phytochemical', 'Algerian Essential Oils( Algeria-Salvia officinalis (Sage), Thymus vulgaris (Thyme), Mentha pulegium L. (Mentha), Rosmarinus officinalis (Rosemary), and Pelargonium roseum (Geranium))', 'T. vulgaris was the most potent, with an inhibition zone of 12-26 mm and an MIC value ranging between 0.25 and 1.25%, followed by S. officinalis with an inhibition zone of 8-12 mm and an MIC value ranging between 0.62 and 2.5%. . Generally, A. baumannii and S. aureus ATCC6538P were the most sensitive strains, whereas P. aeruginosa ATCC27853 was the most resistant strain to the oils', '', 'The in-silico study revealed that sesquiterpenes and thymol had the highest binding free energies against the vital enzymes involved in biosynthesis and repair of cell walls, proteins, and nucleic acids compared to monoterpenes. The results demonstrated that T. vulgaris and S. officinalis are ideal candidates for developing future potentially active remedies against MDR strains.', 36289975),
('Antibacterial Phytochemical', 'tea tree essential oil (TTO) nanoemulsion (nanoTTO)', 'nanoTTO increased the drug accumulation in MDR E. coli by disrupting outer and inner membranes and inhibiting the AcrAB-TolC efflux pump involved in membrane permeability.', '', 'nanoTTO was effective in enhancing antibiotic efficacy in the Galleria mellonella infection model and mouse peritonitis model, suggesting a potential strategy against MDR bacterial infections.', 35854664),
('Antibacterial Phytochemical', 'Seed-Derived Ethanol Extracts from Persea americana Mill', 'displayed a moderate antibacterial activity against Pseudomonas aeruginosa (IC50 = 87 and 187 microg/mL) and Staphylococcus aureus (IC50 = 144 and 159 microg/mL). no antibacterial activity was found against Escherichia coli. avocado seed ethanol extracts (64 microg/mL) downregulated virulence-related factors such as mexT and lasA genes.', 'Ethanol extracts were not cytotoxic to mammalian cells (CC50 > 500 microg/mL)', 'Our results support the potential of bioproducts from P. americana seeds as anti-adhesive and anti-biofilm agents.', 35956958),
('Antibacterial Phytochemical', 'Combination of resveratrol and polymyxin B', 'synergistic effects when tested in vitro with polymyxin B on antibacterial and anti-biofilm activities against multidrug-resistant Pseudomonas aeruginosa', '', 'This suggests that it could be a partner for the combination therapy of polymyxin B in the treatment of topical bacterial infection caused by MDR P.aeruginosa.', 35999263),
('Antibacterial Phytochemical', 'Vetiver essential oil, a product of Chrysopogon zizanioides (L.) Roberty root', 'cell death in Bacillus subtilis caused by sesquiterpenes from Chrysopogon zizanioides (L.) Roberty', '', 'Composition analysis suggested that the sesquiterpene, khusimol, might contribute to the bactericidal activity of the Vetiver extract.', 35418537),
('Antibacterial Phytochemical', 'four commercial essential oils, namely, tea tree, thyme, sage, and eucalyptus', 'Statistical comparison of the EOs'' antimicrobial results showed that thyme gave the lowest minimum inhibitory concentrations (MIC) and minimum biofilm eradication concentrations (MBEC) in P. aeruginosa-resistant isolates,', '', 'making this EO a competitive candidate for the development of efficient and ecologic antimicrobial alternatives.', 35956481),
('Antibacterial Phytochemical', 'extracts of Psoralea corylifolia Linn. Seed', 'The tested strains included S. aureus (ATCC 25923), S. epidermidis (CMCC 26069), E. coli (CICC 20658), and Shigella dysenteriae (CICC 23829), MRSA and Pseudomonas aeruginosa', '', 'We identified eight prenylated flavonoids in Psoralea corylifolia Linn. seed. The antibacterial activity and mechanism studies showed that this type of compound has a unique destructive effect on MRSA cell membranes and does not result in drug resistance. The results revealed that prenylated flavonoids in Psoralea corylifolia Linn. seeds are promising candidates for the development of novel antibiotic agents to combat MRSA-associated infections.', 36296544),
('Antibacterial Phytochemical', 'Ellagic acid and gallic acid', 'minimum inhibitory concentration (MIC) test on the IS-58 and K2068 strains of S. aureus, it was observed that for both strains, the two compounds presented a MIC=1024 microg/ml', 'Ellagic acid and gallic acid showed no toxicity on the model arthropod D. melanogaster.', 'These results indicate the possible use of gallic acid as an adjuvant in antibiotic therapy against multidrug-resistant bacteria.', 36063129),
('Antibacterial Phytochemical', 'Isoespintanol (ISO) is a monoterpene', 'MIC90 minimum inhibitory concentration values ranged from 694.3 to 916.5 microg/mL and MIC50 values from 154.2 to 457.3 microg/mL. The eradication of mature biofilms in P. aeruginosa after 1 h of exposure to ISO was between 6.6 and 77.4%, being higher in all cases than the percentage of biofilm eradication', '', 'ISO has antibacterial and antibiofilm potential against nosocomial bacteria and could serve as an adjuvant in the control of these pathogens.', 36432105),
('Antibacterial Phytochemical', 'Synergistics effect of Glycolipid-Biosurfactant of B12 (GBB12) with antibiotics', 'GBB12-Gentamycin mixture almost completely inhibits the formation of A. baumannii biofilm, reaching 99.8% inhibition. Also, the rate of MRSA biofilm inhibition treated with GBB12-Ciprofloxacin mixture was found to be 99.4%.', '', 'biosurfactant-antibiotic mixture could be adequate replacements for traditional antibiotics in the near future. This study shows the potential of GBB12 as antimicrobial and antibiofilm agent.', 36534183),
('Antibacterial Phytochemical', 'Medicinal Plants from Cameroon(leaves of Leucanthemum vulgare, Cymbopogon citratus, Moringa oleifera and Vernonia amygdalina; barks of Cinchona officinalis and Enantia chlorantha barks and seeds of Garcinia lucida and leaves and seeds of Azadirachta indica using water and ethanol as solvents)', ': Among the most active plants, in decreasing order of antimicrobial activity we found ethanolic (EE) and aqueous extracts (AE) of E. chloranta bark (ECB), EE of L. vulgare leaves and G. lucida seeds . The extracts were tested against Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 6538 and Candida albicans 10231', '', 'The ethanol extract of the bark of E. chlorantha has remarkable, broad-spectrum antimicrobial and contains several palmatine derivatives.', 36575849),
('Antibacterial Phytochemical', 'combined application of Shikonin (SKN) and traditional antibiotics', 'SKN inhibit the expression of proteins and genes related to drug resistance and S. aureus exotoxins.', '', 'Our findings suggest that SKN has the potential to be developed as a promising alternative for the treatment of MRSA infections.', 35886892),
('Antibacterial Phytochemical', 'Gallic acid (GA)', 'GA inhibited the growth and CPS biosynthesis in K. pneumoniae.', '', 'GA possesses bactericidal activity and inhibits the CPS biosynthesis in hypervirulent K. pneumoniae, thereby facilitating pathogen clearance by the host immune system. Therefore, GA may represent a promising strategy for the prevention or treatment of patients with hypervirulent K. pneumoniae infections.', 34326026),
('Antibacterial Phytochemical', 'Aloe vera (L.) Burm. f. (aloe; Liliaceae family)', 'The water extract of A. vera showed considerable potential to reduce the number of fluoxetine-mediated MDR colonies. The extract robustly suppressed the formation of ROS in E. coli.', '', 'A. vera extract directly affected the fluoxetine-triggered early stress response of E. coli and the expression of downstream genes. Meanwhile, A. vera extract was able to inhibit the genetic mutation of SoxR gene in E. coli, as induced by co-cultured with fluoxetine. This study therefore suggested that the extract of A. vera could be an adjuvant agent to combat bacterial MDR during anti-depressant treatment.', 36054995),
('Antibacterial Phytochemical', 'Chinese propolis ethanol extract (CPEE)', 'The diameter of inhibition zone (DIZ) of CPEE was 20.1 mm. The minimal inhibitory concentration (MIC) of CPEE was 32 mg/L, while the minimal bactericidal concentration (MBC) against MRSA was 64 mg/L against MRSA.', '', 'These results demonstrated the anti-MRSA activity of CPEE was mainly due to changing the cell membrane and reversing resistance, which indicates that CPEE could be an attractive candidate for use in future food and medical applications.', 35902505),
('Antibacterial Phytochemical', 'derivativeHalogenated Flavonolignans- (silybins A and B, 2,3-dehydrosilybin, silychristin A, and 2,3-dehydrosilychristin A) was prepared.', 'inhibited the adhesion of bacteria (Staphyloccocus aureus and Pseudomonas aeruginosa) to the surface, preventing biofilm formation.', '', 'these derivatives acted synergistically with antibiotics and reduced the viability of antibiotic-resistant S. aureus. Some flavonolignans were able to reverse the resistant phenotype to a sensitive one, implying that they modulate antibiotic resistance.', 36499444),
('Antibacterial Phytochemical', 'Lactoferrin', 'the prevention of biomass formation and eradication of preformed biofilms by lactoferrin was investigated using a methicillin-resistant Staphylococcus epidermidis (MRSE) strain. In the in vitro biofilm assays, lactoferrin prevented biofilm formation and eradicated established biofilms for up to 24 and 72 h, respectively', '', 'Extensive eradication of MRSE biofilm biomass was accompanied by the significant upregulation of bap gene expression. These data suggest the interaction of lactoferrin with the biofilm components and cell wall of MRSE, including the biofilm-associated protein.', 36265186),
('Antibacterial Phytochemical', 'leaf extract of Gynura procumbens (GP)', 'The extract inhibited the biofilm production (p = 0.05) in P. aeruginosa strains MZ2F and MZ4A. The minimum biofilm eradication concentration (MBEC) was recorded at 250 and 500 microg/ml while total activity was found at 288 and 144 ml/g, respectively.', '', 'compounds were suitable drug candidates with stable binding interactions. Therefore, the anti-QS activity of GP leaves and the identified polyphenols can be used in developing QQ-based therapeutics.', 33403919),
('Antibacterial Phytochemical', 'Essential oil', 'The (MIC) of cinnamon oils against resistant strains ranged from 4.88 to 312.5 microg/ml.', '', 'Cinnamon oil exhibited the highest activity against colistin-resistant strains followed by thyme and eucalyptus oil. mcr-1 gene expression was extremely down-regulated after the treatment of bacterial strains with cinnamon oil and decreased to 20-35-fold. Cinnamon oil exhibits antibacterial activity against colistin-resistant strains, showing it as a promising natural alternative in clinical therapy.', 35839089),
('Antibacterial Phytochemical', 'wild shrub Halexylon salicornicum (Ramth) aqueous and solvent extracts', 'All of the extracts tested had antimicrobial efficacy against tested strains and included bioactive chemicals, particularly the acetone extract, had the highest antibacterial activity against (Enterococcus faecium, Shigella flexneri, Bacillus Cereus, Klebsiella pneumoniae, Staphylococcus aureus, Escherichia coli, Streptococcus pyogens, Pseudomonas aerogenes, Salmonella typhimurium, and Candida albicans)', '', 'All of the extracts tested had antimicrobial efficacy against tested strains and included bioactive chemicals, particularly the acetone extract, had the highest antibacterial activity. As a result, it can be stated that Halexylon salicornicum is a promising important shrub that might be used as a natural antimicrobial alternative for animals or as a food additive.', 35707822),
('Antibacterial Phytochemical', 'crude hydroalcoholic extract of Brazilian red propolis (CHEBRP).', 'CHEBRP presented MIC/MBC of 50 and 100 microg/mL against H. pylori strains (ATCC 43526 and clinical isolate, respectively) and tetracycline MIC/MBC of 0.74 microg/mL.', '', 'The association of CHEBRP with tetracycline had an indifferent effect. In the stomach mucosa of rats, all treatments performed significantly decreased the number of H. pylori, and a concentration of 300 mg/kg was able to modulate the inflammatory response in the tissue. Therefore, CHEBRP showed promising anti-H. pylori in in vitro and in vivo assays.', 36364137),
('Antibacterial Phytochemical', 'six monofloral honeys (jarrah, marri, red bell, banksia, wandoo, and manuka)', 'Jarrah, marri, red bell, banksia, and manuka honeys were highly effective at inhibiting S. aureus and CoNS, with MIC50 values ranging from 4 to 8% w/v honey. S. pyogenes was also inhibited by these same honeys, albeit at higher concentrations (8-29% w/v). Wandoo and multifloral honeys had the least antibacterial activity with MICs of >30% (w/v) for all isolates.', '', 'ata indicated that sub-MIC concentrations of honey were still partially restricting bacterial growth. Our pre-clinical data indicate that honey may be a potential therapeutic agent for the routine treatment of mild impetigo, and we suggest that clinical trials would be appropriate to further investigate this.', 35868137),
('Antibacterial Phytochemical', 'Verbascoside is Antibacterial adjuvant (caffeoyl phenylethanoid glycoside)', '', '', 'verbascoside exerted its antimicrobial activity through multiple mechanisms, including cell membrane dysfunction, biofilm eradication and changes in cell morphology thats why it is expected to be useful as an antibiotic adjuvant to prevent or treat resistant bacteria-related infections and an alternative novel antimicrobial additive in the food industry.', 35956890),
('Antibacterial Phytochemical', 'Gallic acid (GA) is a natural ingredient', 'GA damaged outer and inner membranes, and suppressed the mRNA expressions of acrA, acrB, tolC, acrD and acrF involved in membrane permeability.', '', 'The results revealed that GA exerted bactericidal activity and inhibited the formation of bacterial biofilm. GA showed protective effects against bacterial infection and improved the survival rates of Galleria mellonella and BALB/c mice.', 36243382),
('Antibacterial Phytochemical', 'Synthetic chalcone derivative (r4MB)', 'Compound r4MB showed activity against 100% of the tested strains(Enterococcus faecalis and Enterococcus faecium) with the minimum inhibitory concentration (MIC) in the range of 5-20 microM.', 'No cytotoxic haemolysis was observed with mammalian erythrocytes', 'This fully synthetic chalcone derivative demonstrated activity against ATCC and clinical strains of Enterococcus spp. bacteria. The compound appeared to target the bacterial membrane of E. faecalis, altering its permeabilisation and electric potential, leading to cell death.', 35940279),
('Antibacterial Phytochemical', 'Henna (Lawsonia inermis)', 'Shahdad, Rudbar-e-Jonub, and Qaleh Ganj had MIC against Group B Streptococcus agalactiae (GBS), at 15, 15 and, 4 microg/ml. IC50 of shahdad Henna after 24 h, 48 h, and 72 h was 7.54, 4.83 and 20.54 microg/ml, respectively. IC50 of Rudbar-e-Jonub extract was 5.76, 3.79 and 5.77 microg/ml in different days. IC50 of Qaleh Ganj extract was 6.09, 4.08 and 5.74 microg/ml in different days.', '', 'The amount of total phenol in Qaleh Ganj was higher than the other varieties. In the well diffusion method, Qaleh Ganj was more effective against group B Streptococcus (Gram-positive bacterium) than the other two landraces, and Shahdad landrace was more effective against P. aeruginosa (Gram-negative bacterium) than other.', 35907942),
('Antibacterial Phytochemical', 'Medicinal plant, Moringa (Moringa oleifera)', 'The minimum inhibitory concentrations (MICs) of Ethanolic extract of Moringa oleifera leaf (EMLE) were 400microg/ml and 500microg/ml against Staphylococcus aureus and Escherichia coli respectively.', '', 'The present study showed that Ethanolic extract of Moringa leaf demonstrated antibacterial effects against food borne pathogens', 36189541),
('Antibacterial Phytochemical', 'activity of clove essential oil ( Syzygium aromaticum)', 'The lowest resistance rates were observed for meropenem (4.88%), amikacin (12.20%), and tobramycin (12.2%). All isolates were susceptible to clove oil with an equivalent MIC and MBC from 3.26 to 6.53 mg/mL against Pseudomonas aeruginosa . Eugenol was the major component of the oil.', '', 'Clove EO was effective against MDR strains of P. aeruginosa, indicating an alternative for developing an efficient and low-cost antimicrobial agent to treat canine otitis.', 36425137),
('Antibacterial Phytochemical', 'Polymyxin B in Combination with Glycerol Monolaurate (GML).', 'A. baumannii HR13 (MIC, 4 microg/mL) and K. pneumoniae KP024 (MIC, 8 microg/mL), were resistant to PMNB; the other strains had similar MIC values ranging from 0.5 to 1 microg/mL. However, GML did not exhibit any effective antibacterial activities at a concentration of up to 4000 microg/mL for all Gram-negative pathogens.', '', 'In this study, we confirmed that PMNB synergized with GML increased antimicrobial activity against Gram-negative strains in vitro and in vivo, and this synergistic activity was mainly achieved by exacerbating the destruction of bacterial cell structures, eradicating preformed biofilms, and promoting intracellular ROS accumulation.', 36014995),
('Antibacterial Phytochemical', 'Cannabis sativa CBD Extract', 'Polymyxin B mono-treatment at a MIC of 5 microg/mL exhibited a percent inhibition of 83%, whereas co-treatment with Polymyxin at 0.5 microg/mL and CBD at 1 microg/mL resulted in a percent inhibition of 92%', 'It is a non-toxic and low-resistance chemical', 'The final antibiotic that exhibited promising antibacterial synergy with CBD was polymyxin B. CBD extract from C. sativa has been presented as a promising antibacterial agent with in vitro efficacy against several relevant bacterial pathogens including Staphylococcus aureus, Streptococcus pneumoniae, Salmonella spp. Clostridium difficile, Neisseria spp., Moraxella catarrhalis, and Legionella pneumophila', 36557613),
('Antibacterial Phytochemical', 'Kaempferol Combined with Colistin', 'The MICs of KP against all the 24 strains of Col-R GNB were =512 microg/mL and the MICs of COL ranged from 4 microg/mL to >128 microg/mL but they alone not show much effect. The COL/KP combination had a strong synergistic effect on most of the Col-R strains, with fractional inhibitory concentration index (FICI) ranging from 0.012 to 0.375', 'The findings demonstrated that at the combined ( KP and COL) concentrations with synergistic effects, there were no additional toxic effects investigatted on RAW264.7 cells.', 'KP combined with COL could inhibit the formation of bacterial biofilms and enhanced G. mellonella survival. Hence they designed in vivo infection models of G. mellonella to develop a new treatment for Col-R GNB pathogens. hence the combination exhibits a promising future for use in clinical anti-infection treatments', 36314964),
('Antibacterial Phytochemical', 'amentoflavone', 'the 32 microg ml-1 amentoflavone treatment almost completely blocked Hla pore formation. The minimal inhibitory concentration (MIC) value was higher than 512 microg ml-1, indicating that amentoflavone exerted exactly low viability pressure on S. aureus compared to antibiotics widely used in the clinic.', 'Compared to the other compounds tested, amentoflavone exerted more prominent and coupled inhibitory effects and minor cytotoxicity in the cell lines of lungs mice model', 'amentoflavone was preliminarily identified as a promising lead that inhibited the hemolytic activity of Hla and TLR2-mediated effective against Staphylococcus aureus (S. aureus). This dual action molecule effect this S. aureus', 35754300),
('Antibacterial Phytochemical', 'Medical grade honey (MGH)', 'majority of the wounds were contaminated with (multiresistant) bacteria, both of which contributed to non-healing.', '', 'In this study, MGH was a useful alternative or complementary therapy to antibiotics and expedited the healing of hard-to-heal wounds.', 35797263),
('Antibacterial Phytochemical', 'plant species: Erythrina abyssinica, S. singueana and E. abyssinica. Other plant species with noteworthy biological activities include B. madagascariensis, A. greatheadii, T. bicaudata and E. matabelensis.', 'Erythrina abyssinica had the best antibacterial activity against both ATCC strains and clinical strains with minimum inhibitory concentration (MIC) values ranging from 0.02 to 0.156 mg/ml. The S. singueana extract had the most potent anti-lipoxygenase activity with a mean IC50 value of 1.72 microg/ml.', '', 'This study showed that S. singueana and E. abyssinica had multiple biological activities. The S. singueana acetone extract had moderate antibacterial activity, powerful antioxidant and potent anti-lipoxygenase activities, while the E. abyssinica extract had significant antibacterial activity, good antioxidant and reasonable anti-lipoxygenase activity', 36084819),
('Antibacterial Phytochemical', 'phytobiotics mixtures: H1, containing thymol, menthol, linalool, trans-anethole, methyl salicylate, 1,8-cineol, and p-cymene; H2, in addition to compounds from H1, containing terpinen-4-ol and gamma-terpinene.', 'The values of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were at the level 1:512', '', 'The results suggest that phytobiotic compositions used in this study can be successfully used as a natural alternative to antibiotics in the treatment of E. coli infections in broiler chickens.', 36551476),
('Antibacterial Phytochemical', 'Therapeutics bovine Lactoferrin (MTbLF) alone and in combination with metronidazole and clindamycin', 'the vast majority of the tested strains (45%), exhibiting MIC lower than 2 microg/ml, were considered sensitive; 18 strains (25%) with MIC higher or equal to 8 microg/ml, were classified as resistant, whereas the remaining 21 (30%) were classified as intermediate effective against Bacterial Vaginosis (BV), a common imbalance of the vaginal microbiota', '', 'MTbLF effective against G. vaginalis clinical isolates. Bovine lactoferrin may be a potential candidate to treat Gardnerella species infection.', 36419418),
('Antibacterial Phytochemical', 'therapeutic potential EOs of common thyme (Thymus vulgaris L.) and wild thyme (Thymus serpyllum L.), as well as oregano (Origanum vulgare L.),', 'MIC values for EOs against P. mirabilis strains were 3.125 mg/mL and MBC values ranged between 3.125 and 6.25 mg/mL. On the other hand, EOs of common and wild thyme had low MIC values for S. marcescens isolates (MIC = 1.56 mg/mL). Our results demonstrated that oregano EO showed a lower MBC value for P. mirabilis compared with S. marcescens.', '', 'All tested EOs displayed antibacterial activity against all strains to different extents, while wild and common thyme EOs were the most effective. It could be concluded that the tested EOs represent promising therapeutic candidates for effective non-antibiotic treatment of mastitis.', 36009946),
('Antibacterial Phytochemical', 'docosahexaenoic acid DHA or Omega-3 Fatty Acids', 'At 0.625 mg/L DHA concentration, MRSA showed 0.4', '', 'Docosahexaenoic acid can be considered an option as a therapeutic substance against biofilm formation and may be a good alternative in reducing the risk of MRSA formation.', 35884185),
('Antibacterial Phytochemical', 'Natural essential oil components "EOCs" (carvacrol, cinnamaldehyde, eugenol, geraniol, limonene and thymol), HLE disinfectant solution (3-6% H2O2; 2.2-4.4% lactic acid and 12.5-25 mM EDTA in water) and EDTA', 'The results obtained showed that EOCs -as concentrated natural plant extracts- had different MICs from 10 to 50 microg/mL for CIN followed by TH, CA, LI and GE (100', '', 'The synergistic combinations of EU and HLE/EDTA, TH, CA, GE, LI or CIN + EDTA/HLE caused log reductions in established biofilms of several strains (1-6 log10 CFU) against Pseudomonas sp. strains. Hence this combination became novel antimicrobial formulations as a highly promising alternative against MDR bacteria and ARGs in the food chain and the environment,', 36299714),
('Antibacterial Phytochemical', 'Kaempferol (KPF) is a flavonoid antioxidant found in fruits and vegetables', 'the MICs of kaempferol for L. monocytogenes strains used in this study were no less than 256 microg/mL.', '', 'kaempferol alleviated L. monocytogenes infection via suppressing listeriolysin O pore formation and inflammation response, which might represent a novel antimicrobial-independent strategy to curb listeriosis.', 35856678),
('Antibacterial Phytochemical', 'Nigella sativa oil extract', 'Among the examined samples, with 157 out of 244 (64.3%) contaminated with Enterococci . VRE strains were examined using Vn-MIC agar dilution. A total of 62 cows'' milk and broiler specimens out of 103 (60.1%) samples were VRE, and 82.2% of these isolates showed an MIC ranged from 16 to 32 microg/ml . High level of VR was detected in Enterococcus spp. isolated from broilers samples followed by turkey', '', 'The current study''s findings demonstrated that N. sativa oil has the potential to inhibit VR gene transfer from VREtfm to S. aureus and that the oil has promising antibacterial activity against Enterococcus spp.', 35395119),
('Antibacterial Phytochemical', 'prairie strips''', 'potential for reducing the transport of LAB and ARGs in runoff after litter application', '', 'Although we show that prairie strips can potentially reduce AMR risks, further research is needed to better understand the influence of rainfall timing, soil, and litter characteristics.', 35112354),
('Antibacterial Phytochemical', 'diterpene natural product 12(S),16?-dihydroxycleroda-3,13-dien-15,16-olide, which we refer to as (-)-LZ-2112 synergize with oxacillin', 'against methicillin-resistant Staphylococcus aureus (MRSA)', '', 'A preliminary mode of action study suggests mecA plays a role in the adjuvant activity of (-)-LZ-2112.', 35167718),
('Antibacterial Phytochemical', 'Salacia oblonga Wall Leaf and Root Extracts', 'The most susceptible bacterial and fungal species against ethyl acetate extract are Micrococcus luteus, Mycobacterium tuberculosis, Microsporum canis, Trichophyton interdigitale, and Microsporum gypseum.The MIC for bacteria ranged from 13.0 to > 200 Microgram/ml, whereas for fungi, the MIC ranged from 25.9 to > 200 Microgram/ml. Ethyl acetate extract of root with 100 Microgram/ml concentration showed 29.1 mm and 28.7 mm zone of inhibition against bacterial strains M. luteus and M. tuberculosis, respectively. The ethyl acetate extract of root with a 100 Microgram/ml concentration showed 15.8, 15.2, and 15.6 mm zone of inhibition against fungal isolates M. canis, T. interdigitale, and M. gypseum, respectively.', '', 'The activity of root and leaf extracts increased in a concentration-dependent manner, and further, the compounds isolated from the crude extracts of leaf and root showed antimicrobial activity.', 35612657),
('Antibacterial Phytochemical', 'aqueous leaf extracts of Moringa oleifera, Vernonia amygdalina, Azadirachta indica and Acalypha wilkesiana', 'Vernonia amygdalina and Azadirachta indica showed significant antimicrobial activity at 100 mg/ml and 75 mg/ml, with low susceptibility of less than 10% to 25 mg/ml, 50 mg/ml, and 75 mg/ml Moringa oleifera. High inhibitory concentrations at IC50; 3.23, 3.75 and 4.80 mg/ml (p = 0.02, CI: - 0.08 - 11.52) and IC90; 12.9, 7.5, and 9.6 mg/ml (p = 0.028, CI: 2.72-23.38) were shown by Acalypha wilkesiana, Vernonia amygdalina and Moringa oleifera respectively. Comparative outcome of the plant extracts showed Acalypha wilkesiana, Vernonia amygdalina and Moringa oleifera to exhibit significant inhibition activities (p < 0.05) compared to other extracts.', '', 'Observed high occurrence rate of skin and soft tissue infections caused by biofilm-producing MDR S. aureus requires alternative novel herbal formulations with rich bioactive compounds from Moringa oleifera, Acalypha wilkesiana, Azadirachta indica and Vernonia amygdalina as skin therapeutic agents.', 35189869),
('Antibacterial Phytochemical', 'carvacrol (CAR) and octanoic acid (OA)', 'The minimum inhibitory concentration (MIC) values confirmed that all the tested pathogens were variably susceptible to both EOs and saturated MCFAs. Among essential oils, carvacrol (CAR), trans-cinnamaldehyde (TC) and thymol (TM) showed the highest inhibitory activity at concentration 0', 'After adding CAR and OA at MIC level, there were obvious changes in cell morphology, leakage of small electrolytes and macromolecules at the initial few hours of treatment i.e. within 1-2 h were observed.', 'Our results indicated that CAR and OA could be evaluated as alternatives or adjuncts to antibiotics as intramammary infusion or topical application to treat bovine mastitis, significantly improving the microbiological safety of milk.', 35178733),
('Antibacterial Phytochemical', 'hesperidin', 'The present study revealed the non-antibacterial biofilm inhibitory potential of hesperidin against ATCC strain and clinical isolates of S. aureus. In gene expression study revealed that hesperidin treatment downregulated the biofilm-associated gene (sarA), polysaccharide intracellular adhesion gene (icaA and icaD), autolysin (altA), fibronectin-binding protein (fnbA and fnbB) and staphyloxanthin production (crtM).', '', 'Molecular docking analysis predicted the ability of hesperidin to interact with SarA and CrtM proteins involved in biofilm formation and staphyloxanthin production in MRSA.', 35064842),
('Antibacterial Phytochemical', 'ophthalmic solution containing ozonated oil', 'The aim of this study was to assess the in vitro antimicrobial activity of an ophthalmic solution containing ozonated oil. The treatment exhibited antibacterial activity against all the tested species.', 'The effect was lower against the strains of Pseudomonas aeruginosa and more evident against Staphylococcus and Streptococcus spp.', 'Our results suggest that the administration of ozonated oil may be a candidate agent to treat some infections of the ocular surface with a potential role in antimicrobial prophylaxis.', 35795001);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Phytochemical', 'vitamin C (ascorbic acid)', 'MICs of ascorbic acid among P. aeruginosa isolates were in the range of 156.2-1,250 microg/ml, while MIC50 and MIC90 were 312.5 and 625 microg/ml, respectively. At sub-inhibitory concentrations (19.5-312.5 microg/ml), ascorbic acid had 100% biofilm inhibitory effect.', '', 'Vitamin C shows excellent in vitro results as an antibacterial and anti-biofilm agent. Vitamin C should be routinely prescribed with antibiotics to treat bacterial infections in the clinical setting.', 35668756),
('Antibacterial Phytochemical', 'distilled extract of bergamot (Citrus bergamia Risso et Poiteau)', 'The distilled extract of bergamot exhibited significant antimicrobial activity and a specific bactericidal effect against the bacterial and fungal strains tested. Furthermore, confocal microscope images clearly showed compromised membrane integrity, damage and cell death in bacterial samples treated with the distilled extract of bergamot. In addition, progressive alterations in cell-wall composition, cytoplasmic material and nucleus structure triggered by exposure to the distilled extract of bergamot were identified in the fungal samples considered.', '', 'Conclusions: Our data suggest that the use of essential oils, such as distilled extract of bergamot (Citrus bergamia Risso et Poiteau), can represent a valid alternative therapeutic strategy to counteract antibiotic resistance of pathogens.', 35326824),
('Antibacterial Phytochemical', 'enterocins, oregano, and sage', 'The use of natural substances (enterocins and phytoadditives) seems to be a promising alternative, either in the prevention or treatment of the gastrointestinal tract infections. Eighty-five percent of the Campylobacter strains were susceptible to at least one enterocins, and 77% of the strains were susceptible to enterocin (Ent) 9296, 69% were susceptible to Ent EM41, and 69% were susceptible to Ent A(P). Sage inhibited the growth of 38% of C. jejuni strains and 53% C. coli strains, whereas oregano inhibited the growth of 50% of the C. jejuni strains and up to 67% C. coli strains.', '', 'Owing to the One health concept, application of enterocins and herbal extracts is a more ecological approach for preventing bacterial contamination during production and processing of poultry, which also leads to the protection of human health.', 35076262),
('Antibacterial Phytochemical', 'Conocarpus erectus', 'Statistically significant reduction in bacterial colony count (p<0.05) observed in rat''s sepsis model with C. erectus treated group vs. controls. C. erectus extract offered higher bactericidal effect both in-vitro and in-vivo along no acute toxicity at therapeutic dose.', '', 'We infer that it can serve as alternative promising treatment option against antibiotic resistant against MDR S. aureus strains.', 35228188),
('Antibacterial Phytochemical', 'ethanol extracts of Portuguese propolis combined with gentamicin or with honey, collected from the same apiary as propolis', 'Using the agar dilution method and DPPH free radical scavenging assay, antimicrobial and antioxidant synergistic effects between propolis and gentamicin or honey were assessed. Synergism between propolis and gentamicin was observed for all the tested extracts and against all the indicator bacteria, with particular interest against the Methicillin-Resistant Staphylococcus aureus (MRSA) with a threefold decrease of the gentamicin MIC if mixed with 25 Microgram ml-1 propolis. Likely to propolis and gentamicin, mixtures of sub-MIC concentrations of propolis and honey enhanced the antibacterial action of each individual natural product against the majority of the strains. However, propolis antioxidant capacity decreased along with higher honey content in the mixture.', '', 'Propolis has a strong synergistic effect when combined with gentamicin, allowing the reduction of the therapeutic dose of this drug. Propolis and honey mixtures also display a stronger antibacterial effect than the activity exhibited by each sample when tested individually, whereas the high antioxidant capacity of propolis seems to be not affected when in combination with honey.', 35092131),
('Antibacterial Phytochemical', 'Halexylon salicornicum', 'The goal of this study is to investigate whether Halexylon salicornicum aqueous and solvent extracts have antimicrobial activity on a variety of animal pathogens isolated from cattle and poultry using the agar well diffusion method (Enterococcus faecium, Shigella flexneri, Bacillus Cereus, Klebsiella pneumoniae, Staphylococcus aureus, Escherichia coli, Streptococcus pyogens, Pseudomonas aerogenes, Salmonella typhimurium, and Candida albicans) moreover it''s ethnobotanical and phytochemical. All of the extracts tested had antimicrobial efficacy against tested strains and included bioactive chemicals, particularly the acetone extract, had the highest antibacterial activity.', '', 'As a result, it can be stated that Halexylon salicornicum is a promising important shrub that might be used as a natural antimicrobial alternative for animals or as a food additive.', 35707822),
('Antibacterial Phytochemical', 'essential oil (EO) of Tagetes lucida Cav. and the mixture of its main compounds (PREO)', 'The EO main bioactive compounds were methyl eugenol (relative abundance in EO: 46', '', 'In conclusion, we overcame the unpredictability of EO activity (due to their natural variability) by determining which EO components inhibited bacteria and then producing a PREO to generate a reproducible mixture with predictable antibacterial and modulation of resistance activities. Thus, the PREO, and its components, show potential as alternatives to manage multidrug-resistant pathogens.', 35419861),
('Antibacterial Phytochemical', 'Sida cordifolia', 'Galleria mellonella pre-treated with SCAF5 produced more haemocytes and were more resistant (P < 0.001) to infection with methicillin-resistant Staphylococcus aureus (MRSA) with a 98% reduction in bacterial load in pre-treated larvae compared to the negative control. Extensive fractionation identified two compounds, rosmarinic acid and its 4-O-beta-d-glucoside derivative, which had potent activity against Gram-positive antibiotic-resistant bacteria, including MRSA.', '', 'Conclusions: Sida cordifolia counters bacterial infections through a dual mechanism, and immunomodulatory polysaccharides from this plant should be isolated and characterised to realise their potential as anti-infective agents. Such properties could be developed as an antibiotic alternative (1) in the clinic and (2) alternative growth promoter for the agri-food industry.', 35086541),
('Antibacterial Phytochemical', 'Antibiogram study showed significant (p < 0.05) resistance by P. aeruginosa against tested antibiotics. E. coli, M. morganii and K. pneumoniae were significantly susceptible to erythromycin and S. aureus to lincomycin. Both honey samples at 2% and 5% concentrations showed significant (p < 0.05) inhibition potential of multispecies biofilm by all test groups (g1-g11). Though A. dorsata honey significantly inhibited biofilm formation at 2 and 5% against all groups but 2% concentration was highly s', 'Antibiogram study of all five isolates was tested against three antibiotics viz., erythromycin (20 Microgram/mL), lincomycin (100 Microgram/mL) and rifampicin (100 Microgram/mL). In order to form multispecies biofilm, identified bacteria were grown in batch culture by mixing equal volumes (OD590nm = 0.1) of 2, 3 and 5 bacterial isolates. In total 11 groups (g1-g11) were made.', '', 'Accordingly, honey samples showed significant antibiofilm, anti-QS and biofilm dispersal potentials thus can be considered as good alternative to antibiotics.', 35153244),
('Antibacterial Phytochemical', 'nor 3''-Demethoxyisoguaiacin from Larrea tridentata or L. tridentata hydroalcoholic extract (LTHE)', 'Chemical analyses through HPLC techniques were conducted for the LTHE, fractions, and sub-fraction Ltc1-F3, from which we isolated two compounds, characterized by 1H and 13C NMR analyses. Compound nor-3 demethoxyisoguaiacin exhibited the best antibacterial activity against the evaluated bacteria (MIC: 0.01-3.12 mg/mL; MBC: 0.02-3.12 mg/mL).', '', 'The results indicated that nor-3 demethoxyisoguaiacin can be used as an alternative treatment for multidrug-resistant bacteria associated with mastitis.', 35684556),
('Antibacterial Phytochemical', 'honeycomb extract (HE)', 'HE addition significantly increased average daily feed intake (ADFI), average daily gain (ADG), decrease feed gain ratio (F/G) from 21 to 80 and 51 to 80 days of age compared to the control group, with all 3 HE addition groups having statistically identical values to the antibiotic group. HE implementation dramatically increased spleen index, serum immunoglobulin A (IgA), immunoglobulin M (IgM,), glutathione peroxide (GSH-Px), superoxide dismutase (SOD), total antioxidant capacity (T-AOC), and total cecum bacteria and Lactobacillus compared to the control group, numerically at the same level as, or even better than, the antibiotic group. HE and CTE both markly reduced serum malondialdehyde (MDA) concentration compared to the control group, with higher concentrations of HE reducing the effect more dramatically than antibiotics. Both HE and CTE significantly raised dressed yield compared to the control group.', '', 'In summary, HE, as a potential antibiotic alternative, improved growth performance, carcass traits, immune function, serum antioxidant capacity and intestinal microorganisms in yellow bantam broilers. According to the cubic regression analyses, the recommended supplemental dose of HE was calculated to be 0.15 to 0.17% for female yellow bantam broilers between 21 and 80 d of age.', 35709681),
('Antibacterial Phytochemical', 'Gallic acid (GA)', 'The protective effect of GA pretreatment on bacterial growth, cell adherence, and ESBL-EAEC-lipopolysaccharide (LPS)-treated Caco-2 cells were first assessed, and results revealed direct antibacterial effects and diminished colonic cell inflammation. Collectively, our findings provided the direct evidence of hindgut microbiota and intestinal metabolites, discriminating the health status of neonatal calves post ESBL-EAEC infection.', '', 'The data provided novel insights into GA-mediated remission of colitis via amelioration of hindgut commensal structure and upregulation of SCFA productions. In addition, its eminent role as potential antibiotic alternative or synergist for future clinic ESBL-EAEC control in livestock.', 35399688),
('Antibacterial Phytochemical', 'butyrate and forskolin', 'Butyrate and forskolin synergistically induced the expressions of AvBD9, AvBD10, and MUC2 in chicken HD11 cells (P < 0.05) and the synergy was maintained in the presence of LPS. Butyrate and forskolin also suppressed LPS-induced IL-1beta gene expression in HD11 cells in a synergistic manner (P < 0.05). The two compounds significantly reduced the intestinal lesions of C. perfringens-challenged chickens when combined (P < 0.05), but not individually. Furthermore, butyrate in combination with forskolin-containing CF extract had no influence on weight gain, but significantly reduced feed intake (P < 0.05) with a strong tendency to improve feed efficiency (P = 0.07) in a 42-d feeding trial. Desirably, the butyrate/forskolin combination significantly decreased abdominal fat deposition (P = 0.01) with no impact on the carcass yield, breast meat color, drip loss, or pH of d-42 broilers.', '', 'Conclusions: Butyrate and forskolin has potential to be developed as novel antibiotic alternatives to improve disease resistance, feed efficiency, and carcass composition of broilers.', 35139922),
('Antibacterial Phytochemical', 'Clove Flower Extract (CFE)', 'Clove flower extract (CFE) inhibited distinctively the P. mirabilis bacterium obtained. topical application of CFE hydrogel improved wound size, wound index, mRNA expression of the wound healing markers (Coli1, MMP9, Fibronectin, PCNA, and TGFbeta), growth factor signaling pathways (PPAR-alpha, PGC1-alpha, GLP-1, GLPr-1, EGF-beta, EGF-betar, VEGF-beta, and FGF-beta), inflammatory cytokine expression (IL8, TNFalpha, NFKbeta, IL1beta, and MCP1), as well as anti-inflammatory cytokines (IL4 & IL10), pro-apoptotic markers (FAS, FAS-L, BAX, BAX/BCL-2, Caspase-3, P53, P38), as well as an antiapoptotic one (BCL2).', '', 'Based on the previous notions, it could be concluded that CFE represents a valid antibiotics alternative for DFU therapy since it improves diabetic wound healing and exerts antibacterial activity either in vitro or in vivo.', 35408668),
('Antibacterial Phytochemical', 'Toona sinensis shoots, Koelreuteria paniculate seeds, and Firmiana simplex barks', 'Toona sinensis shoots and Firmiana simplex barks showed high inhibitory activities against Staphylococcus aureus, Shigella dysenteriae, and Escherichia coli strains with minimum inhibitory concentrations (MICs) of 1.56, 0.78, and 0.39 mg/mL, respectively. Salmonella typhi was highly sensitive to Firmiana simplex barks with an inhibitory diameter up to 21.67 ', '', 'Conclusion: Our results indicated that Toona sinensis shoots, Koelreuteria paniculate seeds, and Firmiana simplex barks could be supplied as potential sources of antimicrobial agents. Furthermore, 36 potential bioactive compounds were identified mainly as polyphenols, glycosides, and terpenoids.', 35042282),
('Antibacterial Phytochemical', 'Thymus vulgaris essential oil (TVEO)', 'Thymus vulgaris essential oil (TVEO) against a Gram-negative bacterium Salmonella enterica Typhimurium ATTCC 10028 (S. enterica Typhimurium ATTCC 10028) and two Gram-positive bacteria Staphyloccocus aureus ATCC 6538 (S. aureus ATCC 6538) and Listeria monocytogenes ATCC 19117 (L. monocytogenes ATCC 19117).', '', 'Results indicated that the tested compounds could have multiple biological activities and various enzymatic targets. Findings of our study support that identified compounds of TVEO can be a safe and effective alternative to synthetic drugs and can easily combats hazardous multidrug-resistant bacteria.', 35909468),
('Antibacterial Phytochemical', 'Cinnamomum zeylanicum, Cz; Origanum vulgare, Ov and modified GR-OLI (mGR-OLI)', 'In vitro, Ov toxicity was slightly lower than Cz, while it showed no toxicity on G. mellonella larvae. Ov, Cz and the mGR-OLI showed the strongest antimicrobial activity for all strains, with an inhibitory concentration of 90% of strains (IC90) equal to 0.25%, 0.13% and 0.33% respectively, and the minimal inhibitory concentration (MIC) values ranging from 0.06% to 0.38% v/v for Oz, 0.06% to 0.31% v/v for Cz and 0.08% to 0.38% v/v for mGR-OLI. Cl and M. piperita had the weakest antimicrobial activity with IC90 >2% and MIC values ranging from 1% to >2% v/v for the former and from 0.25% to >2% v/v for the latter.', '', 'In conclusion, the study confirms the importance of evaluating natural products to consolidate the idea of safe EO applications in reducing and preventing intensive livestock infections.', 35456873),
('Antibacterial Phytochemical', 'Shikonin (SH) -liposome', 'The results showed that SH-liposome was successful with a drug load of 4.6 ', 'SH-liposome showed a sustained-release behavior and improved antibacterial ability in a dose-dependent manner.', 'Conclusion: In conclusion, SH-liposome showed an antibacterial effect against S. aureus, promoted effective healing of infected burn wounds; hence, it could be used as an alternative therapy for drug-resistant infections.', 35286935),
('Antibacterial Phytochemical', 'Qing Guo (QG)', 'All QG extracts especially ethyl acetate extract (QGEAE) were rich in phenolic components, with the minimum inhibitory concentrations (MICs) on H.pylori of 39-625 microg/ml and minimum bactericidal concentrations (MBCs) of 78-1250 microg/ml. Both aqueous extract (QGAE) and QGEAE could induce the morphological and structural changes of H. pylori, inhibit urease activity with IC50 of 1093 microg/ml and 332.90 microg/ml, respectively, and down-regulate the virulence genes, such as vacA and cagA.', '', 'Conclusions: QG may exhibit in vitro anti-H. pylori activity by inhibiting growth, destroying the bacterial structure and down-regulating the expression of virulence factors. Moreover, QG is the homology of food and TCM, which can be considered as a safe and convenient agent against H. pylori infection.', 34464702),
('Antibacterial Phytochemical', 'Tanreqing (TRQ)', 'Tanreqing (TRQ) has been used as an alternative treating agent against MRSA. TRQ targeted cell division to inhibit cell growth as shown by illumination microscopy. Besides, we confirmed that TRQ downregulates the expression of virulence factors such as hemolysin and autolysin.', '', 'Altogether, we have proved TRQ formula to be an effective agent against S. aureus infections.', 35573768),
('Antibacterial Phytochemical', 'Essential oils (Cinnamon) and plant extracts (pomegranate and strawberry trees)', 'Cinnamon, pomegranate, and strawberry trees returned the strongest results and were therefore evaluated in a dry-cured ham-based medium assay with water activity of 0.93 or 0.95. The 10% essential oil of cinnamon was capable of completely inhibiting bacterial growth, while strawberry tree and pomegranate extract also showed antilisterial activity (P > 0.05).', 'Water activity influenced the bacterial count of L. monocytogenes in a dry-cured ham-based medium.', 'Conclusions: There was a reduction in L. monocytogenes with the application of cinnamon essential oil but, because of the negative sensory impact of this particular compound in meat products, we suggest the use of pomegranate or strawberry tree for the biocontrol of Listeria in ready-to-eat products. ', 34378213),
('Antibacterial Phytochemical', 'green algae Ulva lactuca extract and Naturally Derived Antimicrobial Drugs Combined with Ulva lactuca Extract', 'n-hexane extract was found to show effective antibacterial activity towards tested pathogens with the lowest MIC and MBC value. Furthermore, the n-hexane extracts have also been used to enhance the efficacy of the naturally-derived (derived from plants and marine organisms) compounds and conventional antibiotics at their sub-inhibitory concentrations. Most of the tested antibiotics and natural drugs at their sub-MIC were found to exhibit synergistic and additive antibacterial activity towards the tested bacterial pathogens.', '', 'Conclusions: The combining of U. lactuca n-hexane extracts with natural drugs resulted in synergistic and additive bactericidal effects on Gram-positive and Gram-negative human pathogenic bacteria. The present study shows a new alternative strategy to revitalize the antimicrobial activity of naturally derived compounds for treating human bacterial pathogens.', 34425745),
('Antibacterial Phytochemical', 'sanguisorbigenin (SGB) isolated from Sanguisorba officinalis L. with six conventional antibiotics', 'SGB showed significant synergy with antibiotics and reduced the minimum inhibitory concentration of antibiotics by 2-16-fold.', '', 'The results indicated that SGB could inhibit biofilm formation and alter cell membrane permeability in MRSA. In addition, SGB was found to exhibit quite low cytotoxicity and hemolysis. The discovery of the superiority of SGB suggests that SGB may be an antibiotic adjuvant for use in combination therapy and as a plant-derived antibacterial agent targeting biofilms.', 35457049),
('Antibacterial Phytochemical', 'palmarosa, basil and rosemary: essential oils (EOs)', 'Palmarosa oil (PMO) showed significantly (p < 0.05) higher inhibition zones against both A. veronii and A. caviae (n = 30) than basil and rosemary in the disk diffusion assay. The MIC (% v/v) of PMO ranged from 0.008% to 1.00%. The mean MIC was significantly higher for A. caviae (0.48 ', '', 'Palmarosa oil could be explored as an alternative antimicrobial agent for mitigating antimicrobial resistance and managing Aeromonas infection in fish and their risks to public health.', 35355377),
('Antibacterial Phytochemical', 'Compost tea', 'The results showed aerobic liquid fermentation reduced ARGs by 65.93 % and 45.20 % in the compost tea of chicken manure and sludge, enriched ARGs by 8.57 % and 37.41 % in the compost tea of pig manure and bovine manure, and increased MGEs and MRGs by 1.25 ', '', 'Tetracycline resistance genes occupied 62.7 % of total ARGs in the compost tea. Alcaligenes and Bacillus enriched by 0.78-39.31 % in the four compost tea, which metabolites had high antimicrobial activity. The potential host of ARGs accounted for 42.1 % bacteria abundance in the four compost tea.', 35803190),
('Antibacterial Phytochemical', 'rare Greek honeys (Fir, manuka, chestnut, cotton, arbutus, oregano )', 'rare Greek honeys against Verona integron-encoded metallo-beta-lactamase (VIM)- or Klebsiella pneumoniae carbapenemase-producing multidrug-resistant Gram-negative pathogens. Total phenols, total flavonoids and free radical scavenging activities were found higher in cotton, arbutus and manuka honey, and finally, manuka and oregano honeys showed higher tyrosinase inhibition activity and kojic acid levels. The antimicrobial susceptibility depended on the type of honey, on its dilution, on the treatment methodology and on the microorganism. Arbutus honey was the most potent against VIM-producing Enterobacter cloacae subsp. dissolvens in 75% concentration, while fir honey was more lethal for the same microorganism in the 25% concentration. Many honeys outperformed manuka honey in their antibacterial potency.', '', 'Although the antimicrobial potency of different honey varieties dependents on their geographical origin and on their compositional differences, the exact underlying mechanism remains yet unclear.', 35326885),
('Antibacterial Phytochemical', '22 Iranian Endemic or Rare Plant Extracts', 'against Mtb H37Rv strain, seven clinical MDR-TB, and two XDR-TB isolates using the resazurin microtiter assay (REMA) method. Out of the 22 plants, 14 plant extracts demonstrated anti-mycobacterial activity with minimum inhibitory concentration (MIC) ranging from 4 to 30microg/mL against Mtb H37Rv. Eight plant extracts also exhibited anti-mycobacterial activity against MDR and XDR clinical strains of Mtb by MICs, i.e., 15-60microg/ml. Crinitaria grimmii and Linum album were the best antimycobacterial plants. Among fractions of Crinitaria grimmii, dichloromethane and n-butanol, and for Linum album, dichloromethane and Ethyl-Acetate fractions displayed more anti-mycobacterial effect as compared to crude extract on Mtb.', '', 'Conclusion: The present study confirms the potential role of some plants to treat respiratory diseases as our results have demonstrated that these plants exhibit anti-mycobacterial activity in the acceptable range against Mtb. Thus, these plants could be good sources and alternatives of plant metabolites for anti-TB-drug development.', 33588723),
('Antibacterial Phytochemical', 'diethyl ether extracts from six medicinal plants', 'diethyl ether extracts from six medicinal plants grown in Viet Nam against Staphylococcus aureus and its variants', '', 'The findings provided evidence of the low-resistance tendency of S. aureus to antimicrobial plant extracts. It is the first time a collateral antibiotic sensitivity of S. aureus adapted to natural compounds has been observed, suggesting an alternative approach to fight antibiotic resistance.', 35285051),
('Antibacterial Phytochemical', 'Anatolian honey bee venom', 'Anatolian (Anadolu) honey bee venom (HBV) against Gram-positive and Gram-negative bacteria and yeast-like fungi. The results of MIC values were varied from 3.06 microg/mL to 50 microg/mL for the tested microorganisms. It was found that Mycobacterium smegmatis and Streptococcus pyogenes were the most susceptible bacteria (3.06 microg/mL), followed by Vibrio sp., Aeromonas sobria, Enterococcus faecalis, Listeria monocytogenes, Staphylococcus aureus (MRSA) and B. subtilis with a MIC concentration of 6.125 microg/mL.', '', 'These findings strongly suggest that Anatolian HBV will be developed as a new antibacterial-antifungal drug against Gram-positive, Gram negative and antibiotic-resistant bacteria and yeast-like fungi. However, further research is required to evaluate their in vivo efficacy and safe and effective delivery methods for their therapeutic use.', 35421436),
('Antibacterial Phytochemical', 'Patchouli essential oil', 'Antioxidant studies estimated by 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging method showed that the PEO has effective antioxidant activity (IC50 19.53 Microgram/mL). At sub-lethal concentrations, PEO potentially reduced the QS regulated violacein synthesis in CV12472 without inhibiting its cell proliferation. Moreover, it also effectively reduced the production of some QS regulated virulence factors and biofilm development in P. aeruginosa PAO1 without hindering its growth.', '', 'The overall results, in vitro and in silico, suggest that PEO could be applied as biocontrol agent against antibiotic resistance pathogens.', 32838699),
('Antibacterial Phytochemical', 'essential oil extracted from Artemisia aragonensis Lam', 'EOA exhibited significant antioxidant activity as measured by DPPH and FRAP assays, with IC50 and EC50 values of 0.034 ', '', 'The results of the current study highlight the importance of EOA as an alternative source of natural antioxidant and antibacterial drugs to combat antibiotic-resistant microbes and free radicals implicated in the inflammatory responses accompanying microbial infection.', 35164402),
('Antibacterial Phytochemical', 'Lucilia sericata', 'Lucilia sericata, is used to treat problematic wounds due to its debridement capabilities and its excretions and secretions that kill some pathogenic bacteria. There was a greater response to P. aeruginosa that increased over time, while few genes responded to A. baumannii exposure, and expression was not time-dependent.', '', 'The response to feeding on pathogens indicates a few common responses and features distinct to each pathogen, which is useful in improving the wound debridement therapy and helps to develop biomimetic alternatives.', 34613655),
('Antibacterial Phytochemical', 'combination of tetracycline with the three EOs, C. capitatus, E. caryophyllata, and T. vulgaris', 'Among the EOs, C. capitatus displayed the best bioactivity in terms of MICs, with the lowest values (0.31 and 0.625 microl/ml). On the contrary, the strains showed the ability to grow in the presence of the maximum concentration of tetracycline employed (256 microg/ml).', 'While not displaying a real synergism according to the FIC index, the combination of tetracycline compounds and the three EOs resulted in a significant reduction in the MIC values to tetracycline (4 microg/ml), suggesting a restoration of the susceptibility to the antibiotic in Salmonella spp.', 'Among the new strategies, the combination of antibiotics with natural compounds such as essential oils (EOs) could be an alternative to challenge bacterial resistance.', 35222307),
('Antibacterial Phytochemical', 'Curcumin loaded PLGA nanoparticles (CUR-NPs)', 'The MIC of nanocurcumin and curcumin for all four H. pylori strains were 8 Microgram/ml and 16 Microgram/ml respectively. The inhibition rate of gastric cancer cells after treatment with curcumin was increased from 6% to 67% for 24h, from 8% to 75% for 48h, from 10% to 83% for 72h. In case of nanocurcumin, the inhibition rate increased from 7% to 69% for 24h, 11% to 87% for 48h and 16% to 97% for 72h. The IC50 of curcumin and Nano-curcumin were 24.20 microM and 18.78 microM respectively for 72 h. The population of cells in sub-G0 population increased from 4.1% in the control group to 24.5% and 57.8% when treated with curcumin and nanocurcumin respectively.', '', 'Conclusion: The Nano curcumin might be used as a potential therapeutics against gastric cancer and H. Pylori. There is need of further in vivo study in order to validate CUR-NPs activity.', 35092372),
('Antibacterial Phytochemical', 'cannabidiol (CBD', 'cannabidiol (CBD), which we have previously shown can enhance the effect of bacitracin (BAC).', '', 'Our study illustrates how antibiotic adjuvants may apply to enhance efficacy of antimicrobial compounds.', 35091344),
('Antibacterial Phytochemical', 'Thymus zygis Essential Oil', 'The T. zygis EO showed antioxidant activity acting through two different mechanisms and antibacterial activity against S. aureus, with antibiofilm and antihaemolytic properties. This EO also demonstrated synergistic or additive interactions in combination with ampicillin, ciprofloxacin or vancomycin against S. aureus strains and, in some cases, changed the antibiotic-resistance phenotype from resistant to susceptible.', '', 'Therefore, the present work demonstrates the good bioactive properties of the EO of T. zygis, mainly the antimicrobial activity against S. aureus, revealing its potential to be used as an antibacterial agent.', 35203749),
('Antibacterial Phytochemical', 'essential oils from selected Iranian plant species such as Ferulago angulata, Zataria multiflora, Cuminum cyminum, and Mentha longifolia', 'Regarding antibiotics, the E. coli strains were highly sensitive to ciprofloxacin. In relation to essential oils, the most effective antibacterial activity was observed with Zataria multiflora; also, the bacteria were semi-sensitive to Cuminum cyminum and Mentha longifolia essential oils. All strains were resistant to Ferulago angulata essential oil.', '', 'According to the results, the essential oil of Zataria multiflora can be considered as a practical and alternative antibacterial strategy to inhibit the growth of multidrug-resistant E. coli of dairy origin.', 35056560),
('Antibacterial Phytochemical', 'ethanolic crude extracts of Camellia sinensis', 'The result revealed an exponential increase in susceptibility with a distinctive unit component of the C. sinensis extract at concentrations of 60 and 80 Microg/ml. The extract also possessed antibacterial and antioxidant activities while having phytochemical constituents (flavonoids, alkaloids, phenolics, saponin, cardiac glycosides, etc.). The gas chromatography-mass spectrometry analysis further affirmed the potential of the extract by revealing 52 bioactive components/compounds as shown in the chromatogram.', '', 'Conclusion: The C. sinensis has antimicrobial and antioxidant potentials, and the constituents of the plant might be of therapeutic importance in the management of various diseases, especially those related to Escherichia coli and Salmonella.', 35966211),
('Antibacterial Phytochemical', 'saponin-polybromophenol antibiotic (CU1) from Cassia fistula Bark', 'inhibited transcription from Escherichia coli as well as Mycobacterium tuberculosis RNA Polymerases', '', 'Conclusion: Phyto-chemicals from Cassia fistula bark are abundant, less toxic, target specific and may be a safer low cost drug against MDR bacterial diseases.', 35198968),
('Antibacterial Phytochemical', 'quercetin and myricetin (extracted from L. sibiricus)', 'highest antibiofilm activity against Pseudomonas aeruginosa, respectively, at MIC values of 135 Microgram/mL and 150 Microgram/mL against P aeruginosa', '', 'Thus, the present study suggests that the active compounds from L. sibiricus can be used as an alternate strategy in inhibiting the biofilm formed by pathogenic organisms.', 34989967),
('Antibacterial Phytochemical', 'Chlamydomonas reinhardtii (Cr-SPs)', 'Minimum inhibitory concentration (MIC50) of Cr-SPs against Klebsiella pneumoniae was found to be 850 Microgram/ml, and it is 800 Microgram/ml in Serratia marcescens. Time-kill and colony-forming ability assays suggest the concentration-dependent bactericidal potential of Cr-SPs. Cr-SPs showed 74-100% decrease in biofilm formation in a concentration-dependent manner by modifying the cell surface hydrophobic properties of these bacteria.', '', 'The current study paves way towards developing Cr-SPs as a control strategy for treatment of respiratory tract infections.', 34449042),
('Antibacterial Phytochemical', 'tetrandrine and MCR-1', 'Our find the combination of tetrandrine with colistin enhances the membrane-damaging ability of colistin, undermines the functions of proton motive force (PMF) and efflux pumps in MCR-positive bacteria. The results of molecular docking and RT-PCR analyses showed that tetrandrine not only affects the expression of mcr-1 but is also an effective MCR-1 inhibitor. ings demonstrated that tetrandrine serves as a potential colistin adjuvant against MCR-positive Salmonella.', '', 'Our findings demonstrated that tetrandrine serves as a potential colistin adjuvant against MCR-positive Salmonella.', 35349932),
('Antibacterial Phytochemical', 'Extra virgin olive oil (EVOO- from Olea europaea L. drupes) based formulations in natural deep eutectic solvents (NaDESs)', 'EVOO extract in choline/glycerol showed the highest antibacterial activity against several clinical strains of Staphylococcus aureus, whereas oleacein in choline/propylene glycol was the most effective toward various clinical strains of Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae, all the formulations tested were effective against Candida spp', '', 'In conclusion, our results suggest EVOO-based formulations in NaDESs as an interesting strategy that may help in reducing the risk of development of drug resistance. Under this perspective, the usage of NaDESs for the preparation of new antimicrobial formulations may represent a promising approach.', 35548334),
('Antibacterial Phytochemical', 'rutin', 'to prevent/eradicate Pseudomonas aeruginosa and MRSA urinary catheter biofilms', '', 'Rutin has shown wide antimicrobial and antibiofilm capacity employing a range of mechanisms that might be used for the development of novel antimicrobials.', 35337182),
('Antibacterial Phytochemical', '3,3''-Diindolylmethane (DIM)', 'Acinetobacter baumannii and Pseudomonas aeruginosa was inhibited respectively by 65% and 70%. Combining the antibiotic tobramycin with DIM enabled a high inhibition (94%) of P. aeruginosa biofilm. A DIM-based formulation, evaluated for its wound-healing efficacy on P. aeruginosa-infected wounds, showed a reduction in its bacterial bioburden, and wound size.', '', 'DIM treatment prevented biofilm formation and destroyed existing biofilm without affecting microbial death rates. This study provides evidence for bacterial virulence attenuation by DIM.', 35631553),
('Antibacterial Phytochemical', 'Carum copticum, Phlomis bruguieri, and Marrubium parviflorum', 'MIC of the extracts of Carum coptimum, Phlomis bruguieri, and Marrubium parviflorum were 3.12, 6.25, and 12.5 mg/ml, respectively. Overall, the highest activity belonged to Carum copticum extract. For the anti-biofilm effect, the OD values of Carum copticum and Marrubium parviflorum were significantly different from that of Phlomis bruguieri.', 'Further studies are recommended to indicate how these extracts perform against the bacteria.', 'Although all of the methanolic herbal extracts can inhibit S. mutans growth and remove the biofilm, the effect of Carum copticum was better than Phlomis bruguieri and Marrubium parviflorum.', 35646170),
('Antibacterial Phytochemical', 'Syncarpia hillii', 'Staphylococcal species were the most susceptible bacterial strain with a MIC value of 0.63 mg/mL to the S. hillii methanol extract. Quercetin-3-O-Beta-D-glucuronide and shikimic acid isolated from S. hillii methanol leaf extracts exhibited enhanced antibacterial effects against the tested bacteria with quercetin-3-O-Beta-D-glucuronide eliciting a MIC value of 0.78 Microgram/mL against E. faecalis.', '', 'Conclusions: S. hillii leaves are comprised of bioactive compounds that are bactericidal against several Gram-positive and Gram-negative bacteria.', 35161262),
('Antibacterial Phytochemical', 'acetonic rosemary and licorice extract', 'in the healing of skin wounds infected with multidrug resistant pathogens', '', 'In vivo histopathological examination revealed that acetonic rosemary and licorice extract could be promising for wound healing, combating MDR pathogens of burn wound infections.', 35727122),
('Antibacterial Phytochemical', 'quercetin and allicin', 'The MIC for allicin and quercetin was found to be 80 Microgram/mL for quercetin and 100 Microgram/mL for amoxicillin against the sessile communities of Pseudomonas aeruginosa associated with the orthopaedic infection.', '', 'The antibiofilm and antimicrobial activities of quercetin and allicin were determined both by in vitro and in silico studies on P. aeruginosa bacterial strain from biofilm-associated orthopaedic infection.', 35142967),
('Antibacterial Phytochemical', 'Antarctic Cultivable Fungus Acrostalagmus luteoalbus CH-6', '72.3-84.8% growth inhibition against C. albicans and Aeromonas salmonicida', '', 'This study further demonstrates the great potential of Antarctic fungi in the development of new compounds and antibiotics.', 35621985),
('Antibacterial Phytochemical', '(+)-alpha-pinene and (-)-borneol', '(+)-alpha-pinene- against E. coli (MIC = 512 Microgram.mL-1), combined with antibiotics, this compound induced a significant improvement in the activity of conventional antibiotics', '', 'The present findings indicate that (+)-alpha-pinene and (-)-borneol are phytocompounds with the potential to be used in the combat of antibacterial resistance.', 35663042),
('Antibacterial Phytochemical', 'Calcium sulfate beads made with plant essential oil', 'inhibit the growth of Staphylococcus aureus (a major etiological agent of periprosthetic joint infection) in agar pour plates when infused in calcium sulfate beads', '', 'These data indicate that antibacterial PEOs warrant further investigations, and may be useful in developing new treatment strategies for periprosthetic joint infection.', 35802739),
('Antibacterial Phytochemical', 'B. atrophaeus SHB2097 (MW821482)', 'against vancomycin-resistant Enterococcus faecalis, Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus, and Klebsiella pneumonia with MIC 6.25 Microgram/mL', '', 'Noteworthy antibacterial activities against clinically important pathogenic bacteria in conjunction with occurrence of genes coding for antimicrobial metabolites inferred that the marine heterotrophic bacterium B. atrophaeus SHB2097 could be used for the development of antibacterial agents against the emerging antibiotic resistance.', 35179656),
('Antibacterial Phytochemical', 'Artemisia afra Leaf Crude Extract', 'MIC value of 6.25mg/mL was recorded when methanolic extract was applied against all clinical pathogens. Moreover, both methanolic and ethanolic extracts showed MBC value of 12.5mg/mL against the four clinical pathogens. However, the methanolic extract gave MBC value of 6.25mg/mL against E. coli.', '', 'Conclusion: From this study, it can be concluded that it is possible to develop and formulate of new, efficacious, less toxic and inexpensive herbal medicine from A.afra leaf extract that act against multi-antibiotic resistant clinical pathogens.', 35813676),
('Antibacterial Phytochemical', 'natural deep eutectic solvents (NADES)', 'to Increase Their Bioactivity', '', 'In addition, taking into account that the extraction step is crucial for the successful development of new bioactive compounds, the use of novel solvents that increase the phytochemical effect, such as natural deep eutectic solvents (NADES), as well as the recent applications of these solvents as antimicrobials are discussed.', 35699842),
('Antibacterial Phytochemical', 'Essential Oils Isolated from Juniperus oxycedrus L. ssp. macrocarpa Aerial Parts', 'showed potent antibacterial activity against Gram-positive bacteria (0.25-2 v/v%) and Salmonella spp. (4 v/v%). The strongest fungicidal activity was recorded against Candida auris sessile cells (median FICI was 0.088)', '', 'The therapeutic potential of Juniperus may be promising for future more extensive research and in vivo tests to develop new drugs against antibiotic and antifungal resistance.', 35456809),
('Antibacterial Phytochemical', 'Nigella sativa oil extract', 'Tn1546 transposon transfer with its VR markers to VSSA was effectively inhibited in treated VREtfm donor strains', '', 'This work offers new insights for overcoming VR conjugal transfer utilizing natural N. sativa oil, as well as a suggestion for a novel specialized conjugation inhibitor that could effectively facilitate the difficulty of eliminating VR bacteria from healthcare settings.', 35395119),
('Antibacterial Phytochemical', 'Plumbagin', 'in combination with tetracyclines showed a synergistic bactericidal effect against Tet(X3)/Tet(X4)-producing bacteria, effective broad-spectrum inhibitor of Tet(X) (also known as monooxygenase) by simultaneously inhibiting the activity and the production of Tet(X3)/Tet(X4)', '', 'Plumbagin, as an inhibitor of Tet(X3)/Tet(X4), represents a promising lead drug, as well as an adjunct with tetracyclines to treat bacterial infections, especially for extensively drug-resistant bacteria harbouring Tet(X3)/Tet(X4).', 35306337),
('Antibacterial Phytochemical', 'cannabidiol (CBD) plus polymyxin B (PB)', 'against PB-resistant gram-negative bacilli', '', 'The antibacterial efficacy of the combination CBD + PB against multidrug-resistant and extensively drug-resistant GNB, especially PB-resistant K. pneumoniae, is particularly promising.', 35440801),
('Antibacterial Phytochemical', 'Spilanthes acmella based emulgel', 'MIC values of pure extract found in the range of 0.83', '', 'The current study thus suggests the use of S. acmella extract-based emulgel for the treatment of bacterial skin infections caused by S. aureus, P. aeruginosa and E. coli.', 35228190),
('Antibacterial Phytochemical', 'Astragalus candolleanus (A. candolleanus) hydromethanolic root extract', 'against Gram-positive (Bacillus subtilis and Staphylococcus aureus) and Gram-negative (Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Kocuria rhizophila) strains', '', 'Overall results of drug design suggest that myxoxanthophyll is a promising bioactive compound endowed with antibacterial activity.', 35528313),
('Antibacterial Phytochemical', 'polar (PF) and non-polar fractions (NPF) of three common Iris species (I. confusa, I. pseudacorus and I. germanica)', 'I. pseudacorus PF exhibited the most potent effect against S. aureus haemolytic activity, I. pseudacorus NPF showed potent biofilm inhibitory potential of 71.4 and 85.8% against biofilm formation of MRSA and MSSA, respectively.', '', 'Conclusions: This is the sole map represents the secondary metabolites profiling of the PFs and NPFs of common Iris species correlating them with the potent explored Staphylococcus aureus anti-virulence activity.', 34555449),
('Antibacterial Phytochemical', 'Pistacia lentiscus bark methanol extract', 'demonstrated substantial antimicrobial activity with width inhibition zones ranging from 10 to 25 mm, has a greater antibacterial effect on Gram-positive bacteria than Gram-negative bacteria', '', 'Taken together, this study highlights the Pistacia lentiscus bark methanol extract as a promising antimicrobial and antiviral agent.', 35624793),
('Antibacterial Phytochemical', 'armeniaspirol A (ARM1)', 'agents against Gram-positive pathogens, exhibited potent antibacterial activity against H. pylori, including MDRS, with MIC range values of 4-16 Microg ml-1', '', 'Thus, these findings demonstrated that ARM1 is a novel potent anti-H. pylori agent, which can be developed as a promising drug lead for treatment of H. pylori infections.', 33780131),
('Antibacterial Phytochemical', 'quercetin, fisetin, luteolin, 3'',4'',7-trihydroxyflavone, apigenin, kaempferol, and taxifolin', 'potent inhibitors of OXA-48 with IC50 values ranging from 0.47 to 4.54 MicroM, Quercetin, fisetin, luteolin, and 3'',4'',7-trihydroxyflavone effectively restored the antibacterial efficacy of piperacillin or imipenem against E. coli producing OXA-48, resulting in 2-8-fold reduction in MIC. Moreover, quercetin combined with piperacillin showed antimicrobial efficacy in mice infection model.', '', 'These studies provide potential lead compounds for the development of beta-lactamase inhibitors and in combination with beta-lactams to combat OXA-48 producing pathogen.', 35814247),
('Antibacterial Phytochemical', 'Hypericum brasiliense', 'until 4 Microg/mL, the Hypericum brasiliense extract showed bactericidal activity against a clinical multidrug-resistant S. aureus strain (HU25) and also inhibited biofilm formation at 1/2xMIC (confirmed by SEM) and 1/4xMIC. The extract was also proportionally active against 6 h-preformed biofilm to its concentration (1/2xMIC, 1/4xMIC, p value = 0.05)', '', 'These promising results make Hypericum brasiliense extract a strong candidate to treat S. aureus infections, including anti-biofilm therapy.', 34075848),
('Antibacterial Phytochemical', 'Syzygium aromaticum', 'The S. aromaticum extracts, aqueous extract (AE) and 75% hydroalcoholic extract (HE), exerted significant antibacterial activities against both antibiotic-sensitive and -resistant H. pylori strains with MICs of 160~320 Microg/ml, without developing drug resistance.', '', 'S. aromaticum extracts were found to combated the abnormal activation of PI3K-Akt and MAPK signaling pathways to treat H. pylori infection. This study should accelerate further research and application of S. aromaticum against H. pylori infection.', 35032584),
('Antibacterial Phytochemical', 'pogostone in combination with polymyxin', 'potential inhibitor of MCR-1 for the treatment of infections caused by MCR-1-positive drug-resistant bacteria, especially MCR-1-positive carbapenem-resistant Enterobacteriaceae (CRE)', '', 'Our results confirm that pogostone is a potential inhibitor of MCR-1 for use in combination with polymyxin for the treatment of severe infections caused by MCR-1-positive Enterobacteriaceae.', 35566163),
('Antibacterial Phytochemical', 'Garlic and Thyme Essential Oils', 'against Salmonella typhimurium', '', 'Therefore, these EOs are considered as potential natural antibacterial options that could be applied in food industry.', 35408576),
('Antibacterial Phytochemical', 'Essential Oil from Syzygium cumini (L.) Skeels synergism with gentamicin, erythromycin and norfloxacin', 'The oil showed moderate activity against E. coli ATCC 25922, with the MIC of 512 Microg/mL; there was no activity against the other strains.', '', 'The oil potentiated the effect of antibiotics demonstrating possible synergism when associated with gentamicin, erythromycin and norfloxacin against E. coli 06 and S. aureus 10.', 35630757),
('Antibacterial Phytochemical', 'Morchella esculenta and Morchella conica', 'All fungal extracts inhibited growth of tested bacteria with inhibitory zone ranging from 10.66 ', '', 'In conclusion, the growth inhibition of tested bacteria by fungal extracts revealed their potential as antibacterial agents and their compounds may be used as drug candidates.', 35699800),
('Antibacterial Phytochemical', 'Riccionidin A, Dothistromin, Fustin, and Morin', 'against S. sonnei infections', 'To confirm their efficacy and evaluate their drug potency, further in vitro analyses are required.', 'This study suggests that these phytochemicals could be used as antibacterial drugs to treat S. sonnei infections in the future.', 35241965),
('Antibacterial Phytochemical', 'Peganum harmala seed extract', 'P. harmala n-BuOH extract exhibited potent bactericidal activity against PAO1 strain at MIC value corresponding to 500 microg/mL and attained 100% killing effect at 24 h of incubation. Furthermore, P. harmala n-BuOH extract showed an antibiofilm activity against P. aeruginosa PAO1 and exhibited 80.43% inhibition at sub-inhibitory concentration. The extract also eradicated 83.99% of the biofilm-forming bacteria.', '', 'Our results revealed that P. harmala seed extract and its active compound harmaline could be considered as a candidate for a new treatment of multidrug-resistant P. aeruginosa pathogens-associated biofilm infections.', 34999965),
('Antibacterial Phytochemical', 'Flavonolignans from silymarin (Silybin A, 2,3-dehydrosilybin B, and 2,3-dehydrosilybin AB)', 'Silybin A, 2,3-dehydrosilybin B, and 2,3-dehydrosilybin AB completely reversed antibiotic resistance at concentrations of 20 MicroM or less.', '', 'In conclusion, the selected flavonolignans, particularly derivatives of 2,3-dehydrosilybin B, 2,3-dehydrosilybin AB, and silybin A are non-toxic modulators of S. aureus multidrug resistance and can decrease the virulence of the bacterium, which deserves further detailed research.', 35303568),
('Antibacterial Phytochemical', 'Boletus edulis (B. edulis) and Neoboletus luridiformis (N. luridiformis) aqueous and methanolic extracts', 'against ESKAPE isolates from clinical wound infections', '', 'Overall, the tested mushrooms extracts are good candidates to further explore its use in the prevention of wound infection, particularly by multidrug-resistant pathogens.', 35281762),
('Antibacterial Phytochemical', 'combination of Ethyl Acetate Fraction (EAF) and synthetic antibiotics (ampicillin, azithromycin, ciprofloxacin, or gentamicin) [Cinnamomum verum leaves extract and fractions]', 'provides a synergistic effect against multidrug resistant strains)', '', 'The results are useful to obtain multi-targeting in a single therapy solution, which on antioxidants molecules plant-derivatives can act synergistically in antimicrobial combinations, a valuable aid as bacterial resistance modifying compounds.', 33749459);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Phytochemical', 'essential oil of Ocotea odorifera (EOOO) and safrole', 'Both the essential oil and the isolated compound showed clinically relevant antibacterial activities against S. aureus. Regarding the modulation of antibiotic resistance, the EOOO was found to enhance the activity of erythromycin against the strains of P. aeruginosa and S. aureus, as well as improving the action of gentamicin against S. aureus.', '', 'It is concluded, therefore, that the EOOO and safrole can enhance the activity of macrolides and aminoglycosides, and as such are useful in the development of therapeutic tools to combat bacterial resistance against these classes of antibiotics.', 34656506),
('Antibacterial Phytochemical', 'neem oil extract or nimbolide', 'effective against H. pylori and its biofilms; MICs and MBCs against the nine tested strains ranged between 1.25-5 Microg/mL and 2.5-10 Microg/mL, respectively', 'The bactericidal activity of nimbolide was time- and dose-dependent, independent of active H. pylori growth, and synergistic with low pH.', 'Conclusions: Nimbolide has significant bactericidal activity against H. pylori, killing both free living bacterial cells as well as cells within a biofilm. Furthermore, the lack of hemolytic activity, synergistic activity at low pH and bactericidal properties even against bacteria in a state of growth arrest are all ideal pharmacological and biologically relevant properties for a potential new agent. This study underscores the potential of neem oil extract or nimbolide to be used as a future treatment for H. pylori infection.', 34763046),
('Antibacterial Phytochemical', 'acetone extract and isolated metabolites from Usnea laevis Nyl.', 'Initially, Ul has shown prominent inhibitory activity (IC50 value: 5.44 ', '', 'Conclusions: The current study lends the first evidence for the presence of antimycobacterial metabolites in U. laevis. The results exposed the Andean folklore use of U. laevis for treating Tb, and the key biomarker metabolites were found to be 1 and 4. Hence, it can be concluded that U. laevis can be used as a potential source for the novel drug development for MDR-Tb.', 34536516),
('Antibacterial Phytochemical', 'Guaiacol (2-methoxy phenol) an active Ingredient of Campsis radicans Essential Oils', 'MBC (MFC) ranged from 0.270 to 0.439 microgram/ml in the free form and from 0.055 to 0.133 microgram/ml in the encapsulated form, EE was 86% particle size on Pseudomonas aeruginos, Escherichia coli, and Candida albicans.', '', 'It was observed that both free and encapsulated forms of Guaiacol had an antimicrobial effect on cotrimoxazole-resistant Pseudomonas aeruginosa, cefixime-resistant Escherichia coli, and fluconazole-resistant Candida albicans., but the encapsulated form had a more antimicrobial effect due to more stability and a more targeted effect.', 36201048),
('Antibacterial Phytochemical', 'Thymus vulgaris an essential oil (TVEO)', 'The obtained MIC values indicates that TVEO was more potent against Gram-positive bacteria ( MICs=0.097 milligram/mL) than Gram-negative bacteria ( MICS=0.195milligram/mL)', 'It is demonstrated through VEGA QSAR that TVEO could be a safe resource for potential antibacterial agents', 'molecular docking simulations revealed that TVEO compounds such as thymol and beta-sesquiphellandrene had an effective antibacterial activity against the tested bacteria by inhibiting topoisomerase II and DNA and RNA polymerase functions leading to vigorous impairment of bacterial DNA replication and transcription processes', 35909468),
('Antibacterial Phytochemical', 'essential oils (EOs) (tea tree, clove, thyme, mentha and basil EOs),', 'The most potent EOs against C. acnes and S. epidermidis were tea tree and thyme, showing MIC values against C. acnes of 0.053 g/mL and 0.026 g/mL, respectively . Tea tree and thyme EOs also showed the lowest MIC values of 0.053 g/mL against S. epidermidis.', '', 'Thyme EO affected cell membrane permeability of both bacterial species, evident by the detection of the leakage of intracellular ions and membrane integrity by the leakage of nucleic acids. Hence thyme EO nanoemulsion showed potent antimicrobial and anti-inflammatory effects compared to the reference antibiotics, suggesting its effectiveness as a natural alternative in acne treatment.', 36144477),
('Antibacterial Phytochemical', 'polyherbal nanocolloids (PHNc)', 'Polyherbal nanocolloids (PHNc) was formulated by using the extracts of Syzygium aromaticum, Cinnamomum verum, Emblica officinalis, Terminalia belerica, Terminalia chebula, and Cymbopogon citratus and physicochemically characterized. From mastitis milk samples, microorganisms were isolated including Acinetobacter junii, Klebsiella pneumoniae, Pseudomonas stutzeri, and Acinetobacter baumannii and screened for antibiotic susceptibility. All the isolated strains were tested with PHNc and compared with antibiotics. Minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and biofilm assays were performed at different concentrations, and antibacterial effects were quantified.', '', 'In our results, PHNc showed potent bacteriostatic, bactericidal, and antibiofilm activity against all the strains. Our results indicated that PHNc can reduce the virulence factors responsible for infection by different bacterial strains. This study confirmed that PHNc had the potential to inhibit the growth of pathogenic Gram-negative and Gram-positive strains and could be utilized as an alternative to antibiotics to inhibit multidrug-resistant microbial pathogens in cattle.', 34762270),
('Antibacterial Phytochemical', 'Hubballi Propolis by Apis Mellifera bees', 'MIC range from 0.1 milligram/ml to 0.25 milligram/ml against Aggregatibacter actinomycetemcomitans', '', 'Hubballi Propolis is effective against Aggregatibacter actinomycetemcomitans infection thus may help in treating peri-implantitis.', 36110765),
('Antibacterial Phytochemical', 'chlorotonil 2b', 'molecule 2 b retained nanomolar activity while being stable in vivo', '', 'Furthermore, in vivo stability of the derivatives was improved while retaining their nanomolar activity against critical human pathogens (e.g. methicillin-resistant Staphylococcus aureus and P. falciparum). Intriguingly, we showed further superb activity for the frontrunner molecule in a mouse model of S. aureus infection.', 35485800),
('Antibacterial Phytochemical', 'Essential oil (EO) of Tagetes lucida Cav with bioactive compounds - methyl eugenol (relative abundance in EO: 46', 'The mixture (PREO) of those compounds at those proportions inhibited the growth of P. aeruginosa in 45% at 683', '', 'The PREO had higher antibacterial and modulatory activities than the original EO. the PREO, and its components, show potential as alternatives to manage multidrug-resistant pathogens.', 35419861),
('Antibacterial Chemical Compound', '(Z)-N-benzylidene-2-(tert-butoxycarbonylamino)-1-(5-iodo-1H-indol-3-yl)ethanamine oxide', 'fourfold decrease of the ciprofloxacin minimum inhibitory concentration against the SA-1199B strain when used at a concentration of 0.5 mg L(-1)', '', '1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors.', 24677763),
('Antibacterial Chemical Compound', '13-Deoxytetrodecamycin (WAC04657)', 'Potent bioactivity against Gram-positive pathogens including multidrug-resistant Staphylococcus aureus and Gram-negative pathogens', '', '13-Deoxytetrodecamycin has potent bioactivity against Gram-positive pathogens including multidrug-resistant Staphylococcus aureus.', 26014719),
('Antibacterial Chemical Compound', '3''-bromo-3''-deoxy-arabinofuranosylthymine (33)', 'MIC(50) = 1 microg/mL against wild-type M. tuberculosis strain (H37Ra) and 1-2 microg/mL against rifampicin-resistant and isoniazid-resistant) strains of M. tuberculosis', 'No cytotoxicity was found up to the highest concentration of compounds tested (CC(50) > 100-200 microg/mL) against a human cell line', '3''-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis. T', 20420370),
('Antibacterial Chemical Compound', 'thiosemicarbazide intermediates', 'thiosemicarbazide intermediates in the syntheses of these compounds are also moderately potent inhibitors of the IMP-1 MBL (metallo-?-lactamases) from Pseudomonas aeruginosa', 'NA', '3-mercapto-1,2,4-triazoles and N-acylated thiosemicarbazides as metallo-?-lactamase inhibitors. The production of ?-lactamases is an effective strategy by which pathogenic bacteria can develop resistance against ?-lactam antibiotics.', 22115595),
('Antibacterial Chemical Compound', '4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-methoxypyridin-2-yl)piperazine- 1-carbothioamide (ML267)', 'exhibit submicromolar inhibition of bacterial Sfp-PPTase with no activity toward the human orthologue', '', '4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-methoxypyridin-2-yl)piperazine- 1-carbothioamide (ML267), a potent inhibitor of bacterial phosphopantetheinyl transferase that attenuates secondary metabolism and thwarts bacterial growth.', 24450337),
('Antibacterial Chemical Compound', '4-Aminoquinolone piperidine amides (AQs)', 'potent DprE1 inhibition (IC50 < 10 nM) along with potent cellular activity (MIC = 60 nM) against Mtb', '', '4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.', 24871036),
('Antibacterial Chemical Compound', '6 beta-Iodopenicillanic acid (UI-38,006)', 'Active against beta-lactamase-producing strains of Staphylococcus aureus, Haemophilus influenzae, Bacteroides fragilis.', '', '6 beta-Iodopenicillanic acid (UI-38,006), a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactam compounds: initial bacteriological characterizationUK-38,006, 6 beta-iodopenicillanic acid, was shown to be a potent inhibitor of beta-lactamase enzymes.', 6272628),
('Antibacterial Chemical Compound', 'poly-D-lysine-Le(b) hexasaccharide and an Le(b) human serum albumin conjugate', 'inhibited adherence of H. pylori to gastric epithelium and displaced adherent bacteria when added to human stomach sections', '', 'A human domain antibody and Lewis b glycoconjugate that inhibit binding of Helicobacter pylori to Lewis b receptor and adhesion to human gastric epithelium', 19832116),
('Antibacterial Chemical Compound', 'Nitrofuranylamides (NFAs)', 'Highly active against drug-susceptible and -resistant strains of M. tuberculosis, with MICs 0.0004-0.05 mg/L', '', 'A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents', 18693235),
('Antibacterial Chemical Compound', 'bispecific antibody BiS4', 'effective against Pseudomonas aeruginosa', '', 'A multifunctional bispecific antibody protects against Pseudomonas aeruginosa. Widespread drug resistance due to empiric use of broad-spectrum antibiotics has stimulated development of bacteria-specific strategies for prophylaxis and therapy based on modern monoclonal antibody (mAb) technologies.', 25391481),
('Antibacterial Chemical Compound', 'aryl isonitrile analogs', '(MIC, in ?M) of isonitrile compounds, against methicillin-sensitive (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) strains rnge 2 - >128 in ?M. The most potent antibacterial aryl isonitrile analogs (MIC 2 ?M) did not show any toxicity against mammalian cells up to a concentration of 64 ?M.', '', 'A new class of compounds featuring an aryl isonitrile moiety has been discovered that exhibits potent inhibitory activity against several clinically-relevant MRSA and VRSA isolates.', 26164843),
('Antibacterial Chemical Compound', 'ketolides prepared with the (R)-alkyl group, compound 5p with an N-(3-quinoxalin-6-yl-propyl)-propionamide moiety', 'potent in vitro antibacterial activities against the key respiratory pathogens including Haemophilus influenzae and erythromycin-resistant S. pneumoniae', '', 'A new type of ketolide bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether: synthesis and structure-activity relationships', 16460944),
('Antibacterial Chemical Compound', '6-Benzyl Ether Benzoxaborole', 'MIC 2 ?M', 'no cytotoxicity against eukaryotic cells', 'A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis In Vitro. We identified a novel 6-benzyl ether benzoxaborole with potent activity against Mycobacterium tuberculosis', 28674058),
('Antibacterial Chemical Compound', '6-O-substituted 8a-aza-8a-homoerythromycin A 3-O-acylides', 'Activity against Haemophilus influenzae and constitutively MLSB-resistant strains of Streptococcus pneumoniae and Streptococcus pyogenes', '', 'A novel series of 6-O-substituted 8a-aza-8a-homoerythromycin A 3-O-acylides has been discovered with potent activity against key respiratory pathogens, including those inducibly and constitutively resistant to erythromycin.', 27657812),
('Antibacterial Chemical Compound', '6,9:11,12-dicarbonate acylide 47 (FMA0122) and 11,12-carbamate acylide 19 (TEA0929)', 'Activity against almost all gram positive and negative pathogens', '', 'A novel series of acylides, 3-O-(aryl)acetylerythromycin A derivatives, were synthesized and evaluated.', 12801234),
('Antibacterial Chemical Compound', '1beta-methyl-2-(5-substituted thiazolo pyrrolidin-3-ylthio)carbapenem derivatives', 'Activities against both Gram-positive including MRSA and Gram-negative bacteria , compound 28c having 4''-amide substituted thiazole moiety is most potent', '', 'A particular compound (28c) having 4''-amide substituted thiazole moiety showed the most potent antibacterial activity.', 12350291),
('Antibacterial Chemical Compound', '7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-ethoxyiminoacetamido]-3-[1-(3-methy laminopropyl)-1H-imidazo[4,5-b]pyridinium-4-yl]methyl-3-cephem-4-carboxylate sulfate (S-3578)', 'activity against both gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and gram-negative bacteria including Pseudomonas aeruginosa', '', 'A series of 7-aminothiadiazolylcephalosporins having a 1-(substituted)-1H-imidazo[4,5-b]pyridinium group at the C-3'' position of the cephem nucleus were synthesized and evaluated for in vitro antibacterial activities.', 12546419),
('Antibacterial Chemical Compound', '1-cyclopropyl-6-fluoro-1, 4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxyli c acid hydrochloride (grepafloxacin)', 'in vitro antibacterial activity against Streptococcus pneumoniae and high in vivo efficacy on the experimental systemic infections caused by the Gram-positive and -negative bacteria tested.', '', 'A series of substituted 1-cyclopropyl-6-fluoro-1, 4-dihydro-5-methyl-4-oxo-3-quinoline carboxylic acids was synthesized and tested for their in vitro and in vivo antibacterial activity.', 8770395),
('Antibacterial Chemical Compound', 'ABT773', '(MIC-90=0.03 mg/l) against the staphylococci , MIC-90 range: <0.0075-0.5mg/l against Streptococcus pneumoniae, S. pyogenes and S. agalactiae irrespective of their antibiotic resistance phenotype.', '', 'ABT773 displays the characteristics of a promising agent that deserves to be introduced as the empirical therapy of infections caused by the bacterial species tested here, even if they are multiply resistant.', 14732308),
('Antibacterial Chemical Compound', 'AFN-1252', 'Maximum reductions in viable count against MSSA 29213 and MRSA S186 were approximately 4 logs, achieved by 450 mg q12h (fAUC/MIC = 1875) dosing at 28 hours', '', 'Activity of AFN-1252, a novel FabI inhibitor, against Staphylococcus aureus in an in vitro pharmacodynamic model simulating human pharmacokinetics.', 23433442),
('Antibacterial Chemical Compound', 'Debio1452 (previously AFN-1252)', 'The MIC50s for MSSA, MRSA, and molecularly characterized MRSA strains were 0.004 ?g/ml, and the MIC90s ranged from 0.008 to 0.03 ?g/ml. Fot coagulase-negative staphylococci (CoNS) MIC50/90, 0.015/0.12 ?g/ml', '', 'Activity of Debio1452, a FabI inhibitor with potent activity against Staphylococcus aureus and coagulase-negative Staphylococcus spp., including multidrug-resistant strains. Staphylococcus aureus and coagulase-negative staphylococci', 25691627),
('Antibacterial Chemical Compound', 'BAL19403, novel macrolide', 'Potent activity against propionibacteria in vitro, >10-fold higher activity than erythromycin', '', 'Activity of the novel macrolide BAL19403 against ribosomes from erythromycin-resistant Propionibacterium acnes.', 17923495),
('Antibacterial Chemical Compound', 'PYRRO-C3D, cephalosporin-3-diazeniumdiolate nitric oxide (NO) donor prodrug', 'a log fold reduction (10-fold reduction or 1-log-unit reduction) in viability (P < 0.05) relative to azithromycin alone.', '', 'Adjunctive therapy with NO mediated through PYRRO-C3D represents a promising approach for reducing biofilm-associated antibiotic tolerance.', 27919896),
('Antibacterial Chemical Compound', 'aerosolized colistin sodium', 'The mean time to spontaneous emergence of sensitive organisms was 144.6+/-48.0 days in candidates who did not use colistin sodium and was significantly longer than in the candidates who used colistin sodium (P=0.007).', '', 'Aerosolized colistin sodium may be a useful therapy to promote emergence of sensitive microbes in CF candidates with pan-resistant isolates of Pseudomonas.', 9311714),
('Antibacterial Chemical Compound', '1,4-naphthoquinones', 'The EC50 was 8 microg/ml for 5-amino-8-hydroxy-1,4-naphthoquinone against S. aureus, S. intermedius, and S. epidermidis.', '', 'An effective in vitro activity of 5-amino-8-hydroxy-1,4-naphthoquinone and encourage further studies for its application in antibiotic therapy.', 12131921),
('Antibacterial Chemical Compound', '3''-azido-3''-deoxythymidine (BW A509U).', 'potent bactericidal activity against many members of the family Enterobacteriaceae, including strains of Escherichia coli, Salmonella typhimurium, Klebsiella pneumoniae, Shigella flexneri, and Enterobacter aerogenes', '', 'Antibacterial activity and mechanism of action of 3''-azido-3''-deoxythymidine (BW A509U). The thymidine analog 3''-azido-3''-deoxythymidine (BW A509U; azidothymidine [AZT]) had potent bactericidal activity against many members of the family Enterobacteriaceae, including strains of Escherichia coli, Salmonella typhimurium, Klebsiella pneumoniae, Shigella flexneri, and Enterobacter aerogenes.', 3551832),
('Antibacterial Chemical Compound', '2-(2'',4''-Dibromophenoxy)-4,6-dibromophenol', 'MIC range was 0.117-2.5 microg/mL against all the Gram positive bacteria and 0.5-2 microg/mL against Gram negative bacteria', '', 'Antibacterial activity of 2-(2'',4''-dibromophenoxy)-4,6-dibromophenol from Dysidea granulosa.', 19841726),
('Antibacterial Chemical Compound', '7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-cyclopentyloxyiminoacetamido]-3-(3, 6-diaminoimidazo[1,2-b]pyridazinium-1-yl)methyl-3-cephem-4-carboxylate', 'IC50 = 1.6 microg/ml for penicillin binding protein 2'' (PBP2''', '', 'Antibacterial Activity of 7?-[2-(5-Amino-1, 2, 4-thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3-(substituted imidazo[1, 2-b]pyridazinium-1-yl)methyl-3-cephem-4-carboxylates and Related Compounds', 11132951),
('Antibacterial Chemical Compound', 'AM-1155, a novel fluoroquinolone', 'For experimental murine pneumonia with S. pneumoniae intermediately resistant to penicillin, oral administration of AM-1155 showed efficacy higher than that of levofloxacin and equal to that of sparfloxacin.', '', 'Antibacterial activity of AM-1155 against penicillin-resistant Streptococcus pneumoniae. AM-1155, a novel fluoroquinolone, exhibited potent activity against Streptococcus pneumoniae, including penicillin-resistant strains; the MIC90 for 48 clinical isolates was 0.25 mg/L.', 9511043),
('Antibacterial Chemical Compound', '1,13-bis{[(2,2-diphenyl)-1-ethyl]thioureido}-4,10-diazatridecane', 'Bactericidal activity, primarily by depolarization of the cytoplasmic membrane and permeabilization of the bacterial outer membrane.', 'limited adverse effects against the HEK293T human kidney embryonic cells and A549 human adenocarcinoma cells', 'Antibacterial Diamines Targeting Bacterial Membranes.', 26964758),
('Antibacterial Chemical Compound', 'ether derivative ?-artecyclopropylmether', 'Exhibited MIC range, MIC(90), and minimum bactericidal concentration range values of 0.25 to 1.0 ?g/ml, 1.0 ?g/ml, and 1 to 16 ?g/ml, respectively, against both resistant and sensitive strains of H. pylori.', '', 'Anti-Helicobacter pylori potential of artemisinin and its derivatives', 22687518),
('Antibacterial Chemical Compound', 'Ceragenins CSA-8 and CSA-13, cationic steroid molecules', 'Activities against clinical isolates of vancomycin-intermediate S. aureus (VISA), heterogeneous vancomycin-intermediate S. aureus (hVISA), as well as vancomycin-resistant S. aureus (VRSA)', '', 'Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus. The rise in the rates of glycopeptide resistance among Staphylococcus aureus isolates is concerning and underscores the need for the development of novel potent compounds.', 17210765),
('Antibacterial Chemical Compound', 'PD127391 (CI-960 and AM-1091) and PD131628, new quinolones', 'PD127391 MIC90, 2 micrograms/ml and PD131628 MIC90 greater than 8 micrograms/ml against Bacteroides fragilis; PD127391 MIC90s, 0.015-1.0 micrograms/ml and PD131628 MIC90s, 0.03 - greater than 8 micrograms/ml against Gram-positive organisms.', '', 'Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628.', 1665774),
('Antibacterial Chemical Compound', 'BC-3781, pleuromutilin compound', 'BC-3781 exhibited potent activity against methicillin-resistant Staphylococcus aureus (MIC(50/90), 0.12/0.25 ?g/ml), coagulase-negative staphylococci (MIC(50/90), 0.06/0.12 ?g/ml), ?-hemolytic streptococci (MIC(50/90), 0.03/0.06 ?g/ml), viridans group streptococci (MIC(50/90), 0.12/0.5 ?g/ml), and Enterococcus faecium (including vancomycin-nonsusceptible strains) (MIC(50/90), 0.12/2 ?g/ml).', '', 'Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections', 22232289),
('Antibacterial Chemical Compound', 'RLP068/Cl', 'Quantitative CLSM studies showed a reduction in biofilm biomass (biofilm disruption) and a decrease in viable cell numbers, as determined by standard plate counting, in the S. aureus and P. aeruginosa biofilms exposed to APDT with the photosensitiser RLP068/Cl.', '', 'Antimicrobial photodynamic therapy (APDT), a non-antibiotic broad-spectrum antimicrobial treatment, is also active against multidrug-resistant micro-organisms such as meticillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.', 24933446),
('Antibacterial Chemical Compound', '1-tert-butyl-1,4-dihydro-7-(4,4-dimethyloxazolidin-3-yl)-6-nitro-4-oxo-1,8-naphth yridine-3-carboxylic acid (10q)', 'MIC of 0.1 microM against MTB and MDR-TB', '', 'Antimycobacterial activities of novel 1-(cyclopropyl/tert-butyl/4-fluorophenyl)-1,4-dihydro- 6-nitro-4-oxo-7-(substituted secondary amino)-1,8-naphthyridine-3-carboxylic acid', 17960928),
('Antibacterial Chemical Compound', 'cerulenin', 'MICs ranging from 1.5 to 12.5 mg/L against Mycobacterial species, inhibition of fatty acid synthesis', '', 'Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis.', 11252327),
('Antibacterial Chemical Compound', '2-isonicotinoyl-N-[2-(trifluoromethyl)phenyl]hydrazinecarbothioamide (4i)', 'Minimum inhibitory concentration of 0.58 microM against M. tuberculosis H(37)R(v) and INH resistant M. tuberculosis', '', 'Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.', 18343086),
('Antibacterial Chemical Compound', 'TD-1792, a multivalent glycopeptide-cephalosporin', 'potent bactericidal activity at ? 0.12 ?g/ml, highly active against methicillin-susceptible S. aureus (MIC(90), 0.015 ?g/ml), methicillin-resistant S. aureus, and heterogeneous vancomycin-intermediate S. aureus (MIC(90), 0.03 ?g/ml)', '', 'Antistaphylococcal activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic.', 22203585),
('Antibacterial Chemical Compound', 'Plakofuranolactone', 'The quorum quenching activity of plakofuranolactone was evaluated using reporter gene assays for long- and short-chain signals (E. coli pSB1075, E. coli pSB401, and C. violeaceum CV026) and was confirmed by measuring the total protease activity (a virulence factor which is under control of the LasI/R system) of the wild-type P. aeruginosa PAO1.', '', 'As an alternative to the classic antibiotic therapy, attenuation of the bacteria virulence affecting their Quorum sensing (QS) system is a promising approach. A new ?-lactone that is capable of inhibiting the LasI/R QS system, plakofuranolactone (1), was discovered in the extract of the marine sponge Plakortis cf. lita, and its structure, including absolute configuration, was determined by NMR spectroscopy, MS spectrometry, and quantum-mechanical prediction of optical rotation.', 28264490),
('Antibacterial Chemical Compound', 'Auranofin and N-heterocyclic carbene gold-analogs', 'Auranofin completely inhibited H. pylori growth at 1.2 ?M, gold(I)-N-heterocyclic carbene compounds has MICs against H. pylori (2 ?M)', 'lower toxicities for human embryonic kidney cells (HEK-293T cells)', 'Auranofin and N-heterocyclic carbene gold-analogs are potent inhibitors of the bacteria Helicobacter pylori. Auranofin is an FDA-approved gold-containing compound used for the treatment of rheumatoid arthritis.', 27279627),
('Antibacterial Chemical Compound', 'AZ6142, bacterial topoisomerase inhibitors', 'inhibits both type II topoisomerases in S. aureus but that DNA gyrase is the primary target', '', 'AZ6142 has very potent activity against Gram-positive organisms, including Staphylococcus aureus, Streptococcus pneumoniae, and Streptococcus pyogenes.', 26077256),
('Antibacterial Chemical Compound', 'ABT-773, a new ketolide', 'Activity against macrolide-susceptible and -resistant S. pneumoniae', '', 'Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.', 12234843),
('Antibacterial Chemical Compound', 'BAL30072, a novel siderophore sulfactam', 'The MIC(90)s were 4 microg/ml for MDR Acinetobacter spp. and 8 microg/ml for MDR P. aeruginosa, whereas the MIC(90) of meropenem for the same sets of isolates was >32 microg/ml.', '', 'BAL30072 showed potent activity against multidrug-resistant (MDR) Pseudomonas aeruginosa and Acinetobacter sp. isolates, including many carbapenem-resistant strains.', 20308379),
('Antibacterial Chemical Compound', 'nitrobenzotrifluoride-containing ohydroxybenzylamine derivatives (3a-3x)', 'FabH inhibitors, inhibitory potency against the aminoacylation of S. aureus tyrosyl-tRNA synthetase', '', 'Based on our previous findings that o-hydroxybenzylamine derivatives demonstrated potent FabH inhibitory and antimicrobial activities, computer-assistant drug design was introduced and then a series of novel nitrobenzotrifluoride-containing ohydroxybenzylamine derivatives (3a-3x) was designed and synthesized.', 25219926),
('Antibacterial Chemical Compound', 'chimeric protein containing human FH domains 6 and 7 fused to human IgG1 Fc (FH6,7/HuFc)', 'At 8 to 9 h after the challenge, the FH6,7/HuFc-treated rats had >100-fold fewer CFU per ml of blood than control animals pretreated with phosphate-buffered saline (PBS) or FH18-20/HuFc, which does not bind to meningococci (P < 0.0001).', '', 'Because many microbes share a common binding region(s) in FH, FH/Fc chimeric proteins may be a promising candidate for adjunctive therapy against drug-resistant pathogens. Copyright ? 2014, American Society for Microbiology.', 25143339),
('Antibacterial Chemical Compound', 'Benzoyl peroxide', '', '', 'Benzoyl peroxide may have underappreciated potential to treat noninflammatory acne as monotherapy or in combination with a topical retinoid, an important antibiotic-sparing strategy.', 19202772),
('Antibacterial Chemical Compound', 'benzoyl peroxide', 'reduce total P acnes count by 99.7%', '', 'Benzoyl peroxide works rapidly on P acnes without causing antibiotic resistance.', 23839205),
('Antibacterial Chemical Compound', 'Combination of Tobramycin and bicarbonate', '', '', 'Bicarbonate synergises with tobramycin to enhance killing of planktonic bacteria.', 28721244),
('Antibacterial Chemical Compound', 'dipyridinium-based cationic amphiphile (compound 1) and compound 1-loaded nanocarrier', 'Anti-biofilm activity on Staphylococcus aureus MTCC 96 and Pseudomonas aeruginosa MTCC 2488', '', 'Biocompatible nanocarrier fortified with a dipyridinium-based amphiphile for eradication of biofilm.', 25162678),
('Antibacterial Chemical Compound', '9H-isothiazolo[5,4-b]quinoline-3,4-diones containing heteroaromatic groups at the 7-position', 'Potent antistaphylococcal activity (MICs 2 microg/mL) against a multi-drug-resistant strain (ATCC 700699)', 'low cytotoxic activity (CC(50)>100 microM) against the human cell line Hep2 (laryngeal carcinoma)', 'Biological evaluation of isothiazoloquinolones containing aromatic heterocycles at the 7-position: In vitro activity of a series of potent antibacterial agents that are effective against methicillin-resistant Staphylococcus aureus.', 16337789),
('Antibacterial Chemical Compound', 'dicationic bis-benzimidazoles', 'in vitro antibacterial activities, including drug-resistant bacterial strains', '', 'Bis-benzimidazole diamidine compounds have potential for further investigation as a new class of potent anti-MRSA and anti-VRE agents.', 19208475),
('Antibacterial Chemical Compound', 'bis-cyclic guanidine compounds', 'in vitro potency against C. difficile UK6 with MIC values of 1.0 ?g mL-1.', 'cytotoxic selectivity index (SI) values up to 37', 'Bis-Cyclic Guanidines as a Novel Class of Compounds Potent against Clostridium difficile.', 29768720),
('Antibacterial Chemical Compound', 'BMS-284756 is a novel des-fluoro(6) quinolone', '30 mg/kg as a single or divided dose', '', 'BMS-284756 is a novel des-fluoro(6) quinolone with a broad antimicrobial activity, including Streptococcus pneumoniae. The bactericidal effect of BMS-284756 in CSF was concentration dependent.', 11600362),
('Antibacterial Chemical Compound', '2-thiopyridine derivatives', 'effective against both active and dormant M. tuberculosis cells', '', 'By means of the model of M. tuberculosis nonculturability, several new 2-thiopyridine derivatives were found to have potent antitubercular activity.', 24126578),
('Antibacterial Chemical Compound', 'Carbon-carbon-linked (pyrazolylphenyl)oxazolidinones', 'alpha-N-substituted methyl pyrazole (10alpha): MICs <or=0.5-1 ?g/mL and 2-8 ?g/mL against Gram positive and negative bacteria respectively; thioamide of the N-cyanomethyl pyrazole analogue : MICs of <or= 0.06-0.25 ?g/mL and MICs of 1 ?g/mL against Gram positive and negative bacteria respectively', '', 'Carbon-carbon-linked (pyrazolylphenyl)oxazolidinones with antibacterial activity against multiple drug resistant gram-positive and fastidious gram-negative bacteria.', 11711300),
('Antibacterial Chemical Compound', 'Cathodic voltage-controlled electrical stimulation of titanium', '', '', 'Cathodic voltage-controlled electrical stimulation of titanium for prevention of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii biofilm infections', 27890730),
('Antibacterial Chemical Compound', 'Cefiderocol', 'MIC against Escherichia coli ATCC 25922 (0.06-0.5 ?g/mL) and Pseudomonas aeruginosa ATCC 27853 (0.06-0.5 ?g/mL).', '', 'Cefiderocol (formerly S-649266) is a new catechol-substituted parenteral siderophore cephalosporin with potent in vitro antibacterial activity against Gram-negative isolates including multidrug-resistant strains.', 28410852),
('Antibacterial Chemical Compound', 'CG400462', 'MIC(90) was 0.5 microg/mL against 238 strains of Staphylococcus aureus and 1.0 microg/mL against 51 strains of coagulase-negative methicillin-susceptible or -resistant staphylococci', '', 'CG400462, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor. CG400462, a novel FabI inhibitor, has a potent antibacterial activity against staphylococci.', 17723291),
('Antibacterial Chemical Compound', 'N2,N4-Disubstituted Quinazoline-2,4-Diamines with 6-position is replaced with a halide or an alkyl substituent', 'MICs 0.5 ?M against multidrug-resistant A. baumannii', '', 'Characterizing the Antimicrobial Activity of N2,N4-Disubstituted Quinazoline-2,4-Diamines toward Multidrug-Resistant Acinetobacter baumannii.', 28289036),
('Antibacterial Chemical Compound', 'N-(2-hydroxypropyl)-3-trimethylammonium chitosan chlorides (HTCC)', 'Bacteria and fungi (MIC = 125-250 ?g/mL). In a murine model of superficial skin infection - (3.2 log MRSA reduction at 100 mg/kg) with no to minimal inflammation.', '', 'Chitosan Derivatives Active against Multidrug-Resistant Bacteria and Pathogenic Fungi: In Vivo Evaluation as Topical Antimicrobials. The continuous rise of antimicrobial resistance and the dearth of new antibiotics in the clinical pipeline raise an urgent call for the development of potent antimicrobial agents.', 27589087),
('Antibacterial Chemical Compound', 'Citrinin', 'Potent antibacterial activity against methicillin-resistant Staphylococcus aureus (S. aureus), rifampicin-resistant S. aureus, wild type S. aureus and vancomycin-resistant Enterococcus faecium with MICs of 3.90, 0.97, 1.95 and 7.81 ?g/mL, respectively.', '', 'Citrinin (1) is reported from sponge associated Penicillium sp. from this study and for its strong antibacterial activity against multi-drug resistant human pathogens including cytotoxicity against brine shrimp larvae, which indicated that sponge associated Penicillium spp. are promising sources of natural bioactive metabolites', 23620853),
('Antibacterial Chemical Compound', 'poly(methyl methacrylate) (PMMA)', '', '', 'Collectively, our in vitro results indicate that PMMA is a more suitable carrier compared to CaSO4 for delivery of Ga(NO3)3; moreover they provide evidence for the potential use of Ga(NO3)3 with PMMA as a strategy for the prevention and/or treatment for orthopaedic infections.', 26885514),
('Antibacterial Chemical Compound', 'Combination of pantothenamides with vanin inhibitors', 'a series of pantetheinase inhibitors based on a pantothenate scaffold that inhibited serum pantetheinase activity in the nanomolar range was synthesized', '', 'Combination of pantothenamides with vanin inhibitors as a novel antibiotic strategy against gram-positive bacteria.', 23877685),
('Antibacterial Chemical Compound', 'TXA709', 'This synergy reduces the dose of TXA709 required for efficacy 3-fold', '', 'Combining the FtsZ-Targeting Prodrug TXA709 and the Cephalosporin Cefdinir Confers Synergy and Reduces the Frequency of Resistance in Methicillin-Resistant Staphylococcus aureus. Combination therapy of bacterial infections with synergistic drug partners offers distinct advantages over monotherapy.', 27161635),
('Antibacterial Chemical Compound', 'Myrtacine(?)', 'Antibiofilm activity against Propionibacterium acnes', '', 'CONCLUSION: The efficiency of Myrtacine(?) New Generation on P. acnes biofilm alone or combined with antibiotics was demonstrated and can lead to consider it as a potent adjunctive product efficient during the antibiotic course for acne vulgaris treatment.', 26969384),
('Antibacterial Chemical Compound', 'IFNG', '1 ? 106 IU of human recombinant IFN gamma or placebo intramuscularly, daily during 4 weeks and then 3 times per week for the next 20 weeks.', 'No severe events were recorded.', 'CONCLUSION: These data suggest that IFN gamma is useful and well tolerated as adjuvant therapy in patients with pulmonary atypical Mycobacteriosis, predominantly MAC.', 18267006),
('Antibacterial Chemical Compound', 'E-101 Solution is composed of porcine myeloperoxidase (pMPO), glucose oxidase, glucose as the substrate and specific amino acids in an aqueous vehicle.', 'E-101 showed MIC(90) values of 0.03, 0.5 and 0.5 mg pMPO/L for staphylococci (n = 140), streptococci (n = 95) and enterococci (n = 55), respectively. MIC(90) values ranged between 0.03-0.5 and ? 0.004-0.12 mg pMPO/L for Enterobacteriaceae (n = 148) and Gram-negative non-Enterobacteriaceae (n = 92) strains, respectively. There was no antimicrobial tolerance to E-101 for Staphylococcus aureus, Streptococcus agalactiae or Streptococcus pyogenes.', '', 'Conclusions E-101 shows potent and broad-spectrum in vitro activity against bacteria that are the causative pathogens of SSIs, thereby providing the impetus to test its clinical utility in the prevention of SSIs.', 21118915),
('Antibacterial Chemical Compound', 'ACHN-490, a sisomicin derivative', 'Active at ? 2 mg/L against all tested isolates with carbapenem resistance mechanisms other than NDM enzyme, mostly with MICs of 0.12-0.5 mg/L', '', 'CONCLUSIONS: ACHN-490 has potent activity versus carbapenem-resistant isolates, except those also harbouring 16S rRNA methylases; isepamicin is also widely active, though less potent than ACHN-490.', 21078604),
('Antibacterial Chemical Compound', 'CG400549', 'FabI inhibitor, MIC90 0.25 mg/L against clinical isolates of S. aureus, and 1 mg/L against clinical isolates of coagulase-negative staphylococci', '', 'CONCLUSIONS: CG400549 had potent in vitro and in vivo activity against staphylococci, including methicillin-, ciprofloxacin- and multidrug-resistant staphylococci strains.', 17606482),
('Antibacterial Chemical Compound', 'platelet-rich plasma (PRP)', 'When compared to control group, PRP and PPP significantly suppressed bacterial growth of MRSA, K. pneumoniae, and P. aeruginosa at 1st, 2nd, 5th, and 10th hours of incubation (p < 0.05).', '', 'CONCLUSIONS: Emerging PRP and other platelet-derived products seem to be promising alternative tools besides antibiotic treatment, debridement, negative pressure wound therapy, hyperbaric oxygen therapy, and other treatment options for treating diabetic foot infections. DOI: 10.1007/s00068-018-0957-0', 29700554),
('Antibacterial Chemical Compound', 'isothiazolone compound REDX04957 and its enantiomers (REDX05967 and REDX05990)', 'activity against the ESKAPE organisms, except of Enterococcus spp and quinolone-resistant strains harbouring GyrA S83L and D87G mutations (MIC ?4 mg/L)', 'lack of cytotoxicity against HepG2 cells at 128 mg/L', 'CONCLUSIONS: Isothiazolone compounds show potent activity against Gram-positive and -negative pathogens with a dual targeting mechanism-of-action and a low potential for resistance development, meriting their continued investigation as broad-spectrum antibacterial agents.', 27353465),
('Antibacterial Chemical Compound', 'LytA lytic enzyme', 'In the time-kill assays, after 5 h of exposure to LytA, Cpl-1 or Pal, the mean differences in colony counts versus controls were -3.55, -2.66 and -2.71 log(10) cfu/mL, respectively.', '', 'CONCLUSIONS: LytA, Cpl-1 or Pal, alone or in combination, might prove to be effective in combination therapy, as well as in monotherapy against S. pneumoniae.', 17827138),
('Antibacterial Chemical Compound', 'Conjugation of the N5-acetyl-N5-hydroxy-L-ornithine tripeptide and the bis(catechol) siderophore to the potent carbacephalosporin', 'antibacterial activity against E. coli X580', '', 'Conjugation of the N5-acetyl-N5-hydroxy-L-ornithine tripeptide and the bis(catechol) siderophore to the potent carbacephalosporin loracarbef and closely related analogs provided compounds which exhibited antibacterial activity against E. coli X580.', 1503447),
('Antibacterial Chemical Compound', '(E)-3-(2-1H-benzo[d]imidazol-1-yl)-1-((4-chlorobenzyl)oxy)imino)ethyl)-2H-chromen -2-one', 'broad spectrum antibacterial activity against Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus subtilis and Proteus vulgaris', 'no cytotoxicity and hemolysis at 10 times the MIC concentration', 'Coumarin-benzimidazole hybrids as a potent antimicrobial agent: synthesis and biological elevation. Molecular hybridization approach is an emerging tool in drug discovery for designing new pharmacophores with biological activity.', 28634338),
('Antibacterial Chemical Compound', '1beta-methylcarbapenems bearing an (imidazo[5,1-b]thiazolium-6-yl)methyl moiety, a 5,5-fused heterobicycle, at the C-2 position (CP0569)', 'potent antibacterial activities against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and Gram-negative bacteria, including Pseudomonas aeruginosa', '', 'CP0569 (1r) and its analogues showed potent antibacterial activities against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and Gram-negative bacteria, including Pseudomonas aeruginosa.', 12878141),
('Antibacterial Chemical Compound', 'cephalosporins bearing a 5,5-fused ring system, an (imidazo[5,1-b]thiazolium-6-yl)methyl group, at the C-3 position', 'potent antibacterial activity against Pseudomonas aeruginosa and MRSA', '', 'CP6679 (1s) and its analogues showed potent antibacterial activities against gram-positive and gram-negative bacteria, including Pseudomonas aeruginosa.', 11131169),
('Antibacterial Chemical Compound', 'fursultiamine hydrochloride (FTH)', '', 'FTH has no cytotoxic effects on either host cells or pathogen at the tested concentrations.', 'Current study validated the antivirulence strategy targeting the HlyU virulence transcription factor and toxin-network of V. vulnificus and demonstrated that FTH, exhibits a potential to inhibit the pathogenesis of deadly, opportunistic human pathogen, V. vulnificus without inducing AMR.', 29868508),
('Antibacterial Chemical Compound', 'CW-270033, a novel pyrrolidinyl-thio carbapenem', 'Potent in-vivo activity against E. coli ATCC 25922, P. aeruginosa ATCC 27853, and S. aureus SMITH', '', 'CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo', 17329859),
('Antibacterial Chemical Compound', 'Cyclothialidine (1, Ro 09-1437) modified structures', 'The best activities were displayed by 14-membered lactones, and representatives of this subclass exhibit excellent and broad in vitro antibacterial activity against Gram-positive pathogens, including Staphylococcus aureus, Streptococcus pyogenes, and Enterococcus faecalis, and overcome resistance against clinically used drugs.', '', 'Cyclothialidine (1, Ro 09-1437) is a potent DNA gyrase inhibitor that was isolated from Streptomyces filipinensis NR0484 and is a member of a new family of natural products.', 14998336),
('Antibacterial Chemical Compound', '3-methoxybenzamide derivatives', 'Most potent compound had average MIC of 0.12 ?g/ml against all staphylococcal species, including methicillin- and multidrug-resistant Staphylococcus aureus and Staphylococcus epidermidis', '', 'Derivatives of 3-methoxybenzamide, including compound PC190723, have been reported to be potent and selective antistaphylococcal agents which exert their effects through the disruption of intracellular FtsZ function.', 23114779),
('Antibacterial Chemical Compound', 'N-3,5-bis(trifluoromethyl)phenyl-3,5-dichlorobenzenesulfonanilide (16b), and 3,5-bis(trifluoromethyl)-N-(3,5-dichlorophenyl)benzenesulfonanilide (16c)', 'compound 16b has [MIC=0.5microg/mL (MRSA), 1.0microg/mL (VRE)], and compound 16c has [MIC=0.5microg/mL (MRSA), 1.0microg/mL (VRE)]', '', 'Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus', 18468909),
('Antibacterial Chemical Compound', 'fluorine-substituted chalcone analogs', 'Potent antimicrobial (tuberculosis and other pathogenic bacteria) and antifungal actifunal activity', '', 'Design of potent fluoro-substituted chalcones as antimicrobial agents.', 28118738),
('Antibacterial Chemical Compound', 'coumarin-chalcone derivatives', 'Antibacterial activity against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and marine pathogen Tenacibaculum maritimum, responsible for tenacibaculosis in fish,', '', 'Design, synthesis and antibacterial study of new potent and selective coumarin-chalcone derivatives for the treatment of tenacibaculosis.', 26433630),
('Antibacterial Chemical Compound', 'ampicillin-tetramic acid hybrid antibiotics', '', '', 'Design, synthesis and microbiological evaluation of ampicillin-tetramic acid hybrid antibiotics. Exploiting iron-uptake pathways by conjugating ?-lactam antibiotics with iron-chelators, such as catechol and hydroxamic acid is a proven strategy to overcome permeability-related resistance in Gram-negative bacteria.', 27189120),
('Antibacterial Chemical Compound', '6-O-arylpropargyl diazalides', 'potent activity against erythromycin-resistant respiratory tract pathogens', '', 'Design, synthesis and structure-activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniae. A novel series of 6-O-arylpropargyl diazalides was synthesized and evaluated for their antibacterial activity.', 15863336),
('Antibacterial Chemical Compound', 'neomycin-C16 and neomycin-C20 conjugates (aminoglycoside-lipid conjugates)', 'The MIC of neomycin-C16 (C20) conjugates against methicillin-resistant Staphylococcus aureus (MRSA) is comparable to clinically used antiseptics.', '', 'Design, synthesis, and antibacterial activities of neomycin-lipid conjugates: polycationic lipids with potent gram-positive activity', 18778047),
('Antibacterial Chemical Compound', 'N-(6-phenylheptyl)demethylvancomycin (12 a)', '~18-fold more efficacious than vancomycin against MRSA', '', 'Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria', 23576378),
('Antibacterial Chemical Compound', 'NO(2) (o) substituted 3-benzofuran-5-aryl-1-pyrazolylcarbonyl-4-oxo-naphthyridin', 'potent activity against Mycobacterium tuberculosis', '', 'Design, synthesis, and antitubercular evaluation of novel series of 3-benzofuran-5-aryl-1-pyrazolyl-pyridylmethanone and 3-benzofuran-5-aryl-1-pyrazolylcarbonyl-4-oxo-naphthyridin analogs', 20576327),
('Antibacterial Chemical Compound', 'fluoroquinolone-flavonoid hybrids', 'Antimicrobial activity against Escherichia coli ATCC 35218, Bacillus subtilis ATCC 6633, Staphylococcus aureus ATCC 25923, Candida albicans ATCC 90873 and other drug resistant pathogens', '', 'Design, synthesis, and evaluation of novel fluoroquinolone-flavonoid hybrids as potent antibiotics against drug-resistant microorganisms.', 24769347),
('Antibacterial Chemical Compound', 'benzoxazinyl-oxazolidinones bearing nonaromatic heterocycle or aryl groups', 'Most active compound has MIC value of 0.25-0.5 ?g/mL against MRSA', '', 'Design, synthesis, and structure-activity relationship studies of highly potent novel benzoxazinyl-oxazolidinone antibacterial agents.', 21955296),
('Antibacterial Chemical Compound', 'thioether pleuromutilin derivatives incorporating various heteroaromatic substituents into the C14 side chain', 'Most potent derivates with MIC = 0.031-0.063 ?g/mL', '', 'Design, synthesis, and structure-activity relationship studies of novel thioether pleuromutilin derivatives as potent antibacterial agents.', 24874438),
('Antibacterial Chemical Compound', 'Ebsulfur derivatives (2-phenyl-1,2-benzisoselenazol-3(2H)-one (Ebselen) analogues with selenium replaced by sulfur)', 'Potent activity against all S. aureus strains with MIC values mostly ?2?g/mL', 'no mamalian cytotoxicity', 'Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.', 27073054),
('Antibacterial Chemical Compound', '4-chloro-flavanone', 'MICs of 30 ?g/mL in S. cerevesiae and 30 ?g/mL in C. neoformans', '', 'Development of non-natural flavanones as antimicrobial agents', 22039419),
('Antibacterial Chemical Compound', 'Diarylthiazole (DAT)', 'bactericidal activity and active against drug-sensitive and resistant Mycobacterium tuberculosis', '', 'Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system.', 24967731),
('Antibacterial Chemical Compound', 'Difluoromethylornithine', 'DFMO inhibited expression of the H. pylori virulence factor cytotoxin associated gene A, and its translocation and phosphorylation.', '', 'Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction.', 21386987),
('Antibacterial Chemical Compound', '(3S)-amino-(4R)-ethylpiperidinyl quinolones', 'activity against resistant Staphylococcus aureus and Streptococcus pneumoniae', '', 'Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.', 12904069),
('Antibacterial Chemical Compound', '4-pyridone derivatives', 'Two 4-pyridone compounds exhibited strong antibacterial activities against 30 clinical isolates of methicillin-resistant S. aureus (MRSA) with MIC(90) of 0.5 and 2 mug/ml, respectively.', '', 'Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus.', 17420562),
('Antibacterial Chemical Compound', '[(E)-N-methyl-N-(2-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-na phthyridin-3-yl)acrylamide]', 'exquisite antistaphylococci activity, with 500 times lower MIC90 than currently available antibiotics', '', 'Discovery of a novel and potent class of FabI-directed antibacterial agents', 12234833);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Chemical Compound', 'Phomallenic acid C (3)', 'MIC of 3.9 microg/mL against wild-type S. aureus. superior to cerulenin and thiolactomycin, two most common FabF inhibitors.', 'NA', 'Discovery of bacterial fatty acid synthase inhibitors from a Phoma species as antimicrobial agents using a new antisense-based strategy. Fatty acids are essential for bacterial growth and viability, with the type II fatty acid synthesis (FAS II) pathway being a potential antibacterial target.', 16562839),
('Antibacterial Chemical Compound', 'kibdelomycin', 'bacterial type II topoisomerase inhibitor, preferentially inhibiting the ATPase activity of DNA gyrase and topoisomerase IV', '', 'Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus. Bacterial resistance to known therapeutics has led to an urgent need for new chemical classes of antibacterial agents.', 21867911),
('Antibacterial Chemical Compound', 'salicylidene acylhydrazide sulfonamides', 'romising activity at 50 ?M concentration against C. trachomatis and C. pneumoniae in HeLa cells', '', 'Discovery of new polypharmacological antibacterial agents with multiple modes of actions can be an alternative to combination therapy and also a possibility to slow development of antibiotic resistance. New antichlamydial agents that also inhibit T3S (type III secretion) in Yersinia pseudotuberculosis.', 26204507),
('Antibacterial Chemical Compound', '1-(3-bromo-2,3-dideoxy-2-fluoro-?-d-arabinofuranosyl)-5-ethyluracil (13) and 1-(?-d-arabinofuranosyl)-4-thio-5-hydroxymethyluracil (21) ,', 'Compound 21 inhibited Mtb (H37Ra) (MIC(50)=0.5 ?g/mL) and M. bovis (MIC(50)=0.5 ?g/mL) at low concentrations', 'No cellular toxicity of 13 or 21 was observed up to the highest concentration tested (CC(50)>100 ?g/mL)', 'Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2''-''up'' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors', 22664188),
('Antibacterial Chemical Compound', 'pyrazolopyridone analogues', 'in vitro bactericidal activity , a 4 log reduction in colony forming units', '', 'Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity.', 24818517),
('Antibacterial Chemical Compound', 'dithiazole thione', 'A novel non-toxic, non-haemolytic dithiazole thione derivative (DTT10) was identified as a potent competitive inhibitor of NorA efflux pump in S. aureus using in silico, in vitro and in vivo studies.', '', 'Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail multi drug resistant clinical isolate of MRSA in a zebrafish infection model. Lowrence Multi drug resistant (MDR) pathogens pose a serious threat to public health since they can easily render most potent drugs ineffective.', 27531512),
('Antibacterial Chemical Compound', 'dithiolopyrrolones', 'ene-dithiol group of DTPs enables high-affinity metal binding as a central mechanism to inhibit metabolic processes', '', 'Dithiolopyrrolones (DTPs) are an underexplored class of disulfide-containing natural products, which exhibit potent antimicrobial activities against multidrug-resistant pathogens.', 28209778),
('Antibacterial Chemical Compound', 'DQ-113, quinolone', 'DQ-113 against: ofloxacin-resistant and methicillin-resistant S. aureus, MIC90 of 0.25microg/ml, all strains of Streptococcus pneumoniae, including penicillin-resistant strains, and Streptococcus pyogenes at 0.06 microg/ml, Enterococcus faecalis and Enterococcus faecium with MIC90s of 0.25 and 2 microg/ml, respectively, vancomycin-resistant enterococci, MIC range from 0.25 to 2 microg/ml, Haemophilus influenzae, including ampicillin-resistant strains (MIC90, 0.015 microg/ml), and Moraxella catarrhalis (MIC90, 0.03 microg/ml).', '', 'DQ-113 also showed a potent activity against Haemophilus influenzae, including ampicillin-resistant strains (MIC90, 0.015 microg/ml), and Moraxella catarrhalis (MIC90, 0.03 microg/ml).', 11850285),
('Antibacterial Chemical Compound', 'DU-6859a, a new fluoroquinolone', '50% inhibitory concentrations of DU-6859a were 0.86 and 1.05 micrograms/ml for the supercoiling activities of DNA gyrases isolated from E. coli and P. aeruginosa', '', 'DU-6859a showed potent broad-spectrum activity against gram-positive, gram-negative, and anaerobic bacteria, and its activity was greater than those of the control quinolones.', 8593031),
('Antibacterial Chemical Compound', 'VRT-125853 and VRT-752586, novel aminobenzimidazole', 'inhibit the essential ATPase activities of bacterial DNA gyrase and topoisomerase IV', '', 'Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds.', 17116675),
('Antibacterial Chemical Compound', 'DX-619, a novel Des-F (6)-quinolone', 'The MIC(90)s were: ?0.016 mg/L and 0.125 mg/L against methicillin-sensitive and -resistant S. aureus, 0.062 and 0.125 mg/L against methicillin-sensitive and -resistant S. epidermidis, respectively. The MIC(90)s for other bacteria are: penicillin-sensitive (0.016 mg/L) and -non-sensitive Streptococcus pneumoniae (0.062 mgL), Enterococcus faecalis (0.25 mg/L) and Enterococcus faecium (0.5 mg/L), Enterobacteriaceae (except for Escherichia coli) and glucose-nonfermenting bacilli (< or =4 mg/L)', '', 'DX-619 was a potent antibacterial compound against multi-drug resistant bacteria including Gram-positive cocci, such as S. aureus and enterococci, which may warrant further exploration.', 18230543),
('Antibacterial Chemical Compound', 'Ebselen, an organoselenium clinical molecule', 'The minimum inhibitory concentrations of ebselen at which 90% of clinical isolates of Enterococcus and Staphylococcus were inhibited (MIC90) were found to be 0.5 and 0.25 mg/L, respectively.', '', 'Ebselen, an organoselenium clinical molecule, possesses potent antimicrobial activity against clinical multidrug-resistant Gram-positive pathogens, including Staphylococcus, Streptococcus, and Enterococcus, but not against Gram-negative pathogens.', 26222252),
('Antibacterial Chemical Compound', 'vanillin, ethyl vanillin, and vanillic acid', 'MICs are 2 mg/ml ethyl vanillin, 3 mg/ml vanillin, and >8 mg/ml vanillic acid.', '', 'Effect of vanillin, ethyl vanillin, and vanillic acid on the growth and heat resistance of Cronobacter species. Preservatives could be part of an effective intervention strategy for the control of Cronobacter species in foods, but few compounds with the desired antimicrobial properties have been identified to date.', 22186046),
('Antibacterial Chemical Compound', '4''''-Deoxy-4''''-episubstituted arbekacin derivatives and 4''''-epi-5-deoxy-5-episubstituted arbekacin derivatives', '5,4''''-diepiarbekacin has more potency against Gram-positive and Gram-negative bacteria, 6''-N-methyl derivative of the 5,4''''-diepiarbekacin was effective against P. aeruginosa', '', 'Effect of varying the 4''''-position of arbekacin derivatives on antibacterial activity against MRSA and Pseudomonas aeruginosa.', 17889537),
('Antibacterial Chemical Compound', 'Biphenyl derivative', 'FtsZ inhibitor (Kd = 0.5 ?M) with high antibacterial activity [MIC (MRSA) = 7 ?M', '', 'Effective GTP-replacing FtsZ inhibitors and antibacterial mechanism of action', 25486266),
('Antibacterial Chemical Compound', 'bis-naphthoquinone thiol-crown ether 7a', 'Active against Staphylococcus aureus methicillin resistance with MIC value of 2.68 microM', '', 'Efficient synthesis of ''redox-switched'' naphthoquinone thiol-crown ethers and their biological activity evaluation', 11937353),
('Antibacterial Chemical Compound', 'Sugar (Man, Fuc, and Gal)', 'BALB/c mice (male; 6?8 wk old; Taconic Farms) were anesthetized with Avertin [250 mg/kg intraperitoneally (IP)], and 50 ?l of 2 ? 108 PAO1 or PDO300 in PBS or PBS containing sugars (5 mM Man+5 mM Fuc+5 mM Gal or 15 mM Fuc) were intratracheally instilled into the lung by a feeding needle (24 gauge)', 'Our findings reveal that sugar inhalation, an inexpensive and safe therapeutic, could be used in combination with conventional antibiotic therapy to more effectively treat P. aeruginosa lung infections.', 'Epub 2013 Jun 21. Sugar administration is an effective adjunctive therapy in the treatment of Pseudomonas aeruginosa pneumonia. Treatment of acute and chronic pulmonary infections caused by opportunistic pathogen Pseudomonas aeruginosa is limited by the increasing frequency of multidrug bacterial resistance.', 23792737),
('Antibacterial Chemical Compound', '21-((1H-imidazol-5-yl)methyl)-pseudopteroxazole (7a)', 'Activity against both replicating and non-replicating persistent forms of M.tuberculosis', 'near absence of in vitro cytotoxicity', 'Evaluation of pseudopteroxazole and pseudopterosin derivatives against Mycobacterium tuberculosis and other pathogen', 23015770),
('Antibacterial Chemical Compound', 'SCA-50', 'Potent concentration-dependent bactericidal activity against MRSA Mu50 strain and very importantly, 2-60 fold more potent inhibitory effect on MRSA Mu50 than all the commonly used antibiotics', '', 'Evaluation of small molecule SecA inhibitors against methicillin-resistant Staphylococcus aureus', 26432604),
('Antibacterial Chemical Compound', 'triazol-1-yl-pyrimidines (AVS2087, AVS2093, AVS2387, and AVS2236)', 'AVS2087, AVS2093, AVS2387, and AVS2236, were identified as potent inhibitors of catalytic subunit with IC(50) values of 1.0 +/- 0.02, 1.0 +/- 0.04, 2.1 +/- 0.12, and 2.0 +/- 0.08 microM, respectively', '', 'Evaluation of substituted triazol-1-yl-pyrimidines as inhibitors of Bacillus anthracis acetohydroxyacid synthase', 20170757),
('Antibacterial Chemical Compound', 'T-3811ME (BMS-284756), a new des-F(6)-quinolone', 'T-3811, the free base of T-3811ME, exhibited potent activity against 28 clinical strains of PRSP at MIC90 0.0625 microg/ml', '', 'Evaluation of T-3811ME (BMS-284756), a new des-F(6)-quinolone, for treatment of meningitis caused by penicillin-resistant Streptococcus pneumoniae in rabbits', 12019087),
('Antibacterial Chemical Compound', '2-phenyl-4(1H)-quinolone and 2-phenyl-4-hydroxyquinoline derivatives', 'The 2-phenyl-4-hydroxyquinoline derivatives 28f and 29f display potent EPI activity against SA-1199B', '', 'Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump', 21751791),
('Antibacterial Chemical Compound', 'Farnesol', '300 ?M of farnesol or vancomycin: 40 mg/L and rifampicin: 10 mg/L', 'NA', 'Farnesol, a quorum-sensing molecule in Candida albicans, has been described as impairing growth of several different microorganisms and we have previously shown its potential as an adjuvant in antimicrobial therapy against S. epidermidis. Farnesol might induce biofilm detachment, as determined by the reduced biofilm biomass, which can partially explain the previous findings regarding its role as a possible chemotherapy adjuvant.', 22591918),
('Antibacterial Chemical Compound', 'd-lysine conjugated tetradecanoyl analogue (D-LANA-14)', 'anti-MRSA activity (MIC = 3.1-6.3 ?g/mL)', 'No skin toxicity even at high concentration', 'Fatty Acid Comprising Lysine Conjugates: Anti-MRSA Agents That Display In Vivo Efficacy by Disrupting Biofilms with No Resistance Development', 28225264),
('Antibacterial Chemical Compound', '1,4-benzothiazine derivatives', 'Almost all derivatives evaluated showed good activity in combination with ciprofloxacin against S. aureus ATCC 25923; some were capable of completely restoring ciprofloxacin activity in a norA-overexpressing strain (SA-K2378)', '', 'From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump', 18578473),
('Antibacterial Chemical Compound', 'sulfonamide derivatives of the alpha-(R)-amino hydroxamic acids, (BB-78484 and BB-78485)', 'antibacterial activities against Escherichia coli', '', 'From this screen, a series of sulfonamide derivatives of the alpha-(R)-amino hydroxamic acids, exemplified by BB-78484 and BB-78485, have been identified as having potent inhibitory activities against LpxC in an in vitro assay.', 12019092),
('Antibacterial Chemical Compound', 'naphtho-?-pyrones (fonsecinones A and C and aurasperones A and E)', 'Fonsecinone A exhibited the most potent antibacterial activity, with minimum inhibitory concentrations (MICs) of 4.26, 17.04, and 4.26 ?g/mL against ESBL-producing E. coli, P. aeruginosa, and E. faecalis, respectively.', '', 'Fungal naphtho-?-pyrones: Potent antibiotics for drug-resistant microbial pathogens', 27063778),
('Antibacterial Chemical Compound', 'Histidine (His) derived lipo-amino acids having pendant lipid tails at N(?)- and N(?)-positions on imidazole group of His', 'antimicrobial activity against Gram-positive and Gram-negative bacteria, also strong anti-MRSA activity', '', 'Furthermore, our designed His-derived lipo-peptidomimetics (HDLPs) consisting of two or three residues displayed strong anti-MRSA activity and protease stability as well as retained potent antimicrobial activity under high salt concentration.', 23933046),
('Antibacterial Chemical Compound', 'biricodar (VX-710) and timcodar (VX-853)', 'lowers MICs of several clinically used antibiotics', '', 'Furthermore, these compounds were effective in lowering the MICs of several clinically used antibiotics, including fluoroquinolones, suggesting that VX-710 and VX-853 are representatives of a new class of bacterial efflux inhibitors with the potential for use in combination therapy.', 15504837),
('Antibacterial Chemical Compound', 'Gallium Compounds ( Ga-protoporphyrin, Ga(NO3)3 and other Ga compounds)', 'Activity against Mycobacterium abscessus, Ga-protoporphyrin was >20 times more active than Ga(NO3)3', '', 'Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus', 26033732),
('Antibacterial Chemical Compound', 'GE23077', 'Selective inhibitor of bacterial RNA polymerase (RNAP), It inhibits Gram-positive (Bacillus subtilis) and Gram-negative (Escherichia coli) RNAPs with IC50 values in the 10(-8) m range', '', 'GE23077, a novel microbial metabolite recently isolated from Actinomadura sp. culture media, is a potent and selective inhibitor of bacterial RNA polymerase (RNAP).', 15265034),
('Antibacterial Chemical Compound', 'GSK1322322', 'GSK1322322 had an MIC(90) of 1 ?g/ml against M. catarrhalis and 4 ?g/ml against H. influenzae, with 88.8% of ?-lactamase-positive strains showing growth inhibition at that concentration. All S. pneumoniae strains were inhibited by ? 4 ?g/ml of GSK1322322, with an MIC(90) of 2 ?g/ml.', '', 'Given the antibacterial potency demonstrated against this panel of organisms, GSK1322322 represents a valuable alternative therapy for the treatment of infectious diseases caused by drug-resistant pathogens.', 23478958),
('Antibacterial Chemical Compound', 'Green-leaf-derived C6-aroma compounds', 'The most effective compound was (3E)-hexenal at concentrations of 0.1 and 1 microg mL(-1), which killed 2.1 x 10(5) cfu mL(-1) of S. aureus IFO 12732 and 1.4 x 10(5) cfu mL(-1) of E. coli IFO 3301', '', 'Green-leaf-derived C6-aroma compounds with potent antibacterial action that act on both Gram-negative and Gram-positive bacteria.', 12475283),
('Antibacterial Chemical Compound', '1-beta-D-2''-arabinofuranosyl and 1-(2''-deoxy-2''-fluoro-beta-D-ribofuranosyl) pyrimidine nucleosides possessing diverse sets of alkynyl, alkenyl, alkyl, and halo substituents at the C-5 position of the uracil', 'Activity against M. tuberculosis, M. bovis, and M. avium with MIC similar or close to that of the reference drug rifampicin', '', 'Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2''-arabinofuranosyl and 1-(2''-deoxy-2''-fluoro-beta-D-2''-ribofuranosyl) pyrimidine nucleoside analogs', 17602465),
('Antibacterial Chemical Compound', 'sulfonyl piperazine and pyrazole compounds', '', '', 'Here we describe the discovery and characterization of sulfonyl piperazine and pyrazole compounds, each with novel mechanisms of action. E. coli mutants resistant to these compounds display no cross-resistance to antibiotics of other classes.', 25733621),
('Antibacterial Chemical Compound', '7-Cl and 7-CF3 substituted N-dodecylamino-4-aminoquinolines (5 and 10)', 'biofilm formation inhibitors with 50% biofilm inhibition at 69 ?M and 63 ?M in S. marcescens and P. aeruginosa', '', 'Here we report a new type of highly potent 4-aminoquinoline derivatives as quorum sensing inhibitors in Serratia marcescens and Pseudomonas aeruginosa, exhibiting weak bactericidal activities (minimum inhibitory concentration (MIC) > 400 ?M).', 28350449),
('Antibacterial Chemical Compound', '1-Hydroxypyridine-2(1H)-thione-6-carboxylic Acid', 'Inhibition Ki 13 nm against VIM-2 (carbapenem-hydrolyzing metallo ?-lactamases (MBL)) that corresponds to a remarkable 0.99 ligand efficiency.', 'low cytotoxicity (CC50 ) of 97 ?m with a corresponding therapeutic index of 880', 'Here we report the discovery of 1-hydroxypyridine-2(1H)-thione-6-carboxylic acid (3) as a first-in-class metallo ?-lactamase inhibitor (MBLi) with a potent inhibition Ki of 13 nm against VIM-2 that corresponds to a remarkable 0.99 ligand efficiency.', 28482143),
('Antibacterial Chemical Compound', 'Hydantoin (imidazolidinedione) derivatives', 'bactericidal and also prevent the development of methicillin-resistant Staphylococcus aureus (MRSA) bacterial resistance', '', 'Herein, we report the design of bacterial membrane-active hydantoin derivatives, from which we identified compounds that show much more potent antimicrobial activity than nitrofurantoin against a panel of clinically relevant Gram-positive and Gram-negative bacterial strains.', 28984451),
('Antibacterial Chemical Compound', 'purine benzimidazole hybrids', 'The most potent analogue has MIC = 4 ?g/mL against multidrug-resistant strains Staphylococcus aureus', '', 'Hexyl appended hybrid 3c gave potent activities against most of the tested bacteria and fungi especially against multidrug-resistant strains Staphylococcus aureus (MIC = 4 ?g/mL).', 29598912),
('Antibacterial Chemical Compound', 'taurine haloamines (TauCl and TauBr)', '', '', 'However, a combined therapy, an application of TauBr together with other anti-biofilm agents (e.g., DNase), seems to be more promising. DOI: 10.1007/978-1-4614-6130-2_23', 23392942),
('Antibacterial Chemical Compound', 'beta-sulfonyl- and beta-sulfinylhydroxamic acid derivatives', 'potent inhibitors of Escherichia coli peptide deformylase (PDF)., antibacterial activities against Chlamydia pneumoniae, Mycoplasma pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.', '', 'Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.', 10882358),
('Antibacterial Chemical Compound', '1-benzyl-3-cetyl-2-methylimidazolium iodide, NH125', 'Active against oxacillin-resistant Staphylococcus aureus (ORSA), vancomycin-resistant Enterococcus faecalis (VRE), penicillin-resistant Streptococcus pneumoniae (PRS)', '', 'Identification and characterization of a potent antibacterial agent, NH125 against drug-resistant bacteria. New imidazole compounds were synthesized to develop a novel and effective antibacterial agent (1-benzyl-3-cetyl-2-methylimidazolium iodide, NH125).', 10830522),
('Antibacterial Chemical Compound', 'ABTZ-1, benzothiazolium salt,', 'Potent activity against multidrug-resistant clinical isolates of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococci (VRE)', 'low hemolytic activity', 'Identification of a novel protein synthesis inhibitor active against gram-positive bacteria', 22362659),
('Antibacterial Chemical Compound', 'AminoPYrimidine-Sulfonamide (APYS1)', 'bactericidal activity against M. tuberculosis', '', 'Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria.', 27677649),
('Antibacterial Chemical Compound', 'novel series of quinoxaline 1,4-di-N-oxides', 'In general, all compounds were active with ratios of MICs against resistant and non-resistant strains of <or=4.00.', '', 'If the bactericidal activity and activity on non-replicating bacteria in vitro translate to in vivo conditions, quinoxaline 1,4-di-N-oxides may offer a path to shortened therapy. DOI: 10.1093/jac/dkn214 PMCID: PMC2574959', 18502817),
('Antibacterial Chemical Compound', 'a biomimetic iron-sequestering polymer (PAI-DHBA)', '', 'NA', 'In addition, bacterial growth was more susceptible to antibiotics combined with PAI-DHBA. Multivalent polymers that bind and sequester iron, such as PAI-DHBA, offer a promising early intervention or adjuvant to antibiotics.', 25872681),
('Antibacterial Chemical Compound', 'BC-3781 is a novel semisynthetic pleuromutilin antibiotic', 'BC-3781 against: ABSSSI such as Staphylococcus aureus (MIC50/90, 0.12/0.12 ?g/ml; 99.8% inhibited at ?0.5 ?g/ml), beta-hemolytic streptococci (MIC50/90, 0.03/0.03 ?g/ml; 99.3% inhibited at ?0.5 ?g/ml), and coagulase-negative staphylococci (CoNS; MIC50/90, 0.06/0.12 ?g/ml; 97.8% inhibited at ?1 ?g/ml), also methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) S. aureus strains. against Enterococcus faecium, with 76.3% of vancomycin-susceptible and 97.0% of vancomycin-resistant isolates at ?1 ?g/ml. Beta-hemolytic and viridans group streptococci 99.3% and 96.7% of isolates inhibited at ?0.5 ?g/ml, respectively, Streptococcus pneumoniae (MIC50/90, 0.12/0.25 ?g/ml), Haemophilus influenzae (MIC50/90, 1/2 ?g/ml), and Moraxella catarrhalis (MIC50/90, 0.12/0.25 ?g/ml) no negative influence by ?-lactamase or resistance to other antimicrobial classes tested.', '', 'In all, BC-3781 displayed a very potent antibacterial profile including the most prevalent bacterial pathogens causing ABSSSI and CABP, thus warranting further clinical development of this antibiotic in these and possibly other indications.', 23836172),
('Antibacterial Chemical Compound', 'DS-8587, novel fluoroquinolone', 'More effective antibacterial activity when compared with ciprofloxacin and levofloxacin.', '', 'In conclusion, DS-8587 exhibits potent antibacterial activity against quinolone-resistant A. baumannii isolates that harbor mutations in quinolone resistance-determining regions.', 24709045),
('Antibacterial Chemical Compound', 'polymyxin B and SERMs', 'Synergistic killing against the polymyxin-resistant P. aeruginosa, K. pneumoniae, and A. baumannii isolates as demonstrated by a ?2-3 log10 decrease in bacterial count (CFU/ml) after 24 hours.', '', 'In conclusion, the combination of polymyxin B and SERMs illustrated a synergistic activity against XDR Gram-negative pathogens, including highly polymyxin-resistant P. aeruginosa isolates, and represents a novel combination therapy strategy for the treatment of infections because of problematic XDR Gram-negative pathogens. DOI: 10.1089/mdr.2016.0196', 27935770),
('Antibacterial Chemical Compound', 'WQ-3810, a new fluoroquinolone', 'Against A. baumannii, including MDR isolates, MIC(90))=1 mg/L, against E. coli and S. pneumoniae, including FQR isolates, MIC(90)=4 mg/L and 0.06 mg/L, respectively', '', 'In conclusion, this study demonstrated that WQ-3810 exhibits extremely potent antibacterial activity over the existing fluoroquinolones, particularly against MDR and FQR pathogens.', 25239276),
('Antibacterial Chemical Compound', 'TAM16', 'TAM16 has excellent pharmacological and safety profiles, and the frequency of resistance for TAM16 is ?100-fold lower than INH', '', 'In multiple mouse models of TB infection, TAM16 showed in vivo efficacy equal to the first-line TB drug isoniazid, both as a monotherapy and in combination therapy with rifampicin.', 28669536),
('Antibacterial Chemical Compound', '3,4-Dihydropyrimidinone-coumarin analogues', 'MIC values against the drug susceptive S. aureus ranging from 0.2 to 6.25?g/mL', '', 'In search of potent antibiotic, taking coumarin and dihydropyrimidinone as lead compound, a green, eco-friendly and efficient protocol has been developed and synthesized the dihydropyrimidin-2(1H)-one/thione derivatives of coumarin 3/4 from substituted 4-formylcoumarins 2 and ethylacetoacetate using urea/thiourea in the presence of catalytic amount of ceric ammonium nitrate is reported.', 28094219),
('Antibacterial Chemical Compound', 'BAS-118, a new benzamide derivative', 'MIC(50), MIC(90) and MIC range of BAS-118 for 100 randomly selected isolates of H. pylori were <or =0.003, 0.013 and < or =0.003-0.025 mg/L, respectively', '', 'In summary, BAS-118 is a novel anti-H. pylori agent with a potent and selective antibacterial activity, which includes CAM- and MNDZ-resistant isolates.', 12096019),
('Antibacterial Chemical Compound', 'Battacin or octapeptin B5', 'MICs of 2 to 4 ?g/ml against hospital strains of Escherichia coli and Pseudomonas aeruginosa', '', 'In the current study, we report the isolation, structure elucidation, and preliminary biological characterization of a new cationic lipopeptide antibiotic, battacin or octapeptin B5, produced from a Paenibacillus tianmuensis soil isolate', 22183171),
('Antibacterial Chemical Compound', 'PLEX (biodegradable Polymer-Lipid Encapsulation MatriX)-doxycycline coating on titanium alloy implants', 'the PLEX-doxycycline coating on titanium alloy implants provided complete protection against implant-associated MSSA osteomyelitis, and resulted in a significant reduction in the number of culture positive samples when challenged with a doxycycline-resistant MRSA.', 'NA', 'In the present study, we investigated the efficacy of a biodegradable Polymer-Lipid Encapsulation MatriX (PLEX) loaded with the antibiotic doxycycline as a local prophylactic strategy against implant-associated osteomyelitis.', 25910578),
('Antibacterial Chemical Compound', 'complestatin abd related compounds (neuroprotectin A and chloropeptin I )', 'Inhibited S. aureus FabI with IC?? of 0.3-0.6 ?M, prevented the growth of S. aureus as well as methicillin-resistance S. aureus (MRSA) and quinolone-resistant S. aureus (QRSA), with minimum inhibitory concentrations (MICs) of 2-4 ?g/mL.', '', 'In the screening of inhibitors of Staphylococcus aureus enoyl-ACP reductase (FabI), complestatin was isolated as a potent inhibitor of S. aureus FabI together with neuroprotectin A and chloropeptin I from Streptomyces chartreusis AN1542.', 25947917),
('Antibacterial Chemical Compound', '8T-W, a novel synthetic dienoyl tetramic acid', 'antimicrobial activity against Gram-positive and Gram-negative anaerobes as well as staphylococci', '', 'In this paper, we report on a novel series of synthetic dienoyl tetramic acids that lack a complex dioxabicyclononane unit. Several of these compounds, particularly 8T-W, exhibit potent antimicrobial activity against Gram-positive and Gram-negative anaerobes as well as staphylococci.', 2709374),
('Antibacterial Chemical Compound', 'pyrrolo[1,5-a]pyrazine-based analogues', 'Most significantly, by in vitro Mtb culture assays, we confirmed that our Eis (Enhanced Intracellular Survival) inhibitors were capable of penetrating the Mtb cell wall and canceling the KAN resistance of Mtb K204, which overexpresses Eis. IC50 (microM) 0.039 - 8.7 against purified Eis_Mtb enzyme. MIC of KAN against Mtb H37Rv in the presence of these compounds <= 1.25 micrograms/mL, MIC of KAN against Mtb K204 range 1.25 micrograms/mL to > 10 micrograms/mL', '', 'In this paper, we report the discovery and development of pyrrolo[1,5-a]pyrazine-based analogues as highly potent inhibitors of the Mycobacterium tuberculosis (Mtb) acetyltransferase enhanced intracellular survival (Eis), whose up-regulation causes clinically observed resistance to the aminoglycoside (AG) antibiotic kanamycin A (KAN).', 28192916),
('Antibacterial Chemical Compound', '1-substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their oxa and selanyl analogs', '(MIC) values reached 1 ?M (0.36-0.44 ?g/mL) against Mycobacterium tuberculosis CNCTC My 331/88 and 0.25-1 ?M against six multidrug-resistant clinically isolated strains of M. tuberculosis.', '', 'In this work, a new class of highly potent antituberculosis agents, 1-substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their oxa and selanyl analogs, is described.', 24927053),
('Antibacterial Chemical Compound', 'trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems', 'potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa', '', 'In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.', 10681308),
('Antibacterial Chemical Compound', 'E-1040 [(6R,7R)-3-[(4-carbamoyl-1-quinuclidinio)methyl]-7-[2-(5-amino-1,2 ,4- thiadiazol-3-yl)-(Z)-2-methoxyiminoacetoamido]-8-oxo-5-thia- 1- azabicyclo(4,2,0)oct-2-ene-2-carboxylate]', 'MIC50 ?0.25 microgram/ml and the MIC90 0.06 to 2 micrograms/ml against Enterobacteriaceae, Pseudomonas aeruginosa, and Haemophilus and Neisseria', '', 'In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa. The in vitro activity of E-1040 [(6R,7R)-3-[(4-carbamoyl-1-quinuclidinio)methyl]-7-[2-(5-amino-1,2 ,4- thiadiazol-3-yl)-(Z)-2-methoxyiminoacetoamido]-8-oxo-5-thia- 1- azabicyclo(4,2,0)oct-2-ene-2-carboxylate], a novel cephalosporin, was compared with that of ceftazidime, cefpirome, cefepime, imipenem, and gentamicin.', 3150915),
('Antibacterial Chemical Compound', '2-(thiazol-2-ylthio)-1beta-methylcarbapenems (SM-197436, SM-232721, and SM-232724)', 'MIC(90) of </=4 micro g/ml against methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus epidermidis (MRSE), MIC ranged from </=0.063 to 0.5 micro g/ml for streptococci, including penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae strains and MIC(90) ranged between 8 and 16 micro g/ml for ampicillin-resistant E. faecium', '', 'In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.', 12878507),
('Antibacterial Chemical Compound', 'PD 0305970 and PD 0326448 (quinazoline-2,4-diones)', 'MIC90 ranges were: staphylococci (0.125 to 0.5 ?g/ml), streptococci (0.03 to 0.06 ?g/ml) , enterococci (0.25 to 2 ?g/ml) and 0.25 to 0.5 ?g/ml for Moraxella catarrhalis, Haemophilus influenzae, Listeria monocytogenes, Legionella pneumophila, and Neisseria spp', '', 'In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups.', 17261623),
('Antibacterial Chemical Compound', 'RBx 14255, Ketolide', 'The MIC(90) Clostridium difficile was 4 ?g/ml (MIC range, 0.125 to 8 ?g/ml)', '', 'In vitro and in vivo activities of the novel Ketolide RBx 14255 against Clostridium difficile', 22869573),
('Antibacterial Chemical Compound', 'CS-023 (RO4908463), 1beta-methylcarbapenem with 5-substituted pyrrolidin-3-ylthio groups, including an amidine moiety at the C-2 position', 'Most potent activity against P. aeruginosa and MRSA, with MIC90s of 4 microg/ml and 8 microg/ml, respectively.', '', 'In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem', 16048932),
('Antibacterial Chemical Compound', 'ER-35786', 'Active against methicillin-susceptible Staphylococcus aureus and streptococci (MIC90S < or = 0.39 ?g/ml), methicillin-resistant S. aureus(MIC90 12.5 ?g/ml), Enterobacteriaceae, Moraxella catarrhalis, and Haemophilus influenzae (MIC90 < or = 1.56?g/ml)', '', 'In vitro and in vivo antibacterial activities of ER-35786, a new antipseudomonal carbapenem. ER-35786 is a new parenteral 1 beta-methyl carbapenem with a broad antibacterial spectrum and a potent antipseudomonal activity.', 9021183),
('Antibacterial Chemical Compound', 'AM-833, a new quinolone derivative', 'potent activity against members of the family Enterobacteriaceae, Neisseria spp., and Haemophilus influenzae and good activity against staphylococci, Pseudomonas aeruginosa, and Branhamella catarrhalis', '', 'In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative. AM-833 showed potent activity against members of the family Enterobacteriaceae, Neisseria spp., and Haemophilus influenzae and good activity against staphylococci, Pseudomonas aeruginosa, and Branhamella catarrhalis.', 2942103),
('Antibacterial Chemical Compound', 'gallium nitrate Ga(NO(3))(3)', 'inhibits the growth of a collection of 58 A. baumannii strains in both chemically defined medium and human serum, at concentrations ranging from 2 to 80 ?M and from 4 to 64 ?M, respectively.', '', 'In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii. Multidrug-resistant Acinetobacter baumannii poses a tremendous challenge to traditional antibiotic therapy.', 22964249),
('Antibacterial Chemical Compound', 'A-80556, new fluoroquinolone', 'MIC90 values: Staphylococcus aureus (0.12 ?h/ml), Streptococcus pneumoniae (0.12 ?h/ml), Escherichia coli (0.06 ?h/ml), Pseudomonas aeruginosa ( 4.0 ?h/ml), Bacteroides fragilis ( 2.0 ?h/ml)', '', 'In vitro and in vivo evaluations of A-80556, a new fluoroquinolone. A-80556 is a novel fluoroquinolone with potent antibacterial activity against gram-positive, gram-negative, and anaerobic organisms.', 8067740),
('Antibacterial Chemical Compound', 'S-013420, a novel bicyclolide', 'Most potent activity against erythromycin-intermediate and -resistant S. pneumoniae with an MIC(90) of 0.25 mg/L and inhibited the growth of all strains of S. pyogenes with macrolide resistance genes at 1 mg/L, MIC(90) values of 0.125, 0.125, 8 and 0.5 mg/L for Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis, respectively', '', 'In vitro antibacterial activities of S-013420, a novel bicyclolide, against respiratory tract pathogens', 20472695),
('Antibacterial Chemical Compound', 'AZD0914, a new spiropyrimidinetrione', 'Bacterial DNA gyrase/topoisomerase inhibitor with potent in vitro antibacterial activity against Gram-positive (Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, and Streptococcus agalactiae), fastidious Gram-negative (Haemophilus influenzae and Neisseria gonorrhoeae), atypical (Legionella pneumophila), and anaerobic (Clostridium difficile) bacterial species', '', 'In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteria.', 25385112),
('Antibacterial Chemical Compound', 'BMY-28142', 'most potent against Enterobacteriaceae with a MIC90 0.12 micrograms/ml', '', 'In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.', 3859244),
('Antibacterial Chemical Compound', 'SM-7338, a new carbapenem antibiotic', 'At a concentration of 0.5 micrograms/ml, SM-7338 inhibited 90% of these strains: Staphylococcus aureus, beta-hemolytic streptococci, Streptococcus pneumoniae, Haemophilus influenzae, Neisseria spp., members of the family Enterobacteriaceae, Pseudomonas spp., and gram-positive and gram-negative anaerobes.', '', 'In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I. SM-7338, a new carbapenem antibiotic, was demonstrated to have potent antibacterial activity against a broad spectrum of aerobes, including Staphylococcus aureus, beta-hemolytic streptococci, Streptococcus pneumoniae, Haemophilus influenzae, Neisseria spp., members of the family Enterobacteriaceae, Pseudomonas spp., and gram-positive and gram-negative anaerobes in a collection of 1,102 unselected clinical isolates.', 2655530),
('Antibacterial Chemical Compound', 'ABT-492, new fluoroquinolone', 'Activity against Enterobacteriaceae, gram-negative species including Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae, Legionella spp. , Pseudomonas aeruginosa and Helicobacter pylori.', '', 'In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone. ABT-492 demonstrated potent antibacterial activity against most quinolone-susceptible pathogens.', 14506039),
('Antibacterial Chemical Compound', 'AT-2266, new pyridonecarboxylic acid', 'inhibited some gram-positive bacteria, such as staphylococci and Bacillus subtilis, and most gram-negative bacteria, including Serratia marcescens, Pseudomonas aeruginosa, Haemophilus influenzae, and Campylobacter jejuni, at concentrations of 0.1 to 0.78 microgram/ml, and most gram-positive bacteria, glucose-nonfermenters, and Mycoplasma pneumoniae at concentrations of 1.56 to 12.5 micrograms/ml.:', '', 'In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid. AT-2266, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3 -carboxylic acid, is a new pyridonecarboxylic acid derivative with broad and potent antibacterial activity.', 6575721),
('Antibacterial Chemical Compound', 'ACH-702, a novel isothiazoloquinolone', 'in vitro antibacterial activity against Mycobacterium tuberculosis, with MICs of <or=1 microg/ml', '', 'In vitro antituberculosis activities of ACH-702, a novel isothiazoloquinolone, against quinolone-susceptible and quinolone-resistant isolates.', 20516287),
('Antibacterial Chemical Compound', 'ABT-492, a novel quinolone', 'penicillin-sensitive, resistant, and levofloxacin-resistant Streptococcus pneumoniae strains : MICs 0.0078 to 0.125 micro g/ml; beta-lactamase-positive and beta-lactamase-negative Haemophilus influenzae strains: MICs 0.000313 to 0.00125 micro g/ml; beta-lactamase-positive and beta-lactamase-negative Moraxella catarrhalis strains : MICs 0.001 to 0.0025 micro g/ml', '', 'In vitro pharmacodynamic activities of ABT-492, a novel quinolone, compared to those of levofloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.', 14693540),
('Antibacterial Chemical Compound', 'ABI-0043, novel rifamycin', 'Bactericidal activity against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA)', '', 'In vitro pharmacodynamics of novel rifamycin ABI-0043 against Staphylococcus aureus.', 18400804),
('Antibacterial Chemical Compound', 'DQ-113, new quinolone', 'Activity against against Streptococcus pneumoniae', '', 'In vivo efficacy of a new quinolone, DQ-113, against Streptococcus pneumoniae in a mouse model. DQ-113 is a new quinolone with potent activity against gram-positive pathogens.', 14638468),
('Antibacterial Chemical Compound', 'NITD-304 and NITD-349', 'potent activity against both drug-sensitive and multidrug-resistant clinical isolates of Mtb', '', 'Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis', 24307692),
('Antibacterial Chemical Compound', '5-acetylenic derivatives of 2'',3''-dideoxyuridine (3-8) and 3''-fluoro-2'',3''-dideoxyuridine (22-27)', '2'',3''-Dideoxyuridine possessing 5-decynyl, 5-dodecynyl, 5-tridecynyl, and 5-tetradecynyl substituents (4-7), 3''-fluoro-2'',3''-dideoxyuridine derivative 5-tetradecynyl analogue (26), displayed the most potent activity against all mycobacteria. 2-amino-6-mercaptoethyl-9-(2,3-dideoxy-beta-d-glyceropentofuranosyl)purine (32) and 2-amino-4-fluoro-7-(2,3-dideoxy-beta-d-glyceropentofuranosyl)pyrrolo[2,3-d]pyrimidine (35) were the most efficacious against M. bovis and M. tuberculosis, and M. avium, respectively', '', 'Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides', 17696514),
('Antibacterial Chemical Compound', 'JNJ-Q2, new fluoroquinolone', 'in vitro activity against Gram-negative and Gram-positive organisms, including methicillin-resistant Staphylococcus aureus (MRSA) and ciprofloxacin-resistant MRSA isolates, with MICs ? 0.12 ?g/m', '', 'Inhibition of S. aureus DNA gyrase and DNA topoisomerase IV enzymes demonstrated that JNJ-Q2 was more potent than comparators against wild-type enzymes and enzymes carrying quinolone-resistant amino acid substitutions, and JNJ-Q2 displayed equipotent activity against both enzymes.', 21911562),
('Antibacterial Chemical Compound', '1-(2-benzoxazolyl)-3,3,3-trifluoro-2-propanone (TF18), a trifluoromethyl ketone derivative', 'Inhibitory activity against clarithromycin-susceptible and-resistant Helicobacter pylori', '', 'Inhibitory action of a new proton pump inhibitor, trifluoromethyl ketone derivative, against the motility of clarithromycin-susceptible and-resistant Helicobacter pylori.', 15194136),
('Antibacterial Chemical Compound', 'chlorhexidine with trisEDTA or miconazole', 'Chlorhexidine/miconazole MICs (median = 0.5 mg/L) were lower than those of either drug alone (P < 0.05) and lower than chlorhexidine/trisEDTA MICs (median = 1 mg/L; P < 0.0005) in each bacterial type and from both regions, except for miconazole in NUK MSSP.', '', 'Interaction of chlorhexidine with trisEDTA or miconazole in vitro against canine meticillin-resistant and -susceptible Staphylococcus pseudintermedius isolates from two UK regions. Clark SM(1), Loeffler A(2), Schmidt VM(3), Chang YM(2), Wilson A(2), Timofte D(3), Bond R(2). Author information: (1)Department of Clinical Sciences and Services, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, AL9 7TA, UK. sclark@rvc.ac.uk. (2)Department of Clinical Sciences and Services, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, AL9 7TA, UK. (3)School of Veterinary Science, University of Liverpool, Chester High Road, Neston, CH64 7TE, UK. BACKGROUND: Topical therapy is an important alternative to systemic antibacterial therapy for treatment of canine superficial pyoderma in light of the emergence of multidrug-resistant staphylococci.', 27406860),
('Antibacterial Chemical Compound', 'Carbohydrate derived fulvic acid (CHD-FA)', 'minimum inhibitory concentration of 0.5%.', 'Despite the widespread use of mouthwashes being used as adjunctive measures to control these biofilms, their prolonged use is not recommended due to various side effects.', 'Investigating the biological properties of carbohydrate derived fulvic acid (CHD-FA) as a potential novel therapy for the management of oral biofilm infections.', 24063298),
('Antibacterial Chemical Compound', 'diethyl malate and 1-methyl malate', 'diethyl malate and 1-methyl malate can decrease the MIC value of benzyl penicillin by sixteen and eight-fold', '', 'Investigation for antimicrobial resistance-modulating activity of diethyl malate and 1-methyl malate against beta-lactamase class A from Bacillus licheniformis by molecular dynamics, in vitro and in vivo studies.', 24836845),
('Antibacterial Chemical Compound', 'lucensimycins', 'Lucensimycin E (5) exhibited the best activity and showed MIC values of 32 microg/mL against Staphylococcus aureus and 8 microg/mL against Streptococcus pneumoniae.', '', 'Isolation, structure, and antibacterial activities of lucensimycins D-G, discovered from Streptomyces lucensis MA7349 using an antisense strategy. Bacterial resistance to existing antibiotics continues to grow, necessitating the discovery of new compounds of this type.', 19115838),
('Antibacterial Chemical Compound', 'PC-904, sodium 6-{d(-)-alpha-(4-hydroxy-1,5-naphthyridine-3-carboxamido) phenylacetamido}-penicillanate', 'Against systemic infections with P. aeruginosa, K. pneumoniae, and E. coli in mice, PC-904 is 7 to 10 times, over 8 times, and 2 to 15 times more active than carbenicillin', '', 'It is confirmed that PC-904 has a very potent in vivo antibacterial activity against gram-negative and gram-positive organisms.', 1046355),
('Antibacterial Chemical Compound', 'JNJ-Q2, a new fluoroquinolone', 'MIC(50) and MIC(90), 0.12 and 0.5 ?g/ml respectively', '', 'JNJ-Q2, a new fluoroquinolone with potent in vitro activity against Staphylococcus aureus, including methicillin- and fluoroquinolone-resistant strains.', 21555765),
('Antibacterial Chemical Compound', 'Lactam hybrid analogues of solonamide B and autoinducing peptides', 'S. aureus AgrC antagonists', '', 'Lactam hybrid analogues of solonamide B and autoinducing peptides as potent S. aureus AgrC antagonists.', 29738955),
('Antibacterial Chemical Compound', 'Undecatungsto(ferri)ferrosilicate ([SiW11O39Fe](6/5-))', '', '', 'Lacunary-substituted undecatungstosilicates sensitize methicillin-resistant Staphylococcus aureus to beta-lactams.', 11558574),
('Antibacterial Chemical Compound', 'Laser-assisted nasal decolonization', '25 patients colonized with MSSA/MRSA were allocated to 4 treatment arms; low-power, dual-wavelength 870-/930-nm laser alone (GR1); low-power, dual-wavelength laser followed by erythromycin (E-mycin) cream (GR2); low-power, dual-wavelength laser followed by peroxide irrigation (GR3); and high-power 940-nm laser alone (GR4).', 'No adverse events or discomfort were reported.', 'Laser therapy can eradicate MRSA and potentially resensitization of bacteria to the antimicrobial effect of erythromycin. Nasal decolonization for GR1, GR2, GR3, and GR4 was 1 of 3, 13 of 14, 2 of 4, and 4 of 4, respectively', 22503099),
('Antibacterial Chemical Compound', 'LCB01-0648 Oxazolidinones', 'MIC90s 0.5 mg/L against the methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci (MRCNS)', '', 'LCB01-0648 showed the most potent antimicrobial activities against clinically isolated Gram-positive bacteria.', 28273820),
('Antibacterial Chemical Compound', 'Q203, an imidazo[1,2-a]pyridine amide derivative', 'activity against Mycobacterium tuberculosis H37Rv', '', 'Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent.', 24870926),
('Antibacterial Chemical Compound', 'lipo-?-AApeptides', 'Potent broad-spectrum activities against fungi and a series of Gram-positive and Gram-negative bacteria', '', 'Lipo-?-AApeptides as a new class of potent and broad-spectrum antimicrobial agents.', 22475244),
('Antibacterial Chemical Compound', 'Marinomycin A', '', '', 'Marinomycin A is a member of a new class of bis-salicylate-containing polyene macrodiolides, which have potent antibiotic activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium.', 22824902),
('Antibacterial Chemical Compound', '(?)-marinopyrrole A and its derivatives', 'para-trifluoromethyl analog (33) of marinopyrrole A is ? 63-, 8-, and 4-fold more potent than vancomycin against methicillin-resistant Staphylococcus epidermidis (MRSE), methicillin-susceptible Staphylococcus aureus (MSSA) and MRSA, respectively', '', 'Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (II)', 23955285),
('Antibacterial Chemical Compound', 'MBX2319, a novel pyranopyridine', 'Exhibit antibacterial activity in combination with other antibiotics only, decreased the MICs of ciprofloxacin (CIP), levofloxacin, and piperacillin versus E. coli AB1157 by 2-, 4-, and 8-fold, respectively', '', 'MBX2319 is a potent EPI with possible utility as an adjunctive therapeutic agent for the treatment of infections caused by Gram-negative pathogens.', 24247144),
('Antibacterial Chemical Compound', 'LFF571', 'antibacterial activity against Clostridium difficile is due to inhibition of translation', '', 'Mechanism of action of and mechanism of reduced susceptibility to the novel anti-Clostridium difficile compound LFF571.', 22644023),
('Antibacterial Chemical Compound', 'liposomal linolenic acid (LipoLLA)', 'potent bactericidal activity against several clinical isolated antibiotic-resistant strains of H. pylori including both the spiral and coccoid form', '', 'Mechanism of antibacterial activity of liposomal linolenic acid against Helicobacter pylor', 25793403),
('Antibacterial Chemical Compound', 'AB206, nalidixic acid derivative', 'Strongly inhibits deoxyribonucleic acid (DNA) synthesis in Escherichia coli', '', 'Mode of action of a new nalidixic acid derivative, AB206. A new chemotherapeutic agent, AB206, shows potent antibacterial activity against gram-negative bacteria, including most of the nalidixic acid-resistant strains tested.', 6156644),
('Antibacterial Chemical Compound', 'Van-M-02, a novel glycopeptide', 'potent activities against Gram-positive bacteria, including vancomycin-resistant enterococci (VRE) and vancomycin-resistant Staphylococcus aureus (VRSA)', '', 'Mode of action of Van-M-02, a novel glycopeptide inhibitor of peptidoglycan synthesis, in vancomycin-resistant bacteria.', 19933802),
('Antibacterial Chemical Compound', 'anacardic acid analogues possessing different side chains viz. phenolic, branched, and alicyclic [6-(4'',8''-dimethylnonyl)salicylic acid, and the alicyclic side-chain analogue, 6-cyclododecylmethyl salicylic acid ]', 'Maximun anti MRSA activiry with (MIC) 0.39 microg/mL', '', 'Molecular design of anti-MRSA agents based on the anacardic acid scaffold', 17601740);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Chemical Compound', 'ilamycin congeners (1-6) bearing rare L-3-nitro-tyrosine and L-2-amino-4-hexenoic acid structural units', 'minimum inhibitory concentration value ?9.8 nM to Mycobacterium tuberculosis H37Rv', '', 'Most impressively, ilamycins E1/E2, which are produced in high titers by a genetically engineered mutant strain, show very potent anti-tuberculosis activity with an minimum inhibitory concentration value ?9.8 nM to Mycobacterium tuberculosis H37Rv constituting extremely potent and exciting anti-tuberculosis drug leads.', 28855504),
('Antibacterial Chemical Compound', 'NB2001, (triclosan in a prodrug form with a cephalosporin scaffold)', 'antibacterial activity was studied against beta lactamase producing strains', 'NA', 'NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strains. Enzyme-catalyzed therapeutic activation (ECTA) is a novel prodrug strategy to overcome drug resistance resulting from enzyme overexpression. beta-Lactamase overexpression is a common mechanism of bacterial resistance to beta-lactam antibiotics.', 11959554),
('Antibacterial Chemical Compound', 'NCL195 (4,6-bis(2-((E)-4-methylbenzylidene)hydrazinyl)pyrimidin-2-amine)', 'potent bactericidal activity against Streptococcus pneumoniae and Staphylococcus aureus', 'less cytotoxic to mammalian cell lines than robenidine', 'NCL195 was bactericidal against Acinetobacter spp and Neisseria meningitidis and also demonstrated potent activity against A. baumannii, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Enterobacter spp. in the presence of sub-inhibitory concentrations of ethylenediaminetetraacetic acid (EDTA) and polymyxin B.', 28873428),
('Antibacterial Chemical Compound', '7-[4-(4-(benzoyl)carbopiperazin-1-yl)]piperazinyl derivative 5h and two 7-[4-(4- (benzenesulfonyl)carbopiperazin-1-yl)]piperazinyl derivatives 5k and 5l', 'MIC values as low as 16 ?g/ml against ciprofloxacin-resistant P. aeruginosa (CRPA)', '', 'New 7-[4-(4-(un)substituted)piperazine-1-carbonyl]- piperazin-1-yl] derivatives of fluoroquinolone: synthesis and antimicrobial evaluation', 23807580),
('Antibacterial Chemical Compound', '1beta-methylcarbapenems with thiazol-2-ylthio groups at the C-2 position [SM-197436 , SM-232721, and SM-232724 ]', 'potent antibacterial activity especially against methicillin-resistant staphylococci, vancomycin-resistant enterococci and penicillin-resistant Streptococcus pneumoniae', '', 'New anti-MRSA and anti-VRE carbapenems; synthesis and structure-activity relationships of 1beta-methyl-2-(thiazol-2-ylthio)carbapenems.', 12374386),
('Antibacterial Chemical Compound', '7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3', 'potent antibacterial activity against MRSA and Pseudomonas aeruginosa', '', 'New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa', 15246098),
('Antibacterial Chemical Compound', '2-((4-(4,5-dibromo-1H-pyrrole-2-carboxamido)phenyl)amino)-2-oxoacetic acid (9a)', 'IC50 of 0.18 ?M against E. coli gyrase', '', 'New N-phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATPase inhibitors of DNA gyrase', 27100032),
('Antibacterial Chemical Compound', 'Nitric oxide', 'Sublethal concentrations of NO inhibited the enzymatic activity of [4Fe-4S]-cofactored aconitase of aerobic and anaerobic B. pseudomallei.', '', 'Nitric oxide-dependent killing of aerobic, anaerobic and persistent Burkholderia pseudomallei. Burkholderia pseudomallei infections are fastidious to treat with conventional antibiotic therapy, often involving a combination of drugs and long-term regimes.', 22521523),
('Antibacterial Chemical Compound', 'Nitrosoglutathione generating nitric oxide (NO)', 'Percent survival in the NO-np+GSH -treated isolates was significantly lower than in the a nitric oxide-releasing nanoparticle (NO-np) (36.1% vs 8.3%; P=.004). In addition, NO-np+GSH accelerated wound closure in P aeruginosa-infected wounds, and NO-np+GSH-treated wounds had significantly lower bacterial burden when compared to NO-np-treated wounds (P<.001).', '', 'Nitrosoglutathione generating nitric oxide nanoparticles as an improved strategy for combating Pseudomonas aeruginosa-infected wounds. Pseudomonas aeruginosa is a community-acquired, nosocomial pathogen that is an important cause of human morbidity and mortality; it is intrinsically resistant to several antibiotics and is capable of developing resistance to newly developed drugs via a variety of mechanisms.', 23377518),
('Antibacterial Chemical Compound', 'Compounds containing the N-alkyl-N-(pyridin-2-yl)hydroxylamine structure', 'potent antibacterial activity against the Gram-positive bacterium Micrococcus luteus ATCC 10240 (MIC(90) = 2.0 ?M or 0.41 ?g/mL) and moderate activity against other Gram-positive strains including antibiotic resistant strains of Staphylococcus aureus (MRSA) and Enterococcus faecalis (VRE)', '', 'N-O chemistry for antibiotics: discovery of N-alkyl-N-(pyridin-2-yl)hydroxylamine scaffolds as selective antibacterial agents using nitroso Diels-Alder and ene chemistry', 21859126),
('Antibacterial Chemical Compound', '3-(2-aminothiazol-4-yl)-7-chloro-6-(pyrrolidin-1-yl) quinolone 12b', 'Activity againts methicillin-resistant Staphylococcus aureus (MRSA) by formation of a compound 12b-Cu(2+)-DNA ternary complex in which the Cu(2+) ion acts as a bridge between the backbone of 3-aminothiazolquinolone and the phosphate group of the nucleic acid.', 'low cytotoxicity to hepatocyte cells', 'Novel 3-Aminothiazolquinolones: Design, Synthesis, Bioactive Evaluation, SARs, and Preliminary Antibacterial Mechanism.', 27115717),
('Antibacterial Chemical Compound', '(R)-Hydroxy-1,5-naphthyridinone left-hand side (LHS) oxabicyclooctane linked pyridoxazinone right-hand side (RHS) containing NBTIs showed a potent Gram-positive antibacterial profile. SAR around the RHS moiety, including substitutions around pyridooxazinone, pyridodioxane, and phenyl propenoids', 'A fluoro substituted pyridoxazinone showed an MIC against Staphylococcus aureus of 0.5 ?g/mL, pyridodioxane-containing NBTI showed a S. aureus MIC of 0.5 ?g/mL', '', 'Novel bacterial topoisomerase inhibitors (NBTIs) are a new class of broad-spectrum antibacterial agents targeting bacterial Gyrase A and ParC and have potential utility in combating antibiotic resistance.', 25978963),
('Antibacterial Chemical Compound', 'bis-cyclic guanidines', 'compromise bacterial membranes without developing resistance, inhibit biofilms formed by E. coli, and exhibit excellent in vivo activity against MRSA', '', 'Novel bis-cyclic guanidines as potent membrane-active antibacterial agents with therapeutic potential. We designed a class of small dimeric cyclic guanidine derivatives which display potent antibacterial activity against both multidrug-resistant Gram-negative and Gram-positive bacteria.', 29052670),
('Antibacterial Chemical Compound', 'bis-(imidazolinylindole) derivatives', 'effective against a broad range of gram-positive and gram-negative bacterial species, including several antibiotic-resistant strains', '', 'Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains', 19635954),
('Antibacterial Chemical Compound', 'fluorinated pyrrolomycin', 'MIC of 73 ng/mL, MBC of 4 ?g/mL, kill staphylococcal-associated biofilm at 8 ?g/mL', '', 'Novel fluorinated pyrrolomycins as potent anti-staphylococcal biofilm agents.', 27565555),
('Antibacterial Chemical Compound', '6-O-substituted and 6,12-di-O-substituted 8a-aza-8a-homoerythromycin A and 9a-aza-9a-homoerythromycin A ketolides and ketolides based on 14-membered erythromycin oxime scaffold', 'Potent activity against a variety of erythromycin-susceptible and macrolide-lincosamide-streptogramin B (MLS(B))-resistant Gram-positive pathogens as well as fastidious Gram-negative pathogens', '', 'Novel hybrids of 15-membered 8a- and 9a-azahomoerythromycin A ketolides and quinolones as potent antibacterials.', 21055953),
('Antibacterial Chemical Compound', 'SKI-356313, new imidazoline scaffold', 'Bactericidal activity against Mycobacterium tuberculosis and Gram-positive cocci, including vancomycin-resistant Enterococcus faecium (VRE) and methicillin-resistant Staphylococcus aureus (MRSA)', '', 'Novel imidazoline antimicrobial scaffold that inhibits DNA replication with activity against mycobacteria and drug resistant Gram-positive cocci', 25222597),
('Antibacterial Chemical Compound', '2-([3-[(1H-benzimidazol-2-ylsulfanyl)methyl]-2-methylphenyl]sulfanyl)ethyl carbamates', 'MIC(90) = 0.25 microg/mL against H. pylori strains', '', 'Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents.', 12213071),
('Antibacterial Chemical Compound', '4-chloro-2,6-dimethylphenol analogues', 'The most potent analogs have a MIC of 160 to 320 nM against B. anthracis and may target the cytoskeletal protein FtsZ', '', 'Oligochlorophens are potent inhibitors of Bacillus anthracis.', 20566769),
('Antibacterial Chemical Compound', 'Derivatives of 2?{[4?(5?bromo?3?methylpyridin?2?yl)butyl]amino}?1,4?dihydroquinolin?4?one', 'The most potent derivative hasexcellent antibacterial activity against staphylococcal and enterococcal pathogens, including strains resistant to clinical antibiotics.', '', 'Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-positive antibacterial activity. Optimisation of the left-hand-side aryl moiety of a file compound screening hit against Staphylococcus aureus methionyl tRNA synthetase led to the identification of a series of potent nanomolar inhibitors.', 12639554),
('Antibacterial Chemical Compound', 'psammaplin A (1) analogues', 'antibacterial agents (e.g. 17, 57, 58, 69, and 70), some possessing greater than 50-fold higher activities than the natural product.', 'In fact, the most interesting compound in this study proved to be the heterodimer 58 consisting of a 3?bromo?phenyl alanine subunit and a 4??fluorophenyl moiety, exhibiting a therapeutic index (TI) of 37.5.', 'Optimization and mechanistic studies of psammaplin A type antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA). N As described in the preceding article, utilizing a novel combinatorial disulfide exchange strategy, a library of psammaplin A (1) analogues was constructed and screened for antibacterial activity leading to the identification of a collection of diverse lead compounds.', 11686610),
('Antibacterial Chemical Compound', 'curcumin', 'treatment for Streptococcus agalactiae infection', '', 'Our results demonstrated that curcumin dietary supplement exerts potent bactericidal action against S. agalactiae, presenting 100% of therapeutic efficacy when compared to infected and non-supplemented animals.', 29407233),
('Antibacterial Chemical Compound', 'silver sulfadiazine and silver-coated dressing', '1% silver sulfadiazine > silver-coated dressing > 3% citric acid > 0.5% chlorhexidine acetate > control group.', '', 'Our results supported the efficacy of topical therapy by silver sulfadiazine and silver-coated dressing on infections caused by multi-drug resistant Pseudomonas spp.', 24229034),
('Antibacterial Chemical Compound', 'quaternised chitosan derivative (hydroxypropyltrimethyl ammonium chloride chitosan, HACC', '', '', 'Our study indicates that 26%HACC-loaded PMMA prevents biofilm formation of Staphylococcus, including antibiotic-resistant strains, on the surface of bone cement, and downregulates the virulence-associated gene expression of antibiotic-resistant staphylococcus, thus providing a promising new strategy for combating implant infections and osteomyelitis.', 22014946),
('Antibacterial Chemical Compound', 'IgA', '', '', 'Our study provides a mechanistic explanation for the well-documented risk of P. aeruginosa infection following antimicrobial therapy, and we propose local administration of IgA as a novel prophylactic strategy.', 29771684),
('Antibacterial Chemical Compound', '5-episinuleptolide', 'anti-biofilm activities against only Gram-negative bacteria', '', 'Our study showed potentially synergistic activity of combination therapy with 5-episinuleptolide and levofloxacin against biofilm formation and biofilm cells.', 27483290),
('Antibacterial Chemical Compound', 'AM-8722, Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor', 'targets DNA gyrase and topoisomerase IV', '', 'Overall, AM-8722 is a selective and potent NBTI that displays broad-spectrum antimicrobial activity in vitro and in vivo.', 27246784),
('Antibacterial Chemical Compound', 'BAG-S53P4', '', '', 'Owing to its osteoconductive, antibacterial and antibiofilm properties, the use of BAG-S53P4 may be a successful strategy for the treatment of bone and prosthetic joint infections.', 26462989),
('Antibacterial Chemical Compound', 'pestalone', 'activity against methicillin-resistant Staphylococcus aureus (MIC = 37 ng/mL) and vancomycin-resistant Enterococcus faecium (MIC = 78 ng/mL)', '', 'Pestalone, a new antibiotic produced by a marine fungus in response to bacterial challenge', 11720529),
('Antibacterial Chemical Compound', 'phosphodiesterase-4 (PDE4) inhibitor, CC-3052,', '"To study the effect of CC-3052 treatment on the ability of INH to kill Mtb in the lungs of infected rabbits, animals were treated from 4 weeks post-infection with high dose INH (50 mg/kg body weight/day) or CC-3052 (25 mg/kg body weight/day), neither or both for 4 or 8 weeks (i.e., 8 or 12 weeks post-infection)."', 'CC-3052, is water soluble, more stable in human plasma and ?200-fold more potent in reducing TNF-? production, compared to the parent drug', 'Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs. These findings provide a basis for exploring the potential use of adjunctive immune modulation with PDE4 inhibitors to enhance the efficacy of existing anti-TB treatment.', 21949656),
('Antibacterial Chemical Compound', '6-methoxytetrahydro ?-mangostin (16)', 'antimycobacterial activity with minimum inhibitory concentration (MIC) of 0.78 ?g/mL', '', 'Potent activity against multidrug-resistant Mycobacterium tuberculosis of ?-mangostin analogs', 23150066),
('Antibacterial Chemical Compound', 'laurinterol and allolaurinterol', '', 'laurinterol and allolaurinterol displayed potent bactericidal activity against MRSA at 3.13 microg mL(-1) and against vancomycin-susceptible Enterococcus at 3.13 microg mL(-1) and 6.25 microg mL(-1), respectively.', 'Potent antibacterial activity of halogenated compounds against antibiotic-resistant bacteria', 15549668),
('Antibacterial Chemical Compound', 'Bisbenzimidazole and Carbonyl Cyanide 3-Chlorophenylhydrazone combination', 'Inhibited biofilm formation, eradicate preformed biofilms and kills the biofilm cells of P. aeruginosa.', '', 'PPEF (bisbenzimidazole) targeting topoisomerase IA is observed to be an effective bactericidal agent against both Gram-positive and Gram-negative bacterial strains and thus can be developed as potent broad-spectrum antibiotic against MDR strains.', 28303897),
('Antibacterial Chemical Compound', 'Chloro[2,6-bis(1-methyl imidazol)pyrazine]gold(I), 2b and chloro [2,6-bis(1-methyl imidazol)pyrazine]silver(I), 2a complexes', 'Inhibit the biofilm formation by Gram-positive bacteria, Streptococcus mutans and Gram-negative bacteria, Escherichia coli, causing drastic damage to the bacterial cell wall and increasing membrane permeability', '', 'Pyrazine functionalized Ag(I) and Au(I)-NHC complexes are potential antibacterial agents', 22680631),
('Antibacterial Chemical Compound', 'Isoamyl- or cyclopropylmethylene-substituted dipyrrole derivatives', 'Binds to minor groove of DNA', '', 'Pyrrole tetraamides are potent antibacterials against vancomycin resistant Enterococci [corrected] and methicillin resistant Staphylococcus aureus. A new series of short pyrrole tetraamides are described whose submicromolar DNA binding affinity is an essential component for their strong antibacterial activity.', 11831893),
('Antibacterial Chemical Compound', 'benzyloxy, benzylamino, and phenoxy derivatives of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters', 'nanomolar activity against the replicating bacteria (R-TB) and low micromolar activity against the nonreplicating bacteria (NRP-TB)', '', 'Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.', 20000577),
('Antibacterial Chemical Compound', '2-phenylquinoline derivatives', 'S. aureus NorA efflux pump inhibitors (EPIs)', '', 'Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance', 23710549),
('Antibacterial Chemical Compound', 'Resazurin', 'At concentration of 44 ?M, a potent bactericidal effect was observed against various Francisella and Neisseria species, including the human pathogens type A F. tularensis (Schu S4) and N. gonorrhoeae.', '', 'Replication of F. tularensis in primary human macrophages and non-phagocytic cells was abolished following treatment with 44 ?M resazurin indicating this compound could be an effective therapy for tularemia in vivo', 24367766),
('Antibacterial Chemical Compound', 'auranofin', 'Potent antibacterial activity against all tested strains of S. aureus, including meticillin-resistant S. aureus (MRSA), vancomycin-intermediate S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA), with minimum inhibitory concentrations (MICs) ranging from 0.0625?g/mL to 0.125?g/mL', '', 'Repurposing auranofin for the treatment of cutaneous staphylococcal infections', 26895605),
('Antibacterial Chemical Compound', 'stannous fluoride (SnF2) dentifrice (SSF)', 'broad antimicrobial activity against both Gram-positives and Gram-negatives and, in particular, has potent activity against Streptococcus mutans', '', 'Results of in vitro time-kill experiments with representative oral bacteria demonstrated that SnF2 exerts broad antimicrobial activity against both Gram-positives and Gram-negatives and, in particular, has potent activity against Streptococcus mutans.', 8593200),
('Antibacterial Chemical Compound', 'BPT L-159,061 (Biphenyl tetrazoles)', 'Inhibition of metallo-beta-lactamase by binding to two zinc atoms in the active site', '', 'RESULTS: Biphenyl tetrazoles (BPTs) are a structural class of potent competitive inhibitors of metallo-beta-lactamase identified through screening and predicted using molecular modeling of the enzyme structure.', 9545432),
('Antibacterial Chemical Compound', 'Retinoids', 'Benzoyl peroxide (BPO) is a nonantibiotic antibacterial agent that is highly effective against P acnes and for which no resistance against it has been detected to date.', '', 'Retinoids are important components in combination therapy for acne, including use with antibiotics, and can serve as an alternative to these agents in maintenance therapy.', 17649854),
('Antibacterial Chemical Compound', 'SCE-129 [3-(4-carbamoyl-1-pyridiniomethyl)-7beta-(d-alpha-sulfophenylacetamido)-ceph-3-em -4-carboxylate monosodium salt]', 'Active against Pseudomonas aeruginosa and some gram-positive bacteria', '', 'SCE-129, antipseudomonal cephalosporin: in vitro and in vivo antibacterial activities. SCE-129 [3-(4-carbamoyl-1-pyridiniomethyl)-7beta-(d-alpha-sulfophenylacetamido)-ceph-3-em -4-carboxylate monosodium salt], a new semisynthetic cephalosporin, shows potent in vitro antibacterial activities against Pseudomonas aeruginosa and some gram-positive bacteria, whereas it shows lower activity against many gram-negative rods.', 417670),
('Antibacterial Chemical Compound', '8-hydroxyquinoline (8HQ)', 'Cu-dependent bactericidal inhibitor with MIC in the presence of Cu 0.16 ?M for replicating and nonreplicating Mycobacterium tuberculosis cells.', '', 'Screening for Cu toxicity-enhancing antibacterial molecules identified 8-hydroxyquinoline (8HQ) to be a potent Cu-dependent bactericidal inhibitor of Mycobacterium tuberculosis .', 27431227),
('Antibacterial Chemical Compound', '?-mangostin and ceftazidime', 'Time-kill curves showed that the AMT/CTZ combination was significantly more efficient (P < 0?01) at reducing CRAB than the individual components.: The data suggest that AMT in combination with CTZ is synergistic and efficient against CRAB.', '?-mangostin has no cytotoxic effects.', 'Sep 3. Synergy and mechanism of action of ?-mangostin and ceftazidime against ceftazidime-resistant Acinetobacter baumannii. Pimchan T(1), Maensiri D(1), Eumkeb G(2). Author information: (1)School of Biology, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima, Thailand. (2)School of Preclinic, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima, Thailand. To address the resistance of Acinetobacter baumannii to ?-lactam antibiotics, combination therapy between different antibiotic classes is increasingly used.', 28799218),
('Antibacterial Chemical Compound', 'Cell-penetrating peptide (P3 and P8) and antibiotic combination', 'lower the MICs against oxacillin, norfloxacin, and vancomycin to susceptible levels', 'no significant hemolytic activity', 'Simultaneously, time-kill kinetics revealed the increased uptake of antibiotics. In summary, CPPs assist to restore the effectiveness of antibiotics at much lower concentration, eliminate the antibiotic toxicity, and represent the CPP-antibiotic combination therapy as a potential novel weapon to combat MRSA infections.', 26837216),
('Antibacterial Chemical Compound', '2-phenylquinoline efflux inhibitor (4-(2-(piperazin-1-yl)ethoxy)-2-(4-propoxyphenyl) quinolone - PQQ4R)', 'destabilization of the E. coli inner membrane potential and ATP production impairment, ultimately leading to efflux pump inhibition by interference with the energy required by the efflux systems', '', 'Since drug resistance mediated by the activity of efflux pumps depends largely on the proton motive force (PMF), dissipaters of PMF such as PQQ4R, can be regarded as future adjuvants of conventional therapy against E. coli and other Gram-negative bacteria, especially their multidrug resistant forms.', 28516003),
('Antibacterial Chemical Compound', '3-(4-(N,N-Dimethylaminomethyl)phenyl)quinoline derivatives', 'Most compounds have IC50 values between 20 and 40 ?m,', '', 'Structural Simplification of Bedaquiline: the Discovery of 3-(4-(N,N-Dimethylaminomethyl)phenyl)quinoline-Derived Antitubercular Lead Compounds. Bedaquiline (BDQ) is a novel and highly potent last-line antituberculosis drug that was approved by the US FDA in 2013.', 27792278),
('Antibacterial Chemical Compound', 'halogenated phenazines (HP)', 'Halogenated phenazine 14 proved to be the most potent biofilm-eradicating agent (?99.9% persister cell killing) against MRSA (MBEC < 10 ?M), MRSE (MBEC = 2.35 ?M), and VRE (MBEC = 0.20 ?M) biofilms while 11 and 12 demonstrated excellent antibacterial activity against M. tuberculosis (MIC = 3.13 ?M).', '', 'Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.', 27018907),
('Antibacterial Chemical Compound', '6 beta-(2-aryl-2-sulfoacetamido)-6 alpha-methoxy penicillanic acids', 'potent activity against Pseudomonas aeruginosa including beta-lactamase producing strains', '', 'Structure-activity studies of these derivatives bearing hydrophilic substituents in the phenyl ring led to the identification of disodium 6 beta-[D-2-(3,4-dihydroxyphenyl)-2-sulfoacetamido]-6 alpha-methoxypenicillanate (2m) as a compound with potent activity against Pseudomonas aeruginosa including beta-lactamase producing strains.', 3096924),
('Antibacterial Chemical Compound', '7-((2-thiazol-2-yl)benzimidazol-1-yl)-2,4 diaminoquinazoline', 'Potent inhibitor of S. aureus DHFR (Ki = 0.002 nM), antibacterial potency against S. aureus with MIC of 0.0125 ?g/mL and trimethoprim-resistant S. aureus (MIC 0.25 ?g/mL)', '', 'Structure-based design of new dihydrofolate reductase antibacterial agents: 7-(benzimidazol-1-yl)-2,4-diaminoquinazolines', 24428639),
('Antibacterial Chemical Compound', 'suramin', '', '', 'Suramin is a potent and selective inhibitor of Mycobacterium tuberculosis RecA protein and the SOS response: RecA as a potential target for antibacterial drug discovery.', 24722837),
('Antibacterial Chemical Compound', '6?-amino-6?-N-[(S)-4-amino-2-hydroxybutyryl]-6?-deoxyarbekacin (6o)', 'antibacterial activity against S. aureus', '', 'Synthesis and antibacterial activity of 4? or 6?-alkanoylamino derivatives of arbekacin.', 25990952),
('Antibacterial Chemical Compound', 'HMR 3647 a new ketolide', 'potent activity against erythromycin susceptible and resistant pathogens, including penicillin G/erythromycin A-resistant S. pneumoniae and H. influenzae.', '', 'Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. In the search for new ketolides with improved activities against erythromycin-resistant S. pneumoniae and H. influenzae we synthesized a new 11,12 carbamate ketolide substituted by an imidazo-pyridyl side chain: HMR 3647.', 10560728),
('Antibacterial Chemical Compound', '4''''-O-carbamoyl erythromycin-A derivatives', 'Derivatives 4c-4e and 4g had most potent activity against all the tested erythromycin-susceptible strains, derivatives 4e and 4g were the most effective against erythromycin-resistant S. pneumoniae encoded by the mef gene (0.25 and 0.25 microg/mL), derivatives 4a and 4b exhibited significantly improved activity against erythromycin-resistant S. pneumoniae encoded by the erm gene.', '', 'Synthesis and antibacterial activity of novel 4''''-O-carbamoyl erythromycin-A derivatives', 20803622),
('Antibacterial Chemical Compound', 'N-[2-(coumarin-3-yl)-2-oxoethyl]ciprofloxacin derivative (compound 8b)', 'antibacterial activity against some gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA)', '', 'Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety', 18072241),
('Antibacterial Chemical Compound', '4?-glycyl linked quinolyl-azithromycins', 'Post potent derivatives have activity against Moraxella catarrhalis, inducibly MLSB resistant Staphylococcus aureus, clinically important respiratory tract pathogens, including erythromycin-susceptible and MLSB resistant strains of Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae', '', 'Synthesis and antibacterial evaluation of novel 4?-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.', 26860929),
('Antibacterial Chemical Compound', 'macrocyclic ?-hairpin-shaped peptidomimetics', 'Activity against Pseudomonas aeruginosa', '', 'Synthesis and antimicrobial activity against Pseudomonas aeruginosa of macrocyclic ?-hairpin peptidomimetic antibiotics containing N-methylated amino acids', 27240465),
('Antibacterial Chemical Compound', 'RP60556A, benzo[b]naphthyridones compound', 'bactericidal multiresistant Staphylococcus aureus', '', 'Synthesis and biological evaluation of benzo[b]naphthyridones, a series of new topical antibacterial agents.', 11294391),
('Antibacterial Chemical Compound', 'indole core-based derivatives', 'in vitro inhibition of different Gram-positive bacteria, Gram-negative and multi drug resistant pathogens', '', 'Synthesis and biological evaluation of indole core-based derivatives with potent antibacterial activity against resistant bacterial pathogens. The emergence of drug resistance in bacterial pathogens is a growing clinical problem that poses difficult challenges in patient management.', 28465626),
('Antibacterial Chemical Compound', 'quinolone (S)-9-fluoro-10-(4-hydroxypiperidin-1-yl)-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxaz ino[2,3,4-ij]quinoline-6-carboxylic acid L-arginine tetrahydrate', 'Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolates, penicillin-resistant Streptococcus pneumoniae clinical isolates, and Streptococcus pyogenes', '', 'Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.', 26238324),
('Antibacterial Chemical Compound', '3-O-chlorobenzyl (3-O-arylalkyl-2,6-difluorobenzamide derivatives)', '3-O-chlorobenzyl derivative 36 was the most effective in antibacterial activity (0.5, 4, and 8 ?g/mL) against Bacillus subtilis ATCC9372, methicillin-resistant Staphylococcus aureus ATCC29213, and penicillin-resistant Staphylococcus aureus PR, while 3-O-methylbenzyl derivative 41 only exhibited the most potent activity (2 ?g/mL) against Staphylococcus aureus ATCC25923.', '', 'Synthesis and Biological Evaluation of Novel FtsZ-targeted 3-arylalkoxy-2,6-difluorobenzamides as Potential Antimicrobial Agents', 26348110),
('Antibacterial Chemical Compound', 'Rhodanine derivatives bearing a quinoline moiety (6a-h, 7a-g, and 8a-e)', 'The most effective derivative has minimum inhibitory concentration (MIC) values of 1 ?g/mL against multidrug-resistant Gram-positive organisms, including methicillin-resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA, respectively)', 'compounds 6g, 7g and 8e exhibited in vitro antibacterial activity at non-cytotoxic concentrations.', 'Synthesis and biological evaluation of rhodanine derivatives bearing a quinoline moiety as potent antimicrobial agents.', 23787100),
('Antibacterial Chemical Compound', 'Dibasic tetrahydropyran-based compounds', 'potent inhibitors of both DNA gyrase and topoisomerase IV, displaying antibacterial activities against Gram-positive and Gram-negative pathogens (Staphylococcus aureus, Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii)', '', 'Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.', 28406300),
('Antibacterial Chemical Compound', '5''''-modified neomycin derivatives', '', '', 'Synthesis and combinational antibacterial study of 5''''-modified neomycin. A library of 5''''-modified neomycin derivatives were synthesized for an antibacterial structure-activity optimization strategy.', 19629142),
('Antibacterial Chemical Compound', '2-acetamido-2-deoxy-?-D-glucopyranosyl N,N-dimethyldithiocarbamate (OCT313, Glc-NAc-DMDC) and its derivatives', 'Glc-NAc-pyrrolidine dithiocarbamate (OCT313HK, Glc-NAc-PDTC) exhibited the most potent anti-tubercular activity with the minimal inhibitory concentration (MIC) of 6.25-12.5 ?g/ml.', '', 'Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives', 21232949),
('Antibacterial Chemical Compound', 'Galf N,N-didecyl sulfenamide 8d', '(MIC) of 1 microg/mL in a cell based assay against a representative strain of Mycobacterium smegmatis', '', 'Synthesis and evaluation of galactofuranosyl N,N-dialkyl sulfenamides and sulfonamides as antimycobacterial agents', 17303419),
('Antibacterial Chemical Compound', '4,4''-bis-[2-(6-N-substituted-amidino)indolyl] diphenyl ether', 'Activity against drug resistant bacterial strains MRSA, MRSE and VRE', '', 'Synthesis and in vitro activity of dicationic indolyl diphenyl ethers as novel potent antibiotic agents against drug-resistant bacteria.', 28109787),
('Antibacterial Chemical Compound', '5-hydroxy-5-trifluoromethyl-4,5-dihydro-1H-1-(isonicotinoyl)-pyrazole (2a) and 5-hydroxy-3-(4-methylphenyl)-5-trifluoromethyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazole (2d)', 'Inhibitors of mycolic acid biosynthesis, active against susceptible M. tuberculosis and several INH-resistant strains', '', 'Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles', 18571384),
('Antibacterial Chemical Compound', '1-(4-fluorophenyl)-3-(4-{1-[(pyridine-4-carbonyl)-hydrazono]ethyl}phenyl)thiourea (4d)', 'minimum inhibitory concentration of 0.49 microM against M. tuberculosis H37Rv and INH-resistant M. tuberculosis.', '', 'Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea', 16303302),
('Antibacterial Chemical Compound', 'oxazolidinone-class antimicrobial agents with 5-substituted octahydrocyclopenta[c]pyrrole moieties at the C-ring of linezolid and an acetamide or 1,2,3-triazole ring as the C-5 side chain of the oxazolidinone ring', 'Active against some resistant Gram-positive and -negative bacteria, derivatives like endo-alcohol 2a and exo-alcohol 2b showed potent inhibitory activity against M. tuberculosis H37Rv, several analoguess showed potent in vitro antibacterial activity against vancomycin-resistant bacteria and s linezolid-resistant methicillin-resistant Staphylococcus aureus (MRSA) strains.', '', 'Synthesis and in vitro evaluation of the antitubercular and antibacterial activity of novel oxazolidinones bearing octahydrocyclopenta[c]pyrrol-2-yl moieties.', 25297523),
('Antibacterial Chemical Compound', '1,2-disubstituted-1H-benzimidazole-N-alkylated-5-carboxamidine derivatives', 'Derivatives with 3,4-dichloro substituted phenyl at the position C-2, of N-bulky alkyl substituted benzimidazolecarboxamidines exhibited the greatest activity with MIC values of 1.56-0.39 microg/ml.', '', 'Synthesis and potent antibacterial activity against MRSA of some novel 1,2-disubstituted-1H-benzimidazole-N-alkylated-5-carboxamidines.', 15992965),
('Antibacterial Chemical Compound', '4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides', 'Highest antibacterial activity was achieved with with MIC values of 3.12 microg/mL against S. aureus, MRSA and MRSE', '', 'Synthesis and potent antimicrobial activity of some novel 4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides.', 15476288),
('Antibacterial Chemical Compound', '[1-(2,4-dichlorobenzyl)-N- (2-diethylaminoethyl)-1H-benzimidazole-5-carboxamidine], with a 3,4-dichlorophenyl group at the C-2 position', 'MIC = 3.12 microg/mL against both some bacteria and the fungus C. albicans', '', 'Synthesis and potent antimicrobial activity of some novel N-(alkyl)-2-phenyl-1H-benzimidazole-5-carboxamidines. A series of 22 novel 1,2-disubstituted-1H-benzimidazole-N-alkylated-5- carboxamidine derivatives were synthesized and evaluated for in vitro antibacterial activity against S. aureus and methicillin resistant S. aureus (MRSA), E. coli, E. faecalis and for antifungal activity against C. albicans.', 18007533),
('Antibacterial Chemical Compound', '1H-benzimidazolecarboxamidines', 'The most potent compound (32) has minimal inhibitory concentrations value 0.78 ?g/mL).', '', 'Synthesis and potent in vitro activity of novel 1H-benzimidazoles as anti-MRSA agents.', 22497759),
('Antibacterial Chemical Compound', '1beta-methyl-2-(naphthosultamyl)methyl-carbapenems (L-786,392)', 'potent anti-MRSA activity', '', 'Synthesis and properties of 2-(naphthosultamyl)methyl-carbapenems with potent anti-MRSA activity: discovery of L-786,392. A series of 1beta-methyl-2-(naphthosultamyl)methyl-carbapenems bearing dicationic groups on the naphthosultamyl moiety was prepared and evaluated for activity against resistant gram-positive bacteria.', 10201828),
('Antibacterial Chemical Compound', 'dicationic diaryl ethers', 'The most potentcompound had anti-MRSA MIC value of 0.06 microg/mL', '', 'Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents', 19589676),
('Antibacterial Chemical Compound', '2-pyridones (pyrido[1,2-alpha]pyrimidine and quinolizine)', 'DNA gyrase inhibitor', '', 'Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents. Two novel series of 2-pyridones were synthesized by transposition of the nitrogen of 4-quinolones to the bridgehead position.', 8759628),
('Antibacterial Chemical Compound', '7-[(3S,4R)-4-(1-aminocyclopropan-1-yl)-3-fluoropyrrolidin-1-yl] derivative 3 (=DQ-113)', 'Activity against clinically isolated resistant pathogens', '', 'Synthesis and structure-activity relationships of 5-amino-6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic acid antibacterials having fluorinated 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] substituents.', 12620077),
('Antibacterial Chemical Compound', 'lincomycin analogs modified at the 6- and 7-positions', 'antibacterial activity against different bacteria', '', 'Synthesis and structure-activity relationships of novel lincomycin derivatives', 28559581),
('Antibacterial Chemical Compound', '2''''-amino-2''''-deoxyarbekacin', 'Active against methicillin-resistant Staphylococcus aureus', '', 'Synthesis of 2''''-amino-2''''-deoxyarbekacin and its analogs having potent activity against methicillin-resistant Staphylococcus aureus. Based on our studies on the enzymatic modifications of arbekacin by methicillin-resistant Staphylococcus aureus (MRSA), replacement of the 2''''-hydroxyl group by an amino group in arbekacin was designed to synthesize derivatives that would be active against MRSA. 2''''-Amino-2''''-deoxyarbekacin and five analogs were synthesized starting from dibekacin.', 8071128),
('Antibacterial Chemical Compound', 'T-3761, a new fluoroquinolone', 'The MIC against methicillin-susceptible Staphylococcus aureus, methicillin-susceptible and -resistant Staphylococcus epidermidis, and Clostridium spp were 0.39 to 6.25 micrograms/ml, aginst streptococci and enterococci tested were 3.13 to 100 micrograms/ml', '', 'T-3761 had a broad spectrum of activity and had potent activity against gram-positive and -negative bacteria.', 1332594),
('Antibacterial Chemical Compound', 'T-3912, a novel non-fluorinated topical quinolone', 'in vitro activity of T-3912 against methicillin-susceptible Staphylococcus aureus, ofloxacin-resistant and methicillin-resistant S. aureus, Staphylococcus epidermidis, ofloxacin-resistant S. epidermidis, penicillin-resistant Streptococcus pneumoniae and Propionibacterium acnes was four-fold to 16 000-fold greater than that of other agents at the MIC90 for the clinical isolate', '', 'T-3912 exhibited more potent bactericidal activity against S. aureus and P. acnes than nadifloxacin and clindamycin in a short time period.', 11864945),
('Antibacterial Chemical Compound', 'TP-434, a novel fluorocycline', 'MIC of TP-434 (0.063 ?g/ml), potent inhibition in E. coli in vitro transcription/translation (50% inhibitory concentration [IC(50)] = 0.29 ? 0.09 ?g/ml) and [(3)H]tetracycline ribosome-binding competition (IC(50) = 0.22 ? 0.07 ?M) assays.', '', 'Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic', 22354310),
('Antibacterial Chemical Compound', '2-hydroxy-N''-{[5-(2-nitrophenyl)-2-furyl]methylene}benzohydrazide (B8I-2)', 'inhibited intracellular growth of B. abortus 2308 in J774 macrophages at relatively low ?M concentrations.', '', 'Targeting bacterial virulence functions in order to disarm pathogens represents a promising alternative to classical antibiotic therapy.', 21173315),
('Antibacterial Chemical Compound', 'tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide (THPP) and N-benzyl-6'',7''-dihydrospiro[piperidine-4,4''-thieno[3,2-c]pyran] (Spiro) analogues', 'reduce >2 logs bacterial cfu counts in the lungs of infected mice', '', 'Tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-benzyl-6'',7''-dihydrospiro[piperidine-4,4''-thieno[3,2-c]pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3', 23613759),
('Antibacterial Chemical Compound', 'ketolides (6-O-methyl-3-oxoerythromycin derivatives)', 'active against penicillin/erythromycin-resistant pneumococci and noninducers of MLSB resistance', '', 'The 11,12-substituted ketolide 61 (HMR 3004) demonstrated a potent activity against multiresistant pneumococci associated with a well-balanced activity against all bacteria involved in respiratory infections including H. influenzae, Mycoplasma catarrhalis, group A streptococci, and atypical bacteria. In addition HMR 3004 displayed high therapeutic activity in animals infected by all major strains, irrespective of their resistance phenotype.', 9767644),
('Antibacterial Chemical Compound', '8-substituted-9,1-[(N-methylimino)methano]- 7-fluoro-5-oxo-5H-thiazolo[3,2-alpha]-quinoline-4-carboxylic acids 5a-q', 'Active against methicillin-resistant Staphylococcus aureus isolates (MRSA)', '', 'The 8-(4-alkyl-1-piperazinyl) derivatives 5g, 5h, 5j, and 5n provided good oral efficacy and exhibited more potent activity than ofloxacin (6) against the systematic infection with S. aureus IID 803 in mice.', 8126698),
('Antibacterial Chemical Compound', 'FK037', 'MIC90s: Streptococcus pyogenes (0.012 ?g/ml), Escherichia coli (0.05 ?g/ml ), Streptococcus pneumoniae (0.1 ?g/ml), Klebsiella pneumoniae (0.39 ?g/ml)', '', 'The advantages of in vitro activity of FK037 were as follows: (1) a broad-spectrum antibacterial activity, (2) the most potent activity (MIC90: 25 micrograms/ml) of the cephalosporins tested against highly methicillin-resistant Staphylococcus aureus (H-MRSA), (3) a strong activity against Enterobacter spp. and Citrobacter freundii resistant to the third-generation cephalosporins tested.', 8205935),
('Antibacterial Chemical Compound', 'teicoplanin and caffeic acid phenethyl ester (CAPE)', '', '', 'The combination of an antioxidant / anti-inflammatory agent, CAPE, added to standard antibiotic therapy might be effective in the treatment of post-sternotomy mediastinitis due to MRSA. DOI: 10.1179/joc.2006.18.3.268', 17129837),
('Antibacterial Chemical Compound', 'combination of nebulized sodium nitrite and colistimethate', '', 'Sodium nitrite has antimicrobial properties and has been tolerated as a nebulized compound at high concentrations in human subjects with pulmonary hypertension', 'The combination of nebulized sodium nitrite and colistimethate may provide a novel therapy for chronic P. aeruginosa airway infections, because sodium nitrite, unlike other antibiotic respiratory chain "poisons," can be safely nebulized at high concentration in humans. .', 25229185),
('Antibacterial Chemical Compound', 'tobramycin-fumarate combination', 'Enhanced killing of up to 6 orders of magnitude of P. aeruginosa persisters over a range of CF isolates, including mucoid and nonmucoid strains, was observed for the tobramycin-fumarate combination compared to killing with tobramycin alone. Furthermore, significant fumarate-mediated potentiation was seen in the presence of azithromycin or CF patient sputum.', 'Fumarate also reduced the cytotoxicity of tobramycin-treated P. aeruginosa to human epithelial airway cells.', 'The combination of the aminoglycoside tobramycin with fumarate as an antibacterial potentiator utilizes an antipersister strategy that is aimed at reducing recurrent Pseudomonas aeruginosa infections by enhancing the killing of P. aeruginosa persisters.', 28923873),
('Antibacterial Chemical Compound', 'PC190723, synthetic antibacterials', 'efficacious in an in vivo model of infection,', '', 'The data validate FtsZ as a target for antibacterial intervention and identify PC190723 as suitable for optimization into a new anti-staphylococcal therapy.', 18801997),
('Antibacterial Chemical Compound', '1,3-benzoxazol-2(3H)-one derivatives', 'antibiofilm activity against Pseudomonas aeruginosa PA01', '', 'The discovery that many bacteria use quorum sensing (QS) to regulate their virulence factor and pathogenicity production makes the QS system an attractive target for antimicrobial therapy.', 22588631),
('Antibacterial Chemical Compound', 'N-thiolated ?-lactams', 'N-thiolated ?-lactams are FAS-inhibiting antimicrobials', 'No reported toxicity.', 'The impact of fatty acids on the antibacterial properties of N-thiolated ?-lactams. Bacterial fatty acid synthesis (FAS) is a potentially important, albeit controversial, target for antimicrobial therapy.', 21821415),
('Antibacterial Chemical Compound', 'BO-2727, new carbapenem', 'MIC90 ? 0.5 microgram/ml against methicillin-susceptible staphylococci and streptococci, 4 to 8 micrograms/ml Against methicillin-resistant staphylococci, 0.006 to 2 micrograms/ml against members of the family Enterobacteriaceae, Haemophilus influenzae, and Moraxella catarrhali, 2 micrograms/ml against Pseudomonas aeruginosa (imipenem-susceptible strains)', '', 'The in vivo efficacy of BO-2727 against experimental septicemia caused by gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus and imipenem-resistant P. aeruginosa, reflected its potent in vitro activity and high levels in plasma.', 7625784),
('Antibacterial Chemical Compound', 'S-4661', 'MIC90 0.5 ?g/ml or less against methicillin-susceptible staphylococci and streptococci, 8 ?g/ml against imipenem-resistant Pseudomonas aeruginosa', '', 'The in vivo efficacy of S-4661 against experimentally induced infections in mice caused by gram-positive and gram-negative bacteria, including penicillin-resistant Streptococcus pneumoniae and drug-resistant P. aeruginosa, reflected its potent in vitro activity and high levels in plasma in mice.', 9449267),
('Antibacterial Chemical Compound', 'berberine and 5''-methoxyhydnocarpin (5''-MHC)', '', '', 'The inhibitor was identified as 5''-methoxyhydnocarpin (5''-MHC), previously reported as a minor component of chaulmoogra oil, a traditional therapy for leprosy.', 10677479),
('Antibacterial Chemical Compound', 'antibiotics in combination with silver nanoparticles', '', '', 'The majority of synergistic effects were observed for combinations of AgNPs given together with gentamicin, but the highest enhancement of antibacterial activity was found with combined therapy together with penicillin G against Actinobacillus pleuropneumoniae.', 26832810),
('Antibacterial Chemical Compound', 'benzo[b]thiophene-2-boronic acid', 'inhibitors of AmpC beta-lactamase', '', 'The most potent of these compounds, benzo[b]thiophene-2-boronic acid , has an affinity for E. coli AmpC of 27 nM.', 9804697),
('Antibacterial Chemical Compound', 'MUT056399', 'active against methicillin-susceptible and resistant S. aureus , linezolid-resistant, and multidrug-resistant strains, with MIC(90)s between 0.03 and 0.12 ?g/ml; and MIC(90)s between 0.12 and 4 ?g/ml against coagulase-negative staphylococci, with', '', 'The MUT056399 inhibitor of FabI is a new antistaphylococcal compound.', 21825292),
('Antibacterial Chemical Compound', 'BO-3482, a novel dithiocarbamate carbapenem', 'Active against methicillin-resistant Staphylococcus aureus', '', 'The potent in vivo activity of BO-3482-cilastatin against such MRSA infections can be ascribed to the good in vitro anti-MRSA activity and improved pharmacokinetics in mice when BO-3482 is combined with cilastatin and to the bactericidal nature of the carbapenem.', 9333062),
('Antibacterial Chemical Compound', 'LY333328', 'MIC90 2 microg/ml in Mueller-Hinton II (MH II) broth and 1 microg/ml in brain heart infusion (BHI) broth', '', 'The prolonged PAE of LY333328, a potent new bactericidal glycopeptide, and its synergy with ampicillin in a large proportion of strains suggest that further evaluation of this drug in pharmacokinetic studies and experimental infections, including those with VRE, is warranted.', 9756756),
('Antibacterial Chemical Compound', 'combinations of SIPI-8294 and ?-lactam antibiotics', '', '', 'The research indicates that it may be a promising strategy for combating MRSA infections with the combinations of SIPI-8294 and ?-lactam antibiotics.', 27173151),
('Antibacterial Chemical Compound', 'coumermycin', 'Active against methicillin-resistant strains of Staphylococcus aureus', '', 'The results indicate that coumermycin is potent against MRSA with activity equal or superior to comparable agents in various experimental mouse infections.', 3492342),
('Antibacterial Chemical Compound', 'benzimidazole Y-754', 'The minimum inhibitory concentration of Y-754 against H. pylori, at 0.025 microg/ml', '', 'The results obtained lead to the expectation that the new benzimidazole Y-754 will, in the near future, be used for H. pylori eradication therapy in peptic ulcer patients.', 15160301),
('Antibacterial Chemical Compound', 'Cefepime', 'Cefepime 2 g every 12 hours', 'only 3% of patients in each group discontinued therapy because of an adverse event. The most common adverse events were headache, diarrhea, nausea, vomiting, pruritus, and rash.', 'The results of this study indicate that cefepime is a promising, effective, and safe single-agent therapy for serious infections in hospitalized patients.', 8678098);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Chemical Compound', '?-Ag 2 MoO 4 microcrystals', 'The silver molybdate was obtained by the conventional hydrothermal method, and the structural, vibrational and morphological properties of the sample were determined using X-ray diffraction, Raman spectroscopy and scanning electron microscopy images.these silver molybdates present a clinically relevant antibacterial activity and enhanced the antibiotic activity of some antibiotics against MDR strain of S. aureus and E. coli, being an interesting alternative to combat antibiotic-resistant bacterial infectious agents.', '', 'The reversion of antibiotic resistance by combinations with Ag2MoO4 could be a novel strategy to combat infections caused by multiple drug resistance (MDR) pathogens.', 28006749),
('Antibacterial Chemical Compound', 'tobramycin', 'Eighty milligrams of a tobramycin solution were inhaled twice daily after physiotherapy via a jet nebulizer.', 'No evidence of ototoxicity or renal damage was observed.', 'The study demonstrates the safety and clinical efficacy of long-term tobramycin aerosol therapy.', 2494640),
('Antibacterial Chemical Compound', '12-oxime and O-oxime ether derivatives of dehydroabietic acid', 'The most potent derivative has MIC of 0.39-0.78?g/mL against S. aureus Newman, some others have MIC values 1.25-3.13?g/mL aginst multidrug-resistant S. aureus', '', 'The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12.', 27777007),
('Antibacterial Chemical Compound', 'third-generation P-glycoprotein inhibitor tariquidar', 'addition of tariquidar resulted in a 10-fold reduction of the ciprofloxacin MIC Staphylococcus aureus 1199B (SA1199B)', '', 'The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance by increasing intracellular drug concentration.', 21393173),
('Antibacterial Chemical Compound', 'titanium dioxide (TiO2)', 'Strain: methicillin resistant Staphylococcus aureus (MRSA 27065)', '', 'The TiO(2) coating with integrated copper ions could offer a new strategy for preventing implant-associated infections, with antibacterial properties not only against the most common bacteria causing implant infections but also against multiresistant strains such as MRSA.', 21188483),
('Antibacterial Chemical Compound', 'isosorbide mononitrate (ISMN)', 'Specifically, exposure to ISMN significantly enhanced the efficacy of ciprofloxacin by reducing the number of CFU (~3log10 or ~2log10) of biofilm-associated and planktonic bacteria respectively, compared to drug alone.', 'NA', 'The use of nitric oxide (NO), a naturally occurring antimicrobial agent, as an alternative strategy to combat bacterial biofilms has recently gained considerable momentum in light of the global threat of emerging antibiotic resistance.', 29305985),
('Antibacterial Chemical Compound', 'verapamil and Q203 combinations', '', '', 'Therefore, the combination of verapamil and Q203 may be a promising combinatorial strategy for anti-TB treatment to accelerate the elimination of M. tuberculosis.', 28416541),
('Antibacterial Chemical Compound', 'liposomal BiEDT-tobramycin (LipoBiEDT-TOB)', 'MIC of LipoBiEDT-TOB (0.25mg/L vs. 1024 mg/L). At 4 mg/L vs. 4096 mg/L eradicated highly resistant P. aeruginosa (PA-48913)', 'LipoBiEDT-TOB was significantly less toxic when compared to the free BiEDT, as evaluated by the MTT and LDH assay.', 'These data suggest that the novel LipoBiEDT-TOB drug delivery system could be utilized as a new strategy to enhance the efficacy of existing antibiotics against resistant organisms that commonly affect individuals with chronic lung infections.', 18448284),
('Antibacterial Chemical Compound', 'titanium dioxide (TiO2)', '', '', 'These findings suggest the created materials with high bacterial interaction ability might be a useful strategy to improve the antimicrobial activity of visible-light-activated TiO2.', 19272171),
('Antibacterial Chemical Compound', 'psammaplin A analogue', 'active against methicillin-resistant Staphylococcus aureus (MRSA)', '', 'These psammaplin A analogues were screened directly against various gram positive bacterial strains leading to the discovery of a series of potent antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA).', 11686609),
('Antibacterial Chemical Compound', 'GAR-936, new glycylcycline', 'MIC against different bacteria: Streptococcus pneumoniae (MIC90, 0.03 ?g/ml), Enterococcus spp. (MIC90, 0.12 or 0.25 ?g/mL), Staphylococcus aureus (MIC50 0.25 ?g/mL), Acinetobacter spp. (MIC90, 2 ?g/mL), Stenotrophomonas maltophilia (MIC90, 4 ?g/mL), Pseudomonas aeruginosa (MIC50, 8 ?g/mL), Haemophilus influenzae (MIC90, 1-2 ?g/mL), Moraxella catarrhalis (MIC90, 0.12 ?g/mL), and various Neisseria spp. (MIC90, 0.12-0.5 ?g/mL)', '', 'These results indicate that GAR-936 has potent in vitro activity against a wide range of clinically important pathogenic bacteria, and that several gram-positive and -negative isolates resistant to older tetracyclines and other drug classes remain susceptible to GAR-936, the newest glycylcycline candidate for clinical use.', 10744364),
('Antibacterial Chemical Compound', 'tannic acid', 'The MICs of EtBr and antibiotics were significantly reduced in the presence of tannic acid, inhibition against the efflux pumps of both strains with a three-fold reduction of the MIC. Bacteria : Staphylococcus aureus', 'NA', 'These results indicate the possible usage of tannic acid as an adjuvant in antibiotic therapy against multidrug resistant bacteria (MDR).', 27057677),
('Antibacterial Chemical Compound', 'tannic acid', 'The MICs of EtBr and antibiotics were significantly different in the presence of tannic acid, indicating the inhibitory effect of this product against efflux pumps of both strains.', '', 'These results indicate the possible usage of tannic acid as an inhibitor and an adjuvant in the antibiotic therapy against multidrug resistant bacteria (MDR). Copyright ? 2017 Elsevier Inc.', 28841421),
('Antibacterial Chemical Compound', 'CS-834, a new oral carbapenem which is an ester-type prodrug of R-95867', 'bactericidal activity against Staphylococcus aureus and Escherichia coli.', '', 'These results suggest that CS-834 may be effective in the therapy of various bacterial infections.', 9818740),
('Antibacterial Chemical Compound', 'Gallium Citrate', 'MIC against K. pneumoniae ranged from 0.125 to 2.0 ?g/ml GaCi.', '', 'These results suggest that with more preclinical testing, a topical application of GaCi may be a promising alternative treatment strategy for K. pneumoniae SSTI.', 26239978),
('Antibacterial Chemical Compound', 'methyl-1,4-hydroquinone and 2,3-dimethyl-1,4-hydroquinone analogues synthesized by amination with amino-?-lactam structures', 'inhibited the growth of several Gram-positive bacterial strains including multidrug-resistant Staphylococcus aureus and Enterococci', '', 'Thirty-eight potential 1,2- and 1,4-hydroquinoid laccase substrates were screened for their antibacterial and cytotoxic activity to select the best substrates for laccase-catalyzed coupling reaction resulting in potent antibacterial derivatives.', 26780358),
('Antibacterial Chemical Compound', 'AU-FQ hybrid compound 251D (anilinouracils (AUs) such as 6-(3-ethyl-4-methylanilino)uracil (EMAU) and fluoroquinolones)', 'active against a broad panel of antibiotic-resistant gram-positive pathogens as well as several gram-negative organisms', 'lacked toxicity in vitro', 'This class of AU-FQ hybrids provides a promising new pharmacophore with an unusual dual mechanism of action and potent activity against antibiotic-sensitive and -resistant gram-positive pathogens.', 17074800),
('Antibacterial Chemical Compound', 'SYN987, SYN1193, and SYN1253', 'Active against streptococci (including penicillin resistant Streptococcus pneumoniae), enterococci and Staphylococcus aureus', '', 'This study demonstrates that SYN 987, 1193 and 1253 are extremely potent antibacterial agents which deserve further evaluation.', 8537267),
('Antibacterial Chemical Compound', 'Azole drugs', 'MIC values of <0.2 and 0.3 micro M, respectively for the drugs econazole and clotrimazole', '', 'This suggests that azole drug therapy may provide a novel antibiotic strategy against strains of M. tuberculosis that have already developed resistance to isoniazid and other front-line drugs.', 12368427),
('Antibacterial Chemical Compound', 'Vertex aminobenzimidazole VT12-008911', 'MIC(50), MIC(90) and MIC range of VT12-008911 were 0.064, 0.125 and ?0.002-0.25 mg/L, respectively', '', 'Time-kill curve analysis showed that VT12-008911 exhibited potent time-dependent bactericidal activity, at or very close to the MIC, against N. gonorrhoeae.', 24651828),
('Antibacterial Chemical Compound', 'BB-3497, N-formyl-hydroxylamine derivative', 'Bacteriostatic, Activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis, some gram-negative bacteria.', '', 'To identify novel PDF inhibitors, we screened a metalloenzyme inhibitor library and identified an N-formyl-hydroxylamine derivative, BB-3497, and a related natural hydroxamic acid antibiotic, actinonin, as potent and selective inhibitors of PDF.', 11158755),
('Antibacterial Chemical Compound', 'propargyl-linked antifolates containing a key pyridyl substituent', 'Antibacterial activity against both methicillin-resistant S. aureus and S. pyogenes at MIC values below 0.1 ?g/mL', 'Minimal cytotoxicity against mammalian cells', 'Toward new therapeutics for skin and soft tissue infections: propargyl-linked antifolates are potent inhibitors of MRSA and Streptococcus pyogenes.', 22347365),
('Antibacterial Chemical Compound', 'SK&F 107647', 'up to 1000-fold reduction in the number of E. coli recovered from blood', 'hematoregulatory activities', 'Treatment of experimental gram-negative and gram-positive bacterial sepsis with the hematoregulatory peptide SK&F 107647.', 8537660),
('Antibacterial Chemical Compound', 'oxabicyclooctane-linked Novel bacterial topoisomerase inhibitors (NBTIs) with new tricyclic-1,5-naphthyridinone left hand side moieties', 'Compounds with a (R)-hydroxy-1,5-naphthyridinone moiety (7) showed potent antibacterial activity (e.g., Staphylococcus aureus MIC 0.25 ?g/mL), acceptable Gram-positive and Gram-negative spectrum with rapidly bactericidal activity.', '', 'Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety', 25851938),
('Antibacterial Chemical Compound', 'TXA497, guanidinomethyl biaryl compounds', 'Bactericidal against methicillin-resistant Staphylococcus aureus (MRSA)', '', 'TXA497 as a topical antibacterial agent: comparative antistaphylococcal, skin deposition, and skin permeation studies with mupirocin', 25263100),
('Antibacterial Chemical Compound', 'Guanylated polymethacrylates', 'kills C. albicans and S. aureus when applied to established polymicrobial biofilms.', '', 'We further compared guanylated polymethacrylates with first-line antistaphylococcal and anti-Candida agents used as combinatorial therapy against polymicrobial biofilms.', 26490013),
('Antibacterial Chemical Compound', 'TXA707, FtsZ-targeting agent', 'acts synergistically with ?-lactams', '', 'We have developed a promising new FtsZ-targeting agent (TXA707) with potent activity against MRSA isolates resistant to current standard-of-care antibiotics.', 28630190),
('Antibacterial Chemical Compound', 'synthetic oxazolidinones, U-100592 and U-100766', 'potent in vitro activity against Mycobacterium tuberculosis', '', 'We have prepared two potent, synthetic oxazolidinones, U-100592 and U-100766, which are currently in clinical development for the treatment of serious multidrug-resistant Gram-positive bacterial infections caused by strains of staphylococci, streptococci, and enterococci.', 8576909),
('Antibacterial Chemical Compound', 'halogenated quinoline (HQ)', 'potent antibacterial (MIC?0.39 ?m) and biofilm eradication (MBEC 1.0-93.8 ?m) activities against drug-resistant Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium strains', '<5 % haemolysis activity against human red blood cells (RBCs) at 200 ?m and low cytotoxicity against HeLa cells', 'We identified diverse analogues that are alkylated and aminated at the 2-position of the HQ scaffold and demonstrate potent antibacterial (MIC?0.39 ?m) and biofilm eradication (MBEC 1.0-93.8 ?m) activities against drug-resistant Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium strains while demonstrating <5 % haemolysis activity against human red blood cells (RBCs) at 200 ?m.', 27245927),
('Antibacterial Chemical Compound', 'geometrical isomers of a macrocyclic bis(bibenzyl) based on isoplagiochin', 'The isomer containing a 1,4-linked ring (5) showed only weak activity, whereas the isomers containing a 1,3-linked (6) or 1,2-linked (7) C ring showed potent anti-MRSA activity.', '', 'We synthesized three geometrical isomers of a macrocyclic bis(bibenzyl) based on isoplagiochin, a natural product isolated from bryophytes, and evaluated their antibacterial activity towards methicillin-resistant Staphylococcus aureus (anti-MRSA activity).', 25999206),
('Antibacterial Chemical Compound', 'XRP 2868, streptogramin', 'MIC50 0.25 ?/ml, MIC90 0.5 ?/ml for pneumococci; for beta-lactamase-positive, beta-lactamase-negative, and beta-lactamase-negative ampicillin-resistant strains MIC50 is 0.25 ?/ml and an MIC90 of 1.0 ?/ml', '', 'XRP 2868 showed potent activity against pneumococci and Haemophilus strains irrespective of their susceptibility to other agents.', 14506040),
('Antibacterial Chemical Compound', 'Combination therapy of Polymyxin B and non-antibiotics from various drug classes', 'Activity againt Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa', '', 'Alternative strategies to treat infectious diseases, such as combination therapy, are urgently needed.', 30240838),
('Antibacterial Chemical Compound', 'Schiff bases of 2-mercaptobenzimidazole were synthesized from 4-(2-(1H-benzo[d]- imidazol-2-ylthio)acetamido)benzohydrazide', 'Compounds 8 (MICpa, an = 2.41, 1.20 ?M/ml), 10 (MICse, sa = 2.50 ?M/ml), 20 (MICec = 2.34 ?M/ml) and 25 (MICca = 1.46 ?M/ml) showed significant antimicrobial activity against tested bacterial and fungal strains', '', 'In general, the synthesized derivatives exhibited moderate antimicrobial and anticancer activities.', 30306865),
('Antibacterial Chemical Compound', '2-chlorobenzyl sulfonamide 1,2,4-triazole 7c', 'Antibacterial activities against MRSA, B. subtilis, B. typhi and E. coli with MIC values of 0.02-0.16 micro mol/mL', '', 'CONCLUSION: Compound 7c could serve as a potential clinical antimicrobial candidate.', 30398118),
('Antibacterial Chemical Compound', 'Azithromycin with bis-2-aminoimidazole adjuvants', 'bis-2-AI exhibits a 1024-fold reduction in the minimum inhibitory concentration of azithromycin in vitro and displays activity in a Galleria mellonella model of infection', '', 'Herein, we describe a novel approach to combatting pseudomonal infections through the use of bis-2-aminoimidazole adjuvants that can potentiate the activity of a macrolide antibiotic commonly prescribed to CF patients as an anti-inflammatory agent.', 30444345),
('Antibacterial Chemical Compound', 'Hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold', 'The most potent derivative had MIC of 0.39-0.78 micro g/mL against S. aureus Newman and Escherichia coli AB1157 strain', '', 'Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents', 30447433),
('Antibacterial Chemical Compound', '4-oxoquinazolin-3(4H)-yl)benzoic acid and benzamide derivatives', 'Potent inhibitory activity against Staphylococcus aureus (MICs = 0.25-0.5 micro g/mL)', '', 'The interesting results obtained suggest the potential utility of the newly synthesized compounds for treatment of multidrug resistant S. aureus infections.', 30471579),
('Antibacterial Chemical Compound', 'Ebsulfur scaffold', 'The best, dose- and time-dependent inhibitor had an IC50 of 0.16 microM, IC50 value of the all compounds ranged from 0.16-9 microM', '', 'Ebsulfur as a potent scaffold for inhibition and labelling of New Delhi metallo-beta-lactamase-1 in vitro and in vivo.', 30502631),
('Antibacterial Chemical Compound', 'Nacubactam', 'MICs of nacubactum alone are in the range of 1-8 mg/L or >32 mg/L, enhance activity in antibiotic combination, activity against MBL-producing Enterobacteriaceae', '', 'Nacubactam combinations, including those using MBL-labile beta-lactams, e.g. meropenem and cefepime, can overcome most MBL-mediated resistance. This behaviour reflects nacubactam''s direct antibacterial and enhancer activity.', 30590470),
('Antibacterial Chemical Compound', '5-chloro-2-(4-chloro-3-methylphenyl)-4-methyl-3(2H)-isothiazolone (Compound 6) and 5-chloro-2-(4-chlorophenyl)-4-methyl-3(2H)-isothiazolone (Compound 7)', 'Potent and cidal activity against 46 different MDR Acinetobacter baumannii clinical isolates and reference strains', '. While cytotoxicity was observed with Compound 7', 'Identification and characterization of novel isothiazolones with potent bactericidal activity against multi-drug resistant Acinetobacter baumannii clinical isolates', 30593847),
('Antibacterial Chemical Compound', 'Metronidazole hybrid 6a : Sulfonamide-Derived Four-Component Molecular Hybrids', '(MIC) value of 0.019 mM against clinical drug-resistant Escherichia coli ( E. coli)', '', 'Novel sulfonamide-based four-component molecular hybrids as potential DNA-targeting antimicrobial agents were developed from marketed acetanilide through convenient procedures.', 30638386),
('Antibacterial Chemical Compound', '5-Arylideneimidazolones with Amine at Position 3', '4-32-fold reduction of oxacillin MIC in highly resistant MRSA HEMSA 5 strain with anthracene-morpholine derivative (16) being the most potent. Significant efflux pump inhibitor (EPI) properties, naphthyl-methylpiperazine derivative 9 showed the most potent "dual action" of both oxacillin adjuvant (MRSA) and EPI', '', '5-Arylideneimidazolones with Amine at Position 3 as Potential Antibiotic Adjuvants against Multidrug Resistant Bacteria', 30691112),
('Antibacterial Chemical Compound', 'Lipophilic Q203 derivatives', 'Show considerable potency against MTB H37Rv strain (MIC < 0.25 microM). Nine compounds (13, 15, 19, 21, 23, 25, 29, 35, 36) have excellent activity against both drug-sensitive and -resistant strains (MIC < 0.035 microM)', '', 'Especially, compound 29 also displays acceptable safety, greater absorption in plasma and aqueous solubility than Q203, suggesting its promising potential to be lead compound for future antitubercular drug discovery.', 30692025),
('Antibacterial Chemical Compound', '5-methoxy-2,3-naphthalimide derivatives', 'The most potent compound showed antimicrobial synergistic activity in combination with levofloxacin by 4 times and 16 times at the concentration of 8 and 16 microg/mL, respectively, and ould effectively abolish Nile Red efflux at 100 microM.', '', 'Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance', 30755336),
('Antibacterial Chemical Compound', 'Acyclic pyridine-containing ligands, H2dedpa and compound 8', 'Improved the activity of meropenem against E. coli harboring the blaNDM-4 gene by nearly 40,960 times. H2dedpa (IC50 = 0.17 ? 0.04 microM) and compound 8 (IC50 = 0.04 ? 0.02 microM) showed higher inhibitory activity against blaNDM-1 enzyme than the positive control ethylenediaminetetraacetic acid (EDTA, IC50 = 28.84 ? 0.70 microM)', '', 'H(2)depda: An acyclic adjuvant potentiates meropenem activity in vitro against metallo-beta-lactamase-producing enterobacterales.', 30776696),
('Antibacterial Chemical Compound', 'Mefloquine-Based Analogs', 'Displayed activity against sensitive Mycobacterium tuberculosis in vitro, with MIC values between 37.2 and 154.8 microM.', 'Low cytotoxicity', 'Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains', 30836914),
('Antibacterial Chemical Compound', 'IID572', 'Broad spectrum beta lactamase inhibitors of the diazabicyclooctane (DBO) class', '', 'IID572: A New Potentially Best-In-Class beta-Lactamase Inhibitor', 30861342),
('Antibacterial Chemical Compound', 'Sulfonium-vancomycin derivatives', 'Activity against some Gram-negative bacteria', '', 'Sulfonium, an Underestimated Moiety for Structural Modification, Alters the Antibacterial Profile of Vancomycin Against Multidrug-Resistant Bacteria', 30908776),
('Antibacterial Chemical Compound', 'Poly (acetyl, arginyl) glucosamine (PAAG)', 'Biofilms reduction of Burkholderia cepacia Complex at 50 to 200 microgram/ml', '', 'New therapeutic strategies targeting bacterial biofilms are anticipated to enhance antibiotic penetration and facilitate resolution of infection.', 30910901),
('Antibacterial Chemical Compound', 'Thiazolin-4-one derivatives', 'Activity against gram-positive and gram-negative bacteria.', '', 'Antioxidant activity and antibacterial evaluation of new thiazolin-4-one derivatives as potential tryptophanyl-tRNA synthetase inhibitors.', 30938216),
('Antibacterial Chemical Compound', 'Analogs of solithromycin synthesized using Cu(I)-mediated click chemistry', 'Potecy against resistant Staphylococcus aureus, Escherichia coli, and multidrug resistant pathogens Enterococcus faecium and Acinetobacter baumannii', '', 'Evaluation of the analogs using Minimum Inhibitory Concentration (MIC) assays against resistant Staphylococcus aureus, Escherichia coli, and multidrug resistant pathogens Enterococcus faecium and Acinetobacter baumannii showed they possess potencies similar to those of solithromycin, thus demonstrating their potential as future therapeutics to combat the existential threat of multidrug resistant pathogens.', 30962084),
('Antibacterial Chemical Compound', 'Arsinothricin', 'Broad-spectrum antibiotic against both Gram-positive and Gram-negative bacteria', '', 'Arsinothricin, an arsenic-containing non-proteinogenic amino acid analog of glutamate, is a broad-spectrum antibiotic', 30993215),
('Antibacterial Chemical Compound', 'Aryl isonitrile compound', 'Inhibited the growth of MRSA clinical isolates at 2-4microM', 'Non-toxic to human keratinocyte', 'An aryl isonitrile compound with an improved physicochemical profile that is effective in two mouse models of multidrug-resistant Staphylococcus aureus infection', 31051286),
('Antibacterial Chemical Compound', 'Phenylthiazoles : 2-thienyl derivative 20 and the hydroxyl-containing derivative 31', 'Inhibition of growth of drug-resistant Staphylococcus aureus at a concentration as low as 1 microgram/mL', '', 'Lipophilic efficient phenylthiazoles with potent undecaprenyl pyrophosphatase inhibitory activity', 31075608),
('Antibacterial Chemical Compound', 'Quinazolinone analogues', 'MIC value 15.625 microgram/mL against S. aureus and with MIC value 31.25 microgram/mL against MRSA', '', 'Design, synthesis, in-silico studies and biological screening of quinazolinone analogues as potential antibacterial agents against MRSA.', 31103406),
('Antibacterial Chemical Compound', '(5-aryloxy-pyrazolyl)- and (5-aryl/olefin-sulfanyl-pyrazolyl)-dibenzo[b,e] [1,4] diazepinone scaffolds', 'Compounds 25c and 29e, overall, registered good to moderate activity against A549 (lung), HeLa (cervix), SW1573 (lung) T-47D (breast) and WiDr (colon) cell lines, with GI50 values in the 2.6-5.1 microM and 1.8-7.5 microM ranges, respectively', '', 'Compounds reported in the present work revealed good antioxidant, antimicrobial and antiproliferative activities with promising FRAP (ferric reducing antioxidant power), bacterial resistance and human solid tumor cell growth inhibitory values, respectively.', 31127460),
('Antibacterial Chemical Compound', 'Cyclohexyl amide-based compounds', 'Suitable antibacterial activity against Gram-positive Staphylococcus aureus', '', 'Results: Described here is the synthesis and biological evaluation of a tiny series of new virtually assembled NBTIs containing synthetically feasible right-hand side fragments capable of binding the GyrA subunit of the bacterial DNA gyrase-DNA complex.', 31140866),
('Antibacterial Chemical Compound', 'Apo-transferrin', 'Inhibit in vitro growth of Klebsiella pneumoniae and Acinetobacter baumannii', '', 'Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria', 31170282),
('Antibacterial Chemical Compound', 's-triazine derivatives', 'Activity against multi-drug resistant (MDR) clinical isolates of Klebsiella pneumoniae and methicillin resistant Staphylococcus aureus', '', 'Compounds 3j and 6b were the most potent antibacterial agents against the tested strains and multi-drug resistant (MDR) clinical isolates of Klebsiella pneumoniae and methicillin resistant Staphylococcus aureus (MRSA1) with minimal toxicity in comparison to the reference drugs.', 31174040),
('Antibacterial Chemical Compound', 'Imidazo[1,2-b][1,2,4,5]tetrazines', 'The most prominent minimal inhibitory concentration on M. tuberculosis H37Rv was 1 microgram/ml', '', 'Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines', 31176094),
('Antibacterial Chemical Compound', 'Nebramine-cyclam conjugate', 'Potentiate beta-lactam antibiotics, as well as other legacy antibiotics, against P. aeruginosa in vitro', '', 'Development of a nebramine-cyclam conjugate as an antibacterial adjuvant to potentiate β-lactam antibiotics against multidrug-resistant P. aeruginosa.', 31420586),
('Antibacterial Chemical Compound', '1,4-Bis[((2-(3-acetyl-1-(4-nitrophenyl)-1H-pyrazole-4-yl)carbonyl) benzofuran-5-yl)methyl]piperazine', 'Compound 5e gave the best inhibitory activity with MIC/MBC values of 18.1/36.2, 9.0/18.1 and 18.1/18.1 ?M, respectively, against MRSA (ATCC:33591 and ATCC:43300) and VRE (ATCC:51575) bacterial strains, respectively and showed IC50 values of 3.0 ? 0.05, 3.2 ? 0.08 and 3.3 ? 0.07 microM against S. aureus, S. mutans and E. coli strains, respectively.', 'Showed better cytotoxic activities', 'Novel bis(pyrazole-benzofuran) hybrids possessing piperazine linker: Synthesis of potent bacterial biofilm and MurB inhibitors.', 32711085),
('Antibacterial Chemical Compound', 'Monosulfactam 0073', 'The monosulfactam 0073 showed promising antimicrobial activity against Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii isolates producing metallo-beta-lactamases (MBLs) and serine beta-lactamases', 'Compound 0073 exhibited safety both in vitro and in vivo In the murine thigh infection model and the pneumonia models in which infection was induced by P. aeruginosa and Klebsiella pneumoniae, 0073 significantly reduced the bacterial burden', 'Monosulfactam 0073 is a potential treatment for infections caused by beta-lactamase-producing multidrug-resistant bacteria.', 32718961),
('Antibacterial Chemical Compound', 'Eravacycline', 'MIC50/90 values were lowest for eravacycline (?0.0078/0.016 mg/L)', '', 'This study demonstrated potent in vitro activity of eravacycline against a large collection of clinical C. difficile strains', 32719870),
('Antibacterial Chemical Compound', '8-nitro-2-(4-((4-(trifluoromethoxy)benzylidene)amino)piperazin1-yl)-6-(tri-fluoromethyl)-4H-benzo[e][1,3]thiazin-4-one', 'It exhibit excellent activity against MTB H37Rv and MDR-MTB strains (MIC <0.029microM).', 'It shows low cytotoxicity in Vero cells (CC50: > 117.00)', 'Compound 1h displays good safety and pharmacokinetic profiles, suggesting its promising potential to be lead compound for future antitubercular drug discovery.', 32736151),
('Antibacterial Chemical Compound', 'Delafloxacin', 'MIC range, MIC50 and MIC90 for delafloxacin were 0.064 ? 32 mg/L, 0.56 mg/L and 2.19 mg/L, respectively against Cystic fibrosis Pseudomonas aeruginosa', '', 'Delafloxacin shows potential in treating ciprofloxacin-resistant P aeruginosa.', 32790867),
('Antibacterial Chemical Compound', '1-Cyclopropyl-7-((4-(2, 4-dimethylphenoxy)pyrimidin-2-yl) amino)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid', 'The most active B14 exhibited activities at submicromolar concentration (0.38microgram/mL)) against a panel of MRSA strains.', 'It also displayed highly selective toxicity toward bacterial cells and low hERG inhibition.', 'Design and synthesis of novel desfluoroquinolone-aminopyrimidine hybrids as potent anti-MRSA agents with low hERG activity.', 32891858),
('Antibacterial Chemical Compound', 'Globomycin analog, G0790', 'The MIC of G0790 was 4- to 8-fold lower than for the parent GBM against WT E. coli (CFT073), Enterobacter cloacae (ATCC 13047), and Klebsiella pneumoniae (ATCC 700603) strains', '', 'G0790, a new globomycin analog and potent inhibitor of the Escherichia coli type II signal peptidase LspA.', 32900806),
('Antibacterial Chemical Compound', 'Aspirin, sodium benzoate and sodium salicylate', 'The highest concentrations of SB, SS and AS decreased colistin MICs 2- to 4-fold for E. coli ATCC 25922 and K. pneumoniae ATCC 700603, whereas colistin MIC for P. aeruginosa ATCC 27853 was only decreased by 28 mM SS, by 2-fold', '', 'Sodium benzoate, sodium salicylate and aspirin are good enhancers to use in antibiotic therapies that include colistin', 32989461),
('Antibacterial Chemical Compound', 'Zidovudine', '', '', 'Zidovudine and tigecycline/colistin combinations achieved synergistic killing and significantly decreased bacterial burdens by >2.5-log10 CFU/g in thigh tissues compared to each monotherapy.', 33020156),
('Antibacterial Chemical Compound', '1-cyclopropyl-6-fluoro-7-(4-((6-methoxy-4-oxo-3,4- dihydroquinazolin-2-yl)methyl)piperazin-1-yl)-4-oxo1,4-dihydroquinoline-3-carboxylic acid (5d) AND 6-fluoro-1-(4-fluorophenyl)-7-(4-((6-methoxy-4-oxo3,4-dihydroquinazolin-2-yl)methyl)piperazin-1-yl)-4-\noxo-1,4-dihydroquinoline-3-carboxylic acid (5i)', 'Amongst all ciprofloxacin-derivatives, compound 5d was the most potent agent with high antibacterial activity against gram-positive bacteria, including MRSA and S. aureus ((minimum inhibitory concentration (MIC) = 16 nM for both), that is 60 times more potent than ciprofloxacin as parent drug. Compound 5i from sarafloxacin-derivatives was the most potent compound against MRSA and S. aureus (MIC = 0.125 microM).', '', 'Compound 5i from sarafloxacin-derivatives was the most potent compound against MRSA and S. aureus (MIC = 0.125 microM)', 33030668),
('Antibacterial Chemical Compound', '2,6-Difluoro-3-((3-(4-butylphenyl)-4,5-dihydroisoxazol-5-yl) methoxy)benzamide (A16)', 'Compound A16 was found to be most potent agent (MIC, 0.25?0.5 microgram/mL) against a variety of MDR S. aureus.', 'Besides, further mouse infection model revealed that A16 could be effective in vivo and non-toxic to Hela cells.', 'Design, synthesis of novel 4,5-dihydroisoxazole-containing benzamide derivatives as highly potent FtsZ inhibitors capable of killing a variety of MDR Staphylococcus aureus.', 33065440),
('Antibacterial Chemical Compound', 'PKZ18-22', 'The 8-microgram/ml MIC of PKZ18-22, in combination with gentamicin (approximately 20 microM), showed no cytotoxicity against eukaryotic cells and significantly lowered the effective dose of gentamicin', 'The analogs have reduced cytotoxicity against eukaryotic cells compared to PKZ18.', 'we show that novel analogs of PKZ18 have improved MICs, bactericidal effects against methicillin-resistant Staphylococcus aureus (MRSA), and increased efficacy in nutrient-limiting conditions', 33077662),
('Antibacterial Chemical Compound', 'Aryl sulfonyl hydrazones conjugated with 1,3-diaryl pyrazoles', 'The in vitro MBLs inhibition showed remarkable inhibition constant for most of the designed compounds at a low micromolar range (1.5-16.4 ?M) against NDM-1, IMP-1 and AIM-1 MBLs.', 'in vivo toxicity testing exhibited that the most active compound was non-toxic and well tolerated by the experimental animals orally up to 350 mg/kg and up to 125 mg/kg parenterally.', 'Design, synthesis, biological evaluation and in silico studies of certain aryl sulfonyl hydrazones conjugated with 1,3-diaryl pyrazoles as potent metallo-β-lactamase inhibitors.', 33137556),
('Antibacterial Chemical Compound', 'oxazolidinone derivatives with nitrogen-containing fused heterocyclic moiety', 'Compound 3b, which exhibited significant antibacterial activity with MIC values ranging 0.5-1.0 microgram/mL against MRSA, MSSA, LREF and VRE.', '', 'Most of them exhibited potent activity against Gram-positive pathogens comparable to Linezolid and Radezolid.', 33144245),
('Antibacterial Chemical Compound', 'CM13 and CM311', 'Two molecules, CM13 and CM311, inhibited ethidium bromide efflux in B. subtilis.', '', 'Using this methodology, we identified two novel inhibitors of BmrA from the Chemotheca small molecule library.', 33212311),
('Antibacterial Chemical Compound', 'Taniborbactam (VNRX-5133)', 'Taniborbactam at a fixed concentration of 4 mg/L was able to restore activity of cefepime in 24 of 26 Enterobacterales clinical isolates harbouring metallo-beta-lactamases with MIC50/MIC90 values of 14 mg/L.', '', 'The inhibition level of NDM enzymes provided by taniborbactam protects the antibacterial activity of cefepime from this important metallo-beta-lactamase.', 33246038),
('Antibacterial Chemical Compound', 'Adamantanol-containing indole-2-carboxamides analogues', 'Three adamantanol derivatives 8i, 8j and 8l showed nearly 2- and 4-fold higher activity (MIC = 1.32 - 2.89 ?M) than ethambutol (MIC = 4.89 ?M). The most potent adamantanol/adamantane-based indoleamides 8j/8k displayed a two-fold surge in potency against extensively DR (XDR) M. tb strains with MIC values of 0.66 and 0.012 ?M, respectively.', 'Remarkably, the most potent adamantanol analogue 8j demonstrated high selectivity towards DS and DR M. tb strains over mammalian cells [IC50 (Vero cells) ? 169 ?M], evincing its lack of cytotoxicity.', 'Overall, the observed antimycobacterial and physicochemical profiles support the notion that adamantanol moiety is a suitable replacement to the adamantane scaffold within the series of indole-2-carboxamide-based MmpL3 inhibitors.', 33276981),
('Antibacterial Chemical Compound', 'BNF15 ; benzonaphthofurandiones analogs', 'BNF15 showed promising effect against all drug-sensitive and drug-resistant M. tuberculosis (MIC: 0.02-0.78 microgram/ml).', 'In acute oral toxicity test, BNF15 did not show toxic effect at a concentration up to 2000 mg/kg.', 'These results highlight the perspective of BNF15 to treat drug-resistant M. tuberculosis.', 33295787),
('Antibacterial Chemical Compound', '22-[4-(4-((Adenine-9-yl)methyl)phenyl)-1H-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (Compound 35), (+)-pleuromutilin conjugates', 'Compound 35, bearing a para-benzyladenine substituent, proved particularly potent against USA300 and additional strains of MRSA', 'no cytotoxicity in four mammalian cell lines', 'Compound 35, bearing a para-benzyladenine substituent, proved particularly potent against USA300 and additional strains of MRSA and displayed as importantly no cytotoxicity in four mammalian cell lines.', 33325700),
('Antibacterial Chemical Compound', 'ridinilazole', 'All strains were susceptible to ridinilazole, with low MICs (0.03?0.25 mg/L).', '', 'Ridinilazole showed potent activity against a range of Asian C. difficile strains, which otherwise frequently displayed resistance to several comparator antimicrobial agents.', 33351917),
('Antibacterial Chemical Compound', 'diaryl-substituted thiosemicarbazone', '1c is the most potent inhibitor (IC50 = 0.038 ?M).', '', 'Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors.', 33383326),
('Antibacterial Chemical Compound', 'Isatin-nicotinohydrazide hybrids', 'Most derivatives exhibited excellent antibacterial activity. K. pneumonia emerged as the most sensitive strain with MIC range: 0.49-7.81 ?g/mL.', '', 'Development of novel isatin-nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing-bacteria.', 33406941),
('Antibacterial Chemical Compound', '5-nitrofurans', 'we showed that 5-nitrofurans, sodium deoxycholate and vancomycin interact synergistically in the growth inhibition of 15 out of 20 Gram-negative strains tested, including clinically significant pathogens such as carbapenemase-producing Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii, and interact indifferently against the Gram-positive strains tested.', '', 'Synergistic combinations of existing antimicrobials show promise due to their enhanced efficacies and reduced dosages which can mitigate adverse effects, and therefore can be used as potential antibacterial therapy.', 33448923),
('Antibacterial Chemical Compound', 'pyranoquinolinyl dihydropyridine carboxylate (PDC) derivatives', '', 'The cytotoxic assay of the PDC derivatives revealed minimal cytotoxicity towards L929 mouse fibroblasts cells at 25 microM concentration wherein the % Cell viability was found to be greater than 90.0% and moderate cytotoxicity at concentrations of at 50.0?100.0 microM', 'Design, synthesis, spectral characterization and molecular docking studies of novel pyranoquinolinyl dihydropyridine carboxylates as potential antibacterial agents including Vibrio cholerae with minimal cytotoxity towards fibroblast cell line (L-929).', 33450547),
('Antibacterial Chemical Compound', '6-fluorobenzo[d]isothiazol-3(2H)-one', 'It exhibited activity against A. baumannii ATCC19606 strain (minimal inhibitory concentration, MIC = 1 mg l-1). We identified the effect of 6D1 on enhancing the antibacterial activity of kanamycin and gentamicin, including against New Delhi metallo-beta-lactamase (NDM-1)-producing carbapenem-resistant Klebsiella pneumoniae.', '', 'we identified a small molecule that suppresses the growth of A. baumannii, interacts with hydroperoxide reductase from A. baumannii ATCC19606 plasmid pMAC, and enhances the antibacterial activity of kanamycin and gentamicin.', 33456052),
('Antibacterial Chemical Compound', 'UPAR415, Cyclopropane-Carboxylic Acid Derivative', '', '', 'Our results provide a robust proof of principle supporting OASS as a potential nonessential antibacterial target to develop a new class of adjuvants and the structural basis for further structure-activity relationship studies.', 33513010),
('Antibacterial Chemical Compound', '?-lactam-containing 5H-benzofuro [3,2-c]quinolin-6-ones', 'Compound 65 demonstrated potent activity against Mtb H37Rv with MIC value between 0.0313 and 0.0625 microgram/mL, with high selectivity to Vero cells (64-128 fold).', '', 'Compound 65 also showed excellent selectivity against actinobacteria and therefore unlikely to develop potential drug resistance to nonpathogenic bacteria.', 33516983),
('Antibacterial Chemical Compound', 'Ciprofloxacin derivatives', 'Isolated bacteria, from male and female patients, resist to ciprofloxacin were tested against synthesized compounds and showed a good effect against K. pneumoniae DF72F which isolated from drain fluid of 72 years old female.', '', 'Development of new derivatives of commercial antibiotics using different organic reagents and testing these derivatives against different microorganisms are the main goals of this article.', 33517003),
('Antibacterial Chemical Compound', 'Morpholine-Containing 5-Arylideneimidazolones derivatives', 'The 4-phenylbenzylidene derivative (15) demonstrated significant MDR-reversal "dual action" for beta-lactam antibiotics in MRSA and inhibited AcrAB-TolC in K. aerogenes.', '15 displayed also satisfied solubility and safety towards CYP3A4 in vitro.', 'In the search for an effective strategy to overcome antimicrobial resistance, a series of new morpholine-containing 5-arylideneimidazolones differing within either the amine moiety or at position five of imidazolones was explored as potential antibiotic adjuvants against Gram-positive and Gram-negative bacteria.', 33669790),
('Antibacterial Chemical Compound', 'N-(1,3,4-oxadiazol-2-yl)benzamides (HSGN-237 and -238)', 'We report the discovery of new N-(1,3,4-oxadiazol-2-yl)benzamides (HSGN-237 and -238) with highly potent activity against N. gonorrhoeae. Additionally, these new compounds were shown to have activity against clinically important Gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and Listeria monocytogenes (minimum inhibitory concentrations (MICs) as low as 0.25 ?g/mL)', 'Both compounds were highly tolerable to human cell lines.', 'Here, we report the discovery of new N-(1,3,4-oxadiazol-2-yl)benzamides (HSGN-237 and -238) with highly potent activity against N. gonorrhoeae.', 33671065),
('Antibacterial Chemical Compound', 'Tricyclic Benzo[1,3]oxazinyloxazolidinones', 'The studies identified a new compound 20aa that displayed good to excellent antibacterial and antitubercular profiles against drug-resistant TB strains (MIC = 0.48-0.82 microgram/mL), MRSA (MIC = 0.25-0.5 microgram/mL), MRSE (MIC = 1 microgram/mL), VISA (MIC = 0.25 microgram/mL), and VRE (MIC = 0.25 microgram/mL) and some linezolid-resistant strains (MIC 1-2 microgram/mL).', 'Compound 20aa was demonstrated as a promising candidate through ADME/T evaluation including microsomal stability, cytotoxicity, and inhibition of hERG and monoamine oxidase.', 'The present study not only successfully provides a novel benzo[1,3]oxazinyloxazolidinone scaffold with superior druggability but also lays a good foundation for new antibacterial drug development.', 33705128),
('Antibacterial Chemical Compound', 'sulfonamides derived from sulfaphenazole', 'In particular, compound 10d displayed good activity (MIC = 5.69 microgram/mL) with low inhibition of CYP 2C9 (IC50 > 10 microM), consequently low potential risk of drug-drug interaction.', '', 'Compounds 10c, 10d, 10f and 10i through the optimization on phenyl ring at the R2 site on the pyrazole displayed promising antimycobacterial activity paired with low cytotoxicity.', 33705901),
('Antibacterial Chemical Compound', '3-aryl substituted benzoxaborole derivatives', 'The most potent inhibitor 9f displayed an IC50 value of 86 nM to KPC-2 SBL and micromolar inhibitory activity towards other tested enzymes.', 'Cell-based assays further revealed that 9f was able to significantly reduce the MICs of meropenem in clinically isolated KPC-2-producing bacterial strains and it showed no apparent toxicity in HEK293T cells.', 'Here we report a series of 3-aryl substituted benzoxaborole derivatives, which manifested broad-spectrum inhibition to representative serine-beta-lactamases (SBLs) and metallo-beta-lactamases (MBLs).', 33744439),
('Antibacterial Chemical Compound', 'PFK-158 derivatives', 'Compounds A1, A3, A14, A15 and B6 exhibited potent antibacterial effect against both clinical drug sensitive and resistant Gram-positive bacteria, and they are 2-8 folds more potent than levofloxacin against Methicillin-resistant staphylococcus epidermidis (MRSE).', '', 'The result can provided a new and broader prospect for the development of new medicine against drug-resistant bacteria.', 33766773),
('Antibacterial Chemical Compound', 'para-aminobenzenesulfonyl oxadiazoles derivatives', 'hexyl derivative 8b (MIC = 1 microgram/mL) was more active than norfloxacin against drug resistant MRSA.', '', 'Unique para-aminobenzenesulfonyl oxadiazoles as novel structural potential membrane active antibacterial agents towards drug-resistant methicillin resistant Staphylococcus aureus.', 33775834),
('Antibacterial Chemical Compound', 'celecoxib analogues', 'Compound 12 exhibited antimicrobial activity against Staphylococcus aureus (MIC: 4 microgram/ml), various clinically isolated strains of MRSA (MIC: 4-16 microgram/ml) and Acinetobacter baumannii (MIC: 4 microgram/ml) when combined with subinhibitory concentrations of colistin B.', '', 'Compound 12 is a promising antibacterial candidate for further development.', 33783231),
('Antibacterial Chemical Compound', 'Linalool', 'Linalool exhibited bactericidal activity alone (11,250 microgram/ml) and in combination with meropenem (5,625 microgram/ml).', '', 'This study was carried out to assess and characterize the adjuvant potential and mode of action of linalool against carbapenemase-producing Klebsiella pneumoniae (KPC-KP).', 33815320),
('Antibacterial Chemical Compound', '(S)-1-((3,5-bis(trifluoromethyl) phenyl)amino)-3-((2-methyl-1-(naphthalen-2-yl)propan-2-yl)amino)propan-2-ol, namely II-6s', 'More importantly, 0.003125% II-6s exhibited significant bactericidal effect against E. faecalis residing in the dentinal tubules, which was comparable to 5.25% NaOCl and 2% CHX.', 'II-6s induced no drug resistance in E. faecalis with lower cytotoxicity as compared to NaOCl and CHX.', 'II-6s has excellent antimicrobial activity, moderate cytotoxicity and induces no drug resistance, and thus is a promising agent for the treatment of endodontic infection.', 34552703),
('Antibacterial Chemical Compound', '1H-imidazole-2-carboxylic acid (ICA)', 'Of the tested ICA inhibitors, 55 displayed potent synergistic antibacterial activity with meropenem against engineered Escherichia coli strains and even intractable clinically isolated Pseudomonas aeruginosa producing VIM-2 MBL.', '', 'Of the tested ICA inhibitors, 55 displayed potent synergistic antibacterial activity with meropenem against engineered Escherichia coli strains and even intractable clinically isolated Pseudomonas aeruginosa producing VIM-2 MBL.', 34763944),
('Antibacterial Chemical Compound', '5-phenyl-3-isoxazolecarboxylic acid methyl ester-chalcone hybrids', 'Among 35 synthesized compounds, 32 analogues displayed potent in-vitro activity against Mycobacterium tuberculosis H37Rv with MIC 0.12-16 microgram/mL.', 'Cell viability test against Vero cells indicated 29 compounds to be non-cytotoxic (CC50 > 20 microgram/mL & SI > 10).', 'Time-kill kinetic study suggested compound 7j displaying concentration-dependent bactericidal killing activity with relatively comparable potency to that of current first-line anti-TB drugs.', 34116324),
('Antibacterial Chemical Compound', 'LCG-N25, a lead compound', '', 'cytotoxicity of LCG-N25 was evaluated by Cell Counting Kit-8 assay', 'We found that LCG-N25 exhibited a good antibacterial activity, low-cytotoxicity, and did not induce drug resistance of cariogenic S. mutans', 33868212),
('Antibacterial Chemical Compound', 'chalcone-conjugated, multi-flexible end-group coumarin thiazole hybrids', 'inhibitory activity against MRSA (MIC = 0.004 mM), which was 6 times better than the anti-MRSA activity of the reference drug norfloxacin (MIC = 0.025 mM).', 'Compound 5i neither conferred apparent resistance onto MRSA strains even after multiple passages nor triggered evident toxicity to human hepatocyte LO2 cells and normal mammalian cells (RAW 264.7).', 'Novel chalcone-conjugated, multi-flexible end-group coumarin thiazole hybrids as potential antibacterial repressors against methicillin-resistant Staphylococcus aureus.', 34139627),
('Antibacterial Chemical Compound', 'DS01750413, a new derivative of PC190723', 'DS01750413 showed potent in vitro activity against MRSA clinical isolates with MIC ranges of 0.5-1 mg/L and also demonstrated concentration-dependent bactericidal killing.', 'In the murine bacteraemia infection model of MRSA, treatment with DS01750413 resulted in prolonged survival of animals compared with placebo-treated animals and exhibited a significant reduction in the bacterial load in liver, spleen, lungs and kidneys.', 'Novel FtsZ inhibitor with potent activity against Staphylococcus aureus.', 34383913),
('Antibacterial Chemical Compound', 'Dapsone based nonionic surfactant', 'The spectroscopic results confirm successful synthesis of novel sulfur based nonionic surfactant that formed spherical shaped drug loaded vesicles with an average size of 97.95 ? 3.45 nm and 56.3 ? 3.15 % entrapment of the model drug (Ceftriaxone sodium).', 'The vesicles displayed negative surface charge of -16.8 ? 3.72 mV and released the entrapped drug in a controlled way in-vitro drug release.', 'Results of this study show that the Dapsone based surfactant is safe, biocompatible, non-toxic and can be used as promising vesicular carrier for enhancing therapeutic efficacy of antibacterial drug, Ceftriaxone sodium.', 34252425),
('Antibacterial Chemical Compound', 'PPAR-gamma agonist pioglitazone', 'PPAR-gamma agonist pioglitazone 6 or 8 h after infection of mice with a highly virulent strain of Klebsiella pneumoniae via the airways results in reduced cytokine and myeloperoxidase levels in the lungs at 24 h after infection, as well as reduced bacterial growth in the lungs and decreased dissemination to distant organs at 42 h post-infection.', '', 'Agonists of peroxisome proliferator-activated receptor (PPAR)-γ have been suggested as potential adjuvant therapy in bacterial pneumonia because of their capacity to inhibit inflammation and enhance bacterial clearance.', 34412637),
('Antibacterial Chemical Compound', '1,10-phenanthroline-5,6-dione (phendione)', 'E. coli, K. pneumoniae, A. baumannii and P. aeruginosa,', '', 'Antimicrobial resistance (AMR) remains one of the greatest public health-perturbing crises of the 21st century, where species have evolved a myriad of defence strategies to resist conventional therapy.', 34827221),
('Antibacterial Chemical Compound', 'Cholic acid', '', '', 'Cholic acid potentially acts as an adjuvant since it can blunt the pro-inflammatory activity in human.', 34398332);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Chemical Compound', 'ZINC000104153710, and ZINC000000217308', 'A 2-8 fold reduction in MIC values against ZINC000104153710, and ZINC000000217308 was observed against all 25 MDR-UPEC isolates in the presence of antibiotics with no alteration in intracellular ROS production.', '', 'Combination of bactericidal antibiotics and inhibitors of Universal stress protein A (UspA): a potential therapeutic alternative against multidrug resistant Escherichia coli in urinary tract infections.', 34526667),
('Antibacterial Chemical Compound', 'a series of novel 1,3,4-oxadiazoles bearing 3,4-dihydropyrimidine heterocyclic motifs [4a-l]', 'Compound 4d was found to be the most promising against Escherichia coli (12.5 ?g/ml), whereas the same compound showed good activity against Staphylococcus aureus at a concentration of 50 ?g/ml. Other compounds of the same series, 4c and 4h, displayed moderate activity against Streptococcus pyogenes at a concentration of 50 ?g/ml. Furthermore, results of the antifungal activity tests revealed that compound 4i showed promising activity against all the strains of fungi, Candida albicans, Aspergillus niger, and Aspergillus clavatus, at concentrations of 100, 50, and 100 ?g/ml, respectively.', '', 'Compound 4d was found to be the most promising against Escherichia coli (12.5 µg/ml), whereas the same compound showed good activity against Staphylococcus aureus at a concentration of 50 µg/ml.', 34169569),
('Antibacterial Chemical Compound', '30 novel pyrazole derivatives', 'Compounds 11, 28, and 29 are potent against S. aureus biofilms with minimum biofilm eradication concentration (MBEC) values as low as 1 ?g/mL.', '', 'Compounds 11, 28, and 29 are potent against S. aureus biofilms with minimum biofilm eradication concentration (MBEC) values as low as 1 µg/mL.', 34443670),
('Antibacterial Chemical Compound', 'thiophene-arylamide compounds', 'Showed activity against both drug-susceptible (minimum inhibitory concentration (MIC) = 0.02-0.12 microgram/mL) and drug-resistant (MIC = 0.031-0.24 microgram/mL) tuberculosis strains while retaining potent DprE1 inhibition (half maximal inhibitory concentration (IC50) = 0.2-0.9 microgram/mL) and good intracellular antimycobacterial activity.', 'showed good hepatocyte stability and low inhibition of the human ether-?-go-go related gene (hERG) channel.', 'Compounds 23j, 24f, 25a, and 25b exhibited potent in vitro activity against both drug-susceptible (minimum inhibitory concentration (MIC) = 0.02-0.12 μg/mL) and drug-resistant (MIC = 0.031-0.24 μg/mL) tuberculosis strains while retaining potent DprE1 inhibition (half maximal inhibitory concentration (IC50) = 0.2-0.9 μg/mL) and good intracellular antimycobacterial activity.', 33852302),
('Antibacterial Chemical Compound', 'pleuromutilin derivatives with 1,2,4-triazole-3-substituted Schiff base', 'Among these derivatives, compound 60 exhibited superior in vitro antibacterial effect against MRSA (MIC = 0.25 microgram/mL) than tiamulin (MIC = 0.5 microgram/mL), and compound 60 (-2.28 log10 CFU/mL) also displayed superior in vivo antibacterial efficacy than tiamulin (-1.40 log10 CFU/mL) in reducing MRSA load in the mouse thigh infection model.', 'Among these derivatives, compound 60 exhibited superior in vitro antibacterial effect against MRSA (MIC = 0.25 microgram/mL) than tiamulin (MIC = 0.5 microgram/mL), and compound 60 (-2.28 log10 CFU/mL) also displayed superior in vivo antibacterial efficacy than tiamulin (-1.40 log10 CFU/mL) in reducing MRSA load in the mouse thigh infection model.', 'Design, synthesis and biological evaluation of pleuromutilin-Schiff base hybrids as potent anti-MRSA agents in vitro and in vivo.', 34153574),
('Antibacterial Chemical Compound', '9-arylalkyl-10-methylacridinium derivatives', '', 'Further cytotoxicity and animal studies demonstrated that 15f not only displayed efficacy in a murine model of bacteremia in vivo, but also no significant hemolysis to mammalian cells.', 'Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents.', 33964649),
('Antibacterial Chemical Compound', 'peptide-imidazo[1,2-a]pyrazine', '', '', 'Design, synthesis, and evaluation of peptide-imidazo[1,2-a]pyrazine bioconjugates as potential bivalent inhibitors of the VirB11 ATPase HP0525.', 34142414),
('Antibacterial Chemical Compound', '3-hydroxy-pyridin-4(1H)-ones', 'the hit compound (20p) was identified with the effects of inhibiting the production of pyocyanin (IC50 = 8.6 microM) and biofilm formation (IC50 = 4.5 microM).', '', 'Development of new bacterial biofilm inhibitors as antibacterial synergists is an effective strategy to solve the resistance of Pseudomonas aeruginosa.', 34951310),
('Antibacterial Chemical Compound', '3'',6-dinonyl- and 3'',6-di(dimethyloctyl)-neamine derivatives', '', '', 'Development of novel therapeutics to treat antibiotic-resistant infections, especially those caused by ESKAPE pathogens, is urgent.', 34445410),
('Antibacterial Chemical Compound', 'Bithionol (BT)', 'we found that BT showed significant antimicrobial and antibiofilm effects against Enterococcus faecalis and vancomycin-resistant Entercococcus faecium in vitro, in a dose-dependent manner, by disrupting the integrity of the bacterial cell membranes.', 'BT effectively reduced the bacterial load in mouse organs when combined with conventional antibiotics in a peritonitis infection model.', 'Drug repurposing is a promising approach in solving this problem.', 34025592),
('Antibacterial Chemical Compound', 'sulfonyl-hybridized imidazolyl ethanols', 'Especially, imidazole derivative 5f could strongly suppressed the growth of MRSA (MIC = 4 microgram/mL), which was 2-fold and 16-fold more potent than the positive control sulfathiazole and norfloxacin.', '', 'Especially, imidazole derivative 5f could strongly suppressed the growth of MRSA (MIC = 4 μg/mL), which was 2-fold and 16-fold more potent than the positive control sulfathiazole and norfloxacin.', 34119615),
('Antibacterial Chemical Compound', 'phenolic acids in Spenceria ramalana Trimen and sliver nanoparticle incorporated thermoplastic polyurethane nanofibrous membrane (TPU/AgNPs/TPA)', 'The antibacterial efficiency is as high as 99% lasting for 36 h.', '', 'Finding new wound dressing with sustained antibacterial property to overcome the problem of resistance is one of clinical challenge.', 34679241),
('Antibacterial Chemical Compound', 'benzoxaborole and dextran', '', '', 'Glycosylated Nanotherapeutics with β-Lactamase Reversible Competitive Inhibitory Activity Reinvigorates Antibiotics against Gram-Negative Bacteria.', 34164980),
('Antibacterial Chemical Compound', 'three ruthenium complexes functionalized with furan-substituted ligands([Ru(phen)2 (CAPIP)](ClO4 )2 (Ru(?)-1), [Ru(dmp)2 (CAPIP)](ClO4 )2 (Ru(?)-2) and [Ru(dmb)2 (CAPIP)](ClO4 )2 (Ru(?)-3) (dmb=4,4''-dimethyl-2,2''-bipyridine, phen=1,10-phenanthroline, dmp=2,9-dimethyl-1,10-phenanthroline, CAPIP=(E)-2- (2-(furan-2-yl)vinyl)-1H-imidazo[4,5-f][1,10]phenanthroline))', 'The MIC values of three complexes range from 0.015 to 0.050 mg/ml.', '', 'In addition, aimed to test whether ruthenium complexes have potential value as antimicrobial adjuvants, the synergism between Ru(Ⅱ)-2 and some antibiotics against S. aureus were examined through checkerboard method.', 34453495),
('Antibacterial Chemical Compound', 'synthetic fatty acid 2-hexadecynoic acid (2-HDA),', 'synthetic fatty acid 2-hexadecynoic acid (2-HDA), when used as a fish food supplement, lowers the conjugation frequency of model plasmids up to 10-fold in controlled water microcosms. When added to the food for mice, 2-HDA diminished the conjugation efficiency 50-fold in controlled plasmid transfer assays carried out in the mouse gut.', '', 'Inhibiting conjugation has been proposed as a feasible strategy to stop or delay the propagation of antibiotic resistance genes.', 34425705),
('Antibacterial Chemical Compound', 'isatin hybridized 1,2,4-triazole', 'showed inhibitory activity against E. coli ATCC 25,922 with an MIC value of 1 ?g/mL', '', 'Isatin-derived azoles as new potential antimicrobial agents: Design, synthesis and biological evaluation.', 33839249),
('Antibacterial Chemical Compound', 'isatin hydrazones 4(a-o) and their thiomorpholine tethered analogues 5(a-o).', 'Interestingly, 4f and 5f emerged as the most potent compounds with IC50 of 3.6 ?M and 1.9 ?M against RIF-R1 MTB strain, followed by INH-R1 MTB strain with IC50 of 3.5 ?M and 3.4 ?M, respectively.', '', 'Novel thiomorpholine tethered isatin hydrazones as potential inhibitors of resistant Mycobacterium tuberculosis.', 34329993),
('Antibacterial Chemical Compound', 'C4BP-IgM', 'C4BP-IgM induced membrane perturbation through complement deposition and membrane attack complex pore insertion facilitates the access of antibiotics to their intracellular targets.', '', 'Our data show that complement activation can potentiate activity of antibiotics and suggest a role for C4BP-IgM as an adjuvant for antibiotic treatment of drug-resistant gonorrhea.', 34539665),
('Antibacterial Chemical Compound', 'ML-7 hydrochloride (ML-7)', '', '', 'Taken together, these results revealed the potential of ML-7 as a novel tigecycline adjuvant to circumvent tigecycline-resistant Klebsiella pneumoniae.', 35071055),
('Antibacterial Chemical Compound', 'colistin and EDTA', 'colistin resistance was significantly reversed in both planktonic and mature biofilms of colistin-resistant K. pneumoniae by a combination of colistin (0.25-1 ?g/ml) with EDTA (12 mg/ml).', '', 'Tanittha.C@chula.ac.th. (#)Contributed equally Development of an effective therapy to overcome colistin resistance in Klebsiella pneumoniae, a common pathogen causing catheter-related biofilm infections in vascular catheters, has become a serious therapeutic challenge that must be addressed urgently.', 34737361),
('Antibacterial Chemical Compound', 'prodrug of the boronic acid-containing beta-lactamase inhibitor 5 (VNRX-5236)', 'n vitro and in vivo studies demonstrated that 5 restored the activity of the oral cephalosporin antibiotic ceftibuten against Enterobacterales expressing Ambler class A extended-spectrum beta-lactamases, class A carbapenemases, class C cephalosporinases, and class D oxacillinases.', '', 'The increasing emergence of β-lactamase-producing multi-drug-resistant "superbugs" has resulted in increases in costly hospital Emergency Department (ED) visits and hospitalizations due to the requirement for parenteral antibiotic therapy for infections caused by these difficult-to-treat bacteria.', 34191513),
('Antibacterial Chemical Compound', 'sesquiterpene farnesol', 'The minimum inhibitory concentration (MIC) of farnesol against C. acnes was 0.14 mM, and the IC50 of 24 h exposure to farnesol in HaCaT keratinocytes was approximately 1.4 mM.', 'The basal hydroxypropyl methylcellulose (HPMC) gel did not exert anti-inflammatory or reparative effects on rat acne lesions.', 'Topical therapy is useful as a single or combined treatment for mild and moderate acne and is often employed as maintenance therapy.', 34577195),
('Antibacterial Chemical Compound', 'triblock copolymers of polyethylene glycol (PEG), guanidinium-functionalized polycarbonate and polylactide, PEG-PGC20-PLLA20 (L2) and PEG-PGC20-PDLA20 (D2)', 'The copolymers self-assemble into micellar nanoparticles (L/D2), and exhibit broad-spectrum antibacterial activity against 20 clinically isolated multidrug-resistant A. baumannii strains.', '', 'Conclusions: Therefore, the combination of L/D2 and imipenem might be an alternative option for the prevention of nosocomial infection caused by A. baumannii. © 2021 The Author(s).', 34856746),
('Antibacterial Chemical Compound', 'haloperidol (HPD, 1)', 'We discovered that an antipsychotic drug, haloperidol (HPD, 1), was a potent Eis inhibitor with IC50 = 0.39 ? 0.08 microM.', '', 'Development of Eis inhibitors as KAN adjuvant therapeutics is an attractive path to forestall and overcome KAN resistance.', 34825186),
('Antibacterial Chemical Compound', 'chitosan-mastoparan nanoconstruct (Mast-Cs NC)', 'The MIC90 of Mast-Cs NC was significantly lower than that of chitosan (4 vs 512 microgram/mL, respectively, p<0.05), with noticeable bacterial damage upon morphological analysis.', 'In a BALB/c mouse sepsis model, a significant reduction in bacterial colony count in the Mast-Cs treated group was observed compared with chitosan and mastoparan alone (p<0.005). Mast-Cs maintained good biocompatibility and cytocompatibility.', 'CONCLUSION: Novel mastoparan-loaded chitosan nanoconstructs signify a successful strategy for achieving a synergistic bactericidal effect and higher therapeutic efficacy against MDR clinical A. baumannii isolates.', 34103914),
('Antibacterial Chemical Compound', '5-arylidenepyrimidine-triones', 'Antibacterial activity (agar well-diffusion assay) and cytotoxicity (alamarBlue assay) of perspective compounds were evaluated.', '', 'Method & results: In this study, a virtual library of 5-arylidene barbituric acids was created and molecular docking was performed for identification of novel possible inhibitors of NDM-1 and MetAP-1.', 33913733),
('Antibacterial Chemical Compound', 'derivatives of cajaninstilbene acid (CSA)', 'It eradicated the adherent biofilm of MRSA in a concentration dependent manner, and showed a synergistic antibacterial effect with piperacilin. In a model mouse abscess caused by MRSA persisters, A6 effectively reduced the bacterial load in vivo.', '', 'Most of the newly synthesized derivatives exhibit more potent antimicrobial properties against S. aureus and MRSA than CSA itself, and 23 of the 37 derivatives show a tendency to eradicate MRSA persisters.', 34274830),
('Antibacterial Chemical Compound', 'Poly(l-ornithine)-Grafted Zinc Phthalocyanines', 'ZnPc-g-PLO micelles exhibited potent and broad-spectrum antibacterial activity in the absence of laser irradiation with MIC values ranging from 12.5 microgram/mL to 25 microgram/mL and a corresponding geometric mean (Gm) (32) value of 18.75 microgram/mL (Table 1).', '', 'Multifunctional antimicrobial peptides that combine the intrinsic microbicidal property of cationic polypeptide chains and additional antibacterial strategy hold promising applications for the treatment of infections caused by antibiotic-resistant bacteria, especially "superbugs". In the present study, star-shaped copolymers ZnPc-g-PLO with a zinc phthalocyanine (ZnPc) core and four poly(l-ornithine) (PLO) arms were designed, synthesized, and evaluated as dual-functional antimicrobial agents, that is, intrinsic membrane damage and photothermal ablation capacity.', 34570483),
('Antibacterial Chemical Compound', 'carbazole-oxadiazoles', 'Bioassay discovered that 3,6-dibromocarbazole derivative 13a had effective inhibitory activities to several Gram-positive bacteria, in particular to S. aureus, S. aureus ATCC 29213, MRSA and S. aureus ATCC 25923 (MICs = 0.6-4.6 nmol/mL)', '', 'Novel carbazole-oxadiazoles as potential Staphylococcus aureus germicides.', 33993967),
('Antibacterial Chemical Compound', 'outer membrane-permeable cationic polyurethanes a polyketide', 'Rifampicin combined with a low-dose treatment of a cationic polyurethane reduced the MIC in E. coli of rifampicin by up to 64-fold.', 'The compositions of cationic polyurethanes were designed to have low hemolysis and low cell cytotoxicity while maintaining high antibacterial activity.', 'Our results demonstrate the potential to rescue the large number of available OM-excluded antibiotics to target normally resistant Gram-negative bacteria via synergistic action with these cationic polyurethanes, acting as a novel antibiotic adjuvant class.', 34085824),
('Antibacterial Chemical Compound', 'Eight novel C3-(N-alkyl-aryl)-aminoalkyl analogues of rifamycin SV', 'anti-tubercular activity (MIC90 = 3 microM)', '', 'Antimicrobial resistance is a main concern in tuberculosis treatment and is often associated with the emergence of Mycobacterium tuberculosis strains resistant to rifampicin (RIF), which is one of the cornerstones of tuberculosis chemotherapy.', 34418786),
('Antibacterial Chemical Compound', 'Antibitic adjuvant : monolaurin, monocaprin, N-acetylcysteine (NAC), polymyxin B nonapeptide, Tris-EDTA, Tris-HCL and disodium EDTA', 'NAC had a minimal inhibitory concentration (MIC) range of 2,500-10,000 microg/mL for the various organisms. Pseudomonas aeruginosa isolates were eight times more susceptible to disodium EDTA in the presence of Tris-HCL in comparison to disodium EDTA alone. Malassezia pachydermatis isolates were most susceptible to Tris-EDTA (MIC90 = 190/60 microg/mL) and disodium EDTA (MIC90 = 120 microg/mL)', '', 'These agents could be combined with other antimicrobial agents in a multimodal approach for mixed ear infections in dogs.', 30548715),
('Antibacterial Chemical Compound', 'Tryptophan-derived rhodanine derivatives', 'The most potent compound had in vitro inhibition activity against PTP1B at IC50 = 0.36 ? 0.02 microM', '', 'Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents', 30978561),
('Antibacterial Chemical Compound', 'Aminothiazolquinolone oximes', 'O-methyl oxime derivative 10b displayed excellent inhibitory efficacy against MRSA and S. aureus 25923 with MIC values of 0.009 and 0.017 mM, respectively.', '', 'A new exploration towards aminothiazolquinolone oximes as potentially multi-targeting antibacterial agents: Design, synthesis and evaluation acting on microbes, DNA, HSA and topoisomerase IV.', 31254919),
('Antibacterial Chemical Compound', 'Piperazine derivatives (1,4-diazinanes)', 'Antibacterial activity against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa', '', 'Design, synthesis, and molecular docking study of new piperazine derivative as potential antimicrobial agents.', 31479986),
('Antibacterial Chemical Compound', 'Novel ciprofloxacin derivatives (No. 3, 5, 10, 14, 15)', 'The half-maximal inhibitory concentration (IC50) values of the most effective five compounds of NCD (No. 3, 5, 10, 14, 15) on Babesia bovis, Babesia bigemina, Babesia caballi, and Theileria equi were 32.9, 13.7, 14.9, and 30.9; 14.9, 25.8, 13.6, and 27.5; 34.9, 33.9, 21.1, and 22.3; 26.7, 28.3, 34.5, and 29.1; and 4.7, 26.6, 33.9, and 29.1 microM, respectively.', 'Tested NCD did not suppress NIH/3T3 and MDBK cell viability, even at the highest concentration used (500 microM).', 'Combination treatments of the identified most effective compounds of NCD/diminazene aceturate (DA), /atovaquone (AQ), and /clofazimine (CF) showed mainly synergistic and additive effects.', 32677000),
('Antibacterial Chemical Compound', 'Aminoguanidine analogues : 3a, 3b, 3e', 'The potent activity against the tested MSSA, MRSA, and VRSA strains, inhibiting their growth at concentrations ranging from 1 to 2 ?g/mL.', 'Compound 3e was highly tolerable and possessed a low metabolic clearance rate and a highly acceptable half-life.', 'Compounds 3a, 3b, and 3e possessed potent activities against multidrug resistant staphylococcal isolates and several clinically important pathogens, such as vancomycin-resistant enterococci (VRE) and Streptococcus pneumoniae.', 32707373),
('Antibacterial Chemical Compound', 'Powdered Activated Carbon (PAC)', 'The analysis of fluorescent-tagged microorganisms demonstrated the efficacy of the PAC adsorption treatment in reducing the load of both susceptible and resistant fluorescent microorganisms in the treated water, reaching a removal efficiency of 99.70%.', '', 'CONCLUSION: Results suggest that wastewater PAC treatment is a promising technology not only for the removal of micropollutants but also for its effect in decreasing antibiotic resistant bacteria release.', 30727884),
('Antibacterial Chemical Compound', 'amphiphilic sofalcone derivatives', 'MIC=1.56 microgram/mL', 'The most promising compound 14, bearing two arginine residues, showed poor hemolytic activity, low cytotoxicity, and excellent antimicrobial activity against Gram-positive bacteria, including MRSA.', 'Our studies suggested that compound 14 possessed promising potential to be used as a novel antimicrobial agent to combat drug-resistant Gram-positive bacteria.', 32659547),
('Antibacterial Chemical Compound', 'JJM-ox-3-70 (synthetic 4-oxazolidione small-molecule)', '', '', 'The results of this study suggest that JJM-ox-3-70 inhibits biofilm formation by indirect inhibition of extracellular matrix production that may be linked to disruption of flagellar motility.?', 32769186),
('Antibacterial Chemical Compound', 'Melatonin (N-acetyl-5-methoxytryptamine)', '', '', 'Our findings revealed that melatonin serves as a promising colistin adjuvant against MCR-positive Gram-negative pathogens', 32929375),
('Antibacterial Chemical Compound', 'Aspartic Acid and Succinic Acid', '', '', 'In conclusion, we provided evidences that Asp and Suc could be potential ciprofloxacin adjuvants to eradicate P. aeruginosa living within polymicrobial communities. Asp-Cip and Suc-Cip could be promising therapeutic options to cope with CF treatment failures.', 32974221),
('Antibacterial Chemical Compound', 'Cu-doped hollow carbon spheres (Cu-HCSs)', '', 'Further animal studies demonstrated that the photolysis activity of Cu-HCSs could be used to treat subcutaneous abscesses and bacteremia caused by MRSA.', 'Thus, this photolysis-based antibacterial platform may help avoid bacterial resistance, with the potential to kill multidrug resistant bacteria.', 33006334),
('Antibacterial Chemical Compound', 'Combination of a macrolide antibiotic with a polyaminoisoprenyl adjuvant', 'MICs ranging from 50 to greater than 200 microM, for Gram negative bacteria: Enterobacteriaceae, such as Klebsiella pneumoniae and Escherichia coli, as well as Pseudomonas aeruginosa and Acinetobacter spp', 'Cytotoxicity was evaluated against Chinese hamster ovary (CHO) cells, with all compounds presenting IC50 ranging from 126 to 150 microM, suggesting that they were minimally toxic. non-toxic adjuvant for non-specific potentiation of antibiotics.', 'New polyaminoisoprenyl compounds which exhibited a strong effect on the level of macrolide antibiotics susceptibility for resistant Gram-negative bacterial strains and also show the ability to alter bacterial outer membrane integrity.', 36293314),
('Antibacterial Chemical Compound', 'Small molecule STK?35 and its newly identified derivative STK?66 , which is two benzene rings with a carboxylic group, a nitro group and a cyclopropyl group', 'STK?35 and STK?66 showed the most effective antimicrobial activity against type strains and MDR clinical isolates of Gram?negative pathogens (A. baumannii, E. coli, K. pneumoniae and P. aeruginosa), with minimal inhibitory concentrations (MICs) ranging from 0', 'STK-35/66 significantly increased the survival rate of E. coli infected mice and induced a decrease in bacterial load of the peritonitis model.', ', these results suggested that STK-35/66 possessed antimicrobial activity against Gram-negative pathogenic bacteria in vitro and in vivo, which could be considered as potential substitutes for the treatment of Gram-negative pathogenic infections after further structure optimization.', 35218030),
('Antibacterial Chemical Compound', 'Phenyl Sulfide-Based Cationic Amphiphiles compound', 'most promising compound 17 exhibited potent antibacterial activity against Gram-positive bacteria (minimum inhibitory concentrations = 0.39', 'low hemolytic activity (HC50 > 200 microg/mL), and high membrane selectivity', '17 can rapidly kill Gram-positive bacteria within 0.5 h through membrane-targeting action and avoid antibiotic resistance. More importantly, 17 showed high in vivo efficacy against Staphylococcus aureus in a murine corneal infection model. Therefore, 17 has great potential as a lead compound for the treatment of Gram-positive bacterial infections.', 36256884),
('Antibacterial Chemical Compound', 'ionenes containing alkylated quaternarized 1,4-diazabicyclo[2.2.2]octane (DABCO) as a positively charged moiety', 'the most hydrophobic C12 Polymer are substantially less active (MIC 16', 'only C2-D-PEG shows significantly lower toxicity against hMSC than its nonPEGylated analog.', 'Incorporating the PEG group into a structure of ionenes improves their selectivity index. Discussed results show that C0-D-PEG and C2-D-PEG, reported here for the first time, open a new opportunity to optimize polycationic structures in search for a better antibacterial agent.', 35524947),
('Antibacterial Chemical Compound', 'Antimicrobial volatiles by nest microbiome of social spiders', '', 'showed the influence of the volatilomes on the antibiotic sensitivity of B. thuringiensis offering novel approaches to counter antibiotic resistance.', 'showed the influence of the volatilomes on the antibiotic sensitivity of B. thuringiensis offering novel approaches to counter antibiotic resistance.', 36073497),
('Antibacterial Chemical Compound', 'poly(D, L-lactide-co-glycolide)-poly(ethylene glycol)-poly(D, L-lactide-co-glycolide) (PLGA-PEG-PLGA)', 'In vitro and in vivo antibacterial experiments showed that the composite sustained-release system exhibited good bone repair characteristics owing to its efficacy in infection treatment.', '', 'Therefore, vancomycin@PLGA-PEG-PLGA/HA allows sustained release of antibiotics and promotes bone tissue repair, showing potential for wide clinical applicability.', 36155793),
('Antibacterial Chemical Compound', 'p-chlorophenylhydrazone derivative 6b', 'p-chlorophenylhydrazone derivative 6b possessed excellent ability to suppress the growth of drug-resistant E. coli (MIC = 0.5 Microg/mL), being 16 folds more potent than norfloxacin (MIC = 8 Microg/mL), favorable inhibitory effect on E. coli biofilms and could act rapidly in bactericidal efficacy', '', 'These results demonstrated that metronidazole-derived three-component hybrids provided a large potential for deep development as prospective antibacterial agents.', 35255343),
('Antibacterial Chemical Compound', '2-(3-hydroxypropyl)-1-(3-phenoxyphenyl)-1,2-dihydrochromeno[2,3-c]pyrrole-3,9-dione (KH-1)', 'It inhibits the growth of both antibiotic-sensitive and -resistant Salmonella strains inside macrophages and reduces lactate dehydrogenase (LDH) release from Salmonella-infected cells. Subsequent screening of KH-1 commercial analogs identified 2-(4-fluorobenzyl)-1-(3-phenoxyphenyl)-1,2-dihydrochromeno[2,3-c] pyrrole-3,9-dione (KH-1-2), which is more effective in controlling Salmonella growth inside macrophages. In vitro KH-1-2 treatment of Salmonella infection resulted in an 8- to 10-fold reduction in bacterial load in infected macrophages. In combination with suboptimal ciprofloxacin treatment, KH-1-2 further reduces Salmonella growth inside macrophages.', 'The toxicity and efficacy of KH-1-2 in controlling Salmonella infection were examined in vivo using a mouse model of typhoid fever. No significant compound-related clinical signs and histological findings of the liver, spleen, or kidney were observed from uninfected mice that were intraperitoneally treated with KH-1-2. KH-1-2 significantly protected mice from a lethal dose of infection by an antibiotic-resistant Salmonella strain.', 'Thus, our study provides support that this is a promising lead compound for the development of a novel host-targeted therapeutic agent to control typhoid fever.', 35579463),
('Antibacterial Chemical Compound', 'AUR combined with phenethyl isothiocyanate (PEITC)', 'AUR combined with phenethyl isothiocyanate (PEITC) in skin infection and determined the synergistic antimicrobial effect on S. aureus by using checkerboard assays and time-kill kinetics analysis. This synergistic antimicrobial activity correlated with increased reactive oxygen species (ROS) generation, disruption of bacterial cell structure, and inhibition of biofilm formation. It also effectively restored the susceptibility to AUR via regulating thioredoxin reductase (TrxR) and rescued mice from subcutaneous abscesses through eliminating S. aureus pathogens, including MRSA.', '', 'These results suggest that AUR and PEITC treatment may be a promising option for S. aureus infection.', 35774400),
('Antibacterial Chemical Compound', 'dithienylethene-bridged dual-fluoroquinolone derivatives', 'Two novel dithienylethene-bridged dual-fluoroquinolone derivatives have been developed by introducing two fluoroquinolone drugs into both ends of the dithienylethene (DTE) switch, in which the fluoroquinolone acts as a fluorophore except for the pharmacodynamic component. As expected, these resultant DTE-based antibacterial agents displayed efficient photochromism and fluorescence switching behavior in dimethyl sulfoxide. Moreover, improved antibacterial activities compared to those of monofluoroquinolone derivatives and a maximum fourfold active difference against Escherichia coli (E. coli) for open and closed isomers and photoswitchable bacterial imaging for Staphylococcus aureus and E. coli were observed.', '', 'The molecular docking to DNA gyrase gave a rationale for the discrepancies in antibacterial activity for both isomers. Therefore, these fluoroquinolone derivatives can act as interesting imaging-guided photopharmacological agents for further in vivo studies.', 35608344),
('Antibacterial Chemical Compound', 'L-Trp-T403', 'L-Trp-T403, which was obtained from L-tryptophan and polyetheramine, exhibited the best antibacterial activity with the minimum inhibitory concentration (MIC) of 1 Microgram/mL against methicillin-resistant S. aureus (MRSA). Time-kill kinetics and multi-passage resistance tests experiments indicated that L-Trp-T403 could rapidly kill bacteria within 1 h. This compound also showed potent antibacterial activity against bacteria over many passages. Moreover, the AAPEAs exhibited outstanding stability and long-term antibacterial activity in complex mammalian body fluids, as well as good biocompatibility, low hemolytic activity, slight toxicity for mammalian cell (L929) and low in vivo toxicity.', '', 'These results demonstrate that membrane-active AAPEAs can serve as emerging long-term and biofilm-disrupting antimicrobial agents to treat biofilm-related infections.', 35158080),
('Antibacterial Chemical Compound', 'Ursodeoxycholic acid (UDCA)', 'Adding ursodiol induced direct antibacterial effects, suppressed proinflammatory effects, and reduced cell integrity damage. Oral ursodiol delivery to neonatal mice exhibited significant antibacterial effects and helped maintain colonic barrier integrity in mouse models of peritonitis sepsis and oral infection. UDCA supplementation attenuated colitis and recovered colonic SCFA production.', '', 'Conclusions: This study provided the first evidence that UDCA could confer diarrhea resistance in ESBL-EAEC-infected newborn dairy calves. UDCA blocked bacterial growth and invasion both in vitro and in vivo, alleviated commensal bacterial dysbiosis during ESBL-EAEC infection in neonatal mouse models of sepsis and colitis via the TGR5-NF-?B axis, and upregulated SCFA production in the hindgut digesta. Our findings provide insight into the UDCA-mediated remission of ESBL-EAEC infections and the potential role of UDCA as an antibiotic alternative. Video abstract.', 35643532),
('Antibacterial Chemical Compound', 'sodium salicylate (NaSa)', 'A concentration-dependent effect of NaSa was further observed, where high concentrations (10 mM) decreased agr expression, while low concentrations (?0.1 mM) increased agr expression. In S. aureus 8325-4 (agr I), a high concentration of NaSa (10 mM) decreased hla expression, and a low concentration of NaSa (?1 mM) increased rnaIII and hla expression. The activity of NaSa on biofilm formation was dependent on agr type and material surface. In addition, compared to the control, ATCC 25923 biofilms formed with 10 mM NaSa in the collagen model were more susceptible to silver.', '', 'It is concluded that NaSa can inhibit QS in S. aureus, decreasing the levels of toxin production with certain modulation of biofilm formation. The effect on biofilm formation was dependent on the strain and material surface. It is suggested that the observed NaSa inhibition of bacterial communication is a potential alternative or adjuvant to traditional antibiotics.', 35992652),
('Antibacterial Chemical Compound', 'mouse and rat stem cell-derived alveolar-like macrophages (ALMs)', 'The characterization of ALMs showed that they share known 1''AM cell surface markers, but unlike 1''AMs are highly proliferative in vitro. ALMs effectively phagocytose and kill laboratory strains of P. aeruginosa (P.A.), E. coli (E.C.) and S. aureus, and clinical strains of P.A. In vivo, ALMs remain viable, adapt additional features of native 1''AMs, but proliferation is reduced. Mouse ALMs phagocytose P.A. and E.C. and rat ALMs phagocytose and kill P.A. within the lung 24 h post-instillation. In a pre-clinical model of P.A.-induced lung injury, rat ALM administration mitigated weight loss and resolved lung injury observed seven days post-instillation. Collectively, ALMs attenuate pulmonary bacterial infections and promote airway repair.', '', 'ALMs could be utilized as an alternative or adjuvant therapy where current treatments are ineffective against antibiotic-resistant bacteria or to enhance routine antibiotic delivery.', 35441437),
('Antibacterial Chemical Compound', 'Galacto-oligosaccharides (GOS)', 'GOS (0.25%', '', 'These findings not only shed light on the anti-inflammatory mechanisms of GOS during lung infections, but GOS might also be a promising anti-bacterial agent for preventing (lung) infections.', 35286857),
('Antibacterial Chemical Compound', 'C12 monoglyceride, C6:0 medium-chain organic acids, potassium diformate, sodium diformate, a blend of C8:0/C10:0', 'The highest inhibitory activity against Staphylococcus aureus and Streptococcus suis was exhibited by the C12 monoglyceride (0.49 mg ml-1 ). The monoglyceride of C12 was more effective than C12:0 against Strep. suis, but neither C12:0 nor its monoglyceride showed efficacy against the gram-negative micro-organisms tested. The most active against Escherichia coli were the C6:0 medium-chain organic acids and potassium diformate (1.95 mg ml-1 ). For Salmonella Typhimurium, potassium diformate, sodium diformate, and a blend of C8:0/C10:0 (each 1.96 mg ml-1 ), and for Actinobacillus pleuropneumoniae, eugenol (0.49 mg ml-1 ) showed the most promising activity.', '', 'Conclusions: We identified broad-spectrum antibacterial activity, such as the C6:0 MCOA, and those with interesting narrow-spectrum activity, notably the killing of Strep. suis by C12 monoglyceride. We have identified additives that show the most promising bioactivity against specific pathogens. We broadly compare a large collection of feed additives and active ingredients for their antibacterial activity against a diverse panel of bacterial swine pathogens. This provides a solid base of evidence which can drive the development of feed supplementation strategies with the aim of reducing dependency on antibiotic use in swine production.', 34608714),
('Antibacterial Chemical Compound', 'polysaccharides extracted from Zizyphus jujuba Mill', 'This jujube polysaccharide was shown to exhibit remarkable inhibitory effects against all the tested oral bacterial pathogens through various mechanisms including growth inhibition, biofilm prevention and disruption, intervention of bacterial infection (adhesion and invasion), attenuation of cytotoxicity, modulation of excessive inflammatory response of LPS-stimulated and MRSA-infected macrophages as well as positive regulation of oral microbiota.', '', 'The present study paves the way to explore jujube polysaccharides for the prevention and treatment of oral infectious diseases.', 35378158),
('Antibacterial Chemical Compound', 'Benzofuran 1', 'Benzofuran 1 was identified as a potential lead for TB inhibiting a novel target, the thioesterase domain of Pks13.', 'Although, having promising activity against Mycobacterium tuberculosis, its main liability was inhibition of the hERG cardiac ion channel. This article describes the optimization of the series toward a preclinical candidate. Despite improvements in the hERG liability in vitro, when new compounds were assessed in ex vivo cardiotoxicity models, they still induced cardiac irregularities. Further series development was stopped because of concerns around an insufficient safety window.', 'However, the demonstration of in vivo activity for multiple series members further validates Pks13 as an attractive novel target for antitubercular drugs and supports development of alternative chemotypes.', 34910486),
('Antibacterial Chemical Compound', 'ron mimetic metal gallium [Ga (III)]', 'Ga (III) inhibits microbial growth by disrupting ferric iron-dependent metabolic pathways. In this study, we revealed that gallium nitrate III (GaN) inhibits the growth of a collection of twenty polymyxin-resistant Klebsiella pneumoniae strains at concentrations ranging from 2 to 16 Microgram/mL, using a medium, on which the low iron content and the presence of human serum better mimic the in vivo environment. GaN was also successful in protecting Caenorhabditis elegans from polymyxin-resistant K. pneumoniae strains lethal infection, with survival rates of >75%.', '', 'GaN also exhibited synergism with polymyxin B, suggesting that a polymyxin B-GaN combination holds promise like as one alternative therapy for infections caused by resistant polymyxin B K. pneumoniae strains.', 34775292),
('Antibacterial Chemical Compound', 'dihydropyrimidinone imidazoles', 'hybridized dihydropyrimidinone imidazole 8b was found to be extremely active against multidrug-resistant K. pneumonia and A. baumanii at a low concentration of 0.5 microg/mL, which outperformed norfloxacin even clinafloxacin. This active compound not only exhibited low cytotoxicity to mammalian cells (human red blood cells, HepG2 and ECs), but also possessed rapid bactericidal property, good biofilm inhibition ability, and a low propensity to induce K. pneumonia and A. baumanii resistance.', 'Further studies revealed that the inhibitory effect of the active compound 8b might be achieved by disrupting membrane integrity, increasing ROS generation, reducing GSH activity and interacting with DNA.', 'These findings provided a bright hope for developing dihydropyrimidinone imidazoles to combat emergent drug resistance.', 35168152),
('Antibacterial Chemical Compound', 'silver ions plus Triton X-100', 'antibacterial activity against both planktonic and biofilm-resident E. faecalis was dramatically improved after TX-100 incorporation. TX-100 and Ag+ mixture demonstrated a similar inhibitory effect as the 2% chlorhexidine (CHX), while the cytotoxicity was much lower than 2% CHX (p < 0.05).', '', 'In conclusion, TX-100 + Ag+ mixture might be developed into a new effective intracanal medication as the 2% CHX.', 34731451),
('Antibacterial Chemical Compound', 'Grape Seed Oligomeric Proanthocyanidins', 'GSOPs were able to alleviate oxidative stress, inflammation and barrier integrity disruption inflicted by bacteria in the co-culture.', '', 'Based on these observations, GSOPs seem to be promising candidates for the prevention and treatment of gastrointestinal bacterial infections.', 35052987),
('Antibacterial Chemical Compound', 'biochar alone or in combination with manure', 'Field experiments revealed class 1 (CL1) integrons were prevalent in all samples, with higher concentration and abundance in manure-treated plots than in biochar-treated ones. Manure considerably enhanced CL1 integrons abundance and antimicrobial resistance, whereas biochar amendments significantly reduced integrons and antimicrobial resistance. The results highlighted the differential effects of biochar and manure on integrons and its gene cassette arrays, showing increased abundance of integrons and antibiotic resistance upon manure application and decrease of the same with biochar.', '', 'The use of biochar alone or in combination with manure could be a beneficial alternative to mitigate the spread of antimicrobial resistance and bacterial evolution in the environment, specifically in paddy soils.', 35847108),
('Antibacterial Chemical Compound', 'Biofumigation of allelochemicals called isothiocyanates (ITCs)', 'Biofumigation, an agricultural technique where Brassica plant tissues are mulched into soils to release antimicrobial plant allelochemicals called isothiocyanates (ITCs), has been proposed as an environmentally friendly alternative to agrochemicals. Here, we used a laboratory model system to compare the efficacy of different types of ITCs against Ralstonia solanacearum plant bacterial pathogen.', '', 'Together, our results suggest that R. solanacearum can rapidly evolve tolerance to allyl-ITC plant allelochemical which could constrain the long-term efficiency of biofumigation biocontrol and potentially shape pathogen evolution with plants.', 35603031),
('Antibacterial Chemical Compound', 'mixed-charge two-dimensional molybdenum disulphide (2D-MoS2)', 'Gram-selective antibacterial system based on two-dimensional molybdenum disulphide (2D-MoS2) functionalized with different proportions of positively and negatively charged ligands. Two representative ESKAPE pathogenic strains, i.e., Gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and Gram-negative Pseudomonas aeruginosa (P. aeruginosa) were considered to evaluate the selective antibacterial activity.The selective generation of intracellular reactive oxygen species (ROS) together with membrane depolarization contributed to the selective killing of the pathogenic bacteria.', '', 'In summary, we prepared simple and efficient Gram-selective 2D-MoS2-based antibacterial agents, which can be extended to other nano-antibiotic systems.', 35640626),
('Antibacterial Chemical Compound', 'methyltransferase', 'The methyltransferase interaction with cellular protein was found to be maximum, due to the maximum PatchDock Score (15808), which was followed by colicin (12864) and amoxicillin (4122). The modeled protein has found to be interact more significantly to inhibit the indicator bacteria than the tested antibiotics and antimicrobial colicin protein.', '', 'Thus, model enzyme methyltransferase could be used as enzymobiotics. Moreover, peptide sequences similar to this enzyme sequence need to be designed and evaluated against the microbial pathogen.', 35069699),
('Antibacterial Chemical Compound', 'rhamnolipid nano-micelles', 'rhamnolipid nano-micelles against selected drug-resistant Gram-negative (Salmonella Montevideo and Salmonella Typhimurium) and Gram-positive bacteria (Staphylococcus aureus, Streptococcus pneumoniae)', 'rhamnolipid nano-micelles are unlikely to cause any harmful effects on the skin.', 'Thus, rhamnolipid nano-micelles could be recommended to replace alcohol-based hand sanitizers; however, they must still be tested by healthcare workers in healthcare settings to ascertain their antimicrobial activity and safety.', 35625249),
('Antibacterial Chemical Compound', 'sulfidated nanoscale zerovalent iron (S-nZVI)', 'When the S/Fe was 0.1, the inactivation efficiency of 1120 mg/L S-nZVI on the donor and recipient bacteria were 2.36 ', '', 'This study provided evidence and insights into possible underlying mechanisms for reducing conjugative transfer, such as hindering cell membrane repair, inducing the overproduction of reactive oxygen species, inhibiting the SOS response, reducing the expression of ARGs and related transfer genes. S-nZVI could inhibit the gene conjugative transfer while inactivating the ARB. The findings provided an alternative method for controlling antibiotic resistance.', 35334272),
('Antibacterial Chemical Compound', 'boswellic acid', 'The most significant effect was found in Enterococcus faecalis ATCC 29212 in a combination of 0.2 ', '', 'With increasing resistance to common antibiotics, boswellic acid-containing extracts could serve as an alternative or work in synergy with commonly available preparations.', 35744925),
('Antibacterial Chemical Compound', 'monoclonal antibodies (mAbs)', 'B39, was found to protect mice in a lethal model of K. pneumoniae pneumonia against both O1 and O2 strains when dosed therapeutically. B39 binds to D-galactan-I and D-galactan-II of the LPS of O1 and O2 strains.', '', 'Thus, we have discovered an mAb with novel binding and functional activity properties that is a promising candidate for development as a novel biotherapeutic for the treatment and prevention of K. pneumoniae infections.', 34923908),
('Antibacterial Chemical Compound', 'Methylene Blue (MB) and TMPyP', 'In experiments on the replication ability of bacteria after photodynamic treatment with TMPyP or MB, a killing rate of 5 log10 steps of the bacteria was achieved.', '', 'A promising approach to support conventional antibiotic therapy is the antimicrobial photodynamic inactivation (aPDI). For the first time, a membrane-damaging effect of TMPyP and MB in both bacterial strains could be shown using flow cytometry analyses. Furthermore, we found that reduction of the replication ability occurs with lower concentrations than needed for membrane damage upon MB suggesting that membrane damage is not the only mechanism of aPDI using MB.', 35061201),
('Antibacterial Chemical Compound', 'Brominated Carbazole with Antibiotic Adjuvant Activity', 'RNA-seq analysis showed 176 and 233 genes significantly up- and downregulated, respectively, in response to cotreatment.', '', 'This study revealed a dramatic impact of our lead adjuvant on the transcriptome that is consistent with a pleiotropic effect due to Stk1 inhibition. These results point to this antibiotic adjuvant having potential broad therapeutic use in combatting MRSA.', 35467845),
('Antibacterial Chemical Compound', 'Iron-Induced Respiration', 'Iron supported the growth of S. coelicolor even under anaerobic conditions. In the presence of potassium cyanide, which reduces aerobic respiration of cells, iron still promoted respiration and antibiotic resistance. This suggests the involvement of a KCN-insensitive type of respiration in the iron effect. This phenomenon was also observed in another actinobacterium, Mycobacterium smegmatis.', '', 'A surprising role of iron to increase respiration, especially in a mode of using less oxygen, appears a fitting strategy to cope with bactericidal antibiotics known to kill bacteria through oxidative damage. This provides new insights into developing antimicrobial treatments based on the availability of iron and oxygen.', 35357210),
('Antibacterial Chemical Compound', '3-hydroxy-pyridin-4(1H)-one compound (20p)', 'compound (20p) was identified with the effects of inhibiting the production of pyocyanin (IC50 = 8.6 microM) and biofilm formation (IC50 = 4.5 microM). Mechanistic studies confirmed that 20p inhibits the formation of bacterial biofilm by inhibiting the expression of pqsA, blocking pqs quorum sensing system quinolone biosynthesis. The bactericidal effects of combining currently approved antibiotics for CF including tobramycin, ciprofloxacin, and colistin E with 20p, which showed obvious antibacterial synergy to overcome antibiotics resistance in multidrug-resistant P. aeruginosa biofilms.', '', 'The result indicates that compound 20p may be used in the future as a potentially novel antibacterial synergist candidate for the treatment of P. aeruginosa infections.', 34951310),
('Antibacterial Chemical Compound', 'SA09-Cu', 'SA09-Cu could convert NDM-1 into an inactive state by oxidizing the Zn(II)-thiolate site of the enzyme. SA09-Cu showed a unique redox tuning ability, and avoided to be reduced by intracellular thiols of bacteria.', '', 'In vivo experiments indicated that SA09 combined with CuGlu could effectively potentiate MER''s effect against NDM-1-producing E. coli (EC23) in the murine infection model. This study provides a highly promising scaffold in developing novel inhibitors to combat NDM-1-producing CREs.', 34794102),
('Antibacterial Chemical Compound', 'Ruthenium(II) complexes', 'Four complexes could absolutely inhibit the growth of Staphylococcus aureus (S. aureus) with MIC values ranging from 15.6 to 100 microg/mL. The most active complex Ru(?)-1 (MIC = 15.6 microg/mL) could kill S. aureus through targeting the membrane integrity without detectably resistance frequencies.', '', 'Finally, based on the mouse model of S. aureus skin infection, Ru(?)-1 showed important antibacterial efficacy against S. aureus in vivo, and almost non-toxic against mouse tissue. Our study indicates that introducing membrane targeting ligands onto ruthenium complexes may be an underappreciated strategy for developing antibacterial agents.', 35635951),
('Antibacterial Chemical Compound', 'Gelatinase Responsive Nanogel (G@CuS)', 'Constructed a "core-shell" nanogel (G@CuS) based on a copper sulfide (CuS) antimicrobial agent and gelatin for targeted drug release and bacterial clearance in a gelatinase infected microenvironment. G@CuS produced heat and reactive oxygen species (ROS) under the irradiation of a laser, which together with the released Cu2+ cause irreversible and efficient physical damage to the bacteria.', '', 'G@CuS eradicated the colonized bacteria in the wound of mice infected with Staphylococcus aureus (S. aureus) and accelerated wound healing. The proposed application strategy of nanogel is expected to provide a new idea for clinical transformation.', 35877482);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Chemical Compound', 'tilapia piscidin 2 (TP2)', 'showed significant antimicrobial activity against multidrug-resistant bacterial species. These peptides also showed minimal cytotoxicity. In addition, they were significantly active in the presence of physiological salts, 50% human serum and elevated temperature. The designed peptides also showed synergistic activity when combined with clinical antibiotics.', '', 'The current approach demonstrates a fruitful strategy for developing potential AMPs for antimicrobial application. Such AMPs have potential for progression to further trials and drug development investigations.', 35216307),
('Antibacterial Chemical Compound', 'conjugates of colistin (CT) and hyaluronic acid (HA)', 'synthesis of conjugates of colistin (CT) and hyaluronic acid (HA) using carbodiimide chemistry to conjugate the amino groups of CT with the carboxyl groups of HA. The obtained polysaccharide carriers had a degree of substitution (DS) with CT molecules of 3-10 %, and the CT content was 129-377 microg/mg. retained antimicrobial activity depending on the DS: at DS 8 %, the minimum inhibitory concentration (MIC) of the conjugate corresponded to the MIC of free CT. The resulting systems also reduced CT nephrotoxicity by 20-50 %.', '', 'These new conjugates of CT with HA are promising for the development of nanodrugs for safe and effective antimicrobial therapy.', 35724903),
('Antibacterial Chemical Compound', 'biofilm-targeted antibiotic liposomes', 'exhibit significantly enhanced bacterial inhibition and biofilm eradication effects that are positively correlated with the cholesterol content of liposomes. Liposome encapsulation with a high cholesterol concentration improves noticeably the pharmacodynamics and biocompatibility of antibiotics after pulmonary administration.', '', 'This work may provide a new direction for the development of antibiofilm formulations that can be widely used for the treatment of infections caused by bacterial biofilms.', 35037424),
('Antibacterial Chemical Compound', 'series of semi-synthetic hybrid antibiotics formed by linking kanglemycin A (Kang A), a rifampicin analog, and a collection of fluoroquinolones', 'Kang A is a natural product antibiotic which contains a novel dimethyl succinic acid moiety that offers a new attachment point for the synthesis of hybrid antibiotics.', '', 'Several hybrids exhibit activity against bacteria resistant to Kang A via the action of the partnered antibiotic, suggesting that the Kang scaffold may provide new avenues for generating antibiotics effective against drug-resistant infections.', 34861348),
('Antibacterial Chemical Compound', 'bismuth nitrate [Bi(NO3)3] and tigecycline', 'bismuth nitrate [Bi(NO3)3], commonly used in clinical treatment of stomach-associated diseases, effectively boost the antibacterial activity of tigecycline against tet(X)-positive bacteria by inhibiting the enzymatic activity of Tet(X) protein. The combination of Bi(NO3)3 and tigecycline prevents the development of higher-level resistance in Tet(X)-expressing Gram-negative bacteria', '', 'Collectively, these findings indicate the high potential of bismuth drugs as novel Tet(X) inhibitors to treat tet(X4)-positive bacteria-associated infections in combination with tigecycline.', 35138168),
('Antibacterial Chemical Compound', 'aminoglycosides modification in the 3''-position via palladium-catalyzed oxidation', 'regioselective modification of aminoglycosides in the 3''-position via palladium-catalyzed oxidation', '', 'To underline the effectiveness of our method for structural modification of aminoglycosides, we have developed two novel antibiotic candidates overcoming APH(3'')s-mediated resistance employing only four synthetic steps.', 35388562),
('Antibacterial Chemical Compound', 'NADH', 'artificially manipulated the redox homeostasis of the model opportunistic pathogen Pseudomonas aeruginosa using specific enzymes that catalyze either the formation or oxidation of NADH. Increased NADH levels led to the activation of antibiotic efflux pumps and high levels of antibiotic resistance. However, higher NADH levels also resulted in increased intracellular ROS and amplified antibiotic killing.', '', 'Our results demonstrate that growth inhibition and killing activity are mediated via different mechanisms. Our results pave the way for a more effective infection resolution and add an antivirulence strategy to maximize chances to combat devastating P. aeruginosa infections while reducing the overall use of antibiotics.', 35038918),
('Antibacterial Chemical Compound', 'dynaplanin [(T094 and T095) and the type strain DSM43634]', 'Arthrobacter globiformis (ATCC 8010) exhibited strong sensitivity', '', 'Overall, our strategy based on bacterial competition led to discovery of a novel antibiotic that inhibits the ability to metabolize nutrients.', 35608300),
('Antibacterial Chemical Compound', 'Combination therapy of niclosamide (NIC) and polymyxin B (PB)', 'the combination of 15 with PB displayed superior elimination of P. aeruginosa DK2. This combination decelerated PB-resistance progress in DK2, along with lower potential toxicity.', '', 'Overall, this study provides a strategy for development antibiotic adjuvants to potentiate PB against MDR P. aeruginosa infections.', 35398731),
('Antibacterial Chemical Compound', 'Memantine (MEM)', 'Combining MEM with the reactive oxygen species (ROS) inhibitor, N-acetyl-l-cysteine, weakened the anti-infective effect of MEM. MEM increased the expression of NADPH p67phox and promoted neutrophilic ROS production. Deleting the p67phox gene significantly weakened the effects of MEM on ROS generation and improving bactericidal effect of neutrophils.', '', 'In conclusion, MEM promoted the bactericidal effect of neutrophils against P. aeruginosa and its drug-resistant strain, and had a synergistic antibacterial effect when combined with AMK. MEM may exert its anti-infective effects by promoting neutrophilic bactericidal activity via increasing the expression level of p67phox and further stimulating ROS generation.', 34357802),
('Antibacterial Chemical Compound', 'amphiphilic poly(ethylene glycol)-Schiff-vancomycin (PEG-Schiff-Van) prodrug and free Van in one drug delivery system', 'on account of the combination of physical encapsulation and chemical conjugation of vancomycin, these nanocarriers with favorable biocompatibility and high drug loading capacity displayed a programmed drug release behavior, which was capable of rapidly reaching high drug concentration to effectively kill the bacteria at an early period and continuously exerting an bacteria-sensitive effect whenever needed over a long period. In addition, more Schiff-base moieties within the PEG-Schiff-Van@Van nanocarriers may also make great contributions on promoting the antimicrobial activity.', '', 'This work represents a synergistic strategy on offering important guidance to rational design of multifunctional antimicrobial vehicles, which would be a promising class of antimicrobial materials for potential clinical translation.', 35386319),
('Antibacterial Chemical Compound', 'simeprevir', 'simeprevir had strong antibacterial activity against MRSA, with a minimum inhibitory concentration of 2-8 Microgram/mL. Simeprevir combined with gentamicin effectively reduced the bacterial burden in an MRSA-infected subcutaneous abscess mouse model.', '', 'Collectively, these results demonstrated the potential of simeprevir as an antimicrobial agent for the treatment of MRSA infections.', 35338386),
('Antibacterial Chemical Compound', 'five dihydroisocoumarin: 6-methoxy mellein (1); 5,6-dihydroxymellein (2); 6-hydroxymellein (3); 4-chloro-6-hydroxymellein (4) and 4-chloro-5,6-di-hydroxymellein (5)', 'All of the compounds exhibited selective antibacterial activity against Gram-positive bacteria Staphylococcus aureus and Bacillus licheniformis except compound 3. The chloro-dihydroisocoumarin derivative, compound 4, showed potential antimicrobial activities against all of the tested strains with the MIC value between 0.8-5.3 microg/mL followed by compound 5, which exhibited a moderate inhibitory effect.', '', 'This work provides an effective strategy for compounds to inhibit bacterial growth or overcome bacterial resistance.', 35684566),
('Antibacterial Chemical Compound', 'magnetically controlled multifunctional micromotor was developed by using H2O2 as the fuel and MnO2 as the catalyst', 'to treat bacterial biofilm infection. In the presence of H2O2, the as-prepared motors could be self-propelled by the generated oxygen microbubbles. Thereby, the remotely controlled motors could drill into the EPS of biofilm and disrupt them completely with the help of bubbles. Finally, the generated highly toxic ', '', 'This strategy combined the mechanical damage, highly toxic ', 35739732),
('Antibacterial Chemical Compound', 'phosphate ester derivative of chrysin', 'as a potent QS inhibitor of the human pathogen Pseudomonas aeruginosa (P. aeruginosa) using a designed luciferase reporter assay. In vitro biochemical analysis shows that the chrysin derivative binds to the bacterial QS regulator LasR and abrogates its DNA-binding capability. In particular, the derivative exhibits higher anti-virulence activity compared to the parent molecule.', '', 'All the results reveal the potential application of flavone derivative as an anti-virulence compound to combat the infectious diseases caused by P. aeruginosa.', 35458637),
('Antibacterial Chemical Compound', 'Synergistic Killing of Polymyxin B in Combination with Cannabidiol', 'The polymyxin B-cannabidiol combination showed synergistic antibacterial activity in checkerboard and static time-kill assays against both polymyxin-susceptible and polymyxin-resistant isolates against Acinetobacter baumannii.', '', 'The study suggests the possibility of cannabidiol repositioning, in combination with polymyxins, for treatment of MDR polymyxin-resistant Gram-negative infections.', 35456620),
('Antibacterial Chemical Compound', 'oxygen-based membrane biofilm reactor (O2-MBfR) treating GW', 'Increasing DO concentration from 0.2 to 0.4 mg/L led to improved organics (> 90%) and nitrogen removal, as well as less EPS (especially for proteins and carbohydrates) and ARGs accumulation (e.g., intI-1, korB and sul-2) in the biofilm; the high-DO-concentration accumulated microbial niches, including Flavobacteriaceae and Cyanobacteria that revealed by LEfSe analysis, contributed to both nitrogen reduction and organics biodegradation.', '', 'These findings suggested the DO-based ARGs reduction regulation strategy in the O2-MBfR treating GW.', 35395308),
('Antibacterial Chemical Compound', 'carbapenem-hydrolyzing class D beta-lactamases (CHDLs)', 'OXA-23-MA-1-206 complex show that the C6 hydroxymethyl group forms a hydrogen bond with the carboxylated catalytic lysine of OXA-23, effectively preventing deacylation.', '', 'These results provide a novel strategy for designing next-generation, carbapenemase-stable carbapenems to fight multidrug-resistant infections caused by Gram-negative pathogens.', 35420470),
('Antibacterial Chemical Compound', 'grafting zwitterionic polymer (poly(sulfobetaine methacrylate) (PSBMA)) on ZnO nanopillars', 'Under dry conditions, this nanopillar surface displays remarkable mechano-bactericidal activity, because the collapsed zwitterionic polymer layer makes no essential influence on nanopillar structure. Once being incubated with aqueous solution, the surface could readily detach the killed bacteria and debris, owing to the swelling of the zwitterionic layer.', '', 'The resultant nanopillar surface also enjoys the advantages of substrate-independency and good biocompatibility, offering potential antibacterial applications for biomedical devices and hospital surfaces.', 35338932),
('Antibacterial Chemical Compound', 'combination of clomiphene with amoxicillin', 'Combination created through the method of sCRilecs-seq (subsets of CRISPR interference libraries extracted by fluorescence activated cell sorting coupled to next generation sequencing)', '', 'These findings could provide a starting point to develop a solution for the increasing amount of hard-to-treat amoxicillin-resistant pneumococcal infections.', 35748540),
('Antibacterial Chemical Compound', 'NANO@PS-LPs', 'a type of antibiotic-adjuvant liposomes (NANO@PS-LPs), co-incorporating azithromycin (AZI), adjuvant (2-nitroimidazole derivative, 6-NIH) and biofilm dispersant (nitric oxide donor, DETA NONOate). NANO@PS-LPs possessing negatively-charged surface and good hydrophilicity could easily penetrate through the sputum layer, then disassembled triggered by overexpressed phospholipase A2 (PLA2) in the microenvironment around biofilms. eliminate mature P. aeruginosa biofilms, effectively kill dispersed bacteria, inhibit the metabolism of survivors and prevent P. aeruginosa adherence to airway epithelial cells, accordingly restrain recurrent infections. performed a remarkable advantage in killing AZI-resistant P. aeruginosa and removing their biofilms', '', 'In summary, NANO@PS-LPs present a potential nano-strategy to treat stubborn pseudomonal pulmonary infections and overcome correlative drug resistance.', 35710071),
('Antibacterial Chemical Compound', 'Tigecycline Adjuvant ML-7', 'ML-7 combined with tigecycline could completely inhibit the growth of bacteria, and the time-kill analysis revealed that the combination exhibited synergistic bactericidal activities for tigecycline-resistant isolates. The tigecycline MIC of the strains ranges from 8 Microgram/mL to 256 Microgram/mL.', '', 'Taken together, these results revealed the potential of ML-7 as a novel tigecycline adjuvant to circumvent tigecycline-resistant Klebsiella pneumoniae.', 35071055),
('Antibacterial Chemical Compound', 'polymyxin B in combination with fosfomycin', 'against KPC-2-producing Klebsiella pneumoniae (polymyxin B MIC, 0.5-64 mg/L; fosfomycin MIC, 16-128 mg/L),', '', 'Our findings suggest that further research is needed to better understand immune-mediated killing in order to identify a strategy which harnesses the power of the immune response against these hard-to-treat bacteria.', 35288260),
('Antibacterial Chemical Compound', 'series of 4-(1,2,3-triazoyl)arylmethanone derivatives', 'series of 4-(1,2,3-triazoyl)arylmethanone derivatives has been synthesized using the one-pot Copper-?Catalyzed Oxidative Cross-?Dehydrogenative Coupling?/Oxidative Cycloaddition strategy to overcome antibiotic resistance and exhibited good anti-TB activities. Notably, compounds 6b, 6f, and 6g gave the most potent efficiency with minimum inhibitory concentration values of 4 microg/ml (12.8, 11.7, and 12.8 micromicro, respectively).', 'Among the synthesized compounds, the cytotoxicity measurements of the 6b, 6f, 6g, 6d, and 6v derivatives were screened and it was found that the 6f derivative did not show any cytotoxicity.', 'Molecular docking analyses are utilized to identify the binding mode and the key interactions between target compounds and the ligand-binding site of M. tuberculosis enoyl-acyl carrier protein reductase enzyme (MtInhA, EC 1.3.1.9). The docking results were in agreement with the in vitro results, which confirm the synthesized ligands bind to MtInha with moderate to low affinity.', 35187763),
('Antibacterial Chemical Compound', 'Qixingjian Decoction (QXJT) with oxacillin (OX)', 'QXJT exhibited antimicrobial activity against both clinical isolates of MRSA, MICs ranging from 18.75 to 37.5 mg/mL. QXJT could cause the disruption of MRSA cell wall, and QXJT + OX could produce greater disruption of MRSA cell wall, elucidating the synergistic effect of the two together on cell wall disruption by microscopic mechanisms. Our study shows that the combination of QXJT and OX can inhibit the expression of MRSA virulence factor, reduce the virulence of MRSA, and have no significant effect on the expression of MRSA resistance gene mecA.', '', 'Conclusion: The results of this study provide scientific experimental data for the traditional application of QXJT and initially explore the mechanism of action of QXJT combined with OX.', 35222666),
('Antibacterial Chemical Compound', 'thymol/colistin combination', 'against Gram-negative bacteria (GNB), including nonfermenting bacteria and Enterobacteriaceae. Could decrease the number of bacteria ?2 log10 CFU/mL after 24 h of therapy in a mouse thigh infection model', '', 'Our results fully prove that thymol and colistin combination possesses a promising treatment option against colistin-resistant GNB infections.', 35700133),
('Antibacterial Chemical Compound', 'Dihydroxyphenyl-substituted thiosemicarbazone', 'potent scaffold for the development of metallo-beta-lactamases inhibitors and antimicrobial. The gained molecules specifically inhibited NDM-1 and ImiS, exhibiting an IC50 value in the range of 0.37-21.35 and 0.45-8.76 microM, and 2a was found to be the best inhibitor, with an IC50 of 0.37 and 0.45 microM, respectively, using meropenem (MER) as substrate. 1a-e, 2a-e and 3a-b alone more strongly sterilized E. coli-ImiS and E. coli-NDM-1 than the MER, displaying a MIC value in the range of 8-128 microg/mL, and 2a was found to be the best reagent with a MIC of 8 and 32 microg/mL. Also, 2a alone strongly sterilized the clinical isolates EC01, EC06-EC08, EC24 and K. pneumonia-KPC-NDM, showing a MIC value in the range of 16-128 microg/mL, and exhibited synergistic inhibition with MER on these bacteria tested, resulting in 8-32-fold reduction in MIC of MER.', '', 'This work offered a promising scaffold for the development of MbetaLs inhibitors, specifically the antimicrobial for clinically drug-resistant isolates.', 35717802),
('Antibacterial Chemical Compound', 'combination of moxifloxacin and T/K', 'When combined with T/K, the mean steady-state concentrations (MSC) of moxifloxacin could prevent 70% of resistance, and the peak concentration (Cmax) prevented 95% of resistance.', '', 'Conclusion: The combination of moxifloxacin and T/K can achieve a good in vitro bactericidal effect and prevent the emergence of resistance at clinical dosage regimens, and may be an optimal therapeutic strategy for S. maltophilia infections, especially for vulnerable immunocompromised and critically ill patients.', 35720255),
('Antibacterial Chemical Compound', 'aminoglycosides co-treatment with n-butanol', '1 min co-treatment with n-butanol greatly and specifically enhances the bactericidal action of aminoglycosides by 5 orders of magnitude against stationary-phase Staphylococcus aureus cells, with n-propanol and isobutanol showing less potency. This combined treatment also rapidly kills various S. aureus persisters, methicillin-resistant S. aureus (MRSA) cells, and numerous Gram-positive and -negative pathogens including some clinically isolated multidrug-resistant pathogens (e.g., S. aureus, Staphylococcus epidermidis, and Enterococcus faecalis) in vitro, as well as S. aureus in mice.', '', 'Given n-butanol is a non-metabolite in the pathogens we tested, our work may open avenues to develop a metabolite-independent strategy for aminoglycoside potentiation to rapidly eliminate antibiotic-resistant/tolerant pathogens, as well as for reducing the toxicity associated with aminoglycoside use.', 35100802),
('Antibacterial Chemical Compound', 'Indolmycin (IND)', 'Important target for developing new antibacterial agents against Mycobacterium tuberculosis (Mtb). The 4?-methylated IND compound, Y-13, showed improved anti-Mtb activity with a minimum inhibitory concentration (MIC) of 1.88 microM (?0.5 microg/mL). Important target for developing new antibacterial agents against Mycobacterium tuberculosis (Mtb)', '', 'Finally, we discuss a strategy to expand the genome mining of antibiotic-producing microbes specifically for antimycobacterial development.', 34908399),
('Antibacterial Chemical Compound', 'crystal structure of Salmonella enterica serotype Typhimurium tryptophan synthase in complex with 3-amino-3-imino-2-phenyldiazenylpropanamide (Compound 1)', 'structure-based strategy using in silico docking screening and molecular dynamics (MD) simulations to identify compounds targeting the alpha subunit of tryptophan synthase with experimental methods involving the whole-cell minimum inhibitory concentration (MIC) test, solution state NMR, and crystallography to confirm the inhibition of L-tryptophan biosynthesis. One successful inhibitor, 3-amino-3-imino-2-phenyldiazenylpropanamide (Compound 1) binds to the alpha subunit. A crystal structure of Salmonella enterica serotype Typhimurium tryptophan synthase in complex with Compound 1 which revealed a binding site at the alphabeta interface of the dimeric enzyme.', '', 'Our results show that this small molecule inhibitor could be a promising lead for future drug development.', 34767267),
('Antibacterial Chemical Compound', 'synergistic pair - microcin J25 and sulfamonomethoxine', 'he former is a lasso peptide that inhibits the function of RNA polymerase and the latter is a sulfonamide antibacterial agent that disrupts the folate pathway', '', 'These results showcase the merit of taking a more targeted approach in the search and study of synergistic antibiotic pairs.', 35201676),
('Antibacterial Chemical Compound', 'fluorine-containing halogenated phenazine (HP) and halogenated acridine (HA) agents', 'phenazines 5g, 5h, 5i, and acridine 9c demonstrated potent antibacterial activities against Gram-positive pathogens (MIC = 0.04-0.78 microM). Additionally, 5g and 9c eradicated Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis biofilms with excellent potency (5g, MBEC = 4.69-6.25 microM; 9c, MBEC = 4.69-50 microM). Using real-time quantitative polymerase chain reaction (RT-qPCR), 5g, 5h, 5i, and 9c rapidly induce the transcription of iron uptake biomarkers isdB and sbnC in methicillin-resistant S. aureus (MRSA) biofilms, and we conclude that these agents operate through iron starvation.', '', 'Overall, fluorinated phenazine and acridine agents could lead to ground-breaking advances in the treatment of challenging bacterial infections.', 35089005),
('Antibacterial Chemical Compound', 'transferrin-conjugated copper peroxide nanoparticle-hydrogel (denoted as CP@Tf-hy)', 'When exposed to an initial acidic wound environment, the CP@Tf-hy simultaneously displays in situ self-supplied H2O2 and pH-responsive release of Fenton catalytic copper ions accompanied by highly toxic hydroxyl radical (', 'the positively charged CP@Tf-hy can efficiently trap and restrain negatively charged bacteria to the range of ', 'The safe, low-cost, and all-in-one CP@Tf-hy holds great prospects as an antibacterial dressing for rapid resistant bacteria-infected purulent wound healing.', 35319859),
('Antibacterial Chemical Compound', 'Chalcone Derivatives (F88 and F90)', 'Potential Inhibitors of P-Glycoprotein and NorA, as potential modulators of both transporters, whose activity on Staphylococcus aureus strains overexpressing NorA and resistant to ciprofloxacin was subsequently confirmed.', '', 'The findings of this study are expected to guide future research towards developing novel potent chalconic inhibitors of P-gp and/or NorA.', 35378788),
('Antibacterial Chemical Compound', 'series of 1-(2-(furan-2-yl)-5-(pyridin-4-yl)-1,3,4-oxadiazol-3(2H)-yl)-3-(aryl)-prop-2-en-1-ones (5a-o)', 'Compound 5b was reported to be the most effective against M. tuberculosis H37 Ra (97.69 percent inhibition at 30 microg/ml) and M. bovis (97.09 percent inhibition at 30 microg/ml).', '', 'We have compared our method with the conventional procedure, and the data show that our procedure is more effective in the preparation of title compounds.', 34414591),
('Antibacterial Chemical Compound', 'acetylcysteine ligand (AF-AcCys)', 'retains an antibacterial effect superimposable with that of AF against Staphylococcus aureus, whereas it is about 20 times less effective against Staphylococcus epidermidis', '', 'From the results, it emerged that the lower lipophilicity of AF-AcCys with respect to AF could be a key feature for its different antibacterial activity.', 35458776),
('Antibacterial Chemical Compound', 'GaMF1 in combination with clofazimine, rifabutin, or amikacin', 'inhibits growth and kills M. abscessus by targeting the F-ATP synthase. GaMF1''s anti-M. abscessus activity increased in combination with clofazimine, rifabutin, or amikacin.', '', 'The study expands the repertoire of anti-M. abscessus compounds targeting oxidative phosphorylation.', 35481752),
('Antibacterial Chemical Compound', 'Natural Berberine-derived Azolyl Ethanols', 'the active compounds 4d and 18b possessed the ability to rapidly kill bacteria and observably eradicate the E. coli biofilm by reducing exopolysaccharide content to prevent bacterial adhesion, which was conducive to alleviating the development of E. coli resistance.', '', 'These results provided powerful information for the further exploitation of natural berberine derivatives against bacterial pathogens.', 34964345),
('Antibacterial Chemical Compound', '3 bis-indole alkaloids-bromodeoxytopsentin, bromotopsentin and spongotine A', 'Against Gram-positive pathogens (MRSA) and Gram-negative gastroenteric pathogen (Vibrio parahaemolyticus). Reduced pathogen cytotoxicity toward mammalian cells indicating their ability to prevent bacterial virulence.', '', 'In conclusion, sponge bis-indole alkaloids are membrane-permeabilizing agents that represent good antibiotic candidates because of their potency against Gram-positive and Gram-negative bacterial pathogens.', 35216106),
('Antibacterial Chemical Compound', 'Methyl-(Z)-11-tetradecenoate Acid', 'the studied E. coli population statistically confirmed different degrees of resistance in most of the samples analyzed in this test', '', 'Conclusions: In one case, the methyl-(Z)-11-tetradecenoate acid was observed to have a relationship with the susceptibility evaluation by using the disc diffusimetric method, which has revealed the lowest rate of antimicrobial resistance, so it has importance in further resistance evaluation studies.', 35734346),
('Antibacterial Chemical Compound', 'Zanthoxylum nitidum', 'two new coumarins, 6-(3-oxo-butyl)-limettin (1) and toddalin I (2), and 24 known compounds were isolated from the roots of Z. nitidum, in which two isoquinoline alkaloids, 6-acetonyl-dihydrofagaridine (16) and 6-acetonyl-dihydrochelerythrine (17) showed anti-MRSA bioactivity in vitro and in vivo. Both 16 and 17 showed synergistic action with ampicillin, which decreased the MIC significantly, and both compounds had a significant ability to destroy bacterial biofilm combined with ampicillin. The combined administration showed a strong scavenging effect on the planktonic bacteria in vitro and cleared skin infection effectively in the model of wound infection in vivo', '', 'Our investigation supported the traditional use of Z. nitidum in treating infections caused by bacteria, and might provide new natural products to reduce the use of antibiotics and the treatment of drug-resistance bacteria.', 35240520),
('Antibacterial Chemical Compound', 'catechin-in-cyclodextrin-in-phospholipid liposome (CCPL)', 'inhibited young biofilm (64.15-72.70%) as well degraded mature biofilm (55.60-63.65%) at ', '', 'Thus, the results of present study revealed that the CCPL can effectively reduce the virulence properties and its application could inhibit the pathogenicity and also prevents the development of drug-resistance in MRSA strains.', 35569694),
('Antibacterial Chemical Compound', 'silver(I) metal organic frameworks Ag2(HBTC)', 'showed an inactivation efficiency of more than 99.9% against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) at a concentration of 200-250 mg L-1', '', 'In general, this study shows a promising perspective on designing MOF/PLA membranes with broad-spectrum disinfection capability for potential environmental sterilization and public healthcare protection.', 35411886),
('Antibacterial Chemical Compound', 'poly-tetrahydropyrimidine (P-THP) polymers', 'effectively inhibit the growth of Gram-positive bacteria (Staphylococcus aureus, S. aureus) and Gram-negative bacteria (Escherichia. coli, E. coli)', '', 'Generally speaking, P-THP polymers have considerable application potential in the field of treating bacterial infections and promoting wound healing.', 35024701),
('Antibacterial Chemical Compound', 'melittin alone and in combination with vancomycin and rifampin', 'The preventive and therapeutic indexes of melittin were improved 8-fold when combined with vancomycin and rifampin', '', 'Based on these findings, the combination of melittin with conventional antibiotics could be proposed for treating or preventing biofilm-associated MRSE infections.', 35123230),
('Antibacterial Chemical Compound', 'Lactobacillus rhamnosus', 'L. rhamnosus from remote Indigenous Australian children are potent inhibitors of respiratory pathogens in vitro.', '', 'Conclusions: L. rhamnosus from remote Indigenous Australian children are potent inhibitors of respiratory pathogens in vitro.', 34606144),
('Antibacterial Chemical Compound', 'polyionenes', 'inactivates MHV completely in 30 s, effective in inhibiting SARS-CoV-2 by >99.999% within 30 s', '', 'Overall, these polyionenes are promising active ingredients for disinfection and prevention of viral and microbial infections.', 34694749),
('Antibacterial Chemical Compound', 'seven phenolic phytochemicals (gallic acid; epicatechin; epigallocatechin gallate; daidzein; genistein; myricetin; 3-hydroxy-6-methoxyflavone) in combination with six antibiotics', 'against multidrug-resistant isolates from the ESKAPE group, 24 showed synergistic effects (12.8%)', '', 'The results highlight the potential use of antibiotic-phytocompound combinations for combating infections with multi-resistant pathogens. Synergistic combinations could downregulate the resistance mechanisms of bacteria.', 34365707),
('Antibacterial Chemical Compound', '1,2,4-triazole-isatin derivatives', 'MIC of 0.8 Microg/ml', '', 'These studies revealed that molecule 5h could act as a potential lead molecule for further studies to find new target-directed molecules.', 35434882),
('Antibacterial Chemical Compound', 'Plantaricin A - OP4 (Derived from Lactiplantibacillus plantarum)', 'intensifies the potency of antibiotics, PlnA1 analogs OP4 heightens the potency of erythromycin against E. coli and relieves inflammation', '', 'In summary, our results showed that the PlnA1 analogs investigated in the present study, especially OP4, reduce the intrinsic antibiotic resistance of Gram-negative pathogens and expand the antibiotic sensitivity spectrum of hydrophobic antibiotics in Gram-negative bacteria.', 35499329),
('Antibacterial Chemical Compound', 'in situ exopolysaccharide (in situ-EPS1)', 'containing rare fucose produced by Lactobacillus helveticus MB2-1 in Sayram ketteki yoghurt exhibited significant antibiofilm effect against MRSA', '', '', 35777514),
('Antibacterial Chemical Compound', 'sodium calcium phosphates (P2O5)50(Na2O)20(CaO)30-X(MO)X, Co + Cu, Co + Zn, and Cu + Zn', 'against Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacterial strains, as well as a fungal strain (Candida albicans). An enhanced antimicrobial effect, at 5 mg/mL concentration, was exhibited by cobalt, copper, and zinc oxide glasses alone and in combinations.', '', 'A synergistic antimicrobial effect was observed by Cu + Co and Cu + Zn against E. coli and Cu + Zn against S. aureus.', 35199992),
('Antibacterial Chemical Compound', 'biphenyl-benzamides as FtsZ inhibitors', 'compound 30 exhibited excellent antibacterial activities, especially against four different Bacillus subtilis strains, with an MIC range of 0.008 Microgram/mL to 0.063 microg/mL', '', 'identified as a promising FtsZ inhibitor worthy of further profiling.', 35763867),
('Antibacterial Chemical Compound', 'pinocembrin', 'MIC and MBC were 256 Microgram/mL and 512 Microgram/mL against A. hydrophila', '', 'Thus, pinocembrin is a candidate drug for the treatment of A. hydrophila infection in aquaculture.', 35438439),
('Antibacterial Chemical Compound', 'STK-35/66', 'MIC and MBC ranges were 0', '', 'In nutshell, these results suggested that STK-35/66 possessed antimicrobial activity against Gram-negative pathogenic bacteria in vitro and in vivo, which could be considered as potential substitutes for the treatment of Gram-negative pathogenic infections after further structure optimization.', 35218030),
('Antibacterial Chemical Compound', 'Recombinant Myeloperoxidase (rMPO)', 'rMPO could kill antibiotic-resistant bacteria, making it very useful for treatment of nosocomial infections and mixed infections', '', 'Our data suggest that recombinant MPO from human cells is a new class of antimicrobials with a broad spectrum of activity.', 35019674),
('Antibacterial Chemical Compound', 'N,N-dimethyldithiocarbamate (DMDC)', 'bactericidal antibiotic against S. pneumoniae', '', 'Taken together, this study provides mechanistic insights regarding DMDC''s activity as an antibiotic at the host-pathogen interface.', 35311543),
('Antibacterial Chemical Compound', 'membrane-active antimicrobial agent nTZDpa', 'exhibit enhanced antibiotic activity against multidrug-resistant Gram-positive pathogens in acidic pH, but also retains antimicrobial potency under anaerobic conditions', '', 'These findings demonstrate that nTZDpa is a promising lead compound for developing new therapeutics against hard-to-cure infections caused by drug-resistant and -tolerant S. aureus.', 35447554),
('Antibacterial Chemical Compound', 'combination of Cu(II) and dissolved biochar', 'when the Cu(II) concentration exceeded 0.5 mg/L, the transfer efficiency was entirely inhibited', 'the transfer frequency was significantly reduced; this occurred regardless of the Cu(II) concentration or pyrolysis temperature of dissolved biochar', 'This study provides a new environmental contaminant treatment approach to eliminate the heavy metal-facilitated transfer of ARGs between bacteria.', 34583164),
('Antibacterial Chemical Compound', 'Combination of Auranofin and Pentamidine', 'slowed down auranofin resistance development in clinically isolated MDR bacteria (Klebsiella pneumoniae)', '', 'Conclusion: The combination of non-antibiotic drugs with complementary antibacterial mechanisms provides a potentially promising approach to discover new antibacterial drugs and delay drug resistance development.', 35378227),
('Antibacterial Chemical Compound', 'O3-based advanced wastewater treatment', 'inactivated all AMRB and AMSB (>99.9%) after 10 min of treatment, removed antimicrobial resistance genes (AMRGs) in the wastewater', '', '', 35203813),
('Antibacterial Chemical Compound', 'unithiol', 'Inhibition of Metallo-beta-Lactamases for the Treatment of Carbapenem-Resistant Gram-Negative Bacterial Infections', '', 'Thus, we demonstrate both experimentally and theoretically that the unithiol is a prospective competitive inhibitor of metallo-Beta-lactamases and it can be utilized in complex therapy together with the known beta-lactam antibiotics.', 35163756),
('Antibacterial Chemical Compound', 'auranofin', 'against N. gonorrhoeae using a murine model of vaginal infection, a 1.04 (91%) and 1.40 (96%) average log10-reduction of recovered N. gonorrhoeae was observed', '', 'In conclusion, auranofin has the potential to be further investigated as a novel, safe anti-gonococcal agent to help meet the urgent need for new antimicrobial agents for N. gonorrhoeae infection.', 35446884),
('Antibacterial Chemical Compound', 'Azadirachta indica (Neem), methanolic extract, Beta.d-Mannofuranoside', 'methanolic extract of neem leaves was found to have antibacterial activity against all pathogenic and reference strains., MIC (32 Microg/ml and 64 Microg/ml) against S. aureus (ATCC 25,923) and E. coli (ATCC 25,922)', '', 'Conclusion: The methanolic extract of A. indica leaves possessed strong antibacterial activity against different types of bacteria. Beta.d-Mannofuranoside, O-geranyl was the most active compound and it passed 5 rules of drug-likeness properties. It could therefore be further processed for animal testing and clinical trials for its possible use as an antibacterial agent with commercial values.', 35610569),
('Antibacterial Chemical Compound', 'Florfenicol-Polyarginine Conjugates', 'Drug-sensitive bacteria, gram-negative bacteria Escherichia coli (E. coli) and gram-positive Staphylococcus aureus (S. aureus), were sensitive to several of the compounds tested. These conjugates also showed excellent activity against drug-resistant strains such as methicillin-resistant S. aureus (MRSA) and florfenicol resistant Escherichia coli strains (2017XJ30, 2019XJ20), one of which as E6 had a minimum inhibitory concentration of 12.5 Micromol/L.', '', 'These new conjugates may provide useful insights for expanding the pool of antibiotics.', 35844651),
('Antibacterial Chemical Compound', 'Amidine Substituted Monocyclic Beta-Lactams (Compound 23d)', 'MIC 0.25 Microg/mL to 2 Microg/mL against tested strains', '', 'Therefore, compound 23d may be a valuable lead target for further investigations against multi-drug resistant Gram-negative bacteria.', 34463230),
('Antibacterial Chemical Compound', 'deep eutectic solvents (DES)', 'improve, by 2 to 4-fold, the susceptibility of Gram-negative (Escherichia coli and Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus) bacteria to the antibiotic, improve the therapeutic efficacy at concentrations where bacteria present resistance, without promoting tolerance development to ciprofloxacin', '', 'The results herein reveal the pioneering use of DES in fluoroquinolone-based formulations and their impact on the antibiotic''s characteristics and on its therapeutic action.', 35151818),
('Antibacterial Chemical Compound', 'sialic acid derivatives', 'potent compounds, which have a 180-fold higher affinity compared to the natural substrate, were tested in bacterial growth assays and indicate bacterial growth delay in methicillin-resistant Staphylococcus aureus', '', 'This study represents the first example and a promising lead in developing sialic acid uptake inhibitors as novel antibacterial agents.', 35675124),
('Antibacterial Chemical Compound', 'QSI-5 (quorum sensing inhibitors)', 'reduced the mortality (88.4%), lesion severity (72.2%), and APEC load (2.8 logs) in chickens', '', 'In conclusion, QSI-5 displayed promising effects in chickens and thus, represents a novel anti-APEC therapeutic.', 35583333),
('Antibacterial Chemical Compound', 'prenylated emodine-type anthranoid Ferruginin A', 'potent activity against both the planktonic and biofilm forms of Gram-positive bacteria (i.e., Staphylococcus aureus and S. epidermidis)', '', 'In conclusion, ferruginin A represents a promising scaffold for the further development of valuable antimicrobial agents.', 35052961),
('Antibacterial Chemical Compound', '3-alkyl-pyridinic analogs', 'The most effective compound 6 has MIC ranging from 0.98 to 3.9 Microgram mL-', '', 'A 3-alkylpyridine-bearing alkaloid exhibits potent antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA) with no detectable resistance', 35636092),
('Antibacterial Chemical Compound', 'combination of carvacrol and thymol', 'combination of carvacrol and thymol was observed to have better inhibition effect on common pathogens in vitro, MICs of thymol and carvacrol in our study were slightly higher for gram-negative bacteria', '', '', 35602084),
('Antibacterial Chemical Compound', '1,2,4-oxadiazole/pyrrolidine hybrids', 'compound 17 outperformed ciprofloxacin against E. coli, with an MIC of 55 ng/ml, compared to 60 ng/ml for ciprofloxacin', '', 'Finally, the docking study, along with the in vitro experiments, supports our promising approach to effectively develop potent leads for further optimization as dual DNA gyrase and Topo IV inhibitors.', 35363388),
('Antibacterial Chemical Compound', '1-{4-[(1E)-2-(3,5-dimethoxyphenyl)ethenyl]phenoxy}-3-{[(4-fluorophenyl)methyl]amino}propan-2-ol(Isopropanolamine-Tailored Pterostilbene Derivative)', 'compound C1 displayed excellent antibacterial potency in vitro, affording an EC50 value of 0.88 Microg mL-1 against Xoo (Xanthomonas oryzae pv. oryzae). C1 could significantly reduce biofilm formation and extracellular polysaccharides (EPS).', '', 'Given these promising profiles, these pterostilbene derivatives can serve as novel antibiofilm agents to suppress plant pathogenic bacteria.', 35437986),
('Antibacterial Chemical Compound', 'biphenyl analogue of macolacin', 'against Gram-negative pathogens expressing mcr-1 and intrinsically resistant pathogens with chromosomally encoded phosphoethanolamine transferase genes', '', 'In a mouse neutropenic infection model, a biphenyl analogue of macolacin proved to be effective against extensively drug-resistant A. baumannii with colistin-resistance, thus providing a naturally inspired and easily produced therapeutic lead for overcoming colistin-resistant pathogens.', 34987225),
('Antibacterial Chemical Compound', 'Polyamino-isoprenyl compound NV716', 'NV716 increased the relative potency of all drugs against intracellular infection by the same bacteria as well as their maximal efficacy and also considerably reduced the MICs of these antibiotics(rifampicin, azithromycin, linezolid, fusidic acid, novobiocin, chloramphenicol, and doxycycline, plus ciprofloxacin as an active drug)', 'no toxicity was evidenced towards eukaryotic cells.', 'NV716 also enhanced rifampicin activity against biofilms from these three species. These data highlight for the first time the potential interest of NV716 as an adjuvant against these Gram-negative bacteria like Escherichia coli, Klebsiella pneumoniae or Acinetobacter baumannii placed in the priority list of WHO for search of new therapies.', 35691172),
('Antibacterial Chemical Compound', 'guanidine derivative isopropoxy benzene guanidine (IBG)', 'the growth of more than 93% of the bacteria (E. coli ATCC 25922 and SHP45) was inhibited after treatment with 10 microg/mL IBG and 0.25 microg/mL colistin in synergy', '', 'IBG, serving as an antibiotic adjuvant, acted synergistically with colistin against diverse MDR Gram-negative bacteria (including colistin-resistant and -susceptible strains) and potentiated the therapeutic effect of colistin in vivo. so as concluded that IBG is a potential lead compound for the design of membrane-active drugs.', 36475769),
('Antibacterial Chemical Compound', 'Novel phenylamino acetamide compound, named 187R', '187R strongly inhibited the expression of the type III secretion system (T3SS) encoding genes and the secretion of the T3SS effector proteins in Pseudomonas aeruginosa', '', 'T3SS is an important virulence factor, 187R-mediated repression of T3SS was dependent on ExsA, the master regulator of T3SS in P. aeruginosa. The impact of 187R on the host-associated microbial community was also tested using the Arabidopsis thaliana phyllosphere as a model. These results suggested that compounds that target virulence factors could serve as an alternative strategy for disease management caused by bacterial pathogens.', 36519869),
('Antibacterial Chemical Compound', 'dipyrrins that supresses colistin resistance', 'MIC of colistin in a highly colistin resistant strain, A. baumannii AB4106, from 1024 microg/mL to 4 microg/mL at a concentration of 5 microM. Against K. pneumoniae strain B9, prodigiosin lowered the colistin MIC from 512 microg/mL to 2 microg/mL at a concentration of 1.25 microM', '', 'an adjuvant approach that can extend the utility and lifespan of a last-resort antibiotic such as colistin has the potential to play an important role in the fight against infections caused by MDR bacteria.', 35704751),
('Antibacterial Chemical Compound', 'Cationic pillar arene with pyridinium groups (PP5)', 'PP5 disrupt the pathogen', 'PP5 has high activity to inhibit Gram-positive and Gram-negative bacteria and/or their biofilms with low cytotoxicity.', 'It was concluded that the microbicidal activity of PP5 was due to the physical disruption of the pathogen''s membrane and the subsequent leakage of cytoplasmic components, which could greatly reduce the rapid generation of resistance against Staphylococcus aureus and Escherichia coli. Hence it can be used as a good candidate for controlling drug-resistant pathogenic bacterial infections and treating MDR bacteria.', 35953617),
('Antibacterial Chemical Compound', 'boric acid and potassium metaborate', '600 microg/ml potassium metaborate and 1,250 microg/ml boric acid exhibited a minimal inhibition of MRSA as a result of dilution with the final concentration of 20 mg/ml boron compounds. Y?lmaz found the MIC value of 3.80 mg/ml when examining the effect of boric acid and borax on the S. aureus ATCC 25923 strain. Similarly, Say?n et al found that the MIC value of 3.09 mg/ml when examining the antibacterial and biofilm effects of boric acid on the S. aureus ATCC 25923 strain.', 'According to the results, potassium metaborate was more effective and exhibited a lower toxicity to fibroblast cells compared to boric acid;', 'the findings of the present study suggest that boric acid and potassium metaborate may be effective in a wound model infected with methicillin?resistant Staphylococcus aureus. Boric acid also increased the IL-10 expression level at the same time.', 35920188),
('Antibacterial Chemical Compound', '4,4''-dihydroxy-azobenzene (DHAB)', 'potential in vitro as an antimicrobial agent against two relevant human and animal pathogens, namely Staphylococcus aureus and Staphylococcus pseudintermedius. The values of minimal inhibitory concentration MIC were 64 and 32 mg/L respectively.', 'It has been proven that the toxicity of this substance is very low particularly at a dermal level.', 'DHAB caused membrane damage as revealed by the increase in thiobarbituric acid reactive substances (TBARS) such as malondialdehyde. Furthermore, differential induction of the enzymes peroxidases and superoxide dismutase in S. aureus and S. pseudintermedius suggested their prevalent role in ROS-scavenging due to the oxidative burst induced by this compound in either species. this suggests that this substance could be a promising candidate as an alternative to antibiotics in the treatment of animal skin infections,', 36551456),
('Antibacterial Chemical Compound', 'Role of sodium salicylate in Staphylococcus aureus', 'NaSa modulates quorum sensing and virulence in agr III-type strain ATCC 25923', '', 'It is suggested that the observed NaSa inhibition of bacterial communication is a potential alternative or adjuvant to traditional antibiotics.', 35992652),
('Antibacterial Chemical Compound', 'novel organoantimony(V) cyanoximates of Sb(C6H5)4L composition', 'Organoantimony(V) compounds is investigated as potential non-antibiotic antimicrobial agents against three Bacterial pathogens included Gram-negative Escherichia coli and Pseudomonas aeruginosa, and Gram-positive Staphylococcus aureus.', '', 'Overall, the new antimony compounds showed a strong potential as both broad- and narrow-spectrum antimicrobials against selected bacterial and fundal pathogens and provide insights for further synthetic modifications of the compounds to increase their activities.', 36363997),
('Antibacterial Chemical Compound', 'effect of combining sodium ascorbate and/or apo-transferrin with imipenem', 'Test isolates demonstrated a broader range of MIC values (8 to 128 microg/mL) when susceptibility to imipenem was assessed. In total, all test isolates (100%) were imipenem resistant (MIC of imipenem [MICimp] > 4 mg/L). However, high MIC values were recorded for sodium ascorbate (512 to 1,024 microg/mL) compared to apo-transferrin (64 to 256 microg/mL)', '', 'The triple combination therapy restored lung function and structure. our findings suggest novel insights about a promising new combination therapy against highly resistant carbapenemase-producing A. baumannii to restore the effectiveness of imipenem.', 35975993),
('Antibacterial Chemical Compound', 'fosfomycin (FOS) combined with rifampin (RIF) showed strong synergistic effects', 'when FOS in conjunction with RIF against CRPA11?20 carbapenem-resistant Pseudomonas aeruginosa, the MICs of FOS notably decreased from 128', '', 'The results of the inhibition biofilm formation assay demonstrated that RIF and FOS at 1/8MIC, 1/16MIC and 1/32MIC have better inhibitory effects on CRPA biofilm formation VS FOS alone or RIF alone . This finding will provide new insights into the treatment of bacterial infections caused by CRPA, which can be further explored in clinical practice.', 36036376);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Chemical Compound', 'New class of antibiotics based on a ring-fused 2-pyridone backbone', 'SAR revealed that by introducing an aryl or benzyl substituent at position C2, the C8 aryl could be changed to a smaller cyclopropyl substituent (chemical synthesis of these compounds is described in the Supplemental Information). This resulted in compounds with increased potency against E. faecalis OG1RF including compounds EC240 (minimal inhibitory concentration [MIC] = 25 microM) and EC305 (MIC = 50 microM). among the C8 methoxy- and C2 alkyl chain analogs, PS757 had substantially improved antibacterial potency (MIC = 3 to 6 microM) compared to EC240 and EC305', '', 'Here they have shown that the new class of 2-pyridone compounds, which named GmPcides, including the second-generation compound PS757, have bactericidal activity against nondividing stationary phase cultures of E. faecalis OG1RF and recently isolated clinical strains of Enterococcus as well as other Gram-positive pathogens. In contrast, concentrations of PS757 which reduced CFUs of stationary phase enterococcal cells by >105 instead showed potent bacteriostatic effects and little to no bactericidal activity against enterococci growing in exponential phase', 36252016),
('Antibacterial Chemical Compound', 'Newly synthesized isatin-decorated thiazole derivatives (7b, 7d, and 14b)', 'The final concentrations of isatin derivatives in the solution ranged from 512 microg/mL to 0.5 microg/mL (512; 256; 128; 64; 32; 16; 8; 4; 2; 1; 0.5 microg/mL) for E. coli and S. aureus, and for C. Albicans.', '', 'In-vitro screening of the newly synthesized compounds for their antimicrobial activity showed promising results against both E. coli and MRSA with anti-biofilm formation activity. Compound 7f, the most potent antimicrobial compound in this study, showed a MIC value eight-fold better than chloramphenicol against MRSA. Hence novel isatin-based thiazole derivatives as promising antibacterial prototypes, against potential target enzymes, is currently under further investigation', 36046334),
('Antibacterial Chemical Compound', 'Cationic compounds, MD-124, which has a diamidine core structure,identified as a potent antibiotiotic adjuvant', 'A checkerboard assay showed that MD-124 sensitized E. coli toward rifampicin in a concentration-dependent manner, reaching over 16,000-fold when 12 microg/mL MD-124 was used, with the MIC of rifampicin being 0.6 ng/mL. To investigate this further, a checkerboard assay of MD-124 in the concentration range of 0', '', 'Besides E. coli, MD-124 also showed sensitization effect on various other WT Gram-negative bacterial species such as Acinetobacter baumannii (ATCC 17978), Klebsiella pneumoniae (ATCC 43816), and Salmonella enterica Typhimurium (ATCC 14028), the resistant strains of which are listed as WHO Priority I pathogens in urgent need of new antibiotics. MD-124 has been shown to be effective against all Gram-negative strains of bacteria studied herein (Figures 1D and 2), presumably because they share very similar LPS structures', 35801980),
('Antibacterial Chemical Compound', 'Two lead compounds 36 and 52 which contained the tetrahydroquinoline core, hydrophobic alkyl chains (n-nonyl or isoprenyl group), different spacer lengths (n = 4 or 8), and cationic guanidine moiety,', 'compounds 36 and 52 exhibited similarly potent in vivo antimicrobial activities in a murine corneal infection caused by Staphylococcus aureus ATCC29213 or Pseudomonas aeruginosa ATCC9027, as compared to vancomycin or gatifloxacin. Against gram positive 0.78-1.56 micro gram MIC for gram positive bacteria and 3.125-6.25 micro gram for gram negative bacteria with compound 52', '', 'The further biological evaluation revealed that compounds 36 and 52 can kill bacteria and fungi rapidly via membrane-targeting action and avoid drug resistance development. These results suggest that compounds 36 and 52 have great potential as new broad-spectrum antimicrobial agents to combat microbial resistance', 36088756),
('Antibacterial Chemical Compound', 'combination of daptomycin and HClO', 'Daptomycin plus HClO lock therapy showed the highest activity for experimental CRI with S. epidermidis.', '', 'HClO could be an effective strategy for treating infections caused by extensively drug-resistant or multidrug-resistant and biofilm-producing strains in medical devices and chronic wounds. The results of the ALT using daptomycin plus HClO may be promising', 36190404),
('Antibacterial Chemical Compound', '2-Aminoimidazole Analogs', 'new 2-aminoimidazole compounds and show that they affect the integrity of the outer membrane in resistant strains of Escherichia coli and Klebsiella pneumoniae.', '', 'They have identified new 2-aminoimidazole containing compounds that target the PhoP response regulator protein. Since PhoP controls various aspects of outer membrane stability in many Gram-negative bacteria, it can be targeted to tackle resistant Gram-negative pathogens. Our work provides solid evidence that the 2-AIs are binding PhoP, altering the protein', 36454711),
('Antibacterial Chemical Compound', 'carbasugar precursors (CSPs)', 'carbasugar precursors (CSPs) and their application as biofilm inhibitors for E. coli and MRSA,. This results in a biofilm reduction of up to 70% for the CSP rac-7 and a reduction in bacterial viability of MRSA by approximately 45% when combined with the otherwise ineffective antibiotic mixture of penicillin and streptomycIN', '', 'Synergy of R-(-)carvone and cyclohexenone-based carbasugar precursors with antibiotics to enhance antibiotic potency and inhibit biofilm formation', 36289389),
('Antibacterial Chemical Compound', 'Novel cationic polysaccharide conjugates Dextran-graft-poly(5-(1,2-dithiolan-3-yl)-N-(2-guanidinoethyl)pentanamide) (Dex-g-PSSn )', 'when compared with Dex-g-PSS15 (MIC = 128 microg mL?1), Dex-g-PSS60 (MIC = 128 microg mL?1), and Dex-g-PSS90 (MIC = 64 microg mL?1), the MIC of Dex-g-PSS30 was 32 microg mL?1 in MDR-AB cells and 8 microg mL?1 in methicillin-resistant Staphylococcus aureus (MRSA) cells, indicating outstanding antibacterial capabilities.', 'Dex-g-PSS30 exhibited relatively low cytotoxicity (half maximal inhibitory concentration (IC50) = 512 microg mL?1) in mouse fibroblast L929 cells. when the concentration was <128 microg mL?1, no significant cytotoxicity was observed.', 'Inner and outer bacterial membranes were damaged and intracellular ROS levels increased by sub-inhibitory Dex-g-PSS30 concentrations, further eliciting damage to bacterial membranes and promoting intracellular antibiotic access. Additionally, bacterial efflux pumps were affected by Dex-g-PSS30 and reduced antibiotic efflux. Finally, bacterial resistance was prevented by Dex-g-PSS30 which restored rifampicin (RIF) efficacy in an MDR-AB-induced pneumonia mouse model. Overall, we present a novel platform for resensitizing MDR bacteria to antibiotics and preventing bacterial resistance.', 35962720),
('Antibacterial Chemical Compound', '5-methylindole adjuvants of aminoglycoside.', 'determined MICs of 5-methylindole to E. coli, P. aeruginosa and Shigella flexneri, which were 8, 16 and 2 mM, MIC of 5-methylindole to K. pneumoniae was determined to be 4 mM, 5-methylindole and 2-methylindole were also able to kill Mycobacterium tuberculosis H37Ra (an avirulent strain) in a concentration-dependent manner', '', 'They observed that 5-methylindole itself exhibited substantial antibacterial activities against a number of Gram-positive and Gram-negative bacterial pathogens, including antibiotic-tolerant S. aureus persisters, MRSA and M. tuberculosis. Second, observed the potentiation effect of 5-methylindole on aminoglycoside antibiotics against S. aureus cells under conventional treatment conditions. Hence findings open a new avenue to develop indole derivatives like 5-methylindole as antibacterial agents or adjuvants of aminoglycoside.', 36124131),
('Antibacterial Chemical Compound', 'Ethyl 4-[[2-chloro-5-(phenylcarbamoyl)phenyl]sulfonylamino]benzoate (SABA1) is a compound', 'SABA1 has a MIC of 0.45', '', '(SABA1) is a compound that has been shown to have antibacterial properties against Pseudomonas aeruginosa and Escherichia coli. SABA1 inhibits biotin carboxylase (BC), the enzyme that catalyses the first half reaction of ACC. SABA1 represents a potentially new class of antibiotics that can be used to combat the antibacterial resistance crisis.', 34894987),
('Antibacterial Chemical Compound', 'NAD+ analogue', 'NAD+ -competitive inhibitor of NADKs, which displayed in vivo activity against Staphylococcus aureus. Analogue benzamide adenine dinucleoside analogue, active against PaNADK Pseudomonas aeruginosa NAD kinase', '', 'Structural analysis led us to design and synthesize a benzamide adenine dinucleoside analogue, active against PaNADK. This novel compound efficiently inhibited PaNADK enzymatic activity in vitro with a Ki of 4.6 microm. Moreover, this compound reduced P. aeruginosa infection in vivo in a zebrafish model.', 36036789),
('Antibacterial Chemical Compound', 'Polymyxin B Analogues Modified at Leu-7, d?Phe-6, and the N?Terminus Enabled by S?Lipidation', '', 'showed minimal kidney nephrotoxicity,', 'Several polymyxin analogues bearing one or more S-linked lipids were found to be equipotent to polymyxin. The S-lipidation strategy has demonstrated potential as a novel approach to prepare innovative new lipopeptide antibiotics.', 36413173),
('Antibacterial Chemical Compound', 'dicationic bisguanidine-arylfuran, originally developed as an antitrypanosomal agent', 'Compounds bearing an electron donating group on the phenyl ring such as CH3 (4) or OCH3 (6) had moderate antibacterial activity. Both compounds had an EC50 of around 28.5 microM against Gram-negative P. carotovorum and around 14.4 microM against P. putida', 'The cytotoxicity of all compounds was evaluated using the human MCF-7 and HepG2 cell lines. All derivatives were moderately cytotoxic with an effective concentration of 50% (EC50) greater than 25 microM in both cell lines. new derivatives were less cytotoxic than the lead molecule, offering better selectivity', 'antibacterial compounds carrying an aminoguanidine group have been reported to potentiate norfloxacin in Staphylococcus aureus, suggesting a possibility to develop the guanidine-containing molecules reported here as co-drugs***', 36009984),
('Antibacterial Chemical Compound', 'synthetic halogenated aminochalcone named (2E)-1-(4-aminophenyl)-3-(4-fluorophenyl)prop-2-en-1-one (C15H12FNO, hereinafter named PA-Fluorine)', 'The PA-Fluorine presented MIC ? 1024 microg/mL for all bacterial strains tested (S. aureus (ATCC 25923) and E. coli (ATCC 25922) strains and multidrug-resistant S. aureus 10 and E. coli 06 strains) Therefore, modulatory activity of antibiotics was observed to PA-Fluorine against strains of E. coli 06 and S. aureus 10. MIC of ampicillin alone on S. aureus was approximately 20 microg/mL. However, this decreased to 5 microg/mL when combined with ampicillin and sulbactam. MIC of ciprofloxacin in S. aureus was 40 microg/mL. The combination with chlorpromazine resulted in a synergism', '', 'PA-Fluorine has the potential to increase the antibacterial activity of antibiotics. In this study, combination with PA-Fluorine modified the activity of ciprofloxacin and gentamicin against MDR S. aureus and E. coli strains. Furthermore, PA-Fluorine modified the activity of the antibiotics norfloxacin, EtBr, and ciprofloxacin, and reduced the MIC for the S. aureus strains 1199B and K2068.', 35475507),
('Antibacterial Chemical Compound', 'amino dihydropyrimidine', 'Dihydropyrimidine represents a solid lead compound for antibacterial development, as it was reported to display significant inhibition of various S. aureus strains (MIC values from 2 to 9 microg/mL (5.5', 'dihydropyrimidine show lack of mammalian toxicity, no inhibition of bovine DHFR, and inactivity in a range of cross-indication assays used to investigate common cytotoxicity modes (up to 100 microM concentrations).', 'A functionalized amino dihydropyrimidine was reported to exhibit antibacterial activity via the inhibition of dihydrofolate reductase, as antibacterial target.', 36312355),
('Antibacterial Chemical Compound', 'novel compound: a 3,5-dinitroindole-2-carboxylate derivative, termed MZ-01.', 'MZ-01 showed bactericidal activity against Gram-positive S. pyogenes and S. pneumoniae (MIC: 5.33 microg/mL), weak antibacterial activity against Gram-positive M. abscessus, and no activity against Gram-negative P. aeruginosa and K. pneumoniae at 128 microg/mL. MZ-01 also appeared to have weak activity against E. coli at 106.67 microg/mL;', 'MZ-01 had low cytotoxicity against eukaryotic cell lines (Vero monkey kidney cells and A549 human lung cancer epithelial cells,', 'In conclusion, we identified that MZ-01 possesses good antibacterial activity against Gram-positive bacterial pathogens, including MRSA. Our finding suggests that MZ-01 is a promising compound for the development of selective antibacterial agents for Gram-positive bacterial infections.', 36358205),
('Antibacterial Chemical Compound', '3-[(3-{[2-({3-[(4-chloro-2-hydroxyphenyl)carbamoyl]naphthalen-2-yl}oxy)ethyl]carbamoyl}naphthalen-2-yl)oxy]propan-1-aminium chloride.( Chemical structure of compound 666-15)', '666-15 showed a synergistic effect on polymyxin B (FICI ?0.281) . The synergistic effects were also found in Acinetobacter baumannii ATCC19606 (FICI ?0.281) and Pseudomonas aeruginosa ATCC27853 (FICI ?0.281), while 666-15 itself had no antibacterial activity (MIC >100 microg/ml). No synergistic effect was found between 666-15 and polymyxin B nonapeptide (PBMN) against K. pneumoniae ATCC13883,', '', 'This result indicated that the synergistic effect between 666-15 and polymyxin B was due to the enhancement of the antibacterial activity of PB by 666-15. In this case, 666-15 should be considered an antibiotic adjuvant. No synergistic effects were observed between 666-15 and other antibiotics', 36147339),
('Antibacterial Chemical Compound', 'protocatechuic acid (PCA), a phenolic compound found in medicinal plants,', 'PCA enhances the activity of levofloxacin (LEV) against Staphylococcus aureus (a) and Escherichia coli (b), as well as that of cefotaxime (CTX) against Escherichia coli (c) and Pseudomonas aeruginosa', '', 'The PCA antioxidant action comes from the property of scavenging free radicals by donating hydrogen atoms or electrons [24], whereas the antibacterial activity is due to the action of decreasing lipid oxidation levels', 35888098),
('Antibacterial Chemical Compound', 'N-{5-ethyl-[1,2,4]triazolo[1,5-c]quinazolin-2-yl}-2,2,2-trifluoroacetamide( Compound IMB-0042)', 'IMB-0042 could inhibit the growth of E. coli ATCC 25,922 with MIC of 25 microg/mL. IMB-0042 also showed growth-inhibition activity against Klebsiella peneumoniae (K. pneumonia), Pseudomonas aeruginosa (P. aeruginosa), and Acinetobacter baumannii (A. baumannii) (MICs were 100 microg/mL, 100 microg/mL, and 25 microg/mL respectively) and synergistic sensitization activity with Polymyxin B. However, for Amikacin and Gentamicin, IMB-0042 only a synergistic effect on P. aeruginosa', 'They used human renal epithelial cell line 293T to detect the growth inhibition effect of IMB-0042 on human cells. No obvious cytotoxicity was detected when treated with IMB-0042 at 50 microg/mL, indicating that human cells are less sensitive to IMB-0042, compared with E. coli cells.', 'compound IMB-0042 was obtained with the capability of blocking LptA/LptC interaction. IMB-0042 showed potent inhibitory activity against the E. coli ATCC 25922 strain. IMB-0042 showed good synergistic sensitization activity with Polymyxin B and aminoglycoside compounds, which can greatly reduce the dosage of these drugs in reducing their possible toxicity and overcoming their drug resistance.', 36290043),
('Antibacterial Chemical Compound', 'naphthalimidopropanediols (NIOLs) as a novel structural', 'these NIOLs could target and destroy the S. aureus or P. aeruginosa membranes.', 'The in vitro and in vivo cytotoxicity assay indicated that these compounds possessed low toxicity.', 'NIOLs cause membrane depolarization, outer/inner membrane permeabilization and leakage of intracellular material efficiently kill the strains within the biofilms. they could disrupt the antioxidant defense systems of S. aureus or P. aeruginosa through up-regulation of reactive oxygen species. These findings of novel NIOLs as potential broad-spectrum antibacterial members provided a bright hope for conquering drug resistance.', 35964427),
('Antibacterial Chemical Compound', 'derivatives of benzothiazole', 'Most compounds showed antimicrobial activity against S. aureus with an MIC range of 0.025 to 2.609 mM. The most active compound, 4-(Benzo[d]thiazole-2-yl)-5-(p-tolyl)-1H-pyrazol-3(2H)-one - 16c, exhibited superior activity against the S. aureus strain with an of MIC 0.025 mM among all tested compounds,', '', 'new derivatives of benzothiazole were synthesized and evaluated for their antimicrobial activity and ability to inhibit the DHPS enzyme. According to the finding, three compounds, 16a-c: 4-(Benzo[d]thiazole-2-yl)-5-(4-florophenyl)-1H-pyrazol-3(2H)-one (16a), 4-(Benzo[d]thiazole-2-yl)-5-(4-chlorophenyl)-1H-pyrazol-3(2H)-one (16b) and 4-(Benzo[d]thiazole-2-yl)-5-(p-tolyl)-1H-pyrazol-3(2H)-one (16c) had IC50 values comparable to the standard drug and revealed that compound 16b was the most active compound with an IC50 value of 7.85 microg/mL, which is comparable to that of sulfadiazine (standard drug) with an IC50 value of 7.13 microg/mL.', 36551457),
('Antibacterial Chemical Compound', 'Thiazolidine derivatives two analogue series of thiazolidine-2,4-dione and 4-thioxo-thiazolidin-2-one', 'The most active derivatives showed MIC between 1', 'None of the thiazolidine derivatives was cytotoxic for human peripheral blood mononuclear cells (PBMC) with IC50 > 100 microg ml?1, but showed moderate cytotoxicity for L929 fibroblasts.', 'The 5-(3,4-dichlorobenzylidene)-4-thioxothiazolidin-2-one (2b) was the most active derivative against Staph. aureus and showed higher selective indices.', 36000385),
('Antibacterial Chemical Compound', 'The anhydride of ferrocenyl-substituted pyrazole, namely, (S)-(3-(3-(carboxyamino)-3H-pyrazol-4-yl)cyclopenta-1,3-dien-1-yl)(cyclopenta-1,3-dien-1-yl)iron was synthesized using expansion cyclocondensation.', 'The newly designed compound was elevated for their antimicrobial potential against S. aureus and K. pneumoniae bacterial stains. The inhibitory action of the compound was measured in terms of zone of inhibition and MIC values were found in the range of 85', '', 'This study described the novel method for the synthesis of biologically active anhydride of ferrocenyl-substituted pyrazole. It is effective by DNA photo-cleaving, and anti-angiogenic activities of ferrocenyl-substituted compounds were studied. In addition, it may open new doors to initiate research against drug resistance bacteria with possible biomedical applications.', 35949692),
('Antibacterial Chemical Compound', 'novel honokiol derivatives (3?,5-Di(prop-2-en-1-yl)[1,1?-biphenyl]-2,4?-diol) as mimics of antimicrobial peptides (AMPs).', 'These mimics showed potent antimicrobial properties against Gram-positive bacteria. killed bacteria rapidly by interrupting the bacterial membrane', 'weak hemolytic and cytotoxic activities.', 'exhibited excellent antibacterial activity, rapid bactericidal properties, avoidance of antibiotic resistance, These results highlight the potential derivative to be used as therapeutic agents', 35820350),
('Antibacterial Chemical Compound', 'Guanylated Hyperbranched Polylysines (HPL-Gxs)', 'The antibacterial activities of HPL1-6 polymers were also determined against two clinically-relevant Gram-negative bacteria (E. coli and P. aeruginosa) and three Gram-positive bacteria (Methicillin-resistant Staphylococcus aureus (MRSA), Methicillin sensitive S. aureus (MSSA) and B. subtilis) . HPL1-6 had strong antibacterial activities against E. coli, P. aeruginosa, MRSA, MSSA, and B. subtilis, and their MICs were in the range of 12', 'hyperbranched polylysines(HPLs) and guanidinium-functionalized derivatives(HPL-Gxs) are hydrophilic and have high selectivity over rabbit red blood cells (RBCs), low toxicity to mammalian cells, and good in vitro and in vivo biocompatibility.', 'HPLs and HPL-Gxs interact with and lysis the cell membranes of microbes, which can mitigate the development of drug resistance.', 35775877),
('Antibacterial Chemical Compound', 'small molecules based on a triazine-piperazine-triazine scaffold that mimic the cationic amphipathic structure of AMPs', 'compounds showed potent biofilm inhibitory and eradicating activities against multidrug-resistant Pseudomonas aeruginosa (MDRPA).', '', 'these compounds displayed synergistic or additive effects when combined with selected clinically used antibiotics. Furthermore, these compounds have been proven to inhibit pro-inflammatory cytokine. our results demonstrate the potential of the designed compounds as a novel class of multifunctional antimicrobial agents to combat bacterial infection.', 36103802),
('Antibacterial Chemical Compound', 'Enterobactin-Muraymycin Conjugate( siderophore enterobactin (Ent) and its novel biomimetic derivative (AcO)EntKL.)', 'result for MraY inhibition by (AcO)EntKL-SS-9 (IC50=89', '', 'Both muraymycin analogue 9 and its enterobactin conjugate (AcO)EntKL-SS-9 displayed remarkably strong inhibitory potencies against the bacterial target protein MraY in vitro. Conjugate (AcO)EntKL-SS-9 showed a pronounced improvement (ca. 11-fold) of antibacterial activity against the efflux-deficient E. coli deltatolC strain relative to 9. This provided a proof-of-concept that siderophore conjugation might become a valuable approach to enhance the antibacterial activities of MraY-inhibiting nucleoside antibiotics such as 9 against Gram-negative pathogens.', 36222466),
('Antibacterial Chemical Compound', 'sialic acid derivatives', 'compound 3f exhibited a 180-fold affinity increase of binding for PmSiaT. Compound 3e showed the highest affinity for SaSiaT, that is, a 31-fold increase. Compound 3f finds ideal fits of both the phenyl ring and the two bromo atoms in the P. mirabilis SiaT site, which may, at least partly, explain the high affinity of compound 3f for this protein.', '', 'compounds 3e and 3f induce a delay in bacterial growth to different extents, with the most pronounced results on S. aureus. Compounds 3e and 3f represent promising leads toward the development of compounds with a new antibacterial mode of action.', 35675124),
('Antibacterial Chemical Compound', 'novel biphenyl-benzamides', '3-({4''-chloro-2''-methyl-[1,1''-biphenyl]-3-yl}methoxy)-2,6-difluorobenzamide (compound 30) exhibited excellent antibacterial activities, especially against four different Bacillus subtilis strains, with an MIC range of 0.008 microg/mL to 0.063 microg/mL. B subtilis ATCC9372 MIC = 0.016microg/mL, B subtilis 168 MIC= 0.008 microg/mL, B subtilis MG27 MIC= 0.031 microg/mL and , B subtilis BS01 MIC = 0.016 microg/mL', '3-({4''-chloro-2''-methyl-[1,1''-biphenyl]-3-yl}methoxy)-2,6-difluorobenzamide (compound 30) also showed good pharmaceutical properties with low cytotoxicity (CC50 > 20 microg/mL), excellent human metabolic stability (T1/2 = 111.98 min)', '3-({4''-chloro-2''-methyl-[1,1''-biphenyl]-3-yl}methoxy)-2,6-difluorobenzamide (compound 30) also showed good pharmaceutical properties with low cytotoxicity, excellent human metabolic stability , moderate pharmacokinetics and in vivo efficacy, which can be identified as a promising FtsZ inhibitor worthy of further profiling. Targeting at the cytoskeletal cell division protein filamenting temperature-sensitive mutant Z (FtsZ) has been validated as an effective and promising approach for antibacterial drug discovery.', 35763867),
('Antibacterial Chemical Compound', 'new aminonaphthol derivatives substituted with 2- and 1-naphthol were synthesised.', 'Derivative Compounds 13 and 14 could inhibit the efflux pump system in susceptible and methicillin-resistant Staphylococcus aureus strains.', '', 'The compounds have also been tested in bacteria in order to reduce or reverse antibiotic resistance. Application of partially aromatic ortho-quionone-methides for the synthesis of novel naphthoxazines with improved antibacterial activity', 35472850),
('Antibacterial Chemical Compound', 'novel triazole-isatin derivatives', 'All the 10 derivatives of isatin demonstrated good antimycobacterial activity with MIC ? 6.25 microg/ml. Compound 5h C17H13N5O2 displayed good antimycobacterial activity with MIC of 0.8 microg/ml', 'good safety profile with higher selectivity index with HEK293 cell line.', 'The triazole-isatin derivatives showed significant binding interactions with amino acid residues in the active site of the enzyme. These studies revealed that molecule 5h could act as a potential lead molecule for further studies to find new target-directed molecules.', 35434882),
('Antibacterial Chemical Compound', 'siderophore-linked ruthenium catalysts', 'effevtive against E. coli', 'the low cytotoxicities of Moxi, C-moxi and especially Ru-s4 with IC50 values greater than 100 microM for two tested mammalian cell lines displayed little toxicity', 'A series of siderophore-linked ruthenium catalysts were investigated for prodrug activation. conjugates containing siderophore units based on catechol and azotochelin were found to be most promising for intracellular prodrug activation.', 36355416),
('Antibacterial Chemical Compound', 'synthesis of endogenous host defense peptides (HDPs)', 'Mocetinostat has been identified as the most potent HDP inducer among all hits identified in this study. It specifically inhibits (histone deacetylase) HDAC1-3 and HDAC11, but with a negligible effect on other HDACs. ( E. coli (ATCC 25922) and Salmonella Enteritidis (ATCC 13076) )', 'Mocetinostat was first evaluated for its ability to promote AvBD9 mRNA expression in a different chicken macrophage cell line, HD11 [40]. As expected, it showed an obvious dose-dependent AvBD9 induction.', 'HDPs are capable of killing a broad spectrum of pathogens through membrane-lytic mechanisms.They have identified multiple classes of HDP inducers, and further characterization of these compounds has led to the identification of mocetinostat as the most potent. With mocetinostat shows promise for further development as a novel antimicrobial agent for disease control and prevention, with minimal risk of triggering resistance.', 35955551),
('Antibacterial Chemical Compound', 'caffeic acid (CA)', 'The MIC of CA against E. coli strains ranged from 250 to 500 microg/ml, and the MBC was 500 microg/ml. For K. pneumoniae strains, the MIC of CA was 500 microg/ml, whereas the MBC was from 500 to 1000 microg/ml. P. aeruginosa strains showed less sensitivity to CA, as compared to other Gram-negative bacteria, as a result of MIC being at 1,000 mg/ml and MBC being at 1,000 to 2,000 microg/ml. As bacteria that induce bovine mastitis, S. aureus strains presented a similar sensitivity to CA, with MIC and MBC ranging from 250 to 500 microg/ml.', '', 'CA eradicates bacterial activity by disrupting both biofilm formation and the adhesion/internalization of the host', 36341408),
('Antibacterial Chemical Compound', '5-amino-4-quinolone agent', '5-amino-4-quinolone 111 with exceptionally potent Gram-positive activity with minimum inhibitory concentrations (MICs) ?0.06 microg/mL against numerous clinical isolates.', 'the lead compound is nontoxic displaying a therapeutic index greater than 500, is devoid of hemolytic activity, and has attractive physicochemical properties (clog P = 3.8, molecular weight (MW) = 441)', 'studies demonstrate that the 5-amino-4-quinolones are bacteriostatic. further investigation of this promising antibacterial scaffold for the treatment of Gram-positive infections.', 36219779),
('Antibacterial Chemical Compound', 'Rhodanine is a 5-membered heterocyclic organic compound possessing a thiazolidine core', 'Rhodanine and Its Related Heterocyclic Compounds: 2a', '', 'They are reported to alter the function of DNA gyrase B, metallo-beta-lactamases, penicillin binding protein (PBP), Mur ligases, RNA polymerase, Enoyl ACP reductases, 1-deoxy-d-xylulose-5-phosphate reductoisomerase. etc which are vital in bacterial growth, survival and replication.', 35714172),
('Antibacterial Chemical Compound', 'new membrane-active nonivamide and capsaicin derivatives as peptidomimetic antimicrobials.', 'Derivative Compound 51 exhibited potent antibacterial activity against both Gram-positive bacteria (MICs = 0.39', '51 Show with low hemolytic activity and low cytotoxicity', 'This Compound 51 displayed a faster bactericidal action through a membrane-disruptive mechanism and avoided bacterial resistance development. Furthermore, compound 51 significantly reduced the microbial burden in a murine model of keratitis infected by Staphylococcus aureus or Pseudomonas aeruginosa. Hence, this design strategy can provide a promising and effective solution to overcome antibiotic resistance.', 36510819),
('Antibacterial Chemical Compound', 'synthesized quinolinequinones (QQs) with N-phenylpiperazine (QQ1-7)', 'This derivative compound QQ3 and QQ4 were the most active molecules against Staphylococcus aureus (ATCC', '', 'In this study, they investigated the bactericidal effects of QQ3 against methicillin-resistant Staphylococcus aureus (MRSA) and Candida albicans strains. The findings of this study suggest that a significant bactericidal effect was seen. Our findings present significant implications for an antimicrobial drug candidate for treating infections, especially those caused by clinically resistant MRSA isolates.', 35921788),
('Antibacterial Chemical Compound', 'conjugates of colistin (CT) and hyaluronic acid (HA)', '', 'The resulting systems also reduced conjugates of colistin CT nephrotoxicity by 20', 'These new conjugates of CT with HA are promising for the development of nanodrugs for safe and effective antimicrobial therapy.', 35724903),
('Antibacterial Chemical Compound', 'cationic antibacterial polytriazoles', 'P2TD and P2CD had MICs of 256 and 64 microg/mL against K. pneumoniae, respectively; while in the case of P. aeruginosa the observed MIC values were lower, but in the same direction, that is, 128 and 32 microg/mL, respectively. When the length of the side chains was increased from one to four carbon atoms, P3TD improved its MIC (4 microg/mL) against the same strains. The P5TD polymer had MIC values of 256 microg/mL and 128 microg/mL against E. faecium and MRSA, respectively. In the case of the P5CD polymer, the MIC was somewhat lower, at 64 microg/mL, against both Gram-positive strains. K. pneumoniae presented high MIC values (> 1024 microg/mL) against polycationic polymers with hydrophilic branches (P5TD and P5CD)', '', 'the resulting cationic polymers are antibacterial and active against different ESKAPE pathogens. Polymers carrying ethylene glycol (more hydrophilic) and heptyl (more lipophilic) side chains were found to have milder antibacterial activity. The P3TD polymer has highest antibacterial activity against bacteria in the tested ESKAPE group, although it also had a high hemolytic activity. Methylated polymers (P2CD and P2TD) have a better balance between hydrophilicity and hydrophobicity, since they had good antibacterial properties and acceptable biocompatibility with hRBC and HGnF. Several polytriazoles have been synthesized containing the same main chain but differing in their side chains.The interaction of these polytriazoles with the Escherichia coli membrane produces both depolarization and disruption of the membrane.', 36432710),
('Antibacterial Chemical Compound', 'novel 4-isocyanophenylamides', 'new weapon against methicillin resistant Staphylococcus aureus infections with MIC of 4 micro mol', 'safe against mammalian keratinocyte and osteoblast at 128 micro mol', 'we identified ** compound 42 as lead compound. It has shown a potent antimicrobial activity and the ability to block the biofilm formation.', 36462437),
('Antibacterial Chemical Compound', 'alkynyl isoquinoline antibacterial compounds, synthesized via Sonogashira coupling', 'HSN584 and HSN739 exhibited moderate antibacterial activity (MIC range = 4', '', 'We showed that the lead compounds can significantly reduce the burden of intracellular MRSA and discovered that S. aureus exhibited a low potential for resistance development against our lead compounds. Our preliminary studies showed that the alkynyl isoquinoline molecule exerted its antibacterial activity through inhibiting three major bacterial processes, DNA synthesis, RNA synthesis and cell wall synthesis. In our future studies, we will seek to evaluate the exact mechanisms by which the alkynyl isoquinoline inhibit these processes. Our findings highlight alkynyl isoquinoline scaffolds as ideal lead molecules for the discovery of potent antibacterial agents.', 36014324),
('Antibacterial Chemical Compound', 'phenyl oxime derivative: Unique iminotetrahydroberberine-corbelled metronidazoles', 'This compound displayed a broad antibacterial spectrum with a quite low MIC value of 0.024 mM against P. aeruginosa, being 63-, 62- and 2-fold to berberine, metronidazole and norfloxacin, respectively.', 'The active compound 8e with low cytotoxicity under effective bacteriostatic concentration', 'This compound could disturb the bacterial membrane to lead to the leakage of cellular contents, thus exerting potent antibacterial potency. It was also revealed that compound 8e could interact with penicillin binding protein via multi-site non-covalent binding in docking simulation. The above results manifested that iminotetrahydroberberine-corbelled metronidazoles might bring hope for the exploitation of new broad-spectrum antibacterial agents with a membrane-destruction mechanism.', 36182008),
('Antibacterial Chemical Compound', 'Novel phenylhydrazone-based oxindole-azoles', 'oxindole-thiolimidazole derived carboxyphenylhydrazone ** 4e exhibited an 8-fold stronger inhibitory ability than norfloxacin on the growth of P. aeruginosa, with MIC value of 1 microg/mL.', '', 'This compound could destruct bacterial cytoplasmic membrane, causing the leakage of cellular contents (protein and nucleic acid) cause death of bacteria. Furthermore, molecule 4e existed supramolecular interactions with DNA to block DNA proliferation. These research results provided a promising light for phenylhydrazone-based oxindole-thiolazoles as novel potential antibacterial agents.', 35716514),
('Antibacterial Chemical Compound', 'A series of new 3-(2-(3-(substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline (9a-i) derivatives have been synthesized.', '3-(2-(3-(substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline (9a', 'Cytotoxicity tests of 3-(2-(3-(substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline (9a', 'a series of 3-(2-(3-(substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline, (9a', 36570236),
('Antibacterial Chemical Compound', 'Tricyclic pyrrolopyrimidines (TPPs)', 'With growth-inhibitory activity in the 0.02 to 0.2 microM range, TPP8 exhibited a markedly higher potency. These results indicate that TPP8 is broadly active against the M. abscessus complex and displays potent antimycobacterial activity.', '', 'the tricyclic pyrrolopyrimidine TPP8 is active against M. abscessus in vitro, ex vivo, and in a mouse model of infection and exerts its antimicrobial activity by inhibiting the B subunit of DNA gyrase. This work adds a new lead compound to the preclinical M. abscessus drug pipeline and provides an attractive chemical starting point for an optimization program aiming at improving oral bioavailability.', 36005813),
('Antibacterial Chemical Compound', 'pyrazinoic acid analogs( Ring substitution, carboxyl isosteres, ring isosteres)', 'pyrazinoic acid analogs represents as potential antimycobacterial agents for first-line TB treatment against Mycobacterium tuberculosis (Mtb)', '', 'report that analogs with ring and carboxylic acid bioisosteres did not significantly enhance the antimicrobial activity, whereas the alkylamino-group substitutions at the 3 and 5 position of POA were found to be up to 5 to 10-fold more potent than POA. Further development and mechanistic analysis of these analogs may lead to a next generation POA analog for treating TB.', 36228522),
('Antibacterial Chemical Compound', 'Brominated furanone (BMF), a halogenated furanone compound', 'Brominated furanone (BMF), a halogenated furanone compound we propose that BMF can effectively inhibit E. coli QS by disrupting the bacterial biofilm and downregulating QS gene expression to reduce the bacterial resistance,', '', 'Brominated furanone (BMF), a halogenated furanone compound is a new type of quorum-sensing inhibitor that can inhibit bacterial quorum sensing and reduce bacterial resistance. This provide a direction for the development of novel antibacterial drug', 36201068),
('Antibacterial Chemical Compound', 'MMV688845 (Nalpha-2-thiophenoyl-d-phenylalanine-2 morpholinoanilide) Compound', 'MMV688845 is active against all three M. abscessus subspecies (M. abscessus subsp. abscessus, M. abscessus subsp. massiliense, and M. abscessus subsp. bolletii). We found MMV688845 to be active against intracellular M. abscessus with an MIC90 of 16 microM', 'Female CD-1 mice (n = 2) were weighed and received a single dose of MMV688845 orally (p.o.) (25 mg/kg of body weight) show good efficacy.', 'The lead compound MMV688845, a substance active against M. abscessus complex, was characterized in depth. In various assays, it showed activity against M. abscessus, synergy with other antibiotics, and bactericidal effects.', 36377951),
('Antibacterial Chemical Compound', 'Gallium(III)-pyridoxal thiosemicarbazone derivatives', 'gallium(III) complexes show potential antimicrobial activity against different strains of Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa and show minimmum inhibitory concentration.', 'no cytotoxicity was detected in eukaryotic cells.', 'Ga(III) complexes were evaluated by UV/Vis spectroscopy. The compounds are active against resistant Gram-negative strain with minimal inhibitory concentration in the microM range, while no cytotoxicity was detected in eukaryotic cells. Hence can be use in future', 36073748),
('Antibacterial Chemical Compound', 'Halogenated Pyrrolopyrimidines with Synergistic Effects with an Antimicrobial Peptide', 'The derivatives with an MIC < 64 mg/L were then subjected to additional MIC profiling towards S. aureus in combination with the antimicrobial peptide. The most active bromo and iodo derivatives had MIC of 8 mg/L.', '', 'A hydroxyl group on the meta- or para position of the 6-aryl unit was found crucial for activity, and heavy halogens (bromo and iodo) in the 4-benzylamine group was strongly potency inducing. Interestingly, when the most potent derivatives were evaluated in combination with the antimicrobial peptide betatide, a four-fold decrease in the MIC value was obtained, a strategy which might be promising for avoiding resistance.', 35892374),
('Antibacterial Chemical Compound', 'alkynyl-containing maleimide derivatives', 'maleimide core led to new compounds with potent activity against Mycobacterium tuberculosis (MIC < 1 microg/mL). Among them, compound 29 not only possessed good activity against extensively drug-resistant TB', 'low cytotoxicity (IC50 > 64 microg/mL) and favorable hepatocyte stability', 'This study lays a good foundation for identifying new alkynyl-containing maleimides as promising leads for treating drug-resistant TB.', 36423487),
('Antibacterial Chemical Compound', 'Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors', 'Compound showed potent anti-TB activity (MIC < 0.016 microg/mL). Compound 32 displayed excellent activity against drug-resistant tuberculosis, good microsomal stability, almost no inhibition of the hERG K+ channel', 'low cytotoxicity (IC50 > 64 microg/mL)', 'the target of the pyrrole-2-carboxamides was identified by measuring their potency against M. smegmatis expressing wild-type and mutated variants of the mmpL3 gene from M. tuberculosis (mmpL3tb) and determining their effect on mycolic acid biosynthesis using a [14C] acetate metabolic labeling assay. The present study provides new MmpL3 inhibitors that are promising anti-TB agents and good in vivo efficacy.', 35915958),
('Antibacterial Chemical Compound', 'endocannabinoid Anandamide (N-arachidonoylethanolamine; AEA)', 'when AEA was combined with methicillin MET, there was a gradual decrease in the CFUs reaching a 85', '', 'AEA was found to inhibit membrane ATPase activity that is necessary for transmembrane transport. AEA caused a reduction in murein hydrolase activities involved in daughter cell separation. Altogether, this study shows that AEA affects several biochemical processes that culminate in the sensitization of the drug-resistant bacteria to antibiotics.', 35887146),
('Antibacterial Chemical Compound', 'benzimidazole derivatives.', 'Compound III showed a potent activity against tolC-mutant Escherichia coli with an MIC value of 2 microg/Ml. *compound 25d displaying the highest potency among the tested compounds with an MIC value of 0.125 microg/mL. compound 25d demonstrated superior activity to the lead compound III.', 'compound 25d exhibited an excellent safety profile without any significant cytotoxicity to mammalian cells', 'compund 25d exhibited a bacteriostatic activity and significantly reduced E. coli JW55031 burden. This compound act as a promising candidate for treatment of Gram-negative bacterial infections', 36584632),
('Antibacterial Chemical Compound', 'Hydroxamic Acid Compounds', 'Concentrations of Compound 4 and 6 were used from a range of 0.5 microM to 100 mM to gain IC50 values for Inhibition of Metallo-beta-Lactamase from Bacillus anthracis', '', 'Compounds 4 and 6 may be useful drug candidates as well as lead compounds for further development.', 36012433),
('Antibacterial Chemical Compound', 'Cuminaldehyde Guanylhydrazone Disinfectant', 'Shoe effective against toxin-producing E. coli (STEC) isolates', '', 'this study contributes to our understanding of the mode of this disinfectant action and facilitates our effort to better use disinfectants for STEC treatments.', 36356001),
('Antibacterial Chemical Compound', 'LEGO-Lipophosphonoxins', 'derivative compound 25 was the best performer with MIC 1', '25 and 38 The compounds were tested at concentrations of 20 and 200 mg/L in both tests. For potential skin irritability, we used the reconstructed human epidermis model test (RhEM). (37) For potential eye irritability, we used the reconstructed human cornea-like epithelium (RhCE) . In both tests, LEGO-LPPOs performed excellently, showing no detrimental effects', 'We tested in detail several selected LEGO-LPPOs, of which the two most promising compounds, 25 and 38, were tested most thoroughly. Of these two compounds, 25 showed a higher therapeutic potential due to its low cytotoxicity.', 35839126),
('Antibacterial Chemical Compound', 'stereoselective epoxidation of chlorotonils and epoxide ring opening derivatives', 'Chlorotonil A displays very pronounced activity against several Gram-positive pathogens, including Staphylococcus aureus (minimum inhibitory concentration, MIC=0.006 microg mL?1) and Streptococcus pneumoniae (MIC=0.0125 microg mL?1). Equipotent activity is also observed with P. falciparum 3D7 where 1 a and 1 b showed IC50s of 0.1 microM and 0.06 microM, respectively. The new derivative **2b suppress growth of multidrug resistant Gram-positive bacteria and P. falciparum in the nanomolar range, but it also showed an increased aqueous kinetic solubility at pH 7.4 (16.2 microM) by more than 200-fold compared to 1 (0.073 microM).', '', 'demonstrated superiority of 2 b against S. aureus when compared to the parent chlorotonil A in vivo. 2 b retained nanomolar activity while being stable in vivo as well as having a significantly improved aqueous solubility and did not result in resistant S. aureus colonies', 35485800),
('Antibacterial Chemical Compound', 'three newly designed hydroxyquinolines derived from sulfanilamide (1), 4-amino benzoic acid (2) and sulfanilic acid (3)', 'sulfanilamide Compounds (1) and sulfanilic acid (3) showed the best binding scores towards PDB ID: 1ZI0/3VOB and 1JIJ/4CJN', '', 'Our in silico results suggest that sulfanilamide (1) or sulfanilic acid (3) hydroxyquinoline derivatives have the potential to be developed as bacterial inhibitors, particularly MRSA inhibitors.', 36399018),
('Antibacterial Chemical Compound', 'cephalosporin derivatives with cyclic disulfide modifications', 'we could demonstrate the successful reduction of biofilm formation for Staphylococcus aureus and Pseudomonas aeruginosa', '', 'We propose that the incorporation of cyclic disulfides is one additional strategy to improve antibiotic activity and to combat bacterial infections.', 36251034),
('Antibacterial Chemical Compound', 'WYBQ-4 compound', 'WYBQ-4 had strong antibacterial activity against methicillin-susceptible Staphylococcus aureus (MSSA) 29213 (MIC, 0.5 microg/mL), MRSA USA300 (MIC, 8 microg/mL), methicillin-resistant Staphylococcus epidermidis (MRSE) 12228 (MIC, 4 microg/mL), and methicillin-susceptible Staphylococcus epidermidis (MSSE) 35984 (MIC, 0.5 microg/mL). WYBQ-4 was also found to be active against Streptococcus pyogenes (MIC, 1 microg/mL)', 'hemolytic activity was measured using rabbit and goat red blood cells. WYBQ-4 did not show hemolytic activity in the concentration range of 0 to 512 microg/mL. The cytotoxicity of WYBQ-4 against A549, HEK-293T, and HepG2 cells using (MTT) assay, and the results showed that the cells were still viable at concentrations of 8 times the MIC against MRSA USA300', 'these results suggest that WYBQ-4 is suitable for the treatment of pneumonia and systemic infections caused by MRSA.', 36098533),
('Antibacterial Chemical Compound', 'pinocembrin chemical compound', 'The minimal inhibitory concentration and minimum bactericidal concentration were 256 microg/mL and 512 microg/mL, respectively against Aeromonas hydrophila is a common pathogen in fish', '', 'When bacteria were treated with 512 microg/mL pinocembrin, lactate dehydrogenase activity and soluble protein content decreased significantly, and electrical conductivity and DNA exosmosis levels increased by 4.21 ', 35438439),
('Antibacterial Chemical Compound', 'Short Tryptamine-Based Peptoids', 'N-(2-(1H-indol-3-yl) ethyl)-2,5-diguanidino-N-(naphthalen-2-ylmethyl) pentanamide (TFA salt) (20a) and (S)-N-(2-(1H-indol-3-yl) ethyl)-2-amino-N-(naphthalen-2-ylmethyl)-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl) sulfonyl) guanidino)pentanamide (22). The most active compounds against Staphylococcus aureus S.aureus 38 were 20a and 22 with MIC = 3.9 microg mL?1 and 5.5 microg mL?1, respectively. . Compound N-(2-(1H-indol-3-yl) ethyl)-4-amino-N-(naphthalen-2-ylmethyl) butanamide (TFA salt) 12c and N-(2-(1H-indol-3-yl) ethyl)-4-guanidino-N-(naphthalen-2-ylmethyl) butanamide (TFA salt) 13c were the most active against E. coli, with MIC > 12 microg mL?1.', 'hemolysis studies toward horse red blood cells showed that the potent compounds are non-toxic at up to 50 microg mL?1.', 'Based on the results of the cytoplasmic membrane permeability assay, the compounds may exhibit membrane damage mechanisms that are similar to most AMPs. These peptoids showed very good antibacterial activity in microbial keratitis bacterial strains which are resistant to ciprofloxacin. These short peptoids are worthy of further development in order to understand their mechanism of action on Gram-positive and Gram-negative bacterial strains.', 36009943),
('Antibacterial Chemical Compound', 'Compounds from the Chembridge DIVERSet library were tested', 'based on the physiochemical analysis and molecular docking studies, the benzamide inhibitors have been identified against alpha-subunit of tryptophan synthase (alpha-TRPS) of Mtb, showing bactericidal activity at 6 microg/Ml. The research on the biological activity of beta-arabino glycosyl sulfones against M. bovis BCG revealed sulfone compounds as potential inhibitors of mycobacterial cell wall biosynthesis', '', 'In time-kill dynamic studies, it was found that co-treatment promoted increased bacterial clearance when compared with the antibiotic or compound group alone. This study describes promising anti-NTM ( non-tuberculous mycobacteria) and anti-Mtb compounds with potential novel mechanisms of action that target intracellular bacteria in activated macrophages.', 36144572);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Chemical Compound', 'A Hydrazine-Hydrazone Adamantine Compound', 'A Hydrazine-Hydrazone Adamantine showed an MIC of 0.2 microg/mL for M. tuberculosis, 0.3 microg/mL for M. bovis BCG, 1.5 microg/mL for M. smegmatis, and 12.5 microg/mL for M. abscessus and M. marinum. It showed an MBC of 0.6 microg/mL for M. bovis BCG and 3 microg/mL for M. smegmatis. We also carried out MIC testing of this compound on S. aureus and E. coli but there was no inhibition at concentrations up to 25 microg/mL, showing that the activity of A Hydrazine-Hydrazone Adamantine compound is likely specific to mycobacteria.', 'cytotoxicity of this compound against two types of human cells lines, SH-SY5Y and HEK 293T, using the tetrazolium reduction assay (MTT). This Compound did not show any significant cytotoxicity up to a concentration of 50 microg/mL and protected Galleria mellonella larvae against M. bovis BCG infection', 'These results suggest that A Hydrazine-Hydrazone Adamantine Compoundis a promising anti-TB agent with the potential to improve TB treatment in combination with standard TB therapies.', 36296721),
('Antibacterial Chemical Compound', 'Oxazolidinone TBI-223', 'the preclinical efficacy of TBI-223 (80 and 160 mg/kg twice daily) was compared with that of linezolid (40 and 80 mg/kg twice daily) in mouse models of MRSA bacteremia, skin wound infection, and orthopedic-implant-associated infection.', 'examined the efficacy of TBI-223 in comparison with linezolid in multiple MRSA infection models in mice. We found that TBI-223 had efficacy comparable to that of linezolid in mouse models of bacteremia, nondiabetic and diabetic skin wound infection, and OIAI. bone marrow toxicity was significantly lower in TBI-223-treated mice than in linezolid-treated mice,', 'a new oxazolidinone named TBI-223 was tested against S. aureus in three mouse models of infection, i.e., bloodstream infection, skin infection, and bone infection. We found that TBI-223 was as effective as linezolid in these three models. Previous data suggest that TBI-223 has a better safety profile than linezolid. Taken together, these findings indicate that this new agent may provide an additional option against MRSA infections.', 36106881),
('Antibacterial Chemical Compound', 'nusbiarylin derivatives', 'Nusbiarylin derivatives displayed excellent antibacterial activity against various clinical methicillin-resistance Staphylococcus aureus (MRSA) and vancomycin-resistance S. aureus (VRSA) strains. The minimum inhibitory concentration (MIC) **compound 22r was lowered to 0.5 microg/mL, comparable to marketed antibiotics.', '', 'Diverse mechanistic studies validated the capability of** 22r inhibiting the function of NusB protein and bacterial rRNA synthesis. In silico study of drug-like properties also provided promising results. Overall, this series of derivatives showed potential antimicrobial activity', 35580381),
('Antibacterial Chemical Compound', 'Potential Inhibitor (MCULE-8777613195-0-12 available at the MCULE purchasable database) of New Delhi Metallo-beta-Lactamase-1 (NDM-1)', '', 'he in vitro enzyme kinetics showed that the catalytic efficiency (i.e., kcat/Km) of NDM-1 on various antibiotics decreased significantly in the presence of MCULE-8777613195-0-12, due to poor catalytic proficiency (kcat) and affinity (Km). The IC50 value of MCULE-8777613195-0-12 (54.2 microM) was comparable to that of a known inhibitor, i.e., D-captopril (10.3 microM).', 'An analysis of the binding pose revealed that MCULE-8777613195-0-12 formed four hydrogen bonds with the catalytic residues of NDM-1 (His120, His122, His189, and Cys208) and interacted with other key residues. Molecular dynamics simulation and principal component analysis confirmed the stability of the NDM-1 and MCULE-8777613195-0-12 complex. MCULE-8777613195-0-12 may serve as a scaffold to further design/develop more potent inhibitors of NDM-1 and other beta-lactamases.', 36144666),
('Antibacterial Chemical Compound', 'Povarov-Doebner derived compounds - HSD 1919', 'Compounds from the Povarov derived SF5-containing compounds inhibited both clinical and laboratory strains of Gram-positive bacteria at minimum inhibitory concentration (MIC) of 0.5 microg/mL to 2 microg/mL. Bithionol (at 1 microg/mL) or nitroxoline (at 4 microg/mL) did not appreciably disperse pre-existing biofilms but when combined with HSD 1919 or HSD 1835 (at 0.5', '', 'mechanistic studies showed inhibition of DNA, RNA, cell wall and protein synthesis in a macromolecular biosynthesis assay indicating that these compounds inhibit bacteria via multiple mechanisms, which is now being appreciated as an effective way to tackle resistant bacteria. Toxicity studies showed that HSD 1919 was nontoxic in-vitro to mammalian red blood cells at 10X MIC. we report HSD 1919 and analogs thereof as critical chemical scaffolds, which can be harnessed to develop highly potent antibiofilm therapeutics.', 35793578),
('Antibacterial Chemical Compound', 'Derivatives of Trimethoxybenzoic Acid and Gallic Acid', 'derivative 10 displayed antibacterial activity against the S. aureus 272123 and S. Typhimurium strains, of 100 and 50 microM, respectively. **derivatives 5 and 6 showed the ability to inhibit EPs in the acrA gene inactivated mutant Salmonella enterica serovar Typhimurium SL1344, and 6 also inhibited EPs in Staphylococcus aureus 272123.', '', 'Structure-activity relationships highlighted trimethoxybenzoic acid as important for EP inhibitory activity. Although further studies are necessary, these results show the potential of simple trimethoxybenzoic acid derivatives as a source of feasible EP inhibitors.', 36430942),
('Antibacterial Chemical Compound', 'Cephem-Pyrazinoic Acid Conjugates', 'The POA conjugates CS-POA and CM-POA exhibited activity commensurate with POA against M. tuberculosis H37Rv with MIC90 100 microg/mL.', '', 'These conjugates are selectively active against M. tuberculosis and related mycobacteria, and activity is retained or even potentiated in multiple resistant strains and models.', 35697660),
('Antibacterial Chemical Compound', 'a novel vancomycin derivative Vb was constructed by conjugation of triazolylthioacetamide and vancomycin molecules', 'The highest dose of Vb (4 microg/mL) resulted in a maximum 128-fold MIC decrease in the antibiotics against S. aureus and MRSA, respectively, and a dose of 16 microg/mL Vb resulted in a 128-fold MIC decrease in cefazolin against VRE. Vb also increased the antimicrobial effect of all tested beta-lactams against K. pneumoniae, resulting in a 16', '', 'The MIC data indicated that Vb gradually increased the antimicrobial effect of all tested beta-lactams with an increasing dose and exhibited a dose-dependent synergistic antibacterial effect against the eight resistant strains. The biological assays showed that Vb had effective antibacterial activity against S. aureus and MRSA, but low antimicrobial activities against Gram-negative K. pneumoniae. This work offers a promising scaffold for the development of metallo-beta-lactamases MbetaLs inhibitors, specifically antimicrobials for clinically drug-resistant isolates.', 36431786),
('Antibacterial Chemical Compound', 'novel beta-lactamase inhibitor combination imipenem/XNW4107', 'XNW4107 in combination with imipenem exhibited potent in vitro activity against carbapenem-resistant bacteria and particularly against carbapenem-resistant Acinetobacter baumannii. MIC90 of imipenem/XNW4107 against imipenem-nonsusceptible A. baumannii (n = 106) was 8 mg/L, MIC90 of imipenem/XNW4107 against imipenem-resistant Klebsiella pneumoniae (n = 54) was 2 mg/L. Hence Imipenem/XNW4107 was bactericidal against A. baumannii, K. pneumoniae, and Escherichia coli.', '', 'XNW4107 is a novel beta-lactamase inhibitor that possesses broad activity against serine-beta-lactamases. Imipenem/XNW4107 provided good protection against imipenem-resistant A. baumannii and K. pneumoniae in vivo', 35820591),
('Antibacterial Chemical Compound', 'potential roles of montmorillonite (Mt) minerals', 'the potential roles of montmorillonite (Mt) in the emergence of ARGs under divalent cadmium ion (Cd2+) stress, Escherichia coli (E. coli) was induced continuously for 15 days under Cd2+ gradient concentrations (16, 32, 64, 96, and 128 microg?mL?1) with and without Mt.', '', 'the study promoted the understanding of Cd2+ in triggering bacterial antibiotic resistance', 35864327),
('Antibacterial Chemical Compound', 'developed a ligand-based workflow based on the chemical structures of nusbiarylins', 'As a result, four compounds, including J098-0498, 1067-0401, M013-0558, and F186-026, were identified as potential antimicrobials against S. aureus, with predicted pMIC values ranging from 3.8 to 4.2.', '', 'The docking study showed that these molecules bound to NusB tightly with the binding free energy ranging from -58 to -66 kcal/mol.', 36613782),
('Antibacterial Chemical Compound', 'modification on the rifamycin ansa?chain ( 25-O-acyl rifabutin )', 'show potency against M. abscessus upto 17nM', '', 'Structure?based derivatization at the C?25 position of rifabutin afforded analogs that are more than a hundred?fold more potent than the widely used rifampicin and are no longer susceptible to the primary rifamycin resistance in M. abscessus through ADP?ribosylation', 36222275),
('Antibacterial Chemical Compound', 'OPS-2071 fluoroquinolone-based compound,', 'he antibacterial activity of OPS-2071 was more potent against Gram-positive bacteria and Campylobacter jejuni, including quinolone-resistant strains.', '', 'The broad and potent in vitro antibacterial activity and lower risk of drug resistance suggested that OPS-2071 may be useful for enteric infections caused by major pathogens including quinolone-resistant Campylobacter.', 36101508),
('Antibacterial Chemical Compound', 'N-quinazolinone-4-hydroxy-2-quinolone-3-carboxamides', 'identified AG-690/11765367, or f1, as a novel and potent inhibitor of the target protein (IC50: 1.21 microM) . * f1 is more potent than the others in terms of antibacterial activity against MRSA (MICs: 4-8 microg/mL)', 'non-toxic to HUVEC and HepG2 (CC50: approximately 50 microM), and metabolically stable (t1/2: > 372.8 min for plasma; 24.5 min for liver microsomes).', 'this study showed that the discovered N-quinazolinone-4-hydroxy-2-quinolone-3-carboxamides are novel GyrB-targeted antibacterial agents; compound **f1 is promising for further development.', 36278813),
('Antibacterial Chemical Compound', 'synergism of orbifloxacin (orb) and propyl gallate (pg).', 'The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of ORB against the E. coli KVCC 1423 resistant strain were 128 microg/ml and 256 microg/ml, respectively. However, the MIC of ORB for the remaining E. coli strains was 0.5 microg/ml', 'The cell viability of the combination was > 80%. The combination of PG and ORB showed the ability to confront bacterial mobility without having any harmful effects on the cell.', 'In conclusion, we demonstrated the antibacterial activity of PG and the combination of PG with ORB against E. coli in vitro. PG could inhibit bacteria growth in both cases, both individually and in combination with ORB. Furthermore, the efficacy of the drugs enhances and MICs reduce when combined; thus, showing a synergistic effect. The combination inhibited E. coli biofilm development.', 36188537),
('Antibacterial Chemical Compound', 'chalcone-alkyl-lysine compounds', 'Compound 6d displayed potent antibacterial activity against Gram-positive bacteria (Staphylococcus aureus and Enterococcus faecalis) and Gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa), with MICs of 1', 'compound 6d did not exhibit any observable toxicity in HeLa and HEK293 cells at 8 ', 'ompound 6d destroys bacterial cell membranes by interacting with phosphatidylglycerol (PG), causing the production of reactive oxygen species (ROS) and the leakage of nucleic acids, resulting in bacterial death. As a result, the findings suggest that compound 6d has potential therapeutic effects against bacterial infections and could be a promising drug candidate for future research.', 36334451),
('Antibacterial Chemical Compound', 'Pyridine-Carbohydrazides', 'compound 6 had potent activity against four MDR strains of Candida spp., with minimum inhibitory concentration (MIC) values being in the range of 16-24 microg/mL and percentage inhibition up to 92.57%', '', 'Overall results suggest that these compounds have the potential to become promising antimicrobial drugs against MDR strains.', 36615406),
('Antibacterial Chemical Compound', 'oxadiazolones as a novel antibacterial chemotype', 'Benzyl (4-(5-methoxy-2-oxo-1,3,4-oxadiazol-3(2H)-yl)-2-methylphenyl)-carbamate 1 was most potent with an MIC of 6.25 microM (2.2 microg/mL). N-(4-(5-methoxy-2-oxo-1,3,4-oxadiazol-3(2H)-yl)-2-methylphenyl)-3-phenoxy-benzamide 3 as our lead compound with a 16-fold improvement in potency against both MRSA USA300 (MIC = 0.8 microM, 0.3 microg/mL) and S. aureus ATCC 29213 (MIC = 1.6 microM) compared to hit 1 in MRSA', 'Time-kill experiments also showed that 3 killed 99% of bacteria within 24 h, starting from a 106 CFU/mL inoculum. Furthermore, 3 exhibits low cytotoxicity selectivity ratio HEK293T/MRSA USA300 = 10.5, HepG2/MRSA300 = 20.3) and is nonhemolytic', 'we here disclose oxadiazolones as a new chemotype with antibiotic activity against S. aureus strains including drug-resistant isolates. A medicinal chemistry program combined with chemical proteomics led to the identification of potent antibacterial compound 3 capable of interacting with multiple bacterial cysteine and serine hydrolases in a covalent manner.', 36584241),
('Antibacterial Chemical Compound', 'novel clarithromycin derivatives incorporating 1,2,3-triazole moieties at the 4?- and 11-OH positions.', 'study of bactericidal kinetics, we can conclude that compound 8f had a concentration- and time-dependent effect on the proliferation of Staphylococcus aureus ATCC43300', 'the results of the cytotoxicity assay showed that **compound 8f exhibited no toxicity', 'These compounds were generally 64- to 128-fold more active than azithromycin, and 32- to 128-fold more active than clarithromycin. The predicted ClogP data suggested that higher values of ClogP (>6.65) enhanced the antibacterial activity of compounds', 35841669),
('Antibacterial Chemical Compound', 'novel reversible pyrrolidinedione-based MurA inhibitors', 'The overall most potent of these compounds was inhibitor 46 with an IC50 value of 4.5 microM against wild type MurA. Remarkably, 46 inhibited the clinically relevant fosfomycin-resistant MurA mutant C115D with equal potency (IC50 = 4.9 microM)', 'A standard MTT assay revealed that compounds 7 and 46 were nontoxic when applied to HepG2 (human liver carcinoma cell line) and the nontumor cell line MRC-5 . The stability of MurA inhibitor 46 was assessed in human S9 liver microsomal fraction.', 'A drastic decrease in the IC90 value of 46 was observed, which was dependent on the concentration of PMBN, reaching 2.3 microM at 6 microg/mL of Polymyxin B nonapeptide (PMBN)', 36269107),
('Antibacterial Chemical Compound', 'neolignan-AMP mimic conjugates', 'compound III5 exhibited the most potent antibacterial activity and a broad inhibition spectrum toward three G+ bacteria, S. aureus, E. faecalis, and M. luteus, and one G', '', 'Mechanism studies reveal that III5 and III15 exhibit rapid bactericidal effects through binding to the phosphatidylglycerol (PG) and cardiolipin (CL) of the bacterial membrane, thereby disrupting the cell membranes and allowing increased reactive oxygen species (ROS) as well as protein and DNA leakage. The results indicate that these neolignan-AMP mimic conjugates could be promising antimicrobial candidates for combating MRSA infections.', 36512751),
('Antibacterial Chemical Compound', 'novel series of 3-(7-nitro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanehydrazide derivatives', 'compounds 6d and 6e displayed MIC values of 9.40 and 9.00 microM, respectively, regarding S. aureus, and 4.70 and 4.50 microM, respectively, regarding S. pneumonia in comparison to ciprofloxacin (12.07 microM).', 'The cytotoxicity of compounds 6d and 6e were performed on normal human WI-38 cell lines with IC50 values of 288.69 and 227.64 microM, respectively assuring their safety and selectivity. Both compounds were found to be safer on the liver and kidney', 'This derivative required for DNA gyrase inhibition are enough for exerting promising antimicrobial activities, but also derivatization with diverse aryl/hetero aryl aldehydes is essential for their enhanced antimicrobial potential.', 36215786),
('Antibacterial Chemical Compound', 'novel pleuromutilin derivative - 22-(2-(2-(4-((4-(4-nitrophenyl)piperazin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)acetamido)phenyl)thioacety-l-yl-22-deoxypleuromutilin (Z33)', 'The MIC values of Z33 against four S. aureus strains ranged from 0.125 to 0.25 microg/mL.', 'Toxicity determination showed that both Z33 and tiamulin displayed low cytotoxicity of RAW264.7 cells. Z33 was found to be a high-security compound with a 50% lethal dose (LD50) above 5000 mg/kg in the acute oral toxicity test in mice', 'In an in vivo antibacterial activity test, Z33 displayed better therapeutic effectiveness than tiamulin in the neutropenic mouse thigh infection model. In summary, Z33 was worthy of further development as a highly effective and safe antibiotic agent against MRSA infection.', 35956888),
('Antibacterial Chemical Compound', 'Ginkgetin- C32H22O10', 'This study showed that Gin treatment significantly inhibited the formation of E. coli ATCC 25922 in a dose-dependent manner (Figure 2A, p < 0.0001). As low as 6.25 microM of Gin was also found to be effective against the formation of biofilm (inhibition rate > 20%).', 'Gin showed no cytotoxic effect at 50 microM or lower concentrations, and cytotoxicity appeared at 100 microM and 200 microM (p < 0.05 and p < 0.0001, respectively).', 'These results showed that Gin could inhibit biofilm without affecting bacterial growth and metabolic activity. Besides, Gin inhibited the bacteria motility, EPS production, and QS of E. coli. These results indicate that Gin was an effective antibiofilm compound which can combine with marketed antibiotics to treat drug resistance caused by biofilms to treat E. coli infections in the future.', 35955943),
('Antibacterial Chemical Compound', 'Flavaspidic acid BB combined with mupirocin', 'The results showed that the FICI value range of the combined use of BB and mupirocin was 0.30 ', '', 'After drugs treatment, the drug-combination showed significantly inhibitory effects on the metabolic activity and total biomass in each stage of biofilm formation. The synergistic effect is likely related to the adhesion between bacteria. Hence study provides the experimental data for the use of BB for the clinical treatment of skin infections and further demonstrate the potential of BB as a novel biofilm inhibitor.', 35840879),
('Antibacterial Chemical Compound', '1,3-diamino-7H-pyrrolo[3,2-f]quinazoline PQZ compounds Derivative, OYYF-171, -172, and -175', 'The PQZ derivatives OYYF-171, -172, and -175 displayed potent antibacterial activities against A. baumannii, with MICs of 0.5', '', 'we identified three PQZ compounds, OYYF-171, -172, and -175 that could serve as the leading compounds for drug development against MDR-AB.', 36500701),
('Antibacterial Chemical Compound', 'two pyrazole derivatives, (1H-pyrazol-1-yl) methanol 1-hydroxymethylpyrazole (SAM1) and 1,1''methandiylbis (1H-pyrazol) (AM1), , with sorbitan monolaurate (polysorbate 21, Tween 21, T21)', 'The addition of T21 resulted in the obvious decrease in mean MIC values from 177.7 to 55.5 microg/mL for SAM1 microg/mL and from 311.1 to 144.4 microg/mL for AM1, respectively cause higher rate of reduction in S. aureus ATTC 33952 cell viability', '', 'The association of T21 with SAM1 and AM1 increased the MIC efficacy of AM1 and SAM1. The time-kill dynamics confirmed the MIC results, and the combination of SAM1 and AM1 with T21 accounted for a significant increase in the killing rate in S. aureus and E coli. . This could widen the range of adjuvants in applications which would be useful in the control of resistant microorganisms.', 36551246),
('Antibacterial Chemical Compound', 'plumbagin (PGN)', 'Plumbagin inhibited the growth of all tested isolates- MDR Gram-negative (Escherichia coli, Klebsiella pneumoniae, Salmonella Typhi, and Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus [S. aureus], Staphylococcus saprophyticus [S. saprophyticus], Streptococcus pyogenes, and Enterococcus faecalis), with S. saprophyticus exhibiting the highest sensitivity. MIC values ranged from 0.029 to 0.117 microg/mL whereas MBC ranged from 0.235 to 0.94 microg/mL, with 79% to 99% growth inhibition.', '', 'all tested isolates showed a marked decrease in biofilm formation, with S. saprophyticus and S. aureus being the most sensitive. Plumbagin is a stand-alone, broad spectrum antibacterial with promising potential against the rising threat of antimicrobial resistance.', 36379534),
('Antibacterial Chemical Compound', 'phenylhydrazine derivatives', 'Derivative 4-cyanophenylhydrazine with potent inhibitory activity against carbapenem-resistant A. baumannii BAA-1605, with minimum inhibitory concentration (MIC) of 0.25 microg/ml and highest selectivity index of 640. The compound also demonstrated potent inhibition against multidrug-resistant A. baumannii isolates (MIC: 0.25-1 microg/ml)', '', 'The identified 4-cyanophenylhydrazine compound exhibited synergistic activity with amikacin, tobramycin and polymyxin B against carbapenem-resistant A. baumannii BAA-1605.', 36326019),
('Antibacterial Chemical Compound', '3-alkylpyridine-bearing alkaloid analogs', 'compound 6 showed promising antibacterial activity against Staphylococcus with minimum inhibitory concentration (MIC) ranging from 0.98 to 3.9 microgmL-', '', 'Compound 6 had the ability to damage the bacterial membrane and induce cell lysis and, due to its action on the membrane, showed low resistance induction potential in vitro.', 35636092),
('Antibacterial Chemical Compound', 'O-Eugenol', 'O-eugenol presented a MIC of 1024 microg/mL against S. aureus', 'The D. melanogaster mortality and geotaxis assays revealed the compound is toxic, with an EC50 of 18 microg/mL within 48 hours of exposure.', 'conclude that the tested product has an efflux pump inhibitory effect, further studies are needed to elucidate its mechanisms of action', 35909475),
('Antibacterial Chemical Compound', 'hecogenin acetate', 'hecogenin acetate showed minimal inhibitory concentration against strains of E. coli, P. aeruginosa and S. aureus', '', 'In the evaluation of the potentiating activity of the antibiotic action, a greater antagonistic behavior is noticed. In the analyzes performed with the efflux pump, it was noticed that the hecogenin acetate does not interfere in the efflux pump mechanism of the analyzed bacteria.', 36462578),
('Antibacterial Chemical Compound', 'Synergistic Effect of Quercetin on Antibacterial Activity of Florfenicol', 'the MIC value of florfenicol against A. hydrophila was observed to be 2.5 microg/mL, and it was 360 microg/mL for quercetin. When quercetin was combined with florfenicol, the fractional inhibitory concentration (FIC) was 90 + 0.078 microg/mL. In particular, quercetin increased the sensitivity of A. hydrophila to florfenicol from 2.5 microg/mL to 0.078 microg/mL against A. hydrophila', '', 'quercetin and florfenicol had an obvious synergistic activity in vivo, reducing the bacterial load in the liver, spleen and kidney tissues of Cyprinus carpio up to 610.6-fold compared with the florfenicol group, and improving the survival rate of infected fish from 10% in the control group to 90% in drug combinations group. These findings indicated that quercetin could potentiate the antibacterial activity of florfenicol against A. hydrophila infection and may reduce the use of antimicrobial drugs and improve the prevention and control capability of bacterial resistance.', 35884183),
('Antibacterial Chemical Compound', 'colistin-EDTA combination', 'The adjuvant-EDTA was discovered to have inhibitory effects on ColRkp at concentrations of 3-24 mg/mL and colistin-EDTA combination displayed substantial synergistic effects (FICI ? 0.5) on all tested 45 ColRkp (carbapenem-resistant Klebsiella pneumoniae)isolates', '', 'colistin-EDTA combination therapy in this study produced potent synergistic effects in both in vitro and in vivo murine bacteremia, with no ColRkp regrowth and improved animal survival, implying the significance of colistin-EDTA combination therapy as systemic therapy for unlocking colistin resistance in ColRkp-associated bacteremia. (carbapenem-resistant Klebsiella pneumoniae )', 35902639),
('Antibacterial Chemical Compound', 'a series of quaternary ammonium cationic compounds with various linkers were designed', 'The best compound, 3e, has good antibacterial activity against Staphylococcus aureus [minimum inhibitory concentration (MIC = 1 microg/mL)]', 'least hemolytic toxicity [hemolytic concentration (HC50 = 905 microg/mL)], is stable in mammalian body fluids, and rarely induces bacterial resistance.', 'This effectively reduce the load of methicillin-resistant Staphylococcus aureus (MRSA) in mouse skin and has a higher in vivo bactericidal efficiency than vancomycin. These findings highlight the significance of divergent linkers in quaternary ammonium cations as antimicrobial peptide mimics and the potential of these cations to treat bacterial infections.', 36549113),
('Antibacterial Chemical Compound', 'Pyroligneous Acid (PA)', '', '', 'The addition of PA could improve silage quality and reduce ARG pollution in alfalfa silage. This study can provide useful information for understanding and controlling ARG pollution in animal production.', 35862964),
('Antibacterial Chemical Compound', 'poly-lactic acid coating incorporating antibiotic loaded coralline bioceramic on Ti6Al4V implant', 'After 24 h, S. aureus biofilm formation and the percentage of live cells found on the surfaces of all 5%-30% (w/w) PLA-Gm-(HAp-Gm) coated Ti6Al4V implants was lower than the control samples.', '', 'These results support the use and application of the antibacterial PLA-Gm-(HAp-Gm) thin film coating design for implants, as an antibiotic release control mechanism to prevent implant-related infections.', 36205495),
('Antibacterial Chemical Compound', 'Relebactam (REL)', 'Relebactam (REL) has the potency to recover antimicrobial activity against carbapenem-resistant Enterobacterales that has porin deficiency.', '', 'The Cefmetazole-CMZ acquisition of resistance was also suppressed by the concomitant use of REL and actually suppressed the decrease in mRNA expression in ompF. It was confirmed that porin reactivated by REL.', 36237294),
('Antibacterial Chemical Compound', 'bismuth complexes of general formula BiLCl2, where L is a thiosemicarbazone bearing a quinoline moiety', 'Quinoline-2-carboxaldehyde-N4-phenyl-3-thiosemicarbazone bismuth dichloride and carbapenem showed synergism in a dose dependent manner with the minimum inhibitory concentration (MIC) of meropenem lowered down 128 folds up to 2 microgmL-1, a concentration lower to the sensitivity level.', 'The IC50 of the compound against A549 human lung carcinoma cells and HuDe human epithelial tissue was 46.96 ', 'Result indicating that a structural optimization of the compounds is needed.', 35690039),
('Antibacterial Chemical Compound', 'Colistimethate sodium-chitosan hydrogel', 'Active against both ATCC (American Type Culture Collection) strains and clinical isolates of Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumoniae.', '', 'The CMS incorporated hydrogel is also capable of inhibiting the biofilm formation. The developed hydrogel can be potentially being used for the treatment of Gram-negative bacterial infected wounds.', 35752341),
('Antibacterial Chemical Compound', 'biphasic calcium sulphate/hydroxyapatite (CaS/HA) biomaterial as a carrier for dual delivery of RIF with vancomycin (VAN) or gentamicin (GEN).', 'Only combinations of CaS/HA-VAN/GEN + RIF exhibited antibacterial and antibiofilm effects yielding no viable bacteria at study endpoint. The S. aureus strains developed resistance to RIF when biofilms were subjected to CaS/HA-RIF alone but not with CaS/HA-VAN/GEN + RIF.', 'Our in vitro results indicate that biphasic CaS/HA loaded with VAN or GEN could be used as a carrier for RIF for local delivery in clinically demanding bone infections.', '', 36349950),
('Antibacterial Chemical Compound', 'polythiophene (PT10), a cationic polymer', 'polythiophene (PT10), a cationic polymer, was capable of both broad-spectrum photo-antimicrobial activity (Gram positive, Gram negative, Fungal, and cyano-bacteria) and broad pH responsiveness. The half-maximal inhibitory concentrations (IC50) of PT10 for bacteria living in acidic, neutral, and alkaline media were generally lower than 2 microg mL-1 (except M. aeruginosa, pH 12, ?30 microg mL-1), which were much lower than common antibiotics and other photosensitizers.', '', 'PT10 was explored for the successful in vivo therapy of oral Candidiasis infection under extreme acidic conditions (pH < 3) and the removal of M. aeruginosa at pH 12. Such near full pH, broad-spectrum photo-antimicrobial activity of polythiophene is appealing for extremely acidic or alkaline applications, such as oral infections, vaginitis, and blooms.', 35723511),
('Antibacterial Chemical Compound', 'recombinant glycoside hydrolases (GHs) in combination with antibiotics', 'recombinant glycoside hydrolases (GHs) that degrade Pel and Psl were evaluated alone and in combination with antibiotics in a mouse model of P. aeruginosa infection.', '', 'Combining GH prophylaxis and treatment with the antibiotic ciprofloxacin resulted in greater reduction in pulmonary bacterial burden than that with either agent alone. This study lays the foundation for further exploration of GH therapy in bacterial infections.', 35862738),
('Antibacterial Chemical Compound', 'N-arylimidazolium an antimicrobial peptide (AMP) Biomimetic Antimicrobial Agents', 'The excellent antibacterial activity could be observed for 1Br.R3 bearing hexyl groups with the respective MIC of 0.5, 0.25, and 1 microgram/mL for MRSA, S. aureus, and E. coli. Methicillin-resistant Staphylococcus aureus (MRSA)-induced lung-infected mice can be effectively treated by the intravenous administration of N-arylimidazolium AMP mimic', '', 'These N-arylimidazolium AMP mimics show potent antibacterial activity against strains along with a low rate of drug resistance, good hemocompatibility, and low cytotoxicity.', 35930690),
('Antibacterial Chemical Compound', 'Check three artificial sweeteners, saccharin, cyclamate and acesulfame-K (ace-K)', 'A minimum inhibitory concentration (MIC) assay was performed for both pathogens - A. baumannii AB5075 and P. aeruginosa PA14, with ace-K concentrations ranging from 0.09 to 7.08%. A significant reduction in growth could be distinguished at 0.89% ace-K for A. baumannii', '', 'Ace-K - Acesulfame potassium (IUPAC ID: potassium 6-methyl-2,2-dioxo-2H-1,2?6,3-oxathiazin-4-olate) can inhibit a range of virulence traits such as biofilm formation, motility and natural transformation. It weakens the bacterial cell membrane leading to loss of morphology and bulge-mediated cell lysis. It can also potentiate the activity of antibiotics including carbapenems. Ace-K shows clinical potential as a topical wound therapeutic.', 36412260),
('Antibacterial Chemical Compound', 'novel [1,2,5]oxadiazolo[3,4-b]pyrazine-containing compound', 'minimal regrowth concentration (MRC) = 0.25- 1 micro gram per ml against S. Typhimirium, K. Pneumunia, A. baumannii, P aeroginosa and E coli', '', 'These results demonstrated these compounds as a novel class of resistance-modifying agents (RMAs) and may be further developed as therapeutic agents.', 35788034),
('Antibacterial Chemical Compound', 'Coumarin thiazoles derivative', 'methyl oxime V-a exerted potent inhibitory efficacy against methicillin-resistant Staphylococcus aureus (MRSA) at low concentration (1 microg/mL) and showed broad antimicrobial spectrum.', 'active molecule V-a exhibited low toxicity toward mammalian cells', 'compound V-a was able to damage the integrity of membrane to trigger leakage of protein, insert into MRSA DNA to block its replication and induce the generation of reactive oxygen species (ROS) to inhibit bacterial growth. Hence molecule V-a was favorable to exert high antimicrobial activity.', 35576797),
('Antibacterial Chemical Compound', 'novel linear polyamines', 'Both AHA-1282 and AHA-1268 displayed an MIC of 32 microg/ml, a greater than eightfold increase in activity whereas AHA-1394 displayed the most potent anti-staphylococcal activity with an MIC of 2 microg/ml, a greater than 64-fold increase in activity.', '', 'we show that AHA-1394 displays a particular proclivity for antibiotic potentiation, restoring sensitivity of MRSA and VRSA isolates to daptomycin, oxacillin and vancomycin. Together this study shows that polyamine derivatives are impressive drug candidates', 36071957),
('Antibacterial Chemical Compound', 'Halogenated Indoles derivatives', 'the MIC of the compounds- 7 brominated indoles, 2 fluorinated indoles, 3 iodinated indoles, 4 chlorinated indoles, and 1 multiple halogenated indole. is above 200 microM, whereas the virulence inhibitory concentration is 20 microM or lower against V. campbellii toward gnotobiotic brine shrimp. 7-fluoroindole inhibited biofilm formation at a concentration of 500 microM and blood hemolysis at a concentration of 100 microM in Pseudomonas aeruginosa; 7-iodoindole and 7-chloroindole inhibited biofilm formation at a concentration of 10 microg/mL (about 40 to 60 microM), bacterial motility at a concentration of 50 microg/mL (about 200 to 300 microM), and protease activity at a concentration of 10 microg/mL in V. parahaemolyticus', '', 'ndole signaling is a valid target for the development of novel therapies to control disease caused by Vibrio campbellii and related bacteria, which are among the major bacterial pathogens in aquaculture. this is the first study of the structure-activity relation of halogenated indole analogues with respect to virulence inhibition of a pathogenic bacterium in an in vivo host model system.', 36154441),
('Antibacterial Chemical Compound', 'N-isopropyloxalyl hydroxamate (IpOHA) and aspterric acid', 'N-isopropyloxalyl hydroxamate (IpOHA) and aspterric acid are both potent inhibitors for both SaDHAD[Staphylococcus aureus Dihydroxy-acid dehydratase (Ki =7.8 and 51.6 microM, respectively)] and CjDHAD[Campylobacter jejuni Dihydroxy-acid dehydratase (Ki =32.9 and 35.1 microM, respectively)]', '', 'These compounds thus present suitable starting points for the development of novel anti-microbial chemotherapeutics.', 35535733),
('Antibacterial Chemical Compound', 'Dihydroxyphenyl-substituted thiosemicarbazone', 'The novel thiosemicarbazones specifically inhibit NDM-1 and ImiS, with an IC50 in the range of 0.37', '', 'Partial thiosemicarbazones enhanced the antimicrobial activity of Meropenem on E. coli-ImiS and E. coli-NDM-1. A thiosemicarbazone in combination with Meropenem significantly reduced the bacterial load in liver and spleen of mice.', 35717802),
('Antibacterial Chemical Compound', 'quinolinequinones', 'QQ6 exhibited the best (27-fold more potent) anti-E. faecalis activity with a MIC value of 4.88 microg/mL, which was superior to the standard drug amikacin (MIC = 128 microg/mL). On the other hand, QQ3 was the second most active one of this series against E. faecalis (13-fold more potent than amikacin with a MIC value of 9.76 microg/mL).', '', 'This compound show biofilm inhibition and effective against gram psotive, negative as well as show potency against fungi also', 36290056),
('Antibacterial Chemical Compound', 'A peptide-based copolymer, poly[phenylalanine10-stat-lysine12]-block-3,4-dihydroxy-l-phenylalanine [Poly(Phe10-stat-Lys12)-DOPA]', 'The poly(Phe10-stat-Lys12)-DOPA polymer showed good antibacterial activity with minimum inhibitory concentrations against S. aureus and E. coli of 32 and 400 microg/mL, respectively.', '', 'In vivo experiments confirmed that this poly(Phe10-stat-Lys12)-DOPA coating can both effectively prevent biofilm formation through surface contact sterilization and avoid local and systemic infections.', 36549042),
('Antibacterial Chemical Compound', 'ruthenium-based complexes', 'In vitro antimicrobial screening demonstrated that four complexes could absolutely inhibit the growth of Staphylococcus aureus (S. aureus) with MIC values ranging from 15.6 to 100 microg/mL. The most active complex Ru(?)-1 (MIC = 15.6 microg/mL) could kill S. aureus through targeting the membrane', 'based on the mouse model of S. aureus skin infection, Ru(?)-1 showed important antibacterial efficacy against S. aureus in vivo, and almost non-toxic against mouse tissue.', 'The results revealed that Ru(?)-1 could inhibit the biofilm formation and alpha-hemolysis secretion in S. aureus at subinhibitory concentration. More interestingly, the combination use of Ru(?)-1 and five traditional antibiotics showing synergistic effect. study indicates that introducing membrane targeting ligands onto ruthenium complexes may be an underappreciated strategy for developing antibacterial agents.', 35635951),
('Antibacterial Chemical Compound', 'PGLb1 and PGLb2', 'substantially reduced the level of antibiotic resistance of multi-drug resistant Escherichia coli, Klebsiella pneumoniae and Shigella flexneri clinical isolates', '', 'These findings indicate that manipulating bacterial membrane electrophysiology could be a valuable tool to overcome antimicrobial resistance.', 35127141),
('Antibacterial Chemical Compound', 'KBP-7072', 'It inhibited the growth of all isolates at 4 mg/liter, including 372 carbapenem-resistant isolates, 37 tigecycline MIC ? 4 mg/liter isolates, and 138 omadacycline MIC ? 4 mg/liter isolates, KBP-7072 (MIC90, 1 mg/liter) outperformed 2-fold and 4-fold more activity against 536 A. baumannii isolates than tigecycline and omadacycline,', '', 'This study has shown excellent in vitro activity of KBP-7072 against clinical A. baumannii isolates collected from different regions of China, regarded as supplementary to KBP-7072 pharmacodynamics data, which is of great significance, as it is promising an alternative treatment in CRAB isolates infections in China.', 35138143),
('Antibacterial Chemical Compound', 'Bacillus licheniformis (B. licheniformis) and Bacillus subtilis (B. subtilis)', 'Bacillus licheniformis (B. licheniformis) and Bacillus subtilis (B. subtilis) proved to be anti-inflammatory and had an antioxidant effect under certain treatment combinations, and further effectively inhibited the adhesion of pathogenic bacteria.', 'Interestingly, they had little effect on paracellular permeability.', 'Based on our results, Bacillus licheniformis and Bacillus subtilis are both promising candidates to contribute to the beneficial effects of probiotic multispecies mixtures.', 35630380),
('Antibacterial Chemical Compound', 'arene-ruthenium(II) complexes and their salts', 'Their antimicrobial activity (MIC, MBC/MFC) was examined in vitro against Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Pseudomonas aeruginosa, Proteus vulgaris and Candida albicans and compared with classic antibiotics used as therapeutics.', 'complexes 3a', 'We believe that arene-ruthenium(II) complexes and their salts presented herein offer great potential in the treatment of bacterial diseases, particularly among people affected by cancer or among patients after surgeries dealing with wounds that are difficult to heal.', 35056783),
('Antibacterial Chemical Compound', 'elasnin', 'superior activity in eradicating daptomycin-resistant MRSA strain biofilm, with a lower MBEC value of 0.625 Microgram/mL, compared to 2.5 Microgram/mL for the wild type', '', 'This study highlights the potential clinical application of elasnin through its superior biofilm eradication activity against a daptomycin-resistant MRSA strain, and revealed the associated processes governing this superior activity through proteomics analysis.', 35196789),
('Antibacterial Chemical Compound', 'cobalt-doped pomelo peel carbon composite (Co-PPCC)/ peroxymonosulfate (PMS) system', 'to remove TC (Tetracycline)', '', 'This study provides a new method to reuse abandoned pomelo peels and synthesize an economical and environmentally friendly catalyst for activating peroxymonosulfate to remove TC antibiotics in water.', 34767166),
('Antibacterial Chemical Compound', 'anthranilate', 'Acts as a Signal to Modulate Biofilm Formation, Virulence, and Antibiotic Tolerance of Pseudomonas aeruginosa and Surrounding Bacteria', '', 'this study shows that anthranilate can be used as an adjuvant to antibiotics.', 35019684),
('Antibacterial Chemical Compound', '1,3,4-thiadiazole derivatives', 'exhibited antifungal activity against Rhizopus&amp;nbsp;oryzae; compounds with an imidazole moiety, such as the compound 7, were documented to have energetic antibacterial, antifungal properties', '', 'As a result of these findings, this research suggests that the synthesized compounds could be an excellent choice for controlling black fungus diseases.', 35684551),
('Antibacterial Chemical Compound', 'synthetic smectite clay minerals and Fe-sulfide microspheres', 'effective at killing the ESKAPE pathogens (Enterococcus sp., Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter sp., Pseudomonas aeruginosa and Enterobacter sp.)', '', 'Our results represent the first step in utilizing a geochemical process to treat antibiotic resistant topical or gastrointestinal infections in the age of antibiotic resistance.', 35075234),
('Antibacterial Chemical Compound', 'amphiphilic cationic polymers in combination with novobiocin', 'reduced the MIC which was less than 0.0625 Microgram/mL against E. coli', '', 'Furthermore, the results showed the possibility that the antimicrobial polymers serve not only as antibiotics to which bacteria have not developed resistance but also as adjuvants for other antibiotics.', 34559588),
('Antibacterial Chemical Compound', 'N-acyl-5-hydroxypyrazolines and N,N''-diacylhydrazines of 6-methyluracil thietanyl- and dioxothietanyl derivatives', 'MIC 0.1-10 Microgram/ml against S. aureus, E. coli, P. vulgaris, K. pneumoniae, C. diversus, E. aerogenes, P. aeruginosa, S. abosit', '', 'N-acyl-5-hydroxypyrazolines and N,N''-diacylhydrazines of 6-methyluracil thietanyl- and dioxothietanyl derivatives showed high antimicrobial activity, which is consistent with the results of structure activity relationship analysis.', 34636064),
('Antibacterial Chemical Compound', 'compound C-2', 'against both gram-positive and gram negative bacteria, and non mutagenic, displayed high antimicrobial potency against Gram-positive bacteria in a murine model', '', 'Thus, compound C-2 had great potential as a promising lead compound for the treatment of bacterial infection.', 35675753),
('Antibacterial Chemical Compound', 'L-valine with p-alkynylaniline (dipeptide mimetic 7)', 'MIC ranging from 2.5 to 5 Microgram/mLantibacterial activity against Gram-negative (Escherichia coli and Klebsiella pneumoniae), Gram-positive (Staphylococcus aureus) and drug-resistant bacterium MRSA (methicillin-resistant S. aureus) but also demonstrated high selectivity for S. aureus versus mammalian erythrocytes', '', 'The mimetics bear considerable potential to be used as antibacterial and anticancer agents to combat antibiotic resistance.', 34772526),
('Antibacterial Chemical Compound', 'multifunctional cationic alternating copolymers', 'against Staphylococcus aureus, Enterococcus faecalis, Pseudomonas aeruginosa, and Escherichia coli, but also reduced the number of biofilm cells even at low concentrations, without killing mammalian cells', '', 'These findings suggest that the multifunctional cationic nanopolymers have potential as a novel antibacterial agent for eradication of multidrug resistant bacterial infections.', 34920337),
('Antibacterial Chemical Compound', 'Fluorothiazinon (FT)', 'effectively suppressed the T3SS of Chlamydia spp., Pseudomonas aeruginosa, and Salmonella sp., inhibitory effect on A. baumannii biofilm formation', '', 'FT may be a promising candidate for the development of a broad-spectrum anti-virulence drug to use in the prevention of nosocomial infections.', 35064243),
('Antibacterial Chemical Compound', 'Compounds 5b (Z)-3-(3-hydroxyphenyl)-5-((1-methyl-1H-indol-3-yl)methylene)-2-thioxothiazolidin-4-one and 5g (Z)-3-[5-(1H-Indol-3-ylmethylene)-4-oxo-2-thioxo-thiazolidin-3-yl]-benzoic acid as well as 5h (Z)-3-(5-((5-methoxy-1H-indol-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)benzoic acid', 'against resistant strains MRSA, P. aeruginosa and E. coli and were found to be more potent than MRSA than reference drugs', '', 'Conclusion: Compounds 5b (Z)-3-(3-hydroxyphenyl)-5-((1-methyl-1H-indol-3-yl)methylene)-2-thioxothiazolidin-4-one and 5g (Z)-3-[5-(1H-Indol-3-ylmethylene)-4-oxo-2-thioxo-thiazolidin-3-yl]-benzoic acid as well as 5h (Z)-3-(5-((5-methoxy-1H-indol-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)benzoic acid can be considered as lead compounds for further development of more potent and safe antibacterial and antifungal agents.', 35164333),
('Antibacterial Chemical Compound', 'polylysines (C6-PLL13)', 'against Staphylococcus aureus (S. aureus) and methicillin-resistant Staphylococcus aureus (MRSA)', '', 'Moreover, C6-PLL13 demonstrated a significant therapeutic effect on an MRSA infection mouse model, which further proved that this synthetic polymer could be used as an effective weapon against bacterial infections.', 35050580),
('Antibacterial Chemical Compound', 'SAICAR Synthetase (PurC) from Mycobacterium abscessus', 'a promising target for novel antibiotics', '', 'This work utilizes a fragment-based design and demonstrates for the first time the potential to develop inhibitors against PurC from Mab.', 35037462),
('Antibacterial Chemical Compound', 'series of vinyl sulfones', 'to enhance their affinity for fungal ASADHs', '', 'The best inactivators will serve as lead compounds for the development of potent and selective antifungal agents.', 34469014),
('Antibacterial Chemical Compound', 'nitric oxide MBs (NOMBs)', 'NOMBs with sub-inhibitory antibiotic produced the most significant reduction in biofilm biomass, corresponding to a 99.9% (SD ', '', 'The results us offer new insight for the development of new clinical treatments, for example, in chronic wounds.', 35992170),
('Antibacterial Chemical Compound', 'Sodium Citrate', 'citrate in silico blocked the Pseudomonas QS receptors and downregulated the expression of QS-encoding genes', '', 'In conclusion, sodium citrate showed a significant ability to diminish bacterial virulence in vitro and interfered with QS; it could serve as a safe adjuvant to traditional antibiotic treatment for aggressive resistant bacterial infections such as Pseudomonas aeruginosa infections.', 35630488),
('Antibacterial Chemical Compound', 'Fenton-like process utilizing a hierarchical macro-mesoporous Co3O4-SiO2 (MM CS)', 'catalyst for activation of peroxymonosulfate (PMS) to inactivate ARB and degrade the intracellular ARGs', '', 'Collectively, this work demonstrated that the MM CS-based heterogeneous photo-Fenton-like process is a promising technology for controlling the spread of antibiotic resistance in aquatic environments.', 35149504),
('Antibacterial Chemical Compound', 'oxindole-thiolimidazole derived carboxyphenylhydrazone 4e', 'oxindole-thiolimidazole derived carboxyphenylhydrazone 4e exhibited an 8-fold stronger inhibitory ability than norfloxacin on the growth of P. aeruginosa, with MIC value of 1 Microg/mL', '', 'These research results provided a promising light for phenylhydrazone-based oxindole-thiolazoles as novel potential antibacterial agents.', 35716514),
('Antibacterial Chemical Compound', '2-[(1E)-2-[4-(dimethylamino)phenyl]ethenyl]-1-methyl-4-(4-methylpiperidin-1-yl)quinolin-1-ium iodide', 'the inhibitors bearing a cyclic amine substituent at the 4-position of the quinolinium ring showed better antibacterial activity (MIC down to 0.25 Microg/mL) than that at the 2-position, especially against Gram-positive bacteria. A3 was identified to exhibit excellent antibacterial activity against S. aureus (MIC = 0.5-1 Microg/mL), S. epidermidis (MIC = 0.25 Microg/mL) and E. faecium (MIC = 1-8 Microg/mL).', '', 'A3 is thus a potent inhibitor of FtsZ and shows potential to be used as a new antibacterial agent against drug-resistant bacteria.', 35421657),
('Antibacterial Chemical Compound', 'Ti(deferasirox)2', 'exhibited promising inhibitory activity against the Gram-positive bacteria methicillin-resistant Staphylococcus aureus and minimal toxicity against human cells', '', 'The ability of this compound to undergo transmetalation with labile Fe(III) sources and, as a consequence, inhibit Fe bioavailability and ribonucleotide reductase is evaluated as a possible mechanism for its antibiotic effect.', 35203761);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Chemical Compound', 'BDDE-Inspired Chalcone Derivatives', 'chalcones 13 and 14 showed promising antifungal activity against the dermatophyte clinical strain of Trichophyton rubrum, and all compounds reversed the resistance to vancomycin in Enterococcus faecalis B3/101, with 9, 14, and 24 able to cause a four-fold decrease in the MIC of vancomycin against this strain. Compounds 17-24 displayed inhibition of EPs and the formation of biofilm by S. aureus 272123', '', 'Overall, the results obtained suggest the potential of dihydrochalcones 16-18 and 22-24, and diarylpropanes 19-21, 25 and 26, as hits for bacterial EPs inhibition, as they are effective in the inhibition of EPs, but present other features that are important in this matter, such as the lack of antibacterial activity and cytotoxicity.', 35621966),
('Antibacterial Chemical Compound', '6-bromo-2-naphthol (6B2N)', 'Pretreatment with 6B2N made A. baumannii cells more susceptible to PMB exposure indicating that it exhibits consequential synergistic action with PMB', '', 'The present findings provide a promising approach for utilizing plant extracts as adjuvants to reduce the toxicity of PMB in A. baumannii infection.', 35595766),
('Antibacterial Chemical Compound', 'Crizotinib', 'synergy with clindamycin and gentamicin. Importantly, the Gram-positive bacteria showed a low tendency to develop resistance to crizotinib.', '', 'Crizotinib is a promising antimicrobial agent and provides a novel choice for the development of treatment for Gram-positive infections.', 35674439),
('Antibacterial Chemical Compound', 'nusbiarylin derivatives', 'compound 22r exhibited the best antimicrobial activity with MIC of 0.5 Microg/mL', '', 'Overall, this series of derivatives showed potential antimicrobial activity and drug-likeness and provided guidance for further optimization.', 35580381),
('Antibacterial Chemical Compound', '1,2,4-Triazole-3-Thione Analogues with a 2-Ethylbenzoic Acid at Position 4', 'as VIM-type Metallo-beta-Lactamase Inhibitors', '', 'Several compounds were shown to restore the beta-lactam susceptibility of VIM-type-producing E. coli laboratory strains and also of K. pneumoniae clinical isolates.', 35050549),
('Antibacterial Chemical Compound', 'Short Guanidinium-Functionalized Poly(2-oxazoline)s', 'Potent Therapeutic Efficacy on Drug-Resistant Fungal Infections', '', 'The easy synthesis and structural diversity of POXs imply their potential as a class of promising antifungal agents.', 35182092),
('Antibacterial Chemical Compound', 'vaccenic acid', 'at a sub-MIC concentration significantly inhibited the virulence production of C. violaceum (chitinase and motility) and MRSA (hemolysin and staphyloxanthin production)', '', 'The results of the present study suggest that vaccenic acid is a promising agent to combat C. violaceum and MRSA.', 35759150),
('Antibacterial Chemical Compound', 'fosfomycin, colistin, trimethoprim and nitrofurantoin', 'against MDR E.coli, FOS/COL, COL/NIT and COL/TRI combinations represent the most effective synergistic (fractional inhibitory concentration index <1) combinations against the seven strains at MICs lower than the susceptible breakpoint ranges, followed by FOS/NIT and FOS/TRI, which achieved synergistic interactions against 1/7 and 2/7 of these strains. Importantly, the bactericidal effects (reduction ?3', '', 'Our data suggested that FOS/COL, COL/NIT and COL/TRI combinations could be a promising option against MDR UPEC infections. Additionally, FOS/NIT and FOS/TRI probably represent a good option for MDR UPEC with lower MICs.', 34839528),
('Antibacterial Chemical Compound', 'reactive organic radicals and silver (Ag) cations-metal-organic frameworks (MOFs)', 'inhibited the growth of four common Gram-negative and Gram-positive human pathogens (Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis, and Staphylococcus aureus), and particularly two multi-drug-resistance bacteria (MRSA and MDR-PA)', '', 'This study unveiled the promising potential of Ag-MOFs for anti-infective therapies and future clinical applications.', 35231687),
('Antibacterial Chemical Compound', 'indole-incorporated coumarin thiazolidinone conjugate 14a', '14a showed a broad antibacterial spectrum and exerted potent inhibition efficiencies to the tested germs at low concentrations (0.25-2 Microg/mL), eradicate bacterial biofilm to avert developing drug resistance.', '', 'ADMET analysis manifested that 14a possessed promising pharmacokinetic properties.', 35168149),
('Antibacterial Chemical Compound', 'Arabinoxylan-Carboxymethylcellulose Composite Films', 'The AMK-loaded AX-CMC films exhibited controlled release of AMK, excellent antibacterial activity, and cytocompatibility.', '', 'Thus, the AX-CMC composite films appear to be promising bioactive dressing materials for the prevention of wound infections.', 35566937),
('Antibacterial Chemical Compound', 'diphenylurea (Compound 24)', 'Compound 24 was 5-times more potent than the lead compound in terms of MIC values, against MRSA and VRSA', '', 'Taken together, these results indicate that the diphenylurea scaffold merits further investigation as a promising anti-staphylococcal treatment option.', 35279608),
('Antibacterial Chemical Compound', 'Icariin in Combination with Amoxycillin-Clavulanate and Ampicillin', 'Increases Antibiotic Sensitivity and Growth Inhibition against Methicillin-Resistant Staphylococcus aureus', '', 'This study demonstrates the potential utility of icariin in permitting lower antibiotic therapeutic doses in alignment with strategies to reduce the spread of antibiotic resistance.', 35203835),
('Antibacterial Chemical Compound', 'Tricyclic beta-Lactam', 'against Carbapenem-Resistant Enterobacterales, Including Strains with Reduced Membrane Permeability and Four-Amino Acid Insertion into Penicillin-Binding Protein 3', '', 'This potent tricyclic beta-lactam is a promising drug candidate for infectious diseases caused by CREs due to its potent therapeutic efficacy in the neutropenic mouse lung infection model and low frequency of producing spontaneously resistant mutants.', 35112852),
('Antibacterial Chemical Compound', 'Eucalyptus globulus n-hexane', 'Lowest mean MIC (10.04', '', 'It was concluded that E. globulus n-hexane fraction exhibited significantly promising results against MRSA .', 35225296),
('Antibacterial Chemical Compound', 'polymyxin B/trimethoprim (PT) + rifampin', 'impressive efficacy toward P. aeruginosa keratitis', '', 'Conclusions: The drug combination of PT + rifampin was effective against a large panel of clinically relevant P. aeruginosa strains and, as such, may represent a promising therapeutic for P. aeruginosa keratitis.', 35612831),
('Antibacterial Chemical Compound', '6-(1-Substituted pyrrole-2-yl)- s-triazine', 'potently inhibited the growth of Staphylococcus aureus regardless of its methicillin-resistant status, displaying minimum inhibitory concentration (MIC) values as low as 1 MicroM', '', 'Further development of these compounds as novel antimicrobial agents will be aimed at expanding our armamentarium of antibiotics.', 35239306),
('Antibacterial Chemical Compound', 'ibuprofen in combination with ciprofloxacin', 'Simultaneous treatment of bacterial cells with ibuprofen and ciprofloxacin significantly decreased bacterial biofilm formation (65%), The MIC of ibuprofen and ciprofloxacin were measured 2048 and 32 microg/mL and the drugs showed synergic antibacterial activity (FIC = 0.4) against P. aeruginosa.', '', 'This work suggests that ibuprofen has considerable anti-virulence potential against P. aeruginosa and could be employed for combination therapy with antibiotics after further characterizations.', 35657493),
('Antibacterial Chemical Compound', 'TP0586532', 'non-hydroxamate LpxC inhibitor, has in vitro and in vivo antibacterial activities against carbapenem-resistant Enterobacteriaceae, The MIC90 of TP0586532 against clinical isolates of carbapenem-resistant Klebsiella pneumoniae was 4 Microg ml-1.', 'showed an in vivo efficacy against murine systemic, urinary tract and lung infection models caused by meropenem- or ciprofloxacin-resistant strains. The estimated maximum unbound plasma concentration value at the effective dose of TP0586532 in murine infection models was around 13 Microg ml-1.', 'TP0586532 is predicted to exhibit a in vivo efficacy without cardiovascular toxicity and showed the potential of non-hydroxamate LpxC inhibitors as antibacterial agents against carbapenem-resistant Enterobacteriaceae.', 34837061),
('Antibacterial Chemical Compound', 'synergistic combination of allicin and selected antibiotics (levofloxacin, ciprofloxacin, oxytetracycline, rifaximin, ornidazole and azithromycin)', 'synergistic combinations showed significantly better (t-test p-value < 0.05) killing effect and biofilm reduction potential compared to their respective monotherapy application, where the highest killing effect was observed with rifaximin-allicin combination (kill rate was more than 5.5 h-1)', '', 'The potential of synergism between antibiotics and allicin combination demonstrated greater killing efficiency at significantly lower concentration compared to monotherapy with increased kill rates in all cases.', 35339353),
('Antibacterial Chemical Compound', 'Dicliptera roxburghiana', 'MIC values and zone of inhibition were measured and were found very effective for DRME, DRHF, DRCF and DREF while these were moderate for DRBF and DRAF. For antifungal assay, DRME and DRHF were potently active and showed more than 70% fungal growth inhibition where as DRCF and DRBF were also displaying appreciable inhibition.', '', 'Hence it can be concluded that plant contain some important compounds that can be used as antimicrobial source for the treatment of different infectious disease.', 35221269),
('Antibacterial Chemical Compound', 'Nevadensin', 'showed antibacterial activity against S. sanguinis with MIC and MBC values of 3750 and 15000 Microg/mL, respectively', '', 'Conclusion: Nevadensin showed potential as a new natural antibacterial agent by inhibiting the MurA enzyme rather than DNA gyrase.', 34238151),
('Antibacterial Chemical Compound', 'methyl oxime V-a', 'exerted potent inhibitory efficacy against methicillin-resistant Staphylococcus aureus (MRSA) at low concentration (1 Microg/mL) and showed broad antimicrobial spectrum', '', 'Computational study manifested that low HOMO-LUMO energy gap of molecule V-a was favorable to exert high antimicrobial activity.', 35576797),
('Antibacterial Chemical Compound', 'fascaplysin derivative 18', 'potent antimicrobial/antibiofilm activity against MRSA in vitro and in vivo, MIC value of 0.098 Microg/ml', '', 'All these results illustrate that fascaplysin derivative 18 is a strong and safe multi-target antibacterial agent, which makes it an attractive candidate for the treatment of MRSA and its biofilm infections.', 35007859),
('Antibacterial Chemical Compound', 'Diazabicyclooctane beta-Lactamase with combinations of amoxicillin (AMOX), imipenem (IMI), and cefuroxime (CXM)', 'The triple drug combinations of CXM-DUR-AMOX and IMI-DUR-AMOX were most potent, with MIC ranges of ?0.06 to 1 Microg/mL and an MIC50/MIC90 of ?0.06/0.25 Microg/mL, respectively.', '', 'The ability of DUR combined with amoxicillin or cefuroxime and imipenem to inactivate multiple targets such as d,d-carboxypeptidase and LdtMab2,4 supports new therapeutic approaches using beta-lactams in eradicating Mab.', 35073757),
('Antibacterial Chemical Compound', 'adamantane derivatives (compound 7)', 'potential anti-MDR agents', '', 'Finally, the in-silico analysis predicted that the most active derivatives had good drug-likeness and safe properties.', 35716118),
('Antibacterial Chemical Compound', 'analogue of robenidine (NCL179)', 'exhibits potent bactericidal activity, returning MICs/MBCs of 1-2 Microg/mL against methicillin-resistant Staphylococcus aureus, MICs/MBCs of 1-2 Microg/mL against methicillin-resistant S. pseudintermedius and MICs/MBCs of 2-4 Microg/mL against vancomycin-resistant enterococci', '', 'These results support NCL179 as a valid candidate for further development to treat MDR bacterial infections as a stand-alone antibiotic or in combination with existing antibiotic classes.', 35052942),
('Antibacterial Chemical Compound', 'phosphonamidates monoesters', 'Metallo-beta-Lactamase Inhibitor', '', 'We show phosphonamidates to have the potential to become a new generation of antibiotic therapeutics to combat metallo-beta-lactamase-resistant bacteria.', 35155946),
('Antibacterial Chemical Compound', 'cationic tetrahydroisoquinoline-triazole (compound 4b)', 'active against S. aureus at a low MIC of 2-4 Microg/mL, Hit compound 4b was also found to eliminate M. tuberculosis H37Rv at MIC of 6 Microg/mL.', '', 'These results identified compound 4b and its analogues as potential candidates for further drug development that could help tackle the threat of antibiotic resistance.', 35124457),
('Antibacterial Chemical Compound', 'o-hydroxy phenyl', 'o-hydroxy phenyl improved the inhibitory activity of Schiff bases on NDM-1. The inhibition mode assays including isothermal titration calorimetry (ITC) disclosed that both compounds 3 and 5 exhibited a reversibly mixed inhibition on NDM-1, with a Ki value of 1.9 and 10.8 microM, respectively. Antibacterial activity tests indicated that a dose of 64 microg', '', 'This study provided a novel scaffold for the development of NDM-1 inhibitors.', 35653899),
('Antibacterial Chemical Compound', 'Clemastine', 'Inhibits the Biofilm and Hemolytic of Staphylococcus aureus through the GdpP Protein', '', 'The discovery of this study identified novel use and mechanism of action of clemastine as a potential anti-biofilm drug for clinical application for S. aureus infectious.', 35234502),
('Antibacterial Chemical Compound', 'indole-2-carboxylates (InCs)', 'potential beta-lactamase stable beta-lactam mimics, new class of potent MBL inhibitor, active against all MBL classes of major clinical relevance, restore carbapenem activity against multiple drug-resistant Gram-negative bacteria and have a low frequency of resistance', '', 'InCs also have a good in vivo safety profile, and when combined with meropenem show a strong in vivo efficacy in peritonitis and thigh mouse infection models.', 34903857),
('Antibacterial Chemical Compound', '2,4-disubstituted quinazoline analogs (Compound 12)', 'showed a 2-4 fold improvement in activity than I against S. aureus Newman, S. pneumoniae DSM-20566 and E. faecalis DSM-20478', '', 'The compounds also showed a good safety profile towards human HepG2 cells.', 35007723),
('Antibacterial Chemical Compound', 'series of bicyclic-oxazolidinone', 'against MDR strains', 'In vivo proof of concept was achieved in a A. baumannii mouse thigh infection model.', 'A novel series of bicyclic-oxazolidinone inhibitors of bacterial type II topoisomerase were identified which display potent broad-spectrum anti-bacterial activity, including against MDR strains, along with an encouraging in vitro safety profile.', 35231579),
('Antibacterial Chemical Compound', 'surfactin isoforms produced by Bacillus velezensis SK', 'The isolated surfactin exhibits good antimicrobial activity (1600 AU/ml) against drug-resistant food-born B. cereus and human pathogen Staphylococcus aureus.', '', 'Hence, identified strain B. velezensis SK and its potent antibacterial surfactin lipopeptide could be used in various food and biomedical applications.', 35084596),
('Antibacterial Chemical Compound', 'Cordycepin', 'antibacterial and anti-inflammatory effects on H. pylori-infected mice', 'against gastritis in Helicobacter pylori-infected mice', 'Cordycepin may serve as a potential candidate for developing a therapeutic regimen for H. pylori-induced gastritis.', 35191475),
('Antibacterial Chemical Compound', 'HSD 1919', 'Compounds from the Povarov derived SF5-containing compounds inhibited both clinical and laboratory strains of Gram-positive bacteria at MIC of 0.5 Microg/mL to 2 Microg/mL. Interestingly, the lead compound, HSD 1919 exhibited rapid bactericidal mode of action against multidrug resistant (MDR) staphylococcal and enterococcal strains such as MRSA and VRE via bacterial membrane disruption. Bithionol (at 1 microg/mL) or nitroxoline (at 4 Microg/mL) when combined with HSD 1919 or HSD 1835 (at 0.5-4 Microg/mL), preformed MRSA biofilms could be dispersed', '', 'Herein, we report HSD 1919 and analogs thereof as critical chemical scaffolds, which can be harnessed to develop highly potent antibiofilm therapeutics.', 35793578),
('Antibacterial Chemical Compound', 'BAY 11-7082 and its analogues synergize with penicillin G', 'inhibits the growth of P. aeruginosa and other priority pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). We synthesized 27 structural analogues, including a series based on the related scaffold 3-(phenylsulfonyl)-2-pyrazinecarbonitrile (PSPC), 10 of which displayed increased anti-Staphylococcal activity.', '', 'Finally, we showed that BAY 11-7082 and its analogues synergize with penicillin G against MRSA, suggesting that this scaffold may serve as an interesting starting point for the development of antibiotic adjuvants.', 34860493),
('Antibacterial Chemical Compound', 'Kanamycin, tobramycin and gentamicin coupled with the laccase substrate 2,5-dihydroxy-N-(2-hydroxyethyl)-benzamide', 'The coupling products showed comparable and, in some cases, better antibacterial activity than the parent antibiotics in the agar diffusion assay, and they were not cytotoxic.', 'The products protected mice against infection with Staphylococcus aureus, which was lethal to the control animals.', 'The results underline the great potential of laccases in obtaining new biologically active compounds, in this case new antibiotic candidates from the class of aminoglycosides.', 35336201),
('Antibacterial Chemical Compound', 'Cationic amphiphilic dendrons', 'Among these cationic amphiphilic dendrons, a prime candidate was identified, which possessed excellent antimicrobial activity against various pathogens (minimum inhibitory concentrations of 9, 3, and 3 microg mL-1 for Escherichia coli, Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus, respectively).', '', 'In general, the synthesized cationic amphiphilic dendrons, which exhibited rapid and broad-spectrum bactericidal activity, may have great potential in antimicrobial applications.', 34982090),
('Antibacterial Chemical Compound', 'Gemcitabine and Derivatives', 'Potent Inhibitors Against Multidrug-Resistant Staphylococcus aureus', '', 'For further improvement, we synthesized selen-containing gemcitabine that demonstrated relatively potent antimicrobial activity against several MDR MRSA in vitro.', 35723616),
('Antibacterial Chemical Compound', 'series of thiophene-benzenesulfonamide derivatives (compound 17b)', 'compound 17b, which had improved activity (MIC 0.023 Microg/mL) compared with the lead compounds, displayed good intracellular antimycobacterial activity in macrophages with a reduction of 1.29 log10 CFU', '', 'Therefore, compound 17b may be a promising antituberculosis lead for further research.', 35101648),
('Antibacterial Chemical Compound', 'Pyridine coupled pyrazole analogues', 'lethal weapon against MRSA, Among the synthesized compounds 6d exhibited good antibacterial activity with MIC value 21 Microg/mL', 'An in-vitro and in-silico approach', 'The docking study of the synthesized compound was carried out and the study depicted that the pyridine ring of all the analogues binds with the various amino acids in the binding pocket of the active site of the Staphylocoagulase and PBP2a protein of MRSA.', 35364241),
('Antibacterial Chemical Compound', 'bispolides C-E (1-3) (isolated from a fermentation broth of the actinomycete strain MG372-hF19)', 'compounds 1-3 exhibited antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci and cytotoxic activity against human cancer cell lines', '', 'Additionally, using a membrane-potential-sensitive fluorescence probe, we found that compounds 1-3 and elaiophylin have a similar effect on membrane potential in A549 human lung cancer cells.', 34873311),
('Antibacterial Chemical Compound', 'thirteen novel O-aryloxycarbonyl hydroxamates', 'inhibited imipenemase-1 (IMP-1) and New Delhi metallo-beta-lactamase-1, exhibiting an IC50 value in the range of 0.10-18.42 and 0.23-22.33 MicroM, respectively', '', 'This work provided a potent scaffold for the development of MbetaLs inhibitors.', 34862744),
('Antibacterial Chemical Compound', 'TP0586532 and meropenem', 'Novel Non-Hydroxamate LpxC Inhibitor potentiating Effect on In Vitro Activity of Meropenem against carbapenem-susceptible K. pneumoniae and E. coli', '', 'Our study revealed that a combination therapy consisting of TP0586532 and meropenem has the potential to be a novel therapeutic option for CRE infections.', 35647694),
('Antibacterial Chemical Compound', 'Nitroxoline and its derivatives', 'potent inhibitors of Carbapenemases such as metallo-beta-lactamases', '', 'Our findings demonstrate that nitroxoline derivatives are potent MBL inhibitors and in combination with imipenem overcome MBL-mediated carbapenem resistance.', 34865870),
('Antibacterial Chemical Compound', 'four selected piperazine derivatives', 'Four molecules enhanced levofloxacin activity against E. coli strains overexpressing RND efflux pumps (AcrAB-TolC and AcrEF-TolC), but not against RND pump-deficient strains.', '', 'Conclusions: Piperazine derivatives are good candidates as inhibitors of RND efflux pumps. They decreased the activity of RND pumps by mixed mechanisms of action. Small structural differences among the molecules can be critical in defining their behaviour.', 34747445),
('Antibacterial Chemical Compound', 'Cinnamaldehyde Analogs', 'Antibiofilm Activities of Cinnamaldehyde Analogs against Uropathogenic Escherichia coli and Staphylococcus aureus', '', 'We suggest efforts be made to determine the therapeutic scope of CNMA analogs, as our results suggest CNMA derivatives have potential therapeutic use for biofilm-associated diseases.', 35806244),
('Antibacterial Chemical Compound', 'benzothiazole?urea hybrids', 'potent anti-bacterial agents against MRSA', '', 'Therefore, our data demonstrated the potential to advance benzothiazole?urea hybrids as a new class of antibiotics.', 35397402),
('Antibacterial Chemical Compound', 'pyridothienopyrimidine derivatives 2a,b-9a,b', 'Compounds 3a, 5a and 9b displayed broad spectrum antimicrobial activity with MIC ranges of 4-16 Microg/mL and potent cytotoxic activity with IC50 ranges of 1.17-2.79 MicroM. In addition, they provided suppressing activity against EGFR with IC50 ranges of 7.27-17.29 nM, higher than that of erlotinib, IC50 = 27.01 nM.', '', 'Many of the target compounds showed significant antimicrobial activity.', 35164067),
('Antibacterial Chemical Compound', 'high dilutions (hd)-antibodies (Abs)', 'hd-Abs in combination with AMC increased survival of mice infected with K. pneumoniae up to 50%, whereas all animals in the AMC group died. Hd-Abs had no direct effect on K. pneumoniae sensitivity to AMC in vitro.', 'The study was performed on an in vivo model of K. pneumoniae BAA-1705 multiresistant strain lethal infection in neutropenic RjOrl:Swiss mice. The mechanism of action of hd-Abs remains to be elucidated in future studies.', 'Thus, hd-Abs increased the antibacterial activity of AMC against the strain resistant to it.', 35248735),
('Antibacterial Chemical Compound', 'Surfactant with 18-carbon single hydrocarbon chain and multi-amine head groups (C18N3) after assembling with Staphylococcus aureus-targeting peptide (CARG) [C18N3/CARG]', 'exhibited excellent antimicrobial activities against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in vitro and in vivo, in which the targeting peptide CARG bonded specifically to Staphylococcus aureus and C18N3 killed bacteria with a mechanism of membrane disruption. Importantly, C18N3 could also work as a beta-lactamase inhibitor to overcome the bacterial resistance to beta-lactam antibiotics through noncompetitive inhibition. The combination of beta-lactam antibiotic and C18N3/CARG assemblies more effectively suppressed methicillin-resistant Staphylococcus aureus', '', 'Thus, the antibacterial platform of antibiotic-carrying surfactant assemblies bearing bacteria-targeted peptides, in which C18N3 performed dual function, antibacterial agent and beta-lactamase inhibitor, may help fight against the difficult-to-treat infections.', 35278861),
('Antibacterial Chemical Compound', 'Quinoline-2-carboxaldehyde-N4-phenyl-3-thiosemicarbazone bismuth dichloride and carbapenem', 'restores carbapenem sensitivity in NDM-1-positive Klebsiella pneumoniae', 'The cytotoxicity against human cells was higher than the effective concentration needed for the synergistic effect in bacterial cells, indicating that a structural optimization of the compounds is needed.', 'Quinoline-2-carboxaldehyde-N4-phenyl-3-thiosemicarbazone bismuth dichloride and carbapenem showed synergism in a dose dependent manner with negligible antibacterial activity when used in a monotherapy and could restore antibiotic sensitivity in the strain producing NDM-1 enzyme.', 35690039),
('Antibacterial Chemical Compound', 'Shikimate Pathway-Derived Phenolic Acids', 'MIC values in the range 31.2 to 62.5 microg/mL against S. aureus, and E. coli, and there was an overall reduction in MIC following their combination with ciprofloxacin', '', 'Taken together, the findings from both the in silico and in vitro evaluations in this study have demonstrated high affinity of p-coumaric acid towards NorA and could be suggestive of its exploration as a novel NorA efflux pump inhibitor.', 35458799),
('Antibacterial Chemical Compound', 'SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin', 'Combats Drug-Resistant Klebsiella pneumoniae, Its Biofilms, and Persister Cells', '', 'In summary, our findings indicated that SPR741, in combination with macrolide antibiotics (double or triple combination), has the potential to serve as a novel treatment option against drug-resistant K. pneumoniae -related infections.', 35372124),
('Antibacterial Chemical Compound', 'Saccharomyces boulardii CNCM I-745 supplementation', 'modifies the fecal resistome during Helicobacter pylori eradication therapy', '', 'Conclusion: Our study demonstrated that the addition of S. boulardii CNCM-I 745 to the conventional antibiotic eradication therapy for H. pylori reduced the abundance of ARGs, particularly those genes that confer resistance to lincosamides, tetracyclines, MLS-B, and a few genes in the beta-lactams class.', 34990038),
('Antibacterial Chemical Compound', 'hydrogel based on peptide DP7 (VQWRIRVAVIRK) and oxidized dextran (DP7-ODEX hydrogel) loaded with ceftazidime into DP7-ODEX hydrogel,', 'DP7 can synergize with many antibiotics; thus, we loaded ceftazidime into DP7-ODEX hydrogel, which showed an obvious advantage in MDR P. aeruginosa inhibition. DP7 could also be used as a wound-healing peptide and accelerate the healing process. We confirmed that the DP7-ODEX hydrogel exerted formidable therapeutic effects in normal or diabetic wound infection model. According to histomorphology analysis we found that DP7 hydrogel also have a scarless wound healing ability.', '', 'In summary, we developed a hydrogel fabricated by the dual functional peptide DP7 that can kill multidrug-resistant bacteria colonizing the wound bed and boost scarless wound healing.', 34973798),
('Antibacterial Chemical Compound', 'WCK 6777 (ertapenem/zidebactam)', 'against carbapenemase-producing Klebsiella pneumoniae', 'in the neutropenic murine pneumonia model', 'Conclusions: Human-simulated exposures of WCK 6777 demonstrated potent in vivo activity against CP-KP, including those with WCK 6777 MICs up to 8 mg/L', 35411395),
('Antibacterial Chemical Compound', 'ascorbic acid with rutoside supplementation', 'The ascorbic acid and rutoside combination, however, significantly decreased biofilm production.', '', 'Conclusions: Our research proves a beneficial impact of ascorbic acid with rutoside supplementation on biofilm of P. mirabilis strains causing urinary tract infections.', 35655208),
('Antibacterial Chemical Compound', 'Telacebec', 'against MDR-TB strains', '', 'Its clinical efficacy, favorable pharmacokinetic properties, low arrhythmogenic risk, and activity against MDR-TB strains make telacebec a suitable candidate for further development.', 35034512),
('Antibacterial Chemical Compound', 'naphthalimide corbelled aminothiazoximes', 'potential allosteric modulators for PBP2a, dimethylenediamine derivative 13d presented a wonderful inhibition on MRSA (MIC = 0.5 microg/mL), and showed excellent membrane selectivity (HC50 > 200 Microg/mL) from an electrostatic distinction of the electronegative bacterial membranes and the electroneutral mammalian membranes', '', 'These findings of naphthalimide corbelled aminothiazoximes as a small-molecule class of anti-MRSA agents held promise in strategies for treatment of MRSA infections.', 34922190),
('Antibacterial Chemical Compound', 'ultraviolet/peracetic acid', 'simultaneously remove antibiotics and antibiotic resistance genes in wastewater, The results showed that UV/PAA disinfection with a high UV dosage (UV/PAA-H) was most effective for the removal of tetracyclines, quinolones, macrolides and beta-lactams; their average removal efficiencies ranged from 25.7% to 100%, while NaClO disinfection was effective for the removal of sulfonamides (?81.6%). The majority of ARGs were well removed after the UV/PAA-H disinfection, while specific genes including tetB, tetC, ermA and blaTEM significantly increased after NaClO disinfection.', '', 'Our study provides valuable information for understanding the simultaneous removal mechanism of antibiotics and ARGs in wastewater during the disinfection processes, especially for the novel UV/PAA combination process.', 34982977),
('Antibacterial Chemical Compound', 'triethylene glycol monomethyl ether side groups (short polyethylene glycol (PEG) analog)', 'PEG moiety and fine-tuned hydrophilic-lipophilic balance of ionenes synergistically lead to low cytotoxic, low hemolytic molecules with high activity against S. aureus, including methicillin-resistant strains (MRSA).', '', 'Many reported polycations show high antimicrobial activity along with low hemolytic activity.', 35524947),
('Antibacterial Chemical Compound', 'dipotassium glycyrrhizinate-loaded hydrogels (HP-3/DG10)', 'antimicrobial activity against Staphylococcus aureus when infused with dipotassium glycyrrhizinate (DG)', 'Using a mouse full-thickness skin defect model, in vivo wound healing evaluations revealed that the DG-loaded hydrogels (HP-3/DG10) applied to the wound resulted in rapid wound closure.', 'The simple preparation method and multifunctionality of the studied hydrogel composites may provide important insights for the development of future biomaterials for wound dressings and other biomedical applications.', 35245682),
('Antibacterial Chemical Compound', 'WCK 1152, WCK 1153', 'treatment of resistant pneumococcal and staphylococcal respiratory infections', '', 'Advance studies suggested either WCK 1152 or WCK 1153 are the worthy candidates for further clinical developments for respiratory infections caused by resistant pneumococci and staphylococci. However, on the basis of in house preclinical work, WCK 1152 had been selected for phase-1 domestic clinical trials.', 35276361),
('Antibacterial Chemical Compound', 'GSK2556286', 'Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment', '', 'These features indicate a compound with a novel mode of action, although still not fully defined, that is effective against both multidrug-resistant (MDR) or extensively drug-resistant (XDR) and drug-sensitive (DS) M. tuberculosis with the potential to shorten the duration of treatment in novel combination drug regimens.', 35607978),
('Antibacterial Chemical Compound', 'Linolenic Acid-Metronidazole', 'Compound Relieving Drug Resistance and Inhibiting Helicobacter pylori, MIC and MBC to Hp were 2~4 Microg/mL, 8~16 Microg/mL. Moreover, in vivo experiments, Lla-Met significantly reduced the colonization of drug-resistant Hp in gastric mucosa.', '', 'Conclusion: Lla-Met, a newly prepared compound, has relatively well antibacterial of Met-resistant and sensitive Hp, with a capability of overcoming the metronidazole resistance of Hp.', 35758720),
('Antibacterial Chemical Compound', 'sodium fusidate antibiotic cutaneous spray based on water-free lipid formulation system', 'significantly stronger antibacterial effect than Fucidin cream showing a clear dose-response relationship for the sodium fusidate content', '', 'Improving the efficacy of topical formulations could potentially shorten the treatment period and avoid the resistance growth.', 35779822),
('Antibacterial Chemical Compound', 'Three novel series of tylosin semisynthetic derivatives were designed', 'Among these derivatives, compound C-2 demonstrated potent antibacterial activity against both gram-positive and gram negative bacteria, and non mutagenic.', '', 'compound C-2 displayed high antimicrobial potency against Gram-positive bacteria in a murine model, and was found to be more efficient than tildipirosin. Thus, compound C-2 had great potential as a promising lead compound for the treatment of bacterial infection.', 35675753),
('Antibacterial Chemical Compound', 'N-{5-ethyl-[1,2,4]triazolo[1,5-c]quinazolin-2-yl}-2,2,2-trifluoroacetamide', 'demonstrated antimicrobial effects against E. coli.', 'no tissue damage or other toxicity was observed after the therapeutic dose treatment.', 'effective compound to used as a treatment option for E. coli related infections.', 36590392),
('Antibacterial Chemical Compound', 'quinoline derivatives', 'compounds active against MDR K. pneumoniae', 'None of the compounds showed hemolytic effect.', 'This study was designed to identify compounds active against MDR K. pneumoniae which causes infections, such as pneumonia and urinary tract infections.', 35796056),
('Antibacterial Chemical Compound', 'New 1,2,4-oxadiazole/pyrrolidine hybrids', 'The derivative Compound 17 ( n= 3,5-difluoro) had the strongest inhibitory effect against Escherichia coli Topo IV of all the synthesized compounds, with an IC50 value of 13 microM, which was comparable to novobiocin (IC50 = 11 microM). compound 17 outperformed ciprofloxacin against E. coli, with an MIC of 55 ng/ml, compared to 60 ng/ml for ciprofloxacin.', '', 'Finally, the docking study, along with the in vitro experiments, supports our promising approach to effectively develop potent leads for further optimization as dual DNA gyrase and Topo IV inhibitors.', 35363388),
('Antibacterial Chemical Compound', 'N-Aryl Malonamides (NAMs)', 'At a concentration of 10 microM NAMs, most compounds substantially reduced pyocyanin production in these MDR P. aeruginosa clinical isolates', '', 'activity of a NAM family of potent and effective anti-MvfR agents. Overall, many NAM derivatives show much better solubility than the benzothiazole analogs. NAMs provide for the development of crucial preventive/therapeutic monotherapy options against untreatable MDR PA infections.', 36042245),
('Antibacterial Chemical Compound', 'polyaminoisoprenyl compound NV716', 'MIC Against PAO1 Pseudomonas aeruginosa, NV716 showed synergistic effects at ?2.5 microM', '', 'NV716 also reduces motility, virulence factors production, and biofilm formation. NV716 shows a unique and highly promising profile of activity when used alone or in combination with antibiotics against P. aeruginosa, combining in a single molecule anti-virulence and potentiator effects. Additional work is required to more thoroughly understand the various functions of NV716', 36008485),
('Antibacterial Chemical Compound', 'Pyrogallol', 'pyrogallol dramatically enhanced the lifespan of A. baumannii-infected zebrafish. Further, the histopathological results also demonstrated the disease protection efficacy of pyrogallol against the pathognomonic sign of A. baumannii infection.', '', 'Pyrogallol inhibiting bacterial colonization, demonstrating the anti-infective potential of pyrogallol against A. baumannii. the pyrogallol treatment effectively improved the immune parameters such as serum myeloperoxidase activity, leukocyte respiratory burst activity, and serum lysozyme activity in zebrafish against A. baumannii infection. Based on the results, the present study strongly proposes pyrogallol as a promising therapeutic agent for treating A. baumannii infection.', 36526063),
('Antibacterial Chemical Compound', 'a polycationic vancomycin aglycone derivative', 'the derivative of Compound 14 is 16 times less active against the vancomycin sensitive strain, than vancomycin, but it is 32 times more potent against the resistant VanA strain. the vancomycin and teicoplanin resistant VanA type E. faecalis was even more susceptible with a MIC of 8 microg/mL.', 'The cationic vancomycin derivative 14 showed a dose-dependent cytotoxicity both on Caco-2 and hCMEC/D3 cells, but fortunately low toxicity was observed in both cases. The IC50 value was 56.22 ', 'it synergized with teicoplanin against Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii, and it was able to potentiate vancomycin against these Gram-negative strains. Moreover, it proved to be active against vancomycin- and teicoplanin-resistant Gram-positive bacteria. ** compound 14 was able to synergize with teicoplanin and strongly potentiated vancomycin against Gram-negative bacteria including Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii, demonstrating the ability of compound 14 to compromise the integrity of the outer membrane of Gram-negative strains.', 36463278),
('Antibacterial Chemical Compound', 'Alcohol-Based and quaternary ammonium compounds - QAC Disinfectants', 'The most abundant genera were Staphylococcus, Micrococcus, and Bacillus. The average MIC values of alcohol-based disinfectants range between 66.61 and 148.82 g/L, and those of QAC-based disinfectants range between 2.4 and 3.5 mg/L.', '', 'The widespread use of disinfectants can induce a reduction in the susceptibility of bacteria against disinfectants and affect the increase in the proportion of antibiotic-resistant bacteria.', 36429408),
('Antibacterial Chemical Compound', 'pyrite (FeS2, naturally abundant mineral) for periodate (PI)', 'FeS2/PI system could disinfect 1 ', '', 'The generated reactive species including Fe(IV), ', 36610181),
('Antibacterial Chemical Compound', 'lysin exebacase (CF-301)', 'Exebacase displayed (i) a significant anti-biomass activity on S. epidermidis biofilms at concentrations ?5 mg/L (mean decrease up to 66% at 150 mg/L), (ii) significant bactericidal activity on biofilms at concentrations ?50 mg/L (mean decrease up to 1.7 log CFU at 150 mg/L), (iii) synergistic effects when used in addition to rifampicin, vancomycin, or daptomycin.', '', 'Exebacase can be considered a promising therapy in addition to rifampicin, vancomycin, or daptomycin . Further in vitro studies are needed to understand its mechanism of action on S. epidermidis biofilms and in vivo investigations are required to confirm these data.', 35861539),
('Antibacterial Chemical Compound', 'N-Terminal Lysozyme Conjugation to a Cationic Polymer', 'Conjugate can efficiently overcome lysozyme resistance in Gram-positive bacteria and antibiotics-resistance in Gram-negative bacteria,', '', 'synergistic interactions of lysozyme and the cationic polymer with the bacteria to disrupt their cell membranes. In a rat periodontitis model, the lysozyme-polymer conjugate not only greatly outperforms lysozyme in therapeutic efficacy but also is superior to minocycline hydrochloride. These findings may provide an efficient strategy to dramatically enhance the antimicrobial activities of lysozyme and pave a way to overcome antimicrobial resistance.', 36239583),
('Antibacterial Chemical Compound', 'polymer, Pluronic F-127 (PF127) solution containing PT-b1', 'Clinical isolated bacteria strain with antibiotic resistance. Escherichia coli, Bacillus subtilis, Mycobacterium smegmatis, Mycobacterium fortuitum;Enterococcus faecalis, Staphylococcus aureus; Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa; Enterobacter cloacae MIC is in range of 0.5 - 16 [microg mL?1] with PF127-PT-b1', 'In 2 h, it could be observed that PT-b1 could eradicate all bacteria, but it also caused ?5% hemolysis at this AMPM concentration. In contrast, PF127-PT-b1 could also remove all bacteria, but with only a <1.5% RBC lysis was seen in the same timeframe.', 'he AMPM- Pluronic F-127 complex, i.e., PF127-PT-b1, was able to kill MDR pathogens, rescue infected RBCs, and remove established biofilms at concentrations with excellent hemocompatibility. Pluronic F-127 as an amphiphilic masking agent to reduce the hemolytic activity of the cationic AMPM while keeping most of its activity, thus the overall therapeutic index of the AMPM can be much improved.', 35545965),
('Antibacterial Chemical Compound', 'Pluronic F127 (polyethylene-polypropylene glycol) -based in situ sprayed biotherapeutic gel (denoted as gel with kombucha)', 'The inhibition rate of biofilm formation by gel with kombucha was 93% for E. coli and 82% for S. aureus, respectively', 'MTT assay substantiated the negligible toxicity of F127 at concentrations below 40 mg mL?1. Intact cellular actin cytoskeleton architecture was well reserved after cells were exposed to gel with kombucha', 'These results indicated that this biotherapeutic gel possessed good biocompatibility within the therapeutical dose, which could be applied in the treatment of bacterial infectious wounds.', 36479844),
('Antibacterial Chemical Compound', 'N-(4-bromophenyl)-1-naphthamide', '', 'compounds N-(3?,5?-dimethyl-[1,1?-biphenyl]-4-yl)-1-naphthamide (4c) and N-(3?,5?-diflouro-[1,1?-biphenyl]-4-yl)-1-naphthamide (4f) showed significant haemolytic activity. N-(4?-chloro-[1,1?-biphenyl]-4-yl)-1-naphthamide (4e) exhibited an efficient biofilm inhibition activity against Gram-negative bacteria Escherichia coli and Gram-positive bacteria Bacillus subtilis.', 'research is focused on the development of agents that inhibit biofilm formation, thus the present work is valuable for preventing future drug resistance.', 34724237),
('Antibacterial Chemical Compound', 'two terpyridine ligands 4''-(4-N,N''-dimethylaminophenyl)-2,2'':6'',2?-terpyridine (L1) and 4''-(4-tolyl)-2,2'':6'',2?-terpyridine (L2)', 'Both compounds L1 and L2 exhibited remarkable inhibitory activities against bacteria, Escherichia coli and Staphylococcus aureus at MIC values 6.25 and 3.125 microg/ml, respectively', 'The toxicity of L1 and L2 was checked using Drosophila melanogaster. The toxicity analysis suggest both are non-cytotoxic in nature.', 'both L1 and L2 could bind Bovine Serum Albumin (BSA) protein and binding interaction has been studied with the help of UV-Visible and fluorescence spectroscopy. While fluorescence of BSA unperturbed in the presence of L2, an addition of L1 to the solution of BSA resulted significant quenching.', 36562209),
('Antibacterial Chemical Compound', '3-phenylpropan-1-amine (3-PPA)', '3-PPA (50.0 microg/mL) reduced S. marcescens NJ01 biofilm formation by 48%. The combination of 3-PPA (50.0 microg/mL) and ofloxacin (0.2 microg/mL) enhanced S. marcescens NJ01 sensitivity to ofloxacin.', '', '3-PPA is feasible as an ofloxacin adjuvant to overcome multidrug-resistant S. marcescens and improve the treatment of intractable infections. 3-PPA reduced virulence factors and eliminated biofilm formation by inhibiting QS in S. marcescens NJ01 bacteria, without affecting bacterial growth, thus restoring sensitivity to ofloxacin. Thus, the discovery of compounds that can restore antibiotic activity against bacteria is a promising strategy to mitigate multidrug resistance in pathogens.', 35972277),
('Antibacterial Chemical Compound', 'silicone Foley catheters (SFC) impregnated with these indole derivatives', 'Reduction of biomass in the P. mirabilis biofilm on the impregnated catheter was very evident when compared to that of untreated controls', 'advantage is the safety of this compound on human cell line.', 'Studying the change in gene expression of P. mirabilis in the presence of this indole extract reveals that their mechanism of action could be due to their action on the virulence factors contributing to bacterial motility, adherence, and urease production thus reducing crystalline biofilm formation by P. mirabilis. Further studies are intended to evaluate this approach by in vivo analysis via long-term catheterization in animal models and studying their possible synergistic activity with other antivirulence compounds to increase their activity.', 36118027),
('Antibacterial Chemical Compound', 'ynergistic Effects of Capric Acid and Colistin', 'Checkerboard assays showed a synergistic effect against all colistin-resistant strains [(FICI, fractional inhibitory concentration index) = 0.02-0.38] and two colistin-susceptible strains', '', 'Time-kill assays confirmed the combination was synergistic. We suggest that the combination of colistin and capric acid is a promising therapeutic strategy against Gram-negative colistin-resistant strains.', 36671237),
('Antibacterial Chemical Compound', 'colistin conjugates (CT) with succinyl chitosan (SucCS)', 'The MICs of SucCS-CT-10 and native CT were 1 microg/mL, while MICs of other samples, such as SucCS-CT-3 and SucCS-CT-5, against P. aeruginosa, were 8 microg/mL. It should be noted that SucCS-CT-3 and SucCS-CT-5 at the concentrations of 0.25', 'e developed systems reduced CT nephrotoxicity by 20-60%', 'The antimicrobial activity of the conjugates depended on the degree of substitution . they also demonstrated the ability to reduce bacterial lipopolysaccharide-induced inflammation in vitro. Thus, these promising CT-SucCS conjugates are prospective for developing safe and effective nanoantibiotics.', 36613610),
('Antibacterial Chemical Compound', 'ruthenium - Ru2', 'Ru2 can efficiently inhibit biofilm formation and alpha-hemolysin secretion from Staphylococcus aureus. in both a mouse skin infection model and a G. mellonella wax worm infection model, Ru2 showed significant antibacterial activity in vivo.', 'the Ru2 complex was almost non-toxic.', 'The results demonstrated that Ru2 could destroy the integrity of bacterial cell membranes. this work demonstrated that ruthenium-based complexes bearing a biphenyl group are promising agents to combat bacterial infection.', 36112764),
('Antibacterial Chemical Compound', 'Zinc Pyrithione in Combination with Gentamicin', 'The results showed that a combination of zinc pyrithione with gentamicin produced a strong synergistic effect (p < 0.001) against all tested streptococcal strains (with FICI values ranging from 0.20 to 0.42). only three out of eight S. aureus strains were highly susceptible to the combination of antimicrobial agents at single concentration (0.25 microg/mL) of zinc pyrithione with range of FICI 0.35?0.43.', '', 'These findings suggest that interference between agents tested in this study can be used for the development of future veterinary pharmaceutical preparations for the treatment of bacterial skin infections of livestock.', 35884214),
('Antibacterial Chemical Compound', 'Pyrimidine-conjugated fluoroquinolones: 4-aminopyrimidinyl compound', '4-aminopyrimidinyl compound exhibited superior antibacterial potency against Enterococcus faecalis with a low MIC of 0.25 microg/mL to norfloxacin and ciprofloxacin.', 'showed a broad antibacterial spectrum and low cytotoxicity', 'The active compound 4-aminopyrimidinyl compound with fast bactericidal potency could inhibit the formation of biofilms and showed much lower trend for the development of drug-resistance than norfloxacin and ciprofloxacin. This compound ROS accumulations in bacterial cells thus facilitating bacterial death. ADME analysis indicated that this compound possessed favorable drug-likeness and promising pharmacokinetic properties. These results demonstrated that pyrimidine-conjugated fluoroquinolones held hope as potential antibacterial candidates and deserve further study.', 35835379),
('Antibacterial Nanocomposites', 'Lactoferrin delivered by biomimetic hydroxyapatite nanoparticles', 'Better performance of lactoferrin delivered by biomimetic hydroxyapatite nanoparticles combined with cell free supernatant from probiotic Lactobacillus paracasei compared to both lactoferrin and probiotic alone or pooled.', '', 'CONCLUSION: These findings indicate the effectiveness and safety of our proposed therapy as alternative treatment for Helicobacter pylori infection.', 27384186),
('Antibacterial Nanocomposites', 'Tobramycin decorated graphene oxide AgNPs (TOB-GO-Ag)', 'Significant loss of bacterial membrane potential from -52 +- 2 mV (control) to -2 +- 1 mV (treated) indicates a severe cell wall damage caused by TOB-GO-Ag composite', '', 'Tobramycin mediated silver nanospheres/graphene oxide composite for synergistic therapy of bacterial infection.', 29763756);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Nanocomposites', 'A PS (beta-carboxyphthalocyanine zinc, CPZ) delivery system with lanthanide-doped upconversion nanoparticles (UCNPs, LiYF4:Yb/Er) and polyvinylpyrrolidone (PVP)', 'Such a near-infrared (NIR) triggered UCNPs-CPZ-PVP system significantly reduced the aggregation of CPZ and presented a high anti-infectious activity against multi-drug resistant (MDR) bacteria (methicillin-resistant Staphylococcus aureus by 4.7 log10 and MDR Escherichia coli by 2.1 log10) post aPDT (at 50 micro g mL-1 UCNPs-CPZ-PVP with 0.5 W cm-2 980 nm light).', '', 'Near-infrared-triggered antibacterial and antifungal photodynamic therapy based on lanthanide-doped upconversion nanoparticles. An alarming worldwide increase in microbial resistance to traditional drugs and classical pharmacophores has spurred the search for new antimicrobial compounds. Antimicrobial photodynamic therapy (aPDT) has recently emerged as an effective modality for the selective destruction of bacteria and other pathogenic microorganisms.', 29881851),
('Antibacterial Nanocomposites', 'Quaternized chitosan hydrogels incorporated with NaYF4:Er/Yb/Mn@photosensitizer-doped silica (UCNPs/MB)', 'Excellent antibacterial efficiency to both DR-S. aureus and DR-E. coli bacteria', '', 'By incorporating UCNPs/MB-doped silica into the hydrogel, we have combined photodynamic therapy (PDT) with quaternized chitosan to obtain a high therapeutic index via a synergistic effect.', 26883410),
('Antibacterial Nanocomposites', 'Monomeric methylene blue conjugated gold nanoparticles', 'In our treatment modality negligible dark toxicity suggests photochemically driven process with 97% killing of MDR bacteria.', '', 'Nanoparticle-based photodynamic therapy (PDT) is increasingly been adopted as a potential antimicrobial option, yet the cytotoxicity associated with PDT is quite unspecific.', 28778019),
('Antibacterial Nanocomposites', 'Catheter loaded with silver', '', '', 'In vitro efficacy of a hydrophilic central venous catheter loaded with silver to prevent microbial colonization. A method was developed to load the surface of a central venous catheter with silver to prevent bacterial colonization.', 9532274),
('Antibacterial Nanocomposites', 'Tungsten nanoparticles', 'The bactericidal activity of newly synthesized tungsten-nanoparticles was tested on clinical multiple drug resistant Escherichia coli isolates from UTI patients with indwelling catheters and Staphylococcus aureus reference strain. The results suggest that the particles tested in this study certainly mediate the inhibition of bacterial growth.', '', 'We believe that the fabrication of W-NPs on catheters could possibly prevent them from being contaminated by pathogens and hence provide continuous protection of the site.', 21213591),
('Antibacterial Nanocomposites', 'Silver nanoparticle-doped SiO(2) microspheres (Ag-SMSs)', 'Effective inhibition against proliferation of E. coli', '', 'Large-scale preparation of strawberry-like, AgNP-doped SiO2 microspheres using the electrospraying method. In this paper, we report on a novel strategy for the preparation of silver nanoparticle-doped SiO(2) microspheres (Ag-SMSs) with an interesting strawberry-like morphology using a simple and efficient electrospraying method.', 21719963),
('Antibacterial Nanocomposites', 'Selenium nanoparticles', 'Study provided the first evidence of strongly inhibited growth of S. aureus in the presence of selenium nanoparticles after 3, 4, and 5 hours at 7.8, 15.5, and 31 ?g/mL. The percentage of live bacteria also decreased in the presence of selenium nanoparticles. Therefore, this study suggests that selenium nanoparticles may be used to effectively prevent and treat S. aureus infections and thus should be further studied for such applications.', '', 'Therefore, this study suggests that selenium nanoparticles may be used to effectively prevent and treat S. aureus infections and thus should be further studied for such applications.', 21845045),
('Antibacterial Nanocomposites', '2-phenoxy-1-phenylethanone, a synthetic analogue of neolignan (LS-2)-loaded microparticles', 'Activity against Mycobacterium tuberculosis H37Rv ATCC 27294', '', 'These findings are encouraging and indicate that LS-2-loaded microparticles are a potential alternative to conventional chemotherapy of TB.', 21854223),
('Antibacterial Nanocomposites', 'Chitosan (CS) nanoparticles', 'Anti-biofilm activity in Streptococcus mutans, Pseudomonas aeruginosa and Candida albicans', '', 'Chitosan nanoparticles for antimicrobial photodynamic inactivation: characterization and in vitro investigation. The growing resistance to antibiotics has rendered antimicrobial photodynamic inactivation (PDI) an attractive alternative treatment modality for infectious diseases.', 22283820),
('Antibacterial Nanocomposites', 'Titanium with chitosan', 'The Chitosan-coated surfaces showed strong inhibition of Actinomyces \nnaeslundii growth', '', 'Functionalization of titanium with chitosan via silanation: evaluation of biological and mechanical performances. Complications in dentistry and orthopaedic surgery are mainly induced by peri-implant bacterial infections and current implant devices do not prevent such infections.', 22859940),
('Antibacterial Nanocomposites', 'Ag-SiO(2) NC (nano composite)', 'Complete mortality of the bacterium was achieved with 80 ?g ml(-1) concentration of Ag-SiO(2) NC. Inside the cytoplasm, a complete inhibition of electron transport system was achieved with 100 ?g ml(-1) Ag-SiO(2) NC, followed by DNA breakage.', '', 'The study thus demonstrates that Ag-SiO(2) NC invades the cytoplasm of the multiple drug-resistant P. aeruginosa by impinging upon the cell wall integrity and kills the cells by interfering with electron transport chain and the genetic stability.SIGNIFICANCE AND IMPACT OF STUDY: Although the synthesis, structural characteristics and biofunction of silver nanoparticles are well understood, their application in antimicrobial therapy is still at its infancy as only a small number of microorganisms are tested to be sensitive to nanoparticles.', 23083417),
('Antibacterial Nanocomposites', 'Silver-conjugated superparamagnetic iron oxide nanoparticles (SPION)', 'A significant decrease in biofilm mass, which corresponds to a seven orders of magnitude decrease in viability, is observed when MRSA biofilms are treated with 1 mg/mL of silver-conjugated SPION (p greater than 0.01).', '', 'For this reason, this study demonstrates for the first time that silver-conjugated SPION could be used as a targeted antibacterial therapy to the infection site.', 23184367),
('Antibacterial Nanocomposites', 'Ferrocene-carborane derivatives (FcSB1 and FcSB2) combining with nanoscaled titania (nano TiO2)', 'FcSB1 and nano TiO2 : FIC (fractional inhibitory concentration) index values 0.375 to 0.106, FcSB2 with nano TiO2 : FIC 0.250 to 0.083', 'NA', 'Synergistic antibacterial activity of new isomeric carborane derivatives through combination with nanoscaled titania. As a novel strategy to combat the nosocomial infection caused by multidrug-resistant (MDR) bacteria like Acinetobacter baumannii, the antibacterial effect of a pair of geometrical isomers ferrocene-carborane derivatives (designated as FcSB1 and FcSB2) combining with nanoscaled titania (nano TiO2) against five MDR A. baumannii strains were explored in this contribution.', 23620994),
('Antibacterial Nanocomposites', 'Silver nanoparticles (Ag NPs, 120 nm)', 'Silver nanoparticles (Ag NPs, 120 nm) showed the greatest potency for reducing N. gonorrhoeae colony formation (MIC: 12.5 ?g/ml)', '', 'This is the first report to screen the effectiveness of nanomaterials against N. gonorrhoeae, and our results indicate that 120 nm Ag NPs deliver low levels of toxicity to human epithelial cells and could be used as an adjuvant with antibiotic therapy, either for topical use or as a coating for biomaterials, to prevent or treat multidrug-resistant N. gonorrhoeae.', 23705013),
('Antibacterial Nanocomposites', 'Polyethyleneimine functionalized zinc oxide nanoparticles', 'Inactivation of metronidazole-resistant Helicobacter pylori', '', 'The molecular basis of inactivation of metronidazole-resistant Helicobacter pylori using polyethyleneimine functionalized zinc oxide nanoparticles. In view of the world wide prevalence of Helicobacter pylori infection, its potentially serious consequences, and the increasing emergence of antibiotic resistant H. pylori strains there is an urgent need for the development of alternative strategies to combat the infection.', 23951006),
('Antibacterial Nanocomposites', 'tin (Sn) doped ZnO nanostructures', 'Sn doping enhanced the inhibitory activity of ZnO against S. aureus', 'Sn doping concentration in ZnO does not alter the cytotoxicity and ROS production, undoped and Sn doped ZnO nanostructures are biosafe and biocompatible materials towards SH-SY5Y Cells.', 'The observed behavior of ZnO nanostructures with Sn doping is a new way to prevent bacterial infections of S. aureus, especially on skin, when using these nanostructures in creams or lotions in addition to their sunscreen property as an ultraviolet filter.', 24109181),
('Antibacterial Nanocomposites', 'Solid lipid nanoparticles loaded with free fatty acids', '', '', 'A strategy was developed to target infections by producing coatings made of non-toxic chemistries lauric acid and oleic acid delivered by core-shell solid lipid nanoparticles that act against bacteria by multiple mechanisms at the nanoscale, including disruption of bacteria leading to DNA release, and reducing the adhesion of dead bacteria to ~1%. This is the first such study to explore an anti-infection surface relying on these multi-tier strategies at the nanoscale.', 24264141),
('Antibacterial Nanocomposites', 'Piperine and gentamicin nanoliposomes', 'MIC values of gentamicin and piperine were 32 and 100 micro g/mL, respectively. Synergetic effects were observed by the combination of gentamicin and piperine and FICI was determined to be 0.5. Following incorporation of gentamicin into liposomal gentamicin and liposomal combination, the MIC values were reduced 16- and 32-fold, respectively. MBC values of gentamicin reduced 4 and 8 times following incorporation into gentamicin and combination liposomes, respectively.', '', 'Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamicin nanoliposomes in methicillin-resistant Staphylococcus aureus.', 24842547),
('Antibacterial Nanocomposites', 'Silver nanoparticles from P. amarus extract', 'Exhibited excellent antibacterial potential against multidrug resistant strains of P. aeruginosa', '', 'CONCLUSION: The present study suggests that silver nanoparticles from P. amarus extract exhibited excellent antibacterial potential against multidrug resistant strains of P. aeruginosa from burn patients and gives insight of their potential applicability as an alternative antibacterial in the health care system to reduce the burden of multidrug resistance.', 25271044),
('Antibacterial Nanocomposites', 'poly(acrylic acid) (PAA)-coated iron oxide (magnetite) nanoparticles (PAA-MNPs)', 'Combination of PAA-MNP and rifampicin exhibits a synergistic 4-fold-higher growth inhibition against Mycobacterium smegmatis.', '', 'Polyacrylic acid-coated iron oxide nanoparticles for targeting drug resistance in mycobacteria. The emergence of drug resistance is a major problem faced in current tuberculosis (TB) therapy, representing a global health concern.', 25375643),
('Antibacterial Nanocomposites', 'Silver nanoparticles and Drosera binata extract', '', '', 'Combination of silver nanoparticles and Drosera binata extract as a possible alternative for antibiotic treatment of burn wound infections caused by resistant Staphylococcus aureus. Staphylococcus aureus is the most common infectious agent involved in the development of skin infections that are associated with antibiotic resistance, such as burn wounds.', 25551660),
('Antibacterial Nanocomposites', 'Erythrosine nanoparticles prepared using poly-lactic-co-glycolic acid (PLGA)', 'Significantly higher uptake and antimicrobial efficacy compared to pure drug in S. aureus cells.', '', 'The introduction of photodynamic antimicrobial therapy (PAT) using erythrosine, a photosensitizer, could eliminate the bacteria without inducing antibiotic resistance or even requiring daily dosing.', 25629633),
('Antibacterial Nanocomposites', 'Silver ion doped calcium phosphate based ceramic nano-powder coated titanium nails', 'Microbiological results showed that less bacterial growth was detected with the use of silver doped ceramic coated implants compared to the other two groups (p=0.003). Accumulation of silver was not detected. ', 'No cellular inflammation was observed around the silver coated prostheses. No toxic effect of silver on bone cells was seen.', 'Silver ion doped ceramic nano-powder coated nails prevent infection in open fractures: In vivo study.', 26589596),
('Antibacterial Nanocomposites', 'ZnO-NPs and TiO2-NPs', 'The IC50 values of ZnO and TiO2-NPs against S. mitis ATCC 6249 were 37 and 77 micro g ml(-1), respectively, while the IC50 values against S. mitis Ora-20 isolate were 31 and 53 micro g ml(-1), respectively', '', 'Results presented in this study verify that ZnO-NPs and TiO2-NPs can control the growth and biofilm formation activities of these strains at very low concentration and hence can be used as alternative antimicrobial agents for oral hygiene.', 26837748),
('Antibacterial Nanocomposites', 'Multi-walled carbon nanotubes (MWCNTs) covalently functionalized with immunoglobulin G', '', '', 'Using IgG molecules bound to MWCNTs, followed by laser irradiation, we obtained a very efficacious nanoshell-mediated laser therapy of individual MRSA agents providing highly localized killing effects for IgG-MWCNTs targeted bacteria.', 27301204),
('Antibacterial Nanocomposites', 'Silver coated single walled carbon nanotubes with antimicrobial peptides (FSWCNTs-Ag, SWCNTs-Ag-M, SWCNTs-Ag-M)', 'The?minimum inhibitory concentration (MIC) of FSWCNTs-Ag were much lower (~7.8-3.9 micro g/ml with IC50: ~4-5 micro g/ml) compared to SWCNTs-Ag-M and plain SWCNTs-Ag (both 62.6 micro g/ml, IC50: ~31-35 micro g/ml), suggesting that the covalent conjugation of TP359 with SWCNTs-Ag was very effective on their counterparts', 'FSWCNTs-Ag are non-toxic to the eukaryotic cells at their MIC concentrations (5-2.5 ?g/ml) compared to SWCNTs-Ag (62.5 ?g/ml).', 'This study described a novel approach to prepare SWCNT-Ag bio-conjugates without loss of antimicrobial activity and reduced toxicity, and this strategy will aid in the development of novel and biologically important nanomaterials.', 27412259),
('Antibacterial Nanocomposites', 'Photo-deposited silver coatings on Foley catheters', '', '', 'The potential of photo-deposited silver coatings on Foley catheters to prevent urinary tract infections.', 27612730),
('Antibacterial Nanocomposites', 'Silver (Ag) NPs and zinc oxide (ZnO) NPs', 'Potent antitubercular activity at a ratio of 8ZnO/2Ag', 'No cytotoxic effects on THP-1 cells', 'Mixed metal oxide nanoparticles inhibit growth of Mycobacterium tuberculosis into THP-1 cells.', 28043541),
('Antibacterial Nanocomposites', 'Linear random copolymers, comprised of oligoethylene glycol (OEG), hydrophobic, and amine groups, SCPNs (single-chain polymeric nanoparticles).', '(SCPNs) had excellent antimicrobial activity against Pseudomonas aeruginosa at 1.4 ?M and kill ?99.99% of both planktonic cells and biofilm in one hour.', '', 'Rational Design of Single-Chain Polymeric Nanoparticles That Kill Planktonic and Biofilm Bacteria. Infections caused by multidrug-resistant bacteria are on the rise and, therefore, new antimicrobial agents are required to prevent the onset of a postantibiotic era.', 28135798),
('Antibacterial Nanocomposites', 'Copper and rifampicin-loaded copper nanoparticles', 'Activity against Staphylococcus aureus, Escherichia coli, Bacillus pumilis and Pseudomonas fluorescens', '', 'The results obtained indicate that adsorption of rifampicin on the copper nanoparticles surface might provide the reduction of antibiotic dosage and prevent its adverse side effects.', 28150115),
('Antibacterial Nanocomposites', 'Imipenem loaded poly ?-caprolactone (PCL) and polylactide-co-glycolide (PLGA) nanocapsules', 'Eliminated bacterial attachment and the biofilm \nassembly of P. aeruginosa and K. pneumoniae planktonic bacteria by 74 \nand 78.4%, respectively.\n', '', 'Successfully, PCL nanocapsules were able to protect imipenem from enzymatic degradation by resistant isolates and prevent the emergence of the resistant colonies, as it lowered the mutation prevention concentration of free imipenem by twofolds.', 28399890),
('Antibacterial Nanocomposites', 'Silver and zinc oxide nanoparticles', 'Silver nanoparticles inhibited the growth of both A. salmonicida and A. invadans at a concentration of 17 micro g/mL. Zinc oxide nanoparticles inhibited the growth of A. salmonicida, Y. ruckeri and A. invadans at concentrations of 15.75, 31.5 and 3.15 micro g/mL respectively. ', '', 'In vitro assessment of the antimicrobial activity of silver and zinc oxide nanoparticles against fish pathogens', 28732514),
('Antibacterial Nanocomposites', 'Honey, polyvinyl alcohol, chitosan nanofibers', 'Complete killing of multidrug-resistant P. aeruginosa', '', 'Apitherapeutics and phage-loaded nanofibers as wound dressings with enhanced wound healing and antibacterial activity. AIM: Develop green wound dressings which exhibit enhanced wound-healing ability and potent antibacterial effects.', 28805554),
('Antibacterial Nanocomposites', 'Synthesis of AgNPs and the ethyl acetate extract from Bacillus cereus A30', 'Active against multi-drug resistant (MDR) pathogens, Methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa', '', 'Antibacterial efficacy of silver nanoparticles and ethyl acetate''s metabolites of the potent halophilic (marine) bacterium, Bacillus cereus A30 on multidrug resistant bacteria. Bacteria are generally responsible for the prevalence of several diseases and pathogenic bacteria are showing increasing resistance to different antibacterials.', 29072532),
('Antibacterial Nanocomposites', 'Trimetal (CuZnFe) oxide nanoparticles (NPs)', 'the antibacterial activity of the trimetal oxide NPs was greater against E. coli than against E. faecalis.', 'However, the cytotoxicity of trimetal NPs to mammalian cells needs to be verified.', 'Conclusion: The combination of three metal oxide NPs (ZnO, CuO, and Fe2O3) in one multimetal (CuZnFe) oxide NPs will enhance the therapeutic strategy against a wide range of microbial infections.', 29317817),
('Antibacterial Nanocomposites', 'Azole complexes combined with AgNPs', '', '', 'The use of azole complexes combined with AgNPs provides a new alternative against bacterial infections, especially when current treatments are associated with the rapid development of antibiotic resistance.', 29419803),
('Antibacterial Nanocomposites', 'Apigenin-mediated AgNPs (Silver Nanoparticles)', 'Efficacy against Prevotella melaninogenica and Arcanobacterium pyogenes', 'Toxic effect of cell death was caused by an increase in oxidative stress', 'Therefore, the biomolecule (apigenin)-mediated synthesis of AgNPs shows potential as an alternative antimicrobial therapy for bovine metritis and endometritis.', 29659523),
('Antibacterial Nanocomposites', 'ZnO-NP', 'Activity against Acinetobacter baumannii', '', 'These results demonstrate that ZnO-NP could be developed as alternative therapeutics against A. baumannii.', 29928271),
('Antibacterial Nanocomposites', 'Bioactive Glass (BG) incorporating silver (BgAg)', 'Active ggainst Pseudomonas aeruginosa and Staphylococcus aureus', '', 'Taken together, the findings provide evidence that BgAg elicits potent antimicrobial effects against planktonic and single-species biofilms, with beneficial effects on the host tissue response.', 30018606),
('Antibacterial Nanocomposites', 'NH2-FF-COOH nanotubes structure', 'potent activity against staphylococcal biofilms, resulting in complete kill at concentrations of 10 mg/mL.', '', 'Self-assembling diphenylalanine peptide nanotubes selectively eradicate bacterial biofilm infection', 30031161),
('Antibacterial Nanocomposites', 'Mercaptopyrimidine conjugated Au NC', 'Have combined mechanism including cell membrane destruction, DNA damage, and reactive oxygen species (ROS) generation', '', 'Herein, we demonstrate that a novel class of Au NCs, mercaptopyrimidine conjugated Au NCs, can act as potent nanoantibiotics targeting these intractable superbugs in vitro and in vivo, without induction of bacterial antibiotic resistance and noticeable cytotoxicity to mammalian cells.', 30063328),
('Antibacterial Nanocomposites', 'Biologically synthesized silver nanoparticles (bio-AgNP), produced by Fusarium oxysporum, and oregano (Origanum vulgare) essential oil OEO', 'Activity against multidrug-resistant bacteria, such as MRSA, and ?-lactamase- and carbapenemase-producing Escherichia coli and Acinetobacter baumannii strains with MIC ranging from 0.298 to 1.193 mg/mL and 62.5 to 250 micro M', '', 'Studies have shown that oregano (Origanum vulgare) essential oil (OEO) and silver nanoparticles have potent antibacterial activity, also against multidrug-resistant strains; however, the strong organoleptic characteristics of OEO and the development of resistance to these metal nanoparticles can limit their use.', 27242772),
('Antibacterial Nanocomposites', 'Cardamom oil loaded chitosan nano-particles', 'Anti-microbial potential against extended spectrum ? lactamase producing Escherichia coli and methicillin resistant Staphylococcus aureus', '', 'Encapsulation of Cardamom Essential Oil in Chitosan Nano-composites: In-vitro Efficacy on Antibiotic-Resistant Bacterial Pathogens and Cytotoxicity Studies.', 27757108),
('Antibacterial Nanocomposites', 'Silver nanoparticles and visible blue light', 'Activity against methicillin-resistant Staphylococcus aureus', '', 'A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA). ', 27530257),
('Antibacterial Nanocomposites', 'ZnO Nanoparticles and Linalool', 'Through in vitro assays on prokaryotic cells, it was proven that ZnO coatings hinder microbial biofilm formation of both Gram-positive and Gram-negative bacteria strains.', 'Histological analyses carried out at 7 days and 14 days after the intraperitoneal administration of linalool modified ZnO NPs revealed the absence of the latter from the brain, kidney, liver, lung, myocardium, and pancreas.', 'Through in vitro assays on prokaryotic cells, it was proven that ZnO coatings hinder microbial biofilm formation of both Gram-positive and Gram-negative bacteria strains.', 34685006),
('Antibacterial Nanocomposites', 'Silver Nanoagents', 'The in vitro antibacterial efficiencies of this non-antibiotic technique were up to 99.6% against Methicillin-resistant Staphylococcus aureus (MRSA) and 98.8% against Escherichia coli (EC), while the in vivo antibacterial efficiencies for MRSA- and Carbapenem-resistant Pseudomonas aeruginosa (CRPA)-infected mice models were 96.8% and 93.6%, respectively.', '', 'Methods: In this strategy, the photoactive antibacterial AgNP was decorated with photosensitizers (Chlorin e6, Ce6) and Raman reporter (4-Mercaptobenzonitrile, 4-MB) to provide new opportunities for clinically monitoring and fighting MDR bacterial infections.', 34150471),
('Antibacterial Nanocomposites', 'molybdenum-based nanodots (MoO3- X )', '', '', 'Most importantly, they present excellent capacity to diminish infection of methicillin-resistant Staphylococcus aureus, manifesting the potent application prospect of MoO3- X nanodots for diabetic wound therapy. © 2021 Wiley-VCH GmbH.', 34927361),
('Antibacterial Nanocomposites', 'AgNPs', 'Excellent antimicrobial activity against extracellular S. aureus with a 100% killing efficacy at concentrations as low as 56 microM', '', 'gNPs and their combination with antibiotics have demonstrated high extracellular and intracellular bacterial killing and presented unique aspects for potential clinical applications, especially for chronic and recurrent infections where intracellular bacteria may be the cause.', 30778552),
('Antibacterial Nanocomposites', 'Melittin-Loaded Niosomal Vesicles', 'Mel-loaded NISVs efficiently inhibited the growth of bacteria, particularly MRSA and VIS', '', 'Therapeutic application of Mel-loaded NISVs could be further developed as an alternative platform for the treatment of skin infection via dermal and transdermal delivery. © 2021 Sangboonruang et al.', 34819727),
('Antibacterial Nanocomposites', 'ascorbyl tocopherol succinate (ATS)', '', '', 'Therefore, ATS shows potential as a novel multifunctional adjuvant for effective and targeted delivery of antibiotics.', 34333022),
('Antibacterial Nanocomposites', 'Anionic solid lipid nanoparticles that were coated with either the cationic bolaamphiphile 12-bis-tetrahydroacridinium or with protamin as carrier for transcription factor decoys (TFD)', 'Antibacterial efficacy confirmed using a model TFD targeting the Fur iron uptake pathway in E. coli under microaerobic conditions.', '', 'Experimental antibacterial oligonucleotide therapeutics, such as transcription factor decoys (TFD), are a promising approach to circumvent AMR.', 30468838),
('Antibacterial Nanocomposites', 'N-halamine polymer nanomaterials based on a strategic copolymerization of 3-allyl-5,5-dimethylhydantoin (ADMH) and methyl methacrylate (MMA)', 'Exhibits in vitro and in vivo antimicrobial efficacy against pathogenic bacteria including Staphylococcus aureus and Escherichia coli', '', 'Based on the synergistic action of antibacterial and wound therapy, the N-halamine polymer nanomaterials are expected to be promising as wound dressing materials in medical healing and biomaterials.', 30645044),
('Antibacterial Nanocomposites', 'Zinc phosphate-based nanoparticles', 'The highest in vitro inhibitory effect was observed against Staphylococcus aureus (inhibitory concentration values, IC50, ranged from 0.5 to 1.6 mmol/L), followed by Escherichia coli (IC50 0.8-1.5 mmol/L). In contrast, methicillin resistant S. aureus (IC50 1.2-4.7 mmol/L) was least affected and this was similar to inhibitory patterns of commercial ZnO-based NPs and ZnO. In vivo activity tested.', '', '', 30805185),
('Antibacterial Nanocomposites', 'Fucoidan-stabilized AuNPs (F-AuNPs)', 'Potenct against Pseudomonas aeruginosa PAO1, minimum inhibitory concentration (MIC): 512 microg/mL, minimum biofilm inhibition concentration (MBIC) and minimum biofilm eradication concentration (MBEC) were identified as 128 microg/mL', '', 'Findings from the present study provide important insights into the potential of F-AuNPs as an effective new drug for controlling P. aeruginosa-biofilm-related infections.', 30987163),
('Antibacterial Nanocomposites', 'Biocompatible composite membrane comprising biomimetic polydopamine-modified eggshell membrane nano/microfibres coated with KR-12 antimicrobial peptide and hyaluronic acid (HA)', 'Excellent antibacterial activity against Gram-positive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA) and Gram-negative Escherichia coli, and it could prevent MRSA biofilm formation on its surface', '', 'These results indicated that the composite membrane is a potential candidate of wound dressings.', 31190796),
('Antibacterial Nanocomposites', 'CADY/ASOs nanoparticles (CADY-NPs)', 'Targeted drug delivery in Acinetobacter baumannii', '', 'Antisense oligonucleotides (ASOs) based therapy is a promising strategy for combating Multi-Drug Resistant (MDR) bacteria because of its high specificity, easy design and lower induction of resistance, but poor cellular uptake by bacteria has restricted the further utilization of this therapy.', 31244437),
('Antibacterial Nanocomposites', 'Beta-Ga2O3:Cr3+', '', '', 'Effective targeted therapy for drug-resistant infection by ICAM-1 antibody-conjugated TPGS modified beta-Ga(2)O(3):Cr(3+) nanoparticles.', 31244919),
('Antibacterial Nanocomposites', 'Artificial bolalipids PC-C32-PC and Me2PE-C32-Me2PE', '', '', 'Antimicrobial photodynamic therapy (aPDT) involves the use of non-toxic photosensitizers in combination with light and in situ oxygen to generate toxic radical species within the microbial environment which circumvents the resistance building mechanism of the bacteria.', 31266209),
('Antibacterial Nanocomposites', 'Vanillin capped gold nanoparticles (VAuNPs) synthesized using the popular flavouring molecule vanillin (C8H8O3)', 'Reductions in minimum inhibitory concentrations (MIC, 10-14-folds) of the antibiotics meropenem (10 fold) and trimethoprim (14 fold) were observed in the presence of VAuNPs (50 microgram/ml); VAuNPs in combination with meropenem or trimethoprim provided 1.5-3-fold better potentiation effects than that of vanillin alone, clinically relevant MexAB-OprM efflux pump components showed down-regulation in mexB and OprM transcripts in VAuNPs treated P. aeruginosa clinical isolates.', '', 'Therefore, this study indicate the ability of VAuNPs and vanillin to be used as antibiotic adjuvants for inhibiting bacterial efflux pumps to potentiate antibiotics for addressing AMR problem affecting human health and environment.', 31312733),
('Antibacterial Nanocomposites', 'Azithromycin-liposomes', 'Encapsulation of AZI in liposomes could improve its solubility, antibacterial activity, and allow the prolonged drug release in the cervicovaginal tissue, while avoiding systemic side effects', '', 'Azithromycin-liposomes as a novel approach for localized therapy of cervicovaginal bacterial infections', 31440052),
('Antibacterial Nanocomposites', 'Carbosilane metallodendrimers with different metals (copper(II) and ruthenium(II)), ligands (chloride and nitrate) a', 'Activity against Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli), Cu(II) metallodendrimers require lower concentration than Ru(II) counterpart to inhibit the production of S. aureus biofilms', 'No hemolysis at the inhibitory concentrations', 'Biofilm formation is a resistance mechanism that is responsible for most human bacterial infections and requires new and effective therapeutic approaches, such as those provided by nanotechnology.', 31450779),
('Antibacterial Nanocomposites', 'biogenic C-dots/ C-dots carrier (CDC)', 'The study of time-dependent bacterial growth and flow cytometry analysis demonstrated that CDC can exhibit a synergistic bactericidal activity against the antibiotics resistant recombinant E. coli cells', '', 'Combination therapy of biogenic C-dots and lysozyme for enhanced antibacterial and antibiofilm activity.', 33080579),
('Antibacterial Nanocomposites', 'MB attached GNPDEX-ConA', 'Photosensitized MB attached GNPDEX-ConA killed the bacteria by >3log10.', '', 'The multi-targeted (Cell wall, DNA and efflux pump) modality of MB attached GNPDEX-ConA in presence of EPI is an effective and alternative therapeutic approach against most potent Klebsiella MDR infections.', 33122117),
('Antibacterial Nanocomposites', 'oxidase-like silver-palladium bimetallic alloy nanocage, AgPd0.38', 'AgPd nanocages exhibited antibacterial profiles ranging from completely inactive (MBC99.9, ?128 microgram/mL) to active against a wide spectrum of bacteria (MBC99.9 of 4- 64 microgram/mL), with AgPd0.08 and AgPd0.38 being the least and most potent, respectively; Staphylococcus aureus and Bacillus subtilis were used as the representatives for Gram-positive bacteria while Escherichia coli and Pseudomonas aeruginosa the representatives for Gram-negative bacteria', 'AgPd0.38 failed to impact the cell viability even at 100 microgram/mL in cell counting kit-8 (CCK-8) assays and this was the case with all four tested cell-lines, indicative of lack of in vitro cytotoxicity.', 'This work opens an avenue toward biocompatible nanozymes and may have implication in our fight against antimicrobial resistance.', 33531505),
('Antibacterial Nanocomposites', 'ZnFe2O4 NPs (zinc ferrite nanoparticles)', 'ZnFe2O4 NPs showed clear growth inhibitory effects against both Gram-negative and Gram-positive microorganisms in the experimental concentration range (12.5?100 microg/mL). The maximum zone of inhibition was produced against the S. aureus (13 ? 0.9 mm) and K. pneumoniae (13 ? 1.6 mm) at a concentration of 100 microg/mL NPs.', 'ZnFe2O4 NPs exhibited dose-dependent cytotoxic effects on human dermal fibroblasts.', 'This study indicated that ZnFe2O4 NPs have the potential to be used as a future antimicrobial and wound healing drug.', 33546702),
('Antibacterial Nanocomposites', 'palladium NPs (Pd-NPs)', 'Pd-NPs exhibited strong antibacterial/antibiofilm activities against them with minimum inhibitory concentration (MIC) in the range of 62.5-125 microgram/mL.', '', 'This study suggested the possible role of PB-extract capped Pd-NPs for successful clinical management of MDR pathogens and breast cancer cells.', 33686169),
('Antibacterial Nanocomposites', 'silver covalently bound to cyanographene (GCN/Ag)', 'Tested also against multidrug resistant strains, the antibacterial activity of GCN/Ag is systematically found as potent as that of free ionic silver or 10 nm colloidal silver nanoparticles.', '', 'Endowed with these properties, GCN/Ag shows that rigid supports selectively and densely functionalized with potent silver-binding ligands, such as cyanographene, may open new avenues against microbial resistance.', 34194925),
('Antibacterial Nanocomposites', 'poly(oxanorborneneimide) (PONI)-based antimicrobial polymeric nanoparticles (PNPs)', 'poly(oxanorborneneimide) (PONI)-based antimicrobial polymeric nanoparticles (PNPs)', 'PNPs displayed minimal fibroblast toxicity and high antimicrobial activity in an in vitro co-culture model comprising fibroblast cells and dual-species biofilms of Escherichia coli and Pseudomonas aeruginosa.', 'we report the efficacy of poly(oxanorborneneimide) (PONI)-based antimicrobial polymeric nanoparticles (PNPs) against multi-species bacterial biofilms.', 34443542),
('Antibacterial Nanocomposites', 'silver nanoparticle-decorated calcium peroxide (CaO2) nanoreactors (CPA)', '', '', 'Developing radical oxygen species (ROS)-generating nanoreactors as new "antibiotics" is a promising strategy for the treatment of multidrug-resistant (MDR) biofilm infections.', 33977986),
('Antibacterial Nanocomposites', 'silver nanoparticles (Ag-NPs)', 'The in vivo effectiveness of various pharmaceutical formulations prepared from a combination of neomycin antibiotic with Ag-NPs in the treatment of induced bacterially infected mice burns showed that maximum healing activity along with faster wound contraction reported with the combination of neomycin-Ag-NPs in the spray formulation.', '', 'Generally, data indicated that incorporating Ag-NPs in combination with certain antibiotics may be a new, promising application for wound treatments, especially burns infected with MDR P. aeruginosa.', 34616370),
('Antibacterial Nanocomposites', 'Fe3O4/Ag and Fe3O4 with SiO2/Ag nanoparticles', 'The values of MIC for sulfamethoxazole, trimethoprim, Fe3O4/Ag/sulfamethoxazole, Fe3O4/Ag/trimethoprim, Fe3O4 attached SiO2/Ag/sulfamethoxazole, and Fe3O4 attached SiO2/Ag/trimethoprim against Escherichia coli were calculated to be 12, 9, 4, 4, 4, and 4 microgram/mL, respectively.', '', 'Nanotechnology is a strategy for overcoming this problem by helping develop novel drug delivery systems.', 34420194),
('Antibacterial Nanocomposites', 'IPM attached AgNPs-PEG-NOTA nanocomposite (silver nanoparticles were coated with SH-PEG-NOTA as well as loaded by imipenem)', 'combatting carbapenem-resistant A. baumannii.', '', 'Additionally, IPM attached AgNPs-PEG-NOTA not only offers immune regulation and accelerates tissue repair to improve therapeutic efficacy in vivo but also can prevent the interaction of pathogens and hosts.', 34161080),
('Antibacterial Nanocomposites', 'Antibiotic-loaded Ag/BN nanocarriers', 'For the rest of the tested E. coli strains, the Ag nanoparticle-containing nanohybrids have shown superior bactericidal efficiency. The Ag/BN nanohybrids and amphotericin B-loaded BN and Ag/BN NPs also reveal high fungicidal activity against C. albicans, C. auris, C. parapsilosis, and N. crassa cells.', '', 'Utilization of antibacterial components-conjugated nanoparticles (NPs) is emerging as an attractive strategy for combating various pathogens.', 34000197),
('Antibacterial Nanocomposites', 'gelatin methacryloyl (GelMA)-based bioinks, incorporated with varying doses of antibacterial superparamagnetic iron oxide nanoparticles (SPIONs).', 'The SPION-laden GelMA scaffolds showed significant resistance against the Staphylococcus aureus growth', '', '3D GelMA demonstrated the significant effect of functionalized scaffolds in inhibiting bacterial growth, while maintaining cell viability and growth. Together, these results present a new promising class of functionalized bioinks to 3D bioprint tissue-engineered scaffold with markedly enhanced properties for the use in a variety of in vitro and clinical applications.', 36065192),
('Antibacterial Nanocomposites', 'Mannose-modified chitosan/PMLA nanoparticles', 'Man-CS-Nps were discovered to have effective anti-adherence and biofilm disruption characteristics in suppressing the development of resistant H. pylori.', '', 'Molecular docking and 20 ns MD simulations revealed that Man-CS-Nps inhibited the target protein through slow-binding inhibition and hydrogen bond interactions with active site residues. As a consequence of the findings of this study, the Man-CS-Nps is an excellent candidate for developing alternative therapies for the increasing incidences of resistant gastric infections.', 36356866),
('Antibacterial Nanocomposites', 'epigallocatechin gallate (EGCG)-coated silver nanoparticles (Ag) (Se@Ag@EGCG)', 'The in vitro bacteriostatic results showed that 40 microg ml-1 Se@Ag@EGCG had significant antibacterial activity against drug-resistant Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) by destroying the formation of bacterial biofilm', '', 'This compound promote the production of high concentration reactive oxygen species and destroying bacterial cell wall. In addition, the results of in vivo antibacterial experiments showed that subcutaneous administration of 10 mg kg-1 of Se@Ag@EGCG could promote wound healing by reducing apoptosis and inflammatory responses in infected wounds. This development strategy of nano-antibacterial materials, which breaks through the drug resistance mechanism, provides new ideas for the development of drugs for drug-resistant bacterial infections.', 35777311),
('Antibacterial Nanocomposites', 'polycationic silver nanoclusters (pAgNCs)', 'The pAgNCs also show greatly enhanced antibacterial efficacy against anaerobic bacteria such as Fusobacterium nucleatum and Streptococcus sanguinis. These results demonstrate that the cationic nature facilitates better penetration to the bacterial cell membrane while the presence of a high percentage (>50%) of silver ions (i.e., Ag+ nanoreservoirs) on the cluster surface maintains their efficiency in both aerobic and anaerobic conditions.', '', 'This study demonstrates a novel design strategy that can lay the foundation for the development of future highly potent nano-antibiotics effective against a broad spectrum of pathogens and biofilms needed in many everyday life applications and industries.', 34935355),
('Antibacterial Nanocomposites', 'Sulfidated nanoscale zerovalent iron (S-nZVI)/peroxymonosulfate (PMS)', 'The optimal condition 28 mg/L S-nZVI coupled with 153.7 mg/L (0.5 mM) PMS was applied to remove both intracellular ARGs (iARGs) and ARB. S-nZVI/PMS effectively inactivated ARB (~7.32 log) within 15 min. Moreover, removal efficiencies of iARGs sul1, intI1 and tetA were 1.52, 1.79 and 1.56 log, respectively.', '', 'These results revealed that S-nZVI and PMS have a synergistic effect against ARB and iARGs. The regrowth assays illustrated that the ARB were effectively inactivated. By verifying the inhibitory impacts of S-nZVI/PMS treatment on conjugation transfer, this work highlights a promising alternative technique for inhibiting the horizontal gene transfer.', 34482079),
('Antibacterial Nanocomposites', 'Phosphate-based coacervates (PC)', 'PC have been the subject of increased interest due to their great potential in tissue regeneration and as controlled delivery systems. Being bioresorbable, they dissolve over time and simultaneously release therapeutic species in a continuous manner. This study investigates a series of PC gels containing a range of concentrations of the antibacterial ion Ag+ (0.1, 0.3 and 0.75 mol%). Dissolution tests have demonstrated controlled release of Ag+ over time, resulting in a significant bacterial reduction (up to 7 log), against both non-AMR and AMR strains of both Gram-positive and Gram-negative bacteria (Staphylococcus aureus, Enterococcus faecalis, Escherichia coli and Pseudomonas aeruginosa). Dissolution tests have also shown controlled release of phosphates, Ca2+, Na+ and Ag+ with most of the release occurring in the first 24 h.', '', 'Biocompatibility studies, assessed using dissolution products in contact with human keratinocyte cells (HaCaT) and bacterial strains, have shown a significant increase in cell viability (p = 0.001) when gels are dissolved in cell medium compared to the control. These results suggest that gel-like silver doped PCs are promising multifunctional materials for smart wound dressings, being capable of simultaneously inhibit pathogenic bacteria and maintain good cell viability.', 35750875),
('Antibacterial Nanocomposites', 'polymyxin-loaded cubosomes polytherapy treatment', 'Importantly, however, cubosome polytherapy with the LPS targeting antibiotic, PMB, resulted in synergistic bactericidal activity against four of seven isolates (FICI = 0.5) and partial synergy against the other three isolates (0.5 < FICI = 1.0).', '', 'These findings demonstrate that nanoparticle-based polytherapy treatments may potentially serve as improved alternatives to the conventional use of drug-loaded lipid nanoparticles for the treatment of "superbugs".', 35039508),
('Antibacterial Nanocomposites', 'silver nanoparticles (AgNPs), zinc oxide nanoparticles (ZnO NPs), copper oxide nanoparticles (CuO NPs), and iron oxide nanoparticles (FeO NPs) have been synthesized by using leaf extract of Ricinus communis.', 'Streptomycin when combined with AgNPs, ZnO NPs, CuO NPs, and FeO NPs showed enhanced antibacterial activity against clinical isolates of S. aureus which suggested synergism between the nanoparticles and antibiotics. The highest enhanced antibacterial potential of Streptomycin was observed in conjugation with ZnO NPs (11 ', '', 'The considerable point of the present investigation is that S. aureus, which was resistant to streptomycin becomes highly susceptible to the same antibiotic when combined with nanoparticles. This particular observation opens up windows to mitigate the current crisis due to antibiotic resistance to combat antimicrobial infections efficiently.', 35324924),
('Antibacterial Nanocomposites', 'Cur-FCNS (covalent modification of chitosan (CS) polymer with curcumin (Cur) )', 'The complexation efficiency of CS with Cur was found as 70 ', '', 'Thus, our results affirmed the exceptional potential of Cur-FCNS as next-generation alternative-medicine to treat resistant H. pylori.', 35157901),
('Antibacterial Nanocomposites', 'Self-Assembling Chimeric Peptide Nanoparticles with High Stability for Combating Piglet Bacterial Infections', 'In vitro studies are used to demonstrate that peptide nanoparticles NPs1 and NPs2 offer broad-spectrum antibacterial activity and desirable biocompatibility, and they retain their antibacterial ability in physiological salt environments. Peptide nanoparticles NPs1 and NPs2 can resist degradation under high concentrations of proteases.', 'In vivo studies illustrate that the toxicity caused by peptide nanoparticles NPs1 and NPs2 is negligible, and these nanoparticles can alleviate systemic bacterial infections in mice and piglets.', 'Collectively, these advances may accelerate the development of peptide-based antibacterial nanomaterials and can be applied to the construction of supramolecular nanomaterials.', 35285170),
('Antibacterial Nanocomposites', 'nanostructured lipid carrier (NLC) formulations loaded with besifloxacin HCl (BHL) and the besifloxacin HCl: sulfobutyl ether beta-cyclodextrin (SBE-CD) complex.', 'In this study, it was found that SBE-CD increased BHL''s solubility by 8-fold based on phase solubility studies. The optimized NLCs were small in size (13.63-16.09 nm) with a low polydispersity index (0.107-0.181) and adequate BHL drug loading efficiency. In vitro release studies showed that formulations were released approximately for 8 h and at levels over the minimum inhibitory concentration of Pseudomonas aeruginosa and Staphylococcus aureus. NLC formulations had a better corneal permeation rate than the marketed product during 6 h of ex vivo studies.', '', 'Conclusions: According to in vitro and ex vivo data, it was determined that the most favorable NLC formulation was the formulation containing BHL/SBE-CD that was covered with chitosan. It has the highest drug loading capacity and one of the highest ex vivo corneal passage levels, along with desired drug release. The formulation containing BHL/SBE-CD and chitosan can be a potential alternative for the treatment of bacterial keratitis.', 35675672),
('Antibacterial Nanocomposites', 'Bioconjugated Thymol-Zinc Oxide Nanocomposite', 'bioconjugation of THO with ZnO nanoparticle (ZO), which resulted in the TZ nanocomposite (NC), as a potent and selective antibacterial agent against Staphylococcus species, particularly S. epidermidis. TZ NC had selective efficacy against Staphylococcus species, with MIC values 2-32-fold lower than THO.', '', 'Our findings suggest that the TZ nanocomposite could improve the selectivity and bactericidal activity of THO against target species.', 35743214),
('Antibacterial Nanocomposites', 'chlorin e6 (Ce6) loaded chitosan functionalized molybdenum sulfide (MoS2)Nanocomposites (M-CS-Ce6)', 'The nanocomposite can not only allow Ce6 to enter the cells of Gram-positive bacteria, but also destroy the cell wall permeability of Gram-negative bacteria and enhance the photo-antibacterial effect. 10 microg/mL of M-CS-Ce6 irradiated by 660 nm laser for 5 min, completely killed the target pathogens, exhibiting significantly enhanced photo-antibacterial performance against both Gram-positive and Gram-negative bacteria.', '', 'Compared with other cationic photodynamic composites, M-CS-Ce6 had stronger and broad-spectrum photo-antibacterial effect. Taken together, M-CS-Ce6 could be a promising and safe broad-spectrum antibacterial agent.', 34893226),
('Antibacterial Nanocomposites', '15 N [Cobalt Ferrite (0.3 CoFe2O4) + Silver chromite (0.7 Ag0.5Cr2.5O4)],', 'Five bacterial species were used in this study: three Gram-positive (Bacillus subtilis, Micrococcus luteus, and Staphylococcus aureus) and two Gram-negative (Escherichia coli and Salmonella enterica). Three fungal species were also tested: Candida albicans, Aspergillus niger, and A. flavus. Maximum antibacterial activity was attained in the case of 15 N [Cobalt Ferrite (0.3 CoFe2O4) + Silver chromite (0.7 Ag0.5Cr2.5O4)] against M. luteus. Concerning antifungal activity, C. albicans was the most susceptible fungal species. The maximum inhibition was recorded also in case of 15 N [Cobalt Ferrite (0.3 CoFe2O4) + Silver chromite (0.7 Ag0.5Cr2.5O4)]. The most promising antimicrobial compound 15 N [Cobalt Ferrite (0.3 CoFe2O4) + Silver chromite (0.7 Ag0.5Cr2.5O4)] was assayed for its antiviral and cytotoxic activity. The tested compound showed weak antiviral activity. The cytotoxic activity against Mammalian cells from African Green Monkey Kidney (Vero) cells was detected. The inhibitory effect against Hepatocellular carcinoma cells was detected using a MTT assay.', 'The antimicrobial effect of the tested compounds depends on the tested microbial species.', 'The tested compounds could be attractive and alternative antibacterial compounds that open a new path in chemotherapy.', 35624524),
('Antibacterial Nanocomposites', 'Mimusops elengi''s floral silver nanoparticles (MENP)', 'The compounds present in the flower extract were identified and their usability against the enzymes under study was assured by silico screening. The in vitro analysis furthermore supports through showing potent antibacterial activity of MENP against selected organisms.', '', 'Hence both in silico and in vitro studies reveal that MENP can be used as an alternative to break multidrug resistance.', 35347673),
('Antibacterial Nanocomposites', 'thermo-responsive nanogels consisting of bacterial cellulose nanowhiskers as the carrier of a carbon-based nanozyme doped with copper atoms', 'nanogels displayed remarkable intelligent response to temperature change with sol-gel transition temperature of ~33 ', '', 'The findings provide a novel strategy for advancing the development of nanocatalysts-based responsive biomaterials for treating bacterial infections.', 34914907);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Nanocomposites', 'Silver and gold nanoparticles (are termed as AgNPs and AuNPs)', 'Contrarily, CS stabilization did not enhance the antibacterial efficacy of AgNPs. CS-stabilized AgNPs and AuNPs achieved biofilm inhibition of 53.21% and 79.39% for Pseudomonas aeruginosa and 48.71% and 48.16% for Staphylococcus aureus, respectively.', '', 'In conclusion, CS-stabilized AgNPs and AuNPs possess both antimicrobial and anti-biofilm activities. However, CS acted differently when combined with AgNPs and AuNPs, needing further investigation and optimization to improve the antimicrobial activity of both nanoparticles.', 35865585),
('Antibacterial Nanocomposites', 'Green synthesis of silver nanoparticles by Conocarpus Lancifolius plant extract', 'The inhibition zones of 18 and 24 mm have been estimated to be antibacterial activity against both bacteria. The potency of up to 100% of AgNPs for bacterial strains was incubated overnight at 60 microg/ml. Based on our results, biogenic AgNPs reveal significant activity against fungal pathogen Rhizopusus stolonifera and Aspergillus flavus that cause leading infectious diseases.', '', 'Additionally, nanomaterials were biocompatible and demonstrated the potential anticancer activities against MDA MB-231 cells after 24-hour exposure.', 35002442),
('Antibacterial Nanocomposites', 'magnetite-based antibiotic delivery systems for ENT (ear, nose and throat)', 'Magnetite nanoparticles were functionalized with streptomycin and neomycin and some were entrapped in polymeric spheres. The obtained nanomaterials are stable, with spherical morphology, their size ranging from ~2.8 to ~4.7 nm for antibiotic-coated magnetite nanoparticles, and from submicron sizes up to several microns for polymer-coated magnetite-antibiotic composites. Cell viability and antimicrobial tests demonstrated their biocompatibility on human diploid cells and their antibacterial effect against Gram-negative (Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus) opportunistic bacteria. The presence of the polymeric coat proved an enhancement in biocompatibility and a slight reduction in the antimicrobial efficiency of the spheres.', '', 'Our results support the idea that functional NPs and polymeric microsystems containing functional NPs could be tailored to achieve more biocompatibility or more antimicrobial effect, depending on the bioactive compounds they incorporate and their intended application.', 35625267),
('Antibacterial Nanocomposites', 'nanoemulsion formulation (X-1735)', 'Swine split-thickness skin wounds were first infected with MRSA and/or VRE, then treated with the nanoemulsion formulation (X-1735) or placebo controls. X-1735 was effective in significantly alleviating multilevel inflammation in the treated wounds.', '', 'X-1735 is a new antimicrobial that is safe to apply to open wounds and effectively kills MRSA and VRE. It appears to also reduce inflammation in these co-infected wounds. The data suggest that this approach offers promise as an antimicrobial for open wounds with MRSA and VRE co-infection.', 35412373),
('Antibacterial Nanocomposites', 'gold-silver alloy nanoparticles (AuAgNPs)', 'Gold-silver alloy nanoparticles (AuAgNPs) toward eradication of bacterial biofilms. The hindering of structural integrity of the biofilm matrix resulted in an increased permeability for entry of antibiotics, which then cause the eradication of biofilm and inhibit subsequent biofilm formation. Additionally, our results that AuAgNPs inhibited the formation of SDSD biofilms via distinct stress pathways that lead to the downregulation of two genes critical for biofilm production, namely, brpA-like encoding biofilm regulatory protein and fbpA fibronectin-binding protein A.', '', 'This study provides useful information to assist the development of nanoparticle-based strategies for the active treatment of biofilm-related infections triggered by photoirradiation in the visible.', 35295305),
('Antibacterial Nanocomposites', 'GA (Gmelina arborea )-AgNPs', 'against pathogenic bacteria Bacillus cereus, Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus', '', 'Our study concluded that biosynthesized GA-AgNPs had enhanced antibacterial, antibiofilm, antioxidant, and wound healing properties.', 34997051),
('Antibacterial Nanocomposites', 'diethylaminoethyl-dextran hydrochloride (dex+) and dextran sulfate (dex-) on calcium carbonate microparticles', 'An inhibitory effect of the particles was observed during bacterial growth in liquid medium, i.e. in the range of 10 % for (dex+/dex-)n coated CaCO3 materials and of 50% for (dex+/dex-)n capsules.', '', 'These findings evidence the high potential of capsules to act as antimicrobial agents in future and in treatments against infections.', 34968549),
('Antibacterial Nanocomposites', 'Imipenem-containing Niosome nanoparticles', 'against high prevalence methicillin-resistant Staphylococcus Epidermidis biofilm. The F1 formulation of niosomal Imipenem with a size of 192.3 ', '', 'The results of the present study indicate that Niosome-encapsulated Imipenem reduces the resistance of MRSE to antibiotics in addition to increasing its anti-biofilm and antibiotic activity, and could prove useful as a new strategy for drug delivery.', 35332241),
('Antibacterial Nanocomposites', 'cefotaxime (CTX) loaded tellurium nanoparticles (Te NPs)', 'Te NPs were fabricated to recover the antibacterial activity of the ineffective beta-lactam antibiotic CTX against methicillin-resistant Staphylococcus aureus (MRSA) and at the same time perform photothermal therapy under light-emitting diode (LED) irradiation with a wavelength in the range of 420-480 nm. The combination of 50 microg mL-1 Te-CTX NPs with 5 min LED irradiation produced a 30.4 ', '', 'Such a synergistic antibiotic and photothermal therapy provides an innovative way for the treatment of antibiotic-resistant bacterial infections.', 35147632),
('Antibacterial Nanocomposites', 'Nanometric layered double hydroxides (LDH) based on Zn(II) and Al(III) and antibiotics', 'Cefazolin (CFZ), a beta-lactam, and nalidixic acid (NAL), a quinolone, were selected and intercalated into LDH obtaining ZnAl-CFZ and ZnAl-NAL samples. These samples were used for the growth of silver nanoparticles with dimension ranging from 2.5 to 8 nm. The release profiles are affected by both the acceptor media water and phosphate buffer and the presence of silver.', '', 'The synergistic antibacterial activity of LDH containing both silver and antibiotics were investigated on gram-positives (Staphylococcus aureus and Streptococcus pneumoniae) and gram-negatives (Pseudomonas aeruginosa) and compared with the plain antimicrobials and LDH containing only antibiotics or silver.', 35160881),
('Antibacterial Nanocomposites', 'Turpentine nanoemulsion (TNE)', 'The developed nano-emulsions displayed two fold enhanced antagonistic activity against S. aureus in comparison with TEOs, with minimum inhibitory concentration (MIC) values at 0.039% (v/v) against MRSA.', '', 'Findings from this study validates the phytomedicinal significance of turpentine nanoemulsions and envisage its exploration as a natural and cost-effective strategy against bacterial biofilms in medical and industrial sectors.', 35429586),
('Antibacterial Nanocomposites', 'Green synthesis of silver nanoparticles using sodium alginate and tannic acid (AgNPs loaded TA/Na-Alg)', 'The antibacterial and antibiofilm activities of the AgNPs loaded TA/Na-Alg constructs against S. aureus ATCC 6538 were investigated. The MIC of the AgNPs was 31.25 microg/mL. After exposure to the AgNPs, planktonic S. aureus showed irreversible cell membrane damage, decreased cell viability, and changes in cellular morphology. In addition, the AgNps significantly inhibited S. aureus biofilm formation at 1/32 MIC. The biofilm elimination rate was 58.87% after exposure to MIC AgNPs.', '', '', 34920064),
('Antibacterial Nanocomposites', 'nanoscale zero-valent iron (nZVI)', 'nZVI addition reduced the concentration of some antibiotics such as doxycycline and sulfamethoxazole. Furthermore, nZVI addition decreased the abundances of most ARGs at the end of composting', '', 'These findings suggest that the addition of nZVI is a promising strategy to minimize ARG release in chicken manure compost.', 34416685),
('Antibacterial Nanocomposites', 'Conjugation of Silver Nanoparticles with Thiosemicarbazide', 'minimum inhibitory concentration values of functionalized Ag NPs were at least twofold lower than the Ag NPs (alone). The quantitative PCR data analysis showed a decrease in the expression of the pslA gene in the presence of Ag@Glu-TSC NPs, up to 60%, which was associated with a reduction of biofilm formation compared to control', '', 'In conclusion, the Ag@Glu-TSC NPs can be considered a new inhibitor of biofilm production in antibiotic-resistant bacteria.', 35005985),
('Antibacterial Nanocomposites', 'D-alpha tocopheryl polyethylene glycol succinate-modified and S-thanatin peptide-functionalized nanorods based on calcium phosphate nanoparticles', 'for tigecycline delivery and pneumonia therapy caused by tigecycline-resistant Klebsiella pneumoniae', '', 'These findings may provide a therapeutic strategy for infections caused by drug-resistant bacteria.', 35768446),
('Antibacterial Nanocomposites', 'cefquinome sulfate oily nanosuspension (CS-NSP)', 'CS-NSP presents suitable stability, physicochemical properties and safety, a rapid release and high bioavailability (about 1.6 times that of commercial cefquinome sulfate injection (CS-INJ, Chuangdao', '', 'Conclusion: The results proved that the new preparation is safe and effective and is expected to become a promising veterinary nanodelivery system.', 35677677),
('Antibacterial Nanocomposites', 'natural colloidal minerals (containing iron) and bacteria', 'With three selected iron minerals perturbation experiments, it was found that the conjugative transfer of plasmid that carried kanamycin resistance gene was 1.35 - 3.91-fold promoted by low concentrations of iron minerals (i.e., 5 - 100 mg L-1), but inhibited at high concentrations (i.e., 1000 - 2000 mg L-1) as 0.10 - 0.22-fold.', '', 'Our findings indicate natural colloidal minerals have great potential for applications in preventing the environmental propagation of ARGs through interfacial interactions.', 35472548),
('Antibacterial Nanocomposites', 'superhydrophobic micro-nano structured titanium surface', 'antibacterial capability was characterized with Staphylococcus aureus and Escherichia coli', '', 'The results indicated that the superhydrophobic micro-nano structured titanium surface reduced bacteria cell adhesion significantly (>90%) and prevented biofilm formation compared to the unmodified titanium surface after 24 h of incubation.', 35188338),
('Antibacterial Nanocomposites', 'AgNP/AMPNanocomposites', 'showed relevant antimicrobial activity in an in vivo subcutaneous infection model in rats', '', 'When compared to single AgNP or AMP coatings, our hybrid nanocoatings showed significant increases in antimicrobial potency against multiple implant infection-related bacterial strains in vitro and in an in vivo rat subcutaneous infection model.', 34896631),
('Antibacterial Nanocomposites', 'CNMs (nanocomposite antibacterial agent based on chitosan nanoparticles and AMP microcin J25)', 'caused fast mortality against different growth phases of tetracycline (Tet)-resistant enterotoxigenic E. coli (ETEC) and significantly killed Tet-resistant ETEC in food biological environments, ability to bind lipopolysaccharides (LPS), neutralize endotoxin, and promote diaphragm permeability by damaging the cell membrane', '', 'Taken together, CNMs could be applied as effective antimicrobial/anti-inflammatory agents with lower cytotoxicity in food, medicine, and agriculture to prevent bacterial contamination and infection, respectively.', 35126369),
('Antibacterial Nanocomposites', 'metallic nanoparticles (MNPs) dip-coating method for PDS-II sutures', 'possess strong in vitro antibacterial properties against P aeruginosa and S. aureus-varying the %of dead bacteria from ~ 40% (for MgO NPs) to ~ 90% (for Fe2O3) compared to ~ 15% for uncoated PDS-II suture, after 7 days', '', 'All sutures demonstrated minimal cytotoxicity (cell viability > 70%) reinforcing the movement towards the use MNPs as a viable antibacterial technology.', 35039588),
('Antibacterial Nanocomposites', 'Ofloxacin@HMPB@HA NPs', 'higher effect against K. pneumoniae by destroying cell integrity and inducing ATP leakage with the assistance of laser irradiation, compared with sole Ofloxacin@HMPB@HA NPs or laser irradiation', '', 'In summary, these results indicate the great potential of this combinational tactic based on Ofloxacin@HMPB@HA NPs for preventing the failure caused by K. pneumoniae infection.', 35338663),
('Antibacterial Nanocomposites', 'zinc oxide nanoparticles', 'with boosted antibacterial performance for hygienic products', '', 'Fabricated fabric presenting high hydrophilicity and antibacterial properties have gained increased applications in fabric industry, including hygiene product industry and hence the result of this study would be a welcomed option.', 35079098),
('Antibacterial Nanocomposites', 'isoniazid and fluoxetine-conjugated multi-walled carbon nanotube nanofluid', 'to increase drug delivery efficiency alongside eliminating drug resistance in vitro for the treatment of M.Tuberculosis', '', 'This nano-drug delivery method combined with host targeted molecules could be a game-changer in the development of a new generation of antibiotics that have high therapeutic efficiencies, low side effects, and the potential to overcome the problem of drug resistance.', 35688860),
('Antibacterial Nanocomposites', 'silver and gold NPs (SNPs and GNPs, respectively)', 'against Brucella melitensis (B. melitensis) and Brucella abortus (B. abortus) strains, MIC values (Microgram/ml) of the 10-nm SNPs and 20-nm GNPs against B. melitensis were 22.43 ', 'Brucella strains develop similar resistance to SNPs and GNPs, and at low dosages, neither SNPs nor GNPs were hazardous to rats.', 'However, a greater dose of NPs (2 mg/kg) harmed all of the tissues studied.', 35834538),
('Antibacterial Nanocomposites', 'chitosan-AgNPs and chitosan-AuNP (conjugation of biogenic silver nanoparticles (AgNPs) from Aspergillus sp. Silv2 extract and gold nanoparticles (AuNPs) from Alternaria sp. Gol2 extracts with chitosan )', 'chitosan-AgNP conjugation had better antibacterial ctivity than chitosan-AuNPs, which exhibited moderate activity against S. aureus and very low activity against E. coli. chitosan-AgNP showed a promising anti-biofilm activities on all strains, especially S. aureus, while chitosan-AuNP conjugates showed moderate anti-biofilm against B. subtilis and weak activities against the other three strains.', '', 'These results showed the superiority of chitosan-AgNP as a promising antibacterial as well as biofilm formation inhibitors.', 35625312),
('Antibacterial Nanocomposites', 'selenium nanowires modified with nano-silver (Ag NPs) and [Ru(bpy)2dppz]2+ (SRA)', 'SRA (12 Microgram/mL) improves the antibacterial activity of various antibiotics against resistant bacteria and significantly slows the development of bacterial resistance to antibiotics', '', 'SRA has the potential of clinical application as multiple antibiotic adjuvants to deal with resistant bacterial infections.', 35929231),
('Antibacterial Nanocomposites', 'As-synthesized copper nanoparticles (CuNPs)', 'against Gram-negative (Escherichia coli and Proteus vulgaris) bacteria', '', 'As-synthesized CuNPs exhibiting promising antibacterial activities and could be a promising candidate for novel antibacterial agents.', 35034356),
('Antibacterial Nanocomposites', 'Pullulan (Pull) decorated with monodisperse Ag and Au nanoparticles (NPs)', 'highest antimicrobial activity was found against Ec as 14.4 ', '', 'The promising performance of AgNPs@Pull compared to the commercial antibiotic gentamicin showed that it has great potential as a therapeutic approach to overcome the bacterial resistance that has developed against conventional antibiotics.', 35113519),
('Antibacterial Nanocomposites', 'antibacterial glucose oxidase (GOx) is embedded in a Ag graphitic nanocapsule (Ag@G) arrayed silk film to fabricate a GOx-synergistic PTT system (named silk-GOx-Ag@G, SGA)', 'superior synergistic antibacterial effect on the infected Escherichia coli, Staphylococcus aureus, and MRSA in vivo', '', 'This system provides a therapeutic method with low resistance and in situ diagnosis capability for efficiently eliminating bacteria.', 34989177),
('Antibacterial Nanocomposites', 'boron nitride (BN) nanosheets', 'potent antibacterial effects in a lung infection model by P. aeruginosa (AMR), displaying a 2-fold increment of survival rate', '', 'Overall, these results suggested that BN nanosheets could be a promising nano-antibiotic to combat resistant bacteria and prevent AMR evolution.', 35511445),
('Antibacterial Nanocomposites', 'combination of nisin Z in both PMDA and Beta- cyclodextrin (CD)-based nanosponges (NSs)', 'The minimum and bactericide inhibitory values of the nisin complex with NSs were potentially decreased against both bacteria, compared with the nisin-free sample, while the nisin complex with beta-CD showed lower antibacterial activity.', '', 'Generally, the present study outcomes suggest that the cross-linked beta-CD-based NSs can present their own antimicrobial potency or serve as promising carriers to deliver and enhance the antibacterial action of nisin Z.', 35336058),
('Antibacterial Nanocomposites', 'Biopolymer-Capped Ag/Au Bimetallic Nanoparticles', 'against Melanoma and Multidrug-Resistant Pathogens', '', 'In this manner, this study provides promising evidence that the presently fabricated Ag/Au-NPs should be further studied for a wide range of antibacterial and anticancer applications.', 35269267),
('Antibacterial Nanocomposites', 'chitosan nanoparticles loaded with beta-lactam antibiotics and beta-lactamase inhibitors', 'The 4 combinations of CNAIs including two cephalosporin antibiotics (cefotaxime and ceftiofur) with two beta-lactamase inhibitors (tazobactam and clavulanate) showed efficient antimicrobial activity against MDR ESBL-producing Enterobacteriaceae.', '', 'Taken together, CNAIs have provided promising potential for treatment of diseases caused by critically important ESBL-producing multidrug resistant pathogens.', 34920071),
('Antibacterial Nanocomposites', 'Functionalized Mn3 O4 Nanosheets', 'functionalized Mn3 O4 nanosheets can effectively treat methicillin-resistant Staphylococcus aureus-infected wounds through the triple synergetic therapy', '', 'Moreover, toxicity evaluation in vitro and in vivo has proved the superior biosafety of this material, which is promising to apply in clinical anti-infective therapy.', 35182457),
('Antibacterial Nanocomposites', 'Zinc Oxide/CurcuminNanocomposites Synthetized from Stachys byzantina Extract', 'The zinc oxide/curcuminNanocomposites demonstrated effective antibacterial effect in disk diffusion method against five bacterial species. Further, the zinc oxide/curcuminNanocomposites showed a significant inhibitory effect on the growth of breast cancer cells in MTT test.', '', 'Thus, it seems that the synthesized zinc oxide/curcuminNanocomposites, have had promissing high potential antimicrobial and cytotoxic effects.', 35400337),
('Antibacterial Nanocomposites', 'Fe3O4@MoS2@SDSNanocomposites', 'displayed superior disinfection ability of Escherichia coli (E. coli), Methicillin-resistant Staphylococcus aureus (MRSA), and Pseudomonas aeruginosa (P. aeruginosa) and in vivo wound healing ability with the help of NIR irradiation', '', 'Overall, our findings revealed that the Fe3O4@MoS2@SDS could be a potential candidate for photothermal-photodynamic therapy and antibiotic resistance gene dissemination inhibition.', 35338964),
('Antibacterial Nanocomposites', 'Camellia sinensis extract (CSE) and Prunus africana bark extract (PAE) green synthesized Copper oxide nanoparticles (CuONPs)', 'against carbapenem-resistant bacteria, Phytosynthesized CuONPs exhibited the highest growth suppression zones of 30 mm with MIC ranging from 30 to 125 Microg/ml against MDR bacteria.', '', 'PAE and CSE successfully bio-reduced copper ions to the nanoscale level with potent antimicrobial, photocatalysis, and antioxidant activities.', 35252130),
('Antibacterial Nanocomposites', 'antibiotic-loaded mesoporous silica nanoparticles (MSNs)', 'externally functionalized with a thermo-responsive polymer capping layer, and decorated in the outermost surface with superparamagnetic iron oxide nanoparticles (SPIONs), exposure of E. coli biofilms to 200 Microg/mL of the nanosystem and the application of an AMF (202 kHz, 30 mT) decreased the number of viable bacteria by 4 log10 units compared with the control', '', 'The results of the present study show that combined hyperthermia and antibiotic treatment is a promising approach for the effective management of biofilm-associated infections.', 35057058),
('Antibacterial Nanocomposites', 'Ag-Au; Ag-Pd; and Ag+-Au+-Pd2+ ions-doped nanoapatites', 'against Drug-Resistant Clinical Strains of Enterococcus faecalis VRE and Staphylococcus aureus MRSA', '', 'Performed analyses confirmed that the nanoapatites doped and co-doped with noble metal ions are safe and excellent antiadhesive and antibiofilm biomaterials with potential use in the future in medical sectors.', 35163457),
('Antibacterial Nanocomposites', 'AgNPs from Origanum vulgare leaves', 'against some fish pathogens ( 3 bacterial strains (Streptococcus agalactiae, and Aeromonas hydrophila, both isolated from Nile tilapia and Vibrio alginolyticus, isolated from sea bass) and 3 fungal strains (Aspergillus flavus, Fusarium moniliforme, and Candida albicans, all isolated from Nile tilapia))', '', 'The results obtained declare that the green biological production of silver nanoparticles is safer and more effective than the chemical one; moreover, AgNPs have interesting dose-dependent antimicrobial properties, with better results for biologically produced ones; their effectiveness against tested bacterial and fungal strains opens the way to their use to limit fish diseases, increase economy and improve human health.', 35280558),
('Antibacterial Nanocomposites', 'Ag-Pt bimetallic nanoparticles using propolis extract', 'evaluated in vitro by the microdilution method against E.coli, S. aureus, Bacillus subtilis, K. pneumoniae, S. epidermidis, and Serratia marcescens. The results confirmed the antimicrobial activity of bimetallic NPs Ag-Pt concentrations of (25, 50, and 100 Microg/ml). A concentration of 100 microg/ml showed low bacterial viability varying between 22.58% and 29.67% for the six tested bacteria.', '', 'The antibacterial effect of the Ag', 34958781),
('Antibacterial Nanocomposites', 'biogenic synthesis of AgNPs using Pseudomonas aeruginosa (MN900691)', 'MIC and MBC concentration against four test strains also showed that among all biogenically synthesized NPs, P. aeruginosa AgNPs showed effective MIC (3.3-3.6 Microg/mL) and MBC (4.3-4.6 Microg/mL).', '', 'Overall, this study suggested that the biogenically synthesized nanoparticles could be utilized as effective antimicrobial agents for effective disease control.', 35034942),
('Antibacterial Nanocomposites', 'nanohook-equipped bionanocatalyst (Ni@Co-NC)', 'With the Ni@Co-NC''s synergistic effects, bacterial populations fall by >99.99 %.', '', 'More surprisingly, the mature biofilm shows no recurrence after treatment with the Ni@Co-NC, demonstrating its tremendous potential for treating MDR bacterial related infections.', 34825759),
('Antibacterial Nanocomposites', '5 nm amino-functionalized silver nanoparticles (NH2-AgNPs)', 'NH2-AgNPs (0.5-10 microg/mL) or Ag+ ions (only at 10 microg/mL) inhibited fimbriae expression', '', 'Potent bactericidal effects demonstrated by biocompatible NH2-AgNPs and the lack of toxicity of Citrate-AgNPs lend credence to the hypothesis that small size, positively charged AgNPs may serve as a next-generation antibacterial agent, potentially addressing the rising HAIs and patient health and safety.', 35468937),
('Antibacterial Nanocomposites', 'Silver Nanoparticles from Extracts of Wild Ginger ( Zingiber zerumbet)', 'against multidrug-resistant (MDR) Staphylococcus aureus, Streptococcus mutans, and Enterococcus faecalis', '', 'This study indicates that AgNPs of wild ginger extracts exhibit potent antibacterial activity against MDR bacterial strains.', 35335369),
('Antibacterial Nanocomposites', 'Photothermal nanofibrillar membrane based on hyaluronic acid and graphene oxide', 'to treat Staphylococcus aureus and Pseudomonas aeruginosa infected wounds', '', 'Here we reported the fabrication of an electrospun membrane based on a hyaluronic acid derivative (HA-EDA) to be used as a bandage for the potential treatment of chronic wounds.', 35760161),
('Antibacterial Nanocomposites', 'carbon dots (CDs) coated calcium carbonate nanocarriers (CCNC)', '', '', 'It is concluded that CCNC has the potential to be used as NC for target delivery of antibiotics and may combat toxicity of antibiotics as the inhibition of E. coli was noticed at low MIC concentration.', 34402682),
('Antibacterial Nanocomposites', 'Copolypeptoids coated onto magnetic nanospheres', 'Potent Activity against Drug Resistant Bacteria and Biofilms', '', 'The prepared antimicrobials, coated onto magnetic nanospheres show recycling properties and enhanced antibacterial activity as combined with near-infrared (NIR)-induced photothermal antibacterial therapy.', 35142040),
('Antibacterial Nanocomposites', 'Carbon nanogels', 'MIC values of the CNGs (0.6 Microg mL-1 against E. coli and S. aureus) remained almost the same against the bacteria after 20 passages; however, the MIC values increased significantly after treatment with Ag nanoparticles, antibiotics, the bacteriostatic chlorhexidine, and especially gentamicin (approximately 140-fold). Additionally, the CNGs showed a negligible MIC value difference against the obtained resistant bacteria after acclimation to the abovementioned antimicrobial agents.', '', 'The findings of this study unveil the development of antimicrobial CNGs as a sustainable solution to combat multidrug-resistant bacteria.', 34742090),
('Antibacterial Nanocomposites', 'Graphitic-N-doped graphene quantum dots (N-GQDs)', 'for photothermal eradication of multidrug-resistant bacteria in the second near-infrared window', '', 'Our work provides a novel carbon-based nanomaterial as a photothermal antibacterial agent for efficiently avoiding bacterial resistance and fighting MDR bacterial infections.', 35380572),
('Antibacterial Nanocomposites', 'nanoparticles (FeTGNPs) with an antibiotic core (gatifloxacin complexing with tannins) and a photothermal shell (ferric iron coordinating with tannins)', 'From the results of antibacterial experiments, with the synergistic effect of APTT and antibiotics, FeTGNPs (400 microg/mL) could effectively kill methicillin-resistant Staphylococcus aureus (sterilizing rate up to 96.5 %) and gatifloxacin-resistant Staphylococcus aureus (sterilizing rate up to 98.7 %) than equivalent antibiotics.', 'Moreover, under slightly acidic microenvironment, such as infection area, gatifloxacin could accelerate its release from the core of FeTGNPs.', 'Therefore, FeTGNPs would be a highly effective antibacterial agent against drug-resistant bacterial infections in the future.', 34785316),
('Antibacterial Nanocomposites', 'SmVO4/UiO-66-NH2 heterojunction nanocomposite', 'for the degradation of antibiotic tetracycline hydrochloride molecules under sunlight, The integration of UiO-66-NH2 with SmVO4 enhanced the light absorption, recombination resistance, carrier lifetime (from 0.382 to 0.411 ns) and specific surface area (from 67.17 to 246 m2/g) of the composite system as confirmed from multiple analyses.', '', 'Therefore, UiO-66-NH2 can be proposed as an effective material to sensitize the rare-earth based photocatalytic material.', 35584713),
('Antibacterial Nanocomposites', 'antibody-conjugated liposomes loaded with indocyanine green (ICG) (HpAb-LiP-ICG)', 'developed for targeted photoacoustic (PA) imaging-guided sonodynamic therapy (SDT) of H. pylori infection in vivo', '', 'In conclusion, the HpAb-LiP-ICG-mediated SDT might shed new light on treating H. pylori infection, indicating the clinical translational prospects of this therapy in near future.', 35219867),
('Antibacterial Nanocomposites', 'Cu2O/Ti3C2Tx nanosheets', 'boost the photocatalytic eradication of multi-drug resistant bacteria from infected wound', '', 'Conclusion: Upon NIR illumination, Cu2O/Ti3C2Tx nanosheets eradicated MRSA and their associated biofilm to promote wound healing. The Cu2O/Ti3C2Tx nanosheets with superior catalytic and photothermal properties have a great scope as an effective antimicrobial modality for the treatment of infected wounds.', 35590324),
('Antibacterial Nanocomposites', 'MoO3-X Nanodots', 'can effectively reduce inflammation, promote epithelial cell regeneration, accelerate angiogenesis, and facilitate DUs recovery', '', 'Most importantly, they present excellent capacity to diminish infection of methicillin-resistant Staphylococcus aureus, manifesting the potent application prospect of MoO3-X nanodots for diabetic wound therapy.', 34927361),
('Antibacterial Nanocomposites', 'Co3 O4 Nanowires', 'significant therapeutic efficacy by eradicating colonized bacteria, thus accelerating the healing process of infected wounds', '', 'This nanostructured capacitive electrode provides an antibiotic-free, rechargeable, and wearable approach to treat bacterial skin infection.', 34725946),
('Antibacterial Nanocomposites', 'mesoporous silica nanoparticles (MSNs) modified with an ovotransferrin-derived antimicrobial peptide (OVTp12)', 'enabling the antibiotic to be delivered to the vicinity of the pathogenic bacteria. Moreover, we observed that OVTp12-modified nanoparticles effectively inhibited the growth of Escherichia coliin vitro and in vivo.', '', 'Thus, this novel bacterial targeted nanoparticle provides advantages in minimizing bacterial drug resistance and treating bacterial infection.', 34936344),
('Antibacterial Nanocomposites', 'palladium nanoparticles decorated bismuth oxybromide nanostructures', 'Pd/BiOBr showed excellent photocatalytic disinfection efficacy with > 99.9% bacterial inactivation. A very low concentration of Pd/BiOBr (0.5 Microg/mL) effectively inhibited the bacterial growth in response to just 2 h of visible light irradiation, while 1 Microg/mL of Pd/BiOBr completely killed all the tested bacterial strains proving their magnificent bactericidal potential.', '', 'The developed materials with exceptional antibacterial broad range efficiency can be used in different photocatalytic disinfection systems including water purification systems, biofilm exclusion and combating differential antibiotic resistance.', 35752021),
('Antibacterial Nanocomposites', 'colistin and silver nanoparticles impregnated human amniotic membrane', 'Pseudomonas aeruginosa was the most prevalent pathogen 308 (43.5%), followed by Klebsiella pneumoniae 300 (42.4%). Topical colistin was 100% sensitive for both bacteria.', 'burn wound infected rat model', 'Our study concluded that the increased antimicrobial activity of the novel combination of colistin and silver nanoparticle-loaded decellularized human amniotic membrane manifested its potential as an effective burn wound dressing.', 35440743),
('Antibacterial Nanocomposites', 'hydrogels based on gelatin/polyvinyl-alcohol and graphene oxide/silver nanoconjugates', '100% of bacterial growth was inhibited by the action of the topical nanocomposite hydrogel treatments.', '', 'These results led to affirm that these treatments can have an excellent performance in this application as well as in wound healing and dressing, bioadhesives, tissue engineering, and other biomedical applications.', 35846480),
('Antibacterial Nanocomposites', 'Nanoassembled amphiphilic choline-calix[4]arene derivative (Chol-Calix)', 'Inhibits Biofilm and Motility of Gram Negative Bacteria', '', 'Chol-Calix appears to be a promising candidate in the search for novel nanosized nonconventional antimicrobials.', 35707153),
('Antibacterial Nanocomposites', 'Chitosan nanocrystals (ChsNCs) are rod-shaped polysaccharide-based nanomaterials,', 'designing ChsNC-based nanomaterials to target specific cells by attaching bioactive peptides to the nanomaterial surface.', '', 'Hence useful in targeting AMR', 36241284),
('Antibacterial Nanocomposites', 'synergistic activity of colistin and selenium nanoparticles (SeNPs)', 'synergistic interactions between colistin and SeNPs against Ac. baumannii isolates determined as colistin-resistant (MIC range 16-256 microg ml-1 ).', '', 'These findings propose colistin/SeNPs combination as a new option to fight pandrug-resistant Ac. baumannii, the therapeutic possibilities of which should be proved in future in vivo studies.', 35612566),
('Antibacterial Nanocomposites', 'single agent or combinational use of three antimicrobials, including cinnamon oil, encapsulated curcumin and zinc oxide nanoparticles (ZnO NPs),', 'The single-agent treatment of cinnamon oil, encapsulated curcumin, or ZnO NPs showed a significant antimicrobial effect against Campylobacter jejuni by generating more than 8-log reduction within 3 h.', '', 'Cinnamon oil affected the integrity of cell membrane, which might lead to an increase in cell permeability. Encapsulated curcumin and ZnO NPs disrupted bacterial outer membranes and cell membranes against the same membrane protein targets. The combinational use of these agents showed synergistic antimicrobial effects. This study provides new insights in combating Campylobacter with minimizing the development of antimicrobial resistance in long-term usage.', 36327661),
('Antibacterial Nanocomposites', 'Green synthesis of Zinc Oxide Nanoparticles (ZnONPs) was performed based on Oak galls extract (OGE)', 'The average MIC90s values for the OGE and the Qi-ZnONPs against H. pylori (ATCC-43526) were 37.5 and 18.75 microg/mL, respectively. In comparison, The MIC90s for amoxicillin and clarithromycin (positive controls) were 0.586 and 0.293 microg/Ml. The average MIC90s values for the OGE and the Qi-ZnONPs against H. pylori (ATCC-43526) were 37.5 and 18.75 microg/mL, respectively. In comparison, The MIC90s for amoxicillin and clarithromycin (positive controls) were 0.586 and 0.293 microg/mL,', '', 'These results demonstrated that the Qi-ZnONPs display a significant inhibitory effect on H. pylori growth and encourage further investigations of the synergistic effects of the Qi-ZnONPs in different combinations with amoxicillin as an economical antibiotic. The MIC90 for amoxicillin combinations with OGE was not significantly different, while the MIC90 values for amoxicillin combinations with Qi-ZnONPs were significantly different. The MIC90 decreased two-fold from 18.75 to 9.38 microg/mL, and two-fold from 18.75 to 4.69 microg/mL for amoxicillin: Qi-ZnONPs (1:1 and 1:4, respectively). The amoxicillin: Qi-ZnONPs (1:4) combination is a promising candidate for further studies for use as an economical, effective, and safe anti-H. pylori. drug', 35889432),
('Antibacterial Nanocomposites', 'new nano-antibiotic formulation based on sceptrin-Au nano-aggregates (SANA), which are drug-metal ion multiple complexes.', 'SANA showed superior antibiotic/antibiofilm activity toward carbapenem-resistant Gram-negative bacteria with minimum inhibitory concentration (MIC): 25 microM', 'low toxicity to red blood cells and endothelial cells reported', 'SANA consists of a sceptrin-Au ion and is a self-assembled nano-formation with electrostatic interaction. The working mechanism of SANA was identified with analysis of the extracellular reactive oxygen species level and membrane depolarization of bacteria. This work presents a new concept for the development of next-generation nano-antibiotics and a more feasible clinical translational pathway.', 35818999),
('Antibacterial Nanocomposites', 'Gold nanocluster adjuvant', 'combining antibiotics and AuNC@CPP, informing a potential approach to improve the treatment of cystic fibrosis and chronic suppurative otitis media (CSOM).', '', 'They established that the mechanism of action of AuNC@CPP is due to disruption of the proton gradient and membrane hyperpolarization. This method could also benefit the current effort to slow resistance development because AuNC@CPP abolished the emergence of drug-resistant strains induced by antibiotics.', 35796201),
('Antibacterial Nanocomposites', 'nanosystems self-assembled with amphiphilic dendrimers composed of a long hydrophobic alkyl chain and a small hydrophilic poly(amidoamine) dendron', 'the amine-terminated dendrimer 1a exhibited strong antibacterial activity against both Gram-negative and Gram-positive bacteria, as well as the drug-resistant strain MRSA, with MIC values of 3.1 microM for all strains. Interestingly, the tertiary amine-terminated dendrimer 1b showed similar levels of antibacterial activity towards E. coli as 1a, but differed from 1a in that it was ineffective against all other tested bacteria', 'To evaluate the safety of these dendrimers, we examined their cytotoxicity on fibroblast (L929) and kidney (HEK293) cell lines using the PrestoBlue assay. No notable adverse effect was observed for amine-terminated dendrimer 1a, tertiary amine-terminated dendrimer 1b and carboxylic acid-terminated dendrimer 1d at concentrations up to 200 microM, whereas arginine-terminated dendrimer 1c showed considerable toxicity towards both cell types', 'treatment with 1a led to significant outer membrane permeation in E. coli , and rapid inner membrane depolarization in both E. coli and MRSA. Suggesting that the bacterial death was indeed associated with permeation and depolarization of both the outer and the inner membranes. The amine-terminated dendrimer 1a showed the most powerful activity against both Gram-positive and Gram-negative bacteria, as well as drug-resistant bacteria and allowed biofilm eradication, while having low toxicity and good safety profile', 35649277),
('Antibacterial Nanocomposites', 'polyvalent phages conjugated with magnetite (Fe3O4) nanoparticles to form nanomicrobial conjugates (NMCs).', 'NMCs showed enhanced antibacterial activity against most of the bacterial isolates obtained from clinical and environmental samples such as (e.g., E. coli, K. pneumoniae, Pantoea agglomerans, Pseudomonas oleovorans) Pilot studies showed that NMCs can selectively eliminate up to 98.3% of AMR in wastewater.', '', 'Biosurfactant-functionalized Fe3O4 nanoparticles (FNMCs) were found to have higher phage loading capacity, with a significant value of p < 0.0127 and a zeta potential of -22.2 mV. These findings indicate a synergistic effect of both phage and nanomaterial and this technology is expected to be a new lead in wastewater management.', 36030912),
('Antibacterial Nanocomposites', 'silver nanoparticles (Ag NPs) from an aqueous extract of Trigonella incise,', 'the nanoparticles showed more significant antimicrobial activity against Salmonella typhi (S. typhi) and Staphylococcus aureus (S. aureus) with an inhibition zone of 21.5 mm and 20.5 mm at 6 microg/mL concentrations, respectively, once compared to the standard reference. At concentrations of 2 microg/mL and 4 microg/mL, all of the bacterial strains showed moderate activity, with inhibition zones ranging from 11 mm to 18.5 mm. Even at high concentrations of AgNPs, S. typhi showed maximum resistance.', '', '(Ag NPs) from an aqueous extract of Trigonella incise, which serves as a reducing and stabilizing agent. The obtained results showed an 85% yield of nanoparticles by using 2:5 (v/v) of 5% plant extract with a 0.5 M solution of AgNO3. They concluded that the antibacterial and antifungal activities showed satisfactory results from the synthesized Ag NPs.', 35889490),
('Antibacterial Nanocomposites', 'nanoparticles containing cinnamon oil (CO-SLN)', 'The antibacterial effects of CO-SLN and Cinnamomum verum (cinnamon oil) CO were reported with MIC Value of 60-75 microg/mL and 155-165 microg/mL and MBC value of 220-235 microg/ml and 540-560 microg/ml, respectively. On the other hand, CO-SLN with 1/2 MIC concentration had the greatest inhibition of biofilm formation in 24 h of incubation (55.25%) against Multi-drug Resistant Escherichia coli', '', 'The data presented indicate that the MIC of CO-SLN has significantly reduced and it seems that Solid lipid nanoparticles (SLN) has facilitated and promoted CO transmission through the cell membrane.', 36352402),
('Antibacterial Nanocomposites', 'bacterial cellulose (BC) was impregnated with graphene quantum dots (GQDs)', 'Novel GQDs-BC hydrogel composites are biocompatible and showed significant inhibition towards Staphylococcus aureus and Streptococcus agalactiae and bactericidal effect towards Methicillin-resistant Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.', 'Novel GQDs-BC hydrogel composites are biocompatible and showed significant inhibition towards Staphylococcus aureus and Streptococcus agalactiae and bactericidal effect towards Methicillin-resistant Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.', 'GQDs-BC hydrogel composites showed very good wound fluid absorption and water retention, which satisfies good dressing properties. results confirm the potential of new designed GQDs-BC composite hydrogels in angiogenesis and regeneration processes necessary to completely restore the structure and function of wounded skin.', 35191591),
('Antibacterial Nanocomposites', 'new nanosystems containing gold (Au) and coated with biodegradable surfactants (TG) linked to the antibiotic (AT) by means of small DNA chains, Au@TG/DNA-AT', 'MICs of biosynthesized AgNPs for E. coli and S. aureus were 6.25 and 50 mg/mL, respectively. Another study showed antimicrobial agents such as biosynthesized ZnONPs, where the MICs were 8 and 4 mg/mL against E. coli and S. aureus, respectively. Another antimicrobial agent was phenyllactic acid, where the MIC was 2.5 against E. coli. Another study showed for green synthesized AgNPs a MIC of 6.25 microg/mL in E. coli', 'In internalization experiments, depending on the treatment application time, greater bacterial destruction was observed for both the Ni precursors and the Ci nanosystems tested after 18 h of incubation time.', 'Finally, our results show that the nanosystem composed of the Au@16-3-16 nanoparticle and the DNA/TC complex is appropriate for medical use. Moreover, Au@16-3-16 nanoparticles act as antibiotics by themselves in the absence of TC, given the fact that gold nanoparticles possess strong antibacterial properties for both Gram-negative and Gram-positive bacteria, possibly due to membrane damage or electrostatic interaction with internalization by endocytosis. Gold-TC nanosystems may be an answer to the necessity for reduction of antibiotics, allowing a decrease of the amount used, especially in Gram-positive bacteria.', 36145689),
('Antibacterial Nanocomposites', 'ZnO and Mn-doped ZnO NPs nanofunctionalized Ti scaffolds', 'ZnO@Ti and ZnxMn(1-x)O@Ti displayed an enhanced antibacterial activity against both Gram-positive Staphylococcus aureus (S. aureus) and Gram-negative Pseudomonas aeruginosa (P. aeruginosa) bacterial strains. t has been observed that ZnxMn(1-x)O@Ti scaffolds reach a complete eradication for S. aureus and 90 % of reduction for P. aeruginosa', '', 'first study reported in the literature describing ZnO and Mn-doped ZnO NPs nanofunctionalized Ti scaffolds with improved antibacterial performance', 36587469),
('Antibacterial Nanocomposites', 'synergistic effect of a polymyxin derivative known as polymyxin B nonapeptide (PMBN) with azithromycin (AZT).', 'PMBN was able to re-sensitize the bacteria to AZT, even in strains with high minimum inhibitory concentrations (MIC: 32 to =128 microg/ml) for AZT, against antibiotic-resistant Escherichia coli', 'Killing kinetics study showed a significant reduction of bacterial growth after 6 h of treatment with complete killing achieved after 24 h.', 'bacteria treated with PMBN alone or in combination with AZT, with evidence of damage to the outer membrane. These results suggested that PMBN acted by increasing the permeability of bacterial outer membrane to AZT. PMBN is a good candidate for use with other antibiotics to potentiate their activity, but further studies are required in vivo. This will significantly contribute to resolving antimicrobial resistance crisis.', 36212888),
('Antibacterial Nanocomposites', 'series of nanolayered structures and nanohybrids', 'The nanomaterials prepared were used against a group of microorganisms, including E. coli, S. aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa. Experimental results revealed that a nanohybrid based on carbon nanotubes and fatty acids showed significant antimicrobial activity against E. coli. nanolayered structure combined with carbon nanotubes showed a significant and clear inhibitory effect on S. aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa.', '', 'It is concluded that the nanolayered structures and nanohybrids, which can be modified at low cost with high productivity, can be considered good candidates for preventing infectious disease and inhibiting the spread of bacteria, especially those that are commonly found in wastewater and the environment.', 36014614),
('Antibacterial Nanocomposites', 'five cationic nano-sized hyperbranched polymers (CNHBPs) with cationic functional groups have been constructed', 'Q12-CNHBP exhibited superior in vivo therapeutic efficacy for methicillin-resistant Staphylococcus aureus (MRSA) infection', 'Q12-CNHBP exhibited superior in vivo therapeutic efficacy in a mouse wound model of methicillin-resistant Staphylococcus aureus (MRSA) infection with low toxicity during treatment', 'negatively charged surfaces of bacterial cells provided Q12-CNHBP with a higher intrinsic electrostatic driving force for bacterial killing than that with S12-CNHBP. These advantages and ease of preparation will undoubtedly distinguish Q12-CNHBP as a new class of suitable candidates to combat multidrug-resistant pathogen infections. This study opens up a new avenue for exploiting antibacterial biomaterials to treat infections caused by drug-resistant bacteria.', 36004750),
('Antibacterial Nanocomposites', 'prepared Au@CDs composite nanoparticles (Au@CD) comprised of gold nanoparticles (AuNPs) and carbon dots (N,S-CDs)', 'The resultant Au@CD membrane exhibited excellent biocompatibility and photothermal antimicrobial activity. In vitro photothermal antibacterial inactivation studies confirmed their efficacy against S. aureus and E. coli (99 + % inactivation of both pathogens under NIR irradiation)', '', 'The resultant Au@CD membrane exhibited excellent biocompatibility and photothermal antimicrobial activity. This reduce the risk of bacterial infection, suppress inflammation as well as improve collagen deposition and angiogenesis, all of which together facilitated wound closure and resulted in a better therapeutic effect than the controls. Taken together, this work confirms that NIR-irradiated Au@CD-based membranes and related materials are promising photothermal antimicrobial platforms for wound dressings and related healthcare applications.', 36308860),
('Antibacterial Nanocomposites', 'multifunctional Gallium-Based Nanoplatform (Ga-mSiO2-BFN) comprised of clinically approved gallium, mesoporous silica, and bromfenac (BFN) as a co-modified', 'Gallium-Based Nanoplatform (Ga-mSiO2-BFN) comprised of clinically approved gallium, mesoporous silica, and bromfenac (BFN) as a co-modified release system to simultaneously eradicate Multidrug-Resistant Pseudomonas aeruginosa', '', 'The released gallium ions can disrupt bacterial iron metabolism. All composites of our nanoplatform were FDA approved, making the Ga-mSiO2-BFN as a potentially promising therapeutic approach for treating Multidrug-Resistant Pseudomonas aeruginosa in PCE accompanying satisfactory prognosis and prospects for clinical translations.', 36373472),
('Antibacterial Nanocomposites', 'novel supramolecular photothermal nanoparticles (MCC/CS NPs), assembled from mono-carboxyl corrole (MCC) and chitosan via hydrogen bonding and p', 'the MCC/CS NPs achieve potent photothermal and inherent antimicrobial synergistic effects against Escherichia coli and methicillin-resistant Staphylococcus aureus (MRSA) in vitro.', '', 'The MCC molecules possess good photothermal performance and the chitosan with inherent bioactivity can exert moderate antibacterial effects. the bacteria-infected diabetic wound model confirms that the MCC/CS NPs can effectively kill drug-resistant bacteria, accelerate wound healing and angiogenesis, and show good biocompatibility, representing a novel and efficient photothermal antibacterial nanoplatform.', 36168853);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Nanocomposites', 'Green synthesis of a multimetallic/ternary nanocomposite formed of silver (Ag), titanium dioxide (TiO2), and iron(III) oxide (Fe2O3), conjugated to chitosan (CS), in which the large spectrum fluoroquinolone antibiotic ciprofloxacin (CIP) has been encapsulated.', 'The antimicrobial potential of the nanoparticulate drug delivery system (NDDS) was elicited by prominent ZIs against MDR E. coli (33 ', 'The viability of bovine mammary gland epithelial cells (BMGE) treated with the NDDS remained superior to 90%, indicating a negligible cytotoxicity (p < 0.05).', 'Nanomaterials have many advantages over traditional antibiotics, including improved stability, controlled antibiotic release, targeted administration, enhanced bioavailability, and the use of antibiotic-loaded nanomaterials. the newly prepared CIP-Ag/TiO2/Fe2O3/CS nanoformulation appears safe, biocompatible, and therapeutically active to fight MDR E. coli strains-causing mastitis.', 36015345),
('Antibacterial Nanocomposites', 'cerium oxide (CeO2 ) nanoparticles (NP) of two different sizes (CeO2 NP1 [1-2 nm] and CeO2 NP2 [10-12 nm])', 'CeO2 NPs were found to show 100% microbial cell viability inhibition at a concentration of 500 mg/L. In addition, CeO2 NP1 and CeO2 NP2 inhibited the biofilm formation of S. aureus and P. aeruginosa.', 'Larger cerium oxide nanoparticles were found to be less toxic against erythrocytes compared with the smaller ones. CeO2 nanoparticles demonstrate low cytotoxicity towards erythrocytes', 'he antimicrobial activity, effects of nanoparticles on DNA cleavage, microbial cell viability, and biofilm formation inhibition were analyzed. CeO2 NP1 and CeO2 NP2 exhibited single-strand DNA cleavage ability. CeO2 nanoparticles demonstrate moderate antimicrobial activity and low cytotoxicity towards erythrocytes, which make them promising antibacterial agents.', 36420776),
('Antibacterial Nanocomposites', 'polyacrylonitrile (PAN) nanofibers coated with silver nanoparticles (AgNPs) and silver(I,III) oxide.', 'New PAN-AgNPNanocomposites generally had better antimicrobial efficiency against E. coli and L. crispatus', '', 'our results indicate that PAN-AgNPNanocomposites successfully display antimicrobial activity against various bacteria. study demostrate PAN-AgNP nanofibers can be used as an effective alternative antimicrobial material that is more cost-effective and easier to store in certain industries or fields of study.', 36591150),
('Antibacterial Nanocomposites', 'novel nanotechnology that combines silver with glutathione (GSH) to form antibacterial nanoclusters, GSH@AgNCs.', 'The results indicated that GSH@AgNCs were more successful in restricting E. coli than S. aureus.In addition, at low concentration (1/8 MIC), GSH@AgNCs significantly inhibited the formation of biofilms and damaged mature biofilms, reducing the viable cells.', '', 'This study demonstrated that GSH@AgNCs effectively hindered the proliferation of foodborne Gram-positive bacteria (S. aureus) and Gram-negative bacteria (E. coli), providing new feasibility for applying organic composite nanomaterials and nanotechnology in the food industry.', 36076447),
('Antibacterial Nanocomposites', 'Polymyxin B- hyaluronic acid (PMB-HA) nanoparticles', 'The antibacterial efficiency of PMB-HA nanoparticles against P. aeruginosa was more than 70% at 4 microg mL-1 (with respect to PMB in the PMB-HA nanoparticles), and reached nearly 100% when the concentration was higher than 8 microg mL-1', 'With respect to the PMB-HA nanoparticles in the NS solution, the hemolysis rates were less than 3% at concentrations ranging from 32 to 1024 microg mL-1. mice were intravenously injected with high doses of PMB-HA nanoparticles or free PMB (10 mg kg-1 with respect to PMB, 3-fold higher than the therapeutic dose. After 24 h of medication, all of the mice in PMB-HA groups were still alive, whereas 4 out of 5 mice treated with free PMB died within the first 20 minutes.', 'results indicated that the PMB-HA nanoparticles exhibited superior treatment outcomes for pneumonia as compared with free PMB. PMB-HA nanoparticles can precisely target the CD44 receptors over-expressed on the membrane of activated endothelial cells in inflammatory sites, and come into contact with the bacteria surrounding the damaged alveolar-capillary membrane. This smart LPS-triggered responsive behavior of nanoparticles enables both increased therapeutic effects and enhanced biosafety', 36039653),
('Antibacterial Nanocomposites', 'graphene oxide-loaded aptamer/berberine bifunctional complex', 'The GO-loaded aptamer/berberine bifunctional complex displayed a higher suppression of biofilm formation against MRSA. 91.3% of fluorescence was quenched by 60 microg/mL GO, suggesting that 60 microg/mL GO could effectively quench the fluorescence of berberine/aptamer 1 (with 200 nM aptamer 1) via fluorescence energy resonance transfer (FERT). Berberine at concentrations of 50 and 100 microg/mL inhibited the expression of four key genes in MRSA biofilm formation. When the berberine concentration was 100 microg/mL, the relative expression levels of these genes decreased to less than 50%', 'For the sensitivity assay, various amounts of MRSA cells ranging from 800 to 107 colony-forming units (CFU)/mL were incubated with 200 nM FAM-labeled aptamer 1.', 'simultaneous delivery system based on GO for the targeted inhibition of MRSA biofilm formation was successfully designed using a self-assembly technology.', 35616277),
('Antibacterial Nanocomposites', 'Nanobodies (NbSOSs)', 'Nanobodies (NbSOSs) repressing SOS response in Escherichia coli', '', 'NbSOSs can inhibit LexA autoproteolysis and block the SOS response axis in bacteria. Biophysical characterization of NbSOSs-LexA complexes discloses inhibition mechanism. Hence studies pave the way to the development of new-generation antibiotic adjuvants for the treatment of bacterial infections.', 36240773),
('Antibacterial Nanocomposites', 'Azithromycin Encapsulated into poly (lactic-co-glycolic acid) (PLGA) Nanoparticle', 'A dramatic improvement of antibacterial activity was recorded for AZI-PLGA NPs over free AZI, where the MIC values of AZI-PLGA NPs were four times less than the MIC value of free AZI. MIC value reduced from >1000 to 256 microg/mL and from 256 to 64 microg/mL for E. faecalis and MRSA, respectively, contrary to no change detected for MIC values in the case of P. aeruginosa.', 'Wi-38 cells, human lung fibroblast cell lines were cultured in a complete DMEM culture medium gainst P. aeruginosa, MRSA, and E. faecalis. This is indicative of the less in vitro cytotoxicity of nano-formulations compared to free AZI.', 'These results revealed that AZI-PLGA NPs retained AZI antibacterial activity against resistant bacteria carrying efflux mechanism. This gave a new hope to manage infections in the future', 36421266),
('Antibacterial Nanocomposites', 'Ofloxacin-loaded HMPB NPs with the combination of PTT', 'a nanocomposite of HMPB NPs with inherent photothermal therapy capability was used to eradicate K. pneumoniae after loading with Ofloxacin', '', 'The nanocomplexes named as Ofloxacin@HMPB@HA NPs showed a higher effect against K. pneumoniae by destroying cell integrity and inducing ATP leakage with the assistance of laser irradiation, compared with sole Ofloxacin@HMPB@HA NPs or laser irradiation. these results indicate the great potential of this combinational tactic based on Ofloxacin@HMPB@HA NPs for preventing the failure caused by K. pneumoniae infection.', 35338663),
('Antibacterial Nanocomposites', 'FeS2@GO-Based Heterogeneous Photo-Fenton Process (nano pyrite (FeS2) on graphene oxide)', 'Low reagent doses of FeS2@GO catalyst (0.25 mg/L) and H2O2 (1.0 mM) were found to be efficient for removing 6-log of Antibiotic Resistant Bacteria ARB and 7-log of extracellular , Antibiotic Resistance Genes ARG (e-ARG) after 30 and 7.5 min treatment, respectively, in synthetic wastewater', '', 'The stable and recyclable composite generated more reactive species, including hydroxyl radicals (HO', 35759741),
('Antibacterial Nanocomposites', 'Nanopolymer-based poly (propargyl alcohol)', 'Nano-PGA-DMF exhibits significant antimicrobial potential against Staphylococcus aureus (S. aureus) (20.20 mm; zone of inhibition (ZOI), and 0.47 microg/mL; minimum inhibitory concentration (MIC), followed by Escherichia coli (E. coli) (14.50 mm; ZOI, and 1.87 microg/mL; MIC. In antibiofilm results, the highest inhibition percentage of the synthesized nano-PGA-W (water), nano-PGA-Ch (chloroform (Ch), and nano-PGA-DMF (dimethylformamide) was documented for S. aureus (17.01%, 37.57%, and 80.27%), followed by E. coli (25.68%, 55.16% and 78.11%), and C. albicans (40.10%, 62.65%, and 76.19%), respectively.', '', 'The amount of bacterial protein removed is directly proportional after increasing the concentration of nano-PGA-W, nano-PGA-Ch, and nano-PGA-DMF samples (at different concentrations) and counted to be 70.58, 102.89, and 200.87 microg/mL, respectively following the treatment with 1.0 mg/mL of each sample. It was found that the nano-PGA polymer prepared in DMF has better antimicrobial activity than one prepared in chloroform than in water.', 36152795),
('Antibacterial Nanocomposites', 'silver nanoparticles obtained by green synthesis using a leaf extract and fungi', 'The minimal inhibitory concentration (MIC) of the NP was tested by the microdilution method, finding that MICs for F-NP (between 4 and 128 microg ml-1) were similar to those for L-NP (between 8 and >128 microg ml-1) effective against P. aeruginosa infections.', 'nanoparticles were nontoxic for larvae of the moth Galleria mellonella,', 'Both nanoparticles showed a potent antibacterial effect, causing severe damage to the cell wall, membrane and DNA, and inducing the production of reactive oxygen species. Moreover, the nanoparticles derived from fungi showed synergistic antibacterial effects with the antibiotics meropenem and levofloxacin. encouraging further research for their implementation in the treatment of P. aeruginosa infections.', 35687297),
('Antibacterial Nanocomposites', 'zinc oxide nanoparticles', 'ZnO NPs exhibited high antibiofilm activity against B. cereus and E. coli with minimum biofilm inhibitory concentration (MBIC) of ZnO NPs at 46.8 microg ml-1 and 93.7 microg ml-1.', '', 'Disruption of membrane integrity exhibited with reduced exopolysaccharides secretion and leakage of nucleic acids. This study emphasizes the potential mechanisms underlying the selective bactericidal properties of ZnO NPs and highlighted the strong interaction of ZnO NPs with intracellular components leading to biofim destruction. Therefore, ZnO NPs could be considered as a promising antibiofilm agent and thus could expand the possibility to use as therapeutic agent.', 36152464),
('Antibacterial Nanocomposites', 'light-mediated oxidation of AgNPs conjugates using protoporphyrin IX (PpIX) as a photosensitizers (PS). Also, polyethyleneimine (PEI) coated AgNPs. Tested the antimicrobial effect of three nanoparticles: AgNPs, PpIX-AgNPs, and PEI-PpIX-AgNPs', 'PpIX-AgNPs were the most effective material achieving >7 log inactivation of MRSA and MDR E. coli. The order of bacterial log inactivation was PpIX-AgNPs > PEI-PpIX-AgNPs > AgNPs.', 'All NPs showed negligible cytotoxicity to mammalian cells at the bacterial inhibitory concentration after 24 h exposure', 'This order correlates with the trend of Ag+ concentration released by the NPs (PpIX-AgNPs > PEI-PpIX-AgNPs > AgNPs). Our study confirms a synergistic effect between PpIX and AgNPs in the inactivation of AR pathogens with about 10-fold increase in inactivation of ARB relative to AgNPs only. The concentration of Ag+ released from NPs determined the log inactivation of MRSA and MDR E. coli more than either the phototoxic effect or the electrostatic interaction promoted by surface charge of nanoparticles with bacteria cells.', 36545324),
('Antibacterial Nanocomposites', 'Gardenia thailandica methanol extract (GTME) to biogenically synthesise zinc oxide nanoparticles (ZnO-NPs)', 'The antibacterial activity of ZnO-NPs was studied both in vitro and in vivo against Pseudomonas aeruginosa clinical isolates. Its minimum inhibitory concentration values ranged from 2 to 64 microg/mL, and it significantly decreased the membrane integrity', 'The in vivo study (biochemical parameters and histological investigation) was conducted and it revealed a protective effect of ZnO-NPs against the deleterious influences of P. aeruginosa bacteria on lung, liver, and kidney tissues.', 'the green synthesised ZnO-NPs by GTME could be regarded as a future antimicrobial compound to treat systemic infections caused by P. aeruginosa. Future clinical investigations should be performed to assure the therapeutic value of ZnO-NPs in humans.', 35361019),
('Antibacterial Nanocomposites', 'colloidal platinum nanoparticles', 'The lowest MIC value obtained for platinum nanoparticles was against K. pneumoniae ESBL+ MFBF 10690 = 3.13 ', '', 'We conclude that platinum nanoparticles exhibit potent antibacterial effects against standard laboratory and resistant strains of E. coli and K. pneumoniae. Both, cell wall damage and ROS induction could have important role as mechanisms of antibacterial activity.', 36015339),
('Antibacterial Nanocomposites', 'Engineered organic nanoparticles', 'EPS destruction and stimuli-responsive release enhance biofilm eradication to the bacteria', '', 'Nanoparticles are potent in biofilm penetration and elimination. Size and surface properties are crucial for biofilm penetration. novel strategies are being developed to further enhance the antibiofilm capacity of NPs, including size optimization, surface modification, stimuli-triggered release, and combined strategies. Thus, NPs represent an effective and promising approach to combat biofilms.', 36403883),
('Antibacterial Nanocomposites', 'novel nanoparticles (NPs) loaded with the natural bactericide farnesol (FSL NPs)', 'The nanoformulation of farnesol improved its antibacterial properties and demonstrated complete eradication of Staphylococcus aureus within less than 3 h, without inducing resistance development, and was able to 100% inhibit the establishment of a drug-resistant S. aureus biofilm. These antibiotic-free nano-antimicrobials also reduced the mature biofilm at a very low concentration of the active agent. The novel FSL NPs demonstrated very strong bacterial growth inhibition at 4 ', 'The novel FSL NPs did not cause skin tissue irritation in a 3D skin tissue model.', 'The hydrophobic nature of farnesol facilitates its accumulation in the bacterial membrane, causing cell leakage and death. These results support the potential of these bio-based nano-actives to replace the existing antibiotics and they may be used for the development of topical pharmaceutic products for controlling microbial skin infections, without inducing resistance development.', 35886883),
('Antibacterial Nanocomposites', 'zinc ferrite nanoparticles (ZnFe2O4 NPs)', 'ZnFe2O4 NPs in an anti-biofilm study by inhibiting biofilm formation up to 81.76% and reducing mature biofilm up to 56.22% at 75 microg/mL the minimum inhibitory concentration value against opportunistic pathogens Klebsiella pneumoniae (K. pneumoniae)', '', 'Results of the present study demonstrate that the ZnFe2O4 NPs endow an excellent antibacterial efficiency with a maximum zone of inhibition i.e.16 mm. The reactive oxygen species (ROS)-induced bacterial damage is caused by the ZnFe2O4 NPs. Hence therapeutic possibilities of the ZnFe2O4 NPs in antimicrobial applications are discussed which are helpful to overcome the challenges associated with biofilm infectivity.', 35467317),
('Antibacterial Nanocomposites', 'Chitosan nanoparticles-microcin J25 (CNM)', 'Anti-infective results proved that oral 0.1% CNM enhances host defense against E. coli O157:H7 infection by improving immune functions', 'high concentrations of CNM induced serious adverse effects, negatively improving intestinal health targets.', 'CNM as a promising AP may markedly enhance host immunity and therapeutic effects by oral administration.', 36153996),
('Antibacterial Nanocomposites', 'CGA-PLGA@PVP nanomicelles', '', '', 'have great properties and are expected to be a novel therapeutic strategy for periodontitis.', 35975567),
('Antibacterial Nanocomposites', 'silver nanoparticles (AgNPs) using the potential probiotic strain Lactobacillus acidophilus', 'The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of green synthesized AgNPs against the Multi-drug Resistant Enteroaggregative Escherichia Coli (MDR-EAEC ) strains were found to be 7.80 mg/L and 15.60 mg/L, respectively.', 'he green synthesized AgNPs were found safe by in vitro haemolytic assay', 'the green synthesized AgNPs exhibited significant biofilm inhibition (P < 0.001) formed by MDR-EAEC strains. Additionally, a concentration-dependent antioxidant activity was observed. Hence, this study demonstrated potential antibacterial as well as antibiofilm activity of green synthesized AgNPs against MDR-EAEC strains with antioxidant properties and warrants further in-depth studies to explore it as an effective antimicrobial agent against MDR infections.', 35715714),
('Antibacterial Nanocomposites', 'Vancomycin Capped with Silver Nanoparticles', 'Vancomycin-coated silver nanoparticles inhibited S. aureus and E. coli', '', 'Van@citrate-AgNPs had improved significant ability towards both S. aureus (Gram-positive) and E. coli (Gram-negative), according to an in vitro antibacterial assay. In the end, it is concluded that the Van@citrate-AgNP is more potent than the single entity vancomycin towards both S. aureus and E. coli.', 36046462),
('Antibacterial Nanocomposites', 'silver nanoparticles', 'The Ag NPs were effective against CPGB, with minimum inhibitory concentrations ranging from 64 to 8 microg/ml on average. combination of Ag NPs and antibiotics demonstrated synergistic and partial synergistic activity (fractional inhibitory concentration between 0.13 and 0.56) against CPGB, significant reduction in antibiotic concentrations, particularly in the case of A. baumanii versus ceftriaxone (1024 to 4 microg/ml)', '', 'The notable synergistic activity of Ag NPs with antibiotics represents a valuable nanomedicine that may find clinical application in the future as a combined remedy.', 36085334),
('Antibacterial Nanocomposites', 'silver and gold complexes of imidazole and 1,2,4-triazole derived N-heterocyclic carbenes', 'Two of the silver(I) complexes have promising antibacterial activity against Acinetobacter baumannii (3f, MIC = 2', '', 'Silver(I) complex 3f and gold(I) complex 4c were tested against multi-drug resistant bacterial strains and high levels of antibacterial activity were observed.', 35876319),
('Antibacterial Nanocomposites', 'Moxifloxacin-loaded solid lipid nanoparticles', 'Nanoparticles loaded them with MOX to determine its release, antibacterial activity against E. coli', 'Cytotoxicity testing did not reveal significant toxicity of nanoparticles, whether Moxifloxacin- MOX-free or MOX-loaded, against RAW 264.7 cells.', 'Moxifloxacin-loaded solid lipid nanoparticles increase antibacterial treatment efficacy in view of the growing antibiotic resistance.', 36607722),
('Antibacterial Nanocomposites', 'trimetallic metal-organic framework nanosheets ( NiCoCu )', 'MOF nanosheets with peroxidase-like activity. (Ni2Co1)0.5Cu0.5 exhibited the best antibacterial activity against gram-positive Escherichia coli and methicillin-resistant Staphylococcus aureus bacteria', '', 'Animal wound healing experiments demonstrate that ultrathin trimetallic nanosheets can effectively contribute to wound healing with excellent biocompatibility. This study reveals the immense potential of ultrathin trimetallic MOF nanosheets for clinical antibacterial therapy for future pragmatic clinical applications.', 36027783),
('Antibacterial Nanocomposites', 'Tryasine-silver nanoparticles', 'Tryasine-silver nanoparticles were more effective with MICs ranging from 30 to 100 microM determined against Staphylococcus aureus, Escherichia coli, methicillin resistant Staphylococcus aureus, and ESBL Escherichia coli', 'Tryasine-silver nanoparticles at concentration of 100 microM only caused 1% hemolysis on human erythrocytes after 30 min of incubation.', 'The findings indicate that Tryasine-silver nanoparticles had good antibacterial activity against pathogenic strains of Gram-positive and Gram-negative bacteria. Additionally, the conjugate showed low hemolytic activity and cytotoxicity. Therefore, conjugation of Tryasine with silver nanoparticles is a promising treatment candidate for bacterial infection with low toxicity.', 36009893),
('Antibacterial Nanocomposites', 'biosynthesize Au-Ag nanoparticles using propolis', 'The MIC and the MBC of P. aeruginosa and S. sciuri were 31.25 microg/mL. However, nanoparticles were more effective on S. enterica with MIC of 7.5 microg/mL and MBC of 15.6 microg/mL. Furthermore, the time-killing curve of the three model bacteria with the treatment was effective at 50 microg/mL.', 'the results indicated that the biosynthesized Au@AgNPs have a cytotoxic effect on HEPG2 cell lines.', 'his research revealed that the green synthesized Au@AgNPs could be effective antibacterial agents against S. sciuri, P. aeruginosa, and S. enterica and anticancer agents against HEPG2.', 35987838),
('Antibacterial Nanocomposites', 'ZnO Nanoparticles', '26 and 22 mm zones of inhibition for a size of 20 nm and a concentration of 20 mM against 105 and 107 CFU/mL S. aureus, respectively. The MIC of ZnO NPs of various sizes, 20 and 50 nm, with 105 CFU/mL was 2.5 and 5 mM, respectively. MIC with 107 CFU/mL was five mM for 20 and 50 nm ZnO NPs. the highest growth reduction percentage, 98.99% in the counts of S. aureus was achieved by ZnO NPs of size 20 nm and concentration of 10 mM.', '', 'morphological changes and cell shape distortion were detected by scanning electron microscope for bacterial cells treated with ZnO NPs.', 36295097),
('Antibacterial Nanocomposites', 'green synthesis of silver nanoparticles from leaf extract of Coleus forskohlii.', 'ilver nanoparticle exhibits significantly better antimicrobial activities as compared to the plant extract in case of nearly all pathogens with a maximum zone of inhibition of 15.33 ', '', 'ecause of this broad-spectrum activity of nanoparticles as well as the leaf extracts against life-threatening microbes, it can be used as future generation drugs.', 35992896),
('Antibacterial Nanocomposites', 'Chrysophyllum albidum peels (mostly regarded as waste) to prepare silver nanoparticles (Alb-AgNPs).', 'The antimicrobial properties of the Alb-AgNPs were studied with selected microorganisms namely; S. aureus, E. coli, K. pneumoniae, B. subtilis, S. mutans, P. aeruginosa, S. typhi, and Candida albicans. High inhibitory activity against the microorganisms were exhibited with MICs ranging from 15.62 to 1000 microg/mL.', '', 'the Alb-AgNPs could serve as a biofilm inhibitor with the highest percent inhibition of about 92% against methicillin-resistant Staphylococcus aureus. The results from this study thus provide access to the simple, sustainable, economic and eco-friendly synthesis of silver nanoparticles with efficient antimicrobial properties as drug candidates as a means of overcoming the prevailing antibiotic resistance menaces.', 36586061),
('Antibacterial Nanocomposites', 'pH-responsive nanoparticles by simply self-assembly of an amphiphilic poly(ethylene glycol)-Schiff-vancomycin (PEG-Schiff-Van) 35386319', 'effectively kill the bacteria at an early period and continuously exerting an bacteria-sensitive effect whenever needed over a long period.', '', 'this system was designed to have programmable structural destabilization and sequential drug release due to changes in pH that were synonymous with bacterial infection sites, thereby presenting prominent antibacterial therapy both in vitro and in vivo. This work represents a synergistic strategy on offering important guidance to rational design of multifunctional antimicrobial vehicles, which would be a promising class of antimicrobial materials for potential clinical translation.', 35386319),
('Antibacterial Nanocomposites', 'Bryophyllum pinnatum mediated synthesis of zinc oxide nanoparticles', 'The synthesized green nanoparticles, when tested against a few highly MDR uropathogenic bacteria (E. coli, E. furgusonii, K. pneumoniae, S. flexneri, and P. aeruginosa), were observed to exhibit high antimicrobial response (zones of inhibition ranging between 22 mm to 28 mm), thus confirming that these were bestowed with potent antimicrobial ability.', '', 'it could be concluded that Bryophyllum- ZnO nanoparticles can be used as potential nanoantibiotic sources to deal with UTIs.', 36303898),
('Antibacterial Nanocomposites', 'Jacalin Lectin-Fortified Cationic Copper Sulfide Nanoparticles (cCuS)', 'The minimum inhibitory concentration (MIC) of cCuS was 62.5 microM, which was 2-fold lower than that of the broad-spectrum antibiotic ciprofloxacin. Treat Carbapenem-Resistant Acinetobacter baumannii Infection', '', 'JcCuS hindered pellicle formation and inhibited the biofilm-associated virulence factor of CRAB such as exopolysaccharide, cell surface hydrophobicity, swarming, and twitching mobility. The anti-infective potential of JcCuS was demonstrated by rescuing CRAB-infected zebrafish. The findings illustrate that lectin fortification offers a unique advantage in enhancing the therapeutic potential of antimicrobials against human pathogens of critical priority worldwide.', 36506188),
('Antibacterial Nanocomposites', 'polymer nanoparticles based on polyglycerol adipate (PGA) grafted with polycaprolactone (PCL) developed as carriers for usnic acid (UA)', 'UA loading (0.3 mg/mg of NP). All of the UA-loaded NP systems showed a significant and prolonged antimicrobial activity towards a standard strain of Staphylococcus epidermidis.', '', 'The developed nanosystems showed a prolonged antimicrobial activity (up to at least 7 days) which could be used in preventing/treating infections occurring at different body sites, including medical device-related infection and mucosal/skin surface, where Gram-positive bacteria are commonly involved.', 36430814),
('Antibacterial Nanocomposites', 'zirconium oxide nanoparticles (ZrO2 NPs)', 'Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values for A. baumannii were 15.6 and 62.5 microg/ml,', '', 'Molecular docking studies of ZrO2 NPs with four proteins (2NAZ, 4HKG, 5D6H, and 5HM6) involved in biofilm formation of A. baumannii revealed the interaction of zirconium with target proteins. These findings suggested the in vitro efficacy of phytosynthesized ZrO2 NPs as antibiofilm. it can be exploited in the development of alternative therapeutic options against MDR A. baumannii.', 36191015),
('Antibacterial Nanocomposites', 'Nanocarrier-Loaded Clavulanic Acid and Antibiotic Cotreatments', '', 'These nanocarriers were also found to have a very low cytotoxic effect against human keratinocytes', 'due to the accumulation of the clavulanic acid-loaded nanocarriers on the bacterial cell walls that allows a higher proportion of the inhibitor to engage with the produced intracellular beta-lactamases. which shows great potential for overcoming enzyme-based AMR.', 35819369),
('Antibacterial Nanocomposites', 'an enzymatic nanoadjuvant (EnzNA) self-assembled from Ag NCs', 'EnzNAs revitalize various existing antibiotics against methicillin-resistant Staphylococcus aureus, and potentiate the antibiotic efficacy against biofilm-mediated skin infection and lethal lung infection in mice.', '', 'isolated Ag NCs exhibiting biofilm destructive oxidase-mimetic activity in the acidic biofilm microenvironment, is developed. Ag NCs switch to reveal the thiol oxidase-mimetic activity to suppress ribosomal biogenesis for AMR reversal and evolution inhibition of pathogens. These findings highlight the capability of enzyme-mimetic nanomaterials to modulate the infectious microenvironment and potentiate antibiotics, providing a paradigm shift for anti-infection therapy.', 36399641),
('Antibacterial Nanocomposites', 'charge-switchable and pH-responsive nanocomplex- one-pot zeolitic imidazolate framework-8 (ZIF-8) encapsulation of proteinase K (PK) and photosensitizer Rose Bengal (RB)', 'The charge-assisted penetration makes PK and RB fully functional, resulting in a cooperative effect concerning high biofilm eradication capacity, as testified by biofilm models both in vitro and in vivo.', '', 'The green synthesis and good therapeutic performance of the nanocomplex manifests its considerable potential as a nontoxic and effective platform for biofilm treatment.', 35850068),
('Antibacterial Nanocomposites', 'cerium oxide (CeO2) nanoparticles (NPs)', 'synthesized KF-CeO2 NPs shown superior biofilm inhibitory activity at 500 microg/mL compared to 800 microg/mL and 1600 microg/Ml against MDR bacteria (S. aureus and K. pneumoniae', 'exhibited significant cytotoxic effects (35.60% cell viability) on HeLa cancer cells. the KF-CeO2 NPs were shown to be highly biocompatible with hMSC and 3T3 cell lines (85.13% and 81.17% cell viability, respectively)', 'These data indicate that KF-CeO2 NPs synthesized using Kochiae Fructus extract are promising alternative treatments for MDR. In addition, this study will give the potential for the sustained development of biocompatible NPs with enhanced biological capabilities derived from vital pharmaceutical plants.', 36474529),
('Antibacterial Nanocomposites', 'Green Synthesis of Zn(OH)2/ZnO-Based Bionanocomposite using Pomegranate Peels', 'bionanocomposite with concentrations of 50 mg/mL and 75 mg/Ml cause the bacterial biofilm degradation efficiency of the Zn(OH)2/ZnO bionanocomposite was clearly demonstrated by the Congo red method against the Bacillus subtilis PF_1 strain', '', 'Zn(OH)2/ZnO bionanocomposite, in which pomegranate waste peels were used as a natural metal salt reducing agent. This study could be very helpful for making advanced bionanocomposite materials as novel antimicrobial agents, thus preventing a number of infectious diseases.', 36234586),
('Antibacterial Nanocomposites', 'metal-organic framework (MOF)-based nanozymes[ TCPP(Fe) (Co-Fe NSs) to zero-dimensional Co-TCPP(Fe) (Co-Fe NDs)]', 'bimetallic Co-Fe NDs can highly efficiently catalyze the lower-concentration H2O2 into reactive oxygen species (ROS), resulting in a favorable antibacterial effect against methicillin-resistant Staphylococcus aureus (MRSA). Co-Fe NDs can effectively promote wound healing and water environment disinfection with good biocompatibility.', '', 'This work reveals the potential of a zero-dimensional bimetallic MOF-based nanozyme in resisting drug-resistant bacteria and holds great promise for future clinical and environmental applications.', 35912946),
('Antibacterial Nanocomposites', 'Synergistic effect of Silver Nanoparticles', 'The MIC range of the AgNPs was 9-12 microg/ml, whereas the MIC range of AgNPs with penicillin was 4-6 microg/ml.', '', 'Most MDR-MRSA contained a plasmid of > 10 kb. To overcome bacterial resistance, AgNPs were applied and displayed high antimicrobial activity and synergistic effect with penicillin. Our findings may help establish programs to control bacterial spread in communities as AgNPs appeared to exert a synergistic effect with penicillin to control bacterial resistance.', 36379700),
('Antibacterial Nanocomposites', 'molecularly imprinted polymer nanoparticles (MIP-NPs) as antibiotic adjuvants', 'Enhanced inhibition rates of 40-80% were achieved in the presence of the MIP-NPs. The dose of antibiotic could be greatly reduced by utilizing the MIP-NPs as adjuvants', '', 'Good biocompatibility (no obvious hemolysis or cytotoxic effects) and apparent antimicrobial efficiency for resisting wound infection in vivo support the fact that well-designed MIP-NPs have a bright future in dealing with the growing threat of antibiotic tolerance and resistance.', 36321529),
('Antibacterial Nanocomposites', 'polyethylene glycol (PEG)ylated nanostructured lipid carrier (PEG-NLC) was synthesized', '', 'the results demonstrated that PEG-TMP/SMZ-NLC after oral administration could decrease the drugs'' side-effects such as renal and hepatic toxicity by ~5-fold in MRSA skin infection in Balb/c mice,', '(PEG-NLC) was synthesized to improve the oral delivery of trimethoprim/sulfamethoxazole (TMP/SMZ) for the treatment of MRSA skin infection in vitro and in vivo. it could improve the antibacterial effects of TMP/SMZ by 3 orders of magnitude. the results of this study suggest that the application of PEGylated NLC nanoparticles is a promising approach to improving the oral delivery of TMP/SMZ for the treatment of MRSA skin infection.', 36015294),
('Antibacterial Nanocomposites', 'small Nanoparticle fraught liposomes (NP-Lip)', 'resulting in an enhancement of antibiotic selectivity by fourfold toward E. coli (both strains) and eightfold toward P. aeruginosa.', '', 'ocular administration of NP-Lip showed a reduction in TNF-alpha and IL-6 levels, implying reduced interaction with mammalian cells in vivo. This work therefore clearly demonstrated how tailoring the nano-bio interaction could result in selective drug delivery and a reduction in toxicity.', 35876358),
('Antibacterial Nanocomposites', 'Polydopamine (PDA) was introduced as an encapsulating agent for FeS nanoparticles. FeS@PDA', '', '', 'PDA, as an intensive light-responsive agent, could play a synergistic antibacterial role with CDT through PTT, compensating for the low photothermal conversion efficiency of FeS nanoparticles. The combination of PTT and CDT exhibited strong synergistic antibacterial effects, exerting oxidative damage to bacterial macromolecules, such as DNA.', 35917910),
('Antibacterial Nanocomposites', 'magnetic nanoparticles enveloped by nanovesicles derived from blood cells (MNVs)', 'MNVs predominantly capture human fecal bacteria, carbapenem-resistant (CR) Escherichia coli, and extended-spectrum beta-lactamases-positive (ESBL-positive) E. coli, vancomycin-intermediate Staphylococcus aureus (VISA), endotoxins, and proinflammatory cytokines in human blood.', '', 'The extracorporeal blood cleansing enables full recovery of lethally infected rodent animals within 7 days by treating them twice in series. It is also validated that parameters reflecting immune homeostasis, such as blood cell counts, cytokine levels, and transcriptomics changes, are restored in blood of the fatally infected rats after treatment.', 36070419),
('Antibacterial Nanocomposites', 'Niosomes with a rifamycin S', 'lower MIC of Niosomes with rifamycin S against S. aureus. Niosomes with a rifamycin S concentration of 0.13 microg/g were satisfactorily prepared.', '', 'Nanovesicles with larger size and higher encapsulation efficiency (EE) were obtained when using glycerol and PEG400 in the aqueous media. Our results showed that niosomes consisting of an aqueous glycerol solution have higher stability and EE across a diversity of temperatures and pHs,', 36559121),
('Antibacterial Nanocomposites', 'silver nanoparticles (Ag NPs) attached to methylene blue (MB)', 'Ag NPs were coupled with MB and used to deactivate the Gram-negative bacteria, Escherichia coli (E. coli), and Gram-positive bacteria, Staphylococcus aureus (S. aureus).', 'Ag NPs do not exhibit cytotoxicity measurement in HEK 293T cell lines up to 50 microg/ml in each solution.', 'MB and Ag NPs mixture exhibited a synergistic activity and was more effective compared to separate use of MB and Ag NPs. Ag NPs/ MB combination has potential to be used in PDT where standard photosensitizers have limitations.', 35545200),
('Antibacterial Nanocomposites', 'PEGylated poly (alpha lipoic acid) (PEG-PALA) copolymer nanoparticles', 'these nanoparticles reduced 3.4-fold of Enterobacteriaceae levels and increased 1.5-fold of the Lactobacillaceae levels compared with the drug administered in the free form.', 'The PEG-PALA nanoparticles demonstrated excellent stability in vitro and biocompatibility toward mammalian Caco-2 and 293 T cells.', 'In the mouse infection model, PEG-PALA nanoparticles encapsulated with ciprofloxacin (PEG-PALA@CIP) reduced the Salmonella colonization in the heart, liver, spleen, lung, cecum, and faeces, prolonged ciprofloxacin persistence in the intestine while reducing its absorption into the blood. As such, this targeted antibiotic delivery systems are for the encapsulation of antibiotics to target specific enteropathogens.', 36202152),
('Antibacterial Nanocomposites', 'tannin-coordinated nanozyme composite-based hybrid hydrogels (TCNH)', 'The nanozyme composite in TCNH seems to penetrate the interior of bacteria and exhibited significant broad-spectrum antibacterial activity owing to its intrinsic and nanozymic catalytic properties.', '', 'CNH eye drops can be successfully applied to treat P. aeruginosa and multidrug-resistant P. aeruginosa keratitis. The findings of this study reveal the potential of tannin-coordinated nanozyme composite-based hybrid hydrogel eye drops for treating infectious diseases.', 36242070),
('Antibacterial Nanocomposites', 'Silver Nanoparticles', 'the viability of all the tested strain Staphylococcus epidermidis (S. epidermidis) decreased with the use of nanosilver at a concentration of 5 microg/mL. The ability to form biofilm also decreased with the use of nanosilver at a concentration of 3 microg/mL.', '', 'investigate the effect of nanosilver on the viability, biofilm formation and gene expression of the icaADBC operon and the icaR gene for biofilm and non-biofilm S. epidermidis strains. Low concentrations of nanosilver may cause increased biofilm production, however no such effect was observed with high concentrations. This confirms that the use of nanoparticles at an appropriately high dose in any future therapy is of utmost importance. Data from our publication confirm the antibacterial and antibiotic properties of nanosilver.', 36012520),
('Antibacterial Nanocomposites', 'Mimusops elengi Flower-Mediated Green Silver Nanoparticles (MENP)', 'MIC For the Staphylococcus aureus strains = 1.5625 microgram/ml and MIC for the Acinetobacter baumannii strains , 6.25 microgram/ml for MTCC1926 and 0.78125 microgram/ml for SN15', '', 'Both insilico and invitro reveal that MENP can be used as an alternative to break multidrug resistance', 35347673),
('Antibacterial Nanocomposites', 'Rhamnolipid-Coated Iron Oxide Nanoparticles', 'The lowest MIC of 1 to 4 microgram m/L were recorded for E. coli', '', 'The novelty regarding the activity of RHL-Fe3O4@PVA@p-CoA/GA biosurfactant NPs reveals their potential effect as an alternative multitarget antivirulence candidate to minimize infection severity by inhibiting biofilm development', 35852338),
('Antibacterial Nanocomposites', 'sodium alginate stabilized MgO nanoparticles and antibiotics', 'G+M+T (gel stabilized MgO and tylosin) showed the lowest (4.883 ', 'mild toxicity.', 'The study thus concluded increasing drug resistance in E. coli of houbara bird while sodium alginate stabilized MgO nanoparticles and antibiotics were effective alternative antibacterial composites with mild toxicity.', 36132226),
('Antibacterial Nanocomposites', 'Gox glucose oxidase-loaded iron-phenolic nanocomplex', 'Fe-GA/GOx could induce over 90% of the biomass of Klebsiella pneumoniae and Staphylococcus aureus by the cascade reactions, producing free radicals to eradicate the invaded bacteria.', 'alleviate the inflammatory response without notable side effects on normal tissues', 'It has been concluded that Reductive polyphenols could promote the Fe3+-to-Fe2+ reaction, enhancing the generation of free radicals. Glucose oxidase (GOx) catalyze glucose oxidation, yielding H2O2 and glucosic acid which promote the subsequent Fenton-like reaction. Therefore, the cascade reaction of GOx/peroxidase offers an efficient pathway to eradicate bacteria, mimicking the natural cascade reaction in immune cells.', 36241091),
('Antibacterial Nanocomposites', 'Bimetallic Nanoparticles from Ocimum basilicum', 'Minimum inhibitory concentration (MIC) assays showed AgPtNP activity till the least concentration of NPs (3.15-1.56 microg/mL) against E. coli, E. faecalis, and S. aureus.', 'The cytotoxic activities of AgNPs, PtNPs and AgPtNPs were assessed on different epithelial cell models, by MTT cell proliferation assay, and discovered low toxicity, with a cell viability of 80%. It ecofriendly and safe method', 'Kirby-Bauer method showed that AgPtNPs gave a zone of inhibition for Gram-positive and Gram-negative bacteria in a range of 9-25 mm. Also obtained AgPtNP synergistic activity in combination with vancomycin or ampicillin antibiotics. These results indicate that bimetallic nanoparticles, synthesized from O. basilicum leaf extract, could represent a natural.', 36432648),
('Antibacterial Nanocomposites', 'Herbal Fennel Essential Oil (FEO) Nanogel', 'The FEO', '', 'Nanoparticles are considered as a promising tool for overcoming the problems in the treatment of infections caused by S. aureus and has a greater ability to remove bacteria. Based on traditional herbal natural chemical compounds, they have shown that FEOs have a significant effect on the tested bacteria', 36421558),
('Antibacterial Nanocomposites', 'engineering protein-only nanoparticles: P128NANO', 'P128NANO has a significantly lower MIC (12.5 microg/mL) than that of P128MONO (50 microg/mL), and thus has a stronger antibacterial ability.', '', 'The damage and leakage of cytoplasmic content result from the nanoparticle', 36194892),
('Antibacterial Nanocomposites', 'Chitosan-pluronic nanoparticles were used to construct nanosized ciprofloxacin and meropenem', 'The in vitro evaluation of combined ciprofloxacin and meropenem-loaded nanoparticles demonstrated that this nanosystem exhibited enhanced antibacterial effect Decreased Emergence of Resistance in Escherichia coli. for all steps of selection, nanosized combined antibiotic mutants expressed significantly lower levels of acrB as well as higher levels of ompC and ompF (p-value <0.01).', '', 'In view of these results, the use of nanosized combined antibiotics may be considered among the new promising strategies to combat infections through their potential efficacy in reducing microorganisms'' ability to form resistant mutants.', 36108336),
('Antibacterial Nanocomposites', 'oxytetracycline- OTc was impregnated in zinc oxide nanoparticles- nZnO', 'OTc also showed MIC of 150 microg ml-1 and for OTc@nZnO it was 7.02 microg ml-1 with faster killing rate (k, -0.95) against oxytetracycline-resistant Aeromonas hydrophila', '', 'This study postulates that [ZnOTc]+ released from OTc@nZnO can escape TetR(E) and TetA(E) resistance proteins and bind at 30S ribosomal subunit with high affinity (<-11.00 kcal mol-1) to exert antibacterial properties. In the recent scenario of recurrent antimicrobial resistance, the develop antibiotic-nanocomposites could come out as potential solution, however further study is required for its feasibility for use in animal health care.', 36123536),
('Antibacterial Nanocomposites', 'polymeric nanoemulsions that encapsulate two hydrophobic antimicrobial agents (eugenol and triclosan) (TE-BNEs)', 'The TE-BNEs are active in an in vivo murine model of mature MDR wound biofilm infections, with 99% bacterial elimination.', '', 'The cationic nanoemulsions efficiently penetrate and accumulate in biofilms, synergistically eradicating MDR bacterial biofilms, including persister cells. the nanoemulsion platform displays excellent biocompatibility and delays emergence of resistance to triclosan. The efficacy of this system coupled with prevention of emergence of bacterial resistance highlight the potential of this combination platform to treat MDR wound biofilm infections.', 35550914),
('Antibacterial Nanocomposites', 'The 2D nanoplatelets are formed using copper ions from the copper surfaces', 'Antibacterial properties of the Cu nanoplatelets are demonstrated in multidrug-resistant (MDR) Escherichia coli, MDR Acinetobacter baumannii, MDR Staphylococcus aureus, E. coli, and Streptococcus mutans.', '', 'Nanoplatelets lead to a marked improvement in antibacterial properties compared to the copper surfaces alone, affecting bacterial cell morphology, preventing bacterial cell division, reducing their viability, damaging bacterial DNA, and altering protein expression. This work presents a robust method to directly assemble copper nanoplatelets onto any copper surface to imbue it with improved antibacterial properties.', 35856392),
('Antibacterial Nanocomposites', 'antibiotic-adjuvant liposomes (NANO@PS-LPs)', 'It was found that NANO@PS-LPs could significantly eliminate mature P. aeruginosa biofilms, effectively kill dispersed bacteria, inhibit the metabolism of survivors and prevent P. aeruginosa adherence. NANO@PS-LPs present a potential nano-strategy to treat stubborn pseudomonal pulmonary infections and overcome correlative drug resistance.', '', 'NANO@PS-LPs possessing negatively-charged surface and good hydrophilicity could easily penetrate through the sputum layer', 35710071),
('Antibacterial Nanocomposites', 'Zinc oxide nanoparticles', 'ZnO-NPs as antibiofilm agent in treatment of S. aureus infections. The MICs of both antibiotics and ZnO-NPs against S. aureus ATCC 6538 tested through broth microdilution assay. The range of molar concentrations of ZnO-NPs and antibiotics used in MIC assay was as follow; ZnO-NPs (6.29 to 0.01 mM); gentamicin (2.14', '', 'ZnO-NPs were capable of decreasing S. aureus cell surface hydrophobicity which could account for observed decrease in bacterial biofilm forming capacity. The expression of biofilm related genes was significantly repressed in ZnO-NPs treated bacteria as compared to untreated cells. ZnO-NPs as adjuvant with other antibiotics targeting S. aureus based on the promising findings obtained herein in order to control infection with this pathogen.', 36221053),
('Antibacterial Nanocomposites', 'ZnO nanocrystal clusters formed by a green structure-tuning synthesis', 'minimal inhibitory concentrations of 0.5 and 0.1 mg/mL against Escherichia coli and Staphylococcus aureus, respectively. attachment of phenolic compounds from olive leaf extract would promote membrane penetration by ZnO nanoparticles, resulting in the improvement of antibacterial activities', '', 'mechanism is related to enhancing contact with bacteria, releasing small ZnO nanoparticles, and generating additional reactive oxygen species, which could aggravate the damage to bacterial cell membrane and eventually lead to bacterial death. developed ZnO clusters have a good prospect in antibacterial applications because of their excellent performance and green fabrication method.', 36576779),
('Antibacterial Nanocomposites', 'encapsulation of hydrophilic metronidazole drug within a hydrophobic ZIF-90 nanoparticle', '', '', 'The antimicrobial proficiency of zinc and metronidazole will expose a synergistic effect in ROS-mediated bacterial inhibition and auto-immunity boosting of normal cells. In vitro, antibacterial activity results revealed that the MI@ZIF-90 nano drug delivery system effectively eradicated human infectious pathogens at the lowest concentrations. the MI@ZIF-90 drug delivery system eradicates the sepsis-causing human pathogenic fungi,', 36509311),
('Antibacterial Nanocomposites', 'scandium-doped phosphate-based glasses (Sc-PBGs)', 'significant inhibition of S. mutans biofilm (1.2 log10 CFU reduction at 6 h) and matrix metalloproteinase-2 (MMP-2) activity', '', 'Since Sc3+ ions might act on various enzymes essential to the biological mechanisms underlying caries, Sc-PBGs could be a promising therapeutic agent against cariogenic bacteria.', 34823880),
('Antibacterial Nanocomposites', 'BSA-CuS nanoparticles', 'as a photothermal reagent to apply photothermal therapy (PTT) to combat drug-resistant bacteria in vitro and subcutaneous abscess in vivo', '', 'BSA-CuS nanoparticles together with 1064 nm NIR laser irradiation could also effectively diminish subcutaneous abscesses caused by drug-resistant bacteria on mice under PTT and depth PTT without causing any serious side effects and organic damage in vivo.', 34719851),
('Antibacterial Nanocomposites', 'green synthesized nanoparticles', 'The result revealed the concentration of 0.0625 mg/ml Ag-NPs was significantly reducing virulence factors in multidrug-resistant E. faecalis without affecting planktonic cell growth.', '', 'Green synthesized Ag-NPs have the ability to combat multi-drug-resistant E. faecalis via reducing virulence factors, which is considered a good approach toward resolving the multidrug resistance crisis.', 36280163),
('Antibacterial Nanocomposites', 'multiple lipid nanoparticles (MLNs) encapsulating the antibiotic moxifloxacin (MOX) - MOX-loaded MLNs were combined with a nanosystem encapsulating a matrix-disruptive agent: N-acetyl-L-cysteine (NAC).', 'a significant decrease in cell viability was observed for free MOX at 0.25 microg mL-1 and higher concentrations, compared with the untreated cells. At the highest concentrations of MOX (1 and 2 microg mL-1), free MOX revealed a potential toxicity effect, with cell viability values below 70%', 'The nanoparticles exhibited low cytotoxicity towards fibroblasts and low hemolytic activity.', 'An increased antibiofilm efficacy was observed when combining the functionalized MOX-loaded MLNs and NAC-loaded nanosystems. Thus, nanosystems as carriers of bactericidal and matrix-disruptive agents are a promising combinatory strategy towards the eradication of S. aureus biofilms.', 36365113);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antibacterial Nanocomposites', 'guanidinium-Ag(0) nanoparticle (AD-L@Ag(0)) hybrid gel', 'Minimum Inhibitory Concentration (MIC) of the AD-L@Ag(0) formulation was tested against Acinetobacter baumannii (25 microg mL-1), Pseudomonas aeruginosa (0.78 microg mL-1), Staphylococcus aureus (0.19 microg mL-1), Klebsiella pneumoniae (0.78 microg mL-1), Escherichia coli (clinical isolate (6.25 microg mL-1)), Klebsiella pneumoniae (clinical isolate (50 microg mL-1)), Shigella flexneri (clinical isolate (0.39 microg mL-1)) and Streptococcus pneumoniae (6.25 microg mL-1).', 'The observed efficacy of this non-cytotoxic therapeutic combination (AD-L@Ag(0)) was found to be better in a small animal BALB/c model.', 'quantification method to establish its potency in inhibition of biofilm formation, as well as eradication of mature biofilms. These effects were attributed to the bactericidal effect of AD-L@Ag(0) on biofilm mass-associated bacteria. AD-L@Ag(0) could be a promising candidate for anti-microbial coatings on surgical instruments, wound dressing, tissue engineering, and medical implants.', 36128224),
('Antibacterial Nanocomposites', 'bone-targeted mesoporous silica nanoparticles', 'The bone-targeted nanoparticles have been thoroughly evaluated in vitro and in vivo, obtaining a notable reduction of the amount of bacteria in the bone in just 24 h after only one dose and paving the way for localized, nanoparticle-mediated treatment of MRSA-caused osteomyelitis.', '', 'These engineered nanoparticles are able to effectively target bone tissue both in vitro and in vivo, showing high biocompatibility and elevated antibacterial effect.', 36341887),
('Bacteriophage Therapy', '(phi)Ef11/(phi)FL1C((phi)36)PnisA', 'The results showed a 10-100-fold decrease in viable cells (CFU/biofilm) after phage treatment, which was consistent with comparisons of treated and untreated biofilm images visualized as max projections of the Z-series.', '', 'A potential alternative to antibiotic therapy is phage therapy. ?Ef11 is a temperate phage that infects strains of E. faecalis.', 27448990),
('Bacteriophage Therapy', 'phiEF24C', 'phiEF24C phage had a shorter latent period and a larger burst size than ordinary tailed phages, indicating that phiEF24C has effective lytic activity against many Enterococcus faecalis strains, including VRE.', '', 'Bacteriophage (phage) therapy is frequently proposed as a potential alternative therapy for infections caused by this bacterium.', 18096017),
('Bacteriophage Therapy', 'bacteriophage isolated by enrichment from hospital sewage sludge.', 'Bacteriophage specific for A. baumannii to resolve wound infection in uncontrolled diabetic rats was evaluated.', '', 'Bacteriophage therapy is a possible alternative treatment for multidrug-resistant (MDR) bacterial infections.', 25411824),
('Bacteriophage Therapy', 'phage ZZ1', 'ZZ1 is highly infectious with a short latent period (9 min) against A. baumanni clinical isolates AB09V, AB0902, and AB0901..', '', 'Bacteriophage therapy is a potential alternative treatment for multidrug-resistant bacterial infections.', 22838726),
('Bacteriophage Therapy', 'Phage ?km18p', 'Combination of phages (?km18p, ?TZ1 and ?314) as a cocktail could lyse all genotype-varying XDRAB isolates.', '', 'CONCLUSION: Infections with XDRAB are extremely difficult to treat and development of a phage cocktails therapy could be a therapeutic alternative in the future.', 23071586),
('Bacteriophage Therapy', 'bacteriophage-therapy (phage) alone or combined with antibiotics', 'In vitro, single-dose phage therapy killed 7 log colony-forming units (CFUs)/g of fibrin clots in 6 hours.: In vivo, single-dose phage therapy killed 2.5 log CFUs/g of vegetations in 6 hours (P < .001 vs untreated controls) and was comparable with ciprofloxacin monotherapy.', '', 'Conclusions: Single-dose phage therapy was active against P. aeruginosa EE and highly synergistic with ciprofloxacin.', 28007922),
('Bacteriophage Therapy', 'bacteriophage TPR7 as antibacterial', 'Bacteriophages can effectively remove clinically resistant E. coli strains', '', 'Currently, with the rapid spread of multi-drug resistant bacteria, phage therapy can be an effective alternative treatment for antibiotic resistant bacteria.', 25834712),
('Bacteriophage Therapy', 'lytic phage EcSw', 'Inhibition of E. coli Sw1 and 0157:H7 strains', '', 'Functional characterization of a novel lytic phage EcSw isolated from Sus scrofa domesticus and its potential for phage therapy.', 25805216),
('Bacteriophage Therapy', 'encapsulation of bacteriophage ?eyfp and the mycobacteriophage TM4 into giant liposomes', '', '', 'Here we report effective encapsulation of the model bacteriophage ?eyfp and the mycobacteriophage TM4 into giant liposomes. Furthermore, we show that liposome-associated bacteriophages are taken up into eukaryotic cells more efficiently than free bacteriophages.', 25937143),
('Bacteriophage Therapy', 'lysin CF-301', 'CF-301 reduced S. aureus by 3-log10 within 30 minutes compared to 6-12 hours required by antibiotics', '', 'Lysin CF-301 is being developed to treat Staphylococcus aureus because of its potent, specific, and rapid bacteriolytic effects.', 24286983),
('Bacteriophage Therapy', 'phages KS12 and KS14', 'B. cenocepacia K56-2-infected Galleria mellonella larvae treated with phage KS12 and low-dose meropenem demonstrated increased survival over controls treated with KS12 or antibiotic alone.', '', 'One proposed alternative treatment is phage therapy, the therapeutic application of bacterial viruses (or bacteriophages). These results suggest that antibiotics can be combined with phages to stimulate increased phage production and/or activity and thus improve the efficacy of bacterial killing.', 25452284),
('Bacteriophage Therapy', 'bacteriophage lysin CHAP(K)', '', '', 'Our findings demonstrate the potential for development of CHAP(K) as an alternative therapeutic against pathogenic staphylococci including MRSA.', 21812876),
('Bacteriophage Therapy', 'Phage lytic enzyme Cpl-1', '', '', 'Recombinant Cpl-1, a phage lysin specific for S. pneumoniae, was evaluated for antimicrobial therapy in experimental pneumococcal meningitis using infant Wistar rats.', 18471063),
('Bacteriophage Therapy', 'Combinations of T4 bacteriophage and cefotaxime', 'The addition of medium (10(4) PFU mL(-1)) and high (10(7) PFU mL(-1)) phage titres reduced the minimum biofilm eradication concentration value of cefotaxime against E. coli ATCC 11303 biofilms from 256 to 128 and 32 ?g mL(-1), respectively.', '', 'Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. The potential application of phage therapy for the control of bacterial biofilms has received increasing attention as resistance to conventional antibiotic agents continues to increase.', 22524448),
('Bacteriophage Therapy', 'Phage Therapy: T4-like phage Bp7', 'For larger yields, its optimal multiplicity of infection (MOI) to infect E. coli was about 0.001. The latent period was 10 to 15 min, and the burst size was 90 PFU/infected cell. It was stable both at pH 5.0 to 10.0 and at 40?C or 50?C for at least 1 h. Bp7 could infect 46% of pathogenic clinical E. coli strains.', '', 'T4-like phage Bp7, a potential antimicrobial agent for controlling drug-resistant Escherichia coli in chickens. Chicken-pathogenic Escherichia coli is severely endangering the poultry industry in China and worldwide, and antibiotic therapy is facing an increasing problem of antibiotic resistance.', 23835183),
('Bacteriophage Therapy', 'Broad-spectrum bacteriophage cocktail', 'The ratio of 10 bacteriophage particles per bacterial cell (MOI=10(1)) was efficient in inhibiting at least 50% of all isolates.', '', 'The use of pathogenic-specific antimicrobials, as proposed by bacteriophage therapy, is expected to reduce the incidence of resistance development.', 20059909),
('Bacteriophage Therapy', 'HydH5, a virion-associated muralytic enzyme of S. aureus bacteriophage vB_SauS-phiIPLA88 (phiIPLA88)', 'high antibiotic activity against early exponential cells, at 45?C and in the absence of divalent cations (Ca2+, Mg2+, Mn2+)', '', 'The virion-associated PG hydrolase HydH5 has lytic activity against S. aureus, which makes it attractive as antimicrobial for food biopreservation and anti-staphylococcal therapy.', 21682850),
('Bacteriophage Therapy', 'bacteriophage lysin, designated LySMP', 'biofilm removal with >80% greater efficacy', '', 'These data suggest that bacteriophage lysin could form part of an effective strategy to treat S. suis infections and represents a new class of antibiofilm agents.', 21984241),
('Bacteriophage Therapy', 'phi MR11', 'In contrast, subsequent intraperitoneal administration of purified phi MR11 (MOI > or = 0.1) suppressed S. aureus-induced lethality.', 'Inoculation with high-dose phi MR11 alone produced no adverse effects attributable to the phage.', 'These results uphold the efficacy of phage therapy against pernicious S. aureus infections in humans and suggest that phi MR11 may be a potential prototype for gene-modified, advanced therapeutic S. aureus phages.', 12599078),
('Bacteriophage Therapy', 'Cpl-1', 'A 2000- microg dose of Cpl-1 reduced pneumococcal titers from a median of log(10) 4.70 CFU/ml to undetectable levels (<log(10) 2.00 CFU/ml) within 15 min.', '', 'We report the use of Cpl-1, the lytic enzyme of a pneumococcal bacteriophage, as an intravenous therapy for pneumococcal bacteremia in a mouse model.', 14573637),
('Bacteriophage Therapy', 'Salmonella-specific bacteriophages UAB_Phi20, UAB_Phi78, and UAB_Phi87', '', '', 'Widespread antibiotic resistance has adversely affected human health and has encouraged the search for alternative antimicrobial agents. The advances in bacteriophage therapy highlight their use in controlling a broad spectrum of food-borne pathogens.', 27148229),
('Bacteriophage Therapy', 'CF-301', 'Potentiate Methicillin-Resistant Staphylococcus aureus Bacteriolysis', '', 'Bacteriophage-derived lysins are cell-wall-hydrolytic enzymes that represent a potential new class of antibacterial therapeutics in development to address burgeoning antimicrobial resistance.', 30670427),
('Bacteriophage Therapy', 'B(theta)-R656 and B(theta)-R1836', 'Activiy against Drug-Resistant Pseudomonas aeruginosa', '', 'Two Novel Bacteriophages Improve Survival in Galleria mellonella Infection and Mouse Acute Pneumonia Models Infected with Extensively Drug-Resistant Pseudomonas aeruginosa', 30824445),
('Bacteriophage Therapy', 'Cocktail of four phages (2-3 ? 109 plaque-forming units/ml of 2003, 2002, 3A, and K; n = 12)', 'As effective as teicoplanin in improving survival and decreasing bacterial load within the lungs of rats infected with methicillin-resistant S. aureus', '', 'Phage therapy is a promising alternative antibacterial strategy.', 31260638),
('Bacteriophage Therapy', 'Cocktail of vB_AbaS_D0 and phage vB_AbaP_D2', 'Activity against Acinetobacter baumannii', '', 'Phage therapy in the murine bacteremia model results showed that the percentage of phage resistant mutant occurrence in the phage D0 or cocktail treatment group was significantly lower than in phage D2 treatment group (P < 0.01).', 31465789),
('Bacteriophage Therapy', 'vB PaeP-SaPL', 'SaPL inhibited Pseudomonas aeruginosa PA-1A growth until 24 h post infection at MOI of 1.', '', 'Based on its efficacy in reducing bacterial growth, selective infectivity against majority of P. aeruginosa strains and its ability to increase survivability in PA-1 challenged mice, SaPL is proposed to be a potential candidate for bacteriophage therapy against difficult to treat MDR P. aeruginosa infections.', 33259872),
('Bacteriophage Therapy', 'phage-platelet hybrid nanoparticle (PPHN)', 'PHNs, which were superior to the BCP1-BGL phages that displayed significantly prolonged anti-bacterial action in vivo against Escherichia coli infection,', '', 'Our work demonstrated a novel strategy in engineering biomimetic phage-based nanoparticles with improved blood retention and anti-bacterial performance and may have implications in phage therapy.', 33500725),
('Bacteriophage Therapy', 'SaGU1', '', '', 'Given that SaGU1 can specifically infect S. aureus from patients with AD, but not S. epidermidis, it may be a strong candidate for developing phage therapy to treat AD.', 33638001),
('Bacteriophage Therapy', 'Engineered anti-CRISPR (Acr) gene-containing phages (EATPs)', 'results showed that the phage titers were negatively correlated with the growth of PA14 and positively correlated with the inhibitory rate.', 'exhibiting low toxicity, suggesting safe and efficient features.', 'EATPs (Engineered Acr gene-containing phages )combined with antibiotics may serve as a novel treatment strategy by which to curb antibiotic resistance P. aeruginosa', 35972246),
('Bacteriophage Therapy', 'phage 1 (MLP1), MLP2, and MLP3, belonging to the Chaseviridae, Myoviridae, and Podoviridae families', 'efficiently infect and kill laboratory reference strains and multidrug-resistant clinical E. coli isolates from patients with diagnosed UTIs, infect intestinal pathogenic E. coli strains (enteroaggregative E. coli) and diffusely adherent E. coli.', '', 'Altogether, our results suggest that these phages may represent an interesting alternative for the treatment of antibiotic-resistant E. coli strains generating urinary tract and/or intestinal infections.', 35171030),
('Bacteriophage Therapy', 'Ev5-WHG phage', 'The combination of zinc acetate and P21 showed increased bactericidal effect on Ev5-WHG. Significantly also, we showed that P21 completely prevented the growth of wild-type WHG40004 in the presence of antibiotics (meropenem and imipenem).', '', 'The results from this study indicate that the analysis of phage resistance signatures during adaptation of bacteria to a lytic phage can inform the choice of agents to work cooperatively with phage to limit and/or reverse resistance. This approach could be important for guiding future successfulPhage therapy.', 35156836),
('Bacteriophage Therapy', 'phage vB_PreP_EPr2 (EPr2)', 'EPr2, a lytic phage with activity against the PDR clinical isolate P. rettgeri MRSN 845308. This study provides evidence that phage treatment is a viable alternative therapeutic option for PDR P. rettgeri infections. Importantly, EPr2 was discovered and isolated in one week from a single environmental source, indicating phages that target clinical P. rettgeri strains can be identified rapidly and on demand. EPr2 demonstrates desirable characteristics for a therapeutic phage, including strong lytic activity against a PDR strain of interest and no genes indicative of a lysogenic lifestyle, drug resistance, or virulence.', '', 'EPr2 was determined to have a narrow host range against a panel of clinical P. rettgeri strains. Despite this fact, EPr2 is a promising lytic phage with potential for use as an alternative therapeutic for treatment of PDR P. rettgeri infections.', 35458437),
('Bacteriophage Therapy', 'lytic bacteriophage TSP', 'The phage efficiently inhibited bacterial growth for up to 12 h at MOI of 1 and 10. TSP phage showed activity against various isolates of MRSA and MSSA, isolated from different clinical samples, with variable antibiotic susceptibility patterns. The bacteriophage TSP showed stability at varying temperatures (25 ', '', 'The strong lytic activity and short latent period in addition to its lytic nature makes it a good candidate forPhage therapy against MRSA infections, if it proves to be effective in in-vivo studies.', 35705576),
('Bacteriophage Therapy', 'in vitro model of human macrophages', 'In this study, we have evaluated, in an in vitro model of human macrophages, the efficacy of a combined treatment consisting of apoptotic body-like liposomes loaded with phosphatidylinositol 5-phosphate (ABL/PI5P) and phiBO1E, a lytic phage specific for the major high-risk clone of KPC-positive MDR-KP. Results show that ABL/PI5P did not affect in a direct manner KKBO-1 viability, being able to reduce only the intracellular KKBO-1 bacterial load. As expected, phiBO1E was effective mainly on reducing extracellular bacilli. Importantly, the combination of both treatments resulted in a simultaneous reduction of both intracellular and extracellular bacilli. Moreover, the combined treatment of KKBO-1-infected cells reduced proinflammatory TNF-alpha and IL-1beta cytokines and increased anti-inflammatory TGF-beta cytokine production.', '', 'Overall, our data support the therapeutic value of a combined host- and pathogen-directed therapy as a promising approach, alternative to single treatments, to simultaneously target intracellular and extracellular pathogens and improve the clinical management of patients infected with MDR pathogens such as MDR-KP.', 35237274),
('Bacteriophage Therapy', 'phage P22', 'The abilities of phage P22 to lyse, eradiate, and disperse the biofilm cells of Salmonella enterica serovar Typhimurium ATCC 19585 (STWT), ciprofloxacin-induced Typhimurium ATCC 19585 (STCIP), S. Typhimurium KCCM 40253 (STKCCM), and multidrug-resistant S. Typhimurium CCARM 8009 (STCCARM) in association with hydrophobicity, auto-aggregation, motility, protein content, extracellular DNA, and depolymerase activity. The affinity to hexadecane was significantly increased in STWT, STKCCM, and STCCARM cells after P22 infection. All strains tested showed relatively higher auto-aggregation abilities in the presence of P22 than the absence of P22. STKCCM showed the greatest auto-aggregative ability (23%) in the presence of P22, while STWT showed the least auto-aggregative ability (9%) in the absence of P22.', '', 'Phages could be considered as promising alternatives for the control of biofilms due to their advantages including enzymatic degradation of extracellular biofilm matrix. The study would provide useful information for understanding the dynamic interactions between phages and biofilms and also designing the effective phage-based control system as an alterative strategy against biofilms.', 34921957),
('Bacteriophage Therapy', 'ethanol extracts of Portuguese propolis combined with gentamicin or with honey, collected from the same apiary as propolis', 'in vitro, plaque assay and minimum inhibitory concentration (MIC) determinations showed that AMX or AMC or cefepime (FEP) inhibited SaP7 plaque formation respectively and SaP7 decreased bacterial susceptibility of Salmonella S7 to AMX, AMC and FEP.', '', 'We discovered the antagonism efficacy of SaP7 combined amoxicillin/potassium clavulanate (AMC) in counteracting Salmonella S7 in piglet-models by bacterial loads in feces and tissues.', 35033842),
('Bacteriophage Therapy', 'phage cocktail with the antibiotic enrofloxacin', 'Enrofloxacin treatment provided 100% survival and the phage cocktail treatment provided 90% survival. However, in terms of mouse recovery, the phage cocktail outperformed enrofloxacin in all measured outcomes. Compared with enrofloxacin treatment, phage treatment led to a faster elimination of enteric pathogens, decreased expression levels of inflammatory markers, increased weight gain, maintenance of a stable relative organ weight, and improved homeostasis of the gut microbiota.', 'However, the effects of phages and antibiotics on organisms when treating intestinal infections have not been precisely studied. Here, we comprehensively compared the therapeutic efficacy of a phage cocktail to the antibiotic enrofloxacin in a mouse model of STEC O157:H7 EDL933 infection.', 'These results provide support for the potential ofPhage therapy to combat enteric pathogens and suggest that phage treatment leads to enhanced recovery of infected mice compared with antibiotics.', 35536028),
('Bacteriophage Therapy', 'T4-like Escherichia phage vB_EcoM-Sa45lw (or Sa45lw)', 'Phage Sa45lw is particularly effective in reducing E. coli O45:H16 both in vitro (MOI = 10) by 5 log and upon application (MOI = 1,000) on the contaminated mung bean seeds for 15 min by 2 log at 25', 'The phage exhibited antimicrobial effects against both pathogenic E. coli and Salmonella without containing virulent or lysogenic genes that could compromise the safety of phage application. In addition, after 15 min of phage treatment, Sa45lw mitigated E. coli O45:H16 on the contaminated mung bean seeds by a 2-log reduction at room temperature, demonstrating the biocontrol potential of non-O157 Shiga toxin-producing E. coli on sprout seeds.', 'These findings highlight the potential of phage application against non-O157 STEC on sprout seeds.', 35107386),
('Bacteriophage Therapy', 'aerosolized phage cocktails', 'The optimal phage cocktails were a combination of different phage families or were constructed by next-evolutionary phage typing with the highest score for the host lysis zone to prevent the development of environmental CRAB phage resistance. The phage infection percentage of the antibiotic-resistant A. baumannii strains was 97.1%, whereas the infection percentage in the antibiotic-susceptible strains was 79.3%. During the phage decontamination periods from 2017 to 2019, the percentage of carbapenem-resistant A. baumannii in test ICUs decreased significantly from 65.3% to 55%. The rate of new acquisitions of CRAB infection over the three years was 4.4 per 1000 patient-days, which was significantly lower than that in the control wards (8.9 per 1000 patient-days) where phage decontamination had never been performed.', '', 'In conclusion, our results support the potential of phage cocktails to decrease CRAB infection rates, and the aerosol generation process may make this approach more comprehensive and time-saving.', 35367880),
('Bacteriophage Therapy', 'phage therapy controlled by inorganic metallic nanomaterials', 'Photothermal heating, performed as a single treatment (15 min) or as two treatments on consecutive days, rapidly reduced the bacterial load and released Zn2+ to promote wound healing. The phage-nanomaterial treatment was significantly more effective than systemic standard-of-care antibiotics, with a >10', '', 'Our results demonstrate thatPhage therapy controlled by inorganic nanomaterials can be a safe and effective antimicrobial strategy in vivo.', 35239330),
('Bacteriophage Therapy', 'En5822', 'The study describes a novel, naturally virulent bacteriophage En5822, from environment capable of lysing multi-drug resistant E. cloacae effectively. The phage could potentially serve as an alternative strategy for treating antibiotic-resistant infections.En5822 is a myovirus with relative pH and thermal stability. En5822 shows a notable reduction of host bacterial biofilm as well as planktonic cultures. Whole genome sequence analysis revealed that the En5822 genome does not contain undesirable temperate lifestyle genes, antibiotic resistance genes and toxin-encoding genes.', '', 'Conclusions: En5822 displays high lytic activity, specificity and biofilm reduction capability. It has a short latent period and high burst size that aid faster activity. Its genomic and physical attributes offer possibilities for its as an alternative antimicrobial for the treatment of drug-resistant E. cloacae infections.', 34927785),
('Bacteriophage Therapy', 'PqsE-RhlR interaction coupled with RNA-seq analyses', 'Biochemical characterization of the PqsE-RhlR interaction coupled with RNA-seq analyses demonstrates that the PqsE-RhlR complex increases the affinity of RhlR for DNA, enabling enhanced expression of genes encoding key virulence factors. These findings provide the mechanism for PqsE-dependent regulation of RhlR and identify a unique regulatory feature of P. aeruginosa QS and its connection to virulence.', '', 'Targeting bacterial behaviors such as QS, rather than bacterial growth, represents an attractive alternative for exploration because such therapies could potentially minimize the development of resistance.', 35019777),
('Bacteriophage Therapy', 'Kluyveromyces lactis and Saccharomyces unisporus isolated from traditional kefir grains', 'Yeasts-fermented killer toxin medium showed Salmonella growth inhibition. The highest alcohol concentration detected was 1.55%, and proteins with known antimicrobial properties including cathelicidin, xanthine dehydrogenase, mucin-1, lactadherin, lactoperoxidase, serum amyloid A protein and lactotransferrin were detected in yeasts fermented killer medium. These proteins are suggested to be responsible for the observed growth inhibition effect of yeasts-fermented killer toxin medium', '', 'Kluyveromyces lactis and Saccharomyces unisporus have anti-salmonella effect comparable to Saccharomyces boulardii strains, and therefore have potential to control Salmonella infection.', 35002451),
('Bacteriophage Therapy', 'endolysin PlyAZ3aT', 'PlyAZ3aT did not improve survival compared to PBS, while survival for vancomycin treated animals was 70% which is a significant improvement when compared to PBS or PlyAZ3aT (p<0.05 each). PlyAZ3aT was not able to control the infection, reflected by the inability to reduce bacterial loads in the CSF, whereas Vancomycin sterilized the CSF and within 25 h. Pharmacokinetic studies indicated that PlyAZ3aT did not cross the blood brain barrier (BBB). In support, PlyAZ3aT showed a peak concentration of 785 microg/ml in serum 2 h after intraperitoneal injection but could not be detected in CSF.', '', 'Conclusion: In experimental pneumococcal meningitis, PlyAZ3aT failed to cure the infection due to an inability to reach the CSF. Optimization of the galenic formulation e.g. using liposomes might enable crossing of the BBB and improve treatment efficacy.', 35472061),
('Bacteriophage Therapy', 'Siphoviridae bacteriophage AXL1 (vB_SmaS-AXL_1) from soil', 'Host range analysis on a panel of 30 clinical S. maltophilia strains reveals a moderate tropism that includes cross-species infection of Xanthomonas, with AXL1 using the type IV pilus as its host surface receptor for infection. Complete genome sequencing and analysis revealed a 63,962 bp genome encoding 83 putative proteins. Comparative genomics place AXL1 in the genus Pamexvirus, along with seven other phages that infect one of Stenotrophomonas, Pseudomonas or Xanthomonas species. Functional genomic analyses identified an AXL1-encoded dihydrofolate reductase enzyme that provides additional resistance to the antibiotic combination trimethoprim-sulfamethoxazole, the current recommended treatment option for S. maltophilia infections.', '', 'This research characterizes the sixth type IV pilus-binding phage of S. maltophilia and is an example of phage-encoded antibiotic resistance.', 35717537),
('Bacteriophage Therapy', 'phage vB_StaM_SA1 (hereinafter as SA1)', 'We identified a novel jumbo phage belonging to Myoviridae family, which can lyse various Staphylococcal strains.Both lys210 and lys211 possessed efficient bactericidal ability, and lys210 could lyse all test strains.', '', 'The results show that phage SA1 and lys210/lys211 could be potentially used as antibiotic agents to treat Staphylococcus infection.', 35572667),
('Bacteriophage Therapy', 'vWUPSU-specific MDR A. baumannii with sacha inchi oil', 'A synergistic antimicrobial effect of the interaction between phage vWUPSU and sacha inchi oil on planktonic cells was observed. The combination of phage and sacha inchi oil significantly inhibited and removed biofilms, compared with the effects of either single treatment.', '', '', 35337089),
('Bacteriophage Therapy', 'Bacillus licheniformis LSG1-1 and Bacillus subtilis LSG2-1', 'The isolated Bacillus licheniformis (LSG1-1) and Bacillus subtilis (LSG2-1) were characterized and performed well in tolerance experiments. In addition, LSG1-1 and LSG2-1 were detected to have higher self-aggregation ability and surface hydrophobicity. In the in vitro adhesion model, LSG1-1 and LSG2-1 showed good adhesion ability and had obvious adhesion inhibitory effect on three pathogens of Aeromonas.', 'The safety of the strains to host fish has also been established.', 'Based on the characteristics observed so far, Bacillus licheniformis LSG1-1 and Bacillus subtilis LSG2-1 could form potential probiotic candidates in the digestive tract of R. lagowskii to help combat diseases in aquaculture.', 35691482),
('Bacteriophage Therapy', '', 'Among 3 phages, ', '', 'Conclusions: As multi-drug resistant bacteria are emerging as a global problem, lytic phages can be an alternative treatment strategy when all available antibiotics fail.', 35615828),
('Bacteriophage Therapy', '?A1122 and PSTPhage therapy (alone or in combination with second-line antibiotics)', 'Phage treatment significantly delayed mortality and limited bacterial proliferation in the lungs. However, the treatment did not prevent bacteremia, suggesting that phage efficiency may decrease in the circulation. Indeed, in vitro phage proliferation assays indicated that blood exerts inhibitory effects on lytic activity, which may be the major cause of treatment inefficiency.', '', 'CombiningPhage therapy and second-line ceftriaxone treatment, which are individually insufficient, provided protection that led to the survival of all infected animals-a synergistic protective effect that represents a proof of concept for efficient combinatorial therapy in an emergency event of a plague outbreak involving MDR Y. pestis strains.', 35458417),
('Bacteriophage Therapy', 'Autographiviridae Phage and Its Combined Effect with Tigecycline', 'To investigate an alternative medical treatment for SSTIs, a broad range lytic Acinetobacter phage, vB _AbP_ABWU2101 (phage vABWU2101), for lysing MDR A. baumannii in associated SSTIs was isolated and the biological aspects of this phage were investigated. Antibiofilm activity of phage vABWU2101 demonstrated good activity against both preformed biofilms and biofilm formation. The combination of phage vABWU2101 and tigecycline showed synergistic antimicrobial activities against planktonic and biofilm cells.', '', 'Scanning electron microscopy confirmed that the antibacterial efficacy of the combination of phage vABWU2101 and tigecycline was more effective than the phage or antibiotic alone. Hence, our findings could potentially be used to develop a therapeutic option for the treatment of SSTIs caused by MDR A. baumannii.', 35215788),
('Bacteriophage Therapy', 'Ab105-2phideltaCI404ad', 'A phage cocktail was formed by combining this phage with the A. baumannii phage vB_AbaP_B3, known to express a depolymerase. Both the individual phages and the phage cocktail showed strong antimicrobial activity against 5 clinical strains and 1 reference strain of A. baumannii tested.', '', 'The antibiofilm activity of the individual phages and the cocktail was assayed. The phage cocktail displayed strong antibiofilm activity.', 35041503),
('Bacteriophage Therapy', 'the combination of the novel antimicrobial "choline kinase inhibitors (ChoKIs)" with a phage cocktail or synthetic phages', 'Inhibition of ChoKs has been proposed as a promising antibacterial strategy. Successful docking of Hemicholinium-3, a choline kinase inhibitor, to the model structure of P. aeruginosa ChoK also supports the use of this inhibitor or its derivatives to inhibit the growth of this microorganism.', '', 'Conclusion: Therefore, the combination of the novel antimicrobial "choline kinase inhibitors (ChoKIs)" with a phage cocktail or synthetic phages as a potential treatment for P. aeruginosa infection has been proposed.', 34961459),
('Bacteriophage Therapy', 'engineered strain of Lactococcus lactis', 'In a mouse model of parenteral ampicillin treatment, oral supplementation with the engineered live biotherapeutic minimized gut dysbiosis without affecting the ampicillin concentration in serum, precluded the enrichment of antimicrobial resistance genes in the gut microbiome and prevented the loss of colonization resistance against Clostridioides difficile.', '', 'Engineered live biotherapeutics that safely degrade antibiotics in the gut may represent a suitable strategy for the prevention of dysbiosis and its associated pathologies.', 35411114),
('Bacteriophage Therapy', 'Polycationic silver nanoclusters (pAgNCs)', '10^6- to 10^7-fold potentiation of vancomycin and 20-fold increase of the sensitizer''s effectiveness were achieved with a combination of a vancomycin derivative and its sensitizer.', '', 'The potential of such derivatization-for-sensitization approach was also supported by the combination''s potent in vivo antimicrobial efficacy in mouse model studies, and the expanded application of such strategy on other antibiotics and sensitizer structures.', 35657057),
('Bacteriophage Therapy', 'Bacteriophages Combined With Subtherapeutic Doses of Flucloxacillin', 'The addition of low-dose flucloxacillin elevated bacterial suppression (? of -5.25 log10 colony forming unit/g [CFU/g] versus treatment onset, P<0.0001) and synergism was confirmed (? of -2.15 log10 CFU/g versus low-dose flucloxacillin alone, P<0.01).', '', 'Conclusions Combining phages with a low-dose standard of care antibiotic represents a promising strategy for the treatment of S. aureus infective endocarditis.', 35043655),
('Bacteriophage Therapy', 'Linker Modification and PEGylation of Vancomycin Conjugates', 'The MICs were assessed as the lowest concentration without visible growth.', '', 'In conclusion, linker modification of vancomycin-polycationic peptide conjugates represents a promising strategy for the modulation of pharmacokinetic behavior while providing potent antimicrobial activity.', 35215272),
('Bacteriophage Therapy', 'Combination of in vivoPhage therapy data with in silico model', 'pneumonia treatment efficacy', '', 'Model-based approaches will foster the deployment of future phage-therapy clinical trials.', 35584666),
('Bacteriophage Therapy', 'C. difficile myoviruses: phiCD08011, phiCD418, phiCD1801, and phiCD2301', 'broad host range activity toward RT 078, infecting 15/16 (93.8%), phiCD1801 could bind to an RT 012 strain only in the presence of a plasmid-borne S-layer cassette corresponding to the slpA allele found in RT 078', '', 'Efforts should be directed toward the isolation of phages with broad host range activity toward defined S-layer cassette types, which could form the basis of an effective phage cocktail for the treatment of CDI.', 35107319),
('Bacteriophage Therapy', 'phage-DAP (daptomycin) -ampicillin (AMP), phage-DAP-ceftaroline (CPT), and phage-DAP-ertapenem (ERT) with HOU503', 'phage-DAP-AMP and phage-DAP-CPT prevented the emergence of DAP and phage resistance', '', 'With HOU503, the combination of phage-DAP-AMP showed the best killing effect, followed closely by phage-DAP-CPT; both showed bactericidal and synergistic effects compared to any single agent (ANOVA range of mean differences 3.99 to 4.08 log10 CFU/mL; p &lt; 0.001).', 35326855),
('Bacteriophage Therapy', 'vB_GEC_EfS_9', 'active against Enterococcus faecium clinical strains', '', 'Obtained results indicate that phage vB_GEC_EfS_9 is a virulent phage which has a very good potential for therapeutic use against strains of E. faecium.', 34648886),
('Bacteriophage Therapy', 'Friunavirus phage vWU2001 in combination with colistin', 'resulted in a significantly greater increase in G. mellonella survival and in bacterial clearance, as compared with that of phage or colistin alone, indicating that the combination was synergistic against CRAB', '', 'The results demonstrated that phage vWU2001 has the potential to be developed as an antibacterial agent.', 35173237),
('Bacteriophage Therapy', 'bacteriophage isolated from raw fish rinse', 'all five phages showed relatively broad host ranges with the bacteriophage originally isolated from raw fish rinse showing lytic activity against all the isolates tested. This phage is suggested to be a member of Siphoviridae family, order Caudovirales', '', 'Apparently, its stability under some of the extreme conditions tested implies its potential to be a candidate for pharmaceutical formulation as an anti-MRSA therapeutic tool.', 35656033),
('Bacteriophage Therapy', 'aerosolized phages (aerophages)', 'Treatment of Pneumonia Due to Methicillin-Resistant Staphylococcus aureus', 'Experimental Study in Rats', 'Conclusions: AerosolizedPhage therapy showed potential for the treatment of MRSA pneumonia in an experimental animal model and warrants further investigation for application in humans.', 33668071),
('Bacteriophage Therapy', '', '', 'two-stage preclinical study using a murine model of severe A. baumannii AB900 bacteraemia', 'This mechanism highlights the clinical potential of usingPhage therapy to target A. baumannii and restore antibiotic activity.', 35537278),
('Bacteriophage Therapy', 'CUB-EPI_14', 'narrow host range against S. epidermidis', '', 'Potent antimicrobial and antibiofilm activities were observed when the phage was tested against a highly susceptible bacterial isolate. These encouraging results open the door to new therapeutic opportunities in the fight against resilient biofilm-associated infections caused by S. epidermidis.', 35746811),
('Bacteriophage Therapy', 'fEg-Eco19', 'active against an antibiotic-resistant clinical Escherichia coli isolate', '', 'Phage therapy, the use of lytic bacteriophages to combat bacterial infectious diseases, is regarded as a promising alternative to the use of antimicrobial agents.', 35399144),
('Bacteriophage Therapy', 'Phage YC#06 and Antibiotics: a Combination Strategy', 'MICs ranging from 1 microgram m/L to 8 microgram m/L by 8 different antibiotics in combination with phage', 'Result suggest that YC#06 could be safely used for therapeutic applications.', 'YC#06 and antibiotic mixtures that include chloramphenicol, imipenem, and cefotaxime in combination could reduce the concentration of effective antibiotics and leading to bacterial resistance', 35736241),
('Bacteriophage Therapy', 'Stnergy virulent phage (phiAB182) with antibiotics', 'In the presence of antibiotics, phage phiAB182 showed the highest synergy (p < 0.0001) with colistin, followed by polymixin B, ceftazidime and cefotaxime', '', 'The findings from this study strongly support the use of phage antibiotic synergy for the successful treatment of biofilm forming MDR A. baumannii infections.', 36174234),
('Bacteriophage Therapy', 'Gp105, a putative lysozyme murein hydrolase from Enterobacter phage myPSH1140', 'The MIC for the Gp105 protein concentrations from 0.125 to 0.5 mg/mL in the case of E. cloacae, K. pneumoniae, P. aeruginosa, S. marcescens, Citrobacter sp., and A. baumannii', '', 'The broad-spectrum activity of Gp105 could be exploited to inhibit or kill pathogenic gram negative bacteria in therapeutic applications.', 35950843),
('Bacteriophage Therapy', 'bacteriophage vB8388 and its synergistic effect with aminoglycosides', 'The combination of phage vB8388 and gentamicin, amikacin, or tobramycin could effectively inhibit the growth of Klebsiella oxytoca strain FK-8388, with a decrease of more than 4 log units within 12 h in vitro. Phage vB8388 showed a strong synergistic effect with gentamicin that could enhance the anti-biofilm effect of vB8388.', 'Bacteriophage able to kill bacteria through different mechanisms without any side effects.', 'The phage + gentamicin combination also showed synergy in vivo in the larval infection model of Galleria mellonella. In conclusion, the findings of this study suggest the potential of phage + antibiotic combination therapy to be used as an alternative therapeutic approach for treating infectious diseases caused by multidrug-resistant bacteria.', 36494020),
('Bacteriophage Therapy', 'phiKZ like jumbo phage', 'Antibiotic susceptibility test results revealed multi-drug resistance in 61 of the total 82 isolated P. aeruginosa strain', '', 'Genetic architecture of phiKZ like jumbo phages infecting P. aeruginosa. The bacteriophages isolated in this study had lytic ability against biofilm-forming and multidrug-resistant P. aeruginosa and could be candidates for further studies towardsPhage therapy.', 36096457),
('Bacteriophage Therapy', 'Two lytic phages, Achr-1 and Achr-2 were isolated from sewage samples', 'phage therapy showed efficacy in reducing bacterial burden of the A. denitrificans subpopulation, shows clinical improvement when phage(s) are used to target refractory Achromobacter infections in the lungs of CF patients', 'Nebulization was tolerated without toxicity,', 'These phages were deployed in the compassionate use treatment of this patient who had declining respiratory status. . Following therapy, the patient achieved stabilization of respiratory status. This report adds to a growing literature that shows clinical improvement when phage(s) are used to target refractory Achromobacter infections in the lungs of CF patients', 36568830),
('Bacteriophage Therapy', 'novel polyvalent phage STP55', 'phage STP55 was able to inhibit single- and dual-species biofilms formation by S. Typhimurium ATCC 14028 and E. coli O157: H7, with a reduction percentage of 51.0%, 47.8% and 52.8%, respectively.', '', 'Broad lytic phages are promising alternatives to conventional technologies for pathogen biocontrol and reducing biofilms. Hence our results demonstrated that STP55 is a promising antimicrobial against Salmonella and E. coli.', 36056994),
('Bacteriophage Therapy', 'phages obtained from hospital sewage against Shigella sonnei (S. sonnei) ATCC', 'To evaluate the specific effects of each phage to inhibit the bacterial growth, 10 microL of lysate phage (at concentration of 8 log PFU/mL) was taken and subjected to 0.5% bacterial LB agar bacterial lawn culture. Following incubation at 37', '', 'Phage cocktails (Shs1, Shs2, Shf1, and Shf2) exhibited higher antimicrobial activity than single phage application against S. sonnei and S. flexneri standard strains.', 36467878),
('Bacteriophage Therapy', 'Phage Cocktails', 'Based on observed CFU of Enterococcus isolates and the titer of each phage, the appropriate volume of isolates and phages were determined at three different MOIs, 0.1, 0.01, and 0.001, to conduct growth curve experiments.', '', 'they show that combinations of two phages are effective at inhibiting growth of several Enterococcus strains over 72 h. Theoretically, using more phages in a cocktail would increase the chances of choosing phages that displayed synergy in reducing the host growth.', 35762793),
('Bacteriophage Therapy', 'Novel Klebsiella Phage PG14', 'Phage PG14 showed more than a 7-log cycle reduction in K. pneumoniae planktonic cells after 24 h of treatment at a multiplicity of infection (MOI) of 10.', '', 'Phage PG14 illustrated a lytic ability covering a variety of bacterial pathogens, including K. pneumoniae, P. aeruginosa, and E. coli, which all can cause nosocomial infections. The promising results of this study nominate phage PG14 as a potential candidate forPhage therapy.', 36374021),
('Bacteriophage Therapy', 'bacteriophage JHA', 'The pH and thermal stability testing showed that JHA phage activity was highest at pH7 and highest activity was found at 37', '', 'The bacterial growth reduction assay exhibited that JHA phage had high adsorption rates and could rapidly inhibit bacterial growth. All the characteristics of JHA phage possess lytic activity against A. baumannii strains and exhibit novel candidates to use as an alternative competitor to antibiotics in controlling such infections.', 36451560),
('Bacteriophage Therapy', 'The two phages were used together as a cocktail, as this combination of SenM-2 and vB_Sen-TO17', '', 'combination of SenM-2 and vB_Sen-TO17 has been found recently to be effective against S. enterica strains and safe for eukaryotic cells in in vitro studies and in experiments with the Galleria mellonella animal model', 'Phage therapy with the cocktail of vB_SenM-2 and vB_Sen-TO17 bacteriophages was as effective as the use of either enrofloxacin or colistin in elimination of experimentally provoked infection of chickens with S. Typhimurium.', 35992162),
('Bacteriophage Therapy', 'phage cocktail with three lytic phages (phage POP12) or flagella (phages POP15 and POP17)', 'The application of the phage cocktail to napa cabbage (Brassica rapa subsp. pekinensis) resulted in significant growth retardation of P. carotovorum subsp. carotovorum (P < 0.05) and prevented the symptoms of soft rot disease.', '', 'these results show that the phage cocktail developed here, which targets two different types of phage receptors, provides an effective strategy for controlling P. carotovorum subsp. carotovorum in agricultural products, with a potential ability to attenuate P. carotovorum subsp. carotovorum virulence.', 36165651),
('Bacteriophage Therapy', 'new endolysin from the Salmonella phage XFII-1,', 'The endolysin XFII exhibited high bactericidal activity at a concentration of 0.5 microg/mL against many Gram-negative bacteria, including Salmonella, E. coli, Acinetobacter baumannii, and Klebsiella pneumoniae.', '', 'The novel globular endolysin XFII was screened and successfully expressed in E. coli BL21. Endolysin XFII exhibits a broad lysis spectrum, a rapid and strong bactericidal activity, good stability at high temperatures and under eutrophic conditions. Combined with chitosan, XFII could spontaneously lyse Gram-negative bacteria without pretreatment.', 35999567),
('Bacteriophage Therapy', 'coliphages phiEC-S-21 and phiEC-OE-11 belonged to Myoviridae, whereas coliphage phiEC-S-24 belonged to the Autographiviridae family derived from the Podoviridae family.', 'All three coliphages possessed diverse infective and lytic mechanisms, viz., lytic murein transglycosylase, peptidoglycan transglycosylase, n-acetylmuramoyl-l-alanine amidase, and putative lysozyme against E. coli', '', 'the three coliphage genomes showed neither the presence of antibiotic resistance genes nor virulence genes, which makes them desirable candidates for use inPhage therapy-based applications.', 36504140),
('Bacteriophage Therapy', 'new phage against H. pylori, named HPy1R', 'characteristics and properties of HPy1R indicate the use ofPhage therapy in the control of infections by H. pylori one of the major human gastric pathogens.', '', 'HPy1R remained stable over a wide range of pHs and temperatures, and despite the small loss observed in the in vitro gastric phase, the results seem to be encouraging. The discovery of new and well-characterized phages, as well as the identification and characterization of endolysins, against H. pylori will pave the way for the use ofPhage therapy as an alternative strategy to control H. pylori infections.', 35887231),
('Bacteriophage Therapy', 'coliphage P762', 'Coliphage P762 can lyse Shiga toxin-producing Escherichia Coli serotypes O157 and non-O157 (17/39), Avian pathogenic E. coli covered serotype O78, O83, and O9 (5/19), and other pathogenic Escherichia coli. The one-step curve of P762 exhibited three bursts of growth stage: two rapid and one slow stage. Furthermore, the first rapid burst size is 80 CFU/PFU, the burst size of the slow stage is 10 CFU/PFU, and the second rapid burst size is about 990 CFU/PFU.', '', 'In vitro antibacterial tests revealed that P762 has high bactericidal activity in lettuce leaves contaminated with STEC. In conclusion, phage P762 might be employed in the future to prevent and control pathogenic Escherichia coli.', 35705841),
('Bacteriophage Therapy', 'monoclonal antibodies by phage display', 'antibody-based inhibitor against mycobacterium tuberculosis', '', 'phage display antibody selection managed to isolate a scFv (single chain fragment variable clone against) the rICL (recombinant Isocitrate lyase) with good specificity. The preliminary inhibition of rICL activity was carried out with the continuous LDH-coupled enzymatic assay showed that a-rICL-C6 monoclonal antibody was able to remit the rICL enzymatic activity with an estimated IC50 of 10 mg/mL.', 35987135),
('Bacteriophage Therapy', 'synergistic combination of an antibacterial natural product allicin and a newly isolated bacteriophage, named BD523, was constructed', '', '', 'allicin interacts with bacterial DNA in the groove region by inserting itself into the DNA double helix and, subsequently, disrupts the bacterial DNA by cleaving phosphate diester bonds of deoxynucleotides. Further, BD523 destroys the cell wall and membrane of bacteria by synthesizing lyase proteins, including holin and endolysins.', 36472428),
('Bacteriophage Therapy', 'A novel bacteriophage CUB19 specific to the bacterial species Stenotrophomonas maltophilia', 'This phage presented a narrow host range, infecting four out of the 40 S. maltophilia strains tested and none of the P. aeruginosa strains,', '', 'combining phage CUB19 with higher rather than lower antibiotic doses generally led to an improved antimicrobial effect, These are encouraging indications for its application as a targeted therapeutic agent against resilient biofilm-associated Stenotrophomonas infections.', 36297651),
('Bacteriophage Therapy', 'encapsulation of lysins (Phage-derived products) in liposomes as a delivery system', '', '', 'The application of the encapsulated lysins to the model P. aeruginosa led to a reduction in cell viability and resulted in cell lysis. these enzybiotics following their incorporation in liposomes were able to potentiate their antibacterial effect against the Gram-negative bacteria P. aeruginosa, used as the model.', 36077542),
('Bacteriophage Therapy', 'CAM-21, a novel lytic phage', 'The growth of E. coli O157:H7 was effectively controlled in milk, ground beef and baby spinach at MOIs of 1000 and 10,000. CAM-21 significantly (P = 0.05) reduced the bacterial counts of the treated foods, ranging from 1.4-2.0 log CFU/mL in milk to 1.3-1.4 log CFU/g in ground beef and baby spinach.', '', 'These findings suggest that the lytic phage, CAM-21, is a potential candidate for controlling E. coli O157:H7 contamination in foods.', 36444789);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Bacteriophage Therapy', 'Brochothrix phage ADU4', 'A newly isolated phage with lytic ability against B. thermosphacta . The optimal MOI value of the phage was determined as 0.1.', '', 'The effects of Brochothrix phages on biofilms have been studied. Phage ADU4 significantly reduced the B. thermosphacta (both planktonic and biofilm forms) in vitro. Phage ADU4 is a promising biocontrol candidate for the control of B. thermosphacta contamination in meat and meat products.', 36064042),
('Bacteriophage Therapy', 'Two Newly Isolated Enterobacter phage Entb_43 (174 kbp, acc. No. ON585039) and Enterobacter phage Entb_45 (173 kbp, acc. No. ON630910).', 'The most effective phage-to-bacteria ratios (MOI = 0.01 and MOI = 0.001) for both the phage amplification ctivity against multidrug-resistant clinical isolates of Enterobacter spp. (E. cloacae, E. hormaechei, and E. kobei),', '', 'study determining the possibility of using our phages in the treatment of UTI, we decided to evaluate their stability in a urine sample. The results turned out to be promising as bacteriophages. this paper strongly suggest the therapeutic potential of the presented Enterobacter-specific bacteriophages.', 35891499),
('Bacteriophage Therapy', 'phage-antibiotic combinations (PAC) (P. aeruginosa phages, representative strains, R10266 and R9316)', 'PAC resulted in regained and improved antibiotic susceptibility to ciprofloxacin (MIC 2 to 0.0625) and meropenem (MIC 32 to 16), respectively, in R9316.', '', 'Phage resistance was prevented or reduced in the presence of several classes of antibiotics and outer membrane vesicle (OMV) production was reduced in the presence of phage for both strains, which was associated with significantly improved bacterial eradication. This study identifies novel bactericidal phage-antibiotic combinations capable of thwarting resistance development in MDR and XDR P. aeruginosa strains.', 35652690),
('Bacteriophage Therapy', 'Autographiviridae bacteriophage IME184', 'Phage IME184 is a promising biological agent that infects Klebsiella pneumoniae', '', 'Phage IME184 can be used in future phage therapies.', 35868353),
('Bacteriophage Therapy', 'lytic virus phi2013', 'data showed that phage phi2013 can efficiently inhibit E. coli growth in the tested foods at 4', '', 'We therefore conclude that phage phi2013 or cocktails containing phi2013 may be used as an antimicrobial agent in extending the shelf-life of food products by effectively controlling the growth of E. coli.', 36194307),
('Bacteriophage Therapy', 'Sb-1 Phage in combination with antibiotics', 'Sb-1 has been shown to be active against ', '', 'the potential activity of Sb-1 treatment in combination with antibiotics against S. aureus cells colonizing stainless steel implants has been demonstrated in vivo.', 36498843),
('Bacteriophage Therapy', 'combination of phages and ciprofloxacin.', 'The in vivo efficacy of the combination of ciprofloxacin (a single oral dose simulating 750 mg in human) with phages (a single intravenous administration of 1010 PFU) was tested in an experimental P. aeruginosa endocarditis in rats', '', 'We demonstrated that dosing schedule of phages first and the antibiotic second prevent the selection of resistant bacteria. These results demonstrate that combination efficacy relies on a strong initial reduction of the bacterial population by phages followed by antibiotics before any resistant arise.', 36135376),
('Bacteriophage Therapy', 'Bacteriophage', 'beat severe antibiotic-resistant strains', '', 'New research is now beginning to show thatPhage therapy may become much more broadly used as treatments for diseases and other infections.', 36301810),
('Bacteriophage Therapy', 'Pseudomonas phages AP025 and AP006', 'When treated with the phage AP025 at an MOI of 1 (8 ', 'mice were injected only with phages at MOI values of 1, 10 or 100 as single doses (i.p.). In this control group, we observed a 100% survival rate, indicating the absence of any toxic substance in the phage preparation.', 'Infected mice which received the higher concentrations of phage, AP025 and AP006, were fully protected (100%) and showed no signs of infection. This study highlights the efficacy of using a single dose of phages to restore mice from bacteremia.', 35909125),
('Bacteriophage Therapy', 'four-phage cocktail- phages GSP162, GSP193, GSP001, and GSP032', 'Our analysis shows that the four-phage cocktail was more effective than each phage alone in killing S. Enteritidis in vitro.', '', 'we observed that the combination of all four phages could continually inhibit bacterial growth for at least 24 h, and the bacterial cell density (optical density at 600 nm [OD600]) remained less than 0.75 until 68 h. These results demonstrated that the four-phage combination was effective in delaying the emergence of phage-resistant mutants. we developed a novel phage cocktail consisting of four phages targeting different host receptors. which could delay the emergence of phage-resistant bacterial mutants. Our mouse model of S. Enteritidis infection also demonstrated that phage cocktail treatment was more effective than single-phage treatment in an animal model.', 36165776),
('Bacteriophage Therapy', 'BFC1 (', '', '', '', 36175406),
('Bacteriophage Therapy', 'Phage therapy', '(bacterio)phages for the treatment of bacterial infection', 'The use of (bacterio)phages for the treatment of bacterial infections (phage therapy) seems safe', 'phage therapy is regaining interest, encouraged by published cases treated successfully with personalized phage combinations as well as significant advances at a preclinical level.', 36382975),
('Bacteriophage Therapy', 'Two enterococci phages (MDA1 and MDA2)', 'targeting several VREfm and VSE strains. The phage cocktail was able to eradicate all the tested bacterial strains(VREfm', 'safety for VREfm infection in the greater wax moth Galleria mellonella model. No virulence-associated genes, antibiotic resistance genes or integrases were detected in the phages'' genomes, rendering them safe to be used in an in vivo model.', 'Phages may constitute an alternative strategy to manage resistant bacteria such as VREfm in an innovative, safe, and natural way. Our results highlight the feasibility and the potential success of these phages in inhibiting VREfm in in vitro and in vivo models.', 36015218),
('Bacteriophage Therapy', 'engineered ? phage (E?) and wild-type ? phage (wt?)', 'In vitro experiments showed that the E? suppressed the growth of enterohemorrhagic Escherichia coli (EHEC) up to 18 h compared with only 6 h with the wt?; at the multiplicity of infection (MOI) of 10, the E? killed the EHEC cells with ~100% efficiency and did not affect the growth of other laboratory- and human-gut isolated E. coli strains.', '', 'Mouse experiments further confirmed the enhanced and strain-specific killing of the E? to EHEC, while the overall mouse gut microbiota was not disturbed. Our methods can be used to target other genes that are responsible for antibiotic resistance genes and/or human toxins, engineer other phages, and support in vivo application of the engineered phages.', 35876591),
('Bacteriophage Therapy', 'lysin Abp013', 'Abp013 treatment, 400, 800, and 1600 Microgram/mL of Abp013 were able to reduce the 3 h biofilm CFU by 2.65-log (99.78%), 2.23-log (99.42%), and 1.51-log (96.93%), respectively, compared to the untreated control. The activity of the lysin against the 3 h A. baumannii biofilms were further verified using confocal microscopy and LIVE/DEAD staining, which indicated that 96.86% of the cells within the biofilm were dead.', 'Abp013 is less effective in treating mature biofilms at a 24 h time point, but higher concentrations of the lysin (800', 'These results highlight the intrinsic bacteriolytic property of Abp013, suggesting the promising use of Abp013 as a novel therapeutic agent.', 35203772),
('Bacteriophage Therapy', 'B. subtilis strains CH311 and S3B', 'Both strains decreased ESBL-E. coli titers by 4 log10 CFU L-1 in an in vitro model of gut content, whereas the B. subtilis CU1 strain did not. In a murine model of intestinal colonization by ESBL-E. coli, CH311 and S3B did not decrease fecal titers of ESBL-E. coli. Ten sequences of putative antimicrobial peptides were identified in the genomes of CH311 and S3B, but not in CU1.', 'Despite strong in vitro activities of new B. subtilis strains against ESBL-E. coli, intestinal colonisation was not altered by curative Bacillus treatment even if their spores proved to germinate in the gut. Thus, this work underlines the importance of in vivo experiments to identify efficient probiotics.', 'Conclusions: Two new B. subtilis strains showed strong in vitro activity against ESBL-E. coli.', 34679216),
('Antifungal Peptides', '4-methoxy-2,3,6-trimethylbenzensulfonyl-substituted D-octapeptide KN20', 'IC(50) 4 microM) and chemosensitized AD/PDR5(+) to FLC, itraconazole, and ketoconazole, also inhibited the ATPase activity of other ABC transporters, such as Candida albicans Cdr1p (IC(50), 30 microM) and Cdr2p (IC(50), 2 microM), and chemosensitized clinical isolates of pathogenic Candida species and S. cerevisiae', '', 'Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative', 15047528),
('Antifungal Peptides', '(Ctn[1-14]) and (Ctn[15-34]), C-terminal peptide fragment of crotalicidin', 'Active against pathogenic yeasts, including several Candida species, both clinical isolates and standard strains, with MICs as low as 5 microM', 'Less cytotoxic to healthy HK-2 cells and less hemolytic to human erythrocytes than the standard-of-care amphotericin B', ' Altogether, Ctn and its fragments, particularly Ctn[15-34], are promising leads,  either alone or in combined regimen with amphotericin B, for the treatment of fungal diseases. ', 27876749),
('Antifungal Peptides', 'A-192411: a novel fungicidal lipopeptide (II)', 'Efficacy demonstrated against Candida albicans', '', ' In vivo characterization of A-192411: a novel fungicidal lipopeptide (II).  The ability of the novel antifungal cyclic hexalipopetide A-192411 to treat fungal infections in rodents is presented.', 12565958),
('Antifungal Peptides', 'Analogous cyclic decapeptides produced by Bacillus aneurinolyticus', 'Tyrocidine peptide complex (Trc mixture) and purified tyrocidines exhibited minimum inhibition concentrations below 13 microg ml(-1) (around 10 microM) and was significantly more potent than that of the commercial imidazole fungicide, bifonazole', '', ' Inhibition of agronomically relevant fungal phytopathogens by tyrocidines, cyclic antimicrobial peptides isolated from Bacillus aneurinolyticus.', 24996824),
('Antifungal Peptides', 'Antimicrobial peptides from norepinephrine-stimulated skin secretions from the foothill yellow-legged frog Rana boylii [Brevinin-1BYa (FLPILASLAA10KFGPKLF CLV20TKKC), peptides from ranatuerin-2 family temporin family ]', 'Brevinin-1BYa particularly potent against C. albicans [minimal inhibitory concentration (MIC) = 3 microm] and also active against Escherichia coli (MIC = 17 microm) and Staphylococcus aureus (MIC = 2 microm)', 'Strong hemolytic activity (HC50 = 4 microm)', ' Isolation of peptides of the brevinin-1 family with potent candidacidal activity  from the skin secretions of the frog Rana boylii.  The emergence of strains of the human pathogen Candida albicans with resistance to commonly used antibiotics has necessitated a search for new types of antifungal agents.', 14531844),
('Antifungal Peptides', 'APS-1 (Glu, Asp, Tyr, Ser, Thr, Pro, Leu, Ile, Val and an unknown amino acid)', 'Antifungal, strong inhibition on the germination of spores of the phytopathogens tested', '', 'Purification and characterization of a novel antifungal peptide APS-1 produced by Bacillus cereus', 12555574),
('Antifungal Peptides', 'Beta-peptide with fluconazole or ketoconazole', 'Enhanced the biological activity of these azoles in planktonic and biofilm Candida, and also in a fluconazole-resistant strain', 'On vitro cytotoxicity of the dual treatment was evaluated towards the human hepatoma cell line, HepG2', ' Natural antimicrobial peptides, AMPs, in  combination with other antifungal agents are a promising avenue to address the prevailing challenges.', 26470850),
('Antifungal Peptides', 'biofunctionalized polyelectrolyte multilayered films using CGA 47-66, chromofungin', 'Inhibit the growth of yeast Candida albicans by 65% and completely stop the proliferation of filamentous fungus Neurospora crassa', 'Cytotoxicity assessed by growing human gingival fibroblasts at its surface', 'Antifungal coating by biofunctionalized polyelectrolyte multilayered films.', 15992921),
('Antifungal Peptides', 'CD101', 'Potent activity against all Candida isolates tested, including azole-resistant strains, MICs were slightly higher at pH 4 versus 7 and at 48 versus 24 h of incubation', '', 'In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis', 28158577),
('Antifungal Peptides', 'Cilofungin (LY-121019), semi-synthetic lipopeptide ', 'The minimal inhibitory concentrations of cilofungin for C. albicans (N = 50) ranged from 0.039 to 5.0 micrograms/ml with a geometric mean of 0.47 micrograms/ml.: The same results were  obtained with C. tropicalis but one strain showed higher resistance (40 micrograms/ml) suggesting an Eagle effect.: The MIC for T. glabrata ranged from 5.0-40.0 micrograms/ml.: C. parapsilosis and C. krusei were less susceptible (5.0-40.0 micrograms/ml).', '', ' Susceptibility of Candida species to cilofungin (LY-121019).  Torres-Rodriguez JM, Carrillo-Mu?oz A, Gallach-Bau C, Madrenys N.  The antifungal activity of a new semi-synthetic lipopeptide named cilofungin (LY-121019) was studied in vitro on 102 strains of Candida and Torulopsis glabrata.', 2779613),
('Antifungal Peptides', 'D-beta-naphthylalanine-substituted antimicrobial peptide [P-113,  Ac-KWRRWVRWI-NH(2), Pac-525, D-Nal-Pac-525]', ' D-Nal-Pac-525 has the potential of becoming a promising antifungal agent, especially for fungal pathogens with intrinsic resistance to fluconazole', '', ' Increased potency of a novel D-beta-naphthylalanine-substituted antimicrobial peptide against fluconazole-resistant fungal pathogens.', 19538482),
('Antifungal Peptides', 'Dipeptide-based amphiphiles', 'Remarkable growth inhibiting activity on several Gram-positive (minimum inhibitory concentration (MIC)=0.1-10 microg/mL) and Gram-negative (MIC=5-150 microg/mL) bacteria as well as on fungus (MIC=1-50 microg/mL)', '', ' The results show that the rational designing of short peptide-based cationic amphiphiles might serve as a promising  strategy in the development of antimicrobial agents with greater cell specificities.', 19081951),
('Antifungal Peptides', 'DS6', 'DS6 is membrane lytic and exhibits antibiofilm activity against Candida tropicalis', '', 'In conclusion, DS6 may have utility as an alternative antifungal therapy for C.?tropicalis.', 28120548),
('Antifungal Peptides', 'FK463', 'MIC range, <==0.0039 to 2 microg/ml against Candida species and <==0.0039 to 0.0313 microg/ml against Aspergillus species also caused a 99% reduction in viability of  C. albicans at concentrations above 0.0156 microg/ml', '', ' In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi.    The in vitro antifungal activity and spectrum of FK463 were compared with those of amphotericin B, fluconazole, and itraconazole by using a broth microdilution method specified by National Committee for Clinical Laboratory Standards document M27-A (National Committee for Clinical Laboratory Standards, Wayne, Pa., 1997).', 10602723),
('Antifungal Peptides', 'FK463', ' MIC values of 0.010, 0.011 and 0.015 microg/ml against FLCZ susceptible, FLCZ susceptible-dose dependent and FLCZ resistant Candida albicans, respectively, Aspergillus fumigatus strains were inhibited  at 0.0078 microg/ml or lower concentrations', '', ' In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.   The antifungal activities of FK463 against various pathogenic fungi were tested by standard broth microdilution methods, and compared with the activities of five currently available antifungal agents; viz., fluconazole (FLCZ), itraconazole, miconazole, amphotericin B and flucytosine.', 11132964),
('Antifungal Peptides', 'Hemocyanin-derived (poly)peptides?', '', '', ' Antifungal peptides are generated from the C terminus of shrimp hemocyanin in response to microbial challenge.  We report here the isolation from plasma of two penaeid shrimp species of novel peptides/polypeptides with exclusive antifungal activities.', 11598107),
('Antifungal Peptides', 'Histatin-5 Bioadhesive Hydrogel Formulation', 'Treatment for Oral candidiasis (OC), caused by the fungal pathogen Candida albicans', '', ' Histatin-5 (Hst-5) specifically has exhibited potent anticandidal activity indicating its potential as an antifungal agent.', 26596951),
('Antifungal Peptides', 'Human lactoferrin (hLF) and synthetic peptides representing N terminal cationic domains hLF(1-11) and hLF(21-31)', 'hLF(1-11) more effective in killing fluconazole-resistant Candida albicans than hLF(21-31) and much more effective than lactoferrin', '', ' Candidacidal activities of human lactoferrin peptides derived from the N terminus.   In light of the need for new antifungal agents, the candidacidal activities of human lactoferrin (hLF) and synthetic peptides representing the first, hLF(1-11), and second, hLF(21-31), cationic domains of its N terminus were compared.', 11083624),
('Antifungal Peptides', 'Lactoferrin peptide (FKCRRWQWRM, Peptide 2; Pep2)', 'Enhance the candidacidal activity of antifungal drugs by promoting anion channel-associated ATP efflux from Candida cells and decreasing efflux of the drugs,', '', ' Antimicrobial peptides enhance the candidacidal activity of antifungal drugs by promoting the efflux of ATP from Candida cells.  The examined peptides, especially Pep2 and Hst5, enhance the candidacidal activity of antifungal drugs by promoting anion channel-associated ATP efflux from Candida cells and decreasing efflux of the drugs, which could be useful clinical applications.', 16291868),
('Antifungal Peptides', 'Lipopeptide Pal-Lys-Lys-NH(2) (PAL)', 'MICs ranged from < or = 0.25 to  > 16 microg mL(-1)', '', ' In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes.   BACKGROUND: An increasing number of antimycotics have become available for the treatment of dermatophytoses; however, there are reports suggesting recalcitrance to therapy or resistance of a dermatophyte against conventional treatment.', 19438437),
('Antifungal Peptides', 'Lipopeptides synthesized by conjugating dodecanoic acid (DDA) to the N-termini of 12-mer peptides LXXLLXXLLXXL (L(6)X(6), X = Lys, His, Arg, and all the leucines are d-amino acid enantiomers)', 'Active against both bacteria and fungi ', '', ' pH-dependent antifungal lipopeptides and their plausible mode of action. In this study we synthesized a  new group of lipopeptides by conjugating dodecanoic acid (DDA) to the N-termini of 12-mer peptides LXXLLXXLLXXL (L(6)X(6), X = Lys, His, Arg, and all the leucines are d-amino acid enantiomers) and investigated their pH-dependent biological activity and a plausible mode of action by using model phospholipids mimicking bacterial, mammalian, and fungal membranes.', 16008362),
('Antifungal Peptides', 'LTX109 (arginine-tertbutyl tryptophan-arginine-phenylethan)', 'Disrupt plasma membrane integrity. S. cerevisiae', '', ' The synthetic amphipathic peptidomimetic LTX109 is a potent fungicide that disturbs plasma membrane integrity in a sphingolipid dependent manner.  ', 23874964),
('Antifungal Peptides', 'LY121019, a new echinocandin derivative', 'Strong anti-Candida activity (in particular against Candida albicans)', 'Low experimental toxicity', ' A study of the antifungal activity of LY121019, a new echinocandin derivative.    LY121019 is a cyclic peptide antibiotic of the echinocandin group, which is characterized by strong anti-Candida activity (in particular against Candida albicans) as well as by low experimental toxicity.', 3288366),
('Antifungal Peptides', 'LY303366', ' For amphotericin B-resistant (AF65), LY303366 at 10 and 25 mg/kg/day was superior to amphotericin B at 2 and 5 mg/kg/day in reducing tissue  colony counts (P = 0.01 to 0.003), and for B-susceptible (AF210), amphotericin B at 5 mg/kg/day and at 5 mg/kg in four doses was more effective than all four regimens of LY303366 in reducing renal culture counts (P = 0.01 to 0.0001).', '', ' Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis.   LY303366 is a novel antifungal echinocandin with excellent in vitro activity against Aspergillus spp.', 9559799),
('Antifungal Peptides', 'MK-0991  (L-743,872)', 'Growth kinetic studies of MK-0991 against Candida albicans and Candida tropicalis isolates showed that the compound exhibited fungicidal activity (i.e., a 99% reduction in viability) within 3 to 7  h at concentrations ranging from 0.06 to 1 microg/ml (0.25 to 4 times the MIC)', '', ' In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991  (L-743,872).   The echinocandin MK-0991, formerly L-743,872, is a water-soluble lipopeptide that has been demonstrated in preclinical studies to have potent activity against Candida spp., Aspergillus fumigatus, and Pneumocystis carinii.', 9371328),
('Antifungal Peptides', 'MUC7 D1', 'Activity against azole-sensitive and azole-resistant C. albicans strains', '', ' The MUC7 D1 candidacidal activity was assessed against azole-sensitive and azole-resistant C. albicans strains and was found, unlike that of the MUC7 D1-15mer, to be comparable with that of Hsn-5, indicating that in addition to Hsn-5, MUC7 D1 could provide an attractive alternative to the classical antifungal agents.', 11095181),
('Antifungal Peptides', 'Mucin MUC7-derived peptide and histatin 5', 'Evaluated efficacy in vivo using the experimental model of murine vulvo-vaginal candidiasis', '', ' Efficacy of human salivary mucin MUC7-derived peptide and histatin 5 in a murine  model of candidiasis.  MUC7 16-mer (residues 36-51 of human salivary mucin, MUC7) and histatin 5 possess potent in vitro antifungal activity.', 14659657),
('Antifungal Peptides', 'Novel Peptides from Skins of Amphibians', 'These AMPs contain a C-terminus cyclic motif and most of them show obvious antimicrobial activities against 18 standard and clinically isolated strains of bacteria, including 4 Gram-positive bacteria, 11 Gram-negative bacteria, and 3 fungus.', '', ' Novel Peptides from Skins of Amphibians Showed Broad-Spectrum Antimicrobial Activities.', 26452973),
('Antifungal Peptides', 'P11-6, 11-residue peptide ', 'Activity against fluconazole-resistant Candida albicans', '', ' Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans.', 28105725),
('Antifungal Peptides', 'Pantinin-1, Pantinin-2 and Pantinin-3', 'All the three peptides possess relatively strong activities against Gram-positive bacteria and a fungus, but have very weak antimicrobial activities against Gram-negative bacteria', '', ' Three new antimicrobial peptides from the scorpion Pandinus imperator.', 23624072),
('Antifungal Peptides', 'PMAP-36-derived peptides (18-mer peptide RI18)', 'Exhibited excellent antimicrobial activity against both bacteria and fungi', 'Low haemolytic activity', ' Meanwhile, modification of AMPs is a promising strategy for developing novel antimicrobials to overcome drug-resistance. ', 27251456),
('Antifungal Peptides', 'Secreted lipopeptide fractions from Bacillus UCMB5113, together with synthetic peptide mimics', 'Suppressed growth of several fungal pathogens infecting Brassica plants', '', ' Analysis by mass spectrometry identified the most potent compounds as novel linear forms of antifungal fengycins, with synthetic peptide mimics confirming the biological activity.', 28961818),
('Antifungal Peptides', 'Synthetic CAP37 peptide  analogs', 'Three of the peptides demonstrated strong antifungal activity for C. albicans, including fluconazole-resistant isolates of C. albicans and were active against C. guilliermondii, C. tropicalis, C. pseudotropicalis, C. parapsilosis, and C. dubliniensis', '', ' Candidacidal activity of synthetic peptides based on the antimicrobial domain of  the neutrophil-derived protein, CAP37.   The primary bactericidal domain of CAP37, a cationic antimicrobial protein with potent activity against Gram-negative organisms was previously shown to reside between amino acids 20 through 44 (NQGRHFCGGALIHARFVMTAASCFQ) of the native protein.', 19626550),
('Antifungal Peptides', 'Synthetic cationic antimicrobial tripeptides', 'Strong general antifungal properties at low micromolar inhibitory concentrations', '', ' Synthetic mimics of antimicrobial peptides are emerging as a promising class of compounds for antifungal treatment.', 27576445),
('Antifungal Peptides', 'Synthetic killer peptide (KP)', 'Impairs Candida albicans biofilm', '', ' The synthetic killer peptide KP impairs Candida albicans biofilm in vitro. This study provides the first evidence on the KP effectiveness against C. albicans biofilm, suggesting that KP may be considered as a potential novel tool for treatment and prevention of biofilm-related C. albicans infections.  ', 28704490),
('Antifungal Peptides', 'Synthetic peptides Mo-CBP3-PepI (CPAIQRCC), Mo-CBP3-PepII (NIQPPCRCC), Mo-CBP3-PepIII (AIQRCC), RcAlb-PepI (AKLIPTIA), RcAlb-PepII (AKLIPTIAL), and RcAlb-PepIII (SLRGCC)', 'Synthetic peptides at 50 microg/mL, a concentration 20-fold lower than griseofulvin, reduced the microconidia viability of Trichophyton mentagrophytes and Trichophyton rubrum by 100%', 'Peptides also induced overproduction of reactive oxygen species (ROS) and enhanced the activity of griseofulvin 10-fold against both fungi, suggesting synergistic effects, and eliminated the toxicity of this drug to human erythrocytes.', 'CONCLUSION: Therefore, our results strongly suggest six peptides with high potential to be employed alone as new drugs or as adjuvants to enhance the activity and decrease the toxicity of griseofulvin.', 32628303),
('Antifungal Peptides', '1,3,4-oxadiazole and an endocyclic amine grafted within the peptide backbone', 'Although few of the oxadiazole-containing macrocyclic peptides displayed activity against Candida albicans on their own, many increased the efficacy of fluconazole, resulting in a synergistic combination that was independent of efflux inhibition.', '', 'Combination therapy has the potential to confer enhanced efficacy as well as mitigate the evolution of resistance.', 32269162),
('Antifungal Peptides', 'Synthetic antimicrobial peptides (SAMPs) : Mo-CBP3 -PepI (CPAIQRCC) and Mo-CBP3 -PepII (NIQPPCRCC)', 'Anticandidal activity by induced the production of reactive oxygen species (ROS), cell wall degradation, and large pores', '', 'Synthetic antimicrobial peptides (SAMPs) have attracted substantial attention as alternatives and/or adjuvants in therapeutic treatments due to their strong activity at low concentrations without apparent toxicity.', 32189445),
('Antifungal Peptides', 'Peptide gH625 analogue (gH625-M)', 'gH625-M was effective in eradicating persister-derived biofilms both alone and in combination with conventional antifungals in Candida albicans', '', 'Biofilm formation poses an important clinical trouble due to resistance to antimicrobial agents; therefore, there is an urgent demand for new antibiofilm strategies that focus on the use of alternative compounds also in combination with conventional drugs.', 32238858),
('Antifungal Peptides', 'Peptides isolated from the venom of bees and their synthetic analogues (lasioglossins, halictines and hylanines)', '', '', 'Naturally occurring antimicrobial peptides and their synthetic analogues are promising candidates for new antifungal drugs.', 31376220),
('Antifungal Peptides', 'Rhesus theta defensin-1 (RTD-1)', 'Papidly fungicidal against clinical isolates of MDR C. albicans in vitro. Here we found that RTD-1 was rapidly fungicidal against blastospores of fluconazole/caspofungin resistant C. albicans strains, and was active against established C. albicans biofilms in vitro. In vivo, promoted long term survival in candidemic mice whether infected with drug-sensitive or MDR strains of C. albicans', '', 'Results of this study suggest that theta-defensins represent a new class of host-directed compounds for treatment of disseminated candidiasis.', 31729441),
('Antifungal Peptides', 'mastoparan B (MB)', 'against a panel of clinically relevant pathogens, including Candida albicans, Candida parapsilosis, Candida tropicalis, and Candida glabrata', '', 'These findings have potential therapeutic implications for the design and development of safe antifungal peptide-based drugs.', 35209228),
('Antifungal Peptides', 'palmitoyl pentapeptide-4', 'MIC values ranging from 2.4 to 5.4 microm against three species of Candida, namely, Candida albicans (ATCC 90028), Candida glabrata (ATCC 90030), and Candida parapsilosis (ATCC 22019).', 'did not show relevant toxicity against the cell lines tested, at up to 100 microM (human foreskin fibroblasts (HFF-1) and human immortalized keratinocytes (HaCaT).', 'have potent wide-spectrum antimicrobial action, including against multidrug-resistant Gram-positive and Gram-negative bacteria, and fungi.', 35950860),
('Antifungal Peptides', 'Synergistic effects of short peptides( LP-23, DP-23, SA4, and SPO) and antibiotics', 'almost all the combinations of peptides/peptoids with amphotericin B and fluconazole also showed effective synergy against Aspergillus niger and Aspergillus flavus.', '', 'The synergy found between LP-23, DP-23, SA4, and SPO with the selected antibiotics may have the potential to be used as a combination therapy against various microbial infections.', 35931657),
('Antifungal Peptides', 'synergistic activity of the human lactoferrin-derived hLF1-11 peptide with caspofungin', 'synergistic effects on preformed biofilm assessed by measuring metabolic activity (FIC range, 0.28 to 0.37) against biofilm-producing strains and by cell viability assay in C. albicans SC5314.', '', 'The synergistic effect observed between caspofungin and hLF1-11 against Candida spp. is of potential clinical relevance, representing a promising novel approach to target caspofungin-resistant Candida species infections.', 35876581),
('Antifungal Peptides', 'three new peptide families, named "Picturins" (PTR), "Pictuseptins" (PTS), and "Boanins" (BNS). from the skin secretions of the Chachi treefrog, Boana picturata', 'PTR displayed moderate activity against Escherichia coli (MIC 24.80 to 48.95 microM), while PTS showed a broad antimicrobial and antifungal effect.', '', 'Nature-inspired solutions have shown their importance mainly for the development of the pharmaceutical industry. Frog skin peptides are excellent examples of the biomedical potential of naturally evolved molecules for specific targets against antimicrobial resistance', 35640793),
('Antifungal Peptides', 'innate defense regulator (IDR) peptides.', 'IDR peptides stimulate or inhibit the body''s immune system, e.g., by stimulating leukocyte migration to the site of infection, driving macrophage differentiation and activation, providing chemotactic action for neutrophils, degranulation and activation of mast cells, altering chemokine and cytokine production, and even induction of angiogenesis and wound healing. Hence proven antibacterial, antifungal, and antiviral activity, also demonstrate anti-inflammatory and immunomodulatory capabilities', '', 'Exploring and utilizing IDR peptides as an indirect weapon against infectious diseases could represent a completely new strategy to cope with the issue of antimicrobial resistance.', 36009931),
('Antifungal Peptides', 'Human beta defensins (hBDs) are antimicrobial peptides', 'The antifungal susceptibility of hBD-1 against C. glabrata was calculated by broth microdilution assay. The susceptibility results confirmed that hBD-1 possessed the minimum inhibitory concentration of 3.12 microg/mL and prevented the growth and caused yeast cell death to various extents.', '', 'he peptide at subinhibitory and inhibitory concentrations blocked the cell cycle in C. glabrata in G0/G1 phase and disturbed the activity of primary and secondary antioxidant enzymes. Furthermore, at higher concentrations disruption of membrane integrity was observed. hBD-1 showed candidicidal activity against C. glabrata and was able to induce oxidative stress and arrested cell cycle in C. auris and therefore has a potential to be developed as an antifungal drug against C. glabrata.', 35988423),
('Antifungal Peptides', 'SA-2 (YYRRLLRVLRRRW) was derived from Cystatin-SA, a saliva protein', 'good inhibitory effect on Candida albicans (C. albicans) and Cryptococcus neoformans (C. neoformans), with MIC values of 16-64 microg/mL and 8-32 microg/mL, respectively. Interestingly, SA-2 effectively killed fluconazole-resistant C. neoformans and C. albicans within 12 h.', 'SA-2 had a low cytotoxicity toward mammalian cells', 'found that the cationic peptide SA-2 could adhere to the negatively charged fungal cell membrane to increase the surface potential of C. neoformans in a dose-dependent manner, and finally disrupted the integrity of fungal cell membrane, reflecting as a 60% positive rate of propidium iodide uptake of C. neoformans cells after SA-2 (4 ', 36333524),
('Antifungal Peptides', '68 amino acid bacteriocin, EntV, secreted by Enterococcus faecalis.', 'EntV68 inhibited biofilm formation of other Candida species including C. tropicalis, C. parapsiolosis and C. glabrata, suggesting its activity may not be limited to C. albicans14. Based on these observations, whether EntV and derivative peptides protected C. elegans from other fungal species and drug resistant strains of C. albicans was tested.', '', 'treatment with EntV significantly reduced the fungal burden, as observed. EntV, or the 12mer peptide (100 nM) is as effective as EntV68 in abrogating an oropharyngeal infection of C. albicans.', 36229448),
('Antifungal Peptides', 'ring-modified histidine-containing short cationic peptides', 'peptides Trp-His[1-(3,5-di-tert-butylbenzyl)-5-iodo]-OMe (10d, IC50 = 2.20 microg/mL; MIC = 4.01 microg/mL) and Trp-His[1-(2-iodophenyl)-5-iodo)]-OMe (10o, IC50 = 2.52 microg/mL; MIC = 4.59 microg/mL) exhibit promising antifungal activities against C. neoformans.', '', 'dipeptides primarily act via membrane disruption, leading to pore formation and causing cell lysis. After entering the cells, the peptides interact with the intracellular components as demonstrated by confocal laser scanning microscopy (CLSM).', 36615282),
('Antifungal Peptides', 'tachplesin I analogue peptide (TP11A)', 'TP11A suppressed the biofilm- and virulence-related genes of C. albicans (hwp 1) and S. aureus (ica A, fnb B, agr A, hla, nor A, and sig B) in the mixed biofilm, according to quantitative reverse transcription polymerase chain reaction analysis', '', 'The findings revealed that TP11A and PLEL@TP11A- TP11A into poly(d,l-lactide)-poly(ethylene glycol)-poly(d,l-lactide) could efficiently reduce bacterial and fungal burden in wound infections, as well as accelerated wound healing. Based on above findings, TP11A might be an effective antimicrobial against C. albicans-S. aureus poly-biofilm formation and mixed infection.', 35998684),
('Antifungal Peptides', 'short (IIKK)3 peptides', 'possess high antifungal activities against the Candida species and Cryptococcus neoformans; some of them displayed faster dynamic killing than antibiotics like amphotericin B. G(IIKK)3I-NH2 and (IIKK)3II-NH2 were particularly potent against not only planktonic microbes but also fungal biofilms with low cytotoxicity to host cells.', '', 'These studies demonstrate the important role of colloid and interface science in further developing short, potent and biocompatible AMPs towards clinical treatments via structure design and optimization.', 34626966),
('Antifungal Peptides', 'Cationic Antifungal Proteins from Filamentous Fungi', 'Inhibit Candida albicans Growth in 3D Skin Infection Models', '', 'In summary, our study proves that the tested AFPs exhibit antifungal potential against cutaneous C. albicans infection in a 3D FT skin model.', 35499318),
('Antifungal Peptides', 'Peptide from Budding Yeast GAPDH (SP1)', 'Serves as a Promising Antifungal against Cryptococcus neoformans', '', 'Our data imply that SP1 has the potential to be developed into a treatment option for cryptococcosis.', 35019693),
('Antifungal Peptides', 'Catestatin-Derived Peptides [D-bCtl, as well as the combination of BSA with L-bCts]', 'Fight the Development of Oral Candidosis', '', 'In this context in vitro D-bCtl, as well as the combination of BSA with L-bCts are potential candidates for the development of new antifungal drugs for the treatment of oral candidosis due to Candida and non-Candida albicans, without detrimental side effects.', 35216181),
('Antifungal Peptides', 'WMR Peptide', 'Results showed a WMR antifungal activity on all Candida planktonic cells at concentrations between 25 MicroM to >50 MicroM and exhibited activity at sub-MIC concentrations to inhibit biofilm formation and eradicate mature biofilm.', '', 'These findings provide novel insights for the antifungal mechanism of WMR against Candida albicans and non-albicans, providing fascinating scenarios for the identification of new potential antifungal targets.', 35216270),
('Antifungal Peptides', 'P255 and P256 with the same composition and different distribution were derived from PAF26', 'P256 exhibited higher antifungal activity against C. albicans than did P255 and PAF26. P256 and P255 exhibited synergism when combined with amphotericin B (AMB).', '', 'These results demonstrate the therapeutic potential of the peptides, particularly P256 with clear amphipathicity, in the development of therapies for C. albicans infections.', 34768011),
('Antifungal Peptides', 'Antimicrobial Peptide from the Skin of Kaloula pulchra', 'weakly active towards fungi due to its membranolytic action.', '', 'Brevinin-2KP is weakly active towards the tested Gram-positive and Gram-negative bacteria as well as fungi due to its membranolytic action.', 35249479),
('Antifungal Peptides', 'Novel Antimicrobial Peptide GK-19 derived from Scorpion venom- Androctonus amoreuxi Antimicrobial Peptide 1 (AamAP1)', 'GK-19 also exhibited distinguished antifungal activity with much lower minimal inhibitory concentration (MIC) values ranging between 5 to 10 microM (C. krusei (5 microM), C. albicans (10 microM), and C. glabrata (10 microM)) in comparison to that of AamAP1', 'GK-19 showed negligible toxicity to mammalian cells, low hemolytic activity and high stability in plasma.', 'For Candida albicans, GK-19 showed significant antimicrobial and healing effects. Overall, it was demonstrated that GK-19 might be a promising drug candidate in the battle against drug-resistant bacterial and fungal infections.', 36145681),
('Antifungal Peptides', 'Host defense peptides and cell-penetrating peptides', 'brilliance in the field of intracellular delivery, the potential of cell-penetrating peptides and their mimics for designing antifungal agents', '', 'effectiveness and potential of cell-penetrating peptide-inspired strategy in designing potent and selective antifungal polymeric agents.', 35996361),
('Antifungal Peptides', 'antifungal peptide targeting the P4-ATPase function', 'A modified peptide, "AW9-Ma" showed a MIC of 64 microg/mL against H99 wild type and a fractional inhibitory concentration (FIC) index value of 0.5 when used in combination with caspofungin.', '', 'Structure-activity relationship studies of the AW9 sequence showed that two lysine residues on the peptide are likely responsible for the interaction with the P4-ATPase, hence critical for its antifungal activity.', 35377230),
('Antifungal Peptides', 'cell penetrating peptide (CPP) octaarginine (R8), elongated to 28 residues poly(d,l-homoarginine)', 'potent antifungal activity against drug-resistant fungi superior to antifungal drugs, excellent stability upon heating and UV exposure, negligible in vitro and in vivo toxicity, and strong therapeutic effects in treating invasive fungal infections', '', 'All these merits imply the effectiveness of our strategy to develop promising antifungal agents.', 35535860),
('Antifungal Peptides', 'Lipo-Gama-AA Peptides', 'MW5, exhibited potent and broad-spectrum antifungal activity. In addition, MW5 potently boosted the efficacy of fluconazole against clinical azole-resistant Candida isolates. resensitize drug-resistant Candida albicans to fluconazole', '', 'Our results demonstrated that lipo-gamma-AA peptides have great promise for use alone or in combination to combat drug-resistant Candida infections.', 35637173),
('Antifungal Peptides', 'Antimicrobial peptides (AMPs) from wasp venom (Vespamandarinia)', 'It displayed potent antimicrobial activities against Gram-positive bacteria (MICs: 4', '', 'Thus, peptide VM-3K could be a promising broad-spectrum antimicrobial candidate for addressing the current antibiotic-resistant infection crisis. It is worth mentioning that this investigation on the relationship between peptide structure and mechanism of action could become an important aspect of drug research on short peptides.', 36138742),
('Antifungal Photodynamic Therapy', 'Cu-sputtered polyester surfaces (Cu-PES) and low intensity visible light irradiation (4.65mW/cm2)', 'Cu-PES exhibited an accelerated fungicidal activity against Candida albicans and Candida glabrata with a reduction of 3.0 and 3.4log10CFU', '', ' These results indicate that Cu-PES represent a promising strategy for decreasing the colonization of surfaces by yeasts and that actinic light can improve its self-disinfecting activity.  ', 28802173),
('Antifungal Photodynamic Therapy', 'a PS (beta-carboxyphthalocyanine zinc, CPZ) delivery system with lanthanide-doped upconversion nanoparticles (UCNPs, LiYF4:Yb/Er) and polyvinylpyrrolidone (PVP)', 'High antifungal efficacy against Candida albicans', '', ' Near-infrared-triggered antibacterial and antifungal photodynamic therapy based on lanthanide-doped upconversion nanoparticles. An alarming worldwide increase in microbial resistance to traditional drugs and classical pharmacophores has spurred the search for new antimicrobial compounds.  Antimicrobial photodynamic therapy (aPDT) has recently emerged as an effective modality for the selective destruction of bacteria and other pathogenic microorganisms.', 29881851),
('Antifungal Photodynamic Therapy', 'Curcumin and blue light', 'Eradication of C. albicans biofilms', '', ' Photodynamic therapy (PDT) utilizing curcumin and blue light was tested as an independent therapy and in combination with fluconazole treatment.', 29364155),
('Antifungal Photodynamic Therapy', 'Fluorescent probes hydroxyphenyl fluorescein (HPF) and aminophenyl fluorescein (APF) after toluidine blue (TBO-37.5 mg/L)-mediated PDT (660 nm, 40 mW, and 0.04 cm2?spot area)', 'Significant generation of hydroxyl radicals and hypochlorite after TBO-PDT with doses around 90 J/cm2; for inactivating Paracoccidioides brasiliensis colonies at 7 and 15 days', '', ' In that way, photodynamic therapy (PDT) arises as a new promising adjuvant treatment for inactivating Paracoccidioides brasiliensis (Pb), the responsible fungus for PCM, and also for helping the patients to deal with such debilitating oral lesions.', 28349345),
('Antifungal Photodynamic Therapy', 'Methylene blue-mediated photodynamic therapy', 'Concentrations from 250 to 400 microgram/mL reduced fungal growth but did not eliminate Candida albicans.: MB concentrations of 450 and 500 microgram/mL totally eradicated Candida albicans from the oral cavity, resulting in reductions from 2.5 log(10) and 2.74 log(10) to 0, respectively', '', ' Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model.   OBJECTIVES: The purpose of this study was to evaluate the efficacy of using methylene blue (MB)-mediated photodynamic therapy to treat oral candidiasis in an immunosuppressed murine model, mimicking what is found in human patients.', 11862203),
('Antifungal Photodynamic Therapy', 'New methylene blue N and red light', 'Effect on Candida albicans proteome', '', ' Here, we report a combination of two-dimensional electrophoresis and tandem mass spectrometry to study the protein damage resulting from treating C. albicans with PDT with new methylene blue N and red light.', 27830217),
('Antifungal Photodynamic Therapy', 'PDT method based on light curing units'' blue LEDs combined to a plaque-disclosing composition (5%  erythrosine)', 'Can  inactivate C. albicans', '', 'Preclinical study of a cost-effective photodynamic therapy protocol for treating  oral candidoses.   Photodynamic therapy (PDT) is a promising treatment for oral candidoses.', 28508242),
('Antifungal Photodynamic Therapy', 'PSs hypericin (HYP) and 1,9-dimethyl methylene blue (DMMB) exposed to two light-emitting diode light fluences (18 and 37 J cm??)', 'The minimal fungicidal concentration of HYP for greater than 3 log?? CFU reduction (0.5 McFarland) was 0.62 micromol l?? for most strains, whereas for DMMB it ranged between 1.25 and 2.5 micromol/L', '', ' Photodynamic fungicidal efficacy of hypericin and dimethyl methylene blue against azole-resistant Candida albicans strains.    Antimicrobial photodynamic therapy (aPDT) is an emerging alternative to treat infections based on the use of photosensitisers (PSs) and visible light.', 23905682),
('Antifungal Photodynamic Therapy', 'Riboflavin/UVA combination (365 nm) combination', '', '', ' Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis.   PURPOSE: To demonstrate the antimicrobial properties of riboflavin/UVA (365 nm) against common pathogens.', 18408193),
('Antifungal Photodynamic Therapy', 'Aloe emodin (AE)', '', '', 'AE exhibited no significant dark toxicity, but in the presence of light, effectively inactivated C. albicans cells in a concentration-dependent manner.', 32232258),
('Antifungal Photodynamic Therapy', 'Tagetes minuta', 'Tagetes minuta extracts as a photosensitizer on growth of Candida and dermatophytes and their effect on Candida virulence factors. T. minuta root hexane and dichloromethane extracts demonstrated high photodynamic antifungal activity.', '', 'Photodynamic therapy (PDT) involves the topical administration of a photosensitizer in combination with light of an appropriate wavelength and molecular oxygen that produces reactive oxygen species (ROS), which promote damage to several vital components of the microorganism.', 31724710),
('Antifungal Photodynamic Therapy', '5-aminolevulinic acid PDT (ALA-PDT)', 'Using combination therapy, we have successfully treated a patient who had a T. asahii skin infection. Further in vitro studies showed that the antifungal effect of ALA-PDT on planktonic and adherent T. asahii was dependent on the concentration of ALA and light dosages used.', '', 'Photodynamic therapy (PDT) is a new therapeutic approach developed not only to combat cancerous lesions but also to treat infectious diseases such as fungal infections.', 33164224),
('Antifungal Photodynamic Therapy', 'Methylene blue, new methylene blue N and S137', 'The results from this model indicate that antimicrobial photodynamic therapy with methylene blue, new methylene blue N and S137 is efficient for the treatment of infection with F. keratoplasticum and F. moniliforme.', '', 'Antimicrobial photodynamic therapy with phenothiazinium photosensitizers in non-vertebrate model Galleria mellonella infected with Fusarium keratoplasticum and Fusarium moniliforme.', 30586617),
('Antifungal Photodynamic Therapy', 'Aminolevulinic acid', 'Our study shows ALA aPDT induced 46% ? 24.23% reduction of the growth of all tested P. wickerhamii strains in T1 group.', '', 'BACKGROUND: Antimicrobial photodynamic therapy(aPDT) has been used to treat localized cutaneous fungal infections that have an enhanced antifungal susceptibility profile.', 30586618),
('Antifungal Photodynamic Therapy', 'Hypocrellin B (HB)', 'Inactivated the azole-sensitive and resistant C. albicans in a light-dose and PS concentration-dependent manner.', 'HB exhibited no significant dark toxicity', 'Antimicrobial photodynamic therapy (aPDT) is an emerging and promising approach for treating localized and superficial C. albicans infections.', 31325521),
('Antifungal Photodynamic Therapy', '5-aminolevulinic acid (5%ALA) in a thermosetting gel (t) (5%ALA-PTt)', 'The 5% ALA-PTt preparation was shown to be effective in reducing the growth of biofilm and inoculum of C. albicans.', '', 'Newly formulated 5% 5-aminolevulinic acid photodynamic therapy on Candida albicans.', 31614222),
('Antifungal Photodynamic Therapy', 'Photodynamic activity of hexane (Hex), dichloromethane (DCM), ethyl acetate (EtOAc) and methanol (MeOH) extracts from T. pentachaeta var. belenidium', 'MIC = 8-256 microgram/mL, synergistic effects with ciprofloxacin and fluconazole', '', 'Taking together, results demonstrated the strong photodynamic effects of T. pentachaeta root extracts under UVA irradiation, making them valuable alternatives to the already established antifungal drugs against C. albicans.', 34148723);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antifungal Photodynamic Therapy', 'Methylene blue (MB)-PDT', 'MICs ?0.004-4 mg/L against Trichophyton species, MIC elevated (MB: 2-8 mg/L and 8-16 mg/L) in isolates from two pigmented cultures of Trichophyton interdigitale (one wildtype and one harbouring L393F) with a darker color when compared to unpigmented cultures (MB: 0.5-4 mg/L)', '', 'Photodynamic therapy: A treatment option for terbinafine resistant Trichophyton species.', 33497815),
('Antifungal Photodynamic Therapy', 'photoimmuno-antimicrobial strategy (PIAS)', 'PIAS acts on a broad range of microbes, including the bacterial pathogen Staphylococcus aureus, fungal pathogen Candida albicans, including their drug-resistant strains,', 'PIAS protects mice from fatal infections without damaging the non-targeted host microbiota and tissues.', 'This study may contribute to the development of next-generation anti-infective therapies.', 35788695),
('Antifungal Photodynamic Therapy', 'therapeutic potential of antimicrobial 265 nm UVC', 'UVC inhibited all tested bacteria and fungi, including mixed culture and strains linked to antibiotic resistance against infectious keratitis.', '', 'In vitro and ex vivo testing confirmed therapeutic potential of UVC. In vivo, UVC administered in two doses, 4 h apart, proved effective in treating murine bacterial keratitis and also fungi related', 35568373),
('Antifungal Phytochemical', '4-Cyclopentene-1,3-dione from Feijoa ( Acca sellowiana)', 'IC50? 1-2 microM against human-pathogenic Candida species', '', 'Bioactivity-Guided Metabolite Profiling of Feijoa ( Acca sellowiana) Cultivars Identifies 4-Cyclopentene-1,3-dione as a Potent Antifungal Inhibitor of Chitin Synthesis.  ', 29546758),
('Antifungal Phytochemical', 'Acetone Lichen Extracts', 'Seven extracts displayed both anti-maturation and anti-biofilm activities (half maximal inhibitory concentrations IC50_mat?and IC50_biof?? 100 microg/mL);?Evernia prunastri?and?Ramalina fastigiata?were the most promising lichens (IC50_mat?< 4 microg/mL and IC50_biof?< 10 microg/mL).', '', 'Antifungal and Anti-Biofilm Activities of Acetone Lichen Extracts against Candida albicans', 28422057),
('Antifungal Phytochemical', 'Aqueous and hydroethanolic extracts from Psidium brownianum Mart ex DC. and Psidium guajava L.', ' A synergistic effect was observed in the combination of fluconazole  with Psidium brownianum extracts against all Candida strains. However, for Psidium guajava extracts the synergistic effect was produced mainly against the Candida albicans LM77 and Candida tropicalis INCQS 400042 strains', '', ' Our results indicated that both P.?brownianum and P.?guajava extracts are effective on potentiating the effect of fluconazole, and  therefore, these plants have the potential for development of new effective drugs for treating fungal infections. ', 27085299),
('Antifungal Phytochemical', 'Beauvericin', 'Inhibits TOR signaling in Candida albicans, potentiates the activity of azole antifungals against azole-resistant Candida isolates via inhibition of multidrug efflux', '', ' Here, we explore a powerful strategy to enhance antifungal efficacy against leading human fungal pathogens by using the natural product beauvericin.', 27736764),
('Antifungal Phytochemical', 'Beauvericin', 'Targets multidrug efflux and TOR signaling', '', ' Dual action antifungal small molecule modulates multidrug efflux and TOR signaling.   There is an urgent need for new strategies to treat invasive fungal infections, which are a leading cause of human mortality. Here, we establish two activities of the natural product beauvericin, which potentiates the activity of the most widely deployed class of antifungal against the leading human fungal pathogens, blocks the emergence of drug resistance, and renders antifungal-resistant pathogens responsive to treatment in mammalian infection models.', 27571477),
('Antifungal Phytochemical', 'Benzo[c]phenanthridine alkaloids from Chelidonium majus Linn [8-hydroxydihydrosanguinarine (1) and 8-hydroxydihydrochelerythrine (2), Dihydrosanguinarine (3), dihydrochelerythrine (4), sanguinarine (5) and chelerythrine (6)]', 'Of the six compounds determined, (1) and (2) demonstrated potent activity against clinical drug-resistant yeast isolates with the MIC ranges of 2-80 and 4-100 microg/mL, respectively. (3), (4), (5) and (6) had some degree of antifungal activit', '', 'The overall results provided important information for the potential application of the 8-hydroxylated alkaloids from Chelidonium majus in the therapy of serious infection caused by drug-resistant fungi.', 19647059),
('Antifungal Phytochemical', 'Brown Brazilian propolis (Apis mellifera)', 'Sporothrix brasiliensis were sensitive to brown propolis between MIC values of 0.19-1.56 mg/mL, including the itraconazole-resistant isolates, whereas the MFC values of propolis were from 0.78 to greater than 3.125 mg/mL', '', ' Brown Brazilian propolis  is a promising antifungal candidate against sporotrichosis and more studies need  to be undertaken to evaluate its safe use to understand its efficacy.  ', 28219829),
('Antifungal Phytochemical', 'Carica papaya Linn. seed essential oil', '?The EO showed inhibitory effect against all the tested Candida strains including C. albicans, C. glabrata, C. krusei, C. parapsilosis and C. tropical with inhibition zone diameters in the range of 14?2-33?2 mm, the minimal inhibitory concentrations (MICs) in the range of 4?0-16?0 microg ml-1?and the minimum fungicidal concentrations (MFCs) in the range of 16?0-64?0 microg ml-1?.', '', ' Carica Papaya may be recognized as a possible new source of natural antifungal agents.  ', 28052349),
('Antifungal Phytochemical', 'Carvacrol', '?Carvacrol has antifungal activity in comparison to voriconazole (VCZ) (MIC 0?5, 0?25 micro g ml-1?respectively)', '', ' Assessment of carvacrol for control of avian aspergillosis in intratracheally challenged chickens in comparison to voriconazole with a reference on economic impact.   AIM: This study was designed to investigate the efficacy of essential oils as an  alternative prophylaxis and treatment for avian aspergillosis.', 28795522),
('Antifungal Phytochemical', 'Enhalus acoroides leaf extract', '?Activity against  C. albicans and E. coli, reduce bacterial and fungal coverage by 60.9 and 73.9%, respectively; affect bacterial biofilm maturation and promote dispersion, up to 70%, in fungal biofilm; increase luminescence in Vibrio harveyi by 25.8%', '', ' E. acoroides leaf extract proved to be the most promising extract among those tested.', 29843708),
('Antifungal Phytochemical', 'Essential Oil From Salvia mirzayanii Leaves', 'The MIC95 were 0.03 to 0.5 microL/mL and 16 to 128 microL/mL for gram-positive and gram-negative bacteria, respectively, MIC50 0.03 to 1 microL/mL for yeast', '', ' Chemical Composition and Antimicrobial Activities of the Essential Oil From Salvia mirzayanii Leaves.   Resistance of many pathogens to available drugs is a global challenge and is leading to growing interest in natural alternative products.', 28689440),
('Antifungal Phytochemical', 'Ethyl acetate extract of the herb Dalea formosa of the American Southwest', 'Activity against azole-sensitive and azole-resistant isolates', '', ' Modulation of the antifungal activity of new medicinal plant extracts active on Candida glabrata by the major transporters and regulators of the pleiotropic drug-resistance network in Saccharomyces cerevisiae. The increased incidence of drug-resistant fungal infections, a process in which active efflux plays an important role, calls for the development of new treatments.', 19216644),
('Antifungal Phytochemical', 'Globiferin isolated from root extracts of Cordia globifera and its derivatives', 'Antimalarial, antifungal, and cytotoxic activities', '', ' Biomimetic transformation and biological activities of Globiferin, a terpenoid benzoquinone from Cordia globifera.    A new 10-membered ring meroterpene (1), named globiferin, was isolated from root  extracts of Cordia globifera. Biomimetic transformations of 1 and its derivatives, either by acid cyclization or by Cope rearrangement, provided information relating to the biogenesis of cordiachromes A-C. Globiferin (1) underwent Cope rearrangement upon refluxing in xylene and DMSO-d(6) to yield cordiachrome C (3) and cordiaquinol C (4), respectively.', 19368377),
('Antifungal Phytochemical', 'Isoflavonoids, sedonans A-F (1-6), a new but-2-enolide, 4''-O-methylpuerol A (7), and the new pterocarpan ent-sandwicensin (8) from the root extract of Dalea formosa', 'MIC = 20 microM of 1 against C. glabrata, Sedonans A-F and ent-sandwicensin active against Saccharomyces cerevisiae strains that express differing ABC transporter-associated resistance mechanisms,', '', 'We observed strong antifungal growth inhibitory activity in the methanol extract of Dalea formosa roots.', 23631483),
('Antifungal Phytochemical', 'IWF1 and IWF2, proteins isolated from the intercellular washing fluid (IWF) of sugar beet leaves', ' Both proteins show strong in vitro antifungal activity against Cercospora beticola, the casual agent of leaf spot disease in sugar beet', '', ' New antifungal proteins from sugar beet (Beta vulgaris L.) showing homology to non-specific lipid transfer proteins.  Two novel, nearly identical antifungal proteins, IWF1 and IWF2, were isolated from the intercellular washing fluid (IWF) of sugar beet leaves.', 8790287),
('Antifungal Phytochemical', 'Lyophilized aqueous extract of the leaves of Acca sellowiana (O.berg) Burret (Myrtaceae) ', 'Candida glabrata showed the lowest MIC values (500-3.90 microg/mL)', '', 'Reversal of fluconazole resistance induced by a synergistic effect with Acca sellowiana in Candida glabrata strains', 27050162),
('Antifungal Phytochemical', 'Methanolic extract of scapes of Syngonanthus nitens (S. nitens extract [SNE]) and an SNE-loaded liquid crystal precursor mucoadhesive systems (LCPM)', 'Activity against Candida krusei, SNE was active against all strains studied, with minimum inhibitory concentration values ranging from 125 to 62.5 microg/mL; after incorporating SNE into F (FE), these values decreased to 62.5 to 31.2 microg/mL, demonstrating that incorporation into the formulation potentiated the action of SNE.', '', ' Liquid crystal precursor mucoadhesive system as a strategy to improve the prophylactic action of Syngonanthus nitens (Bong.)   Vaginal infections caused by Candida krusei are a problem of extreme complexity due to the intrinsic resistance to azole drugs. Therefore, the objective of this study was to evaluate the potential of the methanolic extract of scapes of S. nitens (S. nitens extract [SNE]) and an SNE-loaded LCPM against C. krusei as prophylaxis for vulvovaginal candidiasis.  SNE was active against all strains studied, with minimum inhibitory concentration values ranging from 125 to 62.5 ?g/mL; after incorporating SNE into F (FE), these values decreased to 62.5 to 31.2 ?g/mL, demonstrating that incorporation into the formulation potentiated the action of SNE.', 26719688),
('Antifungal Phytochemical', 'Origanum vulgare (oregano), Pinus sylvestris (pine), and Thymus vulgaris (thyme red) EOs, and their components', 'Activity against Cryptococcus neoformans', '', ' To date, there are very few molecules with any activity towards Cryptococcus neoformans, leading to heightened interest in finding new alternatives or adjuvants to conventional drugs for the treatment of  mycosis caused by this yeast. Use of Pinus sylvestris L. (Pinaceae), Origanum vulgare L. (Lamiaceae), and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans strains', 29724221),
('Antifungal Phytochemical', 'p-coumaroyl-hydroxyagmatine (p-CHA) from barley leaf ', 'Antifungal activity both in vitro and in vivo', '', ' Structural analysis identified this compound as a novel phenolic conjugate, p-coumaroyl-hydroxyagmatine (p-CHA). p-CHA but not the nonhydroxylated derivative p-coumaroylagmatine exhibited antifungal activity both in vitro and in vivo.', 9535889),
('Antifungal Phytochemical', 'Plant-derived essential oils [Pelargonium graveolens (Geraniaceae) (PG-EO) , linalool, geraniol]', 'PG-EO most effective oil, treatments with PG-EO, linalool, and geraniol significantly reduced the number of viable biofilm cells and inhibited biofilm formation in Candida species', '', ' Antifungal activity of plant-derived essential oils on Candida tropicalis planktonic and biofilms cells. PG-EO, geraniol, and linalool were not toxic to normal human lung fibroblasts (GM07492A) at the concentrations they were active against C. tropicalis Together, our results indicated that C. tropicalis is susceptible to treatment with PG-EO, geraniol, and linalool, which could become options to prevent or treat this infection.', 26868902),
('Antifungal Phytochemical', 'Quercetin (QCT)', '64 micro g/mL QCT and/or 128 ?g/mL FCZ could be synergistic against 10 FCZ-resistant planktonic and 17 biofilm cells of C. albicans, and inhibit fungal adherence, cell surface hydrophobicity (CSH), flocculation, yeast-to-hypha transition, metabolism, thickness and dispersion of biofilms', '', ' Together with these results, it could be demonstrated that QCT could  be a favorable antifungal agent and a promising synergist with FCZ in the clinical management of VVC caused by C. albicans biofilm.  ', 27915337),
('Antifungal Phytochemical', 'Selected secondary metabolites from Chilean Calceolaria integrifolia sensu lato complex', 'Mixtures of isorhamnetin/dunnione/kaempferol/ferulic/gallic acid in various combinations were found to have the most potent bactericidal and fungicidal activity with MFC between 10 and 50 microg/ml. Quercetin was found to be the most potent fungistatic single compound with an MIC of 15 microg/ml.', '', 'Biopesticides from plants: Calceolaria integrifolia s.l', 24893349),
('Antifungal Phytochemical', 'Sodium lignosulfonate (LIG)', 'MIC against Candida spp. was found to be 64-128 micro g/ml.', '', 'Deciphering the role of Sodium Lignosulfonate against Candida spp. as persuasive anticandidal agent.  In the race of Candida therapeutics, the revelation  of the antifungal potential of such natural compounds might impact and diversify  the discovery and development of novel antifungal agent. ', 28962848),
('Antifungal Phytochemical', 'Solasodine-3-O-?-d-glucopyranoside (SG) isolated from the medicinal plant Solanum nigrum L', 'In vitro, SG displayed potent fungicidal activity against both azole-sensitive and azole-resistant Candida albicans strains in Spider medium with its MICs of 32 ?g/ml', '', ' Solasodine-3-O-?-d-glucopyranoside kills Candida albicans by disrupting the intracellular vacuole. In?vitro, SG displayed potent fungicidal activity against both  azole-sensitive and azole-resistant Candida albicans strains in Spider medium with its MICs of 32??g/ml.', 28552788),
('Antifungal Phytochemical', 'Steroid saponins from Tribulus terrestris L. (TTS-12, TTS-15)', 'TTS-12 and TTS-15 were very active against fluconazole-resistant C. albicans (MIC(80)=4.4, 9.4 microg/ml), C. neoformans (MIC(80)=10.7, 18.7 microg/ml) and inherently resistant C. krusei (MIC(80)=8.8, 18.4 microg/ml)', '', ' In vitro and in vivo antifungal activities of the eight steroid saponins from Tribulus terrestris L. with potent activity against fluconazole-resistant fungal  pathogens.   Antifungal activity of natural products is being studied widely.', 16327151),
('Antifungal Phytochemical', 'Thymus daenensis and Silybum marianum extracts with Ag-NPs', 'Activity at?12.5 to 50 mg/mL against Staphylococcus aureus (S. aureus, Gram-positive organism) and Escherichia coli (E. coli, Gram-negative organism), and fungal strains were Aspergillus oryzae (A. oryzae) and Candida albicans (C. albicans).', '', 'Ultrasound-assisted extraction of antimicrobial compounds from Thymus daenensis and Silybum marianum: Antimicrobial activity with and without the presence of natural silver nanoparticles', 29429729),
('Antifungal Phytochemical', 'Usnic Acid', 'The biofilm inhibitory concentration of usnic acid (4 ?g/mL) exhibited a significant biofilm inhibition, 71.08 % for azole-resistant and 87.84 % for azole-sensitive C. albicans strains', '', ' Our results suggest that usnic acid could be an alternative for the treatment of Candida infections, which deserves further investigation. ', 27648556),
('Antifungal Phytochemical', 'Xylaria sp. BIOTEC culture collection (BCC) 1067?', 'Promising antifungal effect against yeast Saccharomyces cerevisiae with minimal inhibitory concentration?and minimal fungicidal concentration of 500 and 1000 mg/l, respectively, strong synergy with fractional inhibitory concentration index value of 0.185 for the combination of 60.0 and 0.5 mg/l of extract and ketoconazole, respectively', '', ' BCC 1067 extract is a potentially valuable source of novel antifungals.  ', 28361556),
('Antifungal Phytochemical', 'Zingiber officinale Extract', 'The findings of the present study indicate that ginger extract has good antifungal and antibiofilm formation by fungi against C. albicans and C. Krusei. Concentrations between 0.625 mg/mL and 5 mg/mL had the highest antibiofilm and antifungal effects', '', 'Survey of the Antibiofilm and Antimicrobial Effects of Zingiber officinale (in Vitro Study)', 27127591),
('Antifungal Phytochemical', 'Vanillin', 'Inhibits Candida drug resistance protein 2 (CaCdr2p) activity', '', 'Insight studies into the mechanisms suggested that abrogated efflux by CaCdr2p is due to competitive mode of inhibition by Van as depicted by Lineweaver-Burk plot.', 31937429),
('Antifungal Phytochemical', 'Rumex abyssinicus Jacq. (Polygonaceae)', 'MIC = 8-256 microgramg/mL, synergistic effects with ciprofloxacin and fluconazole', '', 'Graham is a consultant for RedHill Biopharma and Phathom Pharmaceuticals regarding novel H. pylori therapies and was the PI on the clinical trial from which the data were derived.', 34090405),
('Antifungal Phytochemical', 'Mentha x piperita (Lamiaceae) of Pancalieri (Turin, Italy) Essential Oil', 'Fungicidal activity against yeasts and a fungistatic activity against dermatophytes', '', 'Thus, the "Mentha of Pancalieri" EO may act as a potential antifungal agent and could serve as a natural adjuvant for fungal infection treatment.', 31470602),
('Antifungal Phytochemical', 'Essential oils (EOs) such as Thymus vulgaris (thyme red), Origanum vulgare (oregano), Lavandula vera (lavender), Pinus sylvestris (pine), Foeniculum vulgare (fennel), Melissa officinalis (lemon balm), Salvia officinalis (sage), Eugenia caryophyllata (clove) and Pelargonium asperum (geranium), and some of their main components (?-pinene, carvacrol, citronellal, eugenol, ?-terpinene, linalool, linalylacetate, terpinen-4-ol, thymol)', 'Pine exhibited strong antifungal activity against the selected non-albicans Candida isolates and uncommon yeasts. In addition, lemon balm EOs and ?-pinene exhibited strong antifungal activity against the selected non-albicans Candida yeasts. Thymol inhibited the growth of all uncommon yeasts.', '', 'These data showed a promising potential application of EOs as natural adjuvant for management of infections by emerging non-albicans Candida species and uncommon pathogenic yeasts.', 34443525),
('Antifungal Phytochemical', 'Antifungal Creams (AFCs) with Turmeric Essential Oil (TEO) or Aloe vera Gel (AVG)', 'AFCs displayed zones of inhibition with values ranged from 5.0 to 14.3 mm, TEO was 5.0 to 11.0 mm and AVG was 8.0 to 11.7 mm against tested fungi. Minimum Inhibitory Concentration (MIC) by AFCs, TEO and AVG ranged from 1.25 to 10.0 mg/ml.', '', 'Combination effect of antibiotic creams with natural products from plants is prospective strategy to produce new antifungal agent.', 33509168),
('Antifungal Phytochemical', 'Eucalyptal D', 'Eucalyptal D (ED), a formyl-phloroglucinol meroterpenoid, is one of the natural synergists, which could significantly enhance the anticandidal activity of fluconazole (FLC) in treating FLC resistant C. albicans.', '', 'Natural products are a promising synergist source to assist azoles in treating resistant candidiasis.', 31281800),
('Antifungal Phytochemical', 'carvacrol (CRV), cinnamaldehyde (CIN) and thymol (THY)', 'The mean fractional inhibitory concentration index (FICI) showed primary synergies for the combinations carvacrol+nystatin, thymol+nystatin, and carvacrol+miconazole (80%).', '', 'In conclusion, the results obtained indicate that the phytochemicals tested showed relevant in vitro anti-M. pachydermatis activity.', 31455580),
('Antifungal Phytochemical', 'peel extracts (garlic, ginger, onion, potato)', 'Positive inhibition against all fungal strains was observed for all samples, with maximum inhibition against Colletotrichum falcatum.', '', '', 32813867),
('Antifungal Phytochemical', 'Javanicin', 'Recombinant javanicin displayed antifungal properties against human pathogenic fungi, including resistant strains.', 'It displays cytotoxic activities toward the human breast cancer cell lines, MCF-7 & MDA-MB-231.', 'Novel therapeutic agents with a higher efficiency and less side effects for the treatment of certain diseases are urgently needed.', 31804594),
('Antifungal Phytochemical', 'Pecan (Carya illinoinensis) and Chestnut (Castanea sativa) flowers', 'Antimicrobial and antifungal activities were compared by means of agar diffusion tests against bacteria including Staphylococcus aureus, Bacillus cereus, Mycobacterium smegmatis, Acinetobacter haemolyticus, and Chromobacterium violaceum, and the yeasts Candida albicans and Candida parapsilosis.', '', 'Both extracts were rich in ellagic acid and gallic acid and exhibited similar antioxidant properties. Both flower extracts exhibited high antimicrobial and antifungal activities as well as anti-biofilm, anti-QS, and anti-SW activities.', 36053379),
('Antifungal Phytochemical', 'Curcumin', 'At a concentration of 250 microg/mL, curcumin inhibited about 80% of cell growth of C. albicans SC5314', '', 'results also showed that curcumin strongly reduced the transcript levels of HSP90. This might explain why curcumin exhibited greater antifungal activity', 36237434),
('Antifungal Phytochemical', 'Anatolian honey bee venom', '12.5 microg mL-1 against candida albicance, candida tropicalis, saccharomyces cerevisiae', '', 'These findings strongly suggest that Anatolian HBV will be developed as a new antibacterial-antifungal', 35421436),
('Antifungal Phytochemical', 'Tropical Medicinal Plant Extracts: Cymbopogon citratus, Curcuma xanthorrhiza, Curcuma aeruginosa, and Zingiber officinale var. rubrum', 'All plant extracts in this study showed antifungal activities against C. albicans. Among them, Cymbopogon citratus, Curcuma xanthorrhiza, Curcuma aeruginosa, and Zingiber officinale var. rubrum showed the lowest MIC and MFC value of 3.8 mg/mL.', '', 'The growth inhibition of C. albicans on disc diffusion assay was demonstrated by Z. officinale var. rubrum and C. longa, which were comparable to antifungal nystatin. This plant extract develop novel anti-candida agents', 36224024),
('Antifungal Phytochemical', 'synergistic effects of phytoactives piperine and cinnamaldehyde', 'biofilm inhibitory concentration of piperine and cinnamaldehyde was determined to be 32 microg/ml and 64 microg/ml, respectively.', '', 'These proficient phytochemical combinations provide a new therapeutic avenue for the treatment of biofilm-associated oral candidiasis and to combat the recurrent infections due to antibiotic resistance.', 35661216),
('Antifungal Phytochemical', 'A3IS (Mycosinate) is a synthetic product found naturally within honey.', 'A3IS demonstrated broad spectrum in vitro activity against yeast, molds, and the dimorphic fungi Blastomyces dermatitidis and Coccidioides species. Against yeasts, the activity of A3IS ranged from =0.02% to 0.15% wt/vol with both the 50% and 100% inhibition of growth endpoints. all mold isolates tested and ranged from =0.02% to 0.3% wt/vol with both the 50% and 100% inhibition of growth endpoints. As against the fluconazole resistant yeasts, the activity of A3IS was maintained against Aspergillus, Fusarium, Scedosporium, and Lomentospora isolates that demonstrated high-level in vitro resistance to voriconazole (i.e., voriconazole MIC =8 mg/mL). The IC50 (Inhibitory Concentration) of A3IS for P. carinii was 0.6415 microg/mL and 4.155 microg/mL for P. murina,', 'Viability was ranked as follows: viability of 80% or higher, no cytotoxicity; viability higher or equal to 60% and lower than 80%, mild cytotoxicity; viability higher or equal to 40% and lower than 60%, moderate cytotoxicity; viability below 40%, severe cytotoxicity.', 'A3IS may hold promise as a novel treatment for Pneumocystis pneumonia and various other different types of fungi species.', 35852368),
('Antifungal Phytochemical', 'Extracts from Argentinian native plants', 'Only extracts obtained from Acalypha communis, Argemone subfusiformis, Baccharis salicifolia, Lithrea molleoides and Pterocaulon alopecuroides showed antifungal effects with MIC values of 50, 200, 200, 25 and 100 microg/mL, respectively, against both efflux transporters AD/CaMDR1 and AD1-8u- in Candida species. Acalypha communis and Solanum atriplicifolium being the most effective showing 4- to 16-fold reversal of resistance at concentrations = 25 microg/mL', 'To determine the potential cytotoxic effect of the extracts on peripheral blood mononuclear cells (PBMCs), used as a model of normal cells, an MTT assay was performed as previously reported. The A. communis extract showed a half-maximal inhibitory concentration (IC50) value of 64.67 ', 'The non-toxic and highly active extracts from A. communis and S. atripicifolium, provide promising sources of compounds for potentiating the antifungal effect of FCZ by blocking the efflux function of Mdr1 and Cdr1 transporters.', 36224581),
('Antifungal Phytochemical', 'novel Panax stipulcanatus saponin analogues', 'In vitro antifungal activity results indicated that analogue 2 - oleanolic acid 3-O-beta-d-glucopyranosyl-(1 ? 3)-[alpha-l-arabinofuranosyl-(1 ? 4)]-beta-d-glucopyranoside combined with fluconazole showed synergistic antifungal activity against fluconazole-resistant Candida albicans, with MIC50 values 31.80 microg/mL and FICI values 0.32.', '', 'Give postive result against antifungal activity', 35552063),
('Antifungal Phytochemical', 'Hecogenin acetate is a saponin present in plants of the agave genus', 'It have analgesic, antioxidant, antinociceptive, cardioactive, anticancer, antifungal and antimicrobial activity.', 'Hecogenin acetate showed minimal inhibitory concentration without significant relevance.', 'This novel extract can replace antimicrobial resistance and will use in the future', 36462578),
('Antifungal Phytochemical', 'Essential Oil of Acritopappus confertus (Gardner)', 'The results show that the essential oil has an antifungal effect, with C. albicans strains being the most susceptible. Furthermore, the oil can potentiate the effect of fluconazole against strains of C. tropicalis and C. albicans. Regarding its effect on micromorphology, the oil was also able to inhibit the filaments in all strains.', '', 'It can be concluded that the essential oil of A. confertus has potential against pathogenic fungi and bacteria, making it a target for the development of an antimicrobial drug.', 36297389),
('Antifungal Phytochemical', 'Monoterpene Isoespintanol (ISO)', 'action of isoespintanol (ISO) against clinical isolates of Candida tropicalis. Microdilution assays revealed fungal growth inhibition, showing minimum inhibitory concentration (MIC) values between 326.6 and 500 microg/mL.', '', 'The eradication of mature biofilms by ISO was between 20.3 and 25.8% after 1 h of exposure, being in all cases higher than the effect caused by amphotericin B (AFB), with values between 7.2 and 12.4%. This indicates that the antifungal action of ISO is associated with damage to membrane integrity and the induction of iROS production, causing cell death.', 36144544),
('Antifungal Phytochemical', 'volatile phytocomposition of snow mountain garlic (SMG)', 'SMG has shown significantly superior fungicidal power at 2x-MIC dose against C. albicans and C. glabrata in killing kinetic evaluation unlike the fungistatic effect of normal garlic.', '', 'cholesta-4,6-dien-3-ol,(3-beta) was uniquely identified in SMG as a potential inhibitor with high binding affinity to the active site of exo-1,3-betaglucan synthase, an established anti-candida drug target crucial for the biofilm matrix formation, thus suggesting a plausible anti-Candida mechanism.', 35389539),
('Antifungal Phytochemical', 'Lavandula angustifolia essential oil (LAEO).', 'The MICs of LAEO that effectively inhibited grows of C. albicans sputum strains ranged from 0.5 to 2% (mean MIC 1.17%; MIC50 1%; MIC90 2%) and within 30 min of exposure to LAEO, 90% reduction was observed with nine strains (C. albicans PED01, PED03, PED05, PED06, PED07, PED08, PED09, PED13 and PED14) in time range 30 s', '', 'This study demonstrated that 2% solution of LAEO showed a significant antifungal activity which is equally effective against fluconazole and caspofungin susceptible and less-susceptible strains.', 36234837),
('Antifungal Phytochemical', 'Linalool is a monoterpene', 'The main results of this study indicated that the C. albicans strains analyzed were resistant to fluconazole and sensitive to linalool at a dose of 256 microg/mL. Furthermore, the increase in the minimum inhibitory concentration (MIC) of linalool in the presence of sorbitol and ergosterol indicated that this molecule possibly affects the cell wall and plasma membrane integrity of C. albicans. The antimicrobial activity of the phytocompost was interpreted as active or non-active according to the criteria proposed by Morales et al: strong/good activity (MIC: <100 microg/mL); moderate activity (MIC: >100 to 500 microg/mL); weak activity (MIC: >500 to 1000 microg/mL); and inactive/no antimicrobial effect (MIC: >1000 microg/mL).', '', 'the findings of this study indicated that linalool probably causes damage to the cell wall and plasma membrane of C. albicans, possibly by interaction with important enzymes involved in the biosynthesis of these fungal structures', 35976268),
('Antifungal Phytochemical', 'clove essential oil (CEO) and eugenol (EUG)', 'The CEO and EUG showed activity against all Candida strains with a minimal inhibitory concentration (MIC) in the range of 0.25-2 mg/mL.', '', 'It was also found that both natural products bind to ergosterol in the yeast cell membrane. This study confirms that the studied compounds appear to be a very promising group of phytopharmaceuticals used topically in the treatment of superficial candidiasis. However, this requires further studies in vivo.', 36615409),
('Antifungal Phytochemical', 'engineered Saccharomyces cerevisiae (baker''s yeast) and Saccharomyces boulardii (probiotic yeast) to produce the nonantibiotic fungal anhydrotetracycline, TAN-1612', '', '', 'engineered S. boulardii can biosynthesize complex natural products like tetracyclines, setting the stage to equip probiotic yeasts with synthetic therapeutic functionalities to generate living therapeutics or biocontrol agents for clinical and agricultural applications.', 35699947),
('Antifungal Phytochemical', 'distilled extract of bergamot (Citrus bergamia Risso et Poiteau)', '', '', 'Conclusions: Our data suggest that the use of essential oils, such as distilled extract of bergamot (Citrus bergamia Risso et Poiteau), can represent a valid alternative therapeutic strategy to counteract antibiotic resistance of pathogens.', 35326824),
('Antifungal Phytochemical', 'Anatolian honey bee venom', 'against yeast-like fungi', '', 'These findings strongly suggest that Anatolian HBV will be developed as a new antibacterial-antifungal drug against Gram-positive, Gram negative and antibiotic-resistant bacteria and yeast-like fungi.', 35421436),
('Antifungal Phytochemical', 'Salacia oblonga Wall Leaf and Root Extracts', 'The ethyl acetate extract of root with a 100 microg/ml concentration showed 15.8, 15.2, and 15.6 mm zone of inhibition against fungal isolates M. canis, T. interdigitale, and M. gypseum, respectively.', '', 'The activity of root and leaf extracts increased in a concentration-dependent manner, and further, the compounds isolated from the crude extracts of leaf and root showed antimicrobial activity.', 35612657),
('Antifungal Phytochemical', 'Withania somnifera (L.) Dunal whole-plant extracts', 'exhibited anti-sporotrichotic effects by destabilizing peripheral integrity of Sporothrix globosa yeast cells', '', 'In conclusion, this study has demonstrated the anti-sporotrichotic property of the whole plant extract of W. somnifera against S. globosa that could be further explored for the development of a natural antifungal agent against chronic Sporotrichosis.', 35714107),
('Antifungal Phytochemical', 'Essential Oils Isolated from Juniperus oxycedrus L. ssp. macrocarpa Aerial Parts', 'The strongest fungicidal activity was recorded against Candida auris sessile cells (median FICI was 0.088) but not against C. albicans biofilms (median FICI was 1).', '', 'The therapeutic potential of Juniperus may be promising for future more extensive research and in vivo tests to develop new drugs against antibiotic and antifungal resistance.', 35456809),
('Antifungal Phytochemical', 'licorice extract', 'rosemary and licorice extracts were chosen to prepare a topical cream for further in vivo wound healing and histopathology.', '', 'In vivo histopathological examination revealed that acetonic rosemary and licorice extract could be promising for wound healing, combating MDR pathogens of burn wound infections.', 35727122),
('Antifungal Phytochemical', 'Agaricus gennadii extract', 'Trichosporon mucoides and Candida parapsilosis exhibit susceptibility to Agaricus gennadii extract', '', 'Trichosporon mucoides and Candida parapsilosis were susceptible to the fungal extract at all concentrations, however, no effect of the fungal extract on the rest of the studied yeasts. Also, our results demonstrated that the susceptibility was increased with the increase of the fungal extract concentration.', 35491937),
('Antifungal Phytochemical', 'Essential oil from Lavandula angustifolia', 'The results showed that lavender EO possesses potent antifungal activity against F. solani. A complete inhibition in the fungal growth was recorded for lavender EO at 1.6%.', '', 'Results obtained from this study support the possibility of using lavender EO for control of sorghum damping-off.', 35039591),
('Antifungal Phytochemical', 'Essential Oil from Artemisia aragonensis Lam.', 'EOA displayed significant antifungal activity against four strains of fungi: F. oxysporum, C. albicans, A. flavus and A. niger with values of 21.50 ', '', 'The results of the current study highlight the importance of EOA as an alternative source of natural antioxidant and antibacterial drugs to combat antibiotic-resistant microbes and free radicals implicated in the inflammatory responses accompanying microbial infection.', 35164402),
('Antifungal Chemical Compound', ' A32390A, a new biologically active metabolite', ' In vitro antifungal activity of A32390A was found against Candida albicans, Cryptococcus neoformans and Histoplasma capsulatum.', '', ' In vitro and in vivo antifungal activity.  A32390A, an isonitrile-containing derivative of mannitol, represents a new class  of antifungal antibiotics.', 342474),
('Antifungal Chemical Compound', ' Cys-reduced form of S100A7/psoriasin (redS100A7)', ' Inhibits various filamentous fungi, including the mold Aspergillus fumigatus, but not Candida albicans', '', ' Thus, selective fungal  cell-penetrating Zn(2+)-chelators could be useful as an urgently needed novel antifungal therapeutic, which induces programmed cell death in numerous fungi.  ', 26438863),
('Antifungal Chemical Compound', ' FX0685, a novel triazole antifungal agent', 'Potential antifungal for the treatment of various  clinical forms of systemic candidiasis, including those caused by FLC-resistant C. albicans, as well as for the treatment of pulmonary aspergillosis', '', ' In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.', 16010849),
('Antifungal Chemical Compound', ' QACs, cationic lipo-oxazoles', 'Activity against both fluconazole-sensitive and resistant clinical isolates  of Candida albicans as well as non-albicans Candida strains.', '', ' Chain-length-specific anti-Candida activity of cationic lipo-oxazoles: a new class of quaternary ammonium compounds. CONCLUSION: A novel class of QACs, called cationic lipo-oxazoles, was tested and  found to exhibit anti-fungal activity against planktonic cells as well as biofilms of Candida.  ', 29076804),
('Antifungal Chemical Compound', '1-[(biarylmethyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)pro pan-2-ols', 'Broad-spectrum antifungal activities against the most prevalent human pathogenic  fungi (Candida spp. and Aspergillus fumigatus)', '', ' Design, synthesis, and biological evaluation of 1-[(biarylmethyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)pro pan-2-ols as potent antifungal agents: new insights into structure-activity relationships.', 21748853),
('Antifungal Chemical Compound', '1-R-2-([1,2,4]triazolo[1,5-c]quinazoline-2-ylthio)etanon(ol) analogues', 'Antibacterial and antifungal activity', '', ' 1-R-2-([1,2,4]Triazolo[1,5-c]quinazoline-2-ylthio)etanon(ol)s: Synthesis, Bioluminescence Inhibition, Molecular Docking Studies, Antibacterial and Antifungal Activities.  The increasing mortality due to antibacterial resistance necessitates the search  for novel antimicrobial agents.', 27012316),
('Antifungal Chemical Compound', '2-(2''-hydroxy-5''-aminophenyl) benzoxazole (HAMBO)', ' The inhibition provided by HAMBO was lower than that of fluconazole, showing low antifungal activity against Candida spp., but equivalent to that of benzoxazoles tested in similar studies.: HAMBO showed fungistatic activity against all analysed strains.', '', ' In vitro antifungal activity of 2-(2''-hydroxy-5''-aminophenyl)benzoxazole in Candida spp. Strains. This class of novel benzoxazole compounds may be used as template to produce better antifungal drugs. ', 19302462),
('Antifungal Chemical Compound', '2,3,5-tri-O-benzyl-d-ribose (compound 1) and a 2,5-functionalized imidazole (compound 2', 'Inhibited chitin synthases in vitro with IC50 values of 1.8 and 10 microM, respectively and antifungal activity against B. cinerea BD90 strain with MIC values of 190 and 100 microM, respectively', '', ' Discovery of two new inhibitors of Botrytis cinerea chitin synthase by a chemical library screening.   Chitin synthases polymerize UDP-GlcNAC to form chitin polymer, a key component of fungal cell wall biosynthesis.', 23886809),
('Antifungal Chemical Compound', '2,5-disubstituted tetrazole derivatives containing benzothiazole, benzoxazole or phenylsulfonyl moiety synthesized by N-alkylation of aryltetrazole with 2-[(3-chloropropyl)sulfanyl]-1,3-benzothiazole or 2-[(3-chloropropyl)sulfanyl]-1,3-benzoxazole and Michael-type addition of aryltetrazole to phenyl vinyl sulfone', ' All the tetrazole derivatives acted at the same level against C. albicans and demonstrated a high cell growth inhibition (97-99%) at the concentrations ranging from 16 to 0.0313 microg/mL', '', 'Synthesis of novel tetrazole derivatives and evaluation of their antifungal activity.  In this context new 2,5-disubstituted tetrazole derivatives containing benzothiazole, benzoxazole or phenylsulfonyl moiety were synthesized by N-alkylation of aryltetrazole with 2-[(3-chloropropyl)sulfanyl]-1,3-benzothiazole or 2-[(3-chloropropyl)sulfanyl]-1,3-benzoxazole and Michael-type addition of aryltetrazole to phenyl vinyl sulfone.', 27745991),
('Antifungal Chemical Compound', '2-Aminonicotinamide Derivatives', 'Overall MIC80?between 0.0313 to 4.0 microg mL-1,  compounds 11 g [2-amino-N-((5-(((2-fluorophenyl)amino)methyl)thiophen-2-yl)methyl)nicotinamide] and 11 h [2-amino-N-((5-(((3-fluorophenyl)amino)methyl)thiophen-2-yl)methyl)nicotinamide] displayed excellent activity against C. albicans, with MIC80?values of 0.0313 ?g mL-1', '', 'Synthesis and Biological Evaluation of Novel 2-Aminonicotinamide Derivatives as Antifungal Agents.', 28071858),
('Antifungal Chemical Compound', '2-cyclohexylidenhydrazo-4-phenyl-thiazole', ' 99.9% loss of C. albicans viability, also active in inhibiting the growth of C. albicans ATCC 10231 biofilms', '', ' CONCLUSIONS: Based on these results, EM-01D2 could represent a template for the development of novel fungicidal agents.  ', 15772140),
('Antifungal Chemical Compound', '2''-hydroxy-4''-methoxychalcone', 'Activity against fluconazole-resistant Candida albicans', '', 'To identify effective and low toxicity synergistic antifungal compounds, 24 derivatives of chalcone were synthesized to restore the effectiveness of fluconazole against fluconazole-resistant Candida albicans.  Of the synthesized compounds, 2''-hydroxy-4''-methoxychalcone (8) exhibited the most potent in vitro (FICI=0.007) effects.', 27210436),
('Antifungal Chemical Compound', '3-(halogenated phenyl)-5-acyloxymethyl- 2,5-dihydrofuran-2-one derivatives', 'The furanone derivatives displayed broad-spectrum in vitro activity against potentially pathogenic yeasts and molds, especially Aspergillus spp. (MIC <or= 2.0 microg/ml) and fluconazole-resistant yeast isolates, including Candida glabrata and Saccharomyces cerevisiae.  4-bromophenyl derivative was the most effective derivative against the majority of species tested, except for the Candida tropicalis and C. glabrata strains, which were more susceptible to the 3-chlorophenyl derivative. The 3,4-dichlorophenyl derivative possessed a lesser in vitro antifungal effect.', '', ' Thus, the halogenated 3-phenyl-5-acyloxymethyl derivatives of 2,5-dihydrofuran-2-one represent a novel, promising group of compounds with significant activity against relevant opportunistic fungi that are pathogenic to humans.   ', 14982778),
('Antifungal Chemical Compound', '3-Aryl-4-[alpha-(1H-imidazol-1-yl)arylmethyl]pyrrole derivatives', 'The most active derivative (27) was twice as potent (MIC90) as bifonazole, and its activity was 4 times greater than those of miconazole and ketoconazole.: The other nine compounds showed antifungal activity of the same order of that of bifonazole and were ca. 2 times as active as miconazole and ketoconazole.', '', 'A new class of potent antifungal agents, namely, 3-aryl-4-[alpha-(1H-imidazol-1-yl)arylmethyl]-pyrroles, is described.', 7473549),
('Antifungal Chemical Compound', '4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamide derivatives', 'Antibacterial and Antifungal (Candida albicans) activity', '', ' Synthesis and potent antimicrobial activity of some novel 4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides.    A series of 4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides were  synthesized and evaluated for antibacterial and antifungal activities against Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), methicillin-resistant S. epidermis (MRSE), Enterococcus faecalis, Escherichia coli and Candida albicans.', 15476288),
('Antifungal Chemical Compound', '4-bromo-5Z-(bromomethylene)-3-butylfuran-2-one (BF1)', 'Inhibition of Candida albicans growth', '', ' In this study, we demonstrate the antifungal activity of brominated furanones on C. albicans. Studying the structure and activity of this class of furanones reveals that the exocyclic vinyl bromide conjugated with the carbonyl group is the most important structural element for fungal inhibition.', 19756586),
('Antifungal Chemical Compound', 'A series of 3,4-dichloro-, 3-methyl and non-substituted maleimides', 'Of the 63 compounds evaluated, 25 compounds had interesting inhibitory potency with EC50 < 10 microg mL(-1). N-(3,5-Dichlorophenyl)-3,4-dichloromaleimide (EC50 = 1.11 microg mL(-1)) and N-octyl-3-methylmaleimide (EC50 = 1.01 microg mL(-1)) were more potent than the commercial fungicide dicloran (EC50 = 1.72 microg mL(-1)).', '', ' CONCLUSION: The present work demonstrates that some maleimides can be used as potential lead compounds for developing novel antifungal agents against S. sclerotiorum.  ', 24796632),
('Antifungal Chemical Compound', 'Acetophenone-derived bis Mannich bases, B1-B5, bis(beta-aroylethyl)methylamine hydrochlorides', 'All compounds studied have shown antifungal activity, especially against dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans, and Microsporum canis), in the concentration range studied (2-128 microng/ml)', '', ' Antifungal evaluation of bis Mannich bases derived from acetophenones and their corresponding piperidinols and stability studies.   The development of resistance to current antifungal therapeutics drives the search for effective new agents.', 12392084),
('Antifungal Chemical Compound', 'Aflastatin A', 'Completely inhibited aflatoxin production by Aspergillus parasiticus NRRL 2999 in liquid medium or on agar plate at a concentration of 0.5 microgram/ml', '', ' Aflastatin A, a novel inhibitor of aflatoxin production by aflatoxigenic fungi.   Aflastatin A, a novel inhibitor of the production of aflatoxin by aflatoxigenic fungi, has been isolated from the solvent extract of mycelial cake of Streptomyces sp. and its molecular formula was determined as C62H115NO24.', 9099219),
('Antifungal Chemical Compound', 'Alkylated mono-, bis-, and trisbenzimidazole derivatives', 'MIC values ranging from 15.6 to 0.975 microg/mL', '', 'Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.  ', 27301676),
('Antifungal Chemical Compound', 'Ambroxol Hydrochloride Combined with Fluconazole', 'Ambroxol hydrochloride (128 ?g/mL) exhibits synergistic antifungal effects in combination with fluconazole (2 ?g/mL) against resistant planktonic?Candida albicans?(C. albicans) cells and resistant C. albicans biofilms', '', ' In this study, we found that ambroxol hydrochloride (128 ?g/mL) exhibits synergistic antifungal effects in combination with fluconazole (2 ?g/mL) against resistant planktonic Candida albicans (C. albicans) cells. The results show the potential role for this drug combination as a therapeutic alternative to treat resistant C. albicans and provide insights into the development of antifungal targets and new  antifungal agents.  ', 28439502),
('Antifungal Chemical Compound', 'Aminoglycoside antibiotics combined with different sulphate-transport inhibitors', 'Combinations decreased the respective MICs by greater than 8-fold, active aginst human pathogens Candida albicans, C. glabrata and Cryptococcus neoformans, the food spoilage organism Zygosaccharomyces bailii and the phytopathogens Rhizoctonia solani and Zymoseptoria tritici.', '', 'Novel, Synergistic Antifungal Combinations that Target Translation Fidelity', 26573415),
('Antifungal Chemical Compound', 'Anthracene-9-carboxylic and niflumic acid', 'Effect on growth, energy metabolism and anionic current of mycelium of fungus Phycomyces blakesleeanus', '', ' Growth inhibition of fungus Phycomyces blakesleeanus by anion channel inhibitors  anthracene-9-carboxylic and niflumic acid attained through decrease in cellular respiration and energy metabolites.   Increasing resistance of fungal strains to known fungicides has prompted identification of new candidates for fungicides among substances previously used  for other purposes.', 28100310),
('Antifungal Chemical Compound', 'AR-12, Celecoxib Derivative', 'Activity against yeasts (e.g., Candida albicans, non-albicans Candida spp., Cryptococcus neoformans), molds (e.g., Fusarium, Mucor), and dimorphic fungi (Blastomyces, Histoplasma, and Coccidioides) with MICs of 2 to 4 ?g/ml.', '', ' The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis.', 27645246),
('Antifungal Chemical Compound', 'Aryl isonitrile compounds', 'Broad-spectrum antifungal activity primarily against species of Candida and Cryptococcus, most potent derivatives are capable of inhibiting growth of these key pathogens at concentrations as low as 0.5 microM', 'The most active compounds exhibit an excellent safety profile and are non-toxic to mammalian cells even at concentrations up to 256 microM', '  Investigation of aryl isonitrile compounds with potent, broad-spectrum antifungal activity.  ', 28385596),
('Antifungal Chemical Compound', 'aryl-1,2,4-triazol-3-ylthio analogues of fluconazole (ATTAF-1 and ATTAF-2)', 'Showed lowest geometric mean MICs, combinations fluconazole exhibited synergistic effects against fluconazole-susceptible (22 of 23 isolates), fluconazole-susceptible dose-dependent (10 of 13 isolates), and fluconazole-resistant (1 of 16 isolates) Candida isolates.', '', '  In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species.   The in vitro activities of two novel azole compounds (aryl-1,2,4-triazol-3-ylthio analogues of fluconazole [ATTAFs]) and five comparator antifungal agents against  52 clinical Candida isolates from 5 different species were determined.', 27795371);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antifungal Chemical Compound', 'ASP2397', 'ASP2397 MIC50 values were 0.5 mg/L (0.25 to 1) and 0.25 mg/L(0.06 to 0.25) against A. fumigatus CYP51A wild-type isolates and were similarly 0.5 mg/L (0.125 to >4) and 0.125 mg/L (0.06 to >4) against azole-resistant A. fumigatus isolates, respectively. ASP2397 was active against A. terreus CYP51A wild-type isolates (MIC 0.5 to 1) ', '', 'In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.   ASP2397 is a new compound with a novel and as-yet-unknown target different from that of licensed antifungal agents.', 26552973),
('Antifungal Chemical Compound', 'Azoxybacilin', 'Broad spectrum antifungal activity, especially active against mycelial fung', '', ' A new methionine antagonist that has antifungal activity: mode of action.    A new antifungal, azoxybacilin (an unusual amino acid with an azoxy moiety) was identified from Bacillus cereus, and its in vitro antifungal activity and mode of action were investigated.', 7928678),
('Antifungal Chemical Compound', 'Benzimidazole derivatives [(S)-2-aminoalkyl benzimidazole derivative, (S)-2-(1-Aminoisobutyl)-1-(3-chlorobenzyl) benzimidazole]', '(S)-2-(1-Aminoisobutyl)-1-(3-chlorobenzyl) benzimidazole showed the highest antifungal activity against a number of clinical isolates of several species of pathogenic Candida yeasts.', '(S)-2-(1-Aminoisobutyl)-1-(3-chlorobenzyl) benzimidazole showed the showed best compatibility with human cells in several cell culture models', 'A screening assay based on host-pathogen interaction models identifies a set of novel antifungal benzimidazole derivatives.', 21746957),
('Antifungal Chemical Compound', 'Benzofuran derivatives', 'Antifungal activity against C. albicans', '', ' Synthesis and biological activities of benzofuran antifungal agents targeting fungal N-myristoyltransferase.   The C-4 side chain modification of lead compound 1 has resulted in the identification of a potent and selective Candida albicans N-myristoyltransferase  (CaNmt) inhibitor RO-09-4609, which exhibits antifungal activity against C. albicans in vitro.', 13129583),
('Antifungal Chemical Compound', 'Berberine derivative B-7b and fluconazole', ' The potent synergistic activity of B-7b in combination with FLC against FLC-resistant C. albicans, the disruption of protein folding and processing and the weakening of cells'' self-defensive ability contributed to the synergism of FLC and B-7b.', '', ' Together, these results suggested novel scaffold BBR derivative B-7b could be a promising synergist in combination  with FLC for the treatment of invasive fungal infections.  ', 25992630),
('Antifungal Chemical Compound', 'bis(N-amidinohydrazones) and N-(amidino)-N''-aryl-bishydrazones', 'Antibacterial and antifungal agents, MIC values ranging from (less than) 0.5 to (greater tahn) 500 microM against bacteria and 1.0 to (greater than) 31.3 micro g/mL against fungi', 'Minimal emergence of drug resistance to these newly synthesized compounds by bacteria and fungi even after 15 passages, and we found weak to moderate inhibition of the human Ether-?-go-go-related gene (hERG) channel with acceptable IC50?values ranging from 1.12 to 3.29 microM', ' Overall, these studies show that bis(N-amidinohydrazones) and N-(amidino)-N''-aryl-bishydrazones are potentially promising scaffolds for the discovery of novel antibacterial and antifungal agents.  ', 27769670),
('Antifungal Chemical Compound', 'Bromoquinol', 'Active against Aspergillus fumigatus', '', 'The quinoline bromoquinol exhibits broad-spectrum antifungal activity and induces oxidative stress and apoptosis in Aspergillus fumigatus. The most potent, bromoquinol, shows potent wide-spectrum antifungal activity that was blocked in the presence of exogenous iron.', 28475687),
('Antifungal Chemical Compound', 'CAN-296, complex carbohydrate', 'Inhibited proton pumping of Candida albicans, Candida glabrata, Candida krusei, Candida guilliermondii and Saccharomyces cerevisiae at low concentrations (0.078-1.25 mg/l)', '', ' Proton translocating ATPase mediated fungicidal activity of a novel complex carbohydrate: CAN-296.  CAN-296 is a complex carbohydrate (approximately 4300 Da) isolated from the cell  wall of Mucor rouxii.', 10755243),
('Antifungal Chemical Compound', 'Combination therapies using L-743,872, a pneumocandin antifungal drug, and amphotericin B or fluconazole', 'Showed additive and autonomous activities  against fluconazole-resistant isolates', '', ' The results of this study suggest that L-743,872 can enhance the efficacy of fluconazole or amphotericin B in vitro and indicate a potential role  for L-743,872 in combination therapy against C. neoformans.   ', 9021188),
('Antifungal Chemical Compound', 'Combination therapy of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818', 'Activity against Cryptococcus neoformans', '', 'Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans', 10681348),
('Antifungal Chemical Compound', 'Combination therapy of lysine and amphotericin B ', 'Lysine enhances the effect of AmB against Candida albicans in vitro', '', ' Using AmB together with lysine may be a promising strategy for the therapy of disseminated candidiasis.  ', 26711896),
('Antifungal Chemical Compound', 'Copper(II) complexes of 2-methylthionicotinate (2-MeSNic) of the composition Cu(2-MeSNic)2(MeNia)(2).4H2O (where MeNia is N-methylnicotinamide), and Cu(2-MeSNic)2(Nia)(2).2H2O (where Nia is nicotinamide) and Cu(2-MeSNic)2L2 (where L is isonicotinamide, iNia, or ethyl nicotinate, EtNic)', 'IC50 1.5-2.3 mmol/L against  Rhizopus oryzae and Microsporum gypseum, adducts with Nia, MeNia and EtNic at 5 mmol/L induced morphological changes in growing hyphae of Botrytis cinerea, inhibition of sporulation (> 90%) of Alternaria alternata by Cu(2-MeSNic)2.H2O', '', 'Antifungal activity of new copper(II) complexes of 2-methylthionicotinate (2-MeSNic) of the composition Cu(2-MeSNic)2(MeNia)(2).4H2O (where MeNia is N-methylnicotinamide), and Cu(2-MeSNic)2(Nia)(2).2H2O (where Nia is nicotinamide) and Cu(2-MeSNic)2L2 (where L is isonicotinamide, iNia, or ethyl nicotinate, EtNic) were tested on various strains of filamentous fungi by the macrodilution method.', 12094729),
('Antifungal Chemical Compound', 'CS-758, a novel triazole', 'CS-758 exhibited potent in vitro activity (MICs, 0.004 to 0.06 micro g/ml) against the strains used in this murine model including fluconazole-susceptible dose-dependent and fluconazole-resistant strains (fluconazole MICs, 16 to 64 micro g/ml)', '', ' Efficacy of CS-758, a novel triazole, against experimental fluconazole-resistant  oropharyngeal candidiasis in mice.   The therapeutic efficacy of CS-758, a novel triazole, was evaluated against experimental murine oropharyngeal candidiasis induced by Candida albicans with various susceptibilities to fluconazole.', 12543666),
('Antifungal Chemical Compound', 'CW-8/haemofungin', 'Inhibits the growth of pathogenic Aspergillus, Candida, Fusarium and Rhizopus isolates at micromolar concentrations', 'Only weakly affect the growth of mammalian cell lines', ' Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis.', 26747101),
('Antifungal Chemical Compound', 'Cyclohexyliden- and 2-methylcyclohexyliden-hydrazo-4-arylthiazoles', 'Five out of nine compounds were active towards Candida albicans 25 FLC resistant isolated from clinical specimens', '', ' On the basis of our data we can conclude that these derivatives are promising agents for the treatment of resistant C. albicans.  ', 26745285),
('Antifungal Chemical Compound', 'Cyclosporine (CsA) derivatives, (gamma-OH) MeLeu(4)-Cs (211-810) and D-Sar (alpha-SMe)(3) Val(2)-DH-Cs (209-825)', '', '', ' Our findings identify calcineurin as a novel antifungal drug target and suggest nonimmunosuppressive CsA analogs warrant investigation as antifungal agents.   ', 10602736),
('Antifungal Chemical Compound', 'Cystatin, affinity-purified from chicken egg white (CEWC)', ' CEWC inhibited the growth of azole-sensitive Candida albicans isolates with minimal inhibitory concentration (MIC) values ranging from 0.8 to 3.3 micromol l(-1), a potency comparable with those of fluconazole and histatin 5, the antimicrobial peptide of the human saliva.', '', 'The antifungal properties of chicken egg cystatin against Candida yeast isolates  showing different levels of azole resistance.   The increasing incidence of fungal infections together with the emergence of strains resistant to currently available antifungal drugs calls for the development of new classes of antimycotics.', 19549107),
('Antifungal Chemical Compound', 'D0870, antifungal triazole', 'MICs for 50 and 90% of the isolates tested were < or = 0.0078 and 0.06 micrograms/ml', '', ' In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.    We investigated the in vitro activity of a new antifungal triazole, D0870, against 100 Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus by using a broth macrodilution method following the recommendations provided by the National Committee for Clinical Laboratory Standards (document M27-P).', 7872746),
('Antifungal Chemical Compound', 'D75-4590', 'Potent activities against various Candida species, specific inhibitor of beta-1,6-glucan synthesis', '', ' These lines of evidence indicate that D75-4590 is a promising lead compound for novel antifungal drugs.', 19015325),
('Antifungal Chemical Compound', 'Derivatives of the ring system indolo[1,2-c]benzo[1,2,3]triazine 5 synthesized by diazotization of substituted 2-(2-aminophenyl)indoles', 'Antitumour and antifungal activity', 'Antifungal activity at concentrations very close to those inhibiting the proliferation of human cells', ' Derivatives of the new ring system indolo[1,2-c]benzo[1,2,3]triazine with potent  antitumor and antimicrobial activity.   Derivatives of the new ring system indolo[1,2-c]benzo[1,2,3]triazine 5 were synthesized by diazotization of substituted 2-(2-aminophenyl)indoles followed by  an intramolecular coupling reaction of the diazonium group with the indole nitrogen.', 10411476),
('Antifungal Chemical Compound', 'Dichloromethyl-4-chloro-3-nitrophenylsulfone (Compound 1) and chlorodibromomethyl-4-hydrazino-3-nitrophenylsulfone (Compound 2', 'Compound 1 showed higher activity (% = 100 at 4 ?g/ml) than Compound 2 (MIC90 = 16 ?g/ml) against Candida spp', '', 'Sulfone derivatives reduce growth, adhesion and aspartic protease SAP2 gene expression.  Fungal virulence factors represent a strategy for the design of new compounds with effective activities against Candida spp.', 24880247),
('Antifungal Chemical Compound', 'Diguanidino 1-methyl-2,5-diaryl-1H-pyrroles', ' The antifungal activities evaluated against Candida spp. and Aspergillus spp.', '', ' Synthesis of some diguanidino 1-methyl-2,5-diaryl-1H-pyrroles as antifungal agents.   A series of novel 2,5-bis(guanidino-aryl)-1-methyl-1H-pyrroles 9a-h has been synthesized starting from 1-methyl-1H-pyrrole.', 15978808),
('Antifungal Chemical Compound', 'Eugenol and methyl eugenol', 'Antifungal activity by targeting sterol biosynthesis, additional methyl group to eugenol increases its antifungal activity', '', ' The observed fungicidal characteristics of both eugenol and methyl eugenol indicate that both  the compounds might be promising antifungal agents defining a new class of antimycotics.  ', 19835945),
('Antifungal Chemical Compound', 'F901318', 'A. fumigatus WT, MIC90 0.125 mg/L (range 0.031-0.125); TR34/L98H,TR46/Y121F/T289A and azole resistant without known resistance mechanisms, MIC90 0.125 mg/L (range 0.031-0.25); A. fumigatus with cyp51A-associated point mutations, MIC90 0.062 mg/L (range 0.015-0.125); and other species, A. calidoustus MIC90 0.5 mg/L (range 0.125-0.5), A. flavus MIC90 0.062 mg/L (range 0.015-0.62), A. nidulans MIC90 0.125 mg/L (range 0.062-0.25) and A. tubingensis MIC90 0.062 mg/L (range 0.015-0.25)', '', ' In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.', 28605488),
('Antifungal Chemical Compound', 'FK463, a (1,3)-beta-D-glucan synthase inhibitor', 'Efficacy against azole-resistant Candida albicans', '', ' Efficacy of FK463, a (1,3)-beta-D-glucan synthase inhibitor, in disseminated azole-resistant candida albicans infection in mice.  The efficacy of FK463, a new (1,3)-beta-D-glucan synthase inhibitor, against azole-resistant Candida albicans strains has been studied.  In our study, FK463 was found to be a potent antifungal agent against disseminated infection with azole-resistant C. albicans.', 10817741),
('Antifungal Chemical Compound', 'FK-506, immunosuppressant agent', 'antagonist of T-cell activation and an inhibitor of  fungal growth', '', ' Antifungal properties of the immunosuppressant FK-506: identification of an FK-506-responsive yeast gene distinct from FKB1.', 1715022),
('Antifungal Chemical Compound', 'Glabridin', 'Significant decrease in MICs against fluconazole-resistant C. glabrata (MIC50: 8 micro g/mL)', '', ' Glabridin is an originally natural substrate with multiple  biological activities which propose it as a novel anticancer, antimicrobial and antifungal agent.', 28595940),
('Antifungal Chemical Compound', 'Glucosylated solasodine-3-O-beta-d-glucopyranoside?', 'Activity against wild type Candida albicans', '', ' Our study reveals that glucosylation is an alternative approach for introducing potential antifungal activity into C.?albicans cells and overcoming the drug-resistance resulting from hyperactivation of efflux pumps.  ', 28919409),
('Antifungal Chemical Compound', 'Guanylated polymethacrylates', 'The most potent compound kills 99.98% of S. aureus and 82.2% of C. albicans at a concentration of 128 mg/L', '', 'Searching for new strategies against polymicrobial biofilm infections: guanylated polymethacrylates kill mixed fungal/bacterial biofilms.   OBJECTIVES: Biofilm-related human infections have high mortality rates due to drug resistance.', 26490013),
('Antifungal Chemical Compound', 'Halogenated quinoline (HQ) analogues', 'Four HQ analogues inhibited C. albicans growth with a minimum inhibitory concentration (MIC) of 100 nM, whilst 16 analogues effectively inhibited C. neoformans at MICs of 50-780 nM. Remarkably, two HQ analogues eradicated mature C. albicans and C. neoformans biofilms [minimum biofilm eradication concentration (MBEC) = 6.25-62.5 microM].', '', ' HQs are a promising class of small molecules that may be useful in future antifungal treatments.  ', 27256584),
('Antifungal Chemical Compound', 'Hydrogen peroxide', 'Adjunctive therapy for treatment of mucormycosis', '', ' Adjunctive therapy with hydrogen peroxide.  Mucormycosis is a devastating fungal disease affecting mainly diabetic and immunosuppressed patients and frequently causing death.', 8810881),
('Antifungal Chemical Compound', 'Hydroxyaldimines', 'Activity against Cryptococcus gattii and Cryptococcus neoformans strains', '', ' The in vitro anticryptococcal activity of hydroxyaldimines against various strains of C.?gattii and C.?neoformans indicates the potential of this class of molecules as lead compound for the development of selective and efficient anticryptococcal agents.', 23594040),
('Antifungal Chemical Compound', 'IB-367', 'Exerted a fungicidal activity against Trichophyton mentagrophytes, T. rubrum and Microsporum canis', '', ' We propose IB-367 as a promising candidate for the future design of antifungal drugs.  ', 26058322),
('Antifungal Chemical Compound', 'Imidazolium salt 1-n-hexadecyl-3-methylimidazolium chloride (C16 MImCl)', 'Prevents, in concentrations as low as 0?028 microg ml(-1) , the biofilm formation of multidrug-resistant Candida tropicalis isolates', '', ' As  such, C16 MImCl has been identified as a promising antimicotic pharmaceutical candidate for the treatment of candidiasis infections', 25294047),
('Antifungal Chemical Compound', 'Imidazolium salts (1-n-Hexadecyl-3-methylimidazolium chloride (C16 MImCl) and 1-n-hexadecyl-3-methylimidazolium methanesulfonate (C16 MImMeS))', ' All dermatophytes were inhibited by IMS, where the lowest minimum inhibitory concentration (MIC) values  were observed for salts with n-hexadecyl segment in the cation side chain, containing either the chloride or methanesulfonate anion. 1-n-Hexadecyl-3-methylimidazolium chloride (C16 MImCl) and 1-n-hexadecyl-3-methylimidazolium methanesulfonate (C16 MImMeS) acted as fungicides, even in extremely low concentrations, wherein C16 MImMeS exerted this effect on 100% of the tested dermatophytes.', '', ' The expressive antifungal activity of IMS,  combined with the in vitro nontoxicity, makes them promising compounds for the safe and effective treatment of dermatophytoses, mainly when this skin mycosis is unresponsive to conventional drugs.  ', 26043668),
('Antifungal Chemical Compound', 'JS399-19, cyanoacrylate fungicide', 'Targets the motor domain of type I myosin, specific to Fusarium', '', 'Real-time imaging was used to study the effects of a novel Fusarium-specific cyanoacrylate fungicide (JS399-19) on growth and morphology of four Fusarium sp.  This fungicide targets the motor domain of type I myosin.', 27914536),
('Antifungal Chemical Compound', 'KB425796-A congeners', 'Congeners of KB425796-A, named KB425796-B, -C, -D, -E, -F, -G, -H, -I, -J and -K, which exhibited diverse antifungal potencies against A. fumigatus', '', 'Identification of ten KB425796-A congeners from Paenibacillus sp. 530603 using an antifungal assay against Aspergillus fumigatus in combination with micafungin.  ', 23778114),
('Antifungal Chemical Compound', 'KB425796-C in combination with micafungin', 'Antifungal activity against micafungin-resistant fungi and was fungicidal to Trichosporon asahii in vitro', '', ' Synergistic antifungal activity of KB425796-C in combination with micafungin against Aspergillus fumigatus and its efficacy in murine infection models. KB425796-C is a novel antifungal metabolite produced by the newly isolated bacterial strain Paenibacillus sp.', 23756682),
('Antifungal Chemical Compound', 'KP-363, butenafine hydrochloride', 'Wide spectrum activity in vitro against particularly dermatophytes (87 strains; minimal inhibitory concentration (MIC) range, 0.0015 to 0.05 microgram/ml), and also against Aspergillus (15 strains; MIC range, 0.025 to 0.78 microgram/ml), Cryptococcus neoformans (4 strains; MICs 0.78 and 1.56 micrograms/ml) and yeasts of genus Candida (67 strains; MIC range, 3.13 to greater than 100 micrograms/ml).  ', '', ' [Synthesis and antifungal activity of butenafine hydrochloride (KP-363), a new benzylamine antifungal agent].    In screening of new antifungal agents, bis(naphthalenemethyl)amines were found to have more potent antifungal activity than clotrimazole.', 2056447),
('Antifungal Chemical Compound', 'L-733,560, pneumocandin antifungal agent', 'The mean MICs of L-733,560 were 0.15 microgram/ml for C. lusitaniae, 0.72 microgram/ml for C. parapsilosis, 0.78 micrograms/ml for C. krusei, and 1.25 micrograms/ml for C. guilliermondii', '', ' The results indicate that the new antifungal agent L-733,560 demonstrated the best activity with the lowest MICs against C. albicans, T. glabrata, C. tropicalis, and C. kefyr, less activity against C. krusei, C. lusitaniae, and C. parapsilosis, and the least activity against C. guilliermondii.', 8593003),
('Antifungal Chemical Compound', 'L-733560, a new water-soluble hybrid of L-705589 and L-731373', ' Growth inhibition kinetic studies against Candida albicans revealed fungicidal activity within 3 to 5 h', '', ' In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373.', 7625791),
('Antifungal Chemical Compound', 'Luliconazole, Lanoconazole, and Efinaconazole', 'Activity against Melanized Fungi and Relatives', '', ' Therefore, it appears that these new imidazole and triazole drugs are promising candidates for the treatment of infections due to melanized fungi and their relatives.  Copyright ? 2017 American Society for Microbiology.  DOI: 10.1128/AAC.00635-17  PMCID: PMC5655049', 28848012),
('Antifungal Chemical Compound', 'Macrocyclic amidinoureas', 'Potent  antifungal activity against Candida spp', '', ' Biological Characterization and in Vivo Assessment of the Activity of a New Synthetic Macrocyclic Antifungal Compound.   We recently identified a novel family of macrocyclic amidinoureas showing potent  antifungal activity against Candida spp.', 27045868),
('Antifungal Chemical Compound', 'Magnolol', 'MIC?ranging from 10 to 40 micro g/mL against C. albicans?and non-albicans?Candida?species, especially fluconazole-resistant?Candida krusei, with the minimum inhibitory concentrations , BMIC90?(minimum concentration with 90%?Candida?biofilm inhibited) values of magnolol ranged from 20 to 160 micro g/mL', '', ' As an alternative and broad-spectrum antifungal agent, magnolol might be of benefit to the treatment of refractory Candida infection.  ', 28919715),
('Antifungal Chemical Compound', 'ME1111', 'MIC90 against dermatophyte strains was 0.25 micro g/ml, MFC90s against Trichophyton rubrum and Trichophyton mentagrophytes were 8 micro g/ml', '', 'In vitro antifungal activity of ME1111, a new topical agent for onychomycosis, against clinical isolates of dermatophytes.  ME1111 is a novel selective inhibitor of succinate dehydrogenase (complex II) of dermatophyte species, whose small molecular weight enhances its ability to penetrate the nail  plate.', 26055386),
('Antifungal Chemical Compound', 'ME1111', 'ME1111 strongly inhibited the succinate-2,6-dichlorophenolindophenol reductase reaction  in Trichophyton rubrum and T. mentagrophytes (50% inhibitory concentrations [IC50s] of 0.029 and 0.025 microg/ml, respectively)', '', ' ME1111 is a novel antifungal agent that is active against dermatophytes, has an excellent ability to penetrate human nails,  and is being developed as a topical agent for onychomycosis.', 26596944),
('Antifungal Chemical Compound', 'ME1401, a new antifungal agent', 'Broad antifungal spectrum and inhibited all of the 428 strains of 52 species of pathogenic yeasts and filamentous fungi tested at concentrations ranging from 0.01 to 12.5 micrograms/ml.', '', ' In vitro activity of ME1401, a new antifungal agent.  Yamaguchi H, Uchida K, Hiratani T, Hara T, Fukuyasu H, Kazuno Y, Inouye S.  The in vitro antifungal activity of ME1401, a potential topical antifungal agent, was compared with that of haloprogin, clotrimazole, miconazole, tolnaftate, and ciclopirox olamine by using an agar dilution procedure.', 3800346),
('Antifungal Chemical Compound', 'Mono, bis and quaternary Mannich bases derived from acetophenone', 'Activity against Saccharomyces cerevisiae', '', ' Antifungal activity of some mono, bis and quaternary Mannich bases derived from acetophenone.   The development of resistance to current antifungal therapeutics drives search for new effective agents.', 11215330),
('Antifungal Chemical Compound', 'N-(1-benzyl-2-phenylethylidene)-N''-[4-(aryl)thiazol-2-yl]hydrazone (1a-e) and N-(1-phenylbutylidene)-N''-[4-(aryl)thiazol-2-yl]hydrazone (2a-e) derivatives', 'Antifungal activities tested against Candida albicans, Candida glabrata, Candida utilis, Candida tropicalis, Candida krusei, Candida zeylanoides, and Candida parapsilosis', '', ' Studies on hydrazone derivatives as antifungal agents.    The increasing clinical importance of drug-resistant fungal pathogens has urged additional need to fungal research and new antifungal compound development.', 18665994),
('Antifungal Chemical Compound', 'Naphthoquinone thiol-crown ether analogues', 'Bis-naphthoquinone thiol-crown ether 7a was the most potent inhibitor  against Staphylococcus aureus methicillin resistance with MIC value of 2.68 microM.  ', '', 'Efficient synthesis of ''redox-switched'' naphthoquinone thiol-crown ethers and their biological activity evaluation.', 11937353),
('Antifungal Chemical Compound', 'NC1175, styryl ketone', 'All 20 clinical isolates of A. fumigatus examined were susceptible to NC1175 (MIC = 5.54 +/- 2.48 mg/L; range 2.92-11.68 mg/L), and the minimum lethal concentration (MLC) was only twice the MIC, suggesting that NC1175 is fungicidal', '', ' In-vitro and in-vivo susceptibility of Aspergillus fumigatus to a novel conjugated styryl ketone.    We investigated the in-vitro and in-vivo susceptibility of Aspergillus fumigatus  to the novel conjugated styryl ketone NC1175 and the results were compared with those obtained for amphotericin B and itraconazole.', 9848441),
('Antifungal Chemical Compound', 'NCK-10, Aryl-alkyl-lysines', 'Inhibits growth Candida spp., Cryptococcus spp., and Aspergillus fumigatus, mechanism is disruption of the fungal cell membrane', '', ' Overall, aryl-alkyl-lysines were found to be excellent compounds that warrant further investigation as novel antifungal agents.  ', 28238268),
('Antifungal Chemical Compound', 'N-dimethylaminoacetyl-partricin A 2-dimethylaminoethylamide diaspartate (SPA)', 'Showed in vivo activity enhancing mouse resistance to cryptococcal meningoencephalitis and in vitro by potentiating the anticryptococcal activity of murine microglial cells', '', ' Potent antifungal effects of a new derivative of partricin A in a murine model of cerebral cryptococcosis.', 9056019),
('Antifungal Chemical Compound', 'New heptaketides, biatriosporins A-L (1-12), biatriosporin M (13) (a ramulosin derivative), and 19 known compounds (14-32)', 'The most potent compound, compound 4, also sensitized clinically derived azole-resistant Candida albicans strains to fluconazole (FLC)', '', 'Heptaketides from an Endolichenic Fungus Biatriospora sp. and Their Antifungal Activity', 27556953),
('Antifungal Chemical Compound', 'New series of thiazolyl-triazole Schiff bases B1-B15', 'Potential anti-Candida activity with Compound B10 being more potent', '', ' New Thiazolyl-triazole Schiff Bases: Synthesis and Evaluation of the Anti-Candida Potential.  In the context of the dangerous phenomenon of fungal resistance to the available  therapies, we present here the chemical synthesis of a new series of thiazolyl-triazole Schiff bases B1-B15, which were in vitro assessed for their anti-Candida potential.', 27879678),
('Antifungal Chemical Compound', 'New sulfated sterols, geodisterol-3-O-sulfite (1) and 29-demethylgeodisterol-3-O-sulfite (2)', 'Combat the resistance associated with opportunistic fungal infections caused by C. albicans', '', ' Reversal of fluconazole resistance by sulfated sterols from the marine sponge Topsentia sp.', 19653640),
('Antifungal Chemical Compound', 'Nitric-oxide releasing aspirin (NO-ASA)', ' Adhesion to abiotic surfaces, a critical event for biofilm formation, was evaluated in 96-well polystyrene plates using crystal violet assay; 125 micro M NO-ASA significantly inhibited C. albicans adhesion.', '', ' NO-ASA is a promising novel antibiofilm agent for treating fluconazole-resistant strains of C. albicans.  ', 28493889),
('Antifungal Chemical Compound', 'NND-502, imidazole compound', ' The geometric mean (GM)-MICs of NND-502 for 25 strains of M. furfur, 15 strains of M. sympodialis and ten strains of M. slooffiae were approximately 1.4, 0.1 and 1.0 mg/l, respectively', '', ' In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia  species.', 12636984),
('Antifungal Chemical Compound', 'Novel Schiff base [hetero-dinuclear copper(II) Mn(II) complex] (SB) derivative', 'Activity against Candida albicans', '', ' In the current study, a novel Schiff base [hetero-dinuclear copper(II) Mn(II) complex] (SB) derivative was investigated for its anticandidal activity against Candida albicans and possible  mechanisms inducing cell death.', 29080032),
('Antifungal Chemical Compound', 'N-substituted phthalimides (N-vinylphthalimide (4) and 8-[4-(phthalimide-2-yl) butyloxy] quinoline (13) )', 'Compound (4) and (13) were identified as the most promising candidates against B. cinerea and A. solani with the IC50 values of 7.92 microg/mL and 10.85 microg/mL respectively.?', '', ' N-vinylphthalimide (4) and 8-[4-(phthalimide-2-yl) butyloxy] quinoline (13) were  identified as the most promising candidates against B.?cinerea and A.?solani with the IC50 values of 7.92??g/mL and 10.85??g/mL respectively.', 27079471),
('Antifungal Chemical Compound', 'Nylon-3 polymers', ' This polymer is active on its own and in synergy with existing antifungal drugs against multiple species of Candida and Cryptococcus, acts synergistically with azoles against different species of Aspergillus, including some azole-resistant strains.', 'Displayi only mild to moderate toxicity toward mammalian cells.: ', ' These findings indicate that nylon-3 polymers are a promising lead for development of new antifungal therapeutic strategies.  Copyright ? 2017 American Society for Microbiology.', 28739790),
('Antifungal Chemical Compound', 'Orally absorbable imidazole derivatives:  BAY n 7133 and BAY 1 9139', 'Activity comparable to those of ketoconazole and miconazole', '', ' In-vitro inhibitory activities of 2 new orally absorbable imidazole derivatives:  BAY n 7133 and BAY 1 9139.', 6314564),
('Antifungal Chemical Compound', 'Pathogen Box chemical library (Medicines for Malaria Venture [MMV],  Switzerland) (MMV688768, MMV687273, and MMV687807', 'The most potent compound MMV688768, displayed increased antibiofilm activity compared to its activity against planktonic cultures, indicating that it may affect processes with a predominant role during the biofilm mode of growth, in vitro combination assays showed a synergistic interaction between compound MMV688768 and fluconazole against preformed biofilms.', '', ' Interestingly, the most potent of these, compound MMV688768, displayed increased antibiofilm activity compared to its activity against planktonic cultures, indicating that it may affect processes with a predominant role during the biofilm mode of growth.', 27795383),
('Antifungal Chemical Compound', 'PcPAF, antifungal protein produced by the fungal strain Penicillium citrinum W1', 'PcPAF displayed antifungal activity against Trichoderma viride, Fusarium oxysporum, Paecilomyces variotii, and Alternaria longipes at minimum inhibitory concentrations of 1.52, 6.08, 3.04, and 6.08 micro g/disc, respectively.', '', 'Purification and identification of a novel antifungal protein secreted by Penicillium citrinum from the Southwest Indian Ocean.  The results suggested that PcPAF may represent a novel antifungal protein with potential application in controlling plant pathogenic fungal infection.  ', 24931500),
('Antifungal Chemical Compound', 'PLD-118', 'Inhibitor of candida isoleucyl-tRNA synthetase in fluconazole (FLC)-resistant Candida albicans', '', ' Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.  PLD-118, formerly BAY 10-8888, is a synthetic antifungal derivative of the naturally occurring beta-amino acid cispentacin.', 15388459),
('Antifungal Chemical Compound', 'Pneumocandins L-733,560 and L-743,872', 'Activity against amphotericin B- and fluconazole-resistant Candida isolates', '', ' In vitro growth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistant Candida isolates: influence of assay conditions.  L-733,560 and L-743,872 are water-soluble pneumocandins with potent antifungal activity.', 9292427),
('Antifungal Chemical Compound', 'R-135853, a sordarin derivative', 'R-135853 also exhibited potent activities against fluconazole-susceptible dose-dependent and fluconazole-resistant strains of C. albicans, with MICs ranging from 0.03 to 0.06 micro g/ml', '', 'Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice. R-135853 exhibited potent in vitro activities against Candida albicans (fluconazole-susceptible strains), Candida glabrata, Candida tropicalis, and Cryptococcus neoformans, with MICs at which 90% of isolates were inhibited of 0.03, 1, 0.5, and 0.5 microg/ml, respectively.', 15616275),
('Antifungal Chemical Compound', 'Salicyl glycoconjugates containing hydrazide and hydrazone moieties', ' The bioassay indicated that the novel compounds had no in vitro fungicidal activity but showed significant in vivo antifungal activity against the tested fungal pathogens.', '', '  Molecular design and synthesis of novel salicyl glycoconjugates as elicitors against plant diseases.   A new series of salicyl glycoconjugates containing hydrazide and hydrazone moieties were designed and synthesized.', 25259805),
('Antifungal Chemical Compound', 'Sampangine derivatives', 'Potent inhibitors of Candida albicans biofilm formation and yeast-to-hypha morphological transition by down-regulating biofilm-associated genes', '', '  Discovery of simplified sampangine derivatives as novel fungal biofilm inhibitors. ', 29126739),
('Antifungal Chemical Compound', 'Sargramostim (rh-GM-CSF)', 'Exert beneficial effect  in combination with fluconazole in the management of fluconazole-refractory mucosal candidiasis in advanced HIV-positive patients', '', ' CONCLUSION: In this small pilot study, sargramostim appears to exert a beneficial effect on the mucosal mycoflora and may be a possible alternative as adjunctive therapy in the management of fluconazole-refractory mucosal candidiasis in advanced HIV-positive patients. ', 11590502),
('Antifungal Chemical Compound', 'SCH-56592 (SCH) is a novel triazole', 'Varied activity against itraconazole-susceptible resistant  isolate of Aspergillus fumigatus', '', ' Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.  SCH-56592 (SCH) is a novel triazole antifungal agent with excellent in vitro activity against Aspergillus.', 9210674),
('Antifungal Chemical Compound', 'SCY-078', 'Potency against Echinocandin-Resistant Strains of Candida Species', '', '  Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species.  SCY-078 (formerly MK-3118) is a novel orally active inhibitor of fungal ?-(1,3)-glucan synthase (GS).', 28533234),
('Antifungal Chemical Compound', 'T-2307, a novel arylamidine', 'Activity against Cryptococcus gattii', '', ' Conclusions: T-2307 shows excellent in vitro and in vivo antifungal activities against C. gattii and would be a promising new candidate for the treatment of cryptococcosis.  ', 28201509),
('Antifungal Chemical Compound', 'T-2307, novel arylamidine', 'Potent in vitro activity against C. glabrata (geometric mean MIC 0.0135 mg/L),and in vivo efficacy in mice infected with echinocandin-resistant C. glabrata.', '', ' The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata.', 26620102),
('Antifungal Chemical Compound', 'Terbinafine (SF 86-327)', 'The yeasts showed varying degrees of susceptibility (MICs ranging from 10 to 100 micrograms/ml) except for Candida parapsilosis (MICs 1 to 2 micrograms/ml), strong susceptibility was found for molds (MICs 0.1 to 2 micrograms/ml), especially Scopulariopsis brevicaulis and Sporothrix schenkii (MICs 0.2 microgram/ml), dermatophytes were also highly susceptible to terbinafine (MICs 0.001 to 0.02 microgram/ml).  ', '', ' [In vitro spectrum of action of a new antifungal derivative of naftifin: terbinafin (SF 86-327)].    Terbinafine (SF 86-327) is a new antifungal agent derived from naftifine and effective by the oral route.', 3534767),
('Antifungal Chemical Compound', 'Tetrazole VT-1161', 'Trichophyton rubrum CYP51 inhibitor with IC50 of 0.14 microM,?growth inhibition with MIC50, MIC90, and geometric mean MIC values of less than or equal to 0.03, 0.06, and 0.033 micro g ml-1, respectively', '', ' When the activity of VT-1161 was tested against 34 clinical isolates, VT-1161 was a potent inhibitor of T. rubrum growth, with MIC50, MIC90, and geometric mean MIC values of ?0.03, 0.06, and 0.033 ?g ml-1, respectively.', 28483956),
('Antifungal Chemical Compound', 'Thiophene-based guanylhydrazones (iminoguanidines)', 'All guanylhydrazones showed significant activity against broad spectrum of clinically important species of Candida spp., Aspergillus fumigatus, Fusarium oxysporum, Microsporum canis and Trichophyton mentagrophytes, which was in some cases comparable or better than activity of voriconazole.: In vivo embryotoxicity on zebrafish (Danio rerio) showed improved toxicity profile of some compounds in comparison to that of voriconazole.', '', 'Synthesis and evaluation of thiophene-based guanylhydrazones (iminoguanidines) efficient against panel of voriconazole-resistant fungal isolates. However, bis-guanylhydrazone 18 showed better selectivity in terms of  therapeutic index values.', 26867487),
('Antifungal Chemical Compound', 'Thymol and 2,3-dihydroxybenzaldehyde (2,3-D)', 'Chemosensitizing agents act as synergists to commercial antifungal drugs against tolerant strains of Aspergillus fumigatus', '', 'Chemosensitization prevents tolerance of Aspergillus fumigatus to antimycotic drugs', 18486603),
('Antifungal Chemical Compound', 'triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains', 'The highly active compounds have MIC values in the range of 0.125 micro g/mL to 0.0125 micro g/mL against Candida albicans and Cryptococcus neoformans', '', ' Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains. They represent promising leads for the development of new generation of triazole antifungal agents.', 24934573),
('Antifungal Chemical Compound', 'Triazole-thiazolidinedione hybrids [ (Z)-5-(2,4-dichlorobenzylidene)-3-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)thiazolidine-2,4-dione) (15 c), (Z)-3-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-5-(furan-3-ylmethylene)thiazolidine-2,4-dione (15 j), and (Z)-3-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-5-(furan-3-ylmethylene)thiazolidine-2,4-dione (15 r) ]', 'Compounds 15 c, 15 j, 15 r were highly active against Candida albicans, with MIC80 values in the range of 0.03-0.15 microM., compounds 15 j and 15 r were found to be effective against four fluconazole-resistant clinical isolates;', '', ' From antidiabetic to antifungal: discovery of highly potent triazole-thiazolidinedione hybrids as novel antifungal agents.  In an attempt to discover a new generation of triazole antifungal agents, a series of triazole-thiazolidinedione hybrids were designed and synthesized by molecular hybridization of the antifungal agent fluconazole and rosiglitazone (an antidiabetic).', 25196996),
('Antifungal Chemical Compound', 'Voriconazole (UK-109496), a new triazole', '[MIC]90, 0.5 mg/l against Aspergillus fumigatus,  MIC90, 1.0 mg/ against Aspergillus nige and 1.0 mg/l against Aspergillus flavus', '', ' Antifungal activity of a new triazole, voriconazole (UK-109496), against clinical isolates of Aspergillus spp.  Voriconazole is a new triazole antifungal agent with potent activity against yeast and molds.', 11810544),
('Antifungal Chemical Compound', 'VT-1129', 'MIC ranges between 16-32 micro g/ml against fluconazole dose-dependent, and greater than  64 micro g/ml on resistant isolates of Cryptococcus neoformans, overall MIC was 0.027 micro g/ml, the MIC50 was reported to be 0.05 ?g/ml and 0.25 ?g/ml for dose-dependent (n = 27) and resistant isolates (n = 6), respectively.?', '', ' Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.', 27664991),
('Antifungal Chemical Compound', 'VT-1129', ' VT-1129 demonstrated potent activities againstCryptococcus neoformans and Cryptococcus gattii with low MIC50and MIC90values', '', 'The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii.  VT-1129 demonstrated potent activities against bothCryptococcusspecies as demonstrated by low MIC50and MIC90values.', 26787697),
('Antifungal Chemical Compound', 'VT-1161 and VT-1129', 'Promising for the treatment of resistant C. glabrata and C. krusei infections', '', ' VT-1161 and VT-1129 are promising for the treatment of resistant C. glabrata and C. krusei infections.', 27956419),
('Antifungal Chemical Compound', 'LMM11, a new oxadiazole', 'Minimum inhibitory concentration against Candida krusei ranged from 32 to 64 microg/mL with a significant reduction in the colony forming unit (CFU) count (~3 log10), significant reduction in CFU (0.85 log10) in vivo', '', 'Taken together, these results indicate that LMM11 is a promising candidate for the development of a new antifungal agent for the treatment of infections caused by resistant Candida species such as C. krusei.', 31935275),
('Antifungal Chemical Compound', 'Delta-Lactones', 'Broad spectrum of antifungal activity, including against resistant fungal species', 'Toxicity was dose dependent for the viability of human leukocytes, but none of the compounds was mutagenic, genotoxic, or membrane irritant when evaluated at higher concentrations than MIC', 'Structure-based design of Delta-lactones for new antifungal drug development: susceptibility, mechanism of action, and toxicity.', 30734157),
('Antifungal Chemical Compound', '19,20-epoxycytochalasin Q (ECQ) from fungus Xylaria sp. BCC 1067', 'ECQ displayed an antifungal activity with low MIC50 of 410 and 55 mg/l in the model yeast Saccharomyces cerevisiae wild-type and Sc?pdr5 strains, respectively.', '', 'Combination of ECQ and antifungal azoles displayed promising drug synergy against S. cerevisiae strains expressing multi-drug transporters, thereby providing potential solution for antifungal therapy and chemotherapeutic application.', 33227681),
('Antifungal Chemical Compound', '1,3,4-oxadiazoles bearing 3,4-dihydropyrimidine heterocyclic motifs compounds', 'Furthermore, results of the antifungal activity tests revealed that compound 4i showed promising activity against all the strains of fungi, Candida albicans, Aspergillus niger, and Aspergillus clavatus, at concentrations of 100, 50, and 100 microgramg/ml, respectively.', '', 'Compound 4d was found to be the most promising against Escherichia coli (12.5 ?microgramg/ml), whereas the same compound showed good activity against Staphylococcus aureus at a concentration of 50 ?microgramg/ml.', 34169569),
('Antifungal Chemical Compound', '1-(2-Hydroxy-3-{[4-(2-propoxyethoxy)benzoyl]oxy}propyl)-4-(4-nitrophenyl)piperazinediium dichloride', '1-(2-Hydroxy-3-{[4-(2-propoxyethoxy)benzoyl]oxy}propyl)-4-(4-nitrophenyl)piperazinediium dichloride had the highest activity against F. avenaceum (MIC = 14.2 microgramM).', 'All the compounds showed only insignificant toxic effects on human and plant cells.', 'Compounds with a piperazine ring have proved to be promising agents against various pathogens.', 31518219),
('Antifungal Chemical Compound', 'T-2307, a novel arylamidine', 'The ocular T-2307 trough concentration was maintained above the MIC in the infected mice.', '', 'Given these results in experimental disseminated candidiasis, T-2307 may be an effective treatment against the complication of ocular candidiasis.', 30753506),
('Antifungal Chemical Compound', 'echinocandins (anidulafungin, micafungin)', 'In vitro combination of fluconazole with anidulafungin was found to be synergistic (FICI 0.07-0.37) and decreased the MIC range from 4-64 microgramg/mL to 0.5-16 microgramg/mL for fluconazole and from 2-8 microgramg/mL to 0.125-1 microgramg/mL for anidulafungin. Similarly, interactions of fluconazole with micafungin (FICI 0.25-0.5), itraconazole with anidulafungin (FICI 0.15-0.37) and itraconazole with micafungin (FICI 0.09-0.37) were synergistic.', '', 'The combination of fluconazole and itraconazole with either anidulafungin or micafungin demonstrated synergistic interactions against C. parapsilosis species complex, especially against isolates with elevated MIC values.', 31715297),
('Antifungal Chemical Compound', 'Rezafungin', '', '', 'Rezafungin showed excellent in vitro activity against both WT and azole-resistant Candida species, as well as against S. cerevisiae.', 31539426),
('Antifungal Chemical Compound', '4-phenyl-1, 3-thiazol-2-yl', 'Mminimum inhibitory concentration against pathogenic fungi was between 0.0625-4 micro g/ml in vitro, could exhibit significant fungicidal activity and inhibit the biofilm formation of C. albicans at 0.5 micro g/ml. In vivo fungal infection model showed that at 10 mg/kg it significantly increased the survival rate of Galleria mellonella.', 'No obvious cytotoxicity to human umbilical vein endothelial cells with the concentration of 4 microgram/ml', 'Development of effective fungicides can not only provide new means for clinical treatment, but also reduce the occurrence of fungal resistance.', 33117733),
('Antifungal Chemical Compound', 'Aromatic-rich piperazines', 'Inhibit biofilm formation by C. albicans.', '', 'Effective treatment of infectious diseases now requires new antimicrobial therapies.', 33091849),
('Antifungal Chemical Compound', 'Metyltetraprole', 'Activity against Z. tritici, P. teres, Ramularia collo-cygni, Pyrenophora tritici-repentis, and several other plant pathogenic fungi', '', 'The unique behavior of metyltetraprole against the existing QoI-R isolates was confirmed for all tested pathogen species.', 31769927),
('Antifungal Chemical Compound', 'Schiff bases of 2-mercaptobenzimidazole were synthesized from 4-(2-(1H-benzo[d]- imidazol-2-ylthio)acetamido)benzohydrazide', 'Compounds 8 (MICpa, an = 2.41, 1.20 microgramM/ml), 10 (MICse, sa = 2.50 microgramM/ml), 20 (MICec = 2.34 microgramM/ml) and 25 (MICca = 1.46 microgramM/ml) showed significant antimicrobial activity against tested bacterial and fungal strains', '', 'In general, the synthesized derivatives exhibited moderate antimicrobial and anticancer activities.', 30306865),
('Antifungal Chemical Compound', 'triazole, PC945,', 'PC945 (geometric mean MIC = 0.058 mg/L) was 7.4-fold and 1.5-fold more potent than voriconazole and posaconazole, respectively (both P < 0.01).', '', 'PC945 was found to be a more potent inhibitor than posaconazole, voriconazole and fluconazole of C. auris isolates collected globally, warranting further laboratory and clinical evaluations.', 31325309),
('Antifungal Chemical Compound', 'triazole, PC1244', 'PC1244 exhibited potent inhibition [geometric mean MIC (range), 1.0 mg/L (0.125 to >8 mg/L)] of growth of A. fumigatus strains carrying cyp51A gene mutations', 'Compound 4d was found to be the most promising against Escherichia coli (12.5 microgram/ml), whereas the same compound showed good activity against Staphylococcus aureus at a concentration of 50 ?g/ml.', 'PC1244 has the potential to become a novel topical treatment of azole-resistant pulmonary aspergillosis.', 31361006),
('Antifungal Chemical Compound', 'Gepotidacin, a novel triazaacenaphthylene', 'Gepotidacin was active against all 54 M. genitalium isolates with median and modal MICs of 0.125 mg/L and MIC90 of 0.25 mg/L (range ?0.016-0.5 mg/L).', '', 'Combination therapy with doxycycline should be clinically studied to assess effect and potential protection against development and/or spread of gepotidacin resistance.', 32552547),
('Antifungal Chemical Compound', 'Designing Functionally Substituted Pyridine-Carbohydrazides', 'N', '', 'Overall results suggest that these compounds have the potential to become promising antimicrobial drugs against MDR strains.', 36615406),
('Antifungal Chemical Compound', 'Efinaconazole, a novel triazole', 'Fusarium species demonstrated MICs with efinaconazole (0.98 microg/ml)', '', 'Efinaconazole, a novel triazole, may be a promising candidate for the treatment of superficial Fusarium infections.', 36447396),
('Antifungal Chemical Compound', 'Guanylated Hyperbranched Polylysines', 'hyperbranched polylysine (HPL) shows antifungal activities against Candida, especially for drug-sensitive and MDR C. albicans strains, and broad-spectrum antibacterial activities against both Gram-negative and Gram-positive bacteria.', '', 'The in vitro antifungal activities of HPL3 are further enhanced by the modification of amine groups to form guanylated polylysines (HPL3-Gxs) have potentials as broad-spectrum antimicrobials.', 35775877),
('Antifungal Chemical Compound', 'novel isatin-decorated thiazole derivatives', '(3)-5-Bromo-3-((5-(2-(4-fluoro-3-methylphenyl)hydrazono)-4-methylthiazol-2(5H)-ylidene) hydrazono)indolin-2-one - 7h comopund and 5-Bromo-3-((4-ethoxy-5-(2-(4-fluoro-3-methylphenyl)hydrazono)thiazol-2(5H)-ylidene)hydrazono)indolin-2-one Compound 11f were found to have antifungal activities against Candida albicans', '', 'hese novel isatin-based compounds were screened for their probable antimicrobial effect on E. coli, MRSA and C. albicans as well as their potential as anti-biofilm formation agents.', 36046334);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antifungal Chemical Compound', 'NHC 1,3-dibenzyl-4,5-diphenyl-imidazol-2-ylidene silver(I) acetate (SBC3)', 'SBC3 treatment resulted in up to 90% growth inhibition of C. parapsilosis in vitro at the highest test concentration. The determined MIC50 and MIC80 values, representing 15 microg/ml and 25 microg/ml, respectively', 'no adverse effect on mammalian protein synthesis.', 'Silver can also contribute to structural damage. Association with cell membranes/walls and formation of pores alters permeability, resulting in ion leakage, and ultimately, cell death. In fungi, demonstrated inhibition of growth via cell cycle arrest and prevention of cell budding in C. albicans in response to silver.', 35751649),
('Antifungal Chemical Compound', 'novel 3,4-isoxazolediamide derivatives', 'The derivative compound B25 was found to have good synergistic effects with fluconazole against azole-resistant candidiasis', 'to avoid potential mammalian toxicity.', 'promising lead compound for drug discovery targeting fungal Hsp90 and deserves further investigation.', 36029272),
('Antifungal Chemical Compound', 'Non-Antibiotic Antimony-Based Antimicrobials', 'Antifungal effect of new tetraphenyl-antimony(V) cyanoximates determined using a disc-diffusion assay against selected two human fungal pathogens', '', 'Antifungal studies showed that SbPh4(MCO) was the only compound to inhibit the growth of both fungal pathogens C. neoformans and C. albicans, also known for their increasing resistance to antimicrobials. The other compounds inhibited the growth of C. neoformans but not C. albicans.', 36363997),
('Antifungal Chemical Compound', 'new 2-substituted-4-amino-quinolines and -quinazoline', 'The mechanism studies showed that compound III11 (N,2-di-p-tolylquinolin-4-amine hydrochloride) exhibited potent and broad-spectrum antifungal activities with MIC values of 4-32 microg/mL.', '', 'These results suggest that some 4-aminoquinolines may serve as new and promising candidates for further antifungal drug discovery.', 35788035),
('Antifungal Chemical Compound', 'novel compounds containing 1,2,3-triazole side', '(2R,3S)-3-[1-(4-chloro-2-fluorophenyl)-1H-1,2,3-triazol-4-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol compound 9A16 displayed excellent antifungal and anti-drug-resistant fungal ability (MIC80 = 0.0156-8 microg/mL). compound 9A16 showed powerful in vivo efficacy on mice systematically infected with Candida albicans SC5314, Cryptococcus neoformans H99, fluconazole-resistant C. albicans 100, and Aspergillus fumigatus 7544.', 'an acceptable safety profile', 'With favorable pharmacokinetics, an acceptable safety profile, and high potency in vitro and in vivo, compound 9A16 is currently under preclinical investigation.', 36512715),
('Antifungal Chemical Compound', '4,4''-dihydroxyazobenzene, a compound and azobenzene derivatives', 'hese compounds prevented the growth of both fluconazole-susceptible and fluconazole-resistant Candida albicans and Candida auris strains.', '', '', 36403201),
('Antifungal Chemical Compound', 'novel indole and indoline derivatives', 'The results showed that title compounds exhibited good antifungal effect on Azole-resistant C. albicans', '', 'inhibit the biofilm formation and hyphae growth of C. albicans through the Ras-cAMP-PKA signaling pathway.', 35661686),
('Antifungal Chemical Compound', 'The anhydride of ferrocenyl-substituted pyrazole, namely, (S)-(3-(3-(carboxyamino)-3H-pyrazol-4-yl)cyclopenta-1,3-dien-1-yl)(cyclopenta-1,3-dien-1-yl)iron', 'The synthesized compound was found to be biological active in the range of 85-95 microg/ml against various human pathogenic Gram-positive, Gram-negative, and fungal microbial strains.', '', 'The study demonstrations that synthesized ferrocenyl-substituted pyrazole in today''s situation is the encouraging antimicrobial mediator against the human pathogens.', 35949692),
('Antifungal Chemical Compound', 'trimethoxybenzoic acid derivatives', '3,4,5-Trimethoxy-N-(2-(4-methylpiperazin-1-yl)ethyl)benzamide derivative- Susceptibility tests were performed by the broth microdilution method based on the Clinical and Laboratory Standards Institute (CLSI); M27A-3 for yeasts (C. albicans) and M38-A2 [42] for filamentous fungi (A. fumigatus and T. rubrum)', '', 'these results show the potential of simple trimethoxybenzoic acid derivatives as a source of feasible efflux pump (EP) inhibitors.', 36430942),
('Antifungal Chemical Compound', '6-hydroxy-1,2,3,4-tetrahydroquinoline', 'Commercially available 6-hydroxy-1,2,3,4-tetrahydroquinoline (compound 1) was treated with 1-bromoalkanes or 1-iodoalkanes in the presence of K2CO3 to yield compounds. This compound derivative display potent and broad-spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria, as well as fungi', '', 'In conclusion, successfully designed and synthesized a series of amphiphilic tetrahydroquinoline derivatives as effective broad-spectrum antimicrobial agents.', 36088756),
('Antifungal Chemical Compound', 'EGFR inhibitor osimertinib mesylate (OSI)', '(OSI) potentiates azole efficacy against diverse fungal pathogens and overcomes azole resistance. Mechanistic investigation revealed a conserved activity of OSI by promoting intracellular fluconazole accumulation via inhibiting Pdr5 and disrupting V-ATPase function via targeting Vma1 at serine 274, eventually leading to inactivation of the global regulator TOR.', '', 'the identification of OSI as a dual action antifungal with co-targeting activity proposes a potentially effective therapeutic strategy to treat life-threatening fungal infection and overcome antifungal resistance.', 35452875),
('Antifungal Chemical Compound', 'quinolinequinones (QQs) derivative', '7-chloro-6-[4-(3-methylphenyl)piperazin-1-yl]-5,8-dihydroquinoline-5,8-dione QQ3 and QQ4 7-chloro-6-[4-(4-methylphenyl)piperazin-1-yl]-5,8-dihydroquinoline-5,8-dione show two times more activity against fungal strains Candida albicans and Candida parapsilosis. all QQs except QQ5 displayed excellent antifungal activity against the fungi Candida albicans', '', 'In this study, we investigated the bactericidal effects of QQ3 against methicillin-resistant Staphylococcus aureus (MRSA) and Candida albicans strains. The findings of this study suggest that a significant bactericidal effect was seen with all tested 1 ', 35921788),
('Antifungal Chemical Compound', '1,4-quinone molecules fused with heteroatom derivatives', 'two quinolinequinones derivative (QQ7 and QQ8 4.88MIC) displayed better antifungal activity against C. albicans and C. parapsilosis.', '', 'the activity of these compounds against three different strains of Candida fungi (C. albicans, C. parapsilosis, and C. tropicalis) and Gram-positive and Gram-negative pathogenic bacteria were investigated, searching for potential lead compounds.', 36290056),
('Antifungal Chemical Compound', 'C. neoformans 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase/5''-inosine monophosphate cyclohydrolase (ATIC), a bifunctional enzyme', 'a bifunctional enzyme that catalyzes the final two enzymatic steps in the formation of the first purine base inosine monophosphate.', '', '. Overall, our results validate ATIC as a promising antifungal drug target.', 36063996),
('Antifungal Chemical Compound', 'Compounds based on cobalt bis-dicarbollide [COSAN]', 'The presented data prove that metallacarborane derivatives are effective against clinical isolates of Candida albicans, even those resistant to systemic drugs, and show synergistic potential in combination with amphotericin B', 'low toxicity against human cells and Danio rerio embryos.', 'the investigations of the broad spectrum and valuable future medical applications of metallacarboranes, especially in the fight against drug-resistant pathogens.', 36217958),
('Antifungal Chemical Compound', 'baicalein', 'These results indicated that baicalein could increase intracellular oxidative damage by upregulating the expression of Cpd2p so as to inhibit the growth of C. albicans,', '', 'urther in-depth studies revealed that CPD2 disruption reduced the activation of C. albicans metacaspase and partially restored the mitochondrial membrane potential reduction caused by the treatment of baicalein, which indicated that CPD2 was involved in the apoptosis induced by baicalein. Which provides new insights for investigating the antifungal target of baicalein.', 36055797),
('Antifungal Chemical Compound', 'Combined applications of Spent mushroom substrate (SMS) and dicyandiamide compound', 'Compared to the control treatment, the combined applications of SMS and dicyandiamide significantly decreased soil carbendazim content by 38.14%', '', 'he SMS applications into fungicide-contaminated soils could generate double-edged sword effects of facilitating fungicide dissipation. dicyandiamide with SMS might be an effective strategy to decrease the negative effect of health risk.', 36596378),
('Antifungal Chemical Compound', 'two terpyridine ligands 4''-(4-N,N''-dimethylaminophenyl)-2,2'':6'',2?-terpyridine (L1) and 4''-(4-tolyl)-2,2'':6'',2?-terpyridine (L2)', 'Both compounds L1 and L2 exhibited remarkable inhibitory activities against bacteria, Escherichia coli and Staphylococcus aureus at MIC values 6.25 and 3.125 microg/ml, respectively. in silico molecular docking studies were ascertained with bacterial DNA gyrase and fungal demethylase.', 'he toxicity of L1 and L2 was checked using Drosophila melanogaster. The toxicity analysis suggest both the dyes are non-cytotoxic in nature.', 'The binding constant calculations at different temperature confirmed that the ligand has antimicrobial and antifungal activities', 36562209),
('Antifungal Chemical Compound', 'Lipid-Modified Chitin-Binding Domains', 'LysM-AmBisome exhibited a dramatic enhancement of antifungal activity toward Trichoderma viride and Cryptococcus neoformans, demonstrating the marked impact of displaying a cell-wall binder protein on the targeting ability of antifungal liposomal formulations.', '(LysM-Pal) exhibited negligible cytotoxicity to mammalian cells and can be easily anchored to yield LysM-presenting AmBisome (LysM-AmBisome).', 'simple strategy with enzymatic protein lipidation provides a potent approach to upgrade other types of lipid-based drug formulations.', 36066555),
('Antifungal Chemical Compound', 'Novel 3-(2-(3-(Substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline Derivatives', 'compound 3-(2-(3-(benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline (9a) showed good activity against P. mirabilis, B. subtilis, and A. niger with MIC 31.25 microM; compound 3-(2-(3-((4-bromobenzyl)oxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline 9b showed good activity for P. mirabilis, S. albus, and A. niger with MIC 62.5 microM; 4-chlorobenzyloxy in compound 3-(2-(3-((4-chlorobenzyl)oxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline (9c) which showed good activity against P. mirabilis with MIC 62.5 microM and moderate activity against A. niger; compound 8-fluoro-3-(3-fluoro-2-(3-((4-methylbenzyl)oxy)oxetan-3-yl)phenoxy)-2-methylquinoline (9d) which showed good activity against P. mirabilis and A. niger with MIC 62.5 microM. Against A. niger compound 3-cyanobenzyloxy in 8-fluoro-3-(3-fluoro-2-(3-((3-cyanobenzyl)oxy)oxetan-3-yl)phenoxy)-2-methylquinoline (9f) showed good activity with MIC 62.5 microM; compound 3-(2-(3-((3,5-difluorobenzyl)oxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline (9h), which showed good activity against P. mirabilis and A. niger with MIC 31.25 and 62.5 microM, respectively. 6-fluoropyridin-3-yl-methoxy in 8-fluoro-3-(3-fluoro-2-(3-((6-fluoropyridin-3-yl)methoxy)oxetan-3-yl)phenoxy)-2-methylquinoline (9i), which showed good activity against A. niger with MIC 62.5 microM.', 'Cytotoxicity tests of 3-(2-(3-(substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline (9a', 'The newly synthesized oxetanyl-quinoline derivatives were evaluated for in vitro antibacterial activity against Escherichia coli (NCIM 2574), Proteus mirabilis (NCIM 2388), Bacillus subtilis (NCIM 2063), Staphylococcus albus (NCIM 2178), and in vitro antifungal activity against Aspergillus niger (ATCC 504) and Candida albicans (NCIM 3100) show good inhibition and can use as novel compound against antimicrobial resistance', 36570236),
('Antifungal Chemical Compound', 'chelerythrine combined with fluconazole', 'A broth microdilution assay was used to reveal the antifungal activity of chelerythrine combined with fluconazole against C. albicans and the preformed biofilm. A fractional inhibitory concentration index model was used to evaluate the interaction. Chelerythrine strongly synergized with fluconazole against fluconazole-resistant C. albicans and the biofilm preformed for less than 12 h.', '', 'Chelerythrine could reverse the drug resistance of resistant C. albicans and its biofilm to fluconazole, providing new insights for overcoming the drug resistance of C. albicans.', 36111728),
('Antifungal Chemical Compound', 'new chiral triazole fungicide mefentrifluconazole', 'The results suggest that triazole resistance in A. fumigatus could be resulted from the selection of mefentrifluconazole at concentrations larger than 2 mg L-1', '', 'Mefentrifluconazole should be applied within the dosage recommended by good agricultural practice to avoid the resistance in A. fumigatus in soil. This also may be applicable to other triazole fungicides.', 36205310),
('Antifungal Chemical Compound', 'ipflufenoquin, with a new antifungal olorofim', 'Effective against- Azole resistance in Aspergillus fumigatus', '', 'The use of the recently authorized fungicide ipflufenoquin, which shares its mode-of-action with a new antifungal olorofim, underscores the need for risk assessment for dual use of antifungals.', 36283187),
('Antifungal Chemical Compound', 'Compounds 1c (alpha-asarone-related) and 5b (with a pyrrolic core) [Fibrate-Based Compounds and Substituted Pyrroles ]', 'Inhibit the Enzyme 3-Hydroxy-methyl-glutaryl-CoA Reductase of Candida glabrata (CgHMGR), Thus Decreasing Yeast Viability and Ergosterol Synthesis', 'Future studies are needed to modify the structure of the two present test compounds to obtain safer and less toxic antifungals. Moreover, it is important to carry out a more in-depth mechanistic approach.', 'According to the docking analysis, the inhibitory effect of 1c and 5b could possibly be mediated by their interaction with the amino acid residues of the catalytic site of the enzyme. Since 1c displayed higher binding energy than alpha-asarone and 5b, it is the best candidate for further research, which should include structural modifications to increase its specificity and potency.', 35377226),
('Antifungal Chemical Compound', 'amphotericin B (AmB)-loaded nanoemulsion (NE) (NEA) [sunflower oil and cholesterol as the oily phase, polyoxyethylene 20 cetyl ether (Brij', 'control of C. auris infections and resistance as well as decrease the side effects of this drug', '', 'NEA had a better antifungal profile against systemic infection in G. mellonella. It is concluded that the alternative model proved to be an efficient in vivo assay to determine the toxicity and evaluate the therapeutic property of free AmB and NEA in systemic infections caused by C. auris.', 34662607),
('Antifungal Chemical Compound', 'combination effect of AZD8055 and fluconazole', 'Synergism between AZD8055 and fluconazole was observed in six strains (60%) of Candida spp., resulting in reversion of fluconazole resistance. Synergistic combinations resulted in 4-fold to 256-fold reduction of effective MICs of AZD8055 and azoles.', '', 'In summary, the results suggested that AZD8055 combined with azoles may help to enhance the antifungal susceptibilities of azoles against pathogenic fungi and had the potential to overcome azole resistance issues.', 35019705),
('Antifungal Chemical Compound', 'derivative A1Cl of 2-chloro-N-phenylacetamide', 'A1Cl inhibited in vitro biofilm formation at all concentrations tested (1/4MIC to 8 ', '', 'Conclusions: The results suggest that A1Cl is a promising antifungal agent. Furthermore, this activity is related to attenuation of expression of virulence factors and antibiofilm effects against C. tropicalis and C. parapsilosis.', 35179275),
('Antifungal Chemical Compound', 'Boric acid', 'boric acid inhibited C. albicans hyphal formation and reduced mature biofilm biomass and metabolic activity in all isolates in a dose-dependent manner', '', 'Overall, our findings illustrate that boric acid is broadly effective at inhibiting growth across many isolates and morphologies, which could explain why it is an effective treatment for RVVC.', 35446135),
('Antifungal Chemical Compound', 'Nitroxoline', 'MIC50/90 of nitroxoline was 2/2 mg/L (MIC range 0.25-4 mg/L)', '', 'In conclusion, isolates of different Candida species are highly susceptible to nitroxoline, which could be a promising antimicrobial to treat candiduria caused by multidrug resistant yeasts.', 35543103),
('Antifungal Chemical Compound', '15 N [Cobalt Ferrite (0.3 CoFe2O4) + Silver chromite (0.7 Ag0.5Cr2.5O4)]', 'against M. luteus. Concerning antifungal activity, C. albicans was the most susceptible fungal species', '', 'The tested compounds could be attractive and alternative antibacterial compounds that open a new path in chemotherapy.', 35624524),
('Antifungal Chemical Compound', 'juglone (5-hydroxy-1,4-naphthoquinone)', 'against both fluconazole-resistant and susceptible Candida isolates', '', 'Juglone increased the antifungal activity of fluconazole; however, no synergism effects were observed for any combination, and only an insignificant effect was found against all tested Candida species.', 35701335),
('Antifungal Chemical Compound', 'chlorhexidine acetate in combination with fluconazole', 'against suspensions and biofilms of Candida auris', '', 'Conclusion: The combination therapy of fluconazole and chlorhexidine acetate provides a new potential strategy for the treatment of clinical Candida auris infection.', 34674944),
('Antifungal Chemical Compound', 'Heat shock protein 90 (Hsp90)/Histone deacetylase (HDAC)', 'dual inhibitors for the treatment of azoles-resistant Candida albicans', '', 'Therefore, Hsp90/HDAC dual inhibitors represent a new strategy for the development of novel antifungal therapeutics to combat azole-resistant candidiasis.', 34742014),
('Antifungal Chemical Compound', 'Recombinant Myeloperoxidase', '', '', 'Taken together, the data suggest that rMPO purified from a stably expressing human cell line is a new class of antimicrobial agents with the ability to kill a broad spectrum of pathogens, including bacteria and fungi with or without drug resistance.', 35019674),
('Antifungal Chemical Compound', 'Compounds 5b (Z)-3-(3-hydroxyphenyl)-5-((1-methyl-1H-indol-3-yl)methylene)-2-thioxothiazolidin-4-one and 5g (Z)-3-[5-(1H-Indol-3-ylmethylene)-4-oxo-2-thioxo-thiazolidin-3-yl]-benzoic acid as well as 5h (Z)-3-(5-((5-methoxy-1H-indol-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)benzoic acid', 'All compounds demonstrated a higher degree of antifungal activity than the reference drugs bifonazole (6-17-fold) and ketoconazole (13-52-fold).', '', 'Conclusion: Compounds 5b (Z)-3-(3-hydroxyphenyl)-5-((1-methyl-1H-indol-3-yl)methylene)-2-thioxothiazolidin-4-one and 5g (Z)-3-[5-(1H-Indol-3-ylmethylene)-4-oxo-2-thioxo-thiazolidin-3-yl]-benzoic acid as well as 5h (Z)-3-(5-((5-methoxy-1H-indol-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)benzoic acid can be considered as lead compounds for further development of more potent and safe antibacterial and antifungal agents.', 35164333),
('Antifungal Chemical Compound', 'polypyridyl iridium(III) complexes', 'potent agents against resistant Candida albicans', '', 'This study may pave the way for the development of novel antifungal agent based upon polypyridyl iridium(III) complex to combat antifungal resistance.', 35276422),
('Antifungal Chemical Compound', 'Pseudolaric Acid A Combined with Fluconazole', 'against Candida albicans via Inhibition of Adhesion and Yeast-To-Hypha Transition', '', 'In conclusion, these findings demonstrate, for the first time, that the combination of PAA and FLC has an improved antibiofilm effect against the formation of C. albicans biofilms by inhibiting adhesion and yeast-to-hypha transition; this may provide a novel therapeutic strategy for treating C. albicans biofilm-associated infection.', 35297651),
('Antifungal Chemical Compound', 'pyrvinium pamoate (PP)', 'PP inhibited C. auris replication in macrophages, which is a relevant host niche for this yeast pathogen.', '', 'Our study offers a new avenue for therapeutic development against drug-resistant C. auris, shows how complex metabolic dysfunction can be caused by a single compound triggering antifungal inhibition, and provides insights into the metabolic needs of C. auris in immune cell environments.', 35412372),
('Antifungal Chemical Compound', 'chlorogenic acid', 'against strains of Candida spp. resistant to fluconazole', '', 'We concluded that chlorogenic acid has potential use as an adjuvant in antifungal therapies, due to its anti-Candida activity and ability to interact with important drug targets.', 35575783),
('Antifungal Chemical Compound', 'Chrysosporium sp. HSXSD-11-1, Cladosporium sp. HSXSD-12 and Acrostalagmus luteoalbus CH-6', 'the crude extracts of CH-6 displayed the strongest antimicrobial activities with 72.3-84.8% growth inhibition against C. albicans and Aeromonas salmonicida.', '', 'This study further demonstrates the great potential of Antarctic fungi in the development of new compounds and antibiotics.', 35621985),
('Antifungal Chemical Compound', 'calcium supplementation combined with iron deficiency', 'causes dramatic growth inhibition of the human fungal pathogens Aspergillus fumigatus, Candida albicans, and Cryptococcus neoformans', '', 'Thus, there is a mutual effect between iron and calcium in fungal pathogens, and the combination of calcium with an iron chelator could serve to improve antifungal therapy.', 35674440),
('Antifungal Chemical Compound', 'Cold atmospheric plasma (CAP)', 'CAP irradiation significantly inhibited the fungal growth by 25.83 to 89.10%, reduced fungal cell viability by 11.68 to 87.71%, disrupted cellular membranous organelles and structures of the fungal hyphae, and suppressed efficiently the expression of HSP90 gene by 2 folds in 210 s exposure.', '', 'Taken together, our results demonstrated that CAP is an efficient tool with potential in-vivo therapeutic applications against chronic dermatophytosis caused by T. rubrum due to its effectiveness, harmless, and ease of access.', 35676321),
('Antifungal Chemical Compound', 'Thiadiazole-Based Molecules', 'Promising Inhibitors of Black Fungi and Pathogenic Bacteria', '', 'Furthermore, a molecular docking study was achieved on the synthesized compounds, of which compounds 2, 6, and 7 showed the best interactions with the selected protein targets.', 35684551),
('Antifungal Chemical Compound', '4-phenyl-4,5-dihydrooxazole derivatives', 'antifungal activities against eight susceptible strains and seven FLC-resistant strains. Furthermore, the potent compound 22a could prevent the formation of fungalbiofilms and displayed satisfactory fungicidal activity.', '', 'Moreover, pharmacokinetic studies in SD rats showed that compound 22a exhibited pharmacokinetic properties with a bioavailability of 15.22% and a half-life of 4.44 h, indicating that compound 22a is worthy of further study', 34749201),
('Antifungal Chemical Compound', '3-thiophene derivatives', 'showed excellent inhibitory activity against pathogenic and drug-resistant fungi. In addition, the preferred compound 21b could prevent the formation of fungal biofilms and displayed satisfactory fungicidal activity.', '', 'These results strongly suggested that compound 21b is worthy of further study as a potential azole inhibitor.', 35255313),
('Antifungal Chemical Compound', '4,5-Diarylisoxazole Derivatives', 'Combination Treatment of Azole-Resistant Candidiasis', '', 'These data support the feasibility of targeting fungal Hsp90 as a promising antifungal strategy and further development of compound A17 as a valuable research probe for the investigation of fungal Hsp90.', 35298171),
('Antifungal Chemical Compound', 'compound 2a11', 'compound 2a11 can inhibit the growth of azole-resistant strains 103 with the MIC80 of 1 microg/mL.', '', 'Collectively, this work identifies a new covalent allosteric site of CaFBA and discovers the first generation of covalent inhibitors for fungal FBA with potent inhibitory activity against resistant fungi, establishing a structural foundation and providing a promising strategy for the design of potent antifungal drugs.', 35099959),
('Antifungal Chemical Compound', 'berberine hydrochloride', 'against fluconazole-resistant Candida albicans', '', 'Conclusion. BH affects multiple target genes in diminishing the resistance of C. albicans strains to fluconazole. This effect may be related to the action of BH on the HOG-MAPK pathway.', 35679157),
('Antifungal Chemical Compound', 'Benzylic Dehydroxylation of Echinocandin Antifungal Drugs', 'Restores Efficacy against Resistance Conferred by Mutated Glucan Synthase', '', 'This study describes the first example of a chemical modification strategy to restore the efficacy of echinocandin drugs, which have a critical place in the arsenal of antifungal drugs, against resistant fungal pathogens.', 35347986),
('Antifungal Chemical Compound', 'Minocycline (MIN) and azoles', 'in vitro combination of MIN with ITR, VOR or POS showed satisfactory synergistic effects against 8 (80%), 1 (10%), and 9 (90%) strains, respectively. Moreover, combined use of MIN with azoles decreased the minimum inhibitory concentration (MIC) range from 5.33-16 microg/ml to 1-16 microg/ml for ITR, from 0.42-16 microg/ml to 0.21-16 microg/ml for VOR, and from 1.33-16 microg/ml to 0.33-16 microg/ml for POS.', '', 'Conclusions: The present study demonstrated that combinations between MIN and azoles lead to synergistic antimicrobial effects on Scedosporium and Lomentospora species, while showing a potential for overcoming and preventing azole resistance.', 35016611),
('Antifungal Chemical Compound', 'olorofim', 'Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages', '', 'Conclusions: This is the first known study to demonstrate the antibiofilm activity of olorofim, voriconazole and amphotericin B against azole-resistant A. fumigatus.', 35289361),
('Antifungal Chemical Compound', 'Jerveratrum-Type Steroidal Alkaloids', 'Jervine exhibited broad-spectrum antifungal activity and was effective against human-pathogenic fungi, including Candida parapsilosis and Candida krusei. It was also effective against phytopathogenic fungi, including Botrytis cinerea and Puccinia recondita. Jervine exerted a synergistic effect with fluconazole.', '', 'Therefore, jervine, a jerveratrum-type steroidal alkaloid used in pharmaceutical products, represents a new class of antifungals active against mycoses and plant-pathogenic fungi.', 35019680),
('Antifungal Chemical Compound', 'Helja with fluconazole (FLC)', 'The Helja + FLC combination exhibited an inhibitory effect of fungal growth about three times greater than the sum of both compounds separately and inhibited fungal morphological plasticity, an important virulence attribute associated with drug resistance. Cells treated with Helja + FLC showed morphological changes, nucleus disintegration and formation of multimera structures, leading to cell collapse.', '', 'Conclusions: Our findings indicate that the Helja + FLC combination exhibited a potent antifungal activity based on their simultaneous action on different microbial cell targets.', 35332971),
('Antifungal Chemical Compound', 'Delphinium cashmerianum L. (Daidzein compound)', 'Upon analysis, we obtained 5 compounds that were efficiently binding to the drug targets. However, after performing exhaustive molecular docking and molecular dynamic simulation (MDS) analysis, it was observed that Daidzein compound is bound to drug targets more efficiently.', '', 'Conclusion: The results showed that these plant extracts exhibit antimicrobial activity and ethyl acetate extract proved to exhibit the most effective antibacterial and antifungal properties.', 35167935),
('Antifungal Chemical Compound', 'compounds 14a-2 and 20b-2', 'Among of them, target compounds 14a-2 and 20b-2 not only possessed the excellent broad-spectrum anti-fungal activity (MIC50, 0.125-2 Microg/mL), but also maintained the anti-drug-resistant fungal activity (MIC50, 1-4 Microg/mL)', '', 'In addition, we also discovered that compounds 14a-2 and 20b-2 with low toxic and side effects could exert the excellent therapeutic effect in mice model of fungal infection, which was worthy for further in-depth study.', 34772530),
('Antifungal Chemical Compound', 'thiosemicarbazone derivative 19ak as a metal chelator', '19ak exhibits minimal cytotoxicity and potent activity against either azole-sensitive or azole-resistant fungal pathogens, inhibits fungal ribosome biogenesis mainly by disrupting intracellular zinc homeostasis', '', 'This study provides the basis of thiosemicarbazone derivative 19ak as a metal chelator for the treatment of fungal infections.', 35412374),
('Antifungal Chemical Compound', 'BDDE-Inspired Chalcone Derivatives', 'chalcones 13 and 14 showed promising antifungal activity against the dermatophyte clinical strain of Trichophyton rubrum', '', 'BDDE-Inspired Chalcone Derivatives to Fight Bacterial and Fungal Infections', 35621966),
('Antifungal Chemical Compound', 'sertraline with fluconazole', 'luconazole with sertraline (FICI =0.5), where a synergistic effect was observed against all resistant C. glabrata and ATCC strains with a >2-log10 CFU/mL reduction caused by combination compared with a single active agent of fluconazole after 24 hours of incubation', '', 'Conclusion: Our data suggest that blocking active efflux pumps by sertraline may be considered the probable mechanism of synergism with fluconazole. The combination of sertraline with fluconazole could be a promising remedy for treatment of infections caused by resistant C. glabrata.', 35181564),
('Antifungal Chemical Compound', 'eucalyptol in combination with antifungals', 'The geometric mean MBIC of amphotericin B, itraconazole, nystatin and eucalyptol were 3.93 Microg/mL, 12.55 Microg/mL, 0.75 Microg/mL and 798 Microg/mL, respectively. Eucalyptol interacted synergistically with amphotericin B, itraconazole and nystatin against 12.5, 10, and 22.5% of isolates, respectively.', '', 'Eucalyptol demonstrated promising activity against biofilm of C. albicans when tested alone or combined with antifungal drugs.', 35508567),
('Antifungal Chemical Compound', 'benzbromarone', 'potential folate inhibitors of Candida albicans', '', 'Based upon the molecular docking simulation-based virtual screening followed by the molecular dynamic simulation of the macromolecular complex, benzbromarone has been identified as a potential anti-folate agent for the development of a novel therapy for the treatment of candidiasis.', 35716240),
('Antifungal Chemical Compound', 'surfactin', 'exerted antifungal effect against Candida albicans', '', 'Our data demonstrate that surfactin significantly influences the physiology and gene transcription of C. albicans, and could contribute to the development of a novel innovative complementary therapy.', 35671583),
('Antifungal Chemical Compound', 'octenidine', 'against emerging echinocandin-, azole- and multidrug-resistant Candida albicans and Candida glabrata', '', 'Conclusion: These results encourage consideration of the well-tolerated antiseptic molecule OCT in the eradication of emerging (multidrug) resistant C. albicans and C. glabrata.', 35134551),
('Antifungal Chemical Compound', 'Ent-hardwickiic acid from C. pubiflora and its microbial metabolites', 'All the diterpenes showed fungistatic effects (ranging from 19', '', 'Ent-hardwickiic acid from C. pubiflora and its microbial metabolites are more potent than fluconazole in vitro against Candida glabrata', 34995375),
('Antifungal Chemical Compound', 'adamantane derivatives', 'five derivatives (6, 7, 9, 14a, and 14b) displayed the potent activities against the different isolates tested (MIC <8 Microg/ml with fungi) compared with Ciprofloxacin (CIP) and Fluconazole (FCA), showed fungicidal effects based on (MBCs and MFCs) and the time-kill assay. The most active adamantane derivatives 7 and 14b exhibited a synergistic effect of SFIC = 0.5 with CIP and FCA against the bacterial and fungal isolates.', '', 'Finally, the in-silico analysis predicted that the most active derivatives had good drug-likeness and safe properties.', 35716118),
('Antifungal Chemical Compound', 'Dicliptera roxburghiana', 'For antifungal assay, DRME and DRHF were potently active and showed more than 70% fungal growth inhibition where as DRCF and DRBF were also displaying appreciable inhibition.', 'Cytotoxic measurements were very good for DRME, DRHF and DRAF with LD50 values 215, 199 and 392 Microg/ml respectively.', 'These results confirmed antimicrobial and cytotoxic potential of the plant and all its derived fractions. Hence it can be concluded that plant contain some important compounds that can be used as antimicrobial source for the treatment of different infectious disease.', 35221269),
('Antifungal Chemical Compound', 'spirooxindole-pyrrolidine heterocyclic hybrids', 'DPA-3, has potent antifungal activity without inducing mammalian cell cytotoxicity. Furthermore, DPA-3 significantly reduced hyphal and biofilm formation of Candida albicans ATCC 10231 strain, out-competing two FDA approved antifungal drugs.', '', 'The results of our study conclude that DPA-3 is a compelling candidate for further development as an antifungal drug.', 35512603),
('Antifungal Chemical Compound', 'gallic acid (GA)', 'GA presented minimum inhibitory concentrations ranging from 16 to 72 Microg/ml, causing alterations of the membrane integrity and mitochondrial transmembrane potential, production of reactive oxygen species and externalization of phosphatidylserine', '', 'Conclusion: GA has potential antifungal activity against Candida spp.', 35354285),
('Antifungal Chemical Compound', 'indole and indoline derivatives', 'against Candida albicans as potent antifungal agents', '', 'The results showed that title compounds exhibited good antifungal effect on Azole-resistant C. albicans. Further mechanism study demonstrated that S18 could inhibit the biofilm formation and hyphae growth of C. albicans through the Ras-cAMP-PKA signaling pathway.', 35661686),
('Antifungal Chemical Compound', 'Pyridothienopyrimidine Derivatives', 'Compounds 3a, 5a and 9b displayed broad spectrum antimicrobial activity with MIC ranges of 4-16 Microg/mL and potent cytotoxic activity with IC50 ranges of 1.17-2.79 MicroM. In addition, they provided suppressing activity against EGFR with IC50 ranges of 7.27-17.29 nM, higher than that of erlotinib, IC50 = 27.01 nM.', '', 'All new compounds were evaluated against five bacterial and five fungal strains.', 35164067),
('Antifungal Chemical Compound', '2,5-Disubstituted Pyridine', 'as an Inhibitor of Candida albicans Erg11', '', 'This work characterizes the antifungal activity of a 2,5-disubstituted pyridine against C. albicans, supporting the mining of existing chemical collections to identify compounds with novel antifungal activity.', 35531664),
('Antifungal Chemical Compound', 'analogues of Panax stipulcanatus saponin', 'In vitro antifungal activity results indicated that analogue 2 combined with fluconazole showed synergistic antifungal activity against fluconazole-resistant Candida albicans, with MIC50 values 31.80 Microg/mL and FICI values 0.32. intermediate compounds 16 and 17 revealed synergistic antifungal activity against susceptible Candida albicans when combined with fluconazole, with MIC50 values 1.43 Microg/mL and 1.59 Microg/mL, FICI values 0.29 and 0.32, respectively.', '', 'synergistic antifungal activity of analogues of Panax stipulcanatus saponin against fluconazole-resistant Candida albicans', 35552063),
('Antifungal Chemical Compound', 'Arylamidine T-2307', 'the MIC of T-2307 was found to be 0.005 microg mL-1 against C. tropicalis DSM 11951 and C. tropicalis.', 'T-2307 did not affect cell viability on PNT1A cell line', 'these results provide new information on T-2307, indicating this compound as a new and promising alternative therapeutic option for the treatment of Candida infections.', 36555687),
('Antifungal Chemical Compound', 'beta-Nitrostyrene derivatives', 'The results show that beta-Nitrostyrene derivatives inhibited the growth of different species of human pathogenic Candida, particularly the highly prevalent C. albicans, C. glabrata and the emerging pathogenic C. auris species.', '', 'beta-Nitrostyrene derivatives impact cell wall morphology, enhance ROS generation and modulate drug efflux. Collectively this study reveals that beta-Nitrostyrene derivatives have strong antifungal potential with a particular mode of activity similar to known cell wall perturbing antifungal agents', 35932582),
('Antifungal Chemical Compound', 'Hydroxyethyl Naphthalimides', 'These prepared naphthalimides showed better antifungal potency than fluconazole towards some tested fungi including Aspergillus fumigatus, Candida tropicalis and Candida parapsilosis 22019. Especially, thioether benzimidazole derivative with excellent anti-Candida tropicalis efficacy (MIC = 4 microg/mL)', 'possessed low cytotoxicity, safe hemolysis level and less susceptibility to induce resistance.', 'antifungal potency promoted the production and accumulation of reactive oxygen species (ROS) in cells, which destroyed the antioxidant defence system, led to oxidative stress with lipid peroxidation, loss of glutathione, membrane dysfunction and metabolic inactivation, and eventually caused cell death. The chemical and dynamic antifungal synergistic effect initiated by hydroxyethyl naphthalimides was a reasonable treatment window for prospective development.', 36500547),
('Antifungal Chemical Compound', 'adamantane derivatives', 'MIC of <8 microg/ml with fungi) compared with Ciprofloxacin (CIP) and Fluconazole (FCA).', '', 'interaction of DNA gyrase and topoisomerase IV enzymes with the compound Derivative exhibited potent antimicrobial activity using in vitro biochemical assays and gel-based DNA-supercoiling inhibition method', 35716118),
('Antifungal Chemical Compound', 'hexyl-aminolevulinate ethosomes (HAL-ES)', 'No survival was observed after 6 h of incubation with 20 mM HAL, and growth inhibition was noted at 2.5 to 10 mM HAL against Candida albicans. The results showed that HAL-mediated aPDT killed approximately 66.7% of C. albicans cells', '', 'HAL-ES inhibits protein translation by disrupting zinc homeostasis in C. albicans. Hence, provides a novel and effective therapeutic strategy against C. albicans biofilm but also proposes a new strategy to resolve C. albicans biofilm infection by disrupting zinc homeostasis.', 36301105),
('Antifungal Chemical Compound', 'volatilomes nest microbiome of the Namibian, social spider Stegodyphus dumicola', 'The growth of P. lilacinum was inhibited by the volatilome of Streptomyces sp. and Aureobasidium sp.', '', 'The antimicrobial activities of five spider nest microbiome member volatilomes (Massilia sp. IC2-278, Massilia sp. IC2-477, Sphingomonas sp. IC-11, Aureobasidium sp. CE_32, and Streptomyces sp. IC-207) against two putative spider pathogens (B. thuringiensis and P. lilacinum) were tested to prove a potential role in pathogen defense', 36073497),
('Antifungal Nanocomposites', 'Amphotericin B-conjugated silver nanoparticles', 'Biogenic silver nanoparticles revealed low to moderate antifungal activity (4-8 mm +- 0.2), however, the amphotericin B conjugated silver nanoparticles exhibited significant activity against Candida albicans (16 mm +- 1.4) and Candida tropicalis (18 mm +- 1.5)', '', 'Amphotericin B-conjugated biogenic silver nanoparticles as an innovative strategy for fungal infections.  ', 27591110),
('Antifungal Nanocomposites', 'Chitosan silver nanocomposite (CAgNC)', 'Activity of chitosan silver nanocomposite (CAgNC) was tested against C. albicans Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of CAgNC were determined as 25 and 100 microg/ml, respectively', '', ' Overall results from our study indicated that CAgNC could affect negatively on physiological and biochemical functions of C. albicans suggesting CAgNC as a potential alternative for antifungal chemotherapy.  ', 27495320),
('Antifungal Nanocomposites', 'Fluconazole-loaded solid lipid nanoparticles (FLZ-SLNs) ', 'The MIC50 drug concentrations were 2microg/ml, 1microg/ml and 2microg/ml for FLZ-resistant strains of Candida albicans, Candida parapsilosis and Candida glabrata, respectively', '', 'Time to overcome fluconazole resistant Candida isolates: Solid lipid nanoparticles as a novel antifungal drug delivery system. ', 26974361),
('Antifungal Nanocomposites', 'NB-002, a novel nanoemulsion', 'For filamentous nondermatophyte fungi, the  MIC range varied from 0.06 to 0.5 microg/ml for Alternaria spp. to 2 to 8 microg/ml for Paecilomyes spp.: NB-002 had activity against both azole-susceptible and -resistant Candida albicans yeast isolates, with MIC(90)s of 2 microg/ml, respectively, and minimum fungicidal concentrations at which 90% of isolates are  inhibited of 4 and 8 microg/ml, respectively.: NB-002 killed both mycelia and microconidia even when the fungal forms were dormant or not actively growing.', '', '  NB-002, a novel nanoemulsion with broad antifungal activity against dermatophytes, other filamentous fungi, and Candida albicans.    NB-002 is an oil-in-water emulsion designed for use for the treatment of skin, hair, and nail infections.', 19433562),
('Antifungal Nanocomposites', 'Polyvinylpyrrolidone-Coated Silver Nanoparticles and Azole Antifungal', 'Effective in being against the drug-resistant C.  albicans', '', ' Synergy Between Polyvinylpyrrolidone-Coated Silver Nanoparticles and Azole Antifungal Against Drug-Resistant Candida albicans. Our results suggest that the combinational use of engineered nanomaterials (ENMs), such as PVP-coated Ag-NPs, with the conventional antifungal may be a viable strategy to combat drug-resistant fungal infection.  ', 27455637),
('Antifungal Nanocomposites', 'Silver nanoparticles (AgNPs)', 'MIC50 were 0.1 micro g ml(-1)  and MFC were 0.25 and 0.5 microg ml(-1) for C. glabrata and C. krusei, respectively', '', ' In vitro antifungal activity of silver nanoparticles against fluconazole-resistant Candida species.  Nowadays, current advances in nanotechnology constitute a promising alternative in the development of new antimicrobial agents.', 26335058),
('Antifungal Nanocomposites', 'Tea tree oil nanoemulsions', 'Strong in vitro antimicrobial activities on Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae, Staphylococcus aureus and Candida albicans', '', ' Taken together, our results show that the inhalable nanoTTOs are promising nanomedicines for local therapies of fungal and bacterial pneumonia with no obvious adverse events.', 26895502),
('Antifungal Nanocomposites', 'Zinc Oxide (ZnO) nanoparticles and EDTA', 'Effective antifungal properties at the concentration of 5.2, 8.6 microg/ml for Fluconazole susceptible strain and 5.42, 10.8 microg/ml Fluconazole resistant strains of C. tropicalis biofilms', '', ' CONCLUSION: In present study we conclude, ZnO considered as a new agent in field  of prevention C. tropicalis biofilms especially biofilms formed surface of medical device.  ', 27653145),
('Antifungal Nanocomposites', 'Arginine-phenylalanine and arginine-tryptophan-based surfactants', 'Antifungal activity against fluconazole-resistant Candida spp. strains, with a low minimum inhibitory concentration (8.2 microgramg/mL)', '', 'Synthetic amino acid-based surfactants constitute a promising alternative to conventional antimicrobial compounds.', 34391169),
('Antifungal Nanocomposites', 'Ag/BN NPs', 'The Ag/BN nanohybrids and amphotericin B-loaded BN and Ag/BN NPs also reveal high fungicidal activity against C. albicans, C. auris, C. parapsilosis, and N. crassa cells.', '', 'Herein, we demonstrate that Ag/BN NPs and antibiotic-loaded BN and Ag/BN nanoconjugates are promising carriers to fight bacterial and fungal infections', 34000197),
('Antifungal Nanocomposites', 'ultra-small silver nanoclusters (rsAg/NCs)', 'we also established that the apoptosis-inducing potential of rsAg/NCs is due to the activation of Ras signaling, which confirms their application in combating FCZ-resistant C. albicans infections.', '', 'Silver-based nanostructures are suitable for many biomedical applications, but to be useful therapeutic agents, the high toxicity of these nanomaterials must be eliminated.', 30769763),
('Antifungal Nanocomposites', 'Green synthesis of silver nanoparticles by Conocarpus Lancifolius plant extract', 'significant activity against fungal pathogen Rhizopusus stolonifera and Aspergillus flavus', '', 'Based on our results, biogenic AgNPs reveal significant activity against fungal pathogen Rhizopusus stolonifera and Aspergillus flavus that cause leading infectious diseases.', 35002442),
('Antifungal Nanocomposites', 'Synergistic Antimicrobial Metal Oxide-Doped Phosphate Glasses', 'fungal strain (Candida albicans)', '', 'An enhanced antimicrobial effect, at 5 mg/mL concentration, was exhibited by cobalt, copper, and zinc oxide glasses alone and in combinations.', 35199992),
('Antifungal Nanocomposites', 'Short Guanidinium-Functionalized Poly(2-oxazoline)s', 'Displaying Potent Therapeutic Efficacy on Drug-Resistant Fungal Infections', '', 'The easy synthesis and structural diversity of POXs imply their potential as a class of promising antifungal agents.', 35182092),
('Antifungal Nanocomposites', 'chemically and biologically synthesized silver nanoparticles', 'against three fungal strains (Aspergillus flavus, Fusarium moniliforme, and Candida albicans, all isolated from Nile tilapia)', '', '', 35280558),
('Antifungal Nanocomposites', 'poly(methacrylic acid)-silver nanoparticles (PMAA-AgNPs)', 'against fluconazole-resistant Candida albicans strains', '', 'Conclusions: This study demonstrated that, in general, PMAA-AgNPs acts synergistically in combination with fluconazole, inhibiting fluconazole-resistant C. albicans strains. PMAA-AgNPs-fluconazole combination was also able to inhibit germ tube formation, an important virulence factor. Inhibitory effect of PMAA-AgNPs alone or in combination was higher in C. albicans than in mammalian cells.', 35338561),
('Antifungal Nanocomposites', 'polyacrylonitrile (PAN) nanofibers coated with silver nanoparticles (AgNPs) and silver(I,III) oxide.', 'different concentrations of AgNO3 (0, 5, 10, and 15% wt % w.r.t to weight of PAN) were used. results also indicate that PAN-AgNP nanocomposites possess relatively less antimicrobial activity against Gram-negative bacteria compared to Gram-positive bacteria and C. albicans.', '', 'Our study demonstrates that PAN-AgNP nanocomposites, a novel polymer material with long-term universal antimicrobial stability, can potentially be applied as a universal antimicrobial. data also indicate that PAN-AgNP nanocomposites synthesized from higher wt % concentrations of AgNO3 demonstrated more antimicrobial efficiency against all 10 microbes compared to samples synthesized from lower concentrations of metal salts.', 36591150),
('Antifungal Nanocomposites', 'polypropargyl alcohol nanoparticles (nano-PGA)', 'Nano-PGA-DMF (dimethylformamide) exhibits significant antimicrobial potential against Candida albicans (C.albicans) (12.50 mm; ZOI, and 1.87 microg/mL; MIC).', '', 'It was found that the nano-PGA polymer prepared in DMF has better antimicrobial activity than one prepared in chloroform than in water.', 36152795),
('Antifungal Nanocomposites', 'Chrysophyllum albidum fruit peels to prepare silver nanoparticles (Alb-AgNPs).', 'The antimicrobial properties of the Alb-AgNPs were studied with selected microorganisms namely; S. aureus, E. coli, K. pneumoniae, B. subtilis, S. mutans, P. aeruginosa, S. typhi, and Candida albicans. High inhibitory activity against the microorganisms were exhibited with MICs ranging from 15.62 to 1000 microg/mL. the Alb-AgNPs could serve as a biofilm inhibitor with the highest percent inhibition of about 92% against methicillin-resistant Staphylococcus aureus', '', 'The results from this study thus provide access to the simple, sustainable, economic and eco-friendly synthesis of silver nanoparticles with efficient antimicrobial properties as drug candidates as a means of overcoming the prevailing antibiotic resistance menaces.', 36586061),
('Antifungal Nanocomposites', 'silver nanoparticles (AgNPs) from Withania somnifera and Fagonia indica', 'Silver nanoparticles of F. indica exhibited the highest significant activity against Aspergillus flavus and Fusarium oxysporum while AgNPs of W. somnifera were active only against A. flavus. The highest significant inhibition was obtained for crude extract (46.7) and AgNPs (45.7) of F. indica at 1000 microg/ml.', '', 'Both crude and AgNPs showed potent activity; however, in comparison, silver nanoparticles showed slightly enhanced activity. Crude and AgNPs of both plants showed good phytotoxic and insecticidal inhibition. Antimicrobial studies of AgNPs on diseases causing pathogens open a door for new antimicrobial agents and could be the answer to antibiotic resistance after further analysis.', 36440367);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antifungal Nanocomposites', 'anti-biotic drug metronidazole loaded ZIF-90 nanoparticles', 'In anti-fungal activity, studies show excellent growth inhibition against human pathogenic fungi Aspergillus fumigatus and Candida albicans', 'the fabricated MI@ZIF-90 drug delivery system is non-toxic to biomedical applications', 'The overall research findings highlight the design of a smart drug delivery system for sepsis treatment. In future it will be an efficient, low-cost, and biocompatible pharmaceutics for pediatric sepsis management processes.', 36509311),
('Antifungal Nanocomposites', 'gold nanoparticles (AuNP)', 'effects on the architecture of Candida tropicalis biofilms.', '', 'The fungicidal activity and cellular stress of both AuNPs affected biofilm growth through accumulation of reactive oxygen species and reactive nitrogen intermediates. However, cetyltrimethylammonium bromide-stabilized AuNPs revealed a higher redox imbalance. We correlated, for the first time, AuNP effects with the redox imbalance and alterations in the architecture of C. tropicalis biofilms.', 36515357),
('Antifungal Nanocomposites', 'Trigonella incise (Linn) Mediated Biosynthesized Silver Nanoparticles', 'the nanoparticles showed more significant antimicrobial activity against Salmonella typhi (S. typhi) and Staphylococcus aureus (S. aureus) with an inhibition zone of 21.5 mm and 20.5 mm at 6 microg/mL concentrations, respectively. The best antifungal activity was observed by synthesized Ag NPs against Candida albicans (C. albicans) with 21 mm zone of inhibition, as compared to a standard drug which gives 22 mm of inhibition.', '', 'we conclude that the antibacterial and antifungal activities showed satisfactory results from the synthesized Ag NPs.', 35889490),
('Antiviral Peptide', 'C20-Jp-Hp, Antiviral peptides generated by conjugating two known short antiviral peptides: part-1 (named Jp with the sequence of ARLPR) and part-2 (named Hp with the sequence of KKWK)', 'The anti-IAV screening results identified that C20-Jp-Hp was the most potent peptide with IC50 value of 0.53 microM against A/Puerto Rico/8/34 (H1N1) strain.', '', 'Herein, we show a new class of antiviral peptides generated by conjugating two known short antiviral peptides: part-1 (named Jp with the sequence of ARLPR) and part-2 (named Hp with the sequence of KKWK).', 26952867),
('Antiviral Peptide', 'Tripeptide GPG-NH2', 'Inhibits the replication of HIV-1, 50% inhibitory concentrations values were 2.7 to 37 microM', '', 'CONCLUSIONS: The tripeptide GPG-NH2 is a nontoxic compound that inhibits the replication of HIV-1 by an apparently new mode of action. Glycyl-prolyl-glycine-NH2 might prove useful by itself or as a lead compound for the treatment of drug-resistant HIV-1.', 11213928),
('Antiviral Peptide', 'P-1946', 'Specific HIV-1 protease inhibitor that has potent and selective in vitro antiviral activity (EC50 152 nM) against a range of isolates resistant to commercially available protease inhibitors.', '', 'Antiviral activity and cross-resistance profile of P-1946, a novel human immunodeficiency virus type 1 protease inhibitor. The HIV protease inhibitor P-1946 is a member of a novel family of l-Lysine derivatives.', 16473417),
('Antiviral Peptide', 'T-20EK - T-20 (enfuvirtide) through engineered electrostatic interactions between glutamic acid (E) and lysine (K) substitutions.', 'Anti-HIV-1', '', 'HIV-1 resistance mechanism to an electrostatically constrained peptide fusion inhibitor that is active against T-20-resistant strains. T-20EK is a novel fusion inhibitor designed to have enhanced ?-helicity over T-20 (enfuvirtide) through engineered electrostatic interactions between glutamic acid (E) and lysine (K) substitutions.', 23689710),
('Antiviral Peptide', 'King cobra cathelicidin (OH-CATH)', 'Both L- and D-OH-CATH30 showed higher efficacy against (toward) Gram-positive bacteria and stronger antibacterial activity against nearly all Gram-negative bacteria tested compare with antibiotics.', '', 'King cobra peptide OH-CATH30 as a potential candidate drug through clinic drug-resistant isolates. Cationic antimicrobial peptides (AMPs) are considered as important candidate therapeutic agents, which exert potent microbicidal properties against bacteria, fungi and some viruses.', 29515090),
('Antiviral Peptide', 'PIE12-trimer', 'First D-peptide HIV entry inhibitor with the breadth and potency required for clinical use.', '', 'D-peptides (peptides composed of D-amino acids) are promising therapeutic agents due to their insensitivity to protease degradation. PIE12-trimer was designed using structure-guided mirror-image phage display and linker optimization and is the first D-peptide HIV entry inhibitor with the breadth and potency required for clinical use.', 20719956),
('Antiviral Peptide', 'Series of oligomeric HR2 peptides with increased helical structure and with exceptionally high HR1/HR2 bundle stability', 'The engineered peptides are found to be as much as 3,600-fold more active than ENF against viruses that are resistant to the HR2 peptides ENF, T-1249, or T-651.', '', 'Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus. Enfuvirtide (ENF), the first approved fusion inhibitor (FI) for HIV, is a 36-aa peptide that acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus-cell fusion.', 17640899),
('Antiviral Peptide', 'Muramyl dipeptide (MDP)', 'MDP exhibited an inhibitory activity against HIV infection of CD4+ H9 lymphocytes and U937 monocytoid cells.', '', 'Muramyl dipeptide inhibits replication of human immunodeficiency virus in vitro. An inhibitor of viral reverse transcriptase, 2'', 3''-dideoxyadenosine, produced potent inhibition in cultures which were similarly infected with HIV.', 2111159),
('Antiviral Peptide', 'SC34EK', 'Demonstrates remarkably potent inhibition of membrane fusion by the resistant HIV-1 variants as well as wild-type viruses.', '', 'Electrostatically constrained alpha-helical peptide inhibits replication of HIV-1 resistant to enfuvirtide. In particular, the modified peptide, SC34EK, demonstrates remarkably potent inhibition of membrane fusion by the resistant HIV-1 variants as well as wild-type viruses.', 18834950),
('Antiviral Peptide', 'Fatty acid-conjugated lipopeptide named LP-11', 'Showed potent and broad inhibitory activity against diverse primary HIV-1 isolates and clinically drug-resistant mutants, and it had dramatically increased ex-vivo antiviral activity and extended half-life.', '', 'DESIGN: On the basis of the M-T hook structure, we recently developed a short-peptide named HP23, which mainly targets the deep pocket site of gp41 and possesses highly potent antiviral activity.', 26919736),
('Antiviral Peptide', 'Aza-dipeptide analogues [8 aza-dipeptide analogues carrying N-(bis-aryl-methyl) substituents on the (hydroxethyl)hydrazine moiety]', 'Potent and orally absorbed HIV-1 protease inhibitors, candidates for clinical development', '', 'New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors: candidates for clinical development.', 9719591),
('Antiviral Peptide', 'Albuvirtide (ABT), a 3-maleimimidopropionic acid-modified peptide fusion inhibitor', 'ABT had potent inhibitory activity against the subtypes A, B and C that predominate the worldwide AIDS epidemics, and subtype B'', CRF07_BC and CRF01_AE recombinants that are currently circulating in China.', '', 'The results showed that ABT had potent inhibitory activity against the subtypes A, B and C that predominate the worldwide AIDS epidemics, and subtype B'', CRF07_BC and CRF01_AE recombinants that are currently circulating in China.', 22403678),
('Antiviral Peptide', 'Ancestral peptide (named P3)', 'mean IC50, 63.8 nmol/l', '', 'CONCLUSION: P3 is an HIV-2/SIV ancestral peptide with low antigenicity, high stability, and potent activity against both HIV-1, including variants resistant to T-20, and HIV-2.', 23324659),
('Antiviral Peptide', 'Artificial peptides containing four heptad repeats (m4HR) conjugated with a pocket-specific small molecule (pssm) or pssm and cholesterol (chol) [pssm-m4HR or pssm-m4HR-chol]', 'pssm-m4HR conjugates exhibited promising inhibitory activity against HIV-1 Env-mediated cell-cell fusion and laboratory-adapted HIV-1 replication with IC50 values at the low micromolar level, whereas the pssm-m4HR-chol conjugates exhibited dramatically increased anti-HIV-1 activities with IC50 values at the low nanomolar level. Some of the pssm-m4HR-chol conjugates (e.g. 5a and 5b) showed highly potent antiviral activity against infection by primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains.', 'No or low cytotoxicity towards MT-2 cells', 'These results suggest this scaffold design is a promising strategy for developing novel peptide conjugates with improved antiviral activity against a broad spectrum of HIV-1 strains, including those highly resistant to enfuvirtide.', 24500189),
('Antiviral Peptide', 'p5RD(D-form of heparan sulfate binding peptide)', 'Reduce HCMV infectivity in vitro including GCV resistant HCMVs and MCMV infection', '', 'In an effort to develop novel CMV treatments, we tested the effectiveness of the D-form of a novel heparan sulfate binding peptide, p5RD, at reducing infection of ganciclovir (GCV) resistant HCMVs in vitro and MCMV in vivo.', 27678155),
('Antiviral Peptide', 'SK&F 107647', 'Increase natural host resistance to infections caused by both gram-negative and gram-positive bacteria.', '', 'Treatment of experimental gram-negative and gram-positive bacterial sepsis with the hematoregulatory peptide SK&F 107647. SK&F 107647, a novel synthetic low-molecular-weight peptide, has demonstrated potent antiinfective activities in murine models of fungal and viral infection.', 8537660),
('Antiviral Peptide', 'P3 and an arginine-substituted analog, JH-3', 'Potent antimicrobial activities against drug-resistant strains by disrupting and penetrating the bacterial cytoplasmic membrane', '', 'P3, a novel hemoglobin peptide derived from bovine erythrocytes, exhibited modest antimicrobial activity in vitro.', 25753638),
('Antiviral Peptide', 'Labyrinthopeptin A1 (LabyA1)', 'LabyA1 exhibited a consistent and broad anti-HIV activity (EC50s: 0.70-3.3 microM) and anti-HSV activity (EC50s: 0.29-2.8 microM) in cell cultures. LabyA1 also inhibited viral cell-cell transmission between persistently HIV-infected T cells and uninfected CD4(+) T cells (EC50?2.5 microM) and inhibited the transmission of HIV captured by DC-SIGN(+)-cells to uninfected CD4(+) T cells (EC50?4.1 microM).', '', 'LabyA1 can be considered as a novel lead peptide as it had profound antiviral activity against HIV and HSV.', 23724015),
('Antiviral Peptide', 'Peptide (6a)', 'Among the peptides synthesized and evaluated, a lead peptide (6a) with potent activity (IC50: 4.4nM) was identified against the MDR769 HIV-1 protease.', '', 'Design, synthesis and evaluation of a potent substrate analog inhibitor identified by scanning Ala/Phe mutagenesis, mimicking substrate co-evolution, against multidrug-resistant HIV-1 protease.', 23921229),
('Antiviral Peptide', 'antimicrobial peptide conjugated poly (glycolic acid-co-caprolactone) (PGCL) sutures', 'against P. aeruginosa, methicillin-resistant S. aureus (MRSA) strains and viruses by using antimicrobial peptide sequences of KRFRIRVRV-NH2, RWRWRWRW-NH2 and their dual combination (1:1).', 'without any cytotoxic effect to combat surgical site infections is vital.', '', 36510770),
('Antiviral Phytochemical', 'S. chinensis fruit lignans, Schisandrin B and Deoxyschizandrin', 'HIV-1 inhibitor', '', 'From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors. We purified 6 lignans from Schisandra chinensis fruits and assayed their effects on HIV-1 RT and viral replication. Among the S. chinensis fruit lignans, Schisandrin B and Deoxyschizandrin selectively inhibited the HIV-1 RT-associated DNA polymerase activity', 25740376),
('Antiviral Phytochemical', 'Pomegranate rind extract and punicalagin coadministered zinc (II)', 'Herpes simplex virus (HSV)', '', 'Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV. BACKGROUND: There is a clinical need for new therapeutic products against Herpes simplex virus (HSV).', 28665969),
('Antiviral Phytochemical', 'Licochalcone G (1) and seven known (2-8) chalcones', 'Activity influenza viral strains, H1N1, H9N2, novel H1N1 (WT), and oseltamivir-resistant novel H1N1 (H274Y)', '', 'Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata. During our course of an anti-influenza screening program on natural products, one new licochalcone G (1) and seven known (2-8) chalcones were isolated as active principles from the acetone extract of Glycyrrhiza inflata.', 21123068),
('Antiviral Phytochemical', 'Calanolides A (1) and B (4)', 'Against HIV-1', '', 'The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. Eight new coumarin compounds (1-8) were isolated by anti-HIV bioassay-guided fractionation of an extract of Calophyllum lanigerum.', 1379639),
('Antiviral Phytochemical', 'LADANIA067 from the leaves of the wild black currant (Ribes nigrum folium)', 'Anti influenza A viruses (IAV)', '', 'A plant extract of Ribes nigrum folium possesses anti-influenza virus activity in vitro and in vivo by preventing virus entry to host cells. In conclusion, an extract from the leaves of the wild black currant might be a promising source for the development of new antiviral compounds to fight IAV infections.', 23717460),
('Antiviral Phytochemical', 'N-acetylglucosamine-binding protein from Urtica dioica (UDA)', 'Prevents HIV entry', '', 'Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV GP120: a new therapeutic concept to hit the achilles heel of HIV. Mannose-binding proteins derived from several plants (i.e.', 16183648),
('Antiviral Phytochemical', 'Cajanine derivatives Cajanus cajan L.', 'Cajanine was identified as a potent HCV inhibitor with EC50?= 3.17 ? 0.75 microM', '', 'Design and Synthesis of Cajanine Analogues against Hepatitis C Virus through Down-Regulating Host Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1. There still remains a need to develop new anti-HCV agents with distinct mechanism of action (MOA) due to the occurrence of resistance to direct-acting antiviral agents (DAAs).', 27783522),
('Antiviral Phytochemical', 'Melissa extract', 'Free viral particles of two acyclovir-resistant HSV strains at low IC50 values of 0.13 and 0.23 microg/mL', 'Melissa extract exhibits low toxicity and affects attachment and penetration of acyclovir-sensitive and acyclovir-resistant HSVs in vitro.', 'Attachment and penetration of acyclovir-resistant herpes simplex virus are inhibited by Melissa officinalis extract. Medicinal plants are increasingly of interest as novel source of drugs for antiherpetic agents, because herpes simplex virus (HSV) might develop resistance to commonly used antiviral drugs.', 24817544),
('Antiviral Phytochemical', 'Nordihydroguaiaretic acid (6)', 'HIV-1 Nucleocapsid Protein Inhibitors', '', 'Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains. Here, using a multidisciplinary approach combining in silico screening, fluorescence-based molecular assays, and cellular antiviral assays, we identified nordihydroguaiaretic acid (6), as a novel natural product inhibitor of NC.', 29235845),
('Antiviral Phytochemical', 'Cistus incanus (Ci) extracts', 'Ci extracts show potent and broad in vitro antiviral activity against viruses that cause life-threatening diseases in humans and are promising sources of agents that target virus particles.', '', 'Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins. These results demonstrate that Ci extracts show potent and broad in vitro antiviral activity against viruses that cause life-threatening diseases in humans and are promising sources of agents that target virus particles.', 26833261),
('Antiviral Phytochemical', 'Brazilian flora [natural alkaloid isolated from Maytrenus ilicifolia, and the lignans from Peperomia blanda]', 'The compounds APS (EC50=2.3microM), a natural alkaloid isolated from Maytrenus ilicifolia, and the lignans 3(?)43 (EC50=4.0microM), 3(?)20 (EC50=8.2microM) and 5(?)362 (EC50=38.9microM) from Peperomia blanda dramatically inhibited HCV replication as judged by reductions in luciferase activity and HCV protein expression in both the subgenomic and infectious systems.', '', 'Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitro.', 25557602),
('Antiviral Phytochemical', 'Chinese medicinal formula Liangcha', 'Chinese medicinal formula Liangcha, inhibition rate more than 50% at the concentration of 5.3 microg/mL.', 'it was not significantly cytotoxic in several T lymphocytes cell lines with CC50 range 564.79 - 1699.22 microg/mL.', 'RESULTS: The extracts from Chinese medicinal formula Liangcha exhibited potent and broad-spectrum anti-HIV-1 activity on different HIV-1 strains with EC50 range 12.74 -116.87 microg/mL, but weakly inhibited HIV-2 replication.', 21243774),
('Antiviral Phytochemical', 'MeOH extract of Symphyocladia latiuscula', '2,3,6-tribromo-4,5-dihydroxybenzyl methyl ether (TDB) of a CH(2)Cl(2)-soluble fraction was active against wild type HSV-1, as well as AP(r) HSV-1 and TK(-) HSV-1 (IC(50) values of 5.48, 4.81 and 23.3 microg/ml, respectively)', '', 'Antiviral activity of the marine alga Symphyocladia latiuscula against herpes simplex virus (HSV-1) in vitro and its therapeutic efficacy against HSV-1 infection in mice', 16327161),
('Antiviral Phytochemical', 'Acacia catechu extracts', 'The aqueous and 50% ethanolic extracts of A. catechu showed IC50 values of 1.8 ? 0.18 ?g/ml and 3.6 ? 0.31 ?g/ml, respectively in cell-free virus based assay using TZM-bl cells and HIV-1NL4.3 (X-4 tropic), The n-butanol fraction demonstrates a potent inhibitory activity against the viral protease (IC50 = 12.9 microg/ml), but not reverse transcriptase or integrase.', '', 'Extracts from Acacia catechu suppress HIV-1 replication by inhibiting the activities of the viral protease and Tat', 25228267),
('Antiviral Phytochemical', 'Polyphenol rich extract (CYSTUS052) from the Mediterranean plant Cistus incanus', 'Effective dose of 50 microg/ml', '', 'Here we demonstrate that a polyphenol rich extract (CYSTUS052) from the Mediterranean plant Cistus incanus exerts a potent anti-influenza virus activity in A549 or MDCK cell cultures infected with prototype avian and human influenza strains of different subtypes.', 17572513),
('Antiviral Phytochemical', 'Micrococcin P1', 'Inhibiting HCV entry with an EC50 range of 0.1-0.5 microM.', '', 'Accordingly, our study aimed to identify affordable novel HCV inhibitors by screening of natural product compound libraries.', 27387825),
('Antiviral Phytochemical', 'Phyllanthus extract', 'Inhibited HBV DNA synthesis', '', 'Inhibitory effect of Phyllanthus urinaria L. extract on the replication of lamivudine-resistant hepatitis B virus in vitro. These data indicate that Phyllanthus extract may be useful as an alternative therapeutic agent for the treatment of drug-resistant CHB patients.', 26220282),
('Antiviral Phytochemical', 'irisolidone', 'anti-inflammatory, antiangiogenic, anti-cancer, anti-platelet, anti-oxidant, anti-hyperlipidemic, immunomodulating, hepatoprotective and estrogenic potential', '', 'Conclusion: Present work signified the biological importance and therapeutic potential of irisolidone in medicine.', 35249525),
('Antiviral Phytochemical', 'Pistacia lentiscus bark methanol extract', 'extract of P. lentiscus bark could be a beneficial source for novel flavonoid glycosides inhibitors against SARS-CoV-2 infection', '', 'Taken together, this study highlights the Pistacia lentiscus bark methanol extract as a promising antimicrobial and antiviral agent.', 35624793),
('Antiviral Chemical compound', '2-alkyl-2-aminoadamantane derivatives with sufficient adducts', 'Activity against p2009 influenza A', '', 'The results indicate that 2-alkyl-2-aminoadamantane derivatives with sufficient adducts can persistently block p2009 influenza A in vitro through an alternative mechanism.', 24793875),
('Antiviral Chemical compound', 'Naphthyridone 3 (HM13N)', 'Inhibit the HIV-1', '', 'A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication. The emergence of multidrug resistant HIV-1 strains and the inability of the HAART to eradicate HIV-1 virus from infected patients demand new drugs able to interfere with an alternative step of the replicative cycle.', 19958026),
('Antiviral Chemical compound', 'Conjugation of D4T with 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (MKC-442, emivirine)', 'Anti-HIV activity', '', 'Conjugation of D4T with 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (MKC-442, emivirine)-type reverse transcriptase inhibitors via the SATE prodrug approach. This paper reports the synthesis and the antiviral activities of new double-prodrugs against HIV based on the known mixed SATE (S-acyl-2-thioethyl) prodrug approach.', 15715487),
('Antiviral Chemical compound', '2-cyano-3-acrylamide small-molecule', 'Activity against murine norovirus (MNV) and Listeria', '', 'Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens. Due to the rise of antibiotic resistance and the small number of effective antiviral drugs, new approaches for treating infectious diseases are urgently needed.', 27139470),
('Antiviral Chemical compound', '2,4-diarylaniline analogs (DAANs) derivatives 9a-9e', 'HIV-1 reverse transcriptase inhibitors, compound 9e not exhibited extremely high potency against wild-type virus (EC(50) 0.53 nM) and several resistant viral strains (EC(50) 0.36-3.9 nM)', '', 'Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors. The current optimization of 2,4-diarylaniline analogs (DAANs) on the central phenyl ring provided a series of new active DAAN derivatives 9a-9e, indicating an accessible modification approach that could improve anti-HIV potency against wild-type and resistant strains, aqueous solubility, and metabolic stability.', 22406117),
('Antiviral Chemical compound', 'UC 38, analog of oxathiin carboxanilide', 'Anti-HIV activity', '', 'Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor. UC 38, a simple analog of oxathiin carboxanilide, UC 84, lacking the oxathiin ring, was found to be a potent inhibitor of human immunodeficiency virus (HIV)-1-induced cell killing and HIV replication in a variety of human cell lines, as well as in human peripheral blood lymphocytes and macrophages.', 8558446),
('Antiviral Chemical compound', 'Pyridazinone derivative, compound 3711', 'Inhibits hepatitis B virus', '', 'Pyridazinone derivative 3711, a novel chemical entity and HBV inhibitor, may provide a new opportunity to combat chronic HBV infection.', 26349829),
('Antiviral Chemical compound', '1,1,3-trioxo-2H,4H-thieno[3,4-e] [1,2,4]thiadiazine (TTD) derivatives, i.e., 2-(3-fluorobenzyl)-4-cyanomethylen-l,1,3-trioxo-2H,4H- thieno [3,4-e] [1,2,4] thiadiazine) (QM96639)', 'Inhibit human immunodeficiency virus (HIV) type 1 [HIV-1 (IIIB)] at concentration 0.09 microM', '', '1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity. We report the development of a new group of nonnucleoside reverse transcriptase inhibitors (NNRTIs).', 9517942),
('Antiviral Chemical compound', 'BAY 57-1293', 'Against HSV infection', '', 'Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293. BAY 57-1293 belongs to a new class of antiviral compounds and inhibits replication of herpes simplex virus (HSV) type 1 and type 2 in the nanomolar range in vitro by abrogating the enzymatic activity of the viral primase-helicase complex.', 12019088),
('Antiviral Chemical compound', 'Urea-PETT (phenylethylthiazolylthiourea)', 'HIV-1 inhibitor', '', 'Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues. The further development of allosteric HIV-1 RT inhibitors in the urea analogue series of PETT (phenylethylthiazolylthiourea) derivatives is described here. The series includes derivatives with an ethyl linker (1-5) and racemic (6-16) and enantiomeric (17-20) cis-cyclopropane compounds.', 10514285),
('Antiviral Chemical compound', 'Diphenyl heterocyclic compounds(R706)', 'hepatitis C virus (HCV)', '', 'We conclude that R803 and related heterocyclic compounds constitute a new class of HCV-specific inhibitors that could potentially be developed as a treatment for HCV infection.', 18227176),
('Antiviral Chemical compound', 'Crown-Like Oxotricyclic Core as the P2-Ligand', 'HIV-1 inhibitor', '', 'Design and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants. Design, synthesis, and evaluation of a new class of exceptionally potent HIV-1 protease inhibitors are reported.', 28418652),
('Antiviral Chemical compound', 'Neoechinulin B and its analogues', 'Activity against H1N1 virus', '', 'A class of prenylated indole diketopiperazine alkaloids including 15 new compounds namely rubrumlines A-O obtained from marine-derived fungus Eurotium rubrum, were tested against influenza A/WSN/33 virus. Neoechinulin B (18) exerted potent inhibition against H1N1 virus infected in MDCK cells, and is able to inhibit a panel of influenza virus strains including amantadine- and oseltamivir-resistant clinical isolates.', 25681711),
('Antiviral Chemical compound', 'Meso-tetrakis-(3,5-dicarboxy-4,4''-biphenyl) porphyrin', 'Activity against hepatitis C virus (HCV)', '', 'A novel class of meso-tetrakis-porphyrin derivatives exhibits potent activities against hepatitis C virus genotype 1b replicons in vitro. Recent years have seen the rapid advancement of new therapeutic agents against hepatitis C virus (HCV) in response to the need for treatment that is unmet by interferon (IFN)-based therapies.', 19901090),
('Antiviral Chemical compound', 'Combination of the (R)-(hydroxyethylamino)sulfonamide isostere and the cyclic urea component of lopinavir', 'HIV-1 inhibitor', '', 'Discovery of imidazolidine-2,4-dione-linked HIV protease inhibitors with activity against lopinavir-resistant mutant HIV. A new series of HIV protease inhibitors has been designed and synthesized based on the combination of the (R)-(hydroxyethylamino)sulfonamide isostere and the cyclic urea component of lopinavir.', 16828558),
('Antiviral Chemical compound', 'PTC725', 'Targets the hepatitis C Virus NS4B protein', '', 'Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B protein. While new direct-acting antiviral agents for the treatment of chronic hepatitis C virus (HCV) infection have been approved, there is a continued need for novel antiviral agents that act on new targets and can be used in combination with current therapies to enhance efficacy and to restrict the emergence of drug-resistant viral variants.', 23629699),
('Antiviral Chemical compound', 'Acridone derivatives, obtained by reaction of acridone-4-carboxylic acid derivatives with aromatic amines', 'NS3 helicase of hepatitis C virus (HCV) with IC(50) range from 1.5 to 20 microM', '', 'Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication. A new goup of acridone derivatives, obtained by reaction of acridone-4-carboxylic acid derivatives with aromatic amines, was tested to determine the inhibitory properties toward the NS3 helicase of hepatitis C virus (HCV).', 20337460),
('Antiviral Chemical compound', 'Novel compounds generated by merging pharmacophores of salicylate and catechol [2,3-dihydroxybenzamide (5a), structural modifications on the 5a scaffold with carboxamide and the piperidin-1-ylsulfonyl substituted at the phenyl ring to generate (5p), N-(cyclohexylmethyl)-2,3-dihydroxy-5-(piperidin-1-ylsulfonyl) benzamide (5u)]', 'HIV-1 inhibitor, 5p, IC(50)=5 microM, 5u IC(50) value of 8 microM', '', 'Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups. By merging the pharmacophores of salicylate and catechol, the 2,3-dihydroxybenzamide (5a) was identified as a new scaffold to inhibit the strand transfer reaction efficiently.', 21778063),
('Antiviral Chemical compound', 'Bicyclic hydroxy-1H-pyrrolopyridine-triones', 'HIV-1 integrase inhibitors', '', 'Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. We report herein bicyclic hydroxy-1H-pyrrolopyridine-triones as a new family of HIV-1 integrase inhibitors that were efficiently prepared using a key ''Pummerer cyclization deprotonation cycloaddition'' cascade of imidosulfoxides.', 22107736),
('Antiviral Chemical compound', 'N-(2-phenylethyl)-N''-(2-thiazolyl)thiourea (LY73497)', 'Inhibit HIV-1 but not HIV-2', '', 'The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. To identify the minimal structural elements necessary for biological activity, the rigid tricyclic nucleus of the known human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) inhibitor tetrahydroimidazobenzodiazepinthione was subjected to systematic bond disconnection to obtain simpler structures.', 7574525),
('Antiviral Chemical compound', '1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils', 'HIV-1 non-nucleoside reverse transcriptase inhibitors', '', 'Design, synthesis, and biological evaluation of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors with an improved drug resistance profile. Because the emergence of drug-resistant mutants has limited the efficacy of non-nucleoside reverse transcriptase inhibitors (NNRTIs), it is essential to develop new antivirals with better drug resistance and pharmacokinetic profiles. Here we designed and synthesized a series of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils, the HEPT analogues, and evaluated their biological activity using nevirapine and 18 (TNK-651) as reference compounds.', 22283377),
('Antiviral Chemical compound', 'Amidine 6 and guanidine 7', 'Activity against oseltamivir-resistant influenza viruses', '', 'Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A. With the emergence of oseltamivir-resistant influenza viruses and in view of a highly pathogenic flu pandemic, it is important to develop new anti-influenza agents. Several 5-guanidino- and 5-amidino-based oseltamivir derivatives were synthesized and profiled for their anti-influenza activity and in vitro and in vivo PK properties. Amidine 6 and guanidine 7 were comparably effective against a panel of different A/H1N1 and A/H3N2 strains and also inhibited mutant A/H1N1 neuraminidase. Among different prodrug strategies pursued, a simple amidoxime ethyl ester (9) exhibited a superior PK profile with an oral bioavailability of 31% (rats), which is comparable to oseltamivir (36%). Thus, bioisosteric replacement of the 5-guanidine with an acetamidine-in the form of its N-hydroxy prodrug-successfully tackled the two key limitations of currently used NA inhibitors, as exemplified with oseltamivir.', 24422530),
('Antiviral Chemical compound', 'PL-100', 'Potent inhibition of HIV-1 protease and viral replication in vitro (K(i), approximately 36 pM, and 50% effective concentration [EC(50)], approximately 16 nM, respectively)', '', 'In vitro antiviral activity and cross-resistance profile of PL-100, a novel protease inhibitor of human immunodeficiency virus type 1. Despite the success of highly active antiretroviral therapy, the current emergence and spread of drug-resistant variants of human immunodeficiency virus (HIV) stress the need for new inhibitors with distinct properties.', 17638694),
('Antiviral Chemical compound', '1H-1,2,3-triazole-4-carboxamide derivative 3b', 'Anti-influenza A viruses, H5N1 (RG14), amantidine-resistant A/WSN/33 (H1N1), and oseltamivir-resistant A/WSN/1933 (H1N1, 274Y) virus strains', '', 'Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein. The influenza virus nucleoprotein (NP) is an emerging target for anti-influenza drug development.', 22332894),
('Antiviral Chemical compound', '3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides', 'Inhibit HIV-1 Integrase and RNase H', '', '3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H. On the basis of our previously reported 3-hydroxypyrimidine-2,4-dione (HPD) core, we have designed and synthesized a new integrase strand transfer (INST) inhibitor type featuring a 5-N-benzylcarboxamide moiety. Significantly, the 6-alkylamino variant of this new chemotype consistently conferred low nanomolar inhibitory activity against HIV-1.', 27283261),
('Antiviral Chemical compound', '4-Benzyloxy-gamma-sultone (4- and 5-substituted-5H-1,2-oxathiole-2,2-dioxide derivatives ) derivatives', 'Against human cytomegalovirus (HCMV) and varicella zoster virus (VZV)', '', '4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus. We report the synthesis and antiviral activity of a new family of non-nucleoside antivirals, derived from the 4-keto-1,2-oxathiole-2,2-dioxide (beta-keto-gamma-sultone) heterocyclic system.', 19226140),
('Antiviral Chemical compound', '(3aS,4S,7aR)-hexahydro-2H-furo[2,3-b]pyran-4-ol, (-)-7', 'Activity against multidrug-resistant HIV-1 variants', '', 'Design and synthesis of potent HIV-1 protease inhibitors incorporating hexahydrofuropyranol-derived high affinity P(2) ligands: structure-activity studies and biological evaluation. The design, synthesis, and evaluation of a new series of hexahydrofuropyranol-derived HIV-1 protease inhibitors are described.', 21194227),
('Antiviral Chemical compound', 'New series of fused heteroaromatic sulfonamides', 'Against HIV-1', '', 'Design of HIV-1 protease inhibitors active on multidrug-resistant virus. On the basis of structural data gathered during our ongoing HIV-1 protease inhibitors program, from which our clinical candidate TMC114 9 was selected, we have discovered new series of fused heteroaromatic sulfonamides.', 15771440),
('Antiviral Chemical compound', '4-substituted 1,5-diarylanilines( three most promising compounds 14e, 14h, and 15h)', 'Activity against HIV-1, EC(50) values ranging from 0.2 to 10 nM', '', 'Design, synthesis, and preclinical evaluations of novel 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidates. Twenty-one new 4-substituted diarylaniline compounds (DAANs) (series 13, 14, and 15) were designed, synthesized, and evaluated against wild-type and drug resistant HIV-1 viral strains.', 22856541),
('Antiviral Chemical compound', 'MP-134 and MP-167', 'Inhibitors of HIV type 1 protease', '', 'Design, synthesis, and resistance patterns of MP-134 and MP-167, two novel inhibitors of HIV type 1 protease. Inhibitors of HIV-1 protease represent a new class of antiretroviral compounds.', 8825619),
('Antiviral Chemical compound', '1-aryl-4,6-diamino-1,2-dihydrotriazine derivatives', 'Inhibitors of influenza A and B virus and respiratory syncytial virus (RSV) via targeting of the host dihydrofolate reductase (DHFR) enzyme. best compounds (11, 13, 14 and 16) even reached the sub-micromolar potency of zanamivir (EC50 = 0.060 ?M)', '', 'We have identified a series of 1-aryl-4,6-diamino-1,2-dihydrotriazines, structurally related to the antimalarial drug cycloguanil, as new inhibitors of influenza A and B virus and respiratory syncytial virus (RSV) via targeting of the host dihydrofolate reductase (DHFR) enzyme.', 28477572),
('Antiviral Chemical compound', '1H-benzo[de]isoquinoline-1,3(2H)-diones', 'Inhibitors of HCV NS5B polymerase.', '', 'Herein, we present 1H-benzo[de]isoquinoline-1,3(2H)-diones as a new series of selective inhibitors of HCV NS5B polymerase.', 19877603),
('Antiviral Chemical compound', 'Imide derivatives of 3-nitro-1.8-naphthalic acid', 'Activity against herpes simplex type 2 (HSV-2) and adenovirus type 5 (Ad-5)', '', 'Imide derivatives of 3-nitro-1.8-naphthalic acid: their inhibitory activity against DNA viruses. The antiviral action of a new drug, 5-amino-2-(dimethylaminoethyl)-benzo-[de]-isoquinolin-1.3-dione has been studied against herpes simplex type 2 (HSV-2) and adenovirus type 5 (Ad-5) grown in Vero cells.', 6299235),
('Antiviral Chemical compound', 'SPD754 (also known as AVX-754)', 'Activity against HIV-1 and HIV-2 in vitro and against recombinant viruses containing thymidine analogue mutations (TAMs)', '', 'In vitro activity of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor (NRTI), against 215 HIV-1 isolates resistant to other NRTIs.', 16245645),
('Antiviral Chemical compound', '9-phenylcyclohepta[d]pyrimidinedione derivatives', 'Inhibit HIV-1 replication', '', 'Inhibitory activity of 9-phenylcyclohepta[d]pyrimidinedione derivatives against different strains of HIV-1 as non-nucleoside reverse transcriptase inhibitors. BACKGROUND: The non-nucleoside reverse transcriptase inhibitor (NNRTI), as a major component of the highly active antiretroviral therapy (HAART) to HIV-1 (human immunodeficiency virus type 1) infected patients, required the development of new NNRTIs with improved resistance profile and decreased toxicity.', 21569631),
('Antiviral Chemical compound', 'New diarylaniline (DAAN) analogues', 'Anti-HIV potency, especially against the E138K', '', 'Three series (6, 13, and 14) of new diarylaniline (DAAN) analogues were designed, synthesized, and evaluated for anti-HIV potency, especially against the E138K viral strain with a major mutation conferring resistance to the new-generation non-nucleoside reverse transcriptase inhibitor drug rilpivirine (1b).', 27070547),
('Antiviral Chemical compound', 'Pyrrolidine-3,4-bis-N-benzyl-sulfonamides', 'The most promising candidate exhibited a K(i) of 74 nM towards a wild-type HIV protease', '', 'Recently, symmetric pyrrolidine-3,4-bis-N-benzyl-sulfonamides have been developed as a new class of HIV-1 protease inhibitors.', 18692068),
('Antiviral Chemical compound', 'Compounds HIV-1 protease inhibitors with the hydroxyethylamine core and different phenyloxazolidinone P2 ligands?', 'HIV-1 protease inhibitors', '', 'Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones. A series of new HIV-1 protease inhibitors with the hydroxyethylamine core and different phenyloxazolidinone P2 ligands were designed and synthesized.', 20958050),
('Antiviral Chemical compound', 'Diarylpyrimidine (DAPY)', 'Nonnucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-1', '', 'Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1. This paper reports the synthesis and the antiviral properties of new diarylpyrimidine (DAPY) compounds as nonnucleoside reverse transcriptase inhibitors (NNRTIs).', 15771449),
('Antiviral Chemical compound', '2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4(3H)-one (S-DABO) derivatives', 'Target at the non-nucleoside reverse transcriptase inhibitors resistant HIV-1 strain', '', 'The anti-HIV activity of three 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4 (3H)-one derivatives acting as non-nucleoside reverse transcriptase inhibitor in vitro. It was recently shown that several new synthetic 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4(3H)-one (S-DABO) derivatives demonstrated anti-HIV-1 activity.', 21348416),
('Antiviral Chemical compound', 'Lactoside compounds', 'Against HIV-1', '', 'Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection. Despite significant improvements, antiretroviral therapies against HIV-1 are plagued by a high frequency of therapeutic failures that have been associated with acquisition of drug resistance.', 22064534),
('Antiviral Chemical compound', 'New derivative of bevirimat', 'HIV-1 maturation inhibitor', '', 'Synthesis and biological evaluation of a new derivative of bevirimat that targets the Gag CA-SP1 cleavage site. Bevirimat (2), the first-in-class HIV-1 maturation inhibitor, shows a low efficacy due essentially to the natural polymorphism of its target, the CA-SP1 junction.', 23399723),
('Antiviral Chemical compound', 'Alizarine analogues K-49 and KNA-53', 'Inhibitors of the HIV-1,  IC(50) values for both RT-associated functions of ? 10 microm', '', 'Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases. HIV-1 reverse transcriptase (RT) has two associated activities, DNA polymerase and RNase H, both essential for viral replication and validated drug targets.', 21348941),
('Antiviral Chemical compound', 'Proteasome inhibitor VL-01', 'Reduction of influenza virus', '', 'Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses. The appearance of highly pathogenic avian influenza A viruses of the H5N1 subtype being able to infect humans and the 2009 H1N1 pandemic reveals the urgent need for new and efficient countermeasures against these viruses.', 21777621),
('Antiviral Chemical compound', '2-phenylimidazopyridines', 'Herpes infection', '', '2-phenylimidazopyridines, a new series of Golgi compounds with potent antiviral activity. Drugs targeted to viral proteins are highly vulnerable to the development of resistant strains.', 17973358),
('Antiviral Chemical compound', '9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-guanine (BIOLF-62)', 'Activity against herpes simplex virus types 1 and 2', '', 'A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2. A novel nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-guanine (BIOLF-62), was found to have potent antiviral activity against herpes simplex virus types 1 and 2 at concentrations well below cytotoxic levels.', 6289741),
('Antiviral Chemical compound', '1-(omega-phenoxyalkyl)uracils bearing acetanilide fragment in 3 position of pyrimidine ring', 'Inhibitors of Hepatitis C Virus replication', '', 'Here, we describe new 1-(?-phenoxyalkyl)uracils bearing acetanilide fragment in 3 position of pyrimidine ring as potential antiviral drugs against HCV. A detailed structure-activity relationship revealed that the most active compounds were the N(3)-substituted uracil derivatives containing 6-(4-bromophenoxy)hexyl or 8-(4-bromophenoxy)octyl fragment at N(1) position.', 27406141),
('Antiviral Chemical compound', 'Indolyl aryl sulfones bearing the 4,5-difluoro (10) or 5-chloro-4-fluoro (16) substitution pattern at the indole ring ', 'HIV-1 non-nucleoside reverse transcriptase inhibitors', '', 'Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity.', 17803291),
('Antiviral Chemical compound', '2-acetyl-3-methyl-5-(p-tolyl)indeno[1,2-d]thiazolo[3,2- a]pyrimidin-6(5H)-one (9b) and ethyl 3-methyl-6-oxo-5-(p-tolyl)-5,6-dihydroindeno[1,2-d]thiazolo- [3,2-a]pyrimidine-2-carboxylate (9c),', 'Anti-HSV-1', '', 'Merged pyrimidine derivatives were designed by one pot synthesis of pyrimidinethione derivative with halogenated compounds. Amongst the tested compounds 2-acetyl-3-methyl-5-(p-tolyl)indeno[1,2-d]thiazolo[3,2- a]pyrimidin-6(5H)-one (9b) and ethyl 3-methyl-6-oxo-5-(p-tolyl)-5,6-dihydroindeno[1,2-d]thiazolo- [3,2-a]pyrimidine-2-carboxylate (9c), caused viral inhibition over 90%. . CONCLUSION: We succeeded in this context to synthesize a new series of potent fused pyrimidine derivatives as anti-HSV-1.', 29219053),
('Antiviral Chemical compound', '5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines', 'Anti-human immunodeficiency virus (HIV)', '', 'Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines. OBJECTIVES: To discover new potent and selective anti-human immunodeficiency virus (HIV) acyclic nucleoside phosphonate (ANP) drugs with in vivo antiretroviral activity.', 17124193),
('Antiviral Chemical compound', 'SJ-3366', 'Inhibited the entry of both HIV-1 and HIV-2', '', 'SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2. We have identified and characterized a potent new nonnucleoside reverse transcriptase (RT) inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1) that also is active against HIV-2 and which interferes with virus replication by two distinct mechanisms. 1-(3-Cyclopenten-1-yl)methyl-6-(3,5-dimethylbenzoyl)-5-ethyl-2,4-pyrimidinedione (SJ-3366) inhibits HIV-1 replication at concentrations of approximately 1 nM, with a therapeutic index of greater than 4 x 10(6).', 11158731),
('Antiviral Chemical compound', 'Benzamide derivative N-[1-(7-tert-Butyl-1H-indol-3-ylmethyl)-2-(4-cyclopropanecarbonyl-3-methyl-piperazin-1-yl)-2-oxo-ethyl]-4-nitro-benzamide (SP-10)', 'Reduces HIV-1 infectivity (IC50 = 0.036 nM)', '', 'We investigated the in vitro efficacy, safety and mechanism of action of the benzamide derivative N-[1-(7-tert-Butyl-1H-indol-3-ylmethyl)-2-(4-cyclopropanecarbonyl-3-methyl-pipera zin-1-yl)-2-oxo-ethyl]-4-nitro-benzamide (SP-10), a potential new HIV treatment. When HIV-1-responsive engineered HeLa cells were pre-incubated for 48 h with either SP-10 or zidovudine (AZT), SP-10 was able to inhibit viral replication at much lower concentrations (IC50 = 0.036 nM) than AZT (IC50 = 27.4 nM).', 17249247),
('Antiviral Chemical compound', '1,3-oxazinan-2-one, piperidine-2,4-dione, piperidine-2-one and piperidine', 'Activity against Influenza A virus strains (IC50 = 7.7 microM)', '', 'A series of (R)- and (S)-isomers of new adamantane-substituted heterocycles (1,3-oxazinan-2-one, piperidine-2,4-dione, piperidine-2-one and piperidine) with potent activity against rimantadine-resistant strains of influenza A virus were synthesized through the transformation of adamantyl-substituted N-Boc-homoallylamines 8 into piperidine-2,4-diones 11 through the cyclic bromourethanes 9 and key intermediate enol esters 10.', 28338150),
('Antiviral Chemical compound', 'Thiophene[3,2-d]pyrimidine Derivatives', 'HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors', '', 'Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants. In the present study, we designed, synthesized, and biologically tested several series of new derivatives in order to investigate previously unexplored chemical space. Some of the synthesized compounds displayed single-digit nanomolar anti-HIV potencies against wild-type (WT) virus and a panel of NNRTI-resistant mutant viruses in MT-4 cells. Compound 25a was exceptionally potent against the whole viral panel, affording 3-4-fold enhancement of in vitro antiviral potency against WT, L100I, K103N, Y181C, Y188L, E138K, and K103N+Y181C and 10-fold enhancement against F227L+V106A relative to the reference drug etravirine (ETV) in the same cellular assay. Overall, the results indicate that 25a is a promising new drug candidate for treatment of HIV-1 infection.', 28481112),
('Antiviral Chemical compound', 'Triazolo[4,5-g]quinoline derivatives (compounds 1-6). 4,9-Dihydrotriazolo[4,5-g]quinoline-1-oxide (1)', 'Activity against NNRTI-resistant HIV-1 mutants', '', 'Activity and molecular modeling of a new small molecule active against NNRTI-resistant HIV-1 mutants. In this preliminary study we report the antiviral screening of triazolo[4,5-g]quinoline derivatives (compounds 1-6). 4,9-Dihydrotriazolo[4,5-g]quinoline-1-oxide (1) stood out as a new, small molecule endowed with a selective, promising activity in cell-based assays against HIV-1wt and clinically relevant NNRTI resistant mutants.', 19775780);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antiviral Chemical compound', 'PHA767491', 'Activity against human herpes simplex virus(both HSV-1 and HSV-2)', '', 'PHA767491 potently blocked the proliferation of HSV in cells, as well as HSV induced cell death. Further, we found that PHA767491 strongly inhibited HSV infection post viral entry. Moreover, PHA767491 reduced the expression of viral genes required for DNA synthesis including UL30/42 DNA polymerase and UL5/8/52 helicase-primase complex. Thus, PHA767491 could be a promising agent for the development of new anti-HSV therapy.', 28320320),
('Antiviral Chemical compound', 'Alternariol 5-O-Methyl Ether', 'Inhibits HIV-1 Integration by Blocking Nuclear', '', 'Microbial Natural Product Alternariol 5-O-Methyl Ether Inhibits HIV-1 Integration by Blocking Nuclear Import of the Pre-Integration Complex. While Highly Active Antiretroviral Therapy (HAART) has significantly decreased the mortality of human immunodeficiency virus (HIV)-infected patients, emerging drug resistance to approved HIV-1 integrase inhibitors highlights the need to develop new antivirals with novel mechanisms of action.', 28489061),
('Antiviral Chemical compound', '5,6-dimethylxanthenone-4-acetic acid (DMXAA)', 'Activity against H1N1 influenza', '', 'The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-beta-mediated antiviral activity in vitro and in vivo. The 2009 outbreak of pandemic H1N1 influenza, increased drug resistance, and the significant delay in obtaining adequate numbers of vaccine doses have heightened awareness of the need to develop new antiviral drugs that can be used prophylactically or therapeutically.', 21084628),
('Antiviral Chemical compound', '2,3-dihydrobenzofuran derivatives', 'Hepatitis C Virus (HCV) NS5A Inhibitors', '', 'Discovery of Chromane Containing Hepatitis C Virus (HCV) NS5A Inhibitors with Improved Potency against Resistance-Associated Variants. This effort, incorporating the C-1 fluoro substitution at the tetracyclic indole core, led to the discovery of a new series of NS5A inhibitors, such as compounds 14 and 25-28, with significantly improved potency against resistance-associated variants, such as GT2b, GT1a Y93H, and GT1a L31V.', 27792320),
('Antiviral Chemical compound', 'Moronic acid and other triterpene derivatives', 'Moronic acid derivatives 19, 20, and 21 showed significant activity in HIV-1 infected H9 lymphocytes. Compound 20 showed potent anti-HIV activity with EC50 values of 0.0085 microM against NL4-3, 0.021 microM against PI-R (a multiple protease inhibitor resistant strain), and 0.13 microM against FHR-2 (an HIV strain resistant to 8)', '', 'Moronic acid and other triterpene derivatives as novel potent anti-HIV agents.', 16942019),
('Antiviral Chemical compound', 'n-benzenesulphony 1-2 (2 or 3-pyridylethyl) benzimidazole derivatives', 'Coxsackie B5 virus', 'Cytotoxicity tests show that many of these substances are well tolerated by the VERO cells.', 'The antiviral and antiproliferative activity of new compounds having n-benzenesulphony 1-2 (2 or 3-pyridylethyl) benzimidazole as a base structure were studied in vitro. The antiviral and antiproliferative activity of new compounds having n-benzenesulphony 1-2 (2 or 3-pyridylethyl) benzimidazole as a base structure were studied in vitro. Only compound 7a, with the presence of both the pyridyl moiety bound at the ethylenic bridge in C-2 of benzimidazole and the nitro-group in the benzene ring, displays a selective antiproliferative effect against certain leukaemia cells and a good antiviral activity especially towards the Coxsackie B5 virus.', 11169164),
('Antiviral Chemical compound', 'TLT35', 'HIV-1 infection prevention', '', 'Here we reported the design of a novel chimera protein-based fusion inhibitor targeting gp41, TLT35, that uses a flexible 35-mer linker to couple T20 and T1144, the first and next generation HIV-1 fusion inhibitors, respectively.', 21690094),
('Antiviral Chemical compound', 'Benzophenone template compounds 70h (GW678248)', '70h has in vitro antiviral assay IC(50) values of 0.5 nM against wild-type HIV, 1 nM against the K103N mutant associated with clinical resistance to efavirenz, and 0.7 nM against the Y181C mutant associated with clinical resistance to nevirapine', '', 'Structure-activity relationship studies of novel benzophenones leading to the discovery of a potent, next generation HIV nonnucleoside reverse transcriptase inhibitor. These potent inhibitors include 70h (GW678248), which has in vitro antiviral assay IC(50) values of 0.5 nM against wild-type HIV, 1 nM against the K103N mutant associated with clinical resistance to efavirenz, and 0.7 nM against the Y181C mutant associated with clinical resistance to nevirapine. Compound 70h has also demonstrated relatively low clearance in intravenous pharmacokinetic studies in three species, and it is the active component of a drug candidate which has progressed to phase 2 clinical studies..', 16420058),
('Antiviral Chemical compound', 'Thiazolidenebenzenesulfonamides', 'Activity against nevirapine-resistant virus, HIV-1(IIIB-R)', '', 'Studies of nonnucleoside HIV-1 reverse transcriptase inhibitors.', 15519161),
('Antiviral Chemical compound', 'SA-2, the ethyl 4-(2-hydroxymethyl-5-oxopyrrolidin-1-yl)-3-[3-(3-methylbenzoyl)-thioureido] benzoate', 'Activity against influenza A virus', '', 'A target-free and cell-based approach was applied to evaluate the anti-influenza properties of six newly synthesized benzoic acid derivatives. SA-2, the ethyl 4-(2-hydroxymethyl-5-oxopyrrolidin-1-yl)-3-[3-(3-methylbenzoyl)-thioureido] benzoate (compound 2) was screened as a potential drug candidate. Based on these favourable findings, SA-2, a novel anti-influenza agent, with its potent anti-influenza activity in vitro and in vivo, could be a promising antiviral for the treatment of infection of influenza A viruses, including oseltamivir-resistant mutants.', 26802558),
('Antiviral Chemical compound', 'JTK-853', 'Nonnucleoside inhibitor of hepatitis C virus (HCV) RNA-dependent RNA polymerase.', '', 'Collectively, these data demonstrate that JTK-853 is a potent and novel nonnucleoside palm site-binding HCV polymerase inhibitor, suggesting JTK-853 as a potentially useful agent in combination with other DAAs for treatment of HCV infections.', 22615294),
('Antiviral Chemical compound', '1R,2R-dicamphanoyl-3,3-dimethydihydropyrano[2,3-c]xanthen-7(1H)-one (DCX)', 'Reverse transcriptase (RT) inhibitor-resistant HIV-1 (RTMDR-1) strains.', '', 'Design, synthesis, and evaluation of 1R,2R-dicamphanoyl-3,3-dimethyldihydropyrano-[2,3-c]xanthen-7(1H)-one (DCX) derivatives as novel anti-HIV agents. In this study, 1R,2R-dicamphanoyl-3,3-dimethydihydropyrano[2,3-c]xanthen-7(1H)-one (DCX) derivatives were designed and synthesized as novel anti-HIV agents against both wild-type and non-nucleoside reverse transcriptase (RT) inhibitor-resistant HIV-1 (RTMDR-1) strains.', 22063755),
('Antiviral Chemical compound', 'Benzimidazole-related compound', 'To prevent chikungunya virus (CHIKV) infection', '', 'Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus. Screening of chemical compound libraries were performed and one candidate, a benzimidazole-related compound designated Compound-A was found to inhibit infection by several CHIKV strains and a Sindbis virus strain at nanomolar concentrations.', 28236746),
('Antiviral Chemical compound', '141W94 (VX-478) in combination with other antiretroviral agents', 'HIV-1 protease inhibitor with an IC50 of 0.08 microM against HIV-1 (strain IIIB) and a mean IC50 of 0.012 microM against six HIV clinical isolates.', '', 'In vitro antiviral activity of 141W94 (VX-478) in combination with other antiretroviral agents. 141W94 (VX-478) is a novel HIV-1 protease inhibitor with an IC50 of 0.08 microM against HIV-1 (strain IIIB) and a mean IC50 of 0.012 microM against six HIV clinical isolates. 141W94 was synergistic on the basis of isobologram analysis with each of the following reverse transcriptase inhibitors: AZT, 935U83, 524W91, 1592U89 and ddl, 141W94 was also synergistic with saquinavir and additive with either indinavir or ritonavir.', 8721545),
('Antiviral Chemical compound', 'Alkylamidophospholipid analogues', 'Anti-human immunodeficiency virus type 1 agents', '', 'In vitro evaluation and characterization of newly designed alkylamidophospholipid analogues as anti-human immunodeficiency virus type 1 agents. Our laboratories first reported two novel classes of complex synthetic lipids, including alkylamidophosphocholines (PC lipid; CP-51) and alkylamidophosphate ester-linked lipid-AZT conjugates (lipid-AZT conjugates; CP-92), with selective and potent activity against human immunodeficiency virus type 1 (HIV-1).', 9875387),
('Antiviral Chemical compound', '6-{4-[(biphenyl-2-ylcarbonyl) amino]benzoyl}-N-cyclopropyl-5,6-dihydro-4H-thieno[3,2-d][1]benzazepine-2-carboxamide (YM-53403).', 'The EC(50) value 0.20 microM, was about 100-fold more potent than ribavirin.', '', 'YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action', 15708639),
('Antiviral Chemical compound', 'Stavudine-5''-(p-bromophenyl methoxyalaninyl phosphate) (stampidine)', 'Anti-HIV activity', '', 'We have evaluated the clinical potential of stavudine-5''-(p-bromophenyl methoxyalaninyl phosphate(stampidine [STAMP]), a novel aryl phosphate derivative of stavudine, as a new anti-human immunodeficiency virus (anti-HIV) agent, by examining its acute, subacute, and chronic toxicity profile in mice as well as by testing its antiviral activity in a surrogate human peripheral blood lymphocyte (Hu-PBL)-SCID mouse model of human AIDS.', 12384347),
('Antiviral Chemical compound', 'Alkenyldiarylmethanes( most potent of these proved to be 3'',3"-dibromo-4'',4"-dimethoxy-5''5"-bis(methoxycarbonyl)-1,1-diphenyl-1-+ ++heptene)', 'Anti-HIV-1 activity', '', 'Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors. Several novel alkenyldiarylmethane (ADAM) non-nucleoside HIV-1 reverse transcriptase inhibitors were synthesized.', 8759644),
('Antiviral Chemical compound', '17-amino-17-demethoxygeldanamycin derivatives', 'Inhibited duckling hepatitis B virus DNA replication', '', 'The 17-amino-17-demethoxygeldanamycin derivatives could be novel agents with potential antiviral activity.', 20710066),
('Antiviral Chemical compound', '6-methyl-7-substituted-7-deaza purine analogues', 'Compounds 5x (IC50 = 5.88 microM and 6.95 microM for H1N1 and H3N2, respectively) and 5z (IC50 = 3.95 microM and 3.61 microM for H1N1 and H3N2, respectively) demonstrated potent anti-influenza A activity.', '', 'Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents.', 26802557),
('Antiviral Chemical compound', '1592U89, (-)-(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclo pentene-1-methanol', 'Average 50% inhibitory concentration [IC50], 0.26 microM for 1592U89', '', '1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity.', 9145874),
('Antiviral Chemical compound', 'Cytidine analogue, FNC (2''-deoxy-2''-?-fluoro-4''-azidocytidine)', 'Strongly inhibit human HBV and duck HBV (DHBV) replication in vitro and in vivo, respectively.', '', 'A novel cytidine analogue, FNC (2''-deoxy-2''-?-fluoro-4''-azidocytidine), was recently shown to strongly inhibit human HBV and duck HBV (DHBV) replication in vitro and in vivo, respectively.', 22910281),
('Antiviral Chemical compound', '2''-deoxy-3''-thiacytidine (BCH-189)', 'Activity against five different strains of human immunodeficiency virus type 1 (HIV-1) (mean 50% inhibitory dose, 0.73 microM)', 'less toxic than AZT in cell culture', 'Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2''-deoxy-3''-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog. We describe a novel nucleoside analog, 2''-deoxy-3''-thiacytidine (BCH-189), in which the 3'' carbon of the ribose ring of 2''-deoxycytidine has been replaced by a sulfur atom.', 1929298),
('Antiviral Chemical compound', '2'',3''-didehydro-3''-deoxy-4''-ethynylthymidine', 'Activity anti-human immunodeficiency virus type 1 (HIV-1)', 'Weak cytotoxicity in cell cultures', 'Anti-human immunodeficiency virus type 1 activity and resistance profile of 2'',3''-didehydro-3''-deoxy-4''-ethynylthymidine in vitro. 2'',3''-Didehydro-3''-deoxy-4''-ethynylthymidine (4''-Ed4T) has been identified as a novel nucleoside analog with potent and selective anti-human immunodeficiency virus type 1 (HIV-1) activity and weak cytotoxicity in cell cultures. 4''-Ed4T proved to be 5- to 10-fold more active than its structurally related compound, stavudine (d4T).', 16048947),
('Antiviral Chemical compound', 'GS-9148 [(5-(6-amino-purin-9-yl)-4-fluoro-2,5-dihydro-furan-2-yloxymethyl)phosphonic acid]', 'Activity against nucleoside-resistant variants of human immunodeficiency virus type 1', '', 'Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131. GS-9148 [(5-(6-amino-purin-9-yl)-4-fluoro-2,5-dihydro-furan-2-yloxymethyl)phosphonic acid] is a novel ribose-modified human immunodeficiency virus type 1 (HIV-1) nucleotide reverse transcriptase (RT) inhibitor (NRTI) selected from a series of nucleoside phosphonate analogs for its favorable in vitro biological properties including (i) a low potential for mitochondrial toxicity, (ii) a minimal cytotoxicity in renal proximal tubule cells and other cell types, (iii) synergy in combination with other antiretrovirals, and (iv) a unique resistance profile against multiple NRTI-resistant HIV-1 strains.', 18056282),
('Antiviral Chemical compound', '2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine', 'Activity against multidrug-resistant hepatitis B virus mutants', '', 'In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants. The susceptibilities of drug-resistant hepatitis B virus (HBV) mutants to lamivudine, adefovir, tenofovir, entecavir, and 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine (PMEO-DAPym), a novel acyclic pyrimidine analogue, were assessed in vitro.', 17371827),
('Antiviral Chemical compound', 'Pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring', 'Activity against pleconaril-resistant coxsackievirus B3', '', 'New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3. In the present study, novel analogues with different substitutions in the central phenoxy group were synthesized to study their influence on anti-CVB3 activity with the aim to overcome pleconaril resistance.', 18840470),
('Antiviral Chemical compound', '6-(3-trifluoromethylbenzyl) and 6-(fluorobenzyl)', 'Activity against HIV-1 wild type and mutants resistant to non-nucleoside RT inhibitors', '', 'Synthesis and antiviral evaluation of 6-(trifluoromethylbenzyl) and 6-(fluorobenzyl) analogues of HIV drugs emivirine and GCA-186. The present study describes the synthesis and antiviral evaluation of a series of novel 6-(3-trifluoromethylbenzyl) and 6-(fluorobenzyl) analogues of the HIV drugs emivirine and GCA-186.', 18161905),
('Antiviral Chemical compound', '2-amino thiazole [T157602 and its analogs]', 'Inhibitor of herpes simplex virus (HSV) DNA replication', '', 'T157602 and its analogs represent a novel class of specific and reversible anti-HSV agents eliciting their inhibitory effects on HSV replication by interacting with the UL5 helicase.', 9696789),
('Antiviral Chemical compound', '4-[1-hydroxy-2-(4,5-dimethoxy-2-nitrophenyl)ethyl]benzonitrile (LPCRW_0005)', 'Inhibits rhinovirus replication', '', 'A novel benzonitrile analogue inhibits rhinovirus replication.', 24948704),
('Antiviral Chemical compound', '6-PMEO 2,4-diaminopyrimidine and 6-PMPO 2,4-diaminopyrimidine derivatives', 'Potent activity against human immunodeficiency virus (HIV) in the laboratory', '', 'Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates. A novel class of acyclic nucleoside phosphonates has been discovered in which the base consists of a pyrimidine preferably containing an amino group at C-2 and C-4 and a 2-(phosphonomethoxy)ethoxy (PMEO) or a 2-(phosphonomethoxy)propoxy (PMPO) group at C-6.', 12069973),
('Antiviral Chemical compound', '3-Biphenylimidazo[1,2-a]pyridines or [1,2-b]pyridazines and analogues', 'Activity against bovine viral diarrhoea virus (BVDV) and hepatitis C virus (HCV)', '', '3-Biphenylimidazo[1,2-a]pyridines or [1,2-b]pyridazines and analogues, novel Flaviviridae inhibitors. Using Ttou 84 as starting point, a novel class of biphenyl derivatives of imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine was designed to optimize the inhibitory properties on the replication of the bovine viral diarrhoea virus (BVDV) and hepatitis C virus (HCV).', 23665801),
('Antiviral Chemical compound', 'Beta-d-2''-deoxy-2''-?-fluoro-2''-beta-C-methyluridine nucleotide prodrug (PSI-7977)', 'Inhibitors of the HCV NS5B polymerase', '', 'Discovery of a Beta-d-2''-deoxy-2''-?-fluoro-2''-beta-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus. Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease.', 20845908),
('Antiviral Chemical compound', 'BAY 38-4766', 'Inhibitor of human cytomegalovirus (HCMV)', '', 'Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action. As a representative of a novel inhibitory approach, the non-nucleosidic BAY 38-4766 was identified as a highly selective inhibitor of human cytomegalovirus (HCMV).', 11733458),
('Antiviral Chemical compound', 'Elaidic acid ganciclovir (E-GCV)', 'Activity against laboratory and clinical strains of herpes simplex type 1 (HSV-1) and type 2 (HSV-2), varicella-zoster virus (VZV) and human cytomegalovirus (HCMV) in human embryonic lung fibroblasts, IC(50) value of E-GCV for HSV-1 strain KOS being 0.07 nM', '', 'Antiviral activity of ganciclovir elaidic acid ester against herpesviruses', 10771080),
('Antiviral Chemical compound', 'Brecanavir, a novel tyrosyl-based arylsulfonamide', 'Anti-HIV activity', '', 'Brecanavir, a novel tyrosyl-based arylsulfonamide, high-affinity, human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI), has been evaluated for anti-HIV activity in several in vitro assays.', 17620375),
('Antiviral Chemical compound', 'GW678248', 'Anti-human immunodeficiency virus type 1', '', 'GW678248, a novel nonnucleoside reverse transcriptase inhibitor, has been evaluated for anti-human immunodeficiency virus activity in a variety of in vitro assays against laboratory strains and clinical isolates.', 16251284),
('Antiviral Chemical compound', 'PD0084430', 'Non-nucleoside inhibitor of human cytomegalovirus replication', '', 'PD0084430: a non-nucleoside inhibitor of human cytomegalovirus replication in vitro. A novel, non-nucleoside inhibitor of HCMV replication, PD0084430, was identified in a screening assay using the HCMV beta-galactosidase recombinant RC256.', 11675146),
('Antiviral Chemical compound', 'Naphthyridinone GSK364735', 'Potently inhibited recombinant human immunodeficiency virus type 1 (HIV-1) integrase in a strand transfer assay (mean 50% inhibitory concentration +/- standard deviation, 8 +/- 2 nM).', '', 'The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.', 18160521),
('Antiviral Chemical compound', '6-(indol-2-yl)pyridine-3-sulfonamides', 'Inhibit HCV RNA replication in the HCV replicon cell culture assay', '', 'Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4B.', 23683597),
('Antiviral Chemical compound', 'GRL-02031', 'Effective against laboratory HIV-1 strains and primary clinical isolates, including subtypes A, B, C, and E (50% effective concentration [EC(50)] range, 0.015 to 0.038 microM)', 'Minimal cytotoxicity (50% cytotoxic concentration, >100 microM in CD4(+) MT-2 cells)', 'GRL-02031, a novel nonpeptidic protease inhibitor (PI) containing a stereochemically defined fused cyclopentanyltetrahydrofuran potent against multi-PI-resistant human immunodeficiency virus type 1 in vitro.', 18955518),
('Antiviral Chemical compound', 'Benzo[4,5]furo[3,2,d]pyrimidin-2-one NcRTI chemical series', 'Compound A inhibited HIV-1 RT in a primer extension assay (50% inhibitory concentration, 2.6 nM) but had no measurable activity against human DNA polymerase ? at 10 microM. It potently inhibited HIV-1 replication in vitro (50% effective concentration, 1.5 nM)', '', 'Identification and characterization of a novel HIV-1 nucleotide-competing reverse transcriptase inhibitor series', 23545531),
('Antiviral Chemical compound', 'Phosphonylmethoxyalkyl derivatives of adenine', 'Equine herpesvirus 1', '', 'Effective chemotherapy of equine herpesvirus 1 by phosphonylmethoxyalkyl derivatives of adenine demonstrated in a novel murine model for the disease.', 2163242),
('Antiviral Chemical compound', 'Substituted N-phenylbenzenesulphonamides', 'Non-nucleoside hepatitis C virus polymerase inhibitors with IC(50) values up to 40 nM', '', 'Here we describe a novel non-nucleoside inhibitor (NNI) chemotype identified by screening: The substituted N-phenylbenzenesulphonamides (SPBS) which showed reversible inhibition of NS5B from HCV genotype 1b with IC(50) values up to 40 nM.', 22580131),
('Antiviral Chemical compound', 'Pyridinioalkanoyl thioesters (PATEs)', 'Anti-HIV agents, EC(50) < 10 microM', 'Non toxic', 'Synthesis and biological properties of amino acid amide ligand-based pyridinioalkanoyl thioesters as anti-HIV agents.', 11886789),
('Antiviral Chemical compound', '9-Arylpurines', 'These compounds elicit activity against a variety of enteroviruses in the low microM range including Coxsackie virus A16, A21, A24, Coxsackie virus B3, and echovirus 9.', '', '9-Arylpurines as a novel class of enterovirus inhibitors. Here we report on a novel class of enterovirus inhibitors that can be structurally described as 9-arylpurines.', 19924996),
('Antiviral Chemical compound', 'Tricyclic nucleosides [9-benzylamino-3-(?-D-ribofuranosyl)-3H-imidazo[4'',5'':5,6]pyrido[2,3-b]pyrazine (15d)]', 'Inhibited non-structural protein 5A (NS5A) of hepatitis C virus (HCV)', '', 'Novel nucleoside analogues targeting HCV replication through an NS5A-dependent inhibition mechanism', 28245093),
('Antiviral Chemical compound', '4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol (IsoddA)', 'Inhibitor of HIV-1', '', 'Antiviral, metabolic, and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol.', 8540705),
('Antiviral Chemical compound', 'PNU-183792, a 4-oxo-dihydroquinoline', 'Activity against human and animal herpesviruses, specifically inhibit herpesvirus polymerases', '', 'Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses.', 11888654),
('Antiviral Chemical compound', 'Cyclohexyl carboxylic acid analogues [VX-787]', 'Strong potency versus multiple influenza A strains, including pandemic 2009 H1N1 and avian H5N1 flu strains', '', 'Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.', 25019388),
('Antiviral Chemical compound', 'FP-21399 of bis(disulfonaphthalene) dimethoxybenzene class', 'Inhibitor of HIV-1', '', 'FP-21399 is a novel compound of the bis(disulfonaphthalene) dimethoxybenzene class that blocks entry of HIV into CD4+ cells and blocks fusion of infected and noninfected CD4+ cells.', 9094135),
('Antiviral Chemical compound', 'Pirodavir (R 77975), a phenoxy-pyridazinamine', 'Broad-spectrum antipicornaviral activity', '', 'In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity. Pirodavir (R 77975) is the prototype of a novel class of broad-spectrum antipicornavirus compounds.', 1317142),
('Antiviral Chemical compound', '1,5-diphenylpyrazole', 'Nonnucleoside HIV-1 reverse transcriptase inhibitors', '', 'Novel 1,5-diphenylpyrazole nonnucleoside HIV-1 reverse transcriptase inhibitors with enhanced activity versus the delavirdine-resistant P236L mutant: lead identification and SAR of 3- and 4-substituted derivatives. Through computationally directed broad screening, a novel 1, 5-diphenylpyrazole (DPP) class of HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs) has been discovered.', 10715167),
('Antiviral Chemical compound', 'SB 9200', 'SB 9200 has broad-spectrum antiviral activity against RNA viruses including hepatitis C virus (HCV), norovirus, respiratory syncytial virus, and influenza and has demonstrated activity against hepatitis B virus (HBV) in vitro and in vivo.', '', 'SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants. SB 9200 is a novel, first-in-class oral modulator of innate immunity that is believed to act via the activation of the RIG-I and NOD2 pathways.', 28303593),
('Antiviral Chemical compound', '2,4,5-Trisubstituted thiazole derivatives', 'Tested on seven NNRTI-resistant HIV-1 strains, and all exhibited inhibitory effects with fold changes in IC50 ranging from 2.6 to 111', '', '2,4,5-Trisubstituted thiazole derivatives: a novel and potent class of non-nucleoside inhibitors of wild type and mutant HIV-1 reverse transcriptase.', 25072874),
('Antiviral Chemical compound', '2,6-Bis(benzimidazol-2-yl)pyridine (BBP/CSFA-0)', 'BBP/CSFA-0 inhibits the in vitro replication of the classical swine fever virus (CSFV) with an EC50 of 0.330 +/-.25microM. BBP/CSFA-0 proved in vitro inactive against the hepatitis C virus, that belongs like BVDV and CSFV to the family of Flaviviridae.', '', 'Substituted 2,6-bis(benzimidazol-2-yl)pyridines: a novel chemical class of pestivirus inhibitors that targets a hot spot for inhibition of pestivirus replication in the RNA-dependent RNA polymerase.', 24680957),
('Antiviral Chemical compound', 'Bictegravir (GS-9883)', 'Anti-HIV-1, specifically targets IN strand transfer activity (50% inhibitory concentration [IC50] of 7.5 ? 0.3 nM) and HIV-1 integration in cells', 'BIC exhibits potent and selective in vitro antiretroviral activity in both T-cell lines and primary human T lymphocytes, with 50% effective concentrations ranging from 1.5 to 2.4 nM and selectivity indices up to 8,700 relative to cytotoxicity.', 'Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile.', 27645238),
('Antiviral Chemical compound', '6-substituted 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives', 'Active in human immunodeficiency virus type 1 (HIV-1) infection', '', 'Anti-human immunodeficiency virus type 1 activity of novel 6-substituted 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives. Nonnucleoside reverse transcriptase (RT) inhibitors (NNRTIs) are important components of current combination therapies for human immunodeficiency virus type 1 (HIV-1) infection.', 22290950),
('Antiviral Chemical compound', 'ASP2151', 'Activity aginst varicella-zoster virus and herpes simplex virus types 1 and 2', '', 'ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2. OBJECTIVES: To evaluate and describe the anti-herpesvirus effect of ASP2151, amenamevir, a novel non-nucleoside oxadiazolylphenyl-containing herpesvirus helicase-primase complex inhibitor.', 20534624),
('Antiviral Chemical compound', 'F18', 'F18 displayed distinct profiles against 17 NNRTI-resistant pseudoviruses, with an excellent potency especially against one of the most prevalent strains with the Y181C mutation (50% effective concentration, 1.0 nM)', '', 'F18, a novel small-molecule nonnucleoside reverse transcriptase inhibitor, inhibits HIV-1 replication using distinct binding motifs as demonstrated by resistance selection and docking analysis. Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are one of the key components of antiretroviral therapy drug regimen against human immunodeficiency virus type 1 (HIV-1) replication.', 22037848),
('Antiviral Chemical compound', '6-(tert-butyl)-4-phenyl-4-(trifluoromethyl)-1H,3H-1,3,5-triazin-2-one', 'In in vitro assays, HIV-1 reverse transcriptase (RT) activity was inhibited by compound 1 with an EC50 of 4.3 microm', '', 'A Triazinone Derivative Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity. A novel HIV-1 inhibitor, 6-(tert-butyl)-4-phenyl-4-(trifluoromethyl)-1H,3H-1,3,5-triazin-2-one (compound 1), was identified from a compound library screened for the ability to inhibit HIV-1 replication.', 27634404),
('Antiviral Chemical compound', 'GW678248 is a novel benzophenone', 'Preclinical assessment of GW678248 indicates that this compound potently inhibits wild-type (WT) and mutant human immunodeficiency virus type 1 (HIV-1) reverse transcriptase in biochemical assays, with 50% inhibitory concentrations (IC(50)s) between 0.8 and 6.8 nM.', 'Cytotoxicity studies with GW678248 indicate that the 50% cytotoxicity concentration is greater than the level of compound solubility and provides a selectivity index of >2,500-fold for WT, Y181C, or K103N HIV-1.', 'Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitor. The compound GW678248 is a novel benzophenone nonnucleoside reverse transcriptase inhibitor (NNRTI).', 16189079),
('Antiviral Chemical compound', 'UK-201844', 'UK-201844 exhibited antiviral activity against HIV-1 NL4-3 in MT-2 and PM1 cells, with 50% effective concentrations of 1.3 and 2.7 microM, respectively, but did not exhibit measurable antiviral activity against the closely related HIV-1 IIIB laboratory strain.', '', 'Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processing.', 17646410),
('Antiviral Chemical compound', '3-fluoro-2-(phosphonomethoxy)propyl (FPMP) {(S)-FPMPA amidate}', 'Activity against hepatitis B virus (HBV) and varicella-zoster virus (VZV)', '', 'The derivatization of the phosphonic acid functionality of FPMPs with a diamyl aspartate phenoxyamidate group led to a novel generation of compounds that not only demonstrate drastically improved antiretroviral potency but also are characterized by an expanded spectrum of activity that also covers hepatitis B and herpes viruses.', 28682067),
('Antiviral Chemical compound', 'Enviroxime-like compound, AN-12-H5', 'Anti-enterovirus', '', 'These results suggest that AN-12-H5 is a bifunctional anti-enterovirus compound that belongs to a novel class of enviroxime-like compounds and targets both a replication step and an early stage of EV71 infection.', 20660150),
('Antiviral Chemical compound', 'RO-7', 'Inhibited influenza A viruses (seasonal and 2009 pandemic H1N1 and seasonal H3N2) and B viruses (Yamagata and Victoria lineages), zoonotic viruses (H5N1, H7N9, and H9N2), and NAI-resistant variants', '', 'A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In Vitro. Here, we characterized a novel compound, RO-7, identified as a putative PA endonuclease inhibitor.', 27381402),
('Antiviral Chemical compound', 'BIT225', 'BIT225, blocks Vpu ion channel activity and also shows anti-HIV-1 activity, with a 50% effective concentration of 2.25+/-0.23 microM (mean+/-the standard error)', 'minimal in vitro toxicity (50% toxic concentration, 284 microM) in infected MDM, resulting in a selectivity index of 126', 'Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages.', 19995924),
('Antiviral Chemical compound', '4-Oxo-4,7-dihydrothieno[2,3-b]pyridines', 'Inhibitors of human cytomegalovirus and related herpesvirus polymerases', '', '4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases. A novel series of 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides have been identified as potential antivirals against human herpesvirus infections resulting from human cytomegalovirus (HCMV), herpes simplex virus type 1 (HSV-1), and varicella-zoster virus (VZV).', 16134946),
('Antiviral Chemical compound', '4-(5-(2,6-difluorobenzyl)-1-(2-fluorobenzyl)-2-oxo-1,2-dihydropyridin-3-yl)-4-hydroxy-2-oxo-N-(2-oxopyrrolidin-1-yl)but-3-enamide', 'Exhibits low nM antiviral activity against a diverse set of HIV-1 isolates, and against HIV-2 and the simian immunodeficiency virus (SIV).', '', 'A novel anti-HIV active integrase inhibitor with a favorable in vitro cytochrome P450 and uridine 5''-diphospho-glucuronosyltransferase metabolism profile.', 23602851),
('Antiviral Chemical compound', 'Bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065', 'Active against wide spectrum of HIV isolates', '', 'A novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065, is potent against multiple-PI-resistant human immunodeficiency virus in vitro. We designed, synthesized, and identified GRL-98065, a novel nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) containing the structure-based designed privileged cyclic ether-derived nonpeptide P2 ligand, 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane (bis-THF), and a sulfonamide isostere, which is highly potent against laboratory HIV-1 strains and primary clinical isolates (50% effective concentration [EC(50)], 0.0002 to 0.0005 microM) with minimal cytotoxicity (50% cytotoxicity, 35.7 microM in CD4(+) MT-2 cells).', 17371811),
('Antiviral Chemical compound', 'compound 7f (A-98881)', 'HIV-1 protease inhibition assay and the in vitro MT-4 cell culture assay (Ki = approximately 5 pM and EC50 = 0.002 microM).', '', 'A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease. The design, synthesis, and molecular modeling studies of a novel series of azacyclic ureas, which are inhibitors of human immunodeficiency virus type 1 (HIV-1) protease that incorporate different ligands for the S1'', S2, and S2'' substrate-binding sites of HIV-1 protease are described.', 8558507),
('Antiviral Chemical compound', 'Benzophenone derivatives', 'inhibitors of HIV-1 reverse transcriptase (RT) and the growth of HIV-1 in MT-4 cells.', '', 'Benzophenone derivatives: a novel series of potent and selective inhibitors of human immunodeficiency virus type 1 reverse transcriptase. A series of benzophenone derivatives has been synthesized and evaluated as inhibitors of HIV-1 reverse transcriptase (RT) and the growth of HIV-1 in MT-4 cells.', 7538590),
('Antiviral Chemical compound', 'Nonpeptidic macrocyclic HIV protease inhibitors', 'Exerted potent activity against multidrug-resistant HIV-1 variants', '', 'Design, synthesis, protein-ligand X-ray structure, and biological evaluation of a series of novel macrocyclic human immunodeficiency virus-1 protease inhibitors to combat drug resistance. The structure-based design, synthesis, and biological evaluation of a series of nonpeptidic macrocyclic HIV protease inhibitors are described. The inhibitors are designed to effectively fill in the hydrophobic pocket in the S1''-S2'' subsites and retain all major hydrogen bonding interactions with the protein backbone similar to darunavir (1) or inhibitor 2. The ring size, the effect of methyl substitution, and unsaturation within the macrocyclic ring structure were assessed. In general, cyclic inhibitors were significantly more potent than their acyclic homologues, saturated rings were less active than their unsaturated analogues and a preference for 10- and 13-membered macrocylic rings was revealed. The addition of methyl substituents resulted in a reduction of potency. Both inhibitors 14b and 14c exhibited marked enzyme inhibitory and antiviral activity, and they exerted potent activity against multidrug-resistant HIV-1 variants.', 19746963),
('Antiviral Chemical compound', 'Dihydroxythiophenes', 'HIV-1', '', 'Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore. We have identified dihydroxythiophenes (DHT) as a novel series of human immunodeficiency virus type 1 (HIV-1) integrase inhibitors with broad antiviral activities against different HIV isolates in vitro.', 16809294),
('Antiviral Chemical compound', 'ABT-378', 'Human immunodeficiency virus type 1 (HIV-1) protease inhibitor', '', 'In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor. ABT-378, a new human immunodeficiency virus type 1 (HIV-1) protease inhibitor which is significantly more active than ritonavir in cell culture, is currently under investigation for the treatment of AIDS.', 9696850),
('Antiviral Chemical compound', '2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs)', 'Anti-HIV-1', '', 'Investigation of a novel series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as human immunodeficiency virus type 1 integrase inhibitors. We report herein further insight into the biological activities displayed by a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs).', 24793360),
('Antiviral Chemical compound', '8-substituted dipyridodiazepinone', 'Activity against wild type human immunodeficiency virus (HIV-1) and the clinically prevalent K103N/Y181C mutant virus', '', 'Novel 8-substituted dipyridodiazepinone inhibitors with a broad-spectrum of activity against HIV-1 strains resistant to non-nucleoside reverse transcriptase inhibitors. A series of novel 8-substituted dipyridodiazepinone-based inhibitors were investigated for their antiviral activity against wild type human immunodeficiency virus (HIV-1) and the clinically prevalent K103N/Y181C mutant virus.', 16107158),
('Antiviral Chemical compound', 'UIC-94017 (containing a 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane (bis-THF) and a sulfonamide isostere)', 'Activity against laboratory HIV-1 strains and primary clinical isolates (50% inhibitory concentration [IC(50)], approximately 0.003 micro M; IC(90), approximately 0.009 micro M)', 'minimal cytotoxicity (50% cytotoxic concentration for CD4(+) MT-2 cells, 74 micro M)', 'Novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitro. We designed, synthesized, and identified UIC-94017 (TMC114), a novel nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) containing a 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane (bis-THF) and a sulfonamide isostere which is extremely potent against laboratory HIV-1 strains and primary clinical isolates (50% inhibitory concentration [IC(50)], approximately 0.003 micro M; IC(90), approximately 0.009 micro M) with minimal cytotoxicity (50% cytotoxic concentration for CD4(+) MT-2 cells, 74 micro M).', 14506019),
('Antiviral Chemical compound', 'Novel pyridine oxide derivatives', '(HIV-1) and HIV-2 strains', '', 'Novel human immunodeficiency virus (HIV) inhibitors that have a dual mode of anti-HIV action. We have found that novel pyridine oxide derivatives are inhibitors of a wide range of human immunodeficiency virus (HIV) type 1 (HIV-1) and HIV-2 strains in CEM cell cultures.', 14506017),
('Antiviral Chemical compound', 'Stavudine-5''-(p-bromophenyl methoxyalaninyl phosphate) (stampidine [STAMP]), a novel aryl phosphate derivative of stavudine', 'HIV-1', '', 'We report the antiretroviral activity of stavudine-5''-(p-bromophenyl methoxyalaninyl phosphate) (stampidine [STAMP]), a novel aryl phosphate derivative of stavudine, against primary clinical human immunodeficiency virus type 1 (HIV-1) isolates.', 12384373),
('Antiviral Chemical compound', 'Pyrido [1,2a] indole derivatives', 'Inhibitory effect against purified HIV-1 reverse transcriptase (RT) in an in vitro assay', '', 'Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1. Pyrido [1,2a] indole derivatives were identified as potent inhibitors of human immunodeficiency virus type 1 (HIV-1) replication during a random screening programme.', 10335402),
('Antiviral Chemical compound', '1-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-4-methylbenzimida zole (35)', 'an IC50 = 200 nM against HIV-1 WT RT in an in vitro enzyme assay', '', 'Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles. The development of new nonnucleoside inhibitors of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) active against the drug-induced mutations in RT continues to be a very important goal of AIDS research.', 9435891),
('Antiviral Chemical compound', 'MK-4965', 'MK-4965 is also highly potent against the WT virus and two most prevalent NNRTI-resistant viruses (viruses that harbor the K103N or the Y181C mutation), against which it had 95% effective concentrations (EC(95)s) of <30 nM in the presence of 10% fetal bovine serum. The antiviral EC(95) of MK-4965 was reduced approximately four- to sixfold when it was tested in 50% human serum.', '', 'Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor. Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are the mainstays of therapy for the treatment of human immunodeficiency virus type 1 (HIV-1) infections.', 19289522),
('Antiviral Chemical compound', 'TMC310911', 'TMC310911 has potent activity against wild-type (WT) HIV-1 (median 50% effective concentration [EC(50)], 14 nM) and a wide spectrum of recombinant HIV-1 clinical isolates, including multiple-PI-resistant strains with decreased susceptibility to currently approved PIs (fold change [FC] in EC(50), >10).', '', 'TMC310911, a novel human immunodeficiency virus type 1 protease inhibitor, shows in vitro an improved resistance profile and higher genetic barrier to resistance compared with current protease inhibitors. TMC310911 is a novel human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) structurally closely related to darunavir (DRV) but with improved virological characteristics.', 21896904),
('Antiviral Chemical compound', 'GRL-04810 and GRL-05010, containing the structure-based designed privileged cyclic ether-derived nonpeptide P2 ligand, bis-tetrahydrofuranylurethane (bis-THF), and a difluoride moiety', 'Active against the laboratory strain HIV-1LAI (50% effective concentrations [EC50s], 0.0008 and 0.003 microM, respectively)', 'GRL-04810 and GRL-05010 have minimal cytotoxicity (50% cytotoxic concentrations [CC50s], 17.5 and 37.0 microM, respectively', 'GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration.', 24080647),
('Antiviral Chemical compound', 'GRL008 and DRV', '[EC50s], 0.029 and 0.002 microM, respectively) against a multidrug-resistant clinical isolate of HIV-1 (HIVA02)', '', 'A conserved hydrogen-bonding network of P2 bis-tetrahydrofuran-containing HIV-1 protease inhibitors (PIs) with a protease active-site amino acid backbone aids in their activity against PI-resistant HIV.', 24752271),
('Antiviral Chemical compound', 'Thiothymidine derivatives, KAY-2-41 and KAH-39-149', 'Active against herpes simplex virus, varicella-zoster virus (VZV), and particularly against Epstein-Barr virus', '', 'Antiherpesvirus activities of two novel 4''-thiothymidine derivatives, KAY-2-41 and KAH-39-149, are dependent on viral and cellular thymidine kinases. The emergence of drug-resistant herpesviruses represents a significant problem in clinical practice, primarily in immunocompromised patients.', 24820089),
('Antiviral Chemical compound', 'A-790742', '(HIV-1) protease inhibitor, with 50% effective concentrations ranging from 2 to 7 nM against wild-type HIV-1', '', 'Characterization of a novel human immunodeficiency virus type 1 protease inhibitor, A-790742 is a potent human immunodeficiency virus type 1 (HIV-1) protease inhibitor, with 50% effective concentrations ranging from 2 to 7 nM against wild-type HIV-1.', 18212102),
('Antiviral Chemical compound', 'Compounds derived from scaffolds containing a thiazole replacement of the exocyclic amide with modification at position 7 and/or 9 of the bicyclic pyrimidinone core', 'HIV integrase inhibitors', '', 'Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses. A series of novel HIV integrase inhibitors active against rategravir resistant strains are reported.', 20685117),
('Antiviral Chemical compound', 'AIC292, diarylpyrazole-[imidazolidinone]-carboxamides', 'HIV-1', '', 'In vitro and in vivo activities of AIC292, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.', 23959304),
('Antiviral Chemical compound', 'ACH-806 (GS-9132)', 'Inhibits hepatitis C virus (HCV) replication', '', 'Selection of replicon variants resistant to ACH-806, a novel hepatitis C virus inhibitor with no cross-resistance to NS3 protease and NS5B polymerase inhibitors. We have discovered a novel class of compounds active against hepatitis C virus (HCV), using a surrogate cellular system, HCV replicon cells.', 18411324),
('Antiviral Chemical compound', 'C3-substituted cyclopentyltetrahydrofuranyl (Cp-THF)', 'HIV-1 protease inhibitors', '', 'Substituent effects on P2-cyclopentyltetrahydrofuranyl urethanes: design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors. The design, synthesis, and biological evaluation of novel C3-substituted cyclopentyltetrahydrofuranyl (Cp-THF)-derived HIV-1 protease inhibitors are described.', 22364812),
('Antiviral Chemical compound', 'Dexlansoprazole', 'Human immunodeficiency virus (HIV)-1 integrase (IN) inhibitor', '', 'A novel assay for screening inhibitors targeting HIV-1 integrase dimerization based on Ni-NTA magnetic agarose beads. Human immunodeficiency virus (HIV)-1 integrase (IN), which mediates integration of viral cDNA into the cellular chromosome, is a validated antiviral drug target.', 27137477),
('Antiviral Chemical compound', 'Combination of boceprevir with a nucleoside analog or a non-nucleoside HCV NS5B polymerase inhibitor', 'Effective against hepatitis C virus (HCV)', '', 'A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors. Boceprevir (SCH 503034) is an orally active novel inhibitor of the hepatitis C virus (HCV) NS3 protease currently in clinical development for the treatment of hepatitis C.', 19747948),
('Antiviral Chemical compound', 'EI-1, HCV pseudoparticles (HCVpp)', 'Agianst hepatitis C virus (HCV)', '', 'A novel small molecule inhibitor of hepatitis C virus entry. Small molecule inhibitors of hepatitis C virus (HCV) are being developed to complement or replace treatments with pegylated interferons and ribavirin, which have poor response rates and significant side effects.', 20838466),
('Antiviral Chemical compound', '5-[(4-bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine (BPIP)', 'The 50% effective concentration (EC50) for inhibition of bovine viral diarrhea virus (BVDV)-induced cytopathic effect formation was 0.04 +/- 0.01 microM', '', 'A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase. We report on the highly potent and selective antipestivirus activity of 5-[(4-bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine (BPIP).', 16352539),
('Antiviral Chemical compound', 'R165481 and R221239', 'Inhibit wild-type HIV-1 RT and drug-resistant variants, including Tyr181Cys and Lys103Asn RT', '', 'An acrylonitrile substituent on R165481 substantially improves the activity of the compound against wild-type RT (and several mutants) and provides a way to generate novel inhibitors that could interact with conserved elements of HIV-1 RT at the polymerase catalytic site.', 16302798),
('Antiviral Chemical compound', 'NS3/4A proteinase inhibitors screened from Developmental Therapeutics Program (NCI/NIH)', 'Hepatitis C virus (HCV)', '', 'As a result, we identified several novel, previously uncharacterized, nanomolar range inhibitory scaffolds, which suppressed of the NS3/4A activity in vitro and replication of a sub-genomic HCV RNA replicon with a luciferase reporter in human hepatocarcinoma cells.', 22768327),
('Antiviral Chemical compound', 'Sodium (+)-isolaricireinol-2 alpha-sulfate, sodium 3,4-dihydroxy-5-methoxybenzoic acid methyl ester-4-sulfate, sodium (E)-7-hydroxy-1,7-bis(4-hydroxyphenyl)hept-5-ene-3S-sulfonate, and 3-methoxytyramine-betaxanthin', 'Activity against H1N1 influenza viruses', '', 'Based on virtual screening, MD simulation, and interaction energy evaluation, TCM candidates demonstrate good potential as novel H1 inhibitors.', 22012120);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antiviral Chemical compound', 'methyl ((S)-1-((S)-2-(4-(4-(6-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)quinoxalin-2-yl)phenyl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate', 'Activity against hepatitis C virus (HCV)', '', 'By varying the biphenyl-imidazole unit of daclatasvir, novel inhibitors of HCV NS5A were identified with an improved resistance profile against mutant strains of the virus while retaining the picomolar potency of daclatasvir.', 24729513),
('Antiviral Chemical compound', 'GS-5885', 'Hepatitis C virus (HCV) NS5A inhibitor', '', 'Characterization of Hepatitis C virus resistance from a multiple-dose clinical trial of the novel NS5A inhibitor GS-5885. GS-5885 is a novel hepatitis C virus (HCV) NS5A inhibitor.', 23877691),
('Antiviral Chemical compound', '3''-Azidothymidine (AZT)', 'HIV', '', 'Clicking 3''-azidothymidine into novel potent inhibitors of human immunodeficiency virus. 3''-Azidothymidine (AZT) was the first approved antiviral for the treatment of human immunodeficiency virus (HIV).', 24102161),
('Antiviral Chemical compound', 'Cationic N,N-Dimethyl[70]fulleropyrrolidinium Iodide Derivatives', 'Anti-HIV-1', '', 'Collectively, our studies indicate fullerene derivatives 2a-c as potent and novel HIV-1 maturation inhibitors.', 28002960),
('Antiviral Chemical compound', 'EMT-305 and EMT-104', 'Activity against Influenza A virus', '', 'Computational and experimental screening of extensive and water soluble compounds identified novel influenza virus inhibitors that can reduce influenza virus infection without detectable toxic effects on host cells.', 28713784),
('Antiviral Chemical compound', 'Inhibitors designed by incorporating N-phenyloxazolidinone-5-carboxamides into the hydroxyethylene and (hydroxyethyl)hydrazine dipeptide isosteres as P2 and P2'' ligands.', 'HIV-1 protease inhibitor', '', 'Design and synthesis of HIV-1 protease inhibitors incorporating oxazolidinones as P2/P2'' ligands in pseudosymmetric dipeptide isosteres. A series of novel HIV-1 protease inhibitors based on two pseudosymmetric dipeptide isosteres have been synthesized and evaluated.', 17696512),
('Antiviral Chemical compound', '3,5-diamino-N-aryl-1H-pyrazole-4-carbothioamide and 4-amino-5-benzoyl-N-phenyl-2-(substituted-amino)-1H-pyrrole-3-carbothioamide derivatives', 'Anti-HIV-1', '', 'Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.', 28859311),
('Antiviral Chemical compound', 'Triazolo-pyrimidine derivatives', 'Inhibitors of hepatitis B virus surface antigen (HBsAg) secretion', '', 'Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion. The high levels of hepatitis B virus (HBV) surface antigen (HBsAg)-bearing subviral particles in the serum of chronically infected individuals play an important role in suppressing HBV-specific immune response and are only mildly affected by the current small molecule therapies.', 21786803),
('Antiviral Chemical compound', 'Osalmid and its derivative 4-cyclopropyl-2-fluoro-N-(4-hydroxyphenyl) benzamide (YZ51)', 'HBV', '', 'Furthermore, 4-cyclopropyl-2-fluoro-N-(4-hydroxyphenyl) benzamide (YZ51), a novel derivative of osalmid, showed higher efficacy than osalmid with more potent RR inhibitory activity.', 26774458),
('Antiviral Chemical compound', 'GRL-0519, a novel nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) containing tris-tetrahydrofuranylurethane (tris-THF) and a sulfonamide isostere', 'Activity against laboratory HIV-1 strains and primary clinical isolates (50% effective concentration [EC50], 0.0005 to 0.0007 microM)', 'minimal cytotoxicity (50% cytotoxic concentration [CC50], 44.6 microM)', 'GRL-0519, a novel oxatricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor (PI), potently suppresses replication of a wide spectrum of multi-PI-resistant HIV-1 variants in vitroWe report that GRL-0519, a novel nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) containing tris-tetrahydrofuranylurethane (tris-THF) and a sulfonamide isostere, is highly potent against laboratory HIV-1 strains and primary clinical isolates (50% effective concentration [EC50], 0.0005 to 0.0007 microM) with minimal cytotoxicity (50% cytotoxic concentration [CC50], 44.6 microM).', 23403426),
('Antiviral Chemical compound', 'Novel inhibitors of RSV including the P13 fusion inhibitor, and the PG545 virucide', 'Respiratory syncytial virus (RSV)', '', 'Here we describe the cell culture-based methods used in our laboratory in identification of novel inhibitors of RSV including the P13 fusion inhibitor, and the PG545 virucide.', 23821281),
('Antiviral Chemical compound', 'FA-583 and FA-617', 'Influenza A Virus', '', 'Here we identify and characterize two structurally different novel fusion inhibitors of the influenza A virus group 1 hemagglutinin (HA), FA-583 and FA-617, with low nanomolar activities.', 26676787),
('Antiviral Chemical compound', 'cpd 1, 2, and 3', 'Respiratory Syncytial Virus (RSV)', '', 'Here we report the characterization of three novel classes of RSV replication inhibitors identified through a high throughput RSV replicon screen of ?1million compounds in the AstraZeneca compound collection.', 25542974),
('Antiviral Chemical compound', 'GRL-142, containing an unprecedented 6-5-5-ring-fused crown-like tetrahydropyranofuran', 'Potent activity against all HIV-1 strains examined with IC50 values of attomolar-to-picomolar concentrations', '', 'Here, we report GRL-142, a novel HIV-1 protease inhibitor containing an unprecedented 6-5-5-ring-fused crown-like tetrahydropyranofuran, which has extremely potent activity against all HIV-1 strains examined with IC50 values of attomolar-to-picomolar concentrations, virtually no effects on cellular growth, extremely high genetic barrier against the emergence of drug-resistant variants, and favorable intracellular and central nervous system penetration.', 29039736),
('Antiviral Chemical compound', '4''-C-cyano-2-amino-2''-deoxyadenosine (CAdA)', 'Activity against hepatitis B virus (HBV), half maximal inhibitory concentration [IC50 ] = 0.4 nM) and HIV-1 (IC50 = 0.4 nM', '', '4''-modified nucleoside analogs: potent inhibitors active against entecavir-resistant hepatitis B virus', 26122273),
('Antiviral Chemical compound', 'GLS4 (ethyl 4-[2-bromo-4-fluorophenyl]-6-[morpholino-methyl]-2-[2-thiazolyl]-1,4-dihydro-pyrimidine-5-carboxylate)', 'GLS4 demonstrated potent inhibitory activities in HBV HepG2.2.15 cell assay with an EC50 value of 1nM, and it also exhibited high potency against various drug-resistant HBV viral strains with EC50 values in the range of 10-20nM', '', 'Herein we described our lead optimization studies including the synthesis, molecular docking studies and structure-activity relationship (SAR) studies of a series of novel heteroaryldihydropyrimidine (HAP) inhibitors of HBV capsid assembly inhibitors, and the discovery of a potent inhibitor of HBV capsid assembly of GLS4 (ethyl 4-[2-bromo-4-fluorophenyl]-6-[morpholino-methyl]-2-[2-thiazolyl]-1,4-dihydro-pyri midine-5-carboxylate) which is now in clinical phase 2.', 28082068),
('Antiviral Chemical compound', 'Pyridone-based compound PF-46396', 'Anti-HIV-1', '', 'HIV-1 maturation inhibitors are novel as they target the Gag protein, specifically by inhibiting CA-SP1 proteolytic cleavage.', 27384665),
('Antiviral Chemical compound', 'Cytidine analogue D-d4FC (DPC817, Reverset)', 'Anti-HIV-1', '', 'HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2'',3''-dideoxy-2'',3''-didehydro-5-fluorocytidine (Reverset). Nucleoside reverse transcriptase inhibitors (NRTIs) represent the cornerstone of highly active antiretroviral therapy when combined with non-nucleoside reverse transcriptase inhibitors (NNRTIs) or HIV-1 protease inhibitors (PIs).', 12790516),
('Antiviral Chemical compound', 'Three-ring oxadiazole compounds', 'Anti-HIV-1', '', 'Identification of novel bifunctional HIV-1 reverse transcriptase inhibitors. The increasing prevalence of mutations in HIV-1 reverse transcriptase (RT) that confer resistance to existing NRTIs and NNRTIs underscores the need to develop RT inhibitors with novel mode-of-inhibition and distinct resistance profiles.', 29029095),
('Antiviral Chemical compound', 'A series of 1,3,5-triazine compounds', 'Anti-HCV', '', 'Importantly, I719, the most relevant natural polymorphism, did not significantly alter the susceptibility of HCV to the triazine compounds. The preclinical properties of these triazine compounds support further investigation of entry inhibitors as a potential novel therapy for HCV infection.', 22545104),
('Antiviral Chemical compound', 'D4GTP (the planar 2'',3''-unsaturated deoxyribose guanosine analogue that is complementary to D4TTP)', 'Anti-HIV-1', '', 'In contrast to CBVTP, D4GTP was found to be an excellent substrate for RT(WT) and no resistance was conferred by the M184V mutation, thus providing novel insight into structure-activity relationships for nucleoside-based inhibitors.', 11955063),
('Antiviral Chemical compound', 'Bromocriptine (BRC)', 'Dengue virus (DENV) half maximal effective concentration [EC50], 0.8-1.6 microM', 'Half maximal cytotoxicity concentration [CC50], 53.6 microM)', 'In summary, BRC was found to be a novel DENV inhibitor and a potential candidate for the treatment of DENV infectious disease.', 27181378),
('Antiviral Chemical compound', '2,2''-diselenobisbenzamides (DISeBAs)', 'Anti-HIV', '', 'In this manuscript, we have identified a series of 2,2''-diselenobisbenzamides (DISeBAs) as novel HIV retroviral nucleocapsid protein 7 (NCp7) inhibitors.', 26613134),
('Antiviral Chemical compound', 'VRX-329747 and VRX-413638', 'Anti-HIV-1', '', 'In this study, we report a novel series of nonnucleoside inhibitors of HIV-1, exemplified by VRX-329747 and VRX-413638, which inhibit both NNRTI- and NRTI-resistant HIV-1 isolates.', 16870771),
('Antiviral Chemical compound', 'GSK2485852 (referred to here as GSK5852)', 'Hepatitis C virus (HCV) NS5B polymerase inhibitor with 50% effective concentrations (EC50s)', '', 'In vitro characterization of GSK2485852, a novel hepatitis C virus polymerase inhibitor. GSK2485852 (referred to here as GSK5852) is a hepatitis C virus (HCV) NS5B polymerase inhibitor with 50% effective concentrations (EC50s) in the low nanomolar range in the genotype 1 and 2 subgenomic replicon system as well as the infectious HCV cell culture system.', 23939896),
('Antiviral Chemical compound', '3-hydroxypyrimidine-2,4-diones', 'Activity against human immunodeficiency virus (HIV)', '', 'Inhibitors with a novel structure core are essential for combating resistance associated with known IN inhibitors (INIs).', 21381765),
('Antiviral Chemical compound', 'JTK-853', 'hepatitis C virus (HCV)', '', 'JTK-853, a novel non-nucleoside hepatitis C virus polymerase inhibitor, demonstrates a high genetic barrier to resistance in vitro. JTK-853 is a novel, non-nucleoside, palm site-binding hepatitis C virus (HCV) polymerase inhibitor that has demonstrated antiviral activity in HCV-infected patients during 3 days of treatment.', 24008863),
('Antiviral Chemical compound', '1, 4-dihydro-2H-3, 1-benzoxazin-2-ones', 'The compound was a potent inhibitor of the wild-type HIV-1 RT (Ki = 2.93 nM) and exhibited a 95% inhibitory concentration of 1.5 nM for the inhibition of HIV-1 replicative spread in cell culture.', '', 'L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase. The clinical benefit of the human immunodeficiency virus type 1 (HIV-1) nonnucleoside reverse transcriptase (RT) inhibitors (NNRTIs) is limited by the rapid selection of inhibitor-resistant viral variants.', 8592986),
('Antiviral Chemical compound', '2-Hydroxyisoquinoline-1,3(2H,4H)-dione', 'Anti-HIV-1', '', 'Magnesium chelating 2-hydroxyisoquinoline-1,3(2H,4H)-diones, as inhibitors of HIV-1 integrase and/or the HIV-1 reverse transcriptase ribonuclease H domain: discovery of a novel selective inhibitor of the ribonuclease H function. 2-Hydroxyisoquinoline-1,3(2H,4H)-dione was recently discovered as a scaffold for the inhibition of HIV-1 integrase and the ribonuclease H function of HIV-1 reverse transcriptase.', 21366258),
('Antiviral Chemical compound', 'Artocarpin', 'H1N1 IC(50) values, determined in chemiluminescence-based NA inhibition assays, are in the range of 0.18-17 microM', '', 'In particular, artocarpin exhibits high affinity toward three H1N1 oseltamivir-sensitive influenza A viruses. It also inhibits the NA of an oseltamivir-resistant H1N1 isolate.', 21452980),
('Antiviral Chemical compound', 'Sifuvirtide (SFT)', 'Anti-HIV', '', 'Our data present important information for developing SFT for clinical use and for designing novel HIV fusion inhibitors.', 22228771),
('Antiviral Chemical compound', 'Protease inhibitors (PI''s) bearing 1,3,4-oxadiazoles at the P1'' position', 'Anti-HIV-1', '', 'P1'' oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1. HIV-1 protease inhibitors (PI''s) bearing 1,3,4-oxadiazoles at the P1'' position were prepared by a novel method involving the diastereoselective installation of a carboxylic acid and conversion to the P1'' heterocycle.', 15324882),
('Antiviral Chemical compound', 'BPR0Z-194, one of the pyridyl imidazolidinones', 'Enterovirus 71', '', 'Pyridyl imidazolidinone is a novel class of potent and selective human enterovirus 71 inhibitor.', 15328120),
('Antiviral Chemical compound', 'RSV604, a novel benzodiazepine', 'Respiratory syncytial virus (RSV)', '', 'RSV604, a novel inhibitor of respiratory syncytial virus replication. Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infections worldwide, ye+B11t no effective vaccine or antiviral treatment is available.', 17576833),
('Antiviral Chemical compound', 'GSK2248761', '[EC(50)] = 36.9 ng/ml) against HIV-1', '', 'Safety and efficacy of GSK2248761, a next-generation nonnucleoside reverse transcriptase inhibitor, in treatment-naive HIV-1-infected subjects. GSK2248761 is a novel, once-daily (QD), next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) with activity against efavirenz-resistant strains.', 22314532),
('Antiviral Chemical compound', 'A series of novel N-alkoxy-arylsulfonamide', 'HIV protease inhibitors', '', 'Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors. A series of novel N-alkoxy-arylsulfonamide HIV protease inhibitors with low picomolar enzyme activity and single digit nanomolar antiviral activity is disclosed. DOI: 10.1016/j.bmcl.2005.05.101', 15975788),
('Antiviral Chemical compound', '3-aryl-phospho-indole (API)', 'Anti-HIV-1', '', 'Synthesis and biological evaluation of aryl-phospho-indole as novel HIV-1 non-nucleoside reverse transcriptase inhibitors. A novel series of 3-aryl-phospho-indole (API) non-nucleoside reverse transcriptase inhibitors of HIV-1 was developed.', 21142105),
('Antiviral Chemical compound', 'Replacement of the pyridylmethyl moiety in indinavir with a pyridyl oxazole yielded HIV-1 protease inhibitors (PI)', 'Anti-HIV-1', '', 'The design, synthesis and evaluation of novel HIV-1 protease inhibitors with high potency against PI-resistant viral strains. Replacement of the pyridylmethyl moiety in indinavir with a pyridyl oxazole yielded HIV-1 protease inhibitors (PI) with greatly improved potency against PI-resistant HIV-1 strains.', 12852969),
('Antiviral Chemical compound', 'Bicyclams', 'Human immunodeficiency virus type 1 (HIV-1) and HIV-2 inhibitor', '', 'The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication. Bicyclams are a novel class of antiviral compounds which act as potent and selective inhibitors of the replication of human immunodeficiency virus type 1 (HIV-1) and HIV-2.', 8551604),
('Antiviral Chemical compound', 'CP32M', 'Inhibit a large panel of diverse HIV-1 variants, including subtype B'', CRF07_BC, and CRF01_AE recombinants and naturally occurring or induced T20-resistant viruses.', '', 'Therefore, our data present important information for developing novel HIV-1 fusion inhibitors for clinical use.', 22679024),
('Antiviral Chemical compound', 'AZ-27', 'Respiratory syncytial virus (RSV) inhibitors', '', 'This novel and broad-spectrum RSV L polymerase inhibitor may pave the way toward an efficacious RSV therapeutic and provide a new tool for interrogation of the L protein function.', 24777090),
('Antiviral Chemical compound', 'Alkyl Amine Bevirimat Derivatives', 'Anti-HIV-1', '', 'To overcome the loss of BVM activity induced by polymorphisms in SP1, we carried out an extensive medicinal chemistry campaign to develop novel maturation inhibitors.', 26482309),
('Antiviral Chemical compound', 'Protease inhibitor SG85', 'enterovirus 71 (EV71)', '', 'We demonstrate that the novel enteroviral protease inhibitor (PI) SG85 and capsid binder (CB) vapendavir efficiently inhibit the in vitro replication of 21 EV71 strains/isolates that are representative of the different genogroups A, B, and C.', 25199773),
('Antiviral Chemical compound', 'Bisheteroarylpiperazine, U-90152 [1-(5-methanesulfonamido-1H-indol-2-yl-carbonyl)-4-[3-(1-methyl eth yl-amino)pyridinyl]piperazine]', 'Inhibited recombinant HIV-1 RT at a 50% inhibitory concentration (IC50) of 0.26 microM (compared with IC50s of > 440 microM for DNA polymerases alpha and delta)', '', 'We describe a novel bisheteroarylpiperazine, U-90152 [1-(5-methanesulfonamido-1H-indol-2-yl-carbonyl)-4-[3-(1-methyl eth yl-amino)pyridinyl]piperazine], which inhibited recombinant HIV-1 RT at a 50% inhibitory concentration (IC50) of 0.26 microM (compared with IC50s of > 440 microM for DNA polymerases alpha and delta).', 7685995),
('Antiviral Chemical compound', 'ABT-450', 'Inhibitor of HCV NS3/4A protease, with 50% effective concentration values of 1.0, 0.21, 5.3, 19, 0.09, and 0.69 nM against stable HCV replicons with NS3 protease from genotypes 1a, 1b, 2a, 3a, 4a, and 6a, respectively.', '', 'In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450. The development of direct-acting antiviral agents is a promising therapeutic advance in the treatment of hepatitis C virus (HCV) infection. ABT-450 is an efficacious inhibitor of HCV NS3/4A protease, with 50% effective concentration values of 1.0, 0.21, 5.3, 19, 0.09, and 0.69 nM against stable HCV replicons with NS3 protease from genotypes 1a, 1b, 2a, 3a, 4a, and 6a, respectively.', 25451053),
('Antiviral Chemical compound', 'GLS4', 'The IC(50) of GLS4 was 0.012 microM, which is significantly lower than that of lamivudine (0.325 microM).', '', 'CONCLUSIONS: GLS4 is a new and unique potential anti-HBV agent that possesses a different mechanism of action than existing therapeutic drugs.', 22668794),
('Antiviral Chemical compound', '2-phenylbenzimidazole derivatives', 'Selectively and potently active against the bovine viral diarrhea virus (BVDV)', '', 'Pharmacophore modeling, resistant mutant isolation, docking, and MM-PBSA analysis: Combined experimental/computer-assisted approaches to identify new inhibitors of the bovine viral diarrhea virus (BVDV). Starting from a series of our new 2-phenylbenzimidazole derivatives, shown to be selectively and potently active against the bovine viral diarrhea virus (BVDV), we developed a hierarchical combined experimental/molecular modeling strategy to explore the drug leads for the BVDV RNA-dependent RNA-polymerase.', 20189812),
('Antiviral Chemical compound', 'Arylazoenamine derivatives', 'Selectively and potently active against the bovine viral diarrhea virus (BVDV), we developed a hierarchical combined experimental/molecular modeling strategy to explore the drug leads for the BVDV RNA-dependent RNA polymerase.', '', 'Synergistic experimental/computational studies on arylazoenamine derivatives that target the bovine viral diarrhea virus RNA-dependent RNA polymerase. Starting from a series of arylazoenamine derivatives, shown to be selectively and potently active against the bovine viral diarrhea virus (BVDV), we developed a hierarchical combined experimental/molecular modeling strategy to explore the drug leads for the BVDV RNA-dependent RNA polymerase.', 20638852),
('Antiviral Chemical compound', 'Compound 27, piperidine-substituted thiophene[3,2-d]pyrimidine scaffold', 'Compound 27 was the most potent; compared with ETV, its antiviral efficacy was 3-fold greater against WT, 5-7-fold greater against Y181C, Y188L, E138K, and F227L+V106A, and nearly equipotent against L100I and K103N, though somewhat weaker against K103N+Y181C.', '27 has lower cytotoxicity (CC50 > 227 microM) and a huge selectivity index (SI) value (ratio of CC50/EC50) of >159101', 'We designed and synthesized a series of human immunodeficiency virus type 1 (HIV-1) non-nucleoside reverse transcriptase inhibitors (NNRTIs) with a piperidine-substituted thiophene[3,2-d]pyrimidine scaffold, employing a strategy of structure-based molecular hybridization and substituent decorating.', 27541578),
('Antiviral Chemical compound', 'Remazol Brilliant Blue R', 'Remazol Brilliant Blue R (RB19, an anthraquinone dye), which inhibited WT NA and MDR NA with IC(50) values of 3.4 and 4.5 microM, respectively.', '', 'Using this strategy, we identified a new inhibitor, Remazol Brilliant Blue R (RB19, an anthraquinone dye), which inhibited WT NA and MDR NA with IC(50) values of 3.4 and 4.5 microM, respectively.', 23437217),
('Antiviral Chemical compound', 'Macrocyclic acylsulfonamide', 'Potent inhibitor of the NS3-NS4A proteases of all hepatitis C virus genotypes and of a panel of genotype 1-resistant variants.', '', 'This work describes our rational approach toward the identification of a macrocyclic acylsulfonamide that is a potent inhibitor of the NS3-NS4A proteases of all hepatitis C virus genotypes and of a panel of genotype 1-resistant variants.', 23271737),
('Antiviral Chemical compound', 'Chebulagic acid (CHLA) and punicalagin (PUG)', 'Could prevent binding, penetration, and cell-to-cell spread, as well as secondary infection.', 'inhibit HSV-1 entry at noncytotoxic doses in A549 human lung cells.', 'Experiments revealed that both tannins targeted and inactivated HSV-1 viral particles and could prevent binding, penetration, and cell-to-cell spread, as well as secondary infection.', 21307190),
('Antiviral Chemical compound', 'Nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781', '25 microM UC781 provided essentially equivalent microbicidal activity against NNRTI-resistant and wt virus', '', 'In vitro microbicidal activity of the nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 against NNRTI-resistant human immunodeficiency virus type 1. The nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 is under development as a microbicide to prevent sexual transmission of the human immunodeficiency virus type 1 (HIV-1).', 16611904),
('Antiviral Chemical compound', 'Stilbene 1,2-diamines', 'Compounds selectively block the initiation of replication of incoming HCV RNA but have no impact on viral entry, primary translation, or ongoing HCV RNA replication, nor do they suppress persistent HCV infection.', 'prevent HCV infection at nontoxic, low micromolar concentrations in cell culture.', 'Using a cell-based colorimetric screening assay to interrogate a 1,200-compound chemical library for anti-HCV activity, we identified a family of 1,2-diamines derived from trans-stilbene oxide that prevent HCV infection at nontoxic, low micromolar concentrations in cell culture.', 21430055),
('Antiviral Chemical compound', 'Distamycin analogue, 2,2''-[4, 4''-[[aminocarbonyl]amino]bis[N,4''-di[pryrrole-2-carboxamide- 1, 1''-dimethyl]]-6,8-naphthalenedisulfonic acid]hexasodium salt (NSC 651016)', 'NSC 651016 inhibited in vitro replication of a wide range of HIV-1 isolates, as well as HIV-2 and SIV, and exhibited in vivo anti-HIV-1 activity in a murine model.', '', 'NSC 651016 represents an attractive candidate for the chemotherapeutic treatment of HIV-1 infection and as a microbicide to prevent the sexual transmisssion of HIV-1.', 9632350),
('Antiviral Chemical compound', 'D- and L-(beta)-deoxy- and -dideoxynucleoside triphosphate analogues', 'L-(beta)-enantiomers of nucleoside RT inhibitors were synergistic when combined with nonnucleoside RT inhibitors', '', 'Potentiation of inhibition of wild-type and mutant human immunodeficiency virus type 1 reverse transcriptases by combinations of nonnucleoside inhibitors and d- and L-(beta)-dideoxynucleoside triphosphate analogs. Combinations of reverse transcriptase (RT) inhibitors are currently used in anti-human immunodeficiency virus therapy in order to prevent or delay the emergence of resistant virus and to improve the efficacy against viral enzymes carrying resistance mutations.', 11257034),
('Antiviral Chemical compound', 'N-Butyldeoxynojirimycin (NB-DNJ)', 'When encapsulated inside liposomes, NB-DNJ inhibited HIV-1 with final concentrations in the nmol/l range (IC50 = 4 nmol/l), a 100 000-fold enhancement in IC50 relative to free NB-DNJ.', '', 'N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery. NB-DNJ CD4 liposomes demonstrated additional antiviral effects, reducing viral secretion by 81% and effectively neutralizing free viral particles to prevent further infections.', 18753929),
('Antiviral Chemical compound', 'CDG (carbocyclic 2''-deoxyguanosine) and abacavir ([1S,4R]-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol)', 'Drug assays indicated that the lamivudine-resistant virus exhibited reduced sensitivity to penciclovir [9-(4-hydroxy-3-hydroxymethyl-but-1-yl) guanine] but was still inhibited by the nucleoside analogues CDG (carbocyclic 2''-deoxyguanosine) and abacavir ([1S,4R]-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol).', '', 'Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening. Lamivudine [beta-L-(-)-2'',3''-dideoxy-3''-thiacytidine] is a potent inhibitor of hepadnavirus replication and is used both to treat chronic hepatitis B virus (HBV) infections and to prevent reinfection of transplanted livers.', 12760870),
('Antiviral Chemical compound', 'Boceprevir-S isomer (SCH 534128)', 'Median concentration in patients with breakthrough was 48.3 ng/mL (interquartile range 43-58 ng/mL); in others, it was significantly (p 0.019) higher: 151 ng/mL.', '', 'Boceprevir-S isomer (SCH 534128) median concentration in patients with breakthrough was 48.3 ng/mL (interquartile range 43-58 ng/mL); in others, it was significantly (p 0.019) higher: 151 ng/mL. Low boceprevir plasma concentration can lead to virologic resistance; therapeutic drug monitoring should be used to prevent the onset of viral breakthrough during triple-regimen therapy with boceprevir. Copyright ? 2014 European Society of Clinical Microbiology and Infectious Diseases.', 25658567),
('Antiviral Chemical compound', '4-oxo-4H-1-benzopyran-8-carbaldehydes 11a-11g', 'Most promising, and they demonstrated better activities and selectivities comparable to those the reference ribarivin, a nucleoside antiviral agent.', '', 'A series of novel isoflavonoids were synthesized based on structural modifications of daidzein, an active ingredient of traditional Chinese medicine (TCM) and evaluated for their anti-influenza activity, in vitro, against H1N1 Tamiflu-resistant (H1N1 TR) virus in the MDCK cell line. Among them, 4-oxo-4H-1-benzopyran-8-carbaldehydes 11a-11g were most promising, and they demonstrated better activities and selectivities comparable to those the reference ribarivin, a nucleoside antiviral agent. 3-(4-Bromophenyl)-7-hydroxy-4-oxo-4H-1-benzopyran-8-carboxaldehyde (11c) displayed the best inhibitory activity (EC50 , 29.0 microM) and selectivity index (SI>10.3).', 25879510),
('Antiviral Chemical compound', 'Carraguard-based formulation', 'PC-817 appeared no more effective than Carraguard in vivo, due to the limited activity of a single dose of MIV-150 and the dominant barrier effect of Carraguard.', '', 'Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity. Anti-HIV microbicides are being investigated in clinical trials and understanding how promising strategies work, coincident with demonstrating efficacy in vivo, is central to advancing new generation microbicides.', 18776937),
('Antiviral Chemical compound', '4''-methoxyflavone and 2''-hydroxy-4-methoxychalcone', 'In-silico study, binders of the 150-cavity of neuraminidase (NA)', '', 'A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1.', 27412704),
('Antiviral Chemical compound', 'Diphenyl ether', 'Non-nucleoside reverse transcriptase inhibitors with excellent potency against resistant mutant viruses and promising pharmacokinetic properties', '', 'Diphenyl ether non-nucleoside reverse transcriptase inhibitors with excellent potency against resistant mutant viruses and promising pharmacokinetic properties. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are part of the preferred treatment regimens for individuals infected with HIV.', 19006142),
('Antiviral Chemical compound', 'Indolylarylsulfones (IASs), halo- and nitro-substituted IAS derivatives', 'Exhibited high selectivity to the mutant RT in complex with its substrates, behaving as uncompetitive inhibitors.', '', 'Mechanism of interaction of novel indolylarylsulfone derivatives with K103N and Y181I mutant HIV-1 reverse transcriptase in complex with its substrates. BACKGROUND: Novel indolylarylsulfones (IASs), designed through rational structure-based molecular modelling and docking approaches, have been recently characterized as effective inhibitors of the wild-type and drug-resistant mutant HIV-1 reverse transcriptase (RT).', 22095519),
('Antiviral Chemical compound', 'Icosahedral metallacarboranes', 'Potent and specific competitive inhibitors of drug-resistant HIV PRs prepared either by site-directed mutagenesis or cloned from HIV-positive patients.', '', 'Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance. HIV protease (PR) is a prime target for rational anti-HIV drug design.', 18598016),
('Antiviral Chemical compound', 'Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol)', 'Active against ganciclovir- and foscarnet-resistant human cytomegalovirus UL97 mutants', '', 'The Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol) were previously shown to be potent inhibitors of AD169 and Towne HCMV reference strains and postulated to share a common phosphorylation pathway with ganciclovir (GCV) possibly involving the UL97-encoded phosphotransferase.', 12406510),
('Antiviral Chemical compound', 'R1626 plus peginterferon Alfa-2a', 'Potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin', '', 'R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin. R1626, a prodrug of the hepatitis C virus (HCV) RNA polymerase inhibitor R1479, showed time-dependent and dose-dependent reduction of HCV RNA levels in a previous study.', 18570306),
('Antiviral Chemical compound', 'Benzothiadiazine-substituted tetramic acids', 'Potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase', '', 'An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids is reported.', 16455253),
('Antiviral Chemical compound', 'KNI-227 and KNI-272', 'the 50% inhibitory concentrations of KNI-227 against HIV type 1 LAI (HIV-1LAI), HIV-1RF, HIV-1MN, and HIV-2ROD were 0.1, 0.02, 0.03, and 0.1 microM, respectively, while those of KNI-272 were 0.1, 0.02, 0.04, and 0.1 microM, respectively.', 'The ratios of 50% cytotoxic concentrations to 50% inhibitory concentrations for KNI-227 and KNI-272 were approximately 2,500 and > 4,000, respectively, as assessed in peripheral blood mononuclear cells.', 'In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine. Two compounds, KNI-227 and KNI-272, which were highly potent against HIV protease with little inhibition of other aspartic proteases, showed the most potent activity against the infectivity and cytopathic effect of a wide spectrum of HIV strains.', 8494379),
('Antiviral Chemical compound', '2''-deoxy-4''-C-ethynyl-2-fluoroadenosine and 2''-deoxy-4''-C-ethynyl-2-chloroadenosine', 'Have supremely high activity against all human immunodeficiency viruses including multidrug-resistant HIV and low toxicity.', 'low toxicity.', 'Development of modified nucleosides that have supremely high anti-HIV activity and low toxicity and prevent the emergence of resistant HIV mutants. An idea to use 4''-C-substituted-2''-deoxynucleoside derivatives was proposed based on a working hypothesis to solve the problems of existing acquired immune deficiency syndrome chemotherapy (highly active antiretroviral therapy).', 21422739),
('Antiviral Chemical compound', 'GRL-1388 and -1398', 'GRL-1388 was as potent as darunavir (DRV) against various drug-resistant HIV-1 laboratory strains with 50% effective concentration (EC(50)s) of 2.6 to 32.6 nM. GRL-1398 was significantly more potent against such variants than DRV with EC(50)s of 0.1 to 5.7 nM. GRL-1388 and -1398 were also potent against multiple-PI-resistant clinical HIV-1 variants ((CL)HIV-1(MDR)) with EC(50)s ranging from 2.7 to 21.3 nM and from 0.3 to 4.8 nM, respectively.', '', 'Novel HIV-1 protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran, that are potent against multi-PI-resistant HIV-1 variants. We identified GRL-1388 and -1398, potent nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran (Tp-THF).', 21282450),
('Antiviral Chemical compound', 'MK-1439', 'Treatment of HIV infection.', '', 'Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses.', 24412110),
('Antiviral Chemical compound', 'GRL-5010A and GRL-4410A', 'More effective than darunavir in inhibiting mature PR20 and show promise for further development of antiviral agents targeting highly resistant PR mutants.', '', 'Substituted Bis-THF Protease Inhibitors with Improved Potency against Highly Resistant Mature HIV-1 Protease PR20. An extremely drug resistant mutant of HIV-1 protease (PR) bearing 20 mutations (PR20) has been studied with two potent antiviral investigational inhibitors.', 26010498),
('Antiviral Chemical compound', 'TMC647055 (TMC)', 'A novel and potent non-nucleoside inhibitor of the HCV NS5B polymerase.', '', 'TMC647055 (TMC) is a novel and potent non-nucleoside inhibitor of the HCV NS5B polymerase. However, mutations that result in drug resistance to TMC have been reported.', 26836778),
('Antiviral Chemical compound', 'EDP-239', 'Hepatitis C Virus NS5A Inhibitor', '', 'EDP-239, a potent and selective hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor developed for the treatment of HCV infection, has been investigated in vitro and in vivo', 27503644),
('Antiviral Chemical compound', 'Three amide-DAANs 8e, 4a, and 4b', 'High potency against wild-type and rilpivirine-resistant viral strains and multiple desirable drug-like properties.', '', 'Drug-like property-driven optimization of 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against rilpivirine-resistant mutant virus.', 28465101),
('Antiviral Chemical compound', 'TMC125-R165335 (etravirine)', 'TMC125-R165335 and related anti-AIDS drug candidates can bind the enzyme RT in multiple conformations and thereby escape the effects of drug-resistance mutations.', '', 'Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. Anti-AIDS drug candidate and non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC125-R165335 (etravirine) caused an initial drop in viral load similar to that observed with a five-drug combination in na?ve patients and retains potency in patients infected with NNRTI-resistant HIV-1 variants.', 15115397),
('Antiviral Chemical compound', '7-Deaza-2''-C-methyl-adenosine', 'Potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties', '', 'A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties. Improved treatments for chronic hepatitis C virus (HCV) infection are needed due to the suboptimal response rates and deleterious side effects associated with current treatment options.', 15388457),
('Antiviral Chemical compound', 'Aurintricarboxylic acid', 'Potent inhibitor of influenza A and B virus neuraminidases', '', 'Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases. BACKGROUND: Influenza viruses cause serious infections that can be prevented or treated using vaccines or antiviral agents, respectively.', 20020057),
('Antiviral Chemical compound', '2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236)', 'PHI-236 displayed high-binding affinity (Ludi K(i) = 0.07 microM) for HIV-1 RT and robust anti-HIV activity against the wild type (IC50 = <0.001 microM) as well as primary clinical isolates (IC50 = 0.009-0.04 microM) carrying multiple RT gene mutations associated with NRTI and NNRTI resistance.', '', 'Discovery of 2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human immunodeficiency virus microbicide.', 16254003),
('Antiviral Chemical compound', 'beta-L-2'',3''-Dideoxycytidine (beta-L-ddC) and beta-L-5-fluoro-2'',3''-dideoxycytidine (5-F-beta-L-ddC)', 'The beta-L-dideoxycytidine nucleosides had similar anti-HIV-1 activities, significantly greater anti-HBV activities', 'decreased toxicities to a B-cell line, T-cell lines, and human bone marrow progenitor cells.', 'Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides. beta-L-2'',3''-Dideoxycytidine (beta-L-ddC) and beta-L-5-fluoro-2'',3''-dideoxycytidine (5-F-beta-L-ddC) were prepared and shown to have potent activity against human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV).', 7518218),
('Antiviral Chemical compound', '[tetrahydroimidazo[4,5,1-jk] [1,4]benzodiazepin-2(1H)-one and -thione (TIBO), 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine, nevirapine, pyridinone, bis(heteroaryl)piperazine, etc.]', 'Potent inhibitors of HIV-1 replication in cell culture.', '', 'Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors. The human immunodeficiency virus type 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors [tetrahydroimidazo[4,5,1-jk] [1,4]benzodiazepin-2(1H)-one and -thione (TIBO), 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine, nevirapine, pyridinone, bis(heteroaryl)piperazine, etc.] are potent inhibitors of HIV-1 replication in cell culture.', 7682649),
('Antiviral Chemical compound', 'N-[2-(1-cyclohexenyl)ethyl]-N''-[2-(5-bromopyridyl)]-thiourea and N''-[2-(1-cyclohexenyl)ethyl]-N''-[2-(5-chloropyridyl)]-thiourea', 'HIV-1 inhibition assays was: HI-445 = HI-346 (IC50 = 3 nM) > MKC-442 (IC50 = 4 nM) = AZT (IC50 = 4 nM) > trovirdine (IC50 = 7 nM) > delavirdine (IC50 = 9 nM) > nevirapine (IC50 = 34 nM).', '', 'N-[2-(1-cyclohexenyl)ethyl]-N''-[2-(5-bromopyridyl)]-thiourea and N''-[2-(1-cyclohexenyl)ethyl]-N''-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1.', 10509923),
('Antiviral Chemical compound', 'MKC-442 (6-benzyl-1-ethoxymethyl-5-isopropyluracil or I-EBU)', 'The 50 and 90% effective concentrations for HIV-1 (HTLV-IIIB strain) replication in MT-4 cells were 15 and 98 nM, respectively.', '', 'Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro. MKC-442 (6-benzyl-1-ethoxymethyl-5-isopropyluracil or I-EBU) has recently been identified as a highly potent and specific inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.', 7518216),
('Antiviral Chemical compound', '5-Fluorouracil, 5-fluorouridine (FUrd), 5-fluoro-2''-deoxyuridine (FdUrd), 5-fluorocytidine (FCyd), 5-fluoro-2''-deoxycytidine (FdCyd), 5-trifluoro-2''-deoxythymidine (F3dThd), and the 5''-monophosphates and 3'',5''-cyclic monophosphates', 'Activity against thymidine kinase-deficient (TK-) herpes simplex virus', '', 'Potent activity of 5-fluoro-2''-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase. Other 5-substituted 2''-deoxyuridines that have previously been recognized as potent thymidylate synthase inhibitors behaved in a similar fashion.', 3039343),
('Antiviral Chemical compound', '(S,S)-1,2-bis(5-methoxy-2-benzimidazolyl)-1,2-ethanediol', 'Potent inhibitors of rhinoviruses', '', 'Antiviral activity in tissue culture systems of bis-benzimidazoles, potent inhibitors of rhinoviruses.', 4333892),
('Antiviral Chemical compound', 'Pyridinone derivatives', 'Potent and specific inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) and HIV-1 replication in cell culture.', '', 'L-702,019 was also a potent inhibitor of the replication of mutant HIV-1 containing the individual mutations at amino acid 103 or 181 as well as of clinical isolates resistant to L-697,661 and L-696,229.', 7685996),
('Antiviral Chemical compound', 'PNU-140690 (sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrone)', 'A potent, nonpeptidic inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease currently under clinical evaluation.', '', 'In vitro combination of PNU-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and -resistant clinical isolates. PNU-140690 (sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrone) is a potent, nonpeptidic inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease currently under clinical evaluation.', 9371335),
('Antiviral Chemical compound', '(-)-beta-D-2, 6-diaminopurine-dioxolane', 'Suppressive effects of the K65R and L74V mutations on AZT resistance.', '', 'In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3''-azido-3''-deoxythymidine. Human immunodeficiency virus type 1 (HIV-1) isolates resistant to (-)-beta-D-dioxolane-guanosine (DXG), a potent and selective nucleoside analog HIV-1 reverse transcriptase (RT) inhibitor, were selected by serial passage of HIV-1(LAI) in increasing drug concentrations (maximum concentration, 30 microM). Two independent selection experiments were performed.', 10858331),
('Antiviral Chemical compound', '2'',3''-dideoxy-3''-thiacytidine (3TC)', 'A potent inhibitor of wild-type human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT).', '', 'Wild-type and YMDD mutant murine leukemia virus reverse transcriptases are resistant to 2'',3''-dideoxy-3''-thiacytidine. The antiretroviral nucleoside analog 2'',3''-dideoxy-3''-thiacytidine (3TC) is a potent inhibitor of wild-type human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT).', 10864683),
('Antiviral Chemical compound', 'L-chicoric acid', 'A potent and selective inhibitor of HIV-1 integrase that also inhibits HIV-1 replication in cell culture.', '', 'L-chicoric acid is a potent and selective inhibitor of HIV-1 integrase that also inhibits HIV-1 replication in cell culture.', 10867160),
('Antiviral Chemical compound', 'DPC 817, 2'',3''-didehydro-2'',3''-dideoxy-5-fluorocytidine (PSI 5582 D-D4FC)', 'A cytidine nucleoside analog with activity against zidovudine- and lamivudine-resistant viral variants', '', 'DPC 817, 2'',3''-didehydro-2'',3''-dideoxy-5-fluorocytidine (PSI 5582 D-D4FC) is a potent inhibitor of HIV type 1 replication in vitro.', 11959574),
('Antiviral Chemical compound', '1263W94', '1263W94 inhibited viral replication in a dose-dependent manner, with a mean 50% inhibitory concentration (IC(50)) of 0.12 +/- 0.01 microM', '', 'Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. enzimidazole nucleosides have been shown to be potent inhibitors of human cytomegalovirus (HCMV) replication in vitro.', 12121906),
('Antiviral Chemical compound', 'Imidazole-linked pinanamine derivatives (compound 33)', 'Inhibited the amantadine-resistant virus (IC50 = 3.4 microM) and its activity increased by almost 24-fold compared to initial compound, with its action mechanism being not M2 channel mediated.', '', 'Imidazole-based pinanamine derivatives: Discovery of dual inhibitors of the wild-type and drug-resistant mutant of the influenza A virus. We previously reported potent hit compound 4 inhibiting the wild-type influenza A virus A/HK/68 (H3N2) and A/M2-S31N mutant viruses A/WS/33 (H1N1), with its latter activity quite weak.', 26722757),
('Antiviral Chemical compound', 'Benzodithiin compound (RD3-0028)', 'RD3-0028 inhibits RSV replication by interfering with intracellular processing of the RSV fusion protein, or a step immediately thereafter, leading to loss of infectivity.', '', 'Mechanism of selective inhibition of respiratory syncytial virus by a benzodithiin compound (RD3-0028). RD3-0028, a compound with a benzodithiin structure, was found to be a potent inhibitor of respiratory syncytial virus (RSV) replication.', 11529559),
('Antiviral Chemical compound', 'Methyl 3'',3"-dichloro-4'',4"-dimethoxy-5'', 5"-bis(methoxycarbonyl)-6,6-diphenyl-5-hexenoate (ADAM II)', 'ADAM II inhibited HIV-1 reverse transcriptase with an IC50 of 0.3 microM but was inactive as an inhibitor of HIV-1 attachment/fusion to cells, protease, integrase, and the nucleocapsid protein.', '', 'New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors. The most potent compound proved to be methyl 3'',3"-dichloro-4'',4"-dimethoxy-5'', 5"-bis(methoxycarbonyl)-6,6-diphenyl-5-hexenoate (ADAM II), which displayed an EC50 of 13 nM for inhibition of the cytopathic effect of HIV-1RF in CEM-SS cells.', 9622549),
('Antiviral Chemical compound', '2-fluoroadenosine analogue 32', '2-fluoroadenosine analogue 32 showed antiviral potency as well as high cytotoxicity (IC(50) 1.5, 1.1, and 7.6 microM for PBM, CEM, and Vero, respectively) whereas no other compound showed cytotoxicity up to 100 microM.', '', 'Stereoselective synthesis and antiviral activity of D-2'',3''-didehydro-2'',3''-dideoxy-2''-fluoro-4''-thionucleosides. The antiviral activity of the synthesized compounds were evaluated against HIV-1 in human peripheral blood mononuclear (PBM) cells, among which cytidine 17, 5-fluorocytidine 18, adenosine 24, and 2-fluoroadenosine 32 showed moderate to potent anti-HIV activities (EC(50) 1.3, 11.6, 8.1, and 1.2 microM, respectively).', 12383014),
('Antiviral Chemical compound', 'Cytosine 17, 5-fluorocytosine 18, and adenine 27 derivatives', 'Showed potent anti-HIV activities (EC(50) = 0.12, 0.15, and 1.74 microM, respectively) without significant cytotoxicity up to 100 microM in human PBM, CEM, and Vero cells.', '', 'Synthesis, anti-HIV activity, and molecular mechanism of drug resistance of L-2'',3''-didehydro-2'',3''-dideoxy-2''-fluoro-4''-thionucleosides. The antiviral activity of the newly synthesized compounds was evaluated against HIV-1 in human peripheral blood mononuclear (PBM) cells, among which the cytosine 17, 5-fluorocytosine 18, and adenine 27 derivatives showed potent anti-HIV activities (EC(50) = 0.12, 0.15, and 1.74 microM, respectively) without significant cytotoxicity up to 100 microM in human PBM, CEM, and Vero cells.', 12540238),
('Antiviral Chemical compound', 'Diketo acid compound L-742,001', 'Two- to 3-fold resistance was seen for the T20A, L42T, and V122T mutants, and the R124Q and Y130A mutants were 3-fold more sensitive to L-742,001.', '', 'The diketo acid compound L-742,001 was previously identified as a potent inhibitor of the influenza virus endonuclease reaction, but information on its precise binding mode to PA or potential resistance profile is limited.', 23824822);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antiviral Chemical compound', 'DPC 681 and DPC 684', 'A panel of chimeric viruses constructed from clinical samples from patients who failed PI-containing regimens and containing 5 to 11 mutations, including positions 10, 32, 46, 47, 50, 54, 63, 71, 82, 84, and 90 had mean IC(50) values of <20 nM for DPC 681 and DPC 681, respectively', '', 'DPC 681 and DPC 684: potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variants. Two compounds resulting from our studies, designated DPC 681 and DPC 684, are potent and selective inhibitors of HIV protease with IC(90)s for wild-type HIV-1 of 4 to 40 nM.', 11600351),
('Antiviral Chemical compound', 'N-[2-(2,5-dimethoxyphenylethyl)]-N''-[2-(5-bromopyridyl)]-thi ourea (HI-236)', 'The activity of HI-236 against RT-MDR was superior to that of other anti-HIV agents tested, in the following order, from high to low activity; HI-236 (IC50 5 nM), HI-240 (IC50 6 nM), trovirdine (IC50 20 nM), zidovudine (IC50 150 nM), MKC-442 (IC50 300 nM), delavirdine (IC50 400 nM) and nevirapine (IC50 5 microM).', '', 'Our lead compound, N-[2-(2,5-dimethoxyphenylethyl)]-N''-[2-(5-bromopyridyl)]-thi ourea (HI-236) was tested against clinically observed non-nucleoside inhibitor (NNI)-resistant mutated strains of HIV.. HI-236 was more potent than trovirdine, MKC-442 and zidovudine against the drug-sensitive HIV-1 strain IIIB, 50-100 times more effective than delavirdine or nevirapine and twice as effective as our recently reported lead compound N-[2-(2-fluorophenethyl)]-N''-[2-(5-bromopyridyl)]-thiourea (HI-240) against the NNI-resistant Y181C mutant HIV-1 strain A17.', 10574178),
('Antiviral Chemical compound', 'Lignosulfonic acid (LA)', 'LA demonstrated potent inhibitory activity of HIV replication against a wide range of R5 and X4 HIV strains and prevented the uptake of HIV by bystander CD4+ T cells from persistently infected T cells in vitro (IC50: 0.07 - 0.34 microM). LA also inhibited HSV-2 replication in vitro in different cell types (IC50: 0.42 - 1.1 microM) and in rodents in vivo.', '', 'The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications. ', 26132818),
('Antiviral Chemical compound', '4"-Benzoylureido-TSAO derivatives', 'A stringent structure-antiviral activity relationship was observed for the 4"-benzoylureido- TSAO derivatives for which the concomitant presence of a highly lipophilic substituent at both 2''- and 5''-positions was required to fully preserve the antihuman cytomegalovirus efficacy.', '', '4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors.', 18707089),
('Antiviral Chemical compound', '2''-deoxy-3''-oxa-4''-thiocytidine (dOTC)', 'The mean 50% inhibitory concentration of dOTC for drug-naive isolates was 1.76 microM, rising to only 2.53 and 2.5 microM for viruses resistant to 3TC and viruses resistant to 3TC and AZT, respectively.', '', 'Both 5''-triphosphate (TP) derivatives of dOTC were more potent than 3TC-TP at inhibiting HIV-1 reverse transcriptase (RT) in vitro.', 10428900),
('Antiviral Chemical compound', 'Pyromeconic acid and derivatives', 'This approach ultimately resulted in the development of a lead compound with an IC50 value of 14 nM, which displayed an EC50 value of 2.1 microM against H1N1 influenza virus in MDCK cells.', '', 'Fragment-Based Identification of Influenza Endonuclease Inhibitors. Herein we report the development of inhibitors of influenza PA endonuclease derived from lead compounds identified from a metal-binding pharmacophore (MBP) library screen. Pyromeconic acid and derivatives thereof were found to be potent inhibitors of endonuclease.', 27291165),
('Antiviral Chemical compound', 'JM3100, bicyclam derivative', 'JM3100, in which the cyclam moieties are tethered by an aromatic bridge [i.e., phenylenebis(methylene)], inhibits the replication of various HIV-1 and HIV-2 strains in various cell lines at a 50% effective concentration (EC50) of 1 to 10 ng/ml, which is about 100-fold lower than the concentration required for JM2763 to inhibit HIV replication and at least 100,000-fold lower than the cytotoxic concentration (> 500 micrograms/ml).', '', 'Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Bicyclams, in which the cyclam (1,4,8,11-tetraazacyclotetradecane) moieties are tethered via an aliphatic bridge (i.e., propylene, as in JM2763) are potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) (E.', 7913308),
('Antiviral Chemical compound', 'MRL-1237', 'MRL-1237 inhibited poliovirus-specific RNA synthesis in HeLa cells infected with a wild strain but not with an F164Y mutant.', '', 'Mutations in the 2C region of poliovirus responsible for altered sensitivity to benzimidazole derivatives. MRL-1237, [1-(4-fluorophenyl)-2-(4-imino-1,4-dihydropyridin-1-yl) methylbenzimidazole hydrochloride], is a potent and selective inhibitor of the replication of enteroviruses.', 10756027),
('Antiviral Chemical compound', 'AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2'',3''-dideoxy-3''-thiacytidine', 'The potency of AT-61 was not affected by one of the mutations responsible for (-)-beta-L-2'', 3''-dideoxy-3'' thiacytidine (3TC) resistance in HBV, and AT-61 acted synergistic with 3TC to inhibit HBV replication.', 'AT-61 (81 microM) was not cytotoxic or antiproliferative to several cell lines and had no antiviral effect on woodchuck or duck HBV, human immunodeficiency virus type 1, herpes simplex virus type 1, vesicular stomatitis virus, or Newcastle disease virus.', 'AT-61, a member of a novel class of phenylpropenamide derivatives, was found to be a highly selective and potent inhibitor of human hepatitis B virus (HBV) replication in four different human hepatoblastoma cell lines which support the replication of HBV (i.e., HepAD38, HepAD79, 2.2.15, and transiently transfected HepG2 cells).', 9835512),
('Antiviral Chemical compound', '2-(quinolin-3-yl)acetic acid derivatives', 'HIV-1 integrase inhibitors', '', 'We have rationally designed a series of 2-(quinolin-3-yl)acetic acid derivatives (LEDGINs) that act as potent inhibitors of the LEDGF/p75-integrase interaction and HIV-1 replication at submicromolar concentration by blocking the integration step.', 20473303),
('Antiviral Chemical compound', 'Novel fluorine-containing DAPY', 'Activities against wild-type (WT) HIV-1 and NNRTI-resistant strains', '', 'Novel fluorine-containing DAPY derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2014072419.', 26415039),
('Antiviral Chemical compound', 'Organosilanes', 'Potent antiviral activity against a panel of human clinical isolates of influenza A viruses, including viruses that are resistant to amantadine, oseltamivir, or both.', '', 'Design and expeditious synthesis of organosilanes as potent antivirals targeting multidrug-resistant influenza A viruses. In this study we report the design and synthesis of the first class of organosilanes that have potent antiviral activity against a panel of human clinical isolates of influenza A viruses, including viruses that are resistant to amantadine, oseltamivir, or both.', 28433777),
('Antiviral Chemical compound', 'Amino-bis-tetrahydrofuran Derivative [25f, 25i, and 25j]', '25f, 25i, and 25j were evaluated against a number of highly-PI-resistant HIV-1 strains, and they exhibited improved antiviral activity over darunavir.', '', 'Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions: Synthesis, Biological Evaluation, and Protein-Ligand X-ray Studies. Structure-based design, synthesis, and biological evaluation of a series of very potent HIV-1 protease inhibitors are described.', 26306007),
('Antiviral Chemical compound', 'Benzamide derivative named AH0109', 'Exhibits potent anti-HIV-1 activity at an 50% effective concentration of 0.7 microM in HIV-1-susceptible CD4(+) C8166 T cells.', '', 'In this study, we have identified a benzamide derivative named AH0109 that exhibits potent anti-HIV-1 activity at an 50% effective concentration of 0.7 microM in HIV-1-susceptible CD4(+) C8166 T cells.', 23669388),
('Antiviral Chemical compound', '4''-ethynyl-2-fluoro-2''-deoxyadenosine (EFdA)', 'Similar to WT RT, the N348I RT is inhibited by EFdA mainly at the point of incorporation through decreased translocation.', '', 'Bond Life Sciences Center and Department of Molecular Microbiology & Immunology, School of Medicine, University of Missouri, Columbia, MO 65211, USA. 4''-ethynyl-2-fluoro-2''-deoxyadenosine (EFdA) is a highly potent inhibitor of HIV-1 reverse transcriptase (RT).', 23273211),
('Antiviral Chemical compound', 'NVP018', 'A potent inhibitor of hepatitis B virus, hepatitis C virus (HCV), and HIV-1 replication, shows minimal inhibition of major drug transporters, and has a high barrier to generation of both HCV and HIV-1 resistance', '', 'NVP018 is a potent inhibitor of hepatitis B virus, hepatitis C virus (HCV), and HIV-1 replication, shows minimal inhibition of major drug transporters, and has a high barrier to generation of both HCV and HIV-1 resistance.', 25619934),
('Antiviral Chemical compound', '5-[(4-bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine (BPIP)', 'The compound resulted in a dose-dependent antiviral effect in PK(15) cells with a 50% effective concentration (EC(50)) for the inhibition of CSFV Alfort(187) (subgroup 1.1) of 1.6+/-0.4 microM and for CSFV Wingene (subgroup 2.3) 0.8+/-0.2 microM.', '', 'We here report that 5-[(4-bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine (BPIP) is a highly potent inhibitor of the in vitro replication of CSFV.', 17997169),
('Antiviral Chemical compound', 'Phosphonoformate (foscarnet; PFA)', 'Except for an HIV-1 variant encoding the K65R mutation in RT that exhibited 3.3- to 8.2-fold resistance, the nucleoside-resistant viruses included in the panel were sensitive to the PFA prodrugs (<3-fold increase in 50% inhibitory concentration)', 'its use for the treatment of HIV-1 infection is limited by toxicity and the lack of an orally bioavailable formulation.', 'Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance. Phosphonoformate (foscarnet; PFA) is a potent inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT), but its use for the treatment of HIV-1 infection is limited by toxicity and the lack of an orally bioavailable formulation.', 11353603),
('Antiviral Chemical compound', 'BI-RG-587', '50% inhibitory concentration of 84 nM against HIV-1 reverse transcriptase activity.', '', 'BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine. A series of dipyridodiazepinones have been shown to be potent inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.', 1708976),
('Antiviral Chemical compound', 'Compounds bearing a 3-isopropyl and 3-iodine group', 'The most potent inhibitors with EC50 of 4 nM', '', 'Novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) with high potency against NNRTI-resistant HIV-1 strains. Most of the compounds, especially 26 and 22, bearing a 3-isopropyl and 3-iodine group, respectively, exhibited highly potent activity against wild-type HIV-1 strains and those resistant to reverse transcriptase inhibitors (RTIs).', 23540737),
('Antiviral Chemical compound', 'S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (HPMPC)', 'Potent in vitro and in vivo activity against a broad range of herpesviruses, including acyclovir-resistant herpes simplex virus (HSV)', '', 'Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS.', 8077713),
('Antiviral Chemical compound', '2''-deoxy-5-ethyl-beta-4''-thiouridine (4''-S-EtdU)', 'Shown to be a more potent inhibitor of gammaherpesvirus infection than acyclovir.', '', '2''-Deoxy-5-ethyl-beta-4''-thiouridine inhibits replication of murine gammaherpesvirus and delays the onset of virus latency.', 10628807),
('Antiviral Chemical compound', 'BP008', 'The compound reduced the reporter expression of the HCV1b replicon with a 50% effective concentration (EC(50)) and selective index value of 4.1 ? 0.7 nM and >12,195, respectively.', '', 'Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor. Hepatitis C virus (HCV) is a global health problem, affecting approximately 3% of the world''s population.', 22006008),
('Antiviral Chemical compound', '2,6-difluoro analogue (4r)', 'With potent antiviral activity (IC50 = 0.087 ? 0.002 microM)', 'Low cytotoxicity (CC50 = 90.6 ? 2.06 microM)', 'Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation. The subsequent SAR study and drug-like optimization resulted in the discovery of the lead candidate 4r, with potent antiviral activity (IC50 = 0.087 ? 0.002 microM), low cytotoxicity (CC50 = 90.6 ? 2.06 microM), sensitivity to nucleoside analogue-resistant HBV mutants, and synergistic effect with nucleoside analogues in HepG2.2.15 cells.', 27989113),
('Antiviral Chemical compound', '4-{[4-({(3R)-1-Butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5dioxo-1,4,9-triazaspiro [5.5]undec-9-yl}methyl)phenyl]oxy}benzoic acid hydrochloride (873140)', 'A potent allosteric noncompetitive HIV entry inhibitor', '', 'The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor.', 15644495),
('Antiviral Chemical compound', 'Furanyl-containing analog UC10, UC040, UC82, and UC781', 'The most potent inhibitor of human immunodeficiency virus type 1 (HIV-1) replication and a promising candidate for further development.', '', 'From these studies, the furanyl-containing analog UC10 was identified as the most potent inhibitor of human immunodeficiency virus type 1 (HIV-1) replication and a promising candidate for further development.', 9087499),
('Antiviral Chemical compound', 'Dihydrotriazolopyrimidine derivative, hybrid molecules 36 and 37', 'Compound 36 that emerged as the most potent PA-PB1 interaction inhibitor (IC50 = 1.1 microM) among all the small molecules reported so far.', '', 'A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits. Very interesting results were obtained with the hybrid molecules 36 and 37, designed by merging some peculiar structural features known to impart PA-PB1 interaction inhibition, with compound 36 that emerged as the most potent PA-PB1 interaction inhibitor (IC50 = 1.1 microM) among all the small molecules reported so far.', 25856229),
('Antiviral Chemical compound', 'Inhibitors (compounds 1 and 2) of malarial aspartyl protease, plasmepsin-II', 'compounds 1 and 2 show promising inhibitory activity against HIV-1 protease variants and hence are good candidates for further development to enhance their potency against NL4-3 as well as MDR HIV-1 protease variants.', '', 'Two potent inhibitors (compounds 1 and 2) of malarial aspartyl protease, plasmepsin-II, were evaluated against wild type (NL4-3) and multidrug-resistant clinical isolate 769 (MDR) variants of human immunodeficiency virus type-1 (HIV-1) aspartyl protease.', 22469467),
('Antiviral Chemical compound', '5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide analogues', 'These compounds satisfy two structural requirements known for potent inhibition of HIV-1 IN catalysis: a metal chelating moiety and a hydrophobic functionality necessary for selectivity against the strand transfer reaction.', '', 'Design and discovery of 5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide inhibitors of HIV-1 integrase. Most of the new compounds described herein are potent and selective for the strand transfer reaction and show antiviral activity in cell-based assays.', 25150089),
('Antiviral Chemical compound', 'UV-4 or N-(9-methoxynonyl)-1-deoxynojirimycin', 'UV-4, and its hydrochloride salt known as UV-4B, is highly potent against dengue virus in vitro and promotes complete survival in a lethal dengue virus mouse model.', 'UV-4 treatment did not affect the development of protective antibody responses after either influenza infection or vaccination', 'In vivo therapeutic protection against influenza A (H1N1) oseltamivir-sensitive and resistant viruses by the iminosugar UV-4. Our lead iminosugar analog called UV-4 or N-(9-methoxynonyl)-1-deoxynojirimycin inhibits activity of endoplasmic reticulum (ER) ?-glucosidases I and II and is a potent, host-targeted antiviral candidate.', 25786028),
('Antiviral Chemical compound', 'Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine', 'Alkoxyalkyl esters of (S)-HPMPA were 6 to 20 times more active than unmodified (S)-HPMPA on the basis of their 50% effective concentrations in 2.2.15 cells.', '', 'Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine are potent and selective inhibitors of hepatitis B virus (HBV) replication in vitro and in HBV transgenic mice in vivo. Alkoxyalkyl esters of acyclic nucleoside phosphonates have previously been shown to have increased antiviral activity when they are administered orally in animal models of viral diseases, including lethal infections with vaccinia virus, cowpox virus, ectromelia virus, murine cytomegalovirus, and adenovirus. 9-(S)-(3-Hydroxy-2-phosphonomethoxypropyl)adenine [(S)-HPMPA] was previously shown to have activity against hepatitis B virus (HBV) in vitro.', 19398648),
('Antiviral Chemical compound', 'S/GSK1349572', 'Inhibited HIV replication with low-nanomolar or subnanomolar potency and with a selectivity index of 9,400.', '', 'In Vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitor. S/GSK1349572 is a next-generation HIV integrase (IN) inhibitor designed to deliver potent antiviral activity with a low-milligram once-daily dose requiring no pharmacokinetic (PK) booster.', 21115794),
('Antiviral Chemical compound', 'BMS-790052', 'Inhibits hybrid replicons containing HCV genotype-4 NS5A genes with 50% effective concentrations (EC(50)s) ranging from 7 to 13 pM.', '', 'In vitro activity of BMS-790052 on hepatitis C virus genotype 4 NS5A. The antiviral profile of BMS-790052, a potent hepatitis C virus (HCV) replication complex inhibitor targeting nonstructural protein NS5A, is well characterized for HCV genotype-1.', 22203595),
('Antiviral Chemical compound', 'PSI-352938', 'The effective concentration required to achieve 50% inhibition for PSI-352938, determined using genotype 1a-, 1b-, and 2a-derived replicons stably expressed in the Lunet cell line, were 0.20, 0.13, and 0.14 microM, respectively.', '', 'Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of ?-D-2''-deoxy-2''-?-fluoro-2''-?-C-methylguanosine. PSI-352938 is a novel cyclic phosphate prodrug of ?-D-2''-deoxy-2''-?-fluoro-2''-?-C-methylguanosine 5''-monophosphate that has potent activity against hepatitis C virus (HCV) in vitro.', 21444700),
('Antiviral Chemical compound', 'Cepharanthine hydrochloride (CH)', 'CH inhibited replication and HBeAg production by either wild-type or lamivudine-resistant HBV clinical isolates in a dose-dependent manner', '', 'In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates. Cepharanthine hydrochloride (CH), a natural alkaloid-derived compound, has been reported to possess potent activity against various viruses.', 22387093),
('Antiviral Chemical compound', 'TMC125', 'In high-MOI experiments, 1 muM TMC125 completely inhibited the breakthrough of resistant virus from wild-type and NNRTI-resistant HIV-1, in contrast to efavirenz and nevirapine.', '', 'TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments. TMC125 is a potent new investigational nonnucleoside reverse transcriptase inhibitor (NNRTI) that is active against human immunodeficiency virus type 1 (HIV-1) with resistance to currently licensed NNRTIs.', 16188980),
('Antiviral Chemical compound', 'BI 207127', 'Rapid virological response (RVR; HCV RNA <15 IU/ml) at day 28 occurred in 11/19 TN and 4/30 TE patients treated with BI 207127.', 'BI 207127 in combination with PegIFN/RBV demonstrated strong antiviral activity with a favourable safety and tolerability profile. The best benefit/risk ratio was observed at 600 mg.', 'Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin. BACKGROUND & AIMS: BI 207127 is a potent non-nucleoside hepatitis C virus (HCV) NS5B polymerase inhibitor in vitro.', 22414766),
('Antiviral Chemical compound', '1-[2-(2-Benzoyl- and 2-benzylphenoxy)ethyl]uracils', 'The candidate compounds can be regarded as potential lead compounds against the wild-type virus and drug-resistant forms.', '', '1-[2-(2-Benzoyl- and 2-benzylphenoxy)ethyl]uracils as potent anti-HIV-1 agents. Non-nucleoside reverse transcriptase inhibitors (NNRTI) are key components in highly active antiretroviral therapy for treating HIV-1.', 21903401),
('Antiviral Chemical compound', 'PSI-353661, a phosphoramidate prodrug of 2''-deoxy-2''-fluoro-2''-C-methylguanosine-5''-monophosphate', 'PSI-352666 is equally active against wild-type NS5B and NS5B containing the S282T amino acid alteration.', '', 'Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661.', 21600932),
('Antiviral Chemical compound', 'Spiroadamantane amine (3)', 'Inhibits both the M2-WT and M2-V27A mutant with IC50 values of 18.7 and 0.3 microM, respectively', '', 'An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses. Adamantanes such as amantadine (1) and rimantadine (2) are FDA-approved anti-influenza drugs that act by inhibiting the wild-type M2 proton channel from influenza A viruses, thereby inhibiting the uncoating of the virus.', 28087313),
('Antiviral Chemical compound', 'N-[4-Chloro-3-(3-methyl-2-butenyloxy)phenyl]-2-methyl-3-furanca rbothioamide (UC781)', '1:1 molar combination of UC781 and 3''-azido-3''-deoxythymidine (AZT) showed high-level synergy in inhibiting the replication of AZT-resistant virus, implying that UC781 can restore antiviral activity to AZT against AZT-resistant HIV-1.', '', 'The thiocarboxanilide nonnucleoside inhibitor UC781 restores antiviral activity of 3''-azido-3''-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus type 1. N-[4-Chloro-3-(3-methyl-2-butenyloxy)phenyl]-2-methyl-3-furanca rbothioamide (UC781) is an exceptionally potent nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.', 9925515),
('Antiviral Chemical compound', 'Analogues of the dicaffeoylquinic acids (DCQAs) and dicaffeoyltartaric acids (DCTAs) [D-chicoric acid, meso-chicoric acid, bis(3,4-dihydroxydihydrocinnamoyl)-L-tartaric acid, digalloyl-L-tartaric acid, bis(3,4-dihydroxybenzoyl)-L-tartaric acid, dicaffeoylglyceric acid, and bis(3, 4-dihydroxyphenylacetyl)-L-tartaric acid]', 'Seventeen of the 34 analogues had potent activity against HIV-1 integrase ranging from 0. 07 to >10 microM.', '', 'Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.', 9986720),
('Antiviral Chemical compound', 'N-acyl azacyclic ureas (II)', 'The extensive SAR study has yielded a series of N-acyl azacyclic ureas (II), which are highly potent against both wild-type and multiple PI-resistant viral strains.', '', 'Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strains. As part of our efforts to identify potent HIV-1 protease inhibitors that are active against resistant viral strains, structural modification of the azacyclic urea (I) was undertaken by incorporating acyl groups as P(1)'' ligands.', 16203141),
('Antiviral Chemical compound', 'Benzylpyridinones Compounds 14, 19, and 27', 'IC(50) values ranging from 0.2 to 6 nM', '', 'Synthesis and antiviral activity of 4-benzyl pyridinone derivatives as potent and selective non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors. Several 4-benzyl analogues of 5-ethyl-6-methyl-4-(phenylthio)pyridin-2(1H)-ones were synthesized and evaluated for their anti-HIV-l activities.', 11052800),
('Antiviral Chemical compound', 'Monosubstituted 5''-O-fatty acyl derivatives of 3TC', 'The monosubstituted 5''-O-fatty acyl derivatives of 3TC (EC(50) = 0.2-2.3 microM) were more potent than the corresponding monosubstituted N(4)-fatty acyl (EC(50) = 0.4-29.4 microM) and 5''-O-N(4)-disubstituted (EC(50) = 72.6 to >154.0 microM) derivatives of the nucleoside. 5''-O-Myristoyl (16) and 5''-O-12-azidododecanoyl derivatives (17) were found to be the most potent compounds (EC(50) = 0.2-0.9 microM) exhibiting at least 16-36-fold higher anti-HIV activity against cell-free virus than 1 (EC(50) = 11.4-32.7 microM).', '', 'Synthesis and biological evaluation of fatty acyl ester derivatives of (-)-2'',3''-dideoxy-3''-thiacytidine. A number of fatty acyl derivatives of (-)-2'',3''-dideoxy-3''-thiacytidine (lamivudine, 3TC, 1) were synthesized and evaluated for their anti-HIV activity. ', 22533850),
('Antiviral Chemical compound', 'Beta-d-3''-fluoro-2'',3''-unsaturated nucleosides', 'd-3''-fluoro-2'',3''-unsaturated nucleosides against HIV-1 in human peripheral blood mononuclear cells, from which we found that the cytosine derivative 26 was the most potent among the synthesized compounds.', '', 'Synthesis, structure-activity relationships, and drug resistance of beta-d-3''-fluoro-2'',3''-unsaturated nucleosides as anti-HIV Agents. Our recent studies demonstrated that d- and l-2''-fluoro-2'',3''-unsaturated nucleosides (d- and l-2''-F-d4Ns) display moderate to potent antiviral activities against HIV-1 and HBV.', 15189036),
('Antiviral Chemical compound', 'T-1249', 'Antiretroviral activity, as measured by levels of HIV-1 RNA, was not predicted by baseline susceptibility to T-1249 or to ENF; genotypic substitutions that emerged during T-1249 treatment were identified in virus from some patients', '', 'T-1249 retains potent antiretroviral activity in patients who had experienced virological failure while on an enfuvirtide-containing treatment regimen. BACKGROUND: T-1249 is a 39-amino acid synthetic peptide fusion inhibitor (FI) shown to preserve antiretroviral activity in vitro against human immunodeficiency virus (HIV) isolates that have decreased susceptibility to enfuvirtide (ENF).', 15747252),
('Antiviral Chemical compound', 'Peramivir conjugates 8 and 9', 'Thus, conjugates 8 and 9 offer better effect to protect MDCK cells from infection of H275Y virus with low EC50 value (?17 nM)', '', 'The C2-OH group of peramivir is elaborated to link with caffeate derivatives, giving the desired conjugates 8 and 9 that possess potent NA inhibitory activity against both wild-type and H275Y viruses with the IC50 values in nanomolar range.', 29324342),
('Antiviral Chemical compound', 'BMS-986001', 'BMS-986001 inhibited HIV-2 isolates from treatment-naive individuals, with 50% effective concentrations (EC50s) ranging from 30 to 81 nM', '', 'The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1.', 26392486),
('Antiviral Chemical compound', '(E)-5-(2-bromovinyl)-2''-deoxyuridine (BVDU)', 'The phosphoramidate derivatives of BVDU that contain L-alanine exhibited potent anti herpes simplex virus type 1 and varicella-zoster virus activity but lost marked activity against thymidine kinase-deficient virus strains.', '', 'The phosphoramidate derivatives of BVDU that contain L-alanine exhibited potent anti herpes simplex virus type 1 and varicella-zoster virus activity but lost marked activity against thymidine kinase-deficient virus strains.', 11900348),
('Antiviral Chemical compound', 'PF-00868554', 'EC(50) of 0.059 microM', '', 'Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase. Our results indicate that PF-00868554 has potent in vitro antiviral activity against a majority (95.8%) of genotype 1a and 1b replicons, with an overall mean EC(50) of 0.059 microM.', 19307358),
('Antiviral Chemical compound', 'Betulinic acid derivative IC9564', 'IC9564 blocked HIV type 1 (HIV-1) envelope-mediated membrane fusion.', '', 'Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564. The betulinic acid derivative IC9564 is a potent anti-human immunodeficiency virus (anti-HIV) compound that can inhibit both HIV primary isolates and laboratory-adapted strains.', 11120945),
('Antiviral Chemical compound', 'Several 3-(2-methylfuranyl)- and 3-(2-methylthienyl)-thiocarboxanilide ester, (thio)ether, and oxime ether derivatives UC-82', '50% effective concentration, 0.009 to 0.021 microM and 0.015 to 0.021 microM respectively', '', 'Several 3-(2-methylfuranyl)- and 3-(2-methylthienyl)-thiocarboxanilide ester, (thio)ether, and oxime ether derivatives showed exquisitely potent antiviral activity against wild-type HIV-1 (50% effective concentration, 0.009 to 0.021 microM).', 8726019),
('Antiviral Chemical compound', 'Spirodiketopiperazine (SDP) derivative, AK602/ONO4128/GW873140', '50% inhibitory concentration values of 0.1 to 0.6 nM', '', 'Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro. ', 15280474),
('Antiviral Chemical compound', '2-chloro-8-phenylthiomethyl analogue 37', 'Displayed sub-100 nM activity against all HIV-1 RT enzymes tested.', '', 'Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 8. 8-Aryloxymethyl- and 8-arylthiomethyldipyridodiazepinones. The most potent compound was 2-chloro-8-phenylthiomethyl analogue 37 which displayed sub-100 nM activity against all HIV-1 RT enzymes tested.', 9685236),
('Antiviral Chemical compound', '1,2,3-Triazole; 4-Oxoquinoline', 'Oxoquinoline derivative 1i with an EC50 of 0.2 microM', '', 'Oxoquinoline derivative 1i was the most potent compound within this series, inhibiting 94% of wild-type (WT) influenza neuraminidase (NA) activity.', 26643220),
('Antiviral Chemical compound', 'BMS-232632', '50% effective concentration [EC(50)], 2.6 to 5.3 nM; EC(90), 9 to 15 nM', '', 'In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632.', 10952574),
('Antiviral Chemical compound', '5-chloro- or 5-bromo-3-[(3,5-dimethylphenyl)sulfonyl]indole-2-carboxyamide', 'Very potent and selective anti-HIV-1 activity against some mutants carrying NNRTI resistant mutations at positions 103 and 181 of the reverse transcriptase.', '', 'Indolyl aryl sulfones (IASs): development of highly potent NNRTIs active against wt-HIV-1 and clinically relevant drug resistant mutants.', 16305512),
('Antiviral Chemical compound', 'NITD008', 'In cell culture, the compound inhibits EV71 at a 50% effective concentration of 0.67 microM and a 50% cytotoxic concentration of 119.97 microM.', '', 'Inhibition of enterovirus 71 by adenosine analog NITD008. Here we report that NITD008 has potent antiviral activity against EV71.', 25100827),
('Antiviral Chemical compound', 'Tetra-O-glycyl-NDGA (G(4)N)', 'In yield reduction assays, G(4)N inhibited replication of laboratory and clinical strains of wild type HSV-1 and ACV-resistant (HSV-1(R)) strains of HSV-1 in a dose-dependent manner, with average IC(50) values of 4.7 and 3.2 microM against wild-type and HSV-1(R) strains, respectively.', '', 'Inhibition of HSV-1 replication and reactivation by the mutation-insensitive transcription inhibitor tetra-O-glycyl-nordihydroguaiaretic acid. Methylated derivatives of nordihydroguaiaretic acid (NDGA)were previously shown to be potent mutation-resistant inhibitors of herpes simplex virus type 1 (HSV-1) which target Sp1 protein binding to critical viral promoters.', 12719005),
('Antiviral Chemical compound', 'Maraviroc (UK-427,857)', 'Maraviroc was active against 200 clinically derived HIV-1 envelope-recombinant pseudoviruses, 100 of which were derived from viruses resistant to existing drug classes.', '', 'Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Maraviroc (UK-427,857) is a selective CCR5 antagonist with potent anti-human immunodeficiency virus type 1 (HIV-1) activity and favorable pharmacological properties.', 16251317),
('Antiviral Chemical compound', '(-)-Beta-D-1'',3''-Dioxolane guanosine (DXG) and 2,6-diaminopurine (DAPD) dioxolanyl nucleoside', 'In cellular toxicity analyses, DXG and DAPD had 50% cytotoxic concentrations of greater than 500 microM when tested in peripheral blood mononuclear cells and a variety of human tumor and normal cell lines', '', 'Mechanism of action and in vitro activity of 1'',3''-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants. (-)-Beta-D-1'',3''-Dioxolane guanosine (DXG) and 2,6-diaminopurine (DAPD) dioxolanyl nucleoside analogues have been reported to be potent inhibitors of human immunodeficiency virus type 1 (HIV-1).', 10508010),
('Antiviral Chemical compound', '(-)-(2R,4R)-1-(2-Hydroxymethyl-1,3-dioxolan-4yl)thymine (DOT)', 'Has potent in vitro activity against wild-type and nucleoside reverse transcriptase inhibitor (NRTI)-resistant HIV.', '', 'Mechanism of action of (-)-(2R,4R)-1-(2-hydroxymethyl-1,3-dioxolan-4-yl) thymine as an anti-HIV agent. (-)-(2R,4R)-1-(2-Hydroxymethyl-1,3-dioxolan-4yl)thymine (DOT) is a thymidine analogue that has potent in vitro activity against wild-type and nucleoside reverse transcriptase inhibitor (NRTI)-resistant HIV.', 17542153),
('Antiviral Chemical compound', 'MIV-150 with zinc acetate (ZA)', 'While less potent than NNRTIs, ZA was shown to be active in primary cells against laboratory-adapted and primary HIV-1 isolates and HIV-1 isolates/clones with NNRTI and RT resistance mutations, with EC50 values between 20 and 110 microM.', '', 'MIV-150 and zinc acetate combination provides potent and broad activity against HIV-1. We previously showed that the combination of the non-nucleoside reverse transcriptase inhibitor (NNRTI) MIV-150 with zinc acetate (ZA) formulated in a carrageenan (CG; MZC) gel provided macaques significant protection against vaginal simian-human immunodeficiency virus-RT (SHIV-RT) challenge, better than either MIV-150/CG or ZA/CG.', 28812250),
('Antiviral Chemical compound', 'GS-5806', '[EC50] = 0.43 nM', '', 'In summary, GS-5806 is a potent and selective RSV fusion inhibitor with antiviral activity against a diverse set of RSV clinical isolates.', 26666922),
('Antiviral Chemical compound', 'ca603', 'ca603 inhibits rhinovirus replication by interaction with the VP1 protein and, by this, allows to further expand the chemical diversity of capsid-binding molecules.', '', 'In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses. BACKGROUND: Rhinovirus infections do not only cause common colds, but may also trigger severe exacerbations of asthma and chronic obstructive pulmonary disease (COPD). It is confirmed that ca603 inhibits rhinovirus replication by interaction with the VP1 protein and, by this, allows to further expand the chemical diversity of capsid-binding molecules.', 26169596),
('Antiviral Chemical compound', 'D- and L-2'',3''-didehydro-2'',3''-dideoxy-3''-fluoro-carbocyclic nucleosides', 'Among the synthesized L-series nucleosides, compounds 18, 19, 26 and 28 exhibited moderate antiviral activity (EC50 7.1 microM, 6.4 microM, 10.3 microM, and 20.7 microM, respectively), while among the D-series, the guanosine analogue (35, D-3''-F-C-d4G) exhibited the most potent anti-HIV activity (EC50 0.4 microM, EC90 2.8 microM)', '', 'Among the synthesized L-series nucleosides, compounds 18, 19, 26 and 28 exhibited moderate antiviral activity (EC50 7.1 microM, 6.4 microM, 10.3 microM, and 20.7 microM, respectively), while among the D-series, the guanosine analogue (35, D-3''-F-C-d4G) exhibited the most potent anti-HIV activity (EC50 0.4 microM, EC90 2.8 microM).', 17373782),
('Antiviral Chemical compound', '3''-fluoro-3''-deoxythymidine (FLT)', 'IC(50) values for FLT of 0.0014-0.0168 microM', '', 'Anti-HIV type 1 activity of 3''-fluoro-3''-deoxythymidine for several different multidrug-resistant mutants. The objective of this work was to test the antiviral activity of a potent nucleoside reverse transcriptase inhibitor, 3''-fluoro-3''-deoxythymidine (FLT), on both a wild-type human immunodeficiency virus (HIV-1) isolate and multidrug-resistant HIV-1 patient isolates.', 11282008),
('Antiviral Chemical compound', 'Bicyclam derivative JM3100', 'JM3100 exhibits anti-HIV potency at concentrations ranging from 0.001 to 0.01 micrograms/ml', '', 'Antiviral activity of the bicyclam derivative JM3100 against drug-resistant strains of human immunodeficiency virus type 1. Bicyclams have recently been identified as potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) replication.', 8739608),
('Antiviral Chemical compound', 'BMS-955176', 'BMS-955176 exhibits potent activity (50% effective concentration [EC50], 3.9 +/- 3.4 nM ) toward a library (n = 87) of gag/pr recombinant viruses representing 96.5% of subtype B polymorphic Gag diversity near the CA/SP1 cleavage site.', '', 'BMS-955176 exhibits potent activity (50% effective concentration [EC50], 3.9 ? 3.4 nM [mean ? standard deviation]) toward a library (n = 87) of gag/pr recombinant viruses representing 96.5% of subtype B polymorphic Gag diversity near the CA/SP1 cleavage site.', 27090171),
('Antiviral Chemical compound', 'CGP 53437', 'The replication of HIV-1/LAV, HIV-1/Z-84, and HIV-1/pLAI was inhibited with a 90% effective dose of 0.1 microM in acutely infected MT-2 cells.', 'The 50% cytotoxic dose was 100 microM.', 'CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity. CGP 53437 is a peptidomimetic inhibitor of human immunodeficiency virus type 1 (HIV-1) protease containing a hydroxyethylene isostere.', 8257128),
('Antiviral Chemical compound', 'hexadecyloxypropyl-(S)-HPMPA [HDP-(S)-HPMPA] and octadecyloxyethyl-(S)-HPMPA [ODE-(S)-HPMPA]', 'Ec50 is 0.4 to 0.7 nanomolar, active against HIV variants', '', 'Alkoxyalkyl esters of (S)-9-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine are potent inhibitors of the replication of wild-type and drug-resistant human immunodeficiency virus type 1 in vitro.', 16870786),
('Antiviral Chemical compound', 'A titanium containing polyoxotungstate, PM-523 and vanadium substituted polyoxotungstate, PM-1001', 'PM-523 exhibited potent anti-influenza virus (FluV) A and anti-respiratory syncytial virus (RSV). PM-1001 has antiviral activity against FluV A, RSV, parainfluenza virus (PfluV) type 2, Dengue fiver virus, HIV-1 and SARS coronavirus in vitro.', '', 'A titanium containing polyoxotungstate, PM-523 exhibited potent anti-influenza virus (FluV) A and anti-respiratory syncytial virus (RSV) activities in vitro.', 16737794),
('Antiviral Chemical compound', 'Compound-13 (P1-substituted HIV PIs)', 'Compound 13 demonstrated the best balance of potency against drug resistant strains of HIV', '', 'A series of HIV protease inhibitors (PIs) with potent activity against both wild-type (WT) virus and drug-resistant strains of HIV was designed and synthesized.', 21899332),
('Antiviral Chemical compound', 'Compound 2, a copper(I)-catalyzed 1,2,3-triazole derivative', 'IC 50 = 6.0 nM and 15.7 nM against wild -type protease and ultidrug-resistant 6X protease mutant respectively.', '', 'A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant. Treatment with HIV-1 protease inhibitors, a component of highly active antiretroviral therapy (HAART), often results in viral resistance.', 18823110),
('Antiviral Chemical compound', '2''-deoxy-4''-C-ethynyl-2-fluoroadenosine', 'Potent to all human immunodeficiency viruses type 1 (HIV-1s) including multidrug-resistant HIV-1 and has a low toxicity', '', '2''-deoxy-4''-C-ethynyl-2-fluoroadenosine, a nucleoside reverse transcriptase inhibitor, is highly potent against all human immunodeficiency viruses type 1 and has low toxicity. An idea to use 4''-C-substituted-2''-deoxynucleoside derivatives was proposed based on a working hypothesis to solve the problems of existing acquired immune deficiency syndrome chemotherapy (highly active antiretroviral therapy).', 16795005),
('Antiviral Chemical compound', '\nNcRTIs (compound A)', 'Treatment of infections with K65R substitution-containing HIV-1 viruses', '', 'Subtype-specific analysis of the K65R substitution in HIV-1 that confers hypersusceptibility to a novel nucleotide-competing reverse transcriptase inhibitor. Compound A is a novel nucleotide-competing HIV-1 reverse transcriptase (RT) inhibitor (NcRTI) that selects for a unique W153L substitution that confers hypersusceptibility to tenofovir, while the K65R substitution in RT confers resistance against tenofovir and enhances susceptibility to NcRTIs.', 25779585),
('Antiviral Chemical compound', 'Apricitabine (ATC)', 'Promising antiviral activity and effective treatment-experienced patients with M184V', '', 'Antiviral activity of apricitabine in treatment-experienced HIV-1-infected patients with M184V who are failing combination therapy. Apricitabine (ATC) is a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor (NRTI) with significant antiviral activity in vitro, including activity against HIV-1 with reverse transcriptase mutations that confer resistance to other NRTIs.', 21054750),
('Antiviral Chemical compound', 'Calanolide A, costatolide, and dihydrocostatolide', 'Anti-HIV', '', 'The calanolide isomers represent a novel and distinct subgroup of the NNRTI family, and these data suggest that a compound of the calanolide A series, such as costatolide, should be evaluated further for therapeutic use in combination with other anti-HIV agents.', 10428899),
('Antiviral Chemical compound', 'WPR-6 : 1-[(benzyloxy)methyl]-6-(3,5-dimethylbenzyl)-5-iodopyrimidine-2,4(1H,3H)-dione', 'EC50 of 2 to 4nM against laboratory-adapted HIV-1 strain SF33 and an EC50 of 7 to 14 nM against nucleoside reverse transcriptase inhibitor-resistant HIV-1 strain 7391.', '', 'The HEPT Analogue WPR-6 Is Active against a Broad Spectrum of Nonnucleoside Reverse Transcriptase Drug-Resistant HIV-1 Strains of Different Serotypes', 26055365),
('Antiviral Chemical compound', 'Pleconaril variants with F, Cl, Br, CH3, OH and aromatic ring substitutions', 'Pleconaril variants with F, Cl, Br, CH3, OH and aromatic ring substitutions were shown to be effective alternatives to Oseltamivir as anti influenza drugs.', '', 'In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain. Neuraminidase (NA) is a prominent surface antigen of Influenza viruses, which helps in release of viruses from the host cells after replication.', 22340192),
('Antiviral Chemical compound', 'PF-00868554, non-nucleoside inhibitor (NNI)', 'Activity against hepatitis C virus', '', 'The obtained computational results will have important value for the rational design of novel non-nucleoside inhibitors targeting HCV NS5B polymerase.', 24452008),
('Antiviral Chemical compound', 'TBZE-029 {1-(2,6-difluorophenyl)-6-trifluoromethyl-1H,3H-thiazolo[3,4-a]benzimidazole}', 'Inhibits enterovirus replication', '', 'The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C.', 18337578),
('Antiviral Chemical compound', 'Morus alba germin-like protein', 'Silkworm fecal matter is considered one of the richest sources of antimicrobial and antiviral protein (substances)', '', 'Molecular cloning and characterization of novel Morus alba germin-like protein gene which encodes for a silkworm gut digestion-resistant antimicrobial protein. Silkworm fecal matter is considered one of the richest sources of antimicrobial and antiviral protein (substances) and such economically feasible and eco-friendly proteins acting as secondary metabolites from the insect system can be explored for their practical utility in conferring broad spectrum disease resistance against pathogenic microbial specimens.', 23284650),
('Antiviral Chemical compound', 'BP13944', 'BP13944 reduced the expression of the DENV replicon reporter in cells, showing a 50% effective concentration (EC50) of 1.03 +/- 0.09 microM.', '', 'A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease. Dengue virus (DENV) causes disease globally, resulting in an estimated 25 to 100 million new infections per year.', 24145533),
('Antiviral Chemical compound', 'Arylthio isopropyl pyridinylmethylpyrrolemethanols (AThPs)', 'Docking experiments of the potent inhibitors 4k (IC(50) = 0.24 microM, SI = 167) and 5e (IC(50) = 0.11 microM, SI > 1667) of wild-type RT prompted the synthesis and biological evaluation of novel AThP derivatives featuring a number of polar groups in position 3 of the pyrrole ring and larger and more hydrophobic alicyclic substituents in place of the isopropyl group at position 4.', '', 'Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies', 17089434),
('Antiviral Chemical compound', 'KINK-20, a synthetic phosphocholine lipid-AZT conjugate', 'EC50 values were 0.01 and 0.03 microM for INK-20 and 0.0005 and 0.33 microM for AZT, respectively.', '', 'Synthesis and evaluation of a novel synthetic phosphocholine lipid-AZT conjugate that double-targets wild-type and drug resistant variants of HIV.', 15043162),
('Antiviral Chemical compound', 'N(4)-octyl-6,6-dimethyl-N(2)-(4-methylbenzyl)-1,6-dihydro-1,3,5-triazine-2,4-diamine (HM-242)', 'Potent virucidal activity against enveloped viruses such as influenza virus and herpes simplex virus.', '', 'The antimicrobial activities of N(4)-octyl-6,6-dimethyl-N(2)-(4-methylbenzyl)-1,6-dihydro-1,3,5-triazine-2,4-diam ine (HM-242), a novel synthetic compound, were compared with those of chlorhexidine gluconate (CHG).', 19575042),
('Antiviral Chemical compound', 'Alcian Blue (AB)', 'Novel synthetic nonpeptidic antiviral drugs targeting the glycans of the envelope of HIV.', '', 'These data suggest that AB is likely endowed with carbohydrate-binding properties and can be considered an important lead compound in the development of novel synthetic nonpeptidic antiviral drugs targeting the glycans of the envelope of HIV.', 19721061),
('Antiviral Chemical compound', 'Indolocarbazole compounds, G?6976 and NGIC-I', 'Indolocarbazole compounds are potent pUL97 inhibitors and, therefore, represent novel candidates for antiviral drugs that target viral protein kinase functions', '', 'Based on the phosphorylation of ganciclovir (GCV), a novel quantification system for pUL97 kinase activity was established: the phosphorylated form of GCV exerts an easily quantifiable cytotoxic effect in transfected cells.', 11369889),
('Antiviral Chemical compound', 'Sho-seiryu-to (SST)', 'SST is a novel compund with potential as an anti-HCMV.', '', 'These results suggest that SST is a novel compund with potential as an anti-HCMV.', 16542001),
('Antiviral Chemical compound', 'lersivirine (UK-453,061)', 'Binds the RT enzyme in a novel way (resulting in a unique resistance profile), inhibits over 60% of viruses bearing key RT mutations, with 50% effective concentrations (EC(50)s) within 10-fold of those for wt viruses, and has excellent selectivity against a range of human targets.', '', 'The emerging candidate, lersivirine (UK-453,061), binds the RT enzyme in a novel way (resulting in a unique resistance profile), inhibits over 60% of viruses bearing key RT mutations, with 50% effective concentrations (EC(50)s) within 10-fold of those for wt viruses, and has excellent selectivity against a range of human targets.', 20660667),
('Antiviral Chemical compound', 'Raoulic acid', 'raoulic acid was found to possess broad-spectrum antiviral activity against six HRVs with a 50% inhibition concentration of less than 9.5 microg/mL', '', 'Collectively, the results demonstrate that raoulic acid is a novel therapeutic candidate for two different groups of human rhinovirus.', 20412019);
INSERT INTO `all_data` (`THEME`, `ENTITY`, `EVIDENCE`, `SAFETY_INFORMATION`, `POTENCY`, `PMID`) VALUES
('Antiviral Chemical compound', 'Isothiafludine (NZ-4)', 'NZ-4 suppressed intracellular HBV replication in HepG2.2.15 cells with an IC?? value of 1.33 micromol/L, whereas the compound inhibited the cell viability with an IC?? value of 50.4 micromol/L.', '', 'Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation. To investigate the action of isothiafludine (NZ-4), a derivative of bis-heterocycle tandem pairs from the natural product leucamide A, on the replication cycle of hepatitis B virus (HBV) in vitro and in vivo.', 24487969),
('Antiviral Chemical compound', 'Benzenesulfonyl matrinane, 35d', 'Promising anti-enteroviral candidate for the treatment of various diseases infected with coxsackieviruses.', 'The optimized 35d showed the broad-spectrum anti-coxsackieviruse effects, an excellent pharmacokinetics and a good safety profile.', 'SAR evolution and discovery of benzenesulfonyl matrinanes as a novel class of potential coxsakievirus inhibitors.Fifty-one novel 12N-substituted matrinic acid derivatives were synthesized and evaluated for their anti-coxsackievirus B3 activities.', 26867658),
('Antiviral Chemical compound', 'THC19', 'THC19 acts at a relatively early stage of the viral lifecycle.', 'This compound had no cytotoxic effects and did not disrupt cell cycle progression or induce apoptosis in MDCK cells as confirmed by WST-1 assays, flow cytometry analysis, and caspase-3 assays.', 'Taken together, these results suggest that influenza virus PA protein is a potential target for, and may aid the development of, novel compounds that inhibit influenza A virus replication.', 22441116),
('Antiviral Chemical compound', 'R1479', 'Potent and highly selective inhibitor of nonstructural protein 5B-directed hepatitis C virus (HCV) replication in vitro.', 'No resistance to R1479 was observed after 14 days of treatment with R1626.', 'Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis C. The nucleoside analog R1479 is a potent and highly selective inhibitor of nonstructural protein 5B-directed hepatitis C virus (HCV) replication in vitro.', 18553458),
('Antiviral Chemical compound', 'Cyanovirin-N (CV-N)', 'CV-N and related homologs showed highly potent antiviral activity against almost all strains of influenza A and B virus, including clinical isolates and a neuraminidase inhibitor-resistant strain (EC(50) = 0.004 to 0.04 micro g/ml).', '', 'Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin. . The novel antiviral protein cyanovirin-N (CV-N) was initially discovered based on its potent activity against the human immunodeficiency virus (HIV).', 12878514),
('Antiviral Chemical compound', 'TTP-8307', 'A potent inhibitor of the replication of several rhino- and enteroviruses.', '', 'Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor T A novel compound, TTP-8307, was identified as a potent inhibitor of the replication of several rhino- and enteroviruses.', 19237651),
('Antiviral Chemical compound', 'VRX-480773', 'Inhibits viruses from efavirenz-resistant molecular clones and most NNRTI-resistant clinical HIV-1 isolates tested', '', 'In this study, we report a novel and potent NNRTI, VRX-480773, that inhibits viruses from efavirenz-resistant molecular clones and most NNRTI-resistant clinical HIV-1 isolates tested.', 17116677),
('Antiviral Chemical compound', 'Obatoclax', 'Active against alphaviruses, like chikungunya virus (50% effective concentration [EC50] = 0.03 microM) and Semliki Forest virus (SFV; EC50 = 0.11 microM).', '', 'In conclusion, obatoclax is a novel inhibitor of endosomal acidification that prevents viral fusion and that could be pursued as a potential broad-spectrum antiviral candidate.', 27993855),
('Antiviral Chemical compound', 'Benzodiazepine derivative (compound 7)', 'Compound 7 was validated as an inhibitor of infectious EBOV and Marburg virus (MARV) in cell-based assays, with 50% inhibitory concentrations (IC(50)s) of 10 microM and 12 microM, respectively.', '', 'In summary, we have identified a novel series of benzodiazepine compounds that are suitable for optimization as potential inhibitors of filoviral infection.', 21270170),
('Antiviral Chemical compound', '2-(2-benzimidazolyl)-5-[4-(2-imidazolino)phenyl]furan dihydrochloride (DB772)', 'Serum concentrations of DB772 sufficient to inhibit viral replication in calves PI with BVDV types 1 and 2', 'No adverse effects of DB772 administration were detected', 'The purpose of this research was to initiate evaluation of the pharmacokinetic and safety data of a novel antiviral agent in BVDV-free calves and to assess the antiviral efficacy of the same agent in PI calves.', 22182713),
('Antiviral Chemical compound', '4-guanidino-Neu5Ac2en, neuraminidase (NA)-specific inhibitor', 'The lowest resistance in cell culture was seen to zanamivir', '', 'The search for compounds with altered pharmacological properties has led to the identification of a novel series of influenza virus NA inhibitors in which the triol group of zanamivir has been replaced by a hydrophobic group linked by a carboxamide at the 6 position (6-carboxamide).', 9499107),
('Antiviral Chemical compound', 'SC93305', 'Highly effective not only against different HSV-1 and HSV-2 strains but also towards ACV- and multi-resistant HSV-1 and HSV-2 isolates', '', 'In the current study we present SC93305 as a novel potent antiviral substance that proved to be highly effective not only against different HSV-1 and HSV-2 strains but also towards ACV- and multi-resistant HSV-1 and HSV-2 isolates.', 29155164),
('Antiviral Chemical compound', 'GS-9160', 'GS-9160 has potent and selective antiviral activity in primary human T lymphocytes producing a 50% effective concentration (EC(50)) of approximately 2 nM, with a selectivity index (50% cytotoxic concentration/EC(50)) of approximately 2,000. The antiviral potency of GS-9160 decreased by 6- to 10-fold in the presence of human serum.', '', 'Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase. GS-9160 is a novel and potent inhibitor of human immunodeficiency virus type 1 (HIV-1) integrase (IN) that specifically targets the process of strand transfer. It is an authentic inhibitor of HIV-1 integration, since treatment of infected cells results in an elevation of two-long terminal repeat circles and a decrease of integration junctions.', 19104010),
('Antiviral Chemical compound', 'GS-9451', 'GS-9451 200 mg/day or 400 mg/day demonstrated potent antiviral activity in both HCV genotype 1a- and 1b-infected patients.', 'No resistance mutations were detected with GS-9451 60 mg/day.', 'A Phase I, randomized, placebo-controlled, 3-day, ascending-dose study of GS-9451, an NS3/4A protease inhibitor, in genotype 1 hepatitis C patients. GS-9451 is a novel inhibitor of the HCV NS3/4A protease and demonstrates potent in vitro suppression of HCV genotype 1 replicons.', 23047118),
('Antiviral Chemical compound', 'A-315675', 'Influenza virus neuraminidase (NA) inhibitor that has potent enzyme activity and is highly active in cell culture against a variety of strains of influenza A and B viruses.', '', 'A-315675 is a novel influenza virus NA inhibitor that has potent enzyme activity and is highly active in cell culture against a variety of strains of influenza A and B viruses.', 11991966),
('Antiviral Chemical compound', '(1S,2S,3R,4R)-3-[(1S)-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-h ydroxy-cyclopentanecarboxylic acid (RWJ-270201, BCX-1812)', 'The 50% effective concentration (EC(50)) values for RWJ-270201 against wild-type and resistant viruses, determined by using a cytopathic effect inhibition assay, were 0.007 and 23 microM, respectively.', '', 'Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.', 11675142),
('Antiviral Chemical compound', 'RD4-2217, thiadiazole (TDA) derivatives', 'It inhibited replication of the HTLV-IIIB strain in MT-4 cells at a concentration of 6 nM.', '', 'In an attempt to develop more effective and pharmacologically favorable compounds, novel TDA derivatives have been synthesized and examined for their anti-HIV-1 activity in vitro.', 9159403),
('Antiviral Chemical compound', 'KU-55933', 'Inhibitor of ATM kinase activity, capable of suppressing the replication of both wild-type and drug-resistant HIV-1', '', 'Here we show that the activity of HIV-1 integrase stimulates an ataxia-telangiectasia-mutated (ATM)-dependent DNA damage response, and that a deficiency of this ATM kinase sensitizes cells to retrovirus-induced cell death. Consistent with these observations, we demonstrate that a novel and specific small molecule inhibitor of ATM kinase activity, KU-55933, is capable of suppressing the replication of both wild-type and drug-resistant HIV-1.', 15834407),
('Antiviral Chemical compound', 'Cyclic urea amide, SD146', 'IC90 is 5.1 nM', '', 'Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV. Cyclic urea amides, a novel series of HIV-1 protease (HIV PR) inhibitors, have increased activity against drug-resistant mutants of the HIV PR.', 9003516),
('Antiviral Chemical compound', 'EDP-239', 'A single 100-mg dose of EDP-239 resulted in reductions in HCV genotype 1a viral RNA of >3 log10 IU/ml within the first 48 h after dosing and reductions in genotype 1b viral RNA of >4-log10 IU/ml within 96 h', '', 'Preclinical Profile and Clinical Efficacy of a Novel Hepatitis C Virus NS5A Inhibitor, EDP-239. EDP-239, a novel hepatitis C virus (HCV) inhibitor targeting nonstructural protein 5A (NS5A), has been investigated in vitro and in vivo EDP-239 is a potent, selective inhibitor with potency at picomolar to nanomolar concentrations against HCV genotypes 1 through 6.', 27503640),
('Antiviral Chemical compound', 'Benzimidazole Derivative (B5)', 'Inhibits the HCV life cycle by blocking virus entry', '', 'In conclusion, B5 is a novel interesting anti-HCV molecule that could be used to decipher the early steps of the HCV life cycle.IMPORTANCE: In the last 4 years, HCV therapy has been profoundly improved with the approval of direct-acting antivirals in clinical practice.', 27412600),
('Antiviral Chemical compound', 'Cyclosporin A (CsA) analog, CPI-431-32', 'As a single agent or in combination with DAAs, to inhibit both HCV and HIV-1 infections.', '', 'Using this co-culture model, we demonstrate that cyclophilin inhibitors (CypI), including a novel cyclosporin A (CsA) analog, CPI-431-32, simultaneously inhibits replication of both HCV and HIV-1 when added pre- and post-infection.', 26263487),
('Antiviral Chemical compound', 'SCH 900518 (narlaprevir)', 'EC(90)) of 40 nM', '', 'Preclinical characterization of the antiviral activity of SCH 900518 (narlaprevir), a novel mechanism-based inhibitor of hepatitis C virus NS3 protease. Small-molecule hepatitis C virus (HCV) NS3 protease inhibitors such as boceprevir (SCH 503034) have been shown to have antiviral activity when they are used as monotherapy and in combination with pegylated alpha interferon and ribavirin in clinical trials.', 20308381),
('Antiviral Chemical compound', 'N-(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives', 'EC50 is 0.228 microM', '', 'Viral infectivity factor (Vif) is protective against APOBEC3G (A3G)-mediated viral cDNA hypermutations, and development of molecules that inhibit Vif mediated A3G degradation is a novel strategy for blocking HIV-1 replication.', 28235704),
('Antiviral Chemical compound', 'Piperidinylamino-diarylpyrimidine (pDAPY) derivatives', 'EC50 = 0.047 and 4.6 microM against both wild-type and drug-resistant mutant virus strains (K103N+Y181C RT) of HIV-1', '', 'Exploring these hybrid molecules with dual binding conformations might provide optional chemical scaffolds as novel HIV-1 reverse transcriptase inhibitors (HIV-1 NNRTIs).', 24239481),
('Antiviral Chemical compound', 'Pleconaril, guanidine-HCl, and oxoglaucine (PGO)', 'Decreased infectious virus content', '', 'The most important achievement of our previous studies was the development of a novel scheme for in vivo application of a triple combination of EV inhibitors with different modes of action against Coxsackievirus B (CVB) infections in mice.', 26196747),
('Antiviral Chemical compound', 'Pyrrolobenzoxazepinones (PBOs) derivatives', 'Potent against the most common mutant enzymes, including the highly resistant K103N mutant strain.', '', 'Molecular modeling studies based on the X-ray structures of HIV-1 RT prompted the synthesis of novel analogues which were tested as anti-HIV agents.', 16279773),
('Antiviral Chemical compound', '8-hydroxyquinoline tetracyclic lactam', 'Antiviral activity against HIV-1', '', 'A novel series of HIV-1 integrase strand transfer inhibitors were designed using the venerable two-metal binding pharmacophore model and incorporating structural elements from two different literature scaffolds.', 27092410),
('Antiviral Chemical compound', 'Calix[4]arene-based ?-diketo derivatives', 'Inhibit strand transfer (ST) with IC50 values between 5.9 and 21.2 microM', '', 'Docking studies revealed the predominant binding modes that were distinct from the binding modes of raltegravir, which suggests a novel binding region in the IN active site.', 25682937),
('Antiviral Chemical compound', 'TMC114', 'EC50s of <10 nM', '', 'TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates. The purpose of this study was to characterize the antiviral activity, cytotoxicity, and mechanism of action of TMC114, a novel human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI).', 15917527),
('Antiviral Chemical compound', 'Leflunomide', 'Inhibits the production of multiple clinical CMV isolates (including multi-drug-resistant virus) in both human fibroblasts and endothelial cells.', '', 'These findings imply that leflunomide, an effective immunosuppressive agent, shows potential to concurrently attenuate a major complication of immunosuppression, CMV disease, by a novel mechanism of antiviral activity.', 10702725),
('Antiviral Chemical compound', 'AIC246 (Letermovir)', 'AIC246 blocks viral replication without inhibiting the synthesis of progeny HCMV DNA or viral proteins', '', 'The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.', 21752907),
('Antiviral Chemical compound', 'ACH-806', 'This compound was synergistic with NS3 protease inhibitors and NS5B nucleoside and nonnucleoside polymerase inhibitors.', '', 'ACH-806 is a hepatitis C virus NS4A inhibitor with a novel mechanism of action and resistance pathway.', 18332167),
('Antiviral Chemical compound', 'Alpha-hydroxy-glycineamide (alpha-HGA)', 'Inhibits the replication of clinical HIV-1 isolates with acquired resistance to reverse transcriptase and protease inhibitors', '', 'As an antiviral compound, alpha-HGA has an unusually simple structure, a pronounced antiviral specificity, and a novel mechanism of antiviral action.', 18644965),
('Antiviral Chemical compound', 'GRL-0739, a novel nonpeptidic HIV-1 protease inhibitor containing tricycle (cyclohexyl-bis-tetrahydrofuranylurethane [THF]) and a sulfonamide isostere', 'Highly active against laboratory HIV-1 strains and primary clinical isolates (50% effective concentration [EC50], 0.0019 to 0.0036 microM)', 'M, with minimal cytotoxicity (50% cytotoxic concentration [CC50], 21.0 microM)', 'A novel tricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor, GRL-0739, effectively inhibits the replication of multidrug-resistant HIV-1 variants and has a desirable central nervous system penetration property in vitro', 25691652),
('Antiviral Chemical compound', 'Pradimicin A (PRM-A)', 'It invariably inhibits representative virus strains of a variety of HIV-1 clades with X4 and R5 tropisms at nontoxic concentrations.', '', 'PRM-A represents the first prototype compound of a nonpeptidic CBA lead and, together with peptide-based lectins, belongs to a conceptually novel type of potential therapeutics for which drug pressure results in the selection of glycan deletions in the HIV gp120 envelope.', 17050611),
('Antiviral Chemical compound', 'GS-9451', 'In multiple GT1a and GT1b replicon cell lines, GS-9451 had mean 50% effective concentrations (EC50s) of 13 and 5.4 nM, respectively, with minimal cytotoxicity', '', 'Preclinical characterization of the novel hepatitis C virus NS3 protease inhibitor GS-9451. GS-9451 is a selective hepatitis C virus (HCV) NS3 protease inhibitor in development for the treatment of genotype 1 (GT1) HCV infection.', 23939899),
('Antiviral Chemical compound', 'MK-4519', '(EC(50)) of 1.8 nM and MK-4519 is highly active against genotype 1b HCV', '', 'Pharmacodynamic analysis of a serine protease inhibitor, MK-4519, against hepatitis C virus using a novel in vitro pharmacodynamic systemThe development of new antiviral compounds active against hepatitis C virus (HCV) has surged in recent years.', 22155837),
('Antiviral Chemical compound', '2'',3''-Didehydro-3''-deoxy-4''-ethynylthymidine (4''-Ed4T)', 'The purified RT of mutants with the P119S/M184V and T165A/M184V mutations were inhibited by 4''-Ed4TTP with 8- to 13-fold less efficiency than wild-type RT.', '', 'Impact of novel human immunodeficiency virus type 1 reverse transcriptase mutations P119S and T165A on 4''-ethynylthymidine analog resistance profile.2'',3''-Didehydro-3''-deoxy-4''-ethynylthymidine (4''-Ed4T), a derivative of stavudine (d4T), has potent activity against human immunodeficiency virus and is much less inhibitory to mitochondrial DNA synthesis and cell growth than its progenitor, d4T.', 19704131),
('Antiviral Chemical compound', 'Samatasvir (IDX719)', 'EC50s falling within a tight range of 2 to 24 pM in genotype 1 through 5 replicon. The EC90/EC50 ratio was low (2.6). A 50% cytotoxic concentration (CC50) of >100 microM provided a selectivity index of >5 ? 10(7)', '', 'In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus. The hepatitis C virus (HCV) nonstructural 5A (NS5A) protein is a clinically validated target for drugs designed to treat chronic HCV infection.', 24867983),
('Antiviral Chemical compound', 'H1PVAT', 'Inhibitor of poliovirus replication that targets VP1', '', 'A novel small molecule, H1PVAT, was identified as a potent and selective inhibitor of the in vitro replication of all three poliovirus serotypes, whereas no activity was observed against other enteroviruses.', 25043639),
('Antiviral Chemical compound', 'Azvudine', 'Highly potent inhibition on HIV-1 (EC(50)s ranging from 0.03 to 6.92 nanoM), HIV-2 (EC(50)s ranging from 0.018 to 0.025 nanoM) and NRTI-resistant strains (L74V and T69N).', '', 'Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro. Azvudine is a novel nucleoside reverse transcriptase inhibitor with antiviral activity on human immunodeficiency virus, hepatitis B virus and hepatitis C virus.', 25144636),
('Antiviral Chemical compound', 'BPR2-D2', 'BPR2-D2 exhibited an excellent antiviral efficacy for the oseltamivir-resistant virus (EC(50) ranging from 0.021 to 0.040 microM', '', 'BPR2-D2 was identified as a novel inhibitor against influenza virus from a hit obtained from high throughput screening of 20 000 or more compounds.', 19892833),
('Antiviral Chemical compound', 'SC29EK', 'SC29EK blocked the replication of T-20-resistant HIV-1 strains and maintained antiviral activity even in the presence of high serum concentrations (up to 50%).', '', 'We have developed a novel HIV fusion inhibitor, SC34EK, which is a gp41-derived 34-amino-acid peptide with glutamate (E) and lysine (K) substitutions on its solvent-accessible site that stabilize its alpha-helicity.', 19114674),
('Antiviral Chemical compound', 'DMP 450 (bis-methanesulfonic acid salt)', 'A plasmid-based, in vivo assay model suggests that maintenance of plasma levels of DMP 450 near the antiviral IC90 suppresses HIV protease activity in the animal.', '', 'RESULTS: We have synthesized DMP 450 (bis-methanesulfonic acid salt), a water-soluble cyclic urea compound and a potent inhibitor of HIV replication in cell culture that also inhibits variants of HIV with single amino acid substitutions in the protease.', 8807858),
('Antiviral Chemical compound', 'Cyclo-D4G', 'Possessed anti-HIV activity', '', 'Novel use of a guanosine prodrug approach to convert 2'',3''-didehydro-2'',3''-dideoxyguanosine into a viable antiviral agent. Transient kinetic studies with human immunodeficiency virus (HIV) type 1 reverse transcriptase suggest that nucleotide analogs containing the 2'',3''-didehydro-2'',3''-dideoxy ribose ring structure present in D4T (stavudine) triphosphate are among the most effective alternative substrates.', 11850281),
('Antiviral Chemical compound', 'GRL-057-14, GRL-058-14, and GRL-059-14, all of which contain a P2-amino-substituted-bis-tetrahydrofuranylurethane (bis-THF) and a P2''-cyclopropyl-amino-benzothiazole (Cp-Abt).', 'These PIs not only potently inhibit the replication of wild-type HIV-1 (50% effective concentration [EC50], 0.22 nM to 10.4 nM) but also inhibit multi-PI-resistant HIV-1 variants, including highly DRV-resistant HIVDRV R P51 (EC50, 1.6 nM to 30.7 nM).', '', 'Combination antiretroviral therapy has achieved dramatic reductions in the mortality and morbidity in people with HIV-1 infection.', 31085520),
('Antiviral Chemical compound', 'tenofovir alafenamide (TAF) and OBP-601(2,3-didehydro-3-deoxy-4-ethynylthymidine)', 'TAF and OBP-601 inhibited the replication of almost all isolates at a median EC50 of 0.27 nM and 6.83 nM, respectively.', '', 'New antiretroviral drugs are needed to treat HIV-2 infected patients failing therapy.', 30391482),
('Antiviral Chemical compound', 'dihydrofuro[3,4- d]pyrimidine derivatives 13c2 and 13c4', 'Against a wide range of HIV-1 strains carrying single NNRTI-resistant mutations (EC50 = 0.9-8.4 nM), which were remarkably superior to that of etravirine (ETV)', '', 'the small molecule inhibited HBsAg production and hepatitis B virion secretion (10 ?M) at low micromolar concentrations and was also efficacious against a HBV quadruple mutant (CYEI mutant) resistant to tenofovir.', 30624934),
('Antiviral Chemical compound', '2,4,5-Trisubstituted Pyrimidines', 'EC50 = 24.4 nM', '', 'Furthermore, 16c demonstrated favorable pharmacokinetic and safety properties, suggesting the potential of 16c as a promising anti-HIV-1 drug candidate.', 33734714),
('Antiviral Chemical compound', 'ZINC20451377', 'KD of 65.3 nM', '', 'Prolonged therapy with nucleoside/nucleotide analogues targeting the HBV-polymerase may lead to resistance and rarely results in the loss of HBsAg.', 34083665),
('Antiviral Chemical compound', 'Novel Boron-Containing N-Substituted Oseltamivir Derivatives- 4-(3-boronic acid benzyloxy)benzyl group (2c)', 'OSC showed a greater inhibitory potency toward wild-type NAs with IC50 values of 1.1 ', 'low cytotoxicity in vitro and no acute toxicity at the dose of 1000 mg/kg in mice', '4-(3-boronic acid benzyloxy)benzyl group was employed to provide a possible explanation for Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant', 36234966),
('Antiviral Chemical compound', 'Baloxavir acid (BXA), the active compound in baloxavir marboxil (BXM),', 'reduces the propagation of influenza A and B viruses by inhibiting the cap-dependent endonuclease activity of the polymerase acidic (PA) subunit.', '', 'The IC50 of BXA toward influenza A viruses containing PA E198K increased approximately 2- to 6-fold. These findings help to understand the mechanism by which PA substitutions reduce susceptibility to BXA.', 35511288),
('Antiviral Chemical compound', 'Dibenz[a,h]acridine, dibenz[a, i]acridine, NSC114903, dibenz[c,h]acridine, benzo[ a]acridine and their derivatives', 'The binding energy of the modified ligands of HIV-1 subtype C proteases increased, including the poorest-performing molecules.', '', 'Conclusion: Dibenz[a,h]acridine, dibenz[a, i]acridine, NSC114903, dibenz[c,h]acridine, benzo[ a]acridine and their derivatives might be considered as promising HIV-1 subtype C protease inhibitors. This could be confirmed through synthesis and subsequent in vitro assays.', 35114926),
('Antiviral Chemical compound', 'brequinar and homoharringtonine', 'potent HEV inhibitors, which are also effective against the ribavirin resistance variant harboring G1634R mutation', '', 'Thus, successful recapitulation of HEV infection in liver-derived organoids shall facilitate the study of virus-host interactions and development of antiviral therapies.', 35044825),
('Antiviral Chemical compound', '6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives', 'new lead compound 13e, which exhibited an EC50 value of 4.50 MicroM against H1N1 influenza virus in MDCK cells', '', 'Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PAN inhibitors', 34700269),
('Antiviral Chemical compound', 'polyionenes containing quaternary ammoniums and varying hydrophobic components', 'The polyionenes with optimal compositions inactivates mouse hepatitis virus (MHV) completely in 30 s. More importantly, the polyionenes are effective in inhibiting SARS-CoV-2 by >99.999% within 30 s.', 'do not cause damage to the skin and have a high oral lethal dose', 'Overall, these polyionenes are promising active ingredients for disinfection and prevention of viral and microbial infections.', 34694749),
('Antiviral Nanocomposites', 'Multivalent Glycosylated Nanostructures', 'Ebola virus (EBOV) infection', '', 'However, new tridecafullerenes-in which the central alkyne scaffold of [60]fullerene is connected to 12 sugar-containing [60]fullerene units (total 120 mannoses)-exhibit an outstanding antiviral activity with IC50 in the sub-nanomolar range! The multivalent presentation of specific carbohydrates by using 3D fullerenes as controlled biocompatible carbon scaffolds represents a real advance, being currently the most efficient molecules in vitro against EBOV infection.', 28394600),
('Antiviral Nanocomposites', 'Metal oxide microspheres', 'An antiviral activity higher than 2 log of reduction was also observed on H1N1 and HSV-1 viruses', '', 'Antimicrobial activity of metal oxide microspheres: an innovative process for homogeneous incorporation into materials.', 29502354),
('Antiviral Nanocomposites', 'BSA-nano-Ag', 'Potent anti-TB drug', '', 'Nature-inspired novel drug design paradigm using nanosilver: efficacy on multi-drug-resistant clinical isolates of tuberculosis.', 20936471),
('Antiviral Nanocomposites', '15 N [Cobalt Ferrite (0.3 CoFe2O4) + Silver chromite (0.7 Ag0.5Cr2.5O4)]', 'The inhibitory activity of the tested sample against the hepatitis A virus was detected under these experimental conditions with a 50% effective concentration (EC50) = 408.14 ', '', 'The tested compound showed weak antiviral activity.', 35624524),
('Antiviral Nanocomposites', 'Farnesol-Containing Nanoparticles  (NPs) loaded with the natural bactericide farnesol (FSL NPs)', 'the engineered nano-entities demonstrated strong antiviral properties and inhibited the spike proteins of SARS-CoV-2 by up to 83%.', 'The novel FSL NPs did not cause skin tissue irritation and did not induce the secretion of anti-inflammatory cytokines in a 3D skin tissue model.', 'These results support the potential of these bio-based nano-actives to replace the existing antibiotics and they may be used for the development of topical pharmaceutic products as Antibacterial, Antibiofilm, and Antiviral', 35886883),
('Antiviral photodynamic therapy', 'photoimmuno-antimicrobial strategy (PIAS)', 'PIAS acts on a broad range of microbes, including the bacterial pathogen Staphylococcus aureus, fungal pathogen Candida albicans, including their drug-resistant strains, and viral pathogen SARS-CoV-2, the causative agent of COVID-19.', 'PIAS protects mice from fatal infections without damaging the non-targeted host microbiota and tissues.', 'This study may contribute to the development of next-generation anti-infective therapies. Conjugates, 0.1 microg/mL; near-infra-red light (NIR) illumination, 10 J/cm2 used against SARS-CoV-2', 35788695),
('Antiparasitic Peptides', 'Urocortin II (UCNII)', 'Antimicrobial activity against a panel of Gram-positive and Gram-negative bacteria and tropical parasites of the genus Leishmania.', 'Did not affect mammalian cell viability.', 'Therefore, UCNII could be considered as an ancient highly-conserved host peptide involved in the natural antimicrobial defense and emerge as an attractive alternative to current treatments for microbial disorders with associated drug resistances.', 24249730),
('Antiparasitic Peptides', 'temporin-Sha analogue [K3]SHa', 'Exert leishmanicidal activity via a primary membranolytic mechanism but can also trigger apoptotis-like death', '', 'Insight into the mechanism of action of temporin-SHa, a new broad-spectrum antiparasitic and antibacterial agent. Antimicrobial peptides (AMPs) are promising drugs to kill resistant pathogens.', 28319176),
('Antiparasitic Peptides', 'BMAP-28 and two of its isomers the D-amino acid form (D-BMAP-28) and the retro-inverso form (RI-BMAP-28)', 'D-BMAP-28 appears to be the most potent antiparasitic of the three isomers against wild type L. major promastigotes and amastigotes', '', 'An MTS viability assay was utilized to show the potent antiparasitic activity of BMAP-28 and its protease resistant isomers against L. major promastigotes in vitro.', 21655347),
('Antiparasitic Peptides', 'Antimicrobial peptide LL-37 and the three synthetic peptides E6, L-1018, and RI-1018', 'Leishmanicidal activity against promastigotes and intramacrophage amastigotes of Leishmania donovani and Leishmania major', '', 'The results suggest that RI-1018 E6 and LL-37 are promising peptides to develop further into components for antileishmanial therapy.', 26883699),
('Antiparasitic Peptides', 'Combination of alkylphosphocholines with peptaibols', 'Antileishmanial activity', '', 'Furthermore, they revealed the importance of exploring novel classes of bioactive compounds such as peptaibols and demonstrated for the first time that they can act in synergy with currently used antileishmanial drugs to improve the therapeutic outcome.', 29631127),
('Antiparasitic Phytochemicals', 'Hydroalcoholic extract of the leaves of Ziziphus joazeiro Mart. (HELZJ)', 'IC50 was 612.06 micro g/ mL against T. cruzi, and for the protozoans L. braziliensis and L. infantum, IC50 values were greater than 5000 and 693.67 micro g/mL, respectively', 'Low toxicity in fibroblasts in vitro', 'Thus, our results indicate that Z. joazeiro Mart. (HELZJ) could be a source of plant-derived natural products that could lead to the development of promising new antibiotic compounds for infectious diseases.', 25976809),
('Antiparasitic Phytochemicals', 'Petroleum ether, chloroform, ethyl acetate, methanol and aqueous extracts from the roots of T. erecta and a new bithienyl compound, 2-hydroxymethyl-non-3-ynoic acid 2-[2,2'']-bithiophenyl-5-ethyl ester from the roots of the plant', 'Ethyl acetate fraction exhibited IC(50) of 0.02 and 0.07 mg/mL against the chloroquine sensitive and resistant strains of Plasmodium falciparum respectively, the new bithienyl compound also showed significant schizonticidal activity against both chloroquine sensitive and resistant strains of Plasmodium falciparum with the IC(50) values of 0.01 and 0.02 mg/mL', '', 'Five successive extracts (petroleum ether, chloroform, ethyl acetate,  methanol and aqueous) of the roots of T. erecta and a new bithienyl compound, 2-hydroxymethyl-non-3-ynoic acid 2-[2,2'']-bithiophenyl-5-ethyl ester from the roots of the plant, were evaluated for in vitro antiplasmodial activity against chloroquine sensitive and resistant strains of Plasmodium falciparum.', 20818936),
('Antiparasitic Phytochemicals', 'Kenyan medicinal plants (Toddalia asiatica (root bark), Rhamnus prinoides (leaves and root bark),  Vernonia lasiopus (root bark),  root bark and/or leaf extracts of Maytenus acuminata, M. heterophylla, M. senegalensis, Rhamnus staddo and Withania somnifera (root bark))', 'Toddalia asiatica (root bark), Rhamnus prinoides (leaves and root bark) and Vernonia lasiopus (root bark) showed high chemosuppression in the range 51%-75%, activity of V. lasiopus (all parts), leaf extracts of M. senegalensis, R. prinoides and T. asiatica as well as root barks of M. heterophylla, R. staddo and T. asiatica  enhabced in combination with chloroquine', '', 'In Vivo antimalarial activity of aqueous extracts from Kenyan medicinal plants and their chloroquine (CQ) potentiation effects against a blood-induced CQ-resistant rodent parasite in mice', 17221829),
('Antiparasitic Phytochemicals', 'Curcumin', 'Higher than 95% inhibition of Cryptosporidium parvum growth at 50 microM for 24 h', '', 'Altogether curcumin showed promising anticryptosporidial effects under in vitro conditions and deserves further exploration.', 19557435),
('Antiparasitic Phytochemicals', 'Ethanolic extract of P. longifolia (Sonn) Thw. var. pendula stem bark (clerodane diterpenes [16-hydroxycleroda-3,13-dien-16,15-olide (1), 16-oxocleroda-3,13E-dien-15-oic acid (2) and 3,16-dihydroxycleroda-4(18),13(14)Z-dien-15,16-olide (3)], a steroid [beta-stigmasterol (4)] and two alkaloids [darienine (5) and stepholidine (6)])', 'The clerodane diterpenes exhibited significantly potent (p<0.005) blood schizonticidal activity (IC50: 3-6 micro g/ml),?while compounds 4, 5 and 6 exhibited weak antiplasmodial activity (IC50 22-105 micro g/ml)', '', 'The potent antiplasmodial activity of the extract of P. longifolia (Sonn) Thw. var. pendula and compounds therein strongly suggests its usefulness as an antimalarial agent and supports its inclusion or exploitation in formulations of herbal remedies for malaria in Ghana.', 25914039),
('Antiparasitic Phytochemicals', 'Triterpenoids (Piperazine derivatived from betulinic acid)', 'Minimum inhibitory concentration (MIC) value of 91.2 microM against Trichomonas vaginalis', '', 'This is the first report of semisynthetic triterpenoid derivatives with anti-T. Vaginalis activity, revealing the high potential of these compounds as trichomonacidal agents.', 24880238),
('Antiparasitic Phytochemicals', 'Compounds from MEDINA microbial products collection', 'Activity against Plasmodium falciparum?', '', 'A subset of more than 20,000 extracts from the MEDINA microbial products collection has been explored, leading to the discovery of 3 new compounds with antimalarial activity', 26735308),
('Antiparasitic Phytochemicals', 'Sapindus saponins', 'y, the MIC of Sapindus saponins for T. vaginalis (0.005%) was found to be 10-fold lower than its effective spermicidal concentration (0.05%)', '', 'Findings demonstrate the potential of Sapindus saponins for development as a microbicidal contraceptive for human use.', 18544604),
('Antiparasitic Phytochemicals', 'Extra Virgin Olive Oil', 'Our results show that TPF triggers cell-cycle arrest and apoptotic-like changes in Leishmania spp. promastigotes.', '', 'Alternative bioactive phytocompounds may provide a promising source for discovering new anti-leishmanial drugs.', 33428610),
('Antiparasitic Chemical Compounds', '2,2''-bipyridine (bipy), 1,10-phenanthroline (phen) or dipyrido[3,2-d:2'',3''-f]quinoxaline (dpq) synthesized by the reaction with SbCl3 or PhSbCl2.', 'IC50 in the nanomolar range against Sb(III)-sensitive and -resistant Leishmania infantum (syn. Leishmania chagasi) and Leishmania amazonensis strains', '', 'Complexes of different nitrogen donor heterocyclic ligands with SbCl3 and PhSbCl2 as potential antileishmanial agents against Sb (III)-sensitive and -resistant parasites.', 24412095),
('Antiparasitic Chemical Compounds', 'Ketolide agents HMR 3004 and HMR 3647 (telithromycin)', 'In vitro activity of  HMR 3004 and HMR 3647 against?Plasmodium falciparum with IC50 values 3 and 15 nM respectively', '', 'Ketolide agents HMR 3004 and HMR 3647 (telithromycin) inhibit the growth of Plasmodium falciparum in vitro.   Malaria is on the increase due to emergence of parasite drug resistance and there is thus an urgent need for the development of new antiparasitic drugs effective at low concentrations', 26958030),
('Antiparasitic Chemical Compounds', '6-mercaptopurine and 6-thioguanine', 'Of the studied 64 compounds, 22 produced a 50% inhibition of the growth of the human malaria parasite Plasmodium falciparum at a concentration of 50 microM or less.', '', 'Two of the compounds which effectively inhibited parasite growth, 6-mercaptopurine and 6-thioguanine, were found to be potent competitive inhibitors of a key purine-salvaging enzyme (hypoxanthine-guanine-xanthine phosphoribosyltransferase) of the parasite.', 2201255),
('Antiparasitic Chemical Compounds', 'Mollemycin A', 'Potent and selective growth inhibitory activity against Gram-positive and Gram-negative bacteria (IC50 10-50 nM) and drug-sensitive (3D7; IC50 7 nM) and multidrug-resistant (Dd2; IC50 9 nM) clones of the malaria parasite Plasmodium falciparum', '', 'Mollemycin A: an antimalarial and antibacterial glyco-hexadepsipeptide-polyketide from an Australian marine-derived Streptomyces sp. (CMB-M0244)', 24611932),
('Antiparasitic Chemical Compounds', 'Nitrofuran isoxazolines and pentacyclic nitrofurans', 'Nitrofuran isoxazolines were potent inhibitors of T. Bruce proliferation at nanomolar concentrations, with pentacyclic nitrofurans being 100-fold more potent than nifurtimox.', '', 'Pentacyclic nitrofuran isoxazolines warrant further development for the treatment of drug-susceptible and nifurtimox-resistant trypanosome infections.', 26682963),
('Antiparasitic Chemical Compounds', 'Copper catalysed Huigsen azide-alkyne 1, 3-dipolar cycloaddition', 'Excellent broad spectrum antimicrobial and antiparasitic activity targeting Clostridium difficile, Entamoeba histolytica and Giardia lamblia.', '', 'The copper catalysed Huigsen azide-alkyne 1, 3-dipolar cycloaddition offers a way to efficiently assemble new libraries of metronidazole analogues', 26117821),
('Antiparasitic Chemical Compounds', 'Indolone-N-oxide derivatives.', 'Antibacterial, antifungal and antileishmanial activities', '', 'INODs showed a broad spectrum of antimicrobial activity and offer a promising anti-infectious prototype worthy of being developed.', 22828966),
('Antiparasitic Chemical Compounds', 'Nitric Oxide (NO) and Tumor Necrosis Factor-alpha (TNF-alpha)', 'In vitro activation of macrophage NO synthase by IFN-gamma induces a trypanostatic activity and TNF-alpha is involved in NO synthase induction.?', '', 'Macrophage effector molecules participate with other immune effector mechanisms in resistance of host to trypanosomes.', 7496195),
('Antiparasitic Chemical Compounds', '4-aminoquinoline-purine hybrids', 'Antiplasmodial activities against both the sensitive and resistant strains of P. falciparum with up to six-fold better activity (compound 10i, IC50: 0.08 micro M) compared to the reference drug CQ (IC50: 0.5 micro M) against the resistant strain', 'The synthesized compounds were also checked for their cytotoxicity towards mammalian cells and with the exception of two compounds out of the twenty synthesized hybrids, all others were non-cytotoxic up to 11.86 ?M concentration.', 'Design, synthesis and evaluation of 4-aminoquinoline-purine hybrids as potential antiplasmodial agents.', 27936446),
('Antiparasitic Chemical Compounds', '1-amino-6-halo-beta-carbolines', 'Superior activity to chloroquine itself against a resistant Plasmodium falciparum strain', '', 'Here, we report the synthesis of some 6-halo-?-carbolines as analogues of the potent antimalarial natural product, manzamine A, retaining its heteroaromatic core whilst providing compounds with much improved synthetic accessibility.', 22275299),
('Antiparasitic Chemical Compounds', 'Novel ciprofloxacin derivatives (NCD)', 'The half-maximal inhibitory concentration (IC50) values of the most effective five compounds of NCD (No. 3, 5, 10, 14, 15) on Babesia bovis, Babesia bigemina, Babesia caballi, and Theileria equi were 32.9, 13.7, 14.9, and 30.9; 14.9, 25.8, 13.6, and 27.5; 34.9, 33.9, 21.1, and 22.3; 26.7, 28.3, 34.5, and 29.1; and 4.7, 26.6, 33.9, and 29.1 microM, respectively.', 'Tested NCD did not suppress NIH/3T3 and MDBK cell viability, even at the highest concentration used (500 microM)', 'The IC50 values of NCD showed that they are promising future candidates against piroplasmosis.', 32677000),
('Antiparasitic Chemical Compounds', 'SP230, an imidazo[1,2-b]pyridazine salt', 'Intraperitoneal administration of SP230 drastically reduced the number of parasites (more than 97% of reduction) in the brain and lungs of dams, and led to a reduction of 66% of parasite burden in foetuses.', '', 'Treatments currently used to prevent congenital toxoplasmosis are non-specific of Toxoplasma gondii and have grievous side effects.', 34299478),
('Antiparasitic Chemical Compounds', 'N,N-dimethyldithiocarbamate (DMDC)', 'DMDC as a copper-dependent antimicrobial against bacterial, fungal, and parasitic pathogens, as a bactericidal antibiotic against S. pneumoniae', 'DMDC''s ability to work as a copper-dependent antibiotic and its ability to work in vivo warranted further investigation.', 'Taken together, this study provides mechanistic insights regarding DMDC''s activity as an antibiotic at the host-pathogen interface.', 35311543),
('Antiparasitic Chemical Compounds', 'albendazole-ivermectin', 'against soil-transmitted helminthiases', '', 'Low cure rates are observed with standard of care (albendazole); therefore, a more effective combination therapy (albendazole and ivermectin) is being investigated but showed variable treatment efficacies without evidence of intrinsic parasite resistance.', 35217670),
('Antiparasitic Chemical Compounds', 'novel derivatives of azithromycin', 'Seventeen Out of twenty two - azithromycin analogues showed improved quick-killing against both Plasmodium species, with up to 38 to 20-fold higher potency over azithromycin after less than 48 or 28 hours of treatment for P. falciparum and P. knowlesi, respectively.', '', 'The azithromycin analogues privide quick-killing compounds and provide new starting points to develop azithromycin analogues with quick-killing antimalarial activity.', 36530422),
('Antiparasitic Chemical Compounds', 'Thiostrepton Compound', 'results show that Thiostrepton reduces the proliferation of T. cruzi epimastigotes, cell-derived trypomastigotes, and blood trypomastigotes', 'low cytotoxicity on Vero cells.', 'also demonstrated a synergic effect of Thriostepton and Beznidazol. The convenience of seeking treatment alternatives against T. cruzi by repositioning compounds as Thiostrepton is discussed.', 35873171),
('Antiparasitic photodynamic therapy', 'Indocyanine green (ICG) and ethylenediamine tetraacetate (EDTA)', 'PACT mediated by ICG and EDTA led to a more pronounced antibacterial effect in S. aureus and P. aeruginosa compared with ICG alone-mediated PACT. P. aeruginosa was more sensitive to ICG and EDTA-mediated PACT than S. aureus.', '', 'Antimicrobial Photodynamic therapy(A-PDT) or Photodynamic antimicrobial chemotherapy (PACT) has been proposed as an alternative approach for inactivating bacteria, especially resistant bacterial biofilms.', 30633998),
('Antiparasitic photodynamic therapy', 'Methylene blue (MB)-PDT', 'MB-PDT led to complete inhibition of all isolates at geometric mean concentrations of 1-16 mg/L. Efficacy was independent of incubation time prior to illumination, terbinafine susceptibility (MICs ?0.004-4 mg/L) and presence of SQLE mutations', '', 'Terbinafine resistant and susceptible strains are equally susceptible to MB-PDT.', 33497815);

-- --------------------------------------------------------

--
-- Table structure for table `antimicrobial_peptide`
--

CREATE TABLE IF NOT EXISTS `antimicrobial_peptide` (
  `THEME` varchar(50) NOT NULL,
  `PMID` int(50) NOT NULL,
  `EVIDENCE` varchar(2000) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `antimicrobial_peptide`
--

INSERT INTO `antimicrobial_peptide` (`THEME`, `PMID`, `EVIDENCE`) VALUES
('ANTIMICROBIAL PEPTIDE', 24249730, ' Therefore, UCNII could be considered as an ancient highly-conserved host peptide involved in the natural antimicrobial defense and emerge as an attractive alternative to current treatments for microbial disorders with associated drug resistances.  '),
('ANTIMICROBIAL PEPTIDE', 28319176, '  Insight into the mechanism of action of temporin-SHa, a new broad-spectrum antiparasitic and antibacterial agent. Antimicrobial peptides (AMPs) are promising drugs to kill resistant pathogens.'),
('ANTIMICROBIAL PEPTIDE', 21655347, ' An MTS viability assay was utilized to show the potent antiparasitic activity of BMAP-28 and its protease resistant isomers against L. major promastigotes in vitro.'),
('ANTIMICROBIAL PEPTIDE', 27936446, ' Design, synthesis and evaluation of 4-aminoquinoline-purine hybrids as potential  antiplasmodial agents.  '),
('ANTIMICROBIAL PEPTIDE', 25668079, 'The role of phosphoglycans in the susceptibility of Leishmania mexicana to the temporin family of anti-microbial peptides.   Natural product antimicrobial peptides (AMPs) have been proposed as promising agents against the Leishmania species insect vector borne protozoan parasites causing the neglected tropical disease leishmaniasis.'),
('ANTIMICROBIAL PEPTIDE', 26883699, 'The results suggest that RI-1018 E6 and LL-37 are promising peptides to develop further into components  for antileishmanial therapy.  ');

-- --------------------------------------------------------

--
-- Table structure for table `bacteria_amp`
--

CREATE TABLE IF NOT EXISTS `bacteria_amp` (
  `ENTITY` varchar(500) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(2000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `bacteria_amp`
--

INSERT INTO `bacteria_amp` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Antimicrobial peptide KLKLLLLLKLK-NH2 and its D-enantiomer', 'Significant chemotherapeutic activity in MRSA-infected mice', '', 'Chemotherapeutic activity of synthetic antimicrobial peptides: correlation between chemotherapeutic activity and neutrophil-activating activity', 9326370),
('Protegrin-1', '', '', 'CONCLUSIONS: This study shows that protegrin-1 potentially may be used as an alternative or adjunct therapy to standard agents used to treat wound infections.', 11445704),
('Brevinin-2 peptides from the skin of the Hokkaido frog, Rana pirica', 'The most abundant peptide, brevinin-2PRa (680 nmol/g weight of dry skin) showed high potency [minimal inhibitory concentration (MIC) values between 6 and 12 microM] against a range of clinical isolates of P. aeruginosa.', '', 'A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Nine peptides displaying varying degrees of antimicrobial activity were extracted from the skin of the Hokkaido frog, Rana pirica.', 15003829),
('Antimicrobial peptide, human lactoferrin 1-11 (hLF1-11)', '', '', 'The hLF1-11-treated group also had a significantly lower radiological score compared to the gentamicin-treated group. This study demonstrates the efficacy of hLF1-11 incorporated into Ca-P bone cement as a possible therapeutic strategy for the treatment of osteomyelitis, showing efficacy comparable to that of gentamicin.', 15917544),
('[fMLF]PMBN and [fMLF]PMEN', '', '', 'Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria', 16048913),
('Phenothiazinium', 'We used MDR-deficient mutants of Staphylococcus aureus (NorA), Escherichia coli (TolC), and Pseudomonas aeruginosa (MexAB) and found 2 to 4 logs more killing than seen with wild-type strains by use of three different phenothiazinium PSs and red light.: Mutants that overexpress MDRs were protected from killing compared to the wild type.', 'Antimicrobial photodynamic therapy (PDT) combines a nontoxic photoactivatable dye, or photosensitizer (PS), with harmless visible light to generate singlet oxygen and free radicals that kill microbial cells.', 'Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrobial photodynamic therapy (PDT) combines a nontoxic photoactivatable dye, or photosensitizer (PS), with harmless visible light to generate singlet oxygen and free radicals that kill microbial cells.', 16377686),
('Natural toxins and animal venoms (snakes, scorpions and honey bee venoms)', 'Antimicrobial activity against Burkholderia pseudomallei', '', 'In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei', 16784542),
('Antimicrobial peptides (AMPs), UBI 1-59 and synthetic fragments comprising amino acids 31-38', 'In vitro killing of MRSA by synthetic peptides derived from the alpha-helix or beta-sheet domains of the human cationic peptide ubiquicidin (UBI 1-59), allowed selection of AMPs for possible treatment of MRSA infections. The strongest antibacterial activity was observed for the entire peptide UBI 1-59 and for synthetic fragments comprising amino acids 31-38.', '', 'The availability, chemical synthesis opportunities, and size of these small peptides, combined with their strong antimicrobial activity towards MRSA make these compounds promising candidates for antimicrobial therapy and detection of infections in man. ', 16814900),
('Hyaluronic acid binding peptides', 'Effective in experimental surgical wound infections caused by S. aureus', '', 'Treatment with these peptides was highly efficacious in reducing the number of S. aureus cells at the wound site and ameliorated the inflammatory host response associated with these infections.', 17065624),
('Defr1, covalent dimer species of beta-defensin', 'Antimicrobial activity against Pseudomonas aeruginosa PAO1 and an extended panel of multidrug-resistant nosocomial pathogens', '', 'Covalent dimer species of beta-defensin Defr1 display potent antimicrobial activity against multidrug-resistant bacterial pathogens. Beta defensins comprise a family of cationic, cysteine-rich antimicrobial peptides, predominantly expressed at epithelial surfaces.', 17353239),
('Lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin', 'Vancomycin combined to Pal-Lys-Lys-NH(2) exerted the strongest anti-staphylococcal efficacies. The in vitro studies showed, that MIC and MBC values for vancomycin were lower in presence of lipopeptides. They reduce the bacterial load and to enhance the effect of vancomycin in the prevention of vascular graft staphylococcal infections.', '', 'The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.', 17537542),
('Antimicrobial peptide thionin Thi2.1', 'Growth inhibition of S. aureus isolates was dose-dependent, showing a total inhibition at concentrations higher than 3.12 microg/ml.', '', 'Antibacterial activity of thionin Thi2.1 from Arabidopsis thaliana expressed by bovine endothelial cells against Staphylococcus aureus isolates from bovine mastitis. Bovine mastitis is mainly caused by Staphylococcus aureus and antimicrobial therapy, commonly used for its control, has resulted in an increase in the frequency of resistant staphylococci in recent years.', 17961938),
('AP-CECT7121 (an antimicrobial peptide isolated from an environmental strain of Enterococcus faecalis CECT7121)', 'Activity against Enterococcus faecium, Enterococcus faecalis,Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Clostridium perfringens and Clostridium difficile', '', 'CONCLUSIONS: AP-CECT7121 may provide a novel strategy for treating potentially fatal clinical infections in hospitalized patients.', 19494489),
('Arminin', 'Minimal bactericidal concentration, 0.4 microM to 0.8 microM against multiresistant human pathogenic strains, such as methicillin-resistant Staphylococcus aureus (MRSA) strains', '', 'Activity of the novel peptide arminin against multiresistant human pathogens shows the considerable potential of phylogenetically ancient organisms as drug sources', 19770277),
('Laterocidin and its analogues [3 (Asp(1)-->Asn(1), Phe(4)-->Tyr(4) and d-Tyr(6)-->d-Phe(6))]', 'Antimicrobial properties, against clinical Methicillin-resistant Staphylococcus aureus (L-MRSA) and the gram-negative extended-spectrum beta-lactamases-producing Escherichia coli (ESBLs E. coli) and L-E.coli.', '', 'Solid-phase synthesis and antibiotic activities of cyclodecapeptides on the scaffold of naturally occurring Laterocidin', 19932962),
('longicornsin', 'Strong antimicrobial ability against drug-resistant microorganisms and Helicobacter pylori', '', 'A novel defensin-like peptide from salivary glands of the hard tick, Haemaphysalis longicornis', 20027626),
('Alyteserin-1c (GLKEIFKAGLGSLVKGIAAHVAS?NH(2)) and its analogues', 'Alyteserin-1c displayed MIC=5-10 micro M; minimum bactericidal concentration, MBC=5-10 microM), increasing the cationicity of alyteserin-1c by the substitution Glu(4)->Lys enhanced the potency (MIC=1.25-5 micro M; MBC=1.25-5 micro M) against MDRAB', 'alyteserin-1c (LD(50)=220 ?M)and its catonic analogues (HC(50)>400 ?M) has low hemolytic activity against human erythrocytes , and.', 'Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii', 20603168),
('Hominicin (DmIle-Dhb-Pro-Ala-Dhb-Pro-Phe-Dhb-Pro-Ala-Ile-Thr-Glu-Ile-Dhb-Ala-Ala-Val-Ile-Ala -Dmp)', 'Potent activity against Staphylococcus aureus ATCC 25923, methicillin-resistant S. aureus (MRSA) ATCC 11435 and vancomycin-intermediate S. aureus (VISA) CCARM 3501', '', 'Characterization and structure identification of an antimicrobial peptide, hominicin, produced by Staphylococcus hominis MBBL 2-9.', 20654578),
('Acyldepsipeptide 4 (ADEP 4) analog in which the pipecolate was replaced by 4-methyl pipecolate', 'in vitro antibacterial activity against Enterococci that was fourfold higher than the parent compound ADEP 4', '', 'Diversity-oriented synthesis of cyclic acyldepsipeptides leads to the discovery of a potent antibacterial agent.', 20833054),
('PTP-7, lytic peptide', 'Anti-biofilm activity, potent to Gram-positive bacteria and is able to kill antibiotic sensitive and resistant Staphylococcus aureus', '', 'The activity of a small lytic peptide PTP-7 on Staphylococcus aureus biofilms', 21887652),
('C(12)K-2?(12), oligo-acyl-lysyl (OAK) antimicrobial peptidomimetic', 'A dual mode of action against the H. pylori membrane and cytoplasmic components', '', 'The oligo-acyl lysyl antimicrobial peptide C(12)K-2?(12) exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori', 22064541),
('Epidermicin NI01', 'Potent antimicrobial activity toward a wide range of pathogenic Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA), enterococci, and biofilm-forming S. epidermidis strains', '', 'Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci.', 22155816),
('CPF-AM1, PGLa-AM1, B2RP-ERa, [E4K]alyteserin-1c, [D4K]B2RP and [G4K]XT-7', 'Overall colistin-susceptibleminimum inhibitory concentration against colistin-susceptible (MIC) ? 2 micro g/mL] and colistin-resistant (MIC ? 64 micro g/mL) clinical isolates of multidrug-resistant strains of Acinetobacter baumannii and Acinetobacter nosocomialis, with most potent peptides being [D4K]B2RP and [E4K]alyteserin-1c (MIC=4-16 micro g/mL)', 'low haemolytic activity against human erythrocytes.', 'Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group', 22326566),
('OH-CATH30 and its analog OH-CM6', 'The MICs of OH-CATH30 and OH-CM6 ranged from 1.56 to 12.5 micro g/ml against drug-resistant clinical isolates of several pathogenic species, including Escherichia coli, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus.', 'relatively low toxicity and potent efficacy in mouse models', 'Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models.', 22491685),
('Dimeric PpIX-YI13WF (photosensitizer protophophyrin IX - YI13WF (YVLWKRKRKFCFI-Amide)) conjugate', '(MIC) values of dimeric PpIX-YI13WF conjugate itself observed for E. coli DH5a (~4 times), S. enterica (~8 times), and other Gram-negative strains including antibiotic-resistant E. coli BL21 (~8 times) and K. pneumoniae (~16 times).', 'Dimeric PpIX-YI13WF conjugate could selectively recognize bacterial strains over mammalian cells and generate less photo damage to mammalian cells.', 'Lipopolysaccharide neutralizing peptide-porphyrin conjugates for effective photoinactivation and intracellular imaging of gram-negative bacteria strains. A simple and specific strategy based on the bioconjugation of a photosensitizer protophophyrin IX (PpIX) with a lipopolysaccharide (LPS) binding antimicrobial peptide YI13WF (YVLWKRKRKFCFI-Amide) has been developed for the effective fluorescent imaging and photodynamic inactivation of Gram-negative bacterial strains.', 22769015),
('Peptide conjugated phosphorodiamidate morpholino oligomers', 'Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis. ', '', 'Targeting bacterial essential genes using antisense phosphorodiamidate morpholino oligomers (PMOs) represents an important strategy in the development of novel antibacterial therapeutics.', 22978365),
('PEP6R (VKVRVRVRV(D)PPTRVRVRVKV)', 'High potency against bacteria', 'cytocompatible toward human erythrocytes as well as mammalian mesenchymal stem cells', 'Arginine-rich self-assembling peptides as potent antibacterial gels.', 22995710),
('PXL150', 'In vitro a broad spectrum microbicidal action against both Gram-positive and Gram-negative bacteria, including resistant strains', '', 'The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections.', 23053090),
('NK-18', 'Two targets, acts on bacterial membrane and DNA in the cytoplasm', '', 'The double targets of NK-18 make it difficult for bacteria to generate resistance, which may present a new strategy to defend against multidrug-resistant bacteria and provide a new lead in the design of potent antimicrobial peptides with therapeutic application in the presence of increasing resistance to conventional antibiotics.', 23089755),
('LL-37', 'Effective in killing extracellular S. aureus at nanomolar concentrations', '', 'Therefore, LL-37 was shown to be very potent and prompt in eliminating both extra- and intracellular S. aureus and was more effective in killing extra- and intracellular S. aureus than commonly used conventional antibiotics.', 23274662),
('TSG-8-1, WWSYVRRWRSR-amide', 'Antimicrobial activity against E. coli and S. aureus', 'Very little hemolytic activity in human erythrocytes t high dose level', 'Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide', 23570790),
('S-thanatin', 'High activity of S-thanatin against K. pneumoniae in vitro with MIC between 4 and 8 micro g/ml.?', '', 'All above implied that S-thanatin, as an alternative, may provide a novel strategy for treating K. pneumoniae infection and other infections due to multidrug-resistant bacteria.', 23643614),
('Peptidomimetics (Short histidine-derived antimicrobial peptides (SAMPs))', 'High antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA)', 'No hemolytic activity', 'Non hemolytic short peptidomimetics as a new class of potent and broad-spectrum antimicrobial agents.', 23816372),
('R-thanatin', 'Potent in vitro activity against coagulase-negative staphylococci, such as S. epidermidis, S. haemolyticus, and S. hominis, and inhibited biofilm formation at subinhibitory concentrations', '', 'R-thanatin inhibits growth and biofilm formation of methicillin-resistant Staphylococcus epidermidis in vivo and in vitro', 23917310),
('C5a-derived immunobiotic peptide EP67', 'EP67 inhibits GBS growth in vitro and in vivo and that antibacterial activity was specific to Streptococcus species.', '', 'We have employed a host-directed immunomodulatory therapy using a novel peptide, known as EP67, derived from the C-terminal region of human complement component C5a.', 23979760),
('Hymenochirin-1B (IKLSPETKDN(10)LKKVLKGAIK(20)GAIAVAKMV.NH2) analogue in which the Pro(5), Glu(6) and Asp(9) on the hydrophilic face of the ?-helix are substituted by one or more l-lysine or d-lysine residues', '[E6k,D9k]hymenochirin-1B has MIC in the range 0.8-3.1 micro M against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) and a range of Gram-negative bacteria, including multidrug-resistant strains of Acinetobacter baumannii and Stenotrophomonas maltophilia, MIC in the range 3.1-6.25 micro M against NDM-1 carbapenemase-producing clinical isolates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae and Citrobacter freundii.,', 'low hemolytic activity (LC50=302 ?M) of [E6k,D9k]hymenochirin-1B', 'An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties', 24172540),
('BmKn2 scorpion venom peptide and its derivatives', 'Bactericidal, potent activity against N. gonorrhoeae with MIC50 values of 6.9-27.6 ?M', '', 'Potent and rapid antigonococcal activity of the venom peptide BmKn2 and its derivatives against different Maldi biotype of multidrug-resistant Neisseria gonorrhoeae.', 24184420),
('His-derived antimicrobial peptides (HDAMPs)', 'Promising dual antimicrobial and anti-inflammatory activities, as well as anti-methicillin-resistant Staphylococcus aureus (MRSA) activity', '', 'CONCLUSION/SIGNIFICANCE: The combination of the ultra-short size, high-prokaryotic selectivity, potent anti-MRSA activity, anti-inflammatory activity, and proteolytic resistance of the designed HDAMP-1, -3, -5, and -6 makes these molecules promising candidates for future antimicrobial therapeutics.', 24302996),
('Temporin-SHa (FLSGIVGMLGKLF amide)', 'Broad-spectrum activity against Gram-positive and Gram-negative bacteria, yeasts and parasites', '', 'Temporin-SHa (FLSGIVGMLGKLF amide) is a small hydrophobic and low cationic antimicrobial peptide with potent and very broad-spectrum activity against Gram-positive and Gram-negative bacteria, yeasts and parasites.', 24919960),
('Pandinin 2 variants', 'Antimicrobial activity against E. coli, S. aureus, and M. tuberculosis', 'Pin2 [14] presented only 25% of hemolysis toward human erythrocytes at concentrations as high as 100 ?M, while the peptide Pin2 [17] did not show any hemolytic effect at the same concentration', 'Therefore, Pin2 [14] and Pin2 [17] have the potential to be used as an alternative antibiotics and anti-tuberculosis agents with reduced hemolytic effects.', 25019413),
('Peptides human beta-defensin-3 (hBD-3) and cathelicidin (LL-37)', 'Non-cytotoxic concentrations of hBD-3 (10 and 20 micro M) and LL-37 (0.1 and 0.2 micro M)', '', 'This combination of antimicrobial peptides thus shows promising potential as an adjunctive therapy for treating inflammatory periodontitis.', 25187958),
('l isomer of lycosin-I (l-lycosin-I), d isomer of lycosin-I (d-lycosin-I), l- and d-amino acid residues of RKGWFKAMKSIAKFIAKEKLKEHL', 'The MICs of the three isomers of lycosin-I and several other clinical drugs were determined through the broth microdilution method in accordance with the CLSI protocol', '', 'These two compounds displayed high antibacterial activities and rapid bactericidal effects against MDRAB. Moreover, the compounds retained their activity even at high salt (Mg(2+) or Ca(2+)) concentrations.', 25199777),
('G(IIKK)(3)I-NH(2)', 'Effective against ESBL-producing bacterial infection', 'multidrug resistant ESBL-producing bacteria do not develop resistance and low toxicity toward mammalian hosts', 'High cell selectivity and low-level antibacterial resistance of designed amphiphilic peptide G(IIKK)(3)I-NH(2). On the basis of cell cultures involving bacterial strains (Escherichia coli 5? and Bacillus subtilis 168) and a mammalian cell line (NIH 3T3), the potent antibacterial activity and distinct selectivity from designed amphiphilic peptides G(IIKK)nI-NH2 (n = 2-4) have been demonstrated.', 25210781),
('Antimicrobial peptides (AMPs) GPPPQGGRPQG and RFGYGYGPYQPVPEQPLYPQ', 'Antibacterial effect in S. aureus', '', 'These showed to exert an antibacterial effect in Staphylococcus aureus. This report validates the prospection of mammal''s saliva to find new alternatives to antibiotics.BIOLOGICAL SIGNIFICANCE: With the growing problem of antibiotic resistance, the identification of new routes in antibiotic therapy is on the scientific agenda worldwide.', 25534884),
('VRV-PL-V (Vipera russellii venom phospholipase A2 fraction V) of Daboia russellii pulchella venom', 'Antibacterial activity with MIC values ranging from 13 to 24 micro g/ml', '', 'VRV-PL-V demonstrated a potent antibacterial activity against all the human pathogenic strains tested.', 25540009),
('Tilapia piscidin antimicrobial peptides TP3 (H-FIHHIIGGLFSVGKHIHSLIHGH-OH), TP4 (H-FIHHIIGGLFSAGKAIHRLIRRRRR-OH)', 'TP4 MIC against K. pneumonia and A. baumannii in the range < 1.56 microg/mL - 3.125 microg/mL. TP3 MIC against K. pneumonia and A. baumannii in the range < 1.56 microg/mL - 25 microg/mL', '', 'TP3 and TP4 are able at potentiate anti-Acinetobacter baumannii or anti-Klebsiella pneumonia drug activity, reduce bacterial load, and prevent drug resistance, indicating their potential for use in combating multidrug-resistant bacteria.', 25874924),
('VG16KRKP', 'Antimicrobial activity against Gram-negative E. coli and plant pathogens X. oryzae and X. campestris, as well as against human fungal pathogens C. albicans and C. grubii.', '', 'The de novo design of VG16KRKP provides valuable insights into the development of more potent antibacterial and antiendotoxic peptides for the treatment of human and plant infections.', 26144972),
('Synthetic peptides based on LF11( LF11-215 (FWRIRIRR), LF11-227 (FWRRFWRR), DI-MB-LF11-322 (2,2-dimethylbutanoyl-PFWRIRIRR) and DI-MB-LF11-215)', 'Potent anti-biofilm activity against Pseudomonas aeruginosa', '', 'Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms', 26149536),
('NLF20 (NLFRKLTHRLFRRNFGYTLR)', 'Potent antimicrobial effects against the Gram-negative bacteria Escherichia coli and P. aeruginosa, the Gram-positive Bacillus subtilis and Staphylococcus aureus and the fungi Candida albicans and Candida parapsilosis', '', 'NLF20: an antimicrobial peptide with therapeutic potential against invasive Pseudomonas aeruginosa infection', 26503666),
('K1K8: an Hp1404-derived antibacterial peptide', 'Decreased methicillin-resistant Staphylococcus aureus (MRSA) bacterial counts in the wounded region in a mouse skin infection model', 'Low hemolytic activity', 'K1K8: an Hp1404-derived antibacterial peptide. As an alternative class of antimicrobial agents used to overcome drug-resistant infections, antimicrobial peptides (AMPs) have recently gained significant attention.', 26952110),
('D-L91 (SEFAYGSFVRTVSLPVGADE)', 'Enhancement of IFN-gamma(+)TNF-alpha(+) polyfunctional Th1 cells and IL-17A(+)IFN-gamma(+) Th17 cells, enduring memory CD4 T cells and downregulation of PD-1', '', 'The adjunct therapy using drugs and L91 (D-L91) significantly declined the bacterial load in Mtb infected animals.', 27052185),
('CSpK14 , antimicrobial peptide', 'MICs reduced by 8- to 64-fold and 2- to 16-fold in combination wth oxacillin and ampicillin respectively', '', 'CSpK14 was simple to purify, had low molecular mass, was stable over a wide pH range or tested chemicals, had broad inhibitory spectrum, and possessed potent synergistic antimicrobial-antibiofilm properties.', 27787755),
('Series of side-chain hybrid dimer peptides J-AA (Anoplin-Anoplin), J-RR (RW-RW), and J-AR (Anoplin-RW) based on the wasp peptide Anoplin and the arginine- and tryptophan-rich hexapeptide', '', '', 'Design of novel antimicrobial peptide dimer analogues with enhanced antimicrobial activity in vitro and in vivo by intermolecular triazole bridge strategy.', 28040477),
('Thiazomycin, nocathiacin and analogs', 'Activity against drug resistant Mycobacterium tuberculosis with different MICs', '', 'Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis. Thiazolyl peptides are a class of natural products with potent Gram-positive antibacterial activities.', 28096545),
('Heterofunctionalized poly(ethylene glycol) with different lengths (methacrylate-PEGn-tosyl, n=10/45/90) conjugated with polypeptides to form diblock amphiphiles', 'Antimicrobial activity against several pathogenic bacteria like Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and effectively prevent biofilm formation', '', 'Thus, this facilely synthesized PEGylated AMP bottlebrush coating is a feasible method to prevent biomedical devices-associated infections.', 28131941),
('[K3]SHa', '[K3]SHa emerged as a highly potent compound active against a wide range of bacteria, yeasts/fungi, and trypanosomatids (Leishmania and Trypanosoma), with leishmanicidal intramacrophagic activity and efficiency toward antibiotic-resistant strains of S. aureus and antimony-resistant L. infantum.', '', 'To improve activity, we designed analogs of SHa and compared the antibacterial and antiparasitic mechanisms. [K3]SHa emerged as a highly potent compound active against a wide range of bacteria, yeasts/fungi, and trypanosomatids (Leishmania and Trypanosoma), with leishmanicidal intramacrophagic activity and efficiency toward antibiotic-resistant strains of S. aureus and antimony-resistant L. infantum.', 28319176),
('Cecropin A2', 'Synergistic Efficacy in combination with Tetracycline against Pseudomonas aeruginosa', '', 'Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa.', 28483966),
('Sph12-38', 'MIC 3 micro M against Staphylococcus aureus, Corynebacterium glutamicum, Micrococcus lysodeikticus Fleming, Bacillus subtilis, Pseudomonas fluorescens, Aeromonas hydrophila and A. sobria', '', 'Taken together, the synthetic peptide of Sph12-38 had a potent antimicrobial activity against bacteria.', 28600196),
('Free or anchored antimicrobial peptides like  the cathelicidins BMAP-27 and BMAP-28, their (1-18) fragments and the rationally designed, artificial P19(9/G7) peptide', 'Effective at micromolar concentrations against 22 Staphylococcus and Streptococcus isolates from orthopaedic infections,  BMAP-28 and to a lesser extent BMAP-27 were active against Enterococcus faecalis', 'Negligible toxicity towards osteoblasts', 'Alpha-helical antimicrobial peptides (AMPs) may be promising candidates in this respect due to their potent and broad-spectrum antimicrobial activity, their low tendency to elicit resistance and possible retention of efficacy in the immobilized state.', 28707817),
('NZ2114 and MP1102', 'The minimal inhibitory concentration and minimal bactericidal concentration of NZ2114 and MP1102 against resistant C. perfringens type A strain CVCC 46 were 0.91 micro M', '', 'Mode of action of plectasin-derived peptides against gas gangrene-associated Clostridium perfringens type A. .', 28934314),
('Antimicrobial peptide Brevinin-2Ta (GILDTLKNLAKTAGKGILKSLVNTASCKLSGQC)', 'MIC of B-2Ta against S. aureus 64 mg/L, E. coli 32 mg/L, C. albicans 64 mg/L.', '', 'Assessment of antimicrobial and wound healing effects of Brevinin-2Ta against the bacterium Klebsiella pneumoniae in dermally-wounded rats. Antimicrobial peptides (AMPs) are regarded as promising alternatives for antibiotics due to their inherent capacity to prevent microbial drug resistance. Amphibians are rich source of bioactive molecules, which provide numerous AMPs with various structures as drug candidates.', 29340060),
('Histone H5 purified from chicken erythrocytes', 'Active against Gram-positive and Gram-negative planktonic bacteria (MIC range: 1.9 +- 1.8 to 4.9 +- 1.5 micro g/mL)', '', 'Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides. Modern medicine is challenged continuously by the increasing prevalence of antibiotic resistant bacteria.', 29402952),
('OH-CATH30 (L and D)', 'highest bactericidal activity against Acinetobacter spp., including multi-drug-resistant Acinetobacter baumannii (MRAB) and methicillin-resistant Staphylococcus aureus (MRSA)', '', 'King cobra peptide OH-CATH30 as a potential candidate drug through clinic drug-resistant isolates. Cationic antimicrobial peptides (AMPs) are considered as important candidate therapeutic agents, which exert potent microbicidal properties against bacteria, fungi and some viruses.', 29515090),
('Pituitary adenylate cyclase-activating polypeptide (PACAP)', 'Antimicrobial activity against Escherichia coli and Staphylococcus aureus', '', 'Pituitary adenylate cyclase-activating polypeptide (PACAP) is a naturally occurring cationic peptide with potent immunosuppressant and cytoprotective activities.', 29654809),
('Myristoylation of Human alpha-Defensin 5', '', '', 'Our strategy involves the myristoylation of human alpha-defensin 5 (HD5) as a therapeutic target and subsequent self-assembly in aqueous media in the absence of exogenous excipients.', 29856606),
('Antimicrobial peptide N10 and NB2', 'Both peptides were effective against A. baumannii and showed antibacterial activities (minimum inhibitory concentration (MIC) 500 micro g/ml). In the biofilm inhibition assay, NB2 reduced biofilm more efficiently (75%) than N10 (50%).', '', 'The selected peptides showed significant binding to A. baumannii rather than to the human cell line Caco-2. Both peptides were effective against A. baumannii and showed antibacterial activities', 29859290),
('Marcin-18 (FFGHLFKLATKIIPSLFR), Meucin-18 (FFGHLFKLATKIIPSLFQ) and Megicin-18 (FFGALFKLATKIIPSLFR)', 'Showed highly potent inhibitory activity against Gram-positive bacteria (MIC 1.5 to > 48.3 microM), including some clinical antibiotic-resistant strains. Importantly, in a mouse acute peritonitis model, these peptides significantly decreased the bacterial load in ascites and rescued nearly all mice heavily infected with clinical methicillin-resistant Staphylococcus aureus from lethal bacteremia.', '', 'In vitro, chemically synthetic marcin-18 and its homologs (meucin-18 and megicin-18) showed highly potent inhibitory activity against Gram-positive bacteria, including some clinical antibiotic-resistant strains.', 29896190),
('Oligo-lipidated arginyl peptide (OLAP11)', 'antimicrobial actions against MRSA infections', 'low in vitro toxicity', 'Our results showed that OLAP-11 exhibits potent antimicrobial activity against Gram-positive bacteria with improved physico-chemical activity in various physiological conditions.', 30066172),
('LTX21', 'Role on host-pathogen interplay,', '', 'Targeting bacterial virulence or the human host immune system to increase host defence are important strategies in the search for novel antimicrobial drugs.', 30916807),
('Melittin', 'Potency in eradication of extensively drug-resistant (XDR) Acinetobacter spp., killed all examined XDR isolates at 4 microg/mL up to 3 h, significant activity at the minimum dose of 0.062 microg/m', 'No toxixity observed on injured or healthy derma, as well as circulating Red Blood Cells (RBCs) in the examined mice', 'Potent promising antibacterial activity of melittin and the lack of toxicity at the therapeutic dose can clarify that melittin can be implemented as a topical drug lead in a preclinical trial of third degree burn infections.', 30513367),
('MAP-0403 (J-1, J-2, and J-3)', 'MIC reported as, J-1: 5 microM, J-2 : 2.5 microM, J-3: 10 microM', 'J-2 showed significantly reduced hemolytic effect (3.4%), while J-1 and J-3 showed slightly decreased hemolytic effect (46.2%, 55.6%, respectively', 'Design, synthesis, and antimicrobial activities of novel functional peptides against Gram-positive and Gram-negative bacteria', 31059203),
('N-terminal fatty acid modified-antimicrobial peptide', 'Displayed synergistic effects when used together with the antibiotics rifampicin and polymyxin B, had strong membrane permeabilization and depolarization, could damage the integrity of the bacterial membrane and could bind to bacterial DNA', '', 'Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.', 31466017),
('Sphaeropsidin A', 'MIC= 6.25 microgram/mL to 12.5 microgram/mL, methicillin-resistant S. aureus (MRSA)', '', 'Sphaeropsidin A activity appears noteworthy for its ability to inhibit biofilm formation, preventing a growth mode that results in particular resistance to antibiotic treatment.', 32650496),
('Anoplin analogues: Ano-1beta and Ano-8beta', 'Multidrug-resistant P. aeruginosa', '', 'The new peptides Ano-1beta and Ano-8beta might be promising antimicrobial candidates in combating the increasing antibiotic-resistant bacteria.', 32654770),
('Tridecaptin M', 'Tridecaptin M reduced the MIC of vancomycin and rifampicin against A. baumannii by 16-fold', 'Tridecaptin M and rifampicin combination killed the bacteria completely in 4 h in an ex vivo blood infection model and was superior to rifampicin monotherapy', 'This study reports the in vitro potential of an antimicrobial peptide tridecaptin M in combination with other antibiotics against different strains of A. baumannii.', 32708842),
('cCATH-2 (a chicken-derived antimicrobial peptide)', 'All tested concentrations of cCATH-2 (1/32-1/2MIC) significantly reduced the biomass at the biofilm formation stage', '', 'Inhibitory effect of a novel chicken-derived anti-biofilm peptide on P. aeruginosa biofilms and virulence factors.', 32976967),
('PBDM1: YKWFAHLIKGLC and PBDM2: YKWFRHLIKKLC', 'The MIC value of PBDM1 was found to be as 10 microgram/mL against S. aureus, MRSA, and E. coli. Whereas, in case of E. faecalis, VRSA and VRE the MIC was found to be 30, 15, and 20 microgram/mL. But, the MIC value for PBDM2 was 10 microgram/mL when tested against S. aureus, MRSA, VRSA, VRE, and E. coli. Whereas, in case of E. faecalis the MIC was found to be 20 microgram/mL', 'in vitro study with human epithelial cells showed no significant cytotoxic effects with high biocompatibility and good hemocompatibility', 'In conclusion, PBDM peptides displayed significant antibacterial activity against certain drug resistant bacteria which cause infections in human beings', 32983007),
('L1G, L7A, and L1GA5K : Mastoparan-C (MP-C) analogs', 'The newly designed peptides showed synergy or additive effects against Gram-negative bacteria, when they combined with conventional antibiotics gentamicin, rifampin, and polymyxin B.', '', 'Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.', 33285267),
('Astucin from A. tubingensis A01.', 'The MIC of the purified polypeptide was 32 m/L and 128 microgram/mL and the MBIC was 2 and 8 microgram/mL against Staphylococcus aureus and MRSA, respectively', 'The results demonstrated that the antimicrobial and antibiofilm activity of astucin, together with its lack of cytotoxicity, makes it an alternative for application in medicine.', 'This protein shows antimicrobial and antibiofilm activity against S. aureus.', 33309927),
('F12, Lysostaphin', 'F12 possesses high potency and rapid onset of action, it has narrow selectivity against pathogenic staphylococci, and it manifests synergy with numerous SOC antibiotics.', '', 'These results suggest that combinations of F12 and SOC antibiotics are a promising new approach to treating refractory S. aureus infections.', 33318001),
('Nisin and P10', 'Nisin + colistin and P10+ceftazidime/doripenem were effective on XDR A. baumannii . The MIC value of Nisin and P10 against studied pathogens were 64-256 and 8-32 microgram/ml, respectively.', '', 'Combination therapy and using antimicrobial peptides are two strategies with high potential to solve this issue.', 33346078),
('C14-R1 (C14-RWW-NH2) and C12-R2 (C12-RRW-NH2)', 'C14-R1 and C12-R2 showed high antimicrobial potential for gram-positive bacteria.', 'Among them, the new lipopeptides C14-R1 (C14-RWW-NH2) and C12-R2 (C12-RRW-NH2) presented higher selectivity to bacterial membranes over mammalian membranes and low cytotoxicity, which also maintained better antimicrobial activity in the presence of physiological salts or serum.', 'Most of the new lipopeptides exhibited preferable antimicrobial potential against gram-positive bacteria, including MRSA clinical isolates.', 33422980),
('Fungal peptide, NZX', 'We further observed that this peptide was effective against nontuberculous mycobacteria (NTM), such as M. avium and M. abscessus, and several Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus.', 'In vivo, the peptide remained stable in circulation and preserved lung structure better than ethambutol alone', 'Alternative ways to prevent and treat infectious diseases are needed.', 33603037),
('Peptide-Based Antibiotics', 'In both cases, optimization of the N-terminal lipid tails led to the identification of analogues with potent activity toward Escherichia coli and Pseudomonas aeruginosa.', '', 'Peptide natural products stand as promising candidates to meet this need as bacterial resistance is typically slow in response to their unique modes of action.', 33750106),
('Dilipid ultrashort cationic lipopeptides (dUSCLs)', 'Can indirectly disrupt active efflux of chloramphenicol in P. aeruginosa', '', 'Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria', 30392097),
('Microencapsulated-Host Defense Peptides (HDP ) ;Ub2-MS, K4-MS, and Aurein1.2-MS', 'HDP-MS exhibited up to ?3.02 and ?3.41-log decrease in Mycobacterium tuberculosis CFU as compared to blank-MS (drug free) and untreated control group in 96 h', '', 'Mycobactericidal activity of some micro-encapsulated synthetic Host Defense Peptides (HDP) by expediting the permeation of antibiotic: A new paradigm of drug delivery for tuberculosis.', 30630076),
('Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles', 'The most potent, broad-spectrum peptidomimetic showed activity against Gram-positive (methicillin-resistant Staphylococcus aureus - MIC = 2 microg/mL) and Gram-negative (Escherichia coli - MIC = 4 microg/mL) pathogenic bacteria.', '', 'Synthetic small molecular antimicrobial peptidomimetics represent a promising new class of potential antibiotics due to their membrane-disrupting ability and their decreased propensity for bacterial resistance.', 30831407),
('alpha-Peptide/beta-Peptoid Lysine-Based Peptidomimetics', 'High potency against clinical drug-resistant P. aeruginosa strains', '', 'Emergence of bacterial resistance renders existing antibiotics inefficient, and therefore discovery of new antimicrobial agents is highly warranted.', 30842761),
('Cationic Antimicrobial Peptides (CAMPs) : LL-37: human cathelicidin, CAMA: cecropin(1-7)-melittin A(2-9) amide, magainin-II and nisin', 'activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa', '', 'This study showed the potent and rapid antibacterial activity of CAMPs on both laboratory and clinical isolates of S. aureus and P. aeruginosa either susceptible or resistant to antibiotics.', 30849936),
('Peptide dendrimers G3KL and TNS18', 'Can destroy the Pseudomonas aeruginosa biofilm morphological structure and thickness', '', 'Potent activity on planktonic cells and biofilms of P. aeruginosa suggests that peptide dendrimers G3KL and TNS18 are promising candidates of clinical development for treating infections.', 31101943),
('Hybrid antimicrobial peptide (B1) from helical parts taken from the parent peptides: LL-37 and BMAP-27', 'Broad-spectrum activities, the concentration against planktonic cells ranged between 10 and 20 microM, 40-60 microM were needed to eradicate the biofilm', 'Reduced toxicity toward mammalian cells with minimal hemolysis risk', 'Results: The new peptide B1 exhibited broad-spectrum activities against all tested strains.', 31118709),
('Bac1, Bac2 and Bac3', 'Inhibit the growth of Leuconostoc mesenteroides and affect sperm motility', '', 'Bacteriocins, which are bacterially-derived antimicrobial peptides, may fulfill some of the criteria for these new agents.', 31244418),
('vancomycin derivatives carrying LPS binding peptides, vancomycin-LPS binding peptide conjugates (VPCs).', 'were screened against VISA/VRE and Gram-negative strains', '', 'VPCs exhibited enhanced activity against vancomycin resistant bacteria and obtained the activity against Gram-negative bacteria in vitro, providing a novel strategy for vancomycin modification and glycopeptide antibiotics synthesis.', 34015504),
('Activated caseinolytic protease P (ClpP)', 'an antibacterial assessment demonstrated that ONC212 displays excellent activity against Xoo and prevents rice bacterial leaf blight in vivo.', '', 'Additionally, an antibacterial assessment demonstrated that ONC212 displays excellent activity against Xoo and prevents rice bacterial leaf blight in vivo.', 34218658),
('a chimeric peptide-G6, a N6NH2 analog', 'Showed MIC value: 16 microgram/mL and could curb N6NH2-resistant mutants by stronger inhibition of biofilm formation, stronger affinity with LPS, and stronger membrane permeability and depolarization than that of N6NH2.', '', 'Antimicrobial peptides (AMPs) are regarded as the potentially effective therapy.', 34889983),
('AMPR-22 (antimicrobial peptide derived from Romo1)', 'It showed broad-spectrum antimicrobial activity against 17 sepsis-causing bacteria, including MDR strains, by inducing membrane permeabilization.', 'Moreover, treatment with AMPR-22 enabled a remarkable survival rate in mice injected with MDR bacteria in a murine model of sepsis.', 'Based on these results, we suggest that AMPR-22 could be prescribed as a first-line therapy (prior to bacterial identification) for patients diagnosed with sepsis.', 34361008),
('glucose-dependent insulinotropic polypeptide (GIP)', 'While GIP was devoid of direct antimicrobial activity, it has a potent membrane depolarizing effect, and at low concentrations, it significantly potentiated the activity of eight antibiotics and bile salt by reducing MICs by 4-8-fold in E. coli TG1 and 4-20-fold in E. amylovora 1189.', '', 'GIP can thus be regarded as an antimicrobial adjuvant with potential for augmenting the available antibiotic arsenal. © 2020 Walter de Gruyter GmbH, Berlin/Boston.', 33938181),
('beta-defensin-derived peptide', 'The MIC values ranged from 2 to 4?8 microM for all the microorganisms tested, with the exception of the P. aeruginosa MDR strain 1 and A. baumannii strain 1 that are resistant up to a concentration of 32?64 microM of both peptide forms', 'it has great stability in human serum thereby enhancing its antibacterial presence and activity without cytotoxicity in human cells.', 'Currently, the race is on to identify pharmaceutical molecules or combinations of molecules able to prevent or reduce the insurgence and/or progression of infectivity.', 34818435),
('PHNX peptides', 'PHNX-1 demonstrated antibacterial activity (under high and low-salt conditions) against antibiotic resistant and susceptible strains of Gram-positive and Gram-negative bacteria and PHNX-4 to -8 demonstrated low-salt antibacterial activity only.', '', 'Development of new antibiotics has slowed in recent years and novel therapeutics (like AMPs) with a focus against Gram-negative bacteria are needed.', 34867843),
('cationic antimicrobial peptides (AMPs)', 'In contrast, it showed minimum inhibitory concentration values (MICs) lower than reported for several AMPs and other synthetic cationic compounds on Acinetobacter genus (3.2-12.7 microM).', '', 'New therapeutic possibilities are, therefore, urgently needed to circumvent this important problem.', 34298891),
('Synthetic beta-hairpin antimicrobial peptides', 'mutations of only 2 to 4 amino acids at the turn region could impart a wide range of antimicrobial profiles among synthetic beta-hairpin AMPs. BTT2-4 and BTT6 displayed selective potency against Gram-negative bacteria, with minimum inhibitory concentrations (MICs) of 4-8 microM.', 'Our peptides were also determined to be non-cytotoxic against a human cell line.', 'Synthetic β-hairpin antimicrobial peptides (AMPs) offer a useful source for the development of novel antimicrobial agents. β-hairpin peptides generally consist of two side strands bridged by a reverse turn.', 34506975),
('dipicolylamine-containing carbazole amphiphiles with strong Zn2+', 'antimicrobial candidate. 16 combined with 12.5 microgram/mL Zn2+ exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria (MICs = 0.78-3.125 microgram/mL), weak hemolytic activity, and low cytotoxicity.', 'antimicrobial candidate. 16 combined with 12.5 microgram/mL Zn2+ exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria (MICs = 0.78-3.125 microgram/mL), weak hemolytic activity, and low cytotoxicity.', 'Effective broad-spectrum 16 combined with 12.5 μg/mL Zn2+ was identified as the most promising antimicrobial candidate. 16 combined with 12.5 μg/mL Zn2+ exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria (MICs = 0.78-3.125 μg/mL), weak hemolytic activity, and low cytotoxicity.', 34235929),
('cathelicidin-related (CR-) peptides- PepBiotics', 'A relatively small number of PepBiotics remained highly antibacterial against CF-related respiratory pathogens Pseudomonas aeruginosa and Staphylococcus aureus, at high ionic strength and low pH. I', 'Finally, interaction of CR-163 with bacterial-type anionic membranes but not with mammalian-type (zwitterionic lipid) membranes was confirmed using ITC and 31P solid state NMR.', 'Interestingly, these PepBiotics also prevented LPS/LTA induced activation of macrophages and was shown to be non-toxic to primary human nasal epithelial cells.', 34147544),
('Temporin A and the short lipopeptides (C10)2-KKKK-NH2 and (C12)2-KKKK-NH2', '', '', 'The results of the performed experiments suggest that the potential application of peptides as adjuvant agents in the treatment of biofilm-associated infections should be studied further.', 32887236),
('CB6-C', 'effective antimicrobial activity against gram-positive bacteria (in particular, the MIC for MRSA was 16 Microgram/mL)', '', 'In conclusion, this protein CB6-C is a newly discovered antibacterial protein and has the potential to become an effective antibacterial agent due to its high therapeutic index, safety, nontoxicity and great stability.', 34983528),
('Lactoferricin B-Mutant (M4)', 'Among the potent AMP mutants, a Lactoferricin B-Mutant (M4) possessed uniformly high affinity with SHV1, OXA48, NDM1, and AmpC having energies -842.0Kcal/mol, -774.8Kcal/mol, -1103.3Kcal/mol, and -858.8Kcal/mol respectively. Highest affinity of Lactoferricin B_M4 was found with NDM1 due to H-bonds, salt-bridges, and hydrophobic interactions with the metallo-beta-lactamase domain including crucial active-site residue Asp124.', '', 'Molecular dynamics simulation further confirmed the stability of Lactoferricin B_M4-NDM1 complex having low residue-level root-mean square deviations (RMSD), atomic-level fluctuations, and radius of gyration (Rg). The study encourages experimental validations and similar methods to identify potential AMPs against drug-resistant pathogens.', 35188617),
('PaP1', 'TSP showed lytic spectrum of ~ 75%, suggesting its activity against various MRSA and MSSA isolates from different clinical samples. The phage efficiently inhibited bacterial growth for up to 12 h at MOI of 1 and 10. TSP phage showed activity against various isolates of MRSA and MSSA, isolated from different clinical samples, with variable antibiotic susceptibility patterns.', '', 'Despite the necessity for additional preclinical drug development, the collective data from our study support PaP1 as a potential broad-spectrum monotherapy or adjunctive therapy for the topical treatment of polymicrobial infections and provide a foundation for engineering future lysin-derived peptides with improved antibacterial properties.', 35369520),
('two-peptide lantibiotic produced by Vagococcus fluvialis LMGT 4216', 'The combination of the two peptides resulted in a 1,200-fold increase in potency, confirming the two-peptide nature of the bacteriocin, named vagococcin T. The bacteriocin was demonstrated to kill sensitive cells by the formation of pores in the cell membrane, and its inhibition spectrum covers most Gram-positive bacteria, including multiresistant pathogens.', '', 'The novel lantibiotic showed a broad spectrum of inhibition of Gram-positive strains, including vancomycin-resistant Enterococcus faecium, demonstrating its therapeutic potential.', 35730941),
('two CAMPs (LL-37 and CAMA)', 'We observed a greater bactericidal effect when IB3-1 cells were pretreated with sub-minimum bactericidal concentrations (Sub-MBCs) of the CAMPs prior to infection. These findings suggest that CAMPs induce the production of factors by IB3-1 cells that improve their bactericidal action. LL-37 induced a weak inflammatory response in the cells without being toxic.', 'The two CAMPs exerted different effects on PA survival depending on the timing of their administration. However, we observed no bactericidal effect when supra-minimum bactericidal concentrations (Supra-MBCs) of the CAMPs were added to IB3-1 cells at the same time or after infection.', 'In conclusion, our findings suggest a potential prophylactic action of CAMPs. The bactericidal effects were low when the CAMPs were added after cell infection, likely due to degradation of CAMPs by bacterial or epithelial cell proteases and/or due to adherence of CAMPs to cells becoming less available for direct bacterial killing.', 34954126),
('series of AMPs with linear and star-shape (using n-hexylamine and amine-terminated polyamidoamine dendrimers (Gx-PAMAM, x = 1-2) as initiators)', 'The star-shaped AMPs exhibited enhanced bactericidal activity against Gram-negative E. coli and similar bactericidal activity against Gram-positive S. aureus when compared with the linear AMPs. It is worth mentioning that star-shaped AMPs demonstrated a significantly faster bactericidal efficiency (completely killed bacteria within 5 min at a concentration of 2 ', '', 'In addition, both the surfaces grafted with AMPs of different topologies demonstrated favorable biocompatibility in vitro.', 35005755);
INSERT INTO `bacteria_amp` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('metronidazole (MDZ), clindamycin (CLI), and PM-477', 'Determination of the MIC indicated that 60% of a panel of 22 Gardnerella isolates of four different species were resistant to MDZ, while all strains were highly susceptible to CLI and to the endolysin PM-477. All strains were susceptible to PM-477 when grown as preformed biofilms, at minimum biofilm eradication concentrations (MBECs) in the range of 1 to 4 microg/mL.', '', 'Therefore, the high efficacy of PM-477 in eliminating Gardnerella in in vitro biofilms, as well as its high resilience to resistance formation, makes PM-477 a promising potential alternative for the treatment of bacterial vaginosis, especially in patients with frequent recurrence.', 35416708),
('cationic antimicrobial peptides (CAMPs)', 'In this study, the interaction of a CAMP derived from cecropin D-like (?M2) with model membranes mimicking bacterial biomembranes of wild-type (WTPa) strains of P. aeruginosa and CRPa was evaluated through in vitro and in silico approaches.', '', 'This work provides clues for elucidating the membrane-associated mechanism of action of ?M2 against colistin-susceptible and -resistant strains of Pseudomonas aeruginosa. Accordingly, cationic antimicrobial peptides (CAMPs) have emerged as promising alternatives to control resistant bacteria.', 35745820),
('Temporin-PKE', 'Temporin-PKE is a novel peptide extracted from the skin secretion of Pelophylax kl. esculentus and it displays a strong activity against Gram-positive bacteria, with an extreme cytotoxicity. The transformation of the chirality of Ile could reduce haemolytic activity, and an analogue with appropriate D-isoforms could maintain antimicrobial activity and stability. The substitution of hydrophobic residues could bring about more potent and broad-spectrum antimicrobial activities.', 'The analogues with Lys were less harmful to the normal cells and their stabilities remained at similarly high levels compared to temporin-PKE.', 'Temporin-PKE-3K exerted dually efficient functions includingstrong antimicrobial and anticancer activity. This analogue showed a reduced possibility for inducing resistance in MRSA and Klebsiella pneumoniae, a rather strong antimicrobial activity in vivo, and it exhibited the highest therapeutic index such that temporin-PKE-3K has the potential to be developed as a clinical drug.', 35740884),
('Pediocin-like bacteriocins (class IIa bacteriocins)', 'They act on the cytoplasmic membrane of Gram-positive cells by dissipating the transmembrane electrical potential through pore formation with the mannose phosphotransferase system (man-PTS) as the target/receptor. Bacteriocin-producing strains also synthesize a cognate immunity protein that protects them against their own bacteriocins.', 'Pediocin-like bacteriocins, ribosomally synthesized antimicrobial peptides, are generally co-expressed with cognate immunity proteins to protect the bacteriocin-producing strain from its own bacteriocin.', 'Bacteriocins are considered potential alternatives to conventional antibiotics in the context of the bacterial resistance crisis, but the immunity mechanism is unclear. This study uncovered the mechanisms of action and immunity of class IIa bacteriocins.', 35703550),
('Antimicrobial Peptides CATH-1, CATH-3, and PMAP-36 With Erythromycin', 'The results showed that the minimum bactericidal concentration (MBC) of CATH-1,-3 and PMAP-36 was lower than 10 microM, indicating that these three AMPs had good bacterial activity against S. aureus, S. enteritidis, and E. coli. The results showed that the FBCI of AMPs (CATH-1,-3 and PMAP-36) and erythromycin was lower than 0.5 against bacterial pathogens, demonstrating that they had a synergistic bactericidal effect. Furthermore, the time-killing kinetics of AMPs (CATH-1,-3 and PMAP-36) in combination with erythromycin showed that they had a continuous killing effect on bacteria within 3 h. Notably, the combination showed lower hemolytic activity and cytotoxicity to mammal cells compared to erythromycin and peptide alone treatment. In addition, the antibacterial mechanism of CATH-1 and erythromycin combination against E. coli was studied. The results of the scanning electron microscope showed that CATH-1 enhanced the antibacterial activity of erythromycin by increasing the permeability of bacterial cell membrane. Moreover, the results of bacterial migration movement showed that the combination of CATH-1 and erythromycin significantly inhibits the migration of E. coli. Finally, drug resistance analysis was performed and the results showed that CATH-1 delayed the emergence of E. coli resistance to erythromycin.', '', 'In conclusion, the combination of CATH-1 and erythromycin has synergistic antibacterial activity and reduces the emergence of bacterial drug resistance. Our study provides valuable information to develop AMPs as potential substitutes or adjuvants for traditional antibiotics.', 35910608),
('beta-Hairpin Peptide Z-d14CFR or recombinant Zophobas atratus (Z. atratus) defensin', 'Our results showed that Z-d14CFR (RGCRCNSKSFCVCR-NH2) exhibited a broad-spectrum antimicrobial activity to both Gram-positive bacteria and Gram-negative bacteria, including multidrug-resistant bacteria.', 'It possessed less than 5% hemolysis and 10% cytotoxicity, even at a high concentration of 1 mg/mL.', 'Our findings suggest that Z-d14CFR could be a promising candidate against multidrug-resistant bacteria.', 35563007),
('cell-penetrating peptide fused endolysin', 'Bacteriophage encoded endolysin as an alternative antibiotics is a peptidoglycan degrading enzyme with a low rate of resistance. This engineered endolysin, DS-PA90, completely killed A. baumannii at 0.25 microM, at which concentration PA90 could only eliminate less than one log in CFU/ml. Additionally, DS-PA90 has tolerance to NaCl, where the ?50% of activity could be maintained in the presence of 150 mM NaCl, and stable activity was also observed with changes in pH or temperature. Even MDR A. baumannii strains were highly susceptible to DS-PA90 treatment: five out of nine strains were entirely killed and four strains were reduced by 3-4 log in CFU/ml. Consequently, DS-PA90 could protect waxworm from A. baumannii-induced death by ?70% for ATCC 17978 or ?44% for MDR strain 1656-2 infection.', '', 'Collectively, our data suggest that CPP-fused endolysin can be an effective antibacterial agent against Gram-negative pathogens regardless of antibiotics resistance mechanisms.', 35614377),
('tetrameric cell penetrating antimicrobial peptoids', 'Short tetrameric Rhodamine B-labeled peptoids composed of a balance of aromatic and lipophilic residues have potent selective antimicrobial activity against a range of microorganisms. The most potent candidates were active against drug-resistant S. aureus isolates as well as mycobacterial strains, with cell penetrating capabilities reported in HeLa and RAW 264.7 macrophage cells.', '', 'Conclusions: These data suggest that peptoids with novel dual functionalities may potentially be an interesting class of therapeutics and/or molecular delivery agents for anti-infective purposes.', 35227007),
('Human neutrophil peptide-1 (HNP-1)', 'HNP-1 induces bacterial apoptosis and prevents its SOS repair pathway from binding to the RecA protein, which may be a new antibacterial mechanism. In addition, we showed that HNP-1 encapsulated in liposomes inhibits the growth of methicillin-resistant Staphylococcus aureus (MRSA) and meropenem-resistant Pseudomonas aeruginosa (MRPA).', '', 'These results indicated that recombinant protein expression may be a simple and cost-effective solution to produce HNP-1 and that RecA inhibition via HNP-1 may serve as an alternative strategy to counteract antibiotic resistance.', 35019682),
('RPMs : FK20 (L-Phenylalanine-L-Lysine, 20-mer), FdK (L-Phenylalanine-D-Lysine, 20-mer), dFdK (D-Phenylalanine-D-Lysine, 20-mer), and LK20 (L-Leucine-L-Lysine, 20-mer)', 'RPMs rapidly and efficiently kill different strains of A. baumannii, inhibit biofilm formation, and disrupt mature biofilms. Importantly, RPMs attenuated bacterial burden in mouse models of acute pneumonia and soft tissue infection and significantly reduced mouse mortality during sepsis.', '', 'Collectively, our results demonstrate RPMs have the potential to be used as powerful therapeutics against antibiotic-resistant A. baumannii.', 35326876),
('beta-hairpin structure with the template (XY)2RRRF(YX)2-NH2 (X: hydrophobic amino acids; Y: cationic amino acids)', 'Almost all of the new peptides have strong antibacterial activity and negligible hemolytic toxicity. Particularly, the therapeutic index (TI) values of F(RI)2R and F(KW)2K reached up to 115.9 and 70.7, respectively. In addition, they did not show induced drug resistance and inhibited the development of antibiotic resistance when combined and used with traditional antibiotics.', '', 'Moreover, the new peptides F(RI)2R and F(KW)2K showed excellent performance in the pulmonary bacterial infection model and low toxicity in mice. In conclusion, F(RI)2R and F(KW)2K are considered new antimicrobial alternatives to address the antimicrobial-resistance crisis.', 35311294),
('Black Soldier Fly ( Hermetia Illucens) : Hill-Cec1 and Hill-Cec10', 'Hill-Cec1 and Hill-Cec10 also showed high activity against other bacterial species, including Klebsiella pneumoniae and multi-drug resistant P. aeruginosa. Both AMPs are bactericidal and have a rapid onset of action with membrane-permeabilizing effects.', 'Hill-Cec1 and Hill-Cec10 were also able to prevent P. aeruginosa biofilm formation, but no relevant effect was seen on biofilm eradication.', 'Overall, Hill-Cec1 and Hill-Cec10 are promising leads for new antimicrobial development to treat critical infections caused by Gram-negative pathogens such as P. aeruginosa.', 34985302),
('Cathelicidin-Mimetic Antimicrobial Peptoids', 'These peptoids also show efficient and fast (<30 min) killing of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) at low micromolar concentrations without having apparent cytotoxic side effects in vivo. One cationic 12mer, Peptoid 1, shows great promise, as it could prevent formation of and detach biofilms at concentrations as low as 1.6 microM.', 'The use of a bioluminescent S. aureus murine incision wound model demonstrated clearance of infection in peptoid-treated mice within 8 days, conveying another advantage these peptoids have over conventional antibiotics.', 'These results provide clear evidence of the potential for antimicrobial peptoids for the treatment of S. aureus wound infections.', 35467395),
('cell adhesion peptide (CAPs) nanocoatings', 'The two leading nanocoatings upregulated integrin-mediated hemidesmosomes, selectively increased keratinocyte proliferation compared to fibroblasts, which cannot form hemidesmosomes, and expression of junctional epithelium adhesive markers. CAP nanocoatings displayed marked durability under simulated clinical conditions and the top performer CAP nanocoating was validated in a percutaneous implant murine model. Basement membrane CAP nanocoatings, inspired by the tooth and junctional epithelium, may provide an alternative anti-infective strategy for percutaneous devices to mitigate the worldwide threat of antimicrobial resistance.', '', 'Application of cell adhesion peptide nanocoatings may provide an alternative to preventing, rather that necessarily treating, medical device infection across a range of device indications, like dental implants.', 34971784),
('Peptides ASU2056, ASU2060', 'Overall, six peptides inhibited the M. abscessus smooth morphotype (IC50 = 1.7 microM for all peptides) and had reduced activity against the M. abscessus rough morphotype (IC50 range: 13-82 microM). Peptides ASU2056 and ASU2060 had minimum inhibitory concentration values of 32 and 8 microM, respectively, against the M. abscessus smooth morphotype. Additionally, ASU2060 (8 microM) was active against Escherichia coli, including multidrug-resistant E. coli clinical isolates, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus. ASU2056 and ASU2060 exhibited no significant hemolytic activity at biologically relevant concentrations, further supporting these peptides as promising therapeutic candidates. Moreover, ASU2060 retained antibacterial activity after preincubation in human serum for 24 h.', '', 'With antimicrobial resistance on the rise, methods such as those presented here will streamline the peptide discovery process for targeted antimicrobial peptides.', 35847280),
('Purified arasin-likeSp', 'The ELP-intein self-cleavage system was used to produce antimicrobial peptide arasin-likeSp in Escherichia coli. The final yield of arasin-likeSp was about 3.56 mg/L. Purified arasin-likeSp exhibited significant antibacterial activities against the Gram-positive Bacillus subtilis and Gram-negative Vibrio harveyi bacteria.', '', 'Collectively, these data suggest that arasin-likeSp is a candidate AMP for effective inhibition of Vibrio harveyi, a significant bacterial pathogen infecting marine fish and invertebrates. The ELP-intein self-cleavage system described here is a low-cost, simple and potential method for producing antimicrobial peptides, which lays foundations for the large-scale production of antimicrobial peptides in the future.', 35240202),
('hepcidin gene from the fish, Catla catla (Cc-Hep)', 'Sequence analysis revealed that Cc-Hep shared sequence similarity with hepcidin from Sorsogona tuberculata. Sequence analysis revealed that Cc-Hep shared sequence similarity with hepcidin from Sorsogona tuberculata.', '', 'Conclusion: Functional characterization predicted antibacterial, antioxidant, and anticancer potential of Cc-Hep, which can be explored in aquaculture or human health care.', 35344090),
('d,l-K6L9 peptides', 'd,l-K6L9 peptides are stable and resistant to degradation by CF sputum proteases and maintain their activity in a CF sputum environment. Additionally, the d,l-K6L9 peptides do not induce bacterial resistance.', '', 'Overall, these findings should assist in the future development of alternative treatments against resistant bacterial biofilms.', 35759644),
('Lycosin-II isolated from spiders Lycosa singoriensis', 'Lycosin-II showed strong antibacterial activity and biofilm inhibition effects against gram-positive and gram-negative bacteria including oxacillin-resistant Staphylococcus aureus (S. aureus) and meropenem-resistant Pseudomonas aeruginosa (P. aeruginosa) isolated from patients.', 'Lycosin-II was not cytotoxic against human foreskin fibroblast Hs27 or hemolytic against sheep red blood cells at the concentration of which exerted antibacterial activity.', 'Moreover, Lycosin-II showed anti-inflammatory effects by inhibiting the expression of pro-inflammatory cytokines that are increased during bacterial infection in Hs27 cells. These results suggest that Lycosin-II can serve as a therapeutic agent against infections with multidrug-resistant strains.', 34506798),
('WLBU2 (also known as PLG0206)', 'Populations that survived WLBU2 treatment acquired a minimum of two mutations, making the acquisition of resistance more difficult than for most antibiotics, which can be tolerated by mutation of a single target. Major targets of resistance to WLBU2 included the orfN and pmrB genes, previously described to confer resistance to other cationic peptides. More surprisingly, mutations that increase aggregation such as the wsp pathway were also selected despite the ability of WLBU2 to kill cells growing in a biofilm.', '', 'Conclusions and implications: The results show how experimental evolution and WGS can identify genetic targets and actions of new antimicrobial compounds and predict pathways to resistance of new antibiotics in clinical practice.', 35712084),
('insect metallopeptidase inhibitor (IMPI)', 'designed a cohort of 12 single and multiple point mutants, the best of which (I57F) inhibited aureolysin with an estimated inhibition constant (K i) of 346 nM.', '', 'Given that animals lack thermolysins, our strategy may facilitate the development of safe TPs against staphylococcal infections, including strains resistant to conventional antibiotics.', 35465156),
('LcC CL28-25 (Larimichthys crocea), Derived from Piscine Chemokine', 'lcCCL28-25 was capable of rapidly destroying the integrity and permeability of the bacterial cell membrane', '', 'Additionally, the efficacy of lcCCL28-25 in in vivo antibacterial activity in a mammalian model revealed that this compound could be a promising agent for the development of peptide-based antibacterial therapeutics. The novel peptide lcCCL28-25 may prove to be an effective antibacterial agent.', 35616397),
('anti-inhA peptide nucleic acids (PNAs)', 'The antibacterial efficacy of anti-inhA PNA is enhanced when it is combined with permeabilizing drugs, particularly ethambutol. This indicates that the addition of even small concentrations of anti-inhA PNA to the current TB regimen could potentiate their therapeutic efficiency. We hypothesize that this system would also overcome isoniazid resistance, since the resistance mutations lie outside the designed anti-inhA PNA target site.', '', 'We therefore propose that anti-inhA PNA could improve therapy even when applied in minute doses as an addition to the current anti-tuberculosis drug regimen.', 35171048),
('pH-responsive antimicrobial peptides (F5: FLEHLIPHVIHGLVHAIHH-NH2)', 'efficient bacterial killing activity at pH 6.5 and inactivity at pH 7.4. Among the peptides, F5 exhibited outstanding pH-responsive antimicrobial activity and low toxicity. Fluorescence spectroscopy and electron microscopy illustrated that F5 killed bacteria via a membrane-disruptive mechanism at acidic pH values.', 'Mouse cutaneous abscesses revealed that F5 was equipped with excellent therapeutic ability to reduce the bacterial load and cytokines without causing skin toxicity.', 'In summary, this study reveals a strategy for selectively killing bacteria under the pathologic conditions of abscess sites while avoiding the elimination of commensal bacteria under normal physiological pH levels.', 35294199),
('BF15-a1 (lysine-stapled CAMPs)', 'CAMPs with a better amphiphilic structure were inclined to exhibit improved antimicrobial activity, protease stability, and biocompatibility after lysine-stapling. One of the stapled analogues of BF15-a1 was found to have extended half-life in plasma, enhanced antimicrobial activity against clinically isolated MDR ESKAPE pathogens, and remained highly effective in combating MRSA infection in a mouse model.', '', 'Cationic antimicrobial peptides (CAMPs) are promising for treatment of multidrug-resistant (MDR) bacteria-caused infections.', 34968054),
('ZN-5 and ZN-6 (Oreoch-2 analogues)', 'were identified to be broad-spectrum effective analogues, which were superior to their parent peptide Oreoch-2. good stability to the physiological environment, and much higher selectivity to bacterial cells than to mammalian cells. Were typical bactericidal agents and quickly eliminated bacteria in a bactericidal mode by disrupting bacterial cell membrane. Moreover, ZN-5 and ZN-6 could inhibit biofilm formation of Staphylococcus aureus ATCC25923.', 'Compared with their parent peptide Oreoch-2, ZN-5 and ZN-6 not only possessed shortened peptide chains, but also showed slightly improved antibacterial activity and greatly reduced hemolysis.', 'This indicates that they are ideal lead compounds of antimicrobial peptides, which can be developed as substitutes for traditional antibiotics.', 34971943),
('human ApoB-derived antimicrobial peptide r(P)ApoBLAla in combination with low concentrations of conventional antibiotics', 'to treat ureteral catheter-colonizing bacterial communities on clinically isolated bacteria', '', 'The results suggest that combinations of conventional antibiotics and human antimicrobial peptides might synergistically counteract biofilm growth on ureteral catheters, suggesting novel avenues for preventing catheter-associated infections in patients who have undergone radical cystectomy and ureterocutaneostomy.', 35743833),
('P-MtrE1', 'Cotreatment of bacteria with subinhibitory concentrations of the peptide led to 2- to 64-fold increases in susceptibility to erythromycin, azithromycin, ciprofloxacin, and/or ceftriaxone in N. gonorrhoeae strains FA1090, WHO K, WHO P, and WHO X. The cotreatment experiments with peptides P-MtrC1 and P-MtrE1 resulted in increased susceptibilities of WHO P and WHO X to azithromycin, ciprofloxacin, and ceftriaxone that were of the same magnitude seen in MtrCDE mutants.', '', 'Data presented here demonstrate that these peptides may be developed for use as a dual treatment with existing antibiotics to treat multidrug-resistant gonococcal infections.', 34633841),
('caposomes', 'capsosomes selectively deliver their cargo in the presence of bacteria, producing a bactericidal effect to protect the host organism', '', 'Thus, the capsosomes serve as a versatile multidrug, subcompartmentalized microparticle system for preventing antibiotic-resistant bacterial infections, with potential applications to protect wounds or medical device implants from infections.', 35481905),
('DCD-1L', 'The bacterial adhesion and biofilm formation in all A. baumannii isolates were inhibited at 2 ', '', 'Results of this study demonstrated that DCD-1L can inhibit bacterial attachment and biofilm formation and prevent the onset of infection. Taking these properties together, DCD-1L appears as a promising candidate for antimicrobial and anti-biofilm drug development.', 35026999),
('RWWWR (central motif) plus arginine (R) end-tagging', 'great potential in combating Escherichia coli bacteremia and the Staphylococcus aureus skin burn infection model, which induces a 62-90% reduction in bacterial burden, Pep 6 exhibited robust biofilm-inhibiting activity and eliminated 61.33% of the mature methicillin-resistant Staphylococcus aureus (MRSA) biofilm', '', 'These results suggest that the RWWWR motif and binding of arginine end-tagging could be harnessed as a new agent for combating multidrug-resistant bacteria.', 34964342),
('R23F, R23DI, and R23EI hybrid peptides', 'against Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Pseudomonas aeruginosa, Escherichia coli, and Bacillus cereus', '', 'R23F, R23DI, and R23EI can be used as antimicrobial peptides against Gram-positive and Gram-negative bacteria resistant to traditional antibiotics.', 35008951),
('Temporin-1CEc analogs 2K2L and 2K4L', 'against sensitive and multidrug-resistant bacteria, effectively killing the tested multidrug resistant strain Staphylococcus epidermidis (MRSE1208), inhibited the formation of MRSE1208 biofilms at concentrations below its MIC value', '', 'Collectively, these results suggest that 2K2L and 2K4L could be effective antibiotics against multidrug-resistant bacterial strains.', 34953322),
('PEP-38 and PEP-137 peptides', 'active in vitro against carbapenem-resistant isolates of Klebsiella aerogenes and K. pneumoniae. PEP-137 was also active against Pseudomonas aeruginosa.', '', 'The data obtained can be used to develop new antibacterial peptide drugs to combat antibiotic resistance.', 35326874),
('VicBac (Proline-Rich Cathelicidin from the Alpaca Vicugna pacos)', 'Potency to Combat Antibiotic-Resistant Bacteria', '', 'The pronounced antibacterial activity of VicBac, along with its moderate adverse effects on mammalian cells, make this molecule a promising scaffold for the development of peptide antibiotics.', 35629841),
('NZX and P2, fungal defensin-derived peptides', 'MIC values (NZX: 0.11 MicroM, P2: 0.91 MicroM) and MPC (NZX: 1.82 MicroM) against Streptococcus agalactiae', '', 'Conclusion: NZX and P2 are promising antimicrobial agents for streptococcicosis treatment.', 35630326),
('WAM-1', 'MICs of 2-4 mg/L and MBCs of 4-8 mg/L against carbapenem-resistant Klebsiella pneumoniae', '', 'Conclusions: WAM-1 has good antibacterial effect and potential anti-inflammatory effect on infection caused by CRKP.', 35474013),
('RP557 alone or in combination with several clinically effective antibiotics, including clarithromycin, amikacin, cefoxitin and imipenem', 'increases the antibiotic sensitivity of Mycobacterium abscessus by inhibiting biofilm formation', '', 'As such, RP557 is a potential candidate to include in novel strategies to treat M. abscessus infections.', 34813807),
('hyaluronic-acid-based hydrogel', 'The peptidomimetic was found to exhibit antimicrobial and anti-biofilm properties at concentration values ranging from 2.5 to 20 micromol L-1, to be biocompatible toward human skin cell lines, and to protect human keratinocytes from bacterial infections being able to induce a reduction of bacterial units by two or even four orders of magnitude with respect to untreated samples.', '', 'The developed hydrogel-based system represents a promising, effective therapeutic option by combining the mechanical properties of the hyaluronic acid polymer with the anti-infective activity of the antimicrobial peptidomimetic, thus opening novel perspectives in the treatment of skin infections.', 35740323),
('CHRG01, KSR, and KLR', 'active against gram positive as well as gram negative bacteria and kill bacteria by forming membrane pores', '', 'Understanding the molecular level interaction of individual amino acids with the lipid bilayer will greatly help in the design of more efficient antimicrobial peptides.', 34838874),
('guanidinium-functionalized poly(l-lysine) (PLL22 -Gua)', 'kills MRSA with low resistance frequency (<3.3 ', '', 'These promising results show the excellent potential of PLL22 -Gua as an antimicrobial agent against multidrug-resistant infection in vivo.', 34846807),
('peptidomimetic antibiotic 10 (human alpha-defensin 5)', 'potent killing of multiple drug-resistant gram-negative bacteria isolated from patients', '', 'By engaging multiple bacterial targets, the lead compound is efficacious in vitro and in vivo against bacteria with highly inducible antibiotic resistance, promising a useful therapeutic agent for the treatment of infections caused by antibiotic-resistant bacteria.', 35238683),
('Anisaxins', 'potent bactericidal agents in vitro, selectively active against Gram-negative bacteria, including multi-drug resistant strains, at sub-micromolar concentrations', '', 'This membranolytic antibacterial activity does not translate to cytotoxicity towards human peripheral blood mononuclear cells (HPBMCs), which was minimal at well above bactericidal concentrations, making anisaxins promising candidates for further drug development.', 35470073),
('Epinecidin-1 and Beta-Defesin-3', 'showed antibacterial activity in vitro in a concentration of 2 to 32 mg/L', '', 'For K. pneumoniae-sepsis, hBD-3 was shown to be a promising option in overcoming the resistance of Klebsiella spp. to carbapenems, though more research is needed. In the P. aeruginosa-sepsis model, the addition of Epi-1 to hBD-3 was found to have a slightly reduced mortality rate compared to hBD-3 monotherapy.', 35052952),
('Alpha-MSH (melanocyte stimulating hormone) based cationic peptides', 'most cationic analogue, KKK-MSH with a + 5 charge, demonstrated successful eradication of 105 CFU/mL of E. coli cells within 15 min at a concentration as low as 1 MicroM', '', 'Here, we propose alpha-MSH based cationic peptides as promising future agents with broad-spectrum antibacterial efficacy against both Gram-negative and Gram-positive pathogens.', 35132082),
('Nigrocin-PN (Pelophylax nigromaculatus)', 'Nigrocin-PN and ampicillin could delay Staphylococcus aureus antibiotic resistance acquisition', '', 'Conclusions: A broad-spectrum antimicrobial peptide Nigrocin-PN was discovered from the skin secretion of Pelophylax nigromaculatus. Structurally, "Rana box" played a crucial role in reducing toxicities without compromising antibacterial abilities, and Nigrocin-PN could be a desired therapeutic candidate.', 35606468),
('GHaR6R, GHaR7R, GHaR8R and GHaR9W', 'show potent antimicrobial activities against methicillin-resistant (MRSA)', 'GHaR6R, GHaR8R and GHaR9W show less toxicity toward normal cells HL-7702 and hFOB1.19.', 'These results suggest that the GHa-derived peptides may be promising antimicrobial candidates against MRSA infections.', 35538042),
('combination of hydrocarbon stapled to L8 (KRIVQRIKKWLR) and L6 (RRLFRRILRWL) peptides and antibiotics (Vancomycin)', 'different hydrocarbon staples to two previously described peptides shown to act on the outer membrane, L6 and L8, and tested their activity in a zebrafish embryo infection model using a clinical isolate of Acinetobacter baumannii as a pathogen improves its in vivo potentiating activity on antibiotic treatment, without increasing its in vivo antimicrobial activity, toxicity or hemolytic activity', '', 'We show here that combinations of stapled peptide L8S1 and vancomycin may provide an attractive novel therapeutic strategy against nosocomial A. baumannii infection.', 35203875),
('lichenicidin', 'presence of the two mature peptides, Blialpha and Blibeta, is necessary for full activity against target bacteria, both peptides exhibit synergistic activity in their interaction with the target membranes', '', 'Based on this information, we propose a mechanism of action of lichenicidin.', 34973602),
('"Picturins" (PTR) and "Pictuseptins" (PTS)', 'PTR displayed moderate activity against Escherichia coli (MIC 24.80 to 48.95 MicroM), while PTS showed a broad antimicrobial and antifungal effect. PTS-1 was the most active peptide against E. coli (6.8 microM) followed by PTS-3 (11.7 MicroM) and PTS-2 (14.24 MicroM).', '', 'Overall, new unique non-hemolytic and cationic peptide sequences were characterized that could be valuable for the next-generation of anti-infective drugs. Future functional studies should explore the pharmacological potential of Boanins to include them as antimicrobial scaffolds.', 35640793),
('Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin', 'against Cystic Fibrosis Pseudomonas aeruginosa', '', 'Our findings demonstrate that glatiramer acetate is a strong candidate for repurposing as an antibiotic resistance breaker of pathogenic P. aeruginosa.', 35727066),
('h-Lf1-11, MSI-78, LL-37 and magainin-2', 'against Escherichia coli, methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, carbapenem-resistant Klebsiella pneumoniae, and Acinetobacter baumannii. The MSI-78 showed potent bactericidal activity with MIC range of 1.25-40 mg/L against all bacterial strains. The h-Lf1-11, magainin-2, and LL-37 exhibited moderate activity (MIC range of 40-160, 80-160, and 40-160 mg/L, respectively)', '', 'These results revealed that MSI-78, h-Lf1-11, magainin-2, and LL-37 have great potential as antibacterial agents and their activity deserves to be more explored in further studies for the treatment of antibiotic-resistant bacteria.', 34735710),
('temporin B and temporin L with the addition of buforin II, a histone H2A fragment', 'less potent temporin B enhances the cooperativity of the in vitro antibacterial activity of the more potent temporin L against EMRSA-15 and that this may be associated with an altered interaction with the bacterial plasma membrane, a feature critical for the antibacterial activity of most AMPs. Addition of buforin II, a histone H2A fragment, can further increase the cooperativity.', '', 'Exploration of the mechanism of synergy between AMPs isolated from the same organism may therefore yield antibiotic combinations with advantageous pharmacodynamic properties.', 35609188),
('amyloid-beta inspired biocompatible short peptide amphiphile (sPA) molecule-AgNPs', 'potential therapeutic value for the treatment of microbiota triggered progression of neurodegenerative diseases', '', 'Such sPA-AgNPs hybrid structures can be further used to develop antibacterial materials to combat emerging bacterial resistance.', 35684988),
('brevinin-2KP', 'weakly active towards the tested Gram-positive and Gram-negative bacteria as well as fungi due to its membranolytic action', 'brevinin-2KP inhibits the proliferation of several mammal cells with IC50 values ranging from 3.27 to 59.75 microM', 'Conclusion: This is the first report on AMP identified from the skin of K. pulchra. Brevinin-2KP adopts a typical amphipathic alpha-helix conformation in membrane mimic environment and shows antimicrobial and antitumor activities by potential membranolytic mechanism. In addition, brevinin-2KP can promote degranulation and histamine release of mast cells. Brevinin-2KP is expected to become a good drug temple molecule.', 35249479),
('L-Chg10-Teixobactin', 'The MIC and MBC values of L-Chg10-teixobactin against both strains of Enterococcus faecalis were 0.8 Microg/mL.', '', 'Conclusions:L-Chg10-teixobactin demonstrated potent antibacterial and antibiofilm effects against E. faecalis, suggesting its potential role an effective antibacterial and antibiofilm agent in endodontic treatment.', 35744616),
('r(P)ApoBLPro, r(P)ApoBSPro, and r(P)ApoBLAla derived from the human apolipoprotein B (residues 887-922)', 'exhibited potent antimicrobial activity against drug-resistant Klebsiella pneumoniae, Acinetobacter baumannii, and Staphylococci both in vitro and in an animal model', '', 'Our results provide a link between human plasma and innate immunity and point to the blood as a source of much-needed antimicrobials.', 35112568),
('Star-Peptide Polymers', 'preferentially target and kill Gram-positive pathogens including MRSA', '', 'These results highlight the potential utility of peptide/polymers to fabricate materials for therapeutic development against MDR Gram-positive bacterial infections.', 35500245),
('Human Cryptic Host Defence Peptide GVF27', 'Exhibits Anti-Infective Properties against Biofilm Forming Members of the Burkholderia multivorans and Burkholderia cenocepacia', '', 'Overall, all these findings contribute to the elucidation of the main features that a good therapeutic agent directed against these extremely leathery biofilm-forming bacteria should possess.', 35215373),
('Liposome-Encapsulated Tobramycin and IDR-1018 Peptide', 'Biofilm Disruption and Enhanced Antimicrobial Activity against Pseudomonas aeruginosa, the biofilm formation was significantly reduced (p &lt; 0.05) at concentrations of ?4 Microg/mL and ?32 Microg/mL for PA01 and ?32 Microg/mL for MDR 7067 when loading tobramycin into liposomes, with or without the anti-biofilm peptide compared to the free antibiotic, empty liposomes, and IDR-1018-loaded liposomes', '', 'Tobramycin-loaded liposomes could be a potential candidate for treating lung-infected animal models owing to the high therapeutic efficacy and safety profile of this system compared to the free administration of the antibiotic.', 35631547),
('cholic acid analogues 17c and 17d', 'analogues containing lysine-like residues showed the highest antibacterial potency against Gram-positive S. aureus. All di-substituted analogues possess high antimicrobial activity against both Gram-positive S. aureus as well as Gram-negative E. coli and P. aeruginosa.', '', 'These compounds were able to depolarise the bacterial membrane, suggesting that they are potential antimicrobial pore forming agents.', 35563014),
('Mucosal pentraxin 2 (Mptx2)', 'against peritoneal infection by methicillin-resistant staphylococcus aureus', '', 'Mptx2 has bactericidal activity against MRSA both in vitro and in vivo, which may shed light on the discovery and development of novel strategies for MRSA-infected peritonitis.', 35609377),
('symbah-1', 'macrocyclic beta-hairpin peptide antibiotic', '', 'The method of discovery and subsequent characterization of symbah-1 suggests large synthetic peptide libraries bias toward macrocyclic beta-hairpin structure could be designed and screened to rapidly expand and better understand this rare peptide antibiotic class.', 35005555),
('isolate (WUL10) in the Brevibacillus genus', 'MIC of the purified substance was 1 microg/mL against S. aureus TISTR 517 and MRSA strains. This substance showed the bactericidal effect at the concentration of 1-2 Microg/mL against these bacterial indicators.', '', 'This novel AMP would provide an advantage for further development of anti-MRSA substances to manage the situation of antibiotic resistance.', 35736972),
('(SAAP)-148 and Halicin', 'equally effective against antimicrobial-resistant (AMR) Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus bacteria residing in immature and mature biofilms', '', 'Together, combinations of these two novel antimicrobial agents hold promise as an innovative treatment for infections not effectively treatable with current antibiotics.', 35625317),
('Chicken cathelicidins CATH-1(RVKRVWPLVIRTVIAGYNLYAIKKK,), CATH-3(RVKRFWPLVPVAINTVAAGINLYKAIRRK, ) and porcine; PMAP-36(GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG) in combination with conventional antibiotics containing ampicillin tetracycline, gentamicin, and erythromycin', 'FBCIs of only CATH-1 + tetracycline were higher than 0.5 against S. aureus, FBCIs of other combinations (CATH-1,?3 and PMAP-36 with ampicillin, tetracycline, gentamicin, and erythromycin) were lower 0.5. FBCIs of CATH-1,?3 and PMAP-36 combination with erythromycin were lower 0.5 against S. enteritidis and E. coli . FBCIs of other combinations (CATH-1,?3 and PMAP-36 with ampicillin, tetracycline, and gentamicin) were higher than 0.5 or even higher than 1.0 against S. enteritidis and E. coli.', 'mice erythrocytes and macrophages and PK-15 cells were used to determine hemolytic activity and cytotoxicity, respectively. The results showed that CATH-1,?3 and PMAP-36 alone at MBC showed low hemolysis (<20%), and erythromycin alone at MBC showed high hemolysis (>95%). However, AMPs (CATH-1,?3 and PMAP-36) combined with erythromycin at sub-MBC showed lower hemolytic activity (<3%)', 'Hence result show that the combination of CATH-1 and erythromycin has synergistic antibacterial activity and reduces the emergence of bacterial drug resistance.', 35910608),
('TAT-RasGAP317-326 peptide with antibiotics', 'synergistic combinations towards all three bacteria and demonstrated that these combinations had an increased bactericidal effect compared to individual drugs.', '', 'combination of TAT-RasGAP317-326 and meropenem had a promising antibiofilm effect towards A. baumannii.', 36270448),
('The antimicrobial peptide GL13K was derived from the salivary protein BPIFA2.', 'Klebsiella pneumoniae (MICs 16-32 microgram/ml) and Acinetobacter baumannii (MICs 8-32 microgram/ml).', '', 'DGL13K displayed in vitro activity against extended-spectrum beta-lactamase (ESBL)-producing and Klebsiella pneumoniae carbapenemase, P. aeruginosa and Acinetobacter baumannii carrying metallo-beta-lactamases. P. aeruginosa showed low inherent resistance to DGL13K', 36006947),
('Antimicrobial Peptides SAAP-148 and OP-145', 'The concentration of the peptides necessary to kill 99.9% of E. coli and E. hirae cells within 5 min of incubation period was found to be 1.6 microM and 0.4 microM for SAAP-148 and 6.4 microM versus 3.2 microM for OP-145 when tested in NaPi buffer for 1 ', 'The 99.9% lethal concentration (LC99.9%) implies antimicrobial activity and constitutes the lowest peptide concentration that killed ?99.9% of bacteria', 'these peptides immediately bind to negatively charged components and neutralize the surface of Gram-negative bacteria. Then, they insert into the fatty acyl chain region of the outer membrane, inducing higher outer membrane permeability. The increased membrane permeability for small ions will be sufficient to result in cell death.', 36139091),
('Novel antimicrobial peptide Intestinalin (P30), which is derived from the LysC enzyme of Clostridium intestinale strain URNW', 'Intestinalin showed MIC values ranging from 7.8 to >124 microM. The highest MICs (> 124 microM) were observed for S. aureus KPD 740, S. aureus KPD 425, E. cloacae KPD 297, E. coli KPD 217, and K. pneumoniae KPD 298. The lowest MICs (7.8 microM) were against three of four A. baumannii strains tested, as well as for S. hominis KPD 910 and S. pettenkoferi KPD 741.', 'The results showed that Intestinalin was not toxic to HaCaT cells at concentrations up to 100 microM', 'Experimental data showed that Intestinalin interacts with negatively charged lipoteichoic acid (logK based on isothermal titration calorimetry, 7.45 ', 36094301),
('AMP human beta-defensin-2 (HBD-2)', 'the data showed an almost total reduction in the invasive ability of EIEC in transfected cells (> 99%). Enteroinvasive E. coli (EIEC) that is responsible for the bacillary dysentery that causes severe diarrheal symptoms in both children and adults.', '', 'The results showed that HBD-2 is able to significantly reduce the expression of the proinflammatory cytokines by intestinal epithelial cells, the invasiveness ability of enteroinvasive E. coli (EIEC) and the expression of invasion-associated genes.', 36310877),
('Phage Lysin-Derived Peptide P87', 'The MIC values for P88 (20', 'One of the drawbacks usually adduced for the therapeutic application of AMPs is their possible cytotoxic effect against eukaryotic cells.', 'A peptide, P87 from phage lysin Pae87 has been tested as a source for efficient, alternative antimicrobials. To improve its antimicrobial efficacy, a derivative peptide, termed P88, with increased hydrophobic moment and net charge has been designed and proven to possess an enhanced bactericidal and antibiofilm activity.', 36290106),
('new lipopeptide-like pentamer, decanoyl-bis.diaminobutyrate-aminododecanoyl-diaminobutyrate-amide (C10BBc12B)', 'minimal inhibitory concentrations (MIC ? 50 microM) against E.coli, P. aeroginosa, K. pneumoniae, A. baumanni', 'no cytotoxicity towards cell-lines was observed at-least up to 50 microM.', 'action mechanism implicating the pentamer''s de-facto capacity to hijack bacterial efflux pumps for boosting its adjuvant activity through repetitive steps including outer-membrane adhesion, translocation and subsequent expulsion.', 36271103),
('two peptides LP-23 and SA4, as well as their mimetic peptoids DP-23 and SPO were selected. Synergistic effects of short peptides and antibiotics', 'Based on the fraction inhibitory concentration: FICI ? 0.5 synergistic value , LP-23, DP-23, and SPO demonstrated synergy in combination with gentamicin against a gentamicin-resistant clinical isolate of Escherichia coli. For Staphylococcus aureus, Escherichia coli, and Salmonella typhimurium, seven combinations exhibited synergistic effects between peptide/peptoids and the tested antibiotics.', 'These peptides were also evaluated for its cytotoxicity against human embryonic normal kidney cells (HEK 293) and pancreatic cancer cells (MIA PaCa-2) using MTT assay. The average cell survival rate for all peptides in HEK cells was 90% at 100 microg ml?1 and 68% at 500 microg ml?1. In MIA PaCa-2, about 15% cells was compromised at high concentration of 500 microg ml?1', 'Synergy obtained between LP-23, SA4 and their mimetic peptoids DP-23 and SPO with antibiotics have the potential to be used as a combination therapy against microbial infections. These combinations may be helpful in lowering the drug dose and creating better results, which can be applied in future against various MDR strains.', 35931657),
('pentapeptide-4" (PP4, with amino acid sequence KTTKS)', 'peptide effective against Gram-positive (S. aureus, Enterococcus faecalis) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa) bacteria.', '', 'These constructs have potent wide-spectrum antimicrobial action, including against multidrug-resistant Gram-positive and Gram-negative bacteria, and fungi.', 35950860),
('Novel Alligator Cathelicidin As-CATH8', 'MIC of As-CATH8 for S. aureus (0.5 microM) and A. baumannii (0.25 microM) respectively. As-CATH8 demonstrated strong antibacterial effects in a murine abscess model of high-density bacterial infections against clinical isolates of S. aureus and Acinetobacter baumannii,', 'As-CATH8 were moderately cytotoxic against human bronchial epithelial (HBE) cells and peripheral blood mononuclear cells', 'Result declare that As-CATH8 peptide, which has substantial therapeutic promise for treatment of S. aureus and A. baumannii skin infections, two of the most prevalent bacterial species causing SSTIs worldwide.', 36421248),
('designed the (WRX)n hydrophobic tryptophan (W) residues and hydrophilic charged arginine (R) (where X = hydrophilic uncharged amino residues; n = number of repeat units) series engineered peptides with high cell selectivity by introducing hydrophilic uncharged threonine (T), serine (S), glutamine (Q) or asparagine (N) residues into the minimalist design of W- and R-rich AMPs.', 'T6 exhibited potent antibacterial and antiinflammatory capabilities in vivo in a mouse peritonitis-sepsis model infected with Escherichia coli.', '', 'The results showed that the introduction of these hydrophilic uncharged amino residues, especially T residues, significantly improved the cell selectivity of the W- and R-rich engineered peptides. It has potent antibacterial activity, good biocompatibility, high selectivity index, strong tolerance, rapid and efficient time-kill kinetics, and no tendency of resistance. Studies on antibacterial mechanism show that T6 exert antibacterial activity mainly by disrupting bacterial cell membrane and inducing the accumulation of reactive oxygen species in bacterial cells.', 36115654),
('two designed, cationic antimicrobial-derived peptides: Mt6, and its dextroisomer D-Mt6, belonging to the analogs of MAF-1, which is isolated from the instar larvae of houseflies.', 'Mt6 and D-Mt6 showed different degrees of inhibitory activity against Gram-positive bacteria (S. aureus and B. subtilis) and Gram-negative bacteria (E. coli, K. pneumoniae, P. aeruginosa, A. baumannii).', '', 'Both Mt6 and D-Mt6 showed broad-spectrum antimicrobial activity, especially against A. baumannii, by damaging membrane integrity. Moreover, D-Mt6 showed better immunoregulatory activity against LPS induced inflammation through its LPS-neutralizing and suppression on MAPK signaling. This study suggested that D-Mt6 is a promising candidate drug as a derived peptide against A. baumannii.', 36190276),
('rhamnolipid and linezolid', 'Four S.aureus (One ATCC 29213 strain and three methicillin-resistant strains) were used in the study. The minimum inhibitory concentration of the resistant strain decreased from 16 to 4 microg/mL with a four-fold decrease.', '', 'The G.mellonella larval model demonstrated that combined therapy was more effective than monotherapy by survival function tests and CFU determination. RML/LNZ combination improved survival compared to monotherapy and decreased the bacterial burden.', 36526037),
('antimicrobial peptides (AMPs)', 'Anti-microbial Peptides against Methicillin-resistant Staphylococcus aureus', '', 'Anti-microbial peptides could be the next-generation solution to combat drug resistance among Superbugs. New approaches like antimicrobial peptides (AMPs) play a vital role and are more efficacious, economical, time, and energy saviours.', 36529917),
('Innate defense regulator (IDR) peptides', 'he minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of KSL Peptide for C. albicans was determined at the level of 0.78 microg/mL. he MIC of KSL for Staphylococcus aureus and Pseudomonas aeruginosa was 0.78 microg/mL and 1.56 microg/mL, respectively. Bac2A peptide derivative show MICs between 2 and 32 microg/mL for Gram-negative bacteria, and between 0.25 and 16 microg/mL for Gram-positive bacteria. other peptide drive fro naturally occurring molecules as cNK-2, Clavanin-MO, Ac-ApoE, KSLW, SET-M33, GW-A2, AWRK6', '', 'Many studies have shown that the activity of AMPs is mostly associated with bacterial membrane destabilization. However, their activity expressed as MIC is often much lower than that of conventional antibiotics', 36009931),
('novel strategy that combines the human antimicrobial peptide (AMP) LL37 with different antibiotics( vancomycin, azithromycin, polymyxin B, and colistin)', 'For PA103, the MIC of polymyxin B, colistin, and gentamicin decreased twofold to fourfold, but the MIC of vancomycin and azithromycin was still >512 microg/ml, which was the highest concentration tested. The antibacterial inhibitive effects of Ca2+ and Mg2+ ions were also observed for colistin; our preliminary data showed that the MIC of colistin is 0.5 microg/ml when PAO1 was cultured in the MHB medium, but it increased to 1 microg/ml in a cation-adjusted MHB medium.', '', 'Zeta potentials for P. aeruginosa strains PAO1 and PA103 were -40.9 and -10.9 mV, respectively. With the addition of LL37, negative zeta potentials were gradually neutralized. this process of neutralization is believed to have contributed to the increase in outer membrane permeability help to uptake of antibiotics. LL37-vancomycin combination showed a synergistic inhibitory effect to PAO1, as well as a synergistic bactericidal effect to both PAO1 and PA103. Vancomycin can target lipid II, which is embedded in the inner membrane and is also an important molecule needed for the synthesis of the bacterial cell wall', 35922283);
INSERT INTO `bacteria_amp` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Antimicrobial peptide named P4 with sequence RTKLWEMLVELGNMDKAVKLWRKLKR that was constructed from influenza virus protein M1 and containing two cholesterol-recognizing amino-acid consensus (CRAC) motifs.', 'peptide P4 inhibits the growth of E. coli and B. subtilis strains at concentrations that are significantly lower than the cytotoxic concentration that was found for macrophages. The half-maximal inhibitory concentration (IC50) for B. subtilis and E. coli cells were 0.07 ', '', 'the toxic action of peptide P4 is based on membrane permeabilization through the interaction of the peptide cationic domain and anionic lipids of the bacterial membrane. They report antimicrobial activity of the peptide P4 against the representatives of Gram-positive (B. subtilis) and Gram-negative (E. coli) bacteria.', 36013956),
('Synthetic antimicrobial peptide', 'This 6 peptides (ASU2001, ASU2009, ASU2019, ASU2056, ASU2059, and ASU2060) inhibited the M. abscessus smooth morphotype (IC50 = 1.7 microM for all peptides) and had reduced activity against the M. abscessus rough morphotype (IC50 range: 13-82 microM). Peptides ASU2056 and ASU2060 had minimum inhibitory concentration values of 32 and 8 microM, respectively, against the M. abscessus smooth morphotype. Additionally, ASU2060 (8 microM) was active against Escherichia coli, including multidrug-resistant E. coli clinical isolates, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus.', 'The two most potent peptides, ASU2056 and ASU2060, were tested for red blood cell toxicity and neither exhibited significant hRBC hemolytic activity even after prolonged incubation (18 h). ASU2060 was tested for serum stability and retained antibacterial activity after preincubation in human serum for 24 h.', 'The peptides (ASU2001, ASU2009, ASU2019, ASU2056, ASU2059, and ASU2060) were further screened against both Mabs smooth and rough morphotypes to determine the impact of cell wall glycopeptidolipids (GPLs) on activity. All six peptides displayed increased activity against the Mabs smooth morphotype, suggesting that interactions with cell wall GPLs are important for antibacterial activity. Additionally, all peptides exhibited increased inhibition in the presence of EDTA, further suggesting that sequestering divalent metal cations enhances peptide interactions with Mabs.', 35847280),
('Temporins modeified version of brevinin-1GHa (BR-1GHa) from frog skin peptide', 'BR-1GHa-3, in which two alanine residues in the truncated version of BR-1GHa were replaced with leucine, exhibited significantly improved antimicrobial activity against Gram-positive bacterial strains (e.g., S. aureus ATCC 29213 and E. casseliflavus ATCC 700327) with lower hemolytic activity compared to the BR-1GHa peptide. BR-1GHa-4 analogue, in which Gly3 was replaced with Pro, did not show any hemolytic activity except for highest (128 microM) concentration tested and have a strong antimicrobial effect on Gram-positive bacteria (e.g., E. faecalis ATCC 51299 and B. cereus ATCC 13061).', '', 'To enhance the antimicrobial activity of this peptide and to reduce its hemolytic activity, they designed five new temporin like analogues and examined their bioactivities. Temporins are another class of frog skin peptides without hemolytic activity and shorter than brevinins. This show antimicrobial activity', 35852614),
('designed PLP-3, a novel synthetic (protegrin-1 ) PG-1-like peptide', 'Antimicrobial activity screening showed MIC90 values of 2 mg/L for A. baumannii, 16 mg/L for K. pneumoniae and 8 mg/L for P. aeruginosa. The haemolysis IC50 value was 48.53 mg/L', 'Cytotoxicity against human HeLa and A549 cells showed values of ca. 200 mg/L in both cell lines resulting in a 100-fold selectivity window for bacterial over human cells.', 'PLP-3 has potent antimicrobial activity, especially against A. baumannii, while maintaining low haemolysis and toxicity against human cell lines at antimicrobial concentrations. These characteristics make PLP-3 a promising peptide with an interesting therapeutic window.', 35972429),
('plantaricin A an antimicrobial peptide derived from Lactobacillus plantarum, had a synergistic effect with ciprofloxacin (CIP)', 'lantaricin A (PlnA), reducing the IC90 of CIP by eight times and kill Multidrug-resistant Staphylococcus aureus', 'which has low cytotoxicity and haemolysis and powerful inhibitory activity on efflux pumps.', 'The present study showed a new efflux pump inhibitors EPI (plantaricin A) produced by Lactobacillus plantarum, changes in membrane permeability, membrane potential, and reactive oxygen species (ROS) were determined. Therefore, it helps the design of new EPIs and controls the infection of multidrug-resistant Staphylococcus aureus', 36254863),
('Lugdunin (cyclic peptide-1), a nonribosomal cyclic peptide', 'cyclic peptide-1 and its analogues cyclic peptide-11 and cyclic peptide-14 have the ability to disperse mature Methicillin-resistant Staphylococcus aureus (MRSA) biofilms and show anti-clinical MRSA activity, including MRSA persister cells', 'these three cyclic peptide compounds have non-toxicity, lower hemolytic activity and lack of resistance development.', 'Our results indicate that cyclic peptide-1, cyclic peptide-11, and cyclic peptide-14 have great potential as new antimicrobial drug candidates for the treatment of clinical Methicillin-resistant Staphylococcus aureus (MRSA) infections.', 35887376),
('a series of Temporin-PE (T-PE) analogues were designed and synthesized by glutamic acid', '', 'E11K4K10 exhibited slight toxicity to the spleen with slight edema observed in the spleen, but its toxicity was less severe than that of polymyxin B.', 'E11K4K10, the optimized T-PE and the relatively safe AMP, could overcome drug resistance which was expected to be a new antimicrobial agent against clinical resistant bacteria.', 36148510),
('Nv-CATH peptide from the skin of the frog Nanorana ventripunctata', 'S. haemolyticus 13A13770 displayed the highest sensitivity to Nv-CATH (MIC = 3.125 microg/mL), followed by S. aureus ATCC25923 and A. junii 13A15578 (MIC = 12.5 microg/mL).', '100 microg/mL Nv-CATH did not exhibit cytotoxicity toward mouse peritoneal macrophage (MPMs) and bone-marrow-derived neutrophils (BMDNs), and 300 microg/mL Nv-CATH also had no hemolytic activity on rabbit erythrocytes.', 'Nv-CATH inhibited bacterial invasion of target organs via direct bactericidal ability. Nv-CATH selectively promoted CCL and CXCL chemokines', 36378028),
('human beta-defensin 130 (hBD130)', 'hBD130 demonstrated efficient antimicrobial activities, with MICs ranging from 10 to 45 microg/mL. Of note, hBD130 exhibited significant growth inhibition effects against E. coli ATCC 25,922 (10 microg/mL), ETEC BNCC 125,783 (10 microg/mL), L. monocytogenes ATCC 221,633 (25 microg/mL), and S. typhimurium ATCC 14,028 (15 microg/mL). The MICs for hBD130 against gram-negative bacteria, including E. coli and S. typhimurium, were 10', 'hBD130 showed a low hemolytic effect and nearly no cytotoxicity to mammalian cells with a dosage of 400 microg/Ml', 'bactericidal effect of hBD130 showed that hBD130 is a promising antimicrobial agent to treat foodborne bacterial infections and inflammation.', 35720462),
('develop chimeric peptides with dual cell-penetrating and antimicrobial functions by conjugating Cell-penetrating peptides with AMPs', '', '', 'AMPs are regarded as an ideal alternative to antibiotics due to their powerful antimicrobial potential, rapid killing effects, and low propensity to develop resistance. the combination of CPP and AMP gives it a dual function of cell penetration and antimicrobial activity, which may be a feasible method to treat intracellular infections.', 36503077),
('Three novel peptide families ', 'PTR displayed moderate activity against Escherichia coli (MIC 24.80 to 48.95 microM), TS-1 was the most active peptide against E. coli (6.8 microM) followed by PTS-3 (11.7 microM) and PTS-2 (14.24 microM)', '', 'Hence, Frog skin peptides are excellent examples of the biomedical potential of naturally evolved molecules for specific targets, including multi-resistant bacteria.', 35640793),
('Peptide PN5 derived from Pinus densiflora (pine needle)', 'PN5 displayed antimicrobial activity against both Gram-negative and Gram-positive bacteria, with MICs of 2 to 16 microM (2.65 to 21.22 microg mL?1)', '', 'PN5 showed immunomodulatory properties of neutralizing LPS in a mouse septic model. These results indicate that PN5 could be a new and promising therapeutic agent for bacterial infectious disease caused by antibiotic-resistant strains.', 36129300),
('Antimicrobial peptide (AMP) IDR-1018 derived D-amino acids substitution peptides (D1018 and D1018M) were synthesized', 'MIC of IDR-1018, 1018M and D1018 against E. coli ATCC25922 was 8 microg/ mL while that of D1018M was 4 microg/ mL. D1018M owned stronger potential antibacterial activity against E. coli ATCC25922. However, the antimicrobial activity of peptides was not so good as that of polymyxin (MIC = 1.56 microg/mL).', 'he results indicated that peptides IDR-1018, 1018M and 1018M basically had no cytotoxicity against murine macrophage cells, when the concentration was up to 16 times of MIC. However, for D1018M, the safe concentration of murine macrophage cells was only 4 times of MIC.', 'This peptides could interact with E. coli cell wall and cytoplasmic membrane, penetrate the membrane, cause leakage of contents, and disrupt genomic DNA. Among them, D1018 is the most prominent one. these data demonstrate that D1018 is a promising peptide candidate for the treatment of E. coli infection.', 36532445),
('peptide Spgillcin177-189 derived from the amino acid sequence of Spgillcin', 'Spgillcin177-189 also showed rapid bactericidal kinetics for S. aureus and Pseudomonas aeruginosand maintained its antimicrobial activity in different conditions with a range of minimum inhibitory concentrations from 1.5 to 48 microM.', 'did not display any cytotoxicity to mammalian cells( human hepatic cell line (L02), mouse liver cell line (AML12), hepatocellular carcinoma cell line (Hep G2), and non-small-cell lung carcinoma (NSCLC) cell line (NCI-H460)', 'Spgillcin177-189 was mainly involved in the disruption of cell membrane integrity and cause the accumulation of intracellular reactive oxygen species. Spgillcin177-189 exerted a strong anti-biofilm activity by inhibiting biofilm formation and was also effective at killing extracellular S. aureus in the cultural supernatant of RAW 264.7 cells. Taken together, Spgillcin177-189 has strong potential as a substitute for antibiotics in future aquaculture and medical applications.', 36061863),
('Antisense peptide nucleic acids (PNAs)', 'Concentration-dependent bactericidal activity was investigated by treatment of S. pneumoniae TIGR4 in a CPP-antisense PNA conjugate concentration range of 2.5 to 20 microM', '', 'CPP-antisense PNA treatment increased the survival rate of infected Galleria mellonella larvae in vivo. Based on these results, we believe that efficient antisense PNAs can be developed for the treatment of S. pneumoniae infections.', 36321914),
('hydrogel scaffold containing genipin crosslinked HF-18 peptide', 'It was observed that HF-18-loaded OPT (P-OPT) was able to release HF-18 peptide both in acidic and neutral conditions. Antimicrobial activity assessments demonstrated that P-OPT was effectively bactericidal on Staphylococcus aureus and methicillin-resistant S. aureus.', '', 'the optimized scaffold has a composition of 90 mg Ch, 0.25 mg HA, and 0.25 mg CS and is crosslinked with 0.5 mg genipin. This scaffold was found to have highly interconnected pores and high bactericidal activity. It was claimed that HF-18 showed a strong bactericidal effect on MRSA and biocompatibility against L929 cells. As a novel approach, for the first time, HF-18 loaded polymeric scaffold was tested for wound healing. the scaffold OPT was considered a suitable and promising polymeric carrier for AMPs in terms of wound healing.', 36377395),
('novel synthetic antimicrobial peptide, GK-19, derived fromAndroctonus amoreuxi Antimicrobial Peptide 1 ( AamAP1 ) and its derivatives', 'GK-19 exhibited potent antibacterial activity against three Gram-positive and two Gram-negative bacteria with much lower minimal inhibitory concentration (MIC) values ranging between 3 and 10 microM (E. coli (3 microM), K. pneumoniae (5 microM), P. aeruginosa (5 microM), E. faecalis (3 microM), and MRSA (5 microM)) in comparison to that of AamAP1 (>20 microM).', 'GK-19 showed negligible toxicity to mammalian cells, low hemolytic activity and high stability in plasma.', 'GK-19 showed significant antimicrobial and healing effects. Overall, it was demonstrated that GK-19 might be a promising drug candidate in the battle against drug-resistant bacterial and fungal infections.', 36145681),
('Two novel antibacterial peptides were isolated from Alcalase-hydrolyzed chicken plasma', 'VSDH inhibited both S. aureus and B. cereus, while CCCPKAF only showed antibacterial activity toward B. cereus. The MIC values of VSDH and CCCPKAF against B. cereus were 0.5 mM and 0.25 mM, respectively. In addition, the MIC of VSDH against S. aureus was 0.5 mM. Both peptides showed weak inhibition towards S. typhimirium and L. monocytogenes with MIC > 8 mM. They did not inhibit E. coli.', '', '', 36429156),
('scorpion venom peptide ctry2459 was modified to CT-K3K7', 'It can kill S. aureus strain MIC= 2.64 Micro Mol and P. aeruginosa strain PA01 MIC = 10.56 Micro Mol and P. aeruginosa strain ATCC9027 rapidly, and reduce the production of biofilm', 'lower hemolytic activity', 'peptide ctry2459 was modified to CT-K3K7 by lysine substitutions at the 3rd and 7th positions to increase the cationic properties. We discovered that the modified peptides CT-K3K7 had improved antibacterial activity, higher thermal stability, as well as lower hemolytic activity. CT-K3K7 has also been demonstrated to decrease bacterial counts. Hence, the modified peptide CT-K3K7 can be a novel antimicrobial agent candidate for the treatment of infections by S. aureus and P. aeruginosa.', 36113685),
('lead peptide LI14', 'LI14 showed broad-spectrum and strong antibacterial activity against all MDR pathogens with MIC values ranging from 1 to 64 microg/mL, involving methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), carbapenem-resistant Enterobacteriaceae (CRE), MCR-positive E. coli (MCRPEC) and tigecycline-resistant pathogen, which was comparable to that of some antibiotics used clinically.', '', 'In animal models of infection, LI14 or combined with antibiotics are effective against drug-resistant pathogens. These findings suggest that LI14 is a promising antibiotic candidate to tackle MDR bacterial infections.', 36071151),
('antimicrobial peptide conjugated poly (glycolic acid-co-caprolactone) (PGCL) sutures', '(PGCL) sutures were investigated against P. aeruginosa and methicillin-resistant S. aureus (MRSA) strains by using antimicrobial peptide sequences of KRFRIRVRV-NH2, RWRWRWRW-NH2 and their dual combination (1:1)', '', 'Our results indicated that antimicrobial peptide modified sutures could be a potential novel medical device to overcome surgical site infections by the superior acceleration of wound healing.', 36510770),
('Synergistic effect of - Synthetic antimicrobial peptides (SAMPs-Mo-CBP3-PepI, Mo-CBP3-PepII, Mo-CBP3-PepIII, RcAlb-PepI, RcAlb-PepII, RcAlb-PepIII, PepGAT ,and Pep KAA ) with antibiotics', 'combination made by Mo-CBP3-PepIII (6.2 microg mL?1) and ciprofloxacin (0.2 microg mL?1) induced pore formation of biofilm cells of S. aureus. combination with RcAlb-PepI (0.04 microg mL?1) and ciprofloxacin (25 microg mL?1) was it possible to induce pore formation on the membrane of S. aureus in biofilm and RcAlb-PepIII alone at 50 microg mL?1 induce biofilm.', 'synthetic peptides are not toxic to human red blood cells (HRBC). Additionally, it has been shown that during synergistic action, peptides, besides enhancing drugs', 'The mechanism of the combined effect is possible by increasing the cytoplasmatic concentration of ciprofloxacin supported by pores on the membrane of S. aureus cells. Additionally, peptides reduced the toxicity of ciprofloxacin to HRBC. Considering all these findings, it is possible to suggest that the peptides studied are a considerable option to surpass the resistance of S. aureus strains to antibiotics such as ciprofloxacin.', 36145427),
('antimicrobial peptides (AMPs) from marine parasites, Anisakis spp', 'These peptides are potent bactericidal agents in vitro, selectively active against Gram-negative bacteria, including multi-drug resistant strains, at sub-micromolar concentrations.', 'Their toxicity towards host cells is negligible,', 'Anisaxins are membrane-active peptides essential for future design of such biomaterials.', 35470073),
('antimicrobial peptides centered on "RRR" labeled with hydrophobic amino acids at both ends- LWWR (LWWRRRWWL-NH2)', 'Show bactericidal activity against E. coli and S. aureus', '', 'LWWR (LWWRRRWWL-NH2) presented broad-spectrum antibacterial activity both in vitro and in vivo due to its multiple mechanisms and good stability. The findings of this study will provide some inspiration for the design and development of potential antibacterial agents, and contribute to the elimination of bacterial infections worldwide as soon as possible.', 36241015),
('The Antimicrobial Peptide 1018-K6', 'this AMP was seen to be able to kill resistant Gram-positive and Gram-negative microorganisms (5 ', '', 'The AMP 1018-K6 is a candidate to prevent (food preservation) or treat (antibiotic use) infections caused by certain pathogenic bacteria, especially some that are resistant to current antibiotics for three prokaryotic species studied: Salmonella Typhimurium2GN, Escherichia coli3GN, and Staphylococcus aureus3', 36293249),
('Temporin-GHa (GHa) obtained from Hylarana guenther Derived Peptide - GHa4R', 'peptide GHa4R had stronger antibacterial activity and bactericidal efficacy against S. aureus. GHa4R presented antibacterial activity against methicillin-resistant S. aureus (MRSA).', '', 'It was barely affected by temperature, pH, and storage period, showing high stability. it increased the permeability of the cell membrane and damaged the membrane integrity, leading to cell death. The mentioned characteristics make GHa4R a promising candidate for the treatment of S. aureus infections.', 36476441),
('PEGylation at the C-terminal of T9W (CT9W1000) peptide', 'CT9W1000 micelles exhibited good biocompatibility in vitro and in vivo, resulting in highly effective treatment in a mouse acute lung injury model induced by P. aeruginosa PAO1 without drug resistance.', '', 'These advances may profoundly accelerate the clinical transformation of T9W and promote the development of a combination of peptide-based antibiotics and PEGylated nanotechnology.', 36577517),
('lipopeptide', 'against Multidrug-Resistant Pseudomonas aeruginosa', '', 'discovery of lipopeptides against bacterial "superbugs"', 35786900),
('HAZ, a novel peptide', 'HAZ revealed significant antimicrobial activity, with MIC values of 15 ', 'HAZ efficacy was accompanied with minimal hemolytic toxicity on human erythrocytes.', 'HAZ-antibiotics combinations exhibited a synergistic action mode that led to dramatic decrease in the MIC values for both HAZ peptide and the antibiotic. HAZ peptide is a broad-spectrum AMP, and a promising candidate for antimicrobial and anticancer drug development.', 36465844),
('synthetic peptide CD4-PP', 'CD4-PP was active against both clinical and type strains in low concentrations between 0.78 and 1.56 microM. The MIC for E. coli CFT073 and the ESBL strain (CCUG 55971) were 0.78 microM. Klebsiella pneumoniae (ATCC 25955), MDR K. pneumoniae (CCUG 58547), Pseudomonas aeruginosa (ATCC 27853) had MICs of 1.56 microM.', '', 'By developing a peptide with a cyclic backbone, they intended to increase the proteolytic stability and antimicrobial activity of the novel synthetic AMP. they observed that CD4-PP displayed enhanced stability against bacterial protease. CD4-PP was tested against a range of the most clinically important uropathogens indicating a promising clinical application.', 35821354),
('cell-penetrating peptide (CPP) fused endolysin PA90', 'This engineered endolysin, DS-PA90, completely killed A. baumannii at 0.25 microM,', '', 'Hence concluded MDR A. baumannii strains were highly susceptible to DS-PA90 treatment: five out of nine strains were entirely killed and four strains were reduced by 3', 35614377),
('Modified the antimicrobial peptide Cec4 (41 amino acids) and obtained the derived peptide C9 (16 amino acids)', 'Derived peptide C9 (16 amino acids) showing better antimicrobial activity against S. epidermidis with an MIC value of 8 microg/mL.', 'The median lethal dose of C9 in mice was more than 128 mg/kg, and the intraperitoneal administration of 64 mg/kg was less toxic to the liver and kidneys of mice.', 'C9 peptide has rapid bactericidal activity without detectable high-level resistance, showing certain inhibition and eradication ability on S. epidermidis biofilms. In addition, C9 altered the S. epidermidis cell membrane permeability, depolarization levels, fluidity, and reactive oxygen species (ROS) accumulation and possessed the ability to bind genomic DNA.', 36453944),
('melittin-pexiganan combination, combination of temporin-pexiganan, temporin-melittin combination peptides', 'result found that S. aureus went extinct more rapidly when treated with a mixture of two antimicrobial peptides', '', 'These results are consistent with the fact that AMP combinations that contain pexiganan were more effective for delaying resistance evolution', 35862981),
('Novel D-form of hybrid peptide (D-AP19)', 'Geometric mean (MIC) of gram negative : GMb (Gr.? strains) = 7.16 microg/ml and geometric mean for gram positive GMd (Gr. + strains) = 5.86 microg/ml', 'AP-19 show minimal hemolytic and cytotoxic activities in mammalian cells.', 'D-AP19 displayed rapid killing via membrane disruption and leakage of intracellular contents. Additionally, it showed a low tendency to induce bacterial resistance. Among the peptides, AP19 demonstrated the best combination of broad-spectrum antibacterial activity including toward Acinetobacter baumannii', 36151303),
('Host defense peptides (HDPs)- design the amphiphilic peptoid polymers', 'The optimal cyclic peptoid polymer, poly(Naeg0.7Npfbg0.3)20, displays strong antibacterial activities against drug-resistant bacteria.', 'low hemolysis and cytotoxicity', 'we design the amphiphilic peptoid polymers by mimicking the positively charged and hydrophobic structures of HDPs and synthesize a series of cyclic peptoid polymers efficiently via the polymerization on alpha-amino acid N-substituted glycine N-carboxyanhydrides (alpha-NNCAs) using 1,8-diazabicycloundec-7-ene (DBU) as the initiator.', 35788576),
('AMP called Pleurocidin (Ple) and its C-terminal-amidated derivative Pleurocidin-amide (Ple-a)', 'Our results indicated that both Ple and Ple-a exhibited significant antibacterial activity against a broad spectrum of Gram-positive and Gram-negative bacteria, especially marine pathogens, with MIC values ranging from 0.25 to 32 microg/mL.', 'Ple and Ple-a also showed notable cytotoxicity toward various cancer cell lines, with IC50 values ranging from 11 to 340 microM, while normal mouse fibroblast 3T3 cells were less susceptible to these peptides.', 'Our results indicated that both Ple and Ple-a exhibited significant antibacterial activity against a broad spectrum of Gram-positive and Gram-negative bacteria, especially marine pathogens. Our findings provided support for the future application of Ple-a as potential therapeutic agent for bacterial infections.', 36005521),
('ApoE mimetic peptide, COG1410', 'In the case of Gram-positive strains, COG1410 inhibited the growth of Bacillus subtilis, vancomycin-resistant Enterococcus faecalis and Enterococcus faecium, and Mycobacterium smegmatis with MICs ranging from 1 to 32 microg/ml. As for Gram-negative bacteria, COG1410 showed antimicrobial activity against Enterobacter cloacae, Escherichia coli, Citrobacter freundii, and even anaerobe, Porphyromonas gingivalis, with MICs ranging from 16 to 64 microg/ml.', 'The minimal concentration that caused the lysis of half of the red blood cells (EC50) was 441 microg/ml. COG1410 exhibited low hemolytic activity and medium cytotoxicity.', 'COG1410 easily entered bacterial cytoplasm and bound to DNA nonspecifically, the major mechanism of COG1410 killing was to disrupt the integrity of cell membrane and lead to leakage of cytoplasmic contents', 36081797),
('Natural Peptide from Vespa mandarinia Venom and Its Synthetic Analogues', 'VM-3K produced a 90% survival of S. aureus-infected waxworms at a concentration of 5.656 mg/kg, at which concentration the natural template peptide only achieved 50% survival. VM-3G also displayed anti-microbial ability against Gram-negative bacteria and had bactericidal effects on E. coli and P. aeruginosa but not on K. pneumoniae', 'VM-3W exhibited haemolysis at a low concentration.', 'peptide VM-3K could be a promising broad-spectrum antimicrobial candidate for addressing the current antibiotic-resistant infection crisis. It is worth mentioning that this investigation on the relationship between peptide structure and mechanism of action could become an important aspect of drug research on short peptides.', 36138742),
('KDEON WK-11: A short antipseudomonal peptide', 'identified its most potent effect, against Pseudomonas aeruginosa with an MIC value of 3.12 microM', '', 'KDEON WK-11 had a broad range of antimicrobial activity and specific capabilities to fight Pseudomonas aeruginosa with low in vitro cytotoxicity and promising potential to express anti-lipopolysaccharide qualities, which could be exploited to expand its properties into an anti-sepsis agent.', 36465859),
('Amino Acid-Rich Antimicrobial Peptides', 'found 138 Leu-rich AMPs active against Staphylococcus aureus and 81 against Escherichia coli. Likewise, there were 39 Pro-rich peptides against E. coli and 15 against S. aureus in the current database.', '', 'no natural AMPs are simultaneously rich in leucine and lysine, while proline, tryptophan, and cysteine-rich peptides can simultaneously be rich in arginine. These findings can be utilized to guide peptide design. Since multiple candidates are potent against antibiotic-resistant bacteria, rich AMPs stand out as promising future antibiotics.', 36361660),
('tachplesin I analogue peptide (TP11A) and tachplesin I', 'Both inhibited C. albicans monomicrobial, S. aureus monomicrobial, and C. albicans-S. aureus polymicrobial biofilms quite well. TP11A suppressed the biofilm- and virulence-related genes of C. albicans (hwp 1) and S. aureus (ica A, fnb B, agr A, hla, nor A, and sig B) in the mixed biofilm,', '', '', 35998684),
('antimicrobial peptidomimetics called peptoids (sequence-specific oligo-N-substituted glycines) the sequence-specific pentamer TM5', 'the MIC values for TM5 against Pseudomonas aeruginosa (PAO1) and Staphylococcus aureus (SA25923) are 8 microg/mL and 16 microg/mL, respectively.', 'determined the cytotoxicity of TM5 against A549 lung epithelial cells to identify a non-cytotoxic concentration. A549 cell exposure to 50 microg/mL of TM5 for 24 h exposure did not cause cytotoxicity . TM5 has been shown to be safe on 3D human primary cultures of epithelial cells', 'demonstrated that TM5 is a multi-functional platform that can be used to eradicate biofilms and mitigate LPS-induced cytokine production. Future studies will explore the in vivo anti-persister cell activity of TM5 using a chronic biofilm infection animal model. Furthermore, the antimicrobial molecular mechanisms of TM5 seems to prevent resistance development. Although our resistance study showed that resistance development against TM5 is unlikely.', 36018039),
('arenicins, antimicrobial peptides from the lugworm Arenicola marina', 'Peptide AA139, like other arenicins, exhibited an inhibitory effect on complement at a concentration of 160 microg/Ml', '', 'our results suggest that the effect on the complement system should be taken into account in the development of antibiotics based on arenicins.', 36286436),
('Stable isotope analysis with antimicrobial random peptide mixtures (RPMs). The RPMs used in this study consisted of 20-mer peptide composed of either L-phenylalanine and L-lysine (FK20) or phenylalanine with D-lysine (FdK20) in 1:1 molar ratio', 'FK20 induced a reduction of the MIC of four bacteria (i.e. X. campestris, X. perforans, C. michiganensis and P. syringae) to between 4 and 21% of the corresponding untreated control samples (> 200 microg/mL). Two pathogenic bacteria, S. scabies and A. citrulli, were not affected by the treatment with FK20. Effects of FdK20 on the bacteria were very similar with the exception of P. syringae which was not affected by FdK20', '', 'Stable carbon isotope analysis invariably verified the changes in the FA groups of bacteria caused by treatment with FK20 and FdK20. Also, growth inhibition of bacteria by FK20 and FdK20 was generally associated with changes in the FA groups except for FdK20 in the case of C. michiganensis. The approach used in this study could be helpful in the search not only of novel antimicrobial RPMs but also other antibiotics such as polymyxin B.', 35789165),
('Antimicrobial potential of a ponericin-like peptide', 'Results showed that Bm-ponericin-L1, at 4 ppm, inhibited biofilm formation by > 85% (P. aeruginosa) and > 90% (K. pneumoniae), after 24 h of incubation', '', 'Study revealed that infection with P. aeruginosa triggers the humoral response in B. mori larvae. The purified peptide fraction screened from the infected silkoworm found to be active against E. faecium , S. aureus , K. pneumoniae, A. baumannii , P. aeruginosa, and E. agglomerans, belonging to the ESKAPE group. This is the first report regarding the production and isolation of a ponericin in B. mori hemolymph upon P. aeruginosa infection. Bm-ponericin-L1was found to be highly specific towards bacterial cells suggesting its cell selectivity.', 36109567),
('cross-linked lyotropic liquid crystals, formed by the self-assembly of the block copolymer Pluronic F-127.', 'The liquid crystal particles were shown to have antibacterial effect corresponding to a 4 log reduction against Staphylococcus aureus.', '', 'The bonding to the particles gave the AMPs improved stability in serum, as they retained almost all of the antibacterial potency for 2 days compared to free AMPs, which lost all of its antibacterial potency within a day.', 36152992),
('florfenicol-polyarginine conjugates', 'These conjugates also showed excellent activity against drug-resistant strains such as methicillin-resistant S. aureus (MRSA) and florfenicol resistant Escherichia coli strains (2017XJ30, 2019XJ20), one of which as E6 had a minimum inhibitory concentration of 12.5 micromol/L.', '', 'Polyarginine peptides are widely used as CPPs and shown to inhibit bacteria by entering certain microbial cell membranes. This suggested that conjugating arginine to florfenicol succinate effectively modulated the properties of prodrugs. These new conjugates may provide useful insights for expanding the pool of antibiotics.', 35844651),
('three peptides (LS-AMP-E1, LS-AMP-F1, and LS-AMP-G1) from Chinese Wolf Spider Lycosa sinensis', 'LS-AMP-E1 and LS-AMP-F1 exhibited similar antibacterial effects towards tested microbes. The MIC values of LS-AMP-E1 and LS-AMP-F1 against 6 tested strands ranged between 50 and 6.25 microM, except for P. vulgaris and S. aureus (not detected within 50 microM). LS-AMP-G1, on the other hand, had no discernible effect on the growth of any one of the reference strains. (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species)', '', 'In terms of antimicrobial mechanisms, LS-AMP-E1 and LS-AMP-F1 destroyed the integrity of bacterial cell membranes in a short period of time and completely inhibited bacterial growth within 10 min of action. Meanwhile, high concentrations of Mg2+ effectively reduced the antibacterial activity of LS-AMP-E1 and LS-AMP-F1. Together, it suggested that the two peptides interact directly on bacterial cell membranes.', 36432731),
('Parietin (PTN) or physcion', 'Complexation of PTN increased the aqueous solubility 28-fold and the photostability compared to free PTN. PTN/HP-beta-CD complexes reduce the bacterial viability of Staphylococcus saprophyticus and Escherichia coli by > 4.8 log and > 1.0 log after irradiation, respectively.', '', 'As an alternative therapeutic option, antimicrobial photodynamic therapy (aPDT) can successfully eradicate antibiotic-resistant bacteria with a lower probability of developing resistance or systemic toxicity commonly associated with the standard antibiotic treatment.', 35214089);

-- --------------------------------------------------------

--
-- Table structure for table `bacteria_light`
--

CREATE TABLE IF NOT EXISTS `bacteria_light` (
  `ENTITY` varchar(500) NOT NULL,
  `POTENCY` varchar(5000) NOT NULL,
  `SAFETY_INFORMATION` varchar(5000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `bacteria_light`
--

INSERT INTO `bacteria_light` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Polycationic photosensitizer conjugate between poly-L-lysine and chlorin(e6)', 'polycationic photosensitizer penetreted with 660 nm laser light rapidly killed Escherichia coli infecting excisional wounds in mice', '', 'Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. The worldwide rise in antibiotic resistance necessitates the development of novel antimicrobial strategies.', 11837327),
('Poly-L-lysine chlorin e6 conjugate or free chlorin e6 with red light from a diode laser', 'activity against Staphylococcus aureus', '', 'Targeted photodynamic therapy of established soft-tissue infections in mice. The worldwide rise in antibiotic resistance necessitates the development of novel antimicrobial strategies.', 15122362),
('Photosensitizers PS (a polylysine-chlorin(e6) conjugate, pL-c(e6), and methylene blue [MB]) and an anionic molecule, free c(e6), and subsequent exposure to 665-nm light at 0 to 40 J/cm(2)', '', '', 'These data suggest that slime production and stationary phase can be obstacles against PDI for gram-positive bacteria but that these obstacles can be overcome by using cationic PS.', 15155218),
('UV', 'Methicillin-resistant Staphylococcus aureus was found to be sensitive to both germicidal (ultraviolet C) and solar (ultraviolet A and B) ultraviolet radiation (ultraviolet C substantially more lethal).', '', 'The experiments reveal that medium composition (sodium chloride concentration) exerts a substantial effect on methicillin-resistant Staphylococcus aureus ultraviolet resistance and that this species lacks photoreactivation capacity.', 15695834),
('XF porphyrin derivatives', 'Phototoxicity against methicillin-resistant and sensitive Staphylococcus aureus strains, methicillin-resistant Staphylococcus epidermidis strain, Escherichia coli strain', 'No harm against eukaryotic cells', 'Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. The worldwide rise in the rates of antibiotic resistance of bacteria underlines the need for alternative antibacterial agents.', 15793136),
('5-[4-(1-dodecanoylpyridinium)]-10,15,20-triphenyl-porphyrin', '', '', 'Efficient photoinactivation of methicillin-resistant Staphylococcus aureus by a novel porphyrin incorporated into a poly-cationic liposome. Antimicrobial photodynamic therapy is emerging as a promising therapeutic modality for bacterial infections.', 17387034),
('Photodynamic effect of protoporphyrin diarginate (PPArg2)', 'Incubation with 10 microM followed by illumination yielded a 3.6 log(10)-unit reduction in the viable count for Staphylococcus aureus.', 'At the same experimental conditions, only 22.5% of the fibroblasts were photoinactivated.', 'Photodynamic effect of protoporphyrin diarginate (PPArg2) on methicillin-resistant Staphylococcus aureus and human dermal fibroblasts. The worldwide rise in the antibiotic resistance of bacteria forces the development of alternative antimicrobial treatments.', 18217106),
('Porphyrin-mediated photodynamic antimicrobial chemotherapy', 'A Staphylococcus aureus suspension was exposed to a light emitting diode (LED) emitting at 628 nm, 14.6 mW/cm(2), and energy density of 20 J/cm(2), 40 J/cm(2), or 60 J/cm(2) in the presence of different porphyrin concentrations (Photogem). Three drug concentrations were employed: 12 microl/ml, 25 microl/ml, and 50 microl/ml.', 'Data suggest that PDT has the potential to eliminate Staphylococcus aureus in suspension', 'Susceptibility of Staphylococcus aureus to porphyrin-mediated photodynamic antimicrobial chemotherapy: an in vitro study.', 19585079),
('RLP068/Cl is a novel Zn(II) phthalocyanine proposed as a photosensitizer', 'Inhibition concentration S. aureus strain 26A7 : 16ng/nl, and for S. aureus strain 28C65: 8 ng/ml, P. aeruginosa: 1.65 to 26.4 ?g/ml', '', 'RLP068/Cl is a novel Zn(II) phthalocyanine proposed as a photosensitizer suitable for antimicrobial photodynamic therapy (APDT) for localized infections.', 20008782),
('Antimicrobial photodynamic therapy using 5,10,15-tris(1-Methylpyridinium-4-yl)-20-(pentafluorophenyl)-porphyrin triiodide (Tri-Py(+)-Me-PF) as photosensitizer and irradiated with white light (40 W m(-2)) for 270 minutes.', 'Tested against Vibrio fischeri and recombinant Escherichia coli', '', 'aPDT using Tri-Py(+)-Me-PF represents a promising approach to efficiently destroy bacteria since after a single treatment these microorganisms do not recover their viability and after ten generations of partially photosensitized cells neither of the bacteria develop resistance to the photodynamic process', 20161973),
('Chemiluminescent reaction of luminol to excite the photosensitizer - chemiluminescent photodynamic antimicrobial therapy (CPAT)', 'Effect of free and liposome-encapsulated PS (methylene blue or toluidine blue) on bacteria under excitation by either white external light or chemiluminescence emitted by free or liposome-enclosed luminol.', '', 'One alternative to traditional antibiotic therapy is photodynamic antimicrobial chemotherapy (PACT) which is based on the use of a photosensitizer (PS), activated by illumination with visible light.', 20880227),
('Methylene blue and a low power laser', 'The mean reduction in bacterial counts of the strains submitted to PDT ranged from 4.89 to 6.83 CFU (log10)/mL', '', 'Effect of photodynamic therapy on clinical isolates of Staphylococcus spp.', 21359491),
('Rose Bengal and photosensitizing for 30 min using a halogen lamp.', 'Further, mesocosm experiments with V. harveyi and Artemia nauplii demonstrated that in 30 min, the aPDT could kill 78.9% and 91.2% of heterotrophic bacterial and Vibrio population respectively.', '', 'Reducing Vibrio load in Artemia nauplii using antimicrobial photodynamic therapy: a promising strategy to reduce antibiotic application in shrimp larviculture. We propose antimicrobial photodynamic therapy (aPDT) as an alternative strategy to reduce the use of antibiotics in shrimp larviculture systems.', 21951316),
('Porphyrin-cellulose nanocrystals (CNC-Por (1))', 'Excellent efficacy toward the photodynamic inactivation of Acinetobacter baumannii, multidrug-resistant Acinetobacter baumannii (MDRAB) and methicillin-resistant Staphylococcus aureus (MRSA), with the best results achieving 5-6 log units reduction in colony forming units (CFUs) upon illumination with visible light (400-700 nm; 118 J cm(-2))', '', 'Porphyrin-cellulose nanocrystals: a photobactericidal material that exhibits broad spectrum antimicrobial activity. T', 22360680),
('Cationic PS meso-tetra-4-N-methyl pyridyl porphine', 'Analyses revealed that PDT treatments delayed the growth and considerably reduced the glucose consumption capacity of S. aureus cells.', '', 'Molecular targets of antimicrobial photodynamic therapy identified by a proteomic approach.', 23000218),
('Methylene blue (MB) injection followed by photodynamic therapy', 'In the study of antimicrobial PDT, we verified that methylene blue (MB) injected into the insect followed by whole body illumination prolonged the caterpillar survival (P = 0.0192). Interestingly, combination therapy of larvae infected with vancomycin-resistant E. faecium, with antimicrobial PDT followed by vancomycin, significantly prolonged the survival of the caterpillars when compared to either antimicrobial PDT (P = 0.0095) or vancomycin treatment alone (P = 0.0025), suggesting that the aPDT made the vancomycin resistant E. faecium strain more susceptible to vancomycin action.', '', 'Antimicrobial photodynamic therapy (aPDT) is an alternative therapeutic platform that is currently under investigation for the control and treatment of infections.', 23457486),
('Methylene blue derivatives', 'In suspensions with both, gram-positive and gram-negative bacteria, some derivatives were highly active upon illumination to inactivate S. aureus and E. coli up to 7 log10 steps (99.99999%)?', 'No inherent toxicities in the nonirradiated state', 'Hydrogen bond acceptors and additional cationic charges in methylene blue derivatives: photophysics and antimicrobial efficiency. Photodynamic inactivation of bacteria (PIB) by efficient singlet oxygen photosensitizers might be a beneficial alternative to antibiotics in the struggle against multiresistant bacteria.', 23509728),
('antimicrobial PDT (aPDT): photosensitizers TMPyP and ZnTPPS4', 'We tested these two porphyrins on two cell lines and two bacterial strains to compare effectiveness. In addition, we applied photosensitizers bound in the complex created with hp-?-cyclodextrin. The light-emitting diodes were used at the doses 0, 1, 5, 10 J/cm(2) for cells and 0, 150 J/cm(2) for bacteria. Tested concentrations for cells and microbes were from 0.5 to 50 ?M and from 0.78 to 100 ?M, respectively.', 'TMPyP is a promising compound both in aPDT and in PDT, particularly in contrast to ZnTPPS4, which was efficient only in PDT. Furthermore, the eradication of gram-positive bacteria is possible only with higher concentrations of ZnTPPS4.', 'In this work, the photosensitizers TMPyP and ZnTPPS4 are investigated for photodynamic and antimicrobial photodynamic therapy.', 23899404),
('Ruthenium(II) based photosensitising material (PSM) covalently bound to micrometric glass beads', 'Activity against Helicobacter pylori, a  99.99999% decrease was detected in the number of colonies', '', 'Helicobacter pylori inactivation and virulence gene damage using a supported sensitiser for photodynamic therapy.', 23988411),
('Photodynamic antimicrobial chemotherapy with ?-D-galactopyranosyl zinc phthalocyanines', 'Activity against methicillin-resistant Staphylococcus aureus', '', 'Susceptibility of methicillin-resistant Staphylococcus aureus to photodynamic antimicrobial chemotherapy with ?-D-galactopyranosyl zinc phthalocyanines: in vitro study. The incidence of methicillin-resistant strains of Staphylococcus aureus (MRSA) is increasing globally, making urgent the discovery of novel alternative therapies for infections.', 24249355),
('Ru(II)-based photosensitizers', 'Bacterial samples were dosed with a range of photosensitizer concentrations (0.3-12 micro M) and exposed to 530 nm light (90J cm(-2)) in normoxic conditions (ambient atmosphere) and in hypoxic conditions (0.5% O2', '', 'The intrinsic positive charge of the Ru(II) metal combined with the oxygen independent activity demonstrated by this class of photosensitizers presents a new strategy for eradicating both gram-positive and gram-negative bacteria regardless of oxygenation level.', 24284119),
('Photosensitizer safranine O with that of chlorhexidine (0.2% CHX)', '', '', 'In this context, antimicrobial photodynamic therapy (aPDT) may play a crucial part in the future.', 24473989),
('Hypericin', 'Preincubation with HYP (5 min) plus light exposure (10 min) showed bactericidal effect against planktonic methicillin-susceptible S. aureus and methicillin-resistant S. aureus.', '', 'Antimicrobial photodynamic activity of hypericin against methicillin-susceptible and resistant Staphylococcus aureus biofilms.', 25812458),
('PDT using curcumin (C) as a photosensitizing agent irradiated with an LED (L) in the blue wavelength as a light source', 'Suspensions of both strains of Streptococcus mutans , were divided into 4 groups as follows: absence of C and L (control group: C-L-), with C and without L (C group: C+L-), absence of C with L (L group: C-L+) and presence of C and L (PDT group: C+L+). Three different concentrations of curcumin (0.75 mg/ml, 1.5 mg/ml and 3 mg/ml) and three light fluences of studied light source (24, 48 and 72 J cm(-2)) were tested. Aliquots of each studied group was plated in BHI agar and submitted to colony forming units counting (CFU/ml) and the data transformed into logarithmical scale.', 'A high photoinactivation rate of more than 70% was verified to standard S. mutans strain submitted to PDT whereas the clinical isolate showed a lower sensitivity to all the associations of curcumin and LED. A slight bacterial reduction was verified to C+L- and C-L+, demonstrating no toxic effects to the isolated application of light and photosensitizer to both S. mutans strains tested', 'Photodynamic therapy using a combination of curcumin and blue LED presented a substantial antimicrobial effect on S. mutans standard strain in a planktonic suspension model with a less pronounced effect on its clinical isolate counterparts due to resistance to this alternative approach.', 25876942),
('In vitro PDT (photodynamic therapy) of UVA and TC (Tetracycline) as a PS (photosensitizer) before in vivo study. chitosan as booster.', 'At 1mg/mL of TC, chitosan treatment combined with PDT, increased the bactericidal effect by >10,000-fold of the effect of PDT alone.', '', 'The present study showed that PDT using a combination of TC and chitosan is an effective method for killing C. difficile.', 26386640),
('Lysine-porphyrin conjugate (4i)', 'potent photosensitive antibacterial effect on Methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, and Pseudomonas aeruginosa.', '', 'Mechanism and In Vivo Evaluation: Photodynamic Antibacterial Chemotherapy of Lysine-Porphyrin Conjugate.', 26973620),
('Photosensitizer 5,10,15,20-tetrakis(1-methylpyridinium-4-yl)porphyrin tetra-iodide (Tetra-Py(+)-Me)', 'Activity against Staphylococcus aureus', '', 'PDI, contrarily to traditional antibiotics, inhibited the expression of virulence factors, efficiently inactivating either highly virulent strains and low virulent S. aureus strains, inactivating also antibiotic susceptible and resistant strains, without development of photoresistance after at least 10 consecutive cycles of treatment, and so this therapy may become a strong promising alternative to antibiotics to control pathogenic microorganisms.', 27014198),
('Benzylidene cyclopentanone based PSs modified by polyethylene glycol (PEG), carboxylate anionic or pyridyl cationic agents', 'In vitro and in vivo activity against methicillin-resistant Staphylococcus aureus (MRSA)', '', 'Water-soluble benzylidene cyclopentanone based photosensitizers for in vitro and in vivo antimicrobial photodynamic therapy.', 27323899),
('Photodynamic Therapy (photosensitizer, Rhodamine 6G (R6G) in stealth liposomes)', 'The higher photoefficacies and production of more reactive oxygen species', '', 'The antimicrobial photodynamic therapy is an alternative method for killing bacterial cells in view of the rising problem of antibiotic resistance microorganisms.', 27371913),
('DSPE-PEG-Pheo A (DPP) transfersome', 'For enhanced selectivity and skin penetration efficiency, DPP transfersomes are prepared from 1,2?distearoyl?sn?glycero?3?phosphoethanolamine?N?[amino(polyethylene glycol)?2000], pheophorbide A (Pheo A), cholesterol, and Tween?80. Incorporation of Tween?80 as an edge activator increases the deformability of DPP transfersomes, enhancing skin penetration efficiency to four times that of free Pheo A.', '', 'These results demonstrate that DPP transfersome-mediated photodynamic therapy can be used as an alternative method to treat bacterial skin infections. ? 2016 WILEY-VCH Verlag GmbH & Co.', 27863184),
('Photosensitizer ZnPc(TAP)4n+, n = 0, 4, 8, 12', 'IC50 value of 59 nM at a light dosage of 5? J/cm2 toward E. coli.', 'negligible toxicity against human erythocytes', 'ZnPc(TAP)4n+ are highly potent, rapid-acting and non-toxic photosensitizers capable of inactivating bacteria.', 28251266),
('cationic amino acid-porphyrin conjugate 4I with four lysine groups', 'At 3.9 ?M and 7.8 ?M, PACT induced 6 log units of inactivation of sensitive and multidrug resistant strains.', '', 'These results imply that 4I-mediated PACT (Photodynamic antimicrobial chemotherapy) therapy is an effective and safe alternative to conventional antibiotic therapy and has clinical potential for superficial drug-resistant bacterial infections. DOI: 10.1371/journal.pone.0176529 PMCID: PMC5426629', 28493985),
('Antimicrobial blue light (aBL)', '', 'Much less genotoxic to host cells than ultraviolet-C (UVC) irradiation, which directly causes DNA damage in host cells', 'Unlike another light-based antimicrobial approach, antimicrobial photodynamic therapy (aPDT), aBL therapy does not require the involvement of an exogenous photosensitizer.', 28518072),
('Photosensitizing agents rose bengal (RB) or methylene blue (MB), alone or combined with the antibiotics mupirocin (MU) or linezolid (LN).', 'By contrast, RB-aPDT and MB-aPDT effectively inactivated S. aureus, as evidenced by a 6 log10 reduction in bacterial growth', '', 'Antimicrobial photodynamic therapy (aPDT) could constitute an alternative therapy.', 28626456),
('Boronic Acid Functionalized Photosensitizers', 'Treating planktonic cultures and biofilms of Gram-negative E. coli', '', 'This study investigated a new and innovative strategy for targeting polysaccharides found on the bacterial cell envelope and the biofilm matrix using the boronic acid functionalized and highly effective photosensitizer (PS) silicon(IV) phthalocyanine.', 28675648),
('Methylene blue (MB)-mediated Antimicrobial photodynamic therapy (APDT)', 'MB (0.01%) was applied on the lesions and after 5min they were irradiated using a red laser (wavelength=660nm), fluence of 280J/cm2, 8J and 80s per point, 100mW, spot size 0.028cm2 and fluence rate of 3.5W/cm2', '', 'These results show that APDT can be used to treat infectious stomatitis in snakes.', 29037910),
('Photosensitizer rose bengal (RB), combined or uncombined with gentamicin (GN)', 'Different concentrations of RB (ranging from 0.03 to 64 micro g/ml) were added to S. aureus in water suspensions or forming biofilms in the absence or presence of GN (1-40 micro g/ml) and the samples were irradiated (18 or 37 J/cm2).', '', '. Antimicrobial photodynamic therapy (aPDT) could constitute an alternative therapy to antibiotics especially against superficial infections caused by bacteria involved in multidrug resistance processes.', 29196246),
('Methylene blue', 'The CFU/ml count demonstrated significant reduction (p less than or equal to 0.01) at the average 5.0 logs comparing with control group for the two species in all the tested concentrations.', '', 'Photodynamic therapy emerges as an alternative in microbial inactivation, due to its selectivity and to decreasing or dismissing antibiotic use.', 29454901),
('The photosensitizer (PS) curcumin and the light source LED at 450nm)', 'The highest microbial inactivation was observed with 70% biofilm reduction in conditions 1.25 mg/mL curcumin, 2 h of PS incubation and 50 J/cm2.', '', 'Photodynamic therapy (PDT) is an alternative for microbial inactivation noninvasive without stimule of microbial resistance.', 29788897),
('Photosensitizer indocyanine green (ICG) and ethylenediamine tetraacetate (EDTA)', 'In vitro activity against drug resistant Staphylococcus aureus and Pseudomonas aeruginosa,', '', 'Antimicrobial Photodynamic therapy(A-PDT) or Photodynamic antimicrobial chemotherapy (PACT) has been proposed as an alternative approach for inactivating bacteria, especially resistant bacterial biofilms.', 30633998),
('Methylene blue and a low-level laser with a wavelength of 660 nm and fluence of 39.5 J/cm2 (energy of 15 J and time of 428 s)', 'Activity against clinical isolates of carbapenem-susceptible and carbapenem-resistant Acinetobacter baumannii', '', 'Antimicrobial photodynamic therapy against clinical isolates of carbapenem-susceptible and carbapenem-resistant Acinetobacter baumannii.', 30891656),
('aBL (antimicrobial blue light) at 405- and 470-nm wavelengths', 'About 3.12-log10 reduction of bacterial colony forming units (CFU) was achieved by 27 J/cm 2 exposure at 405 nm, while about 3.70-log10 reduction of bacterial CFU was achieved by 234 J/cm2 exposure at 470 nm', '', 'Antimicrobial Blue Light Inactivation of Neisseria gonorrhoeae: Roles of Wavelength, Endogenous Photosensitizer, Oxygen, and Reactive Oxygen Species', 31157931),
('Gallium aluminium arsenide (GaAlAs) laser', 'Reduction in colony count of P. intermedia after being exposed to GaAlAs diode laser for 1 minute from 369-229, 134 and 41; decrease in colony count of P. gingivalis after being exposed to GaAlAs diode laser for 1 minute from 286.52-197, 94 and 39,', '', 'Photodynamic therapy (PDT) kills the bacteria and also leads to the detoxification of endotoxins.', 31235678),
('PDT with polyurethane (PUR) surfaces were coated with hypericin nanoformulations', '4.3 log10 reduction in bacterial growth in vitro', '', 'Synergistic effects of ultrasound and photodynamic therapy leading to biofilm eradication on polyurethane catheter surfaces modified with hypericin nanoformulations.', 31349520),
('indium phosphide quantum dots (InP QDs)', 'We show that the superoxide generated by InP QDs is able to effectively kill drug-resistant bacteria in vivo to reduce subcutaneous abscess infection in mice without being toxic to the animal.', 'We show that the superoxide generated by InP QDs is able to effectively kill drug-resistant bacteria in vivo to reduce subcutaneous abscess infection in mice without being toxic to the animal.', 'These InP QDs thus provide a promising alternative to traditional small-molecule antibiotics, with the potential to be applied to a wide variety of infection types, including wound, respiratory, and urinary tract infections.', 34156817),
('Methylene Blue antimicrobial photodynamic therapy (aPDT) (MB-aPDT)', '', '', 'Antimicrobial photodynamic therapy (aPDT) is a new therapeutic approach for infections, but it also improves healing in many wound models.', 34113639),
('Curcumin and silver nanoparticles (AgNPs)', '', '', 'Antimicrobial photodynamic therapy (aPDT) is a non-invasive strategy against antibiotic-resistant bacteria. aPDT contains the combination of non-toxic dyes with harmless visible light to create reactive oxygen species (ROS) that selectively lead to microbial cell death.', 34379214),
('benzylidene cyclopentanone (BCP) photosensitizers (Y1, P1 and P3)', 'The ex vivo experiments showed that P3 mediated aPDT resulted in 82.4% to 100% reduction of H. pylori CFU without damaging the gastric mucosa.', 'The ex vivo experiments showed that P3 mediated aPDT resulted in 82.4% to 100% reduction of H. pylori CFU without damaging the gastric mucosa.', 'Antimicrobial photodynamic therapy (aPDT) is a promising non-pharmacological antibacterial technology.', 34454316),
('Zeolitic imidazolate framework (ZIF-8) NMOF nanocrystals are attached postsynthetically with SQ (designated as ZIF8-SQ)', 'ZIF8-SQ provides unparalleled aPDT action against methicillin-resistant Staphylococcus aureus (MRSA) and leads to complete loss of adherence of structurally robust bacterial biofilms.', '', 'Antimicrobial photodynamic therapy (aPDT) offers alternative modalities to combat the growing MDR typically by means of targeted cellular internalization of a photosensitizer (PS) capable of producing photoinduced reactive oxygen species (ROS).', 35026912),
('VU0038882 and conjugated anti-Isd MAbs', 'Staphylococcus aureus', '', 'Antimicrobial photodynamic therapy is an effective alternative to antibiotics; therefore we developed an approach to simultaneously expose S. aureus to intracellular and extracellular photosensitizers.', 34516248),
('Riboflavin', 'E.coli and MRSA', '', 'Riboflavin, as a photosensitizer to target mono and dual species bacterial biofilm of MDR E. coli and MRSA.', 32916327),
('antimicrobial blue light and methylene blue', 'antimicrobial blue light and methylene blue-antimicrobial photodynamic therapy led to a significant reduction in the hydrolysis of nitrocefin (81-98 %).', '', 'Antimicrobial blue light and photodynamic therapy inhibit clinically relevant β-lactamases with extended-spectrum (ESBL) and carbapenemase activity.', 33157328),
('Brominated carbon nanodots (BrCND)', 'BrCND demonstrate both type I and type II photosensitization under UV-A irradiation, and furthermore are shown to have significant antimicrobial effects against both Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus and Listeria monocytogenes as well.', '', 'The results described present the BrCND structure as a competitive new antimicrobial agent for controllable sterilization of bacteria.', 33211048),
('5-aminolevulinic acid derivatives; ALA-methyl ester, ALA-hexyl ester, and ALA-13A', 'In vivo studies revealed that ALA-methyl ester, ALA-hexyl ester, and ALA-13A are potent photosensitizers.', '', 'CONCLUSION: Photodynamic therapy is increasingly used to treat different types of skin infections caused by bacterial strains.', 33404073),
('methylene blue (MB)-PDT', 'MB-PDT led to complete inhibition of all isolates at geometric mean concentrations of 1-16 mg/L.', '', 'Terbinafine resistant and susceptible strains are equally susceptible to MB-PDT', 33497815),
('curcumin-aPDT', 'The MIC value of curcumin-aPDT for VRSA was found to be 156.25 microgram/ml whereas sub-MIC (1/2 of MIC) was found to be 78 microgram/ml', 'The test concentration of curcumin (78 ?g/ml) with light treatment (20 J/cm2 = 52 s) was found nontoxic to THP1 cell line.', 'Antimicrobial and antibiofilm photodynamic therapy against vancomycin resistant Staphylococcus aureus (VRSA) induced infection in vitro and in vivo.', 33508436),
('phenothiazinium-based derivatives,', 'these compounds were able to eliminate various types of microorganisms, including Gram-(+) Staphylococcus aureus (S. aureus), Gram-(-) Escherichia coli, multidrug-resistant S. aureus, and their associated biofilms, at low drug and light dosages (e.g., 0.21 ng/mL in vitro and 1.63 ng/cm2 in vivo to eradicate S. aureus at 30 J/cm2).', 'The cytotoxicities of these synthesized pyridophenothiaziniums toward human normal fibroblast cells (WI38 cells) were assessed by using the standard MTT assay, and the results showed that all compounds except 3 displayed negligible cytotoxicity under studied conditions', 'In Vitro and In Vivo Demonstration of Ultraefficient and Broad-Spectrum Antibacterial Agents for Photodynamic Antibacterial Chemotherapy.', 33656316),
('cationic photosensitizer (NB) and bacteriophage (ABP)-based photodynamic antimicrobial agent (APNB)', 'Both in vitro and in vivo experiments prove that APNB can efficiently treat A. baumannii infection.', '', 'Photodynamic antibacterial chemotherapy (PACT) has great potential to solve serious bacterial resistance, but it suffers from the inefficient generation of ROS and the lack of bacterial targeting ability.', 34163871),
('oligo-thiophene-ethynylene (OTE)', 'the neutral OTEs exhibited better antibacterial activity in most cases, and OTEs bearing cyclic amino groups exhibited better antibacterial activity than those bearing acyclic ones in most cases.', '', 'Photodynamic therapy (PDT) is a potential approach to resolve antibiotic resistance, and phenylene/thiophene-ethynylene oligomers have been widely studied as effective antibacterial reagents.', 34410119),
('fluorinated boron dipyrromethene (BODIPY)-based glycomimetics.', '', '', 'Photodynamic therapy is a promising strategy to reduce bacterial antibiotic resistance and employs photosensitizers, excitation light sources, and sufficient oxygen to generate toxic reactive oxygen species (ROS).', 34254513),
('Tripterygium wilfordii Hook. f.', '', 'The in vitro APDT effects were also evaluated in the model animal Caenorhabditis elegans.', 'Natural photosensitizers from Tripterygium wilfordii and their antimicrobial photodynamic therapeutic effects in a Caenorhabditis elegans model.', 33848804),
('buforin II-[Ru(bpy)3]2+ bioconjugate', 'The submicromolar activity of 1 against the multidrug-resistant strains Escherichia coli AR 0114 and Acinetobacter baumannii Naval-17 indicates strong synergy between the ruthenium complex and buforin II.', '', 'Antimicrobial photodynamic therapy (APDT) has gained increased attention because of its broad spectrum activity and lower likelihood to elicit bacterial resistance.', 32993282),
('Cold atmospheric plasma (CAP)', 'We demonstrate that CAP treatment increases intracellular concentrations of reactive oxygen species (ROS) and nitric oxide and promotes the elimination of both antibiotic-sensitive and antibiotic-resistant S. aureus by RAW 264.7 cells.', '', 'Our study shows that CAP has beneficial effects on macrophage defense mechanisms and may potentially be useful in adjuvant antimicrobial therapies.', 34133202),
('ZnTCPP/Ti3 C2 TX', 'a visible light responsive organic-inorganic hybrid of ZnTCPP/Ti3 C2 TX is designed and fabricated to treat bacterial infection with antibacterial efficiency of 99.86% and 99.92% within 10 min against Staphylococcus aureus and Escherichia coli, respectively. The porphyrin-metal complex, ZnTCPP, is assembled on the surface of Ti3 C2 TX MXene to capture bacteria electrostatically and the Schottky junction formed between Ti3 C2 TX and ZnTCPP promotes visible light utilization, accelerates charge separation, and enhances the mobility of photogenerated charges, and finally increases the photocatalytic activity.', 'Supporting Information, even if the concentration is increased from 200 to 400 Microgram mL-1, only ZnTCPP shows some cytotoxicity and ZnTCPP/Ti3C2TX still exhibits excellent cytocompatibility.', 'As a result of the excellent bacteria capturing ability and photocatalytic antibacterial effects, ZnTCPP/Ti3 C2 TX exposed to visible light has excellent antibacterial properties in vitro and in vivo. Therefore, organic-inorganic materials that have been demonstrated to possess good biocompatibility and enhance wound healing have large potential in bio-photocatalysis, antibacterial therapy, as well as antibiotics-free treatment of wounds.', 35657068),
('Boron-dipyrromethene (BODIPY) is a type of photosensitizer (PSs)- BODIPY derivatives (BDP1-BDP6) modified', 'The results indicated that BDP3, which had 2, 6-diiodo and 8-phenyl substitution, was the best PS candidate with the highest reactive oxygen species (ROS) generation efficacy. BDP3 and BDP5 could rapidly kill Staphylococcus aureus (S. aureus) with the minimum inhibitory concentration (MIC) of 10 nM upon illumination.', 'the biosafety evaluation toward the mouse fibroblasts (L929 cells) suggested BDP3 had good cytocompatibility.', 'BDP3 destroyed the cell membrane structure of bacteria by generating ROS, which ultimately led to bacterial lysis and death. This work exhibits the great potential of rational designs of PS for aPDT applications.', 35561846),
('two porphyrin-based photosensitizers (TMPyP and THPTS)', 'Using this method, we could confirm the susceptibility of several bacterial strains to photodynamic treatment, including extensively drug-resistant pathogens (XDR).', '', 'We recommend this luminometric method for high-throughput tasks requiring measurements of bacterial viability in the context of photodynamic treatment approaches.', 35630394),
('TiO2 nanotube arrays (TNTs) decorated with Ag/SnO2-Sb nanoparticles (TNTs-Ag/SnO2-Sb) as the anode and Ti-Pd/SnO2-Sb as the cathode to construct an efficient photoelectrocatalytic (PEC) system', 'In this system, 99.9% of ARB was inactivated in 20 min, meanwhile, ARGs was removed within 30 min, and antibiotics were almost completely degraded within 1 h. Furthermore, the effects of system parameters on the removals of antibiotics, ARB and ARGs were also studied. The redox performance of the system was verified by adding persulfate. Escherichia coli, as a representative microorganism in aquatic environments, was used to evaluate the ecotoxicity of PEC treated chloramphenicol (CAP) solution. The ecotoxicity of CAP solution was significantly reduced after being treated by PEC.', '', 'This study could provide a potential alternative method for controlling antibiotic resistance and protecting the quality of reclaimed water.', 34736195),
('photosensitizer LD4 in photodynamic antimicrobial chemotherapy (PACT), both alone and in combination with an antibiotic, on osteomyelitis', 'In a rabbit tibial osteomyelitis model, a reduction in bacterial numbers of more than 99.9% was recorded in the PACT group and the PACT + antibiotic group 5 weeks after treatment (p < 0.01). In histological analysis, repair of the damaged bone tissue was observed in the PACT group, and bone repair in the PACT + antibiotic group was even more significant. In radiological analysis, the X-ray Norden score showed that the severity of bone tissue defects or destruction followed the pattern: PACT + antibiotic group < PACT group < antibiotic group < control group.', '', 'Photodynamic antibacterial chemotherapy has attracted increasing attention as a potential alternative treatment. Its advantages are a broad antibacterial spectrum, lack of drug resistance, and lack of toxic side effects.', 35531297),
('label-free surface-enhanced Raman spectroscopy (SERS) technology', 'The typical Raman peak intensities of I734/I867 showed a negative and non-linear correlation with the minimum inhibitory concentration (MIC). The correlation coefficient reached above 0.9. The target sites of oxacillin/cefazolin on S. aureus clearly reflected on SERS profiles.', '', 'This study indicates that SERS technology provides a rapid and flexible alternative to current drug susceptibility testing, laying a foundation for qualitative and quantitative evaluation of drug resistance in clinical detection.', 35231762),
('electrochemical disinfection (ED) process assisted by molybdenum carbide (Mo2C) electrodes', 'The established ED process was proved to effectively inactivate multi-resistant ARB (i.e. Escherichia coli K-12 LE392 with resistance to kanamycin, ampicillin, and tetracycline) and to degrade ARGs (including tetA and blaTEM in the form of both intracellular (iARGs) and extracellular ARGs (eARGs)). Specifically, within 15 min treatment by the Mo2C-assisted ED under 2.0 V, a 5-log ARB removal was realized, without any ARB regrowth observed, indicating a permanent inactivation of ARB by the process. Moreover, degradation of the iARGs (0.4-log reduction of the blaTEM and 3.1-log reduction of the tetA) and the eARGs (4.2-log reduction of the blaTEM and 1.1-log reduction of the tetA) were achieved within 60 min, further underpinning the viability of the Mo2C-based ED. While e-, H2O2, and ', '', 'Collectively, the Mo2C-assisted ED demonstrated in the present study represents an attractive alternative to the traditional disinfection methods in combating the spread of antibiotic resistance.', 35334270),
('electrochemical oxidation', 'Disinfection of polymicrobial urines by electrochemical oxidation. 4-6 logs bacterial removal were achieved for every bacterium tested when working with a microfluidic flow-through reactor after 180 min (0.423 Ah dm-3). The MIKROZON', '', 'This electro-ozonizer could be considered as a suitable alternative to reduce the risk of antibiotic resistance spread. Hence, this study provides an insight into different electrochemical reactors for the disinfection of complex hospital urine matrices and contributes to reduce the spread of antibiotic resistance through the elimination of ARGs.', 34923384),
('effects of activated sludge and UV irradiation', 'Significant differences (p < 0.05) in the proportion of pathogens were observed between APT and the other samples, suggesting that the secondary treatment reduced its abundance. The MAS achieved 64.0-99.7% average removal efficiency for total (THB) and resistant heterotrophic bacteria, although the proportions of ARB/THB have increased for sulfamethoxazole, cephalexin, ciprofloxacin, and tetracycline. A total of 107 copies/mL of intI1 gene remained in the final effluent, suggesting that the treatment did not significantly remove this gene and possibly other ARGs.', '', 'In conclusion, disinfected effluents are still a potential source for ARB and ARGs, which highlights the importance to investigate ways to mitigate their release into the environment.', 35060061),
('iridium oxide (IrOx)', 'Research results show that near-infrared light can enhance the peroxidase catalytic activity of IrOx and generate highly toxic hydroxyl radicals (', 'Importantly, IrOx has no obvious cellular and in vivo toxicity.', 'Accordingly, the novel photothermal nanozyme is expected to be applied to bacterial infectious diseases, such as wound healing, sepsis, and implant-related infections. Herein, we synthesized a new type of iridium oxide (IrOx) as an alternative to antibiotics.', 35469514),
('Antimicrobial photodynamic therapy with curcumin', 'The strains were induced to form biofilm and incubated with curcumin for 20 min, irradiated with LED (Light Emitting Diode) 450 nm, at 110 mW/cm2, 50 J/cm2 for 455 s, subsequently counting the Colony Forming Units, Scanning Electron Microscopy (SEM) micrographs, Confocal Microscopy images, Resazurin dye test, ROS quantification to assess the effect of PDT on biofilm. The results show that PDT with curcumin reduced the biofilm growth of the MRSA strain. In addition, confocal microscopy showed that curcumin was internalized by S. aureus in the cells at the concentration used, and when isolated, curcumin and the irradiation parameter did not show cytotoxicity.', '', 'The study demonstrated that the PDT in the established parameters reduced the growth of the MRSA strain biofilm, making it a relevant alternative possibility for the inactivation of this strain.', 35041982),
('light (? = 635 nm) in the presence of MB as a photosensitizer', 'The lethal dose of laser light (cell mortality about 99.9%) was 9.54 J cm-2, which corresponds to 30 min of irradiation. After a 15-fold phototherapy cycle, the tolerance to aPDT decreased, resulting in a decrease in the number of viable cells by 2.15 and 3.23 log10 CFU/ml units with the use of sub-lethal and lethal light doses, respectively. Multiple photosensitizations decreased the biofilm formation efficiency by 25 ', '', 'Many significant changes in the levels of the metabolites were detected demonstrating the response of A. baumannii to oxidative stress.', 35115588),
('zinc phthalocyanine (ZnPcMe)', 'Palladium phthalocyanines (PdPcs) with methylpyridiloxy groups linked peripherally (pPdPc) or non-peripherally (nPdPc) were studied with full photodynamic inactivation for 5.0 microM nPdPc toward both F. hydatis, R and S strains (6 log), but with a half of this value (3 log) for 5.0 microM pPdPc and only for F. hydatis, S.', '', 'ZnPcMe showed optimal photocytotoxicity for inactivation of both F. hydatis R and S. The present study is encouraging for a further development of aPDT with phthalocyanines as an alternative method to antibiotic medication to keep under control the harmful pathogens in aquacultures'' farms.', 35678662),
('organic photo-antimicrobial near-infrared (NIR) AIEgen BDPTV', 'DQVTA and DPTVN, upon photoirradiation of AIEgen BDPTV, the generation of abundant and highly toxic reactive oxygen species (ROS) irreversibly destroys MDR gram-positive bacteria through photodynamic therapy, which is better than commercial photosensitizers (including methylene blue, chlorin e6, and protoporphyrin IX) and antibiotic (cefoxitin). methicillin-resistant Staphylococcus aureus (MRSA) were completely killed. apable of successfully combating MRSA-infected wounds of mice, but not Escherichia coli (E. coli)-infected wounds.', '', 'We hope that this strategy could provide a new method to design powerful AIEgens to avoid the overuse and misuse of antibiotics.', 35635895),
('series of photosensitizer-polypeptide conjugate (PPa-cP)', 'to realize the synergistic antibacterial effects on Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus (MRSA) under light irradiation. Among the synthesized PPa-cP, PPa-cP5 with the degree of polymerization of 37 and modified with a 1-methylimidazole side group exhibits the best antibacterial activity with a minimum inhibitory concentration value of 2 microm without light irradiation and 0.25 microm with light irradiation.', '', 'Overall, the present study establishes an efficient strategy for the treatment of S. aureus and S. aureus biofilm infections.', 35526119),
('methylene blue (MB)-mediated aPDT', 'Pure MB-mediated aPDT significantly reduced the numbers of bacteria with biofilms on the wound surface and in the epidermis compared with those for the control tissue (saline only). However, there were many bacteria in the deeper region of the tissue. In contrast, MB/EDTA/ethanol/DMSO-mediated aPDT minimized the numbers of bacteria in the broad depth region of the tissue.', 'Still, a limited number of bacteria was observed in the subcutaneous tissue.', 'Conclusions: The depthwise analysis of bacteria demonstrated the efficacy of the MB-mediated aPDT with the addition of EDTA, ethanol, and DMSO in controlling burn wound infections. However, further improvement of the therapy is needed to suppress bacterial migration into the deep tissue completely.', 35088588),
('Peripheral Pd(II)-and Zn(II)-Phthalocyanines', 'The photoinactivation results showed a full effect with 8 microM pPdPc for S strain and with 5 microM ZnPcMe for both A.hydrophila R and S strains.', '', 'Comparison between both new isolates of A.hydrophila (S and R) suggests that the uptakes and more likely photoinactivation efficacy of the applied phthalocyanines are independent of the drug sensitivity of the studied strains.', 35203593),
('microwave (MW) irradiation', 'ARGs removal efficiency (85.5%)', '', 'Microwave is a promising technology for disinfecting airborne microbes and preventing the spread of antibiotic resistance.', 35410010),
('heterogeneous photocatalytic oxidation (UVA-TiO2 system)', 'bacterial survival and higher conjugative transfer frequency than E. coli DH5alpha resistant to nalidixic acid and rifampicin', '', 'This new perspective provides detailed information on the practical application of photocatalytic oxidation for inactivating ARB and hampering the spreading of ARGs in the aquatic environment.', 35453030),
('Ti3C2Tx MXene loaded with indocyanine green', 'great anti-MRSA activity of ICG-MXene under NIR was attributed to the combination of photothermal effect of MXene (high temperature) and photodynamic effect of ICG (high level of reactive oxygen species)', '', 'Our findings indicate that MXene can be used as both the photothermal agent and the carrier of photosensitizers to achieve the synergistic PTT/PDT therapy for bacterial infections.', 35785716),
('5-aminolevulinic acid (ALA) Photodynamic therapy', 'significant killing effect on M. abscessus at ALA concentrations greater than 50 Microg/ml and the effect increased with increasing photosensitizer concentrations. ALA-PDT also showed a notable scavenging effect on M. abscessus biofilm, which was also enhanced with increasing ALA concentrations', '', 'Conclusions: ALA-PDT has a significant killing effect on M. abscessus and can increase its antibiotic susceptibility.', 35297368),
('red & blue LED effects', 'Blue LED light inhibited MRSA, ESBLs-Eco, and MDR-Pae in vitro study. In vivo, RBLL accelerated wound healing, reduced levels of pathogenic bacteria on the wound surface while increasing the blood supply to the wound surface and inhibiting the excessive inflammatory response.', 'This study is aimed to evaluate and compare the therapeutic effect of RBLL light on different multi-drug resistant (MDR) bacteria in vitro and male Sprague-Dawley (SD) rat refractory MDR infection wound model in vivo.', 'Conclusion: RBLL showed a great potential gain for the treatment of MDR bacterial infected wounds, suggesting PBM therapy is an inexpensive, convenient, pain-free, and safe therapeutic intervention for refractory MDR infection wounds.', 34989417),
('silver nanoparticles attached to methylene blue', 'effective photodynamic therapy agent used to deactivate the Gram-negative bacteria, E. coli, and Gram-positive bacteria, S. aureus', '', 'Ag NPs/ MB combination has potential to be used in PDT where standard photosensitizers have limitations.', 35545200),
('ALA-PDT', 'treatment of diabetic foot ulcer with infection, All patients'' wounds were firstly irradiated with 20% ALA-PDT (635 nm, 100 J/cm2, 80 mW/cm2) using the red LED to control the infection.', '', 'Conclusions: ALA-PDT treatment for DFUs with infection show successful outcomes and might ultimately avoid amputation.', 35331957),
('Photothermal and photodynamic inactivation of using conjugated polymers', 'These platforms have demonstrated to be a reliable, rapid, and efficient alternative to eliminate tenacious pathogens while avoiding the emergence of resistance mechanisms. showing antimicrobial activity triggered by light, conjugated polymers (CPs) have risen as the most promising option to tackle this complex situation.', 'low cytotoxicity', 'conjugated polymers with applications in photodynamic inactivation and photothermal therapy towards bacteria elimination', 36049287),
('Iridium oxide also has photothermal properties', 'Research results show that near-infrared light can enhance the peroxidase catalytic activity of IrOx and generate highly toxic hydroxyl radicals (', 'IrOx has no obvious cellular and in vivo toxicity.', 'novel photothermal nanozyme is expected to be applied to bacterial infectious diseases, such as wound healing, sepsis, and implant-related infections.', 35469514),
('Photodynamic Inactivation (PDI) at 450 nm wavelength, 40 mW/cm2, with a 5 to 80 J/cm2 light dose.', 'survival of S. aureus in PDI as a function of light dose and fixed concentration of curcumin. No microbial toxicity was observed with the curcumin use in the dark', '', 'Different combination protocols of both therapies exert synergistic or antagonistic effects. The ROS produced by PDI can weaken the cell, facilitating the action of antibiotics, or degrade the antimicrobials, decreasing their efficiency. Moreover, the antibiotic and photosensitizer interaction may compromise photodynamic efficiency.', 36476814),
('new Donor-p-Acceptor (D-p-A ) type luminogen TTTh', 'the bacterial burden of wounds in TTTh group decreased by more than 99.9 % upon infection of S. aureus', 'TTTh treatment did not affect the weight of mice, suggesting acceptable biosafety of TTTh', 'TTTh killed the extracellular MRSA by disrupting the membrane integrity and inducing ROS accumulation in bacteria. TTTh significantly reduced the number of intracellular S. aureus by potentiating the lysosomal acidification and maturation of macrophages.', 36176034),
('photodynamic inactivation (PDI) using violet-blue (VB) light', 'Exposure to 405-nm light resulted in a dose-dependent increase in fluorescence in both C. jejuni and E. coli, suggesting a photoexcitation-induced ROS increase', '', 'VB light increases intracellular reactive oxygen species (ROS) to high levels. They also show that VB light causes rapid inactivation of both pyruvate and 2-oxoglutarate oxidoreductases, thus interrupting the citric acid cycle. They confirmed that C. jejuni is highly susceptible to VB light.', 35924857),
('Combining antimicrobial photodynamic and antibiotic', 'Performing aPDT with the photosensitizer methylene blue (maximum molar absorptivity of 85,000 M-1 cm-1 at 664 nm) in combination with antibiotics chloramphenicol and tetracycline results in significant reductions in resistance for two methicillin-resistant Staphylococcus aureus (MRSA) strains, USA300 and RN4220. the maximum aPDT treatment on S. aureus USA300 altered both Chl and Tet tolerance designations from resistant to susceptible. For RN4220, mean Chl MIC decreased from 29.3 to 6.70 microg/mL (i.e., >4.37-fold), and mean Tet MIC decreased from 1.50 to 0.377 microg/mL (i.e., >3.97-fold).', '', 'these results suggest that concurrent aPDT consistently decreases S. aureus resistance by improving susceptibility to antibiotic treatment.', 36037346),
('organic photo-antimicrobial near-infrared (NIR) AIEgen BDPTV equipped with a phenylboronic acid moiety,', 'in vitro experimental results showed that methicillin-resistant Staphylococcus aureus (MRSA) were completely killed using AIEgen BDPTV', '', 'the generation of abundant and highly toxic reactive oxygen species (ROS) irreversibly destroys MDR gram-positive bacteria through photodynamic therapy, which is better than commercial photosensitizers. More importantly, AIEgen BDPTV was capable of successfully combating MRSA-infected wounds of mice, but not Escherichia coli (E. coli)-infected wounds. We hope that this strategy could provide a new method to design powerful AIEgens to avoid the overuse and misuse of antibiotics.', 35635895),
('Nanomaterials-based photothermal therapy (PTT) and photodynamic therapy (PDT): loaded indocyanine green (ICG) on the Ti3C2Tx MXene nanosheets (454 nm)', 'Under NIR, however, the viability loss of MRSA remarkably increased to 45% for MXene, 66% for ICG and 100% for ICG-Mxene activity against methicillin-resistant Staphylococcus aureus (MRSA).', '', 'We further found that the great anti-MRSA activity of ICG-MXene under NIR was attributed to the combination of photothermal effect of MXene (high temperature) and photodynamic effect of ICG (high level of reactive oxygen species). Our findings indicate that MXene can be used as both the photothermal agent and the carrier of photosensitizers to achieve the synergistic PTT/PDT therapy for bacterial infections.', 35785716);
INSERT INTO `bacteria_light` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('water-soluble NIR fluorescence emission rhodamine-based photosensitizer with aggregation-inducing emission (AIE) effects, referred to as CS-2I', 'CS-2I achieves complete inhibition of methicillin-resistant Staphylococcus aureus (MRSA) at an extremely low concentration (0.5 microm) and light dosage (6 J cm-2 ).', '', 'In summary, we developed a new rhodamine-based NIR PS (CS-2I) with AIE effects and the excellent ability for selective discrimination and ablation of drug-resistant Gram-positive bacteria via PDT. CS-2I was mixed with Carbomer 940 to obtain an antibacterial hydrogel dressing (CS-2I@gel), and in vivo results demonstrated that CS-2I@gel not only provided extraordinary photodynamic bactericidal ability, but also promoted the healing of MRSA-infected wounds in mice due to the adhesiveness and moisture of the hydrogel.', 35750469),
('photosensitizer (pyropheophorbide a, PPa)-conjugated cationic polypeptide (PPa-cP)', 'The developed PPa-cP exhibited excellent antibacterial properties against S. aureus and MRSA under light irradiation. PPa-cP5 modified with methyl imidazole effectively inhibited the growth of S. aureus with a concentration of 0.25 microm under light irradiation, indicating its excellent antibacterial activity.', '', 'Pa-cP exhibited enhanced antibacterial activity and synergistic antibacterial effects under light irradiation. Among these PPa-cP, PPa-cP5 showed the best antibacterial activity and the highest synergistic effect. PPa-cP5 could target the bacterial membrane and destroy the bacterial cell membrane. The hemolysis test revealed that PPa-cP5 showed good biocompatibility. Finally, PPa-cP5 achieved an effective biofilm penetration and eradication by taking advantage of their positive charge. Overall, this study establishes a promising strategy to treat bacterial infections.', 35526119),
('combination of amoxicillin and light-activated methylene blue', 'Amoxicillin and light-activated MB can mutually boost each other''s uptake in S. aureus, producing up to 8 logs of reduction of MRSA infections when they are co-administrated. It can lead to more than 99% of reduction of S. aureus infections', '', 'his simple combination of light-activated MB and amoxicillin can ultimately reform our treatment against MDR S. aureus pathogens including MRSA, significantly alleviating the health and economic burden of S. aureus infections across the world.', 36099788),
('novel palladium nanoparticles decorated bismuth oxybromide (Pd/BiOBr) nanostructures', 'The photocatalytic antibacterial efficiency of Pd/BiOBr was evaluated against some common pathogenic strains of Gram-positive and Gram-negative bacteria (Pseudomonas fluorescens, Pseudomonas aeruginosa, Escherichia coli, Aeromonas salmonicida, Salmonella typhimurium, Klebsiella pneumoniae, Bacillus subtilis). Pd/BiOBr showed excellent photocatalytic disinfection efficacy with > 99.9% bacterial inactivation. A very low concentration of Pd/BiOBr (0.5 microg/mL) effectively inhibited the bacterial growth in response to just 2 h of visible light irradiation, while 1 microg/mL of Pd/BiOBr completely killed all the tested bacterial strains', '', 'The developed materials with exceptional antibacterial broad range efficiency can be used in different photocatalytic disinfection systems including water purification systems, biofilm exclusion and combating differential antibiotic resistance.', 35752021),
('Photothermal Nanozyme-Based Microneedle', '95% bacterial biofilm infections (BBIs) elimination can be achieved by combining heat stress-triggered iron interference with iron-nutrient immune reactivation.', '', 'photothermal microneedle patch (FGO@MN) is synthesized by the growth of Fe3 O4 nanoparticles on graphene oxide nanosheets and then encapsulated in methacrylated hyaluronic acid needle tips.', 36239263),
('cationic aggregation-induced emission luminogens named with triphenylamine thiophen pyridinium (TTPy)', 'S. aureus was killed effectively with nearly no surviving colony in the presence of 0.05 ', 'toxicity was significantly observed at 1.0 ', 'This study exhibits an efficient photodynamic antibacterial treatment to BE, which induces an early intraocular immune response and saves useful vision, endowing TTPy a promising potential for clinical application of ocular infections. TTPy induces innate immune response at an early stage of infection, limiting subsequent robust inflammation and protecting retina from bacterial toxins and inflammation-induced bystander damage.', 35794437),
('a visible light responsive organic-inorganic hybrid of ZnTCPP/Ti3 C2 TX is designed', 'treat bacterial infection with antibacterial efficiency of 99.86% and 99.92% within 10 min against Staphylococcus aureus and Escherichia coli, respectively.', '', 'As a result of the excellent bacteria capturing ability and photocatalytic antibacterial effects, ZnTCPP/Ti3 C2 TX exposed to visible light has excellent antibacterial properties in vitro and in vivo. Therefore, organic-inorganic materials that have been demonstrated to possess good biocompatibility and enhance wound healing have large potential in bio-photocatalysis, antibacterial therapy, as well as antibiotics-free treatment of wounds.', 35657068),
('265 nm UVC', 'Significant P. aeruginosa growth inhibition in the in vitro infection model was achieved with UVC, that resulted in a >3.5 log10 reduction of bacteria in a subsequent ex vivo keratitis model (p < 0.05).', '', 'In vitro and ex vivo testing confirmed therapeutic potential of 15 s UVC, proved effective in treating murine bacterial keratitis.', 35568373),
('Photosensitizers with aggregation-induced far-red/near-infrared emission- AIE-active PSs (TBTPy and TBTCy)', 'Antimicrobial mechanism is found to be changing osmotic pressure of cytoplasm in E. coli, causing cell deformation and destruction of S. aureus and C. albicans', '', 'In vivo anti-infection experiment demonstrated AIE PSs can accelerate the healing process of the burned wounds on rats infected by methicillin-resistant S. aureus (MRSA) or E. coli, indicating their potential to treat tertiary burns in clinical application. Therefore, the attained AIE PSs hold great promise as antimicrobial candidates in infective therapeutic application.', 36563423),
('blue light administered at continuous low-irradiance phototherapy (CLIP)', 'CLIP exposure utilizing irradiances as low as 2.78 mW/cm2 delivered over 24 h resulted in a >3.0-log (>99.9%) and >2.0-log (>99.0%) microbial load reduction when organisms were grown in planktonic and biofilm-encapsulated conditions, respectively. ( 405 nm irradiation)', 'Human fibroblast viability and proliferation were unaffected by CLIP.', 'This is the first report demonstrating the antimicrobial efficacy of CLIP for MDROs found in infected wounds. CLIP did not compromise cultured human fibroblast growth and survival. This study demonstrated that very low fluence rates (irradiances) delivered over extended periods are potently antimicrobial.', 36126289),
('Photoactivated chromophore for keratitis-corneal crosslinking (PACK-CXL)', '365 nm UVA light source for 30 min at 3mW/cm2 (standard protocol) or for 5 min at 18mW/cm2, PACK-CXL treatment protocol delivering the same energy dose (5.4 J/cm2) for keratitis', '', 'PACK-CXL protocols demonstrated a significant bactericidal effect on all tested isolates. The accelerated PACK-CXL protocol can be recommended for empirical use in the treatment of bacterial corneal infections in veterinary patients while awaiting culture results. This will facilitate immediate treatment', 35978428),
('Photothermal nanofibrillar membrane based on hyaluronic acid and graphene oxide', 'In vitro antibacterial activity studies performed on Staphylococcus aureus and Pseudomonas aeruginosa revealed that such electrospun membranes reduce the viability.', '', 'Specific in vitro experiment demonstrated also that is possible to disrupt, through laser irradiation, the biofilms formed onto the membrane.', 35760161),
('Photon-driven advanced oxidation processes (AOPs)', 'Effective against Escherichia coli and Micrococcus flavus', '', '', 35359212),
('pore-forming toxin (PFT)-responsive biomimetic nanobubble is designed', '', '', '(PFT)-responsive biomimetic nanobubble is designed, which is constructed by co-encapsulating a perfluorocarbon nanoemulsion and a photosensitizer within the red blood cell membrane. It is shown that PFTs derived from three pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), group A Streptococcus (GAS), and Listeria monocytogenes (LM), can be effectively absorbed by the nanobubble. In three skin infection models, treatment with the nanobubbles results in significantly decreased lesion formation and reduced inflammation.', 35836329),
('photodynamic therapy (wavelength of 660nm, 400mW/cm2, 300 seconds, methylene blue 0.01%)', 'Photodynamic therapy is a feasible approach to treating nasal carriage of S aureus.', '', 'Randomized controlled pilot study show effective strategy', 36396084),
('methylene blue (MB)-mediated Apdt (photodynamic)', 'The MDR bacterial count decreased immediately after aPDT', '', 'aPDT can be used to treat subgingival MDR bacterial infections, but the long-term effects of treatment need to be further studied.', 36351563),
('photodynamic therapy (aPDT) using two water-soluble tetra-cationic porphyrins (3-H2TMeP and 4-H2TMeP)', 'aPDT against the monoculture using a non-cytotoxic concentration of 3-H2TMeP and 4-H2TMeP porphyrins (40 microM), with 30 min of light irradiation in Gram-positive and 90 min for Gram-negative bacteria. The aPDT using the 4-H2TMeP porphyrin was also tested against five different polycultures (Coagulase positive Staphylococcus (CPS) and Pseudomonas sp.; E. coli and Proteus sp.; Pseudomonas sp. and Proteus sp.; CPS and E. coli; and CPS and Proteus sp.) for 90 min.', '', 'Only the 4-H2TMeP porphyrin had antibacterial activity against MDR bacteria in monoculture, especially S. pseudointermedius and P. aeruginosa. In polyculture, the 4-H2TMeP porphyrin reduced bacterial concentrations (p < 0.05) in the associations of E. coli and S. pseudointermedius, P. aeruginosa and S. pseudointermedius, and P. aeruginosa and P. mirabilis. These results showed that aPDT using 4-H2TMeP is a good option for future associations of aPDT and other therapies or in vivo research.', 36334907),
('Photobiomodulation (PBM) detriments of lasers, Red & Blue LED light (RBLL)', 'Methicillin-resistant Staphylococcus aureus (MRSA), Extended-spectrum beta-lactamases -producing Escherichia coli (ESBLs-Eco), and the MDR Pseudomonas aeruginosa (MDR-Pae) were employed to evaluate the antibacterial effects of the Blue LED light in vitro.', 'safe therapeutic intervention', 'RBLL showed a great potential gain for the treatment of MDR bacterial infected wounds, suggesting PBM therapy is an inexpensive, convenient, pain-free, and safe therapeutic intervention for refractory MDR infection wounds.', 34989417),
('metal oxide samarium orthovanadate (SmVO4) with nanorod structure, coupled with UiO-66-NH2 for the photocatalytic degradation.', 'The integration of UiO-66-NH2 with SmVO4 enhanced the light absorption, recombination resistance, carrier lifetime (from 0.382 to 0.411 ns) and specific surface area (from 67.17 to 246 m2/g) of the composite system as confirmed from multiple analyses. The obtained results further indicated that SmVO4/UiO-66-NH2Nanocomposites could form a direct Z-scheme based heterojunction.', '', 'mechanism of charge transfer leads to the effective degradation of tetracycline hydrochloride- TCH molecules up to 50% in 90 min under solar light, while it is degraded only 30% in the case of bare-SmVO4 nanorods. the incorporation of UiO-66-NH2 positively influences photoelectrochemical properties and improves the overall photoredox properties of SmVO4 for the degradation of complex compounds like antibiotic TCH molecules.', 35584713),
('photosensitizer, prepared by the coupling of commercial IR820 and d-propargylglycine (a type of d-amino acid, DAA)', 'The laser energy at 808 nm could make IR820-DAA a synergistic photothermal/photodynamic agent for efficient antibacterial therapy and wound healing. Furthermore, IR820-DAA exhibits good water solubility and biological safety for clinical translation and even possesses biofilm degradation activity toward methicillin-resistant Staphylococcus aureus (MRSA)', '', 'the proposed IR820-DAA holds great promise as a nonantibiotic tool for the treatment of bacteria-related diseases and offers a blueprint for building the precise synergistic antibacterial therapeutic platform.', 36198018),
('CuS nanospheres with predominant VCuSCu and VCuSS vacancy (abbreviated as CuS and CuS-T150, respectively) by synergistic effect of photodynamic and photothermal therapy.', 'The combination of experimental and theoretical calculation results demonstrates that CuS-T150 exhibits excellent antibacterial, achieving bactericidal rates of 99.9% against to Escherichia coli (E. coli) under 808 nm laser irradiation.', '', 'Compared with CuS, the superior antimicrobial activity of CuS-T150 is mainly attributed to its stronger ability to adsorb oxygen molecules, more easily bind with surface of E. coli, and higher photothermal conversion efficiency (PTCE). This work provides a deeper understanding of nanomaterials with vacancy modulated the antibacterial efficiency by synergistic effect of photodynamic and photothermal therapy.', 36303519),
('Sonoantimicrobial chemotherapy (SACT) is a novel therapy of low-frequency and low-intensity ultrasound (LFLIU) combined with a sonosensitizer (Emodin )', 'Methicillin-sensitive S. aureus (MSSA) was treated with different intensities of S-LFLIU for 15 min. The survival rates of MSSA were evaluated using the value for optical density at 600 nm (OD600) after 6 h and 24 h of incubation. Based on these results, ultrasonic irradiation at 1 W/cm2 may provide favorable conditions for bacterial growth inhibition', '', 'LFLIU could produce a large amount of reactive oxygen species (ROS), destroy the integrity of the bacterial membrane and cell wall, and downregulate the expression of genes involved in oxidative stress, membrane wall synthesis, and bacterial virulence, as well as that of other related genes (agrB, pbp3, sgtB, gmk, zwf, and msrA).', 36069576),
('infrared (NIR) photosensitizer (T780T-Gu) by combining positively-charged guanidinium (Gu)', 'The proposed molecule T780T-Gu exhibits synergistic photothermal therapy/photodynamic therapy effect against both H. pylori biofilms and multidrug-resistant (MDR) clinical strains.', '', 'the phototherapy mechanism of T780T-Gu acquired by the RNA-seq analysis indicates that structural deficiency as well as a decrease in metabolism and defense activity are the possible reasons for the efficient H. pylori phototherapy.', 36417577),
('Visible light-regulated cationic polymer coupled with photodynamic', 'E. coli bacteria multiplied for 20 generations under the continuous stimulation of Ce6-TPP-PEI with light irradiation (630 nm, 30 mW/cm2, 5 min), the MIC value against this bacterium was 1.911 microg/mL', '', 'The combination of photodynamic therapy and cationic polymer exerted significant anti-pathogen and biofilm ablation effects. Finally, hemolysis assay demonstrated that the photosensitizer chlorin e6-loaded polyethyleneimine-based micelle Ce6-TPP-PEI exhibited good biocompatibility, ultra-efficient, anti-drug resistance, and biocompatible multifunctional antibacterial system.', 36424663),
('The combination of algae lipids with innovative strategies, such as antibacterial photodynamic therapy (aPDT)', 'The results revealed that the total extracts of algae promote S. aureus inhibition after light irradiation, with a decrease of ca. 6 log10 (CFU/mL) after 15 min of treatment with both extracts of algae. The polar lipid fractions, composed by phospholipids, glycolipids and betaine lipids, from C. tomentosum and C. vulgaris also revealed antibacterial potential in combination with aPDT, but a decrease of ca. 6 log10 (CFU/mL) was reached at 60 min of treatment', '', 'Lipids isolated from algae have been recognized for their broad-spectrum antimicrobial activities and are considered a promising natural alternative to help control pathogenic microbial infections. These results unveil algae lipids as antibacterial compounds in combination with aPDT displaying an alternative from natural origin to tackle pathogen resistance.', 36181961),
('Antimicrobial blue light (aBL) therapy', 'out of gram positive and negative bacteria, only some bacterial strains were susceptible to 475 nm blue light, which was associated with the lack of RecA, i.e., a fully functional DNA repair mechanism', '', 'It is demonstrated that the insertion of the gene recA reduced the susceptibility, indicating a protective mechanism conveyed by the bacterial SOS response. However, mitigating this pathway via three known RecA inhibiting molecules (ZnAc, curcumin, and Fe(III)-PcTs) did not result in an increase in bactericidal action. Hence, creating synergistic effects by combining a multitarget therapy, such as aBL, with an RecA targeting treatment could be a promising strategy to overcome the dilemma of antibiotic resistance in the future.', 36294934),
('photo-sequencing batch reactor (PSBR)', 'PSBR has similar nutrient removal rate and a 30% higher antibiotics removal rate due to the corporation of microalgae (Chlorella) and bacteria, and the absolute abundance of ARGs decreased by 78% in PSBR. Further investigation showed that PSBR had certain advantages in removing quinolones and the corresponding removal rate could reach up to 90%.', '', 'As concluded photo-sequencing batch reactor (PSBR) in removing multiple antibiotics and nutrients from aquaculture wastewater as well as the antibiotic resistance genes (ARGs) proliferation were firstly investigated. This study provides an alternative and effective method to aquaculture wastewater treatment, which present high nutrients and antibiotics removal efficiencies and low ARGs transmission.', 34006208),
('methylene blue (MB) as an effective photosensitizer was conjugated with carbon quantum dots (CQDs),', 'Combined with 808 nm and 660 nm laser irradiation, the minimum bactericidal concentration of CQDs-MB towards S. aureus and E. coli was 5 microm.', '', 'this study provides a potential candidate material based on CQDs for clinical applications.', 35879646),
('photodynamic nanoagent, composed of chlorin e6 (Ce6)-loaded water-soluble chitosan-coated iron oxide nanoparticles (named Ce6@WCS-IONP)', 'In vitro studies verified that Ce6@WCS-IONP has superior photodynamic bactericidal effect against planktonic MRSA.', 'The fabricated Ce6@WCS-IONP has negligible toxicity to mammalian cells', 'Ce6@WCS-IONP could effectively penetrate into MRSA biofilm, photosensitizer-loaded cationic IONP with effective biofilm penetration and photodynamic eradication potential might be a promising nano platform in fighting against antibiotic-resistant microbial pathogen and biofilm.', 35760234),
('gallium protoporphyrin liquid crystalline lipid nanoparticles (GaPP-LCNP) as a photosensitizer', 'LCNP significantly enhanced the performance of GaPP as photosensitizer by two-fold, which was correlated with higher antibacterial activity, reducing the viability of planktonic P. aeruginosa by 7 log10 using 0.8 microM GaPP-LCNP and a light dose of 17 J.cm-2. GaPP-LCNP also reduced the viability of biofilms by 6 log10 at relatively low light dose of 34.2 J.cm-2 using only 3 microM GaPP-LCNP.', '', 'The high antibiofilm activity of GaPP-LCNP at low GaPP-LCNP dose indicated the high efficiency and safety profile of GaPP-LCNP as a promising platform for photodynamic inactivation of recalcitrant infections.', 36297559),
('conjugation of the cell-binding domain (CBD3) of a Staphylococcus aureus phage endolysin to a photoactivatable silicon phthalocyanine (IRDye 700DX)', 'We show that, upon red-light activation, the resulting CBD3-700DX conjugate generates reactive oxygen species that effectively kill high loads of planktonic and biofilm-resident staphylococci, including MRSA. Furthermore, CBD3-700DX is readily internalized by mammalian cells, where it allows the targeted killing of intracellular MRSA upon photoactivation. Intriguingly, aPDT with CBD3-700DX also affects mammalian cells with internalized MRSA, but it has no detectable side effects on uninfected cells. Altogether, we conclude that CBD3 represents an attractive targeting agent for Staphylococcus-specific aPDT, irrespective of planktonic, biofilm-embedded, or intracellular states of the bacterium.', '', 'aPDT with the resulting conjugate shows high target specificity toward MRSA with minimal side effects.', 35196798);

-- --------------------------------------------------------

--
-- Table structure for table `bacteria_naturalproduct`
--

CREATE TABLE IF NOT EXISTS `bacteria_naturalproduct` (
  `ENTITY` varchar(500) NOT NULL,
  `POTENCY` varchar(5000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(3000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `bacteria_naturalproduct`
--

INSERT INTO `bacteria_naturalproduct` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Totarol: diterpenoids isolated from the bark of Podocarpus nagi (Podocarpaceae)', 'The synergistic activity of anacardic acid caused the minimum bactericidal concentration (MBC) of totarol to be lowered from 1.56 to 0.2 micrograms/ml.', '', 'Totarol [1], the most abundant compound among the six, exhibited potent bactericidal activity only against Gram-positive bacteria, among which Propionibacterium acnes was the most sensitive bacterium.', 1453180),
('Phytoalexin isolate 5,7,2'',6''-tetrahydroxy-6-isoprenyl-8-lavandulyl-4''-methox yflavanone (exiguaflavanone D)and 5, 2'',6''-trihydroxy-8-lavandulyl-7-methoxy-flavanone (exiguaflavanone B)', 'Exiguaflavanone D inhibited MRSA 1.56-6.25 micro g/ml, and Exiguaflavanone B inhibited at 50 micro g/ml concentration', '', 'Flavanones with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. With the therapeutic concept of using the defensive ability of plants against microbial infections, phytoalexin, an antimicrobial phytochemical was studied for its ability to inhibit the growth of methicillin-resistant Staphylococcus aureus (MRSA).', 7897594),
('A sesquiterpene lactone, identified as [3aR-(3a alpha, 7 beta,8a beta)]-3,3a,4,7,8,8a-hexahydro-7- methyl-3-methylene-6-(3-oxo-1-butenyl)-2H-cyclohepta[b]furan-2-one, or xanthatin, isolated from leaves of an annual herb, Xanthium sibiricum Patr er Widd', 'Active against methicillin-resistant Staphylococcus aureus', '', 'By monitoring antibacterial activity against MRSA strains, it was shown that a sesquiterpene lactone, identified as [3aR-(3a alpha, 7 beta,8a beta)]-3,3a,4,7,8,8a-hexahydro-7- methyl-3-methylene-6-(3-oxo-1-butenyl)-2H-cyclohepta[b]furan-2-one, or xanthatin, isolated from leaves of the herb, had outstandingly potent activity against S. aureus species, including MRSA; its activity against MRSA and MSSA strains was similar.', 9364417),
('Natural abietanes: 6,7-dehydroferruginol methyl ether (3), ferruginol (5), 11-hydroxy-12-oxo-7,9(11) ,13-abietatriene (7), royleanone (9), demethyl cryptojaponol (12), salvinolone (14), sugiol methyl ether (16), sugiol (17), 5,6-dehydrosugiol methyl ether (19), 5,6-dehydrosugiol (20), 6beta-hydroxyferruginol (23), and taxodione (25)', 'Phenols (12-hydroxyabieta-8,11,13-trien-6-one 22 and 23), catechols (12 and 14) and taxodione 25 has MIC 4-10 microg/mL against MRSA and 4-16 microg/mL of MIC against VRE, Quinone methide had MIC 0.5-1 microg/mL of against both MRSA and VRE.', '', 'Synthesis of variously oxidized abietane diterpenes and their antibacterial activities against MRSA and VRE.', 11249127),
('2'',4''-dihydroxy-8-gamma,gamma-dimethylallyl-2",2"-dimethylpyrano[5",6":6,7]isofla vanone (bidwillon B)', '(MICs) of 3.13-6.25mg/l against MRSA strains', '', 'Bidwillon B may prove to be a potent phytotherapeutic and/or combination agent with mupirocin in the elimination of nasal and skin carriage of MRSA.', 15325427),
('Vaccinium macrocarpon (cranberry) capsules', 'Twelve hours after consumption of cranberry or placebo hard capsules, the first urine of the morning was collected. Different Escherichia coli strains were cultured in the urine samples. Urinary antibacterial adhesion activity was measured in vitro using the human T24 epithelial cell-line, and in vivo using the Caenorhabditis elegans killing model. With the in-vitro model, 108 mg of cranberry induced a significant reduction in bacterial adherence to T24 cells as compared with placebo (p <0.001).', '', 'Overall, these in-vivo and in-vitro studies suggested that consumption of cranberry juice represents an interesting new strategy to prevent recurrent urinary tract infection.', 18190583),
('Tea tree oil and terpinen-4-ol', 'Antimicrobial activity of terpinen-4-ol and tea tree oil (TTO) against clinical skin isolates of meticillin-resistant Staphylococcus aureus (MRSA) and coagulase-negative staphylococci (CoNS)', 'No cytotoxicity against human fibroblasts', 'CONCLUSIONS: Terpinen-4-ol is a more potent antibacterial agent against MRSA and CoNS isolates than TTO with neither agent exhibiting toxicity to fibroblast cells at the concentrations tested.', 18298453),
('Cannabinoids from Cannabis sativa (cannabidiol, cannabichromene, cannabigerol, Delta (9)-tetrahydrocannabinol, and cannabinol)', 'Activity against a variety of methicillin-resistant Staphylococcus aureus (MRSA) strains of current clinical relevance.', '', 'Antibacterial cannabinoids from Cannabis sativa: a structure-activity study', 18681481),
('Aqueous and ethanol extracts of roselle calyx and protocatechuic acid', 'MIC 112-144 microg/mL(aqueous), 72-96 microg/mL(ethanol), and 24-44 microg/mL (protocatechuic acid) against food spoilage bacteria Salmonella typhimurium DT104, Escherichia coli O157:H7, Listeria monocytogenes, Staphylococcus aureus, and Bacillus cereus', '', 'These data suggest that roselle calyx ethanol extract and protocatechuic acid might be potent agents as food additives to prevent contamination from these bacteria.', 19099360),
('Quercus infectoria Olivier', 'Ethanol extract, an ethyl acetate fraction I, gallic acid and tannic acid could inhibit the growth of clinically isolated MRSA strains with minimum inhibitory concentration values between 63 and 250 microg ml(-1). ', '', 'Detailed studies on Quercus infectoria Olivier (nutgalls) as an alternative treatment for methicillin-resistant Staphylococcus aureus infections.', 19120622),
('Vaccinium berries', '', '', 'Antiadhesion therapy is a promising approach to the fight against pathogens. The results suggest Vaccinium berries as possible sources of antiadhesives against bacterial infections.', 19610031),
('Tualang honey', 'Potential alternative therapeutic agent against certain microorganisms, particularly A. baumannii and S. maltophilia.', '', 'This result suggests that tualang honey could potentially be used as an alternative therapeutic agent against certain microorganisms, particularly A. baumannii and S. maltophilia.', 19754926),
('Diterpenes (Abietane 5 and its 6,12-dibenzoyl, 12-methoxybenzoyl, 12-chlorobenzoyl, and 12-nitrobenzoyl esters)', 'Potent activities against the MDR strain with MIC values between 3.12 and 0.39 microg/ml.', '', 'Antimycobacterial metabolites from Plectranthus: royleanone derivatives against Mycobacterium tuberculosis strains', 20397225),
('Plant-derived terpenes', '', '', 'Induction of fatty acid composition modifications and tolerance to biocides in Salmonella enterica serovar Typhimurium by plant-derived terpenes. To enhance food safety and stability, the food industry tends to use natural antimicrobials such as plant-derived compounds as an attractive alternative to chemical preservatives.', 21131520),
('Ethanolic extracts of Canadian botanicals (Arctostaphylos uva ursi (kinnikinnick or bearberry), Hydrastis canadensis (goldenseal), Prunus serotina (black cherry), and Rhodiola rosea (roseroot))', 'Extracts of Arctostaphylos uva ursi (kinnikinnick or bearberry), Hydrastis canadensis (goldenseal), Prunus serotina (black cherry), and Rhodiola rosea (roseroot) inhibited the growth of all Ng isolates with minimum inhibitory concentrations of 32 micro g/mL, 4 to 32 micro g/mL, 16 to >32 micro g/mL, and 32 to 64 micro g/mL, respectively.', '', 'Extracts of Canadian first nations medicinal plants, used as natural products, inhibit neisseria gonorrhoeae isolates with different antibiotic resistance profiles.', 21301385),
('Capparis spinosa', 'At 2 mg/mL, this extract inhibited the biofilm formation to 79, 75, 73, 70% and EPS production to 58, 46, 66 and 67% in S. marcescens, PAO1, E. coli and P. mirabilis, respectively', '', 'Antiquorum sensing and antibiofilm potential of Capparis spinosa.', 22222491),
('Curtisia dentata', 'Activity against Escherichia coli and Acinetobacter spp., ethanol root bark extracts consistently showed the highest DPPH radical scavenging activity (62.43%), total phenol content (TPH) (57.62 26 mg GAE/g) and reducing power (RP) (41.32%), followed by those of the stem bark and leaf extracts with the respective values of 54.68%, 37.77 mg GAE/g and 21.83%.', '', 'CONCLUSION: Curtisia dentata is a very effective source of antioxidant and a possible alternative to sourcing antiverotoxic antibiotics with novel mechanism of action.', 22504170),
('Aframomum melegueta seed extract (diketone 6-gingerdione (2) and its enolic tautomers, methyl-6-gingerol (5) and rac-6-dihydroparadol (7), 6-Paradol (3), 8-gingerol (6),)', 'moderate to weak antimycobacterial activities, and the best modulators induced a 4- to 16-fold decrease of the MICs of EtBr and rifampicin as well as a reduction of the MIC of isoniazid', '', 'Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta', 22789014),
('Alpha-Mangostin', 'Most potent among them against Gram-positive pathogens (MIC=0.78-1.56 ?g/mL)', '', 'Rapid bactericidal action of alpha-mangostin against MRSA as an outcome of membrane targeting', 22982495),
('Medihoney and rifampicin', 'Methylglyoxal (MGO), believed to be the major antibacterial compound in manuka honey, did not act synergistically with rifampicin and is therefore not the sole factor responsible for the synergistic effect of manuka honey with rifampicin.', '', 'Our findings support the idea that a combination of honey and antibiotics may be an effective new antimicrobial therapy for chronic wound infections', 23469049),
('Oregano essential oil', 'Inhibited the growth of Escherichia coli and Pseudomonas aeruginosa clinical strains with different patters of resistance', '', 'CONCLUSIONS: The obtained outcomes will enable further investigations using oregano essential oil obtained from Origanum heracleoticum L. as alternative antibacterial remedies enhancing healing process in bacterial infections and as an effective means for the prevention of antibiotic-resistant strain development.', 23484421),
('Tea tree oil (TTO) and silver ions (Ag(+) )', 'Antimicrobial efficacy against Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans', '', '\\The activity of alternative antimicrobial agents such as tea tree oil (TTO) and silver ions (Ag(+) ) with multiple target sites impedes the development of antibacterial resistance and might be useful in improving the current treatment strategies for various chronic wound infections.', 23581401),
('Vitex negundo leaf extract (Water and methanol)', 'Methanol extract had MIC: 200-3200 ?g/mL and MBC, 200-400 ?g/mL', '', 'In vitro and in vivo bactericidal activity of Vitex negundo leaf extract against diverse multidrug resistant enteric bacterial pathogens', 23608373),
('Ellagic acid in Rosa rugosa; norwogonin in Scutellaria baicalensis; and chebulagic acid, chebulinic acid, corilagin, and terchebulin in Terminalia chebula', 'The potent compound norwogoninhad a minimum inhibitory concentration of 128 microg/mL, and minimum bactericidal concentration of 256 microg/mL against clinically relevant strains of A. baumannii', '', 'Isolation and characterization of antimicrobial compounds in plant extracts against multidrug-resistant Acinetobacter baumannii', 23630600),
('Leptospermum scoparium (Manuka) oil', 'Inhibitor of S. pseudintermedius biofilm formation, and the majority of bacteria decreased by >50%', '', 'In vitro efficacy of the essential oil from Leptospermum scoparium (manuka) on antimicrobial susceptibility and biofilm formation in Staphylococcus pseudintermedius isolates from dogs', 23772881),
('Propolis extract GH2002', 'MICs in the range of 0.03 to 2 mg/ml against S. pyogenes, S. aureus, E. faecium and Candida. ', '', 'These results suggest that the special propolis extract GH2002 might be used in the development of alternative products for therapy of microbial infections.', 24020127),
('Tabernaemontana alternifolia (Roxb) stem bark aqueous extracts', 'The minimum inhibitory concentration (MIC) of extract against the isolates ranged from 600-800 ?g/ml.', 'The extract did not exhibit cytotoxic activity against Vero cells even at the concentration of 4 mg/ml.', 'CONCLUSION: Our results offer a scientific basis for the traditional use of T. alternifolia in the treatment of skin infections, showing that the plant extract has an enormous potential as a prospective alternative therapy against MRSA skin infections.', 24066905),
('Amphypterygium adstringens anacardic acid mixture', 'anti-quorum sensing activity in P. aeruginosa 94% of inhibition violecin production at 166 micro g/mL, 86% inhibition of pyocyanin at 200 micro g/mL) and 91% inhibition of rhamnolipid production 500 micro g/mL)  and decrease the elastase (75% at 500 ?g/mL) activity', '', 'The aim of this study was to evaluate the anti-quorum sensing (anti-QS) potential of an anacardic acids mixture isolated from Amphipterygium adstringens, a medicinal plant known as "cuachalalate", to prevent the onset of bacterial infections as an alternate to antibiotics.', 24126126),
('essential oils from the leaves of L. gracilis (EOLG)', 'has 38 chemical constituents with thymol (44.4%), carvacrol (22.2%), p-cymene (6.2%) and ?-pinene (5.6%) as major constituents.', '', 'These results demonstrate that natural substances present in EOLG have the capacity to modulate bacterial resistance and can be used as an adjuvant therapy against multi-resistant microorganisms such as S. aureus, Escherichia coli and P. aeruginosa.', 24479735),
('Aloe vera inner gel', 'The inhibitory concentrations of A. vera inner gel were ranging from 6.25 to 800 mg ml(-1) .50% of the detected strains (14 clinical strains and one reference strain of H. pylori), independently of their susceptibility profile, were inhibited in their growth at 100 mg ml(-1) .', 'NA', 'The study demonstrates that the Aloe vera inner gel expresses antibacterial properties against both susceptible and resistant Helicobacter pylori strains.', 24597562),
('Flavonoids [demethylglycyrol (31) and 5,7-di-O-methylluteone (32)] and licorice phenolics [3-arylcoumarins such as licoarylcoumarin (9) and glycycoumarin (26), and 2-arylcoumarones such as gancaonin I (17)]', 'Activity against vancomycin-resistant Enterococcus species', '', 'Structures of two new flavonoids and effects of licorice phenolics on vancomycin-resistant Enterococcus species', 24686577),
('Aspergillomarasmine A (AMA)', 'potent inhibitor of the NDM-1 enzyme and another clinically relevant MBL, VIM-2 etc', '', 'Here we have identified a fungal natural product, aspergillomarasmine A (AMA), that is a rapid and potent inhibitor of the NDM-1 enzyme and another clinically relevant MBL, VIM-2.', 24965651),
('Different extracts from Olea europaea, mastic gum, and Inula viscosa', 'Activity against bacteria and fungi, O. europaea presented MIC and MBC ranges of 0.07-10.00 mg mL(-1) and 0.60-10.00 mg mL(-1), respectively, mean MBC values for mastic gum and I. viscosa were 0.07-10.00 mg mL(-1) and 0.15-10.00 mg mL(-1), respectively', '', 'Ethyl acetate I. viscosa extract and total mastic extract showed considerable antimicrobial activity against oral microorganisms and could therefore be considered as alternative natural anti-infectious agents.', 25054150),
('Essential oil was extracted from leaves of Hyptis martiusii Benth. ? -3-carene, 1, 8-cineole, trans-caryophyllene, Cariophyllene oxide and bicyclogermacrene were important components.', 'Essential oil inhibited growth of bcteria (MIC < 512 ?g/mL) except S. aureus (SA358) multidrug resistant (MRSA) by direct contact. S. aureus ATCC 12692, S. aureus 358 (SA358),Bacillus cereus ATCC, E. coli ATCC 25922, E. coli 27 (EC27), P. aeruginosa (ATCC).', 'NA', 'CONCLUSIONS: These results show that this oil influences the activity of the antibiotic and may be used as an adjuvant in the antibiotic therapy of respiratory tract bacterial pathogens.', 25237640),
(' (-)-Epigallocatehin-3-Gallate (EGCG) and Green Tea Extracts (GTE)', 'EGCG inhibited the growth of P. aeruginosa at a MIC level of 200~400 ?g/ml. The MIC of GTE was a 1 : 16 dilution for P. aeruginosa. EGCG showed antimicrobial activity against E. coli at a MIC of 400 ?g/ml. In the case of GTE, the MIC was a dilution between 1:8 and 1:4 for E. coli.', '', 'CONCLUSION: EGCG and GTE showed potential as alternative or adjunct topical antimicrobial agents for infections that are resistant to traditional antibiotic therapy.', 25324647),
('Vanilla, patchouli and ylang ylang essential oils stabilized by iron oxide@C14 nanostructures', 'Vanilla essential oil loaded nanoparticles pelliculised on the catheter samples surface strongly inhibited both the initial adherence of S. aureus cells (quantified at 24 h) and the development of the mature biofilm quantified at 48 h. Patchouli and ylang-ylang essential oils inhibited mostly the initial adherence phase of S. aureus biofilm development. In the case of K. pneumoniae, all tested nanosystems exhibited similar efficiency, being active mostly against the adherence K. pneumoniae cells to the tested catheter specimens.', '', 'Efficiency of vanilla, patchouli and ylang ylang essential oils stabilized by iron oxide@C14 nanostructures against bacterial adherence and biofilms formed by Staphylococcus aureus and Klebsiella pneumoniae clinical strains.', 25375335),
('Coumarin', 'Quorum sensing inhibitor, active against short, medium and long chain N-acyl-homoserine lactones and also inhibited biofilm', '', 'In this study, we identified coumarin, a natural plant phenolic compound, as a novel QS inhibitor, with potent anti-virulence activity in a broad spectrum of pathogens.', 25672848),
('Organic extracts from Indigofera suffruticosa leaves (diethyl ether, chloroform and acetone)', 'The acetone extract was the most potent inhibitor of S. aureus (MIC and MBC of 0.78 and 3.12 mg/mL), followed by the chloroform extract (MIC and MBC of 3.12 and 6.25 mg/mL).', '', 'Organic extracts from Indigofera suffruticosa leaves have antimicrobial and synergic actions with erythromycin against Staphylococcus aureus', 25699022),
('6, 6''-dihydroxythiobinupharidine from Nuphar japonicum', 'MIC was 1-4 ?g/mL against various MRSA and VRE strains, also inhibited DNA topoisomerase IV (IC50 was 10-15 ?M)', '', 'These results suggest that 6,6''-dihydroxythiobinupharidine may be a potent candidate or seed for novel antibacterial agents.', 25731981),
('Cranberry proanthocyanidin', 'The minimal concentration at which significant inhibitiont occurred was 250 ?g/mL.', '', 'CONCLUSION: Cranberry proanthocyanidins exhibit potent effects on growth, adhesion, and virulence of oropharyngeal and lung isolates of E. coli, suggesting that cranberry proanthocyanidin could be of clinical interest to reduce oropharyngeal colonization and prevent lung infection.', 25803655),
('Essential oils (EOs) from Salvia fruticosa, Salvia officinalis and Salvia sclarea', 'Inhibition the Tet(K) efflux pump of tetracycline resistant Staphylococcus epidermidis', '', 'Our data from molecular and functional analyses of inhibitory effect of Salvia''s essential oils, namely from S. fruticosa, on Tet(K) pump of Staphylococcus epidermidis and from modulatory studies may be the starting point for consecutive study of pharmacokinetic and pharmacodynamic parameters and their perspective use in combination therapy.', 25846244),
('Pomegranate fruit constituents:  caffeic acid, ellagic acid, epigallocatechin-3-gallate (EGCG) and quercetin', 'The peel extracts exhibited greater antimycobacterial activity (MIC 64-1024 ?g/mL) than the potable juice (MIC 256 - > 1024 ?g/mL). EGCG and quercetin exhibited higher antitubercular (MIC 32-256 ?g/mL) and antibacterial (MIC 64-56 ?g/mL) potencies than caffeic acid and ellagic acid (MIC 64-512 ?g/mL).', '', 'Antimicrobial activity of pomegranate fruit constituents against drug-resistant Mycobacterium tuberculosis and beta-lactamase producing Klebsiella pneumoniae. CONTEXT: The global surge in multi-drug resistant bacteria and the imminence of tuberculosis pandemic necessitate alternative therapeutic approaches to augment the existing medications.', 25858784),
('Nasutitermes corniger (Motschulsky, 1855) extract', 'Despite having no significant antimicrobial activity (MIC ? 1000 ?g mL(-1)), the extract showed additive activity to the antibiotic efficacy, significantly reducing its MIC.', '', 'These results suggest that N. corniger and its nest are promising natural products for use in antimicrobial therapy.', 26150745),
('Pectinatella magnifica extract (acetone, methanol )', 'acetone extract had (MIC) 0.004-0.350 mg/mL and MBC 0.007-0.500 mg/mL), while methanol extract had (MIC 0.03-0.12 mg/mL and MFC 0.06-0.25 mg/mL)', '', 'According to the experimental data obtained, P. magnifica methanol extract may be considered as a good resource of novel natural products with potent antibiofilm activity against the bacterium well known for its resistance.', 26252786),
('Chebulinic acid (CA)', 'M. tuberculosis DNA gyrase inhibitor', '', 'Identification of chebulinic acid as potent natural inhibitor of M. tuberculosis DNA gyrase and molecular insights into its binding mode of action.', 26410242),
('Crude ethanolic extract (CEE), ethyl acetate fraction (EAF), and methanolic fraction (MF) from Anacardium microcarpum', 'However, addition of CEE, EAF, and MF to the growth medium at the subinhibitory concentration (MIC/8=64 ?g/mL) significantly modulated amikacin- and gentamicin-resistant E. coli', '', 'A. microcarpum is a natural resource with resistance-modifying antibacterial activity that needs to be further investigated to overcome the present resistant-infection problem.', 26604695),
('Piper betle L.', 'This study revealed the bactericidal activities of all the P. betle leaf crude extracts on methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), extended spectrum ?-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and metallo-?-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii, with minimum bactericidal concentrations that ranged from 19 micro g/ml to 1250 micro g/ml.', '', 'Antimicrobial Activities of Methanol, Ethanol and Supercritical CO2 Extracts of Philippine Piper betle L. on Clinical Isolates of Gram Positive and Gram Negative Bacteria with Transferable Multiple Drug Resistance. Piper betle L. has traditionally been used in alternative medicine in different countries for various therapeutic purposes, including as an anti-infective agent.', 26741962),
('Kisameet Clay', 'Antimicrobial activity against ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species)', '', 'Here, we report the broad-spectrum and potent antibacterial activity of Kisameet clay, a natural clay mineral from British Columbia, Canada, against a group of multidrug-resistant ESKAPE strains.', 26814180),
('Poncirus trifoliata ethyl extract', 'Strong anti-MRSA activity, antibacterial activity with MIC value of 256 micro g ml(-1)', '', 'Studies on antimicrobial activity of Poncirus trifoliata ethyl extract fraction against methicillin-resistant Staphylococcus aureus and to elucidate its antibacterial mechanism.', 26930870),
('Epigallocatachin gallate (EGCG)', 'E. coli LB226692, serotype O104:H4, O104:H4 strain 55989, EDL933, serotype O157:H7, matrix production of all strains was virtually eliminated by EGCG or green tea at 28?C and 37?C', 'NA', 'These findings highlight EGCG as a potential adjuvant for antibiotic therapy of biofilm-associated infections.', 26992034),
('Ginger (Zingiber officinale)', 'The minimum inhibitory concentrations (MICs) of ginger extract for evaluated strains were 40, 40, 20, 20, 20, 20, 10, and 5 mg/mL for Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Bacillus cereus, Acinetobacter baumannii, C. albicans, and C. krusei, respectively.', '', 'Ginger extract has good antifungal and antibiofilm formation by fungi against C. albicans and C. Krusei.', 27127591),
('Petroleum ether extract of seed of Nigella sativa, oil extract from mature ripe fruit husk of Aframomum corrorima and mature unripe fruit of A. corrorima', 'Petroleum ether extract of seed of Nigella sativa: Bacillus cereus [inhibition zone (IZ), 44 ? 0.31 mm] and B. cereus ATCC 10987 (IZ, 40 ? 2.33 mm); oil extract from mature ripe fruit husk of Aframomum corrorima and mature unripe fruit of A. corrorima revealed promising activities against Candida albicans ATCC 90028 (IZ, 35 ? 1.52 mm) and Staphylococcus aureus DSM 346 (IZ, 25 ? 1.32 mm), respectively.', '', 'Antimicrobial and anti-Quorum Sensing activities of selected medicinal plants of Ethiopia: Implication for development of potent antimicrobial agents. BACKGROUND: Traditional medicinal plants have been used as an alternative medicine in many parts of the world, including Ethiopia.', 27400878),
('Ludwigia leptocarpa extracts ( 2?-hydroxyoleanolic acid, (2R,3S,2''''S)-3'''''',4'',4'''''',5,5'''',7,7''''-heptahydroxy-3,8"-biflavanone, and luteolin-8-C-glucoside)', 'Active against Gram-positive bacterium, Staphylococcus aureus, Gram-negative multi-drug-resistant bacteria, Vibrio cholerae and Shigella flexneri (a cause of shigellosis', '', 'Overall, the present results show that L. leptocarpa has the potential to be a natural source of anti-diarrheal and antioxidant products, so further investigation is warranted.', 27431270),
('Monoterpenes nerol', 'Inhibit NorA efflux pump of multi-drug resistant S. aureus strains', '', 'This result shows that bioactives tested, especially the nerol, are able to inhibit NorA efflux pump indicating a potential use as adjuvants of norfloxacin for therapy of infections caused by multi-drug resistant S. aureus strains.', 27565089),
('Tordylium persicum Boiss. & Hausskn extract', 'The results showed that Streptococcus pyogenes was the most susceptible to the methanolic extract (MIC = 25.9 ? 0.0 ?g/mL), while Proteus vulgaris was the most resistant strain (MIC = 295.3 ? 0.0 ?g/mL) among all bacteria evaluated.?', '', 'Tordylium persicum Boiss. & Hausskn extract: A possible alternative for treatment of pediatric infectious diseases. Antimicrobial herbal compounds are one of the important medical resources, and in order to help alleviate the spread of the pediatric infectious diseases, identification of additional bioactive phytochemicals and herbal extracts will be practical in treating illnesses.', 27585257),
('AN(Acacia nilotica) + MKL Sprengel (Murraya koenigii (Linn.)) + Euca (Eucalyptus) + PS (Psidium guajava), AN + MKL Sprengel + Euca', 'All the triple and quadruple combinations of the plant extracts offered antimicrobial benefits either superior or comparable to 0.2% chlorhexidine against S. mutans, S. sanguis, and S. salivarius.', '', 'Antimicrobial efficacy of the combinations of Acacia nilotica,Murrayakoenigii (Linn.) Sprengel, Eucalyptus, and Psidiumguajava on primary plaque colonizers: An in vitro study. BACKGROUND: The rise in disease incidence, increased resistance of pathogenic bacteria to currently used antibiotics and chemotherapeutics, opportunistic infections in immunocompromised individuals, and financial considerations in developing countries necessitates alternate preventive and treatment strategies for oral diseases.', 27723640),
('Ethanolic extract of propolis', 'Combinations of cefixime and propolis gave significant results', '', 'Propolis acted synergistically with cefixime and enhanced the efficacy of antibiotic and reduced its effective dose in combined therapy.', 27887651),
('Pistacia atlantica methanolic extract', 'Active aginst Helicobacter pylori', '', 'The assay demonstrated the thiourea and the extract to be potent urease inhibitors, with the extract having strong bacteriostatic activity against clinical isolates of H. pylori, including such with antibiotic resistance.', 27923651),
('Combination of Oleoresin from Copaifera multijuga Hayne and Biogenic Silver Nanoparticles', 'Bactericidal activity against planktonic Streptococcus agalactiae (group B Streptococcus - GBS) ', '', 'CONCLUSION: These results indicate the potential of copaiba oil, alone or in combination with AgNPbio, for the development of new alternative strategies for controlling GBS infections.', 27978809),
('Cassia alata', '50% inhibition of violacein production in C. violaceum at 0?05 mg ml-1 concentration of fraction rich in flavonoids (F-AF)', '', 'A medicinal herb Cassia alata attenuates quorum sensing in Chromobacterium violaceum and Pseudomonas aeruginosa.', 28035685),
('Combretum zeyheri alkaloid extracts', 'antimycobacterial effects with an MIC value of 125 microg/ml', '', 'Alkaloid extracts from the most potent plant species, Combretum zeyheri were further investigated for time-kill dependency effects on drug transport in Mycobacterium smegmatis.', 28228097),
('Nigella Sativa extract', '', '', 'In conclusion, our literature survey revealed potent antimicrobial properties of N. sativa against MDR strains in vitro that should be further investigated in order to develop novel therapeutic perspectives for combating infectious diseases particularly caused by MDR strains.', 28386474),
('Marine sponge extracts', 'MIC values of the sponge extracts ranged from 0.039 to 1.25mg/mL, best antibacterial profile was observed by its ethyl acetate extract against Staphylococcus aureus and Bacillus cereus with MIC and MBC values of 0.039mg/mL and 0.078mg/mL, respectively. ', '', 'These findings suggest that the antibacterial properties of the tested marine sponge extracts may provide an alternative and complementary strategy to manage bacterial infections.', 28392375),
('Methanolic fruit extract of S. persica L.', 'Methanolic fruit extract of S. persica L. showed a high degree of anti-biofilm formation on PMMA (polymethylmetacrylate) and on violacein (pigment production in Chromobacterium violaceum) inhibition with a percentage of reduction equal to 90% when MIC value (20 mg/ml) was used.', '', 'The aim of this study was to evaluate the antiquorum sensing (anti-QS) and antibiofilm potential of Salvadora persica L. methanolic extracts to prevent the infections due to Staphylococcus as an alternate to antibiotics.', 28552808),
('Puupehenone-like molecules, marine natural product', 'Active against dormant Mtb', '', 'In conclusion, we have identified and characterized antimycobacterial compounds from marine organisms with novel activity profiles which appear to target M. tuberculosis pathways that are conditionally essential for dormancy survival.', 28607021),
('Phenolic Compounds: tannic acid, epigallocatechin gallate, rutin, and eugenol', '', 'Long-term treatment with several conventional antibiotics can cause harmful side effects', 'Phenolic Compounds in Antimicrobial Therapy. Long-term treatment with several conventional antibiotics can cause harmful side effects that can be alleviated by antioxidant therapy.', 28661772),
('Extract of A. deliciosa', 'Activity against Acinetobacter baumannii', '', 'Therefore, it can be concluded that polar extract of A.?deliciosa can be used to find suitable alternative therapeutic to control biofilm formation by carbapenem resistant strain of Acinetobacter baumannii.', 28705748),
('Naphtho[1,2-b]furan-4,5-dione', 'Minimum inhibitory concentration of N12D against MRSA was 4.9-9.8?M', '', 'Naphtho[1,2-b]furan-4,5-dione is a potent anti-MRSA agent against planktonic, biofilm and intracellular bacteria. AIM: Naphtho[1,2-b]furan-4,5-dione (N12D) and naphtho[2,3-b]furan-4,9-dione (N23D) are furanonaphthoquinone derivatives from natural resources.', 28799789),
('Plectranthus amboinicus essential oil (PAEO)', 'The lowest MIC (0.25 mg mL-1) and MBC (0.5 mg mL-1) values were observed when carvacrol was used against OVRSA. When a 0.5 mg mL-1?concentration of PAEO and carvacrol was used, no viable cells were found on S. aureus biofilm.', '', 'Plectranthus amboinicus essential oil and carvacrol bioactive against planktonic and biofilm of oxacillin- and vancomycin-resistant Staphylococcus aureus. BACKGROUND: The emergence of multidrug-resistant bacteria is a worldwide concern and in order to find an alternative to this problem, the occurrence of antimicrobial compounds in Plectranthus amboinicus essential oil was investigated.', 28915875),
('Fennel essential oil', 'Activity in combination with antibiotics against Staphylococcus aureus strains', '', 'Our research showed that the fennel essential oil in combination with mupirocin may be considered as a natural alternative in eradication of S. aureus with iMLSB, cMLSB, MSB resistant phenotypes and is able to decrease the growth rate of antibiotic resistance.', 28917968),
('Manuka honey', 'MIC and MBC against K. pneumoniae ST11 of Manuka honey was 30% (v/v) and (>1 log) reduction was observed in mice.', '', 'CONCLUSION: Manuka honey can be used as an alternate therapeutic approach for management of New Delhi metallo-?-lactamase-producing pathogens.', 29226698),
('Origanum onites essential oil (EO) ', 'Activity against ESBL positive E. coli isolates.', '', 'According to our results, O. onites EO may be an alternative to synthetic drug, used in combination with other antibiotics for treatment of infection caused by multidrug resistant bacteria after testing toxic effects and irritation at preferred doses on human.', 29262709),
('Apple fruit juice', 'Antimicrobial effect against Enterococcus fecalis and Streptococcus mutans', '', 'However, preclinical and clinical trials are needed to evaluate biocompatibility & safety before apple can conclusively be recommended in endodontic therapy, but in vitro observation of apple effectiveness appears promising.', 29284967),
('Passiflora cincinnata Mast', 'Enhances antibiotic activity against Staphylococcus aureus?and?Escherichia coli', '', 'Potentiation of antibiotic activity by Passiflora cincinnata Mast. front of strains Staphylococcus aureus and Escherichia coli. The development of new drugs from plants is an interesting alternative approach to overcoming microbial resistance.', 29379354),
('MCFA lauric acid', 'Inhibitor of?Clostridium difficile?Growth?in Vitro', '', 'Our combined results suggest that the naturally occurring MCFA lauric acid is a novel C. difficile inhibitor and is useful in the development of an alternative or adjunctive treatment for CDI.', 29387044),
('Curcuma longa (Zingiberaceae) rhizomes', 'Tested against Escherichia coli strains, Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus sp', '', 'The results indicated that the ethanolic extract and essential oil of C. longa rhizomes have active compounds with antibacterial properties that could be used in future research as a therapeutic alternative for the treatment of infections caused by nosocomial pathogens.', 29462537),
('Melipona beecheii honey (Cuba)', 'Antimicrobial and antibiofilm activity on Staphylococcus aureus and Pseudomonas aeruginosa cells', '', 'The antibiofilm activity of honeys was tested by assessing their ability to inhibit biofilm formation and to disrupt preformed biofilms.', 29988499),
('Phytochemical flavanones: 2'',4''- or \n2'',6''-dihydroxylation of the B ring and 5,7-dihydroxylation of the A \nring in the flavanone structure', 'Differently substituted flavanones were isolated from Leguminosae.', '', 'The present hydroxyflavanones would be useful in the phytotherapeutic strategy against MRSA infections.', 8778504),
('Mycobacteriolytic preparation (stazyme) from the Staphylococcus strain Clavelis', '', '', 'Stazyme, a mycobacteriolytic preparation from a Staphylococcus strain, is able to break the permeability barrier in multiple drug resistant Mycobacterium avium. As a strategy to augment the potential of existing drugs against Mycobacterium avium we investigated a mycobacteriolytic preparation (stazyme) from the Staphylococcus strain Clavelis, which results in significant mycobacterial growth inhibition.', 9537755),
('Hot aqueous and methanolic extracts prepared from six plants (Terminallia chebula, Terminallia bellerica, Phyllanthus emblica, Punica granatum, Lawsonia alba and Mikania micrantha)', 'Antimicrobial activity against Staphylococcus aureus MTCC 2940, Bacillus subtilis MTCC 441, Escherichia coli MTCC 739, Proteus vulgaris MTCC 426 and Enterobacter aerogenes MTCC 111', '', 'Antibacterial activity of some medicinal plant extracts', 18404337),
('Abrus precatorius extracts from leaves, stem and the seed oil', 'At the different concentrations of the extracts used (512 microg/ml - 4 microg/ml), Staphylococcus aureus was the most sensitive organism with an MIC of 8 ug/ml for the leaf extract', '', 'The in-vitro antimicrobial activity of Abrus precatorius (L) fabaceae extract on some clinical pathogens', 18408781),
('Artemisia douglasiana extract and its active compound, dehydroleucodine.', 'The results showed that both dehydroleucodine and Artemisia douglasiana extract had activity against the microorganism with MICs between 1-8 and 60-120 mg/L, respectively.', '', 'CONCLUSIONS: Artemisia douglasiana may be a useful alternative treatment strategy principally in eradication of metronidazole and clarithromycin-resistant strain.', 19422904),
('Polyphenol-rich extracts from NS (Natural almond skins)', 'MIC (50-90) 64 - 128 microg/mL', 'NA', 'CONCLUSIONS: Polyphenols from almond skins were effective in vitro against H. pylori, irrespective of genotype status and could therefore be used in combination with antibiotics as a novel strategy for antibiotic resistance.', 23659287),
('essential oils and extracts of medicinal and culinary herbs (coriander, lemon balm and spearmint leaves)', 'Antibacterial activity against Esherichia coli', '', 'RESULTS: Most of the oils exhibited antibacterial activity in all three assays, however peppermint, lemon balm and coriander seed oils were most potent, with peppermint and coriander seed oils being more potent than the antibiotic rifaximin in the disc diffusion assay.', 24283351),
('Grape pomace of Cabernet Sauvignon', 'grape pomace extract combined with ?-lactam, quinolone, fluoroquinolone, tetracycline and amphenicol act in synergy in all S. aureus and E. coli strains. (MIC) was reduced 4 to 75 times. quercetin, gallic acid, protocatechuic acid and luteolin with relative abundance of 26.3, 24.4, 16.7 and 11.4%, respectively.', 'It was also shown that combinations of grape pomace extract with antibiotics are not toxic for the HeLa cell line at concentrations in which the synergistic effect was observed (47 micro g/mL of extract and 0.6-375 micro g/mL antibiotics)', 'Synergistic interactions between phenolic compounds identified in grape pomace extract with antibiotics of different classes against Staphylococcus aureus and Escherichia coli. Synergy could be an effective strategy to potentiate and recover antibiotics nowadays useless in clinical treatments against multi-resistant bacteria.', 28235054),
('Totarol: diterpenoids isolated from the bark of Podocarpus nagi (Podocarpaceae)', 'The synergistic activity of anacardic acid caused the minimum bactericidal concentration (MBC) of totarol to be lowered from 1.56 to 0.2 micrograms/ml.', '', 'Totarol [1], the most abundant compound among the six, exhibited potent bactericidal activity only against Gram-positive bacteria, among which Propionibacterium acnes was the most sensitive bacterium.', 1453180),
('Phytoalexin isolate 5,7,2'',6''-tetrahydroxy-6-isoprenyl-8-lavandulyl-4''-methox yflavanone (exiguaflavanone D)and 5, 2'',6''-trihydroxy-8-lavandulyl-7-methoxy-flavanone (exiguaflavanone B)', 'Exiguaflavanone D inhibited MRSA 1.56-6.25 micro g/ml, and Exiguaflavanone B inhibited at 50 micro g/ml concentration', '', 'Flavanones with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. With the therapeutic concept of using the defensive ability of plants against microbial infections, phytoalexin, an antimicrobial phytochemical was studied for its ability to inhibit the growth of methicillin-resistant Staphylococcus aureus (MRSA).', 7897594),
('A sesquiterpene lactone, identified as [3aR-(3a alpha, 7 beta,8a beta)]-3,3a,4,7,8,8a-hexahydro-7- methyl-3-methylene-6-(3-oxo-1-butenyl)-2H-cyclohepta[b]furan-2-one, or xanthatin, isolated from leaves of an annual herb, Xanthium sibiricum Patr er Widd', 'Active against methicillin-resistant Staphylococcus aureus', '', 'By monitoring antibacterial activity against MRSA strains, it was shown that a sesquiterpene lactone, identified as [3aR-(3a alpha, 7 beta,8a beta)]-3,3a,4,7,8,8a-hexahydro-7- methyl-3-methylene-6-(3-oxo-1-butenyl)-2H-cyclohepta[b]furan-2-one, or xanthatin, isolated from leaves of the herb, had outstandingly potent activity against S. aureus species, including MRSA; its activity against MRSA and MSSA strains was similar.', 9364417),
('Natural abietanes: 6,7-dehydroferruginol methyl ether (3), ferruginol (5), 11-hydroxy-12-oxo-7,9(11) ,13-abietatriene (7), royleanone (9), demethyl cryptojaponol (12), salvinolone (14), sugiol methyl ether (16), sugiol (17), 5,6-dehydrosugiol methyl ether (19), 5,6-dehydrosugiol (20), 6beta-hydroxyferruginol (23), and taxodione (25)', 'Phenols (12-hydroxyabieta-8,11,13-trien-6-one 22 and 23), catechols (12 and 14) and taxodione 25 has MIC 4-10 microg/mL against MRSA and 4-16 microg/mL of MIC against VRE, Quinone methide had MIC 0.5-1 microg/mL of against both MRSA and VRE.', '', 'Synthesis of variously oxidized abietane diterpenes and their antibacterial activities against MRSA and VRE.', 11249127),
('2'',4''-dihydroxy-8-gamma,gamma-dimethylallyl-2",2"-dimethylpyrano[5",6":6,7]isofla vanone (bidwillon B)', '(MICs) of 3.13-6.25mg/l against MRSA strains', '', 'Bidwillon B may prove to be a potent phytotherapeutic and/or combination agent with mupirocin in the elimination of nasal and skin carriage of MRSA.', 15325427),
('Vaccinium macrocarpon (cranberry) capsules', 'Twelve hours after consumption of cranberry or placebo hard capsules, the first urine of the morning was collected. Different Escherichia coli strains were cultured in the urine samples. Urinary antibacterial adhesion activity was measured in vitro using the human T24 epithelial cell-line, and in vivo using the Caenorhabditis elegans killing model. With the in-vitro model, 108 mg of cranberry induced a significant reduction in bacterial adherence to T24 cells as compared with placebo (p <0.001).', '', 'Overall, these in-vivo and in-vitro studies suggested that consumption of cranberry juice represents an interesting new strategy to prevent recurrent urinary tract infection.', 18190583),
('Tea tree oil and terpinen-4-ol', 'Antimicrobial activity of terpinen-4-ol and tea tree oil (TTO) against clinical skin isolates of meticillin-resistant Staphylococcus aureus (MRSA) and coagulase-negative staphylococci (CoNS)', 'No cytotoxicity against human fibroblasts', 'CONCLUSIONS: Terpinen-4-ol is a more potent antibacterial agent against MRSA and CoNS isolates than TTO with neither agent exhibiting toxicity to fibroblast cells at the concentrations tested.', 18298453),
('Cannabinoids from Cannabis sativa (cannabidiol, cannabichromene, cannabigerol, Delta (9)-tetrahydrocannabinol, and cannabinol)', 'Activity against a variety of methicillin-resistant Staphylococcus aureus (MRSA) strains of current clinical relevance.', '', 'Antibacterial cannabinoids from Cannabis sativa: a structure-activity study', 18681481),
('Aqueous and ethanol extracts of roselle calyx and protocatechuic acid', 'MIC 112-144 microg/mL(aqueous), 72-96 microg/mL(ethanol), and 24-44 microg/mL (protocatechuic acid) against food spoilage bacteria Salmonella typhimurium DT104, Escherichia coli O157:H7, Listeria monocytogenes, Staphylococcus aureus, and Bacillus cereus', '', 'These data suggest that roselle calyx ethanol extract and protocatechuic acid might be potent agents as food additives to prevent contamination from these bacteria.', 19099360),
('Quercus infectoria Olivier', 'Ethanol extract, an ethyl acetate fraction I, gallic acid and tannic acid could inhibit the growth of clinically isolated MRSA strains with minimum inhibitory concentration values between 63 and 250 microg ml(-1). ', '', 'Detailed studies on Quercus infectoria Olivier (nutgalls) as an alternative treatment for methicillin-resistant Staphylococcus aureus infections.', 19120622),
('Vaccinium berries', '', '', 'Antiadhesion therapy is a promising approach to the fight against pathogens. The results suggest Vaccinium berries as possible sources of antiadhesives against bacterial infections.', 19610031),
('Tualang honey', 'Potential alternative therapeutic agent against certain microorganisms, particularly A. baumannii and S. maltophilia.', '', 'This result suggests that tualang honey could potentially be used as an alternative therapeutic agent against certain microorganisms, particularly A. baumannii and S. maltophilia.', 19754926),
('Diterpenes (Abietane 5 and its 6,12-dibenzoyl, 12-methoxybenzoyl, 12-chlorobenzoyl, and 12-nitrobenzoyl esters)', 'Potent activities against the MDR strain with MIC values between 3.12 and 0.39 microg/ml.', '', 'Antimycobacterial metabolites from Plectranthus: royleanone derivatives against Mycobacterium tuberculosis strains', 20397225),
('Plant-derived terpenes', '', '', 'Induction of fatty acid composition modifications and tolerance to biocides in Salmonella enterica serovar Typhimurium by plant-derived terpenes. To enhance food safety and stability, the food industry tends to use natural antimicrobials such as plant-derived compounds as an attractive alternative to chemical preservatives.', 21131520),
('Ethanolic extracts of Canadian botanicals (Arctostaphylos uva ursi (kinnikinnick or bearberry), Hydrastis canadensis (goldenseal), Prunus serotina (black cherry), and Rhodiola rosea (roseroot))', 'Extracts of Arctostaphylos uva ursi (kinnikinnick or bearberry), Hydrastis canadensis (goldenseal), Prunus serotina (black cherry), and Rhodiola rosea (roseroot) inhibited the growth of all Ng isolates with minimum inhibitory concentrations of 32 micro g/mL, 4 to 32 micro g/mL, 16 to >32 micro g/mL, and 32 to 64 micro g/mL, respectively.', '', 'Extracts of Canadian first nations medicinal plants, used as natural products, inhibit neisseria gonorrhoeae isolates with different antibiotic resistance profiles.', 21301385),
('Capparis spinosa', 'At 2 mg/mL, this extract inhibited the biofilm formation to 79, 75, 73, 70% and EPS production to 58, 46, 66 and 67% in S. marcescens, PAO1, E. coli and P. mirabilis, respectively', '', 'Antiquorum sensing and antibiofilm potential of Capparis spinosa.', 22222491),
('Curtisia dentata', 'Activity against Escherichia coli and Acinetobacter spp., ethanol root bark extracts consistently showed the highest DPPH radical scavenging activity (62.43%), total phenol content (TPH) (57.62 26 mg GAE/g) and reducing power (RP) (41.32%), followed by those of the stem bark and leaf extracts with the respective values of 54.68%, 37.77 mg GAE/g and 21.83%.', '', 'CONCLUSION: Curtisia dentata is a very effective source of antioxidant and a possible alternative to sourcing antiverotoxic antibiotics with novel mechanism of action.', 22504170),
('Aframomum melegueta seed extract (diketone 6-gingerdione (2) and its enolic tautomers, methyl-6-gingerol (5) and rac-6-dihydroparadol (7), 6-Paradol (3), 8-gingerol (6),)', 'moderate to weak antimycobacterial activities, and the best modulators induced a 4- to 16-fold decrease of the MICs of EtBr and rifampicin as well as a reduction of the MIC of isoniazid', '', 'Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta', 22789014),
('Alpha-Mangostin', 'Most potent among them against Gram-positive pathogens (MIC=0.78-1.56 ?g/mL)', '', 'Rapid bactericidal action of alpha-mangostin against MRSA as an outcome of membrane targeting', 22982495),
('Medihoney and rifampicin', 'Methylglyoxal (MGO), believed to be the major antibacterial compound in manuka honey, did not act synergistically with rifampicin and is therefore not the sole factor responsible for the synergistic effect of manuka honey with rifampicin.', '', 'Our findings support the idea that a combination of honey and antibiotics may be an effective new antimicrobial therapy for chronic wound infections', 23469049),
('Oregano essential oil', 'Inhibited the growth of Escherichia coli and Pseudomonas aeruginosa clinical strains with different patters of resistance', '', 'CONCLUSIONS: The obtained outcomes will enable further investigations using oregano essential oil obtained from Origanum heracleoticum L. as alternative antibacterial remedies enhancing healing process in bacterial infections and as an effective means for the prevention of antibiotic-resistant strain development.', 23484421),
('Tea tree oil (TTO) and silver ions (Ag(+) )', 'Antimicrobial efficacy against Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans', '', '\\The activity of alternative antimicrobial agents such as tea tree oil (TTO) and silver ions (Ag(+) ) with multiple target sites impedes the development of antibacterial resistance and might be useful in improving the current treatment strategies for various chronic wound infections.', 23581401),
('Vitex negundo leaf extract (Water and methanol)', 'Methanol extract had MIC: 200-3200 ?g/mL and MBC, 200-400 ?g/mL', '', 'In vitro and in vivo bactericidal activity of Vitex negundo leaf extract against diverse multidrug resistant enteric bacterial pathogens', 23608373),
('Ellagic acid in Rosa rugosa; norwogonin in Scutellaria baicalensis; and chebulagic acid, chebulinic acid, corilagin, and terchebulin in Terminalia chebula', 'The potent compound norwogoninhad a minimum inhibitory concentration of 128 microg/mL, and minimum bactericidal concentration of 256 microg/mL against clinically relevant strains of A. baumannii', '', 'Isolation and characterization of antimicrobial compounds in plant extracts against multidrug-resistant Acinetobacter baumannii', 23630600);
INSERT INTO `bacteria_naturalproduct` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Leptospermum scoparium (Manuka) oil', 'Inhibitor of S. pseudintermedius biofilm formation, and the majority of bacteria decreased by >50%', '', 'In vitro efficacy of the essential oil from Leptospermum scoparium (manuka) on antimicrobial susceptibility and biofilm formation in Staphylococcus pseudintermedius isolates from dogs', 23772881),
('Propolis extract GH2002', 'MICs in the range of 0.03 to 2 mg/ml against S. pyogenes, S. aureus, E. faecium and Candida. ', '', 'These results suggest that the special propolis extract GH2002 might be used in the development of alternative products for therapy of microbial infections.', 24020127),
('Tabernaemontana alternifolia (Roxb) stem bark aqueous extracts', 'The minimum inhibitory concentration (MIC) of extract against the isolates ranged from 600-800 ?g/ml.', 'The extract did not exhibit cytotoxic activity against Vero cells even at the concentration of 4 mg/ml.', 'CONCLUSION: Our results offer a scientific basis for the traditional use of T. alternifolia in the treatment of skin infections, showing that the plant extract has an enormous potential as a prospective alternative therapy against MRSA skin infections.', 24066905),
('Amphypterygium adstringens anacardic acid mixture', 'anti-quorum sensing activity in P. aeruginosa 94% of inhibition violecin production at 166 micro g/mL, 86% inhibition of pyocyanin at 200 micro g/mL) and 91% inhibition of rhamnolipid production 500 micro g/mL)  and decrease the elastase (75% at 500 ?g/mL) activity', '', 'The aim of this study was to evaluate the anti-quorum sensing (anti-QS) potential of an anacardic acids mixture isolated from Amphipterygium adstringens, a medicinal plant known as "cuachalalate", to prevent the onset of bacterial infections as an alternate to antibiotics.', 24126126),
('essential oils from the leaves of L. gracilis (EOLG)', 'has 38 chemical constituents with thymol (44.4%), carvacrol (22.2%), p-cymene (6.2%) and ?-pinene (5.6%) as major constituents.', '', 'These results demonstrate that natural substances present in EOLG have the capacity to modulate bacterial resistance and can be used as an adjuvant therapy against multi-resistant microorganisms such as S. aureus, Escherichia coli and P. aeruginosa.', 24479735),
('Aloe vera inner gel', 'The inhibitory concentrations of A. vera inner gel were ranging from 6.25 to 800 mg ml(-1) .50% of the detected strains (14 clinical strains and one reference strain of H. pylori), independently of their susceptibility profile, were inhibited in their growth at 100 mg ml(-1) .', 'NA', 'The study demonstrates that the Aloe vera inner gel expresses antibacterial properties against both susceptible and resistant Helicobacter pylori strains.', 24597562),
('Flavonoids [demethylglycyrol (31) and 5,7-di-O-methylluteone (32)] and licorice phenolics [3-arylcoumarins such as licoarylcoumarin (9) and glycycoumarin (26), and 2-arylcoumarones such as gancaonin I (17)]', 'Activity against vancomycin-resistant Enterococcus species', '', 'Structures of two new flavonoids and effects of licorice phenolics on vancomycin-resistant Enterococcus species', 24686577),
('Aspergillomarasmine A (AMA)', 'potent inhibitor of the NDM-1 enzyme and another clinically relevant MBL, VIM-2 etc', '', 'Here we have identified a fungal natural product, aspergillomarasmine A (AMA), that is a rapid and potent inhibitor of the NDM-1 enzyme and another clinically relevant MBL, VIM-2.', 24965651),
('Different extracts from Olea europaea, mastic gum, and Inula viscosa', 'Activity against bacteria and fungi, O. europaea presented MIC and MBC ranges of 0.07-10.00 mg mL(-1) and 0.60-10.00 mg mL(-1), respectively, mean MBC values for mastic gum and I. viscosa were 0.07-10.00 mg mL(-1) and 0.15-10.00 mg mL(-1), respectively', '', 'Ethyl acetate I. viscosa extract and total mastic extract showed considerable antimicrobial activity against oral microorganisms and could therefore be considered as alternative natural anti-infectious agents.', 25054150),
('Essential oil was extracted from leaves of Hyptis martiusii Benth. ? -3-carene, 1, 8-cineole, trans-caryophyllene, Cariophyllene oxide and bicyclogermacrene were important components.', 'Essential oil inhibited growth of bcteria (MIC < 512 ?g/mL) except S. aureus (SA358) multidrug resistant (MRSA) by direct contact. S. aureus ATCC 12692, S. aureus 358 (SA358),Bacillus cereus ATCC, E. coli ATCC 25922, E. coli 27 (EC27), P. aeruginosa (ATCC).', 'NA', 'CONCLUSIONS: These results show that this oil influences the activity of the antibiotic and may be used as an adjuvant in the antibiotic therapy of respiratory tract bacterial pathogens.', 25237640),
(' (-)-Epigallocatehin-3-Gallate (EGCG) and Green Tea Extracts (GTE)', 'EGCG inhibited the growth of P. aeruginosa at a MIC level of 200~400 ?g/ml. The MIC of GTE was a 1 : 16 dilution for P. aeruginosa. EGCG showed antimicrobial activity against E. coli at a MIC of 400 ?g/ml. In the case of GTE, the MIC was a dilution between 1:8 and 1:4 for E. coli.', '', 'CONCLUSION: EGCG and GTE showed potential as alternative or adjunct topical antimicrobial agents for infections that are resistant to traditional antibiotic therapy.', 25324647),
('Vanilla, patchouli and ylang ylang essential oils stabilized by iron oxide@C14 nanostructures', 'Vanilla essential oil loaded nanoparticles pelliculised on the catheter samples surface strongly inhibited both the initial adherence of S. aureus cells (quantified at 24 h) and the development of the mature biofilm quantified at 48 h. Patchouli and ylang-ylang essential oils inhibited mostly the initial adherence phase of S. aureus biofilm development. In the case of K. pneumoniae, all tested nanosystems exhibited similar efficiency, being active mostly against the adherence K. pneumoniae cells to the tested catheter specimens.', '', 'Efficiency of vanilla, patchouli and ylang ylang essential oils stabilized by iron oxide@C14 nanostructures against bacterial adherence and biofilms formed by Staphylococcus aureus and Klebsiella pneumoniae clinical strains.', 25375335),
('Coumarin', 'Quorum sensing inhibitor, active against short, medium and long chain N-acyl-homoserine lactones and also inhibited biofilm', '', 'In this study, we identified coumarin, a natural plant phenolic compound, as a novel QS inhibitor, with potent anti-virulence activity in a broad spectrum of pathogens.', 25672848),
('Organic extracts from Indigofera suffruticosa leaves (diethyl ether, chloroform and acetone)', 'The acetone extract was the most potent inhibitor of S. aureus (MIC and MBC of 0.78 and 3.12 mg/mL), followed by the chloroform extract (MIC and MBC of 3.12 and 6.25 mg/mL).', '', 'Organic extracts from Indigofera suffruticosa leaves have antimicrobial and synergic actions with erythromycin against Staphylococcus aureus', 25699022),
('6, 6''-dihydroxythiobinupharidine from Nuphar japonicum', 'MIC was 1-4 ?g/mL against various MRSA and VRE strains, also inhibited DNA topoisomerase IV (IC50 was 10-15 ?M)', '', 'These results suggest that 6,6''-dihydroxythiobinupharidine may be a potent candidate or seed for novel antibacterial agents.', 25731981),
('Cranberry proanthocyanidin', 'The minimal concentration at which significant inhibitiont occurred was 250 ?g/mL.', '', 'CONCLUSION: Cranberry proanthocyanidins exhibit potent effects on growth, adhesion, and virulence of oropharyngeal and lung isolates of E. coli, suggesting that cranberry proanthocyanidin could be of clinical interest to reduce oropharyngeal colonization and prevent lung infection.', 25803655),
('Essential oils (EOs) from Salvia fruticosa, Salvia officinalis and Salvia sclarea', 'Inhibition the Tet(K) efflux pump of tetracycline resistant Staphylococcus epidermidis', '', 'Our data from molecular and functional analyses of inhibitory effect of Salvia''s essential oils, namely from S. fruticosa, on Tet(K) pump of Staphylococcus epidermidis and from modulatory studies may be the starting point for consecutive study of pharmacokinetic and pharmacodynamic parameters and their perspective use in combination therapy.', 25846244),
('Pomegranate fruit constituents:  caffeic acid, ellagic acid, epigallocatechin-3-gallate (EGCG) and quercetin', 'The peel extracts exhibited greater antimycobacterial activity (MIC 64-1024 ?g/mL) than the potable juice (MIC 256 - > 1024 ?g/mL). EGCG and quercetin exhibited higher antitubercular (MIC 32-256 ?g/mL) and antibacterial (MIC 64-56 ?g/mL) potencies than caffeic acid and ellagic acid (MIC 64-512 ?g/mL).', '', 'Antimicrobial activity of pomegranate fruit constituents against drug-resistant Mycobacterium tuberculosis and beta-lactamase producing Klebsiella pneumoniae. CONTEXT: The global surge in multi-drug resistant bacteria and the imminence of tuberculosis pandemic necessitate alternative therapeutic approaches to augment the existing medications.', 25858784),
('Nasutitermes corniger (Motschulsky, 1855) extract', 'Despite having no significant antimicrobial activity (MIC ? 1000 ?g mL(-1)), the extract showed additive activity to the antibiotic efficacy, significantly reducing its MIC.', '', 'These results suggest that N. corniger and its nest are promising natural products for use in antimicrobial therapy.', 26150745),
('Pectinatella magnifica extract (acetone, methanol )', 'acetone extract had (MIC) 0.004-0.350 mg/mL and MBC 0.007-0.500 mg/mL), while methanol extract had (MIC 0.03-0.12 mg/mL and MFC 0.06-0.25 mg/mL)', '', 'According to the experimental data obtained, P. magnifica methanol extract may be considered as a good resource of novel natural products with potent antibiofilm activity against the bacterium well known for its resistance.', 26252786),
('Chebulinic acid (CA)', 'M. tuberculosis DNA gyrase inhibitor', '', 'Identification of chebulinic acid as potent natural inhibitor of M. tuberculosis DNA gyrase and molecular insights into its binding mode of action.', 26410242),
('Crude ethanolic extract (CEE), ethyl acetate fraction (EAF), and methanolic fraction (MF) from Anacardium microcarpum', 'However, addition of CEE, EAF, and MF to the growth medium at the subinhibitory concentration (MIC/8=64 ?g/mL) significantly modulated amikacin- and gentamicin-resistant E. coli', '', 'A. microcarpum is a natural resource with resistance-modifying antibacterial activity that needs to be further investigated to overcome the present resistant-infection problem.', 26604695),
('Piper betle L.', 'This study revealed the bactericidal activities of all the P. betle leaf crude extracts on methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), extended spectrum ?-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and metallo-?-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii, with minimum bactericidal concentrations that ranged from 19 micro g/ml to 1250 micro g/ml.', '', 'Antimicrobial Activities of Methanol, Ethanol and Supercritical CO2 Extracts of Philippine Piper betle L. on Clinical Isolates of Gram Positive and Gram Negative Bacteria with Transferable Multiple Drug Resistance. Piper betle L. has traditionally been used in alternative medicine in different countries for various therapeutic purposes, including as an anti-infective agent.', 26741962),
('Kisameet Clay', 'Antimicrobial activity against ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species)', '', 'Here, we report the broad-spectrum and potent antibacterial activity of Kisameet clay, a natural clay mineral from British Columbia, Canada, against a group of multidrug-resistant ESKAPE strains.', 26814180),
('Poncirus trifoliata ethyl extract', 'Strong anti-MRSA activity, antibacterial activity with MIC value of 256 micro g ml(-1)', '', 'Studies on antimicrobial activity of Poncirus trifoliata ethyl extract fraction against methicillin-resistant Staphylococcus aureus and to elucidate its antibacterial mechanism.', 26930870),
('Epigallocatachin gallate (EGCG)', 'E. coli LB226692, serotype O104:H4, O104:H4 strain 55989, EDL933, serotype O157:H7, matrix production of all strains was virtually eliminated by EGCG or green tea at 28?C and 37?C', 'NA', 'These findings highlight EGCG as a potential adjuvant for antibiotic therapy of biofilm-associated infections.', 26992034),
('Ginger (Zingiber officinale)', 'The minimum inhibitory concentrations (MICs) of ginger extract for evaluated strains were 40, 40, 20, 20, 20, 20, 10, and 5 mg/mL for Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Bacillus cereus, Acinetobacter baumannii, C. albicans, and C. krusei, respectively.', '', 'Ginger extract has good antifungal and antibiofilm formation by fungi against C. albicans and C. Krusei.', 27127591),
('Petroleum ether extract of seed of Nigella sativa, oil extract from mature ripe fruit husk of Aframomum corrorima and mature unripe fruit of A. corrorima', 'Petroleum ether extract of seed of Nigella sativa: Bacillus cereus [inhibition zone (IZ), 44 ? 0.31 mm] and B. cereus ATCC 10987 (IZ, 40 ? 2.33 mm); oil extract from mature ripe fruit husk of Aframomum corrorima and mature unripe fruit of A. corrorima revealed promising activities against Candida albicans ATCC 90028 (IZ, 35 ? 1.52 mm) and Staphylococcus aureus DSM 346 (IZ, 25 ? 1.32 mm), respectively.', '', 'Antimicrobial and anti-Quorum Sensing activities of selected medicinal plants of Ethiopia: Implication for development of potent antimicrobial agents. BACKGROUND: Traditional medicinal plants have been used as an alternative medicine in many parts of the world, including Ethiopia.', 27400878),
('Ludwigia leptocarpa extracts ( 2?-hydroxyoleanolic acid, (2R,3S,2''''S)-3'''''',4'',4'''''',5,5'''',7,7''''-heptahydroxy-3,8"-biflavanone, and luteolin-8-C-glucoside)', 'Active against Gram-positive bacterium, Staphylococcus aureus, Gram-negative multi-drug-resistant bacteria, Vibrio cholerae and Shigella flexneri (a cause of shigellosis', '', 'Overall, the present results show that L. leptocarpa has the potential to be a natural source of anti-diarrheal and antioxidant products, so further investigation is warranted.', 27431270),
('Monoterpenes nerol', 'Inhibit NorA efflux pump of multi-drug resistant S. aureus strains', '', 'This result shows that bioactives tested, especially the nerol, are able to inhibit NorA efflux pump indicating a potential use as adjuvants of norfloxacin for therapy of infections caused by multi-drug resistant S. aureus strains.', 27565089),
('Tordylium persicum Boiss. & Hausskn extract', 'The results showed that Streptococcus pyogenes was the most susceptible to the methanolic extract (MIC = 25.9 ? 0.0 ?g/mL), while Proteus vulgaris was the most resistant strain (MIC = 295.3 ? 0.0 ?g/mL) among all bacteria evaluated.?', '', 'Tordylium persicum Boiss. & Hausskn extract: A possible alternative for treatment of pediatric infectious diseases. Antimicrobial herbal compounds are one of the important medical resources, and in order to help alleviate the spread of the pediatric infectious diseases, identification of additional bioactive phytochemicals and herbal extracts will be practical in treating illnesses.', 27585257),
('AN(Acacia nilotica) + MKL Sprengel (Murraya koenigii (Linn.)) + Euca (Eucalyptus) + PS (Psidium guajava), AN + MKL Sprengel + Euca', 'All the triple and quadruple combinations of the plant extracts offered antimicrobial benefits either superior or comparable to 0.2% chlorhexidine against S. mutans, S. sanguis, and S. salivarius.', '', 'Antimicrobial efficacy of the combinations of Acacia nilotica,Murrayakoenigii (Linn.) Sprengel, Eucalyptus, and Psidiumguajava on primary plaque colonizers: An in vitro study. BACKGROUND: The rise in disease incidence, increased resistance of pathogenic bacteria to currently used antibiotics and chemotherapeutics, opportunistic infections in immunocompromised individuals, and financial considerations in developing countries necessitates alternate preventive and treatment strategies for oral diseases.', 27723640),
('Ethanolic extract of propolis', 'Combinations of cefixime and propolis gave significant results', '', 'Propolis acted synergistically with cefixime and enhanced the efficacy of antibiotic and reduced its effective dose in combined therapy.', 27887651),
('Pistacia atlantica methanolic extract', 'Active aginst Helicobacter pylori', '', 'The assay demonstrated the thiourea and the extract to be potent urease inhibitors, with the extract having strong bacteriostatic activity against clinical isolates of H. pylori, including such with antibiotic resistance.', 27923651),
('Combination of Oleoresin from Copaifera multijuga Hayne and Biogenic Silver Nanoparticles', 'Bactericidal activity against planktonic Streptococcus agalactiae (group B Streptococcus - GBS) ', '', 'CONCLUSION: These results indicate the potential of copaiba oil, alone or in combination with AgNPbio, for the development of new alternative strategies for controlling GBS infections.', 27978809),
('Cassia alata', '50% inhibition of violacein production in C. violaceum at 0?05 mg ml-1 concentration of fraction rich in flavonoids (F-AF)', '', 'A medicinal herb Cassia alata attenuates quorum sensing in Chromobacterium violaceum and Pseudomonas aeruginosa.', 28035685),
('Combretum zeyheri alkaloid extracts', 'antimycobacterial effects with an MIC value of 125 microg/ml', '', 'Alkaloid extracts from the most potent plant species, Combretum zeyheri were further investigated for time-kill dependency effects on drug transport in Mycobacterium smegmatis.', 28228097),
('Nigella Sativa extract', '', '', 'In conclusion, our literature survey revealed potent antimicrobial properties of N. sativa against MDR strains in vitro that should be further investigated in order to develop novel therapeutic perspectives for combating infectious diseases particularly caused by MDR strains.', 28386474),
('Marine sponge extracts', 'MIC values of the sponge extracts ranged from 0.039 to 1.25mg/mL, best antibacterial profile was observed by its ethyl acetate extract against Staphylococcus aureus and Bacillus cereus with MIC and MBC values of 0.039mg/mL and 0.078mg/mL, respectively. ', '', 'These findings suggest that the antibacterial properties of the tested marine sponge extracts may provide an alternative and complementary strategy to manage bacterial infections.', 28392375),
('Methanolic fruit extract of S. persica L.', 'Methanolic fruit extract of S. persica L. showed a high degree of anti-biofilm formation on PMMA (polymethylmetacrylate) and on violacein (pigment production in Chromobacterium violaceum) inhibition with a percentage of reduction equal to 90% when MIC value (20 mg/ml) was used.', '', 'The aim of this study was to evaluate the antiquorum sensing (anti-QS) and antibiofilm potential of Salvadora persica L. methanolic extracts to prevent the infections due to Staphylococcus as an alternate to antibiotics.', 28552808),
('Puupehenone-like molecules, marine natural product', 'Active against dormant Mtb', '', 'In conclusion, we have identified and characterized antimycobacterial compounds from marine organisms with novel activity profiles which appear to target M. tuberculosis pathways that are conditionally essential for dormancy survival.', 28607021),
('Phenolic Compounds: tannic acid, epigallocatechin gallate, rutin, and eugenol', '', 'Long-term treatment with several conventional antibiotics can cause harmful side effects', 'Phenolic Compounds in Antimicrobial Therapy. Long-term treatment with several conventional antibiotics can cause harmful side effects that can be alleviated by antioxidant therapy.', 28661772),
('Extract of A. deliciosa', 'Activity against Acinetobacter baumannii', '', 'Therefore, it can be concluded that polar extract of A.?deliciosa can be used to find suitable alternative therapeutic to control biofilm formation by carbapenem resistant strain of Acinetobacter baumannii.', 28705748),
('Naphtho[1,2-b]furan-4,5-dione', 'Minimum inhibitory concentration of N12D against MRSA was 4.9-9.8?M', '', 'Naphtho[1,2-b]furan-4,5-dione is a potent anti-MRSA agent against planktonic, biofilm and intracellular bacteria. AIM: Naphtho[1,2-b]furan-4,5-dione (N12D) and naphtho[2,3-b]furan-4,9-dione (N23D) are furanonaphthoquinone derivatives from natural resources.', 28799789),
('Plectranthus amboinicus essential oil (PAEO)', 'The lowest MIC (0.25 mg mL-1) and MBC (0.5 mg mL-1) values were observed when carvacrol was used against OVRSA. When a 0.5 mg mL-1?concentration of PAEO and carvacrol was used, no viable cells were found on S. aureus biofilm.', '', 'Plectranthus amboinicus essential oil and carvacrol bioactive against planktonic and biofilm of oxacillin- and vancomycin-resistant Staphylococcus aureus. BACKGROUND: The emergence of multidrug-resistant bacteria is a worldwide concern and in order to find an alternative to this problem, the occurrence of antimicrobial compounds in Plectranthus amboinicus essential oil was investigated.', 28915875),
('Fennel essential oil', 'Activity in combination with antibiotics against Staphylococcus aureus strains', '', 'Our research showed that the fennel essential oil in combination with mupirocin may be considered as a natural alternative in eradication of S. aureus with iMLSB, cMLSB, MSB resistant phenotypes and is able to decrease the growth rate of antibiotic resistance.', 28917968),
('Manuka honey', 'MIC and MBC against K. pneumoniae ST11 of Manuka honey was 30% (v/v) and (>1 log) reduction was observed in mice.', '', 'CONCLUSION: Manuka honey can be used as an alternate therapeutic approach for management of New Delhi metallo-?-lactamase-producing pathogens.', 29226698),
('Origanum onites essential oil (EO) ', 'Activity against ESBL positive E. coli isolates.', '', 'According to our results, O. onites EO may be an alternative to synthetic drug, used in combination with other antibiotics for treatment of infection caused by multidrug resistant bacteria after testing toxic effects and irritation at preferred doses on human.', 29262709),
('Apple fruit juice', 'Antimicrobial effect against Enterococcus fecalis and Streptococcus mutans', '', 'However, preclinical and clinical trials are needed to evaluate biocompatibility & safety before apple can conclusively be recommended in endodontic therapy, but in vitro observation of apple effectiveness appears promising.', 29284967),
('Passiflora cincinnata Mast', 'Enhances antibiotic activity against Staphylococcus aureus?and?Escherichia coli', '', 'Potentiation of antibiotic activity by Passiflora cincinnata Mast. front of strains Staphylococcus aureus and Escherichia coli. The development of new drugs from plants is an interesting alternative approach to overcoming microbial resistance.', 29379354),
('MCFA lauric acid', 'Inhibitor of?Clostridium difficile?Growth?in Vitro', '', 'Our combined results suggest that the naturally occurring MCFA lauric acid is a novel C. difficile inhibitor and is useful in the development of an alternative or adjunctive treatment for CDI.', 29387044),
('Curcuma longa (Zingiberaceae) rhizomes', 'Tested against Escherichia coli strains, Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus sp', '', 'The results indicated that the ethanolic extract and essential oil of C. longa rhizomes have active compounds with antibacterial properties that could be used in future research as a therapeutic alternative for the treatment of infections caused by nosocomial pathogens.', 29462537),
('Melipona beecheii honey (Cuba)', 'Antimicrobial and antibiofilm activity on Staphylococcus aureus and Pseudomonas aeruginosa cells', '', 'The antibiofilm activity of honeys was tested by assessing their ability to inhibit biofilm formation and to disrupt preformed biofilms.', 29988499),
('Phytochemical flavanones: 2'',4''- or \n2'',6''-dihydroxylation of the B ring and 5,7-dihydroxylation of the A \nring in the flavanone structure', 'Differently substituted flavanones were isolated from Leguminosae.', '', 'The present hydroxyflavanones would be useful in the phytotherapeutic strategy against MRSA infections.', 8778504),
('Mycobacteriolytic preparation (stazyme) from the Staphylococcus strain Clavelis', '', '', 'Stazyme, a mycobacteriolytic preparation from a Staphylococcus strain, is able to break the permeability barrier in multiple drug resistant Mycobacterium avium. As a strategy to augment the potential of existing drugs against Mycobacterium avium we investigated a mycobacteriolytic preparation (stazyme) from the Staphylococcus strain Clavelis, which results in significant mycobacterial growth inhibition.', 9537755),
('Hot aqueous and methanolic extracts prepared from six plants (Terminallia chebula, Terminallia bellerica, Phyllanthus emblica, Punica granatum, Lawsonia alba and Mikania micrantha)', 'Antimicrobial activity against Staphylococcus aureus MTCC 2940, Bacillus subtilis MTCC 441, Escherichia coli MTCC 739, Proteus vulgaris MTCC 426 and Enterobacter aerogenes MTCC 111', '', 'Antibacterial activity of some medicinal plant extracts', 18404337),
('Abrus precatorius extracts from leaves, stem and the seed oil', 'At the different concentrations of the extracts used (512 microg/ml - 4 microg/ml), Staphylococcus aureus was the most sensitive organism with an MIC of 8 ug/ml for the leaf extract', '', 'The in-vitro antimicrobial activity of Abrus precatorius (L) fabaceae extract on some clinical pathogens', 18408781),
('Artemisia douglasiana extract and its active compound, dehydroleucodine.', 'The results showed that both dehydroleucodine and Artemisia douglasiana extract had activity against the microorganism with MICs between 1-8 and 60-120 mg/L, respectively.', '', 'CONCLUSIONS: Artemisia douglasiana may be a useful alternative treatment strategy principally in eradication of metronidazole and clarithromycin-resistant strain.', 19422904),
('Polyphenol-rich extracts from NS (Natural almond skins)', 'MIC (50-90) 64 - 128 microg/mL', 'NA', 'CONCLUSIONS: Polyphenols from almond skins were effective in vitro against H. pylori, irrespective of genotype status and could therefore be used in combination with antibiotics as a novel strategy for antibiotic resistance.', 23659287),
('essential oils and extracts of medicinal and culinary herbs (coriander, lemon balm and spearmint leaves)', 'Antibacterial activity against Esherichia coli', '', 'RESULTS: Most of the oils exhibited antibacterial activity in all three assays, however peppermint, lemon balm and coriander seed oils were most potent, with peppermint and coriander seed oils being more potent than the antibiotic rifaximin in the disc diffusion assay.', 24283351),
('Grape pomace of Cabernet Sauvignon', 'grape pomace extract combined with ?-lactam, quinolone, fluoroquinolone, tetracycline and amphenicol act in synergy in all S. aureus and E. coli strains. (MIC) was reduced 4 to 75 times. quercetin, gallic acid, protocatechuic acid and luteolin with relative abundance of 26.3, 24.4, 16.7 and 11.4%, respectively.', 'It was also shown that combinations of grape pomace extract with antibiotics are not toxic for the HeLa cell line at concentrations in which the synergistic effect was observed (47 micro g/mL of extract and 0.6-375 micro g/mL antibiotics)', 'Synergistic interactions between phenolic compounds identified in grape pomace extract with antibiotics of different classes against Staphylococcus aureus and Escherichia coli. Synergy could be an effective strategy to potentiate and recover antibiotics nowadays useless in clinical treatments against multi-resistant bacteria.', 28235054),
('Dipicolinic Acid extracted from endophytic Paenibacillus amylolyticus KMCLE06', 'Antibacterial activity against both gram-positive and gram-negative pathogens, MIC ranged from 62.5 to 125 microg/ml and MBC from 208 to 250 microg/ml', '', 'Bioactive natural compounds play pivotal roles in drug discovery and the emergence of multi-drug resistance pathogens demands the development of better/new drugs.', 30498942),
('Cinnamon bark (Cinnamomum verum J. Presl) essential oil', 'Disruption of carbapenemase (KPC) producing Klebsiella pneumoniae membrane', '', 'Natural products such as essential oils are a promising source due to their complex composition.', 30939149),
('Methanolic extracts of Oxalis corniculata, Artemisia vulgaris, Cinnamomum tamala, and Ageratina adenophora', 'The highest potential was observed in the extract of O. corniculata against Escherichia coli, Salmonella Typhi, MDR Salmonella Typhi, Klebsiella pneumoniae, and Citrobacter koseri with zone of inhibition (ZOI) of 17 mm, 13 mm, 16 mm, 11 mm, and 12 mm, respectively. Oxalis corniculata also showed the highest MIC against test organisms. The methanolic extract of Artemisia vulgaris, Cinnamomum tamala, and Ageratina adenophora showed efficacy against Staphylococcus aureus. Ageratina adenophora also showed antifungal activity against Rhizopus spp.', '', 'Effective treatment of a disease entails the development of new pharmaceuticals or some potential source of novel drugs.', 31065287),
('Analogues of accramycins (1-13)', 'Compounds 1-13 inhibited the Gram-positive pathogens (Staphylococcus aureus, Enterococcus faecalis) and clinical isolates Enterococcus faecium (K59-68 and K60-39) and Staphylococcus haemolyticus with minimal inhibitory concentration (MIC) values in the range of 1.5-12.5 microgram/mL.', '', 'Remarkably, compounds 1-13 displayed superior activity against K60-39 (MIC = 3.1-6.3 ?microgram/mL) compared to ampicillin (MIC = 25 microgram/mL), and offered promising potential for the development of accramycin-based antibiotics that target multidrug-resistant Enterococcus clinical isolates.', 33092156),
('Chromomycin A9 (1), chromomycin Ap (2), chromomycin A2 (3), and chromomycin A3 (4),', 'During a passage experiment, minimum inhibitory concentration (MIC) values for compounds 1-4 showed no more than a 4-fold increase from the starting MIC value, indicating that no resistance was detected over the 21 passages.', '', 'Compounds 1-4 showed potent antibacterial activities against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA).', 33096696),
('Pathogen-derived enzyme (PelAh) from engineered lactic acid bacteria', 'show that our best performing engineered LAB, secreting a pathogen-derived enzyme (PelAh), degrades up to 85% of P. aeruginosa biofilm.', '', 'In this work, we developed a new antimicrobial treatment modality using engineered lactic acid bacteria (LAB)', 33127888),
('Rutin', '', '', 'In this study, we investigated the effect of rutin as a flavonoid compound on photodynamic inactivation by MB on Pseudomonas aeruginosa and Staphylococcus aureus.', 33137496),
('oregano essential oil (OEO)', 'OEO showed antibacterial effect against all Ab-MDR tested, with minimum inhibitory concentrations (MIC) ranging from 1.75 to 3.50 mg mL-1', '', 'The results presented here indicate that the OEO used alone or in combination with polymyxin B in the treatment of Ab-MDR infections is promising.', 33190200),
('Van D, a curcumin mimics', 'The best candidate Van D, a curcumin mimics reduced the MIC of tetracycline (TET) up to 16 folds against multidrug resistant clinical isolates.', 'In acute oral toxicity study, this derivative was well tolerated and found to be safe up to 1000 mg/kg dose.', 'To the best of our knowledge, this is the first report on curcumin mimics as synergistic agent via inhibition of efflux pump.', 33213895),
('Magallana bilineata', 'M. bilineata potentially inhibited the bacterial growth with minimal inhibitory concentration (0.75-20 microgram/ml) and fungal pathogens (0.75-5 microgram/ml) as compared to ciprofloxacin and miconazole.', '', 'Therefore, the oysters surviving in the pollution stress modulate the physiological and immune response may exploit to develop potential antibiotics.', 33271318),
('Napabucasin', 'Napabucasin exhibited good antimicrobial activity against oral streptococcal planktonic cultures and biofilms but with lessened cytotoxicity as compared to chlorhexidine. Napabucasin reduced the cariogenic S. mutans and increased the proportion of the commensal S. gordonii in the multispecies biofilms.', '', 'Napabucasin shows lessened cytotoxicity and comparable antimicrobial effects to chlorhexidine.', 33274224),
('Apple cider vinegar (ACV)', 'The MIC for ACV tablets was 200 microgram/mL for both MRSA and rE. coli respectively', '', 'Therapy involves multiple rounds of ineffective antibiotics alongside unwanted side effects, alternative treatments are crucial.', 33473148),
('"Yellow-brown resins" from Larrea divaricata Cav (LdRe) and L. nitida Cav (LnRe)', 'A strong antimicrobial activity was displayed by both resins against methicillin-sensitive Staphylococcus aureus ATCC 25923(MSSA) and methicillin-resistant S. aureus ATCC 43300(MRSA) (MICs = 16-32 microgram resin/mL).', '', 'Additionally, the combination of LdRe or LnRe with the antibiotic cefotaxime showed an indifferent effect (FICI values = 1-1.25), however, this combinationcould be a potential strategy to reduce the drug doses, and in this way can be a potential alternative to reduce bacterial resistance.', 33525584),
('Essential oils (EOs) of three Moroccan lavender species (Lavandula pedunculata, LP; Lavandula angustifolia, LA; and Lavandula maroccana, LM)', 'EOs alone or combined showed a remarkable antimicrobial activity against the tested bacteria with minimum inhibitory concentrations (MICs) ranging from 3?53 to 15?96 mg ml-1 .', '', 'Chemical composition and synergistic effect of three Moroccan lavender EOs with ciprofloxacin against foodborne bacteria: a promising approach to modulate antimicrobial resistance.', 33570805),
('water-soluble monocarbonyl curcuminoids, curcumin derivatives', 'All compounds exhibited good to moderate anti-TB activity with MIC99 in the range of 3.12-25.0 microM, out of which 7c and 7p were found the most potent compounds with MIC99 in the range of 3.12-6.25 microM.', 'Furthermore, these compounds were observed to be nonhaemolytic, nontoxic, and stable under both physiological as well as reducing conditions.', 'a series of 17 water-soluble monocarbonyl curcuminoids was synthesized and evaluated for antimycobacterial activity.', 33751730),
('Armeniaspirol A, isolated from Streptomyces armeniacus,', 'we found that armeniaspirol A (ARM1) exhibited potent antibacterial activity against H. pylori, including multidrug-resistant strains, with MIC range values of 4-16 microgram ml-1 .', '', 'Thus, these findings demonstrated that ARM1 is a novel potent anti-H. pylori agent, which can be developed as a promising drug lead for treatment of H. pylori infections.', 33780131),
('Coriander essential oil and linalool', 'Increase in antibiotic susceptibility and reversal of antibiotic resistance in Methicillin-resistant Staphylococcus aureus (MRSA), methicillin-susceptible S. aureus, S. epidermidis and Gram-negative bacteria (Pseudomonas aeruginosa, Escherichia coli)', '', 'Combinations of coriander essential oil/linalool and antibiotics are thus very promising for the development of novel antibacterials.', 30471142),
('3-O-methyl-alkylgallates (3-O-methyl-butyl-, 3-O-methyl-hexylgallate, and 3-O-methyl-octylgallate) isolated from the Nigerian mistletoe Loranthus micranthus', 'Growth inhibition in vitro against M. tuberculosis, with a MIC of 6.25 ?M', 'Devoid of cytotoxicity against various human cell lines', 'In the quest for new antibacterial lead structures, activity screening against Mycobacterium tuberculosis identified antitubercular effects of gallic acid derivatives isolated from the Nigerian mistletoe Loranthus micranthus Structure-activity relationship studies indicated that 3-O-methyl-alkylgallates comprising aliphatic ester chains with four to eight carbon atoms showed the strongest growth inhibition in vitro against M. tuberculosis, with a MIC of 6.25 μM.', 31209015),
('4-Hexylresorcinol (4-HR)', '50% of the minimal inhibitory concentration (MIC) of 4-HR caused an up to 50-fold decrease in the MIC of antibiotics of various classes. Using an in vivo mouse model of K. pneumoniae-induced sepsis, we could demonstrate that the combination of 4-HR and polymyxin was highly effective.', '', 'It was therefore the aim of the present study to test whether alkylresorcinols, a class of phenolic lipids, can be used as adjuvants to potentiate the effect of various classes of antibiotics.', 32960928),
('Kisameet clay (KC)', 'The antimicrobial assays presented in this study confirm the potent inhibitory activity of KC against a variety of bacterial strains, including M. marinum as a model for M. ulcerans, as well as against two fungal pathogens, C. albicans and C. neoformans, which are pathogenic fungi mostly causing infections in immunocompromised patients', '', 'Natural clay minerals have a long history of therapeutic and biomedical applications and have lately received specific attention for their potent antimicrobial properties.', 33024043),
('Pimenta Oil', 'Both P. diocia and P. racemosa leaf E.Os showed a bactericidal action against A. baumanii within 6h at 2.08 microgram?mL-1.', '', 'Our finding suggests the potential antimicrobial activity of Pimenta leaf E.O against MDR A. baumannii wound infections and their underlying mechanism and to be further tested clinically as treatment for MDR A. baumannii infections.', 33036456),
('Dolastane diterpenes: (4R,7R,14S)-4alpha,7alpha-diacetoxy-10-one-14alpha-hydroxydolasta-1(15),8-diene, (4R,7R,14S)-4alpha,7alpha-diacetoxy-14alpha-hydroxydolasta-1(15),8-diene, (4R,14S)-4alpha,14alpha-dihydroxydolasta-1(15),8-diene, (4S,9R,14S)-4alpha-acetoxy-9?,14alpha-dihydroxydolasta-1(15),7-diene, 4-acetoxy-14-hydroxydolasta-1(15),7,9-triene and isolinearol', 'Decreases MIC of antibiotics norfloxacin, tetracycline and erythromycin by 4-256 fold', '', 'The results indicate that seaweed extracts and diterpenes are potential sources of antibiotic adjuvant, acting as potential inhibitors of efflux pump.', 29733689),
('p-Coumaric acid', 'Inhibits the Listeria monocytogenes RecA protein', '', 'These findings revealed that p-Coumaric acid is a potent RecA inhibitor, and can be used as an adjuvant to the existing antibiotics which not only enhance the shelf-life but also slow down the emergence of antibiotic resistance in bacteria.', 31416617),
('Melatonin', 'we uncovered that melatonin disrupted bacterial proton motive force (PMF), which is an essential bacterial energy metabolism substance and is important for conjugative process.', '', '', 34813930),
('Leaf Extract from Musa spp. (AAB Group, Silk Subgroup), cv. "Manzano"', 'Minimum Inhibitory Concentration of 12.5 and 6.25 microgram/mL against susceptible and drug-resistant strains of Mycobacterium tuberculosis', '', 'Our results demonstrate the efficiency and selectivity of Musa spp. AAB, cv. "Manzano" against MTB strains and support its traditional use as remedy against tuberculosis in Maya traditional medicine.', 31268391),
('essential oil from Piper caldense (EOPC)', 'The oil showed activity against C. albicans ATCC 10231 (? 512 microgram/mL) and was able to inhibit hyphae formation, an important mechanism of virulence of C. albicans. On the other hand, EOPC was inactive against all bacterial strains tested (? 1,024 microgram mL). However, when combined with Norfloxacin at subinhibitory concentration EOPC reduced the Norfloxacin and Ethidium bromide MIC values against S. aureus strains SA1199B, K2068 and K4100.', '', 'Chemical composition and potentiating action of Norfloxacin mediated by the essential oil of Piper caldense C.D.C. against Staphylococcus aureus strains overexpressing efflux pump genes.', 34052872),
('Fusaricidins cyclic lipopeptides (CLP), CLP 2605-4 and CLP 2612-8.1', 'Both CLPs were able to reduce bacterial counts by approximately 3 log CFU/g by the last assessment day.', '', 'New treatment strategies are needed that will help in both stimulating the wound healing process, as well as preventing and eliminating bacterial wound infections.', 34367114),
('Lactophoricin-I (LPcin-I), found in the proteose peptone component-3 (PP3; lactophorin) of bovine milk', 'shows the minimal inhibitory concentration (MIC) value of YK5. against L. innocua, S. aureus, P. aeruginosa, S. typhimurium, and E. coli in the range of 5.0-12.0 microM.', '', 'Naturally derived antibacterial peptides exhibit excellent pharmacological action without the risk of resistance, suggesting a potential role as biologicals.', 33918526),
('tyrocidine A (Tyrc A) and gramicidin S (GS)', 'Intriguingly, antibacterial mechanism studies revealed that, rather than the ''pore forming'' model that possessed by Tyrc A, peptide 8 likely diffuses membrane in a ''detergent-like'' manner.', '', 'Naturally occurring cyclic antimicrobial peptides (AMPs) such as tyrocidine A (Tyrc A) and gramicidin S (GS) are appealing targets for the development of novel antibiotics.', 33991963),
('berberine-derived azolyl ethanols', 'Preliminary mechanistic explorations suggested that the excellent antibacterial potential of molecules 4d and 18b might be attributed to their ability to disintegrate membrane, accelerate ROS accumulation, reduce bacterial metabolism, and intercalate into DNA groove.', '', 'Natural berberine-derived azolyl ethanols as new structural antibacterial agents were designed and synthesized for fighting with dreadful bacterial resistance.', 34964345),
('Natural berberine-hybridized benzimidazoles', 'Preliminary mechanism studies revealed that the active molecule 7d could damage the membrane integrity, stimulate ROS generation, and bind with DNA as well as S. aureus sortase A, thus exerting powerful antibacterial ability.', '', 'Natural berberine-hybridized benzimidazoles as potential antibacterial agents were constructed to treat Staphylococcus aureus infection in the livestock industry.', 34228443),
('4-methoxybenzoic acid from Seagrass Halodule pinifolia (Miki) Hartog', 'It showed an effective inhibition of bacterial growth and was considered as a lead molecule with minimum inhibitory concentration (MIC) of 62.5 microgram/mL) against Pseudomonas aeruginosa', '', 'The present findings suggests that seagrasses may act as a newer source for the marine based drug discovery and the lead compound 4-MBA derived from H. pinifolia may act as anti-infective agent against P. aeruginosa as it controls the QS-mediated virulence production.', 32711114),
('Water soluble Curcumin', 'The MIC of sCur against Gram-positive and Gram-negative MDR isolates was 32 and 64 microgram/ml', '', 'This work shows that the soluble curcumin can be used to enhance the action of existing antimicrobials against both Gram-positive and Gram-negative bacteria', 32848171),
('Pentagalloyl glucose (PGG) from Schinus terebinthifolia', 'PGG inhibited growth of both carbapenem-resistant Acinetobacter baumannii and susceptible A. baumannii (MIC 64-256 microgram/mL), and also exhibited activity against Pseudomonas aeruginosa (MIC 16 microgram/mL) and Staphylococcus aureus (MIC 64 microgram/mL).', 'A mammalian cytotoxicity assay with human keratinocytes (HaCaTs) yielded an IC50 for PGG of 256 microgram/mL.', 'Pentagalloyl glucose from Schinus terebinthifolia inhibits growth of carbapenem-resistant Acinetobacter baumannii', 32948818),
('Eleutheroside K (ETSK) from Acanthopanax henryi (Oliv.)', 'The MIC values of ETSK against eight clinical S. aureus strains were all 50 microgram ml-1 . At sub-inhibitory concentrations, a synergistic effect between oxacillin (OXA) and ETSK was confirmed.', '', 'Results based on our study verified that ETSK significantly suppressed MRSA infections and emphasized the potential application of ETSK as a novel anti-MRSA natural drug.', 32955753),
('baicalin from Scutellariae radix', 'The results show that baicalin diminished a plenty of important virulence factors in P. aeruginosa, including the Type III secretion system (T3SS).', 'Baicalin treatment reduced the cellular toxicity of P. aeruginosa on the mammalian cells and attenuated in vivo pathogenicity in a Drosophila melanogaster infection model.', 'Therapeutics that target the virulence of pathogens rather than their viability offer a promising alternative for treating infectious diseases and circumventing antibiotic resistance.', 33801847),
('sorafenib derivative, SC5005', '', 'no significant haemolysis or release of LDH from human HT-29 cells was detected.', 'SC5005 is a promising lead compound for developing new therapies for biofilm-related infections caused by S. aureus.', 33855344),
('5% maltodextrin, 1% sodium chloride, 42% citric acid, 18% sodium citrate, 10% silica, 12% malic acid, 9% citrus extract and 3% olive extract', 'Minimum sub-inhibitory concentrations were determined for Campylobacter jejuni (0.25%), Salmonella enterica (0.50%) and Clostridium perfringens (0.50%) required for the in vitro infection assays with MDCK cells.', '', 'The present study describes for the first time that mixtures of natural antimicrobials can prevent the formation of substrates used by bacterial pathogens to grow and survive in anaerobic environments', 34099034),
('quaternary ammonium chitosan derivative, N,N,N-trimethyl chitosan chloride (TMC) with inherent bactericidal property was synthesized and complexed with povidone?iodine (PVP-I)', 'TMC5/PVP-I was significantly effective against multidrug-resistant bacteria S. aureus compared with PVP-I alone. TMC/PVP-I solutions also showed fungicidal property against C. albicans', '', 'with no cytotoxic effects when tested against human fibroblast cells cultured in vitro.', 34051260),
('water-soluble curcumin derivative (Curaq)', 'Only nine (9.4%) Klebsiella isolates were sensitive to meropenem; however, after synergising with Curaq (8 microgram/mL), 85 (88.54%) hvKP isolates became sensitive to the drug.', '', 'A water-soluble curcumin derivative (Curaq) was synthesised, employing a Cu (I) catalysed 1, 3-cyclo addition reaction; it has been evaluated as a potential treatment for multidrug-resistant isolates and as an antibiotic adjuvant for meropenem against hypervirulent multidrug-resistant Klebsiella pneumoniae isolates.', 33916608),
('epicarp extracts of the Malaysian cultivar of yellow rambutan fruit (Nephelium lappaceum L.)', 'Among a series of solvent extracts, fractions of ethyl acetate and acetone have revealed significant activity towards six pathogens tested namely, Bacillus subtilis, methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pyogenes, Pseudomonas aeruginosa, Klebsiella pneumoniae and Salmonella enterica. .', '', 'Chemical profiling of these fractions, via HPLC, LC-MS and GC-MS, has generated a library of potentially bioactive compounds.', 34226594),
('Onosma chitralicum (EtoAc fraction )', 'Compounds 1 (4'',8-dimethoxy-7-hydroxyisoflavone), 6 (5,3'',3-trihydroxy-7,4''-dimethoxyflavanone), and 7 (5'',7,8-trihydroxy-6,3'',4''-trimethoxyflavanone) were found to be more active against Staphylococcus aureus and Salmonella Typhi. Compound 1 inhibited S. typhi and S. aureus to 10 ? 0.21 mm and 10 ? 0.45 mm, whereas compound 6 showed inhibition to 10 ? 0.77 mm and 9 ? 0.20 mm, respectively. Compound 7 inhibited S. aureus to 6 ? 0.36 mm.', '', 'Compounds 6 and 7 showed significant antibacterial potential, and the structure-activity relationship also justifies their binding to the bacterial enzymes, i.e., beta-hydroxyacyl dehydratase (HadAB complex) and tyrosyl-tRNA synthetase.', 33918531),
('Brazilian green and red propolis', 'ERP was more effective by displaying MIC and MBC values <100 microgram mL-1 . Compounds 8 and 9 displayed the lowest MIC values (0.98 to 31.25 microgram mL-1 ) against all tested Gram-positive MDRB. They also inhibited the biofilm formation of S. aureus (ATCC 43300 and clinical isolate) and S. epidermidis (ATCC 14990 and clinical isolate), with MICB50 values between 1.56 and 6.25 microgram mL-1', '', 'Compounds 8 and 9 have great antimicrobial potential. © 2021 Wiley-VHCA AG, Zurich, Switzerland.', 34086414),
('Elaiophylin, derived from Streptomyces hygroscopicus', 'Elaiophylin presented a MIC of 0.5 microgram/mL against the SA-1199 (wild-type) and SA-1199B (NorA over-expressed) strains', '', 'Compounds capable of inhibiting the efflux pump mechanism are a promising alternative against bacterial resistance because, when combined with antibiotics, they can increase the effectiveness of these drugs by inhibiting active efflux.', 34425202),
('silver nanoparticles (AgNPs) from an aqueous extract of Juniperus excelsa', 'The minimum inhibitory concentrations (MICs) of the AgNPs against the tested MDR bacteria ranged from 48 to 56 microgram/ml, while the minimum bactericidal concentrations (MBCs) of the AgNPs against the tested strains ranged from 72 to 96 microgram/ml.', '', 'Consequently, we can use AgNPs with Cefaclor, Cefoxitin, and Erythromycin antibiotics as alternative antimicrobial agents, and they could be utilized in wound dressing to prevent microbial infections. © King Abdulaziz City for Science and Technology 2021.', 33987072),
('Loxostylis alata leaf extract', 'Extracts had low to moderate MIC values from 0.04 to 2.5 mg/mL.', 'Cytotoxicity values ranged from 0.02 to 0.47 mg/mL, while tested extracts were not genotoxic.', 'Extracts of L. alata are promising candidates for development of antimicrobial preparations or food additives against microbial contamination.', 33849505),
('Rumex abyssinicus Jacq. (Polygonaceae)', 'MIC = 8-256 microgram/mL', '', 'Graham is a consultant for RedHill Biopharma and Phathom Pharmaceuticals regarding novel H. pylori therapies and was the PI on the clinical trial from which the data were derived.', 34090405);
INSERT INTO `bacteria_naturalproduct` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Peucedanum ostruthium extracts', 'The extracts H and E show the same effect on both the M. smegmatis wild type and ?lfrA mutant (MIC of 31.25 mg/L).', '', 'Natural compounds have the potential to increase antibiotic effectiveness due to their resistance modulatory and antimicrobial effects.', 34572657),
('29 plant essential oils', 'We found that 25 essential oils possessed antibacterial activity against Escherichia Coli ATCC 25922 and methicillin-resistant Staphylococcus aureus (MRSA) 43300 with MICs that ranged from 0.01% to 2.5% v/v.', '', 'Synergistic combinations for antimicrobial therapies can be a good strategy for the treatment of multidrug resistant infections.', 33923861),
('gamma-glutamyl-S-allyl-cysteine (fraction 18), gamma-glutamyl-phenylalanine (fraction 20), and the two stereoisomers (E and Z) of ajoene FROM gARLIC', 'The MICs of these fractions were 5.41 mg/ml, 4.60 mg/ml, and 0.16 mg/ml, respectively, against Streptococcus agalactiae', '', 'The strategy recommended by the Centers for Disease Control to reduce neonatal GBS infection is the culture-based screening of all pregnant women at 35 to 37 weeks of gestation and intrapartum antibiotic prophylaxis (IAP).', 34817207),
('Solanum granuloso-leprosum (Dunal)', 'All the strains tested were susceptible to granulosain I with MIC from 156.25 to 312.5 microgram/mL and MBC from 312.5 to 625 microgram/mL, respectively against Helicobacter pylori.', 'Besides, granulosain I and RAP did not show toxicological effects at the concentrations studied.', 'Treatment of H. pylori infection includes antibiotics and proton pump inhibitors, but the increasing antibiotic resistance promotes the research of novel, more effective, and natural antibacterial compounds.', 34977105),
('Essential oil from Cerrado plants', 'MIC of 7.80 microgram?mL?1 against multi?resistant Staphylococcus sp. 841', '', 'The essential oil from Cerrado plants proved active against resistant Gram-positive and Gram-negative bacteria, revealing their potentialities for the development of new alternative agents to prevent the spreading of resistant bacterial contamination.', 32708062),
('Azadirachta indica, Moringa oleifera, Murraya koenigii, and Psidium guajava extracts', 'The preliminary antimicrobial study showed pet. ether extract of A. indica and ethanolic extract of P. guajava showed a MIC value of 125 microgram/mL and MBC value of 500 microgram/mL.', 'These extracts showed biofilm inhibition in the range of 60.0-83.9 % and did not possess any hemolytic activity to the human erythrocytes.', 'Our present study, Azadirachta indica, Moringa oleifera, Murraya koenigii, and Psidium guajava extracts were investigated against MRSA.', 32995315),
('Cannabidiol from cannabis', 'It shows a strikingly consistent MIC of 1?4 microgram mL?1 against a diverse range of over 20 types of Gram-positive bacteria, including multiple strains of the key pathogens MRSA, multidrug-resistant (MDR) Streptococcus pneumoniae, Enterococcus faecalis, and the anaerobic bacteria Clostridioides (previously Clostridium) difficile and Cutibacterium (previously Propionibacterium) acnes', '', 'Structure-activity relationship studies demonstrate the potential to advance cannabidiol analogs as a much-needed new class of antibiotics.', 33469147),
('Spirulina (Arthrospira) platensi and sucrose ester SP 70', '', 'Formulations containing SP 70 surfactant with TC showed the most favorable dissolution profiles and were found to be nontoxic.', 'Natural products used in the treatment of acne vulgaris may be promising alternative therapies with fewer side effects and without antibiotic resistance.', 33096785),
('Essential Oil of Acritopappus confertus', 'it was verified that the A. confertus oil did not present direct antibacterial activity against most of the standard and multidrug-resistant strains tested, presenting a MIC above 512 microg/mL. However, an exception was observed against the standard strain S. aureus ATCC 25923, where the oil had a MIC of 256 microg/mL.', '', 'It can be concluded that the essential oil of A. confertus has potential against pathogenic fungi and bacteria, making it a target for the development of an antimicrobial drug.', 36297389),
('two naturally small molecules gallic acid (GA) and diammonium glycyrrhizinate (DG) - GAD hydrogel', 'GAD hydrogel promoting Staphylococcus aureus (S. aureus)-infected wound healing.', '', 'GAD hydrogel had broad antibacterial efficiency against both Gram-positive and Gram-negative bacteria. Taken together, GAD hydrogel is a promising dressing to accelerate bacterial-infected wound healing through reconstructing an intact and thick epidermis without antibiotics or cytokines.', 36442387),
('Novel two-peptide lantibiotic produced by Vagococcus fluvialis LMGT 4216 isolated from fermented maize.', 'The increased tolerance to vagococcin T of four randomly selected spontaneous mutants of E. faecium was tested and showed a 64- to 256-fold increase in the MIC compared to that for the wild type', 'GRAS (generally regarded as safe) status and have high potency and low toxicity', 'Vagococcin T is the first bacteriocin characterized from the genus Vagococcus. Bacteriocins are a promising alternative to traditional antibiotics, as they display activity against antibiotic-resistant pathogens (Enterococcus faecium) and have many desirable properties for the control of microorganisms.', 35730941),
('Anatolian honey bee venom (HBV)', 'The results of MIC values were varied from 3.06 microg/mL to 50 microg/mL for the tested microorganisms. It was found that Mycobacterium smegmatis and Streptococcus pyogenes were the most susceptible bacteria (3.06 microg/mL), followed by Vibrio sp., Aeromonas sobria, Enterococcus faecalis, Listeria monocytogenes, Staphylococcus aureus (MRSA) and B. subtilis with a MIC concentration of 6.125 microg/mL.', '', 'The activity of the Anatolian HBV sample against these microorganisms was determined by the agar well diffusion method, then their zones were measured. These findings strongly suggest that Anatolian HBV will be developed as a new antibacterial-antifungal drug against Gram-positive, Gram negative and antibiotic-resistant bacteria and yeast-like fungi.', 35421436),
('Indonesian Mangrove Sonneratia caseolaris Leaves Ethanol Extract ( Other species- Sonneratia caseolaris, Avicennia marina, Rhizophora mucronata, and Rhizophora apiculata)', 'An antioxidant activity assay showed comparable activity when compared to ascorbic acid, with an IC50 value of 4.2499 ', 'Based on the toxicity criterion, all extracts demonstrated non-lethality with LC50 of >1500 ppm, which might indicate the degradation of phytochemicals over time', 'Further research is needed to elucidate the interaction of the main compounds in S. caseolaris leaves extract in order to confirm their potential either as single or two or more compounds that synergistically function as a nontoxic antioxidant and antibacterial against MRSA.', 36500458),
('silver and gold NPs (SNPs and GNPs, respectively)', 'The MIC values (microg/ml) of the 10-nm SNPs and 20-nm GNPs against B. melitensis were 22.43 ', 'SNPs and GNPs at doses below 2 mg/kg were not harmful to rat tissue according to organ histopathological examinations. However, a greater dose of NPs (2 mg/kg) harmed all of the tissues studied.', 'The bactericidal properties of NPs are demonstrated in this work. Brucella strains develop similar resistance to SNPs and GNPs, and at low dosages, neither SNPs nor GNPs were hazardous to rats.', 35834538),
('The extracts of olive leaf (E1= highly hydrophilic compounds such as hydroxytyrosol and hydroxytyrosol glucosides (14,708 mg/100 g) and E2= moderately hydrophilic compounds, with oleuropein (20,471 mg/100 g) )', '. MIC values for E1 ranged between 1', '', 'Hydroxytyrosol was the main compound responsible, causing the inhibition of growth of Campylobacter strains at low concentrations (0.1-0.25 mg/mL). E2 demonstrated a lower antibacterial effect than E1, reducing growth from 0.52 to 2.49 log CFU/mL. The results of this study suggest that the optimization of the composition of olive-leaf extracts can provide improved treatment results against Campylobacter strains.', 36671227),
('antimicrobial activity of Polyalthia longifolia plants harvested from Cameroon', 'Our results revealed that the tested extracts possess important antimicrobial activities, notably against Gram positive bacteria (MICs as low as 0.039 mg/mL). The extracts showed a synergistic antibacterial activity in combination with penicillin against a MRSA clinical isolate and significantly inhibited S. aureus biofilm formation.', '', 'The mechanism of action is related to the impairment of cell membrane integrity and cell lysis. All these findings suggest that P. longifolia could be an important source of reliable compounds used to develop new antimicrobials.', 36296219),
('novel conjugated ultrashort antimicrobial peptide. The peptide named naprolyginine', 'Naprolyginine managed to inhibit the growth of gram-positive reference S. aureus and MRSA at MIC values of 8 and 15 microM, respectively. Naprolyginine managed to inhibit gram-negative E. coli (ATCC 25922) and ESBL E. coli (ATCC BAA-3054) with MIC values of 18 microM and 25 microM, respectively.', 'the peptide was evaluated for its hemolytic activity against human red blood cells and displayed negligible toxicity.', 'Our results displayed that the peptide exhibits potent synergistic antimicrobial activity against resistant strains of gram-positive and gram-negative bacteria when combined with individual antibiotics. Naprolyginine could prove to be a promising candidate for antimicrobial drug development.', 36704429),
('Use of Vitex doniana (black plum) and Abutilon hirtum (Florida keys) extracts as an integral part of phytomedicine', 'Activity was detected from both plant extracts with MICs of extracted fractions ranging from 150 - 300 microg/mL. Interestingly both plants produced extracts with bactericidal activity from 300 - 600 microg/mL. V. doniana exhibited better activity against the resistant Salmonella strains in terms of greater inhibition zones, but A. hirtum extracts were more consistently active against all isolates.', '', 'Nigeria needs better anti-salmonella products and these results represent a starting point for antibiotic drug discovery.', 36099376),
('Unique coumarin aminophosphonates', '3-hydroxylphenyl aminophosphonate 6f show excellent anti S. aureus activity with MIC = 0.001 Mm', '', 'Molecule * 6f exerted low toxicity, no obvious resistance and good bioavailability. Compound 6f could disturb the membrane integrity and lead to the leakage of intracellular materials and Compound 6f could induce oxidative damage and restrain metabolism.', 36343412),
('synergy between a combination of terpinen-4-ol and alpha-terpineol (10:1)', 'alpha-terpineol was slightly more efficient than terpinen-4-ol on the Gram-negative Escherichia coli, with respective MICs of 0.15', '', 'our data demonstrate that the combination of terpinen-4-ol and alpha-terpineol might be a precious weapon to address ESKAPE pathogens.', 36364298),
('ocotillol-derived lactone compound', 'ocotillol-derived lactone Compound 6d, which exhibited broad antibacterial spectrum, was found to be the most active with minimum inhibitory concentrations (MICs) of 1', 'compound 6d was membrane active and low toxic against mammalian cells', 'ADME- absorption, distribution, metabolism, and excretion properties of this type of compounds have shown drug-likeness with good oral absorption and moderate blood', 34661800),
('protocatechualdehyde (PCA) extracted from the roots of Salvia miltiorrhiza', 'The MICs and MBCs of PCA against tested Y. enterocolitica strains have, MICs ranged from 0.30 to 0.60 mg/mL. It was noting that PCA at 2.40 mg/mL visibly exerted the potent bactericidal action against all strains of Y. enterocolitica', 'Toxic oral dose of 500 mg/kg in mice is known to cause depletion of glutathione in liver and kidney but no mortality. Due to low absorption by oral route, PCA is a nontoxic and a relatively safe compound for oral administration', 'PCA could significantly reduce biofilm formation and suppress the swarming motility of R. solanacearum. the bacteriostatic mechanisms of PCA were evaluated by monitoring changes in membrane potential, intracellular ATP, membrane integrity, intracellular reactive oxygen species and bacterial morphology', 36371064),
('modifying the structural parameters of a natural chickpea-derived AMP-Leg2, termed "functionalized chickpea-derived Leg2 antimicrobial peptides" (FCLAPs)', 'FCLAPs showed potent broad-spectrum antibacterial activity, with MICs in the range of 2.5', '', 'Among the FCLAPs, KTA (RIKTATWRLALRWLKL) and KTR (RIKTRTWRLALRWLKL) showed superior antibacterial potency both in vitro and in vivo. Their findings suggest that KTA and KTR represent promising sources of antibacterial candidates that could aid efforts to fill the drug discovery pipeline as a defense against Gram-negative foodborne bacteria.', 36563134),
('Diosgenin is a naturally occurring steroidal saponin', 'the antimicrobial activity of diosgenin against the standard and multidrug-resistant bacteria of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus,', '', 'Antimicrobial activity against efflux pump-bearing strains revealed that saponin did not interfere with the efflux pump mechanism or intervened antagonistically. Thus, saponin has shown to be very promising against bacterial resistance in association with aminoglycoside, fluoroquinolones and beta-lactam,', 36122765),
('combination of paeoniflorin and norfloxacin', 'FIC results showed that paeoniflorin and norfloxacin exert a synergistic bactericidal effect. Evidence was brought that paeoniflorin reduces the Streptococcus suis', '', 'paeoniflorin can inhibit biofilm formation, thereby promoting the ability of norfloxacin to kill S. suis. Finally, we showed in a mouse model that paeoniflorin in association with norfloxacin is effective to treat S. suis infections.', 36173390),
('endophytic actinobacteria were isolated from Citrullus colocynthis plant', 'had antagonist activity against S. aureus, P. aeruginosa, and E. coli.', '', 'This study reveals the future of new antibiotic developments looks bright against multi-drug resistance', 36217205),
('novel amphiphilic xanthohumol derivative derived from the hop plant, Humulus lupulus L. (Cannabaceae)', 'reported to possess good antibacterial activity [minimum inhibitory concentration (MIC) against S. aureus strains: range 15.6', '', 'Bioactivity evaluation showed that amphiphilic xanthohumol derivative IV15 not only displayed remarkable antibacterial activity against both S. aureus ATCC 29213 and clinical MRSA strains (MICs: 1', 36584344),
('lignin extracted from sugarcane and sorghum bagasse', 'These analyses showed that lignin damages the S. aureus cell membrane, causes increased cell clustering, and inhibits growth synergistically with tunicamycin, a teichoic acid synthesis inhibitor.', 'Although lignin displayed no measurable cytotoxicity against human epidermal keratinocyte (HEK) cells at the concentrations used in these experiments', 'future studies investigating the use of lignin as a topically applied antibiotic adjuvant for treatment of S. aureus skin and soft tissue infections, potentially also in livestock.', 35852361),
('Conjugated alkyne oligomers (e. g., polyynes, polyacetylenes) are widely represented within natural products (NPs) as diynes, triynes, tetraynes, and even polycyclic compounds.3', 'Dodeca-2,4-diyn-1-ol 2dA, the non-specific compound between E. coli and P. fluorescens had a greater efficacy than the specific 2aC, again demonstrating compound specificity.', '', 'the implementation of a mixed synthetic approach utilizing both solid-supported and solution-based chemistries allowed for the rapid synthesis of a series of diyne compounds and their consequent screening for antibiotic activity', 36194525),
('novel BRICHOS-related beta-hairpin antimicrobial peptides were identified in transcriptomes of marine polychaeta species. Two of them-abarenicin from Abarenicola pacifica and UuBRI-21 from Urechis unicinctus-possess', 'Rational design based on individual hydrophobic amino acid substitutions in the structure of abarenicin-1 led us to Ap9 (Y8A, M9R) and Ap11 (Y8A, M9R, V13A) analogs with an enhanced bacterial cell selectivity. Ap9 demonstrated a promising efficacy in E. coli infection in vivo models', '', 'In summary, the abarenicin analog Ap9 is a new attractive drug candidate treatment of diseases caused by Gram-negative bacterial pathogens.', 36005520),
('Penicilazaphilone C (PAC), was isolated from a marine-derived fungus.', 'time-kill assays verified that PAC is a fast and efficient bactericidal agent. PAC significantly influences over 898 proteins in Escherichia coli. It has displayed broad bactericidal activities against Gram-negative and Gram-positive bacteria.', '', 'the mode of PAC action against E. coli was to block respiration, inhibit assimilatory nitrate reduction and dissimilar sulfur reduction, facilitate assimilatory sulfate reduction, suppress cysteine and methionine biosynthesis, down-regulate antioxidant protein expression and induced intracellular ROS accumulation, weaken bacterial chemotaxis, destroy flagellar assembly, etc., and finally cause the bacteria''s death. There findings suggest that PAC could have a multi-target regulatory effect on E. coli and could be used as a new antibiotic in medicine.', 36179970),
('Cinnamomum verum Essential Oil with Sertraline', 'Enterococcus faecalis ATCC 29212 and Enterococcus faecalis MIC value of sertraline was found to decrease from 16.0 (MICo) to 0.5 (MICc) microg/mL (FICI = 0.08) and from 32.0 (MICo) to 1 (MICc) microg/mL (FICI = 0.08), respectively. Furthermore, a promising result was also obtained against Acinetobacter baumannii ATCC 19606, a Gram-negative bacillus resistant to treatment with different antibiotics. In this case, a 32-fold reduction in sertraline MIC (FICI = 0.08) was observed when used in combination with EO too. The strong synergy observed between sertraline and the EO against the Gram-negative Pseudomonas aeruginosa ATCC 27853 (FICI = 0.11) and Klebsiella pneumoniae ATCC 19833 (FICI = 0.43)', '', 'he data reported in this study underline that in vitro CEO possesses a decisive and strong action towards a large panel of bacteria in association with sertraline, a selective serotonin reuptake inhibitor whose antibacterial activity has been successfully confirmed. The sertraline-CEO association resulted in a very strong synergistic mode of action for all Gram-positive and Gram-negative strains tested', 36421261),
('natural marine fungus extracted compounds.', 'The most superior compound was elipyrone A with six hydrogen bonds, -8.5 of binding affinity, and preferable results in the SWISS-ADME examination against Neisseria gonorrhoeae bacteria', '', 'our effort to predict a new natural compound to overcome the resistance of this bacteria.', 36091725),
('Andrographolide and 4-Phenylbutyric Acid', 'Andrographolide and 4-Phenylbutyric Acid Administration Increase the Expression of Antimicrobial Peptides Beta-Defensin-1 and Cathelicidin and Reduce Mortality in Murine Sepsis', '', 'They have shown that these compounds reduce mortality in a murine model of sepsis caused by a carbapenem-resistant Klebsiella aerogenes isolate. From our point of view, these small molecules are promising candidates for further study as potent AMP inducers. The data obtained allow the development of new strategies to combat antibiotic resistance and infectious diseases.', 36421273),
('carvacrol (CAR), a phenolic compound of essential oils', 'MIC values for S. mutans and for S. sanguinis were found both visually and spectrometrically in the concentration 0.1% (93.4 microg/mL), while the MBC value corresponded to 0.39% (373.4 microg/mL). The essential oils that contain CAR have shown antimicrobial activity against both Gram-positive and Gram-negative bacteria . The MIC ranges found for CAR vary between 250 and 2500 microg/mL depending on the microorganism and the experimental conditions', '', 'CAR as an excellent alternative agent to safely prevent periodontal diseases. Thus, CAR could be used preventively in mouthwashes or biomaterials, or in treatments to avoid existing antibiotic resistance.', 36557293),
('conventional antibiotics and plant-derived compounds (Selective Combinatory Effect of Ciprofloxacin with Nitroxoline, Sanguinarine, and Zinc Pyrithione)', 'For the combination of ciprofloxacin with nitroxoline, several synergistic interactions were observed for all five standard diarrheagenic bacteria tested, with FICI values ranging from 0.094 to 0.477. The strongest synergy (FICI, 0.094) was obtained against L. monocytogenes at a nitroxoline concentration of 0.25 microg/mL, when a 13-fold ciprofloxacin MIC decrease was achieved (from 1.333 to 0.104 microg/mL). the highest ciprofloxacin MIC reduction was observed for V. parahaemolyticus, where the nitroxoline concentration of 1 microg/mL caused a 16-fold reduction of ciprofloxacin MIC from 0.125 to 0.008 microg/mL, with a FICI of 0.313. The combination of ciprofloxacin-sanguinarine exerted a growth-inhibitory interaction against the five diarrhea-causing pathogens tested, with the synergistic effect ranging between FICI values of 0.134 and 0.5. combination of ciprofloxacin with zinc pyrithione produced a synergistic antimicrobial effect (FICI ranging from 0.071 to 0.5) against all the pathogenic bacteria. The strongest synergistic activity with a FICI value of 0.071 was achieved against S. flexneri at a zinc pyrithione concentration of 0.125 microg/mL, when a 17-fold ciprofloxacin MIC decrease was attained (from 0.083 to 0.005 microg/mL)', '', 'Metal ion cofactors (e.g., magnesium ion) are known to substantially affect the biological properties of topoisomerases. sanguinarine may also enhance the intracellular penetration of ciprofloxacin because it has been observed that the permeability of the bacterial cell membrane increases in the presence of this alkaloid. In summary, the present study has demonstrated that combinations of ciprofloxacin with nitroxoline, sanguinarine, and zinc pyrithione produce an antibacterial synergistic effect against diarrhea-causing bacteria, namely, B. cereus, E. faecalis, L. monocytogenes, S. flexneri, and V. parahaemolyticus, and, simultaneously, has showed antagonistic action toward gut beneficial strains of bifidobacteria, such as B. adolescentis, B. animalis subsp. Lactis, and B. breve.', 35972279),
('Ginkgo biloba exocarp extract (GBEE)', 'GBEE supernatant liquid inhibited the growth of S. epidermidis, S. haemolyticus, and E. faecium at shallow concentrations with minimum inhibitory concentrations (MICs) of 2 microg/ml, 4 microg/ml and 8 microg/ml, respectively.', '', 'Ginkgo biloba exocarp extract (GBEE) has the functions of unblocking blood vessels and improving brain function, as well as antitumour activity and antibacterial activity. GBEE has an excellent antibacterial effect on gram-positive bacteria and also inhibits the growth of gram-negative bacteria, such as A. baumannii (carbapenem-resistant Acinetobacter baumannii) CRABA and S. maltophilia. GBEE inhibits the biofilm formation of S. haemolyticus by altering the regulation and biofilm material-related genes, including the release of eDNA and cell-surface binding proteins.', 36030030),
('Extracts of Plant Used in Mexican Traditional Medicine( selected plants are rosemary, estafiate, rue, epazote, mint, toloache, ajenjo, and thyme)', 'Our results demonstrate that rosemary MIC 0.13 mg/mL, mint MIC 0.46 mg/mL, and estafiate extracts significantly inhibit C. difficile strains, comparable with vancomycin. All the extracts decreased the motility of bacteria by 40%, but the thyme MMIC 0.49 mg/mL and ajenjo MIC 0.48 mg/mL extracts were the best extracts to block the adherence of bacteria. The rue MIC 0.5 mg/mL extract is the best extract to inhibit the sporulation of strains.', '', 'We found that thyme, ajenjo, and mint were the most effective against the isolates. We identified that the extracts affected protein synthesis. In addition, the extracts affect the strains'' motility, and some, such as thyme extract, affect adherence, whereas rue extract affects sporulation. These results led to the identification of new compounds beneficial to CDI treatment. However, none of the extracts affected germination.', 35890019),
('Novel Fusidic Acid Cream Containing Metal Ions and Natural Products', 'numbers (9.5%) of fusidic-acid-resistant Staphylococcus aureus (FRSA) isolates possessed a high resistance pattern with MIC = 128 microg/mL. In contrast, most tested FRSA isolates (90.5%) had a low resistance pattern with MIC = 8 microg/mL.', '', 'In conclusion, the F2 cream made with fusidic acid, oleuropein, thyme oil, zinc sulfate, and copper sulfate in the right amounts has stable physical and chemical properties and has potential against FRSA as an antimicrobial agent.', 36015264),
('a marine actinomycete Nocardiopsis sp. HB-J378', 'Nocardiopsistin D (Compound 1 C21H13O6Br) was found to have potent activity against two strains of vancomycin-resistant S. aureus (VRSA; 170 and 522) with MICs of 0.031 microg/mL against each strain. 1 also exhibited potent activity against Enterococcus faecium and Bacillus cereus with MICs of 0.031 and 0.063 microg/mL, respectively, compared to >50 and 12.5 microg/mL for nocardiopsistin A', '', 'The single bromination in Nocardiopsistin D - 1 drastically enhanced the anti-MRSA activity by 128-fold without altering cell toxicity and acquired new activities against the bacterial pathogens vancomycin-resistant S. aureus (VRSA), Enterococcus faecium, and Bacillus cereus.', 36269561),
('polyphenolic glycosides, including thirteen new derivatives isolated from the stems of Caesalpinia cucullata,', 'Derivative effectively reduce the dose of ceftiofur in combination in vitro with fractional inhibitory concentration index (FICI) ranging from 0.188 to 0.375 effect on methicillin-resistant Staphylococcus aureus, which meant polyphenolic glycosides have got antibacterial activity with different ways.', '', 'The results indicated that polyphenolic glycosides could be used as promising therapeutic agents to prevent resistance development for S. aureus infections. All compounds exhibited weak to moderate SrtA inhibitory activity. Molecular docking revealed the interactions of active compounds with SrtA enzyme.', 36242982),
('colistin/resveratrol combination', 'The MICs of colistin for the 8 P. aeruginosa strains were measured at 8 to 64 microg/mL, and 75% (6/8) of these strains exhibited MDR phenotypes ans alone resveratrol displayed no antimicrobial activity against these colistin-resistant P. aeruginosa strains (MIC >512 microg/mL) but in combination MIC of colistin exhibited a significant (8 to 16-fold) decrease in the presence of resveratrol, and the FICI of the 8 P. aeruginosa ranged from 0.25 to 0.38 (synergy).', 'the combination of colistin (2 microg/mL) and resveratrol (16, 32 microg/mL) showed a high survival rate at 90 to 100% within 168 h, it was significantly higher than that of the control group and the monotherapy group therapy (P < 0.05) in G. mellonella model', 'In conclusion, our results may provide an efficient alternative pathway against colistin-resistant P. aeruginosa infections. Resveratrol, a naturally occurring polyphenolic antioxidant, can effectively slow down or avoid the occurrence and development of bacterial resistance. In this study, colistin/resveratrol combination could synergistically damage the bacterial cell membrane, thereby inducing cell lysis while addressing the emergence of drug resistance. Moreover, this combination therapy may provide an efficient alternative pathway to combat the colistin-resistant P. aeruginosa in clinical practice.', 36475724),
('loaded plant essential oils (PEOs) into lab-made CaSO4 beads', 'All of the PEOs tested demonstrated significant growth inhibitory activity against planktonic S. aureus when comparing zones of inhibition ZOIs to a null hypothesis of 6 mm (disk size and LOD), except for neroli and wintergreen. Most notably, cilantro PEO exhibited full growth inhibition of S. aureus in all replicates', '', 'six of the significantly active PEO-beads had relatively/consistently high activity compared to all others, including arborvitae (17.4 mm), balsam fir (19.2 mm), cassia (21.8 mm), cinnamon bark (20.7 mm), grapefruit (17.6 mm), and oregano (15.28 mm), and these may represent the best candidates for additional study and optimization for use in beads. To the best of knowledge, this is the first time in which a large set of single plant PEOs have been demonstrated to exhibit growth inhibition of S. aureus in vitro when infused in CaSO4 beads.', 35802739),
('extract of B. monnieri leaves and its bioactive molecules', 'the methanolic extract of B. monnieri had the highest inhibition zone against both microorganisms (K. pneumoniae and P. mirabilis). Oroxindin was considered as a potential bioactive molecule, it is a flavone or a type of phenolic of B. monnieri, is a potent inhibitor of UTIs, establishing pathogens such as K. pneumoniae and P. mirabilis', '', 'The overall results suggest that Oroxindin from B. monnieri can be a potent inhibitor for the effective killing of K. pneumoniae and P. mirabilis. Additionally, its safety has been established, indicating its potential for future drug discovery and development in the treatment for UTIs.', 35956923),
('Polygonum chinense L.aqueous extract', 'Polygonum chinense L.aqueous extract against S. aureus displayed minimum inhibitory concentration (MIC) of 4 mg/mL and minimum biofilm inhibitory concentration (MBIC) of 16 mg/mL against S. aureus.', '', 'Polygonum chinense L.aqueous extract exerts a potent destruction of the cell wall of S. aureus and a significant inhibitory effect on the formation of S. aureus biofilm. In addition, flow cytometry showed the ability of Polygonum chinense L.aqueous extract to promote apoptosis by disrupting cell membranes of S. aureus. These results suggested that Polygonum chinense L.aqueous is a promising alternative antibacterial and anti-biofilm agent for combating infections caused by planktonic and biofilm cells of S. aureus.', 36539472),
('silver nanoparticles (AgNPs) from Withania somnifera and Fagonia indica', 'AgNPs showed statistically highly significant results against S. pneumonia (AgNPs, 14; crude, 8.33 mm). Crude extract showed significant inhibition against two bacterial strains, P. aeruginosa (crude, 21; AgNPs, 11.67 mm) and K. pneumonia (crude, 11.33; AgNPs, 8 mm)', '', 'In phytotoxic results, crude extracts of both tested plants are more effective as compared to AgNPs. The present study has provided a base for the researcher in the field of nanomedicine to synthesize and check the biological activities of nanoparticles and isolated compounds from other medicinal plants against other microorganisms. New antibiotics and therapeutics in nanoform should be made from these natural products and replaced with those showing resistance to microorganisms.', 36440367),
('Synergistic antibacterial activity of baicalin and EDTA in combination with colistin', 'the combination of baicalin and EDTA also showed a stronger synergistic effect on colistin, reversing the colistin resistance of all Salmonella strains.', '', 'Analysis revealed that baicalin and EDTA enhanced colistin activity through multiple pathways, including accelerating the tricarboxylic acid cycle (TCA cycle), inhibiting the bacterial antioxidant system and lipopolysaccharide (LPS) modification, depriving multidrug efflux pump functions and attenuating bacterial virulence. In conclusion, our study indicates that the combination of baicalin and EDTA as a novel colistin adjuvant can provide a reliable basis for formulating the therapeutic regimen for colistin resistant bacterial infection.', 36493546),
('novel pleuromutilin derivatives with a scaffold of 4(3H)-quinazolinone', 'their in vitro activity against Staphylococcus aureus and Staphylococcus epidermidis as well as Gram-negative bacteria (Escherichia coli and Salmonella enterica subsp. enterica serovar pullorum). . Among this series of pleuromutilin analogues, compound 23 with a structure of 2-mercapto-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one displayed the best in vitro antibacterial activity against MRSA (MIC = 0.063 microg/mL)', 'low cytotoxicity to RAW 264.7 cells (IC50>100 microM)', 'Pleuromutilin, a naturally occurring product with moderate antibacterial activity, has a unique structure that has attracted great efforts to modify its scaffold to obtain lead compounds. Hence this was demonstrated to inhibit MRSA ( methicillin-resistant Staphylococcus aureus) effectively in a mouse thigh infection model', 36462445),
('effect of Gentian violet a triarylmethane dye and Safranin', 'Gentian violet dye has been shown to be 100% sensitive to both Gram-positive and Gram-negative bacterial isolates. Although safranin also had high sensitivity (100%) to S. aureus isolates, its sensitivity to P. aeruginosa was only 20%. Staphylococcus aureus was more resistant to iodine (40% sensitivity) compared to P. aeruginosa, which was 100% sensitive to iodine.', '', 'Gentian violet had good antibacterial activity against both Gram-positive and Gram-negative bacteria, making it useful for treating bacterial skin pathogens such as S. aureus and P. aeruginosa especially for MDR bacteria. While safranin has good efficacy against Gram-positive bacteria (S. aureus), its effect against Gram-negative bacteria (e.g. P. aeruginosa) is poor.', 35921487),
('sulforaphane (SFN)', 'results showed that the SFN against M. tuberculosis H37Ra exhibited bactericidal activity in a time and dose-dependent manner', '', 'SFN promoted the bactericidal effect of macrophages on intracellular bacteria in a dose-dependent manner, mediated by increasing intracellular mitochondrial ROS levels and decreasing cytoplasmic ROS levels. studies focusing on the mechanism of SFN in macrophages against M. tuberculosis are essential for developing new host-directed therapeutic approaches against TB.', 36048328),
('synergistic effect of CUR with imipenem (IMP) and Colistin (CST)', 'In this study, IMP MIC values were significantly reduced (two to eight-fold decrease) in the presence of CUR, and partial synergy was observed. For CST, this value decreased two-fold against Pseudomonas aeruginosa.', '', 'It was concluded CUR-antibiotic combinations can provide an alternative approach in the treatment of infections with MDR bacteria.', 35882691),
('Galloylglucoses', 'They showed minimum inhibitory concentration (MIC) values in the range of 2-256 microg/mL across tested bacterial strains active against different MDR strains of Escherichia coli and Klebsiella pneumoniae.', '', 'These findings have added to the number of known galloylglucoses from P. officinalis and highlight their potential against MDR Gram-negative bacteria. The observed antibacterial activities of galloylglucoses are related to their previously reported ability to interact with proteins, carbohydrates, lipids, and metal ions . The compounds characteristically bind to different macromolecules through hydrophobic interactions, as well as via hydrogen, covalent, and ionic or electrostatic bonds', 35956993),
('Pecan (Carya illinoinensis) and Chestnut (Castanea sativa) flowers', 'Anti-quorum sensing (anti-QS), anti-biofilm, and anti-swarming (SW) activities were also studied against Chromobacterium violaceum ATCC 31532, Chromobacterium violaceum ATCC 12472, and Pseudomonas aeruginosa PA01, respectively. . Both extracts were rich in ellagic acid and gallic acid and exhibited similar antioxidant properties.', '', 'Both flower extracts exhibited high antimicrobial and antifungal activities as well as anti-biofilm, anti-QS, and anti-SW activities.', 36053379),
('chrysin is a component of honey in combination with colistin', 'Our results revealed that chrysin and colistin exerted synergistic effects against A. baumannii by damaging the extracellular membrane', '', 'Synergistic effect damage the extracellular membrane and modifying the bacterial membrane potential. The chrysin/colistin combination group demonstrated an inhibitory effect on biofilm formation. In conclusion, it is expected that the synergy between these drugs can allow the use of a lower concentration of colistin for the treatment of A. baumannii infections, thereby reducing dose-dependent side effects. Thus, a combination therapy of chrysin/colistin may provide a new therapeutic option for controlling A. baumannii infections.', 36386691),
('combined effect of blue LED Irradiation and berberine (an alkaloid compound)', 'the combined effect of blue LED Irradiation and berberine on Pseudomonas aeruginosa (Gram-negatives) and Staphylococcus aureus (Gram-positive) and also their effect on human dermal fibroblast (HDF) cells', '', 'This compound destroys bacterial cells by producing reactive oxygen species (ROS). These compounds also prevented the formation of biofilms and were able to destroy the created biofilms.', 36253652),
('Helichrysum italicum (Roth) G. Don essential oil (EO) and hydrosol.', 'The highest antimicrobial effect was shown in the case of C. jejuni strains (12.5% (V/V)), followed by E. coli and P. aeruginosa, both inhibited by 100% V/V and S. aureus showing resistance to the undiluted H. italicum hydrosol.', 'The cytotoxicity of the EO was higher when compared to hydrosol for all cell lines( immortalized cell lines Caco-2 and A375, primary epidermal melanocytes (PEM) and CCD112CoN primary colon fibroblasts). at the tested concentration of 0.084% (V/V) EO, the highest sensitivity was shown for PEM with no viability detected, followed by Caco-2 (approx. 30% viability) and A375 (approx. 75% viability), while CCD112CoN cells were not tested at this concentration due to the higher sensitivity', '', 36009886),
('Crotoxin from Crotalus durissus terrificus (Crotoxin is a beta-neurotoxin from the venom)', 'Crotoxin showed only bacteriostatic activity with a MIC of 46 microM, while the CB subunit acted as both a bacteriostatic and bactericidal agent with a MIC = MBC = 0.21 microm gainst Micrococcus luteus ATCC 10240. Both toxins reduced bacteria viability at the MIC by 72% and 85% for crotoxin- and CB-treated bacteria, respectively', 'Neither crotoxin nor the CB subunit showed any cytotoxic properties to human fibroblasts at the MIC during the three-day incubation.', 'crotoxin leading to the inhibition of bacterial growth. The membrane permeability increased approximately three times within the first hour of incubation with toxins; afterwards, either no significant changes or a decrease of membrane permeability', 36431827),
('Combination of Poly(e-Caprolactone) Biomaterials and Essential Oils', 'PCL-based 3D scaffold was successfully loaded with two different EOs, eugenol and cinnamon oil, at increasing concentrations (from 30 to 50%) to achieve anti-adhesive and anti-biofilm properties against three pathogens involved in biomaterial associated infections, which are S. aureus, S. epidermidis and E. coli.', 'PCL-based biomaterials were not toxic for eukaryotic Saos-2 cells only when the lowest EO concentration (30% eugenol or 30% cinnamon oil) was added to the polymer.', 'The biodegradability and biocompatibility of the PCL together with bioactive natural compounds (EOs) make these 3D scaffolds as eco-friendly anti-adhesive/anti-biofilm constructs, granting the targeted delivery of the EOs into the site of infection where bacteria are allocated, and might have great potential applications in the regenerative medicine field.', 36145620),
('Synergy between Piceatannol (PIC) (natural stilbene extracted from grape skins) and Ciprofloxacin', 'We found that PIC had an inhibitory effect against Staphylococcus aureus (S. aureus); its minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were 128 microg/mL and 256 microg/ Ml. The results showed that when PIC and ciprofloxacin (CIP) were combined, they displayed a synergistic effect against S. aureus.', 'PIC exhibited slight hemolytic activity on mammalian erythrocytes. the hemolysis rate was about 10.2% with a concentration of 1024 microg/ mL', 'PIC also inhibited bacterial adenosine triphosphate (ATP) synthesis and was less likely to induce bacterial resistance. the combination of PIC and CIP is expected to become a new drug combination to combat S. aureus. when using PIC, we should prioritize topical medication and strictly control the dosage within 128 microg/mL to avoid hemolysis', 36499677),
('Dimer stilbene, a resveratrol analogue exhibits synergy with antibiotics', 'structural determinants of stilbenes that could aid in better antibacterial activity and identified Dimer stilbene (DS) as a potent inhibitor of S. aureus. DS exhibited synergy with the aminoglycoside kanamycin and additive effect with tetracycline.', '', 'Our recent work identified important structural determinants of stilbenes that could aid in better antibacterial activity. Synergy with kanamycin was also observed in other stilbenes apart from DS. Thus our study reveals stilbenes could be exploited towards combating S. aureus infections either as standalone drugs or in combination with existing antibiotics.', 35772578),
('natural compound schisandraone', 'In vivo studies further suggested that schisandrone combined with antibiotic ceftiofur exhibited a significant therapeutic effect on S. aureus infection.', '', 'We also found that the addition of schisandrone could down-regulate the transcriptional levels of the alpha-hemolysin hla, agrA and RNAIII and significantly alleviated Hla-mediated injury of A549 cells co-cultured with S. aureus. These findings revealed the role of schisandrone in inhibiting the activity of Hla and we believe that it is a promising anti-virulence candidate to combat MRSA pneumonia.', 36344903),
('Saussurea lappa Extract', '', '', 'Our findings suggest that the S. lappa extract exhibits an immunomodulatory effect with potential to reduce and cure systemic infections by both opaque and translucent colony variants of A. baumannii.', 36188613),
('Mimosa pudica of Nepalese Terai Region', 'The extract showed a potent free radical scavenging activity with an IC50 value of 158.95 ', '', 'The findings of the current study suggest that Mimosa pudica from the Terai region of Nepal is rich in phenolic and flavonoid compounds, has a significant impact on bacterial growth inhibition, and has a notable potential to scavenge free radicals (DPPH). According to the in silico analysis, L-mimosine is a potent antibacterial compound that might be utilised to discover novel antibacterial drugs to combat antibiotic resistance.', 36248409),
('kaempferol glycosides and quercetin', 'the presence of kaempferol-3,7-dirhamnoside (125 and 250 microg/mL) and quercetin (15.63 microg/mL) reduced each other', '', 'a proper compatibility of kaempferol glycosides and quercetin is beneficial to the mutual promotion of their antibacterial activities. Furthermore, GE-EE in combination with penicillin G was found to synergistically inhibit the growth of S. aureus strains BWSA11, BWSA15, and ATCC 43300 with FICs of <0.19, <0.5, and <0.16, respectively', 36354319),
('hydro-ethanolic extract and protoberberine alkaloids from the stem bark of Enantia chlorantha', 'The crude extract (ECB) inhibited the growth of all the tested MDR bacteria, with the minimal inhibitory concentration (MIC) values below 100 microg/mL obtained against Escherichia coli ATCC 10536, AG 102, Enterobacter aerogenes EA 27, Klebsiella pneumoniae ATCC 11296 and KP 55, Providencia stuartii NEA 16, and Staphylococcus aureus MRSA3 and MRSA6. *Compound 1 had the best antibacterial effects with MIC values ranging from 16 to 64 microg/mL.', '', 'The crude extract (ECB) and its isolated compounds 1-6 are potential antibacterial products from Enantia chlorantha. They could be explored more to develop the antibacterial agents that could be used alone or in combination with antibiotics to overcome MDR phenotypes.', 35788039),
('Cinnamomum camphora essential oil', 'The results show that the main components of the essential oil (EO) from the leaves of C. camphora were Eucalyptol. The EO had good antibacterial activity against eight clinical antibiotic-resistant pathogens, namely, Pseudomonas aeruginosa, Acinetobacter baumannii (two strains), Klebsiella pneumonia (two strains), Escherichia coli (one strain), Staphylococcus aureus (two strains).', '', 'These findings may lead to a more complete knowledge of this aromatic plant''s antibacterial action against antibiotic-resistant pathogens (in vitro).', 35993631),
('lemongrass (Cymbopogon citratus) extract', 'MRSA growth inhibition (zones of inhibition) was greatest for the lemongrass oil at concentrations of 1, 2, 5, 10 and 20 % (wt/vol). The MIC for lemongrass oil was 0.5 mg/mL, while it was 4 mg/mL for both the aqueous and ethanol extracts.', '', 'The ethanol extract enhanced the activity of tetracycline and ampicillin, while the aqueous extract only increased the activity of tetracycline against MRSA. It also demonstrates that lemongrass oil potentiates the activities of three antibiotics against the biofilm-forming MRSA. This biocidal, anti-biofilm disruption and antibiotic potentiating abilities are mainly attributable, further evidence of lemongrass oil as a very useful source of phytochemicals, especially citral for the fight against antibiotic resistance.', 36026557),
('Daphnetin (DAP), a coumarin derivative', 'DAP at concentrations of 0.445-1.781 mg/mL and 0.89-1.781 mg/mL can effectively inhibit biofilm formation and eradicate the formed biofilm of P. aeruginosa, respectively.', 'Daphnetin (DAP), a coumarin derivative, is a safe, non-toxic', 'In conclusion, our results support the conclusion that DAP can effectively eradicate formed biofilm and inhibit biofilm formation, bacterial motility, and pyocyanin production of P. aeruginosa and may represent a natural anti-biofilm therapeutic agent.', 36467736),
('effects of cinnamon, oregano, and thyme essential oils', 'Show MIC against Escherichia coli and Trueperella pyogenes, which were isolated from dairy cows with clinical endometritis.', '', 'This study demonstrated a promising antimicrobial activity of cinnamon''s essential oil, indicating that it has excellent potential to be explored as a possible alternative in the treatment of clinical endometritis in dairy cows.', 36413866),
('Algerian Essential Oils( Algeria-Salvia officinalis (Sage), Thymus vulgaris (Thyme), Mentha pulegium L. (Mentha), Rosmarinus officinalis (Rosemary), and Pelargonium roseum (Geranium))', 'T. vulgaris was the most potent, with an inhibition zone of 12-26 mm and an MIC value ranging between 0.25 and 1.25%, followed by S. officinalis with an inhibition zone of 8-12 mm and an MIC value ranging between 0.62 and 2.5%. . Generally, A. baumannii and S. aureus ATCC6538P were the most sensitive strains, whereas P. aeruginosa ATCC27853 was the most resistant strain to the oils', '', 'The in-silico study revealed that sesquiterpenes and thymol had the highest binding free energies against the vital enzymes involved in biosynthesis and repair of cell walls, proteins, and nucleic acids compared to monoterpenes. The results demonstrated that T. vulgaris and S. officinalis are ideal candidates for developing future potentially active remedies against MDR strains.', 36289975),
('tea tree essential oil (TTO) nanoemulsion (nanoTTO)', 'nanoTTO increased the drug accumulation in MDR E. coli by disrupting outer and inner membranes and inhibiting the AcrAB-TolC efflux pump involved in membrane permeability.', '', 'nanoTTO was effective in enhancing antibiotic efficacy in the Galleria mellonella infection model and mouse peritonitis model, suggesting a potential strategy against MDR bacterial infections.', 35854664),
('Seed-Derived Ethanol Extracts from Persea americana Mill', 'displayed a moderate antibacterial activity against Pseudomonas aeruginosa (IC50 = 87 and 187 microg/mL) and Staphylococcus aureus (IC50 = 144 and 159 microg/mL). no antibacterial activity was found against Escherichia coli. avocado seed ethanol extracts (64 microg/mL) downregulated virulence-related factors such as mexT and lasA genes.', 'Ethanol extracts were not cytotoxic to mammalian cells (CC50 > 500 microg/mL)', 'Our results support the potential of bioproducts from P. americana seeds as anti-adhesive and anti-biofilm agents.', 35956958),
('Combination of resveratrol and polymyxin B', 'synergistic effects when tested in vitro with polymyxin B on antibacterial and anti-biofilm activities against multidrug-resistant Pseudomonas aeruginosa', '', 'This suggests that it could be a partner for the combination therapy of polymyxin B in the treatment of topical bacterial infection caused by MDR P.aeruginosa.', 35999263),
('Vetiver essential oil, a product of Chrysopogon zizanioides (L.) Roberty root', 'cell death in Bacillus subtilis caused by sesquiterpenes from Chrysopogon zizanioides (L.) Roberty', '', 'Composition analysis suggested that the sesquiterpene, khusimol, might contribute to the bactericidal activity of the Vetiver extract.', 35418537),
('four commercial essential oils, namely, tea tree, thyme, sage, and eucalyptus', 'Statistical comparison of the EOs'' antimicrobial results showed that thyme gave the lowest minimum inhibitory concentrations (MIC) and minimum biofilm eradication concentrations (MBEC) in P. aeruginosa-resistant isolates,', '', 'making this EO a competitive candidate for the development of efficient and ecologic antimicrobial alternatives.', 35956481);
INSERT INTO `bacteria_naturalproduct` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('extracts of Psoralea corylifolia Linn. Seed', 'The tested strains included S. aureus (ATCC 25923), S. epidermidis (CMCC 26069), E. coli (CICC 20658), and Shigella dysenteriae (CICC 23829), MRSA and Pseudomonas aeruginosa', '', 'We identified eight prenylated flavonoids in Psoralea corylifolia Linn. seed. The antibacterial activity and mechanism studies showed that this type of compound has a unique destructive effect on MRSA cell membranes and does not result in drug resistance. The results revealed that prenylated flavonoids in Psoralea corylifolia Linn. seeds are promising candidates for the development of novel antibiotic agents to combat MRSA-associated infections.', 36296544),
('Ellagic acid and gallic acid', 'minimum inhibitory concentration (MIC) test on the IS-58 and K2068 strains of S. aureus, it was observed that for both strains, the two compounds presented a MIC=1024 microg/ml', 'Ellagic acid and gallic acid showed no toxicity on the model arthropod D. melanogaster.', 'These results indicate the possible use of gallic acid as an adjuvant in antibiotic therapy against multidrug-resistant bacteria.', 36063129),
('Isoespintanol (ISO) is a monoterpene', 'MIC90 minimum inhibitory concentration values ranged from 694.3 to 916.5 microg/mL and MIC50 values from 154.2 to 457.3 microg/mL. The eradication of mature biofilms in P. aeruginosa after 1 h of exposure to ISO was between 6.6 and 77.4%, being higher in all cases than the percentage of biofilm eradication', '', 'ISO has antibacterial and antibiofilm potential against nosocomial bacteria and could serve as an adjuvant in the control of these pathogens.', 36432105),
('Synergistics effect of Glycolipid-Biosurfactant of B12 (GBB12) with antibiotics', 'GBB12-Gentamycin mixture almost completely inhibits the formation of A. baumannii biofilm, reaching 99.8% inhibition. Also, the rate of MRSA biofilm inhibition treated with GBB12-Ciprofloxacin mixture was found to be 99.4%.', '', 'biosurfactant-antibiotic mixture could be adequate replacements for traditional antibiotics in the near future. This study shows the potential of GBB12 as antimicrobial and antibiofilm agent.', 36534183),
('Medicinal Plants from Cameroon(leaves of Leucanthemum vulgare, Cymbopogon citratus, Moringa oleifera and Vernonia amygdalina; barks of Cinchona officinalis and Enantia chlorantha barks and seeds of Garcinia lucida and leaves and seeds of Azadirachta indica using water and ethanol as solvents)', ': Among the most active plants, in decreasing order of antimicrobial activity we found ethanolic (EE) and aqueous extracts (AE) of E. chloranta bark (ECB), EE of L. vulgare leaves and G. lucida seeds . The extracts were tested against Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 6538 and Candida albicans 10231', '', 'The ethanol extract of the bark of E. chlorantha has remarkable, broad-spectrum antimicrobial and contains several palmatine derivatives.', 36575849),
('combined application of Shikonin (SKN) and traditional antibiotics', 'SKN inhibit the expression of proteins and genes related to drug resistance and S. aureus exotoxins.', '', 'Our findings suggest that SKN has the potential to be developed as a promising alternative for the treatment of MRSA infections.', 35886892),
('Gallic acid (GA)', 'GA inhibited the growth and CPS biosynthesis in K. pneumoniae.', '', 'GA possesses bactericidal activity and inhibits the CPS biosynthesis in hypervirulent K. pneumoniae, thereby facilitating pathogen clearance by the host immune system. Therefore, GA may represent a promising strategy for the prevention or treatment of patients with hypervirulent K. pneumoniae infections.', 34326026),
('Aloe vera (L.) Burm. f. (aloe; Liliaceae family)', 'The water extract of A. vera showed considerable potential to reduce the number of fluoxetine-mediated MDR colonies. The extract robustly suppressed the formation of ROS in E. coli.', '', 'A. vera extract directly affected the fluoxetine-triggered early stress response of E. coli and the expression of downstream genes. Meanwhile, A. vera extract was able to inhibit the genetic mutation of SoxR gene in E. coli, as induced by co-cultured with fluoxetine. This study therefore suggested that the extract of A. vera could be an adjuvant agent to combat bacterial MDR during anti-depressant treatment.', 36054995),
('Chinese propolis ethanol extract (CPEE)', 'The diameter of inhibition zone (DIZ) of CPEE was 20.1 mm. The minimal inhibitory concentration (MIC) of CPEE was 32 mg/L, while the minimal bactericidal concentration (MBC) against MRSA was 64 mg/L against MRSA.', '', 'These results demonstrated the anti-MRSA activity of CPEE was mainly due to changing the cell membrane and reversing resistance, which indicates that CPEE could be an attractive candidate for use in future food and medical applications.', 35902505),
('derivativeHalogenated Flavonolignans- (silybins A and B, 2,3-dehydrosilybin, silychristin A, and 2,3-dehydrosilychristin A) was prepared.', 'inhibited the adhesion of bacteria (Staphyloccocus aureus and Pseudomonas aeruginosa) to the surface, preventing biofilm formation.', '', 'these derivatives acted synergistically with antibiotics and reduced the viability of antibiotic-resistant S. aureus. Some flavonolignans were able to reverse the resistant phenotype to a sensitive one, implying that they modulate antibiotic resistance.', 36499444),
('Lactoferrin', 'the prevention of biomass formation and eradication of preformed biofilms by lactoferrin was investigated using a methicillin-resistant Staphylococcus epidermidis (MRSE) strain. In the in vitro biofilm assays, lactoferrin prevented biofilm formation and eradicated established biofilms for up to 24 and 72 h, respectively', '', 'Extensive eradication of MRSE biofilm biomass was accompanied by the significant upregulation of bap gene expression. These data suggest the interaction of lactoferrin with the biofilm components and cell wall of MRSE, including the biofilm-associated protein.', 36265186),
('leaf extract of Gynura procumbens (GP)', 'The extract inhibited the biofilm production (p = 0.05) in P. aeruginosa strains MZ2F and MZ4A. The minimum biofilm eradication concentration (MBEC) was recorded at 250 and 500 microg/ml while total activity was found at 288 and 144 ml/g, respectively.', '', 'compounds were suitable drug candidates with stable binding interactions. Therefore, the anti-QS activity of GP leaves and the identified polyphenols can be used in developing QQ-based therapeutics.', 33403919),
('Essential oil', 'The (MIC) of cinnamon oils against resistant strains ranged from 4.88 to 312.5 microg/ml.', '', 'Cinnamon oil exhibited the highest activity against colistin-resistant strains followed by thyme and eucalyptus oil. mcr-1 gene expression was extremely down-regulated after the treatment of bacterial strains with cinnamon oil and decreased to 20-35-fold. Cinnamon oil exhibits antibacterial activity against colistin-resistant strains, showing it as a promising natural alternative in clinical therapy.', 35839089),
('wild shrub Halexylon salicornicum (Ramth) aqueous and solvent extracts', 'All of the extracts tested had antimicrobial efficacy against tested strains and included bioactive chemicals, particularly the acetone extract, had the highest antibacterial activity against (Enterococcus faecium, Shigella flexneri, Bacillus Cereus, Klebsiella pneumoniae, Staphylococcus aureus, Escherichia coli, Streptococcus pyogens, Pseudomonas aerogenes, Salmonella typhimurium, and Candida albicans)', '', 'All of the extracts tested had antimicrobial efficacy against tested strains and included bioactive chemicals, particularly the acetone extract, had the highest antibacterial activity. As a result, it can be stated that Halexylon salicornicum is a promising important shrub that might be used as a natural antimicrobial alternative for animals or as a food additive.', 35707822),
('crude hydroalcoholic extract of Brazilian red propolis (CHEBRP).', 'CHEBRP presented MIC/MBC of 50 and 100 microg/mL against H. pylori strains (ATCC 43526 and clinical isolate, respectively) and tetracycline MIC/MBC of 0.74 microg/mL.', '', 'The association of CHEBRP with tetracycline had an indifferent effect. In the stomach mucosa of rats, all treatments performed significantly decreased the number of H. pylori, and a concentration of 300 mg/kg was able to modulate the inflammatory response in the tissue. Therefore, CHEBRP showed promising anti-H. pylori in in vitro and in vivo assays.', 36364137),
('six monofloral honeys (jarrah, marri, red bell, banksia, wandoo, and manuka)', 'Jarrah, marri, red bell, banksia, and manuka honeys were highly effective at inhibiting S. aureus and CoNS, with MIC50 values ranging from 4 to 8% w/v honey. S. pyogenes was also inhibited by these same honeys, albeit at higher concentrations (8-29% w/v). Wandoo and multifloral honeys had the least antibacterial activity with MICs of >30% (w/v) for all isolates.', '', 'ata indicated that sub-MIC concentrations of honey were still partially restricting bacterial growth. Our pre-clinical data indicate that honey may be a potential therapeutic agent for the routine treatment of mild impetigo, and we suggest that clinical trials would be appropriate to further investigate this.', 35868137),
('Verbascoside is Antibacterial adjuvant (caffeoyl phenylethanoid glycoside)', '', '', 'verbascoside exerted its antimicrobial activity through multiple mechanisms, including cell membrane dysfunction, biofilm eradication and changes in cell morphology thats why it is expected to be useful as an antibiotic adjuvant to prevent or treat resistant bacteria-related infections and an alternative novel antimicrobial additive in the food industry.', 35956890),
('Gallic acid (GA) is a natural ingredient', 'GA damaged outer and inner membranes, and suppressed the mRNA expressions of acrA, acrB, tolC, acrD and acrF involved in membrane permeability.', '', 'The results revealed that GA exerted bactericidal activity and inhibited the formation of bacterial biofilm. GA showed protective effects against bacterial infection and improved the survival rates of Galleria mellonella and BALB/c mice.', 36243382),
('Synthetic chalcone derivative (r4MB)', 'Compound r4MB showed activity against 100% of the tested strains(Enterococcus faecalis and Enterococcus faecium) with the minimum inhibitory concentration (MIC) in the range of 5-20 microM.', 'No cytotoxic haemolysis was observed with mammalian erythrocytes', 'This fully synthetic chalcone derivative demonstrated activity against ATCC and clinical strains of Enterococcus spp. bacteria. The compound appeared to target the bacterial membrane of E. faecalis, altering its permeabilisation and electric potential, leading to cell death.', 35940279),
('Henna (Lawsonia inermis)', 'Shahdad, Rudbar-e-Jonub, and Qaleh Ganj had MIC against Group B Streptococcus agalactiae (GBS), at 15, 15 and, 4 microg/ml. IC50 of shahdad Henna after 24 h, 48 h, and 72 h was 7.54, 4.83 and 20.54 microg/ml, respectively. IC50 of Rudbar-e-Jonub extract was 5.76, 3.79 and 5.77 microg/ml in different days. IC50 of Qaleh Ganj extract was 6.09, 4.08 and 5.74 microg/ml in different days.', '', 'The amount of total phenol in Qaleh Ganj was higher than the other varieties. In the well diffusion method, Qaleh Ganj was more effective against group B Streptococcus (Gram-positive bacterium) than the other two landraces, and Shahdad landrace was more effective against P. aeruginosa (Gram-negative bacterium) than other.', 35907942),
('Medicinal plant, Moringa (Moringa oleifera)', 'The minimum inhibitory concentrations (MICs) of Ethanolic extract of Moringa oleifera leaf (EMLE) were 400microg/ml and 500microg/ml against Staphylococcus aureus and Escherichia coli respectively.', '', 'The present study showed that Ethanolic extract of Moringa leaf demonstrated antibacterial effects against food borne pathogens', 36189541),
('activity of clove essential oil ( Syzygium aromaticum)', 'The lowest resistance rates were observed for meropenem (4.88%), amikacin (12.20%), and tobramycin (12.2%). All isolates were susceptible to clove oil with an equivalent MIC and MBC from 3.26 to 6.53 mg/mL against Pseudomonas aeruginosa . Eugenol was the major component of the oil.', '', 'Clove EO was effective against MDR strains of P. aeruginosa, indicating an alternative for developing an efficient and low-cost antimicrobial agent to treat canine otitis.', 36425137),
('Polymyxin B in Combination with Glycerol Monolaurate (GML).', 'A. baumannii HR13 (MIC, 4 microg/mL) and K. pneumoniae KP024 (MIC, 8 microg/mL), were resistant to PMNB; the other strains had similar MIC values ranging from 0.5 to 1 microg/mL. However, GML did not exhibit any effective antibacterial activities at a concentration of up to 4000 microg/mL for all Gram-negative pathogens.', '', 'In this study, we confirmed that PMNB synergized with GML increased antimicrobial activity against Gram-negative strains in vitro and in vivo, and this synergistic activity was mainly achieved by exacerbating the destruction of bacterial cell structures, eradicating preformed biofilms, and promoting intracellular ROS accumulation.', 36014995),
('Cannabis sativa CBD Extract', 'Polymyxin B mono-treatment at a MIC of 5 microg/mL exhibited a percent inhibition of 83%, whereas co-treatment with Polymyxin at 0.5 microg/mL and CBD at 1 microg/mL resulted in a percent inhibition of 92%', 'It is a non-toxic and low-resistance chemical', 'The final antibiotic that exhibited promising antibacterial synergy with CBD was polymyxin B. CBD extract from C. sativa has been presented as a promising antibacterial agent with in vitro efficacy against several relevant bacterial pathogens including Staphylococcus aureus, Streptococcus pneumoniae, Salmonella spp. Clostridium difficile, Neisseria spp., Moraxella catarrhalis, and Legionella pneumophila', 36557613),
('Kaempferol Combined with Colistin', 'The MICs of KP against all the 24 strains of Col-R GNB were =512 microg/mL and the MICs of COL ranged from 4 microg/mL to >128 microg/mL but they alone not show much effect. The COL/KP combination had a strong synergistic effect on most of the Col-R strains, with fractional inhibitory concentration index (FICI) ranging from 0.012 to 0.375', 'The findings demonstrated that at the combined ( KP and COL) concentrations with synergistic effects, there were no additional toxic effects investigatted on RAW264.7 cells.', 'KP combined with COL could inhibit the formation of bacterial biofilms and enhanced G. mellonella survival. Hence they designed in vivo infection models of G. mellonella to develop a new treatment for Col-R GNB pathogens. hence the combination exhibits a promising future for use in clinical anti-infection treatments', 36314964),
('amentoflavone', 'the 32 microg ml-1 amentoflavone treatment almost completely blocked Hla pore formation. The minimal inhibitory concentration (MIC) value was higher than 512 microg ml-1, indicating that amentoflavone exerted exactly low viability pressure on S. aureus compared to antibiotics widely used in the clinic.', 'Compared to the other compounds tested, amentoflavone exerted more prominent and coupled inhibitory effects and minor cytotoxicity in the cell lines of lungs mice model', 'amentoflavone was preliminarily identified as a promising lead that inhibited the hemolytic activity of Hla and TLR2-mediated effective against Staphylococcus aureus (S. aureus). This dual action molecule effect this S. aureus', 35754300),
('Medical grade honey (MGH)', 'majority of the wounds were contaminated with (multiresistant) bacteria, both of which contributed to non-healing.', '', 'In this study, MGH was a useful alternative or complementary therapy to antibiotics and expedited the healing of hard-to-heal wounds.', 35797263),
('plant species: Erythrina abyssinica, S. singueana and E. abyssinica. Other plant species with noteworthy biological activities include B. madagascariensis, A. greatheadii, T. bicaudata and E. matabelensis.', 'Erythrina abyssinica had the best antibacterial activity against both ATCC strains and clinical strains with minimum inhibitory concentration (MIC) values ranging from 0.02 to 0.156 mg/ml. The S. singueana extract had the most potent anti-lipoxygenase activity with a mean IC50 value of 1.72 microg/ml.', '', 'This study showed that S. singueana and E. abyssinica had multiple biological activities. The S. singueana acetone extract had moderate antibacterial activity, powerful antioxidant and potent anti-lipoxygenase activities, while the E. abyssinica extract had significant antibacterial activity, good antioxidant and reasonable anti-lipoxygenase activity', 36084819),
('phytobiotics mixtures: H1, containing thymol, menthol, linalool, trans-anethole, methyl salicylate, 1,8-cineol, and p-cymene; H2, in addition to compounds from H1, containing terpinen-4-ol and gamma-terpinene.', 'The values of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were at the level 1:512', '', 'The results suggest that phytobiotic compositions used in this study can be successfully used as a natural alternative to antibiotics in the treatment of E. coli infections in broiler chickens.', 36551476),
('Therapeutics bovine Lactoferrin (MTbLF) alone and in combination with metronidazole and clindamycin', 'the vast majority of the tested strains (45%), exhibiting MIC lower than 2 microg/ml, were considered sensitive; 18 strains (25%) with MIC higher or equal to 8 microg/ml, were classified as resistant, whereas the remaining 21 (30%) were classified as intermediate effective against Bacterial Vaginosis (BV), a common imbalance of the vaginal microbiota', '', 'MTbLF effective against G. vaginalis clinical isolates. Bovine lactoferrin may be a potential candidate to treat Gardnerella species infection.', 36419418),
('therapeutic potential EOs of common thyme (Thymus vulgaris L.) and wild thyme (Thymus serpyllum L.), as well as oregano (Origanum vulgare L.),', 'MIC values for EOs against P. mirabilis strains were 3.125 mg/mL and MBC values ranged between 3.125 and 6.25 mg/mL. On the other hand, EOs of common and wild thyme had low MIC values for S. marcescens isolates (MIC = 1.56 mg/mL). Our results demonstrated that oregano EO showed a lower MBC value for P. mirabilis compared with S. marcescens.', '', 'All tested EOs displayed antibacterial activity against all strains to different extents, while wild and common thyme EOs were the most effective. It could be concluded that the tested EOs represent promising therapeutic candidates for effective non-antibiotic treatment of mastitis.', 36009946),
('docosahexaenoic acid DHA or Omega-3 Fatty Acids', 'At 0.625 mg/L DHA concentration, MRSA showed 0.4', '', 'Docosahexaenoic acid can be considered an option as a therapeutic substance against biofilm formation and may be a good alternative in reducing the risk of MRSA formation.', 35884185),
('Natural essential oil components "EOCs" (carvacrol, cinnamaldehyde, eugenol, geraniol, limonene and thymol), HLE disinfectant solution (3-6% H2O2; 2.2-4.4% lactic acid and 12.5-25 mM EDTA in water) and EDTA', 'The results obtained showed that EOCs -as concentrated natural plant extracts- had different MICs from 10 to 50 microg/mL for CIN followed by TH, CA, LI and GE (100', '', 'The synergistic combinations of EU and HLE/EDTA, TH, CA, GE, LI or CIN + EDTA/HLE caused log reductions in established biofilms of several strains (1-6 log10 CFU) against Pseudomonas sp. strains. Hence this combination became novel antimicrobial formulations as a highly promising alternative against MDR bacteria and ARGs in the food chain and the environment,', 36299714),
('Kaempferol (KPF) is a flavonoid antioxidant found in fruits and vegetables', 'the MICs of kaempferol for L. monocytogenes strains used in this study were no less than 256 microg/mL.', '', 'kaempferol alleviated L. monocytogenes infection via suppressing listeriolysin O pore formation and inflammation response, which might represent a novel antimicrobial-independent strategy to curb listeriosis.', 35856678),
('Nigella sativa oil extract', 'Among the examined samples, with 157 out of 244 (64.3%) contaminated with Enterococci . VRE strains were examined using Vn-MIC agar dilution. A total of 62 cows'' milk and broiler specimens out of 103 (60.1%) samples were VRE, and 82.2% of these isolates showed an MIC ranged from 16 to 32 microg/ml . High level of VR was detected in Enterococcus spp. isolated from broilers samples followed by turkey', '', 'The current study''s findings demonstrated that N. sativa oil has the potential to inhibit VR gene transfer from VREtfm to S. aureus and that the oil has promising antibacterial activity against Enterococcus spp.', 35395119),
('prairie strips''', 'potential for reducing the transport of LAB and ARGs in runoff after litter application', '', 'Although we show that prairie strips can potentially reduce AMR risks, further research is needed to better understand the influence of rainfall timing, soil, and litter characteristics.', 35112354),
('diterpene natural product 12(S),16?-dihydroxycleroda-3,13-dien-15,16-olide, which we refer to as (-)-LZ-2112 synergize with oxacillin', 'against methicillin-resistant Staphylococcus aureus (MRSA)', '', 'A preliminary mode of action study suggests mecA plays a role in the adjuvant activity of (-)-LZ-2112.', 35167718),
('Salacia oblonga Wall Leaf and Root Extracts', 'The most susceptible bacterial and fungal species against ethyl acetate extract are Micrococcus luteus, Mycobacterium tuberculosis, Microsporum canis, Trichophyton interdigitale, and Microsporum gypseum.The MIC for bacteria ranged from 13.0 to > 200 Microgram/ml, whereas for fungi, the MIC ranged from 25.9 to > 200 Microgram/ml. Ethyl acetate extract of root with 100 Microgram/ml concentration showed 29.1 mm and 28.7 mm zone of inhibition against bacterial strains M. luteus and M. tuberculosis, respectively. The ethyl acetate extract of root with a 100 Microgram/ml concentration showed 15.8, 15.2, and 15.6 mm zone of inhibition against fungal isolates M. canis, T. interdigitale, and M. gypseum, respectively.', '', 'The activity of root and leaf extracts increased in a concentration-dependent manner, and further, the compounds isolated from the crude extracts of leaf and root showed antimicrobial activity.', 35612657),
('aqueous leaf extracts of Moringa oleifera, Vernonia amygdalina, Azadirachta indica and Acalypha wilkesiana', 'Vernonia amygdalina and Azadirachta indica showed significant antimicrobial activity at 100 mg/ml and 75 mg/ml, with low susceptibility of less than 10% to 25 mg/ml, 50 mg/ml, and 75 mg/ml Moringa oleifera. High inhibitory concentrations at IC50; 3.23, 3.75 and 4.80 mg/ml (p = 0.02, CI: - 0.08 - 11.52) and IC90; 12.9, 7.5, and 9.6 mg/ml (p = 0.028, CI: 2.72-23.38) were shown by Acalypha wilkesiana, Vernonia amygdalina and Moringa oleifera respectively. Comparative outcome of the plant extracts showed Acalypha wilkesiana, Vernonia amygdalina and Moringa oleifera to exhibit significant inhibition activities (p < 0.05) compared to other extracts.', '', 'Observed high occurrence rate of skin and soft tissue infections caused by biofilm-producing MDR S. aureus requires alternative novel herbal formulations with rich bioactive compounds from Moringa oleifera, Acalypha wilkesiana, Azadirachta indica and Vernonia amygdalina as skin therapeutic agents.', 35189869),
('carvacrol (CAR) and octanoic acid (OA)', 'The minimum inhibitory concentration (MIC) values confirmed that all the tested pathogens were variably susceptible to both EOs and saturated MCFAs. Among essential oils, carvacrol (CAR), trans-cinnamaldehyde (TC) and thymol (TM) showed the highest inhibitory activity at concentration 0', 'After adding CAR and OA at MIC level, there were obvious changes in cell morphology, leakage of small electrolytes and macromolecules at the initial few hours of treatment i.e. within 1-2 h were observed.', 'Our results indicated that CAR and OA could be evaluated as alternatives or adjuncts to antibiotics as intramammary infusion or topical application to treat bovine mastitis, significantly improving the microbiological safety of milk.', 35178733),
('hesperidin', 'The present study revealed the non-antibacterial biofilm inhibitory potential of hesperidin against ATCC strain and clinical isolates of S. aureus. In gene expression study revealed that hesperidin treatment downregulated the biofilm-associated gene (sarA), polysaccharide intracellular adhesion gene (icaA and icaD), autolysin (altA), fibronectin-binding protein (fnbA and fnbB) and staphyloxanthin production (crtM).', '', 'Molecular docking analysis predicted the ability of hesperidin to interact with SarA and CrtM proteins involved in biofilm formation and staphyloxanthin production in MRSA.', 35064842),
('ophthalmic solution containing ozonated oil', 'The aim of this study was to assess the in vitro antimicrobial activity of an ophthalmic solution containing ozonated oil. The treatment exhibited antibacterial activity against all the tested species.', 'The effect was lower against the strains of Pseudomonas aeruginosa and more evident against Staphylococcus and Streptococcus spp.', 'Our results suggest that the administration of ozonated oil may be a candidate agent to treat some infections of the ocular surface with a potential role in antimicrobial prophylaxis.', 35795001),
('vitamin C (ascorbic acid)', 'MICs of ascorbic acid among P. aeruginosa isolates were in the range of 156.2-1,250 microg/ml, while MIC50 and MIC90 were 312.5 and 625 microg/ml, respectively. At sub-inhibitory concentrations (19.5-312.5 microg/ml), ascorbic acid had 100% biofilm inhibitory effect.', '', 'Vitamin C shows excellent in vitro results as an antibacterial and anti-biofilm agent. Vitamin C should be routinely prescribed with antibiotics to treat bacterial infections in the clinical setting.', 35668756),
('distilled extract of bergamot (Citrus bergamia Risso et Poiteau)', 'The distilled extract of bergamot exhibited significant antimicrobial activity and a specific bactericidal effect against the bacterial and fungal strains tested. Furthermore, confocal microscope images clearly showed compromised membrane integrity, damage and cell death in bacterial samples treated with the distilled extract of bergamot. In addition, progressive alterations in cell-wall composition, cytoplasmic material and nucleus structure triggered by exposure to the distilled extract of bergamot were identified in the fungal samples considered.', '', 'Conclusions: Our data suggest that the use of essential oils, such as distilled extract of bergamot (Citrus bergamia Risso et Poiteau), can represent a valid alternative therapeutic strategy to counteract antibiotic resistance of pathogens.', 35326824),
('enterocins, oregano, and sage', 'The use of natural substances (enterocins and phytoadditives) seems to be a promising alternative, either in the prevention or treatment of the gastrointestinal tract infections. Eighty-five percent of the Campylobacter strains were susceptible to at least one enterocins, and 77% of the strains were susceptible to enterocin (Ent) 9296, 69% were susceptible to Ent EM41, and 69% were susceptible to Ent A(P). Sage inhibited the growth of 38% of C. jejuni strains and 53% C. coli strains, whereas oregano inhibited the growth of 50% of the C. jejuni strains and up to 67% C. coli strains.', '', 'Owing to the One health concept, application of enterocins and herbal extracts is a more ecological approach for preventing bacterial contamination during production and processing of poultry, which also leads to the protection of human health.', 35076262),
('Conocarpus erectus', 'Statistically significant reduction in bacterial colony count (p<0.05) observed in rat''s sepsis model with C. erectus treated group vs. controls. C. erectus extract offered higher bactericidal effect both in-vitro and in-vivo along no acute toxicity at therapeutic dose.', '', 'We infer that it can serve as alternative promising treatment option against antibiotic resistant against MDR S. aureus strains.', 35228188),
('ethanol extracts of Portuguese propolis combined with gentamicin or with honey, collected from the same apiary as propolis', 'Using the agar dilution method and DPPH free radical scavenging assay, antimicrobial and antioxidant synergistic effects between propolis and gentamicin or honey were assessed. Synergism between propolis and gentamicin was observed for all the tested extracts and against all the indicator bacteria, with particular interest against the Methicillin-Resistant Staphylococcus aureus (MRSA) with a threefold decrease of the gentamicin MIC if mixed with 25 Microgram ml-1 propolis. Likely to propolis and gentamicin, mixtures of sub-MIC concentrations of propolis and honey enhanced the antibacterial action of each individual natural product against the majority of the strains. However, propolis antioxidant capacity decreased along with higher honey content in the mixture.', '', 'Propolis has a strong synergistic effect when combined with gentamicin, allowing the reduction of the therapeutic dose of this drug. Propolis and honey mixtures also display a stronger antibacterial effect than the activity exhibited by each sample when tested individually, whereas the high antioxidant capacity of propolis seems to be not affected when in combination with honey.', 35092131),
('Halexylon salicornicum', 'The goal of this study is to investigate whether Halexylon salicornicum aqueous and solvent extracts have antimicrobial activity on a variety of animal pathogens isolated from cattle and poultry using the agar well diffusion method (Enterococcus faecium, Shigella flexneri, Bacillus Cereus, Klebsiella pneumoniae, Staphylococcus aureus, Escherichia coli, Streptococcus pyogens, Pseudomonas aerogenes, Salmonella typhimurium, and Candida albicans) moreover it''s ethnobotanical and phytochemical. All of the extracts tested had antimicrobial efficacy against tested strains and included bioactive chemicals, particularly the acetone extract, had the highest antibacterial activity.', '', 'As a result, it can be stated that Halexylon salicornicum is a promising important shrub that might be used as a natural antimicrobial alternative for animals or as a food additive.', 35707822),
('essential oil (EO) of Tagetes lucida Cav. and the mixture of its main compounds (PREO)', 'The EO main bioactive compounds were methyl eugenol (relative abundance in EO: 46', '', 'In conclusion, we overcame the unpredictability of EO activity (due to their natural variability) by determining which EO components inhibited bacteria and then producing a PREO to generate a reproducible mixture with predictable antibacterial and modulation of resistance activities. Thus, the PREO, and its components, show potential as alternatives to manage multidrug-resistant pathogens.', 35419861),
('Sida cordifolia', 'Galleria mellonella pre-treated with SCAF5 produced more haemocytes and were more resistant (P < 0.001) to infection with methicillin-resistant Staphylococcus aureus (MRSA) with a 98% reduction in bacterial load in pre-treated larvae compared to the negative control. Extensive fractionation identified two compounds, rosmarinic acid and its 4-O-beta-d-glucoside derivative, which had potent activity against Gram-positive antibiotic-resistant bacteria, including MRSA.', '', 'Conclusions: Sida cordifolia counters bacterial infections through a dual mechanism, and immunomodulatory polysaccharides from this plant should be isolated and characterised to realise their potential as anti-infective agents. Such properties could be developed as an antibiotic alternative (1) in the clinic and (2) alternative growth promoter for the agri-food industry.', 35086541),
('Antibiogram study showed significant (p < 0.05) resistance by P. aeruginosa against tested antibiotics. E. coli, M. morganii and K. pneumoniae were significantly susceptible to erythromycin and S. aureus to lincomycin. Both honey samples at 2% and 5% concentrations showed significant (p < 0.05) inhibition potential of multispecies biofilm by all test groups (g1-g11). Though A. dorsata honey significantly inhibited biofilm formation at 2 and 5% against all groups but 2% concentration was highly s', 'Antibiogram study of all five isolates was tested against three antibiotics viz., erythromycin (20 Microgram/mL), lincomycin (100 Microgram/mL) and rifampicin (100 Microgram/mL). In order to form multispecies biofilm, identified bacteria were grown in batch culture by mixing equal volumes (OD590nm = 0.1) of 2, 3 and 5 bacterial isolates. In total 11 groups (g1-g11) were made.', '', 'Accordingly, honey samples showed significant antibiofilm, anti-QS and biofilm dispersal potentials thus can be considered as good alternative to antibiotics.', 35153244),
('nor 3''-Demethoxyisoguaiacin from Larrea tridentata or L. tridentata hydroalcoholic extract (LTHE)', 'Chemical analyses through HPLC techniques were conducted for the LTHE, fractions, and sub-fraction Ltc1-F3, from which we isolated two compounds, characterized by 1H and 13C NMR analyses. Compound nor-3 demethoxyisoguaiacin exhibited the best antibacterial activity against the evaluated bacteria (MIC: 0.01-3.12 mg/mL; MBC: 0.02-3.12 mg/mL).', '', 'The results indicated that nor-3 demethoxyisoguaiacin can be used as an alternative treatment for multidrug-resistant bacteria associated with mastitis.', 35684556),
('honeycomb extract (HE)', 'HE addition significantly increased average daily feed intake (ADFI), average daily gain (ADG), decrease feed gain ratio (F/G) from 21 to 80 and 51 to 80 days of age compared to the control group, with all 3 HE addition groups having statistically identical values to the antibiotic group. HE implementation dramatically increased spleen index, serum immunoglobulin A (IgA), immunoglobulin M (IgM,), glutathione peroxide (GSH-Px), superoxide dismutase (SOD), total antioxidant capacity (T-AOC), and total cecum bacteria and Lactobacillus compared to the control group, numerically at the same level as, or even better than, the antibiotic group. HE and CTE both markly reduced serum malondialdehyde (MDA) concentration compared to the control group, with higher concentrations of HE reducing the effect more dramatically than antibiotics. Both HE and CTE significantly raised dressed yield compared to the control group.', '', 'In summary, HE, as a potential antibiotic alternative, improved growth performance, carcass traits, immune function, serum antioxidant capacity and intestinal microorganisms in yellow bantam broilers. According to the cubic regression analyses, the recommended supplemental dose of HE was calculated to be 0.15 to 0.17% for female yellow bantam broilers between 21 and 80 d of age.', 35709681),
('Gallic acid (GA)', 'The protective effect of GA pretreatment on bacterial growth, cell adherence, and ESBL-EAEC-lipopolysaccharide (LPS)-treated Caco-2 cells were first assessed, and results revealed direct antibacterial effects and diminished colonic cell inflammation. Collectively, our findings provided the direct evidence of hindgut microbiota and intestinal metabolites, discriminating the health status of neonatal calves post ESBL-EAEC infection.', '', 'The data provided novel insights into GA-mediated remission of colitis via amelioration of hindgut commensal structure and upregulation of SCFA productions. In addition, its eminent role as potential antibiotic alternative or synergist for future clinic ESBL-EAEC control in livestock.', 35399688),
('butyrate and forskolin', 'Butyrate and forskolin synergistically induced the expressions of AvBD9, AvBD10, and MUC2 in chicken HD11 cells (P < 0.05) and the synergy was maintained in the presence of LPS. Butyrate and forskolin also suppressed LPS-induced IL-1beta gene expression in HD11 cells in a synergistic manner (P < 0.05). The two compounds significantly reduced the intestinal lesions of C. perfringens-challenged chickens when combined (P < 0.05), but not individually. Furthermore, butyrate in combination with forskolin-containing CF extract had no influence on weight gain, but significantly reduced feed intake (P < 0.05) with a strong tendency to improve feed efficiency (P = 0.07) in a 42-d feeding trial. Desirably, the butyrate/forskolin combination significantly decreased abdominal fat deposition (P = 0.01) with no impact on the carcass yield, breast meat color, drip loss, or pH of d-42 broilers.', '', 'Conclusions: Butyrate and forskolin has potential to be developed as novel antibiotic alternatives to improve disease resistance, feed efficiency, and carcass composition of broilers.', 35139922),
('Clove Flower Extract (CFE)', 'Clove flower extract (CFE) inhibited distinctively the P. mirabilis bacterium obtained. topical application of CFE hydrogel improved wound size, wound index, mRNA expression of the wound healing markers (Coli1, MMP9, Fibronectin, PCNA, and TGFbeta), growth factor signaling pathways (PPAR-alpha, PGC1-alpha, GLP-1, GLPr-1, EGF-beta, EGF-betar, VEGF-beta, and FGF-beta), inflammatory cytokine expression (IL8, TNFalpha, NFKbeta, IL1beta, and MCP1), as well as anti-inflammatory cytokines (IL4 & IL10), pro-apoptotic markers (FAS, FAS-L, BAX, BAX/BCL-2, Caspase-3, P53, P38), as well as an antiapoptotic one (BCL2).', '', 'Based on the previous notions, it could be concluded that CFE represents a valid antibiotics alternative for DFU therapy since it improves diabetic wound healing and exerts antibacterial activity either in vitro or in vivo.', 35408668),
('Toona sinensis shoots, Koelreuteria paniculate seeds, and Firmiana simplex barks', 'Toona sinensis shoots and Firmiana simplex barks showed high inhibitory activities against Staphylococcus aureus, Shigella dysenteriae, and Escherichia coli strains with minimum inhibitory concentrations (MICs) of 1.56, 0.78, and 0.39 mg/mL, respectively. Salmonella typhi was highly sensitive to Firmiana simplex barks with an inhibitory diameter up to 21.67 ', '', 'Conclusion: Our results indicated that Toona sinensis shoots, Koelreuteria paniculate seeds, and Firmiana simplex barks could be supplied as potential sources of antimicrobial agents. Furthermore, 36 potential bioactive compounds were identified mainly as polyphenols, glycosides, and terpenoids.', 35042282),
('Thymus vulgaris essential oil (TVEO)', 'Thymus vulgaris essential oil (TVEO) against a Gram-negative bacterium Salmonella enterica Typhimurium ATTCC 10028 (S. enterica Typhimurium ATTCC 10028) and two Gram-positive bacteria Staphyloccocus aureus ATCC 6538 (S. aureus ATCC 6538) and Listeria monocytogenes ATCC 19117 (L. monocytogenes ATCC 19117).', '', 'Results indicated that the tested compounds could have multiple biological activities and various enzymatic targets. Findings of our study support that identified compounds of TVEO can be a safe and effective alternative to synthetic drugs and can easily combats hazardous multidrug-resistant bacteria.', 35909468),
('Cinnamomum zeylanicum, Cz; Origanum vulgare, Ov and modified GR-OLI (mGR-OLI)', 'In vitro, Ov toxicity was slightly lower than Cz, while it showed no toxicity on G. mellonella larvae. Ov, Cz and the mGR-OLI showed the strongest antimicrobial activity for all strains, with an inhibitory concentration of 90% of strains (IC90) equal to 0.25%, 0.13% and 0.33% respectively, and the minimal inhibitory concentration (MIC) values ranging from 0.06% to 0.38% v/v for Oz, 0.06% to 0.31% v/v for Cz and 0.08% to 0.38% v/v for mGR-OLI. Cl and M. piperita had the weakest antimicrobial activity with IC90 >2% and MIC values ranging from 1% to >2% v/v for the former and from 0.25% to >2% v/v for the latter.', '', 'In conclusion, the study confirms the importance of evaluating natural products to consolidate the idea of safe EO applications in reducing and preventing intensive livestock infections.', 35456873),
('Shikonin (SH) -liposome', 'The results showed that SH-liposome was successful with a drug load of 4.6 ', 'SH-liposome showed a sustained-release behavior and improved antibacterial ability in a dose-dependent manner.', 'Conclusion: In conclusion, SH-liposome showed an antibacterial effect against S. aureus, promoted effective healing of infected burn wounds; hence, it could be used as an alternative therapy for drug-resistant infections.', 35286935),
('Qing Guo (QG)', 'All QG extracts especially ethyl acetate extract (QGEAE) were rich in phenolic components, with the minimum inhibitory concentrations (MICs) on H.pylori of 39-625 microg/ml and minimum bactericidal concentrations (MBCs) of 78-1250 microg/ml. Both aqueous extract (QGAE) and QGEAE could induce the morphological and structural changes of H. pylori, inhibit urease activity with IC50 of 1093 microg/ml and 332.90 microg/ml, respectively, and down-regulate the virulence genes, such as vacA and cagA.', '', 'Conclusions: QG may exhibit in vitro anti-H. pylori activity by inhibiting growth, destroying the bacterial structure and down-regulating the expression of virulence factors. Moreover, QG is the homology of food and TCM, which can be considered as a safe and convenient agent against H. pylori infection.', 34464702),
('Tanreqing (TRQ)', 'Tanreqing (TRQ) has been used as an alternative treating agent against MRSA. TRQ targeted cell division to inhibit cell growth as shown by illumination microscopy. Besides, we confirmed that TRQ downregulates the expression of virulence factors such as hemolysin and autolysin.', '', 'Altogether, we have proved TRQ formula to be an effective agent against S. aureus infections.', 35573768),
('Essential oils (Cinnamon) and plant extracts (pomegranate and strawberry trees)', 'Cinnamon, pomegranate, and strawberry trees returned the strongest results and were therefore evaluated in a dry-cured ham-based medium assay with water activity of 0.93 or 0.95. The 10% essential oil of cinnamon was capable of completely inhibiting bacterial growth, while strawberry tree and pomegranate extract also showed antilisterial activity (P > 0.05).', 'Water activity influenced the bacterial count of L. monocytogenes in a dry-cured ham-based medium.', 'Conclusions: There was a reduction in L. monocytogenes with the application of cinnamon essential oil but, because of the negative sensory impact of this particular compound in meat products, we suggest the use of pomegranate or strawberry tree for the biocontrol of Listeria in ready-to-eat products. ', 34378213),
('green algae Ulva lactuca extract and Naturally Derived Antimicrobial Drugs Combined with Ulva lactuca Extract', 'n-hexane extract was found to show effective antibacterial activity towards tested pathogens with the lowest MIC and MBC value. Furthermore, the n-hexane extracts have also been used to enhance the efficacy of the naturally-derived (derived from plants and marine organisms) compounds and conventional antibiotics at their sub-inhibitory concentrations. Most of the tested antibiotics and natural drugs at their sub-MIC were found to exhibit synergistic and additive antibacterial activity towards the tested bacterial pathogens.', '', 'Conclusions: The combining of U. lactuca n-hexane extracts with natural drugs resulted in synergistic and additive bactericidal effects on Gram-positive and Gram-negative human pathogenic bacteria. The present study shows a new alternative strategy to revitalize the antimicrobial activity of naturally derived compounds for treating human bacterial pathogens.', 34425745),
('sanguisorbigenin (SGB) isolated from Sanguisorba officinalis L. with six conventional antibiotics', 'SGB showed significant synergy with antibiotics and reduced the minimum inhibitory concentration of antibiotics by 2-16-fold.', '', 'The results indicated that SGB could inhibit biofilm formation and alter cell membrane permeability in MRSA. In addition, SGB was found to exhibit quite low cytotoxicity and hemolysis. The discovery of the superiority of SGB suggests that SGB may be an antibiotic adjuvant for use in combination therapy and as a plant-derived antibacterial agent targeting biofilms.', 35457049),
('palmarosa, basil and rosemary: essential oils (EOs)', 'Palmarosa oil (PMO) showed significantly (p < 0.05) higher inhibition zones against both A. veronii and A. caviae (n = 30) than basil and rosemary in the disk diffusion assay. The MIC (% v/v) of PMO ranged from 0.008% to 1.00%. The mean MIC was significantly higher for A. caviae (0.48 ', '', 'Palmarosa oil could be explored as an alternative antimicrobial agent for mitigating antimicrobial resistance and managing Aeromonas infection in fish and their risks to public health.', 35355377),
('Compost tea', 'The results showed aerobic liquid fermentation reduced ARGs by 65.93 % and 45.20 % in the compost tea of chicken manure and sludge, enriched ARGs by 8.57 % and 37.41 % in the compost tea of pig manure and bovine manure, and increased MGEs and MRGs by 1.25 ', '', 'Tetracycline resistance genes occupied 62.7 % of total ARGs in the compost tea. Alcaligenes and Bacillus enriched by 0.78-39.31 % in the four compost tea, which metabolites had high antimicrobial activity. The potential host of ARGs accounted for 42.1 % bacteria abundance in the four compost tea.', 35803190),
('rare Greek honeys (Fir, manuka, chestnut, cotton, arbutus, oregano )', 'rare Greek honeys against Verona integron-encoded metallo-beta-lactamase (VIM)- or Klebsiella pneumoniae carbapenemase-producing multidrug-resistant Gram-negative pathogens. Total phenols, total flavonoids and free radical scavenging activities were found higher in cotton, arbutus and manuka honey, and finally, manuka and oregano honeys showed higher tyrosinase inhibition activity and kojic acid levels. The antimicrobial susceptibility depended on the type of honey, on its dilution, on the treatment methodology and on the microorganism. Arbutus honey was the most potent against VIM-producing Enterobacter cloacae subsp. dissolvens in 75% concentration, while fir honey was more lethal for the same microorganism in the 25% concentration. Many honeys outperformed manuka honey in their antibacterial potency.', '', 'Although the antimicrobial potency of different honey varieties dependents on their geographical origin and on their compositional differences, the exact underlying mechanism remains yet unclear.', 35326885),
('22 Iranian Endemic or Rare Plant Extracts', 'against Mtb H37Rv strain, seven clinical MDR-TB, and two XDR-TB isolates using the resazurin microtiter assay (REMA) method. Out of the 22 plants, 14 plant extracts demonstrated anti-mycobacterial activity with minimum inhibitory concentration (MIC) ranging from 4 to 30microg/mL against Mtb H37Rv. Eight plant extracts also exhibited anti-mycobacterial activity against MDR and XDR clinical strains of Mtb by MICs, i.e., 15-60microg/ml. Crinitaria grimmii and Linum album were the best antimycobacterial plants. Among fractions of Crinitaria grimmii, dichloromethane and n-butanol, and for Linum album, dichloromethane and Ethyl-Acetate fractions displayed more anti-mycobacterial effect as compared to crude extract on Mtb.', '', 'Conclusion: The present study confirms the potential role of some plants to treat respiratory diseases as our results have demonstrated that these plants exhibit anti-mycobacterial activity in the acceptable range against Mtb. Thus, these plants could be good sources and alternatives of plant metabolites for anti-TB-drug development.', 33588723),
('diethyl ether extracts from six medicinal plants', 'diethyl ether extracts from six medicinal plants grown in Viet Nam against Staphylococcus aureus and its variants', '', 'The findings provided evidence of the low-resistance tendency of S. aureus to antimicrobial plant extracts. It is the first time a collateral antibiotic sensitivity of S. aureus adapted to natural compounds has been observed, suggesting an alternative approach to fight antibiotic resistance.', 35285051),
('Anatolian honey bee venom', 'Anatolian (Anadolu) honey bee venom (HBV) against Gram-positive and Gram-negative bacteria and yeast-like fungi. The results of MIC values were varied from 3.06 microg/mL to 50 microg/mL for the tested microorganisms. It was found that Mycobacterium smegmatis and Streptococcus pyogenes were the most susceptible bacteria (3.06 microg/mL), followed by Vibrio sp., Aeromonas sobria, Enterococcus faecalis, Listeria monocytogenes, Staphylococcus aureus (MRSA) and B. subtilis with a MIC concentration of 6.125 microg/mL.', '', 'These findings strongly suggest that Anatolian HBV will be developed as a new antibacterial-antifungal drug against Gram-positive, Gram negative and antibiotic-resistant bacteria and yeast-like fungi. However, further research is required to evaluate their in vivo efficacy and safe and effective delivery methods for their therapeutic use.', 35421436),
('Patchouli essential oil', 'Antioxidant studies estimated by 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging method showed that the PEO has effective antioxidant activity (IC50 19.53 Microgram/mL). At sub-lethal concentrations, PEO potentially reduced the QS regulated violacein synthesis in CV12472 without inhibiting its cell proliferation. Moreover, it also effectively reduced the production of some QS regulated virulence factors and biofilm development in P. aeruginosa PAO1 without hindering its growth.', '', 'The overall results, in vitro and in silico, suggest that PEO could be applied as biocontrol agent against antibiotic resistance pathogens.', 32838699);
INSERT INTO `bacteria_naturalproduct` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('essential oil extracted from Artemisia aragonensis Lam', 'EOA exhibited significant antioxidant activity as measured by DPPH and FRAP assays, with IC50 and EC50 values of 0.034 ', '', 'The results of the current study highlight the importance of EOA as an alternative source of natural antioxidant and antibacterial drugs to combat antibiotic-resistant microbes and free radicals implicated in the inflammatory responses accompanying microbial infection.', 35164402),
('Lucilia sericata', 'Lucilia sericata, is used to treat problematic wounds due to its debridement capabilities and its excretions and secretions that kill some pathogenic bacteria. There was a greater response to P. aeruginosa that increased over time, while few genes responded to A. baumannii exposure, and expression was not time-dependent.', '', 'The response to feeding on pathogens indicates a few common responses and features distinct to each pathogen, which is useful in improving the wound debridement therapy and helps to develop biomimetic alternatives.', 34613655),
('combination of tetracycline with the three EOs, C. capitatus, E. caryophyllata, and T. vulgaris', 'Among the EOs, C. capitatus displayed the best bioactivity in terms of MICs, with the lowest values (0.31 and 0.625 microl/ml). On the contrary, the strains showed the ability to grow in the presence of the maximum concentration of tetracycline employed (256 microg/ml).', 'While not displaying a real synergism according to the FIC index, the combination of tetracycline compounds and the three EOs resulted in a significant reduction in the MIC values to tetracycline (4 microg/ml), suggesting a restoration of the susceptibility to the antibiotic in Salmonella spp.', 'Among the new strategies, the combination of antibiotics with natural compounds such as essential oils (EOs) could be an alternative to challenge bacterial resistance.', 35222307),
('Curcumin loaded PLGA nanoparticles (CUR-NPs)', 'The MIC of nanocurcumin and curcumin for all four H. pylori strains were 8 Microgram/ml and 16 Microgram/ml respectively. The inhibition rate of gastric cancer cells after treatment with curcumin was increased from 6% to 67% for 24h, from 8% to 75% for 48h, from 10% to 83% for 72h. In case of nanocurcumin, the inhibition rate increased from 7% to 69% for 24h, 11% to 87% for 48h and 16% to 97% for 72h. The IC50 of curcumin and Nano-curcumin were 24.20 microM and 18.78 microM respectively for 72 h. The population of cells in sub-G0 population increased from 4.1% in the control group to 24.5% and 57.8% when treated with curcumin and nanocurcumin respectively.', '', 'Conclusion: The Nano curcumin might be used as a potential therapeutics against gastric cancer and H. Pylori. There is need of further in vivo study in order to validate CUR-NPs activity.', 35092372),
('cannabidiol (CBD', 'cannabidiol (CBD), which we have previously shown can enhance the effect of bacitracin (BAC).', '', 'Our study illustrates how antibiotic adjuvants may apply to enhance efficacy of antimicrobial compounds.', 35091344),
('Thymus zygis Essential Oil', 'The T. zygis EO showed antioxidant activity acting through two different mechanisms and antibacterial activity against S. aureus, with antibiofilm and antihaemolytic properties. This EO also demonstrated synergistic or additive interactions in combination with ampicillin, ciprofloxacin or vancomycin against S. aureus strains and, in some cases, changed the antibiotic-resistance phenotype from resistant to susceptible.', '', 'Therefore, the present work demonstrates the good bioactive properties of the EO of T. zygis, mainly the antimicrobial activity against S. aureus, revealing its potential to be used as an antibacterial agent.', 35203749),
('essential oils from selected Iranian plant species such as Ferulago angulata, Zataria multiflora, Cuminum cyminum, and Mentha longifolia', 'Regarding antibiotics, the E. coli strains were highly sensitive to ciprofloxacin. In relation to essential oils, the most effective antibacterial activity was observed with Zataria multiflora; also, the bacteria were semi-sensitive to Cuminum cyminum and Mentha longifolia essential oils. All strains were resistant to Ferulago angulata essential oil.', '', 'According to the results, the essential oil of Zataria multiflora can be considered as a practical and alternative antibacterial strategy to inhibit the growth of multidrug-resistant E. coli of dairy origin.', 35056560),
('ethanolic crude extracts of Camellia sinensis', 'The result revealed an exponential increase in susceptibility with a distinctive unit component of the C. sinensis extract at concentrations of 60 and 80 Microg/ml. The extract also possessed antibacterial and antioxidant activities while having phytochemical constituents (flavonoids, alkaloids, phenolics, saponin, cardiac glycosides, etc.). The gas chromatography-mass spectrometry analysis further affirmed the potential of the extract by revealing 52 bioactive components/compounds as shown in the chromatogram.', '', 'Conclusion: The C. sinensis has antimicrobial and antioxidant potentials, and the constituents of the plant might be of therapeutic importance in the management of various diseases, especially those related to Escherichia coli and Salmonella.', 35966211),
('saponin-polybromophenol antibiotic (CU1) from Cassia fistula Bark', 'inhibited transcription from Escherichia coli as well as Mycobacterium tuberculosis RNA Polymerases', '', 'Conclusion: Phyto-chemicals from Cassia fistula bark are abundant, less toxic, target specific and may be a safer low cost drug against MDR bacterial diseases.', 35198968),
('quercetin and myricetin (extracted from L. sibiricus)', 'highest antibiofilm activity against Pseudomonas aeruginosa, respectively, at MIC values of 135 Microgram/mL and 150 Microgram/mL against P aeruginosa', '', 'Thus, the present study suggests that the active compounds from L. sibiricus can be used as an alternate strategy in inhibiting the biofilm formed by pathogenic organisms.', 34989967),
('Chlamydomonas reinhardtii (Cr-SPs)', 'Minimum inhibitory concentration (MIC50) of Cr-SPs against Klebsiella pneumoniae was found to be 850 Microgram/ml, and it is 800 Microgram/ml in Serratia marcescens. Time-kill and colony-forming ability assays suggest the concentration-dependent bactericidal potential of Cr-SPs. Cr-SPs showed 74-100% decrease in biofilm formation in a concentration-dependent manner by modifying the cell surface hydrophobic properties of these bacteria.', '', 'The current study paves way towards developing Cr-SPs as a control strategy for treatment of respiratory tract infections.', 34449042),
('tetrandrine and MCR-1', 'Our find the combination of tetrandrine with colistin enhances the membrane-damaging ability of colistin, undermines the functions of proton motive force (PMF) and efflux pumps in MCR-positive bacteria. The results of molecular docking and RT-PCR analyses showed that tetrandrine not only affects the expression of mcr-1 but is also an effective MCR-1 inhibitor. ings demonstrated that tetrandrine serves as a potential colistin adjuvant against MCR-positive Salmonella.', '', 'Our findings demonstrated that tetrandrine serves as a potential colistin adjuvant against MCR-positive Salmonella.', 35349932),
('Extra virgin olive oil (EVOO- from Olea europaea L. drupes) based formulations in natural deep eutectic solvents (NaDESs)', 'EVOO extract in choline/glycerol showed the highest antibacterial activity against several clinical strains of Staphylococcus aureus, whereas oleacein in choline/propylene glycol was the most effective toward various clinical strains of Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae, all the formulations tested were effective against Candida spp', '', 'In conclusion, our results suggest EVOO-based formulations in NaDESs as an interesting strategy that may help in reducing the risk of development of drug resistance. Under this perspective, the usage of NaDESs for the preparation of new antimicrobial formulations may represent a promising approach.', 35548334),
('rutin', 'to prevent/eradicate Pseudomonas aeruginosa and MRSA urinary catheter biofilms', '', 'Rutin has shown wide antimicrobial and antibiofilm capacity employing a range of mechanisms that might be used for the development of novel antimicrobials.', 35337182),
('3,3''-Diindolylmethane (DIM)', 'Acinetobacter baumannii and Pseudomonas aeruginosa was inhibited respectively by 65% and 70%. Combining the antibiotic tobramycin with DIM enabled a high inhibition (94%) of P. aeruginosa biofilm. A DIM-based formulation, evaluated for its wound-healing efficacy on P. aeruginosa-infected wounds, showed a reduction in its bacterial bioburden, and wound size.', '', 'DIM treatment prevented biofilm formation and destroyed existing biofilm without affecting microbial death rates. This study provides evidence for bacterial virulence attenuation by DIM.', 35631553),
('Carum copticum, Phlomis bruguieri, and Marrubium parviflorum', 'MIC of the extracts of Carum coptimum, Phlomis bruguieri, and Marrubium parviflorum were 3.12, 6.25, and 12.5 mg/ml, respectively. Overall, the highest activity belonged to Carum copticum extract. For the anti-biofilm effect, the OD values of Carum copticum and Marrubium parviflorum were significantly different from that of Phlomis bruguieri.', 'Further studies are recommended to indicate how these extracts perform against the bacteria.', 'Although all of the methanolic herbal extracts can inhibit S. mutans growth and remove the biofilm, the effect of Carum copticum was better than Phlomis bruguieri and Marrubium parviflorum.', 35646170),
('Syncarpia hillii', 'Staphylococcal species were the most susceptible bacterial strain with a MIC value of 0.63 mg/mL to the S. hillii methanol extract. Quercetin-3-O-Beta-D-glucuronide and shikimic acid isolated from S. hillii methanol leaf extracts exhibited enhanced antibacterial effects against the tested bacteria with quercetin-3-O-Beta-D-glucuronide eliciting a MIC value of 0.78 Microgram/mL against E. faecalis.', '', 'Conclusions: S. hillii leaves are comprised of bioactive compounds that are bactericidal against several Gram-positive and Gram-negative bacteria.', 35161262),
('acetonic rosemary and licorice extract', 'in the healing of skin wounds infected with multidrug resistant pathogens', '', 'In vivo histopathological examination revealed that acetonic rosemary and licorice extract could be promising for wound healing, combating MDR pathogens of burn wound infections.', 35727122),
('quercetin and allicin', 'The MIC for allicin and quercetin was found to be 80 Microgram/mL for quercetin and 100 Microgram/mL for amoxicillin against the sessile communities of Pseudomonas aeruginosa associated with the orthopaedic infection.', '', 'The antibiofilm and antimicrobial activities of quercetin and allicin were determined both by in vitro and in silico studies on P. aeruginosa bacterial strain from biofilm-associated orthopaedic infection.', 35142967),
('Antarctic Cultivable Fungus Acrostalagmus luteoalbus CH-6', '72.3-84.8% growth inhibition against C. albicans and Aeromonas salmonicida', '', 'This study further demonstrates the great potential of Antarctic fungi in the development of new compounds and antibiotics.', 35621985),
('(+)-alpha-pinene and (-)-borneol', '(+)-alpha-pinene- against E. coli (MIC = 512 Microgram.mL-1), combined with antibiotics, this compound induced a significant improvement in the activity of conventional antibiotics', '', 'The present findings indicate that (+)-alpha-pinene and (-)-borneol are phytocompounds with the potential to be used in the combat of antibacterial resistance.', 35663042),
('Calcium sulfate beads made with plant essential oil', 'inhibit the growth of Staphylococcus aureus (a major etiological agent of periprosthetic joint infection) in agar pour plates when infused in calcium sulfate beads', '', 'These data indicate that antibacterial PEOs warrant further investigations, and may be useful in developing new treatment strategies for periprosthetic joint infection.', 35802739),
('B. atrophaeus SHB2097 (MW821482)', 'against vancomycin-resistant Enterococcus faecalis, Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus, and Klebsiella pneumonia with MIC 6.25 Microgram/mL', '', 'Noteworthy antibacterial activities against clinically important pathogenic bacteria in conjunction with occurrence of genes coding for antimicrobial metabolites inferred that the marine heterotrophic bacterium B. atrophaeus SHB2097 could be used for the development of antibacterial agents against the emerging antibiotic resistance.', 35179656),
('Artemisia afra Leaf Crude Extract', 'MIC value of 6.25mg/mL was recorded when methanolic extract was applied against all clinical pathogens. Moreover, both methanolic and ethanolic extracts showed MBC value of 12.5mg/mL against the four clinical pathogens. However, the methanolic extract gave MBC value of 6.25mg/mL against E. coli.', '', 'Conclusion: From this study, it can be concluded that it is possible to develop and formulate of new, efficacious, less toxic and inexpensive herbal medicine from A.afra leaf extract that act against multi-antibiotic resistant clinical pathogens.', 35813676),
('natural deep eutectic solvents (NADES)', 'to Increase Their Bioactivity', '', 'In addition, taking into account that the extraction step is crucial for the successful development of new bioactive compounds, the use of novel solvents that increase the phytochemical effect, such as natural deep eutectic solvents (NADES), as well as the recent applications of these solvents as antimicrobials are discussed.', 35699842),
('Essential Oils Isolated from Juniperus oxycedrus L. ssp. macrocarpa Aerial Parts', 'showed potent antibacterial activity against Gram-positive bacteria (0.25-2 v/v%) and Salmonella spp. (4 v/v%). The strongest fungicidal activity was recorded against Candida auris sessile cells (median FICI was 0.088)', '', 'The therapeutic potential of Juniperus may be promising for future more extensive research and in vivo tests to develop new drugs against antibiotic and antifungal resistance.', 35456809),
('Nigella sativa oil extract', 'Tn1546 transposon transfer with its VR markers to VSSA was effectively inhibited in treated VREtfm donor strains', '', 'This work offers new insights for overcoming VR conjugal transfer utilizing natural N. sativa oil, as well as a suggestion for a novel specialized conjugation inhibitor that could effectively facilitate the difficulty of eliminating VR bacteria from healthcare settings.', 35395119),
('Plumbagin', 'in combination with tetracyclines showed a synergistic bactericidal effect against Tet(X3)/Tet(X4)-producing bacteria, effective broad-spectrum inhibitor of Tet(X) (also known as monooxygenase) by simultaneously inhibiting the activity and the production of Tet(X3)/Tet(X4)', '', 'Plumbagin, as an inhibitor of Tet(X3)/Tet(X4), represents a promising lead drug, as well as an adjunct with tetracyclines to treat bacterial infections, especially for extensively drug-resistant bacteria harbouring Tet(X3)/Tet(X4).', 35306337),
('cannabidiol (CBD) plus polymyxin B (PB)', 'against PB-resistant gram-negative bacilli', '', 'The antibacterial efficacy of the combination CBD + PB against multidrug-resistant and extensively drug-resistant GNB, especially PB-resistant K. pneumoniae, is particularly promising.', 35440801),
('Spilanthes acmella based emulgel', 'MIC values of pure extract found in the range of 0.83', '', 'The current study thus suggests the use of S. acmella extract-based emulgel for the treatment of bacterial skin infections caused by S. aureus, P. aeruginosa and E. coli.', 35228190),
('Astragalus candolleanus (A. candolleanus) hydromethanolic root extract', 'against Gram-positive (Bacillus subtilis and Staphylococcus aureus) and Gram-negative (Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Kocuria rhizophila) strains', '', 'Overall results of drug design suggest that myxoxanthophyll is a promising bioactive compound endowed with antibacterial activity.', 35528313),
('polar (PF) and non-polar fractions (NPF) of three common Iris species (I. confusa, I. pseudacorus and I. germanica)', 'I. pseudacorus PF exhibited the most potent effect against S. aureus haemolytic activity, I. pseudacorus NPF showed potent biofilm inhibitory potential of 71.4 and 85.8% against biofilm formation of MRSA and MSSA, respectively.', '', 'Conclusions: This is the sole map represents the secondary metabolites profiling of the PFs and NPFs of common Iris species correlating them with the potent explored Staphylococcus aureus anti-virulence activity.', 34555449),
('Pistacia lentiscus bark methanol extract', 'demonstrated substantial antimicrobial activity with width inhibition zones ranging from 10 to 25 mm, has a greater antibacterial effect on Gram-positive bacteria than Gram-negative bacteria', '', 'Taken together, this study highlights the Pistacia lentiscus bark methanol extract as a promising antimicrobial and antiviral agent.', 35624793),
('armeniaspirol A (ARM1)', 'agents against Gram-positive pathogens, exhibited potent antibacterial activity against H. pylori, including MDRS, with MIC range values of 4-16 Microg ml-1', '', 'Thus, these findings demonstrated that ARM1 is a novel potent anti-H. pylori agent, which can be developed as a promising drug lead for treatment of H. pylori infections.', 33780131),
('quercetin, fisetin, luteolin, 3'',4'',7-trihydroxyflavone, apigenin, kaempferol, and taxifolin', 'potent inhibitors of OXA-48 with IC50 values ranging from 0.47 to 4.54 MicroM, Quercetin, fisetin, luteolin, and 3'',4'',7-trihydroxyflavone effectively restored the antibacterial efficacy of piperacillin or imipenem against E. coli producing OXA-48, resulting in 2-8-fold reduction in MIC. Moreover, quercetin combined with piperacillin showed antimicrobial efficacy in mice infection model.', '', 'These studies provide potential lead compounds for the development of beta-lactamase inhibitors and in combination with beta-lactams to combat OXA-48 producing pathogen.', 35814247),
('Hypericum brasiliense', 'until 4 Microg/mL, the Hypericum brasiliense extract showed bactericidal activity against a clinical multidrug-resistant S. aureus strain (HU25) and also inhibited biofilm formation at 1/2xMIC (confirmed by SEM) and 1/4xMIC. The extract was also proportionally active against 6 h-preformed biofilm to its concentration (1/2xMIC, 1/4xMIC, p value = 0.05)', '', 'These promising results make Hypericum brasiliense extract a strong candidate to treat S. aureus infections, including anti-biofilm therapy.', 34075848),
('Syzygium aromaticum', 'The S. aromaticum extracts, aqueous extract (AE) and 75% hydroalcoholic extract (HE), exerted significant antibacterial activities against both antibiotic-sensitive and -resistant H. pylori strains with MICs of 160~320 Microg/ml, without developing drug resistance.', '', 'S. aromaticum extracts were found to combated the abnormal activation of PI3K-Akt and MAPK signaling pathways to treat H. pylori infection. This study should accelerate further research and application of S. aromaticum against H. pylori infection.', 35032584),
('pogostone in combination with polymyxin', 'potential inhibitor of MCR-1 for the treatment of infections caused by MCR-1-positive drug-resistant bacteria, especially MCR-1-positive carbapenem-resistant Enterobacteriaceae (CRE)', '', 'Our results confirm that pogostone is a potential inhibitor of MCR-1 for use in combination with polymyxin for the treatment of severe infections caused by MCR-1-positive Enterobacteriaceae.', 35566163),
('Garlic and Thyme Essential Oils', 'against Salmonella typhimurium', '', 'Therefore, these EOs are considered as potential natural antibacterial options that could be applied in food industry.', 35408576),
('Essential Oil from Syzygium cumini (L.) Skeels synergism with gentamicin, erythromycin and norfloxacin', 'The oil showed moderate activity against E. coli ATCC 25922, with the MIC of 512 Microg/mL; there was no activity against the other strains.', '', 'The oil potentiated the effect of antibiotics demonstrating possible synergism when associated with gentamicin, erythromycin and norfloxacin against E. coli 06 and S. aureus 10.', 35630757),
('Morchella esculenta and Morchella conica', 'All fungal extracts inhibited growth of tested bacteria with inhibitory zone ranging from 10.66 ', '', 'In conclusion, the growth inhibition of tested bacteria by fungal extracts revealed their potential as antibacterial agents and their compounds may be used as drug candidates.', 35699800),
('Riccionidin A, Dothistromin, Fustin, and Morin', 'against S. sonnei infections', 'To confirm their efficacy and evaluate their drug potency, further in vitro analyses are required.', 'This study suggests that these phytochemicals could be used as antibacterial drugs to treat S. sonnei infections in the future.', 35241965),
('Peganum harmala seed extract', 'P. harmala n-BuOH extract exhibited potent bactericidal activity against PAO1 strain at MIC value corresponding to 500 microg/mL and attained 100% killing effect at 24 h of incubation. Furthermore, P. harmala n-BuOH extract showed an antibiofilm activity against P. aeruginosa PAO1 and exhibited 80.43% inhibition at sub-inhibitory concentration. The extract also eradicated 83.99% of the biofilm-forming bacteria.', '', 'Our results revealed that P. harmala seed extract and its active compound harmaline could be considered as a candidate for a new treatment of multidrug-resistant P. aeruginosa pathogens-associated biofilm infections.', 34999965),
('Flavonolignans from silymarin (Silybin A, 2,3-dehydrosilybin B, and 2,3-dehydrosilybin AB)', 'Silybin A, 2,3-dehydrosilybin B, and 2,3-dehydrosilybin AB completely reversed antibiotic resistance at concentrations of 20 MicroM or less.', '', 'In conclusion, the selected flavonolignans, particularly derivatives of 2,3-dehydrosilybin B, 2,3-dehydrosilybin AB, and silybin A are non-toxic modulators of S. aureus multidrug resistance and can decrease the virulence of the bacterium, which deserves further detailed research.', 35303568),
('Boletus edulis (B. edulis) and Neoboletus luridiformis (N. luridiformis) aqueous and methanolic extracts', 'against ESKAPE isolates from clinical wound infections', '', 'Overall, the tested mushrooms extracts are good candidates to further explore its use in the prevention of wound infection, particularly by multidrug-resistant pathogens.', 35281762),
('combination of Ethyl Acetate Fraction (EAF) and synthetic antibiotics (ampicillin, azithromycin, ciprofloxacin, or gentamicin) [Cinnamomum verum leaves extract and fractions]', 'provides a synergistic effect against multidrug resistant strains)', '', 'The results are useful to obtain multi-targeting in a single therapy solution, which on antioxidants molecules plant-derivatives can act synergistically in antimicrobial combinations, a valuable aid as bacterial resistance modifying compounds.', 33749459),
('essential oil of Ocotea odorifera (EOOO) and safrole', 'Both the essential oil and the isolated compound showed clinically relevant antibacterial activities against S. aureus. Regarding the modulation of antibiotic resistance, the EOOO was found to enhance the activity of erythromycin against the strains of P. aeruginosa and S. aureus, as well as improving the action of gentamicin against S. aureus.', '', 'It is concluded, therefore, that the EOOO and safrole can enhance the activity of macrolides and aminoglycosides, and as such are useful in the development of therapeutic tools to combat bacterial resistance against these classes of antibiotics.', 34656506),
('neem oil extract or nimbolide', 'effective against H. pylori and its biofilms; MICs and MBCs against the nine tested strains ranged between 1.25-5 Microg/mL and 2.5-10 Microg/mL, respectively', 'The bactericidal activity of nimbolide was time- and dose-dependent, independent of active H. pylori growth, and synergistic with low pH.', 'Conclusions: Nimbolide has significant bactericidal activity against H. pylori, killing both free living bacterial cells as well as cells within a biofilm. Furthermore, the lack of hemolytic activity, synergistic activity at low pH and bactericidal properties even against bacteria in a state of growth arrest are all ideal pharmacological and biologically relevant properties for a potential new agent. This study underscores the potential of neem oil extract or nimbolide to be used as a future treatment for H. pylori infection.', 34763046),
('acetone extract and isolated metabolites from Usnea laevis Nyl.', 'Initially, Ul has shown prominent inhibitory activity (IC50 value: 5.44 ', '', 'Conclusions: The current study lends the first evidence for the presence of antimycobacterial metabolites in U. laevis. The results exposed the Andean folklore use of U. laevis for treating Tb, and the key biomarker metabolites were found to be 1 and 4. Hence, it can be concluded that U. laevis can be used as a potential source for the novel drug development for MDR-Tb.', 34536516),
('Guaiacol (2-methoxy phenol) an active Ingredient of Campsis radicans Essential Oils', 'MBC (MFC) ranged from 0.270 to 0.439 microgram/ml in the free form and from 0.055 to 0.133 microgram/ml in the encapsulated form, EE was 86% particle size on Pseudomonas aeruginos, Escherichia coli, and Candida albicans.', '', 'It was observed that both free and encapsulated forms of Guaiacol had an antimicrobial effect on cotrimoxazole-resistant Pseudomonas aeruginosa, cefixime-resistant Escherichia coli, and fluconazole-resistant Candida albicans., but the encapsulated form had a more antimicrobial effect due to more stability and a more targeted effect.', 36201048),
('Thymus vulgaris an essential oil (TVEO)', 'The obtained MIC values indicates that TVEO was more potent against Gram-positive bacteria ( MICs=0.097 milligram/mL) than Gram-negative bacteria ( MICS=0.195milligram/mL)', 'It is demonstrated through VEGA QSAR that TVEO could be a safe resource for potential antibacterial agents', 'molecular docking simulations revealed that TVEO compounds such as thymol and beta-sesquiphellandrene had an effective antibacterial activity against the tested bacteria by inhibiting topoisomerase II and DNA and RNA polymerase functions leading to vigorous impairment of bacterial DNA replication and transcription processes', 35909468),
('essential oils (EOs) (tea tree, clove, thyme, mentha and basil EOs),', 'The most potent EOs against C. acnes and S. epidermidis were tea tree and thyme, showing MIC values against C. acnes of 0.053 g/mL and 0.026 g/mL, respectively . Tea tree and thyme EOs also showed the lowest MIC values of 0.053 g/mL against S. epidermidis.', '', 'Thyme EO affected cell membrane permeability of both bacterial species, evident by the detection of the leakage of intracellular ions and membrane integrity by the leakage of nucleic acids. Hence thyme EO nanoemulsion showed potent antimicrobial and anti-inflammatory effects compared to the reference antibiotics, suggesting its effectiveness as a natural alternative in acne treatment.', 36144477),
('polyherbal nanocolloids (PHNc)', 'Polyherbal nanocolloids (PHNc) was formulated by using the extracts of Syzygium aromaticum, Cinnamomum verum, Emblica officinalis, Terminalia belerica, Terminalia chebula, and Cymbopogon citratus and physicochemically characterized. From mastitis milk samples, microorganisms were isolated including Acinetobacter junii, Klebsiella pneumoniae, Pseudomonas stutzeri, and Acinetobacter baumannii and screened for antibiotic susceptibility. All the isolated strains were tested with PHNc and compared with antibiotics. Minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and biofilm assays were performed at different concentrations, and antibacterial effects were quantified.', '', 'In our results, PHNc showed potent bacteriostatic, bactericidal, and antibiofilm activity against all the strains. Our results indicated that PHNc can reduce the virulence factors responsible for infection by different bacterial strains. This study confirmed that PHNc had the potential to inhibit the growth of pathogenic Gram-negative and Gram-positive strains and could be utilized as an alternative to antibiotics to inhibit multidrug-resistant microbial pathogens in cattle.', 34762270),
('Hubballi Propolis by Apis Mellifera bees', 'MIC range from 0.1 milligram/ml to 0.25 milligram/ml against Aggregatibacter actinomycetemcomitans', '', 'Hubballi Propolis is effective against Aggregatibacter actinomycetemcomitans infection thus may help in treating peri-implantitis.', 36110765),
('chlorotonil 2b', 'molecule 2 b retained nanomolar activity while being stable in vivo', '', 'Furthermore, in vivo stability of the derivatives was improved while retaining their nanomolar activity against critical human pathogens (e.g. methicillin-resistant Staphylococcus aureus and P. falciparum). Intriguingly, we showed further superb activity for the frontrunner molecule in a mouse model of S. aureus infection.', 35485800),
('Essential oil (EO) of Tagetes lucida Cav with bioactive compounds - methyl eugenol (relative abundance in EO: 46', 'The mixture (PREO) of those compounds at those proportions inhibited the growth of P. aeruginosa in 45% at 683', '', 'The PREO had higher antibacterial and modulatory activities than the original EO. the PREO, and its components, show potential as alternatives to manage multidrug-resistant pathogens.', 35419861);

-- --------------------------------------------------------

--
-- Table structure for table `bacteria_novelagent`
--

CREATE TABLE IF NOT EXISTS `bacteria_novelagent` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `bacteria_novelagent`
--

INSERT INTO `bacteria_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('(Z)-N-benzylidene-2-(tert-butoxycarbonylamino)-1-(5-iodo-1H-indol-3-yl)ethanamine oxide', 'fourfold decrease of the ciprofloxacin minimum inhibitory concentration against the SA-1199B strain when used at a concentration of 0.5 mg L(-1)', '', '1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors.', 24677763),
('13-Deoxytetrodecamycin (WAC04657)', 'Potent bioactivity against Gram-positive pathogens including multidrug-resistant Staphylococcus aureus and Gram-negative pathogens', '', '13-Deoxytetrodecamycin has potent bioactivity against Gram-positive pathogens including multidrug-resistant Staphylococcus aureus.', 26014719),
('3''-bromo-3''-deoxy-arabinofuranosylthymine (33)', 'MIC(50) = 1 microg/mL against wild-type M. tuberculosis strain (H37Ra) and 1-2 microg/mL against rifampicin-resistant and isoniazid-resistant) strains of M. tuberculosis', 'No cytotoxicity was found up to the highest concentration of compounds tested (CC(50) > 100-200 microg/mL) against a human cell line', '3''-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis. T', 20420370),
('thiosemicarbazide intermediates', 'thiosemicarbazide intermediates in the syntheses of these compounds are also moderately potent inhibitors of the IMP-1 MBL (metallo-?-lactamases) from Pseudomonas aeruginosa', 'NA', '3-mercapto-1,2,4-triazoles and N-acylated thiosemicarbazides as metallo-?-lactamase inhibitors. The production of ?-lactamases is an effective strategy by which pathogenic bacteria can develop resistance against ?-lactam antibiotics.', 22115595),
('4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-methoxypyridin-2-yl)piperazine- 1-carbothioamide (ML267)', 'exhibit submicromolar inhibition of bacterial Sfp-PPTase with no activity toward the human orthologue', '', '4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-methoxypyridin-2-yl)piperazine- 1-carbothioamide (ML267), a potent inhibitor of bacterial phosphopantetheinyl transferase that attenuates secondary metabolism and thwarts bacterial growth.', 24450337),
('4-Aminoquinolone piperidine amides (AQs)', 'potent DprE1 inhibition (IC50 < 10 nM) along with potent cellular activity (MIC = 60 nM) against Mtb', '', '4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.', 24871036),
('6 beta-Iodopenicillanic acid (UI-38,006)', 'Active against beta-lactamase-producing strains of Staphylococcus aureus, Haemophilus influenzae, Bacteroides fragilis.', '', '6 beta-Iodopenicillanic acid (UI-38,006), a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactam compounds: initial bacteriological characterizationUK-38,006, 6 beta-iodopenicillanic acid, was shown to be a potent inhibitor of beta-lactamase enzymes.', 6272628),
('poly-D-lysine-Le(b) hexasaccharide and an Le(b) human serum albumin conjugate', 'inhibited adherence of H. pylori to gastric epithelium and displaced adherent bacteria when added to human stomach sections', '', 'A human domain antibody and Lewis b glycoconjugate that inhibit binding of Helicobacter pylori to Lewis b receptor and adhesion to human gastric epithelium', 19832116),
('Nitrofuranylamides (NFAs)', 'Highly active against drug-susceptible and -resistant strains of M. tuberculosis, with MICs 0.0004-0.05 mg/L', '', 'A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents', 18693235),
('bispecific antibody BiS4', 'effective against Pseudomonas aeruginosa', '', 'A multifunctional bispecific antibody protects against Pseudomonas aeruginosa. Widespread drug resistance due to empiric use of broad-spectrum antibiotics has stimulated development of bacteria-specific strategies for prophylaxis and therapy based on modern monoclonal antibody (mAb) technologies.', 25391481),
('aryl isonitrile analogs', '(MIC, in ?M) of isonitrile compounds, against methicillin-sensitive (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) strains rnge 2 - >128 in ?M. The most potent antibacterial aryl isonitrile analogs (MIC 2 ?M) did not show any toxicity against mammalian cells up to a concentration of 64 ?M.', '', 'A new class of compounds featuring an aryl isonitrile moiety has been discovered that exhibits potent inhibitory activity against several clinically-relevant MRSA and VRSA isolates.', 26164843),
('ketolides prepared with the (R)-alkyl group, compound 5p with an N-(3-quinoxalin-6-yl-propyl)-propionamide moiety', 'potent in vitro antibacterial activities against the key respiratory pathogens including Haemophilus influenzae and erythromycin-resistant S. pneumoniae', '', 'A new type of ketolide bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether: synthesis and structure-activity relationships', 16460944),
('6-Benzyl Ether Benzoxaborole', 'MIC 2 ?M', 'no cytotoxicity against eukaryotic cells', 'A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis In Vitro. We identified a novel 6-benzyl ether benzoxaborole with potent activity against Mycobacterium tuberculosis', 28674058),
('6-O-substituted 8a-aza-8a-homoerythromycin A 3-O-acylides', 'Activity against Haemophilus influenzae and constitutively MLSB-resistant strains of Streptococcus pneumoniae and Streptococcus pyogenes', '', 'A novel series of 6-O-substituted 8a-aza-8a-homoerythromycin A 3-O-acylides has been discovered with potent activity against key respiratory pathogens, including those inducibly and constitutively resistant to erythromycin.', 27657812),
('6,9:11,12-dicarbonate acylide 47 (FMA0122) and 11,12-carbamate acylide 19 (TEA0929)', 'Activity against almost all gram positive and negative pathogens', '', 'A novel series of acylides, 3-O-(aryl)acetylerythromycin A derivatives, were synthesized and evaluated.', 12801234),
('1beta-methyl-2-(5-substituted thiazolo pyrrolidin-3-ylthio)carbapenem derivatives', 'Activities against both Gram-positive including MRSA and Gram-negative bacteria , compound 28c having 4''-amide substituted thiazole moiety is most potent', '', 'A particular compound (28c) having 4''-amide substituted thiazole moiety showed the most potent antibacterial activity.', 12350291),
('7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-ethoxyiminoacetamido]-3-[1-(3-methy laminopropyl)-1H-imidazo[4,5-b]pyridinium-4-yl]methyl-3-cephem-4-carboxylate sulfate (S-3578)', 'activity against both gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and gram-negative bacteria including Pseudomonas aeruginosa', '', 'A series of 7-aminothiadiazolylcephalosporins having a 1-(substituted)-1H-imidazo[4,5-b]pyridinium group at the C-3'' position of the cephem nucleus were synthesized and evaluated for in vitro antibacterial activities.', 12546419),
('1-cyclopropyl-6-fluoro-1, 4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxyli c acid hydrochloride (grepafloxacin)', 'in vitro antibacterial activity against Streptococcus pneumoniae and high in vivo efficacy on the experimental systemic infections caused by the Gram-positive and -negative bacteria tested.', '', 'A series of substituted 1-cyclopropyl-6-fluoro-1, 4-dihydro-5-methyl-4-oxo-3-quinoline carboxylic acids was synthesized and tested for their in vitro and in vivo antibacterial activity.', 8770395),
('ABT773', '(MIC-90=0.03 mg/l) against the staphylococci , MIC-90 range: <0.0075-0.5mg/l against Streptococcus pneumoniae, S. pyogenes and S. agalactiae irrespective of their antibiotic resistance phenotype.', '', 'ABT773 displays the characteristics of a promising agent that deserves to be introduced as the empirical therapy of infections caused by the bacterial species tested here, even if they are multiply resistant.', 14732308),
('AFN-1252', 'Maximum reductions in viable count against MSSA 29213 and MRSA S186 were approximately 4 logs, achieved by 450 mg q12h (fAUC/MIC = 1875) dosing at 28 hours', '', 'Activity of AFN-1252, a novel FabI inhibitor, against Staphylococcus aureus in an in vitro pharmacodynamic model simulating human pharmacokinetics.', 23433442),
('Debio1452 (previously AFN-1252)', 'The MIC50s for MSSA, MRSA, and molecularly characterized MRSA strains were 0.004 ?g/ml, and the MIC90s ranged from 0.008 to 0.03 ?g/ml. Fot coagulase-negative staphylococci (CoNS) MIC50/90, 0.015/0.12 ?g/ml', '', 'Activity of Debio1452, a FabI inhibitor with potent activity against Staphylococcus aureus and coagulase-negative Staphylococcus spp., including multidrug-resistant strains. Staphylococcus aureus and coagulase-negative staphylococci', 25691627),
('BAL19403, novel macrolide', 'Potent activity against propionibacteria in vitro, >10-fold higher activity than erythromycin', '', 'Activity of the novel macrolide BAL19403 against ribosomes from erythromycin-resistant Propionibacterium acnes.', 17923495),
('PYRRO-C3D, cephalosporin-3-diazeniumdiolate nitric oxide (NO) donor prodrug', 'a log fold reduction (10-fold reduction or 1-log-unit reduction) in viability (P < 0.05) relative to azithromycin alone.', '', 'Adjunctive therapy with NO mediated through PYRRO-C3D represents a promising approach for reducing biofilm-associated antibiotic tolerance.', 27919896),
('aerosolized colistin sodium', 'The mean time to spontaneous emergence of sensitive organisms was 144.6+/-48.0 days in candidates who did not use colistin sodium and was significantly longer than in the candidates who used colistin sodium (P=0.007).', '', 'Aerosolized colistin sodium may be a useful therapy to promote emergence of sensitive microbes in CF candidates with pan-resistant isolates of Pseudomonas.', 9311714),
('1,4-naphthoquinones', 'The EC50 was 8 microg/ml for 5-amino-8-hydroxy-1,4-naphthoquinone against S. aureus, S. intermedius, and S. epidermidis.', '', 'An effective in vitro activity of 5-amino-8-hydroxy-1,4-naphthoquinone and encourage further studies for its application in antibiotic therapy.', 12131921),
('3''-azido-3''-deoxythymidine (BW A509U).', 'potent bactericidal activity against many members of the family Enterobacteriaceae, including strains of Escherichia coli, Salmonella typhimurium, Klebsiella pneumoniae, Shigella flexneri, and Enterobacter aerogenes', '', 'Antibacterial activity and mechanism of action of 3''-azido-3''-deoxythymidine (BW A509U). The thymidine analog 3''-azido-3''-deoxythymidine (BW A509U; azidothymidine [AZT]) had potent bactericidal activity against many members of the family Enterobacteriaceae, including strains of Escherichia coli, Salmonella typhimurium, Klebsiella pneumoniae, Shigella flexneri, and Enterobacter aerogenes.', 3551832),
('2-(2'',4''-Dibromophenoxy)-4,6-dibromophenol', 'MIC range was 0.117-2.5 microg/mL against all the Gram positive bacteria and 0.5-2 microg/mL against Gram negative bacteria', '', 'Antibacterial activity of 2-(2'',4''-dibromophenoxy)-4,6-dibromophenol from Dysidea granulosa.', 19841726),
('7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-cyclopentyloxyiminoacetamido]-3-(3, 6-diaminoimidazo[1,2-b]pyridazinium-1-yl)methyl-3-cephem-4-carboxylate', 'IC50 = 1.6 microg/ml for penicillin binding protein 2'' (PBP2''', '', 'Antibacterial Activity of 7?-[2-(5-Amino-1, 2, 4-thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3-(substituted imidazo[1, 2-b]pyridazinium-1-yl)methyl-3-cephem-4-carboxylates and Related Compounds', 11132951),
('AM-1155, a novel fluoroquinolone', 'For experimental murine pneumonia with S. pneumoniae intermediately resistant to penicillin, oral administration of AM-1155 showed efficacy higher than that of levofloxacin and equal to that of sparfloxacin.', '', 'Antibacterial activity of AM-1155 against penicillin-resistant Streptococcus pneumoniae. AM-1155, a novel fluoroquinolone, exhibited potent activity against Streptococcus pneumoniae, including penicillin-resistant strains; the MIC90 for 48 clinical isolates was 0.25 mg/L.', 9511043),
('1,13-bis{[(2,2-diphenyl)-1-ethyl]thioureido}-4,10-diazatridecane', 'Bactericidal activity, primarily by depolarization of the cytoplasmic membrane and permeabilization of the bacterial outer membrane.', 'limited adverse effects against the HEK293T human kidney embryonic cells and A549 human adenocarcinoma cells', 'Antibacterial Diamines Targeting Bacterial Membranes.', 26964758),
('ether derivative ?-artecyclopropylmether', 'Exhibited MIC range, MIC(90), and minimum bactericidal concentration range values of 0.25 to 1.0 ?g/ml, 1.0 ?g/ml, and 1 to 16 ?g/ml, respectively, against both resistant and sensitive strains of H. pylori.', '', 'Anti-Helicobacter pylori potential of artemisinin and its derivatives', 22687518),
('Ceragenins CSA-8 and CSA-13, cationic steroid molecules', 'Activities against clinical isolates of vancomycin-intermediate S. aureus (VISA), heterogeneous vancomycin-intermediate S. aureus (hVISA), as well as vancomycin-resistant S. aureus (VRSA)', '', 'Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus. The rise in the rates of glycopeptide resistance among Staphylococcus aureus isolates is concerning and underscores the need for the development of novel potent compounds.', 17210765),
('PD127391 (CI-960 and AM-1091) and PD131628, new quinolones', 'PD127391 MIC90, 2 micrograms/ml and PD131628 MIC90 greater than 8 micrograms/ml against Bacteroides fragilis; PD127391 MIC90s, 0.015-1.0 micrograms/ml and PD131628 MIC90s, 0.03 - greater than 8 micrograms/ml against Gram-positive organisms.', '', 'Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628.', 1665774),
('BC-3781, pleuromutilin compound', 'BC-3781 exhibited potent activity against methicillin-resistant Staphylococcus aureus (MIC(50/90), 0.12/0.25 ?g/ml), coagulase-negative staphylococci (MIC(50/90), 0.06/0.12 ?g/ml), ?-hemolytic streptococci (MIC(50/90), 0.03/0.06 ?g/ml), viridans group streptococci (MIC(50/90), 0.12/0.5 ?g/ml), and Enterococcus faecium (including vancomycin-nonsusceptible strains) (MIC(50/90), 0.12/2 ?g/ml).', '', 'Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections', 22232289),
('RLP068/Cl', 'Quantitative CLSM studies showed a reduction in biofilm biomass (biofilm disruption) and a decrease in viable cell numbers, as determined by standard plate counting, in the S. aureus and P. aeruginosa biofilms exposed to APDT with the photosensitiser RLP068/Cl.', '', 'Antimicrobial photodynamic therapy (APDT), a non-antibiotic broad-spectrum antimicrobial treatment, is also active against multidrug-resistant micro-organisms such as meticillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.', 24933446),
('1-tert-butyl-1,4-dihydro-7-(4,4-dimethyloxazolidin-3-yl)-6-nitro-4-oxo-1,8-naphth yridine-3-carboxylic acid (10q)', 'MIC of 0.1 microM against MTB and MDR-TB', '', 'Antimycobacterial activities of novel 1-(cyclopropyl/tert-butyl/4-fluorophenyl)-1,4-dihydro- 6-nitro-4-oxo-7-(substituted secondary amino)-1,8-naphthyridine-3-carboxylic acid', 17960928),
('cerulenin', 'MICs ranging from 1.5 to 12.5 mg/L against Mycobacterial species, inhibition of fatty acid synthesis', '', 'Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis.', 11252327),
('2-isonicotinoyl-N-[2-(trifluoromethyl)phenyl]hydrazinecarbothioamide (4i)', 'Minimum inhibitory concentration of 0.58 microM against M. tuberculosis H(37)R(v) and INH resistant M. tuberculosis', '', 'Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis.', 18343086),
('TD-1792, a multivalent glycopeptide-cephalosporin', 'potent bactericidal activity at ? 0.12 ?g/ml, highly active against methicillin-susceptible S. aureus (MIC(90), 0.015 ?g/ml), methicillin-resistant S. aureus, and heterogeneous vancomycin-intermediate S. aureus (MIC(90), 0.03 ?g/ml)', '', 'Antistaphylococcal activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic.', 22203585),
('Plakofuranolactone', 'The quorum quenching activity of plakofuranolactone was evaluated using reporter gene assays for long- and short-chain signals (E. coli pSB1075, E. coli pSB401, and C. violeaceum CV026) and was confirmed by measuring the total protease activity (a virulence factor which is under control of the LasI/R system) of the wild-type P. aeruginosa PAO1.', '', 'As an alternative to the classic antibiotic therapy, attenuation of the bacteria virulence affecting their Quorum sensing (QS) system is a promising approach. A new ?-lactone that is capable of inhibiting the LasI/R QS system, plakofuranolactone (1), was discovered in the extract of the marine sponge Plakortis cf. lita, and its structure, including absolute configuration, was determined by NMR spectroscopy, MS spectrometry, and quantum-mechanical prediction of optical rotation.', 28264490),
('Auranofin and N-heterocyclic carbene gold-analogs', 'Auranofin completely inhibited H. pylori growth at 1.2 ?M, gold(I)-N-heterocyclic carbene compounds has MICs against H. pylori (2 ?M)', 'lower toxicities for human embryonic kidney cells (HEK-293T cells)', 'Auranofin and N-heterocyclic carbene gold-analogs are potent inhibitors of the bacteria Helicobacter pylori. Auranofin is an FDA-approved gold-containing compound used for the treatment of rheumatoid arthritis.', 27279627),
('AZ6142, bacterial topoisomerase inhibitors', 'inhibits both type II topoisomerases in S. aureus but that DNA gyrase is the primary target', '', 'AZ6142 has very potent activity against Gram-positive organisms, including Staphylococcus aureus, Streptococcus pneumoniae, and Streptococcus pyogenes.', 26077256),
('ABT-773, a new ketolide', 'Activity against macrolide-susceptible and -resistant S. pneumoniae', '', 'Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.', 12234843),
('BAL30072, a novel siderophore sulfactam', 'The MIC(90)s were 4 microg/ml for MDR Acinetobacter spp. and 8 microg/ml for MDR P. aeruginosa, whereas the MIC(90) of meropenem for the same sets of isolates was >32 microg/ml.', '', 'BAL30072 showed potent activity against multidrug-resistant (MDR) Pseudomonas aeruginosa and Acinetobacter sp. isolates, including many carbapenem-resistant strains.', 20308379),
('nitrobenzotrifluoride-containing ohydroxybenzylamine derivatives (3a-3x)', 'FabH inhibitors, inhibitory potency against the aminoacylation of S. aureus tyrosyl-tRNA synthetase', '', 'Based on our previous findings that o-hydroxybenzylamine derivatives demonstrated potent FabH inhibitory and antimicrobial activities, computer-assistant drug design was introduced and then a series of novel nitrobenzotrifluoride-containing ohydroxybenzylamine derivatives (3a-3x) was designed and synthesized.', 25219926),
('chimeric protein containing human FH domains 6 and 7 fused to human IgG1 Fc (FH6,7/HuFc)', 'At 8 to 9 h after the challenge, the FH6,7/HuFc-treated rats had >100-fold fewer CFU per ml of blood than control animals pretreated with phosphate-buffered saline (PBS) or FH18-20/HuFc, which does not bind to meningococci (P < 0.0001).', '', 'Because many microbes share a common binding region(s) in FH, FH/Fc chimeric proteins may be a promising candidate for adjunctive therapy against drug-resistant pathogens. Copyright ? 2014, American Society for Microbiology.', 25143339),
('Benzoyl peroxide', '', '', 'Benzoyl peroxide may have underappreciated potential to treat noninflammatory acne as monotherapy or in combination with a topical retinoid, an important antibiotic-sparing strategy.', 19202772),
('benzoyl peroxide', 'reduce total P acnes count by 99.7%', '', 'Benzoyl peroxide works rapidly on P acnes without causing antibiotic resistance.', 23839205),
('Combination of Tobramycin and bicarbonate', '', '', 'Bicarbonate synergises with tobramycin to enhance killing of planktonic bacteria.', 28721244),
('dipyridinium-based cationic amphiphile (compound 1) and compound 1-loaded nanocarrier', 'Anti-biofilm activity on Staphylococcus aureus MTCC 96 and Pseudomonas aeruginosa MTCC 2488', '', 'Biocompatible nanocarrier fortified with a dipyridinium-based amphiphile for eradication of biofilm.', 25162678),
('9H-isothiazolo[5,4-b]quinoline-3,4-diones containing heteroaromatic groups at the 7-position', 'Potent antistaphylococcal activity (MICs 2 microg/mL) against a multi-drug-resistant strain (ATCC 700699)', 'low cytotoxic activity (CC(50)>100 microM) against the human cell line Hep2 (laryngeal carcinoma)', 'Biological evaluation of isothiazoloquinolones containing aromatic heterocycles at the 7-position: In vitro activity of a series of potent antibacterial agents that are effective against methicillin-resistant Staphylococcus aureus.', 16337789),
('dicationic bis-benzimidazoles', 'in vitro antibacterial activities, including drug-resistant bacterial strains', '', 'Bis-benzimidazole diamidine compounds have potential for further investigation as a new class of potent anti-MRSA and anti-VRE agents.', 19208475),
('bis-cyclic guanidine compounds', 'in vitro potency against C. difficile UK6 with MIC values of 1.0 ?g mL-1.', 'cytotoxic selectivity index (SI) values up to 37', 'Bis-Cyclic Guanidines as a Novel Class of Compounds Potent against Clostridium difficile.', 29768720),
('BMS-284756 is a novel des-fluoro(6) quinolone', '30 mg/kg as a single or divided dose', '', 'BMS-284756 is a novel des-fluoro(6) quinolone with a broad antimicrobial activity, including Streptococcus pneumoniae. The bactericidal effect of BMS-284756 in CSF was concentration dependent.', 11600362),
('2-thiopyridine derivatives', 'effective against both active and dormant M. tuberculosis cells', '', 'By means of the model of M. tuberculosis nonculturability, several new 2-thiopyridine derivatives were found to have potent antitubercular activity.', 24126578),
('Carbon-carbon-linked (pyrazolylphenyl)oxazolidinones', 'alpha-N-substituted methyl pyrazole (10alpha): MICs <or=0.5-1 ?g/mL and 2-8 ?g/mL against Gram positive and negative bacteria respectively; thioamide of the N-cyanomethyl pyrazole analogue : MICs of <or= 0.06-0.25 ?g/mL and MICs of 1 ?g/mL against Gram positive and negative bacteria respectively', '', 'Carbon-carbon-linked (pyrazolylphenyl)oxazolidinones with antibacterial activity against multiple drug resistant gram-positive and fastidious gram-negative bacteria.', 11711300),
('Cathodic voltage-controlled electrical stimulation of titanium', '', '', 'Cathodic voltage-controlled electrical stimulation of titanium for prevention of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii biofilm infections', 27890730),
('Cefiderocol', 'MIC against Escherichia coli ATCC 25922 (0.06-0.5 ?g/mL) and Pseudomonas aeruginosa ATCC 27853 (0.06-0.5 ?g/mL).', '', 'Cefiderocol (formerly S-649266) is a new catechol-substituted parenteral siderophore cephalosporin with potent in vitro antibacterial activity against Gram-negative isolates including multidrug-resistant strains.', 28410852),
('CG400462', 'MIC(90) was 0.5 microg/mL against 238 strains of Staphylococcus aureus and 1.0 microg/mL against 51 strains of coagulase-negative methicillin-susceptible or -resistant staphylococci', '', 'CG400462, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor. CG400462, a novel FabI inhibitor, has a potent antibacterial activity against staphylococci.', 17723291),
('N2,N4-Disubstituted Quinazoline-2,4-Diamines with 6-position is replaced with a halide or an alkyl substituent', 'MICs 0.5 ?M against multidrug-resistant A. baumannii', '', 'Characterizing the Antimicrobial Activity of N2,N4-Disubstituted Quinazoline-2,4-Diamines toward Multidrug-Resistant Acinetobacter baumannii.', 28289036),
('N-(2-hydroxypropyl)-3-trimethylammonium chitosan chlorides (HTCC)', 'Bacteria and fungi (MIC = 125-250 ?g/mL). In a murine model of superficial skin infection - (3.2 log MRSA reduction at 100 mg/kg) with no to minimal inflammation.', '', 'Chitosan Derivatives Active against Multidrug-Resistant Bacteria and Pathogenic Fungi: In Vivo Evaluation as Topical Antimicrobials. The continuous rise of antimicrobial resistance and the dearth of new antibiotics in the clinical pipeline raise an urgent call for the development of potent antimicrobial agents.', 27589087),
('Citrinin', 'Potent antibacterial activity against methicillin-resistant Staphylococcus aureus (S. aureus), rifampicin-resistant S. aureus, wild type S. aureus and vancomycin-resistant Enterococcus faecium with MICs of 3.90, 0.97, 1.95 and 7.81 ?g/mL, respectively.', '', 'Citrinin (1) is reported from sponge associated Penicillium sp. from this study and for its strong antibacterial activity against multi-drug resistant human pathogens including cytotoxicity against brine shrimp larvae, which indicated that sponge associated Penicillium spp. are promising sources of natural bioactive metabolites', 23620853),
('poly(methyl methacrylate) (PMMA)', '', '', 'Collectively, our in vitro results indicate that PMMA is a more suitable carrier compared to CaSO4 for delivery of Ga(NO3)3; moreover they provide evidence for the potential use of Ga(NO3)3 with PMMA as a strategy for the prevention and/or treatment for orthopaedic infections.', 26885514),
('Combination of pantothenamides with vanin inhibitors', 'a series of pantetheinase inhibitors based on a pantothenate scaffold that inhibited serum pantetheinase activity in the nanomolar range was synthesized', '', 'Combination of pantothenamides with vanin inhibitors as a novel antibiotic strategy against gram-positive bacteria.', 23877685),
('TXA709', 'This synergy reduces the dose of TXA709 required for efficacy 3-fold', '', 'Combining the FtsZ-Targeting Prodrug TXA709 and the Cephalosporin Cefdinir Confers Synergy and Reduces the Frequency of Resistance in Methicillin-Resistant Staphylococcus aureus. Combination therapy of bacterial infections with synergistic drug partners offers distinct advantages over monotherapy.', 27161635),
('Myrtacine(?)', 'Antibiofilm activity against Propionibacterium acnes', '', 'CONCLUSION: The efficiency of Myrtacine(?) New Generation on P. acnes biofilm alone or combined with antibiotics was demonstrated and can lead to consider it as a potent adjunctive product efficient during the antibiotic course for acne vulgaris treatment.', 26969384),
('IFNG', '1 ? 106 IU of human recombinant IFN gamma or placebo intramuscularly, daily during 4 weeks and then 3 times per week for the next 20 weeks.', 'No severe events were recorded.', 'CONCLUSION: These data suggest that IFN gamma is useful and well tolerated as adjuvant therapy in patients with pulmonary atypical Mycobacteriosis, predominantly MAC.', 18267006),
('E-101 Solution is composed of porcine myeloperoxidase (pMPO), glucose oxidase, glucose as the substrate and specific amino acids in an aqueous vehicle.', 'E-101 showed MIC(90) values of 0.03, 0.5 and 0.5 mg pMPO/L for staphylococci (n = 140), streptococci (n = 95) and enterococci (n = 55), respectively. MIC(90) values ranged between 0.03-0.5 and ? 0.004-0.12 mg pMPO/L for Enterobacteriaceae (n = 148) and Gram-negative non-Enterobacteriaceae (n = 92) strains, respectively. There was no antimicrobial tolerance to E-101 for Staphylococcus aureus, Streptococcus agalactiae or Streptococcus pyogenes.', '', 'Conclusions E-101 shows potent and broad-spectrum in vitro activity against bacteria that are the causative pathogens of SSIs, thereby providing the impetus to test its clinical utility in the prevention of SSIs.', 21118915),
('ACHN-490, a sisomicin derivative', 'Active at ? 2 mg/L against all tested isolates with carbapenem resistance mechanisms other than NDM enzyme, mostly with MICs of 0.12-0.5 mg/L', '', 'CONCLUSIONS: ACHN-490 has potent activity versus carbapenem-resistant isolates, except those also harbouring 16S rRNA methylases; isepamicin is also widely active, though less potent than ACHN-490.', 21078604),
('CG400549', 'FabI inhibitor, MIC90 0.25 mg/L against clinical isolates of S. aureus, and 1 mg/L against clinical isolates of coagulase-negative staphylococci', '', 'CONCLUSIONS: CG400549 had potent in vitro and in vivo activity against staphylococci, including methicillin-, ciprofloxacin- and multidrug-resistant staphylococci strains.', 17606482),
('platelet-rich plasma (PRP)', 'When compared to control group, PRP and PPP significantly suppressed bacterial growth of MRSA, K. pneumoniae, and P. aeruginosa at 1st, 2nd, 5th, and 10th hours of incubation (p < 0.05).', '', 'CONCLUSIONS: Emerging PRP and other platelet-derived products seem to be promising alternative tools besides antibiotic treatment, debridement, negative pressure wound therapy, hyperbaric oxygen therapy, and other treatment options for treating diabetic foot infections. DOI: 10.1007/s00068-018-0957-0', 29700554),
('isothiazolone compound REDX04957 and its enantiomers (REDX05967 and REDX05990)', 'activity against the ESKAPE organisms, except of Enterococcus spp and quinolone-resistant strains harbouring GyrA S83L and D87G mutations (MIC ?4 mg/L)', 'lack of cytotoxicity against HepG2 cells at 128 mg/L', 'CONCLUSIONS: Isothiazolone compounds show potent activity against Gram-positive and -negative pathogens with a dual targeting mechanism-of-action and a low potential for resistance development, meriting their continued investigation as broad-spectrum antibacterial agents.', 27353465),
('LytA lytic enzyme', 'In the time-kill assays, after 5 h of exposure to LytA, Cpl-1 or Pal, the mean differences in colony counts versus controls were -3.55, -2.66 and -2.71 log(10) cfu/mL, respectively.', '', 'CONCLUSIONS: LytA, Cpl-1 or Pal, alone or in combination, might prove to be effective in combination therapy, as well as in monotherapy against S. pneumoniae.', 17827138),
('Conjugation of the N5-acetyl-N5-hydroxy-L-ornithine tripeptide and the bis(catechol) siderophore to the potent carbacephalosporin', 'antibacterial activity against E. coli X580', '', 'Conjugation of the N5-acetyl-N5-hydroxy-L-ornithine tripeptide and the bis(catechol) siderophore to the potent carbacephalosporin loracarbef and closely related analogs provided compounds which exhibited antibacterial activity against E. coli X580.', 1503447),
('(E)-3-(2-1H-benzo[d]imidazol-1-yl)-1-((4-chlorobenzyl)oxy)imino)ethyl)-2H-chromen -2-one', 'broad spectrum antibacterial activity against Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus subtilis and Proteus vulgaris', 'no cytotoxicity and hemolysis at 10 times the MIC concentration', 'Coumarin-benzimidazole hybrids as a potent antimicrobial agent: synthesis and biological elevation. Molecular hybridization approach is an emerging tool in drug discovery for designing new pharmacophores with biological activity.', 28634338),
('1beta-methylcarbapenems bearing an (imidazo[5,1-b]thiazolium-6-yl)methyl moiety, a 5,5-fused heterobicycle, at the C-2 position (CP0569)', 'potent antibacterial activities against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and Gram-negative bacteria, including Pseudomonas aeruginosa', '', 'CP0569 (1r) and its analogues showed potent antibacterial activities against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and Gram-negative bacteria, including Pseudomonas aeruginosa.', 12878141),
('cephalosporins bearing a 5,5-fused ring system, an (imidazo[5,1-b]thiazolium-6-yl)methyl group, at the C-3 position', 'potent antibacterial activity against Pseudomonas aeruginosa and MRSA', '', 'CP6679 (1s) and its analogues showed potent antibacterial activities against gram-positive and gram-negative bacteria, including Pseudomonas aeruginosa.', 11131169),
('fursultiamine hydrochloride (FTH)', '', 'FTH has no cytotoxic effects on either host cells or pathogen at the tested concentrations.', 'Current study validated the antivirulence strategy targeting the HlyU virulence transcription factor and toxin-network of V. vulnificus and demonstrated that FTH, exhibits a potential to inhibit the pathogenesis of deadly, opportunistic human pathogen, V. vulnificus without inducing AMR.', 29868508),
('CW-270033, a novel pyrrolidinyl-thio carbapenem', 'Potent in-vivo activity against E. coli ATCC 25922, P. aeruginosa ATCC 27853, and S. aureus SMITH', '', 'CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo', 17329859),
('Cyclothialidine (1, Ro 09-1437) modified structures', 'The best activities were displayed by 14-membered lactones, and representatives of this subclass exhibit excellent and broad in vitro antibacterial activity against Gram-positive pathogens, including Staphylococcus aureus, Streptococcus pyogenes, and Enterococcus faecalis, and overcome resistance against clinically used drugs.', '', 'Cyclothialidine (1, Ro 09-1437) is a potent DNA gyrase inhibitor that was isolated from Streptomyces filipinensis NR0484 and is a member of a new family of natural products.', 14998336),
('3-methoxybenzamide derivatives', 'Most potent compound had average MIC of 0.12 ?g/ml against all staphylococcal species, including methicillin- and multidrug-resistant Staphylococcus aureus and Staphylococcus epidermidis', '', 'Derivatives of 3-methoxybenzamide, including compound PC190723, have been reported to be potent and selective antistaphylococcal agents which exert their effects through the disruption of intracellular FtsZ function.', 23114779),
('N-3,5-bis(trifluoromethyl)phenyl-3,5-dichlorobenzenesulfonanilide (16b), and 3,5-bis(trifluoromethyl)-N-(3,5-dichlorophenyl)benzenesulfonanilide (16c)', 'compound 16b has [MIC=0.5microg/mL (MRSA), 1.0microg/mL (VRE)], and compound 16c has [MIC=0.5microg/mL (MRSA), 1.0microg/mL (VRE)]', '', 'Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus', 18468909),
('fluorine-substituted chalcone analogs', 'Potent antimicrobial (tuberculosis and other pathogenic bacteria) and antifungal actifunal activity', '', 'Design of potent fluoro-substituted chalcones as antimicrobial agents.', 28118738),
('coumarin-chalcone derivatives', 'Antibacterial activity against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and marine pathogen Tenacibaculum maritimum, responsible for tenacibaculosis in fish,', '', 'Design, synthesis and antibacterial study of new potent and selective coumarin-chalcone derivatives for the treatment of tenacibaculosis.', 26433630),
('ampicillin-tetramic acid hybrid antibiotics', '', '', 'Design, synthesis and microbiological evaluation of ampicillin-tetramic acid hybrid antibiotics. Exploiting iron-uptake pathways by conjugating ?-lactam antibiotics with iron-chelators, such as catechol and hydroxamic acid is a proven strategy to overcome permeability-related resistance in Gram-negative bacteria.', 27189120),
('6-O-arylpropargyl diazalides', 'potent activity against erythromycin-resistant respiratory tract pathogens', '', 'Design, synthesis and structure-activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniae. A novel series of 6-O-arylpropargyl diazalides was synthesized and evaluated for their antibacterial activity.', 15863336),
('neomycin-C16 and neomycin-C20 conjugates (aminoglycoside-lipid conjugates)', 'The MIC of neomycin-C16 (C20) conjugates against methicillin-resistant Staphylococcus aureus (MRSA) is comparable to clinically used antiseptics.', '', 'Design, synthesis, and antibacterial activities of neomycin-lipid conjugates: polycationic lipids with potent gram-positive activity', 18778047),
('N-(6-phenylheptyl)demethylvancomycin (12 a)', '~18-fold more efficacious than vancomycin against MRSA', '', 'Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria', 23576378),
('NO(2) (o) substituted 3-benzofuran-5-aryl-1-pyrazolylcarbonyl-4-oxo-naphthyridin', 'potent activity against Mycobacterium tuberculosis', '', 'Design, synthesis, and antitubercular evaluation of novel series of 3-benzofuran-5-aryl-1-pyrazolyl-pyridylmethanone and 3-benzofuran-5-aryl-1-pyrazolylcarbonyl-4-oxo-naphthyridin analogs', 20576327),
('fluoroquinolone-flavonoid hybrids', 'Antimicrobial activity against Escherichia coli ATCC 35218, Bacillus subtilis ATCC 6633, Staphylococcus aureus ATCC 25923, Candida albicans ATCC 90873 and other drug resistant pathogens', '', 'Design, synthesis, and evaluation of novel fluoroquinolone-flavonoid hybrids as potent antibiotics against drug-resistant microorganisms.', 24769347),
('benzoxazinyl-oxazolidinones bearing nonaromatic heterocycle or aryl groups', 'Most active compound has MIC value of 0.25-0.5 ?g/mL against MRSA', '', 'Design, synthesis, and structure-activity relationship studies of highly potent novel benzoxazinyl-oxazolidinone antibacterial agents.', 21955296),
('thioether pleuromutilin derivatives incorporating various heteroaromatic substituents into the C14 side chain', 'Most potent derivates with MIC = 0.031-0.063 ?g/mL', '', 'Design, synthesis, and structure-activity relationship studies of novel thioether pleuromutilin derivatives as potent antibacterial agents.', 24874438),
('Ebsulfur derivatives (2-phenyl-1,2-benzisoselenazol-3(2H)-one (Ebselen) analogues with selenium replaced by sulfur)', 'Potent activity against all S. aureus strains with MIC values mostly ?2?g/mL', 'no mamalian cytotoxicity', 'Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.', 27073054),
('4-chloro-flavanone', 'MICs of 30 ?g/mL in S. cerevesiae and 30 ?g/mL in C. neoformans', '', 'Development of non-natural flavanones as antimicrobial agents', 22039419),
('Diarylthiazole (DAT)', 'bactericidal activity and active against drug-sensitive and resistant Mycobacterium tuberculosis', '', 'Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system.', 24967731),
('Difluoromethylornithine', 'DFMO inhibited expression of the H. pylori virulence factor cytotoxin associated gene A, and its translocation and phosphorylation.', '', 'Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction.', 21386987),
('(3S)-amino-(4R)-ethylpiperidinyl quinolones', 'activity against resistant Staphylococcus aureus and Streptococcus pneumoniae', '', 'Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.', 12904069),
('4-pyridone derivatives', 'Two 4-pyridone compounds exhibited strong antibacterial activities against 30 clinical isolates of methicillin-resistant S. aureus (MRSA) with MIC(90) of 0.5 and 2 mug/ml, respectively.', '', 'Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus.', 17420562),
('[(E)-N-methyl-N-(2-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-na phthyridin-3-yl)acrylamide]', 'exquisite antistaphylococci activity, with 500 times lower MIC90 than currently available antibiotics', '', 'Discovery of a novel and potent class of FabI-directed antibacterial agents', 12234833),
('Phomallenic acid C (3)', 'MIC of 3.9 microg/mL against wild-type S. aureus. superior to cerulenin and thiolactomycin, two most common FabF inhibitors.', 'NA', 'Discovery of bacterial fatty acid synthase inhibitors from a Phoma species as antimicrobial agents using a new antisense-based strategy. Fatty acids are essential for bacterial growth and viability, with the type II fatty acid synthesis (FAS II) pathway being a potential antibacterial target.', 16562839),
('kibdelomycin', 'bacterial type II topoisomerase inhibitor, preferentially inhibiting the ATPase activity of DNA gyrase and topoisomerase IV', '', 'Discovery of kibdelomycin, a potent new class of bacterial type II topoisomerase inhibitor by chemical-genetic profiling in Staphylococcus aureus. Bacterial resistance to known therapeutics has led to an urgent need for new chemical classes of antibacterial agents.', 21867911),
('salicylidene acylhydrazide sulfonamides', 'romising activity at 50 ?M concentration against C. trachomatis and C. pneumoniae in HeLa cells', '', 'Discovery of new polypharmacological antibacterial agents with multiple modes of actions can be an alternative to combination therapy and also a possibility to slow development of antibiotic resistance. New antichlamydial agents that also inhibit T3S (type III secretion) in Yersinia pseudotuberculosis.', 26204507),
('1-(3-bromo-2,3-dideoxy-2-fluoro-?-d-arabinofuranosyl)-5-ethyluracil (13) and 1-(?-d-arabinofuranosyl)-4-thio-5-hydroxymethyluracil (21) ,', 'Compound 21 inhibited Mtb (H37Ra) (MIC(50)=0.5 ?g/mL) and M. bovis (MIC(50)=0.5 ?g/mL) at low concentrations', 'No cellular toxicity of 13 or 21 was observed up to the highest concentration tested (CC(50)>100 ?g/mL)', 'Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2''-''up'' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors', 22664188),
('pyrazolopyridone analogues', 'in vitro bactericidal activity , a 4 log reduction in colony forming units', '', 'Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity.', 24818517),
('dithiazole thione', 'A novel non-toxic, non-haemolytic dithiazole thione derivative (DTT10) was identified as a potent competitive inhibitor of NorA efflux pump in S. aureus using in silico, in vitro and in vivo studies.', '', 'Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail multi drug resistant clinical isolate of MRSA in a zebrafish infection model. Lowrence Multi drug resistant (MDR) pathogens pose a serious threat to public health since they can easily render most potent drugs ineffective.', 27531512),
('dithiolopyrrolones', 'ene-dithiol group of DTPs enables high-affinity metal binding as a central mechanism to inhibit metabolic processes', '', 'Dithiolopyrrolones (DTPs) are an underexplored class of disulfide-containing natural products, which exhibit potent antimicrobial activities against multidrug-resistant pathogens.', 28209778),
('DQ-113, quinolone', 'DQ-113 against: ofloxacin-resistant and methicillin-resistant S. aureus, MIC90 of 0.25microg/ml, all strains of Streptococcus pneumoniae, including penicillin-resistant strains, and Streptococcus pyogenes at 0.06 microg/ml, Enterococcus faecalis and Enterococcus faecium with MIC90s of 0.25 and 2 microg/ml, respectively, vancomycin-resistant enterococci, MIC range from 0.25 to 2 microg/ml, Haemophilus influenzae, including ampicillin-resistant strains (MIC90, 0.015 microg/ml), and Moraxella catarrhalis (MIC90, 0.03 microg/ml).', '', 'DQ-113 also showed a potent activity against Haemophilus influenzae, including ampicillin-resistant strains (MIC90, 0.015 microg/ml), and Moraxella catarrhalis (MIC90, 0.03 microg/ml).', 11850285),
('DU-6859a, a new fluoroquinolone', '50% inhibitory concentrations of DU-6859a were 0.86 and 1.05 micrograms/ml for the supercoiling activities of DNA gyrases isolated from E. coli and P. aeruginosa', '', 'DU-6859a showed potent broad-spectrum activity against gram-positive, gram-negative, and anaerobic bacteria, and its activity was greater than those of the control quinolones.', 8593031),
('VRT-125853 and VRT-752586, novel aminobenzimidazole', 'inhibit the essential ATPase activities of bacterial DNA gyrase and topoisomerase IV', '', 'Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds.', 17116675),
('DX-619, a novel Des-F (6)-quinolone', 'The MIC(90)s were: ?0.016 mg/L and 0.125 mg/L against methicillin-sensitive and -resistant S. aureus, 0.062 and 0.125 mg/L against methicillin-sensitive and -resistant S. epidermidis, respectively. The MIC(90)s for other bacteria are: penicillin-sensitive (0.016 mg/L) and -non-sensitive Streptococcus pneumoniae (0.062 mgL), Enterococcus faecalis (0.25 mg/L) and Enterococcus faecium (0.5 mg/L), Enterobacteriaceae (except for Escherichia coli) and glucose-nonfermenting bacilli (< or =4 mg/L)', '', 'DX-619 was a potent antibacterial compound against multi-drug resistant bacteria including Gram-positive cocci, such as S. aureus and enterococci, which may warrant further exploration.', 18230543),
('Ebselen, an organoselenium clinical molecule', 'The minimum inhibitory concentrations of ebselen at which 90% of clinical isolates of Enterococcus and Staphylococcus were inhibited (MIC90) were found to be 0.5 and 0.25 mg/L, respectively.', '', 'Ebselen, an organoselenium clinical molecule, possesses potent antimicrobial activity against clinical multidrug-resistant Gram-positive pathogens, including Staphylococcus, Streptococcus, and Enterococcus, but not against Gram-negative pathogens.', 26222252),
('vanillin, ethyl vanillin, and vanillic acid', 'MICs are 2 mg/ml ethyl vanillin, 3 mg/ml vanillin, and >8 mg/ml vanillic acid.', '', 'Effect of vanillin, ethyl vanillin, and vanillic acid on the growth and heat resistance of Cronobacter species. Preservatives could be part of an effective intervention strategy for the control of Cronobacter species in foods, but few compounds with the desired antimicrobial properties have been identified to date.', 22186046),
('4''''-Deoxy-4''''-episubstituted arbekacin derivatives and 4''''-epi-5-deoxy-5-episubstituted arbekacin derivatives', '5,4''''-diepiarbekacin has more potency against Gram-positive and Gram-negative bacteria, 6''-N-methyl derivative of the 5,4''''-diepiarbekacin was effective against P. aeruginosa', '', 'Effect of varying the 4''''-position of arbekacin derivatives on antibacterial activity against MRSA and Pseudomonas aeruginosa.', 17889537),
('Biphenyl derivative', 'FtsZ inhibitor (Kd = 0.5 ?M) with high antibacterial activity [MIC (MRSA) = 7 ?M', '', 'Effective GTP-replacing FtsZ inhibitors and antibacterial mechanism of action', 25486266),
('bis-naphthoquinone thiol-crown ether 7a', 'Active against Staphylococcus aureus methicillin resistance with MIC value of 2.68 microM', '', 'Efficient synthesis of ''redox-switched'' naphthoquinone thiol-crown ethers and their biological activity evaluation', 11937353),
('Sugar (Man, Fuc, and Gal)', 'BALB/c mice (male; 6?8 wk old; Taconic Farms) were anesthetized with Avertin [250 mg/kg intraperitoneally (IP)], and 50 ?l of 2 ? 108 PAO1 or PDO300 in PBS or PBS containing sugars (5 mM Man+5 mM Fuc+5 mM Gal or 15 mM Fuc) were intratracheally instilled into the lung by a feeding needle (24 gauge)', 'Our findings reveal that sugar inhalation, an inexpensive and safe therapeutic, could be used in combination with conventional antibiotic therapy to more effectively treat P. aeruginosa lung infections.', 'Epub 2013 Jun 21. Sugar administration is an effective adjunctive therapy in the treatment of Pseudomonas aeruginosa pneumonia. Treatment of acute and chronic pulmonary infections caused by opportunistic pathogen Pseudomonas aeruginosa is limited by the increasing frequency of multidrug bacterial resistance.', 23792737),
('21-((1H-imidazol-5-yl)methyl)-pseudopteroxazole (7a)', 'Activity against both replicating and non-replicating persistent forms of M.tuberculosis', 'near absence of in vitro cytotoxicity', 'Evaluation of pseudopteroxazole and pseudopterosin derivatives against Mycobacterium tuberculosis and other pathogen', 23015770),
('SCA-50', 'Potent concentration-dependent bactericidal activity against MRSA Mu50 strain and very importantly, 2-60 fold more potent inhibitory effect on MRSA Mu50 than all the commonly used antibiotics', '', 'Evaluation of small molecule SecA inhibitors against methicillin-resistant Staphylococcus aureus', 26432604),
('triazol-1-yl-pyrimidines (AVS2087, AVS2093, AVS2387, and AVS2236)', 'AVS2087, AVS2093, AVS2387, and AVS2236, were identified as potent inhibitors of catalytic subunit with IC(50) values of 1.0 +/- 0.02, 1.0 +/- 0.04, 2.1 +/- 0.12, and 2.0 +/- 0.08 microM, respectively', '', 'Evaluation of substituted triazol-1-yl-pyrimidines as inhibitors of Bacillus anthracis acetohydroxyacid synthase', 20170757),
('T-3811ME (BMS-284756), a new des-F(6)-quinolone', 'T-3811, the free base of T-3811ME, exhibited potent activity against 28 clinical strains of PRSP at MIC90 0.0625 microg/ml', '', 'Evaluation of T-3811ME (BMS-284756), a new des-F(6)-quinolone, for treatment of meningitis caused by penicillin-resistant Streptococcus pneumoniae in rabbits', 12019087),
('2-phenyl-4(1H)-quinolone and 2-phenyl-4-hydroxyquinoline derivatives', 'The 2-phenyl-4-hydroxyquinoline derivatives 28f and 29f display potent EPI activity against SA-1199B', '', 'Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump', 21751791),
('Farnesol', '300 ?M of farnesol or vancomycin: 40 mg/L and rifampicin: 10 mg/L', 'NA', 'Farnesol, a quorum-sensing molecule in Candida albicans, has been described as impairing growth of several different microorganisms and we have previously shown its potential as an adjuvant in antimicrobial therapy against S. epidermidis. Farnesol might induce biofilm detachment, as determined by the reduced biofilm biomass, which can partially explain the previous findings regarding its role as a possible chemotherapy adjuvant.', 22591918);
INSERT INTO `bacteria_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('d-lysine conjugated tetradecanoyl analogue (D-LANA-14)', 'anti-MRSA activity (MIC = 3.1-6.3 ?g/mL)', 'No skin toxicity even at high concentration', 'Fatty Acid Comprising Lysine Conjugates: Anti-MRSA Agents That Display In Vivo Efficacy by Disrupting Biofilms with No Resistance Development', 28225264),
('1,4-benzothiazine derivatives', 'Almost all derivatives evaluated showed good activity in combination with ciprofloxacin against S. aureus ATCC 25923; some were capable of completely restoring ciprofloxacin activity in a norA-overexpressing strain (SA-K2378)', '', 'From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump', 18578473),
('sulfonamide derivatives of the alpha-(R)-amino hydroxamic acids, (BB-78484 and BB-78485)', 'antibacterial activities against Escherichia coli', '', 'From this screen, a series of sulfonamide derivatives of the alpha-(R)-amino hydroxamic acids, exemplified by BB-78484 and BB-78485, have been identified as having potent inhibitory activities against LpxC in an in vitro assay.', 12019092),
('naphtho-?-pyrones (fonsecinones A and C and aurasperones A and E)', 'Fonsecinone A exhibited the most potent antibacterial activity, with minimum inhibitory concentrations (MICs) of 4.26, 17.04, and 4.26 ?g/mL against ESBL-producing E. coli, P. aeruginosa, and E. faecalis, respectively.', '', 'Fungal naphtho-?-pyrones: Potent antibiotics for drug-resistant microbial pathogens', 27063778),
('Histidine (His) derived lipo-amino acids having pendant lipid tails at N(?)- and N(?)-positions on imidazole group of His', 'antimicrobial activity against Gram-positive and Gram-negative bacteria, also strong anti-MRSA activity', '', 'Furthermore, our designed His-derived lipo-peptidomimetics (HDLPs) consisting of two or three residues displayed strong anti-MRSA activity and protease stability as well as retained potent antimicrobial activity under high salt concentration.', 23933046),
('biricodar (VX-710) and timcodar (VX-853)', 'lowers MICs of several clinically used antibiotics', '', 'Furthermore, these compounds were effective in lowering the MICs of several clinically used antibiotics, including fluoroquinolones, suggesting that VX-710 and VX-853 are representatives of a new class of bacterial efflux inhibitors with the potential for use in combination therapy.', 15504837),
('Gallium Compounds ( Ga-protoporphyrin, Ga(NO3)3 and other Ga compounds)', 'Activity against Mycobacterium abscessus, Ga-protoporphyrin was >20 times more active than Ga(NO3)3', '', 'Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus', 26033732),
('GE23077', 'Selective inhibitor of bacterial RNA polymerase (RNAP), It inhibits Gram-positive (Bacillus subtilis) and Gram-negative (Escherichia coli) RNAPs with IC50 values in the 10(-8) m range', '', 'GE23077, a novel microbial metabolite recently isolated from Actinomadura sp. culture media, is a potent and selective inhibitor of bacterial RNA polymerase (RNAP).', 15265034),
('GSK1322322', 'GSK1322322 had an MIC(90) of 1 ?g/ml against M. catarrhalis and 4 ?g/ml against H. influenzae, with 88.8% of ?-lactamase-positive strains showing growth inhibition at that concentration. All S. pneumoniae strains were inhibited by ? 4 ?g/ml of GSK1322322, with an MIC(90) of 2 ?g/ml.', '', 'Given the antibacterial potency demonstrated against this panel of organisms, GSK1322322 represents a valuable alternative therapy for the treatment of infectious diseases caused by drug-resistant pathogens.', 23478958),
('Green-leaf-derived C6-aroma compounds', 'The most effective compound was (3E)-hexenal at concentrations of 0.1 and 1 microg mL(-1), which killed 2.1 x 10(5) cfu mL(-1) of S. aureus IFO 12732 and 1.4 x 10(5) cfu mL(-1) of E. coli IFO 3301', '', 'Green-leaf-derived C6-aroma compounds with potent antibacterial action that act on both Gram-negative and Gram-positive bacteria.', 12475283),
('1-beta-D-2''-arabinofuranosyl and 1-(2''-deoxy-2''-fluoro-beta-D-ribofuranosyl) pyrimidine nucleosides possessing diverse sets of alkynyl, alkenyl, alkyl, and halo substituents at the C-5 position of the uracil', 'Activity against M. tuberculosis, M. bovis, and M. avium with MIC similar or close to that of the reference drug rifampicin', '', 'Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2''-arabinofuranosyl and 1-(2''-deoxy-2''-fluoro-beta-D-2''-ribofuranosyl) pyrimidine nucleoside analogs', 17602465),
('sulfonyl piperazine and pyrazole compounds', '', '', 'Here we describe the discovery and characterization of sulfonyl piperazine and pyrazole compounds, each with novel mechanisms of action. E. coli mutants resistant to these compounds display no cross-resistance to antibiotics of other classes.', 25733621),
('7-Cl and 7-CF3 substituted N-dodecylamino-4-aminoquinolines (5 and 10)', 'biofilm formation inhibitors with 50% biofilm inhibition at 69 ?M and 63 ?M in S. marcescens and P. aeruginosa', '', 'Here we report a new type of highly potent 4-aminoquinoline derivatives as quorum sensing inhibitors in Serratia marcescens and Pseudomonas aeruginosa, exhibiting weak bactericidal activities (minimum inhibitory concentration (MIC) > 400 ?M).', 28350449),
('1-Hydroxypyridine-2(1H)-thione-6-carboxylic Acid', 'Inhibition Ki 13 nm against VIM-2 (carbapenem-hydrolyzing metallo ?-lactamases (MBL)) that corresponds to a remarkable 0.99 ligand efficiency.', 'low cytotoxicity (CC50 ) of 97 ?m with a corresponding therapeutic index of 880', 'Here we report the discovery of 1-hydroxypyridine-2(1H)-thione-6-carboxylic acid (3) as a first-in-class metallo ?-lactamase inhibitor (MBLi) with a potent inhibition Ki of 13 nm against VIM-2 that corresponds to a remarkable 0.99 ligand efficiency.', 28482143),
('Hydantoin (imidazolidinedione) derivatives', 'bactericidal and also prevent the development of methicillin-resistant Staphylococcus aureus (MRSA) bacterial resistance', '', 'Herein, we report the design of bacterial membrane-active hydantoin derivatives, from which we identified compounds that show much more potent antimicrobial activity than nitrofurantoin against a panel of clinically relevant Gram-positive and Gram-negative bacterial strains.', 28984451),
('purine benzimidazole hybrids', 'The most potent analogue has MIC = 4 ?g/mL against multidrug-resistant strains Staphylococcus aureus', '', 'Hexyl appended hybrid 3c gave potent activities against most of the tested bacteria and fungi especially against multidrug-resistant strains Staphylococcus aureus (MIC = 4 ?g/mL).', 29598912),
('taurine haloamines (TauCl and TauBr)', '', '', 'However, a combined therapy, an application of TauBr together with other anti-biofilm agents (e.g., DNase), seems to be more promising. DOI: 10.1007/978-1-4614-6130-2_23', 23392942),
('beta-sulfonyl- and beta-sulfinylhydroxamic acid derivatives', 'potent inhibitors of Escherichia coli peptide deformylase (PDF)., antibacterial activities against Chlamydia pneumoniae, Mycoplasma pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.', '', 'Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.', 10882358),
('1-benzyl-3-cetyl-2-methylimidazolium iodide, NH125', 'Active against oxacillin-resistant Staphylococcus aureus (ORSA), vancomycin-resistant Enterococcus faecalis (VRE), penicillin-resistant Streptococcus pneumoniae (PRS)', '', 'Identification and characterization of a potent antibacterial agent, NH125 against drug-resistant bacteria. New imidazole compounds were synthesized to develop a novel and effective antibacterial agent (1-benzyl-3-cetyl-2-methylimidazolium iodide, NH125).', 10830522),
('ABTZ-1, benzothiazolium salt,', 'Potent activity against multidrug-resistant clinical isolates of methicillin-resistant S. aureus (MRSA) and vancomycin-resistant enterococci (VRE)', 'low hemolytic activity', 'Identification of a novel protein synthesis inhibitor active against gram-positive bacteria', 22362659),
('AminoPYrimidine-Sulfonamide (APYS1)', 'bactericidal activity against M. tuberculosis', '', 'Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria.', 27677649),
('novel series of quinoxaline 1,4-di-N-oxides', 'In general, all compounds were active with ratios of MICs against resistant and non-resistant strains of <or=4.00.', '', 'If the bactericidal activity and activity on non-replicating bacteria in vitro translate to in vivo conditions, quinoxaline 1,4-di-N-oxides may offer a path to shortened therapy. DOI: 10.1093/jac/dkn214 PMCID: PMC2574959', 18502817),
('a biomimetic iron-sequestering polymer (PAI-DHBA)', '', 'NA', 'In addition, bacterial growth was more susceptible to antibiotics combined with PAI-DHBA. Multivalent polymers that bind and sequester iron, such as PAI-DHBA, offer a promising early intervention or adjuvant to antibiotics.', 25872681),
('BC-3781 is a novel semisynthetic pleuromutilin antibiotic', 'BC-3781 against: ABSSSI such as Staphylococcus aureus (MIC50/90, 0.12/0.12 ?g/ml; 99.8% inhibited at ?0.5 ?g/ml), beta-hemolytic streptococci (MIC50/90, 0.03/0.03 ?g/ml; 99.3% inhibited at ?0.5 ?g/ml), and coagulase-negative staphylococci (CoNS; MIC50/90, 0.06/0.12 ?g/ml; 97.8% inhibited at ?1 ?g/ml), also methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) S. aureus strains. against Enterococcus faecium, with 76.3% of vancomycin-susceptible and 97.0% of vancomycin-resistant isolates at ?1 ?g/ml. Beta-hemolytic and viridans group streptococci 99.3% and 96.7% of isolates inhibited at ?0.5 ?g/ml, respectively, Streptococcus pneumoniae (MIC50/90, 0.12/0.25 ?g/ml), Haemophilus influenzae (MIC50/90, 1/2 ?g/ml), and Moraxella catarrhalis (MIC50/90, 0.12/0.25 ?g/ml) no negative influence by ?-lactamase or resistance to other antimicrobial classes tested.', '', 'In all, BC-3781 displayed a very potent antibacterial profile including the most prevalent bacterial pathogens causing ABSSSI and CABP, thus warranting further clinical development of this antibiotic in these and possibly other indications.', 23836172),
('DS-8587, novel fluoroquinolone', 'More effective antibacterial activity when compared with ciprofloxacin and levofloxacin.', '', 'In conclusion, DS-8587 exhibits potent antibacterial activity against quinolone-resistant A. baumannii isolates that harbor mutations in quinolone resistance-determining regions.', 24709045),
('polymyxin B and SERMs', 'Synergistic killing against the polymyxin-resistant P. aeruginosa, K. pneumoniae, and A. baumannii isolates as demonstrated by a ?2-3 log10 decrease in bacterial count (CFU/ml) after 24 hours.', '', 'In conclusion, the combination of polymyxin B and SERMs illustrated a synergistic activity against XDR Gram-negative pathogens, including highly polymyxin-resistant P. aeruginosa isolates, and represents a novel combination therapy strategy for the treatment of infections because of problematic XDR Gram-negative pathogens. DOI: 10.1089/mdr.2016.0196', 27935770),
('WQ-3810, a new fluoroquinolone', 'Against A. baumannii, including MDR isolates, MIC(90))=1 mg/L, against E. coli and S. pneumoniae, including FQR isolates, MIC(90)=4 mg/L and 0.06 mg/L, respectively', '', 'In conclusion, this study demonstrated that WQ-3810 exhibits extremely potent antibacterial activity over the existing fluoroquinolones, particularly against MDR and FQR pathogens.', 25239276),
('TAM16', 'TAM16 has excellent pharmacological and safety profiles, and the frequency of resistance for TAM16 is ?100-fold lower than INH', '', 'In multiple mouse models of TB infection, TAM16 showed in vivo efficacy equal to the first-line TB drug isoniazid, both as a monotherapy and in combination therapy with rifampicin.', 28669536),
('3,4-Dihydropyrimidinone-coumarin analogues', 'MIC values against the drug susceptive S. aureus ranging from 0.2 to 6.25?g/mL', '', 'In search of potent antibiotic, taking coumarin and dihydropyrimidinone as lead compound, a green, eco-friendly and efficient protocol has been developed and synthesized the dihydropyrimidin-2(1H)-one/thione derivatives of coumarin 3/4 from substituted 4-formylcoumarins 2 and ethylacetoacetate using urea/thiourea in the presence of catalytic amount of ceric ammonium nitrate is reported.', 28094219),
('BAS-118, a new benzamide derivative', 'MIC(50), MIC(90) and MIC range of BAS-118 for 100 randomly selected isolates of H. pylori were <or =0.003, 0.013 and < or =0.003-0.025 mg/L, respectively', '', 'In summary, BAS-118 is a novel anti-H. pylori agent with a potent and selective antibacterial activity, which includes CAM- and MNDZ-resistant isolates.', 12096019),
('Battacin or octapeptin B5', 'MICs of 2 to 4 ?g/ml against hospital strains of Escherichia coli and Pseudomonas aeruginosa', '', 'In the current study, we report the isolation, structure elucidation, and preliminary biological characterization of a new cationic lipopeptide antibiotic, battacin or octapeptin B5, produced from a Paenibacillus tianmuensis soil isolate', 22183171),
('PLEX (biodegradable Polymer-Lipid Encapsulation MatriX)-doxycycline coating on titanium alloy implants', 'the PLEX-doxycycline coating on titanium alloy implants provided complete protection against implant-associated MSSA osteomyelitis, and resulted in a significant reduction in the number of culture positive samples when challenged with a doxycycline-resistant MRSA.', 'NA', 'In the present study, we investigated the efficacy of a biodegradable Polymer-Lipid Encapsulation MatriX (PLEX) loaded with the antibiotic doxycycline as a local prophylactic strategy against implant-associated osteomyelitis.', 25910578),
('complestatin abd related compounds (neuroprotectin A and chloropeptin I )', 'Inhibited S. aureus FabI with IC?? of 0.3-0.6 ?M, prevented the growth of S. aureus as well as methicillin-resistance S. aureus (MRSA) and quinolone-resistant S. aureus (QRSA), with minimum inhibitory concentrations (MICs) of 2-4 ?g/mL.', '', 'In the screening of inhibitors of Staphylococcus aureus enoyl-ACP reductase (FabI), complestatin was isolated as a potent inhibitor of S. aureus FabI together with neuroprotectin A and chloropeptin I from Streptomyces chartreusis AN1542.', 25947917),
('8T-W, a novel synthetic dienoyl tetramic acid', 'antimicrobial activity against Gram-positive and Gram-negative anaerobes as well as staphylococci', '', 'In this paper, we report on a novel series of synthetic dienoyl tetramic acids that lack a complex dioxabicyclononane unit. Several of these compounds, particularly 8T-W, exhibit potent antimicrobial activity against Gram-positive and Gram-negative anaerobes as well as staphylococci.', 2709374),
('pyrrolo[1,5-a]pyrazine-based analogues', 'Most significantly, by in vitro Mtb culture assays, we confirmed that our Eis (Enhanced Intracellular Survival) inhibitors were capable of penetrating the Mtb cell wall and canceling the KAN resistance of Mtb K204, which overexpresses Eis. IC50 (microM) 0.039 - 8.7 against purified Eis_Mtb enzyme. MIC of KAN against Mtb H37Rv in the presence of these compounds <= 1.25 micrograms/mL, MIC of KAN against Mtb K204 range 1.25 micrograms/mL to > 10 micrograms/mL', '', 'In this paper, we report the discovery and development of pyrrolo[1,5-a]pyrazine-based analogues as highly potent inhibitors of the Mycobacterium tuberculosis (Mtb) acetyltransferase enhanced intracellular survival (Eis), whose up-regulation causes clinically observed resistance to the aminoglycoside (AG) antibiotic kanamycin A (KAN).', 28192916),
('1-substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their oxa and selanyl analogs', '(MIC) values reached 1 ?M (0.36-0.44 ?g/mL) against Mycobacterium tuberculosis CNCTC My 331/88 and 0.25-1 ?M against six multidrug-resistant clinically isolated strains of M. tuberculosis.', '', 'In this work, a new class of highly potent antituberculosis agents, 1-substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their oxa and selanyl analogs, is described.', 24927053),
('trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems', 'potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa', '', 'In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.', 10681308),
('E-1040 [(6R,7R)-3-[(4-carbamoyl-1-quinuclidinio)methyl]-7-[2-(5-amino-1,2 ,4- thiadiazol-3-yl)-(Z)-2-methoxyiminoacetoamido]-8-oxo-5-thia- 1- azabicyclo(4,2,0)oct-2-ene-2-carboxylate]', 'MIC50 ?0.25 microgram/ml and the MIC90 0.06 to 2 micrograms/ml against Enterobacteriaceae, Pseudomonas aeruginosa, and Haemophilus and Neisseria', '', 'In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa. The in vitro activity of E-1040 [(6R,7R)-3-[(4-carbamoyl-1-quinuclidinio)methyl]-7-[2-(5-amino-1,2 ,4- thiadiazol-3-yl)-(Z)-2-methoxyiminoacetoamido]-8-oxo-5-thia- 1- azabicyclo(4,2,0)oct-2-ene-2-carboxylate], a novel cephalosporin, was compared with that of ceftazidime, cefpirome, cefepime, imipenem, and gentamicin.', 3150915),
('2-(thiazol-2-ylthio)-1beta-methylcarbapenems (SM-197436, SM-232721, and SM-232724)', 'MIC(90) of </=4 micro g/ml against methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus epidermidis (MRSE), MIC ranged from </=0.063 to 0.5 micro g/ml for streptococci, including penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae strains and MIC(90) ranged between 8 and 16 micro g/ml for ampicillin-resistant E. faecium', '', 'In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.', 12878507),
('PD 0305970 and PD 0326448 (quinazoline-2,4-diones)', 'MIC90 ranges were: staphylococci (0.125 to 0.5 ?g/ml), streptococci (0.03 to 0.06 ?g/ml) , enterococci (0.25 to 2 ?g/ml) and 0.25 to 0.5 ?g/ml for Moraxella catarrhalis, Haemophilus influenzae, Listeria monocytogenes, Legionella pneumophila, and Neisseria spp', '', 'In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups.', 17261623),
('RBx 14255, Ketolide', 'The MIC(90) Clostridium difficile was 4 ?g/ml (MIC range, 0.125 to 8 ?g/ml)', '', 'In vitro and in vivo activities of the novel Ketolide RBx 14255 against Clostridium difficile', 22869573),
('CS-023 (RO4908463), 1beta-methylcarbapenem with 5-substituted pyrrolidin-3-ylthio groups, including an amidine moiety at the C-2 position', 'Most potent activity against P. aeruginosa and MRSA, with MIC90s of 4 microg/ml and 8 microg/ml, respectively.', '', 'In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem', 16048932),
('ER-35786', 'Active against methicillin-susceptible Staphylococcus aureus and streptococci (MIC90S < or = 0.39 ?g/ml), methicillin-resistant S. aureus(MIC90 12.5 ?g/ml), Enterobacteriaceae, Moraxella catarrhalis, and Haemophilus influenzae (MIC90 < or = 1.56?g/ml)', '', 'In vitro and in vivo antibacterial activities of ER-35786, a new antipseudomonal carbapenem. ER-35786 is a new parenteral 1 beta-methyl carbapenem with a broad antibacterial spectrum and a potent antipseudomonal activity.', 9021183),
('AM-833, a new quinolone derivative', 'potent activity against members of the family Enterobacteriaceae, Neisseria spp., and Haemophilus influenzae and good activity against staphylococci, Pseudomonas aeruginosa, and Branhamella catarrhalis', '', 'In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative. AM-833 showed potent activity against members of the family Enterobacteriaceae, Neisseria spp., and Haemophilus influenzae and good activity against staphylococci, Pseudomonas aeruginosa, and Branhamella catarrhalis.', 2942103),
('gallium nitrate Ga(NO(3))(3)', 'inhibits the growth of a collection of 58 A. baumannii strains in both chemically defined medium and human serum, at concentrations ranging from 2 to 80 ?M and from 4 to 64 ?M, respectively.', '', 'In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii. Multidrug-resistant Acinetobacter baumannii poses a tremendous challenge to traditional antibiotic therapy.', 22964249),
('A-80556, new fluoroquinolone', 'MIC90 values: Staphylococcus aureus (0.12 ?h/ml), Streptococcus pneumoniae (0.12 ?h/ml), Escherichia coli (0.06 ?h/ml), Pseudomonas aeruginosa ( 4.0 ?h/ml), Bacteroides fragilis ( 2.0 ?h/ml)', '', 'In vitro and in vivo evaluations of A-80556, a new fluoroquinolone. A-80556 is a novel fluoroquinolone with potent antibacterial activity against gram-positive, gram-negative, and anaerobic organisms.', 8067740),
('S-013420, a novel bicyclolide', 'Most potent activity against erythromycin-intermediate and -resistant S. pneumoniae with an MIC(90) of 0.25 mg/L and inhibited the growth of all strains of S. pyogenes with macrolide resistance genes at 1 mg/L, MIC(90) values of 0.125, 0.125, 8 and 0.5 mg/L for Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis, respectively', '', 'In vitro antibacterial activities of S-013420, a novel bicyclolide, against respiratory tract pathogens', 20472695),
('AZD0914, a new spiropyrimidinetrione', 'Bacterial DNA gyrase/topoisomerase inhibitor with potent in vitro antibacterial activity against Gram-positive (Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus pyogenes, and Streptococcus agalactiae), fastidious Gram-negative (Haemophilus influenzae and Neisseria gonorrhoeae), atypical (Legionella pneumophila), and anaerobic (Clostridium difficile) bacterial species', '', 'In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteria.', 25385112),
('BMY-28142', 'most potent against Enterobacteriaceae with a MIC90 0.12 micrograms/ml', '', 'In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.', 3859244),
('SM-7338, a new carbapenem antibiotic', 'At a concentration of 0.5 micrograms/ml, SM-7338 inhibited 90% of these strains: Staphylococcus aureus, beta-hemolytic streptococci, Streptococcus pneumoniae, Haemophilus influenzae, Neisseria spp., members of the family Enterobacteriaceae, Pseudomonas spp., and gram-positive and gram-negative anaerobes.', '', 'In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I. SM-7338, a new carbapenem antibiotic, was demonstrated to have potent antibacterial activity against a broad spectrum of aerobes, including Staphylococcus aureus, beta-hemolytic streptococci, Streptococcus pneumoniae, Haemophilus influenzae, Neisseria spp., members of the family Enterobacteriaceae, Pseudomonas spp., and gram-positive and gram-negative anaerobes in a collection of 1,102 unselected clinical isolates.', 2655530),
('ABT-492, new fluoroquinolone', 'Activity against Enterobacteriaceae, gram-negative species including Haemophilus influenzae, Moraxella catarrhalis, Neisseria gonorrhoeae, Legionella spp. , Pseudomonas aeruginosa and Helicobacter pylori.', '', 'In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone. ABT-492 demonstrated potent antibacterial activity against most quinolone-susceptible pathogens.', 14506039),
('AT-2266, new pyridonecarboxylic acid', 'inhibited some gram-positive bacteria, such as staphylococci and Bacillus subtilis, and most gram-negative bacteria, including Serratia marcescens, Pseudomonas aeruginosa, Haemophilus influenzae, and Campylobacter jejuni, at concentrations of 0.1 to 0.78 microgram/ml, and most gram-positive bacteria, glucose-nonfermenters, and Mycoplasma pneumoniae at concentrations of 1.56 to 12.5 micrograms/ml.:', '', 'In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid. AT-2266, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3 -carboxylic acid, is a new pyridonecarboxylic acid derivative with broad and potent antibacterial activity.', 6575721),
('ACH-702, a novel isothiazoloquinolone', 'in vitro antibacterial activity against Mycobacterium tuberculosis, with MICs of <or=1 microg/ml', '', 'In vitro antituberculosis activities of ACH-702, a novel isothiazoloquinolone, against quinolone-susceptible and quinolone-resistant isolates.', 20516287),
('ABT-492, a novel quinolone', 'penicillin-sensitive, resistant, and levofloxacin-resistant Streptococcus pneumoniae strains : MICs 0.0078 to 0.125 micro g/ml; beta-lactamase-positive and beta-lactamase-negative Haemophilus influenzae strains: MICs 0.000313 to 0.00125 micro g/ml; beta-lactamase-positive and beta-lactamase-negative Moraxella catarrhalis strains : MICs 0.001 to 0.0025 micro g/ml', '', 'In vitro pharmacodynamic activities of ABT-492, a novel quinolone, compared to those of levofloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.', 14693540),
('ABI-0043, novel rifamycin', 'Bactericidal activity against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA)', '', 'In vitro pharmacodynamics of novel rifamycin ABI-0043 against Staphylococcus aureus.', 18400804),
('DQ-113, new quinolone', 'Activity against against Streptococcus pneumoniae', '', 'In vivo efficacy of a new quinolone, DQ-113, against Streptococcus pneumoniae in a mouse model. DQ-113 is a new quinolone with potent activity against gram-positive pathogens.', 14638468),
('NITD-304 and NITD-349', 'potent activity against both drug-sensitive and multidrug-resistant clinical isolates of Mtb', '', 'Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis', 24307692),
('5-acetylenic derivatives of 2'',3''-dideoxyuridine (3-8) and 3''-fluoro-2'',3''-dideoxyuridine (22-27)', '2'',3''-Dideoxyuridine possessing 5-decynyl, 5-dodecynyl, 5-tridecynyl, and 5-tetradecynyl substituents (4-7), 3''-fluoro-2'',3''-dideoxyuridine derivative 5-tetradecynyl analogue (26), displayed the most potent activity against all mycobacteria. 2-amino-6-mercaptoethyl-9-(2,3-dideoxy-beta-d-glyceropentofuranosyl)purine (32) and 2-amino-4-fluoro-7-(2,3-dideoxy-beta-d-glyceropentofuranosyl)pyrrolo[2,3-d]pyrimidine (35) were the most efficacious against M. bovis and M. tuberculosis, and M. avium, respectively', '', 'Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides', 17696514),
('JNJ-Q2, new fluoroquinolone', 'in vitro activity against Gram-negative and Gram-positive organisms, including methicillin-resistant Staphylococcus aureus (MRSA) and ciprofloxacin-resistant MRSA isolates, with MICs ? 0.12 ?g/m', '', 'Inhibition of S. aureus DNA gyrase and DNA topoisomerase IV enzymes demonstrated that JNJ-Q2 was more potent than comparators against wild-type enzymes and enzymes carrying quinolone-resistant amino acid substitutions, and JNJ-Q2 displayed equipotent activity against both enzymes.', 21911562),
('1-(2-benzoxazolyl)-3,3,3-trifluoro-2-propanone (TF18), a trifluoromethyl ketone derivative', 'Inhibitory activity against clarithromycin-susceptible and-resistant Helicobacter pylori', '', 'Inhibitory action of a new proton pump inhibitor, trifluoromethyl ketone derivative, against the motility of clarithromycin-susceptible and-resistant Helicobacter pylori.', 15194136),
('chlorhexidine with trisEDTA or miconazole', 'Chlorhexidine/miconazole MICs (median = 0.5 mg/L) were lower than those of either drug alone (P < 0.05) and lower than chlorhexidine/trisEDTA MICs (median = 1 mg/L; P < 0.0005) in each bacterial type and from both regions, except for miconazole in NUK MSSP.', '', 'Interaction of chlorhexidine with trisEDTA or miconazole in vitro against canine meticillin-resistant and -susceptible Staphylococcus pseudintermedius isolates from two UK regions. Clark SM(1), Loeffler A(2), Schmidt VM(3), Chang YM(2), Wilson A(2), Timofte D(3), Bond R(2). Author information: (1)Department of Clinical Sciences and Services, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, AL9 7TA, UK. sclark@rvc.ac.uk. (2)Department of Clinical Sciences and Services, Royal Veterinary College, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, AL9 7TA, UK. (3)School of Veterinary Science, University of Liverpool, Chester High Road, Neston, CH64 7TE, UK. BACKGROUND: Topical therapy is an important alternative to systemic antibacterial therapy for treatment of canine superficial pyoderma in light of the emergence of multidrug-resistant staphylococci.', 27406860),
('Carbohydrate derived fulvic acid (CHD-FA)', 'minimum inhibitory concentration of 0.5%.', 'Despite the widespread use of mouthwashes being used as adjunctive measures to control these biofilms, their prolonged use is not recommended due to various side effects.', 'Investigating the biological properties of carbohydrate derived fulvic acid (CHD-FA) as a potential novel therapy for the management of oral biofilm infections.', 24063298),
('diethyl malate and 1-methyl malate', 'diethyl malate and 1-methyl malate can decrease the MIC value of benzyl penicillin by sixteen and eight-fold', '', 'Investigation for antimicrobial resistance-modulating activity of diethyl malate and 1-methyl malate against beta-lactamase class A from Bacillus licheniformis by molecular dynamics, in vitro and in vivo studies.', 24836845),
('lucensimycins', 'Lucensimycin E (5) exhibited the best activity and showed MIC values of 32 microg/mL against Staphylococcus aureus and 8 microg/mL against Streptococcus pneumoniae.', '', 'Isolation, structure, and antibacterial activities of lucensimycins D-G, discovered from Streptomyces lucensis MA7349 using an antisense strategy. Bacterial resistance to existing antibiotics continues to grow, necessitating the discovery of new compounds of this type.', 19115838),
('PC-904, sodium 6-{d(-)-alpha-(4-hydroxy-1,5-naphthyridine-3-carboxamido) phenylacetamido}-penicillanate', 'Against systemic infections with P. aeruginosa, K. pneumoniae, and E. coli in mice, PC-904 is 7 to 10 times, over 8 times, and 2 to 15 times more active than carbenicillin', '', 'It is confirmed that PC-904 has a very potent in vivo antibacterial activity against gram-negative and gram-positive organisms.', 1046355),
('JNJ-Q2, a new fluoroquinolone', 'MIC(50) and MIC(90), 0.12 and 0.5 ?g/ml respectively', '', 'JNJ-Q2, a new fluoroquinolone with potent in vitro activity against Staphylococcus aureus, including methicillin- and fluoroquinolone-resistant strains.', 21555765),
('Lactam hybrid analogues of solonamide B and autoinducing peptides', 'S. aureus AgrC antagonists', '', 'Lactam hybrid analogues of solonamide B and autoinducing peptides as potent S. aureus AgrC antagonists.', 29738955),
('Undecatungsto(ferri)ferrosilicate ([SiW11O39Fe](6/5-))', '', '', 'Lacunary-substituted undecatungstosilicates sensitize methicillin-resistant Staphylococcus aureus to beta-lactams.', 11558574),
('Laser-assisted nasal decolonization', '25 patients colonized with MSSA/MRSA were allocated to 4 treatment arms; low-power, dual-wavelength 870-/930-nm laser alone (GR1); low-power, dual-wavelength laser followed by erythromycin (E-mycin) cream (GR2); low-power, dual-wavelength laser followed by peroxide irrigation (GR3); and high-power 940-nm laser alone (GR4).', 'No adverse events or discomfort were reported.', 'Laser therapy can eradicate MRSA and potentially resensitization of bacteria to the antimicrobial effect of erythromycin. Nasal decolonization for GR1, GR2, GR3, and GR4 was 1 of 3, 13 of 14, 2 of 4, and 4 of 4, respectively', 22503099),
('LCB01-0648 Oxazolidinones', 'MIC90s 0.5 mg/L against the methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci (MRCNS)', '', 'LCB01-0648 showed the most potent antimicrobial activities against clinically isolated Gram-positive bacteria.', 28273820),
('Q203, an imidazo[1,2-a]pyridine amide derivative', 'activity against Mycobacterium tuberculosis H37Rv', '', 'Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent.', 24870926),
('lipo-?-AApeptides', 'Potent broad-spectrum activities against fungi and a series of Gram-positive and Gram-negative bacteria', '', 'Lipo-?-AApeptides as a new class of potent and broad-spectrum antimicrobial agents.', 22475244),
('Marinomycin A', '', '', 'Marinomycin A is a member of a new class of bis-salicylate-containing polyene macrodiolides, which have potent antibiotic activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium.', 22824902),
('(?)-marinopyrrole A and its derivatives', 'para-trifluoromethyl analog (33) of marinopyrrole A is ? 63-, 8-, and 4-fold more potent than vancomycin against methicillin-resistant Staphylococcus epidermidis (MRSE), methicillin-susceptible Staphylococcus aureus (MSSA) and MRSA, respectively', '', 'Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (II)', 23955285),
('MBX2319, a novel pyranopyridine', 'Exhibit antibacterial activity in combination with other antibiotics only, decreased the MICs of ciprofloxacin (CIP), levofloxacin, and piperacillin versus E. coli AB1157 by 2-, 4-, and 8-fold, respectively', '', 'MBX2319 is a potent EPI with possible utility as an adjunctive therapeutic agent for the treatment of infections caused by Gram-negative pathogens.', 24247144),
('LFF571', 'antibacterial activity against Clostridium difficile is due to inhibition of translation', '', 'Mechanism of action of and mechanism of reduced susceptibility to the novel anti-Clostridium difficile compound LFF571.', 22644023),
('liposomal linolenic acid (LipoLLA)', 'potent bactericidal activity against several clinical isolated antibiotic-resistant strains of H. pylori including both the spiral and coccoid form', '', 'Mechanism of antibacterial activity of liposomal linolenic acid against Helicobacter pylor', 25793403),
('AB206, nalidixic acid derivative', 'Strongly inhibits deoxyribonucleic acid (DNA) synthesis in Escherichia coli', '', 'Mode of action of a new nalidixic acid derivative, AB206. A new chemotherapeutic agent, AB206, shows potent antibacterial activity against gram-negative bacteria, including most of the nalidixic acid-resistant strains tested.', 6156644),
('Van-M-02, a novel glycopeptide', 'potent activities against Gram-positive bacteria, including vancomycin-resistant enterococci (VRE) and vancomycin-resistant Staphylococcus aureus (VRSA)', '', 'Mode of action of Van-M-02, a novel glycopeptide inhibitor of peptidoglycan synthesis, in vancomycin-resistant bacteria.', 19933802),
('anacardic acid analogues possessing different side chains viz. phenolic, branched, and alicyclic [6-(4'',8''-dimethylnonyl)salicylic acid, and the alicyclic side-chain analogue, 6-cyclododecylmethyl salicylic acid ]', 'Maximun anti MRSA activiry with (MIC) 0.39 microg/mL', '', 'Molecular design of anti-MRSA agents based on the anacardic acid scaffold', 17601740),
('ilamycin congeners (1-6) bearing rare L-3-nitro-tyrosine and L-2-amino-4-hexenoic acid structural units', 'minimum inhibitory concentration value ?9.8 nM to Mycobacterium tuberculosis H37Rv', '', 'Most impressively, ilamycins E1/E2, which are produced in high titers by a genetically engineered mutant strain, show very potent anti-tuberculosis activity with an minimum inhibitory concentration value ?9.8 nM to Mycobacterium tuberculosis H37Rv constituting extremely potent and exciting anti-tuberculosis drug leads.', 28855504),
('NB2001, (triclosan in a prodrug form with a cephalosporin scaffold)', 'antibacterial activity was studied against beta lactamase producing strains', 'NA', 'NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strains. Enzyme-catalyzed therapeutic activation (ECTA) is a novel prodrug strategy to overcome drug resistance resulting from enzyme overexpression. beta-Lactamase overexpression is a common mechanism of bacterial resistance to beta-lactam antibiotics.', 11959554),
('NCL195 (4,6-bis(2-((E)-4-methylbenzylidene)hydrazinyl)pyrimidin-2-amine)', 'potent bactericidal activity against Streptococcus pneumoniae and Staphylococcus aureus', 'less cytotoxic to mammalian cell lines than robenidine', 'NCL195 was bactericidal against Acinetobacter spp and Neisseria meningitidis and also demonstrated potent activity against A. baumannii, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Enterobacter spp. in the presence of sub-inhibitory concentrations of ethylenediaminetetraacetic acid (EDTA) and polymyxin B.', 28873428),
('7-[4-(4-(benzoyl)carbopiperazin-1-yl)]piperazinyl derivative 5h and two 7-[4-(4- (benzenesulfonyl)carbopiperazin-1-yl)]piperazinyl derivatives 5k and 5l', 'MIC values as low as 16 ?g/ml against ciprofloxacin-resistant P. aeruginosa (CRPA)', '', 'New 7-[4-(4-(un)substituted)piperazine-1-carbonyl]- piperazin-1-yl] derivatives of fluoroquinolone: synthesis and antimicrobial evaluation', 23807580),
('1beta-methylcarbapenems with thiazol-2-ylthio groups at the C-2 position [SM-197436 , SM-232721, and SM-232724 ]', 'potent antibacterial activity especially against methicillin-resistant staphylococci, vancomycin-resistant enterococci and penicillin-resistant Streptococcus pneumoniae', '', 'New anti-MRSA and anti-VRE carbapenems; synthesis and structure-activity relationships of 1beta-methyl-2-(thiazol-2-ylthio)carbapenems.', 12374386),
('7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3', 'potent antibacterial activity against MRSA and Pseudomonas aeruginosa', '', 'New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa', 15246098),
('2-((4-(4,5-dibromo-1H-pyrrole-2-carboxamido)phenyl)amino)-2-oxoacetic acid (9a)', 'IC50 of 0.18 ?M against E. coli gyrase', '', 'New N-phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATPase inhibitors of DNA gyrase', 27100032),
('Nitric oxide', 'Sublethal concentrations of NO inhibited the enzymatic activity of [4Fe-4S]-cofactored aconitase of aerobic and anaerobic B. pseudomallei.', '', 'Nitric oxide-dependent killing of aerobic, anaerobic and persistent Burkholderia pseudomallei. Burkholderia pseudomallei infections are fastidious to treat with conventional antibiotic therapy, often involving a combination of drugs and long-term regimes.', 22521523),
('Nitrosoglutathione generating nitric oxide (NO)', 'Percent survival in the NO-np+GSH -treated isolates was significantly lower than in the a nitric oxide-releasing nanoparticle (NO-np) (36.1% vs 8.3%; P=.004). In addition, NO-np+GSH accelerated wound closure in P aeruginosa-infected wounds, and NO-np+GSH-treated wounds had significantly lower bacterial burden when compared to NO-np-treated wounds (P<.001).', '', 'Nitrosoglutathione generating nitric oxide nanoparticles as an improved strategy for combating Pseudomonas aeruginosa-infected wounds. Pseudomonas aeruginosa is a community-acquired, nosocomial pathogen that is an important cause of human morbidity and mortality; it is intrinsically resistant to several antibiotics and is capable of developing resistance to newly developed drugs via a variety of mechanisms.', 23377518),
('Compounds containing the N-alkyl-N-(pyridin-2-yl)hydroxylamine structure', 'potent antibacterial activity against the Gram-positive bacterium Micrococcus luteus ATCC 10240 (MIC(90) = 2.0 ?M or 0.41 ?g/mL) and moderate activity against other Gram-positive strains including antibiotic resistant strains of Staphylococcus aureus (MRSA) and Enterococcus faecalis (VRE)', '', 'N-O chemistry for antibiotics: discovery of N-alkyl-N-(pyridin-2-yl)hydroxylamine scaffolds as selective antibacterial agents using nitroso Diels-Alder and ene chemistry', 21859126),
('3-(2-aminothiazol-4-yl)-7-chloro-6-(pyrrolidin-1-yl) quinolone 12b', 'Activity againts methicillin-resistant Staphylococcus aureus (MRSA) by formation of a compound 12b-Cu(2+)-DNA ternary complex in which the Cu(2+) ion acts as a bridge between the backbone of 3-aminothiazolquinolone and the phosphate group of the nucleic acid.', 'low cytotoxicity to hepatocyte cells', 'Novel 3-Aminothiazolquinolones: Design, Synthesis, Bioactive Evaluation, SARs, and Preliminary Antibacterial Mechanism.', 27115717),
('(R)-Hydroxy-1,5-naphthyridinone left-hand side (LHS) oxabicyclooctane linked pyridoxazinone right-hand side (RHS) containing NBTIs showed a potent Gram-positive antibacterial profile. SAR around the RHS moiety, including substitutions around pyridooxazinone, pyridodioxane, and phenyl propenoids', 'A fluoro substituted pyridoxazinone showed an MIC against Staphylococcus aureus of 0.5 ?g/mL, pyridodioxane-containing NBTI showed a S. aureus MIC of 0.5 ?g/mL', '', 'Novel bacterial topoisomerase inhibitors (NBTIs) are a new class of broad-spectrum antibacterial agents targeting bacterial Gyrase A and ParC and have potential utility in combating antibiotic resistance.', 25978963),
('bis-cyclic guanidines', 'compromise bacterial membranes without developing resistance, inhibit biofilms formed by E. coli, and exhibit excellent in vivo activity against MRSA', '', 'Novel bis-cyclic guanidines as potent membrane-active antibacterial agents with therapeutic potential. We designed a class of small dimeric cyclic guanidine derivatives which display potent antibacterial activity against both multidrug-resistant Gram-negative and Gram-positive bacteria.', 29052670),
('bis-(imidazolinylindole) derivatives', 'effective against a broad range of gram-positive and gram-negative bacterial species, including several antibiotic-resistant strains', '', 'Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains', 19635954),
('fluorinated pyrrolomycin', 'MIC of 73 ng/mL, MBC of 4 ?g/mL, kill staphylococcal-associated biofilm at 8 ?g/mL', '', 'Novel fluorinated pyrrolomycins as potent anti-staphylococcal biofilm agents.', 27565555),
('6-O-substituted and 6,12-di-O-substituted 8a-aza-8a-homoerythromycin A and 9a-aza-9a-homoerythromycin A ketolides and ketolides based on 14-membered erythromycin oxime scaffold', 'Potent activity against a variety of erythromycin-susceptible and macrolide-lincosamide-streptogramin B (MLS(B))-resistant Gram-positive pathogens as well as fastidious Gram-negative pathogens', '', 'Novel hybrids of 15-membered 8a- and 9a-azahomoerythromycin A ketolides and quinolones as potent antibacterials.', 21055953),
('SKI-356313, new imidazoline scaffold', 'Bactericidal activity against Mycobacterium tuberculosis and Gram-positive cocci, including vancomycin-resistant Enterococcus faecium (VRE) and methicillin-resistant Staphylococcus aureus (MRSA)', '', 'Novel imidazoline antimicrobial scaffold that inhibits DNA replication with activity against mycobacteria and drug resistant Gram-positive cocci', 25222597),
('2-([3-[(1H-benzimidazol-2-ylsulfanyl)methyl]-2-methylphenyl]sulfanyl)ethyl carbamates', 'MIC(90) = 0.25 microg/mL against H. pylori strains', '', 'Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents.', 12213071),
('4-chloro-2,6-dimethylphenol analogues', 'The most potent analogs have a MIC of 160 to 320 nM against B. anthracis and may target the cytoskeletal protein FtsZ', '', 'Oligochlorophens are potent inhibitors of Bacillus anthracis.', 20566769),
('Derivatives of 2?{[4?(5?bromo?3?methylpyridin?2?yl)butyl]amino}?1,4?dihydroquinolin?4?one', 'The most potent derivative hasexcellent antibacterial activity against staphylococcal and enterococcal pathogens, including strains resistant to clinical antibiotics.', '', 'Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-positive antibacterial activity. Optimisation of the left-hand-side aryl moiety of a file compound screening hit against Staphylococcus aureus methionyl tRNA synthetase led to the identification of a series of potent nanomolar inhibitors.', 12639554),
('psammaplin A (1) analogues', 'antibacterial agents (e.g. 17, 57, 58, 69, and 70), some possessing greater than 50-fold higher activities than the natural product.', 'In fact, the most interesting compound in this study proved to be the heterodimer 58 consisting of a 3?bromo?phenyl alanine subunit and a 4??fluorophenyl moiety, exhibiting a therapeutic index (TI) of 37.5.', 'Optimization and mechanistic studies of psammaplin A type antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA). N As described in the preceding article, utilizing a novel combinatorial disulfide exchange strategy, a library of psammaplin A (1) analogues was constructed and screened for antibacterial activity leading to the identification of a collection of diverse lead compounds.', 11686610),
('curcumin', 'treatment for Streptococcus agalactiae infection', '', 'Our results demonstrated that curcumin dietary supplement exerts potent bactericidal action against S. agalactiae, presenting 100% of therapeutic efficacy when compared to infected and non-supplemented animals.', 29407233),
('silver sulfadiazine and silver-coated dressing', '1% silver sulfadiazine > silver-coated dressing > 3% citric acid > 0.5% chlorhexidine acetate > control group.', '', 'Our results supported the efficacy of topical therapy by silver sulfadiazine and silver-coated dressing on infections caused by multi-drug resistant Pseudomonas spp.', 24229034),
('quaternised chitosan derivative (hydroxypropyltrimethyl ammonium chloride chitosan, HACC', '', '', 'Our study indicates that 26%HACC-loaded PMMA prevents biofilm formation of Staphylococcus, including antibiotic-resistant strains, on the surface of bone cement, and downregulates the virulence-associated gene expression of antibiotic-resistant staphylococcus, thus providing a promising new strategy for combating implant infections and osteomyelitis.', 22014946),
('IgA', '', '', 'Our study provides a mechanistic explanation for the well-documented risk of P. aeruginosa infection following antimicrobial therapy, and we propose local administration of IgA as a novel prophylactic strategy.', 29771684),
('5-episinuleptolide', 'anti-biofilm activities against only Gram-negative bacteria', '', 'Our study showed potentially synergistic activity of combination therapy with 5-episinuleptolide and levofloxacin against biofilm formation and biofilm cells.', 27483290),
('AM-8722, Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor', 'targets DNA gyrase and topoisomerase IV', '', 'Overall, AM-8722 is a selective and potent NBTI that displays broad-spectrum antimicrobial activity in vitro and in vivo.', 27246784),
('BAG-S53P4', '', '', 'Owing to its osteoconductive, antibacterial and antibiofilm properties, the use of BAG-S53P4 may be a successful strategy for the treatment of bone and prosthetic joint infections.', 26462989),
('pestalone', 'activity against methicillin-resistant Staphylococcus aureus (MIC = 37 ng/mL) and vancomycin-resistant Enterococcus faecium (MIC = 78 ng/mL)', '', 'Pestalone, a new antibiotic produced by a marine fungus in response to bacterial challenge', 11720529),
('phosphodiesterase-4 (PDE4) inhibitor, CC-3052,', '"To study the effect of CC-3052 treatment on the ability of INH to kill Mtb in the lungs of infected rabbits, animals were treated from 4 weeks post-infection with high dose INH (50 mg/kg body weight/day) or CC-3052 (25 mg/kg body weight/day), neither or both for 4 or 8 weeks (i.e., 8 or 12 weeks post-infection)."', 'CC-3052, is water soluble, more stable in human plasma and ?200-fold more potent in reducing TNF-? production, compared to the parent drug', 'Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs. These findings provide a basis for exploring the potential use of adjunctive immune modulation with PDE4 inhibitors to enhance the efficacy of existing anti-TB treatment.', 21949656),
('6-methoxytetrahydro ?-mangostin (16)', 'antimycobacterial activity with minimum inhibitory concentration (MIC) of 0.78 ?g/mL', '', 'Potent activity against multidrug-resistant Mycobacterium tuberculosis of ?-mangostin analogs', 23150066),
('laurinterol and allolaurinterol', '', 'laurinterol and allolaurinterol displayed potent bactericidal activity against MRSA at 3.13 microg mL(-1) and against vancomycin-susceptible Enterococcus at 3.13 microg mL(-1) and 6.25 microg mL(-1), respectively.', 'Potent antibacterial activity of halogenated compounds against antibiotic-resistant bacteria', 15549668),
('Bisbenzimidazole and Carbonyl Cyanide 3-Chlorophenylhydrazone combination', 'Inhibited biofilm formation, eradicate preformed biofilms and kills the biofilm cells of P. aeruginosa.', '', 'PPEF (bisbenzimidazole) targeting topoisomerase IA is observed to be an effective bactericidal agent against both Gram-positive and Gram-negative bacterial strains and thus can be developed as potent broad-spectrum antibiotic against MDR strains.', 28303897);
INSERT INTO `bacteria_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Chloro[2,6-bis(1-methyl imidazol)pyrazine]gold(I), 2b and chloro [2,6-bis(1-methyl imidazol)pyrazine]silver(I), 2a complexes', 'Inhibit the biofilm formation by Gram-positive bacteria, Streptococcus mutans and Gram-negative bacteria, Escherichia coli, causing drastic damage to the bacterial cell wall and increasing membrane permeability', '', 'Pyrazine functionalized Ag(I) and Au(I)-NHC complexes are potential antibacterial agents', 22680631),
('Isoamyl- or cyclopropylmethylene-substituted dipyrrole derivatives', 'Binds to minor groove of DNA', '', 'Pyrrole tetraamides are potent antibacterials against vancomycin resistant Enterococci [corrected] and methicillin resistant Staphylococcus aureus. A new series of short pyrrole tetraamides are described whose submicromolar DNA binding affinity is an essential component for their strong antibacterial activity.', 11831893),
('benzyloxy, benzylamino, and phenoxy derivatives of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters', 'nanomolar activity against the replicating bacteria (R-TB) and low micromolar activity against the nonreplicating bacteria (NRP-TB)', '', 'Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.', 20000577),
('2-phenylquinoline derivatives', 'S. aureus NorA efflux pump inhibitors (EPIs)', '', 'Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance', 23710549),
('Resazurin', 'At concentration of 44 ?M, a potent bactericidal effect was observed against various Francisella and Neisseria species, including the human pathogens type A F. tularensis (Schu S4) and N. gonorrhoeae.', '', 'Replication of F. tularensis in primary human macrophages and non-phagocytic cells was abolished following treatment with 44 ?M resazurin indicating this compound could be an effective therapy for tularemia in vivo', 24367766),
('auranofin', 'Potent antibacterial activity against all tested strains of S. aureus, including meticillin-resistant S. aureus (MRSA), vancomycin-intermediate S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA), with minimum inhibitory concentrations (MICs) ranging from 0.0625?g/mL to 0.125?g/mL', '', 'Repurposing auranofin for the treatment of cutaneous staphylococcal infections', 26895605),
('stannous fluoride (SnF2) dentifrice (SSF)', 'broad antimicrobial activity against both Gram-positives and Gram-negatives and, in particular, has potent activity against Streptococcus mutans', '', 'Results of in vitro time-kill experiments with representative oral bacteria demonstrated that SnF2 exerts broad antimicrobial activity against both Gram-positives and Gram-negatives and, in particular, has potent activity against Streptococcus mutans.', 8593200),
('BPT L-159,061 (Biphenyl tetrazoles)', 'Inhibition of metallo-beta-lactamase by binding to two zinc atoms in the active site', '', 'RESULTS: Biphenyl tetrazoles (BPTs) are a structural class of potent competitive inhibitors of metallo-beta-lactamase identified through screening and predicted using molecular modeling of the enzyme structure.', 9545432),
('Retinoids', 'Benzoyl peroxide (BPO) is a nonantibiotic antibacterial agent that is highly effective against P acnes and for which no resistance against it has been detected to date.', '', 'Retinoids are important components in combination therapy for acne, including use with antibiotics, and can serve as an alternative to these agents in maintenance therapy.', 17649854),
('SCE-129 [3-(4-carbamoyl-1-pyridiniomethyl)-7beta-(d-alpha-sulfophenylacetamido)-ceph-3-em -4-carboxylate monosodium salt]', 'Active against Pseudomonas aeruginosa and some gram-positive bacteria', '', 'SCE-129, antipseudomonal cephalosporin: in vitro and in vivo antibacterial activities. SCE-129 [3-(4-carbamoyl-1-pyridiniomethyl)-7beta-(d-alpha-sulfophenylacetamido)-ceph-3-em -4-carboxylate monosodium salt], a new semisynthetic cephalosporin, shows potent in vitro antibacterial activities against Pseudomonas aeruginosa and some gram-positive bacteria, whereas it shows lower activity against many gram-negative rods.', 417670),
('8-hydroxyquinoline (8HQ)', 'Cu-dependent bactericidal inhibitor with MIC in the presence of Cu 0.16 ?M for replicating and nonreplicating Mycobacterium tuberculosis cells.', '', 'Screening for Cu toxicity-enhancing antibacterial molecules identified 8-hydroxyquinoline (8HQ) to be a potent Cu-dependent bactericidal inhibitor of Mycobacterium tuberculosis .', 27431227),
('?-mangostin and ceftazidime', 'Time-kill curves showed that the AMT/CTZ combination was significantly more efficient (P < 0?01) at reducing CRAB than the individual components.: The data suggest that AMT in combination with CTZ is synergistic and efficient against CRAB.', '?-mangostin has no cytotoxic effects.', 'Sep 3. Synergy and mechanism of action of ?-mangostin and ceftazidime against ceftazidime-resistant Acinetobacter baumannii. Pimchan T(1), Maensiri D(1), Eumkeb G(2). Author information: (1)School of Biology, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima, Thailand. (2)School of Preclinic, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima, Thailand. To address the resistance of Acinetobacter baumannii to ?-lactam antibiotics, combination therapy between different antibiotic classes is increasingly used.', 28799218),
('Cell-penetrating peptide (P3 and P8) and antibiotic combination', 'lower the MICs against oxacillin, norfloxacin, and vancomycin to susceptible levels', 'no significant hemolytic activity', 'Simultaneously, time-kill kinetics revealed the increased uptake of antibiotics. In summary, CPPs assist to restore the effectiveness of antibiotics at much lower concentration, eliminate the antibiotic toxicity, and represent the CPP-antibiotic combination therapy as a potential novel weapon to combat MRSA infections.', 26837216),
('2-phenylquinoline efflux inhibitor (4-(2-(piperazin-1-yl)ethoxy)-2-(4-propoxyphenyl) quinolone - PQQ4R)', 'destabilization of the E. coli inner membrane potential and ATP production impairment, ultimately leading to efflux pump inhibition by interference with the energy required by the efflux systems', '', 'Since drug resistance mediated by the activity of efflux pumps depends largely on the proton motive force (PMF), dissipaters of PMF such as PQQ4R, can be regarded as future adjuvants of conventional therapy against E. coli and other Gram-negative bacteria, especially their multidrug resistant forms.', 28516003),
('3-(4-(N,N-Dimethylaminomethyl)phenyl)quinoline derivatives', 'Most compounds have IC50 values between 20 and 40 ?m,', '', 'Structural Simplification of Bedaquiline: the Discovery of 3-(4-(N,N-Dimethylaminomethyl)phenyl)quinoline-Derived Antitubercular Lead Compounds. Bedaquiline (BDQ) is a novel and highly potent last-line antituberculosis drug that was approved by the US FDA in 2013.', 27792278),
('halogenated phenazines (HP)', 'Halogenated phenazine 14 proved to be the most potent biofilm-eradicating agent (?99.9% persister cell killing) against MRSA (MBEC < 10 ?M), MRSE (MBEC = 2.35 ?M), and VRE (MBEC = 0.20 ?M) biofilms while 11 and 12 demonstrated excellent antibacterial activity against M. tuberculosis (MIC = 3.13 ?M).', '', 'Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.', 27018907),
('6 beta-(2-aryl-2-sulfoacetamido)-6 alpha-methoxy penicillanic acids', 'potent activity against Pseudomonas aeruginosa including beta-lactamase producing strains', '', 'Structure-activity studies of these derivatives bearing hydrophilic substituents in the phenyl ring led to the identification of disodium 6 beta-[D-2-(3,4-dihydroxyphenyl)-2-sulfoacetamido]-6 alpha-methoxypenicillanate (2m) as a compound with potent activity against Pseudomonas aeruginosa including beta-lactamase producing strains.', 3096924),
('7-((2-thiazol-2-yl)benzimidazol-1-yl)-2,4 diaminoquinazoline', 'Potent inhibitor of S. aureus DHFR (Ki = 0.002 nM), antibacterial potency against S. aureus with MIC of 0.0125 ?g/mL and trimethoprim-resistant S. aureus (MIC 0.25 ?g/mL)', '', 'Structure-based design of new dihydrofolate reductase antibacterial agents: 7-(benzimidazol-1-yl)-2,4-diaminoquinazolines', 24428639),
('suramin', '', '', 'Suramin is a potent and selective inhibitor of Mycobacterium tuberculosis RecA protein and the SOS response: RecA as a potential target for antibacterial drug discovery.', 24722837),
('6?-amino-6?-N-[(S)-4-amino-2-hydroxybutyryl]-6?-deoxyarbekacin (6o)', 'antibacterial activity against S. aureus', '', 'Synthesis and antibacterial activity of 4? or 6?-alkanoylamino derivatives of arbekacin.', 25990952),
('HMR 3647 a new ketolide', 'potent activity against erythromycin susceptible and resistant pathogens, including penicillin G/erythromycin A-resistant S. pneumoniae and H. influenzae.', '', 'Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. In the search for new ketolides with improved activities against erythromycin-resistant S. pneumoniae and H. influenzae we synthesized a new 11,12 carbamate ketolide substituted by an imidazo-pyridyl side chain: HMR 3647.', 10560728),
('4''''-O-carbamoyl erythromycin-A derivatives', 'Derivatives 4c-4e and 4g had most potent activity against all the tested erythromycin-susceptible strains, derivatives 4e and 4g were the most effective against erythromycin-resistant S. pneumoniae encoded by the mef gene (0.25 and 0.25 microg/mL), derivatives 4a and 4b exhibited significantly improved activity against erythromycin-resistant S. pneumoniae encoded by the erm gene.', '', 'Synthesis and antibacterial activity of novel 4''''-O-carbamoyl erythromycin-A derivatives', 20803622),
('N-[2-(coumarin-3-yl)-2-oxoethyl]ciprofloxacin derivative (compound 8b)', 'antibacterial activity against some gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA)', '', 'Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety', 18072241),
('4?-glycyl linked quinolyl-azithromycins', 'Post potent derivatives have activity against Moraxella catarrhalis, inducibly MLSB resistant Staphylococcus aureus, clinically important respiratory tract pathogens, including erythromycin-susceptible and MLSB resistant strains of Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae', '', 'Synthesis and antibacterial evaluation of novel 4?-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.', 26860929),
('macrocyclic ?-hairpin-shaped peptidomimetics', 'Activity against Pseudomonas aeruginosa', '', 'Synthesis and antimicrobial activity against Pseudomonas aeruginosa of macrocyclic ?-hairpin peptidomimetic antibiotics containing N-methylated amino acids', 27240465),
('RP60556A, benzo[b]naphthyridones compound', 'bactericidal multiresistant Staphylococcus aureus', '', 'Synthesis and biological evaluation of benzo[b]naphthyridones, a series of new topical antibacterial agents.', 11294391),
('indole core-based derivatives', 'in vitro inhibition of different Gram-positive bacteria, Gram-negative and multi drug resistant pathogens', '', 'Synthesis and biological evaluation of indole core-based derivatives with potent antibacterial activity against resistant bacterial pathogens. The emergence of drug resistance in bacterial pathogens is a growing clinical problem that poses difficult challenges in patient management.', 28465626),
('quinolone (S)-9-fluoro-10-(4-hydroxypiperidin-1-yl)-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxaz ino[2,3,4-ij]quinoline-6-carboxylic acid L-arginine tetrahydrate', 'Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolates, penicillin-resistant Streptococcus pneumoniae clinical isolates, and Streptococcus pyogenes', '', 'Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.', 26238324),
('3-O-chlorobenzyl (3-O-arylalkyl-2,6-difluorobenzamide derivatives)', '3-O-chlorobenzyl derivative 36 was the most effective in antibacterial activity (0.5, 4, and 8 ?g/mL) against Bacillus subtilis ATCC9372, methicillin-resistant Staphylococcus aureus ATCC29213, and penicillin-resistant Staphylococcus aureus PR, while 3-O-methylbenzyl derivative 41 only exhibited the most potent activity (2 ?g/mL) against Staphylococcus aureus ATCC25923.', '', 'Synthesis and Biological Evaluation of Novel FtsZ-targeted 3-arylalkoxy-2,6-difluorobenzamides as Potential Antimicrobial Agents', 26348110),
('Rhodanine derivatives bearing a quinoline moiety (6a-h, 7a-g, and 8a-e)', 'The most effective derivative has minimum inhibitory concentration (MIC) values of 1 ?g/mL against multidrug-resistant Gram-positive organisms, including methicillin-resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA, respectively)', 'compounds 6g, 7g and 8e exhibited in vitro antibacterial activity at non-cytotoxic concentrations.', 'Synthesis and biological evaluation of rhodanine derivatives bearing a quinoline moiety as potent antimicrobial agents.', 23787100),
('Dibasic tetrahydropyran-based compounds', 'potent inhibitors of both DNA gyrase and topoisomerase IV, displaying antibacterial activities against Gram-positive and Gram-negative pathogens (Staphylococcus aureus, Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii)', '', 'Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria.', 28406300),
('5''''-modified neomycin derivatives', '', '', 'Synthesis and combinational antibacterial study of 5''''-modified neomycin. A library of 5''''-modified neomycin derivatives were synthesized for an antibacterial structure-activity optimization strategy.', 19629142),
('2-acetamido-2-deoxy-?-D-glucopyranosyl N,N-dimethyldithiocarbamate (OCT313, Glc-NAc-DMDC) and its derivatives', 'Glc-NAc-pyrrolidine dithiocarbamate (OCT313HK, Glc-NAc-PDTC) exhibited the most potent anti-tubercular activity with the minimal inhibitory concentration (MIC) of 6.25-12.5 ?g/ml.', '', 'Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives', 21232949),
('Galf N,N-didecyl sulfenamide 8d', '(MIC) of 1 microg/mL in a cell based assay against a representative strain of Mycobacterium smegmatis', '', 'Synthesis and evaluation of galactofuranosyl N,N-dialkyl sulfenamides and sulfonamides as antimycobacterial agents', 17303419),
('4,4''-bis-[2-(6-N-substituted-amidino)indolyl] diphenyl ether', 'Activity against drug resistant bacterial strains MRSA, MRSE and VRE', '', 'Synthesis and in vitro activity of dicationic indolyl diphenyl ethers as novel potent antibiotic agents against drug-resistant bacteria.', 28109787),
('5-hydroxy-5-trifluoromethyl-4,5-dihydro-1H-1-(isonicotinoyl)-pyrazole (2a) and 5-hydroxy-3-(4-methylphenyl)-5-trifluoromethyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazole (2d)', 'Inhibitors of mycolic acid biosynthesis, active against susceptible M. tuberculosis and several INH-resistant strains', '', 'Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles', 18571384),
('1-(4-fluorophenyl)-3-(4-{1-[(pyridine-4-carbonyl)-hydrazono]ethyl}phenyl)thiourea (4d)', 'minimum inhibitory concentration of 0.49 microM against M. tuberculosis H37Rv and INH-resistant M. tuberculosis.', '', 'Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea', 16303302),
('oxazolidinone-class antimicrobial agents with 5-substituted octahydrocyclopenta[c]pyrrole moieties at the C-ring of linezolid and an acetamide or 1,2,3-triazole ring as the C-5 side chain of the oxazolidinone ring', 'Active against some resistant Gram-positive and -negative bacteria, derivatives like endo-alcohol 2a and exo-alcohol 2b showed potent inhibitory activity against M. tuberculosis H37Rv, several analoguess showed potent in vitro antibacterial activity against vancomycin-resistant bacteria and s linezolid-resistant methicillin-resistant Staphylococcus aureus (MRSA) strains.', '', 'Synthesis and in vitro evaluation of the antitubercular and antibacterial activity of novel oxazolidinones bearing octahydrocyclopenta[c]pyrrol-2-yl moieties.', 25297523),
('1,2-disubstituted-1H-benzimidazole-N-alkylated-5-carboxamidine derivatives', 'Derivatives with 3,4-dichloro substituted phenyl at the position C-2, of N-bulky alkyl substituted benzimidazolecarboxamidines exhibited the greatest activity with MIC values of 1.56-0.39 microg/ml.', '', 'Synthesis and potent antibacterial activity against MRSA of some novel 1,2-disubstituted-1H-benzimidazole-N-alkylated-5-carboxamidines.', 15992965),
('4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides', 'Highest antibacterial activity was achieved with with MIC values of 3.12 microg/mL against S. aureus, MRSA and MRSE', '', 'Synthesis and potent antimicrobial activity of some novel 4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides.', 15476288),
('[1-(2,4-dichlorobenzyl)-N- (2-diethylaminoethyl)-1H-benzimidazole-5-carboxamidine], with a 3,4-dichlorophenyl group at the C-2 position', 'MIC = 3.12 microg/mL against both some bacteria and the fungus C. albicans', '', 'Synthesis and potent antimicrobial activity of some novel N-(alkyl)-2-phenyl-1H-benzimidazole-5-carboxamidines. A series of 22 novel 1,2-disubstituted-1H-benzimidazole-N-alkylated-5- carboxamidine derivatives were synthesized and evaluated for in vitro antibacterial activity against S. aureus and methicillin resistant S. aureus (MRSA), E. coli, E. faecalis and for antifungal activity against C. albicans.', 18007533),
('1H-benzimidazolecarboxamidines', 'The most potent compound (32) has minimal inhibitory concentrations value 0.78 ?g/mL).', '', 'Synthesis and potent in vitro activity of novel 1H-benzimidazoles as anti-MRSA agents.', 22497759),
('1beta-methyl-2-(naphthosultamyl)methyl-carbapenems (L-786,392)', 'potent anti-MRSA activity', '', 'Synthesis and properties of 2-(naphthosultamyl)methyl-carbapenems with potent anti-MRSA activity: discovery of L-786,392. A series of 1beta-methyl-2-(naphthosultamyl)methyl-carbapenems bearing dicationic groups on the naphthosultamyl moiety was prepared and evaluated for activity against resistant gram-positive bacteria.', 10201828),
('dicationic diaryl ethers', 'The most potentcompound had anti-MRSA MIC value of 0.06 microg/mL', '', 'Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents', 19589676),
('2-pyridones (pyrido[1,2-alpha]pyrimidine and quinolizine)', 'DNA gyrase inhibitor', '', 'Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents. Two novel series of 2-pyridones were synthesized by transposition of the nitrogen of 4-quinolones to the bridgehead position.', 8759628),
('7-[(3S,4R)-4-(1-aminocyclopropan-1-yl)-3-fluoropyrrolidin-1-yl] derivative 3 (=DQ-113)', 'Activity against clinically isolated resistant pathogens', '', 'Synthesis and structure-activity relationships of 5-amino-6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic acid antibacterials having fluorinated 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] substituents.', 12620077),
('lincomycin analogs modified at the 6- and 7-positions', 'antibacterial activity against different bacteria', '', 'Synthesis and structure-activity relationships of novel lincomycin derivatives', 28559581),
('2''''-amino-2''''-deoxyarbekacin', 'Active against methicillin-resistant Staphylococcus aureus', '', 'Synthesis of 2''''-amino-2''''-deoxyarbekacin and its analogs having potent activity against methicillin-resistant Staphylococcus aureus. Based on our studies on the enzymatic modifications of arbekacin by methicillin-resistant Staphylococcus aureus (MRSA), replacement of the 2''''-hydroxyl group by an amino group in arbekacin was designed to synthesize derivatives that would be active against MRSA. 2''''-Amino-2''''-deoxyarbekacin and five analogs were synthesized starting from dibekacin.', 8071128),
('T-3761, a new fluoroquinolone', 'The MIC against methicillin-susceptible Staphylococcus aureus, methicillin-susceptible and -resistant Staphylococcus epidermidis, and Clostridium spp were 0.39 to 6.25 micrograms/ml, aginst streptococci and enterococci tested were 3.13 to 100 micrograms/ml', '', 'T-3761 had a broad spectrum of activity and had potent activity against gram-positive and -negative bacteria.', 1332594),
('T-3912, a novel non-fluorinated topical quinolone', 'in vitro activity of T-3912 against methicillin-susceptible Staphylococcus aureus, ofloxacin-resistant and methicillin-resistant S. aureus, Staphylococcus epidermidis, ofloxacin-resistant S. epidermidis, penicillin-resistant Streptococcus pneumoniae and Propionibacterium acnes was four-fold to 16 000-fold greater than that of other agents at the MIC90 for the clinical isolate', '', 'T-3912 exhibited more potent bactericidal activity against S. aureus and P. acnes than nadifloxacin and clindamycin in a short time period.', 11864945),
('TP-434, a novel fluorocycline', 'MIC of TP-434 (0.063 ?g/ml), potent inhibition in E. coli in vitro transcription/translation (50% inhibitory concentration [IC(50)] = 0.29 ? 0.09 ?g/ml) and [(3)H]tetracycline ribosome-binding competition (IC(50) = 0.22 ? 0.07 ?M) assays.', '', 'Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic', 22354310),
('2-hydroxy-N''-{[5-(2-nitrophenyl)-2-furyl]methylene}benzohydrazide (B8I-2)', 'inhibited intracellular growth of B. abortus 2308 in J774 macrophages at relatively low ?M concentrations.', '', 'Targeting bacterial virulence functions in order to disarm pathogens represents a promising alternative to classical antibiotic therapy.', 21173315),
('tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide (THPP) and N-benzyl-6'',7''-dihydrospiro[piperidine-4,4''-thieno[3,2-c]pyran] (Spiro) analogues', 'reduce >2 logs bacterial cfu counts in the lungs of infected mice', '', 'Tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-benzyl-6'',7''-dihydrospiro[piperidine-4,4''-thieno[3,2-c]pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3', 23613759),
('ketolides (6-O-methyl-3-oxoerythromycin derivatives)', 'active against penicillin/erythromycin-resistant pneumococci and noninducers of MLSB resistance', '', 'The 11,12-substituted ketolide 61 (HMR 3004) demonstrated a potent activity against multiresistant pneumococci associated with a well-balanced activity against all bacteria involved in respiratory infections including H. influenzae, Mycoplasma catarrhalis, group A streptococci, and atypical bacteria. In addition HMR 3004 displayed high therapeutic activity in animals infected by all major strains, irrespective of their resistance phenotype.', 9767644),
('8-substituted-9,1-[(N-methylimino)methano]- 7-fluoro-5-oxo-5H-thiazolo[3,2-alpha]-quinoline-4-carboxylic acids 5a-q', 'Active against methicillin-resistant Staphylococcus aureus isolates (MRSA)', '', 'The 8-(4-alkyl-1-piperazinyl) derivatives 5g, 5h, 5j, and 5n provided good oral efficacy and exhibited more potent activity than ofloxacin (6) against the systematic infection with S. aureus IID 803 in mice.', 8126698),
('FK037', 'MIC90s: Streptococcus pyogenes (0.012 ?g/ml), Escherichia coli (0.05 ?g/ml ), Streptococcus pneumoniae (0.1 ?g/ml), Klebsiella pneumoniae (0.39 ?g/ml)', '', 'The advantages of in vitro activity of FK037 were as follows: (1) a broad-spectrum antibacterial activity, (2) the most potent activity (MIC90: 25 micrograms/ml) of the cephalosporins tested against highly methicillin-resistant Staphylococcus aureus (H-MRSA), (3) a strong activity against Enterobacter spp. and Citrobacter freundii resistant to the third-generation cephalosporins tested.', 8205935),
('teicoplanin and caffeic acid phenethyl ester (CAPE)', '', '', 'The combination of an antioxidant / anti-inflammatory agent, CAPE, added to standard antibiotic therapy might be effective in the treatment of post-sternotomy mediastinitis due to MRSA. DOI: 10.1179/joc.2006.18.3.268', 17129837),
('combination of nebulized sodium nitrite and colistimethate', '', 'Sodium nitrite has antimicrobial properties and has been tolerated as a nebulized compound at high concentrations in human subjects with pulmonary hypertension', 'The combination of nebulized sodium nitrite and colistimethate may provide a novel therapy for chronic P. aeruginosa airway infections, because sodium nitrite, unlike other antibiotic respiratory chain "poisons," can be safely nebulized at high concentration in humans. .', 25229185),
('tobramycin-fumarate combination', 'Enhanced killing of up to 6 orders of magnitude of P. aeruginosa persisters over a range of CF isolates, including mucoid and nonmucoid strains, was observed for the tobramycin-fumarate combination compared to killing with tobramycin alone. Furthermore, significant fumarate-mediated potentiation was seen in the presence of azithromycin or CF patient sputum.', 'Fumarate also reduced the cytotoxicity of tobramycin-treated P. aeruginosa to human epithelial airway cells.', 'The combination of the aminoglycoside tobramycin with fumarate as an antibacterial potentiator utilizes an antipersister strategy that is aimed at reducing recurrent Pseudomonas aeruginosa infections by enhancing the killing of P. aeruginosa persisters.', 28923873),
('PC190723, synthetic antibacterials', 'efficacious in an in vivo model of infection,', '', 'The data validate FtsZ as a target for antibacterial intervention and identify PC190723 as suitable for optimization into a new anti-staphylococcal therapy.', 18801997),
('1,3-benzoxazol-2(3H)-one derivatives', 'antibiofilm activity against Pseudomonas aeruginosa PA01', '', 'The discovery that many bacteria use quorum sensing (QS) to regulate their virulence factor and pathogenicity production makes the QS system an attractive target for antimicrobial therapy.', 22588631),
('N-thiolated ?-lactams', 'N-thiolated ?-lactams are FAS-inhibiting antimicrobials', 'No reported toxicity.', 'The impact of fatty acids on the antibacterial properties of N-thiolated ?-lactams. Bacterial fatty acid synthesis (FAS) is a potentially important, albeit controversial, target for antimicrobial therapy.', 21821415),
('BO-2727, new carbapenem', 'MIC90 ? 0.5 microgram/ml against methicillin-susceptible staphylococci and streptococci, 4 to 8 micrograms/ml Against methicillin-resistant staphylococci, 0.006 to 2 micrograms/ml against members of the family Enterobacteriaceae, Haemophilus influenzae, and Moraxella catarrhali, 2 micrograms/ml against Pseudomonas aeruginosa (imipenem-susceptible strains)', '', 'The in vivo efficacy of BO-2727 against experimental septicemia caused by gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus and imipenem-resistant P. aeruginosa, reflected its potent in vitro activity and high levels in plasma.', 7625784),
('S-4661', 'MIC90 0.5 ?g/ml or less against methicillin-susceptible staphylococci and streptococci, 8 ?g/ml against imipenem-resistant Pseudomonas aeruginosa', '', 'The in vivo efficacy of S-4661 against experimentally induced infections in mice caused by gram-positive and gram-negative bacteria, including penicillin-resistant Streptococcus pneumoniae and drug-resistant P. aeruginosa, reflected its potent in vitro activity and high levels in plasma in mice.', 9449267),
('berberine and 5''-methoxyhydnocarpin (5''-MHC)', '', '', 'The inhibitor was identified as 5''-methoxyhydnocarpin (5''-MHC), previously reported as a minor component of chaulmoogra oil, a traditional therapy for leprosy.', 10677479),
('antibiotics in combination with silver nanoparticles', '', '', 'The majority of synergistic effects were observed for combinations of AgNPs given together with gentamicin, but the highest enhancement of antibacterial activity was found with combined therapy together with penicillin G against Actinobacillus pleuropneumoniae.', 26832810),
('benzo[b]thiophene-2-boronic acid', 'inhibitors of AmpC beta-lactamase', '', 'The most potent of these compounds, benzo[b]thiophene-2-boronic acid , has an affinity for E. coli AmpC of 27 nM.', 9804697),
('MUT056399', 'active against methicillin-susceptible and resistant S. aureus , linezolid-resistant, and multidrug-resistant strains, with MIC(90)s between 0.03 and 0.12 ?g/ml; and MIC(90)s between 0.12 and 4 ?g/ml against coagulase-negative staphylococci, with', '', 'The MUT056399 inhibitor of FabI is a new antistaphylococcal compound.', 21825292),
('BO-3482, a novel dithiocarbamate carbapenem', 'Active against methicillin-resistant Staphylococcus aureus', '', 'The potent in vivo activity of BO-3482-cilastatin against such MRSA infections can be ascribed to the good in vitro anti-MRSA activity and improved pharmacokinetics in mice when BO-3482 is combined with cilastatin and to the bactericidal nature of the carbapenem.', 9333062),
('LY333328', 'MIC90 2 microg/ml in Mueller-Hinton II (MH II) broth and 1 microg/ml in brain heart infusion (BHI) broth', '', 'The prolonged PAE of LY333328, a potent new bactericidal glycopeptide, and its synergy with ampicillin in a large proportion of strains suggest that further evaluation of this drug in pharmacokinetic studies and experimental infections, including those with VRE, is warranted.', 9756756),
('combinations of SIPI-8294 and ?-lactam antibiotics', '', '', 'The research indicates that it may be a promising strategy for combating MRSA infections with the combinations of SIPI-8294 and ?-lactam antibiotics.', 27173151),
('coumermycin', 'Active against methicillin-resistant strains of Staphylococcus aureus', '', 'The results indicate that coumermycin is potent against MRSA with activity equal or superior to comparable agents in various experimental mouse infections.', 3492342),
('benzimidazole Y-754', 'The minimum inhibitory concentration of Y-754 against H. pylori, at 0.025 microg/ml', '', 'The results obtained lead to the expectation that the new benzimidazole Y-754 will, in the near future, be used for H. pylori eradication therapy in peptic ulcer patients.', 15160301),
('Cefepime', 'Cefepime 2 g every 12 hours', 'only 3% of patients in each group discontinued therapy because of an adverse event. The most common adverse events were headache, diarrhea, nausea, vomiting, pruritus, and rash.', 'The results of this study indicate that cefepime is a promising, effective, and safe single-agent therapy for serious infections in hospitalized patients.', 8678098),
('?-Ag 2 MoO 4 microcrystals', 'The silver molybdate was obtained by the conventional hydrothermal method, and the structural, vibrational and morphological properties of the sample were determined using X-ray diffraction, Raman spectroscopy and scanning electron microscopy images.these silver molybdates present a clinically relevant antibacterial activity and enhanced the antibiotic activity of some antibiotics against MDR strain of S. aureus and E. coli, being an interesting alternative to combat antibiotic-resistant bacterial infectious agents.', '', 'The reversion of antibiotic resistance by combinations with Ag2MoO4 could be a novel strategy to combat infections caused by multiple drug resistance (MDR) pathogens.', 28006749),
('tobramycin', 'Eighty milligrams of a tobramycin solution were inhaled twice daily after physiotherapy via a jet nebulizer.', 'No evidence of ototoxicity or renal damage was observed.', 'The study demonstrates the safety and clinical efficacy of long-term tobramycin aerosol therapy.', 2494640),
('12-oxime and O-oxime ether derivatives of dehydroabietic acid', 'The most potent derivative has MIC of 0.39-0.78?g/mL against S. aureus Newman, some others have MIC values 1.25-3.13?g/mL aginst multidrug-resistant S. aureus', '', 'The synthesis and antistaphylococcal activity of dehydroabietic acid derivatives: Modifications at C-12.', 27777007),
('third-generation P-glycoprotein inhibitor tariquidar', 'addition of tariquidar resulted in a 10-fold reduction of the ciprofloxacin MIC Staphylococcus aureus 1199B (SA1199B)', '', 'The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance by increasing intracellular drug concentration.', 21393173),
('titanium dioxide (TiO2)', 'Strain: methicillin resistant Staphylococcus aureus (MRSA 27065)', '', 'The TiO(2) coating with integrated copper ions could offer a new strategy for preventing implant-associated infections, with antibacterial properties not only against the most common bacteria causing implant infections but also against multiresistant strains such as MRSA.', 21188483),
('isosorbide mononitrate (ISMN)', 'Specifically, exposure to ISMN significantly enhanced the efficacy of ciprofloxacin by reducing the number of CFU (~3log10 or ~2log10) of biofilm-associated and planktonic bacteria respectively, compared to drug alone.', 'NA', 'The use of nitric oxide (NO), a naturally occurring antimicrobial agent, as an alternative strategy to combat bacterial biofilms has recently gained considerable momentum in light of the global threat of emerging antibiotic resistance.', 29305985),
('verapamil and Q203 combinations', '', '', 'Therefore, the combination of verapamil and Q203 may be a promising combinatorial strategy for anti-TB treatment to accelerate the elimination of M. tuberculosis.', 28416541),
('liposomal BiEDT-tobramycin (LipoBiEDT-TOB)', 'MIC of LipoBiEDT-TOB (0.25mg/L vs. 1024 mg/L). At 4 mg/L vs. 4096 mg/L eradicated highly resistant P. aeruginosa (PA-48913)', 'LipoBiEDT-TOB was significantly less toxic when compared to the free BiEDT, as evaluated by the MTT and LDH assay.', 'These data suggest that the novel LipoBiEDT-TOB drug delivery system could be utilized as a new strategy to enhance the efficacy of existing antibiotics against resistant organisms that commonly affect individuals with chronic lung infections.', 18448284),
('titanium dioxide (TiO2)', '', '', 'These findings suggest the created materials with high bacterial interaction ability might be a useful strategy to improve the antimicrobial activity of visible-light-activated TiO2.', 19272171),
('psammaplin A analogue', 'active against methicillin-resistant Staphylococcus aureus (MRSA)', '', 'These psammaplin A analogues were screened directly against various gram positive bacterial strains leading to the discovery of a series of potent antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA).', 11686609),
('GAR-936, new glycylcycline', 'MIC against different bacteria: Streptococcus pneumoniae (MIC90, 0.03 ?g/ml), Enterococcus spp. (MIC90, 0.12 or 0.25 ?g/mL), Staphylococcus aureus (MIC50 0.25 ?g/mL), Acinetobacter spp. (MIC90, 2 ?g/mL), Stenotrophomonas maltophilia (MIC90, 4 ?g/mL), Pseudomonas aeruginosa (MIC50, 8 ?g/mL), Haemophilus influenzae (MIC90, 1-2 ?g/mL), Moraxella catarrhalis (MIC90, 0.12 ?g/mL), and various Neisseria spp. (MIC90, 0.12-0.5 ?g/mL)', '', 'These results indicate that GAR-936 has potent in vitro activity against a wide range of clinically important pathogenic bacteria, and that several gram-positive and -negative isolates resistant to older tetracyclines and other drug classes remain susceptible to GAR-936, the newest glycylcycline candidate for clinical use.', 10744364),
('tannic acid', 'The MICs of EtBr and antibiotics were significantly reduced in the presence of tannic acid, inhibition against the efflux pumps of both strains with a three-fold reduction of the MIC. Bacteria : Staphylococcus aureus', 'NA', 'These results indicate the possible usage of tannic acid as an adjuvant in antibiotic therapy against multidrug resistant bacteria (MDR).', 27057677),
('tannic acid', 'The MICs of EtBr and antibiotics were significantly different in the presence of tannic acid, indicating the inhibitory effect of this product against efflux pumps of both strains.', '', 'These results indicate the possible usage of tannic acid as an inhibitor and an adjuvant in the antibiotic therapy against multidrug resistant bacteria (MDR). Copyright ? 2017 Elsevier Inc.', 28841421),
('CS-834, a new oral carbapenem which is an ester-type prodrug of R-95867', 'bactericidal activity against Staphylococcus aureus and Escherichia coli.', '', 'These results suggest that CS-834 may be effective in the therapy of various bacterial infections.', 9818740),
('Gallium Citrate', 'MIC against K. pneumoniae ranged from 0.125 to 2.0 ?g/ml GaCi.', '', 'These results suggest that with more preclinical testing, a topical application of GaCi may be a promising alternative treatment strategy for K. pneumoniae SSTI.', 26239978),
('methyl-1,4-hydroquinone and 2,3-dimethyl-1,4-hydroquinone analogues synthesized by amination with amino-?-lactam structures', 'inhibited the growth of several Gram-positive bacterial strains including multidrug-resistant Staphylococcus aureus and Enterococci', '', 'Thirty-eight potential 1,2- and 1,4-hydroquinoid laccase substrates were screened for their antibacterial and cytotoxic activity to select the best substrates for laccase-catalyzed coupling reaction resulting in potent antibacterial derivatives.', 26780358),
('AU-FQ hybrid compound 251D (anilinouracils (AUs) such as 6-(3-ethyl-4-methylanilino)uracil (EMAU) and fluoroquinolones)', 'active against a broad panel of antibiotic-resistant gram-positive pathogens as well as several gram-negative organisms', 'lacked toxicity in vitro', 'This class of AU-FQ hybrids provides a promising new pharmacophore with an unusual dual mechanism of action and potent activity against antibiotic-sensitive and -resistant gram-positive pathogens.', 17074800),
('SYN987, SYN1193, and SYN1253', 'Active against streptococci (including penicillin resistant Streptococcus pneumoniae), enterococci and Staphylococcus aureus', '', 'This study demonstrates that SYN 987, 1193 and 1253 are extremely potent antibacterial agents which deserve further evaluation.', 8537267),
('Azole drugs', 'MIC values of <0.2 and 0.3 micro M, respectively for the drugs econazole and clotrimazole', '', 'This suggests that azole drug therapy may provide a novel antibiotic strategy against strains of M. tuberculosis that have already developed resistance to isoniazid and other front-line drugs.', 12368427),
('Vertex aminobenzimidazole VT12-008911', 'MIC(50), MIC(90) and MIC range of VT12-008911 were 0.064, 0.125 and ?0.002-0.25 mg/L, respectively', '', 'Time-kill curve analysis showed that VT12-008911 exhibited potent time-dependent bactericidal activity, at or very close to the MIC, against N. gonorrhoeae.', 24651828),
('BB-3497, N-formyl-hydroxylamine derivative', 'Bacteriostatic, Activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis, some gram-negative bacteria.', '', 'To identify novel PDF inhibitors, we screened a metalloenzyme inhibitor library and identified an N-formyl-hydroxylamine derivative, BB-3497, and a related natural hydroxamic acid antibiotic, actinonin, as potent and selective inhibitors of PDF.', 11158755),
('propargyl-linked antifolates containing a key pyridyl substituent', 'Antibacterial activity against both methicillin-resistant S. aureus and S. pyogenes at MIC values below 0.1 ?g/mL', 'Minimal cytotoxicity against mammalian cells', 'Toward new therapeutics for skin and soft tissue infections: propargyl-linked antifolates are potent inhibitors of MRSA and Streptococcus pyogenes.', 22347365),
('SK&F 107647', 'up to 1000-fold reduction in the number of E. coli recovered from blood', 'hematoregulatory activities', 'Treatment of experimental gram-negative and gram-positive bacterial sepsis with the hematoregulatory peptide SK&F 107647.', 8537660),
('oxabicyclooctane-linked Novel bacterial topoisomerase inhibitors (NBTIs) with new tricyclic-1,5-naphthyridinone left hand side moieties', 'Compounds with a (R)-hydroxy-1,5-naphthyridinone moiety (7) showed potent antibacterial activity (e.g., Staphylococcus aureus MIC 0.25 ?g/mL), acceptable Gram-positive and Gram-negative spectrum with rapidly bactericidal activity.', '', 'Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety', 25851938),
('TXA497, guanidinomethyl biaryl compounds', 'Bactericidal against methicillin-resistant Staphylococcus aureus (MRSA)', '', 'TXA497 as a topical antibacterial agent: comparative antistaphylococcal, skin deposition, and skin permeation studies with mupirocin', 25263100),
('Guanylated polymethacrylates', 'kills C. albicans and S. aureus when applied to established polymicrobial biofilms.', '', 'We further compared guanylated polymethacrylates with first-line antistaphylococcal and anti-Candida agents used as combinatorial therapy against polymicrobial biofilms.', 26490013),
('TXA707, FtsZ-targeting agent', 'acts synergistically with ?-lactams', '', 'We have developed a promising new FtsZ-targeting agent (TXA707) with potent activity against MRSA isolates resistant to current standard-of-care antibiotics.', 28630190),
('synthetic oxazolidinones, U-100592 and U-100766', 'potent in vitro activity against Mycobacterium tuberculosis', '', 'We have prepared two potent, synthetic oxazolidinones, U-100592 and U-100766, which are currently in clinical development for the treatment of serious multidrug-resistant Gram-positive bacterial infections caused by strains of staphylococci, streptococci, and enterococci.', 8576909),
('halogenated quinoline (HQ)', 'potent antibacterial (MIC?0.39 ?m) and biofilm eradication (MBEC 1.0-93.8 ?m) activities against drug-resistant Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium strains', '<5 % haemolysis activity against human red blood cells (RBCs) at 200 ?m and low cytotoxicity against HeLa cells', 'We identified diverse analogues that are alkylated and aminated at the 2-position of the HQ scaffold and demonstrate potent antibacterial (MIC?0.39 ?m) and biofilm eradication (MBEC 1.0-93.8 ?m) activities against drug-resistant Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecium strains while demonstrating <5 % haemolysis activity against human red blood cells (RBCs) at 200 ?m.', 27245927),
('geometrical isomers of a macrocyclic bis(bibenzyl) based on isoplagiochin', 'The isomer containing a 1,4-linked ring (5) showed only weak activity, whereas the isomers containing a 1,3-linked (6) or 1,2-linked (7) C ring showed potent anti-MRSA activity.', '', 'We synthesized three geometrical isomers of a macrocyclic bis(bibenzyl) based on isoplagiochin, a natural product isolated from bryophytes, and evaluated their antibacterial activity towards methicillin-resistant Staphylococcus aureus (anti-MRSA activity).', 25999206),
('XRP 2868, streptogramin', 'MIC50 0.25 ?/ml, MIC90 0.5 ?/ml for pneumococci; for beta-lactamase-positive, beta-lactamase-negative, and beta-lactamase-negative ampicillin-resistant strains MIC50 is 0.25 ?/ml and an MIC90 of 1.0 ?/ml', '', 'XRP 2868 showed potent activity against pneumococci and Haemophilus strains irrespective of their susceptibility to other agents.', 14506040),
('Combination therapy of Polymyxin B and non-antibiotics from various drug classes', 'Activity againt Acinetobacter baumannii, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa', '', 'Alternative strategies to treat infectious diseases, such as combination therapy, are urgently needed.', 30240838),
('Schiff bases of 2-mercaptobenzimidazole were synthesized from 4-(2-(1H-benzo[d]- imidazol-2-ylthio)acetamido)benzohydrazide', 'Compounds 8 (MICpa, an = 2.41, 1.20 ?M/ml), 10 (MICse, sa = 2.50 ?M/ml), 20 (MICec = 2.34 ?M/ml) and 25 (MICca = 1.46 ?M/ml) showed significant antimicrobial activity against tested bacterial and fungal strains', '', 'In general, the synthesized derivatives exhibited moderate antimicrobial and anticancer activities.', 30306865),
('2-chlorobenzyl sulfonamide 1,2,4-triazole 7c', 'Antibacterial activities against MRSA, B. subtilis, B. typhi and E. coli with MIC values of 0.02-0.16 micro mol/mL', '', 'CONCLUSION: Compound 7c could serve as a potential clinical antimicrobial candidate.', 30398118),
('Azithromycin with bis-2-aminoimidazole adjuvants', 'bis-2-AI exhibits a 1024-fold reduction in the minimum inhibitory concentration of azithromycin in vitro and displays activity in a Galleria mellonella model of infection', '', 'Herein, we describe a novel approach to combatting pseudomonal infections through the use of bis-2-aminoimidazole adjuvants that can potentiate the activity of a macrolide antibiotic commonly prescribed to CF patients as an anti-inflammatory agent.', 30444345),
('Hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold', 'The most potent derivative had MIC of 0.39-0.78 micro g/mL against S. aureus Newman and Escherichia coli AB1157 strain', '', 'Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents', 30447433),
('4-oxoquinazolin-3(4H)-yl)benzoic acid and benzamide derivatives', 'Potent inhibitory activity against Staphylococcus aureus (MICs = 0.25-0.5 micro g/mL)', '', 'The interesting results obtained suggest the potential utility of the newly synthesized compounds for treatment of multidrug resistant S. aureus infections.', 30471579),
('Ebsulfur scaffold', 'The best, dose- and time-dependent inhibitor had an IC50 of 0.16 microM, IC50 value of the all compounds ranged from 0.16-9 microM', '', 'Ebsulfur as a potent scaffold for inhibition and labelling of New Delhi metallo-beta-lactamase-1 in vitro and in vivo.', 30502631),
('Nacubactam', 'MICs of nacubactum alone are in the range of 1-8 mg/L or >32 mg/L, enhance activity in antibiotic combination, activity against MBL-producing Enterobacteriaceae', '', 'Nacubactam combinations, including those using MBL-labile beta-lactams, e.g. meropenem and cefepime, can overcome most MBL-mediated resistance. This behaviour reflects nacubactam''s direct antibacterial and enhancer activity.', 30590470),
('5-chloro-2-(4-chloro-3-methylphenyl)-4-methyl-3(2H)-isothiazolone (Compound 6) and 5-chloro-2-(4-chlorophenyl)-4-methyl-3(2H)-isothiazolone (Compound 7)', 'Potent and cidal activity against 46 different MDR Acinetobacter baumannii clinical isolates and reference strains', '. While cytotoxicity was observed with Compound 7', 'Identification and characterization of novel isothiazolones with potent bactericidal activity against multi-drug resistant Acinetobacter baumannii clinical isolates', 30593847),
('Metronidazole hybrid 6a : Sulfonamide-Derived Four-Component Molecular Hybrids', '(MIC) value of 0.019 mM against clinical drug-resistant Escherichia coli ( E. coli)', '', 'Novel sulfonamide-based four-component molecular hybrids as potential DNA-targeting antimicrobial agents were developed from marketed acetanilide through convenient procedures.', 30638386),
('5-Arylideneimidazolones with Amine at Position 3', '4-32-fold reduction of oxacillin MIC in highly resistant MRSA HEMSA 5 strain with anthracene-morpholine derivative (16) being the most potent. Significant efflux pump inhibitor (EPI) properties, naphthyl-methylpiperazine derivative 9 showed the most potent "dual action" of both oxacillin adjuvant (MRSA) and EPI', '', '5-Arylideneimidazolones with Amine at Position 3 as Potential Antibiotic Adjuvants against Multidrug Resistant Bacteria', 30691112),
('Lipophilic Q203 derivatives', 'Show considerable potency against MTB H37Rv strain (MIC < 0.25 microM). Nine compounds (13, 15, 19, 21, 23, 25, 29, 35, 36) have excellent activity against both drug-sensitive and -resistant strains (MIC < 0.035 microM)', '', 'Especially, compound 29 also displays acceptable safety, greater absorption in plasma and aqueous solubility than Q203, suggesting its promising potential to be lead compound for future antitubercular drug discovery.', 30692025),
('5-methoxy-2,3-naphthalimide derivatives', 'The most potent compound showed antimicrobial synergistic activity in combination with levofloxacin by 4 times and 16 times at the concentration of 8 and 16 microg/mL, respectively, and ould effectively abolish Nile Red efflux at 100 microM.', '', 'Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance', 30755336),
('Acyclic pyridine-containing ligands, H2dedpa and compound 8', 'Improved the activity of meropenem against E. coli harboring the blaNDM-4 gene by nearly 40,960 times. H2dedpa (IC50 = 0.17 ? 0.04 microM) and compound 8 (IC50 = 0.04 ? 0.02 microM) showed higher inhibitory activity against blaNDM-1 enzyme than the positive control ethylenediaminetetraacetic acid (EDTA, IC50 = 28.84 ? 0.70 microM)', '', 'H(2)depda: An acyclic adjuvant potentiates meropenem activity in vitro against metallo-beta-lactamase-producing enterobacterales.', 30776696),
('Mefloquine-Based Analogs', 'Displayed activity against sensitive Mycobacterium tuberculosis in vitro, with MIC values between 37.2 and 154.8 microM.', 'Low cytotoxicity', 'Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains', 30836914);
INSERT INTO `bacteria_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('IID572', 'Broad spectrum beta lactamase inhibitors of the diazabicyclooctane (DBO) class', '', 'IID572: A New Potentially Best-In-Class beta-Lactamase Inhibitor', 30861342),
('Sulfonium-vancomycin derivatives', 'Activity against some Gram-negative bacteria', '', 'Sulfonium, an Underestimated Moiety for Structural Modification, Alters the Antibacterial Profile of Vancomycin Against Multidrug-Resistant Bacteria', 30908776),
('Poly (acetyl, arginyl) glucosamine (PAAG)', 'Biofilms reduction of Burkholderia cepacia Complex at 50 to 200 microgram/ml', '', 'New therapeutic strategies targeting bacterial biofilms are anticipated to enhance antibiotic penetration and facilitate resolution of infection.', 30910901),
('Thiazolin-4-one derivatives', 'Activity against gram-positive and gram-negative bacteria.', '', 'Antioxidant activity and antibacterial evaluation of new thiazolin-4-one derivatives as potential tryptophanyl-tRNA synthetase inhibitors.', 30938216),
('Analogs of solithromycin synthesized using Cu(I)-mediated click chemistry', 'Potecy against resistant Staphylococcus aureus, Escherichia coli, and multidrug resistant pathogens Enterococcus faecium and Acinetobacter baumannii', '', 'Evaluation of the analogs using Minimum Inhibitory Concentration (MIC) assays against resistant Staphylococcus aureus, Escherichia coli, and multidrug resistant pathogens Enterococcus faecium and Acinetobacter baumannii showed they possess potencies similar to those of solithromycin, thus demonstrating their potential as future therapeutics to combat the existential threat of multidrug resistant pathogens.', 30962084),
('Arsinothricin', 'Broad-spectrum antibiotic against both Gram-positive and Gram-negative bacteria', '', 'Arsinothricin, an arsenic-containing non-proteinogenic amino acid analog of glutamate, is a broad-spectrum antibiotic', 30993215),
('Aryl isonitrile compound', 'Inhibited the growth of MRSA clinical isolates at 2-4microM', 'Non-toxic to human keratinocyte', 'An aryl isonitrile compound with an improved physicochemical profile that is effective in two mouse models of multidrug-resistant Staphylococcus aureus infection', 31051286),
('Phenylthiazoles : 2-thienyl derivative 20 and the hydroxyl-containing derivative 31', 'Inhibition of growth of drug-resistant Staphylococcus aureus at a concentration as low as 1 microgram/mL', '', 'Lipophilic efficient phenylthiazoles with potent undecaprenyl pyrophosphatase inhibitory activity', 31075608),
('Quinazolinone analogues', 'MIC value 15.625 microgram/mL against S. aureus and with MIC value 31.25 microgram/mL against MRSA', '', 'Design, synthesis, in-silico studies and biological screening of quinazolinone analogues as potential antibacterial agents against MRSA.', 31103406),
('(5-aryloxy-pyrazolyl)- and (5-aryl/olefin-sulfanyl-pyrazolyl)-dibenzo[b,e] [1,4] diazepinone scaffolds', 'Compounds 25c and 29e, overall, registered good to moderate activity against A549 (lung), HeLa (cervix), SW1573 (lung) T-47D (breast) and WiDr (colon) cell lines, with GI50 values in the 2.6-5.1 microM and 1.8-7.5 microM ranges, respectively', '', 'Compounds reported in the present work revealed good antioxidant, antimicrobial and antiproliferative activities with promising FRAP (ferric reducing antioxidant power), bacterial resistance and human solid tumor cell growth inhibitory values, respectively.', 31127460),
('Cyclohexyl amide-based compounds', 'Suitable antibacterial activity against Gram-positive Staphylococcus aureus', '', 'Results: Described here is the synthesis and biological evaluation of a tiny series of new virtually assembled NBTIs containing synthetically feasible right-hand side fragments capable of binding the GyrA subunit of the bacterial DNA gyrase-DNA complex.', 31140866),
('Apo-transferrin', 'Inhibit in vitro growth of Klebsiella pneumoniae and Acinetobacter baumannii', '', 'Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria', 31170282),
('s-triazine derivatives', 'Activity against multi-drug resistant (MDR) clinical isolates of Klebsiella pneumoniae and methicillin resistant Staphylococcus aureus', '', 'Compounds 3j and 6b were the most potent antibacterial agents against the tested strains and multi-drug resistant (MDR) clinical isolates of Klebsiella pneumoniae and methicillin resistant Staphylococcus aureus (MRSA1) with minimal toxicity in comparison to the reference drugs.', 31174040),
('Imidazo[1,2-b][1,2,4,5]tetrazines', 'The most prominent minimal inhibitory concentration on M. tuberculosis H37Rv was 1 microgram/ml', '', 'Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines', 31176094),
('Nebramine-cyclam conjugate', 'Potentiate beta-lactam antibiotics, as well as other legacy antibiotics, against P. aeruginosa in vitro', '', 'Development of a nebramine-cyclam conjugate as an antibacterial adjuvant to potentiate β-lactam antibiotics against multidrug-resistant P. aeruginosa.', 31420586),
('1,4-Bis[((2-(3-acetyl-1-(4-nitrophenyl)-1H-pyrazole-4-yl)carbonyl) benzofuran-5-yl)methyl]piperazine', 'Compound 5e gave the best inhibitory activity with MIC/MBC values of 18.1/36.2, 9.0/18.1 and 18.1/18.1 ?M, respectively, against MRSA (ATCC:33591 and ATCC:43300) and VRE (ATCC:51575) bacterial strains, respectively and showed IC50 values of 3.0 ? 0.05, 3.2 ? 0.08 and 3.3 ? 0.07 microM against S. aureus, S. mutans and E. coli strains, respectively.', 'Showed better cytotoxic activities', 'Novel bis(pyrazole-benzofuran) hybrids possessing piperazine linker: Synthesis of potent bacterial biofilm and MurB inhibitors.', 32711085),
('Monosulfactam 0073', 'The monosulfactam 0073 showed promising antimicrobial activity against Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii isolates producing metallo-beta-lactamases (MBLs) and serine beta-lactamases', 'Compound 0073 exhibited safety both in vitro and in vivo In the murine thigh infection model and the pneumonia models in which infection was induced by P. aeruginosa and Klebsiella pneumoniae, 0073 significantly reduced the bacterial burden', 'Monosulfactam 0073 is a potential treatment for infections caused by beta-lactamase-producing multidrug-resistant bacteria.', 32718961),
('Eravacycline', 'MIC50/90 values were lowest for eravacycline (?0.0078/0.016 mg/L)', '', 'This study demonstrated potent in vitro activity of eravacycline against a large collection of clinical C. difficile strains', 32719870),
('8-nitro-2-(4-((4-(trifluoromethoxy)benzylidene)amino)piperazin1-yl)-6-(tri-fluoromethyl)-4H-benzo[e][1,3]thiazin-4-one', 'It exhibit excellent activity against MTB H37Rv and MDR-MTB strains (MIC <0.029microM).', 'It shows low cytotoxicity in Vero cells (CC50: > 117.00)', 'Compound 1h displays good safety and pharmacokinetic profiles, suggesting its promising potential to be lead compound for future antitubercular drug discovery.', 32736151),
('Delafloxacin', 'MIC range, MIC50 and MIC90 for delafloxacin were 0.064 ? 32 mg/L, 0.56 mg/L and 2.19 mg/L, respectively against Cystic fibrosis Pseudomonas aeruginosa', '', 'Delafloxacin shows potential in treating ciprofloxacin-resistant P aeruginosa.', 32790867),
('1-Cyclopropyl-7-((4-(2, 4-dimethylphenoxy)pyrimidin-2-yl) amino)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid', 'The most active B14 exhibited activities at submicromolar concentration (0.38microgram/mL)) against a panel of MRSA strains.', 'It also displayed highly selective toxicity toward bacterial cells and low hERG inhibition.', 'Design and synthesis of novel desfluoroquinolone-aminopyrimidine hybrids as potent anti-MRSA agents with low hERG activity.', 32891858),
('Globomycin analog, G0790', 'The MIC of G0790 was 4- to 8-fold lower than for the parent GBM against WT E. coli (CFT073), Enterobacter cloacae (ATCC 13047), and Klebsiella pneumoniae (ATCC 700603) strains', '', 'G0790, a new globomycin analog and potent inhibitor of the Escherichia coli type II signal peptidase LspA.', 32900806),
('Aspirin, sodium benzoate and sodium salicylate', 'The highest concentrations of SB, SS and AS decreased colistin MICs 2- to 4-fold for E. coli ATCC 25922 and K. pneumoniae ATCC 700603, whereas colistin MIC for P. aeruginosa ATCC 27853 was only decreased by 28 mM SS, by 2-fold', '', 'Sodium benzoate, sodium salicylate and aspirin are good enhancers to use in antibiotic therapies that include colistin', 32989461),
('Zidovudine', '', '', 'Zidovudine and tigecycline/colistin combinations achieved synergistic killing and significantly decreased bacterial burdens by >2.5-log10 CFU/g in thigh tissues compared to each monotherapy.', 33020156),
('1-cyclopropyl-6-fluoro-7-(4-((6-methoxy-4-oxo-3,4- dihydroquinazolin-2-yl)methyl)piperazin-1-yl)-4-oxo1,4-dihydroquinoline-3-carboxylic acid (5d) AND 6-fluoro-1-(4-fluorophenyl)-7-(4-((6-methoxy-4-oxo3,4-dihydroquinazolin-2-yl)methyl)piperazin-1-yl)-4-\noxo-1,4-dihydroquinoline-3-carboxylic acid (5i)', 'Amongst all ciprofloxacin-derivatives, compound 5d was the most potent agent with high antibacterial activity against gram-positive bacteria, including MRSA and S. aureus ((minimum inhibitory concentration (MIC) = 16 nM for both), that is 60 times more potent than ciprofloxacin as parent drug. Compound 5i from sarafloxacin-derivatives was the most potent compound against MRSA and S. aureus (MIC = 0.125 microM).', '', 'Compound 5i from sarafloxacin-derivatives was the most potent compound against MRSA and S. aureus (MIC = 0.125 microM)', 33030668),
('2,6-Difluoro-3-((3-(4-butylphenyl)-4,5-dihydroisoxazol-5-yl) methoxy)benzamide (A16)', 'Compound A16 was found to be most potent agent (MIC, 0.25?0.5 microgram/mL) against a variety of MDR S. aureus.', 'Besides, further mouse infection model revealed that A16 could be effective in vivo and non-toxic to Hela cells.', 'Design, synthesis of novel 4,5-dihydroisoxazole-containing benzamide derivatives as highly potent FtsZ inhibitors capable of killing a variety of MDR Staphylococcus aureus.', 33065440),
('PKZ18-22', 'The 8-microgram/ml MIC of PKZ18-22, in combination with gentamicin (approximately 20 microM), showed no cytotoxicity against eukaryotic cells and significantly lowered the effective dose of gentamicin', 'The analogs have reduced cytotoxicity against eukaryotic cells compared to PKZ18.', 'we show that novel analogs of PKZ18 have improved MICs, bactericidal effects against methicillin-resistant Staphylococcus aureus (MRSA), and increased efficacy in nutrient-limiting conditions', 33077662),
('Aryl sulfonyl hydrazones conjugated with 1,3-diaryl pyrazoles', 'The in vitro MBLs inhibition showed remarkable inhibition constant for most of the designed compounds at a low micromolar range (1.5-16.4 ?M) against NDM-1, IMP-1 and AIM-1 MBLs.', 'in vivo toxicity testing exhibited that the most active compound was non-toxic and well tolerated by the experimental animals orally up to 350 mg/kg and up to 125 mg/kg parenterally.', 'Design, synthesis, biological evaluation and in silico studies of certain aryl sulfonyl hydrazones conjugated with 1,3-diaryl pyrazoles as potent metallo-β-lactamase inhibitors.', 33137556),
('oxazolidinone derivatives with nitrogen-containing fused heterocyclic moiety', 'Compound 3b, which exhibited significant antibacterial activity with MIC values ranging 0.5-1.0 microgram/mL against MRSA, MSSA, LREF and VRE.', '', 'Most of them exhibited potent activity against Gram-positive pathogens comparable to Linezolid and Radezolid.', 33144245),
('CM13 and CM311', 'Two molecules, CM13 and CM311, inhibited ethidium bromide efflux in B. subtilis.', '', 'Using this methodology, we identified two novel inhibitors of BmrA from the Chemotheca small molecule library.', 33212311),
('Taniborbactam (VNRX-5133)', 'Taniborbactam at a fixed concentration of 4 mg/L was able to restore activity of cefepime in 24 of 26 Enterobacterales clinical isolates harbouring metallo-beta-lactamases with MIC50/MIC90 values of 14 mg/L.', '', 'The inhibition level of NDM enzymes provided by taniborbactam protects the antibacterial activity of cefepime from this important metallo-beta-lactamase.', 33246038),
('Adamantanol-containing indole-2-carboxamides analogues', 'Three adamantanol derivatives 8i, 8j and 8l showed nearly 2- and 4-fold higher activity (MIC = 1.32 - 2.89 ?M) than ethambutol (MIC = 4.89 ?M). The most potent adamantanol/adamantane-based indoleamides 8j/8k displayed a two-fold surge in potency against extensively DR (XDR) M. tb strains with MIC values of 0.66 and 0.012 ?M, respectively.', 'Remarkably, the most potent adamantanol analogue 8j demonstrated high selectivity towards DS and DR M. tb strains over mammalian cells [IC50 (Vero cells) ? 169 ?M], evincing its lack of cytotoxicity.', 'Overall, the observed antimycobacterial and physicochemical profiles support the notion that adamantanol moiety is a suitable replacement to the adamantane scaffold within the series of indole-2-carboxamide-based MmpL3 inhibitors.', 33276981),
('BNF15 ; benzonaphthofurandiones analogs', 'BNF15 showed promising effect against all drug-sensitive and drug-resistant M. tuberculosis (MIC: 0.02-0.78 microgram/ml).', 'In acute oral toxicity test, BNF15 did not show toxic effect at a concentration up to 2000 mg/kg.', 'These results highlight the perspective of BNF15 to treat drug-resistant M. tuberculosis.', 33295787),
('22-[4-(4-((Adenine-9-yl)methyl)phenyl)-1H-1,2,3-triazol-1-yl]-22-deoxypleuromutilin (Compound 35), (+)-pleuromutilin conjugates', 'Compound 35, bearing a para-benzyladenine substituent, proved particularly potent against USA300 and additional strains of MRSA', 'no cytotoxicity in four mammalian cell lines', 'Compound 35, bearing a para-benzyladenine substituent, proved particularly potent against USA300 and additional strains of MRSA and displayed as importantly no cytotoxicity in four mammalian cell lines.', 33325700),
('ridinilazole', 'All strains were susceptible to ridinilazole, with low MICs (0.03?0.25 mg/L).', '', 'Ridinilazole showed potent activity against a range of Asian C. difficile strains, which otherwise frequently displayed resistance to several comparator antimicrobial agents.', 33351917),
('diaryl-substituted thiosemicarbazone', '1c is the most potent inhibitor (IC50 = 0.038 ?M).', '', 'Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors.', 33383326),
('Isatin-nicotinohydrazide hybrids', 'Most derivatives exhibited excellent antibacterial activity. K. pneumonia emerged as the most sensitive strain with MIC range: 0.49-7.81 ?g/mL.', '', 'Development of novel isatin-nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing-bacteria.', 33406941),
('5-nitrofurans', 'we showed that 5-nitrofurans, sodium deoxycholate and vancomycin interact synergistically in the growth inhibition of 15 out of 20 Gram-negative strains tested, including clinically significant pathogens such as carbapenemase-producing Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii, and interact indifferently against the Gram-positive strains tested.', '', 'Synergistic combinations of existing antimicrobials show promise due to their enhanced efficacies and reduced dosages which can mitigate adverse effects, and therefore can be used as potential antibacterial therapy.', 33448923),
('pyranoquinolinyl dihydropyridine carboxylate (PDC) derivatives', '', 'The cytotoxic assay of the PDC derivatives revealed minimal cytotoxicity towards L929 mouse fibroblasts cells at 25 microM concentration wherein the % Cell viability was found to be greater than 90.0% and moderate cytotoxicity at concentrations of at 50.0?100.0 microM', 'Design, synthesis, spectral characterization and molecular docking studies of novel pyranoquinolinyl dihydropyridine carboxylates as potential antibacterial agents including Vibrio cholerae with minimal cytotoxity towards fibroblast cell line (L-929).', 33450547),
('6-fluorobenzo[d]isothiazol-3(2H)-one', 'It exhibited activity against A. baumannii ATCC19606 strain (minimal inhibitory concentration, MIC = 1 mg l-1). We identified the effect of 6D1 on enhancing the antibacterial activity of kanamycin and gentamicin, including against New Delhi metallo-beta-lactamase (NDM-1)-producing carbapenem-resistant Klebsiella pneumoniae.', '', 'we identified a small molecule that suppresses the growth of A. baumannii, interacts with hydroperoxide reductase from A. baumannii ATCC19606 plasmid pMAC, and enhances the antibacterial activity of kanamycin and gentamicin.', 33456052),
('UPAR415, Cyclopropane-Carboxylic Acid Derivative', '', '', 'Our results provide a robust proof of principle supporting OASS as a potential nonessential antibacterial target to develop a new class of adjuvants and the structural basis for further structure-activity relationship studies.', 33513010),
('?-lactam-containing 5H-benzofuro [3,2-c]quinolin-6-ones', 'Compound 65 demonstrated potent activity against Mtb H37Rv with MIC value between 0.0313 and 0.0625 microgram/mL, with high selectivity to Vero cells (64-128 fold).', '', 'Compound 65 also showed excellent selectivity against actinobacteria and therefore unlikely to develop potential drug resistance to nonpathogenic bacteria.', 33516983),
('Ciprofloxacin derivatives', 'Isolated bacteria, from male and female patients, resist to ciprofloxacin were tested against synthesized compounds and showed a good effect against K. pneumoniae DF72F which isolated from drain fluid of 72 years old female.', '', 'Development of new derivatives of commercial antibiotics using different organic reagents and testing these derivatives against different microorganisms are the main goals of this article.', 33517003),
('Morpholine-Containing 5-Arylideneimidazolones derivatives', 'The 4-phenylbenzylidene derivative (15) demonstrated significant MDR-reversal "dual action" for beta-lactam antibiotics in MRSA and inhibited AcrAB-TolC in K. aerogenes.', '15 displayed also satisfied solubility and safety towards CYP3A4 in vitro.', 'In the search for an effective strategy to overcome antimicrobial resistance, a series of new morpholine-containing 5-arylideneimidazolones differing within either the amine moiety or at position five of imidazolones was explored as potential antibiotic adjuvants against Gram-positive and Gram-negative bacteria.', 33669790),
('N-(1,3,4-oxadiazol-2-yl)benzamides (HSGN-237 and -238)', 'We report the discovery of new N-(1,3,4-oxadiazol-2-yl)benzamides (HSGN-237 and -238) with highly potent activity against N. gonorrhoeae. Additionally, these new compounds were shown to have activity against clinically important Gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and Listeria monocytogenes (minimum inhibitory concentrations (MICs) as low as 0.25 ?g/mL)', 'Both compounds were highly tolerable to human cell lines.', 'Here, we report the discovery of new N-(1,3,4-oxadiazol-2-yl)benzamides (HSGN-237 and -238) with highly potent activity against N. gonorrhoeae.', 33671065),
('Tricyclic Benzo[1,3]oxazinyloxazolidinones', 'The studies identified a new compound 20aa that displayed good to excellent antibacterial and antitubercular profiles against drug-resistant TB strains (MIC = 0.48-0.82 microgram/mL), MRSA (MIC = 0.25-0.5 microgram/mL), MRSE (MIC = 1 microgram/mL), VISA (MIC = 0.25 microgram/mL), and VRE (MIC = 0.25 microgram/mL) and some linezolid-resistant strains (MIC 1-2 microgram/mL).', 'Compound 20aa was demonstrated as a promising candidate through ADME/T evaluation including microsomal stability, cytotoxicity, and inhibition of hERG and monoamine oxidase.', 'The present study not only successfully provides a novel benzo[1,3]oxazinyloxazolidinone scaffold with superior druggability but also lays a good foundation for new antibacterial drug development.', 33705128),
('sulfonamides derived from sulfaphenazole', 'In particular, compound 10d displayed good activity (MIC = 5.69 microgram/mL) with low inhibition of CYP 2C9 (IC50 > 10 microM), consequently low potential risk of drug-drug interaction.', '', 'Compounds 10c, 10d, 10f and 10i through the optimization on phenyl ring at the R2 site on the pyrazole displayed promising antimycobacterial activity paired with low cytotoxicity.', 33705901),
('3-aryl substituted benzoxaborole derivatives', 'The most potent inhibitor 9f displayed an IC50 value of 86 nM to KPC-2 SBL and micromolar inhibitory activity towards other tested enzymes.', 'Cell-based assays further revealed that 9f was able to significantly reduce the MICs of meropenem in clinically isolated KPC-2-producing bacterial strains and it showed no apparent toxicity in HEK293T cells.', 'Here we report a series of 3-aryl substituted benzoxaborole derivatives, which manifested broad-spectrum inhibition to representative serine-beta-lactamases (SBLs) and metallo-beta-lactamases (MBLs).', 33744439),
('PFK-158 derivatives', 'Compounds A1, A3, A14, A15 and B6 exhibited potent antibacterial effect against both clinical drug sensitive and resistant Gram-positive bacteria, and they are 2-8 folds more potent than levofloxacin against Methicillin-resistant staphylococcus epidermidis (MRSE).', '', 'The result can provided a new and broader prospect for the development of new medicine against drug-resistant bacteria.', 33766773),
('para-aminobenzenesulfonyl oxadiazoles derivatives', 'hexyl derivative 8b (MIC = 1 microgram/mL) was more active than norfloxacin against drug resistant MRSA.', '', 'Unique para-aminobenzenesulfonyl oxadiazoles as novel structural potential membrane active antibacterial agents towards drug-resistant methicillin resistant Staphylococcus aureus.', 33775834),
('celecoxib analogues', 'Compound 12 exhibited antimicrobial activity against Staphylococcus aureus (MIC: 4 microgram/ml), various clinically isolated strains of MRSA (MIC: 4-16 microgram/ml) and Acinetobacter baumannii (MIC: 4 microgram/ml) when combined with subinhibitory concentrations of colistin B.', '', 'Compound 12 is a promising antibacterial candidate for further development.', 33783231),
('Linalool', 'Linalool exhibited bactericidal activity alone (11,250 microgram/ml) and in combination with meropenem (5,625 microgram/ml).', '', 'This study was carried out to assess and characterize the adjuvant potential and mode of action of linalool against carbapenemase-producing Klebsiella pneumoniae (KPC-KP).', 33815320),
('(S)-1-((3,5-bis(trifluoromethyl) phenyl)amino)-3-((2-methyl-1-(naphthalen-2-yl)propan-2-yl)amino)propan-2-ol, namely II-6s', 'More importantly, 0.003125% II-6s exhibited significant bactericidal effect against E. faecalis residing in the dentinal tubules, which was comparable to 5.25% NaOCl and 2% CHX.', 'II-6s induced no drug resistance in E. faecalis with lower cytotoxicity as compared to NaOCl and CHX.', 'II-6s has excellent antimicrobial activity, moderate cytotoxicity and induces no drug resistance, and thus is a promising agent for the treatment of endodontic infection.', 34552703),
('1H-imidazole-2-carboxylic acid (ICA)', 'Of the tested ICA inhibitors, 55 displayed potent synergistic antibacterial activity with meropenem against engineered Escherichia coli strains and even intractable clinically isolated Pseudomonas aeruginosa producing VIM-2 MBL.', '', 'Of the tested ICA inhibitors, 55 displayed potent synergistic antibacterial activity with meropenem against engineered Escherichia coli strains and even intractable clinically isolated Pseudomonas aeruginosa producing VIM-2 MBL.', 34763944),
('5-phenyl-3-isoxazolecarboxylic acid methyl ester-chalcone hybrids', 'Among 35 synthesized compounds, 32 analogues displayed potent in-vitro activity against Mycobacterium tuberculosis H37Rv with MIC 0.12-16 microgram/mL.', 'Cell viability test against Vero cells indicated 29 compounds to be non-cytotoxic (CC50 > 20 microgram/mL & SI > 10).', 'Time-kill kinetic study suggested compound 7j displaying concentration-dependent bactericidal killing activity with relatively comparable potency to that of current first-line anti-TB drugs.', 34116324),
('LCG-N25, a lead compound', '', 'cytotoxicity of LCG-N25 was evaluated by Cell Counting Kit-8 assay', 'We found that LCG-N25 exhibited a good antibacterial activity, low-cytotoxicity, and did not induce drug resistance of cariogenic S. mutans', 33868212),
('chalcone-conjugated, multi-flexible end-group coumarin thiazole hybrids', 'inhibitory activity against MRSA (MIC = 0.004 mM), which was 6 times better than the anti-MRSA activity of the reference drug norfloxacin (MIC = 0.025 mM).', 'Compound 5i neither conferred apparent resistance onto MRSA strains even after multiple passages nor triggered evident toxicity to human hepatocyte LO2 cells and normal mammalian cells (RAW 264.7).', 'Novel chalcone-conjugated, multi-flexible end-group coumarin thiazole hybrids as potential antibacterial repressors against methicillin-resistant Staphylococcus aureus.', 34139627),
('DS01750413, a new derivative of PC190723', 'DS01750413 showed potent in vitro activity against MRSA clinical isolates with MIC ranges of 0.5-1 mg/L and also demonstrated concentration-dependent bactericidal killing.', 'In the murine bacteraemia infection model of MRSA, treatment with DS01750413 resulted in prolonged survival of animals compared with placebo-treated animals and exhibited a significant reduction in the bacterial load in liver, spleen, lungs and kidneys.', 'Novel FtsZ inhibitor with potent activity against Staphylococcus aureus.', 34383913),
('Dapsone based nonionic surfactant', 'The spectroscopic results confirm successful synthesis of novel sulfur based nonionic surfactant that formed spherical shaped drug loaded vesicles with an average size of 97.95 ? 3.45 nm and 56.3 ? 3.15 % entrapment of the model drug (Ceftriaxone sodium).', 'The vesicles displayed negative surface charge of -16.8 ? 3.72 mV and released the entrapped drug in a controlled way in-vitro drug release.', 'Results of this study show that the Dapsone based surfactant is safe, biocompatible, non-toxic and can be used as promising vesicular carrier for enhancing therapeutic efficacy of antibacterial drug, Ceftriaxone sodium.', 34252425),
('PPAR-gamma agonist pioglitazone', 'PPAR-gamma agonist pioglitazone 6 or 8 h after infection of mice with a highly virulent strain of Klebsiella pneumoniae via the airways results in reduced cytokine and myeloperoxidase levels in the lungs at 24 h after infection, as well as reduced bacterial growth in the lungs and decreased dissemination to distant organs at 42 h post-infection.', '', 'Agonists of peroxisome proliferator-activated receptor (PPAR)-γ have been suggested as potential adjuvant therapy in bacterial pneumonia because of their capacity to inhibit inflammation and enhance bacterial clearance.', 34412637),
('1,10-phenanthroline-5,6-dione (phendione)', 'E. coli, K. pneumoniae, A. baumannii and P. aeruginosa,', '', 'Antimicrobial resistance (AMR) remains one of the greatest public health-perturbing crises of the 21st century, where species have evolved a myriad of defence strategies to resist conventional therapy.', 34827221),
('Cholic acid', '', '', 'Cholic acid potentially acts as an adjuvant since it can blunt the pro-inflammatory activity in human.', 34398332),
('ZINC000104153710, and ZINC000000217308', 'A 2-8 fold reduction in MIC values against ZINC000104153710, and ZINC000000217308 was observed against all 25 MDR-UPEC isolates in the presence of antibiotics with no alteration in intracellular ROS production.', '', 'Combination of bactericidal antibiotics and inhibitors of Universal stress protein A (UspA): a potential therapeutic alternative against multidrug resistant Escherichia coli in urinary tract infections.', 34526667),
('a series of novel 1,3,4-oxadiazoles bearing 3,4-dihydropyrimidine heterocyclic motifs [4a-l]', 'Compound 4d was found to be the most promising against Escherichia coli (12.5 ?g/ml), whereas the same compound showed good activity against Staphylococcus aureus at a concentration of 50 ?g/ml. Other compounds of the same series, 4c and 4h, displayed moderate activity against Streptococcus pyogenes at a concentration of 50 ?g/ml. Furthermore, results of the antifungal activity tests revealed that compound 4i showed promising activity against all the strains of fungi, Candida albicans, Aspergillus niger, and Aspergillus clavatus, at concentrations of 100, 50, and 100 ?g/ml, respectively.', '', 'Compound 4d was found to be the most promising against Escherichia coli (12.5 µg/ml), whereas the same compound showed good activity against Staphylococcus aureus at a concentration of 50 µg/ml.', 34169569),
('30 novel pyrazole derivatives', 'Compounds 11, 28, and 29 are potent against S. aureus biofilms with minimum biofilm eradication concentration (MBEC) values as low as 1 ?g/mL.', '', 'Compounds 11, 28, and 29 are potent against S. aureus biofilms with minimum biofilm eradication concentration (MBEC) values as low as 1 µg/mL.', 34443670),
('thiophene-arylamide compounds', 'Showed activity against both drug-susceptible (minimum inhibitory concentration (MIC) = 0.02-0.12 microgram/mL) and drug-resistant (MIC = 0.031-0.24 microgram/mL) tuberculosis strains while retaining potent DprE1 inhibition (half maximal inhibitory concentration (IC50) = 0.2-0.9 microgram/mL) and good intracellular antimycobacterial activity.', 'showed good hepatocyte stability and low inhibition of the human ether-?-go-go related gene (hERG) channel.', 'Compounds 23j, 24f, 25a, and 25b exhibited potent in vitro activity against both drug-susceptible (minimum inhibitory concentration (MIC) = 0.02-0.12 μg/mL) and drug-resistant (MIC = 0.031-0.24 μg/mL) tuberculosis strains while retaining potent DprE1 inhibition (half maximal inhibitory concentration (IC50) = 0.2-0.9 μg/mL) and good intracellular antimycobacterial activity.', 33852302),
('pleuromutilin derivatives with 1,2,4-triazole-3-substituted Schiff base', 'Among these derivatives, compound 60 exhibited superior in vitro antibacterial effect against MRSA (MIC = 0.25 microgram/mL) than tiamulin (MIC = 0.5 microgram/mL), and compound 60 (-2.28 log10 CFU/mL) also displayed superior in vivo antibacterial efficacy than tiamulin (-1.40 log10 CFU/mL) in reducing MRSA load in the mouse thigh infection model.', 'Among these derivatives, compound 60 exhibited superior in vitro antibacterial effect against MRSA (MIC = 0.25 microgram/mL) than tiamulin (MIC = 0.5 microgram/mL), and compound 60 (-2.28 log10 CFU/mL) also displayed superior in vivo antibacterial efficacy than tiamulin (-1.40 log10 CFU/mL) in reducing MRSA load in the mouse thigh infection model.', 'Design, synthesis and biological evaluation of pleuromutilin-Schiff base hybrids as potent anti-MRSA agents in vitro and in vivo.', 34153574),
('9-arylalkyl-10-methylacridinium derivatives', '', 'Further cytotoxicity and animal studies demonstrated that 15f not only displayed efficacy in a murine model of bacteremia in vivo, but also no significant hemolysis to mammalian cells.', 'Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents.', 33964649),
('peptide-imidazo[1,2-a]pyrazine', '', '', 'Design, synthesis, and evaluation of peptide-imidazo[1,2-a]pyrazine bioconjugates as potential bivalent inhibitors of the VirB11 ATPase HP0525.', 34142414),
('3-hydroxy-pyridin-4(1H)-ones', 'the hit compound (20p) was identified with the effects of inhibiting the production of pyocyanin (IC50 = 8.6 microM) and biofilm formation (IC50 = 4.5 microM).', '', 'Development of new bacterial biofilm inhibitors as antibacterial synergists is an effective strategy to solve the resistance of Pseudomonas aeruginosa.', 34951310),
('3'',6-dinonyl- and 3'',6-di(dimethyloctyl)-neamine derivatives', '', '', 'Development of novel therapeutics to treat antibiotic-resistant infections, especially those caused by ESKAPE pathogens, is urgent.', 34445410),
('Bithionol (BT)', 'we found that BT showed significant antimicrobial and antibiofilm effects against Enterococcus faecalis and vancomycin-resistant Entercococcus faecium in vitro, in a dose-dependent manner, by disrupting the integrity of the bacterial cell membranes.', 'BT effectively reduced the bacterial load in mouse organs when combined with conventional antibiotics in a peritonitis infection model.', 'Drug repurposing is a promising approach in solving this problem.', 34025592),
('sulfonyl-hybridized imidazolyl ethanols', 'Especially, imidazole derivative 5f could strongly suppressed the growth of MRSA (MIC = 4 microgram/mL), which was 2-fold and 16-fold more potent than the positive control sulfathiazole and norfloxacin.', '', 'Especially, imidazole derivative 5f could strongly suppressed the growth of MRSA (MIC = 4 μg/mL), which was 2-fold and 16-fold more potent than the positive control sulfathiazole and norfloxacin.', 34119615),
('phenolic acids in Spenceria ramalana Trimen and sliver nanoparticle incorporated thermoplastic polyurethane nanofibrous membrane (TPU/AgNPs/TPA)', 'The antibacterial efficiency is as high as 99% lasting for 36 h.', '', 'Finding new wound dressing with sustained antibacterial property to overcome the problem of resistance is one of clinical challenge.', 34679241),
('benzoxaborole and dextran', '', '', 'Glycosylated Nanotherapeutics with β-Lactamase Reversible Competitive Inhibitory Activity Reinvigorates Antibiotics against Gram-Negative Bacteria.', 34164980),
('three ruthenium complexes functionalized with furan-substituted ligands([Ru(phen)2 (CAPIP)](ClO4 )2 (Ru(?)-1), [Ru(dmp)2 (CAPIP)](ClO4 )2 (Ru(?)-2) and [Ru(dmb)2 (CAPIP)](ClO4 )2 (Ru(?)-3) (dmb=4,4''-dimethyl-2,2''-bipyridine, phen=1,10-phenanthroline, dmp=2,9-dimethyl-1,10-phenanthroline, CAPIP=(E)-2- (2-(furan-2-yl)vinyl)-1H-imidazo[4,5-f][1,10]phenanthroline))', 'The MIC values of three complexes range from 0.015 to 0.050 mg/ml.', '', 'In addition, aimed to test whether ruthenium complexes have potential value as antimicrobial adjuvants, the synergism between Ru(Ⅱ)-2 and some antibiotics against S. aureus were examined through checkerboard method.', 34453495),
('synthetic fatty acid 2-hexadecynoic acid (2-HDA),', 'synthetic fatty acid 2-hexadecynoic acid (2-HDA), when used as a fish food supplement, lowers the conjugation frequency of model plasmids up to 10-fold in controlled water microcosms. When added to the food for mice, 2-HDA diminished the conjugation efficiency 50-fold in controlled plasmid transfer assays carried out in the mouse gut.', '', 'Inhibiting conjugation has been proposed as a feasible strategy to stop or delay the propagation of antibiotic resistance genes.', 34425705),
('isatin hybridized 1,2,4-triazole', 'showed inhibitory activity against E. coli ATCC 25,922 with an MIC value of 1 ?g/mL', '', 'Isatin-derived azoles as new potential antimicrobial agents: Design, synthesis and biological evaluation.', 33839249),
('isatin hydrazones 4(a-o) and their thiomorpholine tethered analogues 5(a-o).', 'Interestingly, 4f and 5f emerged as the most potent compounds with IC50 of 3.6 ?M and 1.9 ?M against RIF-R1 MTB strain, followed by INH-R1 MTB strain with IC50 of 3.5 ?M and 3.4 ?M, respectively.', '', 'Novel thiomorpholine tethered isatin hydrazones as potential inhibitors of resistant Mycobacterium tuberculosis.', 34329993),
('C4BP-IgM', 'C4BP-IgM induced membrane perturbation through complement deposition and membrane attack complex pore insertion facilitates the access of antibiotics to their intracellular targets.', '', 'Our data show that complement activation can potentiate activity of antibiotics and suggest a role for C4BP-IgM as an adjuvant for antibiotic treatment of drug-resistant gonorrhea.', 34539665),
('ML-7 hydrochloride (ML-7)', '', '', 'Taken together, these results revealed the potential of ML-7 as a novel tigecycline adjuvant to circumvent tigecycline-resistant Klebsiella pneumoniae.', 35071055),
('colistin and EDTA', 'colistin resistance was significantly reversed in both planktonic and mature biofilms of colistin-resistant K. pneumoniae by a combination of colistin (0.25-1 ?g/ml) with EDTA (12 mg/ml).', '', 'Tanittha.C@chula.ac.th. (#)Contributed equally Development of an effective therapy to overcome colistin resistance in Klebsiella pneumoniae, a common pathogen causing catheter-related biofilm infections in vascular catheters, has become a serious therapeutic challenge that must be addressed urgently.', 34737361),
('prodrug of the boronic acid-containing beta-lactamase inhibitor 5 (VNRX-5236)', 'n vitro and in vivo studies demonstrated that 5 restored the activity of the oral cephalosporin antibiotic ceftibuten against Enterobacterales expressing Ambler class A extended-spectrum beta-lactamases, class A carbapenemases, class C cephalosporinases, and class D oxacillinases.', '', 'The increasing emergence of β-lactamase-producing multi-drug-resistant "superbugs" has resulted in increases in costly hospital Emergency Department (ED) visits and hospitalizations due to the requirement for parenteral antibiotic therapy for infections caused by these difficult-to-treat bacteria.', 34191513),
('sesquiterpene farnesol', 'The minimum inhibitory concentration (MIC) of farnesol against C. acnes was 0.14 mM, and the IC50 of 24 h exposure to farnesol in HaCaT keratinocytes was approximately 1.4 mM.', 'The basal hydroxypropyl methylcellulose (HPMC) gel did not exert anti-inflammatory or reparative effects on rat acne lesions.', 'Topical therapy is useful as a single or combined treatment for mild and moderate acne and is often employed as maintenance therapy.', 34577195),
('triblock copolymers of polyethylene glycol (PEG), guanidinium-functionalized polycarbonate and polylactide, PEG-PGC20-PLLA20 (L2) and PEG-PGC20-PDLA20 (D2)', 'The copolymers self-assemble into micellar nanoparticles (L/D2), and exhibit broad-spectrum antibacterial activity against 20 clinically isolated multidrug-resistant A. baumannii strains.', '', 'Conclusions: Therefore, the combination of L/D2 and imipenem might be an alternative option for the prevention of nosocomial infection caused by A. baumannii. © 2021 The Author(s).', 34856746),
('haloperidol (HPD, 1)', 'We discovered that an antipsychotic drug, haloperidol (HPD, 1), was a potent Eis inhibitor with IC50 = 0.39 ? 0.08 microM.', '', 'Development of Eis inhibitors as KAN adjuvant therapeutics is an attractive path to forestall and overcome KAN resistance.', 34825186),
('chitosan-mastoparan nanoconstruct (Mast-Cs NC)', 'The MIC90 of Mast-Cs NC was significantly lower than that of chitosan (4 vs 512 microgram/mL, respectively, p<0.05), with noticeable bacterial damage upon morphological analysis.', 'In a BALB/c mouse sepsis model, a significant reduction in bacterial colony count in the Mast-Cs treated group was observed compared with chitosan and mastoparan alone (p<0.005). Mast-Cs maintained good biocompatibility and cytocompatibility.', 'CONCLUSION: Novel mastoparan-loaded chitosan nanoconstructs signify a successful strategy for achieving a synergistic bactericidal effect and higher therapeutic efficacy against MDR clinical A. baumannii isolates.', 34103914),
('5-arylidenepyrimidine-triones', 'Antibacterial activity (agar well-diffusion assay) and cytotoxicity (alamarBlue assay) of perspective compounds were evaluated.', '', 'Method & results: In this study, a virtual library of 5-arylidene barbituric acids was created and molecular docking was performed for identification of novel possible inhibitors of NDM-1 and MetAP-1.', 33913733),
('derivatives of cajaninstilbene acid (CSA)', 'It eradicated the adherent biofilm of MRSA in a concentration dependent manner, and showed a synergistic antibacterial effect with piperacilin. In a model mouse abscess caused by MRSA persisters, A6 effectively reduced the bacterial load in vivo.', '', 'Most of the newly synthesized derivatives exhibit more potent antimicrobial properties against S. aureus and MRSA than CSA itself, and 23 of the 37 derivatives show a tendency to eradicate MRSA persisters.', 34274830),
('Poly(l-ornithine)-Grafted Zinc Phthalocyanines', 'ZnPc-g-PLO micelles exhibited potent and broad-spectrum antibacterial activity in the absence of laser irradiation with MIC values ranging from 12.5 microgram/mL to 25 microgram/mL and a corresponding geometric mean (Gm) (32) value of 18.75 microgram/mL (Table 1).', '', 'Multifunctional antimicrobial peptides that combine the intrinsic microbicidal property of cationic polypeptide chains and additional antibacterial strategy hold promising applications for the treatment of infections caused by antibiotic-resistant bacteria, especially "superbugs". In the present study, star-shaped copolymers ZnPc-g-PLO with a zinc phthalocyanine (ZnPc) core and four poly(l-ornithine) (PLO) arms were designed, synthesized, and evaluated as dual-functional antimicrobial agents, that is, intrinsic membrane damage and photothermal ablation capacity.', 34570483),
('carbazole-oxadiazoles', 'Bioassay discovered that 3,6-dibromocarbazole derivative 13a had effective inhibitory activities to several Gram-positive bacteria, in particular to S. aureus, S. aureus ATCC 29213, MRSA and S. aureus ATCC 25923 (MICs = 0.6-4.6 nmol/mL)', '', 'Novel carbazole-oxadiazoles as potential Staphylococcus aureus germicides.', 33993967),
('outer membrane-permeable cationic polyurethanes a polyketide', 'Rifampicin combined with a low-dose treatment of a cationic polyurethane reduced the MIC in E. coli of rifampicin by up to 64-fold.', 'The compositions of cationic polyurethanes were designed to have low hemolysis and low cell cytotoxicity while maintaining high antibacterial activity.', 'Our results demonstrate the potential to rescue the large number of available OM-excluded antibiotics to target normally resistant Gram-negative bacteria via synergistic action with these cationic polyurethanes, acting as a novel antibiotic adjuvant class.', 34085824),
('Eight novel C3-(N-alkyl-aryl)-aminoalkyl analogues of rifamycin SV', 'anti-tubercular activity (MIC90 = 3 microM)', '', 'Antimicrobial resistance is a main concern in tuberculosis treatment and is often associated with the emergence of Mycobacterium tuberculosis strains resistant to rifampicin (RIF), which is one of the cornerstones of tuberculosis chemotherapy.', 34418786),
('Antibitic adjuvant : monolaurin, monocaprin, N-acetylcysteine (NAC), polymyxin B nonapeptide, Tris-EDTA, Tris-HCL and disodium EDTA', 'NAC had a minimal inhibitory concentration (MIC) range of 2,500-10,000 microg/mL for the various organisms. Pseudomonas aeruginosa isolates were eight times more susceptible to disodium EDTA in the presence of Tris-HCL in comparison to disodium EDTA alone. Malassezia pachydermatis isolates were most susceptible to Tris-EDTA (MIC90 = 190/60 microg/mL) and disodium EDTA (MIC90 = 120 microg/mL)', '', 'These agents could be combined with other antimicrobial agents in a multimodal approach for mixed ear infections in dogs.', 30548715),
('Tryptophan-derived rhodanine derivatives', 'The most potent compound had in vitro inhibition activity against PTP1B at IC50 = 0.36 ? 0.02 microM', '', 'Synthesis and biological evaluation of tryptophan-derived rhodanine derivatives as PTP1B inhibitors and anti-bacterial agents', 30978561),
('Aminothiazolquinolone oximes', 'O-methyl oxime derivative 10b displayed excellent inhibitory efficacy against MRSA and S. aureus 25923 with MIC values of 0.009 and 0.017 mM, respectively.', '', 'A new exploration towards aminothiazolquinolone oximes as potentially multi-targeting antibacterial agents: Design, synthesis and evaluation acting on microbes, DNA, HSA and topoisomerase IV.', 31254919),
('Piperazine derivatives (1,4-diazinanes)', 'Antibacterial activity against Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa', '', 'Design, synthesis, and molecular docking study of new piperazine derivative as potential antimicrobial agents.', 31479986),
('Novel ciprofloxacin derivatives (No. 3, 5, 10, 14, 15)', 'The half-maximal inhibitory concentration (IC50) values of the most effective five compounds of NCD (No. 3, 5, 10, 14, 15) on Babesia bovis, Babesia bigemina, Babesia caballi, and Theileria equi were 32.9, 13.7, 14.9, and 30.9; 14.9, 25.8, 13.6, and 27.5; 34.9, 33.9, 21.1, and 22.3; 26.7, 28.3, 34.5, and 29.1; and 4.7, 26.6, 33.9, and 29.1 microM, respectively.', 'Tested NCD did not suppress NIH/3T3 and MDBK cell viability, even at the highest concentration used (500 microM).', 'Combination treatments of the identified most effective compounds of NCD/diminazene aceturate (DA), /atovaquone (AQ), and /clofazimine (CF) showed mainly synergistic and additive effects.', 32677000),
('Aminoguanidine analogues : 3a, 3b, 3e', 'The potent activity against the tested MSSA, MRSA, and VRSA strains, inhibiting their growth at concentrations ranging from 1 to 2 ?g/mL.', 'Compound 3e was highly tolerable and possessed a low metabolic clearance rate and a highly acceptable half-life.', 'Compounds 3a, 3b, and 3e possessed potent activities against multidrug resistant staphylococcal isolates and several clinically important pathogens, such as vancomycin-resistant enterococci (VRE) and Streptococcus pneumoniae.', 32707373),
('Powdered Activated Carbon (PAC)', 'The analysis of fluorescent-tagged microorganisms demonstrated the efficacy of the PAC adsorption treatment in reducing the load of both susceptible and resistant fluorescent microorganisms in the treated water, reaching a removal efficiency of 99.70%.', '', 'CONCLUSION: Results suggest that wastewater PAC treatment is a promising technology not only for the removal of micropollutants but also for its effect in decreasing antibiotic resistant bacteria release.', 30727884),
('amphiphilic sofalcone derivatives', 'MIC=1.56 microgram/mL', 'The most promising compound 14, bearing two arginine residues, showed poor hemolytic activity, low cytotoxicity, and excellent antimicrobial activity against Gram-positive bacteria, including MRSA.', 'Our studies suggested that compound 14 possessed promising potential to be used as a novel antimicrobial agent to combat drug-resistant Gram-positive bacteria.', 32659547),
('JJM-ox-3-70 (synthetic 4-oxazolidione small-molecule)', '', '', 'The results of this study suggest that JJM-ox-3-70 inhibits biofilm formation by indirect inhibition of extracellular matrix production that may be linked to disruption of flagellar motility.?', 32769186),
('Melatonin (N-acetyl-5-methoxytryptamine)', '', '', 'Our findings revealed that melatonin serves as a promising colistin adjuvant against MCR-positive Gram-negative pathogens', 32929375),
('Aspartic Acid and Succinic Acid', '', '', 'In conclusion, we provided evidences that Asp and Suc could be potential ciprofloxacin adjuvants to eradicate P. aeruginosa living within polymicrobial communities. Asp-Cip and Suc-Cip could be promising therapeutic options to cope with CF treatment failures.', 32974221),
('Cu-doped hollow carbon spheres (Cu-HCSs)', '', 'Further animal studies demonstrated that the photolysis activity of Cu-HCSs could be used to treat subcutaneous abscesses and bacteremia caused by MRSA.', 'Thus, this photolysis-based antibacterial platform may help avoid bacterial resistance, with the potential to kill multidrug resistant bacteria.', 33006334),
('Combination of a macrolide antibiotic with a polyaminoisoprenyl adjuvant', 'MICs ranging from 50 to greater than 200 microM, for Gram negative bacteria: Enterobacteriaceae, such as Klebsiella pneumoniae and Escherichia coli, as well as Pseudomonas aeruginosa and Acinetobacter spp', 'Cytotoxicity was evaluated against Chinese hamster ovary (CHO) cells, with all compounds presenting IC50 ranging from 126 to 150 microM, suggesting that they were minimally toxic. non-toxic adjuvant for non-specific potentiation of antibiotics.', 'New polyaminoisoprenyl compounds which exhibited a strong effect on the level of macrolide antibiotics susceptibility for resistant Gram-negative bacterial strains and also show the ability to alter bacterial outer membrane integrity.', 36293314),
('Small molecule STK?35 and its newly identified derivative STK?66 , which is two benzene rings with a carboxylic group, a nitro group and a cyclopropyl group', 'STK?35 and STK?66 showed the most effective antimicrobial activity against type strains and MDR clinical isolates of Gram?negative pathogens (A. baumannii, E. coli, K. pneumoniae and P. aeruginosa), with minimal inhibitory concentrations (MICs) ranging from 0', 'STK-35/66 significantly increased the survival rate of E. coli infected mice and induced a decrease in bacterial load of the peritonitis model.', ', these results suggested that STK-35/66 possessed antimicrobial activity against Gram-negative pathogenic bacteria in vitro and in vivo, which could be considered as potential substitutes for the treatment of Gram-negative pathogenic infections after further structure optimization.', 35218030),
('Phenyl Sulfide-Based Cationic Amphiphiles compound', 'most promising compound 17 exhibited potent antibacterial activity against Gram-positive bacteria (minimum inhibitory concentrations = 0.39', 'low hemolytic activity (HC50 > 200 microg/mL), and high membrane selectivity', '17 can rapidly kill Gram-positive bacteria within 0.5 h through membrane-targeting action and avoid antibiotic resistance. More importantly, 17 showed high in vivo efficacy against Staphylococcus aureus in a murine corneal infection model. Therefore, 17 has great potential as a lead compound for the treatment of Gram-positive bacterial infections.', 36256884);
INSERT INTO `bacteria_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('ionenes containing alkylated quaternarized 1,4-diazabicyclo[2.2.2]octane (DABCO) as a positively charged moiety', 'the most hydrophobic C12 Polymer are substantially less active (MIC 16', 'only C2-D-PEG shows significantly lower toxicity against hMSC than its nonPEGylated analog.', 'Incorporating the PEG group into a structure of ionenes improves their selectivity index. Discussed results show that C0-D-PEG and C2-D-PEG, reported here for the first time, open a new opportunity to optimize polycationic structures in search for a better antibacterial agent.', 35524947),
('Antimicrobial volatiles by nest microbiome of social spiders', '', 'showed the influence of the volatilomes on the antibiotic sensitivity of B. thuringiensis offering novel approaches to counter antibiotic resistance.', 'showed the influence of the volatilomes on the antibiotic sensitivity of B. thuringiensis offering novel approaches to counter antibiotic resistance.', 36073497),
('poly(D, L-lactide-co-glycolide)-poly(ethylene glycol)-poly(D, L-lactide-co-glycolide) (PLGA-PEG-PLGA)', 'In vitro and in vivo antibacterial experiments showed that the composite sustained-release system exhibited good bone repair characteristics owing to its efficacy in infection treatment.', '', 'Therefore, vancomycin@PLGA-PEG-PLGA/HA allows sustained release of antibiotics and promotes bone tissue repair, showing potential for wide clinical applicability.', 36155793),
('p-chlorophenylhydrazone derivative 6b', 'p-chlorophenylhydrazone derivative 6b possessed excellent ability to suppress the growth of drug-resistant E. coli (MIC = 0.5 Microg/mL), being 16 folds more potent than norfloxacin (MIC = 8 Microg/mL), favorable inhibitory effect on E. coli biofilms and could act rapidly in bactericidal efficacy', '', 'These results demonstrated that metronidazole-derived three-component hybrids provided a large potential for deep development as prospective antibacterial agents.', 35255343),
('2-(3-hydroxypropyl)-1-(3-phenoxyphenyl)-1,2-dihydrochromeno[2,3-c]pyrrole-3,9-dione (KH-1)', 'It inhibits the growth of both antibiotic-sensitive and -resistant Salmonella strains inside macrophages and reduces lactate dehydrogenase (LDH) release from Salmonella-infected cells. Subsequent screening of KH-1 commercial analogs identified 2-(4-fluorobenzyl)-1-(3-phenoxyphenyl)-1,2-dihydrochromeno[2,3-c] pyrrole-3,9-dione (KH-1-2), which is more effective in controlling Salmonella growth inside macrophages. In vitro KH-1-2 treatment of Salmonella infection resulted in an 8- to 10-fold reduction in bacterial load in infected macrophages. In combination with suboptimal ciprofloxacin treatment, KH-1-2 further reduces Salmonella growth inside macrophages.', 'The toxicity and efficacy of KH-1-2 in controlling Salmonella infection were examined in vivo using a mouse model of typhoid fever. No significant compound-related clinical signs and histological findings of the liver, spleen, or kidney were observed from uninfected mice that were intraperitoneally treated with KH-1-2. KH-1-2 significantly protected mice from a lethal dose of infection by an antibiotic-resistant Salmonella strain.', 'Thus, our study provides support that this is a promising lead compound for the development of a novel host-targeted therapeutic agent to control typhoid fever.', 35579463),
('AUR combined with phenethyl isothiocyanate (PEITC)', 'AUR combined with phenethyl isothiocyanate (PEITC) in skin infection and determined the synergistic antimicrobial effect on S. aureus by using checkerboard assays and time-kill kinetics analysis. This synergistic antimicrobial activity correlated with increased reactive oxygen species (ROS) generation, disruption of bacterial cell structure, and inhibition of biofilm formation. It also effectively restored the susceptibility to AUR via regulating thioredoxin reductase (TrxR) and rescued mice from subcutaneous abscesses through eliminating S. aureus pathogens, including MRSA.', '', 'These results suggest that AUR and PEITC treatment may be a promising option for S. aureus infection.', 35774400),
('dithienylethene-bridged dual-fluoroquinolone derivatives', 'Two novel dithienylethene-bridged dual-fluoroquinolone derivatives have been developed by introducing two fluoroquinolone drugs into both ends of the dithienylethene (DTE) switch, in which the fluoroquinolone acts as a fluorophore except for the pharmacodynamic component. As expected, these resultant DTE-based antibacterial agents displayed efficient photochromism and fluorescence switching behavior in dimethyl sulfoxide. Moreover, improved antibacterial activities compared to those of monofluoroquinolone derivatives and a maximum fourfold active difference against Escherichia coli (E. coli) for open and closed isomers and photoswitchable bacterial imaging for Staphylococcus aureus and E. coli were observed.', '', 'The molecular docking to DNA gyrase gave a rationale for the discrepancies in antibacterial activity for both isomers. Therefore, these fluoroquinolone derivatives can act as interesting imaging-guided photopharmacological agents for further in vivo studies.', 35608344),
('L-Trp-T403', 'L-Trp-T403, which was obtained from L-tryptophan and polyetheramine, exhibited the best antibacterial activity with the minimum inhibitory concentration (MIC) of 1 Microgram/mL against methicillin-resistant S. aureus (MRSA). Time-kill kinetics and multi-passage resistance tests experiments indicated that L-Trp-T403 could rapidly kill bacteria within 1 h. This compound also showed potent antibacterial activity against bacteria over many passages. Moreover, the AAPEAs exhibited outstanding stability and long-term antibacterial activity in complex mammalian body fluids, as well as good biocompatibility, low hemolytic activity, slight toxicity for mammalian cell (L929) and low in vivo toxicity.', '', 'These results demonstrate that membrane-active AAPEAs can serve as emerging long-term and biofilm-disrupting antimicrobial agents to treat biofilm-related infections.', 35158080),
('Ursodeoxycholic acid (UDCA)', 'Adding ursodiol induced direct antibacterial effects, suppressed proinflammatory effects, and reduced cell integrity damage. Oral ursodiol delivery to neonatal mice exhibited significant antibacterial effects and helped maintain colonic barrier integrity in mouse models of peritonitis sepsis and oral infection. UDCA supplementation attenuated colitis and recovered colonic SCFA production.', '', 'Conclusions: This study provided the first evidence that UDCA could confer diarrhea resistance in ESBL-EAEC-infected newborn dairy calves. UDCA blocked bacterial growth and invasion both in vitro and in vivo, alleviated commensal bacterial dysbiosis during ESBL-EAEC infection in neonatal mouse models of sepsis and colitis via the TGR5-NF-?B axis, and upregulated SCFA production in the hindgut digesta. Our findings provide insight into the UDCA-mediated remission of ESBL-EAEC infections and the potential role of UDCA as an antibiotic alternative. Video abstract.', 35643532),
('sodium salicylate (NaSa)', 'A concentration-dependent effect of NaSa was further observed, where high concentrations (10 mM) decreased agr expression, while low concentrations (?0.1 mM) increased agr expression. In S. aureus 8325-4 (agr I), a high concentration of NaSa (10 mM) decreased hla expression, and a low concentration of NaSa (?1 mM) increased rnaIII and hla expression. The activity of NaSa on biofilm formation was dependent on agr type and material surface. In addition, compared to the control, ATCC 25923 biofilms formed with 10 mM NaSa in the collagen model were more susceptible to silver.', '', 'It is concluded that NaSa can inhibit QS in S. aureus, decreasing the levels of toxin production with certain modulation of biofilm formation. The effect on biofilm formation was dependent on the strain and material surface. It is suggested that the observed NaSa inhibition of bacterial communication is a potential alternative or adjuvant to traditional antibiotics.', 35992652),
('mouse and rat stem cell-derived alveolar-like macrophages (ALMs)', 'The characterization of ALMs showed that they share known 1''AM cell surface markers, but unlike 1''AMs are highly proliferative in vitro. ALMs effectively phagocytose and kill laboratory strains of P. aeruginosa (P.A.), E. coli (E.C.) and S. aureus, and clinical strains of P.A. In vivo, ALMs remain viable, adapt additional features of native 1''AMs, but proliferation is reduced. Mouse ALMs phagocytose P.A. and E.C. and rat ALMs phagocytose and kill P.A. within the lung 24 h post-instillation. In a pre-clinical model of P.A.-induced lung injury, rat ALM administration mitigated weight loss and resolved lung injury observed seven days post-instillation. Collectively, ALMs attenuate pulmonary bacterial infections and promote airway repair.', '', 'ALMs could be utilized as an alternative or adjuvant therapy where current treatments are ineffective against antibiotic-resistant bacteria or to enhance routine antibiotic delivery.', 35441437),
('Galacto-oligosaccharides (GOS)', 'GOS (0.25%', '', 'These findings not only shed light on the anti-inflammatory mechanisms of GOS during lung infections, but GOS might also be a promising anti-bacterial agent for preventing (lung) infections.', 35286857),
('C12 monoglyceride, C6:0 medium-chain organic acids, potassium diformate, sodium diformate, a blend of C8:0/C10:0', 'The highest inhibitory activity against Staphylococcus aureus and Streptococcus suis was exhibited by the C12 monoglyceride (0.49 mg ml-1 ). The monoglyceride of C12 was more effective than C12:0 against Strep. suis, but neither C12:0 nor its monoglyceride showed efficacy against the gram-negative micro-organisms tested. The most active against Escherichia coli were the C6:0 medium-chain organic acids and potassium diformate (1.95 mg ml-1 ). For Salmonella Typhimurium, potassium diformate, sodium diformate, and a blend of C8:0/C10:0 (each 1.96 mg ml-1 ), and for Actinobacillus pleuropneumoniae, eugenol (0.49 mg ml-1 ) showed the most promising activity.', '', 'Conclusions: We identified broad-spectrum antibacterial activity, such as the C6:0 MCOA, and those with interesting narrow-spectrum activity, notably the killing of Strep. suis by C12 monoglyceride. We have identified additives that show the most promising bioactivity against specific pathogens. We broadly compare a large collection of feed additives and active ingredients for their antibacterial activity against a diverse panel of bacterial swine pathogens. This provides a solid base of evidence which can drive the development of feed supplementation strategies with the aim of reducing dependency on antibiotic use in swine production.', 34608714),
('polysaccharides extracted from Zizyphus jujuba Mill', 'This jujube polysaccharide was shown to exhibit remarkable inhibitory effects against all the tested oral bacterial pathogens through various mechanisms including growth inhibition, biofilm prevention and disruption, intervention of bacterial infection (adhesion and invasion), attenuation of cytotoxicity, modulation of excessive inflammatory response of LPS-stimulated and MRSA-infected macrophages as well as positive regulation of oral microbiota.', '', 'The present study paves the way to explore jujube polysaccharides for the prevention and treatment of oral infectious diseases.', 35378158),
('Benzofuran 1', 'Benzofuran 1 was identified as a potential lead for TB inhibiting a novel target, the thioesterase domain of Pks13.', 'Although, having promising activity against Mycobacterium tuberculosis, its main liability was inhibition of the hERG cardiac ion channel. This article describes the optimization of the series toward a preclinical candidate. Despite improvements in the hERG liability in vitro, when new compounds were assessed in ex vivo cardiotoxicity models, they still induced cardiac irregularities. Further series development was stopped because of concerns around an insufficient safety window.', 'However, the demonstration of in vivo activity for multiple series members further validates Pks13 as an attractive novel target for antitubercular drugs and supports development of alternative chemotypes.', 34910486),
('ron mimetic metal gallium [Ga (III)]', 'Ga (III) inhibits microbial growth by disrupting ferric iron-dependent metabolic pathways. In this study, we revealed that gallium nitrate III (GaN) inhibits the growth of a collection of twenty polymyxin-resistant Klebsiella pneumoniae strains at concentrations ranging from 2 to 16 Microgram/mL, using a medium, on which the low iron content and the presence of human serum better mimic the in vivo environment. GaN was also successful in protecting Caenorhabditis elegans from polymyxin-resistant K. pneumoniae strains lethal infection, with survival rates of >75%.', '', 'GaN also exhibited synergism with polymyxin B, suggesting that a polymyxin B-GaN combination holds promise like as one alternative therapy for infections caused by resistant polymyxin B K. pneumoniae strains.', 34775292),
('dihydropyrimidinone imidazoles', 'hybridized dihydropyrimidinone imidazole 8b was found to be extremely active against multidrug-resistant K. pneumonia and A. baumanii at a low concentration of 0.5 microg/mL, which outperformed norfloxacin even clinafloxacin. This active compound not only exhibited low cytotoxicity to mammalian cells (human red blood cells, HepG2 and ECs), but also possessed rapid bactericidal property, good biofilm inhibition ability, and a low propensity to induce K. pneumonia and A. baumanii resistance.', 'Further studies revealed that the inhibitory effect of the active compound 8b might be achieved by disrupting membrane integrity, increasing ROS generation, reducing GSH activity and interacting with DNA.', 'These findings provided a bright hope for developing dihydropyrimidinone imidazoles to combat emergent drug resistance.', 35168152),
('silver ions plus Triton X-100', 'antibacterial activity against both planktonic and biofilm-resident E. faecalis was dramatically improved after TX-100 incorporation. TX-100 and Ag+ mixture demonstrated a similar inhibitory effect as the 2% chlorhexidine (CHX), while the cytotoxicity was much lower than 2% CHX (p < 0.05).', '', 'In conclusion, TX-100 + Ag+ mixture might be developed into a new effective intracanal medication as the 2% CHX.', 34731451),
('Grape Seed Oligomeric Proanthocyanidins', 'GSOPs were able to alleviate oxidative stress, inflammation and barrier integrity disruption inflicted by bacteria in the co-culture.', '', 'Based on these observations, GSOPs seem to be promising candidates for the prevention and treatment of gastrointestinal bacterial infections.', 35052987),
('biochar alone or in combination with manure', 'Field experiments revealed class 1 (CL1) integrons were prevalent in all samples, with higher concentration and abundance in manure-treated plots than in biochar-treated ones. Manure considerably enhanced CL1 integrons abundance and antimicrobial resistance, whereas biochar amendments significantly reduced integrons and antimicrobial resistance. The results highlighted the differential effects of biochar and manure on integrons and its gene cassette arrays, showing increased abundance of integrons and antibiotic resistance upon manure application and decrease of the same with biochar.', '', 'The use of biochar alone or in combination with manure could be a beneficial alternative to mitigate the spread of antimicrobial resistance and bacterial evolution in the environment, specifically in paddy soils.', 35847108),
('Biofumigation of allelochemicals called isothiocyanates (ITCs)', 'Biofumigation, an agricultural technique where Brassica plant tissues are mulched into soils to release antimicrobial plant allelochemicals called isothiocyanates (ITCs), has been proposed as an environmentally friendly alternative to agrochemicals. Here, we used a laboratory model system to compare the efficacy of different types of ITCs against Ralstonia solanacearum plant bacterial pathogen.', '', 'Together, our results suggest that R. solanacearum can rapidly evolve tolerance to allyl-ITC plant allelochemical which could constrain the long-term efficiency of biofumigation biocontrol and potentially shape pathogen evolution with plants.', 35603031),
('mixed-charge two-dimensional molybdenum disulphide (2D-MoS2)', 'Gram-selective antibacterial system based on two-dimensional molybdenum disulphide (2D-MoS2) functionalized with different proportions of positively and negatively charged ligands. Two representative ESKAPE pathogenic strains, i.e., Gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and Gram-negative Pseudomonas aeruginosa (P. aeruginosa) were considered to evaluate the selective antibacterial activity.The selective generation of intracellular reactive oxygen species (ROS) together with membrane depolarization contributed to the selective killing of the pathogenic bacteria.', '', 'In summary, we prepared simple and efficient Gram-selective 2D-MoS2-based antibacterial agents, which can be extended to other nano-antibiotic systems.', 35640626),
('methyltransferase', 'The methyltransferase interaction with cellular protein was found to be maximum, due to the maximum PatchDock Score (15808), which was followed by colicin (12864) and amoxicillin (4122). The modeled protein has found to be interact more significantly to inhibit the indicator bacteria than the tested antibiotics and antimicrobial colicin protein.', '', 'Thus, model enzyme methyltransferase could be used as enzymobiotics. Moreover, peptide sequences similar to this enzyme sequence need to be designed and evaluated against the microbial pathogen.', 35069699),
('rhamnolipid nano-micelles', 'rhamnolipid nano-micelles against selected drug-resistant Gram-negative (Salmonella Montevideo and Salmonella Typhimurium) and Gram-positive bacteria (Staphylococcus aureus, Streptococcus pneumoniae)', 'rhamnolipid nano-micelles are unlikely to cause any harmful effects on the skin.', 'Thus, rhamnolipid nano-micelles could be recommended to replace alcohol-based hand sanitizers; however, they must still be tested by healthcare workers in healthcare settings to ascertain their antimicrobial activity and safety.', 35625249),
('sulfidated nanoscale zerovalent iron (S-nZVI)', 'When the S/Fe was 0.1, the inactivation efficiency of 1120 mg/L S-nZVI on the donor and recipient bacteria were 2.36 ', '', 'This study provided evidence and insights into possible underlying mechanisms for reducing conjugative transfer, such as hindering cell membrane repair, inducing the overproduction of reactive oxygen species, inhibiting the SOS response, reducing the expression of ARGs and related transfer genes. S-nZVI could inhibit the gene conjugative transfer while inactivating the ARB. The findings provided an alternative method for controlling antibiotic resistance.', 35334272),
('boswellic acid', 'The most significant effect was found in Enterococcus faecalis ATCC 29212 in a combination of 0.2 ', '', 'With increasing resistance to common antibiotics, boswellic acid-containing extracts could serve as an alternative or work in synergy with commonly available preparations.', 35744925),
('monoclonal antibodies (mAbs)', 'B39, was found to protect mice in a lethal model of K. pneumoniae pneumonia against both O1 and O2 strains when dosed therapeutically. B39 binds to D-galactan-I and D-galactan-II of the LPS of O1 and O2 strains.', '', 'Thus, we have discovered an mAb with novel binding and functional activity properties that is a promising candidate for development as a novel biotherapeutic for the treatment and prevention of K. pneumoniae infections.', 34923908),
('Methylene Blue (MB) and TMPyP', 'In experiments on the replication ability of bacteria after photodynamic treatment with TMPyP or MB, a killing rate of 5 log10 steps of the bacteria was achieved.', '', 'A promising approach to support conventional antibiotic therapy is the antimicrobial photodynamic inactivation (aPDI). For the first time, a membrane-damaging effect of TMPyP and MB in both bacterial strains could be shown using flow cytometry analyses. Furthermore, we found that reduction of the replication ability occurs with lower concentrations than needed for membrane damage upon MB suggesting that membrane damage is not the only mechanism of aPDI using MB.', 35061201),
('Brominated Carbazole with Antibiotic Adjuvant Activity', 'RNA-seq analysis showed 176 and 233 genes significantly up- and downregulated, respectively, in response to cotreatment.', '', 'This study revealed a dramatic impact of our lead adjuvant on the transcriptome that is consistent with a pleiotropic effect due to Stk1 inhibition. These results point to this antibiotic adjuvant having potential broad therapeutic use in combatting MRSA.', 35467845),
('Iron-Induced Respiration', 'Iron supported the growth of S. coelicolor even under anaerobic conditions. In the presence of potassium cyanide, which reduces aerobic respiration of cells, iron still promoted respiration and antibiotic resistance. This suggests the involvement of a KCN-insensitive type of respiration in the iron effect. This phenomenon was also observed in another actinobacterium, Mycobacterium smegmatis.', '', 'A surprising role of iron to increase respiration, especially in a mode of using less oxygen, appears a fitting strategy to cope with bactericidal antibiotics known to kill bacteria through oxidative damage. This provides new insights into developing antimicrobial treatments based on the availability of iron and oxygen.', 35357210),
('3-hydroxy-pyridin-4(1H)-one compound (20p)', 'compound (20p) was identified with the effects of inhibiting the production of pyocyanin (IC50 = 8.6 microM) and biofilm formation (IC50 = 4.5 microM). Mechanistic studies confirmed that 20p inhibits the formation of bacterial biofilm by inhibiting the expression of pqsA, blocking pqs quorum sensing system quinolone biosynthesis. The bactericidal effects of combining currently approved antibiotics for CF including tobramycin, ciprofloxacin, and colistin E with 20p, which showed obvious antibacterial synergy to overcome antibiotics resistance in multidrug-resistant P. aeruginosa biofilms.', '', 'The result indicates that compound 20p may be used in the future as a potentially novel antibacterial synergist candidate for the treatment of P. aeruginosa infections.', 34951310),
('SA09-Cu', 'SA09-Cu could convert NDM-1 into an inactive state by oxidizing the Zn(II)-thiolate site of the enzyme. SA09-Cu showed a unique redox tuning ability, and avoided to be reduced by intracellular thiols of bacteria.', '', 'In vivo experiments indicated that SA09 combined with CuGlu could effectively potentiate MER''s effect against NDM-1-producing E. coli (EC23) in the murine infection model. This study provides a highly promising scaffold in developing novel inhibitors to combat NDM-1-producing CREs.', 34794102),
('Ruthenium(II) complexes', 'Four complexes could absolutely inhibit the growth of Staphylococcus aureus (S. aureus) with MIC values ranging from 15.6 to 100 microg/mL. The most active complex Ru(?)-1 (MIC = 15.6 microg/mL) could kill S. aureus through targeting the membrane integrity without detectably resistance frequencies.', '', 'Finally, based on the mouse model of S. aureus skin infection, Ru(?)-1 showed important antibacterial efficacy against S. aureus in vivo, and almost non-toxic against mouse tissue. Our study indicates that introducing membrane targeting ligands onto ruthenium complexes may be an underappreciated strategy for developing antibacterial agents.', 35635951),
('Gelatinase Responsive Nanogel (G@CuS)', 'Constructed a "core-shell" nanogel (G@CuS) based on a copper sulfide (CuS) antimicrobial agent and gelatin for targeted drug release and bacterial clearance in a gelatinase infected microenvironment. G@CuS produced heat and reactive oxygen species (ROS) under the irradiation of a laser, which together with the released Cu2+ cause irreversible and efficient physical damage to the bacteria.', '', 'G@CuS eradicated the colonized bacteria in the wound of mice infected with Staphylococcus aureus (S. aureus) and accelerated wound healing. The proposed application strategy of nanogel is expected to provide a new idea for clinical transformation.', 35877482),
('tilapia piscidin 2 (TP2)', 'showed significant antimicrobial activity against multidrug-resistant bacterial species. These peptides also showed minimal cytotoxicity. In addition, they were significantly active in the presence of physiological salts, 50% human serum and elevated temperature. The designed peptides also showed synergistic activity when combined with clinical antibiotics.', '', 'The current approach demonstrates a fruitful strategy for developing potential AMPs for antimicrobial application. Such AMPs have potential for progression to further trials and drug development investigations.', 35216307),
('conjugates of colistin (CT) and hyaluronic acid (HA)', 'synthesis of conjugates of colistin (CT) and hyaluronic acid (HA) using carbodiimide chemistry to conjugate the amino groups of CT with the carboxyl groups of HA. The obtained polysaccharide carriers had a degree of substitution (DS) with CT molecules of 3-10 %, and the CT content was 129-377 microg/mg. retained antimicrobial activity depending on the DS: at DS 8 %, the minimum inhibitory concentration (MIC) of the conjugate corresponded to the MIC of free CT. The resulting systems also reduced CT nephrotoxicity by 20-50 %.', '', 'These new conjugates of CT with HA are promising for the development of nanodrugs for safe and effective antimicrobial therapy.', 35724903),
('biofilm-targeted antibiotic liposomes', 'exhibit significantly enhanced bacterial inhibition and biofilm eradication effects that are positively correlated with the cholesterol content of liposomes. Liposome encapsulation with a high cholesterol concentration improves noticeably the pharmacodynamics and biocompatibility of antibiotics after pulmonary administration.', '', 'This work may provide a new direction for the development of antibiofilm formulations that can be widely used for the treatment of infections caused by bacterial biofilms.', 35037424),
('series of semi-synthetic hybrid antibiotics formed by linking kanglemycin A (Kang A), a rifampicin analog, and a collection of fluoroquinolones', 'Kang A is a natural product antibiotic which contains a novel dimethyl succinic acid moiety that offers a new attachment point for the synthesis of hybrid antibiotics.', '', 'Several hybrids exhibit activity against bacteria resistant to Kang A via the action of the partnered antibiotic, suggesting that the Kang scaffold may provide new avenues for generating antibiotics effective against drug-resistant infections.', 34861348),
('bismuth nitrate [Bi(NO3)3] and tigecycline', 'bismuth nitrate [Bi(NO3)3], commonly used in clinical treatment of stomach-associated diseases, effectively boost the antibacterial activity of tigecycline against tet(X)-positive bacteria by inhibiting the enzymatic activity of Tet(X) protein. The combination of Bi(NO3)3 and tigecycline prevents the development of higher-level resistance in Tet(X)-expressing Gram-negative bacteria', '', 'Collectively, these findings indicate the high potential of bismuth drugs as novel Tet(X) inhibitors to treat tet(X4)-positive bacteria-associated infections in combination with tigecycline.', 35138168),
('aminoglycosides modification in the 3''-position via palladium-catalyzed oxidation', 'regioselective modification of aminoglycosides in the 3''-position via palladium-catalyzed oxidation', '', 'To underline the effectiveness of our method for structural modification of aminoglycosides, we have developed two novel antibiotic candidates overcoming APH(3'')s-mediated resistance employing only four synthetic steps.', 35388562),
('NADH', 'artificially manipulated the redox homeostasis of the model opportunistic pathogen Pseudomonas aeruginosa using specific enzymes that catalyze either the formation or oxidation of NADH. Increased NADH levels led to the activation of antibiotic efflux pumps and high levels of antibiotic resistance. However, higher NADH levels also resulted in increased intracellular ROS and amplified antibiotic killing.', '', 'Our results demonstrate that growth inhibition and killing activity are mediated via different mechanisms. Our results pave the way for a more effective infection resolution and add an antivirulence strategy to maximize chances to combat devastating P. aeruginosa infections while reducing the overall use of antibiotics.', 35038918),
('dynaplanin [(T094 and T095) and the type strain DSM43634]', 'Arthrobacter globiformis (ATCC 8010) exhibited strong sensitivity', '', 'Overall, our strategy based on bacterial competition led to discovery of a novel antibiotic that inhibits the ability to metabolize nutrients.', 35608300),
('Combination therapy of niclosamide (NIC) and polymyxin B (PB)', 'the combination of 15 with PB displayed superior elimination of P. aeruginosa DK2. This combination decelerated PB-resistance progress in DK2, along with lower potential toxicity.', '', 'Overall, this study provides a strategy for development antibiotic adjuvants to potentiate PB against MDR P. aeruginosa infections.', 35398731),
('Memantine (MEM)', 'Combining MEM with the reactive oxygen species (ROS) inhibitor, N-acetyl-l-cysteine, weakened the anti-infective effect of MEM. MEM increased the expression of NADPH p67phox and promoted neutrophilic ROS production. Deleting the p67phox gene significantly weakened the effects of MEM on ROS generation and improving bactericidal effect of neutrophils.', '', 'In conclusion, MEM promoted the bactericidal effect of neutrophils against P. aeruginosa and its drug-resistant strain, and had a synergistic antibacterial effect when combined with AMK. MEM may exert its anti-infective effects by promoting neutrophilic bactericidal activity via increasing the expression level of p67phox and further stimulating ROS generation.', 34357802),
('amphiphilic poly(ethylene glycol)-Schiff-vancomycin (PEG-Schiff-Van) prodrug and free Van in one drug delivery system', 'on account of the combination of physical encapsulation and chemical conjugation of vancomycin, these nanocarriers with favorable biocompatibility and high drug loading capacity displayed a programmed drug release behavior, which was capable of rapidly reaching high drug concentration to effectively kill the bacteria at an early period and continuously exerting an bacteria-sensitive effect whenever needed over a long period. In addition, more Schiff-base moieties within the PEG-Schiff-Van@Van nanocarriers may also make great contributions on promoting the antimicrobial activity.', '', 'This work represents a synergistic strategy on offering important guidance to rational design of multifunctional antimicrobial vehicles, which would be a promising class of antimicrobial materials for potential clinical translation.', 35386319),
('simeprevir', 'simeprevir had strong antibacterial activity against MRSA, with a minimum inhibitory concentration of 2-8 Microgram/mL. Simeprevir combined with gentamicin effectively reduced the bacterial burden in an MRSA-infected subcutaneous abscess mouse model.', '', 'Collectively, these results demonstrated the potential of simeprevir as an antimicrobial agent for the treatment of MRSA infections.', 35338386),
('five dihydroisocoumarin: 6-methoxy mellein (1); 5,6-dihydroxymellein (2); 6-hydroxymellein (3); 4-chloro-6-hydroxymellein (4) and 4-chloro-5,6-di-hydroxymellein (5)', 'All of the compounds exhibited selective antibacterial activity against Gram-positive bacteria Staphylococcus aureus and Bacillus licheniformis except compound 3. The chloro-dihydroisocoumarin derivative, compound 4, showed potential antimicrobial activities against all of the tested strains with the MIC value between 0.8-5.3 microg/mL followed by compound 5, which exhibited a moderate inhibitory effect.', '', 'This work provides an effective strategy for compounds to inhibit bacterial growth or overcome bacterial resistance.', 35684566),
('magnetically controlled multifunctional micromotor was developed by using H2O2 as the fuel and MnO2 as the catalyst', 'to treat bacterial biofilm infection. In the presence of H2O2, the as-prepared motors could be self-propelled by the generated oxygen microbubbles. Thereby, the remotely controlled motors could drill into the EPS of biofilm and disrupt them completely with the help of bubbles. Finally, the generated highly toxic ', '', 'This strategy combined the mechanical damage, highly toxic ', 35739732),
('phosphate ester derivative of chrysin', 'as a potent QS inhibitor of the human pathogen Pseudomonas aeruginosa (P. aeruginosa) using a designed luciferase reporter assay. In vitro biochemical analysis shows that the chrysin derivative binds to the bacterial QS regulator LasR and abrogates its DNA-binding capability. In particular, the derivative exhibits higher anti-virulence activity compared to the parent molecule.', '', 'All the results reveal the potential application of flavone derivative as an anti-virulence compound to combat the infectious diseases caused by P. aeruginosa.', 35458637),
('Synergistic Killing of Polymyxin B in Combination with Cannabidiol', 'The polymyxin B-cannabidiol combination showed synergistic antibacterial activity in checkerboard and static time-kill assays against both polymyxin-susceptible and polymyxin-resistant isolates against Acinetobacter baumannii.', '', 'The study suggests the possibility of cannabidiol repositioning, in combination with polymyxins, for treatment of MDR polymyxin-resistant Gram-negative infections.', 35456620),
('oxygen-based membrane biofilm reactor (O2-MBfR) treating GW', 'Increasing DO concentration from 0.2 to 0.4 mg/L led to improved organics (> 90%) and nitrogen removal, as well as less EPS (especially for proteins and carbohydrates) and ARGs accumulation (e.g., intI-1, korB and sul-2) in the biofilm; the high-DO-concentration accumulated microbial niches, including Flavobacteriaceae and Cyanobacteria that revealed by LEfSe analysis, contributed to both nitrogen reduction and organics biodegradation.', '', 'These findings suggested the DO-based ARGs reduction regulation strategy in the O2-MBfR treating GW.', 35395308),
('carbapenem-hydrolyzing class D beta-lactamases (CHDLs)', 'OXA-23-MA-1-206 complex show that the C6 hydroxymethyl group forms a hydrogen bond with the carboxylated catalytic lysine of OXA-23, effectively preventing deacylation.', '', 'These results provide a novel strategy for designing next-generation, carbapenemase-stable carbapenems to fight multidrug-resistant infections caused by Gram-negative pathogens.', 35420470),
('grafting zwitterionic polymer (poly(sulfobetaine methacrylate) (PSBMA)) on ZnO nanopillars', 'Under dry conditions, this nanopillar surface displays remarkable mechano-bactericidal activity, because the collapsed zwitterionic polymer layer makes no essential influence on nanopillar structure. Once being incubated with aqueous solution, the surface could readily detach the killed bacteria and debris, owing to the swelling of the zwitterionic layer.', '', 'The resultant nanopillar surface also enjoys the advantages of substrate-independency and good biocompatibility, offering potential antibacterial applications for biomedical devices and hospital surfaces.', 35338932),
('combination of clomiphene with amoxicillin', 'Combination created through the method of sCRilecs-seq (subsets of CRISPR interference libraries extracted by fluorescence activated cell sorting coupled to next generation sequencing)', '', 'These findings could provide a starting point to develop a solution for the increasing amount of hard-to-treat amoxicillin-resistant pneumococcal infections.', 35748540),
('NANO@PS-LPs', 'a type of antibiotic-adjuvant liposomes (NANO@PS-LPs), co-incorporating azithromycin (AZI), adjuvant (2-nitroimidazole derivative, 6-NIH) and biofilm dispersant (nitric oxide donor, DETA NONOate). NANO@PS-LPs possessing negatively-charged surface and good hydrophilicity could easily penetrate through the sputum layer, then disassembled triggered by overexpressed phospholipase A2 (PLA2) in the microenvironment around biofilms. eliminate mature P. aeruginosa biofilms, effectively kill dispersed bacteria, inhibit the metabolism of survivors and prevent P. aeruginosa adherence to airway epithelial cells, accordingly restrain recurrent infections. performed a remarkable advantage in killing AZI-resistant P. aeruginosa and removing their biofilms', '', 'In summary, NANO@PS-LPs present a potential nano-strategy to treat stubborn pseudomonal pulmonary infections and overcome correlative drug resistance.', 35710071),
('Tigecycline Adjuvant ML-7', 'ML-7 combined with tigecycline could completely inhibit the growth of bacteria, and the time-kill analysis revealed that the combination exhibited synergistic bactericidal activities for tigecycline-resistant isolates. The tigecycline MIC of the strains ranges from 8 Microgram/mL to 256 Microgram/mL.', '', 'Taken together, these results revealed the potential of ML-7 as a novel tigecycline adjuvant to circumvent tigecycline-resistant Klebsiella pneumoniae.', 35071055),
('polymyxin B in combination with fosfomycin', 'against KPC-2-producing Klebsiella pneumoniae (polymyxin B MIC, 0.5-64 mg/L; fosfomycin MIC, 16-128 mg/L),', '', 'Our findings suggest that further research is needed to better understand immune-mediated killing in order to identify a strategy which harnesses the power of the immune response against these hard-to-treat bacteria.', 35288260),
('series of 4-(1,2,3-triazoyl)arylmethanone derivatives', 'series of 4-(1,2,3-triazoyl)arylmethanone derivatives has been synthesized using the one-pot Copper-?Catalyzed Oxidative Cross-?Dehydrogenative Coupling?/Oxidative Cycloaddition strategy to overcome antibiotic resistance and exhibited good anti-TB activities. Notably, compounds 6b, 6f, and 6g gave the most potent efficiency with minimum inhibitory concentration values of 4 microg/ml (12.8, 11.7, and 12.8 micromicro, respectively).', 'Among the synthesized compounds, the cytotoxicity measurements of the 6b, 6f, 6g, 6d, and 6v derivatives were screened and it was found that the 6f derivative did not show any cytotoxicity.', 'Molecular docking analyses are utilized to identify the binding mode and the key interactions between target compounds and the ligand-binding site of M. tuberculosis enoyl-acyl carrier protein reductase enzyme (MtInhA, EC 1.3.1.9). The docking results were in agreement with the in vitro results, which confirm the synthesized ligands bind to MtInha with moderate to low affinity.', 35187763),
('Qixingjian Decoction (QXJT) with oxacillin (OX)', 'QXJT exhibited antimicrobial activity against both clinical isolates of MRSA, MICs ranging from 18.75 to 37.5 mg/mL. QXJT could cause the disruption of MRSA cell wall, and QXJT + OX could produce greater disruption of MRSA cell wall, elucidating the synergistic effect of the two together on cell wall disruption by microscopic mechanisms. Our study shows that the combination of QXJT and OX can inhibit the expression of MRSA virulence factor, reduce the virulence of MRSA, and have no significant effect on the expression of MRSA resistance gene mecA.', '', 'Conclusion: The results of this study provide scientific experimental data for the traditional application of QXJT and initially explore the mechanism of action of QXJT combined with OX.', 35222666),
('thymol/colistin combination', 'against Gram-negative bacteria (GNB), including nonfermenting bacteria and Enterobacteriaceae. Could decrease the number of bacteria ?2 log10 CFU/mL after 24 h of therapy in a mouse thigh infection model', '', 'Our results fully prove that thymol and colistin combination possesses a promising treatment option against colistin-resistant GNB infections.', 35700133),
('Dihydroxyphenyl-substituted thiosemicarbazone', 'potent scaffold for the development of metallo-beta-lactamases inhibitors and antimicrobial. The gained molecules specifically inhibited NDM-1 and ImiS, exhibiting an IC50 value in the range of 0.37-21.35 and 0.45-8.76 microM, and 2a was found to be the best inhibitor, with an IC50 of 0.37 and 0.45 microM, respectively, using meropenem (MER) as substrate. 1a-e, 2a-e and 3a-b alone more strongly sterilized E. coli-ImiS and E. coli-NDM-1 than the MER, displaying a MIC value in the range of 8-128 microg/mL, and 2a was found to be the best reagent with a MIC of 8 and 32 microg/mL. Also, 2a alone strongly sterilized the clinical isolates EC01, EC06-EC08, EC24 and K. pneumonia-KPC-NDM, showing a MIC value in the range of 16-128 microg/mL, and exhibited synergistic inhibition with MER on these bacteria tested, resulting in 8-32-fold reduction in MIC of MER.', '', 'This work offered a promising scaffold for the development of MbetaLs inhibitors, specifically the antimicrobial for clinically drug-resistant isolates.', 35717802),
('combination of moxifloxacin and T/K', 'When combined with T/K, the mean steady-state concentrations (MSC) of moxifloxacin could prevent 70% of resistance, and the peak concentration (Cmax) prevented 95% of resistance.', '', 'Conclusion: The combination of moxifloxacin and T/K can achieve a good in vitro bactericidal effect and prevent the emergence of resistance at clinical dosage regimens, and may be an optimal therapeutic strategy for S. maltophilia infections, especially for vulnerable immunocompromised and critically ill patients.', 35720255),
('aminoglycosides co-treatment with n-butanol', '1 min co-treatment with n-butanol greatly and specifically enhances the bactericidal action of aminoglycosides by 5 orders of magnitude against stationary-phase Staphylococcus aureus cells, with n-propanol and isobutanol showing less potency. This combined treatment also rapidly kills various S. aureus persisters, methicillin-resistant S. aureus (MRSA) cells, and numerous Gram-positive and -negative pathogens including some clinically isolated multidrug-resistant pathogens (e.g., S. aureus, Staphylococcus epidermidis, and Enterococcus faecalis) in vitro, as well as S. aureus in mice.', '', 'Given n-butanol is a non-metabolite in the pathogens we tested, our work may open avenues to develop a metabolite-independent strategy for aminoglycoside potentiation to rapidly eliminate antibiotic-resistant/tolerant pathogens, as well as for reducing the toxicity associated with aminoglycoside use.', 35100802),
('Indolmycin (IND)', 'Important target for developing new antibacterial agents against Mycobacterium tuberculosis (Mtb). The 4?-methylated IND compound, Y-13, showed improved anti-Mtb activity with a minimum inhibitory concentration (MIC) of 1.88 microM (?0.5 microg/mL). Important target for developing new antibacterial agents against Mycobacterium tuberculosis (Mtb)', '', 'Finally, we discuss a strategy to expand the genome mining of antibiotic-producing microbes specifically for antimycobacterial development.', 34908399),
('crystal structure of Salmonella enterica serotype Typhimurium tryptophan synthase in complex with 3-amino-3-imino-2-phenyldiazenylpropanamide (Compound 1)', 'structure-based strategy using in silico docking screening and molecular dynamics (MD) simulations to identify compounds targeting the alpha subunit of tryptophan synthase with experimental methods involving the whole-cell minimum inhibitory concentration (MIC) test, solution state NMR, and crystallography to confirm the inhibition of L-tryptophan biosynthesis. One successful inhibitor, 3-amino-3-imino-2-phenyldiazenylpropanamide (Compound 1) binds to the alpha subunit. A crystal structure of Salmonella enterica serotype Typhimurium tryptophan synthase in complex with Compound 1 which revealed a binding site at the alphabeta interface of the dimeric enzyme.', '', 'Our results show that this small molecule inhibitor could be a promising lead for future drug development.', 34767267),
('synergistic pair - microcin J25 and sulfamonomethoxine', 'he former is a lasso peptide that inhibits the function of RNA polymerase and the latter is a sulfonamide antibacterial agent that disrupts the folate pathway', '', 'These results showcase the merit of taking a more targeted approach in the search and study of synergistic antibiotic pairs.', 35201676),
('fluorine-containing halogenated phenazine (HP) and halogenated acridine (HA) agents', 'phenazines 5g, 5h, 5i, and acridine 9c demonstrated potent antibacterial activities against Gram-positive pathogens (MIC = 0.04-0.78 microM). Additionally, 5g and 9c eradicated Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis biofilms with excellent potency (5g, MBEC = 4.69-6.25 microM; 9c, MBEC = 4.69-50 microM). Using real-time quantitative polymerase chain reaction (RT-qPCR), 5g, 5h, 5i, and 9c rapidly induce the transcription of iron uptake biomarkers isdB and sbnC in methicillin-resistant S. aureus (MRSA) biofilms, and we conclude that these agents operate through iron starvation.', '', 'Overall, fluorinated phenazine and acridine agents could lead to ground-breaking advances in the treatment of challenging bacterial infections.', 35089005),
('transferrin-conjugated copper peroxide nanoparticle-hydrogel (denoted as CP@Tf-hy)', 'When exposed to an initial acidic wound environment, the CP@Tf-hy simultaneously displays in situ self-supplied H2O2 and pH-responsive release of Fenton catalytic copper ions accompanied by highly toxic hydroxyl radical (', 'the positively charged CP@Tf-hy can efficiently trap and restrain negatively charged bacteria to the range of ', 'The safe, low-cost, and all-in-one CP@Tf-hy holds great prospects as an antibacterial dressing for rapid resistant bacteria-infected purulent wound healing.', 35319859),
('Chalcone Derivatives (F88 and F90)', 'Potential Inhibitors of P-Glycoprotein and NorA, as potential modulators of both transporters, whose activity on Staphylococcus aureus strains overexpressing NorA and resistant to ciprofloxacin was subsequently confirmed.', '', 'The findings of this study are expected to guide future research towards developing novel potent chalconic inhibitors of P-gp and/or NorA.', 35378788),
('series of 1-(2-(furan-2-yl)-5-(pyridin-4-yl)-1,3,4-oxadiazol-3(2H)-yl)-3-(aryl)-prop-2-en-1-ones (5a-o)', 'Compound 5b was reported to be the most effective against M. tuberculosis H37 Ra (97.69 percent inhibition at 30 microg/ml) and M. bovis (97.09 percent inhibition at 30 microg/ml).', '', 'We have compared our method with the conventional procedure, and the data show that our procedure is more effective in the preparation of title compounds.', 34414591),
('acetylcysteine ligand (AF-AcCys)', 'retains an antibacterial effect superimposable with that of AF against Staphylococcus aureus, whereas it is about 20 times less effective against Staphylococcus epidermidis', '', 'From the results, it emerged that the lower lipophilicity of AF-AcCys with respect to AF could be a key feature for its different antibacterial activity.', 35458776),
('GaMF1 in combination with clofazimine, rifabutin, or amikacin', 'inhibits growth and kills M. abscessus by targeting the F-ATP synthase. GaMF1''s anti-M. abscessus activity increased in combination with clofazimine, rifabutin, or amikacin.', '', 'The study expands the repertoire of anti-M. abscessus compounds targeting oxidative phosphorylation.', 35481752),
('Natural Berberine-derived Azolyl Ethanols', 'the active compounds 4d and 18b possessed the ability to rapidly kill bacteria and observably eradicate the E. coli biofilm by reducing exopolysaccharide content to prevent bacterial adhesion, which was conducive to alleviating the development of E. coli resistance.', '', 'These results provided powerful information for the further exploitation of natural berberine derivatives against bacterial pathogens.', 34964345),
('3 bis-indole alkaloids-bromodeoxytopsentin, bromotopsentin and spongotine A', 'Against Gram-positive pathogens (MRSA) and Gram-negative gastroenteric pathogen (Vibrio parahaemolyticus). Reduced pathogen cytotoxicity toward mammalian cells indicating their ability to prevent bacterial virulence.', '', 'In conclusion, sponge bis-indole alkaloids are membrane-permeabilizing agents that represent good antibiotic candidates because of their potency against Gram-positive and Gram-negative bacterial pathogens.', 35216106),
('Methyl-(Z)-11-tetradecenoate Acid', 'the studied E. coli population statistically confirmed different degrees of resistance in most of the samples analyzed in this test', '', 'Conclusions: In one case, the methyl-(Z)-11-tetradecenoate acid was observed to have a relationship with the susceptibility evaluation by using the disc diffusimetric method, which has revealed the lowest rate of antimicrobial resistance, so it has importance in further resistance evaluation studies.', 35734346);
INSERT INTO `bacteria_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Zanthoxylum nitidum', 'two new coumarins, 6-(3-oxo-butyl)-limettin (1) and toddalin I (2), and 24 known compounds were isolated from the roots of Z. nitidum, in which two isoquinoline alkaloids, 6-acetonyl-dihydrofagaridine (16) and 6-acetonyl-dihydrochelerythrine (17) showed anti-MRSA bioactivity in vitro and in vivo. Both 16 and 17 showed synergistic action with ampicillin, which decreased the MIC significantly, and both compounds had a significant ability to destroy bacterial biofilm combined with ampicillin. The combined administration showed a strong scavenging effect on the planktonic bacteria in vitro and cleared skin infection effectively in the model of wound infection in vivo', '', 'Our investigation supported the traditional use of Z. nitidum in treating infections caused by bacteria, and might provide new natural products to reduce the use of antibiotics and the treatment of drug-resistance bacteria.', 35240520),
('catechin-in-cyclodextrin-in-phospholipid liposome (CCPL)', 'inhibited young biofilm (64.15-72.70%) as well degraded mature biofilm (55.60-63.65%) at ', '', 'Thus, the results of present study revealed that the CCPL can effectively reduce the virulence properties and its application could inhibit the pathogenicity and also prevents the development of drug-resistance in MRSA strains.', 35569694),
('silver(I) metal organic frameworks Ag2(HBTC)', 'showed an inactivation efficiency of more than 99.9% against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) at a concentration of 200-250 mg L-1', '', 'In general, this study shows a promising perspective on designing MOF/PLA membranes with broad-spectrum disinfection capability for potential environmental sterilization and public healthcare protection.', 35411886),
('poly-tetrahydropyrimidine (P-THP) polymers', 'effectively inhibit the growth of Gram-positive bacteria (Staphylococcus aureus, S. aureus) and Gram-negative bacteria (Escherichia. coli, E. coli)', '', 'Generally speaking, P-THP polymers have considerable application potential in the field of treating bacterial infections and promoting wound healing.', 35024701),
('melittin alone and in combination with vancomycin and rifampin', 'The preventive and therapeutic indexes of melittin were improved 8-fold when combined with vancomycin and rifampin', '', 'Based on these findings, the combination of melittin with conventional antibiotics could be proposed for treating or preventing biofilm-associated MRSE infections.', 35123230),
('Lactobacillus rhamnosus', 'L. rhamnosus from remote Indigenous Australian children are potent inhibitors of respiratory pathogens in vitro.', '', 'Conclusions: L. rhamnosus from remote Indigenous Australian children are potent inhibitors of respiratory pathogens in vitro.', 34606144),
('polyionenes', 'inactivates MHV completely in 30 s, effective in inhibiting SARS-CoV-2 by >99.999% within 30 s', '', 'Overall, these polyionenes are promising active ingredients for disinfection and prevention of viral and microbial infections.', 34694749),
('seven phenolic phytochemicals (gallic acid; epicatechin; epigallocatechin gallate; daidzein; genistein; myricetin; 3-hydroxy-6-methoxyflavone) in combination with six antibiotics', 'against multidrug-resistant isolates from the ESKAPE group, 24 showed synergistic effects (12.8%)', '', 'The results highlight the potential use of antibiotic-phytocompound combinations for combating infections with multi-resistant pathogens. Synergistic combinations could downregulate the resistance mechanisms of bacteria.', 34365707),
('1,2,4-triazole-isatin derivatives', 'MIC of 0.8 Microg/ml', '', 'These studies revealed that molecule 5h could act as a potential lead molecule for further studies to find new target-directed molecules.', 35434882),
('Plantaricin A - OP4 (Derived from Lactiplantibacillus plantarum)', 'intensifies the potency of antibiotics, PlnA1 analogs OP4 heightens the potency of erythromycin against E. coli and relieves inflammation', '', 'In summary, our results showed that the PlnA1 analogs investigated in the present study, especially OP4, reduce the intrinsic antibiotic resistance of Gram-negative pathogens and expand the antibiotic sensitivity spectrum of hydrophobic antibiotics in Gram-negative bacteria.', 35499329),
('in situ exopolysaccharide (in situ-EPS1)', 'containing rare fucose produced by Lactobacillus helveticus MB2-1 in Sayram ketteki yoghurt exhibited significant antibiofilm effect against MRSA', '', '', 35777514),
('sodium calcium phosphates (P2O5)50(Na2O)20(CaO)30-X(MO)X, Co + Cu, Co + Zn, and Cu + Zn', 'against Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacterial strains, as well as a fungal strain (Candida albicans). An enhanced antimicrobial effect, at 5 mg/mL concentration, was exhibited by cobalt, copper, and zinc oxide glasses alone and in combinations.', '', 'A synergistic antimicrobial effect was observed by Cu + Co and Cu + Zn against E. coli and Cu + Zn against S. aureus.', 35199992),
('biphenyl-benzamides as FtsZ inhibitors', 'compound 30 exhibited excellent antibacterial activities, especially against four different Bacillus subtilis strains, with an MIC range of 0.008 Microgram/mL to 0.063 microg/mL', '', 'identified as a promising FtsZ inhibitor worthy of further profiling.', 35763867),
('pinocembrin', 'MIC and MBC were 256 Microgram/mL and 512 Microgram/mL against A. hydrophila', '', 'Thus, pinocembrin is a candidate drug for the treatment of A. hydrophila infection in aquaculture.', 35438439),
('STK-35/66', 'MIC and MBC ranges were 0', '', 'In nutshell, these results suggested that STK-35/66 possessed antimicrobial activity against Gram-negative pathogenic bacteria in vitro and in vivo, which could be considered as potential substitutes for the treatment of Gram-negative pathogenic infections after further structure optimization.', 35218030),
('Recombinant Myeloperoxidase (rMPO)', 'rMPO could kill antibiotic-resistant bacteria, making it very useful for treatment of nosocomial infections and mixed infections', '', 'Our data suggest that recombinant MPO from human cells is a new class of antimicrobials with a broad spectrum of activity.', 35019674),
('N,N-dimethyldithiocarbamate (DMDC)', 'bactericidal antibiotic against S. pneumoniae', '', 'Taken together, this study provides mechanistic insights regarding DMDC''s activity as an antibiotic at the host-pathogen interface.', 35311543),
('membrane-active antimicrobial agent nTZDpa', 'exhibit enhanced antibiotic activity against multidrug-resistant Gram-positive pathogens in acidic pH, but also retains antimicrobial potency under anaerobic conditions', '', 'These findings demonstrate that nTZDpa is a promising lead compound for developing new therapeutics against hard-to-cure infections caused by drug-resistant and -tolerant S. aureus.', 35447554),
('combination of Cu(II) and dissolved biochar', 'when the Cu(II) concentration exceeded 0.5 mg/L, the transfer efficiency was entirely inhibited', 'the transfer frequency was significantly reduced; this occurred regardless of the Cu(II) concentration or pyrolysis temperature of dissolved biochar', 'This study provides a new environmental contaminant treatment approach to eliminate the heavy metal-facilitated transfer of ARGs between bacteria.', 34583164),
('Combination of Auranofin and Pentamidine', 'slowed down auranofin resistance development in clinically isolated MDR bacteria (Klebsiella pneumoniae)', '', 'Conclusion: The combination of non-antibiotic drugs with complementary antibacterial mechanisms provides a potentially promising approach to discover new antibacterial drugs and delay drug resistance development.', 35378227),
('O3-based advanced wastewater treatment', 'inactivated all AMRB and AMSB (>99.9%) after 10 min of treatment, removed antimicrobial resistance genes (AMRGs) in the wastewater', '', '', 35203813),
('unithiol', 'Inhibition of Metallo-beta-Lactamases for the Treatment of Carbapenem-Resistant Gram-Negative Bacterial Infections', '', 'Thus, we demonstrate both experimentally and theoretically that the unithiol is a prospective competitive inhibitor of metallo-Beta-lactamases and it can be utilized in complex therapy together with the known beta-lactam antibiotics.', 35163756),
('auranofin', 'against N. gonorrhoeae using a murine model of vaginal infection, a 1.04 (91%) and 1.40 (96%) average log10-reduction of recovered N. gonorrhoeae was observed', '', 'In conclusion, auranofin has the potential to be further investigated as a novel, safe anti-gonococcal agent to help meet the urgent need for new antimicrobial agents for N. gonorrhoeae infection.', 35446884),
('Azadirachta indica (Neem), methanolic extract, Beta.d-Mannofuranoside', 'methanolic extract of neem leaves was found to have antibacterial activity against all pathogenic and reference strains., MIC (32 Microg/ml and 64 Microg/ml) against S. aureus (ATCC 25,923) and E. coli (ATCC 25,922)', '', 'Conclusion: The methanolic extract of A. indica leaves possessed strong antibacterial activity against different types of bacteria. Beta.d-Mannofuranoside, O-geranyl was the most active compound and it passed 5 rules of drug-likeness properties. It could therefore be further processed for animal testing and clinical trials for its possible use as an antibacterial agent with commercial values.', 35610569),
('Florfenicol-Polyarginine Conjugates', 'Drug-sensitive bacteria, gram-negative bacteria Escherichia coli (E. coli) and gram-positive Staphylococcus aureus (S. aureus), were sensitive to several of the compounds tested. These conjugates also showed excellent activity against drug-resistant strains such as methicillin-resistant S. aureus (MRSA) and florfenicol resistant Escherichia coli strains (2017XJ30, 2019XJ20), one of which as E6 had a minimum inhibitory concentration of 12.5 Micromol/L.', '', 'These new conjugates may provide useful insights for expanding the pool of antibiotics.', 35844651),
('Amidine Substituted Monocyclic Beta-Lactams (Compound 23d)', 'MIC 0.25 Microg/mL to 2 Microg/mL against tested strains', '', 'Therefore, compound 23d may be a valuable lead target for further investigations against multi-drug resistant Gram-negative bacteria.', 34463230),
('deep eutectic solvents (DES)', 'improve, by 2 to 4-fold, the susceptibility of Gram-negative (Escherichia coli and Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus) bacteria to the antibiotic, improve the therapeutic efficacy at concentrations where bacteria present resistance, without promoting tolerance development to ciprofloxacin', '', 'The results herein reveal the pioneering use of DES in fluoroquinolone-based formulations and their impact on the antibiotic''s characteristics and on its therapeutic action.', 35151818),
('sialic acid derivatives', 'potent compounds, which have a 180-fold higher affinity compared to the natural substrate, were tested in bacterial growth assays and indicate bacterial growth delay in methicillin-resistant Staphylococcus aureus', '', 'This study represents the first example and a promising lead in developing sialic acid uptake inhibitors as novel antibacterial agents.', 35675124),
('QSI-5 (quorum sensing inhibitors)', 'reduced the mortality (88.4%), lesion severity (72.2%), and APEC load (2.8 logs) in chickens', '', 'In conclusion, QSI-5 displayed promising effects in chickens and thus, represents a novel anti-APEC therapeutic.', 35583333),
('prenylated emodine-type anthranoid Ferruginin A', 'potent activity against both the planktonic and biofilm forms of Gram-positive bacteria (i.e., Staphylococcus aureus and S. epidermidis)', '', 'In conclusion, ferruginin A represents a promising scaffold for the further development of valuable antimicrobial agents.', 35052961),
('3-alkyl-pyridinic analogs', 'The most effective compound 6 has MIC ranging from 0.98 to 3.9 Microgram mL-', '', 'A 3-alkylpyridine-bearing alkaloid exhibits potent antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA) with no detectable resistance', 35636092),
('combination of carvacrol and thymol', 'combination of carvacrol and thymol was observed to have better inhibition effect on common pathogens in vitro, MICs of thymol and carvacrol in our study were slightly higher for gram-negative bacteria', '', '', 35602084),
('1,2,4-oxadiazole/pyrrolidine hybrids', 'compound 17 outperformed ciprofloxacin against E. coli, with an MIC of 55 ng/ml, compared to 60 ng/ml for ciprofloxacin', '', 'Finally, the docking study, along with the in vitro experiments, supports our promising approach to effectively develop potent leads for further optimization as dual DNA gyrase and Topo IV inhibitors.', 35363388),
('1-{4-[(1E)-2-(3,5-dimethoxyphenyl)ethenyl]phenoxy}-3-{[(4-fluorophenyl)methyl]amino}propan-2-ol(Isopropanolamine-Tailored Pterostilbene Derivative)', 'compound C1 displayed excellent antibacterial potency in vitro, affording an EC50 value of 0.88 Microg mL-1 against Xoo (Xanthomonas oryzae pv. oryzae). C1 could significantly reduce biofilm formation and extracellular polysaccharides (EPS).', '', 'Given these promising profiles, these pterostilbene derivatives can serve as novel antibiofilm agents to suppress plant pathogenic bacteria.', 35437986),
('biphenyl analogue of macolacin', 'against Gram-negative pathogens expressing mcr-1 and intrinsically resistant pathogens with chromosomally encoded phosphoethanolamine transferase genes', '', 'In a mouse neutropenic infection model, a biphenyl analogue of macolacin proved to be effective against extensively drug-resistant A. baumannii with colistin-resistance, thus providing a naturally inspired and easily produced therapeutic lead for overcoming colistin-resistant pathogens.', 34987225),
('Polyamino-isoprenyl compound NV716', 'NV716 increased the relative potency of all drugs against intracellular infection by the same bacteria as well as their maximal efficacy and also considerably reduced the MICs of these antibiotics(rifampicin, azithromycin, linezolid, fusidic acid, novobiocin, chloramphenicol, and doxycycline, plus ciprofloxacin as an active drug)', 'no toxicity was evidenced towards eukaryotic cells.', 'NV716 also enhanced rifampicin activity against biofilms from these three species. These data highlight for the first time the potential interest of NV716 as an adjuvant against these Gram-negative bacteria like Escherichia coli, Klebsiella pneumoniae or Acinetobacter baumannii placed in the priority list of WHO for search of new therapies.', 35691172),
('guanidine derivative isopropoxy benzene guanidine (IBG)', 'the growth of more than 93% of the bacteria (E. coli ATCC 25922 and SHP45) was inhibited after treatment with 10 microg/mL IBG and 0.25 microg/mL colistin in synergy', '', 'IBG, serving as an antibiotic adjuvant, acted synergistically with colistin against diverse MDR Gram-negative bacteria (including colistin-resistant and -susceptible strains) and potentiated the therapeutic effect of colistin in vivo. so as concluded that IBG is a potential lead compound for the design of membrane-active drugs.', 36475769),
('Novel phenylamino acetamide compound, named 187R', '187R strongly inhibited the expression of the type III secretion system (T3SS) encoding genes and the secretion of the T3SS effector proteins in Pseudomonas aeruginosa', '', 'T3SS is an important virulence factor, 187R-mediated repression of T3SS was dependent on ExsA, the master regulator of T3SS in P. aeruginosa. The impact of 187R on the host-associated microbial community was also tested using the Arabidopsis thaliana phyllosphere as a model. These results suggested that compounds that target virulence factors could serve as an alternative strategy for disease management caused by bacterial pathogens.', 36519869),
('dipyrrins that supresses colistin resistance', 'MIC of colistin in a highly colistin resistant strain, A. baumannii AB4106, from 1024 microg/mL to 4 microg/mL at a concentration of 5 microM. Against K. pneumoniae strain B9, prodigiosin lowered the colistin MIC from 512 microg/mL to 2 microg/mL at a concentration of 1.25 microM', '', 'an adjuvant approach that can extend the utility and lifespan of a last-resort antibiotic such as colistin has the potential to play an important role in the fight against infections caused by MDR bacteria.', 35704751),
('Cationic pillar arene with pyridinium groups (PP5)', 'PP5 disrupt the pathogen', 'PP5 has high activity to inhibit Gram-positive and Gram-negative bacteria and/or their biofilms with low cytotoxicity.', 'It was concluded that the microbicidal activity of PP5 was due to the physical disruption of the pathogen''s membrane and the subsequent leakage of cytoplasmic components, which could greatly reduce the rapid generation of resistance against Staphylococcus aureus and Escherichia coli. Hence it can be used as a good candidate for controlling drug-resistant pathogenic bacterial infections and treating MDR bacteria.', 35953617),
('boric acid and potassium metaborate', '600 microg/ml potassium metaborate and 1,250 microg/ml boric acid exhibited a minimal inhibition of MRSA as a result of dilution with the final concentration of 20 mg/ml boron compounds. Y?lmaz found the MIC value of 3.80 mg/ml when examining the effect of boric acid and borax on the S. aureus ATCC 25923 strain. Similarly, Say?n et al found that the MIC value of 3.09 mg/ml when examining the antibacterial and biofilm effects of boric acid on the S. aureus ATCC 25923 strain.', 'According to the results, potassium metaborate was more effective and exhibited a lower toxicity to fibroblast cells compared to boric acid;', 'the findings of the present study suggest that boric acid and potassium metaborate may be effective in a wound model infected with methicillin?resistant Staphylococcus aureus. Boric acid also increased the IL-10 expression level at the same time.', 35920188),
('4,4''-dihydroxy-azobenzene (DHAB)', 'potential in vitro as an antimicrobial agent against two relevant human and animal pathogens, namely Staphylococcus aureus and Staphylococcus pseudintermedius. The values of minimal inhibitory concentration MIC were 64 and 32 mg/L respectively.', 'It has been proven that the toxicity of this substance is very low particularly at a dermal level.', 'DHAB caused membrane damage as revealed by the increase in thiobarbituric acid reactive substances (TBARS) such as malondialdehyde. Furthermore, differential induction of the enzymes peroxidases and superoxide dismutase in S. aureus and S. pseudintermedius suggested their prevalent role in ROS-scavenging due to the oxidative burst induced by this compound in either species. this suggests that this substance could be a promising candidate as an alternative to antibiotics in the treatment of animal skin infections,', 36551456),
('Role of sodium salicylate in Staphylococcus aureus', 'NaSa modulates quorum sensing and virulence in agr III-type strain ATCC 25923', '', 'It is suggested that the observed NaSa inhibition of bacterial communication is a potential alternative or adjuvant to traditional antibiotics.', 35992652),
('novel organoantimony(V) cyanoximates of Sb(C6H5)4L composition', 'Organoantimony(V) compounds is investigated as potential non-antibiotic antimicrobial agents against three Bacterial pathogens included Gram-negative Escherichia coli and Pseudomonas aeruginosa, and Gram-positive Staphylococcus aureus.', '', 'Overall, the new antimony compounds showed a strong potential as both broad- and narrow-spectrum antimicrobials against selected bacterial and fundal pathogens and provide insights for further synthetic modifications of the compounds to increase their activities.', 36363997),
('effect of combining sodium ascorbate and/or apo-transferrin with imipenem', 'Test isolates demonstrated a broader range of MIC values (8 to 128 microg/mL) when susceptibility to imipenem was assessed. In total, all test isolates (100%) were imipenem resistant (MIC of imipenem [MICimp] > 4 mg/L). However, high MIC values were recorded for sodium ascorbate (512 to 1,024 microg/mL) compared to apo-transferrin (64 to 256 microg/mL)', '', 'The triple combination therapy restored lung function and structure. our findings suggest novel insights about a promising new combination therapy against highly resistant carbapenemase-producing A. baumannii to restore the effectiveness of imipenem.', 35975993),
('fosfomycin (FOS) combined with rifampin (RIF) showed strong synergistic effects', 'when FOS in conjunction with RIF against CRPA11?20 carbapenem-resistant Pseudomonas aeruginosa, the MICs of FOS notably decreased from 128', '', 'The results of the inhibition biofilm formation assay demonstrated that RIF and FOS at 1/8MIC, 1/16MIC and 1/32MIC have better inhibitory effects on CRPA biofilm formation VS FOS alone or RIF alone . This finding will provide new insights into the treatment of bacterial infections caused by CRPA, which can be further explored in clinical practice.', 36036376),
('New class of antibiotics based on a ring-fused 2-pyridone backbone', 'SAR revealed that by introducing an aryl or benzyl substituent at position C2, the C8 aryl could be changed to a smaller cyclopropyl substituent (chemical synthesis of these compounds is described in the Supplemental Information). This resulted in compounds with increased potency against E. faecalis OG1RF including compounds EC240 (minimal inhibitory concentration [MIC] = 25 microM) and EC305 (MIC = 50 microM). among the C8 methoxy- and C2 alkyl chain analogs, PS757 had substantially improved antibacterial potency (MIC = 3 to 6 microM) compared to EC240 and EC305', '', 'Here they have shown that the new class of 2-pyridone compounds, which named GmPcides, including the second-generation compound PS757, have bactericidal activity against nondividing stationary phase cultures of E. faecalis OG1RF and recently isolated clinical strains of Enterococcus as well as other Gram-positive pathogens. In contrast, concentrations of PS757 which reduced CFUs of stationary phase enterococcal cells by >105 instead showed potent bacteriostatic effects and little to no bactericidal activity against enterococci growing in exponential phase', 36252016),
('Newly synthesized isatin-decorated thiazole derivatives (7b, 7d, and 14b)', 'The final concentrations of isatin derivatives in the solution ranged from 512 microg/mL to 0.5 microg/mL (512; 256; 128; 64; 32; 16; 8; 4; 2; 1; 0.5 microg/mL) for E. coli and S. aureus, and for C. Albicans.', '', 'In-vitro screening of the newly synthesized compounds for their antimicrobial activity showed promising results against both E. coli and MRSA with anti-biofilm formation activity. Compound 7f, the most potent antimicrobial compound in this study, showed a MIC value eight-fold better than chloramphenicol against MRSA. Hence novel isatin-based thiazole derivatives as promising antibacterial prototypes, against potential target enzymes, is currently under further investigation', 36046334),
('Cationic compounds, MD-124, which has a diamidine core structure,identified as a potent antibiotiotic adjuvant', 'A checkerboard assay showed that MD-124 sensitized E. coli toward rifampicin in a concentration-dependent manner, reaching over 16,000-fold when 12 microg/mL MD-124 was used, with the MIC of rifampicin being 0.6 ng/mL. To investigate this further, a checkerboard assay of MD-124 in the concentration range of 0', '', 'Besides E. coli, MD-124 also showed sensitization effect on various other WT Gram-negative bacterial species such as Acinetobacter baumannii (ATCC 17978), Klebsiella pneumoniae (ATCC 43816), and Salmonella enterica Typhimurium (ATCC 14028), the resistant strains of which are listed as WHO Priority I pathogens in urgent need of new antibiotics. MD-124 has been shown to be effective against all Gram-negative strains of bacteria studied herein (Figures 1D and 2), presumably because they share very similar LPS structures', 35801980),
('Two lead compounds 36 and 52 which contained the tetrahydroquinoline core, hydrophobic alkyl chains (n-nonyl or isoprenyl group), different spacer lengths (n = 4 or 8), and cationic guanidine moiety,', 'compounds 36 and 52 exhibited similarly potent in vivo antimicrobial activities in a murine corneal infection caused by Staphylococcus aureus ATCC29213 or Pseudomonas aeruginosa ATCC9027, as compared to vancomycin or gatifloxacin. Against gram positive 0.78-1.56 micro gram MIC for gram positive bacteria and 3.125-6.25 micro gram for gram negative bacteria with compound 52', '', 'The further biological evaluation revealed that compounds 36 and 52 can kill bacteria and fungi rapidly via membrane-targeting action and avoid drug resistance development. These results suggest that compounds 36 and 52 have great potential as new broad-spectrum antimicrobial agents to combat microbial resistance', 36088756),
('combination of daptomycin and HClO', 'Daptomycin plus HClO lock therapy showed the highest activity for experimental CRI with S. epidermidis.', '', 'HClO could be an effective strategy for treating infections caused by extensively drug-resistant or multidrug-resistant and biofilm-producing strains in medical devices and chronic wounds. The results of the ALT using daptomycin plus HClO may be promising', 36190404),
('2-Aminoimidazole Analogs', 'new 2-aminoimidazole compounds and show that they affect the integrity of the outer membrane in resistant strains of Escherichia coli and Klebsiella pneumoniae.', '', 'They have identified new 2-aminoimidazole containing compounds that target the PhoP response regulator protein. Since PhoP controls various aspects of outer membrane stability in many Gram-negative bacteria, it can be targeted to tackle resistant Gram-negative pathogens. Our work provides solid evidence that the 2-AIs are binding PhoP, altering the protein', 36454711),
('carbasugar precursors (CSPs)', 'carbasugar precursors (CSPs) and their application as biofilm inhibitors for E. coli and MRSA,. This results in a biofilm reduction of up to 70% for the CSP rac-7 and a reduction in bacterial viability of MRSA by approximately 45% when combined with the otherwise ineffective antibiotic mixture of penicillin and streptomycIN', '', 'Synergy of R-(-)carvone and cyclohexenone-based carbasugar precursors with antibiotics to enhance antibiotic potency and inhibit biofilm formation', 36289389),
('Novel cationic polysaccharide conjugates Dextran-graft-poly(5-(1,2-dithiolan-3-yl)-N-(2-guanidinoethyl)pentanamide) (Dex-g-PSSn )', 'when compared with Dex-g-PSS15 (MIC = 128 microg mL?1), Dex-g-PSS60 (MIC = 128 microg mL?1), and Dex-g-PSS90 (MIC = 64 microg mL?1), the MIC of Dex-g-PSS30 was 32 microg mL?1 in MDR-AB cells and 8 microg mL?1 in methicillin-resistant Staphylococcus aureus (MRSA) cells, indicating outstanding antibacterial capabilities.', 'Dex-g-PSS30 exhibited relatively low cytotoxicity (half maximal inhibitory concentration (IC50) = 512 microg mL?1) in mouse fibroblast L929 cells. when the concentration was <128 microg mL?1, no significant cytotoxicity was observed.', 'Inner and outer bacterial membranes were damaged and intracellular ROS levels increased by sub-inhibitory Dex-g-PSS30 concentrations, further eliciting damage to bacterial membranes and promoting intracellular antibiotic access. Additionally, bacterial efflux pumps were affected by Dex-g-PSS30 and reduced antibiotic efflux. Finally, bacterial resistance was prevented by Dex-g-PSS30 which restored rifampicin (RIF) efficacy in an MDR-AB-induced pneumonia mouse model. Overall, we present a novel platform for resensitizing MDR bacteria to antibiotics and preventing bacterial resistance.', 35962720),
('5-methylindole adjuvants of aminoglycoside.', 'determined MICs of 5-methylindole to E. coli, P. aeruginosa and Shigella flexneri, which were 8, 16 and 2 mM, MIC of 5-methylindole to K. pneumoniae was determined to be 4 mM, 5-methylindole and 2-methylindole were also able to kill Mycobacterium tuberculosis H37Ra (an avirulent strain) in a concentration-dependent manner', '', 'They observed that 5-methylindole itself exhibited substantial antibacterial activities against a number of Gram-positive and Gram-negative bacterial pathogens, including antibiotic-tolerant S. aureus persisters, MRSA and M. tuberculosis. Second, observed the potentiation effect of 5-methylindole on aminoglycoside antibiotics against S. aureus cells under conventional treatment conditions. Hence findings open a new avenue to develop indole derivatives like 5-methylindole as antibacterial agents or adjuvants of aminoglycoside.', 36124131),
('Ethyl 4-[[2-chloro-5-(phenylcarbamoyl)phenyl]sulfonylamino]benzoate (SABA1) is a compound', 'SABA1 has a MIC of 0.45', '', '(SABA1) is a compound that has been shown to have antibacterial properties against Pseudomonas aeruginosa and Escherichia coli. SABA1 inhibits biotin carboxylase (BC), the enzyme that catalyses the first half reaction of ACC. SABA1 represents a potentially new class of antibiotics that can be used to combat the antibacterial resistance crisis.', 34894987),
('NAD+ analogue', 'NAD+ -competitive inhibitor of NADKs, which displayed in vivo activity against Staphylococcus aureus. Analogue benzamide adenine dinucleoside analogue, active against PaNADK Pseudomonas aeruginosa NAD kinase', '', 'Structural analysis led us to design and synthesize a benzamide adenine dinucleoside analogue, active against PaNADK. This novel compound efficiently inhibited PaNADK enzymatic activity in vitro with a Ki of 4.6 microm. Moreover, this compound reduced P. aeruginosa infection in vivo in a zebrafish model.', 36036789),
('Polymyxin B Analogues Modified at Leu-7, d?Phe-6, and the N?Terminus Enabled by S?Lipidation', '', 'showed minimal kidney nephrotoxicity,', 'Several polymyxin analogues bearing one or more S-linked lipids were found to be equipotent to polymyxin. The S-lipidation strategy has demonstrated potential as a novel approach to prepare innovative new lipopeptide antibiotics.', 36413173),
('dicationic bisguanidine-arylfuran, originally developed as an antitrypanosomal agent', 'Compounds bearing an electron donating group on the phenyl ring such as CH3 (4) or OCH3 (6) had moderate antibacterial activity. Both compounds had an EC50 of around 28.5 microM against Gram-negative P. carotovorum and around 14.4 microM against P. putida', 'The cytotoxicity of all compounds was evaluated using the human MCF-7 and HepG2 cell lines. All derivatives were moderately cytotoxic with an effective concentration of 50% (EC50) greater than 25 microM in both cell lines. new derivatives were less cytotoxic than the lead molecule, offering better selectivity', 'antibacterial compounds carrying an aminoguanidine group have been reported to potentiate norfloxacin in Staphylococcus aureus, suggesting a possibility to develop the guanidine-containing molecules reported here as co-drugs***', 36009984),
('synthetic halogenated aminochalcone named (2E)-1-(4-aminophenyl)-3-(4-fluorophenyl)prop-2-en-1-one (C15H12FNO, hereinafter named PA-Fluorine)', 'The PA-Fluorine presented MIC ? 1024 microg/mL for all bacterial strains tested (S. aureus (ATCC 25923) and E. coli (ATCC 25922) strains and multidrug-resistant S. aureus 10 and E. coli 06 strains) Therefore, modulatory activity of antibiotics was observed to PA-Fluorine against strains of E. coli 06 and S. aureus 10. MIC of ampicillin alone on S. aureus was approximately 20 microg/mL. However, this decreased to 5 microg/mL when combined with ampicillin and sulbactam. MIC of ciprofloxacin in S. aureus was 40 microg/mL. The combination with chlorpromazine resulted in a synergism', '', 'PA-Fluorine has the potential to increase the antibacterial activity of antibiotics. In this study, combination with PA-Fluorine modified the activity of ciprofloxacin and gentamicin against MDR S. aureus and E. coli strains. Furthermore, PA-Fluorine modified the activity of the antibiotics norfloxacin, EtBr, and ciprofloxacin, and reduced the MIC for the S. aureus strains 1199B and K2068.', 35475507),
('amino dihydropyrimidine', 'Dihydropyrimidine represents a solid lead compound for antibacterial development, as it was reported to display significant inhibition of various S. aureus strains (MIC values from 2 to 9 microg/mL (5.5', 'dihydropyrimidine show lack of mammalian toxicity, no inhibition of bovine DHFR, and inactivity in a range of cross-indication assays used to investigate common cytotoxicity modes (up to 100 microM concentrations).', 'A functionalized amino dihydropyrimidine was reported to exhibit antibacterial activity via the inhibition of dihydrofolate reductase, as antibacterial target.', 36312355),
('novel compound: a 3,5-dinitroindole-2-carboxylate derivative, termed MZ-01.', 'MZ-01 showed bactericidal activity against Gram-positive S. pyogenes and S. pneumoniae (MIC: 5.33 microg/mL), weak antibacterial activity against Gram-positive M. abscessus, and no activity against Gram-negative P. aeruginosa and K. pneumoniae at 128 microg/mL. MZ-01 also appeared to have weak activity against E. coli at 106.67 microg/mL;', 'MZ-01 had low cytotoxicity against eukaryotic cell lines (Vero monkey kidney cells and A549 human lung cancer epithelial cells,', 'In conclusion, we identified that MZ-01 possesses good antibacterial activity against Gram-positive bacterial pathogens, including MRSA. Our finding suggests that MZ-01 is a promising compound for the development of selective antibacterial agents for Gram-positive bacterial infections.', 36358205),
('3-[(3-{[2-({3-[(4-chloro-2-hydroxyphenyl)carbamoyl]naphthalen-2-yl}oxy)ethyl]carbamoyl}naphthalen-2-yl)oxy]propan-1-aminium chloride.( Chemical structure of compound 666-15)', '666-15 showed a synergistic effect on polymyxin B (FICI ?0.281) . The synergistic effects were also found in Acinetobacter baumannii ATCC19606 (FICI ?0.281) and Pseudomonas aeruginosa ATCC27853 (FICI ?0.281), while 666-15 itself had no antibacterial activity (MIC >100 microg/ml). No synergistic effect was found between 666-15 and polymyxin B nonapeptide (PBMN) against K. pneumoniae ATCC13883,', '', 'This result indicated that the synergistic effect between 666-15 and polymyxin B was due to the enhancement of the antibacterial activity of PB by 666-15. In this case, 666-15 should be considered an antibiotic adjuvant. No synergistic effects were observed between 666-15 and other antibiotics', 36147339),
('protocatechuic acid (PCA), a phenolic compound found in medicinal plants,', 'PCA enhances the activity of levofloxacin (LEV) against Staphylococcus aureus (a) and Escherichia coli (b), as well as that of cefotaxime (CTX) against Escherichia coli (c) and Pseudomonas aeruginosa', '', 'The PCA antioxidant action comes from the property of scavenging free radicals by donating hydrogen atoms or electrons [24], whereas the antibacterial activity is due to the action of decreasing lipid oxidation levels', 35888098),
('N-{5-ethyl-[1,2,4]triazolo[1,5-c]quinazolin-2-yl}-2,2,2-trifluoroacetamide( Compound IMB-0042)', 'IMB-0042 could inhibit the growth of E. coli ATCC 25,922 with MIC of 25 microg/mL. IMB-0042 also showed growth-inhibition activity against Klebsiella peneumoniae (K. pneumonia), Pseudomonas aeruginosa (P. aeruginosa), and Acinetobacter baumannii (A. baumannii) (MICs were 100 microg/mL, 100 microg/mL, and 25 microg/mL respectively) and synergistic sensitization activity with Polymyxin B. However, for Amikacin and Gentamicin, IMB-0042 only a synergistic effect on P. aeruginosa', 'They used human renal epithelial cell line 293T to detect the growth inhibition effect of IMB-0042 on human cells. No obvious cytotoxicity was detected when treated with IMB-0042 at 50 microg/mL, indicating that human cells are less sensitive to IMB-0042, compared with E. coli cells.', 'compound IMB-0042 was obtained with the capability of blocking LptA/LptC interaction. IMB-0042 showed potent inhibitory activity against the E. coli ATCC 25922 strain. IMB-0042 showed good synergistic sensitization activity with Polymyxin B and aminoglycoside compounds, which can greatly reduce the dosage of these drugs in reducing their possible toxicity and overcoming their drug resistance.', 36290043),
('naphthalimidopropanediols (NIOLs) as a novel structural', 'these NIOLs could target and destroy the S. aureus or P. aeruginosa membranes.', 'The in vitro and in vivo cytotoxicity assay indicated that these compounds possessed low toxicity.', 'NIOLs cause membrane depolarization, outer/inner membrane permeabilization and leakage of intracellular material efficiently kill the strains within the biofilms. they could disrupt the antioxidant defense systems of S. aureus or P. aeruginosa through up-regulation of reactive oxygen species. These findings of novel NIOLs as potential broad-spectrum antibacterial members provided a bright hope for conquering drug resistance.', 35964427),
('derivatives of benzothiazole', 'Most compounds showed antimicrobial activity against S. aureus with an MIC range of 0.025 to 2.609 mM. The most active compound, 4-(Benzo[d]thiazole-2-yl)-5-(p-tolyl)-1H-pyrazol-3(2H)-one - 16c, exhibited superior activity against the S. aureus strain with an of MIC 0.025 mM among all tested compounds,', '', 'new derivatives of benzothiazole were synthesized and evaluated for their antimicrobial activity and ability to inhibit the DHPS enzyme. According to the finding, three compounds, 16a-c: 4-(Benzo[d]thiazole-2-yl)-5-(4-florophenyl)-1H-pyrazol-3(2H)-one (16a), 4-(Benzo[d]thiazole-2-yl)-5-(4-chlorophenyl)-1H-pyrazol-3(2H)-one (16b) and 4-(Benzo[d]thiazole-2-yl)-5-(p-tolyl)-1H-pyrazol-3(2H)-one (16c) had IC50 values comparable to the standard drug and revealed that compound 16b was the most active compound with an IC50 value of 7.85 microg/mL, which is comparable to that of sulfadiazine (standard drug) with an IC50 value of 7.13 microg/mL.', 36551457),
('Thiazolidine derivatives two analogue series of thiazolidine-2,4-dione and 4-thioxo-thiazolidin-2-one', 'The most active derivatives showed MIC between 1', 'None of the thiazolidine derivatives was cytotoxic for human peripheral blood mononuclear cells (PBMC) with IC50 > 100 microg ml?1, but showed moderate cytotoxicity for L929 fibroblasts.', 'The 5-(3,4-dichlorobenzylidene)-4-thioxothiazolidin-2-one (2b) was the most active derivative against Staph. aureus and showed higher selective indices.', 36000385),
('The anhydride of ferrocenyl-substituted pyrazole, namely, (S)-(3-(3-(carboxyamino)-3H-pyrazol-4-yl)cyclopenta-1,3-dien-1-yl)(cyclopenta-1,3-dien-1-yl)iron was synthesized using expansion cyclocondensation.', 'The newly designed compound was elevated for their antimicrobial potential against S. aureus and K. pneumoniae bacterial stains. The inhibitory action of the compound was measured in terms of zone of inhibition and MIC values were found in the range of 85', '', 'This study described the novel method for the synthesis of biologically active anhydride of ferrocenyl-substituted pyrazole. It is effective by DNA photo-cleaving, and anti-angiogenic activities of ferrocenyl-substituted compounds were studied. In addition, it may open new doors to initiate research against drug resistance bacteria with possible biomedical applications.', 35949692),
('novel honokiol derivatives (3?,5-Di(prop-2-en-1-yl)[1,1?-biphenyl]-2,4?-diol) as mimics of antimicrobial peptides (AMPs).', 'These mimics showed potent antimicrobial properties against Gram-positive bacteria. killed bacteria rapidly by interrupting the bacterial membrane', 'weak hemolytic and cytotoxic activities.', 'exhibited excellent antibacterial activity, rapid bactericidal properties, avoidance of antibiotic resistance, These results highlight the potential derivative to be used as therapeutic agents', 35820350),
('Guanylated Hyperbranched Polylysines (HPL-Gxs)', 'The antibacterial activities of HPL1-6 polymers were also determined against two clinically-relevant Gram-negative bacteria (E. coli and P. aeruginosa) and three Gram-positive bacteria (Methicillin-resistant Staphylococcus aureus (MRSA), Methicillin sensitive S. aureus (MSSA) and B. subtilis) . HPL1-6 had strong antibacterial activities against E. coli, P. aeruginosa, MRSA, MSSA, and B. subtilis, and their MICs were in the range of 12', 'hyperbranched polylysines(HPLs) and guanidinium-functionalized derivatives(HPL-Gxs) are hydrophilic and have high selectivity over rabbit red blood cells (RBCs), low toxicity to mammalian cells, and good in vitro and in vivo biocompatibility.', 'HPLs and HPL-Gxs interact with and lysis the cell membranes of microbes, which can mitigate the development of drug resistance.', 35775877),
('small molecules based on a triazine-piperazine-triazine scaffold that mimic the cationic amphipathic structure of AMPs', 'compounds showed potent biofilm inhibitory and eradicating activities against multidrug-resistant Pseudomonas aeruginosa (MDRPA).', '', 'these compounds displayed synergistic or additive effects when combined with selected clinically used antibiotics. Furthermore, these compounds have been proven to inhibit pro-inflammatory cytokine. our results demonstrate the potential of the designed compounds as a novel class of multifunctional antimicrobial agents to combat bacterial infection.', 36103802),
('Enterobactin-Muraymycin Conjugate( siderophore enterobactin (Ent) and its novel biomimetic derivative (AcO)EntKL.)', 'result for MraY inhibition by (AcO)EntKL-SS-9 (IC50=89', '', 'Both muraymycin analogue 9 and its enterobactin conjugate (AcO)EntKL-SS-9 displayed remarkably strong inhibitory potencies against the bacterial target protein MraY in vitro. Conjugate (AcO)EntKL-SS-9 showed a pronounced improvement (ca. 11-fold) of antibacterial activity against the efflux-deficient E. coli deltatolC strain relative to 9. This provided a proof-of-concept that siderophore conjugation might become a valuable approach to enhance the antibacterial activities of MraY-inhibiting nucleoside antibiotics such as 9 against Gram-negative pathogens.', 36222466),
('sialic acid derivatives', 'compound 3f exhibited a 180-fold affinity increase of binding for PmSiaT. Compound 3e showed the highest affinity for SaSiaT, that is, a 31-fold increase. Compound 3f finds ideal fits of both the phenyl ring and the two bromo atoms in the P. mirabilis SiaT site, which may, at least partly, explain the high affinity of compound 3f for this protein.', '', 'compounds 3e and 3f induce a delay in bacterial growth to different extents, with the most pronounced results on S. aureus. Compounds 3e and 3f represent promising leads toward the development of compounds with a new antibacterial mode of action.', 35675124),
('novel biphenyl-benzamides', '3-({4''-chloro-2''-methyl-[1,1''-biphenyl]-3-yl}methoxy)-2,6-difluorobenzamide (compound 30) exhibited excellent antibacterial activities, especially against four different Bacillus subtilis strains, with an MIC range of 0.008 microg/mL to 0.063 microg/mL. B subtilis ATCC9372 MIC = 0.016microg/mL, B subtilis 168 MIC= 0.008 microg/mL, B subtilis MG27 MIC= 0.031 microg/mL and , B subtilis BS01 MIC = 0.016 microg/mL', '3-({4''-chloro-2''-methyl-[1,1''-biphenyl]-3-yl}methoxy)-2,6-difluorobenzamide (compound 30) also showed good pharmaceutical properties with low cytotoxicity (CC50 > 20 microg/mL), excellent human metabolic stability (T1/2 = 111.98 min)', '3-({4''-chloro-2''-methyl-[1,1''-biphenyl]-3-yl}methoxy)-2,6-difluorobenzamide (compound 30) also showed good pharmaceutical properties with low cytotoxicity, excellent human metabolic stability , moderate pharmacokinetics and in vivo efficacy, which can be identified as a promising FtsZ inhibitor worthy of further profiling. Targeting at the cytoskeletal cell division protein filamenting temperature-sensitive mutant Z (FtsZ) has been validated as an effective and promising approach for antibacterial drug discovery.', 35763867),
('new aminonaphthol derivatives substituted with 2- and 1-naphthol were synthesised.', 'Derivative Compounds 13 and 14 could inhibit the efflux pump system in susceptible and methicillin-resistant Staphylococcus aureus strains.', '', 'The compounds have also been tested in bacteria in order to reduce or reverse antibiotic resistance. Application of partially aromatic ortho-quionone-methides for the synthesis of novel naphthoxazines with improved antibacterial activity', 35472850),
('novel triazole-isatin derivatives', 'All the 10 derivatives of isatin demonstrated good antimycobacterial activity with MIC ? 6.25 microg/ml. Compound 5h C17H13N5O2 displayed good antimycobacterial activity with MIC of 0.8 microg/ml', 'good safety profile with higher selectivity index with HEK293 cell line.', 'The triazole-isatin derivatives showed significant binding interactions with amino acid residues in the active site of the enzyme. These studies revealed that molecule 5h could act as a potential lead molecule for further studies to find new target-directed molecules.', 35434882),
('siderophore-linked ruthenium catalysts', 'effevtive against E. coli', 'the low cytotoxicities of Moxi, C-moxi and especially Ru-s4 with IC50 values greater than 100 microM for two tested mammalian cell lines displayed little toxicity', 'A series of siderophore-linked ruthenium catalysts were investigated for prodrug activation. conjugates containing siderophore units based on catechol and azotochelin were found to be most promising for intracellular prodrug activation.', 36355416),
('synthesis of endogenous host defense peptides (HDPs)', 'Mocetinostat has been identified as the most potent HDP inducer among all hits identified in this study. It specifically inhibits (histone deacetylase) HDAC1-3 and HDAC11, but with a negligible effect on other HDACs. ( E. coli (ATCC 25922) and Salmonella Enteritidis (ATCC 13076) )', 'Mocetinostat was first evaluated for its ability to promote AvBD9 mRNA expression in a different chicken macrophage cell line, HD11 [40]. As expected, it showed an obvious dose-dependent AvBD9 induction.', 'HDPs are capable of killing a broad spectrum of pathogens through membrane-lytic mechanisms.They have identified multiple classes of HDP inducers, and further characterization of these compounds has led to the identification of mocetinostat as the most potent. With mocetinostat shows promise for further development as a novel antimicrobial agent for disease control and prevention, with minimal risk of triggering resistance.', 35955551),
('caffeic acid (CA)', 'The MIC of CA against E. coli strains ranged from 250 to 500 microg/ml, and the MBC was 500 microg/ml. For K. pneumoniae strains, the MIC of CA was 500 microg/ml, whereas the MBC was from 500 to 1000 microg/ml. P. aeruginosa strains showed less sensitivity to CA, as compared to other Gram-negative bacteria, as a result of MIC being at 1,000 mg/ml and MBC being at 1,000 to 2,000 microg/ml. As bacteria that induce bovine mastitis, S. aureus strains presented a similar sensitivity to CA, with MIC and MBC ranging from 250 to 500 microg/ml.', '', 'CA eradicates bacterial activity by disrupting both biofilm formation and the adhesion/internalization of the host', 36341408),
('5-amino-4-quinolone agent', '5-amino-4-quinolone 111 with exceptionally potent Gram-positive activity with minimum inhibitory concentrations (MICs) ?0.06 microg/mL against numerous clinical isolates.', 'the lead compound is nontoxic displaying a therapeutic index greater than 500, is devoid of hemolytic activity, and has attractive physicochemical properties (clog P = 3.8, molecular weight (MW) = 441)', 'studies demonstrate that the 5-amino-4-quinolones are bacteriostatic. further investigation of this promising antibacterial scaffold for the treatment of Gram-positive infections.', 36219779),
('Rhodanine is a 5-membered heterocyclic organic compound possessing a thiazolidine core', 'Rhodanine and Its Related Heterocyclic Compounds: 2a', '', 'They are reported to alter the function of DNA gyrase B, metallo-beta-lactamases, penicillin binding protein (PBP), Mur ligases, RNA polymerase, Enoyl ACP reductases, 1-deoxy-d-xylulose-5-phosphate reductoisomerase. etc which are vital in bacterial growth, survival and replication.', 35714172),
('new membrane-active nonivamide and capsaicin derivatives as peptidomimetic antimicrobials.', 'Derivative Compound 51 exhibited potent antibacterial activity against both Gram-positive bacteria (MICs = 0.39', '51 Show with low hemolytic activity and low cytotoxicity', 'This Compound 51 displayed a faster bactericidal action through a membrane-disruptive mechanism and avoided bacterial resistance development. Furthermore, compound 51 significantly reduced the microbial burden in a murine model of keratitis infected by Staphylococcus aureus or Pseudomonas aeruginosa. Hence, this design strategy can provide a promising and effective solution to overcome antibiotic resistance.', 36510819),
('synthesized quinolinequinones (QQs) with N-phenylpiperazine (QQ1-7)', 'This derivative compound QQ3 and QQ4 were the most active molecules against Staphylococcus aureus (ATCC', '', 'In this study, they investigated the bactericidal effects of QQ3 against methicillin-resistant Staphylococcus aureus (MRSA) and Candida albicans strains. The findings of this study suggest that a significant bactericidal effect was seen. Our findings present significant implications for an antimicrobial drug candidate for treating infections, especially those caused by clinically resistant MRSA isolates.', 35921788),
('conjugates of colistin (CT) and hyaluronic acid (HA)', '', 'The resulting systems also reduced conjugates of colistin CT nephrotoxicity by 20', 'These new conjugates of CT with HA are promising for the development of nanodrugs for safe and effective antimicrobial therapy.', 35724903);
INSERT INTO `bacteria_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('cationic antibacterial polytriazoles', 'P2TD and P2CD had MICs of 256 and 64 microg/mL against K. pneumoniae, respectively; while in the case of P. aeruginosa the observed MIC values were lower, but in the same direction, that is, 128 and 32 microg/mL, respectively. When the length of the side chains was increased from one to four carbon atoms, P3TD improved its MIC (4 microg/mL) against the same strains. The P5TD polymer had MIC values of 256 microg/mL and 128 microg/mL against E. faecium and MRSA, respectively. In the case of the P5CD polymer, the MIC was somewhat lower, at 64 microg/mL, against both Gram-positive strains. K. pneumoniae presented high MIC values (> 1024 microg/mL) against polycationic polymers with hydrophilic branches (P5TD and P5CD)', '', 'the resulting cationic polymers are antibacterial and active against different ESKAPE pathogens. Polymers carrying ethylene glycol (more hydrophilic) and heptyl (more lipophilic) side chains were found to have milder antibacterial activity. The P3TD polymer has highest antibacterial activity against bacteria in the tested ESKAPE group, although it also had a high hemolytic activity. Methylated polymers (P2CD and P2TD) have a better balance between hydrophilicity and hydrophobicity, since they had good antibacterial properties and acceptable biocompatibility with hRBC and HGnF. Several polytriazoles have been synthesized containing the same main chain but differing in their side chains.The interaction of these polytriazoles with the Escherichia coli membrane produces both depolarization and disruption of the membrane.', 36432710),
('novel 4-isocyanophenylamides', 'new weapon against methicillin resistant Staphylococcus aureus infections with MIC of 4 micro mol', 'safe against mammalian keratinocyte and osteoblast at 128 micro mol', 'we identified ** compound 42 as lead compound. It has shown a potent antimicrobial activity and the ability to block the biofilm formation.', 36462437),
('alkynyl isoquinoline antibacterial compounds, synthesized via Sonogashira coupling', 'HSN584 and HSN739 exhibited moderate antibacterial activity (MIC range = 4', '', 'We showed that the lead compounds can significantly reduce the burden of intracellular MRSA and discovered that S. aureus exhibited a low potential for resistance development against our lead compounds. Our preliminary studies showed that the alkynyl isoquinoline molecule exerted its antibacterial activity through inhibiting three major bacterial processes, DNA synthesis, RNA synthesis and cell wall synthesis. In our future studies, we will seek to evaluate the exact mechanisms by which the alkynyl isoquinoline inhibit these processes. Our findings highlight alkynyl isoquinoline scaffolds as ideal lead molecules for the discovery of potent antibacterial agents.', 36014324),
('phenyl oxime derivative: Unique iminotetrahydroberberine-corbelled metronidazoles', 'This compound displayed a broad antibacterial spectrum with a quite low MIC value of 0.024 mM against P. aeruginosa, being 63-, 62- and 2-fold to berberine, metronidazole and norfloxacin, respectively.', 'The active compound 8e with low cytotoxicity under effective bacteriostatic concentration', 'This compound could disturb the bacterial membrane to lead to the leakage of cellular contents, thus exerting potent antibacterial potency. It was also revealed that compound 8e could interact with penicillin binding protein via multi-site non-covalent binding in docking simulation. The above results manifested that iminotetrahydroberberine-corbelled metronidazoles might bring hope for the exploitation of new broad-spectrum antibacterial agents with a membrane-destruction mechanism.', 36182008),
('Novel phenylhydrazone-based oxindole-azoles', 'oxindole-thiolimidazole derived carboxyphenylhydrazone ** 4e exhibited an 8-fold stronger inhibitory ability than norfloxacin on the growth of P. aeruginosa, with MIC value of 1 microg/mL.', '', 'This compound could destruct bacterial cytoplasmic membrane, causing the leakage of cellular contents (protein and nucleic acid) cause death of bacteria. Furthermore, molecule 4e existed supramolecular interactions with DNA to block DNA proliferation. These research results provided a promising light for phenylhydrazone-based oxindole-thiolazoles as novel potential antibacterial agents.', 35716514),
('A series of new 3-(2-(3-(substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline (9a-i) derivatives have been synthesized.', '3-(2-(3-(substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline (9a', 'Cytotoxicity tests of 3-(2-(3-(substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline (9a', 'a series of 3-(2-(3-(substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline, (9a', 36570236),
('Tricyclic pyrrolopyrimidines (TPPs)', 'With growth-inhibitory activity in the 0.02 to 0.2 microM range, TPP8 exhibited a markedly higher potency. These results indicate that TPP8 is broadly active against the M. abscessus complex and displays potent antimycobacterial activity.', '', 'the tricyclic pyrrolopyrimidine TPP8 is active against M. abscessus in vitro, ex vivo, and in a mouse model of infection and exerts its antimicrobial activity by inhibiting the B subunit of DNA gyrase. This work adds a new lead compound to the preclinical M. abscessus drug pipeline and provides an attractive chemical starting point for an optimization program aiming at improving oral bioavailability.', 36005813),
('pyrazinoic acid analogs( Ring substitution, carboxyl isosteres, ring isosteres)', 'pyrazinoic acid analogs represents as potential antimycobacterial agents for first-line TB treatment against Mycobacterium tuberculosis (Mtb)', '', 'report that analogs with ring and carboxylic acid bioisosteres did not significantly enhance the antimicrobial activity, whereas the alkylamino-group substitutions at the 3 and 5 position of POA were found to be up to 5 to 10-fold more potent than POA. Further development and mechanistic analysis of these analogs may lead to a next generation POA analog for treating TB.', 36228522),
('Brominated furanone (BMF), a halogenated furanone compound', 'Brominated furanone (BMF), a halogenated furanone compound we propose that BMF can effectively inhibit E. coli QS by disrupting the bacterial biofilm and downregulating QS gene expression to reduce the bacterial resistance,', '', 'Brominated furanone (BMF), a halogenated furanone compound is a new type of quorum-sensing inhibitor that can inhibit bacterial quorum sensing and reduce bacterial resistance. This provide a direction for the development of novel antibacterial drug', 36201068),
('MMV688845 (Nalpha-2-thiophenoyl-d-phenylalanine-2 morpholinoanilide) Compound', 'MMV688845 is active against all three M. abscessus subspecies (M. abscessus subsp. abscessus, M. abscessus subsp. massiliense, and M. abscessus subsp. bolletii). We found MMV688845 to be active against intracellular M. abscessus with an MIC90 of 16 microM', 'Female CD-1 mice (n = 2) were weighed and received a single dose of MMV688845 orally (p.o.) (25 mg/kg of body weight) show good efficacy.', 'The lead compound MMV688845, a substance active against M. abscessus complex, was characterized in depth. In various assays, it showed activity against M. abscessus, synergy with other antibiotics, and bactericidal effects.', 36377951),
('Gallium(III)-pyridoxal thiosemicarbazone derivatives', 'gallium(III) complexes show potential antimicrobial activity against different strains of Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa and show minimmum inhibitory concentration.', 'no cytotoxicity was detected in eukaryotic cells.', 'Ga(III) complexes were evaluated by UV/Vis spectroscopy. The compounds are active against resistant Gram-negative strain with minimal inhibitory concentration in the microM range, while no cytotoxicity was detected in eukaryotic cells. Hence can be use in future', 36073748),
('Halogenated Pyrrolopyrimidines with Synergistic Effects with an Antimicrobial Peptide', 'The derivatives with an MIC < 64 mg/L were then subjected to additional MIC profiling towards S. aureus in combination with the antimicrobial peptide. The most active bromo and iodo derivatives had MIC of 8 mg/L.', '', 'A hydroxyl group on the meta- or para position of the 6-aryl unit was found crucial for activity, and heavy halogens (bromo and iodo) in the 4-benzylamine group was strongly potency inducing. Interestingly, when the most potent derivatives were evaluated in combination with the antimicrobial peptide betatide, a four-fold decrease in the MIC value was obtained, a strategy which might be promising for avoiding resistance.', 35892374),
('alkynyl-containing maleimide derivatives', 'maleimide core led to new compounds with potent activity against Mycobacterium tuberculosis (MIC < 1 microg/mL). Among them, compound 29 not only possessed good activity against extensively drug-resistant TB', 'low cytotoxicity (IC50 > 64 microg/mL) and favorable hepatocyte stability', 'This study lays a good foundation for identifying new alkynyl-containing maleimides as promising leads for treating drug-resistant TB.', 36423487),
('Pyrrole-2-carboxamide Derivatives as Mycobacterial Membrane Protein Large 3 Inhibitors', 'Compound showed potent anti-TB activity (MIC < 0.016 microg/mL). Compound 32 displayed excellent activity against drug-resistant tuberculosis, good microsomal stability, almost no inhibition of the hERG K+ channel', 'low cytotoxicity (IC50 > 64 microg/mL)', 'the target of the pyrrole-2-carboxamides was identified by measuring their potency against M. smegmatis expressing wild-type and mutated variants of the mmpL3 gene from M. tuberculosis (mmpL3tb) and determining their effect on mycolic acid biosynthesis using a [14C] acetate metabolic labeling assay. The present study provides new MmpL3 inhibitors that are promising anti-TB agents and good in vivo efficacy.', 35915958),
('endocannabinoid Anandamide (N-arachidonoylethanolamine; AEA)', 'when AEA was combined with methicillin MET, there was a gradual decrease in the CFUs reaching a 85', '', 'AEA was found to inhibit membrane ATPase activity that is necessary for transmembrane transport. AEA caused a reduction in murein hydrolase activities involved in daughter cell separation. Altogether, this study shows that AEA affects several biochemical processes that culminate in the sensitization of the drug-resistant bacteria to antibiotics.', 35887146),
('benzimidazole derivatives.', 'Compound III showed a potent activity against tolC-mutant Escherichia coli with an MIC value of 2 microg/Ml. *compound 25d displaying the highest potency among the tested compounds with an MIC value of 0.125 microg/mL. compound 25d demonstrated superior activity to the lead compound III.', 'compound 25d exhibited an excellent safety profile without any significant cytotoxicity to mammalian cells', 'compund 25d exhibited a bacteriostatic activity and significantly reduced E. coli JW55031 burden. This compound act as a promising candidate for treatment of Gram-negative bacterial infections', 36584632),
('Hydroxamic Acid Compounds', 'Concentrations of Compound 4 and 6 were used from a range of 0.5 microM to 100 mM to gain IC50 values for Inhibition of Metallo-beta-Lactamase from Bacillus anthracis', '', 'Compounds 4 and 6 may be useful drug candidates as well as lead compounds for further development.', 36012433),
('Cuminaldehyde Guanylhydrazone Disinfectant', 'Shoe effective against toxin-producing E. coli (STEC) isolates', '', 'this study contributes to our understanding of the mode of this disinfectant action and facilitates our effort to better use disinfectants for STEC treatments.', 36356001),
('LEGO-Lipophosphonoxins', 'derivative compound 25 was the best performer with MIC 1', '25 and 38 The compounds were tested at concentrations of 20 and 200 mg/L in both tests. For potential skin irritability, we used the reconstructed human epidermis model test (RhEM). (37) For potential eye irritability, we used the reconstructed human cornea-like epithelium (RhCE) . In both tests, LEGO-LPPOs performed excellently, showing no detrimental effects', 'We tested in detail several selected LEGO-LPPOs, of which the two most promising compounds, 25 and 38, were tested most thoroughly. Of these two compounds, 25 showed a higher therapeutic potential due to its low cytotoxicity.', 35839126),
('stereoselective epoxidation of chlorotonils and epoxide ring opening derivatives', 'Chlorotonil A displays very pronounced activity against several Gram-positive pathogens, including Staphylococcus aureus (minimum inhibitory concentration, MIC=0.006 microg mL?1) and Streptococcus pneumoniae (MIC=0.0125 microg mL?1). Equipotent activity is also observed with P. falciparum 3D7 where 1 a and 1 b showed IC50s of 0.1 microM and 0.06 microM, respectively. The new derivative **2b suppress growth of multidrug resistant Gram-positive bacteria and P. falciparum in the nanomolar range, but it also showed an increased aqueous kinetic solubility at pH 7.4 (16.2 microM) by more than 200-fold compared to 1 (0.073 microM).', '', 'demonstrated superiority of 2 b against S. aureus when compared to the parent chlorotonil A in vivo. 2 b retained nanomolar activity while being stable in vivo as well as having a significantly improved aqueous solubility and did not result in resistant S. aureus colonies', 35485800),
('three newly designed hydroxyquinolines derived from sulfanilamide (1), 4-amino benzoic acid (2) and sulfanilic acid (3)', 'sulfanilamide Compounds (1) and sulfanilic acid (3) showed the best binding scores towards PDB ID: 1ZI0/3VOB and 1JIJ/4CJN', '', 'Our in silico results suggest that sulfanilamide (1) or sulfanilic acid (3) hydroxyquinoline derivatives have the potential to be developed as bacterial inhibitors, particularly MRSA inhibitors.', 36399018),
('cephalosporin derivatives with cyclic disulfide modifications', 'we could demonstrate the successful reduction of biofilm formation for Staphylococcus aureus and Pseudomonas aeruginosa', '', 'We propose that the incorporation of cyclic disulfides is one additional strategy to improve antibiotic activity and to combat bacterial infections.', 36251034),
('WYBQ-4 compound', 'WYBQ-4 had strong antibacterial activity against methicillin-susceptible Staphylococcus aureus (MSSA) 29213 (MIC, 0.5 microg/mL), MRSA USA300 (MIC, 8 microg/mL), methicillin-resistant Staphylococcus epidermidis (MRSE) 12228 (MIC, 4 microg/mL), and methicillin-susceptible Staphylococcus epidermidis (MSSE) 35984 (MIC, 0.5 microg/mL). WYBQ-4 was also found to be active against Streptococcus pyogenes (MIC, 1 microg/mL)', 'hemolytic activity was measured using rabbit and goat red blood cells. WYBQ-4 did not show hemolytic activity in the concentration range of 0 to 512 microg/mL. The cytotoxicity of WYBQ-4 against A549, HEK-293T, and HepG2 cells using (MTT) assay, and the results showed that the cells were still viable at concentrations of 8 times the MIC against MRSA USA300', 'these results suggest that WYBQ-4 is suitable for the treatment of pneumonia and systemic infections caused by MRSA.', 36098533),
('pinocembrin chemical compound', 'The minimal inhibitory concentration and minimum bactericidal concentration were 256 microg/mL and 512 microg/mL, respectively against Aeromonas hydrophila is a common pathogen in fish', '', 'When bacteria were treated with 512 microg/mL pinocembrin, lactate dehydrogenase activity and soluble protein content decreased significantly, and electrical conductivity and DNA exosmosis levels increased by 4.21 ', 35438439),
('Short Tryptamine-Based Peptoids', 'N-(2-(1H-indol-3-yl) ethyl)-2,5-diguanidino-N-(naphthalen-2-ylmethyl) pentanamide (TFA salt) (20a) and (S)-N-(2-(1H-indol-3-yl) ethyl)-2-amino-N-(naphthalen-2-ylmethyl)-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl) sulfonyl) guanidino)pentanamide (22). The most active compounds against Staphylococcus aureus S.aureus 38 were 20a and 22 with MIC = 3.9 microg mL?1 and 5.5 microg mL?1, respectively. . Compound N-(2-(1H-indol-3-yl) ethyl)-4-amino-N-(naphthalen-2-ylmethyl) butanamide (TFA salt) 12c and N-(2-(1H-indol-3-yl) ethyl)-4-guanidino-N-(naphthalen-2-ylmethyl) butanamide (TFA salt) 13c were the most active against E. coli, with MIC > 12 microg mL?1.', 'hemolysis studies toward horse red blood cells showed that the potent compounds are non-toxic at up to 50 microg mL?1.', 'Based on the results of the cytoplasmic membrane permeability assay, the compounds may exhibit membrane damage mechanisms that are similar to most AMPs. These peptoids showed very good antibacterial activity in microbial keratitis bacterial strains which are resistant to ciprofloxacin. These short peptoids are worthy of further development in order to understand their mechanism of action on Gram-positive and Gram-negative bacterial strains.', 36009943),
('Compounds from the Chembridge DIVERSet library were tested', 'based on the physiochemical analysis and molecular docking studies, the benzamide inhibitors have been identified against alpha-subunit of tryptophan synthase (alpha-TRPS) of Mtb, showing bactericidal activity at 6 microg/Ml. The research on the biological activity of beta-arabino glycosyl sulfones against M. bovis BCG revealed sulfone compounds as potential inhibitors of mycobacterial cell wall biosynthesis', '', 'In time-kill dynamic studies, it was found that co-treatment promoted increased bacterial clearance when compared with the antibiotic or compound group alone. This study describes promising anti-NTM ( non-tuberculous mycobacteria) and anti-Mtb compounds with potential novel mechanisms of action that target intracellular bacteria in activated macrophages.', 36144572),
('A Hydrazine-Hydrazone Adamantine Compound', 'A Hydrazine-Hydrazone Adamantine showed an MIC of 0.2 microg/mL for M. tuberculosis, 0.3 microg/mL for M. bovis BCG, 1.5 microg/mL for M. smegmatis, and 12.5 microg/mL for M. abscessus and M. marinum. It showed an MBC of 0.6 microg/mL for M. bovis BCG and 3 microg/mL for M. smegmatis. We also carried out MIC testing of this compound on S. aureus and E. coli but there was no inhibition at concentrations up to 25 microg/mL, showing that the activity of A Hydrazine-Hydrazone Adamantine compound is likely specific to mycobacteria.', 'cytotoxicity of this compound against two types of human cells lines, SH-SY5Y and HEK 293T, using the tetrazolium reduction assay (MTT). This Compound did not show any significant cytotoxicity up to a concentration of 50 microg/mL and protected Galleria mellonella larvae against M. bovis BCG infection', 'These results suggest that A Hydrazine-Hydrazone Adamantine Compoundis a promising anti-TB agent with the potential to improve TB treatment in combination with standard TB therapies.', 36296721),
('Oxazolidinone TBI-223', 'the preclinical efficacy of TBI-223 (80 and 160 mg/kg twice daily) was compared with that of linezolid (40 and 80 mg/kg twice daily) in mouse models of MRSA bacteremia, skin wound infection, and orthopedic-implant-associated infection.', 'examined the efficacy of TBI-223 in comparison with linezolid in multiple MRSA infection models in mice. We found that TBI-223 had efficacy comparable to that of linezolid in mouse models of bacteremia, nondiabetic and diabetic skin wound infection, and OIAI. bone marrow toxicity was significantly lower in TBI-223-treated mice than in linezolid-treated mice,', 'a new oxazolidinone named TBI-223 was tested against S. aureus in three mouse models of infection, i.e., bloodstream infection, skin infection, and bone infection. We found that TBI-223 was as effective as linezolid in these three models. Previous data suggest that TBI-223 has a better safety profile than linezolid. Taken together, these findings indicate that this new agent may provide an additional option against MRSA infections.', 36106881),
('nusbiarylin derivatives', 'Nusbiarylin derivatives displayed excellent antibacterial activity against various clinical methicillin-resistance Staphylococcus aureus (MRSA) and vancomycin-resistance S. aureus (VRSA) strains. The minimum inhibitory concentration (MIC) **compound 22r was lowered to 0.5 microg/mL, comparable to marketed antibiotics.', '', 'Diverse mechanistic studies validated the capability of** 22r inhibiting the function of NusB protein and bacterial rRNA synthesis. In silico study of drug-like properties also provided promising results. Overall, this series of derivatives showed potential antimicrobial activity', 35580381),
('Potential Inhibitor (MCULE-8777613195-0-12 available at the MCULE purchasable database) of New Delhi Metallo-beta-Lactamase-1 (NDM-1)', '', 'he in vitro enzyme kinetics showed that the catalytic efficiency (i.e., kcat/Km) of NDM-1 on various antibiotics decreased significantly in the presence of MCULE-8777613195-0-12, due to poor catalytic proficiency (kcat) and affinity (Km). The IC50 value of MCULE-8777613195-0-12 (54.2 microM) was comparable to that of a known inhibitor, i.e., D-captopril (10.3 microM).', 'An analysis of the binding pose revealed that MCULE-8777613195-0-12 formed four hydrogen bonds with the catalytic residues of NDM-1 (His120, His122, His189, and Cys208) and interacted with other key residues. Molecular dynamics simulation and principal component analysis confirmed the stability of the NDM-1 and MCULE-8777613195-0-12 complex. MCULE-8777613195-0-12 may serve as a scaffold to further design/develop more potent inhibitors of NDM-1 and other beta-lactamases.', 36144666),
('Povarov-Doebner derived compounds - HSD 1919', 'Compounds from the Povarov derived SF5-containing compounds inhibited both clinical and laboratory strains of Gram-positive bacteria at minimum inhibitory concentration (MIC) of 0.5 microg/mL to 2 microg/mL. Bithionol (at 1 microg/mL) or nitroxoline (at 4 microg/mL) did not appreciably disperse pre-existing biofilms but when combined with HSD 1919 or HSD 1835 (at 0.5', '', 'mechanistic studies showed inhibition of DNA, RNA, cell wall and protein synthesis in a macromolecular biosynthesis assay indicating that these compounds inhibit bacteria via multiple mechanisms, which is now being appreciated as an effective way to tackle resistant bacteria. Toxicity studies showed that HSD 1919 was nontoxic in-vitro to mammalian red blood cells at 10X MIC. we report HSD 1919 and analogs thereof as critical chemical scaffolds, which can be harnessed to develop highly potent antibiofilm therapeutics.', 35793578),
('Derivatives of Trimethoxybenzoic Acid and Gallic Acid', 'derivative 10 displayed antibacterial activity against the S. aureus 272123 and S. Typhimurium strains, of 100 and 50 microM, respectively. **derivatives 5 and 6 showed the ability to inhibit EPs in the acrA gene inactivated mutant Salmonella enterica serovar Typhimurium SL1344, and 6 also inhibited EPs in Staphylococcus aureus 272123.', '', 'Structure-activity relationships highlighted trimethoxybenzoic acid as important for EP inhibitory activity. Although further studies are necessary, these results show the potential of simple trimethoxybenzoic acid derivatives as a source of feasible EP inhibitors.', 36430942),
('Cephem-Pyrazinoic Acid Conjugates', 'The POA conjugates CS-POA and CM-POA exhibited activity commensurate with POA against M. tuberculosis H37Rv with MIC90 100 microg/mL.', '', 'These conjugates are selectively active against M. tuberculosis and related mycobacteria, and activity is retained or even potentiated in multiple resistant strains and models.', 35697660),
('a novel vancomycin derivative Vb was constructed by conjugation of triazolylthioacetamide and vancomycin molecules', 'The highest dose of Vb (4 microg/mL) resulted in a maximum 128-fold MIC decrease in the antibiotics against S. aureus and MRSA, respectively, and a dose of 16 microg/mL Vb resulted in a 128-fold MIC decrease in cefazolin against VRE. Vb also increased the antimicrobial effect of all tested beta-lactams against K. pneumoniae, resulting in a 16', '', 'The MIC data indicated that Vb gradually increased the antimicrobial effect of all tested beta-lactams with an increasing dose and exhibited a dose-dependent synergistic antibacterial effect against the eight resistant strains. The biological assays showed that Vb had effective antibacterial activity against S. aureus and MRSA, but low antimicrobial activities against Gram-negative K. pneumoniae. This work offers a promising scaffold for the development of metallo-beta-lactamases MbetaLs inhibitors, specifically antimicrobials for clinically drug-resistant isolates.', 36431786),
('novel beta-lactamase inhibitor combination imipenem/XNW4107', 'XNW4107 in combination with imipenem exhibited potent in vitro activity against carbapenem-resistant bacteria and particularly against carbapenem-resistant Acinetobacter baumannii. MIC90 of imipenem/XNW4107 against imipenem-nonsusceptible A. baumannii (n = 106) was 8 mg/L, MIC90 of imipenem/XNW4107 against imipenem-resistant Klebsiella pneumoniae (n = 54) was 2 mg/L. Hence Imipenem/XNW4107 was bactericidal against A. baumannii, K. pneumoniae, and Escherichia coli.', '', 'XNW4107 is a novel beta-lactamase inhibitor that possesses broad activity against serine-beta-lactamases. Imipenem/XNW4107 provided good protection against imipenem-resistant A. baumannii and K. pneumoniae in vivo', 35820591),
('potential roles of montmorillonite (Mt) minerals', 'the potential roles of montmorillonite (Mt) in the emergence of ARGs under divalent cadmium ion (Cd2+) stress, Escherichia coli (E. coli) was induced continuously for 15 days under Cd2+ gradient concentrations (16, 32, 64, 96, and 128 microg?mL?1) with and without Mt.', '', 'the study promoted the understanding of Cd2+ in triggering bacterial antibiotic resistance', 35864327),
('developed a ligand-based workflow based on the chemical structures of nusbiarylins', 'As a result, four compounds, including J098-0498, 1067-0401, M013-0558, and F186-026, were identified as potential antimicrobials against S. aureus, with predicted pMIC values ranging from 3.8 to 4.2.', '', 'The docking study showed that these molecules bound to NusB tightly with the binding free energy ranging from -58 to -66 kcal/mol.', 36613782),
('modification on the rifamycin ansa?chain ( 25-O-acyl rifabutin )', 'show potency against M. abscessus upto 17nM', '', 'Structure?based derivatization at the C?25 position of rifabutin afforded analogs that are more than a hundred?fold more potent than the widely used rifampicin and are no longer susceptible to the primary rifamycin resistance in M. abscessus through ADP?ribosylation', 36222275),
('OPS-2071 fluoroquinolone-based compound,', 'he antibacterial activity of OPS-2071 was more potent against Gram-positive bacteria and Campylobacter jejuni, including quinolone-resistant strains.', '', 'The broad and potent in vitro antibacterial activity and lower risk of drug resistance suggested that OPS-2071 may be useful for enteric infections caused by major pathogens including quinolone-resistant Campylobacter.', 36101508),
('N-quinazolinone-4-hydroxy-2-quinolone-3-carboxamides', 'identified AG-690/11765367, or f1, as a novel and potent inhibitor of the target protein (IC50: 1.21 microM) . * f1 is more potent than the others in terms of antibacterial activity against MRSA (MICs: 4-8 microg/mL)', 'non-toxic to HUVEC and HepG2 (CC50: approximately 50 microM), and metabolically stable (t1/2: > 372.8 min for plasma; 24.5 min for liver microsomes).', 'this study showed that the discovered N-quinazolinone-4-hydroxy-2-quinolone-3-carboxamides are novel GyrB-targeted antibacterial agents; compound **f1 is promising for further development.', 36278813),
('synergism of orbifloxacin (orb) and propyl gallate (pg).', 'The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of ORB against the E. coli KVCC 1423 resistant strain were 128 microg/ml and 256 microg/ml, respectively. However, the MIC of ORB for the remaining E. coli strains was 0.5 microg/ml', 'The cell viability of the combination was > 80%. The combination of PG and ORB showed the ability to confront bacterial mobility without having any harmful effects on the cell.', 'In conclusion, we demonstrated the antibacterial activity of PG and the combination of PG with ORB against E. coli in vitro. PG could inhibit bacteria growth in both cases, both individually and in combination with ORB. Furthermore, the efficacy of the drugs enhances and MICs reduce when combined; thus, showing a synergistic effect. The combination inhibited E. coli biofilm development.', 36188537),
('chalcone-alkyl-lysine compounds', 'Compound 6d displayed potent antibacterial activity against Gram-positive bacteria (Staphylococcus aureus and Enterococcus faecalis) and Gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa), with MICs of 1', 'compound 6d did not exhibit any observable toxicity in HeLa and HEK293 cells at 8 ', 'ompound 6d destroys bacterial cell membranes by interacting with phosphatidylglycerol (PG), causing the production of reactive oxygen species (ROS) and the leakage of nucleic acids, resulting in bacterial death. As a result, the findings suggest that compound 6d has potential therapeutic effects against bacterial infections and could be a promising drug candidate for future research.', 36334451),
('Pyridine-Carbohydrazides', 'compound 6 had potent activity against four MDR strains of Candida spp., with minimum inhibitory concentration (MIC) values being in the range of 16-24 microg/mL and percentage inhibition up to 92.57%', '', 'Overall results suggest that these compounds have the potential to become promising antimicrobial drugs against MDR strains.', 36615406),
('oxadiazolones as a novel antibacterial chemotype', 'Benzyl (4-(5-methoxy-2-oxo-1,3,4-oxadiazol-3(2H)-yl)-2-methylphenyl)-carbamate 1 was most potent with an MIC of 6.25 microM (2.2 microg/mL). N-(4-(5-methoxy-2-oxo-1,3,4-oxadiazol-3(2H)-yl)-2-methylphenyl)-3-phenoxy-benzamide 3 as our lead compound with a 16-fold improvement in potency against both MRSA USA300 (MIC = 0.8 microM, 0.3 microg/mL) and S. aureus ATCC 29213 (MIC = 1.6 microM) compared to hit 1 in MRSA', 'Time-kill experiments also showed that 3 killed 99% of bacteria within 24 h, starting from a 106 CFU/mL inoculum. Furthermore, 3 exhibits low cytotoxicity selectivity ratio HEK293T/MRSA USA300 = 10.5, HepG2/MRSA300 = 20.3) and is nonhemolytic', 'we here disclose oxadiazolones as a new chemotype with antibiotic activity against S. aureus strains including drug-resistant isolates. A medicinal chemistry program combined with chemical proteomics led to the identification of potent antibacterial compound 3 capable of interacting with multiple bacterial cysteine and serine hydrolases in a covalent manner.', 36584241),
('novel clarithromycin derivatives incorporating 1,2,3-triazole moieties at the 4?- and 11-OH positions.', 'study of bactericidal kinetics, we can conclude that compound 8f had a concentration- and time-dependent effect on the proliferation of Staphylococcus aureus ATCC43300', 'the results of the cytotoxicity assay showed that **compound 8f exhibited no toxicity', 'These compounds were generally 64- to 128-fold more active than azithromycin, and 32- to 128-fold more active than clarithromycin. The predicted ClogP data suggested that higher values of ClogP (>6.65) enhanced the antibacterial activity of compounds', 35841669),
('novel reversible pyrrolidinedione-based MurA inhibitors', 'The overall most potent of these compounds was inhibitor 46 with an IC50 value of 4.5 microM against wild type MurA. Remarkably, 46 inhibited the clinically relevant fosfomycin-resistant MurA mutant C115D with equal potency (IC50 = 4.9 microM)', 'A standard MTT assay revealed that compounds 7 and 46 were nontoxic when applied to HepG2 (human liver carcinoma cell line) and the nontumor cell line MRC-5 . The stability of MurA inhibitor 46 was assessed in human S9 liver microsomal fraction.', 'A drastic decrease in the IC90 value of 46 was observed, which was dependent on the concentration of PMBN, reaching 2.3 microM at 6 microg/mL of Polymyxin B nonapeptide (PMBN)', 36269107),
('neolignan-AMP mimic conjugates', 'compound III5 exhibited the most potent antibacterial activity and a broad inhibition spectrum toward three G+ bacteria, S. aureus, E. faecalis, and M. luteus, and one G', '', 'Mechanism studies reveal that III5 and III15 exhibit rapid bactericidal effects through binding to the phosphatidylglycerol (PG) and cardiolipin (CL) of the bacterial membrane, thereby disrupting the cell membranes and allowing increased reactive oxygen species (ROS) as well as protein and DNA leakage. The results indicate that these neolignan-AMP mimic conjugates could be promising antimicrobial candidates for combating MRSA infections.', 36512751),
('novel series of 3-(7-nitro-3-oxo-3,4-dihydroquinoxalin-2-yl)propanehydrazide derivatives', 'compounds 6d and 6e displayed MIC values of 9.40 and 9.00 microM, respectively, regarding S. aureus, and 4.70 and 4.50 microM, respectively, regarding S. pneumonia in comparison to ciprofloxacin (12.07 microM).', 'The cytotoxicity of compounds 6d and 6e were performed on normal human WI-38 cell lines with IC50 values of 288.69 and 227.64 microM, respectively assuring their safety and selectivity. Both compounds were found to be safer on the liver and kidney', 'This derivative required for DNA gyrase inhibition are enough for exerting promising antimicrobial activities, but also derivatization with diverse aryl/hetero aryl aldehydes is essential for their enhanced antimicrobial potential.', 36215786),
('novel pleuromutilin derivative - 22-(2-(2-(4-((4-(4-nitrophenyl)piperazin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)acetamido)phenyl)thioacety-l-yl-22-deoxypleuromutilin (Z33)', 'The MIC values of Z33 against four S. aureus strains ranged from 0.125 to 0.25 microg/mL.', 'Toxicity determination showed that both Z33 and tiamulin displayed low cytotoxicity of RAW264.7 cells. Z33 was found to be a high-security compound with a 50% lethal dose (LD50) above 5000 mg/kg in the acute oral toxicity test in mice', 'In an in vivo antibacterial activity test, Z33 displayed better therapeutic effectiveness than tiamulin in the neutropenic mouse thigh infection model. In summary, Z33 was worthy of further development as a highly effective and safe antibiotic agent against MRSA infection.', 35956888),
('Ginkgetin- C32H22O10', 'This study showed that Gin treatment significantly inhibited the formation of E. coli ATCC 25922 in a dose-dependent manner (Figure 2A, p < 0.0001). As low as 6.25 microM of Gin was also found to be effective against the formation of biofilm (inhibition rate > 20%).', 'Gin showed no cytotoxic effect at 50 microM or lower concentrations, and cytotoxicity appeared at 100 microM and 200 microM (p < 0.05 and p < 0.0001, respectively).', 'These results showed that Gin could inhibit biofilm without affecting bacterial growth and metabolic activity. Besides, Gin inhibited the bacteria motility, EPS production, and QS of E. coli. These results indicate that Gin was an effective antibiofilm compound which can combine with marketed antibiotics to treat drug resistance caused by biofilms to treat E. coli infections in the future.', 35955943),
('Flavaspidic acid BB combined with mupirocin', 'The results showed that the FICI value range of the combined use of BB and mupirocin was 0.30 ', '', 'After drugs treatment, the drug-combination showed significantly inhibitory effects on the metabolic activity and total biomass in each stage of biofilm formation. The synergistic effect is likely related to the adhesion between bacteria. Hence study provides the experimental data for the use of BB for the clinical treatment of skin infections and further demonstrate the potential of BB as a novel biofilm inhibitor.', 35840879),
('1,3-diamino-7H-pyrrolo[3,2-f]quinazoline PQZ compounds Derivative, OYYF-171, -172, and -175', 'The PQZ derivatives OYYF-171, -172, and -175 displayed potent antibacterial activities against A. baumannii, with MICs of 0.5', '', 'we identified three PQZ compounds, OYYF-171, -172, and -175 that could serve as the leading compounds for drug development against MDR-AB.', 36500701),
('two pyrazole derivatives, (1H-pyrazol-1-yl) methanol 1-hydroxymethylpyrazole (SAM1) and 1,1''methandiylbis (1H-pyrazol) (AM1), , with sorbitan monolaurate (polysorbate 21, Tween 21, T21)', 'The addition of T21 resulted in the obvious decrease in mean MIC values from 177.7 to 55.5 microg/mL for SAM1 microg/mL and from 311.1 to 144.4 microg/mL for AM1, respectively cause higher rate of reduction in S. aureus ATTC 33952 cell viability', '', 'The association of T21 with SAM1 and AM1 increased the MIC efficacy of AM1 and SAM1. The time-kill dynamics confirmed the MIC results, and the combination of SAM1 and AM1 with T21 accounted for a significant increase in the killing rate in S. aureus and E coli. . This could widen the range of adjuvants in applications which would be useful in the control of resistant microorganisms.', 36551246),
('plumbagin (PGN)', 'Plumbagin inhibited the growth of all tested isolates- MDR Gram-negative (Escherichia coli, Klebsiella pneumoniae, Salmonella Typhi, and Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus [S. aureus], Staphylococcus saprophyticus [S. saprophyticus], Streptococcus pyogenes, and Enterococcus faecalis), with S. saprophyticus exhibiting the highest sensitivity. MIC values ranged from 0.029 to 0.117 microg/mL whereas MBC ranged from 0.235 to 0.94 microg/mL, with 79% to 99% growth inhibition.', '', 'all tested isolates showed a marked decrease in biofilm formation, with S. saprophyticus and S. aureus being the most sensitive. Plumbagin is a stand-alone, broad spectrum antibacterial with promising potential against the rising threat of antimicrobial resistance.', 36379534),
('phenylhydrazine derivatives', 'Derivative 4-cyanophenylhydrazine with potent inhibitory activity against carbapenem-resistant A. baumannii BAA-1605, with minimum inhibitory concentration (MIC) of 0.25 microg/ml and highest selectivity index of 640. The compound also demonstrated potent inhibition against multidrug-resistant A. baumannii isolates (MIC: 0.25-1 microg/ml)', '', 'The identified 4-cyanophenylhydrazine compound exhibited synergistic activity with amikacin, tobramycin and polymyxin B against carbapenem-resistant A. baumannii BAA-1605.', 36326019),
('3-alkylpyridine-bearing alkaloid analogs', 'compound 6 showed promising antibacterial activity against Staphylococcus with minimum inhibitory concentration (MIC) ranging from 0.98 to 3.9 microgmL-', '', 'Compound 6 had the ability to damage the bacterial membrane and induce cell lysis and, due to its action on the membrane, showed low resistance induction potential in vitro.', 35636092),
('O-Eugenol', 'O-eugenol presented a MIC of 1024 microg/mL against S. aureus', 'The D. melanogaster mortality and geotaxis assays revealed the compound is toxic, with an EC50 of 18 microg/mL within 48 hours of exposure.', 'conclude that the tested product has an efflux pump inhibitory effect, further studies are needed to elucidate its mechanisms of action', 35909475),
('hecogenin acetate', 'hecogenin acetate showed minimal inhibitory concentration against strains of E. coli, P. aeruginosa and S. aureus', '', 'In the evaluation of the potentiating activity of the antibiotic action, a greater antagonistic behavior is noticed. In the analyzes performed with the efflux pump, it was noticed that the hecogenin acetate does not interfere in the efflux pump mechanism of the analyzed bacteria.', 36462578),
('Synergistic Effect of Quercetin on Antibacterial Activity of Florfenicol', 'the MIC value of florfenicol against A. hydrophila was observed to be 2.5 microg/mL, and it was 360 microg/mL for quercetin. When quercetin was combined with florfenicol, the fractional inhibitory concentration (FIC) was 90 + 0.078 microg/mL. In particular, quercetin increased the sensitivity of A. hydrophila to florfenicol from 2.5 microg/mL to 0.078 microg/mL against A. hydrophila', '', 'quercetin and florfenicol had an obvious synergistic activity in vivo, reducing the bacterial load in the liver, spleen and kidney tissues of Cyprinus carpio up to 610.6-fold compared with the florfenicol group, and improving the survival rate of infected fish from 10% in the control group to 90% in drug combinations group. These findings indicated that quercetin could potentiate the antibacterial activity of florfenicol against A. hydrophila infection and may reduce the use of antimicrobial drugs and improve the prevention and control capability of bacterial resistance.', 35884183),
('colistin-EDTA combination', 'The adjuvant-EDTA was discovered to have inhibitory effects on ColRkp at concentrations of 3-24 mg/mL and colistin-EDTA combination displayed substantial synergistic effects (FICI ? 0.5) on all tested 45 ColRkp (carbapenem-resistant Klebsiella pneumoniae)isolates', '', 'colistin-EDTA combination therapy in this study produced potent synergistic effects in both in vitro and in vivo murine bacteremia, with no ColRkp regrowth and improved animal survival, implying the significance of colistin-EDTA combination therapy as systemic therapy for unlocking colistin resistance in ColRkp-associated bacteremia. (carbapenem-resistant Klebsiella pneumoniae )', 35902639),
('a series of quaternary ammonium cationic compounds with various linkers were designed', 'The best compound, 3e, has good antibacterial activity against Staphylococcus aureus [minimum inhibitory concentration (MIC = 1 microg/mL)]', 'least hemolytic toxicity [hemolytic concentration (HC50 = 905 microg/mL)], is stable in mammalian body fluids, and rarely induces bacterial resistance.', 'This effectively reduce the load of methicillin-resistant Staphylococcus aureus (MRSA) in mouse skin and has a higher in vivo bactericidal efficiency than vancomycin. These findings highlight the significance of divergent linkers in quaternary ammonium cations as antimicrobial peptide mimics and the potential of these cations to treat bacterial infections.', 36549113),
('Pyroligneous Acid (PA)', '', '', 'The addition of PA could improve silage quality and reduce ARG pollution in alfalfa silage. This study can provide useful information for understanding and controlling ARG pollution in animal production.', 35862964),
('poly-lactic acid coating incorporating antibiotic loaded coralline bioceramic on Ti6Al4V implant', 'After 24 h, S. aureus biofilm formation and the percentage of live cells found on the surfaces of all 5%-30% (w/w) PLA-Gm-(HAp-Gm) coated Ti6Al4V implants was lower than the control samples.', '', 'These results support the use and application of the antibacterial PLA-Gm-(HAp-Gm) thin film coating design for implants, as an antibiotic release control mechanism to prevent implant-related infections.', 36205495),
('Relebactam (REL)', 'Relebactam (REL) has the potency to recover antimicrobial activity against carbapenem-resistant Enterobacterales that has porin deficiency.', '', 'The Cefmetazole-CMZ acquisition of resistance was also suppressed by the concomitant use of REL and actually suppressed the decrease in mRNA expression in ompF. It was confirmed that porin reactivated by REL.', 36237294),
('bismuth complexes of general formula BiLCl2, where L is a thiosemicarbazone bearing a quinoline moiety', 'Quinoline-2-carboxaldehyde-N4-phenyl-3-thiosemicarbazone bismuth dichloride and carbapenem showed synergism in a dose dependent manner with the minimum inhibitory concentration (MIC) of meropenem lowered down 128 folds up to 2 microgmL-1, a concentration lower to the sensitivity level.', 'The IC50 of the compound against A549 human lung carcinoma cells and HuDe human epithelial tissue was 46.96 ', 'Result indicating that a structural optimization of the compounds is needed.', 35690039),
('Colistimethate sodium-chitosan hydrogel', 'Active against both ATCC (American Type Culture Collection) strains and clinical isolates of Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumoniae.', '', 'The CMS incorporated hydrogel is also capable of inhibiting the biofilm formation. The developed hydrogel can be potentially being used for the treatment of Gram-negative bacterial infected wounds.', 35752341),
('biphasic calcium sulphate/hydroxyapatite (CaS/HA) biomaterial as a carrier for dual delivery of RIF with vancomycin (VAN) or gentamicin (GEN).', 'Only combinations of CaS/HA-VAN/GEN + RIF exhibited antibacterial and antibiofilm effects yielding no viable bacteria at study endpoint. The S. aureus strains developed resistance to RIF when biofilms were subjected to CaS/HA-RIF alone but not with CaS/HA-VAN/GEN + RIF.', 'Our in vitro results indicate that biphasic CaS/HA loaded with VAN or GEN could be used as a carrier for RIF for local delivery in clinically demanding bone infections.', '', 36349950),
('polythiophene (PT10), a cationic polymer', 'polythiophene (PT10), a cationic polymer, was capable of both broad-spectrum photo-antimicrobial activity (Gram positive, Gram negative, Fungal, and cyano-bacteria) and broad pH responsiveness. The half-maximal inhibitory concentrations (IC50) of PT10 for bacteria living in acidic, neutral, and alkaline media were generally lower than 2 microg mL-1 (except M. aeruginosa, pH 12, ?30 microg mL-1), which were much lower than common antibiotics and other photosensitizers.', '', 'PT10 was explored for the successful in vivo therapy of oral Candidiasis infection under extreme acidic conditions (pH < 3) and the removal of M. aeruginosa at pH 12. Such near full pH, broad-spectrum photo-antimicrobial activity of polythiophene is appealing for extremely acidic or alkaline applications, such as oral infections, vaginitis, and blooms.', 35723511),
('recombinant glycoside hydrolases (GHs) in combination with antibiotics', 'recombinant glycoside hydrolases (GHs) that degrade Pel and Psl were evaluated alone and in combination with antibiotics in a mouse model of P. aeruginosa infection.', '', 'Combining GH prophylaxis and treatment with the antibiotic ciprofloxacin resulted in greater reduction in pulmonary bacterial burden than that with either agent alone. This study lays the foundation for further exploration of GH therapy in bacterial infections.', 35862738),
('N-arylimidazolium an antimicrobial peptide (AMP) Biomimetic Antimicrobial Agents', 'The excellent antibacterial activity could be observed for 1Br.R3 bearing hexyl groups with the respective MIC of 0.5, 0.25, and 1 microgram/mL for MRSA, S. aureus, and E. coli. Methicillin-resistant Staphylococcus aureus (MRSA)-induced lung-infected mice can be effectively treated by the intravenous administration of N-arylimidazolium AMP mimic', '', 'These N-arylimidazolium AMP mimics show potent antibacterial activity against strains along with a low rate of drug resistance, good hemocompatibility, and low cytotoxicity.', 35930690),
('Check three artificial sweeteners, saccharin, cyclamate and acesulfame-K (ace-K)', 'A minimum inhibitory concentration (MIC) assay was performed for both pathogens - A. baumannii AB5075 and P. aeruginosa PA14, with ace-K concentrations ranging from 0.09 to 7.08%. A significant reduction in growth could be distinguished at 0.89% ace-K for A. baumannii', '', 'Ace-K - Acesulfame potassium (IUPAC ID: potassium 6-methyl-2,2-dioxo-2H-1,2?6,3-oxathiazin-4-olate) can inhibit a range of virulence traits such as biofilm formation, motility and natural transformation. It weakens the bacterial cell membrane leading to loss of morphology and bulge-mediated cell lysis. It can also potentiate the activity of antibiotics including carbapenems. Ace-K shows clinical potential as a topical wound therapeutic.', 36412260),
('novel [1,2,5]oxadiazolo[3,4-b]pyrazine-containing compound', 'minimal regrowth concentration (MRC) = 0.25- 1 micro gram per ml against S. Typhimirium, K. Pneumunia, A. baumannii, P aeroginosa and E coli', '', 'These results demonstrated these compounds as a novel class of resistance-modifying agents (RMAs) and may be further developed as therapeutic agents.', 35788034),
('Coumarin thiazoles derivative', 'methyl oxime V-a exerted potent inhibitory efficacy against methicillin-resistant Staphylococcus aureus (MRSA) at low concentration (1 microg/mL) and showed broad antimicrobial spectrum.', 'active molecule V-a exhibited low toxicity toward mammalian cells', 'compound V-a was able to damage the integrity of membrane to trigger leakage of protein, insert into MRSA DNA to block its replication and induce the generation of reactive oxygen species (ROS) to inhibit bacterial growth. Hence molecule V-a was favorable to exert high antimicrobial activity.', 35576797),
('novel linear polyamines', 'Both AHA-1282 and AHA-1268 displayed an MIC of 32 microg/ml, a greater than eightfold increase in activity whereas AHA-1394 displayed the most potent anti-staphylococcal activity with an MIC of 2 microg/ml, a greater than 64-fold increase in activity.', '', 'we show that AHA-1394 displays a particular proclivity for antibiotic potentiation, restoring sensitivity of MRSA and VRSA isolates to daptomycin, oxacillin and vancomycin. Together this study shows that polyamine derivatives are impressive drug candidates', 36071957);
INSERT INTO `bacteria_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Halogenated Indoles derivatives', 'the MIC of the compounds- 7 brominated indoles, 2 fluorinated indoles, 3 iodinated indoles, 4 chlorinated indoles, and 1 multiple halogenated indole. is above 200 microM, whereas the virulence inhibitory concentration is 20 microM or lower against V. campbellii toward gnotobiotic brine shrimp. 7-fluoroindole inhibited biofilm formation at a concentration of 500 microM and blood hemolysis at a concentration of 100 microM in Pseudomonas aeruginosa; 7-iodoindole and 7-chloroindole inhibited biofilm formation at a concentration of 10 microg/mL (about 40 to 60 microM), bacterial motility at a concentration of 50 microg/mL (about 200 to 300 microM), and protease activity at a concentration of 10 microg/mL in V. parahaemolyticus', '', 'ndole signaling is a valid target for the development of novel therapies to control disease caused by Vibrio campbellii and related bacteria, which are among the major bacterial pathogens in aquaculture. this is the first study of the structure-activity relation of halogenated indole analogues with respect to virulence inhibition of a pathogenic bacterium in an in vivo host model system.', 36154441),
('N-isopropyloxalyl hydroxamate (IpOHA) and aspterric acid', 'N-isopropyloxalyl hydroxamate (IpOHA) and aspterric acid are both potent inhibitors for both SaDHAD[Staphylococcus aureus Dihydroxy-acid dehydratase (Ki =7.8 and 51.6 microM, respectively)] and CjDHAD[Campylobacter jejuni Dihydroxy-acid dehydratase (Ki =32.9 and 35.1 microM, respectively)]', '', 'These compounds thus present suitable starting points for the development of novel anti-microbial chemotherapeutics.', 35535733),
('Dihydroxyphenyl-substituted thiosemicarbazone', 'The novel thiosemicarbazones specifically inhibit NDM-1 and ImiS, with an IC50 in the range of 0.37', '', 'Partial thiosemicarbazones enhanced the antimicrobial activity of Meropenem on E. coli-ImiS and E. coli-NDM-1. A thiosemicarbazone in combination with Meropenem significantly reduced the bacterial load in liver and spleen of mice.', 35717802),
('quinolinequinones', 'QQ6 exhibited the best (27-fold more potent) anti-E. faecalis activity with a MIC value of 4.88 microg/mL, which was superior to the standard drug amikacin (MIC = 128 microg/mL). On the other hand, QQ3 was the second most active one of this series against E. faecalis (13-fold more potent than amikacin with a MIC value of 9.76 microg/mL).', '', 'This compound show biofilm inhibition and effective against gram psotive, negative as well as show potency against fungi also', 36290056),
('A peptide-based copolymer, poly[phenylalanine10-stat-lysine12]-block-3,4-dihydroxy-l-phenylalanine [Poly(Phe10-stat-Lys12)-DOPA]', 'The poly(Phe10-stat-Lys12)-DOPA polymer showed good antibacterial activity with minimum inhibitory concentrations against S. aureus and E. coli of 32 and 400 microg/mL, respectively.', '', 'In vivo experiments confirmed that this poly(Phe10-stat-Lys12)-DOPA coating can both effectively prevent biofilm formation through surface contact sterilization and avoid local and systemic infections.', 36549042),
('ruthenium-based complexes', 'In vitro antimicrobial screening demonstrated that four complexes could absolutely inhibit the growth of Staphylococcus aureus (S. aureus) with MIC values ranging from 15.6 to 100 microg/mL. The most active complex Ru(?)-1 (MIC = 15.6 microg/mL) could kill S. aureus through targeting the membrane', 'based on the mouse model of S. aureus skin infection, Ru(?)-1 showed important antibacterial efficacy against S. aureus in vivo, and almost non-toxic against mouse tissue.', 'The results revealed that Ru(?)-1 could inhibit the biofilm formation and alpha-hemolysis secretion in S. aureus at subinhibitory concentration. More interestingly, the combination use of Ru(?)-1 and five traditional antibiotics showing synergistic effect. study indicates that introducing membrane targeting ligands onto ruthenium complexes may be an underappreciated strategy for developing antibacterial agents.', 35635951),
('PGLb1 and PGLb2', 'substantially reduced the level of antibiotic resistance of multi-drug resistant Escherichia coli, Klebsiella pneumoniae and Shigella flexneri clinical isolates', '', 'These findings indicate that manipulating bacterial membrane electrophysiology could be a valuable tool to overcome antimicrobial resistance.', 35127141),
('KBP-7072', 'It inhibited the growth of all isolates at 4 mg/liter, including 372 carbapenem-resistant isolates, 37 tigecycline MIC ? 4 mg/liter isolates, and 138 omadacycline MIC ? 4 mg/liter isolates, KBP-7072 (MIC90, 1 mg/liter) outperformed 2-fold and 4-fold more activity against 536 A. baumannii isolates than tigecycline and omadacycline,', '', 'This study has shown excellent in vitro activity of KBP-7072 against clinical A. baumannii isolates collected from different regions of China, regarded as supplementary to KBP-7072 pharmacodynamics data, which is of great significance, as it is promising an alternative treatment in CRAB isolates infections in China.', 35138143),
('Bacillus licheniformis (B. licheniformis) and Bacillus subtilis (B. subtilis)', 'Bacillus licheniformis (B. licheniformis) and Bacillus subtilis (B. subtilis) proved to be anti-inflammatory and had an antioxidant effect under certain treatment combinations, and further effectively inhibited the adhesion of pathogenic bacteria.', 'Interestingly, they had little effect on paracellular permeability.', 'Based on our results, Bacillus licheniformis and Bacillus subtilis are both promising candidates to contribute to the beneficial effects of probiotic multispecies mixtures.', 35630380),
('arene-ruthenium(II) complexes and their salts', 'Their antimicrobial activity (MIC, MBC/MFC) was examined in vitro against Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Pseudomonas aeruginosa, Proteus vulgaris and Candida albicans and compared with classic antibiotics used as therapeutics.', 'complexes 3a', 'We believe that arene-ruthenium(II) complexes and their salts presented herein offer great potential in the treatment of bacterial diseases, particularly among people affected by cancer or among patients after surgeries dealing with wounds that are difficult to heal.', 35056783),
('elasnin', 'superior activity in eradicating daptomycin-resistant MRSA strain biofilm, with a lower MBEC value of 0.625 Microgram/mL, compared to 2.5 Microgram/mL for the wild type', '', 'This study highlights the potential clinical application of elasnin through its superior biofilm eradication activity against a daptomycin-resistant MRSA strain, and revealed the associated processes governing this superior activity through proteomics analysis.', 35196789),
('cobalt-doped pomelo peel carbon composite (Co-PPCC)/ peroxymonosulfate (PMS) system', 'to remove TC (Tetracycline)', '', 'This study provides a new method to reuse abandoned pomelo peels and synthesize an economical and environmentally friendly catalyst for activating peroxymonosulfate to remove TC antibiotics in water.', 34767166),
('anthranilate', 'Acts as a Signal to Modulate Biofilm Formation, Virulence, and Antibiotic Tolerance of Pseudomonas aeruginosa and Surrounding Bacteria', '', 'this study shows that anthranilate can be used as an adjuvant to antibiotics.', 35019684),
('1,3,4-thiadiazole derivatives', 'exhibited antifungal activity against Rhizopus&amp;nbsp;oryzae; compounds with an imidazole moiety, such as the compound 7, were documented to have energetic antibacterial, antifungal properties', '', 'As a result of these findings, this research suggests that the synthesized compounds could be an excellent choice for controlling black fungus diseases.', 35684551),
('synthetic smectite clay minerals and Fe-sulfide microspheres', 'effective at killing the ESKAPE pathogens (Enterococcus sp., Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter sp., Pseudomonas aeruginosa and Enterobacter sp.)', '', 'Our results represent the first step in utilizing a geochemical process to treat antibiotic resistant topical or gastrointestinal infections in the age of antibiotic resistance.', 35075234),
('amphiphilic cationic polymers in combination with novobiocin', 'reduced the MIC which was less than 0.0625 Microgram/mL against E. coli', '', 'Furthermore, the results showed the possibility that the antimicrobial polymers serve not only as antibiotics to which bacteria have not developed resistance but also as adjuvants for other antibiotics.', 34559588),
('N-acyl-5-hydroxypyrazolines and N,N''-diacylhydrazines of 6-methyluracil thietanyl- and dioxothietanyl derivatives', 'MIC 0.1-10 Microgram/ml against S. aureus, E. coli, P. vulgaris, K. pneumoniae, C. diversus, E. aerogenes, P. aeruginosa, S. abosit', '', 'N-acyl-5-hydroxypyrazolines and N,N''-diacylhydrazines of 6-methyluracil thietanyl- and dioxothietanyl derivatives showed high antimicrobial activity, which is consistent with the results of structure activity relationship analysis.', 34636064),
('compound C-2', 'against both gram-positive and gram negative bacteria, and non mutagenic, displayed high antimicrobial potency against Gram-positive bacteria in a murine model', '', 'Thus, compound C-2 had great potential as a promising lead compound for the treatment of bacterial infection.', 35675753),
('L-valine with p-alkynylaniline (dipeptide mimetic 7)', 'MIC ranging from 2.5 to 5 Microgram/mLantibacterial activity against Gram-negative (Escherichia coli and Klebsiella pneumoniae), Gram-positive (Staphylococcus aureus) and drug-resistant bacterium MRSA (methicillin-resistant S. aureus) but also demonstrated high selectivity for S. aureus versus mammalian erythrocytes', '', 'The mimetics bear considerable potential to be used as antibacterial and anticancer agents to combat antibiotic resistance.', 34772526),
('multifunctional cationic alternating copolymers', 'against Staphylococcus aureus, Enterococcus faecalis, Pseudomonas aeruginosa, and Escherichia coli, but also reduced the number of biofilm cells even at low concentrations, without killing mammalian cells', '', 'These findings suggest that the multifunctional cationic nanopolymers have potential as a novel antibacterial agent for eradication of multidrug resistant bacterial infections.', 34920337),
('Fluorothiazinon (FT)', 'effectively suppressed the T3SS of Chlamydia spp., Pseudomonas aeruginosa, and Salmonella sp., inhibitory effect on A. baumannii biofilm formation', '', 'FT may be a promising candidate for the development of a broad-spectrum anti-virulence drug to use in the prevention of nosocomial infections.', 35064243),
('Compounds 5b (Z)-3-(3-hydroxyphenyl)-5-((1-methyl-1H-indol-3-yl)methylene)-2-thioxothiazolidin-4-one and 5g (Z)-3-[5-(1H-Indol-3-ylmethylene)-4-oxo-2-thioxo-thiazolidin-3-yl]-benzoic acid as well as 5h (Z)-3-(5-((5-methoxy-1H-indol-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)benzoic acid', 'against resistant strains MRSA, P. aeruginosa and E. coli and were found to be more potent than MRSA than reference drugs', '', 'Conclusion: Compounds 5b (Z)-3-(3-hydroxyphenyl)-5-((1-methyl-1H-indol-3-yl)methylene)-2-thioxothiazolidin-4-one and 5g (Z)-3-[5-(1H-Indol-3-ylmethylene)-4-oxo-2-thioxo-thiazolidin-3-yl]-benzoic acid as well as 5h (Z)-3-(5-((5-methoxy-1H-indol-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)benzoic acid can be considered as lead compounds for further development of more potent and safe antibacterial and antifungal agents.', 35164333),
('polylysines (C6-PLL13)', 'against Staphylococcus aureus (S. aureus) and methicillin-resistant Staphylococcus aureus (MRSA)', '', 'Moreover, C6-PLL13 demonstrated a significant therapeutic effect on an MRSA infection mouse model, which further proved that this synthetic polymer could be used as an effective weapon against bacterial infections.', 35050580),
('SAICAR Synthetase (PurC) from Mycobacterium abscessus', 'a promising target for novel antibiotics', '', 'This work utilizes a fragment-based design and demonstrates for the first time the potential to develop inhibitors against PurC from Mab.', 35037462),
('series of vinyl sulfones', 'to enhance their affinity for fungal ASADHs', '', 'The best inactivators will serve as lead compounds for the development of potent and selective antifungal agents.', 34469014),
('nitric oxide MBs (NOMBs)', 'NOMBs with sub-inhibitory antibiotic produced the most significant reduction in biofilm biomass, corresponding to a 99.9% (SD ', '', 'The results us offer new insight for the development of new clinical treatments, for example, in chronic wounds.', 35992170),
('Sodium Citrate', 'citrate in silico blocked the Pseudomonas QS receptors and downregulated the expression of QS-encoding genes', '', 'In conclusion, sodium citrate showed a significant ability to diminish bacterial virulence in vitro and interfered with QS; it could serve as a safe adjuvant to traditional antibiotic treatment for aggressive resistant bacterial infections such as Pseudomonas aeruginosa infections.', 35630488),
('Fenton-like process utilizing a hierarchical macro-mesoporous Co3O4-SiO2 (MM CS)', 'catalyst for activation of peroxymonosulfate (PMS) to inactivate ARB and degrade the intracellular ARGs', '', 'Collectively, this work demonstrated that the MM CS-based heterogeneous photo-Fenton-like process is a promising technology for controlling the spread of antibiotic resistance in aquatic environments.', 35149504),
('oxindole-thiolimidazole derived carboxyphenylhydrazone 4e', 'oxindole-thiolimidazole derived carboxyphenylhydrazone 4e exhibited an 8-fold stronger inhibitory ability than norfloxacin on the growth of P. aeruginosa, with MIC value of 1 Microg/mL', '', 'These research results provided a promising light for phenylhydrazone-based oxindole-thiolazoles as novel potential antibacterial agents.', 35716514),
('2-[(1E)-2-[4-(dimethylamino)phenyl]ethenyl]-1-methyl-4-(4-methylpiperidin-1-yl)quinolin-1-ium iodide', 'the inhibitors bearing a cyclic amine substituent at the 4-position of the quinolinium ring showed better antibacterial activity (MIC down to 0.25 Microg/mL) than that at the 2-position, especially against Gram-positive bacteria. A3 was identified to exhibit excellent antibacterial activity against S. aureus (MIC = 0.5-1 Microg/mL), S. epidermidis (MIC = 0.25 Microg/mL) and E. faecium (MIC = 1-8 Microg/mL).', '', 'A3 is thus a potent inhibitor of FtsZ and shows potential to be used as a new antibacterial agent against drug-resistant bacteria.', 35421657),
('Ti(deferasirox)2', 'exhibited promising inhibitory activity against the Gram-positive bacteria methicillin-resistant Staphylococcus aureus and minimal toxicity against human cells', '', 'The ability of this compound to undergo transmetalation with labile Fe(III) sources and, as a consequence, inhibit Fe bioavailability and ribonucleotide reductase is evaluated as a possible mechanism for its antibiotic effect.', 35203761),
('BDDE-Inspired Chalcone Derivatives', 'chalcones 13 and 14 showed promising antifungal activity against the dermatophyte clinical strain of Trichophyton rubrum, and all compounds reversed the resistance to vancomycin in Enterococcus faecalis B3/101, with 9, 14, and 24 able to cause a four-fold decrease in the MIC of vancomycin against this strain. Compounds 17-24 displayed inhibition of EPs and the formation of biofilm by S. aureus 272123', '', 'Overall, the results obtained suggest the potential of dihydrochalcones 16-18 and 22-24, and diarylpropanes 19-21, 25 and 26, as hits for bacterial EPs inhibition, as they are effective in the inhibition of EPs, but present other features that are important in this matter, such as the lack of antibacterial activity and cytotoxicity.', 35621966),
('6-bromo-2-naphthol (6B2N)', 'Pretreatment with 6B2N made A. baumannii cells more susceptible to PMB exposure indicating that it exhibits consequential synergistic action with PMB', '', 'The present findings provide a promising approach for utilizing plant extracts as adjuvants to reduce the toxicity of PMB in A. baumannii infection.', 35595766),
('Crizotinib', 'synergy with clindamycin and gentamicin. Importantly, the Gram-positive bacteria showed a low tendency to develop resistance to crizotinib.', '', 'Crizotinib is a promising antimicrobial agent and provides a novel choice for the development of treatment for Gram-positive infections.', 35674439),
('nusbiarylin derivatives', 'compound 22r exhibited the best antimicrobial activity with MIC of 0.5 Microg/mL', '', 'Overall, this series of derivatives showed potential antimicrobial activity and drug-likeness and provided guidance for further optimization.', 35580381),
('1,2,4-Triazole-3-Thione Analogues with a 2-Ethylbenzoic Acid at Position 4', 'as VIM-type Metallo-beta-Lactamase Inhibitors', '', 'Several compounds were shown to restore the beta-lactam susceptibility of VIM-type-producing E. coli laboratory strains and also of K. pneumoniae clinical isolates.', 35050549),
('Short Guanidinium-Functionalized Poly(2-oxazoline)s', 'Potent Therapeutic Efficacy on Drug-Resistant Fungal Infections', '', 'The easy synthesis and structural diversity of POXs imply their potential as a class of promising antifungal agents.', 35182092),
('vaccenic acid', 'at a sub-MIC concentration significantly inhibited the virulence production of C. violaceum (chitinase and motility) and MRSA (hemolysin and staphyloxanthin production)', '', 'The results of the present study suggest that vaccenic acid is a promising agent to combat C. violaceum and MRSA.', 35759150),
('fosfomycin, colistin, trimethoprim and nitrofurantoin', 'against MDR E.coli, FOS/COL, COL/NIT and COL/TRI combinations represent the most effective synergistic (fractional inhibitory concentration index <1) combinations against the seven strains at MICs lower than the susceptible breakpoint ranges, followed by FOS/NIT and FOS/TRI, which achieved synergistic interactions against 1/7 and 2/7 of these strains. Importantly, the bactericidal effects (reduction ?3', '', 'Our data suggested that FOS/COL, COL/NIT and COL/TRI combinations could be a promising option against MDR UPEC infections. Additionally, FOS/NIT and FOS/TRI probably represent a good option for MDR UPEC with lower MICs.', 34839528),
('reactive organic radicals and silver (Ag) cations-metal-organic frameworks (MOFs)', 'inhibited the growth of four common Gram-negative and Gram-positive human pathogens (Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis, and Staphylococcus aureus), and particularly two multi-drug-resistance bacteria (MRSA and MDR-PA)', '', 'This study unveiled the promising potential of Ag-MOFs for anti-infective therapies and future clinical applications.', 35231687),
('indole-incorporated coumarin thiazolidinone conjugate 14a', '14a showed a broad antibacterial spectrum and exerted potent inhibition efficiencies to the tested germs at low concentrations (0.25-2 Microg/mL), eradicate bacterial biofilm to avert developing drug resistance.', '', 'ADMET analysis manifested that 14a possessed promising pharmacokinetic properties.', 35168149),
('Arabinoxylan-Carboxymethylcellulose Composite Films', 'The AMK-loaded AX-CMC films exhibited controlled release of AMK, excellent antibacterial activity, and cytocompatibility.', '', 'Thus, the AX-CMC composite films appear to be promising bioactive dressing materials for the prevention of wound infections.', 35566937),
('diphenylurea (Compound 24)', 'Compound 24 was 5-times more potent than the lead compound in terms of MIC values, against MRSA and VRSA', '', 'Taken together, these results indicate that the diphenylurea scaffold merits further investigation as a promising anti-staphylococcal treatment option.', 35279608),
('Icariin in Combination with Amoxycillin-Clavulanate and Ampicillin', 'Increases Antibiotic Sensitivity and Growth Inhibition against Methicillin-Resistant Staphylococcus aureus', '', 'This study demonstrates the potential utility of icariin in permitting lower antibiotic therapeutic doses in alignment with strategies to reduce the spread of antibiotic resistance.', 35203835),
('Tricyclic beta-Lactam', 'against Carbapenem-Resistant Enterobacterales, Including Strains with Reduced Membrane Permeability and Four-Amino Acid Insertion into Penicillin-Binding Protein 3', '', 'This potent tricyclic beta-lactam is a promising drug candidate for infectious diseases caused by CREs due to its potent therapeutic efficacy in the neutropenic mouse lung infection model and low frequency of producing spontaneously resistant mutants.', 35112852),
('Eucalyptus globulus n-hexane', 'Lowest mean MIC (10.04', '', 'It was concluded that E. globulus n-hexane fraction exhibited significantly promising results against MRSA .', 35225296),
('polymyxin B/trimethoprim (PT) + rifampin', 'impressive efficacy toward P. aeruginosa keratitis', '', 'Conclusions: The drug combination of PT + rifampin was effective against a large panel of clinically relevant P. aeruginosa strains and, as such, may represent a promising therapeutic for P. aeruginosa keratitis.', 35612831),
('6-(1-Substituted pyrrole-2-yl)- s-triazine', 'potently inhibited the growth of Staphylococcus aureus regardless of its methicillin-resistant status, displaying minimum inhibitory concentration (MIC) values as low as 1 MicroM', '', 'Further development of these compounds as novel antimicrobial agents will be aimed at expanding our armamentarium of antibiotics.', 35239306),
('ibuprofen in combination with ciprofloxacin', 'Simultaneous treatment of bacterial cells with ibuprofen and ciprofloxacin significantly decreased bacterial biofilm formation (65%), The MIC of ibuprofen and ciprofloxacin were measured 2048 and 32 microg/mL and the drugs showed synergic antibacterial activity (FIC = 0.4) against P. aeruginosa.', '', 'This work suggests that ibuprofen has considerable anti-virulence potential against P. aeruginosa and could be employed for combination therapy with antibiotics after further characterizations.', 35657493),
('TP0586532', 'non-hydroxamate LpxC inhibitor, has in vitro and in vivo antibacterial activities against carbapenem-resistant Enterobacteriaceae, The MIC90 of TP0586532 against clinical isolates of carbapenem-resistant Klebsiella pneumoniae was 4 Microg ml-1.', 'showed an in vivo efficacy against murine systemic, urinary tract and lung infection models caused by meropenem- or ciprofloxacin-resistant strains. The estimated maximum unbound plasma concentration value at the effective dose of TP0586532 in murine infection models was around 13 Microg ml-1.', 'TP0586532 is predicted to exhibit a in vivo efficacy without cardiovascular toxicity and showed the potential of non-hydroxamate LpxC inhibitors as antibacterial agents against carbapenem-resistant Enterobacteriaceae.', 34837061),
('synergistic combination of allicin and selected antibiotics (levofloxacin, ciprofloxacin, oxytetracycline, rifaximin, ornidazole and azithromycin)', 'synergistic combinations showed significantly better (t-test p-value < 0.05) killing effect and biofilm reduction potential compared to their respective monotherapy application, where the highest killing effect was observed with rifaximin-allicin combination (kill rate was more than 5.5 h-1)', '', 'The potential of synergism between antibiotics and allicin combination demonstrated greater killing efficiency at significantly lower concentration compared to monotherapy with increased kill rates in all cases.', 35339353),
('Dicliptera roxburghiana', 'MIC values and zone of inhibition were measured and were found very effective for DRME, DRHF, DRCF and DREF while these were moderate for DRBF and DRAF. For antifungal assay, DRME and DRHF were potently active and showed more than 70% fungal growth inhibition where as DRCF and DRBF were also displaying appreciable inhibition.', '', 'Hence it can be concluded that plant contain some important compounds that can be used as antimicrobial source for the treatment of different infectious disease.', 35221269),
('Nevadensin', 'showed antibacterial activity against S. sanguinis with MIC and MBC values of 3750 and 15000 Microg/mL, respectively', '', 'Conclusion: Nevadensin showed potential as a new natural antibacterial agent by inhibiting the MurA enzyme rather than DNA gyrase.', 34238151),
('methyl oxime V-a', 'exerted potent inhibitory efficacy against methicillin-resistant Staphylococcus aureus (MRSA) at low concentration (1 Microg/mL) and showed broad antimicrobial spectrum', '', 'Computational study manifested that low HOMO-LUMO energy gap of molecule V-a was favorable to exert high antimicrobial activity.', 35576797),
('fascaplysin derivative 18', 'potent antimicrobial/antibiofilm activity against MRSA in vitro and in vivo, MIC value of 0.098 Microg/ml', '', 'All these results illustrate that fascaplysin derivative 18 is a strong and safe multi-target antibacterial agent, which makes it an attractive candidate for the treatment of MRSA and its biofilm infections.', 35007859),
('Diazabicyclooctane beta-Lactamase with combinations of amoxicillin (AMOX), imipenem (IMI), and cefuroxime (CXM)', 'The triple drug combinations of CXM-DUR-AMOX and IMI-DUR-AMOX were most potent, with MIC ranges of ?0.06 to 1 Microg/mL and an MIC50/MIC90 of ?0.06/0.25 Microg/mL, respectively.', '', 'The ability of DUR combined with amoxicillin or cefuroxime and imipenem to inactivate multiple targets such as d,d-carboxypeptidase and LdtMab2,4 supports new therapeutic approaches using beta-lactams in eradicating Mab.', 35073757),
('adamantane derivatives (compound 7)', 'potential anti-MDR agents', '', 'Finally, the in-silico analysis predicted that the most active derivatives had good drug-likeness and safe properties.', 35716118),
('analogue of robenidine (NCL179)', 'exhibits potent bactericidal activity, returning MICs/MBCs of 1-2 Microg/mL against methicillin-resistant Staphylococcus aureus, MICs/MBCs of 1-2 Microg/mL against methicillin-resistant S. pseudintermedius and MICs/MBCs of 2-4 Microg/mL against vancomycin-resistant enterococci', '', 'These results support NCL179 as a valid candidate for further development to treat MDR bacterial infections as a stand-alone antibiotic or in combination with existing antibiotic classes.', 35052942),
('phosphonamidates monoesters', 'Metallo-beta-Lactamase Inhibitor', '', 'We show phosphonamidates to have the potential to become a new generation of antibiotic therapeutics to combat metallo-beta-lactamase-resistant bacteria.', 35155946),
('cationic tetrahydroisoquinoline-triazole (compound 4b)', 'active against S. aureus at a low MIC of 2-4 Microg/mL, Hit compound 4b was also found to eliminate M. tuberculosis H37Rv at MIC of 6 Microg/mL.', '', 'These results identified compound 4b and its analogues as potential candidates for further drug development that could help tackle the threat of antibiotic resistance.', 35124457),
('o-hydroxy phenyl', 'o-hydroxy phenyl improved the inhibitory activity of Schiff bases on NDM-1. The inhibition mode assays including isothermal titration calorimetry (ITC) disclosed that both compounds 3 and 5 exhibited a reversibly mixed inhibition on NDM-1, with a Ki value of 1.9 and 10.8 microM, respectively. Antibacterial activity tests indicated that a dose of 64 microg', '', 'This study provided a novel scaffold for the development of NDM-1 inhibitors.', 35653899),
('Clemastine', 'Inhibits the Biofilm and Hemolytic of Staphylococcus aureus through the GdpP Protein', '', 'The discovery of this study identified novel use and mechanism of action of clemastine as a potential anti-biofilm drug for clinical application for S. aureus infectious.', 35234502),
('indole-2-carboxylates (InCs)', 'potential beta-lactamase stable beta-lactam mimics, new class of potent MBL inhibitor, active against all MBL classes of major clinical relevance, restore carbapenem activity against multiple drug-resistant Gram-negative bacteria and have a low frequency of resistance', '', 'InCs also have a good in vivo safety profile, and when combined with meropenem show a strong in vivo efficacy in peritonitis and thigh mouse infection models.', 34903857),
('2,4-disubstituted quinazoline analogs (Compound 12)', 'showed a 2-4 fold improvement in activity than I against S. aureus Newman, S. pneumoniae DSM-20566 and E. faecalis DSM-20478', '', 'The compounds also showed a good safety profile towards human HepG2 cells.', 35007723),
('series of bicyclic-oxazolidinone', 'against MDR strains', 'In vivo proof of concept was achieved in a A. baumannii mouse thigh infection model.', 'A novel series of bicyclic-oxazolidinone inhibitors of bacterial type II topoisomerase were identified which display potent broad-spectrum anti-bacterial activity, including against MDR strains, along with an encouraging in vitro safety profile.', 35231579),
('surfactin isoforms produced by Bacillus velezensis SK', 'The isolated surfactin exhibits good antimicrobial activity (1600 AU/ml) against drug-resistant food-born B. cereus and human pathogen Staphylococcus aureus.', '', 'Hence, identified strain B. velezensis SK and its potent antibacterial surfactin lipopeptide could be used in various food and biomedical applications.', 35084596),
('Cordycepin', 'antibacterial and anti-inflammatory effects on H. pylori-infected mice', 'against gastritis in Helicobacter pylori-infected mice', 'Cordycepin may serve as a potential candidate for developing a therapeutic regimen for H. pylori-induced gastritis.', 35191475),
('HSD 1919', 'Compounds from the Povarov derived SF5-containing compounds inhibited both clinical and laboratory strains of Gram-positive bacteria at MIC of 0.5 Microg/mL to 2 Microg/mL. Interestingly, the lead compound, HSD 1919 exhibited rapid bactericidal mode of action against multidrug resistant (MDR) staphylococcal and enterococcal strains such as MRSA and VRE via bacterial membrane disruption. Bithionol (at 1 microg/mL) or nitroxoline (at 4 Microg/mL) when combined with HSD 1919 or HSD 1835 (at 0.5-4 Microg/mL), preformed MRSA biofilms could be dispersed', '', 'Herein, we report HSD 1919 and analogs thereof as critical chemical scaffolds, which can be harnessed to develop highly potent antibiofilm therapeutics.', 35793578),
('BAY 11-7082 and its analogues synergize with penicillin G', 'inhibits the growth of P. aeruginosa and other priority pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). We synthesized 27 structural analogues, including a series based on the related scaffold 3-(phenylsulfonyl)-2-pyrazinecarbonitrile (PSPC), 10 of which displayed increased anti-Staphylococcal activity.', '', 'Finally, we showed that BAY 11-7082 and its analogues synergize with penicillin G against MRSA, suggesting that this scaffold may serve as an interesting starting point for the development of antibiotic adjuvants.', 34860493),
('Kanamycin, tobramycin and gentamicin coupled with the laccase substrate 2,5-dihydroxy-N-(2-hydroxyethyl)-benzamide', 'The coupling products showed comparable and, in some cases, better antibacterial activity than the parent antibiotics in the agar diffusion assay, and they were not cytotoxic.', 'The products protected mice against infection with Staphylococcus aureus, which was lethal to the control animals.', 'The results underline the great potential of laccases in obtaining new biologically active compounds, in this case new antibiotic candidates from the class of aminoglycosides.', 35336201),
('Cationic amphiphilic dendrons', 'Among these cationic amphiphilic dendrons, a prime candidate was identified, which possessed excellent antimicrobial activity against various pathogens (minimum inhibitory concentrations of 9, 3, and 3 microg mL-1 for Escherichia coli, Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus, respectively).', '', 'In general, the synthesized cationic amphiphilic dendrons, which exhibited rapid and broad-spectrum bactericidal activity, may have great potential in antimicrobial applications.', 34982090),
('Gemcitabine and Derivatives', 'Potent Inhibitors Against Multidrug-Resistant Staphylococcus aureus', '', 'For further improvement, we synthesized selen-containing gemcitabine that demonstrated relatively potent antimicrobial activity against several MDR MRSA in vitro.', 35723616),
('series of thiophene-benzenesulfonamide derivatives (compound 17b)', 'compound 17b, which had improved activity (MIC 0.023 Microg/mL) compared with the lead compounds, displayed good intracellular antimycobacterial activity in macrophages with a reduction of 1.29 log10 CFU', '', 'Therefore, compound 17b may be a promising antituberculosis lead for further research.', 35101648),
('Pyridine coupled pyrazole analogues', 'lethal weapon against MRSA, Among the synthesized compounds 6d exhibited good antibacterial activity with MIC value 21 Microg/mL', 'An in-vitro and in-silico approach', 'The docking study of the synthesized compound was carried out and the study depicted that the pyridine ring of all the analogues binds with the various amino acids in the binding pocket of the active site of the Staphylocoagulase and PBP2a protein of MRSA.', 35364241),
('bispolides C-E (1-3) (isolated from a fermentation broth of the actinomycete strain MG372-hF19)', 'compounds 1-3 exhibited antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci and cytotoxic activity against human cancer cell lines', '', 'Additionally, using a membrane-potential-sensitive fluorescence probe, we found that compounds 1-3 and elaiophylin have a similar effect on membrane potential in A549 human lung cancer cells.', 34873311),
('thirteen novel O-aryloxycarbonyl hydroxamates', 'inhibited imipenemase-1 (IMP-1) and New Delhi metallo-beta-lactamase-1, exhibiting an IC50 value in the range of 0.10-18.42 and 0.23-22.33 MicroM, respectively', '', 'This work provided a potent scaffold for the development of MbetaLs inhibitors.', 34862744),
('TP0586532 and meropenem', 'Novel Non-Hydroxamate LpxC Inhibitor potentiating Effect on In Vitro Activity of Meropenem against carbapenem-susceptible K. pneumoniae and E. coli', '', 'Our study revealed that a combination therapy consisting of TP0586532 and meropenem has the potential to be a novel therapeutic option for CRE infections.', 35647694),
('Nitroxoline and its derivatives', 'potent inhibitors of Carbapenemases such as metallo-beta-lactamases', '', 'Our findings demonstrate that nitroxoline derivatives are potent MBL inhibitors and in combination with imipenem overcome MBL-mediated carbapenem resistance.', 34865870),
('four selected piperazine derivatives', 'Four molecules enhanced levofloxacin activity against E. coli strains overexpressing RND efflux pumps (AcrAB-TolC and AcrEF-TolC), but not against RND pump-deficient strains.', '', 'Conclusions: Piperazine derivatives are good candidates as inhibitors of RND efflux pumps. They decreased the activity of RND pumps by mixed mechanisms of action. Small structural differences among the molecules can be critical in defining their behaviour.', 34747445),
('Cinnamaldehyde Analogs', 'Antibiofilm Activities of Cinnamaldehyde Analogs against Uropathogenic Escherichia coli and Staphylococcus aureus', '', 'We suggest efforts be made to determine the therapeutic scope of CNMA analogs, as our results suggest CNMA derivatives have potential therapeutic use for biofilm-associated diseases.', 35806244),
('benzothiazole?urea hybrids', 'potent anti-bacterial agents against MRSA', '', 'Therefore, our data demonstrated the potential to advance benzothiazole?urea hybrids as a new class of antibiotics.', 35397402),
('pyridothienopyrimidine derivatives 2a,b-9a,b', 'Compounds 3a, 5a and 9b displayed broad spectrum antimicrobial activity with MIC ranges of 4-16 Microg/mL and potent cytotoxic activity with IC50 ranges of 1.17-2.79 MicroM. In addition, they provided suppressing activity against EGFR with IC50 ranges of 7.27-17.29 nM, higher than that of erlotinib, IC50 = 27.01 nM.', '', 'Many of the target compounds showed significant antimicrobial activity.', 35164067),
('high dilutions (hd)-antibodies (Abs)', 'hd-Abs in combination with AMC increased survival of mice infected with K. pneumoniae up to 50%, whereas all animals in the AMC group died. Hd-Abs had no direct effect on K. pneumoniae sensitivity to AMC in vitro.', 'The study was performed on an in vivo model of K. pneumoniae BAA-1705 multiresistant strain lethal infection in neutropenic RjOrl:Swiss mice. The mechanism of action of hd-Abs remains to be elucidated in future studies.', 'Thus, hd-Abs increased the antibacterial activity of AMC against the strain resistant to it.', 35248735),
('Surfactant with 18-carbon single hydrocarbon chain and multi-amine head groups (C18N3) after assembling with Staphylococcus aureus-targeting peptide (CARG) [C18N3/CARG]', 'exhibited excellent antimicrobial activities against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in vitro and in vivo, in which the targeting peptide CARG bonded specifically to Staphylococcus aureus and C18N3 killed bacteria with a mechanism of membrane disruption. Importantly, C18N3 could also work as a beta-lactamase inhibitor to overcome the bacterial resistance to beta-lactam antibiotics through noncompetitive inhibition. The combination of beta-lactam antibiotic and C18N3/CARG assemblies more effectively suppressed methicillin-resistant Staphylococcus aureus', '', 'Thus, the antibacterial platform of antibiotic-carrying surfactant assemblies bearing bacteria-targeted peptides, in which C18N3 performed dual function, antibacterial agent and beta-lactamase inhibitor, may help fight against the difficult-to-treat infections.', 35278861),
('Quinoline-2-carboxaldehyde-N4-phenyl-3-thiosemicarbazone bismuth dichloride and carbapenem', 'restores carbapenem sensitivity in NDM-1-positive Klebsiella pneumoniae', 'The cytotoxicity against human cells was higher than the effective concentration needed for the synergistic effect in bacterial cells, indicating that a structural optimization of the compounds is needed.', 'Quinoline-2-carboxaldehyde-N4-phenyl-3-thiosemicarbazone bismuth dichloride and carbapenem showed synergism in a dose dependent manner with negligible antibacterial activity when used in a monotherapy and could restore antibiotic sensitivity in the strain producing NDM-1 enzyme.', 35690039),
('Shikimate Pathway-Derived Phenolic Acids', 'MIC values in the range 31.2 to 62.5 microg/mL against S. aureus, and E. coli, and there was an overall reduction in MIC following their combination with ciprofloxacin', '', 'Taken together, the findings from both the in silico and in vitro evaluations in this study have demonstrated high affinity of p-coumaric acid towards NorA and could be suggestive of its exploration as a novel NorA efflux pump inhibitor.', 35458799),
('SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin', 'Combats Drug-Resistant Klebsiella pneumoniae, Its Biofilms, and Persister Cells', '', 'In summary, our findings indicated that SPR741, in combination with macrolide antibiotics (double or triple combination), has the potential to serve as a novel treatment option against drug-resistant K. pneumoniae -related infections.', 35372124),
('Saccharomyces boulardii CNCM I-745 supplementation', 'modifies the fecal resistome during Helicobacter pylori eradication therapy', '', 'Conclusion: Our study demonstrated that the addition of S. boulardii CNCM-I 745 to the conventional antibiotic eradication therapy for H. pylori reduced the abundance of ARGs, particularly those genes that confer resistance to lincosamides, tetracyclines, MLS-B, and a few genes in the beta-lactams class.', 34990038),
('hydrogel based on peptide DP7 (VQWRIRVAVIRK) and oxidized dextran (DP7-ODEX hydrogel) loaded with ceftazidime into DP7-ODEX hydrogel,', 'DP7 can synergize with many antibiotics; thus, we loaded ceftazidime into DP7-ODEX hydrogel, which showed an obvious advantage in MDR P. aeruginosa inhibition. DP7 could also be used as a wound-healing peptide and accelerate the healing process. We confirmed that the DP7-ODEX hydrogel exerted formidable therapeutic effects in normal or diabetic wound infection model. According to histomorphology analysis we found that DP7 hydrogel also have a scarless wound healing ability.', '', 'In summary, we developed a hydrogel fabricated by the dual functional peptide DP7 that can kill multidrug-resistant bacteria colonizing the wound bed and boost scarless wound healing.', 34973798),
('WCK 6777 (ertapenem/zidebactam)', 'against carbapenemase-producing Klebsiella pneumoniae', 'in the neutropenic murine pneumonia model', 'Conclusions: Human-simulated exposures of WCK 6777 demonstrated potent in vivo activity against CP-KP, including those with WCK 6777 MICs up to 8 mg/L', 35411395),
('ascorbic acid with rutoside supplementation', 'The ascorbic acid and rutoside combination, however, significantly decreased biofilm production.', '', 'Conclusions: Our research proves a beneficial impact of ascorbic acid with rutoside supplementation on biofilm of P. mirabilis strains causing urinary tract infections.', 35655208),
('Telacebec', 'against MDR-TB strains', '', 'Its clinical efficacy, favorable pharmacokinetic properties, low arrhythmogenic risk, and activity against MDR-TB strains make telacebec a suitable candidate for further development.', 35034512),
('naphthalimide corbelled aminothiazoximes', 'potential allosteric modulators for PBP2a, dimethylenediamine derivative 13d presented a wonderful inhibition on MRSA (MIC = 0.5 microg/mL), and showed excellent membrane selectivity (HC50 > 200 Microg/mL) from an electrostatic distinction of the electronegative bacterial membranes and the electroneutral mammalian membranes', '', 'These findings of naphthalimide corbelled aminothiazoximes as a small-molecule class of anti-MRSA agents held promise in strategies for treatment of MRSA infections.', 34922190),
('ultraviolet/peracetic acid', 'simultaneously remove antibiotics and antibiotic resistance genes in wastewater, The results showed that UV/PAA disinfection with a high UV dosage (UV/PAA-H) was most effective for the removal of tetracyclines, quinolones, macrolides and beta-lactams; their average removal efficiencies ranged from 25.7% to 100%, while NaClO disinfection was effective for the removal of sulfonamides (?81.6%). The majority of ARGs were well removed after the UV/PAA-H disinfection, while specific genes including tetB, tetC, ermA and blaTEM significantly increased after NaClO disinfection.', '', 'Our study provides valuable information for understanding the simultaneous removal mechanism of antibiotics and ARGs in wastewater during the disinfection processes, especially for the novel UV/PAA combination process.', 34982977),
('triethylene glycol monomethyl ether side groups (short polyethylene glycol (PEG) analog)', 'PEG moiety and fine-tuned hydrophilic-lipophilic balance of ionenes synergistically lead to low cytotoxic, low hemolytic molecules with high activity against S. aureus, including methicillin-resistant strains (MRSA).', '', 'Many reported polycations show high antimicrobial activity along with low hemolytic activity.', 35524947),
('dipotassium glycyrrhizinate-loaded hydrogels (HP-3/DG10)', 'antimicrobial activity against Staphylococcus aureus when infused with dipotassium glycyrrhizinate (DG)', 'Using a mouse full-thickness skin defect model, in vivo wound healing evaluations revealed that the DG-loaded hydrogels (HP-3/DG10) applied to the wound resulted in rapid wound closure.', 'The simple preparation method and multifunctionality of the studied hydrogel composites may provide important insights for the development of future biomaterials for wound dressings and other biomedical applications.', 35245682),
('WCK 1152, WCK 1153', 'treatment of resistant pneumococcal and staphylococcal respiratory infections', '', 'Advance studies suggested either WCK 1152 or WCK 1153 are the worthy candidates for further clinical developments for respiratory infections caused by resistant pneumococci and staphylococci. However, on the basis of in house preclinical work, WCK 1152 had been selected for phase-1 domestic clinical trials.', 35276361),
('GSK2556286', 'Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment', '', 'These features indicate a compound with a novel mode of action, although still not fully defined, that is effective against both multidrug-resistant (MDR) or extensively drug-resistant (XDR) and drug-sensitive (DS) M. tuberculosis with the potential to shorten the duration of treatment in novel combination drug regimens.', 35607978),
('Linolenic Acid-Metronidazole', 'Compound Relieving Drug Resistance and Inhibiting Helicobacter pylori, MIC and MBC to Hp were 2~4 Microg/mL, 8~16 Microg/mL. Moreover, in vivo experiments, Lla-Met significantly reduced the colonization of drug-resistant Hp in gastric mucosa.', '', 'Conclusion: Lla-Met, a newly prepared compound, has relatively well antibacterial of Met-resistant and sensitive Hp, with a capability of overcoming the metronidazole resistance of Hp.', 35758720),
('sodium fusidate antibiotic cutaneous spray based on water-free lipid formulation system', 'significantly stronger antibacterial effect than Fucidin cream showing a clear dose-response relationship for the sodium fusidate content', '', 'Improving the efficacy of topical formulations could potentially shorten the treatment period and avoid the resistance growth.', 35779822),
('Three novel series of tylosin semisynthetic derivatives were designed', 'Among these derivatives, compound C-2 demonstrated potent antibacterial activity against both gram-positive and gram negative bacteria, and non mutagenic.', '', 'compound C-2 displayed high antimicrobial potency against Gram-positive bacteria in a murine model, and was found to be more efficient than tildipirosin. Thus, compound C-2 had great potential as a promising lead compound for the treatment of bacterial infection.', 35675753),
('N-{5-ethyl-[1,2,4]triazolo[1,5-c]quinazolin-2-yl}-2,2,2-trifluoroacetamide', 'demonstrated antimicrobial effects against E. coli.', 'no tissue damage or other toxicity was observed after the therapeutic dose treatment.', 'effective compound to used as a treatment option for E. coli related infections.', 36590392),
('quinoline derivatives', 'compounds active against MDR K. pneumoniae', 'None of the compounds showed hemolytic effect.', 'This study was designed to identify compounds active against MDR K. pneumoniae which causes infections, such as pneumonia and urinary tract infections.', 35796056),
('New 1,2,4-oxadiazole/pyrrolidine hybrids', 'The derivative Compound 17 ( n= 3,5-difluoro) had the strongest inhibitory effect against Escherichia coli Topo IV of all the synthesized compounds, with an IC50 value of 13 microM, which was comparable to novobiocin (IC50 = 11 microM). compound 17 outperformed ciprofloxacin against E. coli, with an MIC of 55 ng/ml, compared to 60 ng/ml for ciprofloxacin.', '', 'Finally, the docking study, along with the in vitro experiments, supports our promising approach to effectively develop potent leads for further optimization as dual DNA gyrase and Topo IV inhibitors.', 35363388),
('N-Aryl Malonamides (NAMs)', 'At a concentration of 10 microM NAMs, most compounds substantially reduced pyocyanin production in these MDR P. aeruginosa clinical isolates', '', 'activity of a NAM family of potent and effective anti-MvfR agents. Overall, many NAM derivatives show much better solubility than the benzothiazole analogs. NAMs provide for the development of crucial preventive/therapeutic monotherapy options against untreatable MDR PA infections.', 36042245),
('polyaminoisoprenyl compound NV716', 'MIC Against PAO1 Pseudomonas aeruginosa, NV716 showed synergistic effects at ?2.5 microM', '', 'NV716 also reduces motility, virulence factors production, and biofilm formation. NV716 shows a unique and highly promising profile of activity when used alone or in combination with antibiotics against P. aeruginosa, combining in a single molecule anti-virulence and potentiator effects. Additional work is required to more thoroughly understand the various functions of NV716', 36008485),
('Pyrogallol', 'pyrogallol dramatically enhanced the lifespan of A. baumannii-infected zebrafish. Further, the histopathological results also demonstrated the disease protection efficacy of pyrogallol against the pathognomonic sign of A. baumannii infection.', '', 'Pyrogallol inhibiting bacterial colonization, demonstrating the anti-infective potential of pyrogallol against A. baumannii. the pyrogallol treatment effectively improved the immune parameters such as serum myeloperoxidase activity, leukocyte respiratory burst activity, and serum lysozyme activity in zebrafish against A. baumannii infection. Based on the results, the present study strongly proposes pyrogallol as a promising therapeutic agent for treating A. baumannii infection.', 36526063);
INSERT INTO `bacteria_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('a polycationic vancomycin aglycone derivative', 'the derivative of Compound 14 is 16 times less active against the vancomycin sensitive strain, than vancomycin, but it is 32 times more potent against the resistant VanA strain. the vancomycin and teicoplanin resistant VanA type E. faecalis was even more susceptible with a MIC of 8 microg/mL.', 'The cationic vancomycin derivative 14 showed a dose-dependent cytotoxicity both on Caco-2 and hCMEC/D3 cells, but fortunately low toxicity was observed in both cases. The IC50 value was 56.22 ', 'it synergized with teicoplanin against Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii, and it was able to potentiate vancomycin against these Gram-negative strains. Moreover, it proved to be active against vancomycin- and teicoplanin-resistant Gram-positive bacteria. ** compound 14 was able to synergize with teicoplanin and strongly potentiated vancomycin against Gram-negative bacteria including Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii, demonstrating the ability of compound 14 to compromise the integrity of the outer membrane of Gram-negative strains.', 36463278),
('Alcohol-Based and quaternary ammonium compounds - QAC Disinfectants', 'The most abundant genera were Staphylococcus, Micrococcus, and Bacillus. The average MIC values of alcohol-based disinfectants range between 66.61 and 148.82 g/L, and those of QAC-based disinfectants range between 2.4 and 3.5 mg/L.', '', 'The widespread use of disinfectants can induce a reduction in the susceptibility of bacteria against disinfectants and affect the increase in the proportion of antibiotic-resistant bacteria.', 36429408),
('pyrite (FeS2, naturally abundant mineral) for periodate (PI)', 'FeS2/PI system could disinfect 1 ', '', 'The generated reactive species including Fe(IV), ', 36610181),
('lysin exebacase (CF-301)', 'Exebacase displayed (i) a significant anti-biomass activity on S. epidermidis biofilms at concentrations ?5 mg/L (mean decrease up to 66% at 150 mg/L), (ii) significant bactericidal activity on biofilms at concentrations ?50 mg/L (mean decrease up to 1.7 log CFU at 150 mg/L), (iii) synergistic effects when used in addition to rifampicin, vancomycin, or daptomycin.', '', 'Exebacase can be considered a promising therapy in addition to rifampicin, vancomycin, or daptomycin . Further in vitro studies are needed to understand its mechanism of action on S. epidermidis biofilms and in vivo investigations are required to confirm these data.', 35861539),
('N-Terminal Lysozyme Conjugation to a Cationic Polymer', 'Conjugate can efficiently overcome lysozyme resistance in Gram-positive bacteria and antibiotics-resistance in Gram-negative bacteria,', '', 'synergistic interactions of lysozyme and the cationic polymer with the bacteria to disrupt their cell membranes. In a rat periodontitis model, the lysozyme-polymer conjugate not only greatly outperforms lysozyme in therapeutic efficacy but also is superior to minocycline hydrochloride. These findings may provide an efficient strategy to dramatically enhance the antimicrobial activities of lysozyme and pave a way to overcome antimicrobial resistance.', 36239583),
('polymer, Pluronic F-127 (PF127) solution containing PT-b1', 'Clinical isolated bacteria strain with antibiotic resistance. Escherichia coli, Bacillus subtilis, Mycobacterium smegmatis, Mycobacterium fortuitum;Enterococcus faecalis, Staphylococcus aureus; Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa; Enterobacter cloacae MIC is in range of 0.5 - 16 [microg mL?1] with PF127-PT-b1', 'In 2 h, it could be observed that PT-b1 could eradicate all bacteria, but it also caused ?5% hemolysis at this AMPM concentration. In contrast, PF127-PT-b1 could also remove all bacteria, but with only a <1.5% RBC lysis was seen in the same timeframe.', 'he AMPM- Pluronic F-127 complex, i.e., PF127-PT-b1, was able to kill MDR pathogens, rescue infected RBCs, and remove established biofilms at concentrations with excellent hemocompatibility. Pluronic F-127 as an amphiphilic masking agent to reduce the hemolytic activity of the cationic AMPM while keeping most of its activity, thus the overall therapeutic index of the AMPM can be much improved.', 35545965),
('Pluronic F127 (polyethylene-polypropylene glycol) -based in situ sprayed biotherapeutic gel (denoted as gel with kombucha)', 'The inhibition rate of biofilm formation by gel with kombucha was 93% for E. coli and 82% for S. aureus, respectively', 'MTT assay substantiated the negligible toxicity of F127 at concentrations below 40 mg mL?1. Intact cellular actin cytoskeleton architecture was well reserved after cells were exposed to gel with kombucha', 'These results indicated that this biotherapeutic gel possessed good biocompatibility within the therapeutical dose, which could be applied in the treatment of bacterial infectious wounds.', 36479844),
('N-(4-bromophenyl)-1-naphthamide', '', 'compounds N-(3?,5?-dimethyl-[1,1?-biphenyl]-4-yl)-1-naphthamide (4c) and N-(3?,5?-diflouro-[1,1?-biphenyl]-4-yl)-1-naphthamide (4f) showed significant haemolytic activity. N-(4?-chloro-[1,1?-biphenyl]-4-yl)-1-naphthamide (4e) exhibited an efficient biofilm inhibition activity against Gram-negative bacteria Escherichia coli and Gram-positive bacteria Bacillus subtilis.', 'research is focused on the development of agents that inhibit biofilm formation, thus the present work is valuable for preventing future drug resistance.', 34724237),
('two terpyridine ligands 4''-(4-N,N''-dimethylaminophenyl)-2,2'':6'',2?-terpyridine (L1) and 4''-(4-tolyl)-2,2'':6'',2?-terpyridine (L2)', 'Both compounds L1 and L2 exhibited remarkable inhibitory activities against bacteria, Escherichia coli and Staphylococcus aureus at MIC values 6.25 and 3.125 microg/ml, respectively', 'The toxicity of L1 and L2 was checked using Drosophila melanogaster. The toxicity analysis suggest both are non-cytotoxic in nature.', 'both L1 and L2 could bind Bovine Serum Albumin (BSA) protein and binding interaction has been studied with the help of UV-Visible and fluorescence spectroscopy. While fluorescence of BSA unperturbed in the presence of L2, an addition of L1 to the solution of BSA resulted significant quenching.', 36562209),
('3-phenylpropan-1-amine (3-PPA)', '3-PPA (50.0 microg/mL) reduced S. marcescens NJ01 biofilm formation by 48%. The combination of 3-PPA (50.0 microg/mL) and ofloxacin (0.2 microg/mL) enhanced S. marcescens NJ01 sensitivity to ofloxacin.', '', '3-PPA is feasible as an ofloxacin adjuvant to overcome multidrug-resistant S. marcescens and improve the treatment of intractable infections. 3-PPA reduced virulence factors and eliminated biofilm formation by inhibiting QS in S. marcescens NJ01 bacteria, without affecting bacterial growth, thus restoring sensitivity to ofloxacin. Thus, the discovery of compounds that can restore antibiotic activity against bacteria is a promising strategy to mitigate multidrug resistance in pathogens.', 35972277),
('silicone Foley catheters (SFC) impregnated with these indole derivatives', 'Reduction of biomass in the P. mirabilis biofilm on the impregnated catheter was very evident when compared to that of untreated controls', 'advantage is the safety of this compound on human cell line.', 'Studying the change in gene expression of P. mirabilis in the presence of this indole extract reveals that their mechanism of action could be due to their action on the virulence factors contributing to bacterial motility, adherence, and urease production thus reducing crystalline biofilm formation by P. mirabilis. Further studies are intended to evaluate this approach by in vivo analysis via long-term catheterization in animal models and studying their possible synergistic activity with other antivirulence compounds to increase their activity.', 36118027),
('ynergistic Effects of Capric Acid and Colistin', 'Checkerboard assays showed a synergistic effect against all colistin-resistant strains [(FICI, fractional inhibitory concentration index) = 0.02-0.38] and two colistin-susceptible strains', '', 'Time-kill assays confirmed the combination was synergistic. We suggest that the combination of colistin and capric acid is a promising therapeutic strategy against Gram-negative colistin-resistant strains.', 36671237),
('colistin conjugates (CT) with succinyl chitosan (SucCS)', 'The MICs of SucCS-CT-10 and native CT were 1 microg/mL, while MICs of other samples, such as SucCS-CT-3 and SucCS-CT-5, against P. aeruginosa, were 8 microg/mL. It should be noted that SucCS-CT-3 and SucCS-CT-5 at the concentrations of 0.25', 'e developed systems reduced CT nephrotoxicity by 20-60%', 'The antimicrobial activity of the conjugates depended on the degree of substitution . they also demonstrated the ability to reduce bacterial lipopolysaccharide-induced inflammation in vitro. Thus, these promising CT-SucCS conjugates are prospective for developing safe and effective nanoantibiotics.', 36613610),
('ruthenium - Ru2', 'Ru2 can efficiently inhibit biofilm formation and alpha-hemolysin secretion from Staphylococcus aureus. in both a mouse skin infection model and a G. mellonella wax worm infection model, Ru2 showed significant antibacterial activity in vivo.', 'the Ru2 complex was almost non-toxic.', 'The results demonstrated that Ru2 could destroy the integrity of bacterial cell membranes. this work demonstrated that ruthenium-based complexes bearing a biphenyl group are promising agents to combat bacterial infection.', 36112764),
('Zinc Pyrithione in Combination with Gentamicin', 'The results showed that a combination of zinc pyrithione with gentamicin produced a strong synergistic effect (p < 0.001) against all tested streptococcal strains (with FICI values ranging from 0.20 to 0.42). only three out of eight S. aureus strains were highly susceptible to the combination of antimicrobial agents at single concentration (0.25 microg/mL) of zinc pyrithione with range of FICI 0.35?0.43.', '', 'These findings suggest that interference between agents tested in this study can be used for the development of future veterinary pharmaceutical preparations for the treatment of bacterial skin infections of livestock.', 35884214),
('Pyrimidine-conjugated fluoroquinolones: 4-aminopyrimidinyl compound', '4-aminopyrimidinyl compound exhibited superior antibacterial potency against Enterococcus faecalis with a low MIC of 0.25 microg/mL to norfloxacin and ciprofloxacin.', 'showed a broad antibacterial spectrum and low cytotoxicity', 'The active compound 4-aminopyrimidinyl compound with fast bactericidal potency could inhibit the formation of biofilms and showed much lower trend for the development of drug-resistance than norfloxacin and ciprofloxacin. This compound ROS accumulations in bacterial cells thus facilitating bacterial death. ADME analysis indicated that this compound possessed favorable drug-likeness and promising pharmacokinetic properties. These results demonstrated that pyrimidine-conjugated fluoroquinolones held hope as potential antibacterial candidates and deserve further study.', 35835379);

-- --------------------------------------------------------

--
-- Table structure for table `bacteria_np`
--

CREATE TABLE IF NOT EXISTS `bacteria_np` (
  `ENTITY` varchar(500) NOT NULL,
  `POTENCY` varchar(5000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `bacteria_np`
--

INSERT INTO `bacteria_np` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Lactoferrin delivered by biomimetic hydroxyapatite nanoparticles', 'Better performance of lactoferrin delivered by biomimetic hydroxyapatite nanoparticles combined with cell free supernatant from probiotic Lactobacillus paracasei compared to both lactoferrin and probiotic alone or pooled.', '', 'CONCLUSION: These findings indicate the effectiveness and safety of our proposed therapy as alternative treatment for Helicobacter pylori infection.', 27384186),
('Tobramycin decorated graphene oxide AgNPs (TOB-GO-Ag)', 'Significant loss of bacterial membrane potential from -52 +- 2 mV (control) to -2 +- 1 mV (treated) indicates a severe cell wall damage caused by TOB-GO-Ag composite', '', 'Tobramycin mediated silver nanospheres/graphene oxide composite for synergistic therapy of bacterial infection.', 29763756),
('A PS (beta-carboxyphthalocyanine zinc, CPZ) delivery system with lanthanide-doped upconversion nanoparticles (UCNPs, LiYF4:Yb/Er) and polyvinylpyrrolidone (PVP)', 'Such a near-infrared (NIR) triggered UCNPs-CPZ-PVP system significantly reduced the aggregation of CPZ and presented a high anti-infectious activity against multi-drug resistant (MDR) bacteria (methicillin-resistant Staphylococcus aureus by 4.7 log10 and MDR Escherichia coli by 2.1 log10) post aPDT (at 50 micro g mL-1 UCNPs-CPZ-PVP with 0.5 W cm-2 980 nm light).', '', 'Near-infrared-triggered antibacterial and antifungal photodynamic therapy based on lanthanide-doped upconversion nanoparticles. An alarming worldwide increase in microbial resistance to traditional drugs and classical pharmacophores has spurred the search for new antimicrobial compounds. Antimicrobial photodynamic therapy (aPDT) has recently emerged as an effective modality for the selective destruction of bacteria and other pathogenic microorganisms.', 29881851),
('Quaternized chitosan hydrogels incorporated with NaYF4:Er/Yb/Mn@photosensitizer-doped silica (UCNPs/MB)', 'Excellent antibacterial efficiency to both DR-S. aureus and DR-E. coli bacteria', '', 'By incorporating UCNPs/MB-doped silica into the hydrogel, we have combined photodynamic therapy (PDT) with quaternized chitosan to obtain a high therapeutic index via a synergistic effect.', 26883410),
('Monomeric methylene blue conjugated gold nanoparticles', 'In our treatment modality negligible dark toxicity suggests photochemically driven process with 97% killing of MDR bacteria.', '', 'Nanoparticle-based photodynamic therapy (PDT) is increasingly been adopted as a potential antimicrobial option, yet the cytotoxicity associated with PDT is quite unspecific.', 28778019),
('Catheter loaded with silver', '', '', 'In vitro efficacy of a hydrophilic central venous catheter loaded with silver to prevent microbial colonization. A method was developed to load the surface of a central venous catheter with silver to prevent bacterial colonization.', 9532274),
('Tungsten nanoparticles', 'The bactericidal activity of newly synthesized tungsten-nanoparticles was tested on clinical multiple drug resistant Escherichia coli isolates from UTI patients with indwelling catheters and Staphylococcus aureus reference strain. The results suggest that the particles tested in this study certainly mediate the inhibition of bacterial growth.', '', 'We believe that the fabrication of W-NPs on catheters could possibly prevent them from being contaminated by pathogens and hence provide continuous protection of the site.', 21213591),
('Silver nanoparticle-doped SiO(2) microspheres (Ag-SMSs)', 'Effective inhibition against proliferation of E. coli', '', 'Large-scale preparation of strawberry-like, AgNP-doped SiO2 microspheres using the electrospraying method. In this paper, we report on a novel strategy for the preparation of silver nanoparticle-doped SiO(2) microspheres (Ag-SMSs) with an interesting strawberry-like morphology using a simple and efficient electrospraying method.', 21719963),
('Selenium nanoparticles', 'Study provided the first evidence of strongly inhibited growth of S. aureus in the presence of selenium nanoparticles after 3, 4, and 5 hours at 7.8, 15.5, and 31 ?g/mL. The percentage of live bacteria also decreased in the presence of selenium nanoparticles. Therefore, this study suggests that selenium nanoparticles may be used to effectively prevent and treat S. aureus infections and thus should be further studied for such applications.', '', 'Therefore, this study suggests that selenium nanoparticles may be used to effectively prevent and treat S. aureus infections and thus should be further studied for such applications.', 21845045),
('2-phenoxy-1-phenylethanone, a synthetic analogue of neolignan (LS-2)-loaded microparticles', 'Activity against Mycobacterium tuberculosis H37Rv ATCC 27294', '', 'These findings are encouraging and indicate that LS-2-loaded microparticles are a potential alternative to conventional chemotherapy of TB.', 21854223),
('Chitosan (CS) nanoparticles', 'Anti-biofilm activity in Streptococcus mutans, Pseudomonas aeruginosa and Candida albicans', '', 'Chitosan nanoparticles for antimicrobial photodynamic inactivation: characterization and in vitro investigation. The growing resistance to antibiotics has rendered antimicrobial photodynamic inactivation (PDI) an attractive alternative treatment modality for infectious diseases.', 22283820),
('Titanium with chitosan', 'The Chitosan-coated surfaces showed strong inhibition of Actinomyces \nnaeslundii growth', '', 'Functionalization of titanium with chitosan via silanation: evaluation of biological and mechanical performances. Complications in dentistry and orthopaedic surgery are mainly induced by peri-implant bacterial infections and current implant devices do not prevent such infections.', 22859940),
('Ag-SiO(2) NC (nano composite)', 'Complete mortality of the bacterium was achieved with 80 ?g ml(-1) concentration of Ag-SiO(2) NC. Inside the cytoplasm, a complete inhibition of electron transport system was achieved with 100 ?g ml(-1) Ag-SiO(2) NC, followed by DNA breakage.', '', 'The study thus demonstrates that Ag-SiO(2) NC invades the cytoplasm of the multiple drug-resistant P. aeruginosa by impinging upon the cell wall integrity and kills the cells by interfering with electron transport chain and the genetic stability.SIGNIFICANCE AND IMPACT OF STUDY: Although the synthesis, structural characteristics and biofunction of silver nanoparticles are well understood, their application in antimicrobial therapy is still at its infancy as only a small number of microorganisms are tested to be sensitive to nanoparticles.', 23083417),
('Silver-conjugated superparamagnetic iron oxide nanoparticles (SPION)', 'A significant decrease in biofilm mass, which corresponds to a seven orders of magnitude decrease in viability, is observed when MRSA biofilms are treated with 1 mg/mL of silver-conjugated SPION (p greater than 0.01).', '', 'For this reason, this study demonstrates for the first time that silver-conjugated SPION could be used as a targeted antibacterial therapy to the infection site.', 23184367),
('Ferrocene-carborane derivatives (FcSB1 and FcSB2) combining with nanoscaled titania (nano TiO2)', 'FcSB1 and nano TiO2 : FIC (fractional inhibitory concentration) index values 0.375 to 0.106, FcSB2 with nano TiO2 : FIC 0.250 to 0.083', 'NA', 'Synergistic antibacterial activity of new isomeric carborane derivatives through combination with nanoscaled titania. As a novel strategy to combat the nosocomial infection caused by multidrug-resistant (MDR) bacteria like Acinetobacter baumannii, the antibacterial effect of a pair of geometrical isomers ferrocene-carborane derivatives (designated as FcSB1 and FcSB2) combining with nanoscaled titania (nano TiO2) against five MDR A. baumannii strains were explored in this contribution.', 23620994),
('Silver nanoparticles (Ag NPs, 120 nm)', 'Silver nanoparticles (Ag NPs, 120 nm) showed the greatest potency for reducing N. gonorrhoeae colony formation (MIC: 12.5 ?g/ml)', '', 'This is the first report to screen the effectiveness of nanomaterials against N. gonorrhoeae, and our results indicate that 120 nm Ag NPs deliver low levels of toxicity to human epithelial cells and could be used as an adjuvant with antibiotic therapy, either for topical use or as a coating for biomaterials, to prevent or treat multidrug-resistant N. gonorrhoeae.', 23705013),
('Polyethyleneimine functionalized zinc oxide nanoparticles', 'Inactivation of metronidazole-resistant Helicobacter pylori', '', 'The molecular basis of inactivation of metronidazole-resistant Helicobacter pylori using polyethyleneimine functionalized zinc oxide nanoparticles. In view of the world wide prevalence of Helicobacter pylori infection, its potentially serious consequences, and the increasing emergence of antibiotic resistant H. pylori strains there is an urgent need for the development of alternative strategies to combat the infection.', 23951006),
('tin (Sn) doped ZnO nanostructures', 'Sn doping enhanced the inhibitory activity of ZnO against S. aureus', 'Sn doping concentration in ZnO does not alter the cytotoxicity and ROS production, undoped and Sn doped ZnO nanostructures are biosafe and biocompatible materials towards SH-SY5Y Cells.', 'The observed behavior of ZnO nanostructures with Sn doping is a new way to prevent bacterial infections of S. aureus, especially on skin, when using these nanostructures in creams or lotions in addition to their sunscreen property as an ultraviolet filter.', 24109181),
('Solid lipid nanoparticles loaded with free fatty acids', '', '', 'A strategy was developed to target infections by producing coatings made of non-toxic chemistries lauric acid and oleic acid delivered by core-shell solid lipid nanoparticles that act against bacteria by multiple mechanisms at the nanoscale, including disruption of bacteria leading to DNA release, and reducing the adhesion of dead bacteria to ~1%. This is the first such study to explore an anti-infection surface relying on these multi-tier strategies at the nanoscale.', 24264141),
('Piperine and gentamicin nanoliposomes', 'MIC values of gentamicin and piperine were 32 and 100 micro g/mL, respectively. Synergetic effects were observed by the combination of gentamicin and piperine and FICI was determined to be 0.5. Following incorporation of gentamicin into liposomal gentamicin and liposomal combination, the MIC values were reduced 16- and 32-fold, respectively. MBC values of gentamicin reduced 4 and 8 times following incorporation into gentamicin and combination liposomes, respectively.', '', 'Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamicin nanoliposomes in methicillin-resistant Staphylococcus aureus.', 24842547),
('Silver nanoparticles from P. amarus extract', 'Exhibited excellent antibacterial potential against multidrug resistant strains of P. aeruginosa', '', 'CONCLUSION: The present study suggests that silver nanoparticles from P. amarus extract exhibited excellent antibacterial potential against multidrug resistant strains of P. aeruginosa from burn patients and gives insight of their potential applicability as an alternative antibacterial in the health care system to reduce the burden of multidrug resistance.', 25271044),
('poly(acrylic acid) (PAA)-coated iron oxide (magnetite) nanoparticles (PAA-MNPs)', 'Combination of PAA-MNP and rifampicin exhibits a synergistic 4-fold-higher growth inhibition against Mycobacterium smegmatis.', '', 'Polyacrylic acid-coated iron oxide nanoparticles for targeting drug resistance in mycobacteria. The emergence of drug resistance is a major problem faced in current tuberculosis (TB) therapy, representing a global health concern.', 25375643),
('Silver nanoparticles and Drosera binata extract', '', '', 'Combination of silver nanoparticles and Drosera binata extract as a possible alternative for antibiotic treatment of burn wound infections caused by resistant Staphylococcus aureus. Staphylococcus aureus is the most common infectious agent involved in the development of skin infections that are associated with antibiotic resistance, such as burn wounds.', 25551660),
('Erythrosine nanoparticles prepared using poly-lactic-co-glycolic acid (PLGA)', 'Significantly higher uptake and antimicrobial efficacy compared to pure drug in S. aureus cells.', '', 'The introduction of photodynamic antimicrobial therapy (PAT) using erythrosine, a photosensitizer, could eliminate the bacteria without inducing antibiotic resistance or even requiring daily dosing.', 25629633),
('Silver ion doped calcium phosphate based ceramic nano-powder coated titanium nails', 'Microbiological results showed that less bacterial growth was detected with the use of silver doped ceramic coated implants compared to the other two groups (p=0.003). Accumulation of silver was not detected. ', 'No cellular inflammation was observed around the silver coated prostheses. No toxic effect of silver on bone cells was seen.', 'Silver ion doped ceramic nano-powder coated nails prevent infection in open fractures: In vivo study.', 26589596),
('ZnO-NPs and TiO2-NPs', 'The IC50 values of ZnO and TiO2-NPs against S. mitis ATCC 6249 were 37 and 77 micro g ml(-1), respectively, while the IC50 values against S. mitis Ora-20 isolate were 31 and 53 micro g ml(-1), respectively', '', 'Results presented in this study verify that ZnO-NPs and TiO2-NPs can control the growth and biofilm formation activities of these strains at very low concentration and hence can be used as alternative antimicrobial agents for oral hygiene.', 26837748),
('Multi-walled carbon nanotubes (MWCNTs) covalently functionalized with immunoglobulin G', '', '', 'Using IgG molecules bound to MWCNTs, followed by laser irradiation, we obtained a very efficacious nanoshell-mediated laser therapy of individual MRSA agents providing highly localized killing effects for IgG-MWCNTs targeted bacteria.', 27301204),
('Silver coated single walled carbon nanotubes with antimicrobial peptides (FSWCNTs-Ag, SWCNTs-Ag-M, SWCNTs-Ag-M)', 'The?minimum inhibitory concentration (MIC) of FSWCNTs-Ag were much lower (~7.8-3.9 micro g/ml with IC50: ~4-5 micro g/ml) compared to SWCNTs-Ag-M and plain SWCNTs-Ag (both 62.6 micro g/ml, IC50: ~31-35 micro g/ml), suggesting that the covalent conjugation of TP359 with SWCNTs-Ag was very effective on their counterparts', 'FSWCNTs-Ag are non-toxic to the eukaryotic cells at their MIC concentrations (5-2.5 ?g/ml) compared to SWCNTs-Ag (62.5 ?g/ml).', 'This study described a novel approach to prepare SWCNT-Ag bio-conjugates without loss of antimicrobial activity and reduced toxicity, and this strategy will aid in the development of novel and biologically important nanomaterials.', 27412259),
('Photo-deposited silver coatings on Foley catheters', '', '', 'The potential of photo-deposited silver coatings on Foley catheters to prevent urinary tract infections.', 27612730),
('Silver (Ag) NPs and zinc oxide (ZnO) NPs', 'Potent antitubercular activity at a ratio of 8ZnO/2Ag', 'No cytotoxic effects on THP-1 cells', 'Mixed metal oxide nanoparticles inhibit growth of Mycobacterium tuberculosis into THP-1 cells.', 28043541),
('Linear random copolymers, comprised of oligoethylene glycol (OEG), hydrophobic, and amine groups, SCPNs (single-chain polymeric nanoparticles).', '(SCPNs) had excellent antimicrobial activity against Pseudomonas aeruginosa at 1.4 ?M and kill ?99.99% of both planktonic cells and biofilm in one hour.', '', 'Rational Design of Single-Chain Polymeric Nanoparticles That Kill Planktonic and Biofilm Bacteria. Infections caused by multidrug-resistant bacteria are on the rise and, therefore, new antimicrobial agents are required to prevent the onset of a postantibiotic era.', 28135798),
('Copper and rifampicin-loaded copper nanoparticles', 'Activity against Staphylococcus aureus, Escherichia coli, Bacillus pumilis and Pseudomonas fluorescens', '', 'The results obtained indicate that adsorption of rifampicin on the copper nanoparticles surface might provide the reduction of antibiotic dosage and prevent its adverse side effects.', 28150115),
('Imipenem loaded poly ?-caprolactone (PCL) and polylactide-co-glycolide (PLGA) nanocapsules', 'Eliminated bacterial attachment and the biofilm \nassembly of P. aeruginosa and K. pneumoniae planktonic bacteria by 74 \nand 78.4%, respectively.\n', '', 'Successfully, PCL nanocapsules were able to protect imipenem from enzymatic degradation by resistant isolates and prevent the emergence of the resistant colonies, as it lowered the mutation prevention concentration of free imipenem by twofolds.', 28399890),
('Silver and zinc oxide nanoparticles', 'Silver nanoparticles inhibited the growth of both A. salmonicida and A. invadans at a concentration of 17 micro g/mL. Zinc oxide nanoparticles inhibited the growth of A. salmonicida, Y. ruckeri and A. invadans at concentrations of 15.75, 31.5 and 3.15 micro g/mL respectively. ', '', 'In vitro assessment of the antimicrobial activity of silver and zinc oxide nanoparticles against fish pathogens', 28732514),
('Honey, polyvinyl alcohol, chitosan nanofibers', 'Complete killing of multidrug-resistant P. aeruginosa', '', 'Apitherapeutics and phage-loaded nanofibers as wound dressings with enhanced wound healing and antibacterial activity. AIM: Develop green wound dressings which exhibit enhanced wound-healing ability and potent antibacterial effects.', 28805554),
('Synthesis of AgNPs and the ethyl acetate extract from Bacillus cereus A30', 'Active against multi-drug resistant (MDR) pathogens, Methicillin-resistant Staphylococcus aureus (MRSA), Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa', '', 'Antibacterial efficacy of silver nanoparticles and ethyl acetate''s metabolites of the potent halophilic (marine) bacterium, Bacillus cereus A30 on multidrug resistant bacteria. Bacteria are generally responsible for the prevalence of several diseases and pathogenic bacteria are showing increasing resistance to different antibacterials.', 29072532),
('Trimetal (CuZnFe) oxide nanoparticles (NPs)', 'the antibacterial activity of the trimetal oxide NPs was greater against E. coli than against E. faecalis.', 'However, the cytotoxicity of trimetal NPs to mammalian cells needs to be verified.', 'Conclusion: The combination of three metal oxide NPs (ZnO, CuO, and Fe2O3) in one multimetal (CuZnFe) oxide NPs will enhance the therapeutic strategy against a wide range of microbial infections.', 29317817),
('Azole complexes combined with AgNPs', '', '', 'The use of azole complexes combined with AgNPs provides a new alternative against bacterial infections, especially when current treatments are associated with the rapid development of antibiotic resistance.', 29419803),
('Apigenin-mediated AgNPs (Silver Nanoparticles)', 'Efficacy against Prevotella melaninogenica and Arcanobacterium pyogenes', 'Toxic effect of cell death was caused by an increase in oxidative stress', 'Therefore, the biomolecule (apigenin)-mediated synthesis of AgNPs shows potential as an alternative antimicrobial therapy for bovine metritis and endometritis.', 29659523),
('ZnO-NP', 'Activity against Acinetobacter baumannii', '', 'These results demonstrate that ZnO-NP could be developed as alternative therapeutics against A. baumannii.', 29928271),
('Bioactive Glass (BG) incorporating silver (BgAg)', 'Active ggainst Pseudomonas aeruginosa and Staphylococcus aureus', '', 'Taken together, the findings provide evidence that BgAg elicits potent antimicrobial effects against planktonic and single-species biofilms, with beneficial effects on the host tissue response.', 30018606),
('NH2-FF-COOH nanotubes structure', 'potent activity against staphylococcal biofilms, resulting in complete kill at concentrations of 10 mg/mL.', '', 'Self-assembling diphenylalanine peptide nanotubes selectively eradicate bacterial biofilm infection', 30031161),
('Mercaptopyrimidine conjugated Au NC', 'Have combined mechanism including cell membrane destruction, DNA damage, and reactive oxygen species (ROS) generation', '', 'Herein, we demonstrate that a novel class of Au NCs, mercaptopyrimidine conjugated Au NCs, can act as potent nanoantibiotics targeting these intractable superbugs in vitro and in vivo, without induction of bacterial antibiotic resistance and noticeable cytotoxicity to mammalian cells.', 30063328),
('Biologically synthesized silver nanoparticles (bio-AgNP), produced by Fusarium oxysporum, and oregano (Origanum vulgare) essential oil OEO', 'Activity against multidrug-resistant bacteria, such as MRSA, and ?-lactamase- and carbapenemase-producing Escherichia coli and Acinetobacter baumannii strains with MIC ranging from 0.298 to 1.193 mg/mL and 62.5 to 250 micro M', '', 'Studies have shown that oregano (Origanum vulgare) essential oil (OEO) and silver nanoparticles have potent antibacterial activity, also against multidrug-resistant strains; however, the strong organoleptic characteristics of OEO and the development of resistance to these metal nanoparticles can limit their use.', 27242772),
('Cardamom oil loaded chitosan nano-particles', 'Anti-microbial potential against extended spectrum ? lactamase producing Escherichia coli and methicillin resistant Staphylococcus aureus', '', 'Encapsulation of Cardamom Essential Oil in Chitosan Nano-composites: In-vitro Efficacy on Antibiotic-Resistant Bacterial Pathogens and Cytotoxicity Studies.', 27757108),
('Silver nanoparticles and visible blue light', 'Activity against methicillin-resistant Staphylococcus aureus', '', 'A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA). ', 27530257),
('ZnO Nanoparticles and Linalool', 'Through in vitro assays on prokaryotic cells, it was proven that ZnO coatings hinder microbial biofilm formation of both Gram-positive and Gram-negative bacteria strains.', 'Histological analyses carried out at 7 days and 14 days after the intraperitoneal administration of linalool modified ZnO NPs revealed the absence of the latter from the brain, kidney, liver, lung, myocardium, and pancreas.', 'Through in vitro assays on prokaryotic cells, it was proven that ZnO coatings hinder microbial biofilm formation of both Gram-positive and Gram-negative bacteria strains.', 34685006),
('Silver Nanoagents', 'The in vitro antibacterial efficiencies of this non-antibiotic technique were up to 99.6% against Methicillin-resistant Staphylococcus aureus (MRSA) and 98.8% against Escherichia coli (EC), while the in vivo antibacterial efficiencies for MRSA- and Carbapenem-resistant Pseudomonas aeruginosa (CRPA)-infected mice models were 96.8% and 93.6%, respectively.', '', 'Methods: In this strategy, the photoactive antibacterial AgNP was decorated with photosensitizers (Chlorin e6, Ce6) and Raman reporter (4-Mercaptobenzonitrile, 4-MB) to provide new opportunities for clinically monitoring and fighting MDR bacterial infections.', 34150471),
('molybdenum-based nanodots (MoO3- X )', '', '', 'Most importantly, they present excellent capacity to diminish infection of methicillin-resistant Staphylococcus aureus, manifesting the potent application prospect of MoO3- X nanodots for diabetic wound therapy. © 2021 Wiley-VCH GmbH.', 34927361),
('AgNPs', 'Excellent antimicrobial activity against extracellular S. aureus with a 100% killing efficacy at concentrations as low as 56 microM', '', 'gNPs and their combination with antibiotics have demonstrated high extracellular and intracellular bacterial killing and presented unique aspects for potential clinical applications, especially for chronic and recurrent infections where intracellular bacteria may be the cause.', 30778552),
('Melittin-Loaded Niosomal Vesicles', 'Mel-loaded NISVs efficiently inhibited the growth of bacteria, particularly MRSA and VIS', '', 'Therapeutic application of Mel-loaded NISVs could be further developed as an alternative platform for the treatment of skin infection via dermal and transdermal delivery. © 2021 Sangboonruang et al.', 34819727),
('ascorbyl tocopherol succinate (ATS)', '', '', 'Therefore, ATS shows potential as a novel multifunctional adjuvant for effective and targeted delivery of antibiotics.', 34333022),
('Anionic solid lipid nanoparticles that were coated with either the cationic bolaamphiphile 12-bis-tetrahydroacridinium or with protamin as carrier for transcription factor decoys (TFD)', 'Antibacterial efficacy confirmed using a model TFD targeting the Fur iron uptake pathway in E. coli under microaerobic conditions.', '', 'Experimental antibacterial oligonucleotide therapeutics, such as transcription factor decoys (TFD), are a promising approach to circumvent AMR.', 30468838),
('N-halamine polymer nanomaterials based on a strategic copolymerization of 3-allyl-5,5-dimethylhydantoin (ADMH) and methyl methacrylate (MMA)', 'Exhibits in vitro and in vivo antimicrobial efficacy against pathogenic bacteria including Staphylococcus aureus and Escherichia coli', '', 'Based on the synergistic action of antibacterial and wound therapy, the N-halamine polymer nanomaterials are expected to be promising as wound dressing materials in medical healing and biomaterials.', 30645044),
('Zinc phosphate-based nanoparticles', 'The highest in vitro inhibitory effect was observed against Staphylococcus aureus (inhibitory concentration values, IC50, ranged from 0.5 to 1.6 mmol/L), followed by Escherichia coli (IC50 0.8-1.5 mmol/L). In contrast, methicillin resistant S. aureus (IC50 1.2-4.7 mmol/L) was least affected and this was similar to inhibitory patterns of commercial ZnO-based NPs and ZnO. In vivo activity tested.', '', '', 30805185),
('Fucoidan-stabilized AuNPs (F-AuNPs)', 'Potenct against Pseudomonas aeruginosa PAO1, minimum inhibitory concentration (MIC): 512 microg/mL, minimum biofilm inhibition concentration (MBIC) and minimum biofilm eradication concentration (MBEC) were identified as 128 microg/mL', '', 'Findings from the present study provide important insights into the potential of F-AuNPs as an effective new drug for controlling P. aeruginosa-biofilm-related infections.', 30987163),
('Biocompatible composite membrane comprising biomimetic polydopamine-modified eggshell membrane nano/microfibres coated with KR-12 antimicrobial peptide and hyaluronic acid (HA)', 'Excellent antibacterial activity against Gram-positive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA) and Gram-negative Escherichia coli, and it could prevent MRSA biofilm formation on its surface', '', 'These results indicated that the composite membrane is a potential candidate of wound dressings.', 31190796),
('CADY/ASOs nanoparticles (CADY-NPs)', 'Targeted drug delivery in Acinetobacter baumannii', '', 'Antisense oligonucleotides (ASOs) based therapy is a promising strategy for combating Multi-Drug Resistant (MDR) bacteria because of its high specificity, easy design and lower induction of resistance, but poor cellular uptake by bacteria has restricted the further utilization of this therapy.', 31244437),
('Beta-Ga2O3:Cr3+', '', '', 'Effective targeted therapy for drug-resistant infection by ICAM-1 antibody-conjugated TPGS modified beta-Ga(2)O(3):Cr(3+) nanoparticles.', 31244919),
('Artificial bolalipids PC-C32-PC and Me2PE-C32-Me2PE', '', '', 'Antimicrobial photodynamic therapy (aPDT) involves the use of non-toxic photosensitizers in combination with light and in situ oxygen to generate toxic radical species within the microbial environment which circumvents the resistance building mechanism of the bacteria.', 31266209),
('Vanillin capped gold nanoparticles (VAuNPs) synthesized using the popular flavouring molecule vanillin (C8H8O3)', 'Reductions in minimum inhibitory concentrations (MIC, 10-14-folds) of the antibiotics meropenem (10 fold) and trimethoprim (14 fold) were observed in the presence of VAuNPs (50 microgram/ml); VAuNPs in combination with meropenem or trimethoprim provided 1.5-3-fold better potentiation effects than that of vanillin alone, clinically relevant MexAB-OprM efflux pump components showed down-regulation in mexB and OprM transcripts in VAuNPs treated P. aeruginosa clinical isolates.', '', 'Therefore, this study indicate the ability of VAuNPs and vanillin to be used as antibiotic adjuvants for inhibiting bacterial efflux pumps to potentiate antibiotics for addressing AMR problem affecting human health and environment.', 31312733),
('Azithromycin-liposomes', 'Encapsulation of AZI in liposomes could improve its solubility, antibacterial activity, and allow the prolonged drug release in the cervicovaginal tissue, while avoiding systemic side effects', '', 'Azithromycin-liposomes as a novel approach for localized therapy of cervicovaginal bacterial infections', 31440052),
('Carbosilane metallodendrimers with different metals (copper(II) and ruthenium(II)), ligands (chloride and nitrate) a', 'Activity against Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli), Cu(II) metallodendrimers require lower concentration than Ru(II) counterpart to inhibit the production of S. aureus biofilms', 'No hemolysis at the inhibitory concentrations', 'Biofilm formation is a resistance mechanism that is responsible for most human bacterial infections and requires new and effective therapeutic approaches, such as those provided by nanotechnology.', 31450779),
('biogenic C-dots/ C-dots carrier (CDC)', 'The study of time-dependent bacterial growth and flow cytometry analysis demonstrated that CDC can exhibit a synergistic bactericidal activity against the antibiotics resistant recombinant E. coli cells', '', 'Combination therapy of biogenic C-dots and lysozyme for enhanced antibacterial and antibiofilm activity.', 33080579),
('MB attached GNPDEX-ConA', 'Photosensitized MB attached GNPDEX-ConA killed the bacteria by >3log10.', '', 'The multi-targeted (Cell wall, DNA and efflux pump) modality of MB attached GNPDEX-ConA in presence of EPI is an effective and alternative therapeutic approach against most potent Klebsiella MDR infections.', 33122117),
('oxidase-like silver-palladium bimetallic alloy nanocage, AgPd0.38', 'AgPd nanocages exhibited antibacterial profiles ranging from completely inactive (MBC99.9, ?128 microgram/mL) to active against a wide spectrum of bacteria (MBC99.9 of 4- 64 microgram/mL), with AgPd0.08 and AgPd0.38 being the least and most potent, respectively; Staphylococcus aureus and Bacillus subtilis were used as the representatives for Gram-positive bacteria while Escherichia coli and Pseudomonas aeruginosa the representatives for Gram-negative bacteria', 'AgPd0.38 failed to impact the cell viability even at 100 microgram/mL in cell counting kit-8 (CCK-8) assays and this was the case with all four tested cell-lines, indicative of lack of in vitro cytotoxicity.', 'This work opens an avenue toward biocompatible nanozymes and may have implication in our fight against antimicrobial resistance.', 33531505),
('ZnFe2O4 NPs (zinc ferrite nanoparticles)', 'ZnFe2O4 NPs showed clear growth inhibitory effects against both Gram-negative and Gram-positive microorganisms in the experimental concentration range (12.5?100 microg/mL). The maximum zone of inhibition was produced against the S. aureus (13 ? 0.9 mm) and K. pneumoniae (13 ? 1.6 mm) at a concentration of 100 microg/mL NPs.', 'ZnFe2O4 NPs exhibited dose-dependent cytotoxic effects on human dermal fibroblasts.', 'This study indicated that ZnFe2O4 NPs have the potential to be used as a future antimicrobial and wound healing drug.', 33546702),
('palladium NPs (Pd-NPs)', 'Pd-NPs exhibited strong antibacterial/antibiofilm activities against them with minimum inhibitory concentration (MIC) in the range of 62.5-125 microgram/mL.', '', 'This study suggested the possible role of PB-extract capped Pd-NPs for successful clinical management of MDR pathogens and breast cancer cells.', 33686169),
('silver covalently bound to cyanographene (GCN/Ag)', 'Tested also against multidrug resistant strains, the antibacterial activity of GCN/Ag is systematically found as potent as that of free ionic silver or 10 nm colloidal silver nanoparticles.', '', 'Endowed with these properties, GCN/Ag shows that rigid supports selectively and densely functionalized with potent silver-binding ligands, such as cyanographene, may open new avenues against microbial resistance.', 34194925),
('poly(oxanorborneneimide) (PONI)-based antimicrobial polymeric nanoparticles (PNPs)', 'poly(oxanorborneneimide) (PONI)-based antimicrobial polymeric nanoparticles (PNPs)', 'PNPs displayed minimal fibroblast toxicity and high antimicrobial activity in an in vitro co-culture model comprising fibroblast cells and dual-species biofilms of Escherichia coli and Pseudomonas aeruginosa.', 'we report the efficacy of poly(oxanorborneneimide) (PONI)-based antimicrobial polymeric nanoparticles (PNPs) against multi-species bacterial biofilms.', 34443542),
('silver nanoparticle-decorated calcium peroxide (CaO2) nanoreactors (CPA)', '', '', 'Developing radical oxygen species (ROS)-generating nanoreactors as new "antibiotics" is a promising strategy for the treatment of multidrug-resistant (MDR) biofilm infections.', 33977986),
('silver nanoparticles (Ag-NPs)', 'The in vivo effectiveness of various pharmaceutical formulations prepared from a combination of neomycin antibiotic with Ag-NPs in the treatment of induced bacterially infected mice burns showed that maximum healing activity along with faster wound contraction reported with the combination of neomycin-Ag-NPs in the spray formulation.', '', 'Generally, data indicated that incorporating Ag-NPs in combination with certain antibiotics may be a new, promising application for wound treatments, especially burns infected with MDR P. aeruginosa.', 34616370),
('Fe3O4/Ag and Fe3O4 with SiO2/Ag nanoparticles', 'The values of MIC for sulfamethoxazole, trimethoprim, Fe3O4/Ag/sulfamethoxazole, Fe3O4/Ag/trimethoprim, Fe3O4 attached SiO2/Ag/sulfamethoxazole, and Fe3O4 attached SiO2/Ag/trimethoprim against Escherichia coli were calculated to be 12, 9, 4, 4, 4, and 4 microgram/mL, respectively.', '', 'Nanotechnology is a strategy for overcoming this problem by helping develop novel drug delivery systems.', 34420194),
('IPM attached AgNPs-PEG-NOTA nanocomposite (silver nanoparticles were coated with SH-PEG-NOTA as well as loaded by imipenem)', 'combatting carbapenem-resistant A. baumannii.', '', 'Additionally, IPM attached AgNPs-PEG-NOTA not only offers immune regulation and accelerates tissue repair to improve therapeutic efficacy in vivo but also can prevent the interaction of pathogens and hosts.', 34161080),
('Antibiotic-loaded Ag/BN nanocarriers', 'For the rest of the tested E. coli strains, the Ag nanoparticle-containing nanohybrids have shown superior bactericidal efficiency. The Ag/BN nanohybrids and amphotericin B-loaded BN and Ag/BN NPs also reveal high fungicidal activity against C. albicans, C. auris, C. parapsilosis, and N. crassa cells.', '', 'Utilization of antibacterial components-conjugated nanoparticles (NPs) is emerging as an attractive strategy for combating various pathogens.', 34000197),
('gelatin methacryloyl (GelMA)-based bioinks, incorporated with varying doses of antibacterial superparamagnetic iron oxide nanoparticles (SPIONs).', 'The SPION-laden GelMA scaffolds showed significant resistance against the Staphylococcus aureus growth', '', '3D GelMA demonstrated the significant effect of functionalized scaffolds in inhibiting bacterial growth, while maintaining cell viability and growth. Together, these results present a new promising class of functionalized bioinks to 3D bioprint tissue-engineered scaffold with markedly enhanced properties for the use in a variety of in vitro and clinical applications.', 36065192),
('Mannose-modified chitosan/PMLA nanoparticles', 'Man-CS-Nps were discovered to have effective anti-adherence and biofilm disruption characteristics in suppressing the development of resistant H. pylori.', '', 'Molecular docking and 20 ns MD simulations revealed that Man-CS-Nps inhibited the target protein through slow-binding inhibition and hydrogen bond interactions with active site residues. As a consequence of the findings of this study, the Man-CS-Nps is an excellent candidate for developing alternative therapies for the increasing incidences of resistant gastric infections.', 36356866),
('epigallocatechin gallate (EGCG)-coated silver nanoparticles (Ag) (Se@Ag@EGCG)', 'The in vitro bacteriostatic results showed that 40 microg ml-1 Se@Ag@EGCG had significant antibacterial activity against drug-resistant Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) by destroying the formation of bacterial biofilm', '', 'This compound promote the production of high concentration reactive oxygen species and destroying bacterial cell wall. In addition, the results of in vivo antibacterial experiments showed that subcutaneous administration of 10 mg kg-1 of Se@Ag@EGCG could promote wound healing by reducing apoptosis and inflammatory responses in infected wounds. This development strategy of nano-antibacterial materials, which breaks through the drug resistance mechanism, provides new ideas for the development of drugs for drug-resistant bacterial infections.', 35777311),
('polycationic silver nanoclusters (pAgNCs)', 'The pAgNCs also show greatly enhanced antibacterial efficacy against anaerobic bacteria such as Fusobacterium nucleatum and Streptococcus sanguinis. These results demonstrate that the cationic nature facilitates better penetration to the bacterial cell membrane while the presence of a high percentage (>50%) of silver ions (i.e., Ag+ nanoreservoirs) on the cluster surface maintains their efficiency in both aerobic and anaerobic conditions.', '', 'This study demonstrates a novel design strategy that can lay the foundation for the development of future highly potent nano-antibiotics effective against a broad spectrum of pathogens and biofilms needed in many everyday life applications and industries.', 34935355),
('Sulfidated nanoscale zerovalent iron (S-nZVI)/peroxymonosulfate (PMS)', 'The optimal condition 28 mg/L S-nZVI coupled with 153.7 mg/L (0.5 mM) PMS was applied to remove both intracellular ARGs (iARGs) and ARB. S-nZVI/PMS effectively inactivated ARB (~7.32 log) within 15 min. Moreover, removal efficiencies of iARGs sul1, intI1 and tetA were 1.52, 1.79 and 1.56 log, respectively.', '', 'These results revealed that S-nZVI and PMS have a synergistic effect against ARB and iARGs. The regrowth assays illustrated that the ARB were effectively inactivated. By verifying the inhibitory impacts of S-nZVI/PMS treatment on conjugation transfer, this work highlights a promising alternative technique for inhibiting the horizontal gene transfer.', 34482079),
('Phosphate-based coacervates (PC)', 'PC have been the subject of increased interest due to their great potential in tissue regeneration and as controlled delivery systems. Being bioresorbable, they dissolve over time and simultaneously release therapeutic species in a continuous manner. This study investigates a series of PC gels containing a range of concentrations of the antibacterial ion Ag+ (0.1, 0.3 and 0.75 mol%). Dissolution tests have demonstrated controlled release of Ag+ over time, resulting in a significant bacterial reduction (up to 7 log), against both non-AMR and AMR strains of both Gram-positive and Gram-negative bacteria (Staphylococcus aureus, Enterococcus faecalis, Escherichia coli and Pseudomonas aeruginosa). Dissolution tests have also shown controlled release of phosphates, Ca2+, Na+ and Ag+ with most of the release occurring in the first 24 h.', '', 'Biocompatibility studies, assessed using dissolution products in contact with human keratinocyte cells (HaCaT) and bacterial strains, have shown a significant increase in cell viability (p = 0.001) when gels are dissolved in cell medium compared to the control. These results suggest that gel-like silver doped PCs are promising multifunctional materials for smart wound dressings, being capable of simultaneously inhibit pathogenic bacteria and maintain good cell viability.', 35750875),
('polymyxin-loaded cubosomes polytherapy treatment', 'Importantly, however, cubosome polytherapy with the LPS targeting antibiotic, PMB, resulted in synergistic bactericidal activity against four of seven isolates (FICI = 0.5) and partial synergy against the other three isolates (0.5 < FICI = 1.0).', '', 'These findings demonstrate that nanoparticle-based polytherapy treatments may potentially serve as improved alternatives to the conventional use of drug-loaded lipid nanoparticles for the treatment of "superbugs".', 35039508),
('silver nanoparticles (AgNPs), zinc oxide nanoparticles (ZnO NPs), copper oxide nanoparticles (CuO NPs), and iron oxide nanoparticles (FeO NPs) have been synthesized by using leaf extract of Ricinus communis.', 'Streptomycin when combined with AgNPs, ZnO NPs, CuO NPs, and FeO NPs showed enhanced antibacterial activity against clinical isolates of S. aureus which suggested synergism between the nanoparticles and antibiotics. The highest enhanced antibacterial potential of Streptomycin was observed in conjugation with ZnO NPs (11 ', '', 'The considerable point of the present investigation is that S. aureus, which was resistant to streptomycin becomes highly susceptible to the same antibiotic when combined with nanoparticles. This particular observation opens up windows to mitigate the current crisis due to antibiotic resistance to combat antimicrobial infections efficiently.', 35324924),
('Cur-FCNS (covalent modification of chitosan (CS) polymer with curcumin (Cur) )', 'The complexation efficiency of CS with Cur was found as 70 ', '', 'Thus, our results affirmed the exceptional potential of Cur-FCNS as next-generation alternative-medicine to treat resistant H. pylori.', 35157901),
('Self-Assembling Chimeric Peptide Nanoparticles with High Stability for Combating Piglet Bacterial Infections', 'In vitro studies are used to demonstrate that peptide nanoparticles NPs1 and NPs2 offer broad-spectrum antibacterial activity and desirable biocompatibility, and they retain their antibacterial ability in physiological salt environments. Peptide nanoparticles NPs1 and NPs2 can resist degradation under high concentrations of proteases.', 'In vivo studies illustrate that the toxicity caused by peptide nanoparticles NPs1 and NPs2 is negligible, and these nanoparticles can alleviate systemic bacterial infections in mice and piglets.', 'Collectively, these advances may accelerate the development of peptide-based antibacterial nanomaterials and can be applied to the construction of supramolecular nanomaterials.', 35285170),
('nanostructured lipid carrier (NLC) formulations loaded with besifloxacin HCl (BHL) and the besifloxacin HCl: sulfobutyl ether beta-cyclodextrin (SBE-CD) complex.', 'In this study, it was found that SBE-CD increased BHL''s solubility by 8-fold based on phase solubility studies. The optimized NLCs were small in size (13.63-16.09 nm) with a low polydispersity index (0.107-0.181) and adequate BHL drug loading efficiency. In vitro release studies showed that formulations were released approximately for 8 h and at levels over the minimum inhibitory concentration of Pseudomonas aeruginosa and Staphylococcus aureus. NLC formulations had a better corneal permeation rate than the marketed product during 6 h of ex vivo studies.', '', 'Conclusions: According to in vitro and ex vivo data, it was determined that the most favorable NLC formulation was the formulation containing BHL/SBE-CD that was covered with chitosan. It has the highest drug loading capacity and one of the highest ex vivo corneal passage levels, along with desired drug release. The formulation containing BHL/SBE-CD and chitosan can be a potential alternative for the treatment of bacterial keratitis.', 35675672),
('Bioconjugated Thymol-Zinc Oxide Nanocomposite', 'bioconjugation of THO with ZnO nanoparticle (ZO), which resulted in the TZ nanocomposite (NC), as a potent and selective antibacterial agent against Staphylococcus species, particularly S. epidermidis. TZ NC had selective efficacy against Staphylococcus species, with MIC values 2-32-fold lower than THO.', '', 'Our findings suggest that the TZ nanocomposite could improve the selectivity and bactericidal activity of THO against target species.', 35743214),
('chlorin e6 (Ce6) loaded chitosan functionalized molybdenum sulfide (MoS2)Nanocomposites (M-CS-Ce6)', 'The nanocomposite can not only allow Ce6 to enter the cells of Gram-positive bacteria, but also destroy the cell wall permeability of Gram-negative bacteria and enhance the photo-antibacterial effect. 10 microg/mL of M-CS-Ce6 irradiated by 660 nm laser for 5 min, completely killed the target pathogens, exhibiting significantly enhanced photo-antibacterial performance against both Gram-positive and Gram-negative bacteria.', '', 'Compared with other cationic photodynamic composites, M-CS-Ce6 had stronger and broad-spectrum photo-antibacterial effect. Taken together, M-CS-Ce6 could be a promising and safe broad-spectrum antibacterial agent.', 34893226),
('15 N [Cobalt Ferrite (0.3 CoFe2O4) + Silver chromite (0.7 Ag0.5Cr2.5O4)],', 'Five bacterial species were used in this study: three Gram-positive (Bacillus subtilis, Micrococcus luteus, and Staphylococcus aureus) and two Gram-negative (Escherichia coli and Salmonella enterica). Three fungal species were also tested: Candida albicans, Aspergillus niger, and A. flavus. Maximum antibacterial activity was attained in the case of 15 N [Cobalt Ferrite (0.3 CoFe2O4) + Silver chromite (0.7 Ag0.5Cr2.5O4)] against M. luteus. Concerning antifungal activity, C. albicans was the most susceptible fungal species. The maximum inhibition was recorded also in case of 15 N [Cobalt Ferrite (0.3 CoFe2O4) + Silver chromite (0.7 Ag0.5Cr2.5O4)]. The most promising antimicrobial compound 15 N [Cobalt Ferrite (0.3 CoFe2O4) + Silver chromite (0.7 Ag0.5Cr2.5O4)] was assayed for its antiviral and cytotoxic activity. The tested compound showed weak antiviral activity. The cytotoxic activity against Mammalian cells from African Green Monkey Kidney (Vero) cells was detected. The inhibitory effect against Hepatocellular carcinoma cells was detected using a MTT assay.', 'The antimicrobial effect of the tested compounds depends on the tested microbial species.', 'The tested compounds could be attractive and alternative antibacterial compounds that open a new path in chemotherapy.', 35624524),
('Mimusops elengi''s floral silver nanoparticles (MENP)', 'The compounds present in the flower extract were identified and their usability against the enzymes under study was assured by silico screening. The in vitro analysis furthermore supports through showing potent antibacterial activity of MENP against selected organisms.', '', 'Hence both in silico and in vitro studies reveal that MENP can be used as an alternative to break multidrug resistance.', 35347673),
('thermo-responsive nanogels consisting of bacterial cellulose nanowhiskers as the carrier of a carbon-based nanozyme doped with copper atoms', 'nanogels displayed remarkable intelligent response to temperature change with sol-gel transition temperature of ~33 ', '', 'The findings provide a novel strategy for advancing the development of nanocatalysts-based responsive biomaterials for treating bacterial infections.', 34914907),
('Silver and gold nanoparticles (are termed as AgNPs and AuNPs)', 'Contrarily, CS stabilization did not enhance the antibacterial efficacy of AgNPs. CS-stabilized AgNPs and AuNPs achieved biofilm inhibition of 53.21% and 79.39% for Pseudomonas aeruginosa and 48.71% and 48.16% for Staphylococcus aureus, respectively.', '', 'In conclusion, CS-stabilized AgNPs and AuNPs possess both antimicrobial and anti-biofilm activities. However, CS acted differently when combined with AgNPs and AuNPs, needing further investigation and optimization to improve the antimicrobial activity of both nanoparticles.', 35865585),
('Green synthesis of silver nanoparticles by Conocarpus Lancifolius plant extract', 'The inhibition zones of 18 and 24 mm have been estimated to be antibacterial activity against both bacteria. The potency of up to 100% of AgNPs for bacterial strains was incubated overnight at 60 microg/ml. Based on our results, biogenic AgNPs reveal significant activity against fungal pathogen Rhizopusus stolonifera and Aspergillus flavus that cause leading infectious diseases.', '', 'Additionally, nanomaterials were biocompatible and demonstrated the potential anticancer activities against MDA MB-231 cells after 24-hour exposure.', 35002442),
('magnetite-based antibiotic delivery systems for ENT (ear, nose and throat)', 'Magnetite nanoparticles were functionalized with streptomycin and neomycin and some were entrapped in polymeric spheres. The obtained nanomaterials are stable, with spherical morphology, their size ranging from ~2.8 to ~4.7 nm for antibiotic-coated magnetite nanoparticles, and from submicron sizes up to several microns for polymer-coated magnetite-antibiotic composites. Cell viability and antimicrobial tests demonstrated their biocompatibility on human diploid cells and their antibacterial effect against Gram-negative (Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus) opportunistic bacteria. The presence of the polymeric coat proved an enhancement in biocompatibility and a slight reduction in the antimicrobial efficiency of the spheres.', '', 'Our results support the idea that functional NPs and polymeric microsystems containing functional NPs could be tailored to achieve more biocompatibility or more antimicrobial effect, depending on the bioactive compounds they incorporate and their intended application.', 35625267);
INSERT INTO `bacteria_np` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('nanoemulsion formulation (X-1735)', 'Swine split-thickness skin wounds were first infected with MRSA and/or VRE, then treated with the nanoemulsion formulation (X-1735) or placebo controls. X-1735 was effective in significantly alleviating multilevel inflammation in the treated wounds.', '', 'X-1735 is a new antimicrobial that is safe to apply to open wounds and effectively kills MRSA and VRE. It appears to also reduce inflammation in these co-infected wounds. The data suggest that this approach offers promise as an antimicrobial for open wounds with MRSA and VRE co-infection.', 35412373),
('gold-silver alloy nanoparticles (AuAgNPs)', 'Gold-silver alloy nanoparticles (AuAgNPs) toward eradication of bacterial biofilms. The hindering of structural integrity of the biofilm matrix resulted in an increased permeability for entry of antibiotics, which then cause the eradication of biofilm and inhibit subsequent biofilm formation. Additionally, our results that AuAgNPs inhibited the formation of SDSD biofilms via distinct stress pathways that lead to the downregulation of two genes critical for biofilm production, namely, brpA-like encoding biofilm regulatory protein and fbpA fibronectin-binding protein A.', '', 'This study provides useful information to assist the development of nanoparticle-based strategies for the active treatment of biofilm-related infections triggered by photoirradiation in the visible.', 35295305),
('GA (Gmelina arborea )-AgNPs', 'against pathogenic bacteria Bacillus cereus, Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus', '', 'Our study concluded that biosynthesized GA-AgNPs had enhanced antibacterial, antibiofilm, antioxidant, and wound healing properties.', 34997051),
('diethylaminoethyl-dextran hydrochloride (dex+) and dextran sulfate (dex-) on calcium carbonate microparticles', 'An inhibitory effect of the particles was observed during bacterial growth in liquid medium, i.e. in the range of 10 % for (dex+/dex-)n coated CaCO3 materials and of 50% for (dex+/dex-)n capsules.', '', 'These findings evidence the high potential of capsules to act as antimicrobial agents in future and in treatments against infections.', 34968549),
('Imipenem-containing Niosome nanoparticles', 'against high prevalence methicillin-resistant Staphylococcus Epidermidis biofilm. The F1 formulation of niosomal Imipenem with a size of 192.3 ', '', 'The results of the present study indicate that Niosome-encapsulated Imipenem reduces the resistance of MRSE to antibiotics in addition to increasing its anti-biofilm and antibiotic activity, and could prove useful as a new strategy for drug delivery.', 35332241),
('cefotaxime (CTX) loaded tellurium nanoparticles (Te NPs)', 'Te NPs were fabricated to recover the antibacterial activity of the ineffective beta-lactam antibiotic CTX against methicillin-resistant Staphylococcus aureus (MRSA) and at the same time perform photothermal therapy under light-emitting diode (LED) irradiation with a wavelength in the range of 420-480 nm. The combination of 50 microg mL-1 Te-CTX NPs with 5 min LED irradiation produced a 30.4 ', '', 'Such a synergistic antibiotic and photothermal therapy provides an innovative way for the treatment of antibiotic-resistant bacterial infections.', 35147632),
('Nanometric layered double hydroxides (LDH) based on Zn(II) and Al(III) and antibiotics', 'Cefazolin (CFZ), a beta-lactam, and nalidixic acid (NAL), a quinolone, were selected and intercalated into LDH obtaining ZnAl-CFZ and ZnAl-NAL samples. These samples were used for the growth of silver nanoparticles with dimension ranging from 2.5 to 8 nm. The release profiles are affected by both the acceptor media water and phosphate buffer and the presence of silver.', '', 'The synergistic antibacterial activity of LDH containing both silver and antibiotics were investigated on gram-positives (Staphylococcus aureus and Streptococcus pneumoniae) and gram-negatives (Pseudomonas aeruginosa) and compared with the plain antimicrobials and LDH containing only antibiotics or silver.', 35160881),
('Turpentine nanoemulsion (TNE)', 'The developed nano-emulsions displayed two fold enhanced antagonistic activity against S. aureus in comparison with TEOs, with minimum inhibitory concentration (MIC) values at 0.039% (v/v) against MRSA.', '', 'Findings from this study validates the phytomedicinal significance of turpentine nanoemulsions and envisage its exploration as a natural and cost-effective strategy against bacterial biofilms in medical and industrial sectors.', 35429586),
('Green synthesis of silver nanoparticles using sodium alginate and tannic acid (AgNPs loaded TA/Na-Alg)', 'The antibacterial and antibiofilm activities of the AgNPs loaded TA/Na-Alg constructs against S. aureus ATCC 6538 were investigated. The MIC of the AgNPs was 31.25 microg/mL. After exposure to the AgNPs, planktonic S. aureus showed irreversible cell membrane damage, decreased cell viability, and changes in cellular morphology. In addition, the AgNps significantly inhibited S. aureus biofilm formation at 1/32 MIC. The biofilm elimination rate was 58.87% after exposure to MIC AgNPs.', '', '', 34920064),
('nanoscale zero-valent iron (nZVI)', 'nZVI addition reduced the concentration of some antibiotics such as doxycycline and sulfamethoxazole. Furthermore, nZVI addition decreased the abundances of most ARGs at the end of composting', '', 'These findings suggest that the addition of nZVI is a promising strategy to minimize ARG release in chicken manure compost.', 34416685),
('Conjugation of Silver Nanoparticles with Thiosemicarbazide', 'minimum inhibitory concentration values of functionalized Ag NPs were at least twofold lower than the Ag NPs (alone). The quantitative PCR data analysis showed a decrease in the expression of the pslA gene in the presence of Ag@Glu-TSC NPs, up to 60%, which was associated with a reduction of biofilm formation compared to control', '', 'In conclusion, the Ag@Glu-TSC NPs can be considered a new inhibitor of biofilm production in antibiotic-resistant bacteria.', 35005985),
('D-alpha tocopheryl polyethylene glycol succinate-modified and S-thanatin peptide-functionalized nanorods based on calcium phosphate nanoparticles', 'for tigecycline delivery and pneumonia therapy caused by tigecycline-resistant Klebsiella pneumoniae', '', 'These findings may provide a therapeutic strategy for infections caused by drug-resistant bacteria.', 35768446),
('cefquinome sulfate oily nanosuspension (CS-NSP)', 'CS-NSP presents suitable stability, physicochemical properties and safety, a rapid release and high bioavailability (about 1.6 times that of commercial cefquinome sulfate injection (CS-INJ, Chuangdao', '', 'Conclusion: The results proved that the new preparation is safe and effective and is expected to become a promising veterinary nanodelivery system.', 35677677),
('natural colloidal minerals (containing iron) and bacteria', 'With three selected iron minerals perturbation experiments, it was found that the conjugative transfer of plasmid that carried kanamycin resistance gene was 1.35 - 3.91-fold promoted by low concentrations of iron minerals (i.e., 5 - 100 mg L-1), but inhibited at high concentrations (i.e., 1000 - 2000 mg L-1) as 0.10 - 0.22-fold.', '', 'Our findings indicate natural colloidal minerals have great potential for applications in preventing the environmental propagation of ARGs through interfacial interactions.', 35472548),
('superhydrophobic micro-nano structured titanium surface', 'antibacterial capability was characterized with Staphylococcus aureus and Escherichia coli', '', 'The results indicated that the superhydrophobic micro-nano structured titanium surface reduced bacteria cell adhesion significantly (>90%) and prevented biofilm formation compared to the unmodified titanium surface after 24 h of incubation.', 35188338),
('AgNP/AMPNanocomposites', 'showed relevant antimicrobial activity in an in vivo subcutaneous infection model in rats', '', 'When compared to single AgNP or AMP coatings, our hybrid nanocoatings showed significant increases in antimicrobial potency against multiple implant infection-related bacterial strains in vitro and in an in vivo rat subcutaneous infection model.', 34896631),
('CNMs (nanocomposite antibacterial agent based on chitosan nanoparticles and AMP microcin J25)', 'caused fast mortality against different growth phases of tetracycline (Tet)-resistant enterotoxigenic E. coli (ETEC) and significantly killed Tet-resistant ETEC in food biological environments, ability to bind lipopolysaccharides (LPS), neutralize endotoxin, and promote diaphragm permeability by damaging the cell membrane', '', 'Taken together, CNMs could be applied as effective antimicrobial/anti-inflammatory agents with lower cytotoxicity in food, medicine, and agriculture to prevent bacterial contamination and infection, respectively.', 35126369),
('metallic nanoparticles (MNPs) dip-coating method for PDS-II sutures', 'possess strong in vitro antibacterial properties against P aeruginosa and S. aureus-varying the %of dead bacteria from ~ 40% (for MgO NPs) to ~ 90% (for Fe2O3) compared to ~ 15% for uncoated PDS-II suture, after 7 days', '', 'All sutures demonstrated minimal cytotoxicity (cell viability > 70%) reinforcing the movement towards the use MNPs as a viable antibacterial technology.', 35039588),
('Ofloxacin@HMPB@HA NPs', 'higher effect against K. pneumoniae by destroying cell integrity and inducing ATP leakage with the assistance of laser irradiation, compared with sole Ofloxacin@HMPB@HA NPs or laser irradiation', '', 'In summary, these results indicate the great potential of this combinational tactic based on Ofloxacin@HMPB@HA NPs for preventing the failure caused by K. pneumoniae infection.', 35338663),
('zinc oxide nanoparticles', 'with boosted antibacterial performance for hygienic products', '', 'Fabricated fabric presenting high hydrophilicity and antibacterial properties have gained increased applications in fabric industry, including hygiene product industry and hence the result of this study would be a welcomed option.', 35079098),
('isoniazid and fluoxetine-conjugated multi-walled carbon nanotube nanofluid', 'to increase drug delivery efficiency alongside eliminating drug resistance in vitro for the treatment of M.Tuberculosis', '', 'This nano-drug delivery method combined with host targeted molecules could be a game-changer in the development of a new generation of antibiotics that have high therapeutic efficiencies, low side effects, and the potential to overcome the problem of drug resistance.', 35688860),
('silver and gold NPs (SNPs and GNPs, respectively)', 'against Brucella melitensis (B. melitensis) and Brucella abortus (B. abortus) strains, MIC values (Microgram/ml) of the 10-nm SNPs and 20-nm GNPs against B. melitensis were 22.43 ', 'Brucella strains develop similar resistance to SNPs and GNPs, and at low dosages, neither SNPs nor GNPs were hazardous to rats.', 'However, a greater dose of NPs (2 mg/kg) harmed all of the tissues studied.', 35834538),
('chitosan-AgNPs and chitosan-AuNP (conjugation of biogenic silver nanoparticles (AgNPs) from Aspergillus sp. Silv2 extract and gold nanoparticles (AuNPs) from Alternaria sp. Gol2 extracts with chitosan )', 'chitosan-AgNP conjugation had better antibacterial ctivity than chitosan-AuNPs, which exhibited moderate activity against S. aureus and very low activity against E. coli. chitosan-AgNP showed a promising anti-biofilm activities on all strains, especially S. aureus, while chitosan-AuNP conjugates showed moderate anti-biofilm against B. subtilis and weak activities against the other three strains.', '', 'These results showed the superiority of chitosan-AgNP as a promising antibacterial as well as biofilm formation inhibitors.', 35625312),
('selenium nanowires modified with nano-silver (Ag NPs) and [Ru(bpy)2dppz]2+ (SRA)', 'SRA (12 Microgram/mL) improves the antibacterial activity of various antibiotics against resistant bacteria and significantly slows the development of bacterial resistance to antibiotics', '', 'SRA has the potential of clinical application as multiple antibiotic adjuvants to deal with resistant bacterial infections.', 35929231),
('As-synthesized copper nanoparticles (CuNPs)', 'against Gram-negative (Escherichia coli and Proteus vulgaris) bacteria', '', 'As-synthesized CuNPs exhibiting promising antibacterial activities and could be a promising candidate for novel antibacterial agents.', 35034356),
('Pullulan (Pull) decorated with monodisperse Ag and Au nanoparticles (NPs)', 'highest antimicrobial activity was found against Ec as 14.4 ', '', 'The promising performance of AgNPs@Pull compared to the commercial antibiotic gentamicin showed that it has great potential as a therapeutic approach to overcome the bacterial resistance that has developed against conventional antibiotics.', 35113519),
('antibacterial glucose oxidase (GOx) is embedded in a Ag graphitic nanocapsule (Ag@G) arrayed silk film to fabricate a GOx-synergistic PTT system (named silk-GOx-Ag@G, SGA)', 'superior synergistic antibacterial effect on the infected Escherichia coli, Staphylococcus aureus, and MRSA in vivo', '', 'This system provides a therapeutic method with low resistance and in situ diagnosis capability for efficiently eliminating bacteria.', 34989177),
('boron nitride (BN) nanosheets', 'potent antibacterial effects in a lung infection model by P. aeruginosa (AMR), displaying a 2-fold increment of survival rate', '', 'Overall, these results suggested that BN nanosheets could be a promising nano-antibiotic to combat resistant bacteria and prevent AMR evolution.', 35511445),
('combination of nisin Z in both PMDA and Beta- cyclodextrin (CD)-based nanosponges (NSs)', 'The minimum and bactericide inhibitory values of the nisin complex with NSs were potentially decreased against both bacteria, compared with the nisin-free sample, while the nisin complex with beta-CD showed lower antibacterial activity.', '', 'Generally, the present study outcomes suggest that the cross-linked beta-CD-based NSs can present their own antimicrobial potency or serve as promising carriers to deliver and enhance the antibacterial action of nisin Z.', 35336058),
('Biopolymer-Capped Ag/Au Bimetallic Nanoparticles', 'against Melanoma and Multidrug-Resistant Pathogens', '', 'In this manner, this study provides promising evidence that the presently fabricated Ag/Au-NPs should be further studied for a wide range of antibacterial and anticancer applications.', 35269267),
('chitosan nanoparticles loaded with beta-lactam antibiotics and beta-lactamase inhibitors', 'The 4 combinations of CNAIs including two cephalosporin antibiotics (cefotaxime and ceftiofur) with two beta-lactamase inhibitors (tazobactam and clavulanate) showed efficient antimicrobial activity against MDR ESBL-producing Enterobacteriaceae.', '', 'Taken together, CNAIs have provided promising potential for treatment of diseases caused by critically important ESBL-producing multidrug resistant pathogens.', 34920071),
('Functionalized Mn3 O4 Nanosheets', 'functionalized Mn3 O4 nanosheets can effectively treat methicillin-resistant Staphylococcus aureus-infected wounds through the triple synergetic therapy', '', 'Moreover, toxicity evaluation in vitro and in vivo has proved the superior biosafety of this material, which is promising to apply in clinical anti-infective therapy.', 35182457),
('Zinc Oxide/CurcuminNanocomposites Synthetized from Stachys byzantina Extract', 'The zinc oxide/curcuminNanocomposites demonstrated effective antibacterial effect in disk diffusion method against five bacterial species. Further, the zinc oxide/curcuminNanocomposites showed a significant inhibitory effect on the growth of breast cancer cells in MTT test.', '', 'Thus, it seems that the synthesized zinc oxide/curcuminNanocomposites, have had promissing high potential antimicrobial and cytotoxic effects.', 35400337),
('Fe3O4@MoS2@SDSNanocomposites', 'displayed superior disinfection ability of Escherichia coli (E. coli), Methicillin-resistant Staphylococcus aureus (MRSA), and Pseudomonas aeruginosa (P. aeruginosa) and in vivo wound healing ability with the help of NIR irradiation', '', 'Overall, our findings revealed that the Fe3O4@MoS2@SDS could be a potential candidate for photothermal-photodynamic therapy and antibiotic resistance gene dissemination inhibition.', 35338964),
('Camellia sinensis extract (CSE) and Prunus africana bark extract (PAE) green synthesized Copper oxide nanoparticles (CuONPs)', 'against carbapenem-resistant bacteria, Phytosynthesized CuONPs exhibited the highest growth suppression zones of 30 mm with MIC ranging from 30 to 125 Microg/ml against MDR bacteria.', '', 'PAE and CSE successfully bio-reduced copper ions to the nanoscale level with potent antimicrobial, photocatalysis, and antioxidant activities.', 35252130),
('antibiotic-loaded mesoporous silica nanoparticles (MSNs)', 'externally functionalized with a thermo-responsive polymer capping layer, and decorated in the outermost surface with superparamagnetic iron oxide nanoparticles (SPIONs), exposure of E. coli biofilms to 200 Microg/mL of the nanosystem and the application of an AMF (202 kHz, 30 mT) decreased the number of viable bacteria by 4 log10 units compared with the control', '', 'The results of the present study show that combined hyperthermia and antibiotic treatment is a promising approach for the effective management of biofilm-associated infections.', 35057058),
('Ag-Au; Ag-Pd; and Ag+-Au+-Pd2+ ions-doped nanoapatites', 'against Drug-Resistant Clinical Strains of Enterococcus faecalis VRE and Staphylococcus aureus MRSA', '', 'Performed analyses confirmed that the nanoapatites doped and co-doped with noble metal ions are safe and excellent antiadhesive and antibiofilm biomaterials with potential use in the future in medical sectors.', 35163457),
('AgNPs from Origanum vulgare leaves', 'against some fish pathogens ( 3 bacterial strains (Streptococcus agalactiae, and Aeromonas hydrophila, both isolated from Nile tilapia and Vibrio alginolyticus, isolated from sea bass) and 3 fungal strains (Aspergillus flavus, Fusarium moniliforme, and Candida albicans, all isolated from Nile tilapia))', '', 'The results obtained declare that the green biological production of silver nanoparticles is safer and more effective than the chemical one; moreover, AgNPs have interesting dose-dependent antimicrobial properties, with better results for biologically produced ones; their effectiveness against tested bacterial and fungal strains opens the way to their use to limit fish diseases, increase economy and improve human health.', 35280558),
('Ag-Pt bimetallic nanoparticles using propolis extract', 'evaluated in vitro by the microdilution method against E.coli, S. aureus, Bacillus subtilis, K. pneumoniae, S. epidermidis, and Serratia marcescens. The results confirmed the antimicrobial activity of bimetallic NPs Ag-Pt concentrations of (25, 50, and 100 Microg/ml). A concentration of 100 microg/ml showed low bacterial viability varying between 22.58% and 29.67% for the six tested bacteria.', '', 'The antibacterial effect of the Ag', 34958781),
('biogenic synthesis of AgNPs using Pseudomonas aeruginosa (MN900691)', 'MIC and MBC concentration against four test strains also showed that among all biogenically synthesized NPs, P. aeruginosa AgNPs showed effective MIC (3.3-3.6 Microg/mL) and MBC (4.3-4.6 Microg/mL).', '', 'Overall, this study suggested that the biogenically synthesized nanoparticles could be utilized as effective antimicrobial agents for effective disease control.', 35034942),
('nanohook-equipped bionanocatalyst (Ni@Co-NC)', 'With the Ni@Co-NC''s synergistic effects, bacterial populations fall by >99.99 %.', '', 'More surprisingly, the mature biofilm shows no recurrence after treatment with the Ni@Co-NC, demonstrating its tremendous potential for treating MDR bacterial related infections.', 34825759),
('5 nm amino-functionalized silver nanoparticles (NH2-AgNPs)', 'NH2-AgNPs (0.5-10 microg/mL) or Ag+ ions (only at 10 microg/mL) inhibited fimbriae expression', '', 'Potent bactericidal effects demonstrated by biocompatible NH2-AgNPs and the lack of toxicity of Citrate-AgNPs lend credence to the hypothesis that small size, positively charged AgNPs may serve as a next-generation antibacterial agent, potentially addressing the rising HAIs and patient health and safety.', 35468937),
('Silver Nanoparticles from Extracts of Wild Ginger ( Zingiber zerumbet)', 'against multidrug-resistant (MDR) Staphylococcus aureus, Streptococcus mutans, and Enterococcus faecalis', '', 'This study indicates that AgNPs of wild ginger extracts exhibit potent antibacterial activity against MDR bacterial strains.', 35335369),
('Photothermal nanofibrillar membrane based on hyaluronic acid and graphene oxide', 'to treat Staphylococcus aureus and Pseudomonas aeruginosa infected wounds', '', 'Here we reported the fabrication of an electrospun membrane based on a hyaluronic acid derivative (HA-EDA) to be used as a bandage for the potential treatment of chronic wounds.', 35760161),
('carbon dots (CDs) coated calcium carbonate nanocarriers (CCNC)', '', '', 'It is concluded that CCNC has the potential to be used as NC for target delivery of antibiotics and may combat toxicity of antibiotics as the inhibition of E. coli was noticed at low MIC concentration.', 34402682),
('Copolypeptoids coated onto magnetic nanospheres', 'Potent Activity against Drug Resistant Bacteria and Biofilms', '', 'The prepared antimicrobials, coated onto magnetic nanospheres show recycling properties and enhanced antibacterial activity as combined with near-infrared (NIR)-induced photothermal antibacterial therapy.', 35142040),
('Carbon nanogels', 'MIC values of the CNGs (0.6 Microg mL-1 against E. coli and S. aureus) remained almost the same against the bacteria after 20 passages; however, the MIC values increased significantly after treatment with Ag nanoparticles, antibiotics, the bacteriostatic chlorhexidine, and especially gentamicin (approximately 140-fold). Additionally, the CNGs showed a negligible MIC value difference against the obtained resistant bacteria after acclimation to the abovementioned antimicrobial agents.', '', 'The findings of this study unveil the development of antimicrobial CNGs as a sustainable solution to combat multidrug-resistant bacteria.', 34742090),
('Graphitic-N-doped graphene quantum dots (N-GQDs)', 'for photothermal eradication of multidrug-resistant bacteria in the second near-infrared window', '', 'Our work provides a novel carbon-based nanomaterial as a photothermal antibacterial agent for efficiently avoiding bacterial resistance and fighting MDR bacterial infections.', 35380572),
('nanoparticles (FeTGNPs) with an antibiotic core (gatifloxacin complexing with tannins) and a photothermal shell (ferric iron coordinating with tannins)', 'From the results of antibacterial experiments, with the synergistic effect of APTT and antibiotics, FeTGNPs (400 microg/mL) could effectively kill methicillin-resistant Staphylococcus aureus (sterilizing rate up to 96.5 %) and gatifloxacin-resistant Staphylococcus aureus (sterilizing rate up to 98.7 %) than equivalent antibiotics.', 'Moreover, under slightly acidic microenvironment, such as infection area, gatifloxacin could accelerate its release from the core of FeTGNPs.', 'Therefore, FeTGNPs would be a highly effective antibacterial agent against drug-resistant bacterial infections in the future.', 34785316),
('SmVO4/UiO-66-NH2 heterojunction nanocomposite', 'for the degradation of antibiotic tetracycline hydrochloride molecules under sunlight, The integration of UiO-66-NH2 with SmVO4 enhanced the light absorption, recombination resistance, carrier lifetime (from 0.382 to 0.411 ns) and specific surface area (from 67.17 to 246 m2/g) of the composite system as confirmed from multiple analyses.', '', 'Therefore, UiO-66-NH2 can be proposed as an effective material to sensitize the rare-earth based photocatalytic material.', 35584713),
('antibody-conjugated liposomes loaded with indocyanine green (ICG) (HpAb-LiP-ICG)', 'developed for targeted photoacoustic (PA) imaging-guided sonodynamic therapy (SDT) of H. pylori infection in vivo', '', 'In conclusion, the HpAb-LiP-ICG-mediated SDT might shed new light on treating H. pylori infection, indicating the clinical translational prospects of this therapy in near future.', 35219867),
('Cu2O/Ti3C2Tx nanosheets', 'boost the photocatalytic eradication of multi-drug resistant bacteria from infected wound', '', 'Conclusion: Upon NIR illumination, Cu2O/Ti3C2Tx nanosheets eradicated MRSA and their associated biofilm to promote wound healing. The Cu2O/Ti3C2Tx nanosheets with superior catalytic and photothermal properties have a great scope as an effective antimicrobial modality for the treatment of infected wounds.', 35590324),
('MoO3-X Nanodots', 'can effectively reduce inflammation, promote epithelial cell regeneration, accelerate angiogenesis, and facilitate DUs recovery', '', 'Most importantly, they present excellent capacity to diminish infection of methicillin-resistant Staphylococcus aureus, manifesting the potent application prospect of MoO3-X nanodots for diabetic wound therapy.', 34927361),
('Co3 O4 Nanowires', 'significant therapeutic efficacy by eradicating colonized bacteria, thus accelerating the healing process of infected wounds', '', 'This nanostructured capacitive electrode provides an antibiotic-free, rechargeable, and wearable approach to treat bacterial skin infection.', 34725946),
('mesoporous silica nanoparticles (MSNs) modified with an ovotransferrin-derived antimicrobial peptide (OVTp12)', 'enabling the antibiotic to be delivered to the vicinity of the pathogenic bacteria. Moreover, we observed that OVTp12-modified nanoparticles effectively inhibited the growth of Escherichia coliin vitro and in vivo.', '', 'Thus, this novel bacterial targeted nanoparticle provides advantages in minimizing bacterial drug resistance and treating bacterial infection.', 34936344),
('palladium nanoparticles decorated bismuth oxybromide nanostructures', 'Pd/BiOBr showed excellent photocatalytic disinfection efficacy with > 99.9% bacterial inactivation. A very low concentration of Pd/BiOBr (0.5 Microg/mL) effectively inhibited the bacterial growth in response to just 2 h of visible light irradiation, while 1 Microg/mL of Pd/BiOBr completely killed all the tested bacterial strains proving their magnificent bactericidal potential.', '', 'The developed materials with exceptional antibacterial broad range efficiency can be used in different photocatalytic disinfection systems including water purification systems, biofilm exclusion and combating differential antibiotic resistance.', 35752021),
('colistin and silver nanoparticles impregnated human amniotic membrane', 'Pseudomonas aeruginosa was the most prevalent pathogen 308 (43.5%), followed by Klebsiella pneumoniae 300 (42.4%). Topical colistin was 100% sensitive for both bacteria.', 'burn wound infected rat model', 'Our study concluded that the increased antimicrobial activity of the novel combination of colistin and silver nanoparticle-loaded decellularized human amniotic membrane manifested its potential as an effective burn wound dressing.', 35440743),
('hydrogels based on gelatin/polyvinyl-alcohol and graphene oxide/silver nanoconjugates', '100% of bacterial growth was inhibited by the action of the topical nanocomposite hydrogel treatments.', '', 'These results led to affirm that these treatments can have an excellent performance in this application as well as in wound healing and dressing, bioadhesives, tissue engineering, and other biomedical applications.', 35846480),
('Nanoassembled amphiphilic choline-calix[4]arene derivative (Chol-Calix)', 'Inhibits Biofilm and Motility of Gram Negative Bacteria', '', 'Chol-Calix appears to be a promising candidate in the search for novel nanosized nonconventional antimicrobials.', 35707153),
('Chitosan nanocrystals (ChsNCs) are rod-shaped polysaccharide-based nanomaterials,', 'designing ChsNC-based nanomaterials to target specific cells by attaching bioactive peptides to the nanomaterial surface.', '', 'Hence useful in targeting AMR', 36241284),
('synergistic activity of colistin and selenium nanoparticles (SeNPs)', 'synergistic interactions between colistin and SeNPs against Ac. baumannii isolates determined as colistin-resistant (MIC range 16-256 microg ml-1 ).', '', 'These findings propose colistin/SeNPs combination as a new option to fight pandrug-resistant Ac. baumannii, the therapeutic possibilities of which should be proved in future in vivo studies.', 35612566),
('single agent or combinational use of three antimicrobials, including cinnamon oil, encapsulated curcumin and zinc oxide nanoparticles (ZnO NPs),', 'The single-agent treatment of cinnamon oil, encapsulated curcumin, or ZnO NPs showed a significant antimicrobial effect against Campylobacter jejuni by generating more than 8-log reduction within 3 h.', '', 'Cinnamon oil affected the integrity of cell membrane, which might lead to an increase in cell permeability. Encapsulated curcumin and ZnO NPs disrupted bacterial outer membranes and cell membranes against the same membrane protein targets. The combinational use of these agents showed synergistic antimicrobial effects. This study provides new insights in combating Campylobacter with minimizing the development of antimicrobial resistance in long-term usage.', 36327661),
('Green synthesis of Zinc Oxide Nanoparticles (ZnONPs) was performed based on Oak galls extract (OGE)', 'The average MIC90s values for the OGE and the Qi-ZnONPs against H. pylori (ATCC-43526) were 37.5 and 18.75 microg/mL, respectively. In comparison, The MIC90s for amoxicillin and clarithromycin (positive controls) were 0.586 and 0.293 microg/Ml. The average MIC90s values for the OGE and the Qi-ZnONPs against H. pylori (ATCC-43526) were 37.5 and 18.75 microg/mL, respectively. In comparison, The MIC90s for amoxicillin and clarithromycin (positive controls) were 0.586 and 0.293 microg/mL,', '', 'These results demonstrated that the Qi-ZnONPs display a significant inhibitory effect on H. pylori growth and encourage further investigations of the synergistic effects of the Qi-ZnONPs in different combinations with amoxicillin as an economical antibiotic. The MIC90 for amoxicillin combinations with OGE was not significantly different, while the MIC90 values for amoxicillin combinations with Qi-ZnONPs were significantly different. The MIC90 decreased two-fold from 18.75 to 9.38 microg/mL, and two-fold from 18.75 to 4.69 microg/mL for amoxicillin: Qi-ZnONPs (1:1 and 1:4, respectively). The amoxicillin: Qi-ZnONPs (1:4) combination is a promising candidate for further studies for use as an economical, effective, and safe anti-H. pylori. drug', 35889432),
('new nano-antibiotic formulation based on sceptrin-Au nano-aggregates (SANA), which are drug-metal ion multiple complexes.', 'SANA showed superior antibiotic/antibiofilm activity toward carbapenem-resistant Gram-negative bacteria with minimum inhibitory concentration (MIC): 25 microM', 'low toxicity to red blood cells and endothelial cells reported', 'SANA consists of a sceptrin-Au ion and is a self-assembled nano-formation with electrostatic interaction. The working mechanism of SANA was identified with analysis of the extracellular reactive oxygen species level and membrane depolarization of bacteria. This work presents a new concept for the development of next-generation nano-antibiotics and a more feasible clinical translational pathway.', 35818999),
('Gold nanocluster adjuvant', 'combining antibiotics and AuNC@CPP, informing a potential approach to improve the treatment of cystic fibrosis and chronic suppurative otitis media (CSOM).', '', 'They established that the mechanism of action of AuNC@CPP is due to disruption of the proton gradient and membrane hyperpolarization. This method could also benefit the current effort to slow resistance development because AuNC@CPP abolished the emergence of drug-resistant strains induced by antibiotics.', 35796201),
('nanosystems self-assembled with amphiphilic dendrimers composed of a long hydrophobic alkyl chain and a small hydrophilic poly(amidoamine) dendron', 'the amine-terminated dendrimer 1a exhibited strong antibacterial activity against both Gram-negative and Gram-positive bacteria, as well as the drug-resistant strain MRSA, with MIC values of 3.1 microM for all strains. Interestingly, the tertiary amine-terminated dendrimer 1b showed similar levels of antibacterial activity towards E. coli as 1a, but differed from 1a in that it was ineffective against all other tested bacteria', 'To evaluate the safety of these dendrimers, we examined their cytotoxicity on fibroblast (L929) and kidney (HEK293) cell lines using the PrestoBlue assay. No notable adverse effect was observed for amine-terminated dendrimer 1a, tertiary amine-terminated dendrimer 1b and carboxylic acid-terminated dendrimer 1d at concentrations up to 200 microM, whereas arginine-terminated dendrimer 1c showed considerable toxicity towards both cell types', 'treatment with 1a led to significant outer membrane permeation in E. coli , and rapid inner membrane depolarization in both E. coli and MRSA. Suggesting that the bacterial death was indeed associated with permeation and depolarization of both the outer and the inner membranes. The amine-terminated dendrimer 1a showed the most powerful activity against both Gram-positive and Gram-negative bacteria, as well as drug-resistant bacteria and allowed biofilm eradication, while having low toxicity and good safety profile', 35649277),
('polyvalent phages conjugated with magnetite (Fe3O4) nanoparticles to form nanomicrobial conjugates (NMCs).', 'NMCs showed enhanced antibacterial activity against most of the bacterial isolates obtained from clinical and environmental samples such as (e.g., E. coli, K. pneumoniae, Pantoea agglomerans, Pseudomonas oleovorans) Pilot studies showed that NMCs can selectively eliminate up to 98.3% of AMR in wastewater.', '', 'Biosurfactant-functionalized Fe3O4 nanoparticles (FNMCs) were found to have higher phage loading capacity, with a significant value of p < 0.0127 and a zeta potential of -22.2 mV. These findings indicate a synergistic effect of both phage and nanomaterial and this technology is expected to be a new lead in wastewater management.', 36030912),
('silver nanoparticles (Ag NPs) from an aqueous extract of Trigonella incise,', 'the nanoparticles showed more significant antimicrobial activity against Salmonella typhi (S. typhi) and Staphylococcus aureus (S. aureus) with an inhibition zone of 21.5 mm and 20.5 mm at 6 microg/mL concentrations, respectively, once compared to the standard reference. At concentrations of 2 microg/mL and 4 microg/mL, all of the bacterial strains showed moderate activity, with inhibition zones ranging from 11 mm to 18.5 mm. Even at high concentrations of AgNPs, S. typhi showed maximum resistance.', '', '(Ag NPs) from an aqueous extract of Trigonella incise, which serves as a reducing and stabilizing agent. The obtained results showed an 85% yield of nanoparticles by using 2:5 (v/v) of 5% plant extract with a 0.5 M solution of AgNO3. They concluded that the antibacterial and antifungal activities showed satisfactory results from the synthesized Ag NPs.', 35889490),
('nanoparticles containing cinnamon oil (CO-SLN)', 'The antibacterial effects of CO-SLN and Cinnamomum verum (cinnamon oil) CO were reported with MIC Value of 60-75 microg/mL and 155-165 microg/mL and MBC value of 220-235 microg/ml and 540-560 microg/ml, respectively. On the other hand, CO-SLN with 1/2 MIC concentration had the greatest inhibition of biofilm formation in 24 h of incubation (55.25%) against Multi-drug Resistant Escherichia coli', '', 'The data presented indicate that the MIC of CO-SLN has significantly reduced and it seems that Solid lipid nanoparticles (SLN) has facilitated and promoted CO transmission through the cell membrane.', 36352402),
('bacterial cellulose (BC) was impregnated with graphene quantum dots (GQDs)', 'Novel GQDs-BC hydrogel composites are biocompatible and showed significant inhibition towards Staphylococcus aureus and Streptococcus agalactiae and bactericidal effect towards Methicillin-resistant Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.', 'Novel GQDs-BC hydrogel composites are biocompatible and showed significant inhibition towards Staphylococcus aureus and Streptococcus agalactiae and bactericidal effect towards Methicillin-resistant Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.', 'GQDs-BC hydrogel composites showed very good wound fluid absorption and water retention, which satisfies good dressing properties. results confirm the potential of new designed GQDs-BC composite hydrogels in angiogenesis and regeneration processes necessary to completely restore the structure and function of wounded skin.', 35191591),
('new nanosystems containing gold (Au) and coated with biodegradable surfactants (TG) linked to the antibiotic (AT) by means of small DNA chains, Au@TG/DNA-AT', 'MICs of biosynthesized AgNPs for E. coli and S. aureus were 6.25 and 50 mg/mL, respectively. Another study showed antimicrobial agents such as biosynthesized ZnONPs, where the MICs were 8 and 4 mg/mL against E. coli and S. aureus, respectively. Another antimicrobial agent was phenyllactic acid, where the MIC was 2.5 against E. coli. Another study showed for green synthesized AgNPs a MIC of 6.25 microg/mL in E. coli', 'In internalization experiments, depending on the treatment application time, greater bacterial destruction was observed for both the Ni precursors and the Ci nanosystems tested after 18 h of incubation time.', 'Finally, our results show that the nanosystem composed of the Au@16-3-16 nanoparticle and the DNA/TC complex is appropriate for medical use. Moreover, Au@16-3-16 nanoparticles act as antibiotics by themselves in the absence of TC, given the fact that gold nanoparticles possess strong antibacterial properties for both Gram-negative and Gram-positive bacteria, possibly due to membrane damage or electrostatic interaction with internalization by endocytosis. Gold-TC nanosystems may be an answer to the necessity for reduction of antibiotics, allowing a decrease of the amount used, especially in Gram-positive bacteria.', 36145689),
('ZnO and Mn-doped ZnO NPs nanofunctionalized Ti scaffolds', 'ZnO@Ti and ZnxMn(1-x)O@Ti displayed an enhanced antibacterial activity against both Gram-positive Staphylococcus aureus (S. aureus) and Gram-negative Pseudomonas aeruginosa (P. aeruginosa) bacterial strains. t has been observed that ZnxMn(1-x)O@Ti scaffolds reach a complete eradication for S. aureus and 90 % of reduction for P. aeruginosa', '', 'first study reported in the literature describing ZnO and Mn-doped ZnO NPs nanofunctionalized Ti scaffolds with improved antibacterial performance', 36587469),
('synergistic effect of a polymyxin derivative known as polymyxin B nonapeptide (PMBN) with azithromycin (AZT).', 'PMBN was able to re-sensitize the bacteria to AZT, even in strains with high minimum inhibitory concentrations (MIC: 32 to =128 microg/ml) for AZT, against antibiotic-resistant Escherichia coli', 'Killing kinetics study showed a significant reduction of bacterial growth after 6 h of treatment with complete killing achieved after 24 h.', 'bacteria treated with PMBN alone or in combination with AZT, with evidence of damage to the outer membrane. These results suggested that PMBN acted by increasing the permeability of bacterial outer membrane to AZT. PMBN is a good candidate for use with other antibiotics to potentiate their activity, but further studies are required in vivo. This will significantly contribute to resolving antimicrobial resistance crisis.', 36212888),
('series of nanolayered structures and nanohybrids', 'The nanomaterials prepared were used against a group of microorganisms, including E. coli, S. aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa. Experimental results revealed that a nanohybrid based on carbon nanotubes and fatty acids showed significant antimicrobial activity against E. coli. nanolayered structure combined with carbon nanotubes showed a significant and clear inhibitory effect on S. aureus, Klebsiella pneumoniae and Pseudomonas aeruginosa.', '', 'It is concluded that the nanolayered structures and nanohybrids, which can be modified at low cost with high productivity, can be considered good candidates for preventing infectious disease and inhibiting the spread of bacteria, especially those that are commonly found in wastewater and the environment.', 36014614),
('five cationic nano-sized hyperbranched polymers (CNHBPs) with cationic functional groups have been constructed', 'Q12-CNHBP exhibited superior in vivo therapeutic efficacy for methicillin-resistant Staphylococcus aureus (MRSA) infection', 'Q12-CNHBP exhibited superior in vivo therapeutic efficacy in a mouse wound model of methicillin-resistant Staphylococcus aureus (MRSA) infection with low toxicity during treatment', 'negatively charged surfaces of bacterial cells provided Q12-CNHBP with a higher intrinsic electrostatic driving force for bacterial killing than that with S12-CNHBP. These advantages and ease of preparation will undoubtedly distinguish Q12-CNHBP as a new class of suitable candidates to combat multidrug-resistant pathogen infections. This study opens up a new avenue for exploiting antibacterial biomaterials to treat infections caused by drug-resistant bacteria.', 36004750),
('prepared Au@CDs composite nanoparticles (Au@CD) comprised of gold nanoparticles (AuNPs) and carbon dots (N,S-CDs)', 'The resultant Au@CD membrane exhibited excellent biocompatibility and photothermal antimicrobial activity. In vitro photothermal antibacterial inactivation studies confirmed their efficacy against S. aureus and E. coli (99 + % inactivation of both pathogens under NIR irradiation)', '', 'The resultant Au@CD membrane exhibited excellent biocompatibility and photothermal antimicrobial activity. This reduce the risk of bacterial infection, suppress inflammation as well as improve collagen deposition and angiogenesis, all of which together facilitated wound closure and resulted in a better therapeutic effect than the controls. Taken together, this work confirms that NIR-irradiated Au@CD-based membranes and related materials are promising photothermal antimicrobial platforms for wound dressings and related healthcare applications.', 36308860),
('multifunctional Gallium-Based Nanoplatform (Ga-mSiO2-BFN) comprised of clinically approved gallium, mesoporous silica, and bromfenac (BFN) as a co-modified', 'Gallium-Based Nanoplatform (Ga-mSiO2-BFN) comprised of clinically approved gallium, mesoporous silica, and bromfenac (BFN) as a co-modified release system to simultaneously eradicate Multidrug-Resistant Pseudomonas aeruginosa', '', 'The released gallium ions can disrupt bacterial iron metabolism. All composites of our nanoplatform were FDA approved, making the Ga-mSiO2-BFN as a potentially promising therapeutic approach for treating Multidrug-Resistant Pseudomonas aeruginosa in PCE accompanying satisfactory prognosis and prospects for clinical translations.', 36373472),
('novel supramolecular photothermal nanoparticles (MCC/CS NPs), assembled from mono-carboxyl corrole (MCC) and chitosan via hydrogen bonding and p', 'the MCC/CS NPs achieve potent photothermal and inherent antimicrobial synergistic effects against Escherichia coli and methicillin-resistant Staphylococcus aureus (MRSA) in vitro.', '', 'The MCC molecules possess good photothermal performance and the chitosan with inherent bioactivity can exert moderate antibacterial effects. the bacteria-infected diabetic wound model confirms that the MCC/CS NPs can effectively kill drug-resistant bacteria, accelerate wound healing and angiogenesis, and show good biocompatibility, representing a novel and efficient photothermal antibacterial nanoplatform.', 36168853),
('Green synthesis of a multimetallic/ternary nanocomposite formed of silver (Ag), titanium dioxide (TiO2), and iron(III) oxide (Fe2O3), conjugated to chitosan (CS), in which the large spectrum fluoroquinolone antibiotic ciprofloxacin (CIP) has been encapsulated.', 'The antimicrobial potential of the nanoparticulate drug delivery system (NDDS) was elicited by prominent ZIs against MDR E. coli (33 ', 'The viability of bovine mammary gland epithelial cells (BMGE) treated with the NDDS remained superior to 90%, indicating a negligible cytotoxicity (p < 0.05).', 'Nanomaterials have many advantages over traditional antibiotics, including improved stability, controlled antibiotic release, targeted administration, enhanced bioavailability, and the use of antibiotic-loaded nanomaterials. the newly prepared CIP-Ag/TiO2/Fe2O3/CS nanoformulation appears safe, biocompatible, and therapeutically active to fight MDR E. coli strains-causing mastitis.', 36015345),
('cerium oxide (CeO2 ) nanoparticles (NP) of two different sizes (CeO2 NP1 [1-2 nm] and CeO2 NP2 [10-12 nm])', 'CeO2 NPs were found to show 100% microbial cell viability inhibition at a concentration of 500 mg/L. In addition, CeO2 NP1 and CeO2 NP2 inhibited the biofilm formation of S. aureus and P. aeruginosa.', 'Larger cerium oxide nanoparticles were found to be less toxic against erythrocytes compared with the smaller ones. CeO2 nanoparticles demonstrate low cytotoxicity towards erythrocytes', 'he antimicrobial activity, effects of nanoparticles on DNA cleavage, microbial cell viability, and biofilm formation inhibition were analyzed. CeO2 NP1 and CeO2 NP2 exhibited single-strand DNA cleavage ability. CeO2 nanoparticles demonstrate moderate antimicrobial activity and low cytotoxicity towards erythrocytes, which make them promising antibacterial agents.', 36420776),
('polyacrylonitrile (PAN) nanofibers coated with silver nanoparticles (AgNPs) and silver(I,III) oxide.', 'New PAN-AgNPNanocomposites generally had better antimicrobial efficiency against E. coli and L. crispatus', '', 'our results indicate that PAN-AgNPNanocomposites successfully display antimicrobial activity against various bacteria. study demostrate PAN-AgNP nanofibers can be used as an effective alternative antimicrobial material that is more cost-effective and easier to store in certain industries or fields of study.', 36591150),
('novel nanotechnology that combines silver with glutathione (GSH) to form antibacterial nanoclusters, GSH@AgNCs.', 'The results indicated that GSH@AgNCs were more successful in restricting E. coli than S. aureus.In addition, at low concentration (1/8 MIC), GSH@AgNCs significantly inhibited the formation of biofilms and damaged mature biofilms, reducing the viable cells.', '', 'This study demonstrated that GSH@AgNCs effectively hindered the proliferation of foodborne Gram-positive bacteria (S. aureus) and Gram-negative bacteria (E. coli), providing new feasibility for applying organic composite nanomaterials and nanotechnology in the food industry.', 36076447),
('Polymyxin B- hyaluronic acid (PMB-HA) nanoparticles', 'The antibacterial efficiency of PMB-HA nanoparticles against P. aeruginosa was more than 70% at 4 microg mL-1 (with respect to PMB in the PMB-HA nanoparticles), and reached nearly 100% when the concentration was higher than 8 microg mL-1', 'With respect to the PMB-HA nanoparticles in the NS solution, the hemolysis rates were less than 3% at concentrations ranging from 32 to 1024 microg mL-1. mice were intravenously injected with high doses of PMB-HA nanoparticles or free PMB (10 mg kg-1 with respect to PMB, 3-fold higher than the therapeutic dose. After 24 h of medication, all of the mice in PMB-HA groups were still alive, whereas 4 out of 5 mice treated with free PMB died within the first 20 minutes.', 'results indicated that the PMB-HA nanoparticles exhibited superior treatment outcomes for pneumonia as compared with free PMB. PMB-HA nanoparticles can precisely target the CD44 receptors over-expressed on the membrane of activated endothelial cells in inflammatory sites, and come into contact with the bacteria surrounding the damaged alveolar-capillary membrane. This smart LPS-triggered responsive behavior of nanoparticles enables both increased therapeutic effects and enhanced biosafety', 36039653),
('graphene oxide-loaded aptamer/berberine bifunctional complex', 'The GO-loaded aptamer/berberine bifunctional complex displayed a higher suppression of biofilm formation against MRSA. 91.3% of fluorescence was quenched by 60 microg/mL GO, suggesting that 60 microg/mL GO could effectively quench the fluorescence of berberine/aptamer 1 (with 200 nM aptamer 1) via fluorescence energy resonance transfer (FERT). Berberine at concentrations of 50 and 100 microg/mL inhibited the expression of four key genes in MRSA biofilm formation. When the berberine concentration was 100 microg/mL, the relative expression levels of these genes decreased to less than 50%', 'For the sensitivity assay, various amounts of MRSA cells ranging from 800 to 107 colony-forming units (CFU)/mL were incubated with 200 nM FAM-labeled aptamer 1.', 'simultaneous delivery system based on GO for the targeted inhibition of MRSA biofilm formation was successfully designed using a self-assembly technology.', 35616277),
('Nanobodies (NbSOSs)', 'Nanobodies (NbSOSs) repressing SOS response in Escherichia coli', '', 'NbSOSs can inhibit LexA autoproteolysis and block the SOS response axis in bacteria. Biophysical characterization of NbSOSs-LexA complexes discloses inhibition mechanism. Hence studies pave the way to the development of new-generation antibiotic adjuvants for the treatment of bacterial infections.', 36240773);
INSERT INTO `bacteria_np` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Azithromycin Encapsulated into poly (lactic-co-glycolic acid) (PLGA) Nanoparticle', 'A dramatic improvement of antibacterial activity was recorded for AZI-PLGA NPs over free AZI, where the MIC values of AZI-PLGA NPs were four times less than the MIC value of free AZI. MIC value reduced from >1000 to 256 microg/mL and from 256 to 64 microg/mL for E. faecalis and MRSA, respectively, contrary to no change detected for MIC values in the case of P. aeruginosa.', 'Wi-38 cells, human lung fibroblast cell lines were cultured in a complete DMEM culture medium gainst P. aeruginosa, MRSA, and E. faecalis. This is indicative of the less in vitro cytotoxicity of nano-formulations compared to free AZI.', 'These results revealed that AZI-PLGA NPs retained AZI antibacterial activity against resistant bacteria carrying efflux mechanism. This gave a new hope to manage infections in the future', 36421266),
('Ofloxacin-loaded HMPB NPs with the combination of PTT', 'a nanocomposite of HMPB NPs with inherent photothermal therapy capability was used to eradicate K. pneumoniae after loading with Ofloxacin', '', 'The nanocomplexes named as Ofloxacin@HMPB@HA NPs showed a higher effect against K. pneumoniae by destroying cell integrity and inducing ATP leakage with the assistance of laser irradiation, compared with sole Ofloxacin@HMPB@HA NPs or laser irradiation. these results indicate the great potential of this combinational tactic based on Ofloxacin@HMPB@HA NPs for preventing the failure caused by K. pneumoniae infection.', 35338663),
('FeS2@GO-Based Heterogeneous Photo-Fenton Process (nano pyrite (FeS2) on graphene oxide)', 'Low reagent doses of FeS2@GO catalyst (0.25 mg/L) and H2O2 (1.0 mM) were found to be efficient for removing 6-log of Antibiotic Resistant Bacteria ARB and 7-log of extracellular , Antibiotic Resistance Genes ARG (e-ARG) after 30 and 7.5 min treatment, respectively, in synthetic wastewater', '', 'The stable and recyclable composite generated more reactive species, including hydroxyl radicals (HO', 35759741),
('Nanopolymer-based poly (propargyl alcohol)', 'Nano-PGA-DMF exhibits significant antimicrobial potential against Staphylococcus aureus (S. aureus) (20.20 mm; zone of inhibition (ZOI), and 0.47 microg/mL; minimum inhibitory concentration (MIC), followed by Escherichia coli (E. coli) (14.50 mm; ZOI, and 1.87 microg/mL; MIC. In antibiofilm results, the highest inhibition percentage of the synthesized nano-PGA-W (water), nano-PGA-Ch (chloroform (Ch), and nano-PGA-DMF (dimethylformamide) was documented for S. aureus (17.01%, 37.57%, and 80.27%), followed by E. coli (25.68%, 55.16% and 78.11%), and C. albicans (40.10%, 62.65%, and 76.19%), respectively.', '', 'The amount of bacterial protein removed is directly proportional after increasing the concentration of nano-PGA-W, nano-PGA-Ch, and nano-PGA-DMF samples (at different concentrations) and counted to be 70.58, 102.89, and 200.87 microg/mL, respectively following the treatment with 1.0 mg/mL of each sample. It was found that the nano-PGA polymer prepared in DMF has better antimicrobial activity than one prepared in chloroform than in water.', 36152795),
('silver nanoparticles obtained by green synthesis using a leaf extract and fungi', 'The minimal inhibitory concentration (MIC) of the NP was tested by the microdilution method, finding that MICs for F-NP (between 4 and 128 microg ml-1) were similar to those for L-NP (between 8 and >128 microg ml-1) effective against P. aeruginosa infections.', 'nanoparticles were nontoxic for larvae of the moth Galleria mellonella,', 'Both nanoparticles showed a potent antibacterial effect, causing severe damage to the cell wall, membrane and DNA, and inducing the production of reactive oxygen species. Moreover, the nanoparticles derived from fungi showed synergistic antibacterial effects with the antibiotics meropenem and levofloxacin. encouraging further research for their implementation in the treatment of P. aeruginosa infections.', 35687297),
('zinc oxide nanoparticles', 'ZnO NPs exhibited high antibiofilm activity against B. cereus and E. coli with minimum biofilm inhibitory concentration (MBIC) of ZnO NPs at 46.8 microg ml-1 and 93.7 microg ml-1.', '', 'Disruption of membrane integrity exhibited with reduced exopolysaccharides secretion and leakage of nucleic acids. This study emphasizes the potential mechanisms underlying the selective bactericidal properties of ZnO NPs and highlighted the strong interaction of ZnO NPs with intracellular components leading to biofim destruction. Therefore, ZnO NPs could be considered as a promising antibiofilm agent and thus could expand the possibility to use as therapeutic agent.', 36152464),
('light-mediated oxidation of AgNPs conjugates using protoporphyrin IX (PpIX) as a photosensitizers (PS). Also, polyethyleneimine (PEI) coated AgNPs. Tested the antimicrobial effect of three nanoparticles: AgNPs, PpIX-AgNPs, and PEI-PpIX-AgNPs', 'PpIX-AgNPs were the most effective material achieving >7 log inactivation of MRSA and MDR E. coli. The order of bacterial log inactivation was PpIX-AgNPs > PEI-PpIX-AgNPs > AgNPs.', 'All NPs showed negligible cytotoxicity to mammalian cells at the bacterial inhibitory concentration after 24 h exposure', 'This order correlates with the trend of Ag+ concentration released by the NPs (PpIX-AgNPs > PEI-PpIX-AgNPs > AgNPs). Our study confirms a synergistic effect between PpIX and AgNPs in the inactivation of AR pathogens with about 10-fold increase in inactivation of ARB relative to AgNPs only. The concentration of Ag+ released from NPs determined the log inactivation of MRSA and MDR E. coli more than either the phototoxic effect or the electrostatic interaction promoted by surface charge of nanoparticles with bacteria cells.', 36545324),
('Gardenia thailandica methanol extract (GTME) to biogenically synthesise zinc oxide nanoparticles (ZnO-NPs)', 'The antibacterial activity of ZnO-NPs was studied both in vitro and in vivo against Pseudomonas aeruginosa clinical isolates. Its minimum inhibitory concentration values ranged from 2 to 64 microg/mL, and it significantly decreased the membrane integrity', 'The in vivo study (biochemical parameters and histological investigation) was conducted and it revealed a protective effect of ZnO-NPs against the deleterious influences of P. aeruginosa bacteria on lung, liver, and kidney tissues.', 'the green synthesised ZnO-NPs by GTME could be regarded as a future antimicrobial compound to treat systemic infections caused by P. aeruginosa. Future clinical investigations should be performed to assure the therapeutic value of ZnO-NPs in humans.', 35361019),
('colloidal platinum nanoparticles', 'The lowest MIC value obtained for platinum nanoparticles was against K. pneumoniae ESBL+ MFBF 10690 = 3.13 ', '', 'We conclude that platinum nanoparticles exhibit potent antibacterial effects against standard laboratory and resistant strains of E. coli and K. pneumoniae. Both, cell wall damage and ROS induction could have important role as mechanisms of antibacterial activity.', 36015339),
('Engineered organic nanoparticles', 'EPS destruction and stimuli-responsive release enhance biofilm eradication to the bacteria', '', 'Nanoparticles are potent in biofilm penetration and elimination. Size and surface properties are crucial for biofilm penetration. novel strategies are being developed to further enhance the antibiofilm capacity of NPs, including size optimization, surface modification, stimuli-triggered release, and combined strategies. Thus, NPs represent an effective and promising approach to combat biofilms.', 36403883),
('novel nanoparticles (NPs) loaded with the natural bactericide farnesol (FSL NPs)', 'The nanoformulation of farnesol improved its antibacterial properties and demonstrated complete eradication of Staphylococcus aureus within less than 3 h, without inducing resistance development, and was able to 100% inhibit the establishment of a drug-resistant S. aureus biofilm. These antibiotic-free nano-antimicrobials also reduced the mature biofilm at a very low concentration of the active agent. The novel FSL NPs demonstrated very strong bacterial growth inhibition at 4 ', 'The novel FSL NPs did not cause skin tissue irritation in a 3D skin tissue model.', 'The hydrophobic nature of farnesol facilitates its accumulation in the bacterial membrane, causing cell leakage and death. These results support the potential of these bio-based nano-actives to replace the existing antibiotics and they may be used for the development of topical pharmaceutic products for controlling microbial skin infections, without inducing resistance development.', 35886883),
('zinc ferrite nanoparticles (ZnFe2O4 NPs)', 'ZnFe2O4 NPs in an anti-biofilm study by inhibiting biofilm formation up to 81.76% and reducing mature biofilm up to 56.22% at 75 microg/mL the minimum inhibitory concentration value against opportunistic pathogens Klebsiella pneumoniae (K. pneumoniae)', '', 'Results of the present study demonstrate that the ZnFe2O4 NPs endow an excellent antibacterial efficiency with a maximum zone of inhibition i.e.16 mm. The reactive oxygen species (ROS)-induced bacterial damage is caused by the ZnFe2O4 NPs. Hence therapeutic possibilities of the ZnFe2O4 NPs in antimicrobial applications are discussed which are helpful to overcome the challenges associated with biofilm infectivity.', 35467317),
('Chitosan nanoparticles-microcin J25 (CNM)', 'Anti-infective results proved that oral 0.1% CNM enhances host defense against E. coli O157:H7 infection by improving immune functions', 'high concentrations of CNM induced serious adverse effects, negatively improving intestinal health targets.', 'CNM as a promising AP may markedly enhance host immunity and therapeutic effects by oral administration.', 36153996),
('CGA-PLGA@PVP nanomicelles', '', '', 'have great properties and are expected to be a novel therapeutic strategy for periodontitis.', 35975567),
('silver nanoparticles (AgNPs) using the potential probiotic strain Lactobacillus acidophilus', 'The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of green synthesized AgNPs against the Multi-drug Resistant Enteroaggregative Escherichia Coli (MDR-EAEC ) strains were found to be 7.80 mg/L and 15.60 mg/L, respectively.', 'he green synthesized AgNPs were found safe by in vitro haemolytic assay', 'the green synthesized AgNPs exhibited significant biofilm inhibition (P < 0.001) formed by MDR-EAEC strains. Additionally, a concentration-dependent antioxidant activity was observed. Hence, this study demonstrated potential antibacterial as well as antibiofilm activity of green synthesized AgNPs against MDR-EAEC strains with antioxidant properties and warrants further in-depth studies to explore it as an effective antimicrobial agent against MDR infections.', 35715714),
('Vancomycin Capped with Silver Nanoparticles', 'Vancomycin-coated silver nanoparticles inhibited S. aureus and E. coli', '', 'Van@citrate-AgNPs had improved significant ability towards both S. aureus (Gram-positive) and E. coli (Gram-negative), according to an in vitro antibacterial assay. In the end, it is concluded that the Van@citrate-AgNP is more potent than the single entity vancomycin towards both S. aureus and E. coli.', 36046462),
('silver nanoparticles', 'The Ag NPs were effective against CPGB, with minimum inhibitory concentrations ranging from 64 to 8 microg/ml on average. combination of Ag NPs and antibiotics demonstrated synergistic and partial synergistic activity (fractional inhibitory concentration between 0.13 and 0.56) against CPGB, significant reduction in antibiotic concentrations, particularly in the case of A. baumanii versus ceftriaxone (1024 to 4 microg/ml)', '', 'The notable synergistic activity of Ag NPs with antibiotics represents a valuable nanomedicine that may find clinical application in the future as a combined remedy.', 36085334),
('silver and gold complexes of imidazole and 1,2,4-triazole derived N-heterocyclic carbenes', 'Two of the silver(I) complexes have promising antibacterial activity against Acinetobacter baumannii (3f, MIC = 2', '', 'Silver(I) complex 3f and gold(I) complex 4c were tested against multi-drug resistant bacterial strains and high levels of antibacterial activity were observed.', 35876319),
('Moxifloxacin-loaded solid lipid nanoparticles', 'Nanoparticles loaded them with MOX to determine its release, antibacterial activity against E. coli', 'Cytotoxicity testing did not reveal significant toxicity of nanoparticles, whether Moxifloxacin- MOX-free or MOX-loaded, against RAW 264.7 cells.', 'Moxifloxacin-loaded solid lipid nanoparticles increase antibacterial treatment efficacy in view of the growing antibiotic resistance.', 36607722),
('trimetallic metal-organic framework nanosheets ( NiCoCu )', 'MOF nanosheets with peroxidase-like activity. (Ni2Co1)0.5Cu0.5 exhibited the best antibacterial activity against gram-positive Escherichia coli and methicillin-resistant Staphylococcus aureus bacteria', '', 'Animal wound healing experiments demonstrate that ultrathin trimetallic nanosheets can effectively contribute to wound healing with excellent biocompatibility. This study reveals the immense potential of ultrathin trimetallic MOF nanosheets for clinical antibacterial therapy for future pragmatic clinical applications.', 36027783),
('Tryasine-silver nanoparticles', 'Tryasine-silver nanoparticles were more effective with MICs ranging from 30 to 100 microM determined against Staphylococcus aureus, Escherichia coli, methicillin resistant Staphylococcus aureus, and ESBL Escherichia coli', 'Tryasine-silver nanoparticles at concentration of 100 microM only caused 1% hemolysis on human erythrocytes after 30 min of incubation.', 'The findings indicate that Tryasine-silver nanoparticles had good antibacterial activity against pathogenic strains of Gram-positive and Gram-negative bacteria. Additionally, the conjugate showed low hemolytic activity and cytotoxicity. Therefore, conjugation of Tryasine with silver nanoparticles is a promising treatment candidate for bacterial infection with low toxicity.', 36009893),
('biosynthesize Au-Ag nanoparticles using propolis', 'The MIC and the MBC of P. aeruginosa and S. sciuri were 31.25 microg/mL. However, nanoparticles were more effective on S. enterica with MIC of 7.5 microg/mL and MBC of 15.6 microg/mL. Furthermore, the time-killing curve of the three model bacteria with the treatment was effective at 50 microg/mL.', 'the results indicated that the biosynthesized Au@AgNPs have a cytotoxic effect on HEPG2 cell lines.', 'his research revealed that the green synthesized Au@AgNPs could be effective antibacterial agents against S. sciuri, P. aeruginosa, and S. enterica and anticancer agents against HEPG2.', 35987838),
('ZnO Nanoparticles', '26 and 22 mm zones of inhibition for a size of 20 nm and a concentration of 20 mM against 105 and 107 CFU/mL S. aureus, respectively. The MIC of ZnO NPs of various sizes, 20 and 50 nm, with 105 CFU/mL was 2.5 and 5 mM, respectively. MIC with 107 CFU/mL was five mM for 20 and 50 nm ZnO NPs. the highest growth reduction percentage, 98.99% in the counts of S. aureus was achieved by ZnO NPs of size 20 nm and concentration of 10 mM.', '', 'morphological changes and cell shape distortion were detected by scanning electron microscope for bacterial cells treated with ZnO NPs.', 36295097),
('green synthesis of silver nanoparticles from leaf extract of Coleus forskohlii.', 'ilver nanoparticle exhibits significantly better antimicrobial activities as compared to the plant extract in case of nearly all pathogens with a maximum zone of inhibition of 15.33 ', '', 'ecause of this broad-spectrum activity of nanoparticles as well as the leaf extracts against life-threatening microbes, it can be used as future generation drugs.', 35992896),
('Chrysophyllum albidum peels (mostly regarded as waste) to prepare silver nanoparticles (Alb-AgNPs).', 'The antimicrobial properties of the Alb-AgNPs were studied with selected microorganisms namely; S. aureus, E. coli, K. pneumoniae, B. subtilis, S. mutans, P. aeruginosa, S. typhi, and Candida albicans. High inhibitory activity against the microorganisms were exhibited with MICs ranging from 15.62 to 1000 microg/mL.', '', 'the Alb-AgNPs could serve as a biofilm inhibitor with the highest percent inhibition of about 92% against methicillin-resistant Staphylococcus aureus. The results from this study thus provide access to the simple, sustainable, economic and eco-friendly synthesis of silver nanoparticles with efficient antimicrobial properties as drug candidates as a means of overcoming the prevailing antibiotic resistance menaces.', 36586061),
('pH-responsive nanoparticles by simply self-assembly of an amphiphilic poly(ethylene glycol)-Schiff-vancomycin (PEG-Schiff-Van) 35386319', 'effectively kill the bacteria at an early period and continuously exerting an bacteria-sensitive effect whenever needed over a long period.', '', 'this system was designed to have programmable structural destabilization and sequential drug release due to changes in pH that were synonymous with bacterial infection sites, thereby presenting prominent antibacterial therapy both in vitro and in vivo. This work represents a synergistic strategy on offering important guidance to rational design of multifunctional antimicrobial vehicles, which would be a promising class of antimicrobial materials for potential clinical translation.', 35386319),
('Bryophyllum pinnatum mediated synthesis of zinc oxide nanoparticles', 'The synthesized green nanoparticles, when tested against a few highly MDR uropathogenic bacteria (E. coli, E. furgusonii, K. pneumoniae, S. flexneri, and P. aeruginosa), were observed to exhibit high antimicrobial response (zones of inhibition ranging between 22 mm to 28 mm), thus confirming that these were bestowed with potent antimicrobial ability.', '', 'it could be concluded that Bryophyllum- ZnO nanoparticles can be used as potential nanoantibiotic sources to deal with UTIs.', 36303898),
('Jacalin Lectin-Fortified Cationic Copper Sulfide Nanoparticles (cCuS)', 'The minimum inhibitory concentration (MIC) of cCuS was 62.5 microM, which was 2-fold lower than that of the broad-spectrum antibiotic ciprofloxacin. Treat Carbapenem-Resistant Acinetobacter baumannii Infection', '', 'JcCuS hindered pellicle formation and inhibited the biofilm-associated virulence factor of CRAB such as exopolysaccharide, cell surface hydrophobicity, swarming, and twitching mobility. The anti-infective potential of JcCuS was demonstrated by rescuing CRAB-infected zebrafish. The findings illustrate that lectin fortification offers a unique advantage in enhancing the therapeutic potential of antimicrobials against human pathogens of critical priority worldwide.', 36506188),
('polymer nanoparticles based on polyglycerol adipate (PGA) grafted with polycaprolactone (PCL) developed as carriers for usnic acid (UA)', 'UA loading (0.3 mg/mg of NP). All of the UA-loaded NP systems showed a significant and prolonged antimicrobial activity towards a standard strain of Staphylococcus epidermidis.', '', 'The developed nanosystems showed a prolonged antimicrobial activity (up to at least 7 days) which could be used in preventing/treating infections occurring at different body sites, including medical device-related infection and mucosal/skin surface, where Gram-positive bacteria are commonly involved.', 36430814),
('zirconium oxide nanoparticles (ZrO2 NPs)', 'Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values for A. baumannii were 15.6 and 62.5 microg/ml,', '', 'Molecular docking studies of ZrO2 NPs with four proteins (2NAZ, 4HKG, 5D6H, and 5HM6) involved in biofilm formation of A. baumannii revealed the interaction of zirconium with target proteins. These findings suggested the in vitro efficacy of phytosynthesized ZrO2 NPs as antibiofilm. it can be exploited in the development of alternative therapeutic options against MDR A. baumannii.', 36191015),
('Nanocarrier-Loaded Clavulanic Acid and Antibiotic Cotreatments', '', 'These nanocarriers were also found to have a very low cytotoxic effect against human keratinocytes', 'due to the accumulation of the clavulanic acid-loaded nanocarriers on the bacterial cell walls that allows a higher proportion of the inhibitor to engage with the produced intracellular beta-lactamases. which shows great potential for overcoming enzyme-based AMR.', 35819369),
('an enzymatic nanoadjuvant (EnzNA) self-assembled from Ag NCs', 'EnzNAs revitalize various existing antibiotics against methicillin-resistant Staphylococcus aureus, and potentiate the antibiotic efficacy against biofilm-mediated skin infection and lethal lung infection in mice.', '', 'isolated Ag NCs exhibiting biofilm destructive oxidase-mimetic activity in the acidic biofilm microenvironment, is developed. Ag NCs switch to reveal the thiol oxidase-mimetic activity to suppress ribosomal biogenesis for AMR reversal and evolution inhibition of pathogens. These findings highlight the capability of enzyme-mimetic nanomaterials to modulate the infectious microenvironment and potentiate antibiotics, providing a paradigm shift for anti-infection therapy.', 36399641),
('charge-switchable and pH-responsive nanocomplex- one-pot zeolitic imidazolate framework-8 (ZIF-8) encapsulation of proteinase K (PK) and photosensitizer Rose Bengal (RB)', 'The charge-assisted penetration makes PK and RB fully functional, resulting in a cooperative effect concerning high biofilm eradication capacity, as testified by biofilm models both in vitro and in vivo.', '', 'The green synthesis and good therapeutic performance of the nanocomplex manifests its considerable potential as a nontoxic and effective platform for biofilm treatment.', 35850068),
('cerium oxide (CeO2) nanoparticles (NPs)', 'synthesized KF-CeO2 NPs shown superior biofilm inhibitory activity at 500 microg/mL compared to 800 microg/mL and 1600 microg/Ml against MDR bacteria (S. aureus and K. pneumoniae', 'exhibited significant cytotoxic effects (35.60% cell viability) on HeLa cancer cells. the KF-CeO2 NPs were shown to be highly biocompatible with hMSC and 3T3 cell lines (85.13% and 81.17% cell viability, respectively)', 'These data indicate that KF-CeO2 NPs synthesized using Kochiae Fructus extract are promising alternative treatments for MDR. In addition, this study will give the potential for the sustained development of biocompatible NPs with enhanced biological capabilities derived from vital pharmaceutical plants.', 36474529),
('Green Synthesis of Zn(OH)2/ZnO-Based Bionanocomposite using Pomegranate Peels', 'bionanocomposite with concentrations of 50 mg/mL and 75 mg/Ml cause the bacterial biofilm degradation efficiency of the Zn(OH)2/ZnO bionanocomposite was clearly demonstrated by the Congo red method against the Bacillus subtilis PF_1 strain', '', 'Zn(OH)2/ZnO bionanocomposite, in which pomegranate waste peels were used as a natural metal salt reducing agent. This study could be very helpful for making advanced bionanocomposite materials as novel antimicrobial agents, thus preventing a number of infectious diseases.', 36234586),
('metal-organic framework (MOF)-based nanozymes[ TCPP(Fe) (Co-Fe NSs) to zero-dimensional Co-TCPP(Fe) (Co-Fe NDs)]', 'bimetallic Co-Fe NDs can highly efficiently catalyze the lower-concentration H2O2 into reactive oxygen species (ROS), resulting in a favorable antibacterial effect against methicillin-resistant Staphylococcus aureus (MRSA). Co-Fe NDs can effectively promote wound healing and water environment disinfection with good biocompatibility.', '', 'This work reveals the potential of a zero-dimensional bimetallic MOF-based nanozyme in resisting drug-resistant bacteria and holds great promise for future clinical and environmental applications.', 35912946),
('Synergistic effect of Silver Nanoparticles', 'The MIC range of the AgNPs was 9-12 microg/ml, whereas the MIC range of AgNPs with penicillin was 4-6 microg/ml.', '', 'Most MDR-MRSA contained a plasmid of > 10 kb. To overcome bacterial resistance, AgNPs were applied and displayed high antimicrobial activity and synergistic effect with penicillin. Our findings may help establish programs to control bacterial spread in communities as AgNPs appeared to exert a synergistic effect with penicillin to control bacterial resistance.', 36379700),
('molecularly imprinted polymer nanoparticles (MIP-NPs) as antibiotic adjuvants', 'Enhanced inhibition rates of 40-80% were achieved in the presence of the MIP-NPs. The dose of antibiotic could be greatly reduced by utilizing the MIP-NPs as adjuvants', '', 'Good biocompatibility (no obvious hemolysis or cytotoxic effects) and apparent antimicrobial efficiency for resisting wound infection in vivo support the fact that well-designed MIP-NPs have a bright future in dealing with the growing threat of antibiotic tolerance and resistance.', 36321529),
('polyethylene glycol (PEG)ylated nanostructured lipid carrier (PEG-NLC) was synthesized', '', 'the results demonstrated that PEG-TMP/SMZ-NLC after oral administration could decrease the drugs'' side-effects such as renal and hepatic toxicity by ~5-fold in MRSA skin infection in Balb/c mice,', '(PEG-NLC) was synthesized to improve the oral delivery of trimethoprim/sulfamethoxazole (TMP/SMZ) for the treatment of MRSA skin infection in vitro and in vivo. it could improve the antibacterial effects of TMP/SMZ by 3 orders of magnitude. the results of this study suggest that the application of PEGylated NLC nanoparticles is a promising approach to improving the oral delivery of TMP/SMZ for the treatment of MRSA skin infection.', 36015294),
('small Nanoparticle fraught liposomes (NP-Lip)', 'resulting in an enhancement of antibiotic selectivity by fourfold toward E. coli (both strains) and eightfold toward P. aeruginosa.', '', 'ocular administration of NP-Lip showed a reduction in TNF-alpha and IL-6 levels, implying reduced interaction with mammalian cells in vivo. This work therefore clearly demonstrated how tailoring the nano-bio interaction could result in selective drug delivery and a reduction in toxicity.', 35876358),
('Polydopamine (PDA) was introduced as an encapsulating agent for FeS nanoparticles. FeS@PDA', '', '', 'PDA, as an intensive light-responsive agent, could play a synergistic antibacterial role with CDT through PTT, compensating for the low photothermal conversion efficiency of FeS nanoparticles. The combination of PTT and CDT exhibited strong synergistic antibacterial effects, exerting oxidative damage to bacterial macromolecules, such as DNA.', 35917910),
('magnetic nanoparticles enveloped by nanovesicles derived from blood cells (MNVs)', 'MNVs predominantly capture human fecal bacteria, carbapenem-resistant (CR) Escherichia coli, and extended-spectrum beta-lactamases-positive (ESBL-positive) E. coli, vancomycin-intermediate Staphylococcus aureus (VISA), endotoxins, and proinflammatory cytokines in human blood.', '', 'The extracorporeal blood cleansing enables full recovery of lethally infected rodent animals within 7 days by treating them twice in series. It is also validated that parameters reflecting immune homeostasis, such as blood cell counts, cytokine levels, and transcriptomics changes, are restored in blood of the fatally infected rats after treatment.', 36070419),
('Niosomes with a rifamycin S', 'lower MIC of Niosomes with rifamycin S against S. aureus. Niosomes with a rifamycin S concentration of 0.13 microg/g were satisfactorily prepared.', '', 'Nanovesicles with larger size and higher encapsulation efficiency (EE) were obtained when using glycerol and PEG400 in the aqueous media. Our results showed that niosomes consisting of an aqueous glycerol solution have higher stability and EE across a diversity of temperatures and pHs,', 36559121),
('silver nanoparticles (Ag NPs) attached to methylene blue (MB)', 'Ag NPs were coupled with MB and used to deactivate the Gram-negative bacteria, Escherichia coli (E. coli), and Gram-positive bacteria, Staphylococcus aureus (S. aureus).', 'Ag NPs do not exhibit cytotoxicity measurement in HEK 293T cell lines up to 50 microg/ml in each solution.', 'MB and Ag NPs mixture exhibited a synergistic activity and was more effective compared to separate use of MB and Ag NPs. Ag NPs/ MB combination has potential to be used in PDT where standard photosensitizers have limitations.', 35545200),
('PEGylated poly (alpha lipoic acid) (PEG-PALA) copolymer nanoparticles', 'these nanoparticles reduced 3.4-fold of Enterobacteriaceae levels and increased 1.5-fold of the Lactobacillaceae levels compared with the drug administered in the free form.', 'The PEG-PALA nanoparticles demonstrated excellent stability in vitro and biocompatibility toward mammalian Caco-2 and 293 T cells.', 'In the mouse infection model, PEG-PALA nanoparticles encapsulated with ciprofloxacin (PEG-PALA@CIP) reduced the Salmonella colonization in the heart, liver, spleen, lung, cecum, and faeces, prolonged ciprofloxacin persistence in the intestine while reducing its absorption into the blood. As such, this targeted antibiotic delivery systems are for the encapsulation of antibiotics to target specific enteropathogens.', 36202152),
('tannin-coordinated nanozyme composite-based hybrid hydrogels (TCNH)', 'The nanozyme composite in TCNH seems to penetrate the interior of bacteria and exhibited significant broad-spectrum antibacterial activity owing to its intrinsic and nanozymic catalytic properties.', '', 'CNH eye drops can be successfully applied to treat P. aeruginosa and multidrug-resistant P. aeruginosa keratitis. The findings of this study reveal the potential of tannin-coordinated nanozyme composite-based hybrid hydrogel eye drops for treating infectious diseases.', 36242070),
('Silver Nanoparticles', 'the viability of all the tested strain Staphylococcus epidermidis (S. epidermidis) decreased with the use of nanosilver at a concentration of 5 microg/mL. The ability to form biofilm also decreased with the use of nanosilver at a concentration of 3 microg/mL.', '', 'investigate the effect of nanosilver on the viability, biofilm formation and gene expression of the icaADBC operon and the icaR gene for biofilm and non-biofilm S. epidermidis strains. Low concentrations of nanosilver may cause increased biofilm production, however no such effect was observed with high concentrations. This confirms that the use of nanoparticles at an appropriately high dose in any future therapy is of utmost importance. Data from our publication confirm the antibacterial and antibiotic properties of nanosilver.', 36012520),
('Mimusops elengi Flower-Mediated Green Silver Nanoparticles (MENP)', 'MIC For the Staphylococcus aureus strains = 1.5625 microgram/ml and MIC for the Acinetobacter baumannii strains , 6.25 microgram/ml for MTCC1926 and 0.78125 microgram/ml for SN15', '', 'Both insilico and invitro reveal that MENP can be used as an alternative to break multidrug resistance', 35347673),
('Rhamnolipid-Coated Iron Oxide Nanoparticles', 'The lowest MIC of 1 to 4 microgram m/L were recorded for E. coli', '', 'The novelty regarding the activity of RHL-Fe3O4@PVA@p-CoA/GA biosurfactant NPs reveals their potential effect as an alternative multitarget antivirulence candidate to minimize infection severity by inhibiting biofilm development', 35852338),
('sodium alginate stabilized MgO nanoparticles and antibiotics', 'G+M+T (gel stabilized MgO and tylosin) showed the lowest (4.883 ', 'mild toxicity.', 'The study thus concluded increasing drug resistance in E. coli of houbara bird while sodium alginate stabilized MgO nanoparticles and antibiotics were effective alternative antibacterial composites with mild toxicity.', 36132226),
('Gox glucose oxidase-loaded iron-phenolic nanocomplex', 'Fe-GA/GOx could induce over 90% of the biomass of Klebsiella pneumoniae and Staphylococcus aureus by the cascade reactions, producing free radicals to eradicate the invaded bacteria.', 'alleviate the inflammatory response without notable side effects on normal tissues', 'It has been concluded that Reductive polyphenols could promote the Fe3+-to-Fe2+ reaction, enhancing the generation of free radicals. Glucose oxidase (GOx) catalyze glucose oxidation, yielding H2O2 and glucosic acid which promote the subsequent Fenton-like reaction. Therefore, the cascade reaction of GOx/peroxidase offers an efficient pathway to eradicate bacteria, mimicking the natural cascade reaction in immune cells.', 36241091),
('Bimetallic Nanoparticles from Ocimum basilicum', 'Minimum inhibitory concentration (MIC) assays showed AgPtNP activity till the least concentration of NPs (3.15-1.56 microg/mL) against E. coli, E. faecalis, and S. aureus.', 'The cytotoxic activities of AgNPs, PtNPs and AgPtNPs were assessed on different epithelial cell models, by MTT cell proliferation assay, and discovered low toxicity, with a cell viability of 80%. It ecofriendly and safe method', 'Kirby-Bauer method showed that AgPtNPs gave a zone of inhibition for Gram-positive and Gram-negative bacteria in a range of 9-25 mm. Also obtained AgPtNP synergistic activity in combination with vancomycin or ampicillin antibiotics. These results indicate that bimetallic nanoparticles, synthesized from O. basilicum leaf extract, could represent a natural.', 36432648),
('Herbal Fennel Essential Oil (FEO) Nanogel', 'The FEO', '', 'Nanoparticles are considered as a promising tool for overcoming the problems in the treatment of infections caused by S. aureus and has a greater ability to remove bacteria. Based on traditional herbal natural chemical compounds, they have shown that FEOs have a significant effect on the tested bacteria', 36421558),
('engineering protein-only nanoparticles: P128NANO', 'P128NANO has a significantly lower MIC (12.5 microg/mL) than that of P128MONO (50 microg/mL), and thus has a stronger antibacterial ability.', '', 'The damage and leakage of cytoplasmic content result from the nanoparticle', 36194892),
('Chitosan-pluronic nanoparticles were used to construct nanosized ciprofloxacin and meropenem', 'The in vitro evaluation of combined ciprofloxacin and meropenem-loaded nanoparticles demonstrated that this nanosystem exhibited enhanced antibacterial effect Decreased Emergence of Resistance in Escherichia coli. for all steps of selection, nanosized combined antibiotic mutants expressed significantly lower levels of acrB as well as higher levels of ompC and ompF (p-value <0.01).', '', 'In view of these results, the use of nanosized combined antibiotics may be considered among the new promising strategies to combat infections through their potential efficacy in reducing microorganisms'' ability to form resistant mutants.', 36108336),
('oxytetracycline- OTc was impregnated in zinc oxide nanoparticles- nZnO', 'OTc also showed MIC of 150 microg ml-1 and for OTc@nZnO it was 7.02 microg ml-1 with faster killing rate (k, -0.95) against oxytetracycline-resistant Aeromonas hydrophila', '', 'This study postulates that [ZnOTc]+ released from OTc@nZnO can escape TetR(E) and TetA(E) resistance proteins and bind at 30S ribosomal subunit with high affinity (<-11.00 kcal mol-1) to exert antibacterial properties. In the recent scenario of recurrent antimicrobial resistance, the develop antibiotic-nanocomposites could come out as potential solution, however further study is required for its feasibility for use in animal health care.', 36123536),
('polymeric nanoemulsions that encapsulate two hydrophobic antimicrobial agents (eugenol and triclosan) (TE-BNEs)', 'The TE-BNEs are active in an in vivo murine model of mature MDR wound biofilm infections, with 99% bacterial elimination.', '', 'The cationic nanoemulsions efficiently penetrate and accumulate in biofilms, synergistically eradicating MDR bacterial biofilms, including persister cells. the nanoemulsion platform displays excellent biocompatibility and delays emergence of resistance to triclosan. The efficacy of this system coupled with prevention of emergence of bacterial resistance highlight the potential of this combination platform to treat MDR wound biofilm infections.', 35550914),
('The 2D nanoplatelets are formed using copper ions from the copper surfaces', 'Antibacterial properties of the Cu nanoplatelets are demonstrated in multidrug-resistant (MDR) Escherichia coli, MDR Acinetobacter baumannii, MDR Staphylococcus aureus, E. coli, and Streptococcus mutans.', '', 'Nanoplatelets lead to a marked improvement in antibacterial properties compared to the copper surfaces alone, affecting bacterial cell morphology, preventing bacterial cell division, reducing their viability, damaging bacterial DNA, and altering protein expression. This work presents a robust method to directly assemble copper nanoplatelets onto any copper surface to imbue it with improved antibacterial properties.', 35856392),
('antibiotic-adjuvant liposomes (NANO@PS-LPs)', 'It was found that NANO@PS-LPs could significantly eliminate mature P. aeruginosa biofilms, effectively kill dispersed bacteria, inhibit the metabolism of survivors and prevent P. aeruginosa adherence. NANO@PS-LPs present a potential nano-strategy to treat stubborn pseudomonal pulmonary infections and overcome correlative drug resistance.', '', 'NANO@PS-LPs possessing negatively-charged surface and good hydrophilicity could easily penetrate through the sputum layer', 35710071),
('Zinc oxide nanoparticles', 'ZnO-NPs as antibiofilm agent in treatment of S. aureus infections. The MICs of both antibiotics and ZnO-NPs against S. aureus ATCC 6538 tested through broth microdilution assay. The range of molar concentrations of ZnO-NPs and antibiotics used in MIC assay was as follow; ZnO-NPs (6.29 to 0.01 mM); gentamicin (2.14', '', 'ZnO-NPs were capable of decreasing S. aureus cell surface hydrophobicity which could account for observed decrease in bacterial biofilm forming capacity. The expression of biofilm related genes was significantly repressed in ZnO-NPs treated bacteria as compared to untreated cells. ZnO-NPs as adjuvant with other antibiotics targeting S. aureus based on the promising findings obtained herein in order to control infection with this pathogen.', 36221053),
('ZnO nanocrystal clusters formed by a green structure-tuning synthesis', 'minimal inhibitory concentrations of 0.5 and 0.1 mg/mL against Escherichia coli and Staphylococcus aureus, respectively. attachment of phenolic compounds from olive leaf extract would promote membrane penetration by ZnO nanoparticles, resulting in the improvement of antibacterial activities', '', 'mechanism is related to enhancing contact with bacteria, releasing small ZnO nanoparticles, and generating additional reactive oxygen species, which could aggravate the damage to bacterial cell membrane and eventually lead to bacterial death. developed ZnO clusters have a good prospect in antibacterial applications because of their excellent performance and green fabrication method.', 36576779),
('encapsulation of hydrophilic metronidazole drug within a hydrophobic ZIF-90 nanoparticle', '', '', 'The antimicrobial proficiency of zinc and metronidazole will expose a synergistic effect in ROS-mediated bacterial inhibition and auto-immunity boosting of normal cells. In vitro, antibacterial activity results revealed that the MI@ZIF-90 nano drug delivery system effectively eradicated human infectious pathogens at the lowest concentrations. the MI@ZIF-90 drug delivery system eradicates the sepsis-causing human pathogenic fungi,', 36509311),
('scandium-doped phosphate-based glasses (Sc-PBGs)', 'significant inhibition of S. mutans biofilm (1.2 log10 CFU reduction at 6 h) and matrix metalloproteinase-2 (MMP-2) activity', '', 'Since Sc3+ ions might act on various enzymes essential to the biological mechanisms underlying caries, Sc-PBGs could be a promising therapeutic agent against cariogenic bacteria.', 34823880),
('BSA-CuS nanoparticles', 'as a photothermal reagent to apply photothermal therapy (PTT) to combat drug-resistant bacteria in vitro and subcutaneous abscess in vivo', '', 'BSA-CuS nanoparticles together with 1064 nm NIR laser irradiation could also effectively diminish subcutaneous abscesses caused by drug-resistant bacteria on mice under PTT and depth PTT without causing any serious side effects and organic damage in vivo.', 34719851),
('green synthesized nanoparticles', 'The result revealed the concentration of 0.0625 mg/ml Ag-NPs was significantly reducing virulence factors in multidrug-resistant E. faecalis without affecting planktonic cell growth.', '', 'Green synthesized Ag-NPs have the ability to combat multi-drug-resistant E. faecalis via reducing virulence factors, which is considered a good approach toward resolving the multidrug resistance crisis.', 36280163),
('multiple lipid nanoparticles (MLNs) encapsulating the antibiotic moxifloxacin (MOX) - MOX-loaded MLNs were combined with a nanosystem encapsulating a matrix-disruptive agent: N-acetyl-L-cysteine (NAC).', 'a significant decrease in cell viability was observed for free MOX at 0.25 microg mL-1 and higher concentrations, compared with the untreated cells. At the highest concentrations of MOX (1 and 2 microg mL-1), free MOX revealed a potential toxicity effect, with cell viability values below 70%', 'The nanoparticles exhibited low cytotoxicity towards fibroblasts and low hemolytic activity.', 'An increased antibiofilm efficacy was observed when combining the functionalized MOX-loaded MLNs and NAC-loaded nanosystems. Thus, nanosystems as carriers of bactericidal and matrix-disruptive agents are a promising combinatory strategy towards the eradication of S. aureus biofilms.', 36365113),
('guanidinium-Ag(0) nanoparticle (AD-L@Ag(0)) hybrid gel', 'Minimum Inhibitory Concentration (MIC) of the AD-L@Ag(0) formulation was tested against Acinetobacter baumannii (25 microg mL-1), Pseudomonas aeruginosa (0.78 microg mL-1), Staphylococcus aureus (0.19 microg mL-1), Klebsiella pneumoniae (0.78 microg mL-1), Escherichia coli (clinical isolate (6.25 microg mL-1)), Klebsiella pneumoniae (clinical isolate (50 microg mL-1)), Shigella flexneri (clinical isolate (0.39 microg mL-1)) and Streptococcus pneumoniae (6.25 microg mL-1).', 'The observed efficacy of this non-cytotoxic therapeutic combination (AD-L@Ag(0)) was found to be better in a small animal BALB/c model.', 'quantification method to establish its potency in inhibition of biofilm formation, as well as eradication of mature biofilms. These effects were attributed to the bactericidal effect of AD-L@Ag(0) on biofilm mass-associated bacteria. AD-L@Ag(0) could be a promising candidate for anti-microbial coatings on surgical instruments, wound dressing, tissue engineering, and medical implants.', 36128224),
('bone-targeted mesoporous silica nanoparticles', 'The bone-targeted nanoparticles have been thoroughly evaluated in vitro and in vivo, obtaining a notable reduction of the amount of bacteria in the bone in just 24 h after only one dose and paving the way for localized, nanoparticle-mediated treatment of MRSA-caused osteomyelitis.', '', 'These engineered nanoparticles are able to effectively target bone tissue both in vitro and in vivo, showing high biocompatibility and elevated antibacterial effect.', 36341887);

-- --------------------------------------------------------

--
-- Table structure for table `bacteria_phage`
--

CREATE TABLE IF NOT EXISTS `bacteria_phage` (
  `ENTITY` varchar(500) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(2000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `bacteria_phage`
--

INSERT INTO `bacteria_phage` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('(phi)Ef11/(phi)FL1C((phi)36)PnisA', 'The results showed a 10-100-fold decrease in viable cells (CFU/biofilm) after phage treatment, which was consistent with comparisons of treated and untreated biofilm images visualized as max projections of the Z-series.', '', 'A potential alternative to antibiotic therapy is phage therapy. ?Ef11 is a temperate phage that infects strains of E. faecalis.', 27448990),
('phiEF24C', 'phiEF24C phage had a shorter latent period and a larger burst size than ordinary tailed phages, indicating that phiEF24C has effective lytic activity against many Enterococcus faecalis strains, including VRE.', '', 'Bacteriophage (phage) therapy is frequently proposed as a potential alternative therapy for infections caused by this bacterium.', 18096017),
('bacteriophage isolated by enrichment from hospital sewage sludge.', 'Bacteriophage specific for A. baumannii to resolve wound infection in uncontrolled diabetic rats was evaluated.', '', 'Bacteriophage therapy is a possible alternative treatment for multidrug-resistant (MDR) bacterial infections.', 25411824),
('phage ZZ1', 'ZZ1 is highly infectious with a short latent period (9 min) against A. baumanni clinical isolates AB09V, AB0902, and AB0901..', '', 'Bacteriophage therapy is a potential alternative treatment for multidrug-resistant bacterial infections.', 22838726),
('Phage ?km18p', 'Combination of phages (?km18p, ?TZ1 and ?314) as a cocktail could lyse all genotype-varying XDRAB isolates.', '', 'CONCLUSION: Infections with XDRAB are extremely difficult to treat and development of a phage cocktails therapy could be a therapeutic alternative in the future.', 23071586),
('bacteriophage-therapy (phage) alone or combined with antibiotics', 'In vitro, single-dose phage therapy killed 7 log colony-forming units (CFUs)/g of fibrin clots in 6 hours.: In vivo, single-dose phage therapy killed 2.5 log CFUs/g of vegetations in 6 hours (P < .001 vs untreated controls) and was comparable with ciprofloxacin monotherapy.', '', 'Conclusions: Single-dose phage therapy was active against P. aeruginosa EE and highly synergistic with ciprofloxacin.', 28007922),
('bacteriophage TPR7 as antibacterial', 'Bacteriophages can effectively remove clinically resistant E. coli strains', '', 'Currently, with the rapid spread of multi-drug resistant bacteria, phage therapy can be an effective alternative treatment for antibiotic resistant bacteria.', 25834712),
('lytic phage EcSw', 'Inhibition of E. coli Sw1 and 0157:H7 strains', '', 'Functional characterization of a novel lytic phage EcSw isolated from Sus scrofa domesticus and its potential for phage therapy.', 25805216),
('encapsulation of bacteriophage ?eyfp and the mycobacteriophage TM4 into giant liposomes', '', '', 'Here we report effective encapsulation of the model bacteriophage ?eyfp and the mycobacteriophage TM4 into giant liposomes. Furthermore, we show that liposome-associated bacteriophages are taken up into eukaryotic cells more efficiently than free bacteriophages.', 25937143),
('lysin CF-301', 'CF-301 reduced S. aureus by 3-log10 within 30 minutes compared to 6-12 hours required by antibiotics', '', 'Lysin CF-301 is being developed to treat Staphylococcus aureus because of its potent, specific, and rapid bacteriolytic effects.', 24286983),
('phages KS12 and KS14', 'B. cenocepacia K56-2-infected Galleria mellonella larvae treated with phage KS12 and low-dose meropenem demonstrated increased survival over controls treated with KS12 or antibiotic alone.', '', 'One proposed alternative treatment is phage therapy, the therapeutic application of bacterial viruses (or bacteriophages). These results suggest that antibiotics can be combined with phages to stimulate increased phage production and/or activity and thus improve the efficacy of bacterial killing.', 25452284),
('bacteriophage lysin CHAP(K)', '', '', 'Our findings demonstrate the potential for development of CHAP(K) as an alternative therapeutic against pathogenic staphylococci including MRSA.', 21812876),
('Phage lytic enzyme Cpl-1', '', '', 'Recombinant Cpl-1, a phage lysin specific for S. pneumoniae, was evaluated for antimicrobial therapy in experimental pneumococcal meningitis using infant Wistar rats.', 18471063),
('Combinations of T4 bacteriophage and cefotaxime', 'The addition of medium (10(4) PFU mL(-1)) and high (10(7) PFU mL(-1)) phage titres reduced the minimum biofilm eradication concentration value of cefotaxime against E. coli ATCC 11303 biofilms from 256 to 128 and 32 ?g mL(-1), respectively.', '', 'Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. The potential application of phage therapy for the control of bacterial biofilms has received increasing attention as resistance to conventional antibiotic agents continues to increase.', 22524448),
('Phage Therapy: T4-like phage Bp7', 'For larger yields, its optimal multiplicity of infection (MOI) to infect E. coli was about 0.001. The latent period was 10 to 15 min, and the burst size was 90 PFU/infected cell. It was stable both at pH 5.0 to 10.0 and at 40?C or 50?C for at least 1 h. Bp7 could infect 46% of pathogenic clinical E. coli strains.', '', 'T4-like phage Bp7, a potential antimicrobial agent for controlling drug-resistant Escherichia coli in chickens. Chicken-pathogenic Escherichia coli is severely endangering the poultry industry in China and worldwide, and antibiotic therapy is facing an increasing problem of antibiotic resistance.', 23835183),
('Broad-spectrum bacteriophage cocktail', 'The ratio of 10 bacteriophage particles per bacterial cell (MOI=10(1)) was efficient in inhibiting at least 50% of all isolates.', '', 'The use of pathogenic-specific antimicrobials, as proposed by bacteriophage therapy, is expected to reduce the incidence of resistance development.', 20059909),
('HydH5, a virion-associated muralytic enzyme of S. aureus bacteriophage vB_SauS-phiIPLA88 (phiIPLA88)', 'high antibiotic activity against early exponential cells, at 45?C and in the absence of divalent cations (Ca2+, Mg2+, Mn2+)', '', 'The virion-associated PG hydrolase HydH5 has lytic activity against S. aureus, which makes it attractive as antimicrobial for food biopreservation and anti-staphylococcal therapy.', 21682850),
('bacteriophage lysin, designated LySMP', 'biofilm removal with >80% greater efficacy', '', 'These data suggest that bacteriophage lysin could form part of an effective strategy to treat S. suis infections and represents a new class of antibiofilm agents.', 21984241),
('phi MR11', 'In contrast, subsequent intraperitoneal administration of purified phi MR11 (MOI > or = 0.1) suppressed S. aureus-induced lethality.', 'Inoculation with high-dose phi MR11 alone produced no adverse effects attributable to the phage.', 'These results uphold the efficacy of phage therapy against pernicious S. aureus infections in humans and suggest that phi MR11 may be a potential prototype for gene-modified, advanced therapeutic S. aureus phages.', 12599078),
('Cpl-1', 'A 2000- microg dose of Cpl-1 reduced pneumococcal titers from a median of log(10) 4.70 CFU/ml to undetectable levels (<log(10) 2.00 CFU/ml) within 15 min.', '', 'We report the use of Cpl-1, the lytic enzyme of a pneumococcal bacteriophage, as an intravenous therapy for pneumococcal bacteremia in a mouse model.', 14573637),
('Salmonella-specific bacteriophages UAB_Phi20, UAB_Phi78, and UAB_Phi87', '', '', 'Widespread antibiotic resistance has adversely affected human health and has encouraged the search for alternative antimicrobial agents. The advances in bacteriophage therapy highlight their use in controlling a broad spectrum of food-borne pathogens.', 27148229),
('CF-301', 'Potentiate Methicillin-Resistant Staphylococcus aureus Bacteriolysis', '', 'Bacteriophage-derived lysins are cell-wall-hydrolytic enzymes that represent a potential new class of antibacterial therapeutics in development to address burgeoning antimicrobial resistance.', 30670427),
('B(theta)-R656 and B(theta)-R1836', 'Activiy against Drug-Resistant Pseudomonas aeruginosa', '', 'Two Novel Bacteriophages Improve Survival in Galleria mellonella Infection and Mouse Acute Pneumonia Models Infected with Extensively Drug-Resistant Pseudomonas aeruginosa', 30824445),
('Cocktail of four phages (2-3 ? 109 plaque-forming units/ml of 2003, 2002, 3A, and K; n = 12)', 'As effective as teicoplanin in improving survival and decreasing bacterial load within the lungs of rats infected with methicillin-resistant S. aureus', '', 'Phage therapy is a promising alternative antibacterial strategy.', 31260638),
('Cocktail of vB_AbaS_D0 and phage vB_AbaP_D2', 'Activity against Acinetobacter baumannii', '', 'Phage therapy in the murine bacteremia model results showed that the percentage of phage resistant mutant occurrence in the phage D0 or cocktail treatment group was significantly lower than in phage D2 treatment group (P < 0.01).', 31465789),
('vB PaeP-SaPL', 'SaPL inhibited Pseudomonas aeruginosa PA-1A growth until 24 h post infection at MOI of 1.', '', 'Based on its efficacy in reducing bacterial growth, selective infectivity against majority of P. aeruginosa strains and its ability to increase survivability in PA-1 challenged mice, SaPL is proposed to be a potential candidate for bacteriophage therapy against difficult to treat MDR P. aeruginosa infections.', 33259872),
('phage-platelet hybrid nanoparticle (PPHN)', 'PHNs, which were superior to the BCP1-BGL phages that displayed significantly prolonged anti-bacterial action in vivo against Escherichia coli infection,', '', 'Our work demonstrated a novel strategy in engineering biomimetic phage-based nanoparticles with improved blood retention and anti-bacterial performance and may have implications in phage therapy.', 33500725),
('SaGU1', '', '', 'Given that SaGU1 can specifically infect S. aureus from patients with AD, but not S. epidermidis, it may be a strong candidate for developing phage therapy to treat AD.', 33638001),
('Engineered anti-CRISPR (Acr) gene-containing phages (EATPs)', 'results showed that the phage titers were negatively correlated with the growth of PA14 and positively correlated with the inhibitory rate.', 'exhibiting low toxicity, suggesting safe and efficient features.', 'EATPs (Engineered Acr gene-containing phages )combined with antibiotics may serve as a novel treatment strategy by which to curb antibiotic resistance P. aeruginosa', 35972246),
('phage 1 (MLP1), MLP2, and MLP3, belonging to the Chaseviridae, Myoviridae, and Podoviridae families', 'efficiently infect and kill laboratory reference strains and multidrug-resistant clinical E. coli isolates from patients with diagnosed UTIs, infect intestinal pathogenic E. coli strains (enteroaggregative E. coli) and diffusely adherent E. coli.', '', 'Altogether, our results suggest that these phages may represent an interesting alternative for the treatment of antibiotic-resistant E. coli strains generating urinary tract and/or intestinal infections.', 35171030),
('Ev5-WHG phage', 'The combination of zinc acetate and P21 showed increased bactericidal effect on Ev5-WHG. Significantly also, we showed that P21 completely prevented the growth of wild-type WHG40004 in the presence of antibiotics (meropenem and imipenem).', '', 'The results from this study indicate that the analysis of phage resistance signatures during adaptation of bacteria to a lytic phage can inform the choice of agents to work cooperatively with phage to limit and/or reverse resistance. This approach could be important for guiding future successfulPhage therapy.', 35156836),
('phage vB_PreP_EPr2 (EPr2)', 'EPr2, a lytic phage with activity against the PDR clinical isolate P. rettgeri MRSN 845308. This study provides evidence that phage treatment is a viable alternative therapeutic option for PDR P. rettgeri infections. Importantly, EPr2 was discovered and isolated in one week from a single environmental source, indicating phages that target clinical P. rettgeri strains can be identified rapidly and on demand. EPr2 demonstrates desirable characteristics for a therapeutic phage, including strong lytic activity against a PDR strain of interest and no genes indicative of a lysogenic lifestyle, drug resistance, or virulence.', '', 'EPr2 was determined to have a narrow host range against a panel of clinical P. rettgeri strains. Despite this fact, EPr2 is a promising lytic phage with potential for use as an alternative therapeutic for treatment of PDR P. rettgeri infections.', 35458437),
('lytic bacteriophage TSP', 'The phage efficiently inhibited bacterial growth for up to 12 h at MOI of 1 and 10. TSP phage showed activity against various isolates of MRSA and MSSA, isolated from different clinical samples, with variable antibiotic susceptibility patterns. The bacteriophage TSP showed stability at varying temperatures (25 ', '', 'The strong lytic activity and short latent period in addition to its lytic nature makes it a good candidate forPhage therapy against MRSA infections, if it proves to be effective in in-vivo studies.', 35705576),
('in vitro model of human macrophages', 'In this study, we have evaluated, in an in vitro model of human macrophages, the efficacy of a combined treatment consisting of apoptotic body-like liposomes loaded with phosphatidylinositol 5-phosphate (ABL/PI5P) and phiBO1E, a lytic phage specific for the major high-risk clone of KPC-positive MDR-KP. Results show that ABL/PI5P did not affect in a direct manner KKBO-1 viability, being able to reduce only the intracellular KKBO-1 bacterial load. As expected, phiBO1E was effective mainly on reducing extracellular bacilli. Importantly, the combination of both treatments resulted in a simultaneous reduction of both intracellular and extracellular bacilli. Moreover, the combined treatment of KKBO-1-infected cells reduced proinflammatory TNF-alpha and IL-1beta cytokines and increased anti-inflammatory TGF-beta cytokine production.', '', 'Overall, our data support the therapeutic value of a combined host- and pathogen-directed therapy as a promising approach, alternative to single treatments, to simultaneously target intracellular and extracellular pathogens and improve the clinical management of patients infected with MDR pathogens such as MDR-KP.', 35237274),
('phage P22', 'The abilities of phage P22 to lyse, eradiate, and disperse the biofilm cells of Salmonella enterica serovar Typhimurium ATCC 19585 (STWT), ciprofloxacin-induced Typhimurium ATCC 19585 (STCIP), S. Typhimurium KCCM 40253 (STKCCM), and multidrug-resistant S. Typhimurium CCARM 8009 (STCCARM) in association with hydrophobicity, auto-aggregation, motility, protein content, extracellular DNA, and depolymerase activity. The affinity to hexadecane was significantly increased in STWT, STKCCM, and STCCARM cells after P22 infection. All strains tested showed relatively higher auto-aggregation abilities in the presence of P22 than the absence of P22. STKCCM showed the greatest auto-aggregative ability (23%) in the presence of P22, while STWT showed the least auto-aggregative ability (9%) in the absence of P22.', '', 'Phages could be considered as promising alternatives for the control of biofilms due to their advantages including enzymatic degradation of extracellular biofilm matrix. The study would provide useful information for understanding the dynamic interactions between phages and biofilms and also designing the effective phage-based control system as an alterative strategy against biofilms.', 34921957),
('ethanol extracts of Portuguese propolis combined with gentamicin or with honey, collected from the same apiary as propolis', 'in vitro, plaque assay and minimum inhibitory concentration (MIC) determinations showed that AMX or AMC or cefepime (FEP) inhibited SaP7 plaque formation respectively and SaP7 decreased bacterial susceptibility of Salmonella S7 to AMX, AMC and FEP.', '', 'We discovered the antagonism efficacy of SaP7 combined amoxicillin/potassium clavulanate (AMC) in counteracting Salmonella S7 in piglet-models by bacterial loads in feces and tissues.', 35033842),
('phage cocktail with the antibiotic enrofloxacin', 'Enrofloxacin treatment provided 100% survival and the phage cocktail treatment provided 90% survival. However, in terms of mouse recovery, the phage cocktail outperformed enrofloxacin in all measured outcomes. Compared with enrofloxacin treatment, phage treatment led to a faster elimination of enteric pathogens, decreased expression levels of inflammatory markers, increased weight gain, maintenance of a stable relative organ weight, and improved homeostasis of the gut microbiota.', 'However, the effects of phages and antibiotics on organisms when treating intestinal infections have not been precisely studied. Here, we comprehensively compared the therapeutic efficacy of a phage cocktail to the antibiotic enrofloxacin in a mouse model of STEC O157:H7 EDL933 infection.', 'These results provide support for the potential ofPhage therapy to combat enteric pathogens and suggest that phage treatment leads to enhanced recovery of infected mice compared with antibiotics.', 35536028),
('T4-like Escherichia phage vB_EcoM-Sa45lw (or Sa45lw)', 'Phage Sa45lw is particularly effective in reducing E. coli O45:H16 both in vitro (MOI = 10) by 5 log and upon application (MOI = 1,000) on the contaminated mung bean seeds for 15 min by 2 log at 25', 'The phage exhibited antimicrobial effects against both pathogenic E. coli and Salmonella without containing virulent or lysogenic genes that could compromise the safety of phage application. In addition, after 15 min of phage treatment, Sa45lw mitigated E. coli O45:H16 on the contaminated mung bean seeds by a 2-log reduction at room temperature, demonstrating the biocontrol potential of non-O157 Shiga toxin-producing E. coli on sprout seeds.', 'These findings highlight the potential of phage application against non-O157 STEC on sprout seeds.', 35107386),
('aerosolized phage cocktails', 'The optimal phage cocktails were a combination of different phage families or were constructed by next-evolutionary phage typing with the highest score for the host lysis zone to prevent the development of environmental CRAB phage resistance. The phage infection percentage of the antibiotic-resistant A. baumannii strains was 97.1%, whereas the infection percentage in the antibiotic-susceptible strains was 79.3%. During the phage decontamination periods from 2017 to 2019, the percentage of carbapenem-resistant A. baumannii in test ICUs decreased significantly from 65.3% to 55%. The rate of new acquisitions of CRAB infection over the three years was 4.4 per 1000 patient-days, which was significantly lower than that in the control wards (8.9 per 1000 patient-days) where phage decontamination had never been performed.', '', 'In conclusion, our results support the potential of phage cocktails to decrease CRAB infection rates, and the aerosol generation process may make this approach more comprehensive and time-saving.', 35367880),
('phage therapy controlled by inorganic metallic nanomaterials', 'Photothermal heating, performed as a single treatment (15 min) or as two treatments on consecutive days, rapidly reduced the bacterial load and released Zn2+ to promote wound healing. The phage-nanomaterial treatment was significantly more effective than systemic standard-of-care antibiotics, with a >10', '', 'Our results demonstrate thatPhage therapy controlled by inorganic nanomaterials can be a safe and effective antimicrobial strategy in vivo.', 35239330),
('En5822', 'The study describes a novel, naturally virulent bacteriophage En5822, from environment capable of lysing multi-drug resistant E. cloacae effectively. The phage could potentially serve as an alternative strategy for treating antibiotic-resistant infections.En5822 is a myovirus with relative pH and thermal stability. En5822 shows a notable reduction of host bacterial biofilm as well as planktonic cultures. Whole genome sequence analysis revealed that the En5822 genome does not contain undesirable temperate lifestyle genes, antibiotic resistance genes and toxin-encoding genes.', '', 'Conclusions: En5822 displays high lytic activity, specificity and biofilm reduction capability. It has a short latent period and high burst size that aid faster activity. Its genomic and physical attributes offer possibilities for its as an alternative antimicrobial for the treatment of drug-resistant E. cloacae infections.', 34927785),
('PqsE-RhlR interaction coupled with RNA-seq analyses', 'Biochemical characterization of the PqsE-RhlR interaction coupled with RNA-seq analyses demonstrates that the PqsE-RhlR complex increases the affinity of RhlR for DNA, enabling enhanced expression of genes encoding key virulence factors. These findings provide the mechanism for PqsE-dependent regulation of RhlR and identify a unique regulatory feature of P. aeruginosa QS and its connection to virulence.', '', 'Targeting bacterial behaviors such as QS, rather than bacterial growth, represents an attractive alternative for exploration because such therapies could potentially minimize the development of resistance.', 35019777),
('Kluyveromyces lactis and Saccharomyces unisporus isolated from traditional kefir grains', 'Yeasts-fermented killer toxin medium showed Salmonella growth inhibition. The highest alcohol concentration detected was 1.55%, and proteins with known antimicrobial properties including cathelicidin, xanthine dehydrogenase, mucin-1, lactadherin, lactoperoxidase, serum amyloid A protein and lactotransferrin were detected in yeasts fermented killer medium. These proteins are suggested to be responsible for the observed growth inhibition effect of yeasts-fermented killer toxin medium', '', 'Kluyveromyces lactis and Saccharomyces unisporus have anti-salmonella effect comparable to Saccharomyces boulardii strains, and therefore have potential to control Salmonella infection.', 35002451),
('endolysin PlyAZ3aT', 'PlyAZ3aT did not improve survival compared to PBS, while survival for vancomycin treated animals was 70% which is a significant improvement when compared to PBS or PlyAZ3aT (p<0.05 each). PlyAZ3aT was not able to control the infection, reflected by the inability to reduce bacterial loads in the CSF, whereas Vancomycin sterilized the CSF and within 25 h. Pharmacokinetic studies indicated that PlyAZ3aT did not cross the blood brain barrier (BBB). In support, PlyAZ3aT showed a peak concentration of 785 microg/ml in serum 2 h after intraperitoneal injection but could not be detected in CSF.', '', 'Conclusion: In experimental pneumococcal meningitis, PlyAZ3aT failed to cure the infection due to an inability to reach the CSF. Optimization of the galenic formulation e.g. using liposomes might enable crossing of the BBB and improve treatment efficacy.', 35472061),
('Siphoviridae bacteriophage AXL1 (vB_SmaS-AXL_1) from soil', 'Host range analysis on a panel of 30 clinical S. maltophilia strains reveals a moderate tropism that includes cross-species infection of Xanthomonas, with AXL1 using the type IV pilus as its host surface receptor for infection. Complete genome sequencing and analysis revealed a 63,962 bp genome encoding 83 putative proteins. Comparative genomics place AXL1 in the genus Pamexvirus, along with seven other phages that infect one of Stenotrophomonas, Pseudomonas or Xanthomonas species. Functional genomic analyses identified an AXL1-encoded dihydrofolate reductase enzyme that provides additional resistance to the antibiotic combination trimethoprim-sulfamethoxazole, the current recommended treatment option for S. maltophilia infections.', '', 'This research characterizes the sixth type IV pilus-binding phage of S. maltophilia and is an example of phage-encoded antibiotic resistance.', 35717537),
('phage vB_StaM_SA1 (hereinafter as SA1)', 'We identified a novel jumbo phage belonging to Myoviridae family, which can lyse various Staphylococcal strains.Both lys210 and lys211 possessed efficient bactericidal ability, and lys210 could lyse all test strains.', '', 'The results show that phage SA1 and lys210/lys211 could be potentially used as antibiotic agents to treat Staphylococcus infection.', 35572667),
('vWUPSU-specific MDR A. baumannii with sacha inchi oil', 'A synergistic antimicrobial effect of the interaction between phage vWUPSU and sacha inchi oil on planktonic cells was observed. The combination of phage and sacha inchi oil significantly inhibited and removed biofilms, compared with the effects of either single treatment.', '', '', 35337089),
('Bacillus licheniformis LSG1-1 and Bacillus subtilis LSG2-1', 'The isolated Bacillus licheniformis (LSG1-1) and Bacillus subtilis (LSG2-1) were characterized and performed well in tolerance experiments. In addition, LSG1-1 and LSG2-1 were detected to have higher self-aggregation ability and surface hydrophobicity. In the in vitro adhesion model, LSG1-1 and LSG2-1 showed good adhesion ability and had obvious adhesion inhibitory effect on three pathogens of Aeromonas.', 'The safety of the strains to host fish has also been established.', 'Based on the characteristics observed so far, Bacillus licheniformis LSG1-1 and Bacillus subtilis LSG2-1 could form potential probiotic candidates in the digestive tract of R. lagowskii to help combat diseases in aquaculture.', 35691482),
('', 'Among 3 phages, ', '', 'Conclusions: As multi-drug resistant bacteria are emerging as a global problem, lytic phages can be an alternative treatment strategy when all available antibiotics fail.', 35615828),
('?A1122 and PSTPhage therapy (alone or in combination with second-line antibiotics)', 'Phage treatment significantly delayed mortality and limited bacterial proliferation in the lungs. However, the treatment did not prevent bacteremia, suggesting that phage efficiency may decrease in the circulation. Indeed, in vitro phage proliferation assays indicated that blood exerts inhibitory effects on lytic activity, which may be the major cause of treatment inefficiency.', '', 'CombiningPhage therapy and second-line ceftriaxone treatment, which are individually insufficient, provided protection that led to the survival of all infected animals-a synergistic protective effect that represents a proof of concept for efficient combinatorial therapy in an emergency event of a plague outbreak involving MDR Y. pestis strains.', 35458417),
('Autographiviridae Phage and Its Combined Effect with Tigecycline', 'To investigate an alternative medical treatment for SSTIs, a broad range lytic Acinetobacter phage, vB _AbP_ABWU2101 (phage vABWU2101), for lysing MDR A. baumannii in associated SSTIs was isolated and the biological aspects of this phage were investigated. Antibiofilm activity of phage vABWU2101 demonstrated good activity against both preformed biofilms and biofilm formation. The combination of phage vABWU2101 and tigecycline showed synergistic antimicrobial activities against planktonic and biofilm cells.', '', 'Scanning electron microscopy confirmed that the antibacterial efficacy of the combination of phage vABWU2101 and tigecycline was more effective than the phage or antibiotic alone. Hence, our findings could potentially be used to develop a therapeutic option for the treatment of SSTIs caused by MDR A. baumannii.', 35215788),
('Ab105-2phideltaCI404ad', 'A phage cocktail was formed by combining this phage with the A. baumannii phage vB_AbaP_B3, known to express a depolymerase. Both the individual phages and the phage cocktail showed strong antimicrobial activity against 5 clinical strains and 1 reference strain of A. baumannii tested.', '', 'The antibiofilm activity of the individual phages and the cocktail was assayed. The phage cocktail displayed strong antibiofilm activity.', 35041503),
('the combination of the novel antimicrobial "choline kinase inhibitors (ChoKIs)" with a phage cocktail or synthetic phages', 'Inhibition of ChoKs has been proposed as a promising antibacterial strategy. Successful docking of Hemicholinium-3, a choline kinase inhibitor, to the model structure of P. aeruginosa ChoK also supports the use of this inhibitor or its derivatives to inhibit the growth of this microorganism.', '', 'Conclusion: Therefore, the combination of the novel antimicrobial "choline kinase inhibitors (ChoKIs)" with a phage cocktail or synthetic phages as a potential treatment for P. aeruginosa infection has been proposed.', 34961459),
('engineered strain of Lactococcus lactis', 'In a mouse model of parenteral ampicillin treatment, oral supplementation with the engineered live biotherapeutic minimized gut dysbiosis without affecting the ampicillin concentration in serum, precluded the enrichment of antimicrobial resistance genes in the gut microbiome and prevented the loss of colonization resistance against Clostridioides difficile.', '', 'Engineered live biotherapeutics that safely degrade antibiotics in the gut may represent a suitable strategy for the prevention of dysbiosis and its associated pathologies.', 35411114),
('Polycationic silver nanoclusters (pAgNCs)', '10^6- to 10^7-fold potentiation of vancomycin and 20-fold increase of the sensitizer''s effectiveness were achieved with a combination of a vancomycin derivative and its sensitizer.', '', 'The potential of such derivatization-for-sensitization approach was also supported by the combination''s potent in vivo antimicrobial efficacy in mouse model studies, and the expanded application of such strategy on other antibiotics and sensitizer structures.', 35657057),
('Bacteriophages Combined With Subtherapeutic Doses of Flucloxacillin', 'The addition of low-dose flucloxacillin elevated bacterial suppression (? of -5.25 log10 colony forming unit/g [CFU/g] versus treatment onset, P<0.0001) and synergism was confirmed (? of -2.15 log10 CFU/g versus low-dose flucloxacillin alone, P<0.01).', '', 'Conclusions Combining phages with a low-dose standard of care antibiotic represents a promising strategy for the treatment of S. aureus infective endocarditis.', 35043655),
('Linker Modification and PEGylation of Vancomycin Conjugates', 'The MICs were assessed as the lowest concentration without visible growth.', '', 'In conclusion, linker modification of vancomycin-polycationic peptide conjugates represents a promising strategy for the modulation of pharmacokinetic behavior while providing potent antimicrobial activity.', 35215272),
('Combination of in vivoPhage therapy data with in silico model', 'pneumonia treatment efficacy', '', 'Model-based approaches will foster the deployment of future phage-therapy clinical trials.', 35584666),
('C. difficile myoviruses: phiCD08011, phiCD418, phiCD1801, and phiCD2301', 'broad host range activity toward RT 078, infecting 15/16 (93.8%), phiCD1801 could bind to an RT 012 strain only in the presence of a plasmid-borne S-layer cassette corresponding to the slpA allele found in RT 078', '', 'Efforts should be directed toward the isolation of phages with broad host range activity toward defined S-layer cassette types, which could form the basis of an effective phage cocktail for the treatment of CDI.', 35107319),
('phage-DAP (daptomycin) -ampicillin (AMP), phage-DAP-ceftaroline (CPT), and phage-DAP-ertapenem (ERT) with HOU503', 'phage-DAP-AMP and phage-DAP-CPT prevented the emergence of DAP and phage resistance', '', 'With HOU503, the combination of phage-DAP-AMP showed the best killing effect, followed closely by phage-DAP-CPT; both showed bactericidal and synergistic effects compared to any single agent (ANOVA range of mean differences 3.99 to 4.08 log10 CFU/mL; p &lt; 0.001).', 35326855),
('vB_GEC_EfS_9', 'active against Enterococcus faecium clinical strains', '', 'Obtained results indicate that phage vB_GEC_EfS_9 is a virulent phage which has a very good potential for therapeutic use against strains of E. faecium.', 34648886),
('Friunavirus phage vWU2001 in combination with colistin', 'resulted in a significantly greater increase in G. mellonella survival and in bacterial clearance, as compared with that of phage or colistin alone, indicating that the combination was synergistic against CRAB', '', 'The results demonstrated that phage vWU2001 has the potential to be developed as an antibacterial agent.', 35173237),
('bacteriophage isolated from raw fish rinse', 'all five phages showed relatively broad host ranges with the bacteriophage originally isolated from raw fish rinse showing lytic activity against all the isolates tested. This phage is suggested to be a member of Siphoviridae family, order Caudovirales', '', 'Apparently, its stability under some of the extreme conditions tested implies its potential to be a candidate for pharmaceutical formulation as an anti-MRSA therapeutic tool.', 35656033),
('aerosolized phages (aerophages)', 'Treatment of Pneumonia Due to Methicillin-Resistant Staphylococcus aureus', 'Experimental Study in Rats', 'Conclusions: AerosolizedPhage therapy showed potential for the treatment of MRSA pneumonia in an experimental animal model and warrants further investigation for application in humans.', 33668071),
('', '', 'two-stage preclinical study using a murine model of severe A. baumannii AB900 bacteraemia', 'This mechanism highlights the clinical potential of usingPhage therapy to target A. baumannii and restore antibiotic activity.', 35537278),
('CUB-EPI_14', 'narrow host range against S. epidermidis', '', 'Potent antimicrobial and antibiofilm activities were observed when the phage was tested against a highly susceptible bacterial isolate. These encouraging results open the door to new therapeutic opportunities in the fight against resilient biofilm-associated infections caused by S. epidermidis.', 35746811),
('fEg-Eco19', 'active against an antibiotic-resistant clinical Escherichia coli isolate', '', 'Phage therapy, the use of lytic bacteriophages to combat bacterial infectious diseases, is regarded as a promising alternative to the use of antimicrobial agents.', 35399144),
('Phage YC#06 and Antibiotics: a Combination Strategy', 'MICs ranging from 1 microgram m/L to 8 microgram m/L by 8 different antibiotics in combination with phage', 'Result suggest that YC#06 could be safely used for therapeutic applications.', 'YC#06 and antibiotic mixtures that include chloramphenicol, imipenem, and cefotaxime in combination could reduce the concentration of effective antibiotics and leading to bacterial resistance', 35736241),
('Stnergy virulent phage (phiAB182) with antibiotics', 'In the presence of antibiotics, phage phiAB182 showed the highest synergy (p < 0.0001) with colistin, followed by polymixin B, ceftazidime and cefotaxime', '', 'The findings from this study strongly support the use of phage antibiotic synergy for the successful treatment of biofilm forming MDR A. baumannii infections.', 36174234),
('Gp105, a putative lysozyme murein hydrolase from Enterobacter phage myPSH1140', 'The MIC for the Gp105 protein concentrations from 0.125 to 0.5 mg/mL in the case of E. cloacae, K. pneumoniae, P. aeruginosa, S. marcescens, Citrobacter sp., and A. baumannii', '', 'The broad-spectrum activity of Gp105 could be exploited to inhibit or kill pathogenic gram negative bacteria in therapeutic applications.', 35950843),
('bacteriophage vB8388 and its synergistic effect with aminoglycosides', 'The combination of phage vB8388 and gentamicin, amikacin, or tobramycin could effectively inhibit the growth of Klebsiella oxytoca strain FK-8388, with a decrease of more than 4 log units within 12 h in vitro. Phage vB8388 showed a strong synergistic effect with gentamicin that could enhance the anti-biofilm effect of vB8388.', 'Bacteriophage able to kill bacteria through different mechanisms without any side effects.', 'The phage + gentamicin combination also showed synergy in vivo in the larval infection model of Galleria mellonella. In conclusion, the findings of this study suggest the potential of phage + antibiotic combination therapy to be used as an alternative therapeutic approach for treating infectious diseases caused by multidrug-resistant bacteria.', 36494020),
('phiKZ like jumbo phage', 'Antibiotic susceptibility test results revealed multi-drug resistance in 61 of the total 82 isolated P. aeruginosa strain', '', 'Genetic architecture of phiKZ like jumbo phages infecting P. aeruginosa. The bacteriophages isolated in this study had lytic ability against biofilm-forming and multidrug-resistant P. aeruginosa and could be candidates for further studies towardsPhage therapy.', 36096457),
('Two lytic phages, Achr-1 and Achr-2 were isolated from sewage samples', 'phage therapy showed efficacy in reducing bacterial burden of the A. denitrificans subpopulation, shows clinical improvement when phage(s) are used to target refractory Achromobacter infections in the lungs of CF patients', 'Nebulization was tolerated without toxicity,', 'These phages were deployed in the compassionate use treatment of this patient who had declining respiratory status. . Following therapy, the patient achieved stabilization of respiratory status. This report adds to a growing literature that shows clinical improvement when phage(s) are used to target refractory Achromobacter infections in the lungs of CF patients', 36568830),
('novel polyvalent phage STP55', 'phage STP55 was able to inhibit single- and dual-species biofilms formation by S. Typhimurium ATCC 14028 and E. coli O157: H7, with a reduction percentage of 51.0%, 47.8% and 52.8%, respectively.', '', 'Broad lytic phages are promising alternatives to conventional technologies for pathogen biocontrol and reducing biofilms. Hence our results demonstrated that STP55 is a promising antimicrobial against Salmonella and E. coli.', 36056994),
('phages obtained from hospital sewage against Shigella sonnei (S. sonnei) ATCC', 'To evaluate the specific effects of each phage to inhibit the bacterial growth, 10 microL of lysate phage (at concentration of 8 log PFU/mL) was taken and subjected to 0.5% bacterial LB agar bacterial lawn culture. Following incubation at 37', '', 'Phage cocktails (Shs1, Shs2, Shf1, and Shf2) exhibited higher antimicrobial activity than single phage application against S. sonnei and S. flexneri standard strains.', 36467878),
('Phage Cocktails', 'Based on observed CFU of Enterococcus isolates and the titer of each phage, the appropriate volume of isolates and phages were determined at three different MOIs, 0.1, 0.01, and 0.001, to conduct growth curve experiments.', '', 'they show that combinations of two phages are effective at inhibiting growth of several Enterococcus strains over 72 h. Theoretically, using more phages in a cocktail would increase the chances of choosing phages that displayed synergy in reducing the host growth.', 35762793),
('Novel Klebsiella Phage PG14', 'Phage PG14 showed more than a 7-log cycle reduction in K. pneumoniae planktonic cells after 24 h of treatment at a multiplicity of infection (MOI) of 10.', '', 'Phage PG14 illustrated a lytic ability covering a variety of bacterial pathogens, including K. pneumoniae, P. aeruginosa, and E. coli, which all can cause nosocomial infections. The promising results of this study nominate phage PG14 as a potential candidate forPhage therapy.', 36374021),
('bacteriophage JHA', 'The pH and thermal stability testing showed that JHA phage activity was highest at pH7 and highest activity was found at 37', '', 'The bacterial growth reduction assay exhibited that JHA phage had high adsorption rates and could rapidly inhibit bacterial growth. All the characteristics of JHA phage possess lytic activity against A. baumannii strains and exhibit novel candidates to use as an alternative competitor to antibiotics in controlling such infections.', 36451560),
('The two phages were used together as a cocktail, as this combination of SenM-2 and vB_Sen-TO17', '', 'combination of SenM-2 and vB_Sen-TO17 has been found recently to be effective against S. enterica strains and safe for eukaryotic cells in in vitro studies and in experiments with the Galleria mellonella animal model', 'Phage therapy with the cocktail of vB_SenM-2 and vB_Sen-TO17 bacteriophages was as effective as the use of either enrofloxacin or colistin in elimination of experimentally provoked infection of chickens with S. Typhimurium.', 35992162),
('phage cocktail with three lytic phages (phage POP12) or flagella (phages POP15 and POP17)', 'The application of the phage cocktail to napa cabbage (Brassica rapa subsp. pekinensis) resulted in significant growth retardation of P. carotovorum subsp. carotovorum (P < 0.05) and prevented the symptoms of soft rot disease.', '', 'these results show that the phage cocktail developed here, which targets two different types of phage receptors, provides an effective strategy for controlling P. carotovorum subsp. carotovorum in agricultural products, with a potential ability to attenuate P. carotovorum subsp. carotovorum virulence.', 36165651),
('new endolysin from the Salmonella phage XFII-1,', 'The endolysin XFII exhibited high bactericidal activity at a concentration of 0.5 microg/mL against many Gram-negative bacteria, including Salmonella, E. coli, Acinetobacter baumannii, and Klebsiella pneumoniae.', '', 'The novel globular endolysin XFII was screened and successfully expressed in E. coli BL21. Endolysin XFII exhibits a broad lysis spectrum, a rapid and strong bactericidal activity, good stability at high temperatures and under eutrophic conditions. Combined with chitosan, XFII could spontaneously lyse Gram-negative bacteria without pretreatment.', 35999567),
('coliphages phiEC-S-21 and phiEC-OE-11 belonged to Myoviridae, whereas coliphage phiEC-S-24 belonged to the Autographiviridae family derived from the Podoviridae family.', 'All three coliphages possessed diverse infective and lytic mechanisms, viz., lytic murein transglycosylase, peptidoglycan transglycosylase, n-acetylmuramoyl-l-alanine amidase, and putative lysozyme against E. coli', '', 'the three coliphage genomes showed neither the presence of antibiotic resistance genes nor virulence genes, which makes them desirable candidates for use inPhage therapy-based applications.', 36504140),
('new phage against H. pylori, named HPy1R', 'characteristics and properties of HPy1R indicate the use ofPhage therapy in the control of infections by H. pylori one of the major human gastric pathogens.', '', 'HPy1R remained stable over a wide range of pHs and temperatures, and despite the small loss observed in the in vitro gastric phase, the results seem to be encouraging. The discovery of new and well-characterized phages, as well as the identification and characterization of endolysins, against H. pylori will pave the way for the use ofPhage therapy as an alternative strategy to control H. pylori infections.', 35887231),
('coliphage P762', 'Coliphage P762 can lyse Shiga toxin-producing Escherichia Coli serotypes O157 and non-O157 (17/39), Avian pathogenic E. coli covered serotype O78, O83, and O9 (5/19), and other pathogenic Escherichia coli. The one-step curve of P762 exhibited three bursts of growth stage: two rapid and one slow stage. Furthermore, the first rapid burst size is 80 CFU/PFU, the burst size of the slow stage is 10 CFU/PFU, and the second rapid burst size is about 990 CFU/PFU.', '', 'In vitro antibacterial tests revealed that P762 has high bactericidal activity in lettuce leaves contaminated with STEC. In conclusion, phage P762 might be employed in the future to prevent and control pathogenic Escherichia coli.', 35705841),
('monoclonal antibodies by phage display', 'antibody-based inhibitor against mycobacterium tuberculosis', '', 'phage display antibody selection managed to isolate a scFv (single chain fragment variable clone against) the rICL (recombinant Isocitrate lyase) with good specificity. The preliminary inhibition of rICL activity was carried out with the continuous LDH-coupled enzymatic assay showed that a-rICL-C6 monoclonal antibody was able to remit the rICL enzymatic activity with an estimated IC50 of 10 mg/mL.', 35987135),
('synergistic combination of an antibacterial natural product allicin and a newly isolated bacteriophage, named BD523, was constructed', '', '', 'allicin interacts with bacterial DNA in the groove region by inserting itself into the DNA double helix and, subsequently, disrupts the bacterial DNA by cleaving phosphate diester bonds of deoxynucleotides. Further, BD523 destroys the cell wall and membrane of bacteria by synthesizing lyase proteins, including holin and endolysins.', 36472428),
('A novel bacteriophage CUB19 specific to the bacterial species Stenotrophomonas maltophilia', 'This phage presented a narrow host range, infecting four out of the 40 S. maltophilia strains tested and none of the P. aeruginosa strains,', '', 'combining phage CUB19 with higher rather than lower antibiotic doses generally led to an improved antimicrobial effect, These are encouraging indications for its application as a targeted therapeutic agent against resilient biofilm-associated Stenotrophomonas infections.', 36297651),
('encapsulation of lysins (Phage-derived products) in liposomes as a delivery system', '', '', 'The application of the encapsulated lysins to the model P. aeruginosa led to a reduction in cell viability and resulted in cell lysis. these enzybiotics following their incorporation in liposomes were able to potentiate their antibacterial effect against the Gram-negative bacteria P. aeruginosa, used as the model.', 36077542),
('CAM-21, a novel lytic phage', 'The growth of E. coli O157:H7 was effectively controlled in milk, ground beef and baby spinach at MOIs of 1000 and 10,000. CAM-21 significantly (P = 0.05) reduced the bacterial counts of the treated foods, ranging from 1.4-2.0 log CFU/mL in milk to 1.3-1.4 log CFU/g in ground beef and baby spinach.', '', 'These findings suggest that the lytic phage, CAM-21, is a potential candidate for controlling E. coli O157:H7 contamination in foods.', 36444789),
('Brochothrix phage ADU4', 'A newly isolated phage with lytic ability against B. thermosphacta . The optimal MOI value of the phage was determined as 0.1.', '', 'The effects of Brochothrix phages on biofilms have been studied. Phage ADU4 significantly reduced the B. thermosphacta (both planktonic and biofilm forms) in vitro. Phage ADU4 is a promising biocontrol candidate for the control of B. thermosphacta contamination in meat and meat products.', 36064042),
('Two Newly Isolated Enterobacter phage Entb_43 (174 kbp, acc. No. ON585039) and Enterobacter phage Entb_45 (173 kbp, acc. No. ON630910).', 'The most effective phage-to-bacteria ratios (MOI = 0.01 and MOI = 0.001) for both the phage amplification ctivity against multidrug-resistant clinical isolates of Enterobacter spp. (E. cloacae, E. hormaechei, and E. kobei),', '', 'study determining the possibility of using our phages in the treatment of UTI, we decided to evaluate their stability in a urine sample. The results turned out to be promising as bacteriophages. this paper strongly suggest the therapeutic potential of the presented Enterobacter-specific bacteriophages.', 35891499),
('phage-antibiotic combinations (PAC) (P. aeruginosa phages, representative strains, R10266 and R9316)', 'PAC resulted in regained and improved antibiotic susceptibility to ciprofloxacin (MIC 2 to 0.0625) and meropenem (MIC 32 to 16), respectively, in R9316.', '', 'Phage resistance was prevented or reduced in the presence of several classes of antibiotics and outer membrane vesicle (OMV) production was reduced in the presence of phage for both strains, which was associated with significantly improved bacterial eradication. This study identifies novel bactericidal phage-antibiotic combinations capable of thwarting resistance development in MDR and XDR P. aeruginosa strains.', 35652690),
('Autographiviridae bacteriophage IME184', 'Phage IME184 is a promising biological agent that infects Klebsiella pneumoniae', '', 'Phage IME184 can be used in future phage therapies.', 35868353),
('lytic virus phi2013', 'data showed that phage phi2013 can efficiently inhibit E. coli growth in the tested foods at 4', '', 'We therefore conclude that phage phi2013 or cocktails containing phi2013 may be used as an antimicrobial agent in extending the shelf-life of food products by effectively controlling the growth of E. coli.', 36194307),
('Sb-1 Phage in combination with antibiotics', 'Sb-1 has been shown to be active against ', '', 'the potential activity of Sb-1 treatment in combination with antibiotics against S. aureus cells colonizing stainless steel implants has been demonstrated in vivo.', 36498843),
('combination of phages and ciprofloxacin.', 'The in vivo efficacy of the combination of ciprofloxacin (a single oral dose simulating 750 mg in human) with phages (a single intravenous administration of 1010 PFU) was tested in an experimental P. aeruginosa endocarditis in rats', '', 'We demonstrated that dosing schedule of phages first and the antibiotic second prevent the selection of resistant bacteria. These results demonstrate that combination efficacy relies on a strong initial reduction of the bacterial population by phages followed by antibiotics before any resistant arise.', 36135376),
('Bacteriophage', 'beat severe antibiotic-resistant strains', '', 'New research is now beginning to show thatPhage therapy may become much more broadly used as treatments for diseases and other infections.', 36301810);
INSERT INTO `bacteria_phage` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Pseudomonas phages AP025 and AP006', 'When treated with the phage AP025 at an MOI of 1 (8 ', 'mice were injected only with phages at MOI values of 1, 10 or 100 as single doses (i.p.). In this control group, we observed a 100% survival rate, indicating the absence of any toxic substance in the phage preparation.', 'Infected mice which received the higher concentrations of phage, AP025 and AP006, were fully protected (100%) and showed no signs of infection. This study highlights the efficacy of using a single dose of phages to restore mice from bacteremia.', 35909125),
('four-phage cocktail- phages GSP162, GSP193, GSP001, and GSP032', 'Our analysis shows that the four-phage cocktail was more effective than each phage alone in killing S. Enteritidis in vitro.', '', 'we observed that the combination of all four phages could continually inhibit bacterial growth for at least 24 h, and the bacterial cell density (optical density at 600 nm [OD600]) remained less than 0.75 until 68 h. These results demonstrated that the four-phage combination was effective in delaying the emergence of phage-resistant mutants. we developed a novel phage cocktail consisting of four phages targeting different host receptors. which could delay the emergence of phage-resistant bacterial mutants. Our mouse model of S. Enteritidis infection also demonstrated that phage cocktail treatment was more effective than single-phage treatment in an animal model.', 36165776),
('BFC1 (', '', '', '', 36175406),
('Phage therapy', '(bacterio)phages for the treatment of bacterial infection', 'The use of (bacterio)phages for the treatment of bacterial infections (phage therapy) seems safe', 'phage therapy is regaining interest, encouraged by published cases treated successfully with personalized phage combinations as well as significant advances at a preclinical level.', 36382975),
('Two enterococci phages (MDA1 and MDA2)', 'targeting several VREfm and VSE strains. The phage cocktail was able to eradicate all the tested bacterial strains(VREfm', 'safety for VREfm infection in the greater wax moth Galleria mellonella model. No virulence-associated genes, antibiotic resistance genes or integrases were detected in the phages'' genomes, rendering them safe to be used in an in vivo model.', 'Phages may constitute an alternative strategy to manage resistant bacteria such as VREfm in an innovative, safe, and natural way. Our results highlight the feasibility and the potential success of these phages in inhibiting VREfm in in vitro and in vivo models.', 36015218),
('engineered ? phage (E?) and wild-type ? phage (wt?)', 'In vitro experiments showed that the E? suppressed the growth of enterohemorrhagic Escherichia coli (EHEC) up to 18 h compared with only 6 h with the wt?; at the multiplicity of infection (MOI) of 10, the E? killed the EHEC cells with ~100% efficiency and did not affect the growth of other laboratory- and human-gut isolated E. coli strains.', '', 'Mouse experiments further confirmed the enhanced and strain-specific killing of the E? to EHEC, while the overall mouse gut microbiota was not disturbed. Our methods can be used to target other genes that are responsible for antibiotic resistance genes and/or human toxins, engineer other phages, and support in vivo application of the engineered phages.', 35876591),
('lysin Abp013', 'Abp013 treatment, 400, 800, and 1600 Microgram/mL of Abp013 were able to reduce the 3 h biofilm CFU by 2.65-log (99.78%), 2.23-log (99.42%), and 1.51-log (96.93%), respectively, compared to the untreated control. The activity of the lysin against the 3 h A. baumannii biofilms were further verified using confocal microscopy and LIVE/DEAD staining, which indicated that 96.86% of the cells within the biofilm were dead.', 'Abp013 is less effective in treating mature biofilms at a 24 h time point, but higher concentrations of the lysin (800', 'These results highlight the intrinsic bacteriolytic property of Abp013, suggesting the promising use of Abp013 as a novel therapeutic agent.', 35203772),
('B. subtilis strains CH311 and S3B', 'Both strains decreased ESBL-E. coli titers by 4 log10 CFU L-1 in an in vitro model of gut content, whereas the B. subtilis CU1 strain did not. In a murine model of intestinal colonization by ESBL-E. coli, CH311 and S3B did not decrease fecal titers of ESBL-E. coli. Ten sequences of putative antimicrobial peptides were identified in the genomes of CH311 and S3B, but not in CU1.', 'Despite strong in vitro activities of new B. subtilis strains against ESBL-E. coli, intestinal colonisation was not altered by curative Bacillus treatment even if their spores proved to germinate in the gut. Thus, this work underlines the importance of in vivo experiments to identify efficient probiotics.', 'Conclusions: Two new B. subtilis strains showed strong in vitro activity against ESBL-E. coli.', 34679216);

-- --------------------------------------------------------

--
-- Table structure for table `drug_target`
--

CREATE TABLE IF NOT EXISTS `drug_target` (
  `THEME` varchar(50) NOT NULL,
  `PMID` int(50) NOT NULL,
  `EVIDENCE` varchar(2000) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `drug_target`
--

INSERT INTO `drug_target` (`THEME`, `PMID`, `EVIDENCE`) VALUES
('DRUG TARGET', 12758284, ' Lipid metabolism in Plasmodium falciparum-infected erythrocytes: possible new targets for malaria chemotherapy.  The emergence and spread of drug-resistant parasites coupled with the absence of  an effective vaccine makes malaria treatment more complicated, and thus the development of new antimalarial drugs is one of the urgent tasks in malaria research.'),
('', 15473867, ' Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase.  Isoprenoid biosynthesis via the methylerythritol phosphate pathway is a target against pathogenic bacteria and the malaria parasite Plasmodium falciparum. 4-(Hydroxyamino)-4-oxobutylphosphonic acid and 4-[hydroxy(methyl)amino]-4-oxobutyl phosphonic acid, two novel inhibitors of DXR  (1-deoxy-D-xylulose 5-phosphate reducto-isomerase), the second enzyme of the pathway, have been synthesized and compared with fosmidomycin, the best known inhibitor of this enzyme.'),
('', 27720295, ' We hypothesize that targeting the HSP60/10 chaperonin systems in T. brucei is a viable anti-trypanosomal strategy as parasites rely on these stress response elements for their development and survival.'),
('', 25174342, ' A novel high throughput approach for the identification of chemically diverse inhibitors of the CoA synthesis pathway is reported.'),
('', 16892205, ' Preclinical drug metabolism and pharmacokinetic evaluation of GW844520, a novel anti-malarial mitochondrial electron transport inhibitor.  '),
('', 10353643, ' Furthermore, the relative lack of redundancy of cysteine proteases in parasites compared to their mammalian hosts makes them attractive targets for the development of new antiparasitic chemotherapy.'),
('', 21503171, ' Thus, H(+)-PPases from Leishmania plasma membrane might be potential target in rational chemotherapy of the disease caused by Leishmania parasites.'),
('', 17194200, 'We investigated the erythrocyte guanine nucleotide regulatory protein Gs as a novel antimalarial target. Together these data establish that, in addition to invasion, erythrocyte G protein signaling is needed for intracellular parasite proliferation and thus may present a novel antimalarial target.'),
('', 15811524, ' Together, these results underscore the importance of the proper assembly and function of CN in plasmodial biology and suggest that the inhibition of CN can be a potential mechanism behind the CsA-sensitivity of the malaria parasite.  ');

-- --------------------------------------------------------

--
-- Table structure for table `fungi_amp`
--

CREATE TABLE IF NOT EXISTS `fungi_amp` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `fungi_amp`
--

INSERT INTO `fungi_amp` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('4-methoxy-2,3,6-trimethylbenzensulfonyl-substituted D-octapeptide KN20', 'IC(50) 4 microM) and chemosensitized AD/PDR5(+) to FLC, itraconazole, and ketoconazole, also inhibited the ATPase activity of other ABC transporters, such as Candida albicans Cdr1p (IC(50), 30 microM) and Cdr2p (IC(50), 2 microM), and chemosensitized clinical isolates of pathogenic Candida species and S. cerevisiae', '', 'Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative', 15047528),
('(Ctn[1-14]) and (Ctn[15-34]), C-terminal peptide fragment of crotalicidin', 'Active against pathogenic yeasts, including several Candida species, both clinical isolates and standard strains, with MICs as low as 5 microM', 'Less cytotoxic to healthy HK-2 cells and less hemolytic to human erythrocytes than the standard-of-care amphotericin B', ' Altogether, Ctn and its fragments, particularly Ctn[15-34], are promising leads,  either alone or in combined regimen with amphotericin B, for the treatment of fungal diseases. ', 27876749),
('A-192411: a novel fungicidal lipopeptide (II)', 'Efficacy demonstrated against Candida albicans', '', ' In vivo characterization of A-192411: a novel fungicidal lipopeptide (II).  The ability of the novel antifungal cyclic hexalipopetide A-192411 to treat fungal infections in rodents is presented.', 12565958),
('Analogous cyclic decapeptides produced by Bacillus aneurinolyticus', 'Tyrocidine peptide complex (Trc mixture) and purified tyrocidines exhibited minimum inhibition concentrations below 13 microg ml(-1) (around 10 microM) and was significantly more potent than that of the commercial imidazole fungicide, bifonazole', '', ' Inhibition of agronomically relevant fungal phytopathogens by tyrocidines, cyclic antimicrobial peptides isolated from Bacillus aneurinolyticus.', 24996824),
('Antimicrobial peptides from norepinephrine-stimulated skin secretions from the foothill yellow-legged frog Rana boylii [Brevinin-1BYa (FLPILASLAA10KFGPKLF CLV20TKKC), peptides from ranatuerin-2 family temporin family ]', 'Brevinin-1BYa particularly potent against C. albicans [minimal inhibitory concentration (MIC) = 3 microm] and also active against Escherichia coli (MIC = 17 microm) and Staphylococcus aureus (MIC = 2 microm)', 'Strong hemolytic activity (HC50 = 4 microm)', ' Isolation of peptides of the brevinin-1 family with potent candidacidal activity  from the skin secretions of the frog Rana boylii.  The emergence of strains of the human pathogen Candida albicans with resistance to commonly used antibiotics has necessitated a search for new types of antifungal agents.', 14531844),
('APS-1 (Glu, Asp, Tyr, Ser, Thr, Pro, Leu, Ile, Val and an unknown amino acid)', 'Antifungal, strong inhibition on the germination of spores of the phytopathogens tested', '', 'Purification and characterization of a novel antifungal peptide APS-1 produced by Bacillus cereus', 12555574),
('Beta-peptide with fluconazole or ketoconazole', 'Enhanced the biological activity of these azoles in planktonic and biofilm Candida, and also in a fluconazole-resistant strain', 'On vitro cytotoxicity of the dual treatment was evaluated towards the human hepatoma cell line, HepG2', ' Natural antimicrobial peptides, AMPs, in  combination with other antifungal agents are a promising avenue to address the prevailing challenges.', 26470850),
('biofunctionalized polyelectrolyte multilayered films using CGA 47-66, chromofungin', 'Inhibit the growth of yeast Candida albicans by 65% and completely stop the proliferation of filamentous fungus Neurospora crassa', 'Cytotoxicity assessed by growing human gingival fibroblasts at its surface', 'Antifungal coating by biofunctionalized polyelectrolyte multilayered films.', 15992921),
('CD101', 'Potent activity against all Candida isolates tested, including azole-resistant strains, MICs were slightly higher at pH 4 versus 7 and at 48 versus 24 h of incubation', '', 'In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis', 28158577),
('Cilofungin (LY-121019), semi-synthetic lipopeptide ', 'The minimal inhibitory concentrations of cilofungin for C. albicans (N = 50) ranged from 0.039 to 5.0 micrograms/ml with a geometric mean of 0.47 micrograms/ml.: The same results were  obtained with C. tropicalis but one strain showed higher resistance (40 micrograms/ml) suggesting an Eagle effect.: The MIC for T. glabrata ranged from 5.0-40.0 micrograms/ml.: C. parapsilosis and C. krusei were less susceptible (5.0-40.0 micrograms/ml).', '', ' Susceptibility of Candida species to cilofungin (LY-121019).  Torres-Rodriguez JM, Carrillo-Mu?oz A, Gallach-Bau C, Madrenys N.  The antifungal activity of a new semi-synthetic lipopeptide named cilofungin (LY-121019) was studied in vitro on 102 strains of Candida and Torulopsis glabrata.', 2779613),
('D-beta-naphthylalanine-substituted antimicrobial peptide [P-113,  Ac-KWRRWVRWI-NH(2), Pac-525, D-Nal-Pac-525]', ' D-Nal-Pac-525 has the potential of becoming a promising antifungal agent, especially for fungal pathogens with intrinsic resistance to fluconazole', '', ' Increased potency of a novel D-beta-naphthylalanine-substituted antimicrobial peptide against fluconazole-resistant fungal pathogens.', 19538482),
('Dipeptide-based amphiphiles', 'Remarkable growth inhibiting activity on several Gram-positive (minimum inhibitory concentration (MIC)=0.1-10 microg/mL) and Gram-negative (MIC=5-150 microg/mL) bacteria as well as on fungus (MIC=1-50 microg/mL)', '', ' The results show that the rational designing of short peptide-based cationic amphiphiles might serve as a promising  strategy in the development of antimicrobial agents with greater cell specificities.', 19081951),
('DS6', 'DS6 is membrane lytic and exhibits antibiofilm activity against Candida tropicalis', '', 'In conclusion, DS6 may have utility as an alternative antifungal therapy for C.?tropicalis.', 28120548),
('FK463', 'MIC range, <==0.0039 to 2 microg/ml against Candida species and <==0.0039 to 0.0313 microg/ml against Aspergillus species also caused a 99% reduction in viability of  C. albicans at concentrations above 0.0156 microg/ml', '', ' In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi.    The in vitro antifungal activity and spectrum of FK463 were compared with those of amphotericin B, fluconazole, and itraconazole by using a broth microdilution method specified by National Committee for Clinical Laboratory Standards document M27-A (National Committee for Clinical Laboratory Standards, Wayne, Pa., 1997).', 10602723),
('FK463', ' MIC values of 0.010, 0.011 and 0.015 microg/ml against FLCZ susceptible, FLCZ susceptible-dose dependent and FLCZ resistant Candida albicans, respectively, Aspergillus fumigatus strains were inhibited  at 0.0078 microg/ml or lower concentrations', '', ' In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.   The antifungal activities of FK463 against various pathogenic fungi were tested by standard broth microdilution methods, and compared with the activities of five currently available antifungal agents; viz., fluconazole (FLCZ), itraconazole, miconazole, amphotericin B and flucytosine.', 11132964),
('Hemocyanin-derived (poly)peptides?', '', '', ' Antifungal peptides are generated from the C terminus of shrimp hemocyanin in response to microbial challenge.  We report here the isolation from plasma of two penaeid shrimp species of novel peptides/polypeptides with exclusive antifungal activities.', 11598107),
('Histatin-5 Bioadhesive Hydrogel Formulation', 'Treatment for Oral candidiasis (OC), caused by the fungal pathogen Candida albicans', '', ' Histatin-5 (Hst-5) specifically has exhibited potent anticandidal activity indicating its potential as an antifungal agent.', 26596951),
('Human lactoferrin (hLF) and synthetic peptides representing N terminal cationic domains hLF(1-11) and hLF(21-31)', 'hLF(1-11) more effective in killing fluconazole-resistant Candida albicans than hLF(21-31) and much more effective than lactoferrin', '', ' Candidacidal activities of human lactoferrin peptides derived from the N terminus.   In light of the need for new antifungal agents, the candidacidal activities of human lactoferrin (hLF) and synthetic peptides representing the first, hLF(1-11), and second, hLF(21-31), cationic domains of its N terminus were compared.', 11083624),
('Lactoferrin peptide (FKCRRWQWRM, Peptide 2; Pep2)', 'Enhance the candidacidal activity of antifungal drugs by promoting anion channel-associated ATP efflux from Candida cells and decreasing efflux of the drugs,', '', ' Antimicrobial peptides enhance the candidacidal activity of antifungal drugs by promoting the efflux of ATP from Candida cells.  The examined peptides, especially Pep2 and Hst5, enhance the candidacidal activity of antifungal drugs by promoting anion channel-associated ATP efflux from Candida cells and decreasing efflux of the drugs, which could be useful clinical applications.', 16291868),
('Lipopeptide Pal-Lys-Lys-NH(2) (PAL)', 'MICs ranged from < or = 0.25 to  > 16 microg mL(-1)', '', ' In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes.   BACKGROUND: An increasing number of antimycotics have become available for the treatment of dermatophytoses; however, there are reports suggesting recalcitrance to therapy or resistance of a dermatophyte against conventional treatment.', 19438437),
('Lipopeptides synthesized by conjugating dodecanoic acid (DDA) to the N-termini of 12-mer peptides LXXLLXXLLXXL (L(6)X(6), X = Lys, His, Arg, and all the leucines are d-amino acid enantiomers)', 'Active against both bacteria and fungi ', '', ' pH-dependent antifungal lipopeptides and their plausible mode of action. In this study we synthesized a  new group of lipopeptides by conjugating dodecanoic acid (DDA) to the N-termini of 12-mer peptides LXXLLXXLLXXL (L(6)X(6), X = Lys, His, Arg, and all the leucines are d-amino acid enantiomers) and investigated their pH-dependent biological activity and a plausible mode of action by using model phospholipids mimicking bacterial, mammalian, and fungal membranes.', 16008362),
('LTX109 (arginine-tertbutyl tryptophan-arginine-phenylethan)', 'Disrupt plasma membrane integrity. S. cerevisiae', '', ' The synthetic amphipathic peptidomimetic LTX109 is a potent fungicide that disturbs plasma membrane integrity in a sphingolipid dependent manner.  ', 23874964),
('LY121019, a new echinocandin derivative', 'Strong anti-Candida activity (in particular against Candida albicans)', 'Low experimental toxicity', ' A study of the antifungal activity of LY121019, a new echinocandin derivative.    LY121019 is a cyclic peptide antibiotic of the echinocandin group, which is characterized by strong anti-Candida activity (in particular against Candida albicans) as well as by low experimental toxicity.', 3288366),
('LY303366', ' For amphotericin B-resistant (AF65), LY303366 at 10 and 25 mg/kg/day was superior to amphotericin B at 2 and 5 mg/kg/day in reducing tissue  colony counts (P = 0.01 to 0.003), and for B-susceptible (AF210), amphotericin B at 5 mg/kg/day and at 5 mg/kg in four doses was more effective than all four regimens of LY303366 in reducing renal culture counts (P = 0.01 to 0.0001).', '', ' Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis.   LY303366 is a novel antifungal echinocandin with excellent in vitro activity against Aspergillus spp.', 9559799),
('MK-0991  (L-743,872)', 'Growth kinetic studies of MK-0991 against Candida albicans and Candida tropicalis isolates showed that the compound exhibited fungicidal activity (i.e., a 99% reduction in viability) within 3 to 7  h at concentrations ranging from 0.06 to 1 microg/ml (0.25 to 4 times the MIC)', '', ' In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991  (L-743,872).   The echinocandin MK-0991, formerly L-743,872, is a water-soluble lipopeptide that has been demonstrated in preclinical studies to have potent activity against Candida spp., Aspergillus fumigatus, and Pneumocystis carinii.', 9371328),
('MUC7 D1', 'Activity against azole-sensitive and azole-resistant C. albicans strains', '', ' The MUC7 D1 candidacidal activity was assessed against azole-sensitive and azole-resistant C. albicans strains and was found, unlike that of the MUC7 D1-15mer, to be comparable with that of Hsn-5, indicating that in addition to Hsn-5, MUC7 D1 could provide an attractive alternative to the classical antifungal agents.', 11095181),
('Mucin MUC7-derived peptide and histatin 5', 'Evaluated efficacy in vivo using the experimental model of murine vulvo-vaginal candidiasis', '', ' Efficacy of human salivary mucin MUC7-derived peptide and histatin 5 in a murine  model of candidiasis.  MUC7 16-mer (residues 36-51 of human salivary mucin, MUC7) and histatin 5 possess potent in vitro antifungal activity.', 14659657),
('Novel Peptides from Skins of Amphibians', 'These AMPs contain a C-terminus cyclic motif and most of them show obvious antimicrobial activities against 18 standard and clinically isolated strains of bacteria, including 4 Gram-positive bacteria, 11 Gram-negative bacteria, and 3 fungus.', '', ' Novel Peptides from Skins of Amphibians Showed Broad-Spectrum Antimicrobial Activities.', 26452973),
('P11-6, 11-residue peptide ', 'Activity against fluconazole-resistant Candida albicans', '', ' Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans.', 28105725),
('Pantinin-1, Pantinin-2 and Pantinin-3', 'All the three peptides possess relatively strong activities against Gram-positive bacteria and a fungus, but have very weak antimicrobial activities against Gram-negative bacteria', '', ' Three new antimicrobial peptides from the scorpion Pandinus imperator.', 23624072),
('PMAP-36-derived peptides (18-mer peptide RI18)', 'Exhibited excellent antimicrobial activity against both bacteria and fungi', 'Low haemolytic activity', ' Meanwhile, modification of AMPs is a promising strategy for developing novel antimicrobials to overcome drug-resistance. ', 27251456),
('Secreted lipopeptide fractions from Bacillus UCMB5113, together with synthetic peptide mimics', 'Suppressed growth of several fungal pathogens infecting Brassica plants', '', ' Analysis by mass spectrometry identified the most potent compounds as novel linear forms of antifungal fengycins, with synthetic peptide mimics confirming the biological activity.', 28961818),
('Synthetic CAP37 peptide  analogs', 'Three of the peptides demonstrated strong antifungal activity for C. albicans, including fluconazole-resistant isolates of C. albicans and were active against C. guilliermondii, C. tropicalis, C. pseudotropicalis, C. parapsilosis, and C. dubliniensis', '', ' Candidacidal activity of synthetic peptides based on the antimicrobial domain of  the neutrophil-derived protein, CAP37.   The primary bactericidal domain of CAP37, a cationic antimicrobial protein with potent activity against Gram-negative organisms was previously shown to reside between amino acids 20 through 44 (NQGRHFCGGALIHARFVMTAASCFQ) of the native protein.', 19626550),
('Synthetic cationic antimicrobial tripeptides', 'Strong general antifungal properties at low micromolar inhibitory concentrations', '', ' Synthetic mimics of antimicrobial peptides are emerging as a promising class of compounds for antifungal treatment.', 27576445),
('Synthetic killer peptide (KP)', 'Impairs Candida albicans biofilm', '', ' The synthetic killer peptide KP impairs Candida albicans biofilm in vitro. This study provides the first evidence on the KP effectiveness against C. albicans biofilm, suggesting that KP may be considered as a potential novel tool for treatment and prevention of biofilm-related C. albicans infections.  ', 28704490),
('Synthetic peptides Mo-CBP3-PepI (CPAIQRCC), Mo-CBP3-PepII (NIQPPCRCC), Mo-CBP3-PepIII (AIQRCC), RcAlb-PepI (AKLIPTIA), RcAlb-PepII (AKLIPTIAL), and RcAlb-PepIII (SLRGCC)', 'Synthetic peptides at 50 microg/mL, a concentration 20-fold lower than griseofulvin, reduced the microconidia viability of Trichophyton mentagrophytes and Trichophyton rubrum by 100%', 'Peptides also induced overproduction of reactive oxygen species (ROS) and enhanced the activity of griseofulvin 10-fold against both fungi, suggesting synergistic effects, and eliminated the toxicity of this drug to human erythrocytes.', 'CONCLUSION: Therefore, our results strongly suggest six peptides with high potential to be employed alone as new drugs or as adjuvants to enhance the activity and decrease the toxicity of griseofulvin.', 32628303),
('1,3,4-oxadiazole and an endocyclic amine grafted within the peptide backbone', 'Although few of the oxadiazole-containing macrocyclic peptides displayed activity against Candida albicans on their own, many increased the efficacy of fluconazole, resulting in a synergistic combination that was independent of efflux inhibition.', '', 'Combination therapy has the potential to confer enhanced efficacy as well as mitigate the evolution of resistance.', 32269162),
('Synthetic antimicrobial peptides (SAMPs) : Mo-CBP3 -PepI (CPAIQRCC) and Mo-CBP3 -PepII (NIQPPCRCC)', 'Anticandidal activity by induced the production of reactive oxygen species (ROS), cell wall degradation, and large pores', '', 'Synthetic antimicrobial peptides (SAMPs) have attracted substantial attention as alternatives and/or adjuvants in therapeutic treatments due to their strong activity at low concentrations without apparent toxicity.', 32189445),
('Peptide gH625 analogue (gH625-M)', 'gH625-M was effective in eradicating persister-derived biofilms both alone and in combination with conventional antifungals in Candida albicans', '', 'Biofilm formation poses an important clinical trouble due to resistance to antimicrobial agents; therefore, there is an urgent demand for new antibiofilm strategies that focus on the use of alternative compounds also in combination with conventional drugs.', 32238858),
('Peptides isolated from the venom of bees and their synthetic analogues (lasioglossins, halictines and hylanines)', '', '', 'Naturally occurring antimicrobial peptides and their synthetic analogues are promising candidates for new antifungal drugs.', 31376220),
('Rhesus theta defensin-1 (RTD-1)', 'Papidly fungicidal against clinical isolates of MDR C. albicans in vitro. Here we found that RTD-1 was rapidly fungicidal against blastospores of fluconazole/caspofungin resistant C. albicans strains, and was active against established C. albicans biofilms in vitro. In vivo, promoted long term survival in candidemic mice whether infected with drug-sensitive or MDR strains of C. albicans', '', 'Results of this study suggest that theta-defensins represent a new class of host-directed compounds for treatment of disseminated candidiasis.', 31729441),
('mastoparan B (MB)', 'against a panel of clinically relevant pathogens, including Candida albicans, Candida parapsilosis, Candida tropicalis, and Candida glabrata', '', 'These findings have potential therapeutic implications for the design and development of safe antifungal peptide-based drugs.', 35209228),
('palmitoyl pentapeptide-4', 'MIC values ranging from 2.4 to 5.4 microm against three species of Candida, namely, Candida albicans (ATCC 90028), Candida glabrata (ATCC 90030), and Candida parapsilosis (ATCC 22019).', 'did not show relevant toxicity against the cell lines tested, at up to 100 microM (human foreskin fibroblasts (HFF-1) and human immortalized keratinocytes (HaCaT).', 'have potent wide-spectrum antimicrobial action, including against multidrug-resistant Gram-positive and Gram-negative bacteria, and fungi.', 35950860),
('Synergistic effects of short peptides( LP-23, DP-23, SA4, and SPO) and antibiotics', 'almost all the combinations of peptides/peptoids with amphotericin B and fluconazole also showed effective synergy against Aspergillus niger and Aspergillus flavus.', '', 'The synergy found between LP-23, DP-23, SA4, and SPO with the selected antibiotics may have the potential to be used as a combination therapy against various microbial infections.', 35931657),
('synergistic activity of the human lactoferrin-derived hLF1-11 peptide with caspofungin', 'synergistic effects on preformed biofilm assessed by measuring metabolic activity (FIC range, 0.28 to 0.37) against biofilm-producing strains and by cell viability assay in C. albicans SC5314.', '', 'The synergistic effect observed between caspofungin and hLF1-11 against Candida spp. is of potential clinical relevance, representing a promising novel approach to target caspofungin-resistant Candida species infections.', 35876581),
('three new peptide families, named "Picturins" (PTR), "Pictuseptins" (PTS), and "Boanins" (BNS). from the skin secretions of the Chachi treefrog, Boana picturata', 'PTR displayed moderate activity against Escherichia coli (MIC 24.80 to 48.95 microM), while PTS showed a broad antimicrobial and antifungal effect.', '', 'Nature-inspired solutions have shown their importance mainly for the development of the pharmaceutical industry. Frog skin peptides are excellent examples of the biomedical potential of naturally evolved molecules for specific targets against antimicrobial resistance', 35640793),
('innate defense regulator (IDR) peptides.', 'IDR peptides stimulate or inhibit the body''s immune system, e.g., by stimulating leukocyte migration to the site of infection, driving macrophage differentiation and activation, providing chemotactic action for neutrophils, degranulation and activation of mast cells, altering chemokine and cytokine production, and even induction of angiogenesis and wound healing. Hence proven antibacterial, antifungal, and antiviral activity, also demonstrate anti-inflammatory and immunomodulatory capabilities', '', 'Exploring and utilizing IDR peptides as an indirect weapon against infectious diseases could represent a completely new strategy to cope with the issue of antimicrobial resistance.', 36009931),
('Human beta defensins (hBDs) are antimicrobial peptides', 'The antifungal susceptibility of hBD-1 against C. glabrata was calculated by broth microdilution assay. The susceptibility results confirmed that hBD-1 possessed the minimum inhibitory concentration of 3.12 microg/mL and prevented the growth and caused yeast cell death to various extents.', '', 'he peptide at subinhibitory and inhibitory concentrations blocked the cell cycle in C. glabrata in G0/G1 phase and disturbed the activity of primary and secondary antioxidant enzymes. Furthermore, at higher concentrations disruption of membrane integrity was observed. hBD-1 showed candidicidal activity against C. glabrata and was able to induce oxidative stress and arrested cell cycle in C. auris and therefore has a potential to be developed as an antifungal drug against C. glabrata.', 35988423),
('SA-2 (YYRRLLRVLRRRW) was derived from Cystatin-SA, a saliva protein', 'good inhibitory effect on Candida albicans (C. albicans) and Cryptococcus neoformans (C. neoformans), with MIC values of 16-64 microg/mL and 8-32 microg/mL, respectively. Interestingly, SA-2 effectively killed fluconazole-resistant C. neoformans and C. albicans within 12 h.', 'SA-2 had a low cytotoxicity toward mammalian cells', 'found that the cationic peptide SA-2 could adhere to the negatively charged fungal cell membrane to increase the surface potential of C. neoformans in a dose-dependent manner, and finally disrupted the integrity of fungal cell membrane, reflecting as a 60% positive rate of propidium iodide uptake of C. neoformans cells after SA-2 (4 ', 36333524),
('68 amino acid bacteriocin, EntV, secreted by Enterococcus faecalis.', 'EntV68 inhibited biofilm formation of other Candida species including C. tropicalis, C. parapsiolosis and C. glabrata, suggesting its activity may not be limited to C. albicans14. Based on these observations, whether EntV and derivative peptides protected C. elegans from other fungal species and drug resistant strains of C. albicans was tested.', '', 'treatment with EntV significantly reduced the fungal burden, as observed. EntV, or the 12mer peptide (100 nM) is as effective as EntV68 in abrogating an oropharyngeal infection of C. albicans.', 36229448),
('ring-modified histidine-containing short cationic peptides', 'peptides Trp-His[1-(3,5-di-tert-butylbenzyl)-5-iodo]-OMe (10d, IC50 = 2.20 microg/mL; MIC = 4.01 microg/mL) and Trp-His[1-(2-iodophenyl)-5-iodo)]-OMe (10o, IC50 = 2.52 microg/mL; MIC = 4.59 microg/mL) exhibit promising antifungal activities against C. neoformans.', '', 'dipeptides primarily act via membrane disruption, leading to pore formation and causing cell lysis. After entering the cells, the peptides interact with the intracellular components as demonstrated by confocal laser scanning microscopy (CLSM).', 36615282),
('tachplesin I analogue peptide (TP11A)', 'TP11A suppressed the biofilm- and virulence-related genes of C. albicans (hwp 1) and S. aureus (ica A, fnb B, agr A, hla, nor A, and sig B) in the mixed biofilm, according to quantitative reverse transcription polymerase chain reaction analysis', '', 'The findings revealed that TP11A and PLEL@TP11A- TP11A into poly(d,l-lactide)-poly(ethylene glycol)-poly(d,l-lactide) could efficiently reduce bacterial and fungal burden in wound infections, as well as accelerated wound healing. Based on above findings, TP11A might be an effective antimicrobial against C. albicans-S. aureus poly-biofilm formation and mixed infection.', 35998684),
('short (IIKK)3 peptides', 'possess high antifungal activities against the Candida species and Cryptococcus neoformans; some of them displayed faster dynamic killing than antibiotics like amphotericin B. G(IIKK)3I-NH2 and (IIKK)3II-NH2 were particularly potent against not only planktonic microbes but also fungal biofilms with low cytotoxicity to host cells.', '', 'These studies demonstrate the important role of colloid and interface science in further developing short, potent and biocompatible AMPs towards clinical treatments via structure design and optimization.', 34626966),
('Cationic Antifungal Proteins from Filamentous Fungi', 'Inhibit Candida albicans Growth in 3D Skin Infection Models', '', 'In summary, our study proves that the tested AFPs exhibit antifungal potential against cutaneous C. albicans infection in a 3D FT skin model.', 35499318),
('Peptide from Budding Yeast GAPDH (SP1)', 'Serves as a Promising Antifungal against Cryptococcus neoformans', '', 'Our data imply that SP1 has the potential to be developed into a treatment option for cryptococcosis.', 35019693),
('Catestatin-Derived Peptides [D-bCtl, as well as the combination of BSA with L-bCts]', 'Fight the Development of Oral Candidosis', '', 'In this context in vitro D-bCtl, as well as the combination of BSA with L-bCts are potential candidates for the development of new antifungal drugs for the treatment of oral candidosis due to Candida and non-Candida albicans, without detrimental side effects.', 35216181),
('WMR Peptide', 'Results showed a WMR antifungal activity on all Candida planktonic cells at concentrations between 25 MicroM to >50 MicroM and exhibited activity at sub-MIC concentrations to inhibit biofilm formation and eradicate mature biofilm.', '', 'These findings provide novel insights for the antifungal mechanism of WMR against Candida albicans and non-albicans, providing fascinating scenarios for the identification of new potential antifungal targets.', 35216270),
('P255 and P256 with the same composition and different distribution were derived from PAF26', 'P256 exhibited higher antifungal activity against C. albicans than did P255 and PAF26. P256 and P255 exhibited synergism when combined with amphotericin B (AMB).', '', 'These results demonstrate the therapeutic potential of the peptides, particularly P256 with clear amphipathicity, in the development of therapies for C. albicans infections.', 34768011),
('Antimicrobial Peptide from the Skin of Kaloula pulchra', 'weakly active towards fungi due to its membranolytic action.', '', 'Brevinin-2KP is weakly active towards the tested Gram-positive and Gram-negative bacteria as well as fungi due to its membranolytic action.', 35249479),
('Novel Antimicrobial Peptide GK-19 derived from Scorpion venom- Androctonus amoreuxi Antimicrobial Peptide 1 (AamAP1)', 'GK-19 also exhibited distinguished antifungal activity with much lower minimal inhibitory concentration (MIC) values ranging between 5 to 10 microM (C. krusei (5 microM), C. albicans (10 microM), and C. glabrata (10 microM)) in comparison to that of AamAP1', 'GK-19 showed negligible toxicity to mammalian cells, low hemolytic activity and high stability in plasma.', 'For Candida albicans, GK-19 showed significant antimicrobial and healing effects. Overall, it was demonstrated that GK-19 might be a promising drug candidate in the battle against drug-resistant bacterial and fungal infections.', 36145681),
('Host defense peptides and cell-penetrating peptides', 'brilliance in the field of intracellular delivery, the potential of cell-penetrating peptides and their mimics for designing antifungal agents', '', 'effectiveness and potential of cell-penetrating peptide-inspired strategy in designing potent and selective antifungal polymeric agents.', 35996361),
('antifungal peptide targeting the P4-ATPase function', 'A modified peptide, "AW9-Ma" showed a MIC of 64 microg/mL against H99 wild type and a fractional inhibitory concentration (FIC) index value of 0.5 when used in combination with caspofungin.', '', 'Structure-activity relationship studies of the AW9 sequence showed that two lysine residues on the peptide are likely responsible for the interaction with the P4-ATPase, hence critical for its antifungal activity.', 35377230),
('cell penetrating peptide (CPP) octaarginine (R8), elongated to 28 residues poly(d,l-homoarginine)', 'potent antifungal activity against drug-resistant fungi superior to antifungal drugs, excellent stability upon heating and UV exposure, negligible in vitro and in vivo toxicity, and strong therapeutic effects in treating invasive fungal infections', '', 'All these merits imply the effectiveness of our strategy to develop promising antifungal agents.', 35535860),
('Lipo-Gama-AA Peptides', 'MW5, exhibited potent and broad-spectrum antifungal activity. In addition, MW5 potently boosted the efficacy of fluconazole against clinical azole-resistant Candida isolates. resensitize drug-resistant Candida albicans to fluconazole', '', 'Our results demonstrated that lipo-gamma-AA peptides have great promise for use alone or in combination to combat drug-resistant Candida infections.', 35637173),
('Antimicrobial peptides (AMPs) from wasp venom (Vespamandarinia)', 'It displayed potent antimicrobial activities against Gram-positive bacteria (MICs: 4', '', 'Thus, peptide VM-3K could be a promising broad-spectrum antimicrobial candidate for addressing the current antibiotic-resistant infection crisis. It is worth mentioning that this investigation on the relationship between peptide structure and mechanism of action could become an important aspect of drug research on short peptides.', 36138742);

-- --------------------------------------------------------

--
-- Table structure for table `fungi_light`
--

CREATE TABLE IF NOT EXISTS `fungi_light` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `fungi_light`
--

INSERT INTO `fungi_light` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Cu-sputtered polyester surfaces (Cu-PES) and low intensity visible light irradiation (4.65mW/cm2)', 'Cu-PES exhibited an accelerated fungicidal activity against Candida albicans and Candida glabrata with a reduction of 3.0 and 3.4log10CFU', '', ' These results indicate that Cu-PES represent a promising strategy for decreasing the colonization of surfaces by yeasts and that actinic light can improve its self-disinfecting activity.  ', 28802173),
('a PS (beta-carboxyphthalocyanine zinc, CPZ) delivery system with lanthanide-doped upconversion nanoparticles (UCNPs, LiYF4:Yb/Er) and polyvinylpyrrolidone (PVP)', 'High antifungal efficacy against Candida albicans', '', ' Near-infrared-triggered antibacterial and antifungal photodynamic therapy based on lanthanide-doped upconversion nanoparticles. An alarming worldwide increase in microbial resistance to traditional drugs and classical pharmacophores has spurred the search for new antimicrobial compounds.  Antimicrobial photodynamic therapy (aPDT) has recently emerged as an effective modality for the selective destruction of bacteria and other pathogenic microorganisms.', 29881851),
('Curcumin and blue light', 'Eradication of C. albicans biofilms', '', ' Photodynamic therapy (PDT) utilizing curcumin and blue light was tested as an independent therapy and in combination with fluconazole treatment.', 29364155),
('Fluorescent probes hydroxyphenyl fluorescein (HPF) and aminophenyl fluorescein (APF) after toluidine blue (TBO-37.5 mg/L)-mediated PDT (660 nm, 40 mW, and 0.04 cm2?spot area)', 'Significant generation of hydroxyl radicals and hypochlorite after TBO-PDT with doses around 90 J/cm2; for inactivating Paracoccidioides brasiliensis colonies at 7 and 15 days', '', ' In that way, photodynamic therapy (PDT) arises as a new promising adjuvant treatment for inactivating Paracoccidioides brasiliensis (Pb), the responsible fungus for PCM, and also for helping the patients to deal with such debilitating oral lesions.', 28349345),
('Methylene blue-mediated photodynamic therapy', 'Concentrations from 250 to 400 microgram/mL reduced fungal growth but did not eliminate Candida albicans.: MB concentrations of 450 and 500 microgram/mL totally eradicated Candida albicans from the oral cavity, resulting in reductions from 2.5 log(10) and 2.74 log(10) to 0, respectively', '', ' Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model.   OBJECTIVES: The purpose of this study was to evaluate the efficacy of using methylene blue (MB)-mediated photodynamic therapy to treat oral candidiasis in an immunosuppressed murine model, mimicking what is found in human patients.', 11862203),
('New methylene blue N and red light', 'Effect on Candida albicans proteome', '', ' Here, we report a combination of two-dimensional electrophoresis and tandem mass spectrometry to study the protein damage resulting from treating C. albicans with PDT with new methylene blue N and red light.', 27830217),
('PDT method based on light curing units'' blue LEDs combined to a plaque-disclosing composition (5%  erythrosine)', 'Can  inactivate C. albicans', '', 'Preclinical study of a cost-effective photodynamic therapy protocol for treating  oral candidoses.   Photodynamic therapy (PDT) is a promising treatment for oral candidoses.', 28508242),
('PSs hypericin (HYP) and 1,9-dimethyl methylene blue (DMMB) exposed to two light-emitting diode light fluences (18 and 37 J cm??)', 'The minimal fungicidal concentration of HYP for greater than 3 log?? CFU reduction (0.5 McFarland) was 0.62 micromol l?? for most strains, whereas for DMMB it ranged between 1.25 and 2.5 micromol/L', '', ' Photodynamic fungicidal efficacy of hypericin and dimethyl methylene blue against azole-resistant Candida albicans strains.    Antimicrobial photodynamic therapy (aPDT) is an emerging alternative to treat infections based on the use of photosensitisers (PSs) and visible light.', 23905682),
('Riboflavin/UVA combination (365 nm) combination', '', '', ' Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis.   PURPOSE: To demonstrate the antimicrobial properties of riboflavin/UVA (365 nm) against common pathogens.', 18408193),
('Aloe emodin (AE)', '', '', 'AE exhibited no significant dark toxicity, but in the presence of light, effectively inactivated C. albicans cells in a concentration-dependent manner.', 32232258),
('Tagetes minuta', 'Tagetes minuta extracts as a photosensitizer on growth of Candida and dermatophytes and their effect on Candida virulence factors. T. minuta root hexane and dichloromethane extracts demonstrated high photodynamic antifungal activity.', '', 'Photodynamic therapy (PDT) involves the topical administration of a photosensitizer in combination with light of an appropriate wavelength and molecular oxygen that produces reactive oxygen species (ROS), which promote damage to several vital components of the microorganism.', 31724710),
('5-aminolevulinic acid PDT (ALA-PDT)', 'Using combination therapy, we have successfully treated a patient who had a T. asahii skin infection. Further in vitro studies showed that the antifungal effect of ALA-PDT on planktonic and adherent T. asahii was dependent on the concentration of ALA and light dosages used.', '', 'Photodynamic therapy (PDT) is a new therapeutic approach developed not only to combat cancerous lesions but also to treat infectious diseases such as fungal infections.', 33164224),
('Methylene blue, new methylene blue N and S137', 'The results from this model indicate that antimicrobial photodynamic therapy with methylene blue, new methylene blue N and S137 is efficient for the treatment of infection with F. keratoplasticum and F. moniliforme.', '', 'Antimicrobial photodynamic therapy with phenothiazinium photosensitizers in non-vertebrate model Galleria mellonella infected with Fusarium keratoplasticum and Fusarium moniliforme.', 30586617),
('Aminolevulinic acid', 'Our study shows ALA aPDT induced 46% ? 24.23% reduction of the growth of all tested P. wickerhamii strains in T1 group.', '', 'BACKGROUND: Antimicrobial photodynamic therapy(aPDT) has been used to treat localized cutaneous fungal infections that have an enhanced antifungal susceptibility profile.', 30586618),
('Hypocrellin B (HB)', 'Inactivated the azole-sensitive and resistant C. albicans in a light-dose and PS concentration-dependent manner.', 'HB exhibited no significant dark toxicity', 'Antimicrobial photodynamic therapy (aPDT) is an emerging and promising approach for treating localized and superficial C. albicans infections.', 31325521),
('5-aminolevulinic acid (5%ALA) in a thermosetting gel (t) (5%ALA-PTt)', 'The 5% ALA-PTt preparation was shown to be effective in reducing the growth of biofilm and inoculum of C. albicans.', '', 'Newly formulated 5% 5-aminolevulinic acid photodynamic therapy on Candida albicans.', 31614222),
('Photodynamic activity of hexane (Hex), dichloromethane (DCM), ethyl acetate (EtOAc) and methanol (MeOH) extracts from T. pentachaeta var. belenidium', 'MIC = 8-256 microgram/mL, synergistic effects with ciprofloxacin and fluconazole', '', 'Taking together, results demonstrated the strong photodynamic effects of T. pentachaeta root extracts under UVA irradiation, making them valuable alternatives to the already established antifungal drugs against C. albicans.', 34148723),
('Methylene blue (MB)-PDT', 'MICs ?0.004-4 mg/L against Trichophyton species, MIC elevated (MB: 2-8 mg/L and 8-16 mg/L) in isolates from two pigmented cultures of Trichophyton interdigitale (one wildtype and one harbouring L393F) with a darker color when compared to unpigmented cultures (MB: 0.5-4 mg/L)', '', 'Photodynamic therapy: A treatment option for terbinafine resistant Trichophyton species.', 33497815),
('photoimmuno-antimicrobial strategy (PIAS)', 'PIAS acts on a broad range of microbes, including the bacterial pathogen Staphylococcus aureus, fungal pathogen Candida albicans, including their drug-resistant strains,', 'PIAS protects mice from fatal infections without damaging the non-targeted host microbiota and tissues.', 'This study may contribute to the development of next-generation anti-infective therapies.', 35788695),
('therapeutic potential of antimicrobial 265 nm UVC', 'UVC inhibited all tested bacteria and fungi, including mixed culture and strains linked to antibiotic resistance against infectious keratitis.', '', 'In vitro and ex vivo testing confirmed therapeutic potential of UVC. In vivo, UVC administered in two doses, 4 h apart, proved effective in treating murine bacterial keratitis and also fungi related', 35568373);

-- --------------------------------------------------------

--
-- Table structure for table `fungi_naturalproduct`
--

CREATE TABLE IF NOT EXISTS `fungi_naturalproduct` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `fungi_naturalproduct`
--

INSERT INTO `fungi_naturalproduct` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('4-Cyclopentene-1,3-dione from Feijoa ( Acca sellowiana)', 'IC50? 1-2 microM against human-pathogenic Candida species', '', 'Bioactivity-Guided Metabolite Profiling of Feijoa ( Acca sellowiana) Cultivars Identifies 4-Cyclopentene-1,3-dione as a Potent Antifungal Inhibitor of Chitin Synthesis.  ', 29546758),
('Acetone Lichen Extracts', 'Seven extracts displayed both anti-maturation and anti-biofilm activities (half maximal inhibitory concentrations IC50_mat?and IC50_biof?? 100 microg/mL);?Evernia prunastri?and?Ramalina fastigiata?were the most promising lichens (IC50_mat?< 4 microg/mL and IC50_biof?< 10 microg/mL).', '', 'Antifungal and Anti-Biofilm Activities of Acetone Lichen Extracts against Candida albicans', 28422057),
('Aqueous and hydroethanolic extracts from Psidium brownianum Mart ex DC. and Psidium guajava L.', ' A synergistic effect was observed in the combination of fluconazole  with Psidium brownianum extracts against all Candida strains. However, for Psidium guajava extracts the synergistic effect was produced mainly against the Candida albicans LM77 and Candida tropicalis INCQS 400042 strains', '', ' Our results indicated that both P.?brownianum and P.?guajava extracts are effective on potentiating the effect of fluconazole, and  therefore, these plants have the potential for development of new effective drugs for treating fungal infections. ', 27085299),
('Beauvericin', 'Inhibits TOR signaling in Candida albicans, potentiates the activity of azole antifungals against azole-resistant Candida isolates via inhibition of multidrug efflux', '', ' Here, we explore a powerful strategy to enhance antifungal efficacy against leading human fungal pathogens by using the natural product beauvericin.', 27736764),
('Beauvericin', 'Targets multidrug efflux and TOR signaling', '', ' Dual action antifungal small molecule modulates multidrug efflux and TOR signaling.   There is an urgent need for new strategies to treat invasive fungal infections, which are a leading cause of human mortality. Here, we establish two activities of the natural product beauvericin, which potentiates the activity of the most widely deployed class of antifungal against the leading human fungal pathogens, blocks the emergence of drug resistance, and renders antifungal-resistant pathogens responsive to treatment in mammalian infection models.', 27571477),
('Benzo[c]phenanthridine alkaloids from Chelidonium majus Linn [8-hydroxydihydrosanguinarine (1) and 8-hydroxydihydrochelerythrine (2), Dihydrosanguinarine (3), dihydrochelerythrine (4), sanguinarine (5) and chelerythrine (6)]', 'Of the six compounds determined, (1) and (2) demonstrated potent activity against clinical drug-resistant yeast isolates with the MIC ranges of 2-80 and 4-100 microg/mL, respectively. (3), (4), (5) and (6) had some degree of antifungal activit', '', 'The overall results provided important information for the potential application of the 8-hydroxylated alkaloids from Chelidonium majus in the therapy of serious infection caused by drug-resistant fungi.', 19647059),
('Brown Brazilian propolis (Apis mellifera)', 'Sporothrix brasiliensis were sensitive to brown propolis between MIC values of 0.19-1.56 mg/mL, including the itraconazole-resistant isolates, whereas the MFC values of propolis were from 0.78 to greater than 3.125 mg/mL', '', ' Brown Brazilian propolis  is a promising antifungal candidate against sporotrichosis and more studies need  to be undertaken to evaluate its safe use to understand its efficacy.  ', 28219829),
('Carica papaya Linn. seed essential oil', '?The EO showed inhibitory effect against all the tested Candida strains including C. albicans, C. glabrata, C. krusei, C. parapsilosis and C. tropical with inhibition zone diameters in the range of 14?2-33?2 mm, the minimal inhibitory concentrations (MICs) in the range of 4?0-16?0 microg ml-1?and the minimum fungicidal concentrations (MFCs) in the range of 16?0-64?0 microg ml-1?.', '', ' Carica Papaya may be recognized as a possible new source of natural antifungal agents.  ', 28052349),
('Carvacrol', '?Carvacrol has antifungal activity in comparison to voriconazole (VCZ) (MIC 0?5, 0?25 micro g ml-1?respectively)', '', ' Assessment of carvacrol for control of avian aspergillosis in intratracheally challenged chickens in comparison to voriconazole with a reference on economic impact.   AIM: This study was designed to investigate the efficacy of essential oils as an  alternative prophylaxis and treatment for avian aspergillosis.', 28795522),
('Enhalus acoroides leaf extract', '?Activity against  C. albicans and E. coli, reduce bacterial and fungal coverage by 60.9 and 73.9%, respectively; affect bacterial biofilm maturation and promote dispersion, up to 70%, in fungal biofilm; increase luminescence in Vibrio harveyi by 25.8%', '', ' E. acoroides leaf extract proved to be the most promising extract among those tested.', 29843708),
('Essential Oil From Salvia mirzayanii Leaves', 'The MIC95 were 0.03 to 0.5 microL/mL and 16 to 128 microL/mL for gram-positive and gram-negative bacteria, respectively, MIC50 0.03 to 1 microL/mL for yeast', '', ' Chemical Composition and Antimicrobial Activities of the Essential Oil From Salvia mirzayanii Leaves.   Resistance of many pathogens to available drugs is a global challenge and is leading to growing interest in natural alternative products.', 28689440),
('Ethyl acetate extract of the herb Dalea formosa of the American Southwest', 'Activity against azole-sensitive and azole-resistant isolates', '', ' Modulation of the antifungal activity of new medicinal plant extracts active on Candida glabrata by the major transporters and regulators of the pleiotropic drug-resistance network in Saccharomyces cerevisiae. The increased incidence of drug-resistant fungal infections, a process in which active efflux plays an important role, calls for the development of new treatments.', 19216644),
('Globiferin isolated from root extracts of Cordia globifera and its derivatives', 'Antimalarial, antifungal, and cytotoxic activities', '', ' Biomimetic transformation and biological activities of Globiferin, a terpenoid benzoquinone from Cordia globifera.    A new 10-membered ring meroterpene (1), named globiferin, was isolated from root  extracts of Cordia globifera. Biomimetic transformations of 1 and its derivatives, either by acid cyclization or by Cope rearrangement, provided information relating to the biogenesis of cordiachromes A-C. Globiferin (1) underwent Cope rearrangement upon refluxing in xylene and DMSO-d(6) to yield cordiachrome C (3) and cordiaquinol C (4), respectively.', 19368377),
('Isoflavonoids, sedonans A-F (1-6), a new but-2-enolide, 4''-O-methylpuerol A (7), and the new pterocarpan ent-sandwicensin (8) from the root extract of Dalea formosa', 'MIC = 20 microM of 1 against C. glabrata, Sedonans A-F and ent-sandwicensin active against Saccharomyces cerevisiae strains that express differing ABC transporter-associated resistance mechanisms,', '', 'We observed strong antifungal growth inhibitory activity in the methanol extract of Dalea formosa roots.', 23631483),
('IWF1 and IWF2, proteins isolated from the intercellular washing fluid (IWF) of sugar beet leaves', ' Both proteins show strong in vitro antifungal activity against Cercospora beticola, the casual agent of leaf spot disease in sugar beet', '', ' New antifungal proteins from sugar beet (Beta vulgaris L.) showing homology to non-specific lipid transfer proteins.  Two novel, nearly identical antifungal proteins, IWF1 and IWF2, were isolated from the intercellular washing fluid (IWF) of sugar beet leaves.', 8790287),
('Lyophilized aqueous extract of the leaves of Acca sellowiana (O.berg) Burret (Myrtaceae) ', 'Candida glabrata showed the lowest MIC values (500-3.90 microg/mL)', '', 'Reversal of fluconazole resistance induced by a synergistic effect with Acca sellowiana in Candida glabrata strains', 27050162),
('Methanolic extract of scapes of Syngonanthus nitens (S. nitens extract [SNE]) and an SNE-loaded liquid crystal precursor mucoadhesive systems (LCPM)', 'Activity against Candida krusei, SNE was active against all strains studied, with minimum inhibitory concentration values ranging from 125 to 62.5 microg/mL; after incorporating SNE into F (FE), these values decreased to 62.5 to 31.2 microg/mL, demonstrating that incorporation into the formulation potentiated the action of SNE.', '', ' Liquid crystal precursor mucoadhesive system as a strategy to improve the prophylactic action of Syngonanthus nitens (Bong.)   Vaginal infections caused by Candida krusei are a problem of extreme complexity due to the intrinsic resistance to azole drugs. Therefore, the objective of this study was to evaluate the potential of the methanolic extract of scapes of S. nitens (S. nitens extract [SNE]) and an SNE-loaded LCPM against C. krusei as prophylaxis for vulvovaginal candidiasis.  SNE was active against all strains studied, with minimum inhibitory concentration values ranging from 125 to 62.5 ?g/mL; after incorporating SNE into F (FE), these values decreased to 62.5 to 31.2 ?g/mL, demonstrating that incorporation into the formulation potentiated the action of SNE.', 26719688),
('Origanum vulgare (oregano), Pinus sylvestris (pine), and Thymus vulgaris (thyme red) EOs, and their components', 'Activity against Cryptococcus neoformans', '', ' To date, there are very few molecules with any activity towards Cryptococcus neoformans, leading to heightened interest in finding new alternatives or adjuvants to conventional drugs for the treatment of  mycosis caused by this yeast. Use of Pinus sylvestris L. (Pinaceae), Origanum vulgare L. (Lamiaceae), and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans strains', 29724221),
('p-coumaroyl-hydroxyagmatine (p-CHA) from barley leaf ', 'Antifungal activity both in vitro and in vivo', '', ' Structural analysis identified this compound as a novel phenolic conjugate, p-coumaroyl-hydroxyagmatine (p-CHA). p-CHA but not the nonhydroxylated derivative p-coumaroylagmatine exhibited antifungal activity both in vitro and in vivo.', 9535889),
('Plant-derived essential oils [Pelargonium graveolens (Geraniaceae) (PG-EO) , linalool, geraniol]', 'PG-EO most effective oil, treatments with PG-EO, linalool, and geraniol significantly reduced the number of viable biofilm cells and inhibited biofilm formation in Candida species', '', ' Antifungal activity of plant-derived essential oils on Candida tropicalis planktonic and biofilms cells. PG-EO, geraniol, and linalool were not toxic to normal human lung fibroblasts (GM07492A) at the concentrations they were active against C. tropicalis Together, our results indicated that C. tropicalis is susceptible to treatment with PG-EO, geraniol, and linalool, which could become options to prevent or treat this infection.', 26868902),
('Quercetin (QCT)', '64 micro g/mL QCT and/or 128 ?g/mL FCZ could be synergistic against 10 FCZ-resistant planktonic and 17 biofilm cells of C. albicans, and inhibit fungal adherence, cell surface hydrophobicity (CSH), flocculation, yeast-to-hypha transition, metabolism, thickness and dispersion of biofilms', '', ' Together with these results, it could be demonstrated that QCT could  be a favorable antifungal agent and a promising synergist with FCZ in the clinical management of VVC caused by C. albicans biofilm.  ', 27915337),
('Selected secondary metabolites from Chilean Calceolaria integrifolia sensu lato complex', 'Mixtures of isorhamnetin/dunnione/kaempferol/ferulic/gallic acid in various combinations were found to have the most potent bactericidal and fungicidal activity with MFC between 10 and 50 microg/ml. Quercetin was found to be the most potent fungistatic single compound with an MIC of 15 microg/ml.', '', 'Biopesticides from plants: Calceolaria integrifolia s.l', 24893349),
('Sodium lignosulfonate (LIG)', 'MIC against Candida spp. was found to be 64-128 micro g/ml.', '', 'Deciphering the role of Sodium Lignosulfonate against Candida spp. as persuasive anticandidal agent.  In the race of Candida therapeutics, the revelation  of the antifungal potential of such natural compounds might impact and diversify  the discovery and development of novel antifungal agent. ', 28962848),
('Solasodine-3-O-?-d-glucopyranoside (SG) isolated from the medicinal plant Solanum nigrum L', 'In vitro, SG displayed potent fungicidal activity against both azole-sensitive and azole-resistant Candida albicans strains in Spider medium with its MICs of 32 ?g/ml', '', ' Solasodine-3-O-?-d-glucopyranoside kills Candida albicans by disrupting the intracellular vacuole. In?vitro, SG displayed potent fungicidal activity against both  azole-sensitive and azole-resistant Candida albicans strains in Spider medium with its MICs of 32??g/ml.', 28552788),
('Steroid saponins from Tribulus terrestris L. (TTS-12, TTS-15)', 'TTS-12 and TTS-15 were very active against fluconazole-resistant C. albicans (MIC(80)=4.4, 9.4 microg/ml), C. neoformans (MIC(80)=10.7, 18.7 microg/ml) and inherently resistant C. krusei (MIC(80)=8.8, 18.4 microg/ml)', '', ' In vitro and in vivo antifungal activities of the eight steroid saponins from Tribulus terrestris L. with potent activity against fluconazole-resistant fungal  pathogens.   Antifungal activity of natural products is being studied widely.', 16327151),
('Thymus daenensis and Silybum marianum extracts with Ag-NPs', 'Activity at?12.5 to 50 mg/mL against Staphylococcus aureus (S. aureus, Gram-positive organism) and Escherichia coli (E. coli, Gram-negative organism), and fungal strains were Aspergillus oryzae (A. oryzae) and Candida albicans (C. albicans).', '', 'Ultrasound-assisted extraction of antimicrobial compounds from Thymus daenensis and Silybum marianum: Antimicrobial activity with and without the presence of natural silver nanoparticles', 29429729),
('Usnic Acid', 'The biofilm inhibitory concentration of usnic acid (4 ?g/mL) exhibited a significant biofilm inhibition, 71.08 % for azole-resistant and 87.84 % for azole-sensitive C. albicans strains', '', ' Our results suggest that usnic acid could be an alternative for the treatment of Candida infections, which deserves further investigation. ', 27648556),
('Xylaria sp. BIOTEC culture collection (BCC) 1067?', 'Promising antifungal effect against yeast Saccharomyces cerevisiae with minimal inhibitory concentration?and minimal fungicidal concentration of 500 and 1000 mg/l, respectively, strong synergy with fractional inhibitory concentration index value of 0.185 for the combination of 60.0 and 0.5 mg/l of extract and ketoconazole, respectively', '', ' BCC 1067 extract is a potentially valuable source of novel antifungals.  ', 28361556),
('Zingiber officinale Extract', 'The findings of the present study indicate that ginger extract has good antifungal and antibiofilm formation by fungi against C. albicans and C. Krusei. Concentrations between 0.625 mg/mL and 5 mg/mL had the highest antibiofilm and antifungal effects', '', 'Survey of the Antibiofilm and Antimicrobial Effects of Zingiber officinale (in Vitro Study)', 27127591),
('Vanillin', 'Inhibits Candida drug resistance protein 2 (CaCdr2p) activity', '', 'Insight studies into the mechanisms suggested that abrogated efflux by CaCdr2p is due to competitive mode of inhibition by Van as depicted by Lineweaver-Burk plot.', 31937429),
('Rumex abyssinicus Jacq. (Polygonaceae)', 'MIC = 8-256 microgramg/mL, synergistic effects with ciprofloxacin and fluconazole', '', 'Graham is a consultant for RedHill Biopharma and Phathom Pharmaceuticals regarding novel H. pylori therapies and was the PI on the clinical trial from which the data were derived.', 34090405),
('Mentha x piperita (Lamiaceae) of Pancalieri (Turin, Italy) Essential Oil', 'Fungicidal activity against yeasts and a fungistatic activity against dermatophytes', '', 'Thus, the "Mentha of Pancalieri" EO may act as a potential antifungal agent and could serve as a natural adjuvant for fungal infection treatment.', 31470602),
('Essential oils (EOs) such as Thymus vulgaris (thyme red), Origanum vulgare (oregano), Lavandula vera (lavender), Pinus sylvestris (pine), Foeniculum vulgare (fennel), Melissa officinalis (lemon balm), Salvia officinalis (sage), Eugenia caryophyllata (clove) and Pelargonium asperum (geranium), and some of their main components (?-pinene, carvacrol, citronellal, eugenol, ?-terpinene, linalool, linalylacetate, terpinen-4-ol, thymol)', 'Pine exhibited strong antifungal activity against the selected non-albicans Candida isolates and uncommon yeasts. In addition, lemon balm EOs and ?-pinene exhibited strong antifungal activity against the selected non-albicans Candida yeasts. Thymol inhibited the growth of all uncommon yeasts.', '', 'These data showed a promising potential application of EOs as natural adjuvant for management of infections by emerging non-albicans Candida species and uncommon pathogenic yeasts.', 34443525),
('Antifungal Creams (AFCs) with Turmeric Essential Oil (TEO) or Aloe vera Gel (AVG)', 'AFCs displayed zones of inhibition with values ranged from 5.0 to 14.3 mm, TEO was 5.0 to 11.0 mm and AVG was 8.0 to 11.7 mm against tested fungi. Minimum Inhibitory Concentration (MIC) by AFCs, TEO and AVG ranged from 1.25 to 10.0 mg/ml.', '', 'Combination effect of antibiotic creams with natural products from plants is prospective strategy to produce new antifungal agent.', 33509168),
('Eucalyptal D', 'Eucalyptal D (ED), a formyl-phloroglucinol meroterpenoid, is one of the natural synergists, which could significantly enhance the anticandidal activity of fluconazole (FLC) in treating FLC resistant C. albicans.', '', 'Natural products are a promising synergist source to assist azoles in treating resistant candidiasis.', 31281800),
('carvacrol (CRV), cinnamaldehyde (CIN) and thymol (THY)', 'The mean fractional inhibitory concentration index (FICI) showed primary synergies for the combinations carvacrol+nystatin, thymol+nystatin, and carvacrol+miconazole (80%).', '', 'In conclusion, the results obtained indicate that the phytochemicals tested showed relevant in vitro anti-M. pachydermatis activity.', 31455580),
('peel extracts (garlic, ginger, onion, potato)', 'Positive inhibition against all fungal strains was observed for all samples, with maximum inhibition against Colletotrichum falcatum.', '', '', 32813867),
('Javanicin', 'Recombinant javanicin displayed antifungal properties against human pathogenic fungi, including resistant strains.', 'It displays cytotoxic activities toward the human breast cancer cell lines, MCF-7 & MDA-MB-231.', 'Novel therapeutic agents with a higher efficiency and less side effects for the treatment of certain diseases are urgently needed.', 31804594),
('Pecan (Carya illinoinensis) and Chestnut (Castanea sativa) flowers', 'Antimicrobial and antifungal activities were compared by means of agar diffusion tests against bacteria including Staphylococcus aureus, Bacillus cereus, Mycobacterium smegmatis, Acinetobacter haemolyticus, and Chromobacterium violaceum, and the yeasts Candida albicans and Candida parapsilosis.', '', 'Both extracts were rich in ellagic acid and gallic acid and exhibited similar antioxidant properties. Both flower extracts exhibited high antimicrobial and antifungal activities as well as anti-biofilm, anti-QS, and anti-SW activities.', 36053379),
('Curcumin', 'At a concentration of 250 microg/mL, curcumin inhibited about 80% of cell growth of C. albicans SC5314', '', 'results also showed that curcumin strongly reduced the transcript levels of HSP90. This might explain why curcumin exhibited greater antifungal activity', 36237434),
('Anatolian honey bee venom', '12.5 microg mL-1 against candida albicance, candida tropicalis, saccharomyces cerevisiae', '', 'These findings strongly suggest that Anatolian HBV will be developed as a new antibacterial-antifungal', 35421436),
('Tropical Medicinal Plant Extracts: Cymbopogon citratus, Curcuma xanthorrhiza, Curcuma aeruginosa, and Zingiber officinale var. rubrum', 'All plant extracts in this study showed antifungal activities against C. albicans. Among them, Cymbopogon citratus, Curcuma xanthorrhiza, Curcuma aeruginosa, and Zingiber officinale var. rubrum showed the lowest MIC and MFC value of 3.8 mg/mL.', '', 'The growth inhibition of C. albicans on disc diffusion assay was demonstrated by Z. officinale var. rubrum and C. longa, which were comparable to antifungal nystatin. This plant extract develop novel anti-candida agents', 36224024),
('synergistic effects of phytoactives piperine and cinnamaldehyde', 'biofilm inhibitory concentration of piperine and cinnamaldehyde was determined to be 32 microg/ml and 64 microg/ml, respectively.', '', 'These proficient phytochemical combinations provide a new therapeutic avenue for the treatment of biofilm-associated oral candidiasis and to combat the recurrent infections due to antibiotic resistance.', 35661216),
('A3IS (Mycosinate) is a synthetic product found naturally within honey.', 'A3IS demonstrated broad spectrum in vitro activity against yeast, molds, and the dimorphic fungi Blastomyces dermatitidis and Coccidioides species. Against yeasts, the activity of A3IS ranged from =0.02% to 0.15% wt/vol with both the 50% and 100% inhibition of growth endpoints. all mold isolates tested and ranged from =0.02% to 0.3% wt/vol with both the 50% and 100% inhibition of growth endpoints. As against the fluconazole resistant yeasts, the activity of A3IS was maintained against Aspergillus, Fusarium, Scedosporium, and Lomentospora isolates that demonstrated high-level in vitro resistance to voriconazole (i.e., voriconazole MIC =8 mg/mL). The IC50 (Inhibitory Concentration) of A3IS for P. carinii was 0.6415 microg/mL and 4.155 microg/mL for P. murina,', 'Viability was ranked as follows: viability of 80% or higher, no cytotoxicity; viability higher or equal to 60% and lower than 80%, mild cytotoxicity; viability higher or equal to 40% and lower than 60%, moderate cytotoxicity; viability below 40%, severe cytotoxicity.', 'A3IS may hold promise as a novel treatment for Pneumocystis pneumonia and various other different types of fungi species.', 35852368),
('Extracts from Argentinian native plants', 'Only extracts obtained from Acalypha communis, Argemone subfusiformis, Baccharis salicifolia, Lithrea molleoides and Pterocaulon alopecuroides showed antifungal effects with MIC values of 50, 200, 200, 25 and 100 microg/mL, respectively, against both efflux transporters AD/CaMDR1 and AD1-8u- in Candida species. Acalypha communis and Solanum atriplicifolium being the most effective showing 4- to 16-fold reversal of resistance at concentrations = 25 microg/mL', 'To determine the potential cytotoxic effect of the extracts on peripheral blood mononuclear cells (PBMCs), used as a model of normal cells, an MTT assay was performed as previously reported. The A. communis extract showed a half-maximal inhibitory concentration (IC50) value of 64.67 ', 'The non-toxic and highly active extracts from A. communis and S. atripicifolium, provide promising sources of compounds for potentiating the antifungal effect of FCZ by blocking the efflux function of Mdr1 and Cdr1 transporters.', 36224581),
('novel Panax stipulcanatus saponin analogues', 'In vitro antifungal activity results indicated that analogue 2 - oleanolic acid 3-O-beta-d-glucopyranosyl-(1 ? 3)-[alpha-l-arabinofuranosyl-(1 ? 4)]-beta-d-glucopyranoside combined with fluconazole showed synergistic antifungal activity against fluconazole-resistant Candida albicans, with MIC50 values 31.80 microg/mL and FICI values 0.32.', '', 'Give postive result against antifungal activity', 35552063),
('Hecogenin acetate is a saponin present in plants of the agave genus', 'It have analgesic, antioxidant, antinociceptive, cardioactive, anticancer, antifungal and antimicrobial activity.', 'Hecogenin acetate showed minimal inhibitory concentration without significant relevance.', 'This novel extract can replace antimicrobial resistance and will use in the future', 36462578),
('Essential Oil of Acritopappus confertus (Gardner)', 'The results show that the essential oil has an antifungal effect, with C. albicans strains being the most susceptible. Furthermore, the oil can potentiate the effect of fluconazole against strains of C. tropicalis and C. albicans. Regarding its effect on micromorphology, the oil was also able to inhibit the filaments in all strains.', '', 'It can be concluded that the essential oil of A. confertus has potential against pathogenic fungi and bacteria, making it a target for the development of an antimicrobial drug.', 36297389),
('Monoterpene Isoespintanol (ISO)', 'action of isoespintanol (ISO) against clinical isolates of Candida tropicalis. Microdilution assays revealed fungal growth inhibition, showing minimum inhibitory concentration (MIC) values between 326.6 and 500 microg/mL.', '', 'The eradication of mature biofilms by ISO was between 20.3 and 25.8% after 1 h of exposure, being in all cases higher than the effect caused by amphotericin B (AFB), with values between 7.2 and 12.4%. This indicates that the antifungal action of ISO is associated with damage to membrane integrity and the induction of iROS production, causing cell death.', 36144544),
('volatile phytocomposition of snow mountain garlic (SMG)', 'SMG has shown significantly superior fungicidal power at 2x-MIC dose against C. albicans and C. glabrata in killing kinetic evaluation unlike the fungistatic effect of normal garlic.', '', 'cholesta-4,6-dien-3-ol,(3-beta) was uniquely identified in SMG as a potential inhibitor with high binding affinity to the active site of exo-1,3-betaglucan synthase, an established anti-candida drug target crucial for the biofilm matrix formation, thus suggesting a plausible anti-Candida mechanism.', 35389539),
('Lavandula angustifolia essential oil (LAEO).', 'The MICs of LAEO that effectively inhibited grows of C. albicans sputum strains ranged from 0.5 to 2% (mean MIC 1.17%; MIC50 1%; MIC90 2%) and within 30 min of exposure to LAEO, 90% reduction was observed with nine strains (C. albicans PED01, PED03, PED05, PED06, PED07, PED08, PED09, PED13 and PED14) in time range 30 s', '', 'This study demonstrated that 2% solution of LAEO showed a significant antifungal activity which is equally effective against fluconazole and caspofungin susceptible and less-susceptible strains.', 36234837),
('Linalool is a monoterpene', 'The main results of this study indicated that the C. albicans strains analyzed were resistant to fluconazole and sensitive to linalool at a dose of 256 microg/mL. Furthermore, the increase in the minimum inhibitory concentration (MIC) of linalool in the presence of sorbitol and ergosterol indicated that this molecule possibly affects the cell wall and plasma membrane integrity of C. albicans. The antimicrobial activity of the phytocompost was interpreted as active or non-active according to the criteria proposed by Morales et al: strong/good activity (MIC: <100 microg/mL); moderate activity (MIC: >100 to 500 microg/mL); weak activity (MIC: >500 to 1000 microg/mL); and inactive/no antimicrobial effect (MIC: >1000 microg/mL).', '', 'the findings of this study indicated that linalool probably causes damage to the cell wall and plasma membrane of C. albicans, possibly by interaction with important enzymes involved in the biosynthesis of these fungal structures', 35976268),
('clove essential oil (CEO) and eugenol (EUG)', 'The CEO and EUG showed activity against all Candida strains with a minimal inhibitory concentration (MIC) in the range of 0.25-2 mg/mL.', '', 'It was also found that both natural products bind to ergosterol in the yeast cell membrane. This study confirms that the studied compounds appear to be a very promising group of phytopharmaceuticals used topically in the treatment of superficial candidiasis. However, this requires further studies in vivo.', 36615409),
('engineered Saccharomyces cerevisiae (baker''s yeast) and Saccharomyces boulardii (probiotic yeast) to produce the nonantibiotic fungal anhydrotetracycline, TAN-1612', '', '', 'engineered S. boulardii can biosynthesize complex natural products like tetracyclines, setting the stage to equip probiotic yeasts with synthetic therapeutic functionalities to generate living therapeutics or biocontrol agents for clinical and agricultural applications.', 35699947),
('distilled extract of bergamot (Citrus bergamia Risso et Poiteau)', '', '', 'Conclusions: Our data suggest that the use of essential oils, such as distilled extract of bergamot (Citrus bergamia Risso et Poiteau), can represent a valid alternative therapeutic strategy to counteract antibiotic resistance of pathogens.', 35326824),
('Anatolian honey bee venom', 'against yeast-like fungi', '', 'These findings strongly suggest that Anatolian HBV will be developed as a new antibacterial-antifungal drug against Gram-positive, Gram negative and antibiotic-resistant bacteria and yeast-like fungi.', 35421436),
('Salacia oblonga Wall Leaf and Root Extracts', 'The ethyl acetate extract of root with a 100 microg/ml concentration showed 15.8, 15.2, and 15.6 mm zone of inhibition against fungal isolates M. canis, T. interdigitale, and M. gypseum, respectively.', '', 'The activity of root and leaf extracts increased in a concentration-dependent manner, and further, the compounds isolated from the crude extracts of leaf and root showed antimicrobial activity.', 35612657),
('Withania somnifera (L.) Dunal whole-plant extracts', 'exhibited anti-sporotrichotic effects by destabilizing peripheral integrity of Sporothrix globosa yeast cells', '', 'In conclusion, this study has demonstrated the anti-sporotrichotic property of the whole plant extract of W. somnifera against S. globosa that could be further explored for the development of a natural antifungal agent against chronic Sporotrichosis.', 35714107),
('Essential Oils Isolated from Juniperus oxycedrus L. ssp. macrocarpa Aerial Parts', 'The strongest fungicidal activity was recorded against Candida auris sessile cells (median FICI was 0.088) but not against C. albicans biofilms (median FICI was 1).', '', 'The therapeutic potential of Juniperus may be promising for future more extensive research and in vivo tests to develop new drugs against antibiotic and antifungal resistance.', 35456809),
('licorice extract', 'rosemary and licorice extracts were chosen to prepare a topical cream for further in vivo wound healing and histopathology.', '', 'In vivo histopathological examination revealed that acetonic rosemary and licorice extract could be promising for wound healing, combating MDR pathogens of burn wound infections.', 35727122),
('Agaricus gennadii extract', 'Trichosporon mucoides and Candida parapsilosis exhibit susceptibility to Agaricus gennadii extract', '', 'Trichosporon mucoides and Candida parapsilosis were susceptible to the fungal extract at all concentrations, however, no effect of the fungal extract on the rest of the studied yeasts. Also, our results demonstrated that the susceptibility was increased with the increase of the fungal extract concentration.', 35491937),
('Essential oil from Lavandula angustifolia', 'The results showed that lavender EO possesses potent antifungal activity against F. solani. A complete inhibition in the fungal growth was recorded for lavender EO at 1.6%.', '', 'Results obtained from this study support the possibility of using lavender EO for control of sorghum damping-off.', 35039591),
('Essential Oil from Artemisia aragonensis Lam.', 'EOA displayed significant antifungal activity against four strains of fungi: F. oxysporum, C. albicans, A. flavus and A. niger with values of 21.50 ', '', 'The results of the current study highlight the importance of EOA as an alternative source of natural antioxidant and antibacterial drugs to combat antibiotic-resistant microbes and free radicals implicated in the inflammatory responses accompanying microbial infection.', 35164402);

-- --------------------------------------------------------

--
-- Table structure for table `fungi_novelagent`
--

CREATE TABLE IF NOT EXISTS `fungi_novelagent` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `fungi_novelagent`
--

INSERT INTO `fungi_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
(' A32390A, a new biologically active metabolite', ' In vitro antifungal activity of A32390A was found against Candida albicans, Cryptococcus neoformans and Histoplasma capsulatum.', '', ' In vitro and in vivo antifungal activity.  A32390A, an isonitrile-containing derivative of mannitol, represents a new class  of antifungal antibiotics.', 342474),
(' Cys-reduced form of S100A7/psoriasin (redS100A7)', ' Inhibits various filamentous fungi, including the mold Aspergillus fumigatus, but not Candida albicans', '', ' Thus, selective fungal  cell-penetrating Zn(2+)-chelators could be useful as an urgently needed novel antifungal therapeutic, which induces programmed cell death in numerous fungi.  ', 26438863),
(' FX0685, a novel triazole antifungal agent', 'Potential antifungal for the treatment of various  clinical forms of systemic candidiasis, including those caused by FLC-resistant C. albicans, as well as for the treatment of pulmonary aspergillosis', '', ' In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.', 16010849),
(' QACs, cationic lipo-oxazoles', 'Activity against both fluconazole-sensitive and resistant clinical isolates  of Candida albicans as well as non-albicans Candida strains.', '', ' Chain-length-specific anti-Candida activity of cationic lipo-oxazoles: a new class of quaternary ammonium compounds. CONCLUSION: A novel class of QACs, called cationic lipo-oxazoles, was tested and  found to exhibit anti-fungal activity against planktonic cells as well as biofilms of Candida.  ', 29076804),
('1-[(biarylmethyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)pro pan-2-ols', 'Broad-spectrum antifungal activities against the most prevalent human pathogenic  fungi (Candida spp. and Aspergillus fumigatus)', '', ' Design, synthesis, and biological evaluation of 1-[(biarylmethyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)pro pan-2-ols as potent antifungal agents: new insights into structure-activity relationships.', 21748853),
('1-R-2-([1,2,4]triazolo[1,5-c]quinazoline-2-ylthio)etanon(ol) analogues', 'Antibacterial and antifungal activity', '', ' 1-R-2-([1,2,4]Triazolo[1,5-c]quinazoline-2-ylthio)etanon(ol)s: Synthesis, Bioluminescence Inhibition, Molecular Docking Studies, Antibacterial and Antifungal Activities.  The increasing mortality due to antibacterial resistance necessitates the search  for novel antimicrobial agents.', 27012316),
('2-(2''-hydroxy-5''-aminophenyl) benzoxazole (HAMBO)', ' The inhibition provided by HAMBO was lower than that of fluconazole, showing low antifungal activity against Candida spp., but equivalent to that of benzoxazoles tested in similar studies.: HAMBO showed fungistatic activity against all analysed strains.', '', ' In vitro antifungal activity of 2-(2''-hydroxy-5''-aminophenyl)benzoxazole in Candida spp. Strains. This class of novel benzoxazole compounds may be used as template to produce better antifungal drugs. ', 19302462),
('2,3,5-tri-O-benzyl-d-ribose (compound 1) and a 2,5-functionalized imidazole (compound 2', 'Inhibited chitin synthases in vitro with IC50 values of 1.8 and 10 microM, respectively and antifungal activity against B. cinerea BD90 strain with MIC values of 190 and 100 microM, respectively', '', ' Discovery of two new inhibitors of Botrytis cinerea chitin synthase by a chemical library screening.   Chitin synthases polymerize UDP-GlcNAC to form chitin polymer, a key component of fungal cell wall biosynthesis.', 23886809),
('2,5-disubstituted tetrazole derivatives containing benzothiazole, benzoxazole or phenylsulfonyl moiety synthesized by N-alkylation of aryltetrazole with 2-[(3-chloropropyl)sulfanyl]-1,3-benzothiazole or 2-[(3-chloropropyl)sulfanyl]-1,3-benzoxazole and Michael-type addition of aryltetrazole to phenyl vinyl sulfone', ' All the tetrazole derivatives acted at the same level against C. albicans and demonstrated a high cell growth inhibition (97-99%) at the concentrations ranging from 16 to 0.0313 microg/mL', '', 'Synthesis of novel tetrazole derivatives and evaluation of their antifungal activity.  In this context new 2,5-disubstituted tetrazole derivatives containing benzothiazole, benzoxazole or phenylsulfonyl moiety were synthesized by N-alkylation of aryltetrazole with 2-[(3-chloropropyl)sulfanyl]-1,3-benzothiazole or 2-[(3-chloropropyl)sulfanyl]-1,3-benzoxazole and Michael-type addition of aryltetrazole to phenyl vinyl sulfone.', 27745991),
('2-Aminonicotinamide Derivatives', 'Overall MIC80?between 0.0313 to 4.0 microg mL-1,  compounds 11 g [2-amino-N-((5-(((2-fluorophenyl)amino)methyl)thiophen-2-yl)methyl)nicotinamide] and 11 h [2-amino-N-((5-(((3-fluorophenyl)amino)methyl)thiophen-2-yl)methyl)nicotinamide] displayed excellent activity against C. albicans, with MIC80?values of 0.0313 ?g mL-1', '', 'Synthesis and Biological Evaluation of Novel 2-Aminonicotinamide Derivatives as Antifungal Agents.', 28071858),
('2-cyclohexylidenhydrazo-4-phenyl-thiazole', ' 99.9% loss of C. albicans viability, also active in inhibiting the growth of C. albicans ATCC 10231 biofilms', '', ' CONCLUSIONS: Based on these results, EM-01D2 could represent a template for the development of novel fungicidal agents.  ', 15772140),
('2''-hydroxy-4''-methoxychalcone', 'Activity against fluconazole-resistant Candida albicans', '', 'To identify effective and low toxicity synergistic antifungal compounds, 24 derivatives of chalcone were synthesized to restore the effectiveness of fluconazole against fluconazole-resistant Candida albicans.  Of the synthesized compounds, 2''-hydroxy-4''-methoxychalcone (8) exhibited the most potent in vitro (FICI=0.007) effects.', 27210436),
('3-(halogenated phenyl)-5-acyloxymethyl- 2,5-dihydrofuran-2-one derivatives', 'The furanone derivatives displayed broad-spectrum in vitro activity against potentially pathogenic yeasts and molds, especially Aspergillus spp. (MIC <or= 2.0 microg/ml) and fluconazole-resistant yeast isolates, including Candida glabrata and Saccharomyces cerevisiae.  4-bromophenyl derivative was the most effective derivative against the majority of species tested, except for the Candida tropicalis and C. glabrata strains, which were more susceptible to the 3-chlorophenyl derivative. The 3,4-dichlorophenyl derivative possessed a lesser in vitro antifungal effect.', '', ' Thus, the halogenated 3-phenyl-5-acyloxymethyl derivatives of 2,5-dihydrofuran-2-one represent a novel, promising group of compounds with significant activity against relevant opportunistic fungi that are pathogenic to humans.   ', 14982778),
('3-Aryl-4-[alpha-(1H-imidazol-1-yl)arylmethyl]pyrrole derivatives', 'The most active derivative (27) was twice as potent (MIC90) as bifonazole, and its activity was 4 times greater than those of miconazole and ketoconazole.: The other nine compounds showed antifungal activity of the same order of that of bifonazole and were ca. 2 times as active as miconazole and ketoconazole.', '', 'A new class of potent antifungal agents, namely, 3-aryl-4-[alpha-(1H-imidazol-1-yl)arylmethyl]-pyrroles, is described.', 7473549),
('4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamide derivatives', 'Antibacterial and Antifungal (Candida albicans) activity', '', ' Synthesis and potent antimicrobial activity of some novel 4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides.    A series of 4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides were  synthesized and evaluated for antibacterial and antifungal activities against Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), methicillin-resistant S. epidermis (MRSE), Enterococcus faecalis, Escherichia coli and Candida albicans.', 15476288),
('4-bromo-5Z-(bromomethylene)-3-butylfuran-2-one (BF1)', 'Inhibition of Candida albicans growth', '', ' In this study, we demonstrate the antifungal activity of brominated furanones on C. albicans. Studying the structure and activity of this class of furanones reveals that the exocyclic vinyl bromide conjugated with the carbonyl group is the most important structural element for fungal inhibition.', 19756586),
('A series of 3,4-dichloro-, 3-methyl and non-substituted maleimides', 'Of the 63 compounds evaluated, 25 compounds had interesting inhibitory potency with EC50 < 10 microg mL(-1). N-(3,5-Dichlorophenyl)-3,4-dichloromaleimide (EC50 = 1.11 microg mL(-1)) and N-octyl-3-methylmaleimide (EC50 = 1.01 microg mL(-1)) were more potent than the commercial fungicide dicloran (EC50 = 1.72 microg mL(-1)).', '', ' CONCLUSION: The present work demonstrates that some maleimides can be used as potential lead compounds for developing novel antifungal agents against S. sclerotiorum.  ', 24796632),
('Acetophenone-derived bis Mannich bases, B1-B5, bis(beta-aroylethyl)methylamine hydrochlorides', 'All compounds studied have shown antifungal activity, especially against dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans, and Microsporum canis), in the concentration range studied (2-128 microng/ml)', '', ' Antifungal evaluation of bis Mannich bases derived from acetophenones and their corresponding piperidinols and stability studies.   The development of resistance to current antifungal therapeutics drives the search for effective new agents.', 12392084),
('Aflastatin A', 'Completely inhibited aflatoxin production by Aspergillus parasiticus NRRL 2999 in liquid medium or on agar plate at a concentration of 0.5 microgram/ml', '', ' Aflastatin A, a novel inhibitor of aflatoxin production by aflatoxigenic fungi.   Aflastatin A, a novel inhibitor of the production of aflatoxin by aflatoxigenic fungi, has been isolated from the solvent extract of mycelial cake of Streptomyces sp. and its molecular formula was determined as C62H115NO24.', 9099219),
('Alkylated mono-, bis-, and trisbenzimidazole derivatives', 'MIC values ranging from 15.6 to 0.975 microg/mL', '', 'Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.  ', 27301676),
('Ambroxol Hydrochloride Combined with Fluconazole', 'Ambroxol hydrochloride (128 ?g/mL) exhibits synergistic antifungal effects in combination with fluconazole (2 ?g/mL) against resistant planktonic?Candida albicans?(C. albicans) cells and resistant C. albicans biofilms', '', ' In this study, we found that ambroxol hydrochloride (128 ?g/mL) exhibits synergistic antifungal effects in combination with fluconazole (2 ?g/mL) against resistant planktonic Candida albicans (C. albicans) cells. The results show the potential role for this drug combination as a therapeutic alternative to treat resistant C. albicans and provide insights into the development of antifungal targets and new  antifungal agents.  ', 28439502),
('Aminoglycoside antibiotics combined with different sulphate-transport inhibitors', 'Combinations decreased the respective MICs by greater than 8-fold, active aginst human pathogens Candida albicans, C. glabrata and Cryptococcus neoformans, the food spoilage organism Zygosaccharomyces bailii and the phytopathogens Rhizoctonia solani and Zymoseptoria tritici.', '', 'Novel, Synergistic Antifungal Combinations that Target Translation Fidelity', 26573415),
('Anthracene-9-carboxylic and niflumic acid', 'Effect on growth, energy metabolism and anionic current of mycelium of fungus Phycomyces blakesleeanus', '', ' Growth inhibition of fungus Phycomyces blakesleeanus by anion channel inhibitors  anthracene-9-carboxylic and niflumic acid attained through decrease in cellular respiration and energy metabolites.   Increasing resistance of fungal strains to known fungicides has prompted identification of new candidates for fungicides among substances previously used  for other purposes.', 28100310),
('AR-12, Celecoxib Derivative', 'Activity against yeasts (e.g., Candida albicans, non-albicans Candida spp., Cryptococcus neoformans), molds (e.g., Fusarium, Mucor), and dimorphic fungi (Blastomyces, Histoplasma, and Coccidioides) with MICs of 2 to 4 ?g/ml.', '', ' The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis.', 27645246),
('Aryl isonitrile compounds', 'Broad-spectrum antifungal activity primarily against species of Candida and Cryptococcus, most potent derivatives are capable of inhibiting growth of these key pathogens at concentrations as low as 0.5 microM', 'The most active compounds exhibit an excellent safety profile and are non-toxic to mammalian cells even at concentrations up to 256 microM', '  Investigation of aryl isonitrile compounds with potent, broad-spectrum antifungal activity.  ', 28385596),
('aryl-1,2,4-triazol-3-ylthio analogues of fluconazole (ATTAF-1 and ATTAF-2)', 'Showed lowest geometric mean MICs, combinations fluconazole exhibited synergistic effects against fluconazole-susceptible (22 of 23 isolates), fluconazole-susceptible dose-dependent (10 of 13 isolates), and fluconazole-resistant (1 of 16 isolates) Candida isolates.', '', '  In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species.   The in vitro activities of two novel azole compounds (aryl-1,2,4-triazol-3-ylthio analogues of fluconazole [ATTAFs]) and five comparator antifungal agents against  52 clinical Candida isolates from 5 different species were determined.', 27795371),
('ASP2397', 'ASP2397 MIC50 values were 0.5 mg/L (0.25 to 1) and 0.25 mg/L(0.06 to 0.25) against A. fumigatus CYP51A wild-type isolates and were similarly 0.5 mg/L (0.125 to >4) and 0.125 mg/L (0.06 to >4) against azole-resistant A. fumigatus isolates, respectively. ASP2397 was active against A. terreus CYP51A wild-type isolates (MIC 0.5 to 1) ', '', 'In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.   ASP2397 is a new compound with a novel and as-yet-unknown target different from that of licensed antifungal agents.', 26552973),
('Azoxybacilin', 'Broad spectrum antifungal activity, especially active against mycelial fung', '', ' A new methionine antagonist that has antifungal activity: mode of action.    A new antifungal, azoxybacilin (an unusual amino acid with an azoxy moiety) was identified from Bacillus cereus, and its in vitro antifungal activity and mode of action were investigated.', 7928678),
('Benzimidazole derivatives [(S)-2-aminoalkyl benzimidazole derivative, (S)-2-(1-Aminoisobutyl)-1-(3-chlorobenzyl) benzimidazole]', '(S)-2-(1-Aminoisobutyl)-1-(3-chlorobenzyl) benzimidazole showed the highest antifungal activity against a number of clinical isolates of several species of pathogenic Candida yeasts.', '(S)-2-(1-Aminoisobutyl)-1-(3-chlorobenzyl) benzimidazole showed the showed best compatibility with human cells in several cell culture models', 'A screening assay based on host-pathogen interaction models identifies a set of novel antifungal benzimidazole derivatives.', 21746957),
('Benzofuran derivatives', 'Antifungal activity against C. albicans', '', ' Synthesis and biological activities of benzofuran antifungal agents targeting fungal N-myristoyltransferase.   The C-4 side chain modification of lead compound 1 has resulted in the identification of a potent and selective Candida albicans N-myristoyltransferase  (CaNmt) inhibitor RO-09-4609, which exhibits antifungal activity against C. albicans in vitro.', 13129583),
('Berberine derivative B-7b and fluconazole', ' The potent synergistic activity of B-7b in combination with FLC against FLC-resistant C. albicans, the disruption of protein folding and processing and the weakening of cells'' self-defensive ability contributed to the synergism of FLC and B-7b.', '', ' Together, these results suggested novel scaffold BBR derivative B-7b could be a promising synergist in combination  with FLC for the treatment of invasive fungal infections.  ', 25992630),
('bis(N-amidinohydrazones) and N-(amidino)-N''-aryl-bishydrazones', 'Antibacterial and antifungal agents, MIC values ranging from (less than) 0.5 to (greater tahn) 500 microM against bacteria and 1.0 to (greater than) 31.3 micro g/mL against fungi', 'Minimal emergence of drug resistance to these newly synthesized compounds by bacteria and fungi even after 15 passages, and we found weak to moderate inhibition of the human Ether-?-go-go-related gene (hERG) channel with acceptable IC50?values ranging from 1.12 to 3.29 microM', ' Overall, these studies show that bis(N-amidinohydrazones) and N-(amidino)-N''-aryl-bishydrazones are potentially promising scaffolds for the discovery of novel antibacterial and antifungal agents.  ', 27769670),
('Bromoquinol', 'Active against Aspergillus fumigatus', '', 'The quinoline bromoquinol exhibits broad-spectrum antifungal activity and induces oxidative stress and apoptosis in Aspergillus fumigatus. The most potent, bromoquinol, shows potent wide-spectrum antifungal activity that was blocked in the presence of exogenous iron.', 28475687),
('CAN-296, complex carbohydrate', 'Inhibited proton pumping of Candida albicans, Candida glabrata, Candida krusei, Candida guilliermondii and Saccharomyces cerevisiae at low concentrations (0.078-1.25 mg/l)', '', ' Proton translocating ATPase mediated fungicidal activity of a novel complex carbohydrate: CAN-296.  CAN-296 is a complex carbohydrate (approximately 4300 Da) isolated from the cell  wall of Mucor rouxii.', 10755243),
('Combination therapies using L-743,872, a pneumocandin antifungal drug, and amphotericin B or fluconazole', 'Showed additive and autonomous activities  against fluconazole-resistant isolates', '', ' The results of this study suggest that L-743,872 can enhance the efficacy of fluconazole or amphotericin B in vitro and indicate a potential role  for L-743,872 in combination therapy against C. neoformans.   ', 9021188),
('Combination therapy of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818', 'Activity against Cryptococcus neoformans', '', 'Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans', 10681348),
('Combination therapy of lysine and amphotericin B ', 'Lysine enhances the effect of AmB against Candida albicans in vitro', '', ' Using AmB together with lysine may be a promising strategy for the therapy of disseminated candidiasis.  ', 26711896),
('Copper(II) complexes of 2-methylthionicotinate (2-MeSNic) of the composition Cu(2-MeSNic)2(MeNia)(2).4H2O (where MeNia is N-methylnicotinamide), and Cu(2-MeSNic)2(Nia)(2).2H2O (where Nia is nicotinamide) and Cu(2-MeSNic)2L2 (where L is isonicotinamide, iNia, or ethyl nicotinate, EtNic)', 'IC50 1.5-2.3 mmol/L against  Rhizopus oryzae and Microsporum gypseum, adducts with Nia, MeNia and EtNic at 5 mmol/L induced morphological changes in growing hyphae of Botrytis cinerea, inhibition of sporulation (> 90%) of Alternaria alternata by Cu(2-MeSNic)2.H2O', '', 'Antifungal activity of new copper(II) complexes of 2-methylthionicotinate (2-MeSNic) of the composition Cu(2-MeSNic)2(MeNia)(2).4H2O (where MeNia is N-methylnicotinamide), and Cu(2-MeSNic)2(Nia)(2).2H2O (where Nia is nicotinamide) and Cu(2-MeSNic)2L2 (where L is isonicotinamide, iNia, or ethyl nicotinate, EtNic) were tested on various strains of filamentous fungi by the macrodilution method.', 12094729),
('CS-758, a novel triazole', 'CS-758 exhibited potent in vitro activity (MICs, 0.004 to 0.06 micro g/ml) against the strains used in this murine model including fluconazole-susceptible dose-dependent and fluconazole-resistant strains (fluconazole MICs, 16 to 64 micro g/ml)', '', ' Efficacy of CS-758, a novel triazole, against experimental fluconazole-resistant  oropharyngeal candidiasis in mice.   The therapeutic efficacy of CS-758, a novel triazole, was evaluated against experimental murine oropharyngeal candidiasis induced by Candida albicans with various susceptibilities to fluconazole.', 12543666),
('CW-8/haemofungin', 'Inhibits the growth of pathogenic Aspergillus, Candida, Fusarium and Rhizopus isolates at micromolar concentrations', 'Only weakly affect the growth of mammalian cell lines', ' Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis.', 26747101),
('Cyclohexyliden- and 2-methylcyclohexyliden-hydrazo-4-arylthiazoles', 'Five out of nine compounds were active towards Candida albicans 25 FLC resistant isolated from clinical specimens', '', ' On the basis of our data we can conclude that these derivatives are promising agents for the treatment of resistant C. albicans.  ', 26745285),
('Cyclosporine (CsA) derivatives, (gamma-OH) MeLeu(4)-Cs (211-810) and D-Sar (alpha-SMe)(3) Val(2)-DH-Cs (209-825)', '', '', ' Our findings identify calcineurin as a novel antifungal drug target and suggest nonimmunosuppressive CsA analogs warrant investigation as antifungal agents.   ', 10602736),
('Cystatin, affinity-purified from chicken egg white (CEWC)', ' CEWC inhibited the growth of azole-sensitive Candida albicans isolates with minimal inhibitory concentration (MIC) values ranging from 0.8 to 3.3 micromol l(-1), a potency comparable with those of fluconazole and histatin 5, the antimicrobial peptide of the human saliva.', '', 'The antifungal properties of chicken egg cystatin against Candida yeast isolates  showing different levels of azole resistance.   The increasing incidence of fungal infections together with the emergence of strains resistant to currently available antifungal drugs calls for the development of new classes of antimycotics.', 19549107),
('D0870, antifungal triazole', 'MICs for 50 and 90% of the isolates tested were < or = 0.0078 and 0.06 micrograms/ml', '', ' In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.    We investigated the in vitro activity of a new antifungal triazole, D0870, against 100 Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus by using a broth macrodilution method following the recommendations provided by the National Committee for Clinical Laboratory Standards (document M27-P).', 7872746),
('D75-4590', 'Potent activities against various Candida species, specific inhibitor of beta-1,6-glucan synthesis', '', ' These lines of evidence indicate that D75-4590 is a promising lead compound for novel antifungal drugs.', 19015325),
('Derivatives of the ring system indolo[1,2-c]benzo[1,2,3]triazine 5 synthesized by diazotization of substituted 2-(2-aminophenyl)indoles', 'Antitumour and antifungal activity', 'Antifungal activity at concentrations very close to those inhibiting the proliferation of human cells', ' Derivatives of the new ring system indolo[1,2-c]benzo[1,2,3]triazine with potent  antitumor and antimicrobial activity.   Derivatives of the new ring system indolo[1,2-c]benzo[1,2,3]triazine 5 were synthesized by diazotization of substituted 2-(2-aminophenyl)indoles followed by  an intramolecular coupling reaction of the diazonium group with the indole nitrogen.', 10411476),
('Dichloromethyl-4-chloro-3-nitrophenylsulfone (Compound 1) and chlorodibromomethyl-4-hydrazino-3-nitrophenylsulfone (Compound 2', 'Compound 1 showed higher activity (% = 100 at 4 ?g/ml) than Compound 2 (MIC90 = 16 ?g/ml) against Candida spp', '', 'Sulfone derivatives reduce growth, adhesion and aspartic protease SAP2 gene expression.  Fungal virulence factors represent a strategy for the design of new compounds with effective activities against Candida spp.', 24880247),
('Diguanidino 1-methyl-2,5-diaryl-1H-pyrroles', ' The antifungal activities evaluated against Candida spp. and Aspergillus spp.', '', ' Synthesis of some diguanidino 1-methyl-2,5-diaryl-1H-pyrroles as antifungal agents.   A series of novel 2,5-bis(guanidino-aryl)-1-methyl-1H-pyrroles 9a-h has been synthesized starting from 1-methyl-1H-pyrrole.', 15978808),
('Eugenol and methyl eugenol', 'Antifungal activity by targeting sterol biosynthesis, additional methyl group to eugenol increases its antifungal activity', '', ' The observed fungicidal characteristics of both eugenol and methyl eugenol indicate that both  the compounds might be promising antifungal agents defining a new class of antimycotics.  ', 19835945),
('F901318', 'A. fumigatus WT, MIC90 0.125 mg/L (range 0.031-0.125); TR34/L98H,TR46/Y121F/T289A and azole resistant without known resistance mechanisms, MIC90 0.125 mg/L (range 0.031-0.25); A. fumigatus with cyp51A-associated point mutations, MIC90 0.062 mg/L (range 0.015-0.125); and other species, A. calidoustus MIC90 0.5 mg/L (range 0.125-0.5), A. flavus MIC90 0.062 mg/L (range 0.015-0.62), A. nidulans MIC90 0.125 mg/L (range 0.062-0.25) and A. tubingensis MIC90 0.062 mg/L (range 0.015-0.25)', '', ' In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.', 28605488),
('FK463, a (1,3)-beta-D-glucan synthase inhibitor', 'Efficacy against azole-resistant Candida albicans', '', ' Efficacy of FK463, a (1,3)-beta-D-glucan synthase inhibitor, in disseminated azole-resistant candida albicans infection in mice.  The efficacy of FK463, a new (1,3)-beta-D-glucan synthase inhibitor, against azole-resistant Candida albicans strains has been studied.  In our study, FK463 was found to be a potent antifungal agent against disseminated infection with azole-resistant C. albicans.', 10817741),
('FK-506, immunosuppressant agent', 'antagonist of T-cell activation and an inhibitor of  fungal growth', '', ' Antifungal properties of the immunosuppressant FK-506: identification of an FK-506-responsive yeast gene distinct from FKB1.', 1715022),
('Glabridin', 'Significant decrease in MICs against fluconazole-resistant C. glabrata (MIC50: 8 micro g/mL)', '', ' Glabridin is an originally natural substrate with multiple  biological activities which propose it as a novel anticancer, antimicrobial and antifungal agent.', 28595940),
('Glucosylated solasodine-3-O-beta-d-glucopyranoside?', 'Activity against wild type Candida albicans', '', ' Our study reveals that glucosylation is an alternative approach for introducing potential antifungal activity into C.?albicans cells and overcoming the drug-resistance resulting from hyperactivation of efflux pumps.  ', 28919409),
('Guanylated polymethacrylates', 'The most potent compound kills 99.98% of S. aureus and 82.2% of C. albicans at a concentration of 128 mg/L', '', 'Searching for new strategies against polymicrobial biofilm infections: guanylated polymethacrylates kill mixed fungal/bacterial biofilms.   OBJECTIVES: Biofilm-related human infections have high mortality rates due to drug resistance.', 26490013),
('Halogenated quinoline (HQ) analogues', 'Four HQ analogues inhibited C. albicans growth with a minimum inhibitory concentration (MIC) of 100 nM, whilst 16 analogues effectively inhibited C. neoformans at MICs of 50-780 nM. Remarkably, two HQ analogues eradicated mature C. albicans and C. neoformans biofilms [minimum biofilm eradication concentration (MBEC) = 6.25-62.5 microM].', '', ' HQs are a promising class of small molecules that may be useful in future antifungal treatments.  ', 27256584),
('Hydrogen peroxide', 'Adjunctive therapy for treatment of mucormycosis', '', ' Adjunctive therapy with hydrogen peroxide.  Mucormycosis is a devastating fungal disease affecting mainly diabetic and immunosuppressed patients and frequently causing death.', 8810881),
('Hydroxyaldimines', 'Activity against Cryptococcus gattii and Cryptococcus neoformans strains', '', ' The in vitro anticryptococcal activity of hydroxyaldimines against various strains of C.?gattii and C.?neoformans indicates the potential of this class of molecules as lead compound for the development of selective and efficient anticryptococcal agents.', 23594040),
('IB-367', 'Exerted a fungicidal activity against Trichophyton mentagrophytes, T. rubrum and Microsporum canis', '', ' We propose IB-367 as a promising candidate for the future design of antifungal drugs.  ', 26058322),
('Imidazolium salt 1-n-hexadecyl-3-methylimidazolium chloride (C16 MImCl)', 'Prevents, in concentrations as low as 0?028 microg ml(-1) , the biofilm formation of multidrug-resistant Candida tropicalis isolates', '', ' As  such, C16 MImCl has been identified as a promising antimicotic pharmaceutical candidate for the treatment of candidiasis infections', 25294047),
('Imidazolium salts (1-n-Hexadecyl-3-methylimidazolium chloride (C16 MImCl) and 1-n-hexadecyl-3-methylimidazolium methanesulfonate (C16 MImMeS))', ' All dermatophytes were inhibited by IMS, where the lowest minimum inhibitory concentration (MIC) values  were observed for salts with n-hexadecyl segment in the cation side chain, containing either the chloride or methanesulfonate anion. 1-n-Hexadecyl-3-methylimidazolium chloride (C16 MImCl) and 1-n-hexadecyl-3-methylimidazolium methanesulfonate (C16 MImMeS) acted as fungicides, even in extremely low concentrations, wherein C16 MImMeS exerted this effect on 100% of the tested dermatophytes.', '', ' The expressive antifungal activity of IMS,  combined with the in vitro nontoxicity, makes them promising compounds for the safe and effective treatment of dermatophytoses, mainly when this skin mycosis is unresponsive to conventional drugs.  ', 26043668),
('JS399-19, cyanoacrylate fungicide', 'Targets the motor domain of type I myosin, specific to Fusarium', '', 'Real-time imaging was used to study the effects of a novel Fusarium-specific cyanoacrylate fungicide (JS399-19) on growth and morphology of four Fusarium sp.  This fungicide targets the motor domain of type I myosin.', 27914536),
('KB425796-A congeners', 'Congeners of KB425796-A, named KB425796-B, -C, -D, -E, -F, -G, -H, -I, -J and -K, which exhibited diverse antifungal potencies against A. fumigatus', '', 'Identification of ten KB425796-A congeners from Paenibacillus sp. 530603 using an antifungal assay against Aspergillus fumigatus in combination with micafungin.  ', 23778114),
('KB425796-C in combination with micafungin', 'Antifungal activity against micafungin-resistant fungi and was fungicidal to Trichosporon asahii in vitro', '', ' Synergistic antifungal activity of KB425796-C in combination with micafungin against Aspergillus fumigatus and its efficacy in murine infection models. KB425796-C is a novel antifungal metabolite produced by the newly isolated bacterial strain Paenibacillus sp.', 23756682),
('KP-363, butenafine hydrochloride', 'Wide spectrum activity in vitro against particularly dermatophytes (87 strains; minimal inhibitory concentration (MIC) range, 0.0015 to 0.05 microgram/ml), and also against Aspergillus (15 strains; MIC range, 0.025 to 0.78 microgram/ml), Cryptococcus neoformans (4 strains; MICs 0.78 and 1.56 micrograms/ml) and yeasts of genus Candida (67 strains; MIC range, 3.13 to greater than 100 micrograms/ml).  ', '', ' [Synthesis and antifungal activity of butenafine hydrochloride (KP-363), a new benzylamine antifungal agent].    In screening of new antifungal agents, bis(naphthalenemethyl)amines were found to have more potent antifungal activity than clotrimazole.', 2056447),
('L-733,560, pneumocandin antifungal agent', 'The mean MICs of L-733,560 were 0.15 microgram/ml for C. lusitaniae, 0.72 microgram/ml for C. parapsilosis, 0.78 micrograms/ml for C. krusei, and 1.25 micrograms/ml for C. guilliermondii', '', ' The results indicate that the new antifungal agent L-733,560 demonstrated the best activity with the lowest MICs against C. albicans, T. glabrata, C. tropicalis, and C. kefyr, less activity against C. krusei, C. lusitaniae, and C. parapsilosis, and the least activity against C. guilliermondii.', 8593003),
('L-733560, a new water-soluble hybrid of L-705589 and L-731373', ' Growth inhibition kinetic studies against Candida albicans revealed fungicidal activity within 3 to 5 h', '', ' In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373.', 7625791),
('Luliconazole, Lanoconazole, and Efinaconazole', 'Activity against Melanized Fungi and Relatives', '', ' Therefore, it appears that these new imidazole and triazole drugs are promising candidates for the treatment of infections due to melanized fungi and their relatives.  Copyright ? 2017 American Society for Microbiology.  DOI: 10.1128/AAC.00635-17  PMCID: PMC5655049', 28848012),
('Macrocyclic amidinoureas', 'Potent  antifungal activity against Candida spp', '', ' Biological Characterization and in Vivo Assessment of the Activity of a New Synthetic Macrocyclic Antifungal Compound.   We recently identified a novel family of macrocyclic amidinoureas showing potent  antifungal activity against Candida spp.', 27045868),
('Magnolol', 'MIC?ranging from 10 to 40 micro g/mL against C. albicans?and non-albicans?Candida?species, especially fluconazole-resistant?Candida krusei, with the minimum inhibitory concentrations , BMIC90?(minimum concentration with 90%?Candida?biofilm inhibited) values of magnolol ranged from 20 to 160 micro g/mL', '', ' As an alternative and broad-spectrum antifungal agent, magnolol might be of benefit to the treatment of refractory Candida infection.  ', 28919715),
('ME1111', 'MIC90 against dermatophyte strains was 0.25 micro g/ml, MFC90s against Trichophyton rubrum and Trichophyton mentagrophytes were 8 micro g/ml', '', 'In vitro antifungal activity of ME1111, a new topical agent for onychomycosis, against clinical isolates of dermatophytes.  ME1111 is a novel selective inhibitor of succinate dehydrogenase (complex II) of dermatophyte species, whose small molecular weight enhances its ability to penetrate the nail  plate.', 26055386),
('ME1111', 'ME1111 strongly inhibited the succinate-2,6-dichlorophenolindophenol reductase reaction  in Trichophyton rubrum and T. mentagrophytes (50% inhibitory concentrations [IC50s] of 0.029 and 0.025 microg/ml, respectively)', '', ' ME1111 is a novel antifungal agent that is active against dermatophytes, has an excellent ability to penetrate human nails,  and is being developed as a topical agent for onychomycosis.', 26596944),
('ME1401, a new antifungal agent', 'Broad antifungal spectrum and inhibited all of the 428 strains of 52 species of pathogenic yeasts and filamentous fungi tested at concentrations ranging from 0.01 to 12.5 micrograms/ml.', '', ' In vitro activity of ME1401, a new antifungal agent.  Yamaguchi H, Uchida K, Hiratani T, Hara T, Fukuyasu H, Kazuno Y, Inouye S.  The in vitro antifungal activity of ME1401, a potential topical antifungal agent, was compared with that of haloprogin, clotrimazole, miconazole, tolnaftate, and ciclopirox olamine by using an agar dilution procedure.', 3800346),
('Mono, bis and quaternary Mannich bases derived from acetophenone', 'Activity against Saccharomyces cerevisiae', '', ' Antifungal activity of some mono, bis and quaternary Mannich bases derived from acetophenone.   The development of resistance to current antifungal therapeutics drives search for new effective agents.', 11215330),
('N-(1-benzyl-2-phenylethylidene)-N''-[4-(aryl)thiazol-2-yl]hydrazone (1a-e) and N-(1-phenylbutylidene)-N''-[4-(aryl)thiazol-2-yl]hydrazone (2a-e) derivatives', 'Antifungal activities tested against Candida albicans, Candida glabrata, Candida utilis, Candida tropicalis, Candida krusei, Candida zeylanoides, and Candida parapsilosis', '', ' Studies on hydrazone derivatives as antifungal agents.    The increasing clinical importance of drug-resistant fungal pathogens has urged additional need to fungal research and new antifungal compound development.', 18665994),
('Naphthoquinone thiol-crown ether analogues', 'Bis-naphthoquinone thiol-crown ether 7a was the most potent inhibitor  against Staphylococcus aureus methicillin resistance with MIC value of 2.68 microM.  ', '', 'Efficient synthesis of ''redox-switched'' naphthoquinone thiol-crown ethers and their biological activity evaluation.', 11937353),
('NC1175, styryl ketone', 'All 20 clinical isolates of A. fumigatus examined were susceptible to NC1175 (MIC = 5.54 +/- 2.48 mg/L; range 2.92-11.68 mg/L), and the minimum lethal concentration (MLC) was only twice the MIC, suggesting that NC1175 is fungicidal', '', ' In-vitro and in-vivo susceptibility of Aspergillus fumigatus to a novel conjugated styryl ketone.    We investigated the in-vitro and in-vivo susceptibility of Aspergillus fumigatus  to the novel conjugated styryl ketone NC1175 and the results were compared with those obtained for amphotericin B and itraconazole.', 9848441),
('NCK-10, Aryl-alkyl-lysines', 'Inhibits growth Candida spp., Cryptococcus spp., and Aspergillus fumigatus, mechanism is disruption of the fungal cell membrane', '', ' Overall, aryl-alkyl-lysines were found to be excellent compounds that warrant further investigation as novel antifungal agents.  ', 28238268),
('N-dimethylaminoacetyl-partricin A 2-dimethylaminoethylamide diaspartate (SPA)', 'Showed in vivo activity enhancing mouse resistance to cryptococcal meningoencephalitis and in vitro by potentiating the anticryptococcal activity of murine microglial cells', '', ' Potent antifungal effects of a new derivative of partricin A in a murine model of cerebral cryptococcosis.', 9056019),
('New heptaketides, biatriosporins A-L (1-12), biatriosporin M (13) (a ramulosin derivative), and 19 known compounds (14-32)', 'The most potent compound, compound 4, also sensitized clinically derived azole-resistant Candida albicans strains to fluconazole (FLC)', '', 'Heptaketides from an Endolichenic Fungus Biatriospora sp. and Their Antifungal Activity', 27556953),
('New series of thiazolyl-triazole Schiff bases B1-B15', 'Potential anti-Candida activity with Compound B10 being more potent', '', ' New Thiazolyl-triazole Schiff Bases: Synthesis and Evaluation of the Anti-Candida Potential.  In the context of the dangerous phenomenon of fungal resistance to the available  therapies, we present here the chemical synthesis of a new series of thiazolyl-triazole Schiff bases B1-B15, which were in vitro assessed for their anti-Candida potential.', 27879678),
('New sulfated sterols, geodisterol-3-O-sulfite (1) and 29-demethylgeodisterol-3-O-sulfite (2)', 'Combat the resistance associated with opportunistic fungal infections caused by C. albicans', '', ' Reversal of fluconazole resistance by sulfated sterols from the marine sponge Topsentia sp.', 19653640),
('Nitric-oxide releasing aspirin (NO-ASA)', ' Adhesion to abiotic surfaces, a critical event for biofilm formation, was evaluated in 96-well polystyrene plates using crystal violet assay; 125 micro M NO-ASA significantly inhibited C. albicans adhesion.', '', ' NO-ASA is a promising novel antibiofilm agent for treating fluconazole-resistant strains of C. albicans.  ', 28493889),
('NND-502, imidazole compound', ' The geometric mean (GM)-MICs of NND-502 for 25 strains of M. furfur, 15 strains of M. sympodialis and ten strains of M. slooffiae were approximately 1.4, 0.1 and 1.0 mg/l, respectively', '', ' In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia  species.', 12636984),
('Novel Schiff base [hetero-dinuclear copper(II) Mn(II) complex] (SB) derivative', 'Activity against Candida albicans', '', ' In the current study, a novel Schiff base [hetero-dinuclear copper(II) Mn(II) complex] (SB) derivative was investigated for its anticandidal activity against Candida albicans and possible  mechanisms inducing cell death.', 29080032),
('N-substituted phthalimides (N-vinylphthalimide (4) and 8-[4-(phthalimide-2-yl) butyloxy] quinoline (13) )', 'Compound (4) and (13) were identified as the most promising candidates against B. cinerea and A. solani with the IC50 values of 7.92 microg/mL and 10.85 microg/mL respectively.?', '', ' N-vinylphthalimide (4) and 8-[4-(phthalimide-2-yl) butyloxy] quinoline (13) were  identified as the most promising candidates against B.?cinerea and A.?solani with the IC50 values of 7.92??g/mL and 10.85??g/mL respectively.', 27079471),
('Nylon-3 polymers', ' This polymer is active on its own and in synergy with existing antifungal drugs against multiple species of Candida and Cryptococcus, acts synergistically with azoles against different species of Aspergillus, including some azole-resistant strains.', 'Displayi only mild to moderate toxicity toward mammalian cells.: ', ' These findings indicate that nylon-3 polymers are a promising lead for development of new antifungal therapeutic strategies.  Copyright ? 2017 American Society for Microbiology.', 28739790),
('Orally absorbable imidazole derivatives:  BAY n 7133 and BAY 1 9139', 'Activity comparable to those of ketoconazole and miconazole', '', ' In-vitro inhibitory activities of 2 new orally absorbable imidazole derivatives:  BAY n 7133 and BAY 1 9139.', 6314564),
('Pathogen Box chemical library (Medicines for Malaria Venture [MMV],  Switzerland) (MMV688768, MMV687273, and MMV687807', 'The most potent compound MMV688768, displayed increased antibiofilm activity compared to its activity against planktonic cultures, indicating that it may affect processes with a predominant role during the biofilm mode of growth, in vitro combination assays showed a synergistic interaction between compound MMV688768 and fluconazole against preformed biofilms.', '', ' Interestingly, the most potent of these, compound MMV688768, displayed increased antibiofilm activity compared to its activity against planktonic cultures, indicating that it may affect processes with a predominant role during the biofilm mode of growth.', 27795383),
('PcPAF, antifungal protein produced by the fungal strain Penicillium citrinum W1', 'PcPAF displayed antifungal activity against Trichoderma viride, Fusarium oxysporum, Paecilomyces variotii, and Alternaria longipes at minimum inhibitory concentrations of 1.52, 6.08, 3.04, and 6.08 micro g/disc, respectively.', '', 'Purification and identification of a novel antifungal protein secreted by Penicillium citrinum from the Southwest Indian Ocean.  The results suggested that PcPAF may represent a novel antifungal protein with potential application in controlling plant pathogenic fungal infection.  ', 24931500),
('PLD-118', 'Inhibitor of candida isoleucyl-tRNA synthetase in fluconazole (FLC)-resistant Candida albicans', '', ' Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.  PLD-118, formerly BAY 10-8888, is a synthetic antifungal derivative of the naturally occurring beta-amino acid cispentacin.', 15388459),
('Pneumocandins L-733,560 and L-743,872', 'Activity against amphotericin B- and fluconazole-resistant Candida isolates', '', ' In vitro growth-inhibitory activity of pneumocandins L-733,560 and L-743,872 against putatively amphotericin B- and fluconazole-resistant Candida isolates: influence of assay conditions.  L-733,560 and L-743,872 are water-soluble pneumocandins with potent antifungal activity.', 9292427),
('R-135853, a sordarin derivative', 'R-135853 also exhibited potent activities against fluconazole-susceptible dose-dependent and fluconazole-resistant strains of C. albicans, with MICs ranging from 0.03 to 0.06 micro g/ml', '', 'Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice. R-135853 exhibited potent in vitro activities against Candida albicans (fluconazole-susceptible strains), Candida glabrata, Candida tropicalis, and Cryptococcus neoformans, with MICs at which 90% of isolates were inhibited of 0.03, 1, 0.5, and 0.5 microg/ml, respectively.', 15616275),
('Salicyl glycoconjugates containing hydrazide and hydrazone moieties', ' The bioassay indicated that the novel compounds had no in vitro fungicidal activity but showed significant in vivo antifungal activity against the tested fungal pathogens.', '', '  Molecular design and synthesis of novel salicyl glycoconjugates as elicitors against plant diseases.   A new series of salicyl glycoconjugates containing hydrazide and hydrazone moieties were designed and synthesized.', 25259805),
('Sampangine derivatives', 'Potent inhibitors of Candida albicans biofilm formation and yeast-to-hypha morphological transition by down-regulating biofilm-associated genes', '', '  Discovery of simplified sampangine derivatives as novel fungal biofilm inhibitors. ', 29126739),
('Sargramostim (rh-GM-CSF)', 'Exert beneficial effect  in combination with fluconazole in the management of fluconazole-refractory mucosal candidiasis in advanced HIV-positive patients', '', ' CONCLUSION: In this small pilot study, sargramostim appears to exert a beneficial effect on the mucosal mycoflora and may be a possible alternative as adjunctive therapy in the management of fluconazole-refractory mucosal candidiasis in advanced HIV-positive patients. ', 11590502),
('SCH-56592 (SCH) is a novel triazole', 'Varied activity against itraconazole-susceptible resistant  isolate of Aspergillus fumigatus', '', ' Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.  SCH-56592 (SCH) is a novel triazole antifungal agent with excellent in vitro activity against Aspergillus.', 9210674),
('SCY-078', 'Potency against Echinocandin-Resistant Strains of Candida Species', '', '  Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species.  SCY-078 (formerly MK-3118) is a novel orally active inhibitor of fungal ?-(1,3)-glucan synthase (GS).', 28533234),
('T-2307, a novel arylamidine', 'Activity against Cryptococcus gattii', '', ' Conclusions: T-2307 shows excellent in vitro and in vivo antifungal activities against C. gattii and would be a promising new candidate for the treatment of cryptococcosis.  ', 28201509),
('T-2307, novel arylamidine', 'Potent in vitro activity against C. glabrata (geometric mean MIC 0.0135 mg/L),and in vivo efficacy in mice infected with echinocandin-resistant C. glabrata.', '', ' The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata.', 26620102),
('Terbinafine (SF 86-327)', 'The yeasts showed varying degrees of susceptibility (MICs ranging from 10 to 100 micrograms/ml) except for Candida parapsilosis (MICs 1 to 2 micrograms/ml), strong susceptibility was found for molds (MICs 0.1 to 2 micrograms/ml), especially Scopulariopsis brevicaulis and Sporothrix schenkii (MICs 0.2 microgram/ml), dermatophytes were also highly susceptible to terbinafine (MICs 0.001 to 0.02 microgram/ml).  ', '', ' [In vitro spectrum of action of a new antifungal derivative of naftifin: terbinafin (SF 86-327)].    Terbinafine (SF 86-327) is a new antifungal agent derived from naftifine and effective by the oral route.', 3534767),
('Tetrazole VT-1161', 'Trichophyton rubrum CYP51 inhibitor with IC50 of 0.14 microM,?growth inhibition with MIC50, MIC90, and geometric mean MIC values of less than or equal to 0.03, 0.06, and 0.033 micro g ml-1, respectively', '', ' When the activity of VT-1161 was tested against 34 clinical isolates, VT-1161 was a potent inhibitor of T. rubrum growth, with MIC50, MIC90, and geometric mean MIC values of ?0.03, 0.06, and 0.033 ?g ml-1, respectively.', 28483956),
('Thiophene-based guanylhydrazones (iminoguanidines)', 'All guanylhydrazones showed significant activity against broad spectrum of clinically important species of Candida spp., Aspergillus fumigatus, Fusarium oxysporum, Microsporum canis and Trichophyton mentagrophytes, which was in some cases comparable or better than activity of voriconazole.: In vivo embryotoxicity on zebrafish (Danio rerio) showed improved toxicity profile of some compounds in comparison to that of voriconazole.', '', 'Synthesis and evaluation of thiophene-based guanylhydrazones (iminoguanidines) efficient against panel of voriconazole-resistant fungal isolates. However, bis-guanylhydrazone 18 showed better selectivity in terms of  therapeutic index values.', 26867487),
('Thymol and 2,3-dihydroxybenzaldehyde (2,3-D)', 'Chemosensitizing agents act as synergists to commercial antifungal drugs against tolerant strains of Aspergillus fumigatus', '', 'Chemosensitization prevents tolerance of Aspergillus fumigatus to antimycotic drugs', 18486603),
('triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains', 'The highly active compounds have MIC values in the range of 0.125 micro g/mL to 0.0125 micro g/mL against Candida albicans and Cryptococcus neoformans', '', ' Design, synthesis and antifungal activity of novel triazole derivatives containing substituted 1,2,3-triazole-piperdine side chains. They represent promising leads for the development of new generation of triazole antifungal agents.', 24934573);
INSERT INTO `fungi_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Triazole-thiazolidinedione hybrids [ (Z)-5-(2,4-dichlorobenzylidene)-3-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)thiazolidine-2,4-dione) (15 c), (Z)-3-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-5-(furan-3-ylmethylene)thiazolidine-2,4-dione (15 j), and (Z)-3-(2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)-5-(furan-3-ylmethylene)thiazolidine-2,4-dione (15 r) ]', 'Compounds 15 c, 15 j, 15 r were highly active against Candida albicans, with MIC80 values in the range of 0.03-0.15 microM., compounds 15 j and 15 r were found to be effective against four fluconazole-resistant clinical isolates;', '', ' From antidiabetic to antifungal: discovery of highly potent triazole-thiazolidinedione hybrids as novel antifungal agents.  In an attempt to discover a new generation of triazole antifungal agents, a series of triazole-thiazolidinedione hybrids were designed and synthesized by molecular hybridization of the antifungal agent fluconazole and rosiglitazone (an antidiabetic).', 25196996),
('Voriconazole (UK-109496), a new triazole', '[MIC]90, 0.5 mg/l against Aspergillus fumigatus,  MIC90, 1.0 mg/ against Aspergillus nige and 1.0 mg/l against Aspergillus flavus', '', ' Antifungal activity of a new triazole, voriconazole (UK-109496), against clinical isolates of Aspergillus spp.  Voriconazole is a new triazole antifungal agent with potent activity against yeast and molds.', 11810544),
('VT-1129', 'MIC ranges between 16-32 micro g/ml against fluconazole dose-dependent, and greater than  64 micro g/ml on resistant isolates of Cryptococcus neoformans, overall MIC was 0.027 micro g/ml, the MIC50 was reported to be 0.05 ?g/ml and 0.25 ?g/ml for dose-dependent (n = 27) and resistant isolates (n = 6), respectively.?', '', ' Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.', 27664991),
('VT-1129', ' VT-1129 demonstrated potent activities againstCryptococcus neoformans and Cryptococcus gattii with low MIC50and MIC90values', '', 'The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii.  VT-1129 demonstrated potent activities against bothCryptococcusspecies as demonstrated by low MIC50and MIC90values.', 26787697),
('VT-1161 and VT-1129', 'Promising for the treatment of resistant C. glabrata and C. krusei infections', '', ' VT-1161 and VT-1129 are promising for the treatment of resistant C. glabrata and C. krusei infections.', 27956419),
('LMM11, a new oxadiazole', 'Minimum inhibitory concentration against Candida krusei ranged from 32 to 64 microg/mL with a significant reduction in the colony forming unit (CFU) count (~3 log10), significant reduction in CFU (0.85 log10) in vivo', '', 'Taken together, these results indicate that LMM11 is a promising candidate for the development of a new antifungal agent for the treatment of infections caused by resistant Candida species such as C. krusei.', 31935275),
('Delta-Lactones', 'Broad spectrum of antifungal activity, including against resistant fungal species', 'Toxicity was dose dependent for the viability of human leukocytes, but none of the compounds was mutagenic, genotoxic, or membrane irritant when evaluated at higher concentrations than MIC', 'Structure-based design of Delta-lactones for new antifungal drug development: susceptibility, mechanism of action, and toxicity.', 30734157),
('19,20-epoxycytochalasin Q (ECQ) from fungus Xylaria sp. BCC 1067', 'ECQ displayed an antifungal activity with low MIC50 of 410 and 55 mg/l in the model yeast Saccharomyces cerevisiae wild-type and Sc?pdr5 strains, respectively.', '', 'Combination of ECQ and antifungal azoles displayed promising drug synergy against S. cerevisiae strains expressing multi-drug transporters, thereby providing potential solution for antifungal therapy and chemotherapeutic application.', 33227681),
('1,3,4-oxadiazoles bearing 3,4-dihydropyrimidine heterocyclic motifs compounds', 'Furthermore, results of the antifungal activity tests revealed that compound 4i showed promising activity against all the strains of fungi, Candida albicans, Aspergillus niger, and Aspergillus clavatus, at concentrations of 100, 50, and 100 microgramg/ml, respectively.', '', 'Compound 4d was found to be the most promising against Escherichia coli (12.5 ?microgramg/ml), whereas the same compound showed good activity against Staphylococcus aureus at a concentration of 50 ?microgramg/ml.', 34169569),
('1-(2-Hydroxy-3-{[4-(2-propoxyethoxy)benzoyl]oxy}propyl)-4-(4-nitrophenyl)piperazinediium dichloride', '1-(2-Hydroxy-3-{[4-(2-propoxyethoxy)benzoyl]oxy}propyl)-4-(4-nitrophenyl)piperazinediium dichloride had the highest activity against F. avenaceum (MIC = 14.2 microgramM).', 'All the compounds showed only insignificant toxic effects on human and plant cells.', 'Compounds with a piperazine ring have proved to be promising agents against various pathogens.', 31518219),
('T-2307, a novel arylamidine', 'The ocular T-2307 trough concentration was maintained above the MIC in the infected mice.', '', 'Given these results in experimental disseminated candidiasis, T-2307 may be an effective treatment against the complication of ocular candidiasis.', 30753506),
('echinocandins (anidulafungin, micafungin)', 'In vitro combination of fluconazole with anidulafungin was found to be synergistic (FICI 0.07-0.37) and decreased the MIC range from 4-64 microgramg/mL to 0.5-16 microgramg/mL for fluconazole and from 2-8 microgramg/mL to 0.125-1 microgramg/mL for anidulafungin. Similarly, interactions of fluconazole with micafungin (FICI 0.25-0.5), itraconazole with anidulafungin (FICI 0.15-0.37) and itraconazole with micafungin (FICI 0.09-0.37) were synergistic.', '', 'The combination of fluconazole and itraconazole with either anidulafungin or micafungin demonstrated synergistic interactions against C. parapsilosis species complex, especially against isolates with elevated MIC values.', 31715297),
('Rezafungin', '', '', 'Rezafungin showed excellent in vitro activity against both WT and azole-resistant Candida species, as well as against S. cerevisiae.', 31539426),
('4-phenyl-1, 3-thiazol-2-yl', 'Mminimum inhibitory concentration against pathogenic fungi was between 0.0625-4 micro g/ml in vitro, could exhibit significant fungicidal activity and inhibit the biofilm formation of C. albicans at 0.5 micro g/ml. In vivo fungal infection model showed that at 10 mg/kg it significantly increased the survival rate of Galleria mellonella.', 'No obvious cytotoxicity to human umbilical vein endothelial cells with the concentration of 4 microgram/ml', 'Development of effective fungicides can not only provide new means for clinical treatment, but also reduce the occurrence of fungal resistance.', 33117733),
('Aromatic-rich piperazines', 'Inhibit biofilm formation by C. albicans.', '', 'Effective treatment of infectious diseases now requires new antimicrobial therapies.', 33091849),
('Metyltetraprole', 'Activity against Z. tritici, P. teres, Ramularia collo-cygni, Pyrenophora tritici-repentis, and several other plant pathogenic fungi', '', 'The unique behavior of metyltetraprole against the existing QoI-R isolates was confirmed for all tested pathogen species.', 31769927),
('Schiff bases of 2-mercaptobenzimidazole were synthesized from 4-(2-(1H-benzo[d]- imidazol-2-ylthio)acetamido)benzohydrazide', 'Compounds 8 (MICpa, an = 2.41, 1.20 microgramM/ml), 10 (MICse, sa = 2.50 microgramM/ml), 20 (MICec = 2.34 microgramM/ml) and 25 (MICca = 1.46 microgramM/ml) showed significant antimicrobial activity against tested bacterial and fungal strains', '', 'In general, the synthesized derivatives exhibited moderate antimicrobial and anticancer activities.', 30306865),
('triazole, PC945,', 'PC945 (geometric mean MIC = 0.058 mg/L) was 7.4-fold and 1.5-fold more potent than voriconazole and posaconazole, respectively (both P < 0.01).', '', 'PC945 was found to be a more potent inhibitor than posaconazole, voriconazole and fluconazole of C. auris isolates collected globally, warranting further laboratory and clinical evaluations.', 31325309),
('triazole, PC1244', 'PC1244 exhibited potent inhibition [geometric mean MIC (range), 1.0 mg/L (0.125 to >8 mg/L)] of growth of A. fumigatus strains carrying cyp51A gene mutations', 'Compound 4d was found to be the most promising against Escherichia coli (12.5 microgram/ml), whereas the same compound showed good activity against Staphylococcus aureus at a concentration of 50 ?g/ml.', 'PC1244 has the potential to become a novel topical treatment of azole-resistant pulmonary aspergillosis.', 31361006),
('Gepotidacin, a novel triazaacenaphthylene', 'Gepotidacin was active against all 54 M. genitalium isolates with median and modal MICs of 0.125 mg/L and MIC90 of 0.25 mg/L (range ?0.016-0.5 mg/L).', '', 'Combination therapy with doxycycline should be clinically studied to assess effect and potential protection against development and/or spread of gepotidacin resistance.', 32552547),
('Designing Functionally Substituted Pyridine-Carbohydrazides', 'N', '', 'Overall results suggest that these compounds have the potential to become promising antimicrobial drugs against MDR strains.', 36615406),
('Efinaconazole, a novel triazole', 'Fusarium species demonstrated MICs with efinaconazole (0.98 microg/ml)', '', 'Efinaconazole, a novel triazole, may be a promising candidate for the treatment of superficial Fusarium infections.', 36447396),
('Guanylated Hyperbranched Polylysines', 'hyperbranched polylysine (HPL) shows antifungal activities against Candida, especially for drug-sensitive and MDR C. albicans strains, and broad-spectrum antibacterial activities against both Gram-negative and Gram-positive bacteria.', '', 'The in vitro antifungal activities of HPL3 are further enhanced by the modification of amine groups to form guanylated polylysines (HPL3-Gxs) have potentials as broad-spectrum antimicrobials.', 35775877),
('novel isatin-decorated thiazole derivatives', '(3)-5-Bromo-3-((5-(2-(4-fluoro-3-methylphenyl)hydrazono)-4-methylthiazol-2(5H)-ylidene) hydrazono)indolin-2-one - 7h comopund and 5-Bromo-3-((4-ethoxy-5-(2-(4-fluoro-3-methylphenyl)hydrazono)thiazol-2(5H)-ylidene)hydrazono)indolin-2-one Compound 11f were found to have antifungal activities against Candida albicans', '', 'hese novel isatin-based compounds were screened for their probable antimicrobial effect on E. coli, MRSA and C. albicans as well as their potential as anti-biofilm formation agents.', 36046334),
('NHC 1,3-dibenzyl-4,5-diphenyl-imidazol-2-ylidene silver(I) acetate (SBC3)', 'SBC3 treatment resulted in up to 90% growth inhibition of C. parapsilosis in vitro at the highest test concentration. The determined MIC50 and MIC80 values, representing 15 microg/ml and 25 microg/ml, respectively', 'no adverse effect on mammalian protein synthesis.', 'Silver can also contribute to structural damage. Association with cell membranes/walls and formation of pores alters permeability, resulting in ion leakage, and ultimately, cell death. In fungi, demonstrated inhibition of growth via cell cycle arrest and prevention of cell budding in C. albicans in response to silver.', 35751649),
('novel 3,4-isoxazolediamide derivatives', 'The derivative compound B25 was found to have good synergistic effects with fluconazole against azole-resistant candidiasis', 'to avoid potential mammalian toxicity.', 'promising lead compound for drug discovery targeting fungal Hsp90 and deserves further investigation.', 36029272),
('Non-Antibiotic Antimony-Based Antimicrobials', 'Antifungal effect of new tetraphenyl-antimony(V) cyanoximates determined using a disc-diffusion assay against selected two human fungal pathogens', '', 'Antifungal studies showed that SbPh4(MCO) was the only compound to inhibit the growth of both fungal pathogens C. neoformans and C. albicans, also known for their increasing resistance to antimicrobials. The other compounds inhibited the growth of C. neoformans but not C. albicans.', 36363997),
('new 2-substituted-4-amino-quinolines and -quinazoline', 'The mechanism studies showed that compound III11 (N,2-di-p-tolylquinolin-4-amine hydrochloride) exhibited potent and broad-spectrum antifungal activities with MIC values of 4-32 microg/mL.', '', 'These results suggest that some 4-aminoquinolines may serve as new and promising candidates for further antifungal drug discovery.', 35788035),
('novel compounds containing 1,2,3-triazole side', '(2R,3S)-3-[1-(4-chloro-2-fluorophenyl)-1H-1,2,3-triazol-4-yl]-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol compound 9A16 displayed excellent antifungal and anti-drug-resistant fungal ability (MIC80 = 0.0156-8 microg/mL). compound 9A16 showed powerful in vivo efficacy on mice systematically infected with Candida albicans SC5314, Cryptococcus neoformans H99, fluconazole-resistant C. albicans 100, and Aspergillus fumigatus 7544.', 'an acceptable safety profile', 'With favorable pharmacokinetics, an acceptable safety profile, and high potency in vitro and in vivo, compound 9A16 is currently under preclinical investigation.', 36512715),
('4,4''-dihydroxyazobenzene, a compound and azobenzene derivatives', 'hese compounds prevented the growth of both fluconazole-susceptible and fluconazole-resistant Candida albicans and Candida auris strains.', '', '', 36403201),
('novel indole and indoline derivatives', 'The results showed that title compounds exhibited good antifungal effect on Azole-resistant C. albicans', '', 'inhibit the biofilm formation and hyphae growth of C. albicans through the Ras-cAMP-PKA signaling pathway.', 35661686),
('The anhydride of ferrocenyl-substituted pyrazole, namely, (S)-(3-(3-(carboxyamino)-3H-pyrazol-4-yl)cyclopenta-1,3-dien-1-yl)(cyclopenta-1,3-dien-1-yl)iron', 'The synthesized compound was found to be biological active in the range of 85-95 microg/ml against various human pathogenic Gram-positive, Gram-negative, and fungal microbial strains.', '', 'The study demonstrations that synthesized ferrocenyl-substituted pyrazole in today''s situation is the encouraging antimicrobial mediator against the human pathogens.', 35949692),
('trimethoxybenzoic acid derivatives', '3,4,5-Trimethoxy-N-(2-(4-methylpiperazin-1-yl)ethyl)benzamide derivative- Susceptibility tests were performed by the broth microdilution method based on the Clinical and Laboratory Standards Institute (CLSI); M27A-3 for yeasts (C. albicans) and M38-A2 [42] for filamentous fungi (A. fumigatus and T. rubrum)', '', 'these results show the potential of simple trimethoxybenzoic acid derivatives as a source of feasible efflux pump (EP) inhibitors.', 36430942),
('6-hydroxy-1,2,3,4-tetrahydroquinoline', 'Commercially available 6-hydroxy-1,2,3,4-tetrahydroquinoline (compound 1) was treated with 1-bromoalkanes or 1-iodoalkanes in the presence of K2CO3 to yield compounds. This compound derivative display potent and broad-spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria, as well as fungi', '', 'In conclusion, successfully designed and synthesized a series of amphiphilic tetrahydroquinoline derivatives as effective broad-spectrum antimicrobial agents.', 36088756),
('EGFR inhibitor osimertinib mesylate (OSI)', '(OSI) potentiates azole efficacy against diverse fungal pathogens and overcomes azole resistance. Mechanistic investigation revealed a conserved activity of OSI by promoting intracellular fluconazole accumulation via inhibiting Pdr5 and disrupting V-ATPase function via targeting Vma1 at serine 274, eventually leading to inactivation of the global regulator TOR.', '', 'the identification of OSI as a dual action antifungal with co-targeting activity proposes a potentially effective therapeutic strategy to treat life-threatening fungal infection and overcome antifungal resistance.', 35452875),
('quinolinequinones (QQs) derivative', '7-chloro-6-[4-(3-methylphenyl)piperazin-1-yl]-5,8-dihydroquinoline-5,8-dione QQ3 and QQ4 7-chloro-6-[4-(4-methylphenyl)piperazin-1-yl]-5,8-dihydroquinoline-5,8-dione show two times more activity against fungal strains Candida albicans and Candida parapsilosis. all QQs except QQ5 displayed excellent antifungal activity against the fungi Candida albicans', '', 'In this study, we investigated the bactericidal effects of QQ3 against methicillin-resistant Staphylococcus aureus (MRSA) and Candida albicans strains. The findings of this study suggest that a significant bactericidal effect was seen with all tested 1 ', 35921788),
('1,4-quinone molecules fused with heteroatom derivatives', 'two quinolinequinones derivative (QQ7 and QQ8 4.88MIC) displayed better antifungal activity against C. albicans and C. parapsilosis.', '', 'the activity of these compounds against three different strains of Candida fungi (C. albicans, C. parapsilosis, and C. tropicalis) and Gram-positive and Gram-negative pathogenic bacteria were investigated, searching for potential lead compounds.', 36290056),
('C. neoformans 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase/5''-inosine monophosphate cyclohydrolase (ATIC), a bifunctional enzyme', 'a bifunctional enzyme that catalyzes the final two enzymatic steps in the formation of the first purine base inosine monophosphate.', '', '. Overall, our results validate ATIC as a promising antifungal drug target.', 36063996),
('Compounds based on cobalt bis-dicarbollide [COSAN]', 'The presented data prove that metallacarborane derivatives are effective against clinical isolates of Candida albicans, even those resistant to systemic drugs, and show synergistic potential in combination with amphotericin B', 'low toxicity against human cells and Danio rerio embryos.', 'the investigations of the broad spectrum and valuable future medical applications of metallacarboranes, especially in the fight against drug-resistant pathogens.', 36217958),
('baicalein', 'These results indicated that baicalein could increase intracellular oxidative damage by upregulating the expression of Cpd2p so as to inhibit the growth of C. albicans,', '', 'urther in-depth studies revealed that CPD2 disruption reduced the activation of C. albicans metacaspase and partially restored the mitochondrial membrane potential reduction caused by the treatment of baicalein, which indicated that CPD2 was involved in the apoptosis induced by baicalein. Which provides new insights for investigating the antifungal target of baicalein.', 36055797),
('Combined applications of Spent mushroom substrate (SMS) and dicyandiamide compound', 'Compared to the control treatment, the combined applications of SMS and dicyandiamide significantly decreased soil carbendazim content by 38.14%', '', 'he SMS applications into fungicide-contaminated soils could generate double-edged sword effects of facilitating fungicide dissipation. dicyandiamide with SMS might be an effective strategy to decrease the negative effect of health risk.', 36596378),
('two terpyridine ligands 4''-(4-N,N''-dimethylaminophenyl)-2,2'':6'',2?-terpyridine (L1) and 4''-(4-tolyl)-2,2'':6'',2?-terpyridine (L2)', 'Both compounds L1 and L2 exhibited remarkable inhibitory activities against bacteria, Escherichia coli and Staphylococcus aureus at MIC values 6.25 and 3.125 microg/ml, respectively. in silico molecular docking studies were ascertained with bacterial DNA gyrase and fungal demethylase.', 'he toxicity of L1 and L2 was checked using Drosophila melanogaster. The toxicity analysis suggest both the dyes are non-cytotoxic in nature.', 'The binding constant calculations at different temperature confirmed that the ligand has antimicrobial and antifungal activities', 36562209),
('Lipid-Modified Chitin-Binding Domains', 'LysM-AmBisome exhibited a dramatic enhancement of antifungal activity toward Trichoderma viride and Cryptococcus neoformans, demonstrating the marked impact of displaying a cell-wall binder protein on the targeting ability of antifungal liposomal formulations.', '(LysM-Pal) exhibited negligible cytotoxicity to mammalian cells and can be easily anchored to yield LysM-presenting AmBisome (LysM-AmBisome).', 'simple strategy with enzymatic protein lipidation provides a potent approach to upgrade other types of lipid-based drug formulations.', 36066555),
('Novel 3-(2-(3-(Substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline Derivatives', 'compound 3-(2-(3-(benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline (9a) showed good activity against P. mirabilis, B. subtilis, and A. niger with MIC 31.25 microM; compound 3-(2-(3-((4-bromobenzyl)oxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline 9b showed good activity for P. mirabilis, S. albus, and A. niger with MIC 62.5 microM; 4-chlorobenzyloxy in compound 3-(2-(3-((4-chlorobenzyl)oxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline (9c) which showed good activity against P. mirabilis with MIC 62.5 microM and moderate activity against A. niger; compound 8-fluoro-3-(3-fluoro-2-(3-((4-methylbenzyl)oxy)oxetan-3-yl)phenoxy)-2-methylquinoline (9d) which showed good activity against P. mirabilis and A. niger with MIC 62.5 microM. Against A. niger compound 3-cyanobenzyloxy in 8-fluoro-3-(3-fluoro-2-(3-((3-cyanobenzyl)oxy)oxetan-3-yl)phenoxy)-2-methylquinoline (9f) showed good activity with MIC 62.5 microM; compound 3-(2-(3-((3,5-difluorobenzyl)oxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline (9h), which showed good activity against P. mirabilis and A. niger with MIC 31.25 and 62.5 microM, respectively. 6-fluoropyridin-3-yl-methoxy in 8-fluoro-3-(3-fluoro-2-(3-((6-fluoropyridin-3-yl)methoxy)oxetan-3-yl)phenoxy)-2-methylquinoline (9i), which showed good activity against A. niger with MIC 62.5 microM.', 'Cytotoxicity tests of 3-(2-(3-(substituted benzyloxy)oxetan-3-yl)-3-fluorophenoxy)-8-fluoro-2-methylquinoline (9a', 'The newly synthesized oxetanyl-quinoline derivatives were evaluated for in vitro antibacterial activity against Escherichia coli (NCIM 2574), Proteus mirabilis (NCIM 2388), Bacillus subtilis (NCIM 2063), Staphylococcus albus (NCIM 2178), and in vitro antifungal activity against Aspergillus niger (ATCC 504) and Candida albicans (NCIM 3100) show good inhibition and can use as novel compound against antimicrobial resistance', 36570236),
('chelerythrine combined with fluconazole', 'A broth microdilution assay was used to reveal the antifungal activity of chelerythrine combined with fluconazole against C. albicans and the preformed biofilm. A fractional inhibitory concentration index model was used to evaluate the interaction. Chelerythrine strongly synergized with fluconazole against fluconazole-resistant C. albicans and the biofilm preformed for less than 12 h.', '', 'Chelerythrine could reverse the drug resistance of resistant C. albicans and its biofilm to fluconazole, providing new insights for overcoming the drug resistance of C. albicans.', 36111728),
('new chiral triazole fungicide mefentrifluconazole', 'The results suggest that triazole resistance in A. fumigatus could be resulted from the selection of mefentrifluconazole at concentrations larger than 2 mg L-1', '', 'Mefentrifluconazole should be applied within the dosage recommended by good agricultural practice to avoid the resistance in A. fumigatus in soil. This also may be applicable to other triazole fungicides.', 36205310),
('ipflufenoquin, with a new antifungal olorofim', 'Effective against- Azole resistance in Aspergillus fumigatus', '', 'The use of the recently authorized fungicide ipflufenoquin, which shares its mode-of-action with a new antifungal olorofim, underscores the need for risk assessment for dual use of antifungals.', 36283187),
('Compounds 1c (alpha-asarone-related) and 5b (with a pyrrolic core) [Fibrate-Based Compounds and Substituted Pyrroles ]', 'Inhibit the Enzyme 3-Hydroxy-methyl-glutaryl-CoA Reductase of Candida glabrata (CgHMGR), Thus Decreasing Yeast Viability and Ergosterol Synthesis', 'Future studies are needed to modify the structure of the two present test compounds to obtain safer and less toxic antifungals. Moreover, it is important to carry out a more in-depth mechanistic approach.', 'According to the docking analysis, the inhibitory effect of 1c and 5b could possibly be mediated by their interaction with the amino acid residues of the catalytic site of the enzyme. Since 1c displayed higher binding energy than alpha-asarone and 5b, it is the best candidate for further research, which should include structural modifications to increase its specificity and potency.', 35377226),
('amphotericin B (AmB)-loaded nanoemulsion (NE) (NEA) [sunflower oil and cholesterol as the oily phase, polyoxyethylene 20 cetyl ether (Brij', 'control of C. auris infections and resistance as well as decrease the side effects of this drug', '', 'NEA had a better antifungal profile against systemic infection in G. mellonella. It is concluded that the alternative model proved to be an efficient in vivo assay to determine the toxicity and evaluate the therapeutic property of free AmB and NEA in systemic infections caused by C. auris.', 34662607),
('combination effect of AZD8055 and fluconazole', 'Synergism between AZD8055 and fluconazole was observed in six strains (60%) of Candida spp., resulting in reversion of fluconazole resistance. Synergistic combinations resulted in 4-fold to 256-fold reduction of effective MICs of AZD8055 and azoles.', '', 'In summary, the results suggested that AZD8055 combined with azoles may help to enhance the antifungal susceptibilities of azoles against pathogenic fungi and had the potential to overcome azole resistance issues.', 35019705),
('derivative A1Cl of 2-chloro-N-phenylacetamide', 'A1Cl inhibited in vitro biofilm formation at all concentrations tested (1/4MIC to 8 ', '', 'Conclusions: The results suggest that A1Cl is a promising antifungal agent. Furthermore, this activity is related to attenuation of expression of virulence factors and antibiofilm effects against C. tropicalis and C. parapsilosis.', 35179275),
('Boric acid', 'boric acid inhibited C. albicans hyphal formation and reduced mature biofilm biomass and metabolic activity in all isolates in a dose-dependent manner', '', 'Overall, our findings illustrate that boric acid is broadly effective at inhibiting growth across many isolates and morphologies, which could explain why it is an effective treatment for RVVC.', 35446135),
('Nitroxoline', 'MIC50/90 of nitroxoline was 2/2 mg/L (MIC range 0.25-4 mg/L)', '', 'In conclusion, isolates of different Candida species are highly susceptible to nitroxoline, which could be a promising antimicrobial to treat candiduria caused by multidrug resistant yeasts.', 35543103),
('15 N [Cobalt Ferrite (0.3 CoFe2O4) + Silver chromite (0.7 Ag0.5Cr2.5O4)]', 'against M. luteus. Concerning antifungal activity, C. albicans was the most susceptible fungal species', '', 'The tested compounds could be attractive and alternative antibacterial compounds that open a new path in chemotherapy.', 35624524),
('juglone (5-hydroxy-1,4-naphthoquinone)', 'against both fluconazole-resistant and susceptible Candida isolates', '', 'Juglone increased the antifungal activity of fluconazole; however, no synergism effects were observed for any combination, and only an insignificant effect was found against all tested Candida species.', 35701335),
('chlorhexidine acetate in combination with fluconazole', 'against suspensions and biofilms of Candida auris', '', 'Conclusion: The combination therapy of fluconazole and chlorhexidine acetate provides a new potential strategy for the treatment of clinical Candida auris infection.', 34674944),
('Heat shock protein 90 (Hsp90)/Histone deacetylase (HDAC)', 'dual inhibitors for the treatment of azoles-resistant Candida albicans', '', 'Therefore, Hsp90/HDAC dual inhibitors represent a new strategy for the development of novel antifungal therapeutics to combat azole-resistant candidiasis.', 34742014),
('Recombinant Myeloperoxidase', '', '', 'Taken together, the data suggest that rMPO purified from a stably expressing human cell line is a new class of antimicrobial agents with the ability to kill a broad spectrum of pathogens, including bacteria and fungi with or without drug resistance.', 35019674),
('Compounds 5b (Z)-3-(3-hydroxyphenyl)-5-((1-methyl-1H-indol-3-yl)methylene)-2-thioxothiazolidin-4-one and 5g (Z)-3-[5-(1H-Indol-3-ylmethylene)-4-oxo-2-thioxo-thiazolidin-3-yl]-benzoic acid as well as 5h (Z)-3-(5-((5-methoxy-1H-indol-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)benzoic acid', 'All compounds demonstrated a higher degree of antifungal activity than the reference drugs bifonazole (6-17-fold) and ketoconazole (13-52-fold).', '', 'Conclusion: Compounds 5b (Z)-3-(3-hydroxyphenyl)-5-((1-methyl-1H-indol-3-yl)methylene)-2-thioxothiazolidin-4-one and 5g (Z)-3-[5-(1H-Indol-3-ylmethylene)-4-oxo-2-thioxo-thiazolidin-3-yl]-benzoic acid as well as 5h (Z)-3-(5-((5-methoxy-1H-indol-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)benzoic acid can be considered as lead compounds for further development of more potent and safe antibacterial and antifungal agents.', 35164333),
('polypyridyl iridium(III) complexes', 'potent agents against resistant Candida albicans', '', 'This study may pave the way for the development of novel antifungal agent based upon polypyridyl iridium(III) complex to combat antifungal resistance.', 35276422),
('Pseudolaric Acid A Combined with Fluconazole', 'against Candida albicans via Inhibition of Adhesion and Yeast-To-Hypha Transition', '', 'In conclusion, these findings demonstrate, for the first time, that the combination of PAA and FLC has an improved antibiofilm effect against the formation of C. albicans biofilms by inhibiting adhesion and yeast-to-hypha transition; this may provide a novel therapeutic strategy for treating C. albicans biofilm-associated infection.', 35297651),
('pyrvinium pamoate (PP)', 'PP inhibited C. auris replication in macrophages, which is a relevant host niche for this yeast pathogen.', '', 'Our study offers a new avenue for therapeutic development against drug-resistant C. auris, shows how complex metabolic dysfunction can be caused by a single compound triggering antifungal inhibition, and provides insights into the metabolic needs of C. auris in immune cell environments.', 35412372),
('chlorogenic acid', 'against strains of Candida spp. resistant to fluconazole', '', 'We concluded that chlorogenic acid has potential use as an adjuvant in antifungal therapies, due to its anti-Candida activity and ability to interact with important drug targets.', 35575783),
('Chrysosporium sp. HSXSD-11-1, Cladosporium sp. HSXSD-12 and Acrostalagmus luteoalbus CH-6', 'the crude extracts of CH-6 displayed the strongest antimicrobial activities with 72.3-84.8% growth inhibition against C. albicans and Aeromonas salmonicida.', '', 'This study further demonstrates the great potential of Antarctic fungi in the development of new compounds and antibiotics.', 35621985),
('calcium supplementation combined with iron deficiency', 'causes dramatic growth inhibition of the human fungal pathogens Aspergillus fumigatus, Candida albicans, and Cryptococcus neoformans', '', 'Thus, there is a mutual effect between iron and calcium in fungal pathogens, and the combination of calcium with an iron chelator could serve to improve antifungal therapy.', 35674440),
('Cold atmospheric plasma (CAP)', 'CAP irradiation significantly inhibited the fungal growth by 25.83 to 89.10%, reduced fungal cell viability by 11.68 to 87.71%, disrupted cellular membranous organelles and structures of the fungal hyphae, and suppressed efficiently the expression of HSP90 gene by 2 folds in 210 s exposure.', '', 'Taken together, our results demonstrated that CAP is an efficient tool with potential in-vivo therapeutic applications against chronic dermatophytosis caused by T. rubrum due to its effectiveness, harmless, and ease of access.', 35676321),
('Thiadiazole-Based Molecules', 'Promising Inhibitors of Black Fungi and Pathogenic Bacteria', '', 'Furthermore, a molecular docking study was achieved on the synthesized compounds, of which compounds 2, 6, and 7 showed the best interactions with the selected protein targets.', 35684551),
('4-phenyl-4,5-dihydrooxazole derivatives', 'antifungal activities against eight susceptible strains and seven FLC-resistant strains. Furthermore, the potent compound 22a could prevent the formation of fungalbiofilms and displayed satisfactory fungicidal activity.', '', 'Moreover, pharmacokinetic studies in SD rats showed that compound 22a exhibited pharmacokinetic properties with a bioavailability of 15.22% and a half-life of 4.44 h, indicating that compound 22a is worthy of further study', 34749201),
('3-thiophene derivatives', 'showed excellent inhibitory activity against pathogenic and drug-resistant fungi. In addition, the preferred compound 21b could prevent the formation of fungal biofilms and displayed satisfactory fungicidal activity.', '', 'These results strongly suggested that compound 21b is worthy of further study as a potential azole inhibitor.', 35255313),
('4,5-Diarylisoxazole Derivatives', 'Combination Treatment of Azole-Resistant Candidiasis', '', 'These data support the feasibility of targeting fungal Hsp90 as a promising antifungal strategy and further development of compound A17 as a valuable research probe for the investigation of fungal Hsp90.', 35298171),
('compound 2a11', 'compound 2a11 can inhibit the growth of azole-resistant strains 103 with the MIC80 of 1 microg/mL.', '', 'Collectively, this work identifies a new covalent allosteric site of CaFBA and discovers the first generation of covalent inhibitors for fungal FBA with potent inhibitory activity against resistant fungi, establishing a structural foundation and providing a promising strategy for the design of potent antifungal drugs.', 35099959),
('berberine hydrochloride', 'against fluconazole-resistant Candida albicans', '', 'Conclusion. BH affects multiple target genes in diminishing the resistance of C. albicans strains to fluconazole. This effect may be related to the action of BH on the HOG-MAPK pathway.', 35679157),
('Benzylic Dehydroxylation of Echinocandin Antifungal Drugs', 'Restores Efficacy against Resistance Conferred by Mutated Glucan Synthase', '', 'This study describes the first example of a chemical modification strategy to restore the efficacy of echinocandin drugs, which have a critical place in the arsenal of antifungal drugs, against resistant fungal pathogens.', 35347986),
('Minocycline (MIN) and azoles', 'in vitro combination of MIN with ITR, VOR or POS showed satisfactory synergistic effects against 8 (80%), 1 (10%), and 9 (90%) strains, respectively. Moreover, combined use of MIN with azoles decreased the minimum inhibitory concentration (MIC) range from 5.33-16 microg/ml to 1-16 microg/ml for ITR, from 0.42-16 microg/ml to 0.21-16 microg/ml for VOR, and from 1.33-16 microg/ml to 0.33-16 microg/ml for POS.', '', 'Conclusions: The present study demonstrated that combinations between MIN and azoles lead to synergistic antimicrobial effects on Scedosporium and Lomentospora species, while showing a potential for overcoming and preventing azole resistance.', 35016611),
('olorofim', 'Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages', '', 'Conclusions: This is the first known study to demonstrate the antibiofilm activity of olorofim, voriconazole and amphotericin B against azole-resistant A. fumigatus.', 35289361),
('Jerveratrum-Type Steroidal Alkaloids', 'Jervine exhibited broad-spectrum antifungal activity and was effective against human-pathogenic fungi, including Candida parapsilosis and Candida krusei. It was also effective against phytopathogenic fungi, including Botrytis cinerea and Puccinia recondita. Jervine exerted a synergistic effect with fluconazole.', '', 'Therefore, jervine, a jerveratrum-type steroidal alkaloid used in pharmaceutical products, represents a new class of antifungals active against mycoses and plant-pathogenic fungi.', 35019680),
('Helja with fluconazole (FLC)', 'The Helja + FLC combination exhibited an inhibitory effect of fungal growth about three times greater than the sum of both compounds separately and inhibited fungal morphological plasticity, an important virulence attribute associated with drug resistance. Cells treated with Helja + FLC showed morphological changes, nucleus disintegration and formation of multimera structures, leading to cell collapse.', '', 'Conclusions: Our findings indicate that the Helja + FLC combination exhibited a potent antifungal activity based on their simultaneous action on different microbial cell targets.', 35332971),
('Delphinium cashmerianum L. (Daidzein compound)', 'Upon analysis, we obtained 5 compounds that were efficiently binding to the drug targets. However, after performing exhaustive molecular docking and molecular dynamic simulation (MDS) analysis, it was observed that Daidzein compound is bound to drug targets more efficiently.', '', 'Conclusion: The results showed that these plant extracts exhibit antimicrobial activity and ethyl acetate extract proved to exhibit the most effective antibacterial and antifungal properties.', 35167935),
('compounds 14a-2 and 20b-2', 'Among of them, target compounds 14a-2 and 20b-2 not only possessed the excellent broad-spectrum anti-fungal activity (MIC50, 0.125-2 Microg/mL), but also maintained the anti-drug-resistant fungal activity (MIC50, 1-4 Microg/mL)', '', 'In addition, we also discovered that compounds 14a-2 and 20b-2 with low toxic and side effects could exert the excellent therapeutic effect in mice model of fungal infection, which was worthy for further in-depth study.', 34772530),
('thiosemicarbazone derivative 19ak as a metal chelator', '19ak exhibits minimal cytotoxicity and potent activity against either azole-sensitive or azole-resistant fungal pathogens, inhibits fungal ribosome biogenesis mainly by disrupting intracellular zinc homeostasis', '', 'This study provides the basis of thiosemicarbazone derivative 19ak as a metal chelator for the treatment of fungal infections.', 35412374),
('BDDE-Inspired Chalcone Derivatives', 'chalcones 13 and 14 showed promising antifungal activity against the dermatophyte clinical strain of Trichophyton rubrum', '', 'BDDE-Inspired Chalcone Derivatives to Fight Bacterial and Fungal Infections', 35621966),
('sertraline with fluconazole', 'luconazole with sertraline (FICI =0.5), where a synergistic effect was observed against all resistant C. glabrata and ATCC strains with a >2-log10 CFU/mL reduction caused by combination compared with a single active agent of fluconazole after 24 hours of incubation', '', 'Conclusion: Our data suggest that blocking active efflux pumps by sertraline may be considered the probable mechanism of synergism with fluconazole. The combination of sertraline with fluconazole could be a promising remedy for treatment of infections caused by resistant C. glabrata.', 35181564),
('eucalyptol in combination with antifungals', 'The geometric mean MBIC of amphotericin B, itraconazole, nystatin and eucalyptol were 3.93 Microg/mL, 12.55 Microg/mL, 0.75 Microg/mL and 798 Microg/mL, respectively. Eucalyptol interacted synergistically with amphotericin B, itraconazole and nystatin against 12.5, 10, and 22.5% of isolates, respectively.', '', 'Eucalyptol demonstrated promising activity against biofilm of C. albicans when tested alone or combined with antifungal drugs.', 35508567),
('benzbromarone', 'potential folate inhibitors of Candida albicans', '', 'Based upon the molecular docking simulation-based virtual screening followed by the molecular dynamic simulation of the macromolecular complex, benzbromarone has been identified as a potential anti-folate agent for the development of a novel therapy for the treatment of candidiasis.', 35716240),
('surfactin', 'exerted antifungal effect against Candida albicans', '', 'Our data demonstrate that surfactin significantly influences the physiology and gene transcription of C. albicans, and could contribute to the development of a novel innovative complementary therapy.', 35671583),
('octenidine', 'against emerging echinocandin-, azole- and multidrug-resistant Candida albicans and Candida glabrata', '', 'Conclusion: These results encourage consideration of the well-tolerated antiseptic molecule OCT in the eradication of emerging (multidrug) resistant C. albicans and C. glabrata.', 35134551),
('Ent-hardwickiic acid from C. pubiflora and its microbial metabolites', 'All the diterpenes showed fungistatic effects (ranging from 19', '', 'Ent-hardwickiic acid from C. pubiflora and its microbial metabolites are more potent than fluconazole in vitro against Candida glabrata', 34995375),
('adamantane derivatives', 'five derivatives (6, 7, 9, 14a, and 14b) displayed the potent activities against the different isolates tested (MIC <8 Microg/ml with fungi) compared with Ciprofloxacin (CIP) and Fluconazole (FCA), showed fungicidal effects based on (MBCs and MFCs) and the time-kill assay. The most active adamantane derivatives 7 and 14b exhibited a synergistic effect of SFIC = 0.5 with CIP and FCA against the bacterial and fungal isolates.', '', 'Finally, the in-silico analysis predicted that the most active derivatives had good drug-likeness and safe properties.', 35716118),
('Dicliptera roxburghiana', 'For antifungal assay, DRME and DRHF were potently active and showed more than 70% fungal growth inhibition where as DRCF and DRBF were also displaying appreciable inhibition.', 'Cytotoxic measurements were very good for DRME, DRHF and DRAF with LD50 values 215, 199 and 392 Microg/ml respectively.', 'These results confirmed antimicrobial and cytotoxic potential of the plant and all its derived fractions. Hence it can be concluded that plant contain some important compounds that can be used as antimicrobial source for the treatment of different infectious disease.', 35221269),
('spirooxindole-pyrrolidine heterocyclic hybrids', 'DPA-3, has potent antifungal activity without inducing mammalian cell cytotoxicity. Furthermore, DPA-3 significantly reduced hyphal and biofilm formation of Candida albicans ATCC 10231 strain, out-competing two FDA approved antifungal drugs.', '', 'The results of our study conclude that DPA-3 is a compelling candidate for further development as an antifungal drug.', 35512603),
('gallic acid (GA)', 'GA presented minimum inhibitory concentrations ranging from 16 to 72 Microg/ml, causing alterations of the membrane integrity and mitochondrial transmembrane potential, production of reactive oxygen species and externalization of phosphatidylserine', '', 'Conclusion: GA has potential antifungal activity against Candida spp.', 35354285),
('indole and indoline derivatives', 'against Candida albicans as potent antifungal agents', '', 'The results showed that title compounds exhibited good antifungal effect on Azole-resistant C. albicans. Further mechanism study demonstrated that S18 could inhibit the biofilm formation and hyphae growth of C. albicans through the Ras-cAMP-PKA signaling pathway.', 35661686),
('Pyridothienopyrimidine Derivatives', 'Compounds 3a, 5a and 9b displayed broad spectrum antimicrobial activity with MIC ranges of 4-16 Microg/mL and potent cytotoxic activity with IC50 ranges of 1.17-2.79 MicroM. In addition, they provided suppressing activity against EGFR with IC50 ranges of 7.27-17.29 nM, higher than that of erlotinib, IC50 = 27.01 nM.', '', 'All new compounds were evaluated against five bacterial and five fungal strains.', 35164067),
('2,5-Disubstituted Pyridine', 'as an Inhibitor of Candida albicans Erg11', '', 'This work characterizes the antifungal activity of a 2,5-disubstituted pyridine against C. albicans, supporting the mining of existing chemical collections to identify compounds with novel antifungal activity.', 35531664),
('analogues of Panax stipulcanatus saponin', 'In vitro antifungal activity results indicated that analogue 2 combined with fluconazole showed synergistic antifungal activity against fluconazole-resistant Candida albicans, with MIC50 values 31.80 Microg/mL and FICI values 0.32. intermediate compounds 16 and 17 revealed synergistic antifungal activity against susceptible Candida albicans when combined with fluconazole, with MIC50 values 1.43 Microg/mL and 1.59 Microg/mL, FICI values 0.29 and 0.32, respectively.', '', 'synergistic antifungal activity of analogues of Panax stipulcanatus saponin against fluconazole-resistant Candida albicans', 35552063),
('Arylamidine T-2307', 'the MIC of T-2307 was found to be 0.005 microg mL-1 against C. tropicalis DSM 11951 and C. tropicalis.', 'T-2307 did not affect cell viability on PNT1A cell line', 'these results provide new information on T-2307, indicating this compound as a new and promising alternative therapeutic option for the treatment of Candida infections.', 36555687),
('beta-Nitrostyrene derivatives', 'The results show that beta-Nitrostyrene derivatives inhibited the growth of different species of human pathogenic Candida, particularly the highly prevalent C. albicans, C. glabrata and the emerging pathogenic C. auris species.', '', 'beta-Nitrostyrene derivatives impact cell wall morphology, enhance ROS generation and modulate drug efflux. Collectively this study reveals that beta-Nitrostyrene derivatives have strong antifungal potential with a particular mode of activity similar to known cell wall perturbing antifungal agents', 35932582),
('Hydroxyethyl Naphthalimides', 'These prepared naphthalimides showed better antifungal potency than fluconazole towards some tested fungi including Aspergillus fumigatus, Candida tropicalis and Candida parapsilosis 22019. Especially, thioether benzimidazole derivative with excellent anti-Candida tropicalis efficacy (MIC = 4 microg/mL)', 'possessed low cytotoxicity, safe hemolysis level and less susceptibility to induce resistance.', 'antifungal potency promoted the production and accumulation of reactive oxygen species (ROS) in cells, which destroyed the antioxidant defence system, led to oxidative stress with lipid peroxidation, loss of glutathione, membrane dysfunction and metabolic inactivation, and eventually caused cell death. The chemical and dynamic antifungal synergistic effect initiated by hydroxyethyl naphthalimides was a reasonable treatment window for prospective development.', 36500547),
('adamantane derivatives', 'MIC of <8 microg/ml with fungi) compared with Ciprofloxacin (CIP) and Fluconazole (FCA).', '', 'interaction of DNA gyrase and topoisomerase IV enzymes with the compound Derivative exhibited potent antimicrobial activity using in vitro biochemical assays and gel-based DNA-supercoiling inhibition method', 35716118),
('hexyl-aminolevulinate ethosomes (HAL-ES)', 'No survival was observed after 6 h of incubation with 20 mM HAL, and growth inhibition was noted at 2.5 to 10 mM HAL against Candida albicans. The results showed that HAL-mediated aPDT killed approximately 66.7% of C. albicans cells', '', 'HAL-ES inhibits protein translation by disrupting zinc homeostasis in C. albicans. Hence, provides a novel and effective therapeutic strategy against C. albicans biofilm but also proposes a new strategy to resolve C. albicans biofilm infection by disrupting zinc homeostasis.', 36301105),
('volatilomes nest microbiome of the Namibian, social spider Stegodyphus dumicola', 'The growth of P. lilacinum was inhibited by the volatilome of Streptomyces sp. and Aureobasidium sp.', '', 'The antimicrobial activities of five spider nest microbiome member volatilomes (Massilia sp. IC2-278, Massilia sp. IC2-477, Sphingomonas sp. IC-11, Aureobasidium sp. CE_32, and Streptomyces sp. IC-207) against two putative spider pathogens (B. thuringiensis and P. lilacinum) were tested to prove a potential role in pathogen defense', 36073497);

-- --------------------------------------------------------

--
-- Table structure for table `fungi_np`
--

CREATE TABLE IF NOT EXISTS `fungi_np` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(2000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `fungi_np`
--

INSERT INTO `fungi_np` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Amphotericin B-conjugated silver nanoparticles', 'Biogenic silver nanoparticles revealed low to moderate antifungal activity (4-8 mm +- 0.2), however, the amphotericin B conjugated silver nanoparticles exhibited significant activity against Candida albicans (16 mm +- 1.4) and Candida tropicalis (18 mm +- 1.5)', '', 'Amphotericin B-conjugated biogenic silver nanoparticles as an innovative strategy for fungal infections.  ', 27591110),
('Chitosan silver nanocomposite (CAgNC)', 'Activity of chitosan silver nanocomposite (CAgNC) was tested against C. albicans Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of CAgNC were determined as 25 and 100 microg/ml, respectively', '', ' Overall results from our study indicated that CAgNC could affect negatively on physiological and biochemical functions of C. albicans suggesting CAgNC as a potential alternative for antifungal chemotherapy.  ', 27495320),
('Fluconazole-loaded solid lipid nanoparticles (FLZ-SLNs) ', 'The MIC50 drug concentrations were 2microg/ml, 1microg/ml and 2microg/ml for FLZ-resistant strains of Candida albicans, Candida parapsilosis and Candida glabrata, respectively', '', 'Time to overcome fluconazole resistant Candida isolates: Solid lipid nanoparticles as a novel antifungal drug delivery system. ', 26974361),
('NB-002, a novel nanoemulsion', 'For filamentous nondermatophyte fungi, the  MIC range varied from 0.06 to 0.5 microg/ml for Alternaria spp. to 2 to 8 microg/ml for Paecilomyes spp.: NB-002 had activity against both azole-susceptible and -resistant Candida albicans yeast isolates, with MIC(90)s of 2 microg/ml, respectively, and minimum fungicidal concentrations at which 90% of isolates are  inhibited of 4 and 8 microg/ml, respectively.: NB-002 killed both mycelia and microconidia even when the fungal forms were dormant or not actively growing.', '', '  NB-002, a novel nanoemulsion with broad antifungal activity against dermatophytes, other filamentous fungi, and Candida albicans.    NB-002 is an oil-in-water emulsion designed for use for the treatment of skin, hair, and nail infections.', 19433562),
('Polyvinylpyrrolidone-Coated Silver Nanoparticles and Azole Antifungal', 'Effective in being against the drug-resistant C.  albicans', '', ' Synergy Between Polyvinylpyrrolidone-Coated Silver Nanoparticles and Azole Antifungal Against Drug-Resistant Candida albicans. Our results suggest that the combinational use of engineered nanomaterials (ENMs), such as PVP-coated Ag-NPs, with the conventional antifungal may be a viable strategy to combat drug-resistant fungal infection.  ', 27455637),
('Silver nanoparticles (AgNPs)', 'MIC50 were 0.1 micro g ml(-1)  and MFC were 0.25 and 0.5 microg ml(-1) for C. glabrata and C. krusei, respectively', '', ' In vitro antifungal activity of silver nanoparticles against fluconazole-resistant Candida species.  Nowadays, current advances in nanotechnology constitute a promising alternative in the development of new antimicrobial agents.', 26335058),
('Tea tree oil nanoemulsions', 'Strong in vitro antimicrobial activities on Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae, Staphylococcus aureus and Candida albicans', '', ' Taken together, our results show that the inhalable nanoTTOs are promising nanomedicines for local therapies of fungal and bacterial pneumonia with no obvious adverse events.', 26895502),
('Zinc Oxide (ZnO) nanoparticles and EDTA', 'Effective antifungal properties at the concentration of 5.2, 8.6 microg/ml for Fluconazole susceptible strain and 5.42, 10.8 microg/ml Fluconazole resistant strains of C. tropicalis biofilms', '', ' CONCLUSION: In present study we conclude, ZnO considered as a new agent in field  of prevention C. tropicalis biofilms especially biofilms formed surface of medical device.  ', 27653145),
('Arginine-phenylalanine and arginine-tryptophan-based surfactants', 'Antifungal activity against fluconazole-resistant Candida spp. strains, with a low minimum inhibitory concentration (8.2 microgramg/mL)', '', 'Synthetic amino acid-based surfactants constitute a promising alternative to conventional antimicrobial compounds.', 34391169),
('Ag/BN NPs', 'The Ag/BN nanohybrids and amphotericin B-loaded BN and Ag/BN NPs also reveal high fungicidal activity against C. albicans, C. auris, C. parapsilosis, and N. crassa cells.', '', 'Herein, we demonstrate that Ag/BN NPs and antibiotic-loaded BN and Ag/BN nanoconjugates are promising carriers to fight bacterial and fungal infections', 34000197),
('ultra-small silver nanoclusters (rsAg/NCs)', 'we also established that the apoptosis-inducing potential of rsAg/NCs is due to the activation of Ras signaling, which confirms their application in combating FCZ-resistant C. albicans infections.', '', 'Silver-based nanostructures are suitable for many biomedical applications, but to be useful therapeutic agents, the high toxicity of these nanomaterials must be eliminated.', 30769763),
('Green synthesis of silver nanoparticles by Conocarpus Lancifolius plant extract', 'significant activity against fungal pathogen Rhizopusus stolonifera and Aspergillus flavus', '', 'Based on our results, biogenic AgNPs reveal significant activity against fungal pathogen Rhizopusus stolonifera and Aspergillus flavus that cause leading infectious diseases.', 35002442),
('Synergistic Antimicrobial Metal Oxide-Doped Phosphate Glasses', 'fungal strain (Candida albicans)', '', 'An enhanced antimicrobial effect, at 5 mg/mL concentration, was exhibited by cobalt, copper, and zinc oxide glasses alone and in combinations.', 35199992),
('Short Guanidinium-Functionalized Poly(2-oxazoline)s', 'Displaying Potent Therapeutic Efficacy on Drug-Resistant Fungal Infections', '', 'The easy synthesis and structural diversity of POXs imply their potential as a class of promising antifungal agents.', 35182092),
('chemically and biologically synthesized silver nanoparticles', 'against three fungal strains (Aspergillus flavus, Fusarium moniliforme, and Candida albicans, all isolated from Nile tilapia)', '', '', 35280558),
('poly(methacrylic acid)-silver nanoparticles (PMAA-AgNPs)', 'against fluconazole-resistant Candida albicans strains', '', 'Conclusions: This study demonstrated that, in general, PMAA-AgNPs acts synergistically in combination with fluconazole, inhibiting fluconazole-resistant C. albicans strains. PMAA-AgNPs-fluconazole combination was also able to inhibit germ tube formation, an important virulence factor. Inhibitory effect of PMAA-AgNPs alone or in combination was higher in C. albicans than in mammalian cells.', 35338561),
('polyacrylonitrile (PAN) nanofibers coated with silver nanoparticles (AgNPs) and silver(I,III) oxide.', 'different concentrations of AgNO3 (0, 5, 10, and 15% wt % w.r.t to weight of PAN) were used. results also indicate that PAN-AgNP nanocomposites possess relatively less antimicrobial activity against Gram-negative bacteria compared to Gram-positive bacteria and C. albicans.', '', 'Our study demonstrates that PAN-AgNP nanocomposites, a novel polymer material with long-term universal antimicrobial stability, can potentially be applied as a universal antimicrobial. data also indicate that PAN-AgNP nanocomposites synthesized from higher wt % concentrations of AgNO3 demonstrated more antimicrobial efficiency against all 10 microbes compared to samples synthesized from lower concentrations of metal salts.', 36591150),
('polypropargyl alcohol nanoparticles (nano-PGA)', 'Nano-PGA-DMF (dimethylformamide) exhibits significant antimicrobial potential against Candida albicans (C.albicans) (12.50 mm; ZOI, and 1.87 microg/mL; MIC).', '', 'It was found that the nano-PGA polymer prepared in DMF has better antimicrobial activity than one prepared in chloroform than in water.', 36152795),
('Chrysophyllum albidum fruit peels to prepare silver nanoparticles (Alb-AgNPs).', 'The antimicrobial properties of the Alb-AgNPs were studied with selected microorganisms namely; S. aureus, E. coli, K. pneumoniae, B. subtilis, S. mutans, P. aeruginosa, S. typhi, and Candida albicans. High inhibitory activity against the microorganisms were exhibited with MICs ranging from 15.62 to 1000 microg/mL. the Alb-AgNPs could serve as a biofilm inhibitor with the highest percent inhibition of about 92% against methicillin-resistant Staphylococcus aureus', '', 'The results from this study thus provide access to the simple, sustainable, economic and eco-friendly synthesis of silver nanoparticles with efficient antimicrobial properties as drug candidates as a means of overcoming the prevailing antibiotic resistance menaces.', 36586061),
('silver nanoparticles (AgNPs) from Withania somnifera and Fagonia indica', 'Silver nanoparticles of F. indica exhibited the highest significant activity against Aspergillus flavus and Fusarium oxysporum while AgNPs of W. somnifera were active only against A. flavus. The highest significant inhibition was obtained for crude extract (46.7) and AgNPs (45.7) of F. indica at 1000 microg/ml.', '', 'Both crude and AgNPs showed potent activity; however, in comparison, silver nanoparticles showed slightly enhanced activity. Crude and AgNPs of both plants showed good phytotoxic and insecticidal inhibition. Antimicrobial studies of AgNPs on diseases causing pathogens open a door for new antimicrobial agents and could be the answer to antibiotic resistance after further analysis.', 36440367),
('anti-biotic drug metronidazole loaded ZIF-90 nanoparticles', 'In anti-fungal activity, studies show excellent growth inhibition against human pathogenic fungi Aspergillus fumigatus and Candida albicans', 'the fabricated MI@ZIF-90 drug delivery system is non-toxic to biomedical applications', 'The overall research findings highlight the design of a smart drug delivery system for sepsis treatment. In future it will be an efficient, low-cost, and biocompatible pharmaceutics for pediatric sepsis management processes.', 36509311),
('gold nanoparticles (AuNP)', 'effects on the architecture of Candida tropicalis biofilms.', '', 'The fungicidal activity and cellular stress of both AuNPs affected biofilm growth through accumulation of reactive oxygen species and reactive nitrogen intermediates. However, cetyltrimethylammonium bromide-stabilized AuNPs revealed a higher redox imbalance. We correlated, for the first time, AuNP effects with the redox imbalance and alterations in the architecture of C. tropicalis biofilms.', 36515357),
('Trigonella incise (Linn) Mediated Biosynthesized Silver Nanoparticles', 'the nanoparticles showed more significant antimicrobial activity against Salmonella typhi (S. typhi) and Staphylococcus aureus (S. aureus) with an inhibition zone of 21.5 mm and 20.5 mm at 6 microg/mL concentrations, respectively. The best antifungal activity was observed by synthesized Ag NPs against Candida albicans (C. albicans) with 21 mm zone of inhibition, as compared to a standard drug which gives 22 mm of inhibition.', '', 'we conclude that the antibacterial and antifungal activities showed satisfactory results from the synthesized Ag NPs.', 35889490);

-- --------------------------------------------------------

--
-- Table structure for table `natural_product`
--

CREATE TABLE IF NOT EXISTS `natural_product` (
  `THEME` varchar(50) NOT NULL,
  `PMID` int(50) NOT NULL,
  `EVIDENCE` varchar(2000) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `natural_product`
--

INSERT INTO `natural_product` (`THEME`, `PMID`, `EVIDENCE`) VALUES
('NATURAL PRODUCTS', 25976809, ' Thus, our results indicate that Z. joazeiro Mart. (HELZJ) could be a source of plant-derived natural products that could lead to the development of promising new antibiotic compounds for infectious diseases.  '),
('NATURAL PRODUCTS', 20818936, ' Five successive extracts (petroleum ether, chloroform, ethyl acetate,  methanol and aqueous) of the roots of T. erecta and a new bithienyl compound, 2-hydroxymethyl-non-3-ynoic acid 2-[2,2'']-bithiophenyl-5-ethyl ester from the roots of the plant, were evaluated for in vitro antiplasmodial activity against chloroquine sensitive and resistant strains of Plasmodium falciparum.'),
('NATURAL PRODUCTS', 17221829, ' Plants, which showed significant antimalarial activity including V. lasiopus, T. asiatica and R. prinoides, should further be evaluated in the search for novel agents against drug-resistant malaria. '),
('NATURAL PRODUCTS', 19557435, ' Altogether curcumin showed promising anticryptosporidial effects under in vitro  conditions and deserves further exploration. '),
('NATURAL PRODUCTS', 29631127, ' Furthermore, they revealed the importance of exploring novel classes of bioactive compounds such as peptaibols and demonstrated for the first time that they can act in synergy with  currently used antileishmanial drugs to improve the therapeutic outcome.  '),
('NATURAL PRODUCTS', 21595907, ' A novel paratransgenic strategy aimed at control of vectorial transmission of L. donovani is presented using Bacillus subtilis, a commensal bacterium isolated from the sand fly gut.'),
('NATURAL PRODUCTS', 25914039, ' Bioassay guided fractionation of the extract yielded; three clerodane diterpenes [16-hydroxycleroda-3,13-dien-16,15-olide (1), 16-oxocleroda-3,13E-dien-15-oic acid (2) and 3,16-dihydroxycleroda-4(18),13(14)Z-dien-15,16-olide (3)], a steroid [beta-stigmasterol (4)] and two alkaloids [darienine (5) and stepholidine (6)]. While compounds 4, 5 and 6 exhibited weak antiplasmodial activity (IC50 22-105?g/ml), the clerodane diterpenes exhibited significantly potent (p<0.005) blood schizonticidal activity (IC50: 3-6?g/ml).'),
('NATURAL PRODUCTS', 24880238, ' This is the first report of semisynthetic triterpenoid derivatives with anti-T. vaginalis activity, revealing the high potential of these compounds as trichomonacidal agents.  '),
('NATURAL PRODUCTS', 26735308, ' A subset of more than 20,000 extracts from the MEDINA microbial products collection has been explored, leading to the discovery of 3 new compounds with antimalarial activity.'),
('NATURAL PRODUCTS', 22275299, ' Here, we report the synthesis of some  6-halo-?-carbolines as analogues of the potent antimalarial natural product, manzamine A, retaining its heteroaromatic core whilst providing compounds with much improved synthetic accessibility.'),
('NATURAL PRODUCTS', 18544604, ' Findings demonstrate the potential of Sapindus saponins for development as a microbicidal contraceptive for human use.');

-- --------------------------------------------------------

--
-- Table structure for table `parasite_amp`
--

CREATE TABLE IF NOT EXISTS `parasite_amp` (
  `ENTITY` varchar(500) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(2000) NOT NULL,
  `PMID` int(11) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `parasite_amp`
--

INSERT INTO `parasite_amp` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Urocortin II (UCNII)', 'Antimicrobial activity against a panel of Gram-positive and Gram-negative bacteria and tropical parasites of the genus Leishmania.', 'Did not affect mammalian cell viability.', 'Therefore, UCNII could be considered as an ancient highly-conserved host peptide involved in the natural antimicrobial defense and emerge as an attractive alternative to current treatments for microbial disorders with associated drug resistances.', 24249730),
('temporin-Sha analogue [K3]SHa', 'Exert leishmanicidal activity via a primary membranolytic mechanism but can also trigger apoptotis-like death', '', 'Insight into the mechanism of action of temporin-SHa, a new broad-spectrum antiparasitic and antibacterial agent. Antimicrobial peptides (AMPs) are promising drugs to kill resistant pathogens.', 28319176),
('BMAP-28 and two of its isomers the D-amino acid form (D-BMAP-28) and the retro-inverso form (RI-BMAP-28)', 'D-BMAP-28 appears to be the most potent antiparasitic of the three isomers against wild type L. major promastigotes and amastigotes', '', 'An MTS viability assay was utilized to show the potent antiparasitic activity of BMAP-28 and its protease resistant isomers against L. major promastigotes in vitro.', 21655347),
('Antimicrobial peptide LL-37 and the three synthetic peptides E6, L-1018, and RI-1018', 'Leishmanicidal activity against promastigotes and intramacrophage amastigotes of Leishmania donovani and Leishmania major', '', 'The results suggest that RI-1018 E6 and LL-37 are promising peptides to develop further into components for antileishmanial therapy.', 26883699),
('Combination of alkylphosphocholines with peptaibols', 'Antileishmanial activity', '', 'Furthermore, they revealed the importance of exploring novel classes of bioactive compounds such as peptaibols and demonstrated for the first time that they can act in synergy with currently used antileishmanial drugs to improve the therapeutic outcome.', 29631127);

-- --------------------------------------------------------

--
-- Table structure for table `parasite_light`
--

CREATE TABLE IF NOT EXISTS `parasite_light` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` text NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `parasite_light`
--

INSERT INTO `parasite_light` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Indocyanine green (ICG) and ethylenediamine tetraacetate (EDTA)', 'PACT mediated by ICG and EDTA led to a more pronounced antibacterial effect in S. aureus and P. aeruginosa compared with ICG alone-mediated PACT. P. aeruginosa was more sensitive to ICG and EDTA-mediated PACT than S. aureus.', '', 'Antimicrobial Photodynamic therapy(A-PDT) or Photodynamic antimicrobial chemotherapy (PACT) has been proposed as an alternative approach for inactivating bacteria, especially resistant bacterial biofilms.', 30633998),
('Methylene blue (MB)-PDT', 'MB-PDT led to complete inhibition of all isolates at geometric mean concentrations of 1-16 mg/L. Efficacy was independent of incubation time prior to illumination, terbinafine susceptibility (MICs ?0.004-4 mg/L) and presence of SQLE mutations', '', 'Terbinafine resistant and susceptible strains are equally susceptible to MB-PDT.', 33497815);

-- --------------------------------------------------------

--
-- Table structure for table `parasite_naturalproduct`
--

CREATE TABLE IF NOT EXISTS `parasite_naturalproduct` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `parasite_naturalproduct`
--

INSERT INTO `parasite_naturalproduct` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Hydroalcoholic extract of the leaves of Ziziphus joazeiro Mart. (HELZJ)', 'IC50 was 612.06 micro g/ mL against T. cruzi, and for the protozoans L. braziliensis and L. infantum, IC50 values were greater than 5000 and 693.67 micro g/mL, respectively', 'Low toxicity in fibroblasts in vitro', 'Thus, our results indicate that Z. joazeiro Mart. (HELZJ) could be a source of plant-derived natural products that could lead to the development of promising new antibiotic compounds for infectious diseases.', 25976809),
('Petroleum ether, chloroform, ethyl acetate, methanol and aqueous extracts from the roots of T. erecta and a new bithienyl compound, 2-hydroxymethyl-non-3-ynoic acid 2-[2,2'']-bithiophenyl-5-ethyl ester from the roots of the plant', 'Ethyl acetate fraction exhibited IC(50) of 0.02 and 0.07 mg/mL against the chloroquine sensitive and resistant strains of Plasmodium falciparum respectively, the new bithienyl compound also showed significant schizonticidal activity against both chloroquine sensitive and resistant strains of Plasmodium falciparum with the IC(50) values of 0.01 and 0.02 mg/mL', '', 'Five successive extracts (petroleum ether, chloroform, ethyl acetate,  methanol and aqueous) of the roots of T. erecta and a new bithienyl compound, 2-hydroxymethyl-non-3-ynoic acid 2-[2,2'']-bithiophenyl-5-ethyl ester from the roots of the plant, were evaluated for in vitro antiplasmodial activity against chloroquine sensitive and resistant strains of Plasmodium falciparum.', 20818936),
('Kenyan medicinal plants (Toddalia asiatica (root bark), Rhamnus prinoides (leaves and root bark),  Vernonia lasiopus (root bark),  root bark and/or leaf extracts of Maytenus acuminata, M. heterophylla, M. senegalensis, Rhamnus staddo and Withania somnifera (root bark))', 'Toddalia asiatica (root bark), Rhamnus prinoides (leaves and root bark) and Vernonia lasiopus (root bark) showed high chemosuppression in the range 51%-75%, activity of V. lasiopus (all parts), leaf extracts of M. senegalensis, R. prinoides and T. asiatica as well as root barks of M. heterophylla, R. staddo and T. asiatica  enhabced in combination with chloroquine', '', 'In Vivo antimalarial activity of aqueous extracts from Kenyan medicinal plants and their chloroquine (CQ) potentiation effects against a blood-induced CQ-resistant rodent parasite in mice', 17221829),
('Curcumin', 'Higher than 95% inhibition of Cryptosporidium parvum growth at 50 microM for 24 h', '', 'Altogether curcumin showed promising anticryptosporidial effects under in vitro conditions and deserves further exploration.', 19557435),
('Ethanolic extract of P. longifolia (Sonn) Thw. var. pendula stem bark (clerodane diterpenes [16-hydroxycleroda-3,13-dien-16,15-olide (1), 16-oxocleroda-3,13E-dien-15-oic acid (2) and 3,16-dihydroxycleroda-4(18),13(14)Z-dien-15,16-olide (3)], a steroid [beta-stigmasterol (4)] and two alkaloids [darienine (5) and stepholidine (6)])', 'The clerodane diterpenes exhibited significantly potent (p<0.005) blood schizonticidal activity (IC50: 3-6 micro g/ml),?while compounds 4, 5 and 6 exhibited weak antiplasmodial activity (IC50 22-105 micro g/ml)', '', 'The potent antiplasmodial activity of the extract of P. longifolia (Sonn) Thw. var. pendula and compounds therein strongly suggests its usefulness as an antimalarial agent and supports its inclusion or exploitation in formulations of herbal remedies for malaria in Ghana.', 25914039),
('Triterpenoids (Piperazine derivatived from betulinic acid)', 'Minimum inhibitory concentration (MIC) value of 91.2 microM against Trichomonas vaginalis', '', 'This is the first report of semisynthetic triterpenoid derivatives with anti-T. Vaginalis activity, revealing the high potential of these compounds as trichomonacidal agents.', 24880238),
('Compounds from MEDINA microbial products collection', 'Activity against Plasmodium falciparum?', '', 'A subset of more than 20,000 extracts from the MEDINA microbial products collection has been explored, leading to the discovery of 3 new compounds with antimalarial activity', 26735308),
('Sapindus saponins', 'y, the MIC of Sapindus saponins for T. vaginalis (0.005%) was found to be 10-fold lower than its effective spermicidal concentration (0.05%)', '', 'Findings demonstrate the potential of Sapindus saponins for development as a microbicidal contraceptive for human use.', 18544604),
('Extra Virgin Olive Oil', 'Our results show that TPF triggers cell-cycle arrest and apoptotic-like changes in Leishmania spp. promastigotes.', '', 'Alternative bioactive phytocompounds may provide a promising source for discovering new anti-leishmanial drugs.', 33428610);

-- --------------------------------------------------------

--
-- Table structure for table `parasite_novelagent`
--

CREATE TABLE IF NOT EXISTS `parasite_novelagent` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `parasite_novelagent`
--

INSERT INTO `parasite_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('2-alkyl-2-aminoadamantane derivatives with sufficient adducts', 'Activity against p2009 influenza A', '', 'The results indicate that 2-alkyl-2-aminoadamantane derivatives with sufficient adducts can persistently block p2009 influenza A in vitro through an alternative mechanism.', 24793875),
('Naphthyridone 3 (HM13N)', 'Inhibit the HIV-1', '', 'A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication. The emergence of multidrug resistant HIV-1 strains and the inability of the HAART to eradicate HIV-1 virus from infected patients demand new drugs able to interfere with an alternative step of the replicative cycle.', 19958026),
('Conjugation of D4T with 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (MKC-442, emivirine)', 'Anti-HIV activity', '', 'Conjugation of D4T with 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (MKC-442, emivirine)-type reverse transcriptase inhibitors via the SATE prodrug approach. This paper reports the synthesis and the antiviral activities of new double-prodrugs against HIV based on the known mixed SATE (S-acyl-2-thioethyl) prodrug approach.', 15715487),
('2-cyano-3-acrylamide small-molecule', 'Activity against murine norovirus (MNV) and Listeria', '', 'Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens. Due to the rise of antibiotic resistance and the small number of effective antiviral drugs, new approaches for treating infectious diseases are urgently needed.', 27139470),
('2,4-diarylaniline analogs (DAANs) derivatives 9a-9e', 'HIV-1 reverse transcriptase inhibitors, compound 9e not exhibited extremely high potency against wild-type virus (EC(50) 0.53 nM) and several resistant viral strains (EC(50) 0.36-3.9 nM)', '', 'Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors. The current optimization of 2,4-diarylaniline analogs (DAANs) on the central phenyl ring provided a series of new active DAAN derivatives 9a-9e, indicating an accessible modification approach that could improve anti-HIV potency against wild-type and resistant strains, aqueous solubility, and metabolic stability.', 22406117),
('UC 38, analog of oxathiin carboxanilide', 'Anti-HIV activity', '', 'Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor. UC 38, a simple analog of oxathiin carboxanilide, UC 84, lacking the oxathiin ring, was found to be a potent inhibitor of human immunodeficiency virus (HIV)-1-induced cell killing and HIV replication in a variety of human cell lines, as well as in human peripheral blood lymphocytes and macrophages.', 8558446),
('Pyridazinone derivative, compound 3711', 'Inhibits hepatitis B virus', '', 'Pyridazinone derivative 3711, a novel chemical entity and HBV inhibitor, may provide a new opportunity to combat chronic HBV infection.', 26349829),
('1,1,3-trioxo-2H,4H-thieno[3,4-e] [1,2,4]thiadiazine (TTD) derivatives, i.e., 2-(3-fluorobenzyl)-4-cyanomethylen-l,1,3-trioxo-2H,4H- thieno [3,4-e] [1,2,4] thiadiazine) (QM96639)', 'Inhibit human immunodeficiency virus (HIV) type 1 [HIV-1 (IIIB)] at concentration 0.09 microM', '', '1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity. We report the development of a new group of nonnucleoside reverse transcriptase inhibitors (NNRTIs).', 9517942),
('BAY 57-1293', 'Against HSV infection', '', 'Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293. BAY 57-1293 belongs to a new class of antiviral compounds and inhibits replication of herpes simplex virus (HSV) type 1 and type 2 in the nanomolar range in vitro by abrogating the enzymatic activity of the viral primase-helicase complex.', 12019088),
('Urea-PETT (phenylethylthiazolylthiourea)', 'HIV-1 inhibitor', '', 'Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues. The further development of allosteric HIV-1 RT inhibitors in the urea analogue series of PETT (phenylethylthiazolylthiourea) derivatives is described here. The series includes derivatives with an ethyl linker (1-5) and racemic (6-16) and enantiomeric (17-20) cis-cyclopropane compounds.', 10514285),
('Diphenyl heterocyclic compounds(R706)', 'hepatitis C virus (HCV)', '', 'We conclude that R803 and related heterocyclic compounds constitute a new class of HCV-specific inhibitors that could potentially be developed as a treatment for HCV infection.', 18227176),
('Crown-Like Oxotricyclic Core as the P2-Ligand', 'HIV-1 inhibitor', '', 'Design and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants. Design, synthesis, and evaluation of a new class of exceptionally potent HIV-1 protease inhibitors are reported.', 28418652),
('Neoechinulin B and its analogues', 'Activity against H1N1 virus', '', 'A class of prenylated indole diketopiperazine alkaloids including 15 new compounds namely rubrumlines A-O obtained from marine-derived fungus Eurotium rubrum, were tested against influenza A/WSN/33 virus. Neoechinulin B (18) exerted potent inhibition against H1N1 virus infected in MDCK cells, and is able to inhibit a panel of influenza virus strains including amantadine- and oseltamivir-resistant clinical isolates.', 25681711),
('Meso-tetrakis-(3,5-dicarboxy-4,4''-biphenyl) porphyrin', 'Activity against hepatitis C virus (HCV)', '', 'A novel class of meso-tetrakis-porphyrin derivatives exhibits potent activities against hepatitis C virus genotype 1b replicons in vitro. Recent years have seen the rapid advancement of new therapeutic agents against hepatitis C virus (HCV) in response to the need for treatment that is unmet by interferon (IFN)-based therapies.', 19901090),
('Combination of the (R)-(hydroxyethylamino)sulfonamide isostere and the cyclic urea component of lopinavir', 'HIV-1 inhibitor', '', 'Discovery of imidazolidine-2,4-dione-linked HIV protease inhibitors with activity against lopinavir-resistant mutant HIV. A new series of HIV protease inhibitors has been designed and synthesized based on the combination of the (R)-(hydroxyethylamino)sulfonamide isostere and the cyclic urea component of lopinavir.', 16828558),
('PTC725', 'Targets the hepatitis C Virus NS4B protein', '', 'Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B protein. While new direct-acting antiviral agents for the treatment of chronic hepatitis C virus (HCV) infection have been approved, there is a continued need for novel antiviral agents that act on new targets and can be used in combination with current therapies to enhance efficacy and to restrict the emergence of drug-resistant viral variants.', 23629699),
('Acridone derivatives, obtained by reaction of acridone-4-carboxylic acid derivatives with aromatic amines', 'NS3 helicase of hepatitis C virus (HCV) with IC(50) range from 1.5 to 20 microM', '', 'Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication. A new goup of acridone derivatives, obtained by reaction of acridone-4-carboxylic acid derivatives with aromatic amines, was tested to determine the inhibitory properties toward the NS3 helicase of hepatitis C virus (HCV).', 20337460),
('Novel compounds generated by merging pharmacophores of salicylate and catechol [2,3-dihydroxybenzamide (5a), structural modifications on the 5a scaffold with carboxamide and the piperidin-1-ylsulfonyl substituted at the phenyl ring to generate (5p), N-(cyclohexylmethyl)-2,3-dihydroxy-5-(piperidin-1-ylsulfonyl) benzamide (5u)]', 'HIV-1 inhibitor, 5p, IC(50)=5 microM, 5u IC(50) value of 8 microM', '', 'Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups. By merging the pharmacophores of salicylate and catechol, the 2,3-dihydroxybenzamide (5a) was identified as a new scaffold to inhibit the strand transfer reaction efficiently.', 21778063),
('Bicyclic hydroxy-1H-pyrrolopyridine-triones', 'HIV-1 integrase inhibitors', '', 'Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. We report herein bicyclic hydroxy-1H-pyrrolopyridine-triones as a new family of HIV-1 integrase inhibitors that were efficiently prepared using a key ''Pummerer cyclization deprotonation cycloaddition'' cascade of imidosulfoxides.', 22107736),
('N-(2-phenylethyl)-N''-(2-thiazolyl)thiourea (LY73497)', 'Inhibit HIV-1 but not HIV-2', '', 'The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. To identify the minimal structural elements necessary for biological activity, the rigid tricyclic nucleus of the known human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) inhibitor tetrahydroimidazobenzodiazepinthione was subjected to systematic bond disconnection to obtain simpler structures.', 7574525),
('1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils', 'HIV-1 non-nucleoside reverse transcriptase inhibitors', '', 'Design, synthesis, and biological evaluation of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors with an improved drug resistance profile. Because the emergence of drug-resistant mutants has limited the efficacy of non-nucleoside reverse transcriptase inhibitors (NNRTIs), it is essential to develop new antivirals with better drug resistance and pharmacokinetic profiles. Here we designed and synthesized a series of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils, the HEPT analogues, and evaluated their biological activity using nevirapine and 18 (TNK-651) as reference compounds.', 22283377),
('Amidine 6 and guanidine 7', 'Activity against oseltamivir-resistant influenza viruses', '', 'Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A. With the emergence of oseltamivir-resistant influenza viruses and in view of a highly pathogenic flu pandemic, it is important to develop new anti-influenza agents. Several 5-guanidino- and 5-amidino-based oseltamivir derivatives were synthesized and profiled for their anti-influenza activity and in vitro and in vivo PK properties. Amidine 6 and guanidine 7 were comparably effective against a panel of different A/H1N1 and A/H3N2 strains and also inhibited mutant A/H1N1 neuraminidase. Among different prodrug strategies pursued, a simple amidoxime ethyl ester (9) exhibited a superior PK profile with an oral bioavailability of 31% (rats), which is comparable to oseltamivir (36%). Thus, bioisosteric replacement of the 5-guanidine with an acetamidine-in the form of its N-hydroxy prodrug-successfully tackled the two key limitations of currently used NA inhibitors, as exemplified with oseltamivir.', 24422530),
('PL-100', 'Potent inhibition of HIV-1 protease and viral replication in vitro (K(i), approximately 36 pM, and 50% effective concentration [EC(50)], approximately 16 nM, respectively)', '', 'In vitro antiviral activity and cross-resistance profile of PL-100, a novel protease inhibitor of human immunodeficiency virus type 1. Despite the success of highly active antiretroviral therapy, the current emergence and spread of drug-resistant variants of human immunodeficiency virus (HIV) stress the need for new inhibitors with distinct properties.', 17638694),
('1H-1,2,3-triazole-4-carboxamide derivative 3b', 'Anti-influenza A viruses, H5N1 (RG14), amantidine-resistant A/WSN/33 (H1N1), and oseltamivir-resistant A/WSN/1933 (H1N1, 274Y) virus strains', '', 'Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein. The influenza virus nucleoprotein (NP) is an emerging target for anti-influenza drug development.', 22332894),
('3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides', 'Inhibit HIV-1 Integrase and RNase H', '', '3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H. On the basis of our previously reported 3-hydroxypyrimidine-2,4-dione (HPD) core, we have designed and synthesized a new integrase strand transfer (INST) inhibitor type featuring a 5-N-benzylcarboxamide moiety. Significantly, the 6-alkylamino variant of this new chemotype consistently conferred low nanomolar inhibitory activity against HIV-1.', 27283261),
('4-Benzyloxy-gamma-sultone (4- and 5-substituted-5H-1,2-oxathiole-2,2-dioxide derivatives ) derivatives', 'Against human cytomegalovirus (HCMV) and varicella zoster virus (VZV)', '', '4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus. We report the synthesis and antiviral activity of a new family of non-nucleoside antivirals, derived from the 4-keto-1,2-oxathiole-2,2-dioxide (beta-keto-gamma-sultone) heterocyclic system.', 19226140),
('(3aS,4S,7aR)-hexahydro-2H-furo[2,3-b]pyran-4-ol, (-)-7', 'Activity against multidrug-resistant HIV-1 variants', '', 'Design and synthesis of potent HIV-1 protease inhibitors incorporating hexahydrofuropyranol-derived high affinity P(2) ligands: structure-activity studies and biological evaluation. The design, synthesis, and evaluation of a new series of hexahydrofuropyranol-derived HIV-1 protease inhibitors are described.', 21194227),
('New series of fused heteroaromatic sulfonamides', 'Against HIV-1', '', 'Design of HIV-1 protease inhibitors active on multidrug-resistant virus. On the basis of structural data gathered during our ongoing HIV-1 protease inhibitors program, from which our clinical candidate TMC114 9 was selected, we have discovered new series of fused heteroaromatic sulfonamides.', 15771440),
('4-substituted 1,5-diarylanilines( three most promising compounds 14e, 14h, and 15h)', 'Activity against HIV-1, EC(50) values ranging from 0.2 to 10 nM', '', 'Design, synthesis, and preclinical evaluations of novel 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidates. Twenty-one new 4-substituted diarylaniline compounds (DAANs) (series 13, 14, and 15) were designed, synthesized, and evaluated against wild-type and drug resistant HIV-1 viral strains.', 22856541),
('MP-134 and MP-167', 'Inhibitors of HIV type 1 protease', '', 'Design, synthesis, and resistance patterns of MP-134 and MP-167, two novel inhibitors of HIV type 1 protease. Inhibitors of HIV-1 protease represent a new class of antiretroviral compounds.', 8825619),
('1-aryl-4,6-diamino-1,2-dihydrotriazine derivatives', 'Inhibitors of influenza A and B virus and respiratory syncytial virus (RSV) via targeting of the host dihydrofolate reductase (DHFR) enzyme. best compounds (11, 13, 14 and 16) even reached the sub-micromolar potency of zanamivir (EC50 = 0.060 ?M)', '', 'We have identified a series of 1-aryl-4,6-diamino-1,2-dihydrotriazines, structurally related to the antimalarial drug cycloguanil, as new inhibitors of influenza A and B virus and respiratory syncytial virus (RSV) via targeting of the host dihydrofolate reductase (DHFR) enzyme.', 28477572),
('1H-benzo[de]isoquinoline-1,3(2H)-diones', 'Inhibitors of HCV NS5B polymerase.', '', 'Herein, we present 1H-benzo[de]isoquinoline-1,3(2H)-diones as a new series of selective inhibitors of HCV NS5B polymerase.', 19877603),
('Imide derivatives of 3-nitro-1.8-naphthalic acid', 'Activity against herpes simplex type 2 (HSV-2) and adenovirus type 5 (Ad-5)', '', 'Imide derivatives of 3-nitro-1.8-naphthalic acid: their inhibitory activity against DNA viruses. The antiviral action of a new drug, 5-amino-2-(dimethylaminoethyl)-benzo-[de]-isoquinolin-1.3-dione has been studied against herpes simplex type 2 (HSV-2) and adenovirus type 5 (Ad-5) grown in Vero cells.', 6299235),
('SPD754 (also known as AVX-754)', 'Activity against HIV-1 and HIV-2 in vitro and against recombinant viruses containing thymidine analogue mutations (TAMs)', '', 'In vitro activity of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor (NRTI), against 215 HIV-1 isolates resistant to other NRTIs.', 16245645),
('9-phenylcyclohepta[d]pyrimidinedione derivatives', 'Inhibit HIV-1 replication', '', 'Inhibitory activity of 9-phenylcyclohepta[d]pyrimidinedione derivatives against different strains of HIV-1 as non-nucleoside reverse transcriptase inhibitors. BACKGROUND: The non-nucleoside reverse transcriptase inhibitor (NNRTI), as a major component of the highly active antiretroviral therapy (HAART) to HIV-1 (human immunodeficiency virus type 1) infected patients, required the development of new NNRTIs with improved resistance profile and decreased toxicity.', 21569631),
('New diarylaniline (DAAN) analogues', 'Anti-HIV potency, especially against the E138K', '', 'Three series (6, 13, and 14) of new diarylaniline (DAAN) analogues were designed, synthesized, and evaluated for anti-HIV potency, especially against the E138K viral strain with a major mutation conferring resistance to the new-generation non-nucleoside reverse transcriptase inhibitor drug rilpivirine (1b).', 27070547),
('Pyrrolidine-3,4-bis-N-benzyl-sulfonamides', 'The most promising candidate exhibited a K(i) of 74 nM towards a wild-type HIV protease', '', 'Recently, symmetric pyrrolidine-3,4-bis-N-benzyl-sulfonamides have been developed as a new class of HIV-1 protease inhibitors.', 18692068),
('Compounds HIV-1 protease inhibitors with the hydroxyethylamine core and different phenyloxazolidinone P2 ligands?', 'HIV-1 protease inhibitors', '', 'Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones. A series of new HIV-1 protease inhibitors with the hydroxyethylamine core and different phenyloxazolidinone P2 ligands were designed and synthesized.', 20958050),
('Diarylpyrimidine (DAPY)', 'Nonnucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-1', '', 'Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1. This paper reports the synthesis and the antiviral properties of new diarylpyrimidine (DAPY) compounds as nonnucleoside reverse transcriptase inhibitors (NNRTIs).', 15771449),
('2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4(3H)-one (S-DABO) derivatives', 'Target at the non-nucleoside reverse transcriptase inhibitors resistant HIV-1 strain', '', 'The anti-HIV activity of three 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4 (3H)-one derivatives acting as non-nucleoside reverse transcriptase inhibitor in vitro. It was recently shown that several new synthetic 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4(3H)-one (S-DABO) derivatives demonstrated anti-HIV-1 activity.', 21348416),
('Lactoside compounds', 'Against HIV-1', '', 'Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection. Despite significant improvements, antiretroviral therapies against HIV-1 are plagued by a high frequency of therapeutic failures that have been associated with acquisition of drug resistance.', 22064534),
('New derivative of bevirimat', 'HIV-1 maturation inhibitor', '', 'Synthesis and biological evaluation of a new derivative of bevirimat that targets the Gag CA-SP1 cleavage site. Bevirimat (2), the first-in-class HIV-1 maturation inhibitor, shows a low efficacy due essentially to the natural polymorphism of its target, the CA-SP1 junction.', 23399723),
('Alizarine analogues K-49 and KNA-53', 'Inhibitors of the HIV-1,  IC(50) values for both RT-associated functions of ? 10 microm', '', 'Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases. HIV-1 reverse transcriptase (RT) has two associated activities, DNA polymerase and RNase H, both essential for viral replication and validated drug targets.', 21348941),
('Proteasome inhibitor VL-01', 'Reduction of influenza virus', '', 'Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses. The appearance of highly pathogenic avian influenza A viruses of the H5N1 subtype being able to infect humans and the 2009 H1N1 pandemic reveals the urgent need for new and efficient countermeasures against these viruses.', 21777621),
('2-phenylimidazopyridines', 'Herpes infection', '', '2-phenylimidazopyridines, a new series of Golgi compounds with potent antiviral activity. Drugs targeted to viral proteins are highly vulnerable to the development of resistant strains.', 17973358),
('9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-guanine (BIOLF-62)', 'Activity against herpes simplex virus types 1 and 2', '', 'A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2. A novel nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-guanine (BIOLF-62), was found to have potent antiviral activity against herpes simplex virus types 1 and 2 at concentrations well below cytotoxic levels.', 6289741),
('1-(omega-phenoxyalkyl)uracils bearing acetanilide fragment in 3 position of pyrimidine ring', 'Inhibitors of Hepatitis C Virus replication', '', 'Here, we describe new 1-(?-phenoxyalkyl)uracils bearing acetanilide fragment in 3 position of pyrimidine ring as potential antiviral drugs against HCV. A detailed structure-activity relationship revealed that the most active compounds were the N(3)-substituted uracil derivatives containing 6-(4-bromophenoxy)hexyl or 8-(4-bromophenoxy)octyl fragment at N(1) position.', 27406141),
('Indolyl aryl sulfones bearing the 4,5-difluoro (10) or 5-chloro-4-fluoro (16) substitution pattern at the indole ring ', 'HIV-1 non-nucleoside reverse transcriptase inhibitors', '', 'Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity.', 17803291),
('2-acetyl-3-methyl-5-(p-tolyl)indeno[1,2-d]thiazolo[3,2- a]pyrimidin-6(5H)-one (9b) and ethyl 3-methyl-6-oxo-5-(p-tolyl)-5,6-dihydroindeno[1,2-d]thiazolo- [3,2-a]pyrimidine-2-carboxylate (9c),', 'Anti-HSV-1', '', 'Merged pyrimidine derivatives were designed by one pot synthesis of pyrimidinethione derivative with halogenated compounds. Amongst the tested compounds 2-acetyl-3-methyl-5-(p-tolyl)indeno[1,2-d]thiazolo[3,2- a]pyrimidin-6(5H)-one (9b) and ethyl 3-methyl-6-oxo-5-(p-tolyl)-5,6-dihydroindeno[1,2-d]thiazolo- [3,2-a]pyrimidine-2-carboxylate (9c), caused viral inhibition over 90%. . CONCLUSION: We succeeded in this context to synthesize a new series of potent fused pyrimidine derivatives as anti-HSV-1.', 29219053),
('5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines', 'Anti-human immunodeficiency virus (HIV)', '', 'Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines. OBJECTIVES: To discover new potent and selective anti-human immunodeficiency virus (HIV) acyclic nucleoside phosphonate (ANP) drugs with in vivo antiretroviral activity.', 17124193),
('SJ-3366', 'Inhibited the entry of both HIV-1 and HIV-2', '', 'SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2. We have identified and characterized a potent new nonnucleoside reverse transcriptase (RT) inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1) that also is active against HIV-2 and which interferes with virus replication by two distinct mechanisms. 1-(3-Cyclopenten-1-yl)methyl-6-(3,5-dimethylbenzoyl)-5-ethyl-2,4-pyrimidinedione (SJ-3366) inhibits HIV-1 replication at concentrations of approximately 1 nM, with a therapeutic index of greater than 4 x 10(6).', 11158731),
('Benzamide derivative N-[1-(7-tert-Butyl-1H-indol-3-ylmethyl)-2-(4-cyclopropanecarbonyl-3-methyl-piperazin-1-yl)-2-oxo-ethyl]-4-nitro-benzamide (SP-10)', 'Reduces HIV-1 infectivity (IC50 = 0.036 nM)', '', 'We investigated the in vitro efficacy, safety and mechanism of action of the benzamide derivative N-[1-(7-tert-Butyl-1H-indol-3-ylmethyl)-2-(4-cyclopropanecarbonyl-3-methyl-pipera zin-1-yl)-2-oxo-ethyl]-4-nitro-benzamide (SP-10), a potential new HIV treatment. When HIV-1-responsive engineered HeLa cells were pre-incubated for 48 h with either SP-10 or zidovudine (AZT), SP-10 was able to inhibit viral replication at much lower concentrations (IC50 = 0.036 nM) than AZT (IC50 = 27.4 nM).', 17249247),
('1,3-oxazinan-2-one, piperidine-2,4-dione, piperidine-2-one and piperidine', 'Activity against Influenza A virus strains (IC50 = 7.7 microM)', '', 'A series of (R)- and (S)-isomers of new adamantane-substituted heterocycles (1,3-oxazinan-2-one, piperidine-2,4-dione, piperidine-2-one and piperidine) with potent activity against rimantadine-resistant strains of influenza A virus were synthesized through the transformation of adamantyl-substituted N-Boc-homoallylamines 8 into piperidine-2,4-diones 11 through the cyclic bromourethanes 9 and key intermediate enol esters 10.', 28338150),
('Thiophene[3,2-d]pyrimidine Derivatives', 'HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors', '', 'Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants. In the present study, we designed, synthesized, and biologically tested several series of new derivatives in order to investigate previously unexplored chemical space. Some of the synthesized compounds displayed single-digit nanomolar anti-HIV potencies against wild-type (WT) virus and a panel of NNRTI-resistant mutant viruses in MT-4 cells. Compound 25a was exceptionally potent against the whole viral panel, affording 3-4-fold enhancement of in vitro antiviral potency against WT, L100I, K103N, Y181C, Y188L, E138K, and K103N+Y181C and 10-fold enhancement against F227L+V106A relative to the reference drug etravirine (ETV) in the same cellular assay. Overall, the results indicate that 25a is a promising new drug candidate for treatment of HIV-1 infection.', 28481112),
('Triazolo[4,5-g]quinoline derivatives (compounds 1-6). 4,9-Dihydrotriazolo[4,5-g]quinoline-1-oxide (1)', 'Activity against NNRTI-resistant HIV-1 mutants', '', 'Activity and molecular modeling of a new small molecule active against NNRTI-resistant HIV-1 mutants. In this preliminary study we report the antiviral screening of triazolo[4,5-g]quinoline derivatives (compounds 1-6). 4,9-Dihydrotriazolo[4,5-g]quinoline-1-oxide (1) stood out as a new, small molecule endowed with a selective, promising activity in cell-based assays against HIV-1wt and clinically relevant NNRTI resistant mutants.', 19775780),
('PHA767491', 'Activity against human herpes simplex virus(both HSV-1 and HSV-2)', '', 'PHA767491 potently blocked the proliferation of HSV in cells, as well as HSV induced cell death. Further, we found that PHA767491 strongly inhibited HSV infection post viral entry. Moreover, PHA767491 reduced the expression of viral genes required for DNA synthesis including UL30/42 DNA polymerase and UL5/8/52 helicase-primase complex. Thus, PHA767491 could be a promising agent for the development of new anti-HSV therapy.', 28320320),
('Alternariol 5-O-Methyl Ether', 'Inhibits HIV-1 Integration by Blocking Nuclear', '', 'Microbial Natural Product Alternariol 5-O-Methyl Ether Inhibits HIV-1 Integration by Blocking Nuclear Import of the Pre-Integration Complex. While Highly Active Antiretroviral Therapy (HAART) has significantly decreased the mortality of human immunodeficiency virus (HIV)-infected patients, emerging drug resistance to approved HIV-1 integrase inhibitors highlights the need to develop new antivirals with novel mechanisms of action.', 28489061),
('5,6-dimethylxanthenone-4-acetic acid (DMXAA)', 'Activity against H1N1 influenza', '', 'The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-beta-mediated antiviral activity in vitro and in vivo. The 2009 outbreak of pandemic H1N1 influenza, increased drug resistance, and the significant delay in obtaining adequate numbers of vaccine doses have heightened awareness of the need to develop new antiviral drugs that can be used prophylactically or therapeutically.', 21084628),
('2,3-dihydrobenzofuran derivatives', 'Hepatitis C Virus (HCV) NS5A Inhibitors', '', 'Discovery of Chromane Containing Hepatitis C Virus (HCV) NS5A Inhibitors with Improved Potency against Resistance-Associated Variants. This effort, incorporating the C-1 fluoro substitution at the tetracyclic indole core, led to the discovery of a new series of NS5A inhibitors, such as compounds 14 and 25-28, with significantly improved potency against resistance-associated variants, such as GT2b, GT1a Y93H, and GT1a L31V.', 27792320),
('Moronic acid and other triterpene derivatives', 'Moronic acid derivatives 19, 20, and 21 showed significant activity in HIV-1 infected H9 lymphocytes. Compound 20 showed potent anti-HIV activity with EC50 values of 0.0085 microM against NL4-3, 0.021 microM against PI-R (a multiple protease inhibitor resistant strain), and 0.13 microM against FHR-2 (an HIV strain resistant to 8)', '', 'Moronic acid and other triterpene derivatives as novel potent anti-HIV agents.', 16942019),
('n-benzenesulphony 1-2 (2 or 3-pyridylethyl) benzimidazole derivatives', 'Coxsackie B5 virus', 'Cytotoxicity tests show that many of these substances are well tolerated by the VERO cells.', 'The antiviral and antiproliferative activity of new compounds having n-benzenesulphony 1-2 (2 or 3-pyridylethyl) benzimidazole as a base structure were studied in vitro. The antiviral and antiproliferative activity of new compounds having n-benzenesulphony 1-2 (2 or 3-pyridylethyl) benzimidazole as a base structure were studied in vitro. Only compound 7a, with the presence of both the pyridyl moiety bound at the ethylenic bridge in C-2 of benzimidazole and the nitro-group in the benzene ring, displays a selective antiproliferative effect against certain leukaemia cells and a good antiviral activity especially towards the Coxsackie B5 virus.', 11169164),
('TLT35', 'HIV-1 infection prevention', '', 'Here we reported the design of a novel chimera protein-based fusion inhibitor targeting gp41, TLT35, that uses a flexible 35-mer linker to couple T20 and T1144, the first and next generation HIV-1 fusion inhibitors, respectively.', 21690094),
('Benzophenone template compounds 70h (GW678248)', '70h has in vitro antiviral assay IC(50) values of 0.5 nM against wild-type HIV, 1 nM against the K103N mutant associated with clinical resistance to efavirenz, and 0.7 nM against the Y181C mutant associated with clinical resistance to nevirapine', '', 'Structure-activity relationship studies of novel benzophenones leading to the discovery of a potent, next generation HIV nonnucleoside reverse transcriptase inhibitor. These potent inhibitors include 70h (GW678248), which has in vitro antiviral assay IC(50) values of 0.5 nM against wild-type HIV, 1 nM against the K103N mutant associated with clinical resistance to efavirenz, and 0.7 nM against the Y181C mutant associated with clinical resistance to nevirapine. Compound 70h has also demonstrated relatively low clearance in intravenous pharmacokinetic studies in three species, and it is the active component of a drug candidate which has progressed to phase 2 clinical studies..', 16420058),
('Thiazolidenebenzenesulfonamides', 'Activity against nevirapine-resistant virus, HIV-1(IIIB-R)', '', 'Studies of nonnucleoside HIV-1 reverse transcriptase inhibitors.', 15519161),
('SA-2, the ethyl 4-(2-hydroxymethyl-5-oxopyrrolidin-1-yl)-3-[3-(3-methylbenzoyl)-thioureido] benzoate', 'Activity against influenza A virus', '', 'A target-free and cell-based approach was applied to evaluate the anti-influenza properties of six newly synthesized benzoic acid derivatives. SA-2, the ethyl 4-(2-hydroxymethyl-5-oxopyrrolidin-1-yl)-3-[3-(3-methylbenzoyl)-thioureido] benzoate (compound 2) was screened as a potential drug candidate. Based on these favourable findings, SA-2, a novel anti-influenza agent, with its potent anti-influenza activity in vitro and in vivo, could be a promising antiviral for the treatment of infection of influenza A viruses, including oseltamivir-resistant mutants.', 26802558),
('JTK-853', 'Nonnucleoside inhibitor of hepatitis C virus (HCV) RNA-dependent RNA polymerase.', '', 'Collectively, these data demonstrate that JTK-853 is a potent and novel nonnucleoside palm site-binding HCV polymerase inhibitor, suggesting JTK-853 as a potentially useful agent in combination with other DAAs for treatment of HCV infections.', 22615294),
('1R,2R-dicamphanoyl-3,3-dimethydihydropyrano[2,3-c]xanthen-7(1H)-one (DCX)', 'Reverse transcriptase (RT) inhibitor-resistant HIV-1 (RTMDR-1) strains.', '', 'Design, synthesis, and evaluation of 1R,2R-dicamphanoyl-3,3-dimethyldihydropyrano-[2,3-c]xanthen-7(1H)-one (DCX) derivatives as novel anti-HIV agents. In this study, 1R,2R-dicamphanoyl-3,3-dimethydihydropyrano[2,3-c]xanthen-7(1H)-one (DCX) derivatives were designed and synthesized as novel anti-HIV agents against both wild-type and non-nucleoside reverse transcriptase (RT) inhibitor-resistant HIV-1 (RTMDR-1) strains.', 22063755),
('Benzimidazole-related compound', 'To prevent chikungunya virus (CHIKV) infection', '', 'Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus. Screening of chemical compound libraries were performed and one candidate, a benzimidazole-related compound designated Compound-A was found to inhibit infection by several CHIKV strains and a Sindbis virus strain at nanomolar concentrations.', 28236746),
('141W94 (VX-478) in combination with other antiretroviral agents', 'HIV-1 protease inhibitor with an IC50 of 0.08 microM against HIV-1 (strain IIIB) and a mean IC50 of 0.012 microM against six HIV clinical isolates.', '', 'In vitro antiviral activity of 141W94 (VX-478) in combination with other antiretroviral agents. 141W94 (VX-478) is a novel HIV-1 protease inhibitor with an IC50 of 0.08 microM against HIV-1 (strain IIIB) and a mean IC50 of 0.012 microM against six HIV clinical isolates. 141W94 was synergistic on the basis of isobologram analysis with each of the following reverse transcriptase inhibitors: AZT, 935U83, 524W91, 1592U89 and ddl, 141W94 was also synergistic with saquinavir and additive with either indinavir or ritonavir.', 8721545),
('Alkylamidophospholipid analogues', 'Anti-human immunodeficiency virus type 1 agents', '', 'In vitro evaluation and characterization of newly designed alkylamidophospholipid analogues as anti-human immunodeficiency virus type 1 agents. Our laboratories first reported two novel classes of complex synthetic lipids, including alkylamidophosphocholines (PC lipid; CP-51) and alkylamidophosphate ester-linked lipid-AZT conjugates (lipid-AZT conjugates; CP-92), with selective and potent activity against human immunodeficiency virus type 1 (HIV-1).', 9875387),
('6-{4-[(biphenyl-2-ylcarbonyl) amino]benzoyl}-N-cyclopropyl-5,6-dihydro-4H-thieno[3,2-d][1]benzazepine-2-carboxamide (YM-53403).', 'The EC(50) value 0.20 microM, was about 100-fold more potent than ribavirin.', '', 'YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action', 15708639),
('Stavudine-5''-(p-bromophenyl methoxyalaninyl phosphate) (stampidine)', 'Anti-HIV activity', '', 'We have evaluated the clinical potential of stavudine-5''-(p-bromophenyl methoxyalaninyl phosphate(stampidine [STAMP]), a novel aryl phosphate derivative of stavudine, as a new anti-human immunodeficiency virus (anti-HIV) agent, by examining its acute, subacute, and chronic toxicity profile in mice as well as by testing its antiviral activity in a surrogate human peripheral blood lymphocyte (Hu-PBL)-SCID mouse model of human AIDS.', 12384347),
('Alkenyldiarylmethanes( most potent of these proved to be 3'',3"-dibromo-4'',4"-dimethoxy-5''5"-bis(methoxycarbonyl)-1,1-diphenyl-1-+ ++heptene)', 'Anti-HIV-1 activity', '', 'Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors. Several novel alkenyldiarylmethane (ADAM) non-nucleoside HIV-1 reverse transcriptase inhibitors were synthesized.', 8759644),
('17-amino-17-demethoxygeldanamycin derivatives', 'Inhibited duckling hepatitis B virus DNA replication', '', 'The 17-amino-17-demethoxygeldanamycin derivatives could be novel agents with potential antiviral activity.', 20710066),
('6-methyl-7-substituted-7-deaza purine analogues', 'Compounds 5x (IC50 = 5.88 microM and 6.95 microM for H1N1 and H3N2, respectively) and 5z (IC50 = 3.95 microM and 3.61 microM for H1N1 and H3N2, respectively) demonstrated potent anti-influenza A activity.', '', 'Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents.', 26802557),
('1592U89, (-)-(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclo pentene-1-methanol', 'Average 50% inhibitory concentration [IC50], 0.26 microM for 1592U89', '', '1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity.', 9145874),
('Cytidine analogue, FNC (2''-deoxy-2''-?-fluoro-4''-azidocytidine)', 'Strongly inhibit human HBV and duck HBV (DHBV) replication in vitro and in vivo, respectively.', '', 'A novel cytidine analogue, FNC (2''-deoxy-2''-?-fluoro-4''-azidocytidine), was recently shown to strongly inhibit human HBV and duck HBV (DHBV) replication in vitro and in vivo, respectively.', 22910281),
('2''-deoxy-3''-thiacytidine (BCH-189)', 'Activity against five different strains of human immunodeficiency virus type 1 (HIV-1) (mean 50% inhibitory dose, 0.73 microM)', 'less toxic than AZT in cell culture', 'Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2''-deoxy-3''-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog. We describe a novel nucleoside analog, 2''-deoxy-3''-thiacytidine (BCH-189), in which the 3'' carbon of the ribose ring of 2''-deoxycytidine has been replaced by a sulfur atom.', 1929298),
('2'',3''-didehydro-3''-deoxy-4''-ethynylthymidine', 'Activity anti-human immunodeficiency virus type 1 (HIV-1)', 'Weak cytotoxicity in cell cultures', 'Anti-human immunodeficiency virus type 1 activity and resistance profile of 2'',3''-didehydro-3''-deoxy-4''-ethynylthymidine in vitro. 2'',3''-Didehydro-3''-deoxy-4''-ethynylthymidine (4''-Ed4T) has been identified as a novel nucleoside analog with potent and selective anti-human immunodeficiency virus type 1 (HIV-1) activity and weak cytotoxicity in cell cultures. 4''-Ed4T proved to be 5- to 10-fold more active than its structurally related compound, stavudine (d4T).', 16048947),
('GS-9148 [(5-(6-amino-purin-9-yl)-4-fluoro-2,5-dihydro-furan-2-yloxymethyl)phosphonic acid]', 'Activity against nucleoside-resistant variants of human immunodeficiency virus type 1', '', 'Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131. GS-9148 [(5-(6-amino-purin-9-yl)-4-fluoro-2,5-dihydro-furan-2-yloxymethyl)phosphonic acid] is a novel ribose-modified human immunodeficiency virus type 1 (HIV-1) nucleotide reverse transcriptase (RT) inhibitor (NRTI) selected from a series of nucleoside phosphonate analogs for its favorable in vitro biological properties including (i) a low potential for mitochondrial toxicity, (ii) a minimal cytotoxicity in renal proximal tubule cells and other cell types, (iii) synergy in combination with other antiretrovirals, and (iv) a unique resistance profile against multiple NRTI-resistant HIV-1 strains.', 18056282),
('2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine', 'Activity against multidrug-resistant hepatitis B virus mutants', '', 'In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants. The susceptibilities of drug-resistant hepatitis B virus (HBV) mutants to lamivudine, adefovir, tenofovir, entecavir, and 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine (PMEO-DAPym), a novel acyclic pyrimidine analogue, were assessed in vitro.', 17371827),
('Pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring', 'Activity against pleconaril-resistant coxsackievirus B3', '', 'New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3. In the present study, novel analogues with different substitutions in the central phenoxy group were synthesized to study their influence on anti-CVB3 activity with the aim to overcome pleconaril resistance.', 18840470),
('6-(3-trifluoromethylbenzyl) and 6-(fluorobenzyl)', 'Activity against HIV-1 wild type and mutants resistant to non-nucleoside RT inhibitors', '', 'Synthesis and antiviral evaluation of 6-(trifluoromethylbenzyl) and 6-(fluorobenzyl) analogues of HIV drugs emivirine and GCA-186. The present study describes the synthesis and antiviral evaluation of a series of novel 6-(3-trifluoromethylbenzyl) and 6-(fluorobenzyl) analogues of the HIV drugs emivirine and GCA-186.', 18161905),
('2-amino thiazole [T157602 and its analogs]', 'Inhibitor of herpes simplex virus (HSV) DNA replication', '', 'T157602 and its analogs represent a novel class of specific and reversible anti-HSV agents eliciting their inhibitory effects on HSV replication by interacting with the UL5 helicase.', 9696789),
('4-[1-hydroxy-2-(4,5-dimethoxy-2-nitrophenyl)ethyl]benzonitrile (LPCRW_0005)', 'Inhibits rhinovirus replication', '', 'A novel benzonitrile analogue inhibits rhinovirus replication.', 24948704),
('6-PMEO 2,4-diaminopyrimidine and 6-PMPO 2,4-diaminopyrimidine derivatives', 'Potent activity against human immunodeficiency virus (HIV) in the laboratory', '', 'Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates. A novel class of acyclic nucleoside phosphonates has been discovered in which the base consists of a pyrimidine preferably containing an amino group at C-2 and C-4 and a 2-(phosphonomethoxy)ethoxy (PMEO) or a 2-(phosphonomethoxy)propoxy (PMPO) group at C-6.', 12069973),
('3-Biphenylimidazo[1,2-a]pyridines or [1,2-b]pyridazines and analogues', 'Activity against bovine viral diarrhoea virus (BVDV) and hepatitis C virus (HCV)', '', '3-Biphenylimidazo[1,2-a]pyridines or [1,2-b]pyridazines and analogues, novel Flaviviridae inhibitors. Using Ttou 84 as starting point, a novel class of biphenyl derivatives of imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine was designed to optimize the inhibitory properties on the replication of the bovine viral diarrhoea virus (BVDV) and hepatitis C virus (HCV).', 23665801),
('Beta-d-2''-deoxy-2''-?-fluoro-2''-beta-C-methyluridine nucleotide prodrug (PSI-7977)', 'Inhibitors of the HCV NS5B polymerase', '', 'Discovery of a Beta-d-2''-deoxy-2''-?-fluoro-2''-beta-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus. Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease.', 20845908),
('BAY 38-4766', 'Inhibitor of human cytomegalovirus (HCMV)', '', 'Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action. As a representative of a novel inhibitory approach, the non-nucleosidic BAY 38-4766 was identified as a highly selective inhibitor of human cytomegalovirus (HCMV).', 11733458),
('Elaidic acid ganciclovir (E-GCV)', 'Activity against laboratory and clinical strains of herpes simplex type 1 (HSV-1) and type 2 (HSV-2), varicella-zoster virus (VZV) and human cytomegalovirus (HCMV) in human embryonic lung fibroblasts, IC(50) value of E-GCV for HSV-1 strain KOS being 0.07 nM', '', 'Antiviral activity of ganciclovir elaidic acid ester against herpesviruses', 10771080),
('Brecanavir, a novel tyrosyl-based arylsulfonamide', 'Anti-HIV activity', '', 'Brecanavir, a novel tyrosyl-based arylsulfonamide, high-affinity, human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI), has been evaluated for anti-HIV activity in several in vitro assays.', 17620375),
('GW678248', 'Anti-human immunodeficiency virus type 1', '', 'GW678248, a novel nonnucleoside reverse transcriptase inhibitor, has been evaluated for anti-human immunodeficiency virus activity in a variety of in vitro assays against laboratory strains and clinical isolates.', 16251284),
('PD0084430', 'Non-nucleoside inhibitor of human cytomegalovirus replication', '', 'PD0084430: a non-nucleoside inhibitor of human cytomegalovirus replication in vitro. A novel, non-nucleoside inhibitor of HCMV replication, PD0084430, was identified in a screening assay using the HCMV beta-galactosidase recombinant RC256.', 11675146),
('Naphthyridinone GSK364735', 'Potently inhibited recombinant human immunodeficiency virus type 1 (HIV-1) integrase in a strand transfer assay (mean 50% inhibitory concentration +/- standard deviation, 8 +/- 2 nM).', '', 'The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.', 18160521),
('6-(indol-2-yl)pyridine-3-sulfonamides', 'Inhibit HCV RNA replication in the HCV replicon cell culture assay', '', 'Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4B.', 23683597),
('GRL-02031', 'Effective against laboratory HIV-1 strains and primary clinical isolates, including subtypes A, B, C, and E (50% effective concentration [EC(50)] range, 0.015 to 0.038 microM)', 'Minimal cytotoxicity (50% cytotoxic concentration, >100 microM in CD4(+) MT-2 cells)', 'GRL-02031, a novel nonpeptidic protease inhibitor (PI) containing a stereochemically defined fused cyclopentanyltetrahydrofuran potent against multi-PI-resistant human immunodeficiency virus type 1 in vitro.', 18955518),
('Benzo[4,5]furo[3,2,d]pyrimidin-2-one NcRTI chemical series', 'Compound A inhibited HIV-1 RT in a primer extension assay (50% inhibitory concentration, 2.6 nM) but had no measurable activity against human DNA polymerase ? at 10 microM. It potently inhibited HIV-1 replication in vitro (50% effective concentration, 1.5 nM)', '', 'Identification and characterization of a novel HIV-1 nucleotide-competing reverse transcriptase inhibitor series', 23545531),
('Phosphonylmethoxyalkyl derivatives of adenine', 'Equine herpesvirus 1', '', 'Effective chemotherapy of equine herpesvirus 1 by phosphonylmethoxyalkyl derivatives of adenine demonstrated in a novel murine model for the disease.', 2163242),
('Substituted N-phenylbenzenesulphonamides', 'Non-nucleoside hepatitis C virus polymerase inhibitors with IC(50) values up to 40 nM', '', 'Here we describe a novel non-nucleoside inhibitor (NNI) chemotype identified by screening: The substituted N-phenylbenzenesulphonamides (SPBS) which showed reversible inhibition of NS5B from HCV genotype 1b with IC(50) values up to 40 nM.', 22580131),
('Pyridinioalkanoyl thioesters (PATEs)', 'Anti-HIV agents, EC(50) < 10 microM', 'Non toxic', 'Synthesis and biological properties of amino acid amide ligand-based pyridinioalkanoyl thioesters as anti-HIV agents.', 11886789),
('9-Arylpurines', 'These compounds elicit activity against a variety of enteroviruses in the low microM range including Coxsackie virus A16, A21, A24, Coxsackie virus B3, and echovirus 9.', '', '9-Arylpurines as a novel class of enterovirus inhibitors. Here we report on a novel class of enterovirus inhibitors that can be structurally described as 9-arylpurines.', 19924996),
('Tricyclic nucleosides [9-benzylamino-3-(?-D-ribofuranosyl)-3H-imidazo[4'',5'':5,6]pyrido[2,3-b]pyrazine (15d)]', 'Inhibited non-structural protein 5A (NS5A) of hepatitis C virus (HCV)', '', 'Novel nucleoside analogues targeting HCV replication through an NS5A-dependent inhibition mechanism', 28245093),
('4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol (IsoddA)', 'Inhibitor of HIV-1', '', 'Antiviral, metabolic, and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol.', 8540705),
('PNU-183792, a 4-oxo-dihydroquinoline', 'Activity against human and animal herpesviruses, specifically inhibit herpesvirus polymerases', '', 'Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses.', 11888654),
('Cyclohexyl carboxylic acid analogues [VX-787]', 'Strong potency versus multiple influenza A strains, including pandemic 2009 H1N1 and avian H5N1 flu strains', '', 'Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.', 25019388),
('FP-21399 of bis(disulfonaphthalene) dimethoxybenzene class', 'Inhibitor of HIV-1', '', 'FP-21399 is a novel compound of the bis(disulfonaphthalene) dimethoxybenzene class that blocks entry of HIV into CD4+ cells and blocks fusion of infected and noninfected CD4+ cells.', 9094135);
INSERT INTO `parasite_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Pirodavir (R 77975), a phenoxy-pyridazinamine', 'Broad-spectrum antipicornaviral activity', '', 'In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity. Pirodavir (R 77975) is the prototype of a novel class of broad-spectrum antipicornavirus compounds.', 1317142),
('1,5-diphenylpyrazole', 'Nonnucleoside HIV-1 reverse transcriptase inhibitors', '', 'Novel 1,5-diphenylpyrazole nonnucleoside HIV-1 reverse transcriptase inhibitors with enhanced activity versus the delavirdine-resistant P236L mutant: lead identification and SAR of 3- and 4-substituted derivatives. Through computationally directed broad screening, a novel 1, 5-diphenylpyrazole (DPP) class of HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs) has been discovered.', 10715167),
('SB 9200', 'SB 9200 has broad-spectrum antiviral activity against RNA viruses including hepatitis C virus (HCV), norovirus, respiratory syncytial virus, and influenza and has demonstrated activity against hepatitis B virus (HBV) in vitro and in vivo.', '', 'SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants. SB 9200 is a novel, first-in-class oral modulator of innate immunity that is believed to act via the activation of the RIG-I and NOD2 pathways.', 28303593),
('2,4,5-Trisubstituted thiazole derivatives', 'Tested on seven NNRTI-resistant HIV-1 strains, and all exhibited inhibitory effects with fold changes in IC50 ranging from 2.6 to 111', '', '2,4,5-Trisubstituted thiazole derivatives: a novel and potent class of non-nucleoside inhibitors of wild type and mutant HIV-1 reverse transcriptase.', 25072874),
('2,6-Bis(benzimidazol-2-yl)pyridine (BBP/CSFA-0)', 'BBP/CSFA-0 inhibits the in vitro replication of the classical swine fever virus (CSFV) with an EC50 of 0.330 +/-.25microM. BBP/CSFA-0 proved in vitro inactive against the hepatitis C virus, that belongs like BVDV and CSFV to the family of Flaviviridae.', '', 'Substituted 2,6-bis(benzimidazol-2-yl)pyridines: a novel chemical class of pestivirus inhibitors that targets a hot spot for inhibition of pestivirus replication in the RNA-dependent RNA polymerase.', 24680957),
('Bictegravir (GS-9883)', 'Anti-HIV-1, specifically targets IN strand transfer activity (50% inhibitory concentration [IC50] of 7.5 ? 0.3 nM) and HIV-1 integration in cells', 'BIC exhibits potent and selective in vitro antiretroviral activity in both T-cell lines and primary human T lymphocytes, with 50% effective concentrations ranging from 1.5 to 2.4 nM and selectivity indices up to 8,700 relative to cytotoxicity.', 'Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile.', 27645238),
('6-substituted 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives', 'Active in human immunodeficiency virus type 1 (HIV-1) infection', '', 'Anti-human immunodeficiency virus type 1 activity of novel 6-substituted 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives. Nonnucleoside reverse transcriptase (RT) inhibitors (NNRTIs) are important components of current combination therapies for human immunodeficiency virus type 1 (HIV-1) infection.', 22290950),
('ASP2151', 'Activity aginst varicella-zoster virus and herpes simplex virus types 1 and 2', '', 'ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2. OBJECTIVES: To evaluate and describe the anti-herpesvirus effect of ASP2151, amenamevir, a novel non-nucleoside oxadiazolylphenyl-containing herpesvirus helicase-primase complex inhibitor.', 20534624),
('F18', 'F18 displayed distinct profiles against 17 NNRTI-resistant pseudoviruses, with an excellent potency especially against one of the most prevalent strains with the Y181C mutation (50% effective concentration, 1.0 nM)', '', 'F18, a novel small-molecule nonnucleoside reverse transcriptase inhibitor, inhibits HIV-1 replication using distinct binding motifs as demonstrated by resistance selection and docking analysis. Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are one of the key components of antiretroviral therapy drug regimen against human immunodeficiency virus type 1 (HIV-1) replication.', 22037848),
('6-(tert-butyl)-4-phenyl-4-(trifluoromethyl)-1H,3H-1,3,5-triazin-2-one', 'In in vitro assays, HIV-1 reverse transcriptase (RT) activity was inhibited by compound 1 with an EC50 of 4.3 microm', '', 'A Triazinone Derivative Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity. A novel HIV-1 inhibitor, 6-(tert-butyl)-4-phenyl-4-(trifluoromethyl)-1H,3H-1,3,5-triazin-2-one (compound 1), was identified from a compound library screened for the ability to inhibit HIV-1 replication.', 27634404),
('GW678248 is a novel benzophenone', 'Preclinical assessment of GW678248 indicates that this compound potently inhibits wild-type (WT) and mutant human immunodeficiency virus type 1 (HIV-1) reverse transcriptase in biochemical assays, with 50% inhibitory concentrations (IC(50)s) between 0.8 and 6.8 nM.', 'Cytotoxicity studies with GW678248 indicate that the 50% cytotoxicity concentration is greater than the level of compound solubility and provides a selectivity index of >2,500-fold for WT, Y181C, or K103N HIV-1.', 'Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitor. The compound GW678248 is a novel benzophenone nonnucleoside reverse transcriptase inhibitor (NNRTI).', 16189079),
('UK-201844', 'UK-201844 exhibited antiviral activity against HIV-1 NL4-3 in MT-2 and PM1 cells, with 50% effective concentrations of 1.3 and 2.7 microM, respectively, but did not exhibit measurable antiviral activity against the closely related HIV-1 IIIB laboratory strain.', '', 'Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processing.', 17646410),
('3-fluoro-2-(phosphonomethoxy)propyl (FPMP) {(S)-FPMPA amidate}', 'Activity against hepatitis B virus (HBV) and varicella-zoster virus (VZV)', '', 'The derivatization of the phosphonic acid functionality of FPMPs with a diamyl aspartate phenoxyamidate group led to a novel generation of compounds that not only demonstrate drastically improved antiretroviral potency but also are characterized by an expanded spectrum of activity that also covers hepatitis B and herpes viruses.', 28682067),
('Enviroxime-like compound, AN-12-H5', 'Anti-enterovirus', '', 'These results suggest that AN-12-H5 is a bifunctional anti-enterovirus compound that belongs to a novel class of enviroxime-like compounds and targets both a replication step and an early stage of EV71 infection.', 20660150),
('RO-7', 'Inhibited influenza A viruses (seasonal and 2009 pandemic H1N1 and seasonal H3N2) and B viruses (Yamagata and Victoria lineages), zoonotic viruses (H5N1, H7N9, and H9N2), and NAI-resistant variants', '', 'A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In Vitro. Here, we characterized a novel compound, RO-7, identified as a putative PA endonuclease inhibitor.', 27381402),
('BIT225', 'BIT225, blocks Vpu ion channel activity and also shows anti-HIV-1 activity, with a 50% effective concentration of 2.25+/-0.23 microM (mean+/-the standard error)', 'minimal in vitro toxicity (50% toxic concentration, 284 microM) in infected MDM, resulting in a selectivity index of 126', 'Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages.', 19995924),
('4-Oxo-4,7-dihydrothieno[2,3-b]pyridines', 'Inhibitors of human cytomegalovirus and related herpesvirus polymerases', '', '4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases. A novel series of 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides have been identified as potential antivirals against human herpesvirus infections resulting from human cytomegalovirus (HCMV), herpes simplex virus type 1 (HSV-1), and varicella-zoster virus (VZV).', 16134946),
('4-(5-(2,6-difluorobenzyl)-1-(2-fluorobenzyl)-2-oxo-1,2-dihydropyridin-3-yl)-4-hydroxy-2-oxo-N-(2-oxopyrrolidin-1-yl)but-3-enamide', 'Exhibits low nM antiviral activity against a diverse set of HIV-1 isolates, and against HIV-2 and the simian immunodeficiency virus (SIV).', '', 'A novel anti-HIV active integrase inhibitor with a favorable in vitro cytochrome P450 and uridine 5''-diphospho-glucuronosyltransferase metabolism profile.', 23602851),
('Bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065', 'Active against wide spectrum of HIV isolates', '', 'A novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065, is potent against multiple-PI-resistant human immunodeficiency virus in vitro. We designed, synthesized, and identified GRL-98065, a novel nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) containing the structure-based designed privileged cyclic ether-derived nonpeptide P2 ligand, 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane (bis-THF), and a sulfonamide isostere, which is highly potent against laboratory HIV-1 strains and primary clinical isolates (50% effective concentration [EC(50)], 0.0002 to 0.0005 microM) with minimal cytotoxicity (50% cytotoxicity, 35.7 microM in CD4(+) MT-2 cells).', 17371811),
('compound 7f (A-98881)', 'HIV-1 protease inhibition assay and the in vitro MT-4 cell culture assay (Ki = approximately 5 pM and EC50 = 0.002 microM).', '', 'A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease. The design, synthesis, and molecular modeling studies of a novel series of azacyclic ureas, which are inhibitors of human immunodeficiency virus type 1 (HIV-1) protease that incorporate different ligands for the S1'', S2, and S2'' substrate-binding sites of HIV-1 protease are described.', 8558507),
('Benzophenone derivatives', 'inhibitors of HIV-1 reverse transcriptase (RT) and the growth of HIV-1 in MT-4 cells.', '', 'Benzophenone derivatives: a novel series of potent and selective inhibitors of human immunodeficiency virus type 1 reverse transcriptase. A series of benzophenone derivatives has been synthesized and evaluated as inhibitors of HIV-1 reverse transcriptase (RT) and the growth of HIV-1 in MT-4 cells.', 7538590),
('Nonpeptidic macrocyclic HIV protease inhibitors', 'Exerted potent activity against multidrug-resistant HIV-1 variants', '', 'Design, synthesis, protein-ligand X-ray structure, and biological evaluation of a series of novel macrocyclic human immunodeficiency virus-1 protease inhibitors to combat drug resistance. The structure-based design, synthesis, and biological evaluation of a series of nonpeptidic macrocyclic HIV protease inhibitors are described. The inhibitors are designed to effectively fill in the hydrophobic pocket in the S1''-S2'' subsites and retain all major hydrogen bonding interactions with the protein backbone similar to darunavir (1) or inhibitor 2. The ring size, the effect of methyl substitution, and unsaturation within the macrocyclic ring structure were assessed. In general, cyclic inhibitors were significantly more potent than their acyclic homologues, saturated rings were less active than their unsaturated analogues and a preference for 10- and 13-membered macrocylic rings was revealed. The addition of methyl substituents resulted in a reduction of potency. Both inhibitors 14b and 14c exhibited marked enzyme inhibitory and antiviral activity, and they exerted potent activity against multidrug-resistant HIV-1 variants.', 19746963),
('Dihydroxythiophenes', 'HIV-1', '', 'Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore. We have identified dihydroxythiophenes (DHT) as a novel series of human immunodeficiency virus type 1 (HIV-1) integrase inhibitors with broad antiviral activities against different HIV isolates in vitro.', 16809294),
('ABT-378', 'Human immunodeficiency virus type 1 (HIV-1) protease inhibitor', '', 'In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor. ABT-378, a new human immunodeficiency virus type 1 (HIV-1) protease inhibitor which is significantly more active than ritonavir in cell culture, is currently under investigation for the treatment of AIDS.', 9696850),
('2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs)', 'Anti-HIV-1', '', 'Investigation of a novel series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as human immunodeficiency virus type 1 integrase inhibitors. We report herein further insight into the biological activities displayed by a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs).', 24793360),
('8-substituted dipyridodiazepinone', 'Activity against wild type human immunodeficiency virus (HIV-1) and the clinically prevalent K103N/Y181C mutant virus', '', 'Novel 8-substituted dipyridodiazepinone inhibitors with a broad-spectrum of activity against HIV-1 strains resistant to non-nucleoside reverse transcriptase inhibitors. A series of novel 8-substituted dipyridodiazepinone-based inhibitors were investigated for their antiviral activity against wild type human immunodeficiency virus (HIV-1) and the clinically prevalent K103N/Y181C mutant virus.', 16107158),
('UIC-94017 (containing a 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane (bis-THF) and a sulfonamide isostere)', 'Activity against laboratory HIV-1 strains and primary clinical isolates (50% inhibitory concentration [IC(50)], approximately 0.003 micro M; IC(90), approximately 0.009 micro M)', 'minimal cytotoxicity (50% cytotoxic concentration for CD4(+) MT-2 cells, 74 micro M)', 'Novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitro. We designed, synthesized, and identified UIC-94017 (TMC114), a novel nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) containing a 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane (bis-THF) and a sulfonamide isostere which is extremely potent against laboratory HIV-1 strains and primary clinical isolates (50% inhibitory concentration [IC(50)], approximately 0.003 micro M; IC(90), approximately 0.009 micro M) with minimal cytotoxicity (50% cytotoxic concentration for CD4(+) MT-2 cells, 74 micro M).', 14506019),
('Novel pyridine oxide derivatives', '(HIV-1) and HIV-2 strains', '', 'Novel human immunodeficiency virus (HIV) inhibitors that have a dual mode of anti-HIV action. We have found that novel pyridine oxide derivatives are inhibitors of a wide range of human immunodeficiency virus (HIV) type 1 (HIV-1) and HIV-2 strains in CEM cell cultures.', 14506017),
('Stavudine-5''-(p-bromophenyl methoxyalaninyl phosphate) (stampidine [STAMP]), a novel aryl phosphate derivative of stavudine', 'HIV-1', '', 'We report the antiretroviral activity of stavudine-5''-(p-bromophenyl methoxyalaninyl phosphate) (stampidine [STAMP]), a novel aryl phosphate derivative of stavudine, against primary clinical human immunodeficiency virus type 1 (HIV-1) isolates.', 12384373),
('Pyrido [1,2a] indole derivatives', 'Inhibitory effect against purified HIV-1 reverse transcriptase (RT) in an in vitro assay', '', 'Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1. Pyrido [1,2a] indole derivatives were identified as potent inhibitors of human immunodeficiency virus type 1 (HIV-1) replication during a random screening programme.', 10335402),
('1-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-4-methylbenzimida zole (35)', 'an IC50 = 200 nM against HIV-1 WT RT in an in vitro enzyme assay', '', 'Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles. The development of new nonnucleoside inhibitors of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) active against the drug-induced mutations in RT continues to be a very important goal of AIDS research.', 9435891),
('MK-4965', 'MK-4965 is also highly potent against the WT virus and two most prevalent NNRTI-resistant viruses (viruses that harbor the K103N or the Y181C mutation), against which it had 95% effective concentrations (EC(95)s) of <30 nM in the presence of 10% fetal bovine serum. The antiviral EC(95) of MK-4965 was reduced approximately four- to sixfold when it was tested in 50% human serum.', '', 'Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor. Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are the mainstays of therapy for the treatment of human immunodeficiency virus type 1 (HIV-1) infections.', 19289522),
('TMC310911', 'TMC310911 has potent activity against wild-type (WT) HIV-1 (median 50% effective concentration [EC(50)], 14 nM) and a wide spectrum of recombinant HIV-1 clinical isolates, including multiple-PI-resistant strains with decreased susceptibility to currently approved PIs (fold change [FC] in EC(50), >10).', '', 'TMC310911, a novel human immunodeficiency virus type 1 protease inhibitor, shows in vitro an improved resistance profile and higher genetic barrier to resistance compared with current protease inhibitors. TMC310911 is a novel human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) structurally closely related to darunavir (DRV) but with improved virological characteristics.', 21896904),
('GRL-04810 and GRL-05010, containing the structure-based designed privileged cyclic ether-derived nonpeptide P2 ligand, bis-tetrahydrofuranylurethane (bis-THF), and a difluoride moiety', 'Active against the laboratory strain HIV-1LAI (50% effective concentrations [EC50s], 0.0008 and 0.003 microM, respectively)', 'GRL-04810 and GRL-05010 have minimal cytotoxicity (50% cytotoxic concentrations [CC50s], 17.5 and 37.0 microM, respectively', 'GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration.', 24080647),
('GRL008 and DRV', '[EC50s], 0.029 and 0.002 microM, respectively) against a multidrug-resistant clinical isolate of HIV-1 (HIVA02)', '', 'A conserved hydrogen-bonding network of P2 bis-tetrahydrofuran-containing HIV-1 protease inhibitors (PIs) with a protease active-site amino acid backbone aids in their activity against PI-resistant HIV.', 24752271),
('Thiothymidine derivatives, KAY-2-41 and KAH-39-149', 'Active against herpes simplex virus, varicella-zoster virus (VZV), and particularly against Epstein-Barr virus', '', 'Antiherpesvirus activities of two novel 4''-thiothymidine derivatives, KAY-2-41 and KAH-39-149, are dependent on viral and cellular thymidine kinases. The emergence of drug-resistant herpesviruses represents a significant problem in clinical practice, primarily in immunocompromised patients.', 24820089),
('A-790742', '(HIV-1) protease inhibitor, with 50% effective concentrations ranging from 2 to 7 nM against wild-type HIV-1', '', 'Characterization of a novel human immunodeficiency virus type 1 protease inhibitor, A-790742 is a potent human immunodeficiency virus type 1 (HIV-1) protease inhibitor, with 50% effective concentrations ranging from 2 to 7 nM against wild-type HIV-1.', 18212102),
('Compounds derived from scaffolds containing a thiazole replacement of the exocyclic amide with modification at position 7 and/or 9 of the bicyclic pyrimidinone core', 'HIV integrase inhibitors', '', 'Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses. A series of novel HIV integrase inhibitors active against rategravir resistant strains are reported.', 20685117),
('AIC292, diarylpyrazole-[imidazolidinone]-carboxamides', 'HIV-1', '', 'In vitro and in vivo activities of AIC292, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.', 23959304),
('ACH-806 (GS-9132)', 'Inhibits hepatitis C virus (HCV) replication', '', 'Selection of replicon variants resistant to ACH-806, a novel hepatitis C virus inhibitor with no cross-resistance to NS3 protease and NS5B polymerase inhibitors. We have discovered a novel class of compounds active against hepatitis C virus (HCV), using a surrogate cellular system, HCV replicon cells.', 18411324),
('C3-substituted cyclopentyltetrahydrofuranyl (Cp-THF)', 'HIV-1 protease inhibitors', '', 'Substituent effects on P2-cyclopentyltetrahydrofuranyl urethanes: design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors. The design, synthesis, and biological evaluation of novel C3-substituted cyclopentyltetrahydrofuranyl (Cp-THF)-derived HIV-1 protease inhibitors are described.', 22364812),
('Dexlansoprazole', 'Human immunodeficiency virus (HIV)-1 integrase (IN) inhibitor', '', 'A novel assay for screening inhibitors targeting HIV-1 integrase dimerization based on Ni-NTA magnetic agarose beads. Human immunodeficiency virus (HIV)-1 integrase (IN), which mediates integration of viral cDNA into the cellular chromosome, is a validated antiviral drug target.', 27137477),
('Combination of boceprevir with a nucleoside analog or a non-nucleoside HCV NS5B polymerase inhibitor', 'Effective against hepatitis C virus (HCV)', '', 'A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors. Boceprevir (SCH 503034) is an orally active novel inhibitor of the hepatitis C virus (HCV) NS3 protease currently in clinical development for the treatment of hepatitis C.', 19747948),
('EI-1, HCV pseudoparticles (HCVpp)', 'Agianst hepatitis C virus (HCV)', '', 'A novel small molecule inhibitor of hepatitis C virus entry. Small molecule inhibitors of hepatitis C virus (HCV) are being developed to complement or replace treatments with pegylated interferons and ribavirin, which have poor response rates and significant side effects.', 20838466),
('5-[(4-bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine (BPIP)', 'The 50% effective concentration (EC50) for inhibition of bovine viral diarrhea virus (BVDV)-induced cytopathic effect formation was 0.04 +/- 0.01 microM', '', 'A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase. We report on the highly potent and selective antipestivirus activity of 5-[(4-bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine (BPIP).', 16352539),
('R165481 and R221239', 'Inhibit wild-type HIV-1 RT and drug-resistant variants, including Tyr181Cys and Lys103Asn RT', '', 'An acrylonitrile substituent on R165481 substantially improves the activity of the compound against wild-type RT (and several mutants) and provides a way to generate novel inhibitors that could interact with conserved elements of HIV-1 RT at the polymerase catalytic site.', 16302798),
('NS3/4A proteinase inhibitors screened from Developmental Therapeutics Program (NCI/NIH)', 'Hepatitis C virus (HCV)', '', 'As a result, we identified several novel, previously uncharacterized, nanomolar range inhibitory scaffolds, which suppressed of the NS3/4A activity in vitro and replication of a sub-genomic HCV RNA replicon with a luciferase reporter in human hepatocarcinoma cells.', 22768327),
('Sodium (+)-isolaricireinol-2 alpha-sulfate, sodium 3,4-dihydroxy-5-methoxybenzoic acid methyl ester-4-sulfate, sodium (E)-7-hydroxy-1,7-bis(4-hydroxyphenyl)hept-5-ene-3S-sulfonate, and 3-methoxytyramine-betaxanthin', 'Activity against H1N1 influenza viruses', '', 'Based on virtual screening, MD simulation, and interaction energy evaluation, TCM candidates demonstrate good potential as novel H1 inhibitors.', 22012120),
('methyl ((S)-1-((S)-2-(4-(4-(6-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)quinoxalin-2-yl)phenyl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate', 'Activity against hepatitis C virus (HCV)', '', 'By varying the biphenyl-imidazole unit of daclatasvir, novel inhibitors of HCV NS5A were identified with an improved resistance profile against mutant strains of the virus while retaining the picomolar potency of daclatasvir.', 24729513),
('GS-5885', 'Hepatitis C virus (HCV) NS5A inhibitor', '', 'Characterization of Hepatitis C virus resistance from a multiple-dose clinical trial of the novel NS5A inhibitor GS-5885. GS-5885 is a novel hepatitis C virus (HCV) NS5A inhibitor.', 23877691),
('3''-Azidothymidine (AZT)', 'HIV', '', 'Clicking 3''-azidothymidine into novel potent inhibitors of human immunodeficiency virus. 3''-Azidothymidine (AZT) was the first approved antiviral for the treatment of human immunodeficiency virus (HIV).', 24102161),
('Cationic N,N-Dimethyl[70]fulleropyrrolidinium Iodide Derivatives', 'Anti-HIV-1', '', 'Collectively, our studies indicate fullerene derivatives 2a-c as potent and novel HIV-1 maturation inhibitors.', 28002960),
('EMT-305 and EMT-104', 'Activity against Influenza A virus', '', 'Computational and experimental screening of extensive and water soluble compounds identified novel influenza virus inhibitors that can reduce influenza virus infection without detectable toxic effects on host cells.', 28713784),
('Inhibitors designed by incorporating N-phenyloxazolidinone-5-carboxamides into the hydroxyethylene and (hydroxyethyl)hydrazine dipeptide isosteres as P2 and P2'' ligands.', 'HIV-1 protease inhibitor', '', 'Design and synthesis of HIV-1 protease inhibitors incorporating oxazolidinones as P2/P2'' ligands in pseudosymmetric dipeptide isosteres. A series of novel HIV-1 protease inhibitors based on two pseudosymmetric dipeptide isosteres have been synthesized and evaluated.', 17696512),
('3,5-diamino-N-aryl-1H-pyrazole-4-carbothioamide and 4-amino-5-benzoyl-N-phenyl-2-(substituted-amino)-1H-pyrrole-3-carbothioamide derivatives', 'Anti-HIV-1', '', 'Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.', 28859311),
('Triazolo-pyrimidine derivatives', 'Inhibitors of hepatitis B virus surface antigen (HBsAg) secretion', '', 'Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion. The high levels of hepatitis B virus (HBV) surface antigen (HBsAg)-bearing subviral particles in the serum of chronically infected individuals play an important role in suppressing HBV-specific immune response and are only mildly affected by the current small molecule therapies.', 21786803),
('Osalmid and its derivative 4-cyclopropyl-2-fluoro-N-(4-hydroxyphenyl) benzamide (YZ51)', 'HBV', '', 'Furthermore, 4-cyclopropyl-2-fluoro-N-(4-hydroxyphenyl) benzamide (YZ51), a novel derivative of osalmid, showed higher efficacy than osalmid with more potent RR inhibitory activity.', 26774458),
('GRL-0519, a novel nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) containing tris-tetrahydrofuranylurethane (tris-THF) and a sulfonamide isostere', 'Activity against laboratory HIV-1 strains and primary clinical isolates (50% effective concentration [EC50], 0.0005 to 0.0007 microM)', 'minimal cytotoxicity (50% cytotoxic concentration [CC50], 44.6 microM)', 'GRL-0519, a novel oxatricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor (PI), potently suppresses replication of a wide spectrum of multi-PI-resistant HIV-1 variants in vitroWe report that GRL-0519, a novel nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) containing tris-tetrahydrofuranylurethane (tris-THF) and a sulfonamide isostere, is highly potent against laboratory HIV-1 strains and primary clinical isolates (50% effective concentration [EC50], 0.0005 to 0.0007 microM) with minimal cytotoxicity (50% cytotoxic concentration [CC50], 44.6 microM).', 23403426),
('Novel inhibitors of RSV including the P13 fusion inhibitor, and the PG545 virucide', 'Respiratory syncytial virus (RSV)', '', 'Here we describe the cell culture-based methods used in our laboratory in identification of novel inhibitors of RSV including the P13 fusion inhibitor, and the PG545 virucide.', 23821281),
('FA-583 and FA-617', 'Influenza A Virus', '', 'Here we identify and characterize two structurally different novel fusion inhibitors of the influenza A virus group 1 hemagglutinin (HA), FA-583 and FA-617, with low nanomolar activities.', 26676787),
('cpd 1, 2, and 3', 'Respiratory Syncytial Virus (RSV)', '', 'Here we report the characterization of three novel classes of RSV replication inhibitors identified through a high throughput RSV replicon screen of ?1million compounds in the AstraZeneca compound collection.', 25542974),
('GRL-142, containing an unprecedented 6-5-5-ring-fused crown-like tetrahydropyranofuran', 'Potent activity against all HIV-1 strains examined with IC50 values of attomolar-to-picomolar concentrations', '', 'Here, we report GRL-142, a novel HIV-1 protease inhibitor containing an unprecedented 6-5-5-ring-fused crown-like tetrahydropyranofuran, which has extremely potent activity against all HIV-1 strains examined with IC50 values of attomolar-to-picomolar concentrations, virtually no effects on cellular growth, extremely high genetic barrier against the emergence of drug-resistant variants, and favorable intracellular and central nervous system penetration.', 29039736),
('4''-C-cyano-2-amino-2''-deoxyadenosine (CAdA)', 'Activity against hepatitis B virus (HBV), half maximal inhibitory concentration [IC50 ] = 0.4 nM) and HIV-1 (IC50 = 0.4 nM', '', '4''-modified nucleoside analogs: potent inhibitors active against entecavir-resistant hepatitis B virus', 26122273),
('GLS4 (ethyl 4-[2-bromo-4-fluorophenyl]-6-[morpholino-methyl]-2-[2-thiazolyl]-1,4-dihydro-pyrimidine-5-carboxylate)', 'GLS4 demonstrated potent inhibitory activities in HBV HepG2.2.15 cell assay with an EC50 value of 1nM, and it also exhibited high potency against various drug-resistant HBV viral strains with EC50 values in the range of 10-20nM', '', 'Herein we described our lead optimization studies including the synthesis, molecular docking studies and structure-activity relationship (SAR) studies of a series of novel heteroaryldihydropyrimidine (HAP) inhibitors of HBV capsid assembly inhibitors, and the discovery of a potent inhibitor of HBV capsid assembly of GLS4 (ethyl 4-[2-bromo-4-fluorophenyl]-6-[morpholino-methyl]-2-[2-thiazolyl]-1,4-dihydro-pyri midine-5-carboxylate) which is now in clinical phase 2.', 28082068),
('Pyridone-based compound PF-46396', 'Anti-HIV-1', '', 'HIV-1 maturation inhibitors are novel as they target the Gag protein, specifically by inhibiting CA-SP1 proteolytic cleavage.', 27384665),
('Cytidine analogue D-d4FC (DPC817, Reverset)', 'Anti-HIV-1', '', 'HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2'',3''-dideoxy-2'',3''-didehydro-5-fluorocytidine (Reverset). Nucleoside reverse transcriptase inhibitors (NRTIs) represent the cornerstone of highly active antiretroviral therapy when combined with non-nucleoside reverse transcriptase inhibitors (NNRTIs) or HIV-1 protease inhibitors (PIs).', 12790516),
('Three-ring oxadiazole compounds', 'Anti-HIV-1', '', 'Identification of novel bifunctional HIV-1 reverse transcriptase inhibitors. The increasing prevalence of mutations in HIV-1 reverse transcriptase (RT) that confer resistance to existing NRTIs and NNRTIs underscores the need to develop RT inhibitors with novel mode-of-inhibition and distinct resistance profiles.', 29029095),
('A series of 1,3,5-triazine compounds', 'Anti-HCV', '', 'Importantly, I719, the most relevant natural polymorphism, did not significantly alter the susceptibility of HCV to the triazine compounds. The preclinical properties of these triazine compounds support further investigation of entry inhibitors as a potential novel therapy for HCV infection.', 22545104),
('D4GTP (the planar 2'',3''-unsaturated deoxyribose guanosine analogue that is complementary to D4TTP)', 'Anti-HIV-1', '', 'In contrast to CBVTP, D4GTP was found to be an excellent substrate for RT(WT) and no resistance was conferred by the M184V mutation, thus providing novel insight into structure-activity relationships for nucleoside-based inhibitors.', 11955063),
('Bromocriptine (BRC)', 'Dengue virus (DENV) half maximal effective concentration [EC50], 0.8-1.6 microM', 'Half maximal cytotoxicity concentration [CC50], 53.6 microM)', 'In summary, BRC was found to be a novel DENV inhibitor and a potential candidate for the treatment of DENV infectious disease.', 27181378),
('2,2''-diselenobisbenzamides (DISeBAs)', 'Anti-HIV', '', 'In this manuscript, we have identified a series of 2,2''-diselenobisbenzamides (DISeBAs) as novel HIV retroviral nucleocapsid protein 7 (NCp7) inhibitors.', 26613134),
('VRX-329747 and VRX-413638', 'Anti-HIV-1', '', 'In this study, we report a novel series of nonnucleoside inhibitors of HIV-1, exemplified by VRX-329747 and VRX-413638, which inhibit both NNRTI- and NRTI-resistant HIV-1 isolates.', 16870771),
('GSK2485852 (referred to here as GSK5852)', 'Hepatitis C virus (HCV) NS5B polymerase inhibitor with 50% effective concentrations (EC50s)', '', 'In vitro characterization of GSK2485852, a novel hepatitis C virus polymerase inhibitor. GSK2485852 (referred to here as GSK5852) is a hepatitis C virus (HCV) NS5B polymerase inhibitor with 50% effective concentrations (EC50s) in the low nanomolar range in the genotype 1 and 2 subgenomic replicon system as well as the infectious HCV cell culture system.', 23939896),
('3-hydroxypyrimidine-2,4-diones', 'Activity against human immunodeficiency virus (HIV)', '', 'Inhibitors with a novel structure core are essential for combating resistance associated with known IN inhibitors (INIs).', 21381765),
('JTK-853', 'hepatitis C virus (HCV)', '', 'JTK-853, a novel non-nucleoside hepatitis C virus polymerase inhibitor, demonstrates a high genetic barrier to resistance in vitro. JTK-853 is a novel, non-nucleoside, palm site-binding hepatitis C virus (HCV) polymerase inhibitor that has demonstrated antiviral activity in HCV-infected patients during 3 days of treatment.', 24008863),
('1, 4-dihydro-2H-3, 1-benzoxazin-2-ones', 'The compound was a potent inhibitor of the wild-type HIV-1 RT (Ki = 2.93 nM) and exhibited a 95% inhibitory concentration of 1.5 nM for the inhibition of HIV-1 replicative spread in cell culture.', '', 'L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase. The clinical benefit of the human immunodeficiency virus type 1 (HIV-1) nonnucleoside reverse transcriptase (RT) inhibitors (NNRTIs) is limited by the rapid selection of inhibitor-resistant viral variants.', 8592986),
('2-Hydroxyisoquinoline-1,3(2H,4H)-dione', 'Anti-HIV-1', '', 'Magnesium chelating 2-hydroxyisoquinoline-1,3(2H,4H)-diones, as inhibitors of HIV-1 integrase and/or the HIV-1 reverse transcriptase ribonuclease H domain: discovery of a novel selective inhibitor of the ribonuclease H function. 2-Hydroxyisoquinoline-1,3(2H,4H)-dione was recently discovered as a scaffold for the inhibition of HIV-1 integrase and the ribonuclease H function of HIV-1 reverse transcriptase.', 21366258),
('Artocarpin', 'H1N1 IC(50) values, determined in chemiluminescence-based NA inhibition assays, are in the range of 0.18-17 microM', '', 'In particular, artocarpin exhibits high affinity toward three H1N1 oseltamivir-sensitive influenza A viruses. It also inhibits the NA of an oseltamivir-resistant H1N1 isolate.', 21452980),
('Sifuvirtide (SFT)', 'Anti-HIV', '', 'Our data present important information for developing SFT for clinical use and for designing novel HIV fusion inhibitors.', 22228771),
('Protease inhibitors (PI''s) bearing 1,3,4-oxadiazoles at the P1'' position', 'Anti-HIV-1', '', 'P1'' oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1. HIV-1 protease inhibitors (PI''s) bearing 1,3,4-oxadiazoles at the P1'' position were prepared by a novel method involving the diastereoselective installation of a carboxylic acid and conversion to the P1'' heterocycle.', 15324882),
('BPR0Z-194, one of the pyridyl imidazolidinones', 'Enterovirus 71', '', 'Pyridyl imidazolidinone is a novel class of potent and selective human enterovirus 71 inhibitor.', 15328120),
('RSV604, a novel benzodiazepine', 'Respiratory syncytial virus (RSV)', '', 'RSV604, a novel inhibitor of respiratory syncytial virus replication. Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infections worldwide, ye+B11t no effective vaccine or antiviral treatment is available.', 17576833),
('GSK2248761', '[EC(50)] = 36.9 ng/ml) against HIV-1', '', 'Safety and efficacy of GSK2248761, a next-generation nonnucleoside reverse transcriptase inhibitor, in treatment-naive HIV-1-infected subjects. GSK2248761 is a novel, once-daily (QD), next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) with activity against efavirenz-resistant strains.', 22314532),
('A series of novel N-alkoxy-arylsulfonamide', 'HIV protease inhibitors', '', 'Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors. A series of novel N-alkoxy-arylsulfonamide HIV protease inhibitors with low picomolar enzyme activity and single digit nanomolar antiviral activity is disclosed. DOI: 10.1016/j.bmcl.2005.05.101', 15975788),
('3-aryl-phospho-indole (API)', 'Anti-HIV-1', '', 'Synthesis and biological evaluation of aryl-phospho-indole as novel HIV-1 non-nucleoside reverse transcriptase inhibitors. A novel series of 3-aryl-phospho-indole (API) non-nucleoside reverse transcriptase inhibitors of HIV-1 was developed.', 21142105),
('Replacement of the pyridylmethyl moiety in indinavir with a pyridyl oxazole yielded HIV-1 protease inhibitors (PI)', 'Anti-HIV-1', '', 'The design, synthesis and evaluation of novel HIV-1 protease inhibitors with high potency against PI-resistant viral strains. Replacement of the pyridylmethyl moiety in indinavir with a pyridyl oxazole yielded HIV-1 protease inhibitors (PI) with greatly improved potency against PI-resistant HIV-1 strains.', 12852969),
('Bicyclams', 'Human immunodeficiency virus type 1 (HIV-1) and HIV-2 inhibitor', '', 'The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication. Bicyclams are a novel class of antiviral compounds which act as potent and selective inhibitors of the replication of human immunodeficiency virus type 1 (HIV-1) and HIV-2.', 8551604),
('CP32M', 'Inhibit a large panel of diverse HIV-1 variants, including subtype B'', CRF07_BC, and CRF01_AE recombinants and naturally occurring or induced T20-resistant viruses.', '', 'Therefore, our data present important information for developing novel HIV-1 fusion inhibitors for clinical use.', 22679024),
('AZ-27', 'Respiratory syncytial virus (RSV) inhibitors', '', 'This novel and broad-spectrum RSV L polymerase inhibitor may pave the way toward an efficacious RSV therapeutic and provide a new tool for interrogation of the L protein function.', 24777090),
('Alkyl Amine Bevirimat Derivatives', 'Anti-HIV-1', '', 'To overcome the loss of BVM activity induced by polymorphisms in SP1, we carried out an extensive medicinal chemistry campaign to develop novel maturation inhibitors.', 26482309),
('Protease inhibitor SG85', 'enterovirus 71 (EV71)', '', 'We demonstrate that the novel enteroviral protease inhibitor (PI) SG85 and capsid binder (CB) vapendavir efficiently inhibit the in vitro replication of 21 EV71 strains/isolates that are representative of the different genogroups A, B, and C.', 25199773),
('Bisheteroarylpiperazine, U-90152 [1-(5-methanesulfonamido-1H-indol-2-yl-carbonyl)-4-[3-(1-methyl eth yl-amino)pyridinyl]piperazine]', 'Inhibited recombinant HIV-1 RT at a 50% inhibitory concentration (IC50) of 0.26 microM (compared with IC50s of > 440 microM for DNA polymerases alpha and delta)', '', 'We describe a novel bisheteroarylpiperazine, U-90152 [1-(5-methanesulfonamido-1H-indol-2-yl-carbonyl)-4-[3-(1-methyl eth yl-amino)pyridinyl]piperazine], which inhibited recombinant HIV-1 RT at a 50% inhibitory concentration (IC50) of 0.26 microM (compared with IC50s of > 440 microM for DNA polymerases alpha and delta).', 7685995),
('ABT-450', 'Inhibitor of HCV NS3/4A protease, with 50% effective concentration values of 1.0, 0.21, 5.3, 19, 0.09, and 0.69 nM against stable HCV replicons with NS3 protease from genotypes 1a, 1b, 2a, 3a, 4a, and 6a, respectively.', '', 'In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450. The development of direct-acting antiviral agents is a promising therapeutic advance in the treatment of hepatitis C virus (HCV) infection. ABT-450 is an efficacious inhibitor of HCV NS3/4A protease, with 50% effective concentration values of 1.0, 0.21, 5.3, 19, 0.09, and 0.69 nM against stable HCV replicons with NS3 protease from genotypes 1a, 1b, 2a, 3a, 4a, and 6a, respectively.', 25451053),
('GLS4', 'The IC(50) of GLS4 was 0.012 microM, which is significantly lower than that of lamivudine (0.325 microM).', '', 'CONCLUSIONS: GLS4 is a new and unique potential anti-HBV agent that possesses a different mechanism of action than existing therapeutic drugs.', 22668794),
('2-phenylbenzimidazole derivatives', 'Selectively and potently active against the bovine viral diarrhea virus (BVDV)', '', 'Pharmacophore modeling, resistant mutant isolation, docking, and MM-PBSA analysis: Combined experimental/computer-assisted approaches to identify new inhibitors of the bovine viral diarrhea virus (BVDV). Starting from a series of our new 2-phenylbenzimidazole derivatives, shown to be selectively and potently active against the bovine viral diarrhea virus (BVDV), we developed a hierarchical combined experimental/molecular modeling strategy to explore the drug leads for the BVDV RNA-dependent RNA-polymerase.', 20189812),
('Arylazoenamine derivatives', 'Selectively and potently active against the bovine viral diarrhea virus (BVDV), we developed a hierarchical combined experimental/molecular modeling strategy to explore the drug leads for the BVDV RNA-dependent RNA polymerase.', '', 'Synergistic experimental/computational studies on arylazoenamine derivatives that target the bovine viral diarrhea virus RNA-dependent RNA polymerase. Starting from a series of arylazoenamine derivatives, shown to be selectively and potently active against the bovine viral diarrhea virus (BVDV), we developed a hierarchical combined experimental/molecular modeling strategy to explore the drug leads for the BVDV RNA-dependent RNA polymerase.', 20638852),
('Compound 27, piperidine-substituted thiophene[3,2-d]pyrimidine scaffold', 'Compound 27 was the most potent; compared with ETV, its antiviral efficacy was 3-fold greater against WT, 5-7-fold greater against Y181C, Y188L, E138K, and F227L+V106A, and nearly equipotent against L100I and K103N, though somewhat weaker against K103N+Y181C.', '27 has lower cytotoxicity (CC50 > 227 microM) and a huge selectivity index (SI) value (ratio of CC50/EC50) of >159101', 'We designed and synthesized a series of human immunodeficiency virus type 1 (HIV-1) non-nucleoside reverse transcriptase inhibitors (NNRTIs) with a piperidine-substituted thiophene[3,2-d]pyrimidine scaffold, employing a strategy of structure-based molecular hybridization and substituent decorating.', 27541578),
('Remazol Brilliant Blue R', 'Remazol Brilliant Blue R (RB19, an anthraquinone dye), which inhibited WT NA and MDR NA with IC(50) values of 3.4 and 4.5 microM, respectively.', '', 'Using this strategy, we identified a new inhibitor, Remazol Brilliant Blue R (RB19, an anthraquinone dye), which inhibited WT NA and MDR NA with IC(50) values of 3.4 and 4.5 microM, respectively.', 23437217),
('Macrocyclic acylsulfonamide', 'Potent inhibitor of the NS3-NS4A proteases of all hepatitis C virus genotypes and of a panel of genotype 1-resistant variants.', '', 'This work describes our rational approach toward the identification of a macrocyclic acylsulfonamide that is a potent inhibitor of the NS3-NS4A proteases of all hepatitis C virus genotypes and of a panel of genotype 1-resistant variants.', 23271737),
('Chebulagic acid (CHLA) and punicalagin (PUG)', 'Could prevent binding, penetration, and cell-to-cell spread, as well as secondary infection.', 'inhibit HSV-1 entry at noncytotoxic doses in A549 human lung cells.', 'Experiments revealed that both tannins targeted and inactivated HSV-1 viral particles and could prevent binding, penetration, and cell-to-cell spread, as well as secondary infection.', 21307190),
('Nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781', '25 microM UC781 provided essentially equivalent microbicidal activity against NNRTI-resistant and wt virus', '', 'In vitro microbicidal activity of the nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 against NNRTI-resistant human immunodeficiency virus type 1. The nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 is under development as a microbicide to prevent sexual transmission of the human immunodeficiency virus type 1 (HIV-1).', 16611904),
('Stilbene 1,2-diamines', 'Compounds selectively block the initiation of replication of incoming HCV RNA but have no impact on viral entry, primary translation, or ongoing HCV RNA replication, nor do they suppress persistent HCV infection.', 'prevent HCV infection at nontoxic, low micromolar concentrations in cell culture.', 'Using a cell-based colorimetric screening assay to interrogate a 1,200-compound chemical library for anti-HCV activity, we identified a family of 1,2-diamines derived from trans-stilbene oxide that prevent HCV infection at nontoxic, low micromolar concentrations in cell culture.', 21430055),
('Distamycin analogue, 2,2''-[4, 4''-[[aminocarbonyl]amino]bis[N,4''-di[pryrrole-2-carboxamide- 1, 1''-dimethyl]]-6,8-naphthalenedisulfonic acid]hexasodium salt (NSC 651016)', 'NSC 651016 inhibited in vitro replication of a wide range of HIV-1 isolates, as well as HIV-2 and SIV, and exhibited in vivo anti-HIV-1 activity in a murine model.', '', 'NSC 651016 represents an attractive candidate for the chemotherapeutic treatment of HIV-1 infection and as a microbicide to prevent the sexual transmisssion of HIV-1.', 9632350),
('D- and L-(beta)-deoxy- and -dideoxynucleoside triphosphate analogues', 'L-(beta)-enantiomers of nucleoside RT inhibitors were synergistic when combined with nonnucleoside RT inhibitors', '', 'Potentiation of inhibition of wild-type and mutant human immunodeficiency virus type 1 reverse transcriptases by combinations of nonnucleoside inhibitors and d- and L-(beta)-dideoxynucleoside triphosphate analogs. Combinations of reverse transcriptase (RT) inhibitors are currently used in anti-human immunodeficiency virus therapy in order to prevent or delay the emergence of resistant virus and to improve the efficacy against viral enzymes carrying resistance mutations.', 11257034),
('N-Butyldeoxynojirimycin (NB-DNJ)', 'When encapsulated inside liposomes, NB-DNJ inhibited HIV-1 with final concentrations in the nmol/l range (IC50 = 4 nmol/l), a 100 000-fold enhancement in IC50 relative to free NB-DNJ.', '', 'N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery. NB-DNJ CD4 liposomes demonstrated additional antiviral effects, reducing viral secretion by 81% and effectively neutralizing free viral particles to prevent further infections.', 18753929),
('CDG (carbocyclic 2''-deoxyguanosine) and abacavir ([1S,4R]-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol)', 'Drug assays indicated that the lamivudine-resistant virus exhibited reduced sensitivity to penciclovir [9-(4-hydroxy-3-hydroxymethyl-but-1-yl) guanine] but was still inhibited by the nucleoside analogues CDG (carbocyclic 2''-deoxyguanosine) and abacavir ([1S,4R]-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol).', '', 'Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening. Lamivudine [beta-L-(-)-2'',3''-dideoxy-3''-thiacytidine] is a potent inhibitor of hepadnavirus replication and is used both to treat chronic hepatitis B virus (HBV) infections and to prevent reinfection of transplanted livers.', 12760870),
('Boceprevir-S isomer (SCH 534128)', 'Median concentration in patients with breakthrough was 48.3 ng/mL (interquartile range 43-58 ng/mL); in others, it was significantly (p 0.019) higher: 151 ng/mL.', '', 'Boceprevir-S isomer (SCH 534128) median concentration in patients with breakthrough was 48.3 ng/mL (interquartile range 43-58 ng/mL); in others, it was significantly (p 0.019) higher: 151 ng/mL. Low boceprevir plasma concentration can lead to virologic resistance; therapeutic drug monitoring should be used to prevent the onset of viral breakthrough during triple-regimen therapy with boceprevir. Copyright ? 2014 European Society of Clinical Microbiology and Infectious Diseases.', 25658567);
INSERT INTO `parasite_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('4-oxo-4H-1-benzopyran-8-carbaldehydes 11a-11g', 'Most promising, and they demonstrated better activities and selectivities comparable to those the reference ribarivin, a nucleoside antiviral agent.', '', 'A series of novel isoflavonoids were synthesized based on structural modifications of daidzein, an active ingredient of traditional Chinese medicine (TCM) and evaluated for their anti-influenza activity, in vitro, against H1N1 Tamiflu-resistant (H1N1 TR) virus in the MDCK cell line. Among them, 4-oxo-4H-1-benzopyran-8-carbaldehydes 11a-11g were most promising, and they demonstrated better activities and selectivities comparable to those the reference ribarivin, a nucleoside antiviral agent. 3-(4-Bromophenyl)-7-hydroxy-4-oxo-4H-1-benzopyran-8-carboxaldehyde (11c) displayed the best inhibitory activity (EC50 , 29.0 microM) and selectivity index (SI>10.3).', 25879510),
('Carraguard-based formulation', 'PC-817 appeared no more effective than Carraguard in vivo, due to the limited activity of a single dose of MIV-150 and the dominant barrier effect of Carraguard.', '', 'Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity. Anti-HIV microbicides are being investigated in clinical trials and understanding how promising strategies work, coincident with demonstrating efficacy in vivo, is central to advancing new generation microbicides.', 18776937),
('4''-methoxyflavone and 2''-hydroxy-4-methoxychalcone', 'In-silico study, binders of the 150-cavity of neuraminidase (NA)', '', 'A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1.', 27412704),
('Diphenyl ether', 'Non-nucleoside reverse transcriptase inhibitors with excellent potency against resistant mutant viruses and promising pharmacokinetic properties', '', 'Diphenyl ether non-nucleoside reverse transcriptase inhibitors with excellent potency against resistant mutant viruses and promising pharmacokinetic properties. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are part of the preferred treatment regimens for individuals infected with HIV.', 19006142),
('Indolylarylsulfones (IASs), halo- and nitro-substituted IAS derivatives', 'Exhibited high selectivity to the mutant RT in complex with its substrates, behaving as uncompetitive inhibitors.', '', 'Mechanism of interaction of novel indolylarylsulfone derivatives with K103N and Y181I mutant HIV-1 reverse transcriptase in complex with its substrates. BACKGROUND: Novel indolylarylsulfones (IASs), designed through rational structure-based molecular modelling and docking approaches, have been recently characterized as effective inhibitors of the wild-type and drug-resistant mutant HIV-1 reverse transcriptase (RT).', 22095519),
('Icosahedral metallacarboranes', 'Potent and specific competitive inhibitors of drug-resistant HIV PRs prepared either by site-directed mutagenesis or cloned from HIV-positive patients.', '', 'Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance. HIV protease (PR) is a prime target for rational anti-HIV drug design.', 18598016),
('Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol)', 'Active against ganciclovir- and foscarnet-resistant human cytomegalovirus UL97 mutants', '', 'The Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol) were previously shown to be potent inhibitors of AD169 and Towne HCMV reference strains and postulated to share a common phosphorylation pathway with ganciclovir (GCV) possibly involving the UL97-encoded phosphotransferase.', 12406510),
('R1626 plus peginterferon Alfa-2a', 'Potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin', '', 'R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin. R1626, a prodrug of the hepatitis C virus (HCV) RNA polymerase inhibitor R1479, showed time-dependent and dose-dependent reduction of HCV RNA levels in a previous study.', 18570306),
('Benzothiadiazine-substituted tetramic acids', 'Potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase', '', 'An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids is reported.', 16455253),
('KNI-227 and KNI-272', 'the 50% inhibitory concentrations of KNI-227 against HIV type 1 LAI (HIV-1LAI), HIV-1RF, HIV-1MN, and HIV-2ROD were 0.1, 0.02, 0.03, and 0.1 microM, respectively, while those of KNI-272 were 0.1, 0.02, 0.04, and 0.1 microM, respectively.', 'The ratios of 50% cytotoxic concentrations to 50% inhibitory concentrations for KNI-227 and KNI-272 were approximately 2,500 and > 4,000, respectively, as assessed in peripheral blood mononuclear cells.', 'In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine. Two compounds, KNI-227 and KNI-272, which were highly potent against HIV protease with little inhibition of other aspartic proteases, showed the most potent activity against the infectivity and cytopathic effect of a wide spectrum of HIV strains.', 8494379),
('2''-deoxy-4''-C-ethynyl-2-fluoroadenosine and 2''-deoxy-4''-C-ethynyl-2-chloroadenosine', 'Have supremely high activity against all human immunodeficiency viruses including multidrug-resistant HIV and low toxicity.', 'low toxicity.', 'Development of modified nucleosides that have supremely high anti-HIV activity and low toxicity and prevent the emergence of resistant HIV mutants. An idea to use 4''-C-substituted-2''-deoxynucleoside derivatives was proposed based on a working hypothesis to solve the problems of existing acquired immune deficiency syndrome chemotherapy (highly active antiretroviral therapy).', 21422739),
('GRL-1388 and -1398', 'GRL-1388 was as potent as darunavir (DRV) against various drug-resistant HIV-1 laboratory strains with 50% effective concentration (EC(50)s) of 2.6 to 32.6 nM. GRL-1398 was significantly more potent against such variants than DRV with EC(50)s of 0.1 to 5.7 nM. GRL-1388 and -1398 were also potent against multiple-PI-resistant clinical HIV-1 variants ((CL)HIV-1(MDR)) with EC(50)s ranging from 2.7 to 21.3 nM and from 0.3 to 4.8 nM, respectively.', '', 'Novel HIV-1 protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran, that are potent against multi-PI-resistant HIV-1 variants. We identified GRL-1388 and -1398, potent nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran (Tp-THF).', 21282450),
('MK-1439', 'Treatment of HIV infection.', '', 'Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses.', 24412110),
('GRL-5010A and GRL-4410A', 'More effective than darunavir in inhibiting mature PR20 and show promise for further development of antiviral agents targeting highly resistant PR mutants.', '', 'Substituted Bis-THF Protease Inhibitors with Improved Potency against Highly Resistant Mature HIV-1 Protease PR20. An extremely drug resistant mutant of HIV-1 protease (PR) bearing 20 mutations (PR20) has been studied with two potent antiviral investigational inhibitors.', 26010498),
('TMC647055 (TMC)', 'A novel and potent non-nucleoside inhibitor of the HCV NS5B polymerase.', '', 'TMC647055 (TMC) is a novel and potent non-nucleoside inhibitor of the HCV NS5B polymerase. However, mutations that result in drug resistance to TMC have been reported.', 26836778),
('EDP-239', 'Hepatitis C Virus NS5A Inhibitor', '', 'EDP-239, a potent and selective hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor developed for the treatment of HCV infection, has been investigated in vitro and in vivo', 27503644),
('Three amide-DAANs 8e, 4a, and 4b', 'High potency against wild-type and rilpivirine-resistant viral strains and multiple desirable drug-like properties.', '', 'Drug-like property-driven optimization of 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against rilpivirine-resistant mutant virus.', 28465101),
('TMC125-R165335 (etravirine)', 'TMC125-R165335 and related anti-AIDS drug candidates can bind the enzyme RT in multiple conformations and thereby escape the effects of drug-resistance mutations.', '', 'Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. Anti-AIDS drug candidate and non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC125-R165335 (etravirine) caused an initial drop in viral load similar to that observed with a five-drug combination in na?ve patients and retains potency in patients infected with NNRTI-resistant HIV-1 variants.', 15115397),
('7-Deaza-2''-C-methyl-adenosine', 'Potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties', '', 'A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties. Improved treatments for chronic hepatitis C virus (HCV) infection are needed due to the suboptimal response rates and deleterious side effects associated with current treatment options.', 15388457),
('Aurintricarboxylic acid', 'Potent inhibitor of influenza A and B virus neuraminidases', '', 'Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases. BACKGROUND: Influenza viruses cause serious infections that can be prevented or treated using vaccines or antiviral agents, respectively.', 20020057),
('2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236)', 'PHI-236 displayed high-binding affinity (Ludi K(i) = 0.07 microM) for HIV-1 RT and robust anti-HIV activity against the wild type (IC50 = <0.001 microM) as well as primary clinical isolates (IC50 = 0.009-0.04 microM) carrying multiple RT gene mutations associated with NRTI and NNRTI resistance.', '', 'Discovery of 2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human immunodeficiency virus microbicide.', 16254003),
('beta-L-2'',3''-Dideoxycytidine (beta-L-ddC) and beta-L-5-fluoro-2'',3''-dideoxycytidine (5-F-beta-L-ddC)', 'The beta-L-dideoxycytidine nucleosides had similar anti-HIV-1 activities, significantly greater anti-HBV activities', 'decreased toxicities to a B-cell line, T-cell lines, and human bone marrow progenitor cells.', 'Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides. beta-L-2'',3''-Dideoxycytidine (beta-L-ddC) and beta-L-5-fluoro-2'',3''-dideoxycytidine (5-F-beta-L-ddC) were prepared and shown to have potent activity against human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV).', 7518218),
('[tetrahydroimidazo[4,5,1-jk] [1,4]benzodiazepin-2(1H)-one and -thione (TIBO), 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine, nevirapine, pyridinone, bis(heteroaryl)piperazine, etc.]', 'Potent inhibitors of HIV-1 replication in cell culture.', '', 'Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors. The human immunodeficiency virus type 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors [tetrahydroimidazo[4,5,1-jk] [1,4]benzodiazepin-2(1H)-one and -thione (TIBO), 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine, nevirapine, pyridinone, bis(heteroaryl)piperazine, etc.] are potent inhibitors of HIV-1 replication in cell culture.', 7682649),
('N-[2-(1-cyclohexenyl)ethyl]-N''-[2-(5-bromopyridyl)]-thiourea and N''-[2-(1-cyclohexenyl)ethyl]-N''-[2-(5-chloropyridyl)]-thiourea', 'HIV-1 inhibition assays was: HI-445 = HI-346 (IC50 = 3 nM) > MKC-442 (IC50 = 4 nM) = AZT (IC50 = 4 nM) > trovirdine (IC50 = 7 nM) > delavirdine (IC50 = 9 nM) > nevirapine (IC50 = 34 nM).', '', 'N-[2-(1-cyclohexenyl)ethyl]-N''-[2-(5-bromopyridyl)]-thiourea and N''-[2-(1-cyclohexenyl)ethyl]-N''-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1.', 10509923),
('MKC-442 (6-benzyl-1-ethoxymethyl-5-isopropyluracil or I-EBU)', 'The 50 and 90% effective concentrations for HIV-1 (HTLV-IIIB strain) replication in MT-4 cells were 15 and 98 nM, respectively.', '', 'Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro. MKC-442 (6-benzyl-1-ethoxymethyl-5-isopropyluracil or I-EBU) has recently been identified as a highly potent and specific inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.', 7518216),
('5-Fluorouracil, 5-fluorouridine (FUrd), 5-fluoro-2''-deoxyuridine (FdUrd), 5-fluorocytidine (FCyd), 5-fluoro-2''-deoxycytidine (FdCyd), 5-trifluoro-2''-deoxythymidine (F3dThd), and the 5''-monophosphates and 3'',5''-cyclic monophosphates', 'Activity against thymidine kinase-deficient (TK-) herpes simplex virus', '', 'Potent activity of 5-fluoro-2''-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase. Other 5-substituted 2''-deoxyuridines that have previously been recognized as potent thymidylate synthase inhibitors behaved in a similar fashion.', 3039343),
('(S,S)-1,2-bis(5-methoxy-2-benzimidazolyl)-1,2-ethanediol', 'Potent inhibitors of rhinoviruses', '', 'Antiviral activity in tissue culture systems of bis-benzimidazoles, potent inhibitors of rhinoviruses.', 4333892),
('Pyridinone derivatives', 'Potent and specific inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) and HIV-1 replication in cell culture.', '', 'L-702,019 was also a potent inhibitor of the replication of mutant HIV-1 containing the individual mutations at amino acid 103 or 181 as well as of clinical isolates resistant to L-697,661 and L-696,229.', 7685996),
('PNU-140690 (sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrone)', 'A potent, nonpeptidic inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease currently under clinical evaluation.', '', 'In vitro combination of PNU-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and -resistant clinical isolates. PNU-140690 (sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrone) is a potent, nonpeptidic inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease currently under clinical evaluation.', 9371335),
('(-)-beta-D-2, 6-diaminopurine-dioxolane', 'Suppressive effects of the K65R and L74V mutations on AZT resistance.', '', 'In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3''-azido-3''-deoxythymidine. Human immunodeficiency virus type 1 (HIV-1) isolates resistant to (-)-beta-D-dioxolane-guanosine (DXG), a potent and selective nucleoside analog HIV-1 reverse transcriptase (RT) inhibitor, were selected by serial passage of HIV-1(LAI) in increasing drug concentrations (maximum concentration, 30 microM). Two independent selection experiments were performed.', 10858331),
('2'',3''-dideoxy-3''-thiacytidine (3TC)', 'A potent inhibitor of wild-type human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT).', '', 'Wild-type and YMDD mutant murine leukemia virus reverse transcriptases are resistant to 2'',3''-dideoxy-3''-thiacytidine. The antiretroviral nucleoside analog 2'',3''-dideoxy-3''-thiacytidine (3TC) is a potent inhibitor of wild-type human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT).', 10864683),
('L-chicoric acid', 'A potent and selective inhibitor of HIV-1 integrase that also inhibits HIV-1 replication in cell culture.', '', 'L-chicoric acid is a potent and selective inhibitor of HIV-1 integrase that also inhibits HIV-1 replication in cell culture.', 10867160),
('DPC 817, 2'',3''-didehydro-2'',3''-dideoxy-5-fluorocytidine (PSI 5582 D-D4FC)', 'A cytidine nucleoside analog with activity against zidovudine- and lamivudine-resistant viral variants', '', 'DPC 817, 2'',3''-didehydro-2'',3''-dideoxy-5-fluorocytidine (PSI 5582 D-D4FC) is a potent inhibitor of HIV type 1 replication in vitro.', 11959574),
('1263W94', '1263W94 inhibited viral replication in a dose-dependent manner, with a mean 50% inhibitory concentration (IC(50)) of 0.12 +/- 0.01 microM', '', 'Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. enzimidazole nucleosides have been shown to be potent inhibitors of human cytomegalovirus (HCMV) replication in vitro.', 12121906),
('Imidazole-linked pinanamine derivatives (compound 33)', 'Inhibited the amantadine-resistant virus (IC50 = 3.4 microM) and its activity increased by almost 24-fold compared to initial compound, with its action mechanism being not M2 channel mediated.', '', 'Imidazole-based pinanamine derivatives: Discovery of dual inhibitors of the wild-type and drug-resistant mutant of the influenza A virus. We previously reported potent hit compound 4 inhibiting the wild-type influenza A virus A/HK/68 (H3N2) and A/M2-S31N mutant viruses A/WS/33 (H1N1), with its latter activity quite weak.', 26722757),
('Benzodithiin compound (RD3-0028)', 'RD3-0028 inhibits RSV replication by interfering with intracellular processing of the RSV fusion protein, or a step immediately thereafter, leading to loss of infectivity.', '', 'Mechanism of selective inhibition of respiratory syncytial virus by a benzodithiin compound (RD3-0028). RD3-0028, a compound with a benzodithiin structure, was found to be a potent inhibitor of respiratory syncytial virus (RSV) replication.', 11529559),
('Methyl 3'',3"-dichloro-4'',4"-dimethoxy-5'', 5"-bis(methoxycarbonyl)-6,6-diphenyl-5-hexenoate (ADAM II)', 'ADAM II inhibited HIV-1 reverse transcriptase with an IC50 of 0.3 microM but was inactive as an inhibitor of HIV-1 attachment/fusion to cells, protease, integrase, and the nucleocapsid protein.', '', 'New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors. The most potent compound proved to be methyl 3'',3"-dichloro-4'',4"-dimethoxy-5'', 5"-bis(methoxycarbonyl)-6,6-diphenyl-5-hexenoate (ADAM II), which displayed an EC50 of 13 nM for inhibition of the cytopathic effect of HIV-1RF in CEM-SS cells.', 9622549),
('2-fluoroadenosine analogue 32', '2-fluoroadenosine analogue 32 showed antiviral potency as well as high cytotoxicity (IC(50) 1.5, 1.1, and 7.6 microM for PBM, CEM, and Vero, respectively) whereas no other compound showed cytotoxicity up to 100 microM.', '', 'Stereoselective synthesis and antiviral activity of D-2'',3''-didehydro-2'',3''-dideoxy-2''-fluoro-4''-thionucleosides. The antiviral activity of the synthesized compounds were evaluated against HIV-1 in human peripheral blood mononuclear (PBM) cells, among which cytidine 17, 5-fluorocytidine 18, adenosine 24, and 2-fluoroadenosine 32 showed moderate to potent anti-HIV activities (EC(50) 1.3, 11.6, 8.1, and 1.2 microM, respectively).', 12383014),
('Cytosine 17, 5-fluorocytosine 18, and adenine 27 derivatives', 'Showed potent anti-HIV activities (EC(50) = 0.12, 0.15, and 1.74 microM, respectively) without significant cytotoxicity up to 100 microM in human PBM, CEM, and Vero cells.', '', 'Synthesis, anti-HIV activity, and molecular mechanism of drug resistance of L-2'',3''-didehydro-2'',3''-dideoxy-2''-fluoro-4''-thionucleosides. The antiviral activity of the newly synthesized compounds was evaluated against HIV-1 in human peripheral blood mononuclear (PBM) cells, among which the cytosine 17, 5-fluorocytosine 18, and adenine 27 derivatives showed potent anti-HIV activities (EC(50) = 0.12, 0.15, and 1.74 microM, respectively) without significant cytotoxicity up to 100 microM in human PBM, CEM, and Vero cells.', 12540238),
('Diketo acid compound L-742,001', 'Two- to 3-fold resistance was seen for the T20A, L42T, and V122T mutants, and the R124Q and Y130A mutants were 3-fold more sensitive to L-742,001.', '', 'The diketo acid compound L-742,001 was previously identified as a potent inhibitor of the influenza virus endonuclease reaction, but information on its precise binding mode to PA or potential resistance profile is limited.', 23824822),
('DPC 681 and DPC 684', 'A panel of chimeric viruses constructed from clinical samples from patients who failed PI-containing regimens and containing 5 to 11 mutations, including positions 10, 32, 46, 47, 50, 54, 63, 71, 82, 84, and 90 had mean IC(50) values of <20 nM for DPC 681 and DPC 681, respectively', '', 'DPC 681 and DPC 684: potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variants. Two compounds resulting from our studies, designated DPC 681 and DPC 684, are potent and selective inhibitors of HIV protease with IC(90)s for wild-type HIV-1 of 4 to 40 nM.', 11600351),
('N-[2-(2,5-dimethoxyphenylethyl)]-N''-[2-(5-bromopyridyl)]-thi ourea (HI-236)', 'The activity of HI-236 against RT-MDR was superior to that of other anti-HIV agents tested, in the following order, from high to low activity; HI-236 (IC50 5 nM), HI-240 (IC50 6 nM), trovirdine (IC50 20 nM), zidovudine (IC50 150 nM), MKC-442 (IC50 300 nM), delavirdine (IC50 400 nM) and nevirapine (IC50 5 microM).', '', 'Our lead compound, N-[2-(2,5-dimethoxyphenylethyl)]-N''-[2-(5-bromopyridyl)]-thi ourea (HI-236) was tested against clinically observed non-nucleoside inhibitor (NNI)-resistant mutated strains of HIV.. HI-236 was more potent than trovirdine, MKC-442 and zidovudine against the drug-sensitive HIV-1 strain IIIB, 50-100 times more effective than delavirdine or nevirapine and twice as effective as our recently reported lead compound N-[2-(2-fluorophenethyl)]-N''-[2-(5-bromopyridyl)]-thiourea (HI-240) against the NNI-resistant Y181C mutant HIV-1 strain A17.', 10574178),
('Lignosulfonic acid (LA)', 'LA demonstrated potent inhibitory activity of HIV replication against a wide range of R5 and X4 HIV strains and prevented the uptake of HIV by bystander CD4+ T cells from persistently infected T cells in vitro (IC50: 0.07 - 0.34 microM). LA also inhibited HSV-2 replication in vitro in different cell types (IC50: 0.42 - 1.1 microM) and in rodents in vivo.', '', 'The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications. ', 26132818),
('4"-Benzoylureido-TSAO derivatives', 'A stringent structure-antiviral activity relationship was observed for the 4"-benzoylureido- TSAO derivatives for which the concomitant presence of a highly lipophilic substituent at both 2''- and 5''-positions was required to fully preserve the antihuman cytomegalovirus efficacy.', '', '4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors.', 18707089),
('2''-deoxy-3''-oxa-4''-thiocytidine (dOTC)', 'The mean 50% inhibitory concentration of dOTC for drug-naive isolates was 1.76 microM, rising to only 2.53 and 2.5 microM for viruses resistant to 3TC and viruses resistant to 3TC and AZT, respectively.', '', 'Both 5''-triphosphate (TP) derivatives of dOTC were more potent than 3TC-TP at inhibiting HIV-1 reverse transcriptase (RT) in vitro.', 10428900),
('Pyromeconic acid and derivatives', 'This approach ultimately resulted in the development of a lead compound with an IC50 value of 14 nM, which displayed an EC50 value of 2.1 microM against H1N1 influenza virus in MDCK cells.', '', 'Fragment-Based Identification of Influenza Endonuclease Inhibitors. Herein we report the development of inhibitors of influenza PA endonuclease derived from lead compounds identified from a metal-binding pharmacophore (MBP) library screen. Pyromeconic acid and derivatives thereof were found to be potent inhibitors of endonuclease.', 27291165),
('JM3100, bicyclam derivative', 'JM3100, in which the cyclam moieties are tethered by an aromatic bridge [i.e., phenylenebis(methylene)], inhibits the replication of various HIV-1 and HIV-2 strains in various cell lines at a 50% effective concentration (EC50) of 1 to 10 ng/ml, which is about 100-fold lower than the concentration required for JM2763 to inhibit HIV replication and at least 100,000-fold lower than the cytotoxic concentration (> 500 micrograms/ml).', '', 'Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Bicyclams, in which the cyclam (1,4,8,11-tetraazacyclotetradecane) moieties are tethered via an aliphatic bridge (i.e., propylene, as in JM2763) are potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) (E.', 7913308),
('MRL-1237', 'MRL-1237 inhibited poliovirus-specific RNA synthesis in HeLa cells infected with a wild strain but not with an F164Y mutant.', '', 'Mutations in the 2C region of poliovirus responsible for altered sensitivity to benzimidazole derivatives. MRL-1237, [1-(4-fluorophenyl)-2-(4-imino-1,4-dihydropyridin-1-yl) methylbenzimidazole hydrochloride], is a potent and selective inhibitor of the replication of enteroviruses.', 10756027),
('AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2'',3''-dideoxy-3''-thiacytidine', 'The potency of AT-61 was not affected by one of the mutations responsible for (-)-beta-L-2'', 3''-dideoxy-3'' thiacytidine (3TC) resistance in HBV, and AT-61 acted synergistic with 3TC to inhibit HBV replication.', 'AT-61 (81 microM) was not cytotoxic or antiproliferative to several cell lines and had no antiviral effect on woodchuck or duck HBV, human immunodeficiency virus type 1, herpes simplex virus type 1, vesicular stomatitis virus, or Newcastle disease virus.', 'AT-61, a member of a novel class of phenylpropenamide derivatives, was found to be a highly selective and potent inhibitor of human hepatitis B virus (HBV) replication in four different human hepatoblastoma cell lines which support the replication of HBV (i.e., HepAD38, HepAD79, 2.2.15, and transiently transfected HepG2 cells).', 9835512),
('2-(quinolin-3-yl)acetic acid derivatives', 'HIV-1 integrase inhibitors', '', 'We have rationally designed a series of 2-(quinolin-3-yl)acetic acid derivatives (LEDGINs) that act as potent inhibitors of the LEDGF/p75-integrase interaction and HIV-1 replication at submicromolar concentration by blocking the integration step.', 20473303),
('Novel fluorine-containing DAPY', 'Activities against wild-type (WT) HIV-1 and NNRTI-resistant strains', '', 'Novel fluorine-containing DAPY derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2014072419.', 26415039),
('Organosilanes', 'Potent antiviral activity against a panel of human clinical isolates of influenza A viruses, including viruses that are resistant to amantadine, oseltamivir, or both.', '', 'Design and expeditious synthesis of organosilanes as potent antivirals targeting multidrug-resistant influenza A viruses. In this study we report the design and synthesis of the first class of organosilanes that have potent antiviral activity against a panel of human clinical isolates of influenza A viruses, including viruses that are resistant to amantadine, oseltamivir, or both.', 28433777),
('Amino-bis-tetrahydrofuran Derivative [25f, 25i, and 25j]', '25f, 25i, and 25j were evaluated against a number of highly-PI-resistant HIV-1 strains, and they exhibited improved antiviral activity over darunavir.', '', 'Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions: Synthesis, Biological Evaluation, and Protein-Ligand X-ray Studies. Structure-based design, synthesis, and biological evaluation of a series of very potent HIV-1 protease inhibitors are described.', 26306007),
('Benzamide derivative named AH0109', 'Exhibits potent anti-HIV-1 activity at an 50% effective concentration of 0.7 microM in HIV-1-susceptible CD4(+) C8166 T cells.', '', 'In this study, we have identified a benzamide derivative named AH0109 that exhibits potent anti-HIV-1 activity at an 50% effective concentration of 0.7 microM in HIV-1-susceptible CD4(+) C8166 T cells.', 23669388),
('4''-ethynyl-2-fluoro-2''-deoxyadenosine (EFdA)', 'Similar to WT RT, the N348I RT is inhibited by EFdA mainly at the point of incorporation through decreased translocation.', '', 'Bond Life Sciences Center and Department of Molecular Microbiology & Immunology, School of Medicine, University of Missouri, Columbia, MO 65211, USA. 4''-ethynyl-2-fluoro-2''-deoxyadenosine (EFdA) is a highly potent inhibitor of HIV-1 reverse transcriptase (RT).', 23273211),
('NVP018', 'A potent inhibitor of hepatitis B virus, hepatitis C virus (HCV), and HIV-1 replication, shows minimal inhibition of major drug transporters, and has a high barrier to generation of both HCV and HIV-1 resistance', '', 'NVP018 is a potent inhibitor of hepatitis B virus, hepatitis C virus (HCV), and HIV-1 replication, shows minimal inhibition of major drug transporters, and has a high barrier to generation of both HCV and HIV-1 resistance.', 25619934),
('5-[(4-bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine (BPIP)', 'The compound resulted in a dose-dependent antiviral effect in PK(15) cells with a 50% effective concentration (EC(50)) for the inhibition of CSFV Alfort(187) (subgroup 1.1) of 1.6+/-0.4 microM and for CSFV Wingene (subgroup 2.3) 0.8+/-0.2 microM.', '', 'We here report that 5-[(4-bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine (BPIP) is a highly potent inhibitor of the in vitro replication of CSFV.', 17997169),
('Phosphonoformate (foscarnet; PFA)', 'Except for an HIV-1 variant encoding the K65R mutation in RT that exhibited 3.3- to 8.2-fold resistance, the nucleoside-resistant viruses included in the panel were sensitive to the PFA prodrugs (<3-fold increase in 50% inhibitory concentration)', 'its use for the treatment of HIV-1 infection is limited by toxicity and the lack of an orally bioavailable formulation.', 'Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance. Phosphonoformate (foscarnet; PFA) is a potent inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT), but its use for the treatment of HIV-1 infection is limited by toxicity and the lack of an orally bioavailable formulation.', 11353603),
('BI-RG-587', '50% inhibitory concentration of 84 nM against HIV-1 reverse transcriptase activity.', '', 'BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine. A series of dipyridodiazepinones have been shown to be potent inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.', 1708976),
('Compounds bearing a 3-isopropyl and 3-iodine group', 'The most potent inhibitors with EC50 of 4 nM', '', 'Novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) with high potency against NNRTI-resistant HIV-1 strains. Most of the compounds, especially 26 and 22, bearing a 3-isopropyl and 3-iodine group, respectively, exhibited highly potent activity against wild-type HIV-1 strains and those resistant to reverse transcriptase inhibitors (RTIs).', 23540737),
('S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (HPMPC)', 'Potent in vitro and in vivo activity against a broad range of herpesviruses, including acyclovir-resistant herpes simplex virus (HSV)', '', 'Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS.', 8077713),
('2''-deoxy-5-ethyl-beta-4''-thiouridine (4''-S-EtdU)', 'Shown to be a more potent inhibitor of gammaherpesvirus infection than acyclovir.', '', '2''-Deoxy-5-ethyl-beta-4''-thiouridine inhibits replication of murine gammaherpesvirus and delays the onset of virus latency.', 10628807),
('BP008', 'The compound reduced the reporter expression of the HCV1b replicon with a 50% effective concentration (EC(50)) and selective index value of 4.1 ? 0.7 nM and >12,195, respectively.', '', 'Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor. Hepatitis C virus (HCV) is a global health problem, affecting approximately 3% of the world''s population.', 22006008),
('2,6-difluoro analogue (4r)', 'With potent antiviral activity (IC50 = 0.087 ? 0.002 microM)', 'Low cytotoxicity (CC50 = 90.6 ? 2.06 microM)', 'Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation. The subsequent SAR study and drug-like optimization resulted in the discovery of the lead candidate 4r, with potent antiviral activity (IC50 = 0.087 ? 0.002 microM), low cytotoxicity (CC50 = 90.6 ? 2.06 microM), sensitivity to nucleoside analogue-resistant HBV mutants, and synergistic effect with nucleoside analogues in HepG2.2.15 cells.', 27989113),
('4-{[4-({(3R)-1-Butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5dioxo-1,4,9-triazaspiro [5.5]undec-9-yl}methyl)phenyl]oxy}benzoic acid hydrochloride (873140)', 'A potent allosteric noncompetitive HIV entry inhibitor', '', 'The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor.', 15644495),
('Furanyl-containing analog UC10, UC040, UC82, and UC781', 'The most potent inhibitor of human immunodeficiency virus type 1 (HIV-1) replication and a promising candidate for further development.', '', 'From these studies, the furanyl-containing analog UC10 was identified as the most potent inhibitor of human immunodeficiency virus type 1 (HIV-1) replication and a promising candidate for further development.', 9087499),
('Dihydrotriazolopyrimidine derivative, hybrid molecules 36 and 37', 'Compound 36 that emerged as the most potent PA-PB1 interaction inhibitor (IC50 = 1.1 microM) among all the small molecules reported so far.', '', 'A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits. Very interesting results were obtained with the hybrid molecules 36 and 37, designed by merging some peculiar structural features known to impart PA-PB1 interaction inhibition, with compound 36 that emerged as the most potent PA-PB1 interaction inhibitor (IC50 = 1.1 microM) among all the small molecules reported so far.', 25856229),
('Inhibitors (compounds 1 and 2) of malarial aspartyl protease, plasmepsin-II', 'compounds 1 and 2 show promising inhibitory activity against HIV-1 protease variants and hence are good candidates for further development to enhance their potency against NL4-3 as well as MDR HIV-1 protease variants.', '', 'Two potent inhibitors (compounds 1 and 2) of malarial aspartyl protease, plasmepsin-II, were evaluated against wild type (NL4-3) and multidrug-resistant clinical isolate 769 (MDR) variants of human immunodeficiency virus type-1 (HIV-1) aspartyl protease.', 22469467),
('5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide analogues', 'These compounds satisfy two structural requirements known for potent inhibition of HIV-1 IN catalysis: a metal chelating moiety and a hydrophobic functionality necessary for selectivity against the strand transfer reaction.', '', 'Design and discovery of 5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide inhibitors of HIV-1 integrase. Most of the new compounds described herein are potent and selective for the strand transfer reaction and show antiviral activity in cell-based assays.', 25150089),
('UV-4 or N-(9-methoxynonyl)-1-deoxynojirimycin', 'UV-4, and its hydrochloride salt known as UV-4B, is highly potent against dengue virus in vitro and promotes complete survival in a lethal dengue virus mouse model.', 'UV-4 treatment did not affect the development of protective antibody responses after either influenza infection or vaccination', 'In vivo therapeutic protection against influenza A (H1N1) oseltamivir-sensitive and resistant viruses by the iminosugar UV-4. Our lead iminosugar analog called UV-4 or N-(9-methoxynonyl)-1-deoxynojirimycin inhibits activity of endoplasmic reticulum (ER) ?-glucosidases I and II and is a potent, host-targeted antiviral candidate.', 25786028),
('Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine', 'Alkoxyalkyl esters of (S)-HPMPA were 6 to 20 times more active than unmodified (S)-HPMPA on the basis of their 50% effective concentrations in 2.2.15 cells.', '', 'Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine are potent and selective inhibitors of hepatitis B virus (HBV) replication in vitro and in HBV transgenic mice in vivo. Alkoxyalkyl esters of acyclic nucleoside phosphonates have previously been shown to have increased antiviral activity when they are administered orally in animal models of viral diseases, including lethal infections with vaccinia virus, cowpox virus, ectromelia virus, murine cytomegalovirus, and adenovirus. 9-(S)-(3-Hydroxy-2-phosphonomethoxypropyl)adenine [(S)-HPMPA] was previously shown to have activity against hepatitis B virus (HBV) in vitro.', 19398648),
('S/GSK1349572', 'Inhibited HIV replication with low-nanomolar or subnanomolar potency and with a selectivity index of 9,400.', '', 'In Vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitor. S/GSK1349572 is a next-generation HIV integrase (IN) inhibitor designed to deliver potent antiviral activity with a low-milligram once-daily dose requiring no pharmacokinetic (PK) booster.', 21115794),
('BMS-790052', 'Inhibits hybrid replicons containing HCV genotype-4 NS5A genes with 50% effective concentrations (EC(50)s) ranging from 7 to 13 pM.', '', 'In vitro activity of BMS-790052 on hepatitis C virus genotype 4 NS5A. The antiviral profile of BMS-790052, a potent hepatitis C virus (HCV) replication complex inhibitor targeting nonstructural protein NS5A, is well characterized for HCV genotype-1.', 22203595),
('PSI-352938', 'The effective concentration required to achieve 50% inhibition for PSI-352938, determined using genotype 1a-, 1b-, and 2a-derived replicons stably expressed in the Lunet cell line, were 0.20, 0.13, and 0.14 microM, respectively.', '', 'Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of ?-D-2''-deoxy-2''-?-fluoro-2''-?-C-methylguanosine. PSI-352938 is a novel cyclic phosphate prodrug of ?-D-2''-deoxy-2''-?-fluoro-2''-?-C-methylguanosine 5''-monophosphate that has potent activity against hepatitis C virus (HCV) in vitro.', 21444700),
('Cepharanthine hydrochloride (CH)', 'CH inhibited replication and HBeAg production by either wild-type or lamivudine-resistant HBV clinical isolates in a dose-dependent manner', '', 'In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates. Cepharanthine hydrochloride (CH), a natural alkaloid-derived compound, has been reported to possess potent activity against various viruses.', 22387093),
('TMC125', 'In high-MOI experiments, 1 muM TMC125 completely inhibited the breakthrough of resistant virus from wild-type and NNRTI-resistant HIV-1, in contrast to efavirenz and nevirapine.', '', 'TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments. TMC125 is a potent new investigational nonnucleoside reverse transcriptase inhibitor (NNRTI) that is active against human immunodeficiency virus type 1 (HIV-1) with resistance to currently licensed NNRTIs.', 16188980),
('BI 207127', 'Rapid virological response (RVR; HCV RNA <15 IU/ml) at day 28 occurred in 11/19 TN and 4/30 TE patients treated with BI 207127.', 'BI 207127 in combination with PegIFN/RBV demonstrated strong antiviral activity with a favourable safety and tolerability profile. The best benefit/risk ratio was observed at 600 mg.', 'Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin. BACKGROUND & AIMS: BI 207127 is a potent non-nucleoside hepatitis C virus (HCV) NS5B polymerase inhibitor in vitro.', 22414766),
('1-[2-(2-Benzoyl- and 2-benzylphenoxy)ethyl]uracils', 'The candidate compounds can be regarded as potential lead compounds against the wild-type virus and drug-resistant forms.', '', '1-[2-(2-Benzoyl- and 2-benzylphenoxy)ethyl]uracils as potent anti-HIV-1 agents. Non-nucleoside reverse transcriptase inhibitors (NNRTI) are key components in highly active antiretroviral therapy for treating HIV-1.', 21903401),
('PSI-353661, a phosphoramidate prodrug of 2''-deoxy-2''-fluoro-2''-C-methylguanosine-5''-monophosphate', 'PSI-352666 is equally active against wild-type NS5B and NS5B containing the S282T amino acid alteration.', '', 'Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661.', 21600932),
('Spiroadamantane amine (3)', 'Inhibits both the M2-WT and M2-V27A mutant with IC50 values of 18.7 and 0.3 microM, respectively', '', 'An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses. Adamantanes such as amantadine (1) and rimantadine (2) are FDA-approved anti-influenza drugs that act by inhibiting the wild-type M2 proton channel from influenza A viruses, thereby inhibiting the uncoating of the virus.', 28087313),
('N-[4-Chloro-3-(3-methyl-2-butenyloxy)phenyl]-2-methyl-3-furanca rbothioamide (UC781)', '1:1 molar combination of UC781 and 3''-azido-3''-deoxythymidine (AZT) showed high-level synergy in inhibiting the replication of AZT-resistant virus, implying that UC781 can restore antiviral activity to AZT against AZT-resistant HIV-1.', '', 'The thiocarboxanilide nonnucleoside inhibitor UC781 restores antiviral activity of 3''-azido-3''-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus type 1. N-[4-Chloro-3-(3-methyl-2-butenyloxy)phenyl]-2-methyl-3-furanca rbothioamide (UC781) is an exceptionally potent nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.', 9925515),
('Analogues of the dicaffeoylquinic acids (DCQAs) and dicaffeoyltartaric acids (DCTAs) [D-chicoric acid, meso-chicoric acid, bis(3,4-dihydroxydihydrocinnamoyl)-L-tartaric acid, digalloyl-L-tartaric acid, bis(3,4-dihydroxybenzoyl)-L-tartaric acid, dicaffeoylglyceric acid, and bis(3, 4-dihydroxyphenylacetyl)-L-tartaric acid]', 'Seventeen of the 34 analogues had potent activity against HIV-1 integrase ranging from 0. 07 to >10 microM.', '', 'Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.', 9986720),
('N-acyl azacyclic ureas (II)', 'The extensive SAR study has yielded a series of N-acyl azacyclic ureas (II), which are highly potent against both wild-type and multiple PI-resistant viral strains.', '', 'Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strains. As part of our efforts to identify potent HIV-1 protease inhibitors that are active against resistant viral strains, structural modification of the azacyclic urea (I) was undertaken by incorporating acyl groups as P(1)'' ligands.', 16203141),
('Benzylpyridinones Compounds 14, 19, and 27', 'IC(50) values ranging from 0.2 to 6 nM', '', 'Synthesis and antiviral activity of 4-benzyl pyridinone derivatives as potent and selective non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors. Several 4-benzyl analogues of 5-ethyl-6-methyl-4-(phenylthio)pyridin-2(1H)-ones were synthesized and evaluated for their anti-HIV-l activities.', 11052800),
('Monosubstituted 5''-O-fatty acyl derivatives of 3TC', 'The monosubstituted 5''-O-fatty acyl derivatives of 3TC (EC(50) = 0.2-2.3 microM) were more potent than the corresponding monosubstituted N(4)-fatty acyl (EC(50) = 0.4-29.4 microM) and 5''-O-N(4)-disubstituted (EC(50) = 72.6 to >154.0 microM) derivatives of the nucleoside. 5''-O-Myristoyl (16) and 5''-O-12-azidododecanoyl derivatives (17) were found to be the most potent compounds (EC(50) = 0.2-0.9 microM) exhibiting at least 16-36-fold higher anti-HIV activity against cell-free virus than 1 (EC(50) = 11.4-32.7 microM).', '', 'Synthesis and biological evaluation of fatty acyl ester derivatives of (-)-2'',3''-dideoxy-3''-thiacytidine. A number of fatty acyl derivatives of (-)-2'',3''-dideoxy-3''-thiacytidine (lamivudine, 3TC, 1) were synthesized and evaluated for their anti-HIV activity. ', 22533850),
('Beta-d-3''-fluoro-2'',3''-unsaturated nucleosides', 'd-3''-fluoro-2'',3''-unsaturated nucleosides against HIV-1 in human peripheral blood mononuclear cells, from which we found that the cytosine derivative 26 was the most potent among the synthesized compounds.', '', 'Synthesis, structure-activity relationships, and drug resistance of beta-d-3''-fluoro-2'',3''-unsaturated nucleosides as anti-HIV Agents. Our recent studies demonstrated that d- and l-2''-fluoro-2'',3''-unsaturated nucleosides (d- and l-2''-F-d4Ns) display moderate to potent antiviral activities against HIV-1 and HBV.', 15189036),
('T-1249', 'Antiretroviral activity, as measured by levels of HIV-1 RNA, was not predicted by baseline susceptibility to T-1249 or to ENF; genotypic substitutions that emerged during T-1249 treatment were identified in virus from some patients', '', 'T-1249 retains potent antiretroviral activity in patients who had experienced virological failure while on an enfuvirtide-containing treatment regimen. BACKGROUND: T-1249 is a 39-amino acid synthetic peptide fusion inhibitor (FI) shown to preserve antiretroviral activity in vitro against human immunodeficiency virus (HIV) isolates that have decreased susceptibility to enfuvirtide (ENF).', 15747252),
('Peramivir conjugates 8 and 9', 'Thus, conjugates 8 and 9 offer better effect to protect MDCK cells from infection of H275Y virus with low EC50 value (?17 nM)', '', 'The C2-OH group of peramivir is elaborated to link with caffeate derivatives, giving the desired conjugates 8 and 9 that possess potent NA inhibitory activity against both wild-type and H275Y viruses with the IC50 values in nanomolar range.', 29324342),
('BMS-986001', 'BMS-986001 inhibited HIV-2 isolates from treatment-naive individuals, with 50% effective concentrations (EC50s) ranging from 30 to 81 nM', '', 'The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1.', 26392486),
('(E)-5-(2-bromovinyl)-2''-deoxyuridine (BVDU)', 'The phosphoramidate derivatives of BVDU that contain L-alanine exhibited potent anti herpes simplex virus type 1 and varicella-zoster virus activity but lost marked activity against thymidine kinase-deficient virus strains.', '', 'The phosphoramidate derivatives of BVDU that contain L-alanine exhibited potent anti herpes simplex virus type 1 and varicella-zoster virus activity but lost marked activity against thymidine kinase-deficient virus strains.', 11900348),
('PF-00868554', 'EC(50) of 0.059 microM', '', 'Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase. Our results indicate that PF-00868554 has potent in vitro antiviral activity against a majority (95.8%) of genotype 1a and 1b replicons, with an overall mean EC(50) of 0.059 microM.', 19307358),
('Betulinic acid derivative IC9564', 'IC9564 blocked HIV type 1 (HIV-1) envelope-mediated membrane fusion.', '', 'Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564. The betulinic acid derivative IC9564 is a potent anti-human immunodeficiency virus (anti-HIV) compound that can inhibit both HIV primary isolates and laboratory-adapted strains.', 11120945),
('Several 3-(2-methylfuranyl)- and 3-(2-methylthienyl)-thiocarboxanilide ester, (thio)ether, and oxime ether derivatives UC-82', '50% effective concentration, 0.009 to 0.021 microM and 0.015 to 0.021 microM respectively', '', 'Several 3-(2-methylfuranyl)- and 3-(2-methylthienyl)-thiocarboxanilide ester, (thio)ether, and oxime ether derivatives showed exquisitely potent antiviral activity against wild-type HIV-1 (50% effective concentration, 0.009 to 0.021 microM).', 8726019),
('Spirodiketopiperazine (SDP) derivative, AK602/ONO4128/GW873140', '50% inhibitory concentration values of 0.1 to 0.6 nM', '', 'Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro. ', 15280474);
INSERT INTO `parasite_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('2-chloro-8-phenylthiomethyl analogue 37', 'Displayed sub-100 nM activity against all HIV-1 RT enzymes tested.', '', 'Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 8. 8-Aryloxymethyl- and 8-arylthiomethyldipyridodiazepinones. The most potent compound was 2-chloro-8-phenylthiomethyl analogue 37 which displayed sub-100 nM activity against all HIV-1 RT enzymes tested.', 9685236),
('1,2,3-Triazole; 4-Oxoquinoline', 'Oxoquinoline derivative 1i with an EC50 of 0.2 microM', '', 'Oxoquinoline derivative 1i was the most potent compound within this series, inhibiting 94% of wild-type (WT) influenza neuraminidase (NA) activity.', 26643220),
('BMS-232632', '50% effective concentration [EC(50)], 2.6 to 5.3 nM; EC(90), 9 to 15 nM', '', 'In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632.', 10952574),
('5-chloro- or 5-bromo-3-[(3,5-dimethylphenyl)sulfonyl]indole-2-carboxyamide', 'Very potent and selective anti-HIV-1 activity against some mutants carrying NNRTI resistant mutations at positions 103 and 181 of the reverse transcriptase.', '', 'Indolyl aryl sulfones (IASs): development of highly potent NNRTIs active against wt-HIV-1 and clinically relevant drug resistant mutants.', 16305512),
('NITD008', 'In cell culture, the compound inhibits EV71 at a 50% effective concentration of 0.67 microM and a 50% cytotoxic concentration of 119.97 microM.', '', 'Inhibition of enterovirus 71 by adenosine analog NITD008. Here we report that NITD008 has potent antiviral activity against EV71.', 25100827),
('Tetra-O-glycyl-NDGA (G(4)N)', 'In yield reduction assays, G(4)N inhibited replication of laboratory and clinical strains of wild type HSV-1 and ACV-resistant (HSV-1(R)) strains of HSV-1 in a dose-dependent manner, with average IC(50) values of 4.7 and 3.2 microM against wild-type and HSV-1(R) strains, respectively.', '', 'Inhibition of HSV-1 replication and reactivation by the mutation-insensitive transcription inhibitor tetra-O-glycyl-nordihydroguaiaretic acid. Methylated derivatives of nordihydroguaiaretic acid (NDGA)were previously shown to be potent mutation-resistant inhibitors of herpes simplex virus type 1 (HSV-1) which target Sp1 protein binding to critical viral promoters.', 12719005),
('Maraviroc (UK-427,857)', 'Maraviroc was active against 200 clinically derived HIV-1 envelope-recombinant pseudoviruses, 100 of which were derived from viruses resistant to existing drug classes.', '', 'Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Maraviroc (UK-427,857) is a selective CCR5 antagonist with potent anti-human immunodeficiency virus type 1 (HIV-1) activity and favorable pharmacological properties.', 16251317),
('(-)-Beta-D-1'',3''-Dioxolane guanosine (DXG) and 2,6-diaminopurine (DAPD) dioxolanyl nucleoside', 'In cellular toxicity analyses, DXG and DAPD had 50% cytotoxic concentrations of greater than 500 microM when tested in peripheral blood mononuclear cells and a variety of human tumor and normal cell lines', '', 'Mechanism of action and in vitro activity of 1'',3''-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants. (-)-Beta-D-1'',3''-Dioxolane guanosine (DXG) and 2,6-diaminopurine (DAPD) dioxolanyl nucleoside analogues have been reported to be potent inhibitors of human immunodeficiency virus type 1 (HIV-1).', 10508010),
('(-)-(2R,4R)-1-(2-Hydroxymethyl-1,3-dioxolan-4yl)thymine (DOT)', 'Has potent in vitro activity against wild-type and nucleoside reverse transcriptase inhibitor (NRTI)-resistant HIV.', '', 'Mechanism of action of (-)-(2R,4R)-1-(2-hydroxymethyl-1,3-dioxolan-4-yl) thymine as an anti-HIV agent. (-)-(2R,4R)-1-(2-Hydroxymethyl-1,3-dioxolan-4yl)thymine (DOT) is a thymidine analogue that has potent in vitro activity against wild-type and nucleoside reverse transcriptase inhibitor (NRTI)-resistant HIV.', 17542153),
('MIV-150 with zinc acetate (ZA)', 'While less potent than NNRTIs, ZA was shown to be active in primary cells against laboratory-adapted and primary HIV-1 isolates and HIV-1 isolates/clones with NNRTI and RT resistance mutations, with EC50 values between 20 and 110 microM.', '', 'MIV-150 and zinc acetate combination provides potent and broad activity against HIV-1. We previously showed that the combination of the non-nucleoside reverse transcriptase inhibitor (NNRTI) MIV-150 with zinc acetate (ZA) formulated in a carrageenan (CG; MZC) gel provided macaques significant protection against vaginal simian-human immunodeficiency virus-RT (SHIV-RT) challenge, better than either MIV-150/CG or ZA/CG.', 28812250),
('GS-5806', '[EC50] = 0.43 nM', '', 'In summary, GS-5806 is a potent and selective RSV fusion inhibitor with antiviral activity against a diverse set of RSV clinical isolates.', 26666922),
('ca603', 'ca603 inhibits rhinovirus replication by interaction with the VP1 protein and, by this, allows to further expand the chemical diversity of capsid-binding molecules.', '', 'In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses. BACKGROUND: Rhinovirus infections do not only cause common colds, but may also trigger severe exacerbations of asthma and chronic obstructive pulmonary disease (COPD). It is confirmed that ca603 inhibits rhinovirus replication by interaction with the VP1 protein and, by this, allows to further expand the chemical diversity of capsid-binding molecules.', 26169596),
('D- and L-2'',3''-didehydro-2'',3''-dideoxy-3''-fluoro-carbocyclic nucleosides', 'Among the synthesized L-series nucleosides, compounds 18, 19, 26 and 28 exhibited moderate antiviral activity (EC50 7.1 microM, 6.4 microM, 10.3 microM, and 20.7 microM, respectively), while among the D-series, the guanosine analogue (35, D-3''-F-C-d4G) exhibited the most potent anti-HIV activity (EC50 0.4 microM, EC90 2.8 microM)', '', 'Among the synthesized L-series nucleosides, compounds 18, 19, 26 and 28 exhibited moderate antiviral activity (EC50 7.1 microM, 6.4 microM, 10.3 microM, and 20.7 microM, respectively), while among the D-series, the guanosine analogue (35, D-3''-F-C-d4G) exhibited the most potent anti-HIV activity (EC50 0.4 microM, EC90 2.8 microM).', 17373782),
('3''-fluoro-3''-deoxythymidine (FLT)', 'IC(50) values for FLT of 0.0014-0.0168 microM', '', 'Anti-HIV type 1 activity of 3''-fluoro-3''-deoxythymidine for several different multidrug-resistant mutants. The objective of this work was to test the antiviral activity of a potent nucleoside reverse transcriptase inhibitor, 3''-fluoro-3''-deoxythymidine (FLT), on both a wild-type human immunodeficiency virus (HIV-1) isolate and multidrug-resistant HIV-1 patient isolates.', 11282008),
('Bicyclam derivative JM3100', 'JM3100 exhibits anti-HIV potency at concentrations ranging from 0.001 to 0.01 micrograms/ml', '', 'Antiviral activity of the bicyclam derivative JM3100 against drug-resistant strains of human immunodeficiency virus type 1. Bicyclams have recently been identified as potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) replication.', 8739608),
('BMS-955176', 'BMS-955176 exhibits potent activity (50% effective concentration [EC50], 3.9 +/- 3.4 nM ) toward a library (n = 87) of gag/pr recombinant viruses representing 96.5% of subtype B polymorphic Gag diversity near the CA/SP1 cleavage site.', '', 'BMS-955176 exhibits potent activity (50% effective concentration [EC50], 3.9 ? 3.4 nM [mean ? standard deviation]) toward a library (n = 87) of gag/pr recombinant viruses representing 96.5% of subtype B polymorphic Gag diversity near the CA/SP1 cleavage site.', 27090171),
('CGP 53437', 'The replication of HIV-1/LAV, HIV-1/Z-84, and HIV-1/pLAI was inhibited with a 90% effective dose of 0.1 microM in acutely infected MT-2 cells.', 'The 50% cytotoxic dose was 100 microM.', 'CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity. CGP 53437 is a peptidomimetic inhibitor of human immunodeficiency virus type 1 (HIV-1) protease containing a hydroxyethylene isostere.', 8257128),
('hexadecyloxypropyl-(S)-HPMPA [HDP-(S)-HPMPA] and octadecyloxyethyl-(S)-HPMPA [ODE-(S)-HPMPA]', 'Ec50 is 0.4 to 0.7 nanomolar, active against HIV variants', '', 'Alkoxyalkyl esters of (S)-9-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine are potent inhibitors of the replication of wild-type and drug-resistant human immunodeficiency virus type 1 in vitro.', 16870786),
('A titanium containing polyoxotungstate, PM-523 and vanadium substituted polyoxotungstate, PM-1001', 'PM-523 exhibited potent anti-influenza virus (FluV) A and anti-respiratory syncytial virus (RSV). PM-1001 has antiviral activity against FluV A, RSV, parainfluenza virus (PfluV) type 2, Dengue fiver virus, HIV-1 and SARS coronavirus in vitro.', '', 'A titanium containing polyoxotungstate, PM-523 exhibited potent anti-influenza virus (FluV) A and anti-respiratory syncytial virus (RSV) activities in vitro.', 16737794),
('Compound-13 (P1-substituted HIV PIs)', 'Compound 13 demonstrated the best balance of potency against drug resistant strains of HIV', '', 'A series of HIV protease inhibitors (PIs) with potent activity against both wild-type (WT) virus and drug-resistant strains of HIV was designed and synthesized.', 21899332),
('Compound 2, a copper(I)-catalyzed 1,2,3-triazole derivative', 'IC 50 = 6.0 nM and 15.7 nM against wild -type protease and ultidrug-resistant 6X protease mutant respectively.', '', 'A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant. Treatment with HIV-1 protease inhibitors, a component of highly active antiretroviral therapy (HAART), often results in viral resistance.', 18823110),
('2''-deoxy-4''-C-ethynyl-2-fluoroadenosine', 'Potent to all human immunodeficiency viruses type 1 (HIV-1s) including multidrug-resistant HIV-1 and has a low toxicity', '', '2''-deoxy-4''-C-ethynyl-2-fluoroadenosine, a nucleoside reverse transcriptase inhibitor, is highly potent against all human immunodeficiency viruses type 1 and has low toxicity. An idea to use 4''-C-substituted-2''-deoxynucleoside derivatives was proposed based on a working hypothesis to solve the problems of existing acquired immune deficiency syndrome chemotherapy (highly active antiretroviral therapy).', 16795005),
('\nNcRTIs (compound A)', 'Treatment of infections with K65R substitution-containing HIV-1 viruses', '', 'Subtype-specific analysis of the K65R substitution in HIV-1 that confers hypersusceptibility to a novel nucleotide-competing reverse transcriptase inhibitor. Compound A is a novel nucleotide-competing HIV-1 reverse transcriptase (RT) inhibitor (NcRTI) that selects for a unique W153L substitution that confers hypersusceptibility to tenofovir, while the K65R substitution in RT confers resistance against tenofovir and enhances susceptibility to NcRTIs.', 25779585),
('Apricitabine (ATC)', 'Promising antiviral activity and effective treatment-experienced patients with M184V', '', 'Antiviral activity of apricitabine in treatment-experienced HIV-1-infected patients with M184V who are failing combination therapy. Apricitabine (ATC) is a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor (NRTI) with significant antiviral activity in vitro, including activity against HIV-1 with reverse transcriptase mutations that confer resistance to other NRTIs.', 21054750),
('Calanolide A, costatolide, and dihydrocostatolide', 'Anti-HIV', '', 'The calanolide isomers represent a novel and distinct subgroup of the NNRTI family, and these data suggest that a compound of the calanolide A series, such as costatolide, should be evaluated further for therapeutic use in combination with other anti-HIV agents.', 10428899),
('WPR-6 : 1-[(benzyloxy)methyl]-6-(3,5-dimethylbenzyl)-5-iodopyrimidine-2,4(1H,3H)-dione', 'EC50 of 2 to 4nM against laboratory-adapted HIV-1 strain SF33 and an EC50 of 7 to 14 nM against nucleoside reverse transcriptase inhibitor-resistant HIV-1 strain 7391.', '', 'The HEPT Analogue WPR-6 Is Active against a Broad Spectrum of Nonnucleoside Reverse Transcriptase Drug-Resistant HIV-1 Strains of Different Serotypes', 26055365),
('Pleconaril variants with F, Cl, Br, CH3, OH and aromatic ring substitutions', 'Pleconaril variants with F, Cl, Br, CH3, OH and aromatic ring substitutions were shown to be effective alternatives to Oseltamivir as anti influenza drugs.', '', 'In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain. Neuraminidase (NA) is a prominent surface antigen of Influenza viruses, which helps in release of viruses from the host cells after replication.', 22340192),
('PF-00868554, non-nucleoside inhibitor (NNI)', 'Activity against hepatitis C virus', '', 'The obtained computational results will have important value for the rational design of novel non-nucleoside inhibitors targeting HCV NS5B polymerase.', 24452008),
('TBZE-029 {1-(2,6-difluorophenyl)-6-trifluoromethyl-1H,3H-thiazolo[3,4-a]benzimidazole}', 'Inhibits enterovirus replication', '', 'The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C.', 18337578),
('Morus alba germin-like protein', 'Silkworm fecal matter is considered one of the richest sources of antimicrobial and antiviral protein (substances)', '', 'Molecular cloning and characterization of novel Morus alba germin-like protein gene which encodes for a silkworm gut digestion-resistant antimicrobial protein. Silkworm fecal matter is considered one of the richest sources of antimicrobial and antiviral protein (substances) and such economically feasible and eco-friendly proteins acting as secondary metabolites from the insect system can be explored for their practical utility in conferring broad spectrum disease resistance against pathogenic microbial specimens.', 23284650),
('BP13944', 'BP13944 reduced the expression of the DENV replicon reporter in cells, showing a 50% effective concentration (EC50) of 1.03 +/- 0.09 microM.', '', 'A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease. Dengue virus (DENV) causes disease globally, resulting in an estimated 25 to 100 million new infections per year.', 24145533),
('Arylthio isopropyl pyridinylmethylpyrrolemethanols (AThPs)', 'Docking experiments of the potent inhibitors 4k (IC(50) = 0.24 microM, SI = 167) and 5e (IC(50) = 0.11 microM, SI > 1667) of wild-type RT prompted the synthesis and biological evaluation of novel AThP derivatives featuring a number of polar groups in position 3 of the pyrrole ring and larger and more hydrophobic alicyclic substituents in place of the isopropyl group at position 4.', '', 'Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies', 17089434),
('KINK-20, a synthetic phosphocholine lipid-AZT conjugate', 'EC50 values were 0.01 and 0.03 microM for INK-20 and 0.0005 and 0.33 microM for AZT, respectively.', '', 'Synthesis and evaluation of a novel synthetic phosphocholine lipid-AZT conjugate that double-targets wild-type and drug resistant variants of HIV.', 15043162),
('N(4)-octyl-6,6-dimethyl-N(2)-(4-methylbenzyl)-1,6-dihydro-1,3,5-triazine-2,4-diamine (HM-242)', 'Potent virucidal activity against enveloped viruses such as influenza virus and herpes simplex virus.', '', 'The antimicrobial activities of N(4)-octyl-6,6-dimethyl-N(2)-(4-methylbenzyl)-1,6-dihydro-1,3,5-triazine-2,4-diam ine (HM-242), a novel synthetic compound, were compared with those of chlorhexidine gluconate (CHG).', 19575042),
('Alcian Blue (AB)', 'Novel synthetic nonpeptidic antiviral drugs targeting the glycans of the envelope of HIV.', '', 'These data suggest that AB is likely endowed with carbohydrate-binding properties and can be considered an important lead compound in the development of novel synthetic nonpeptidic antiviral drugs targeting the glycans of the envelope of HIV.', 19721061),
('Indolocarbazole compounds, G?6976 and NGIC-I', 'Indolocarbazole compounds are potent pUL97 inhibitors and, therefore, represent novel candidates for antiviral drugs that target viral protein kinase functions', '', 'Based on the phosphorylation of ganciclovir (GCV), a novel quantification system for pUL97 kinase activity was established: the phosphorylated form of GCV exerts an easily quantifiable cytotoxic effect in transfected cells.', 11369889),
('Sho-seiryu-to (SST)', 'SST is a novel compund with potential as an anti-HCMV.', '', 'These results suggest that SST is a novel compund with potential as an anti-HCMV.', 16542001),
('lersivirine (UK-453,061)', 'Binds the RT enzyme in a novel way (resulting in a unique resistance profile), inhibits over 60% of viruses bearing key RT mutations, with 50% effective concentrations (EC(50)s) within 10-fold of those for wt viruses, and has excellent selectivity against a range of human targets.', '', 'The emerging candidate, lersivirine (UK-453,061), binds the RT enzyme in a novel way (resulting in a unique resistance profile), inhibits over 60% of viruses bearing key RT mutations, with 50% effective concentrations (EC(50)s) within 10-fold of those for wt viruses, and has excellent selectivity against a range of human targets.', 20660667),
('Raoulic acid', 'raoulic acid was found to possess broad-spectrum antiviral activity against six HRVs with a 50% inhibition concentration of less than 9.5 microg/mL', '', 'Collectively, the results demonstrate that raoulic acid is a novel therapeutic candidate for two different groups of human rhinovirus.', 20412019),
('Isothiafludine (NZ-4)', 'NZ-4 suppressed intracellular HBV replication in HepG2.2.15 cells with an IC?? value of 1.33 micromol/L, whereas the compound inhibited the cell viability with an IC?? value of 50.4 micromol/L.', '', 'Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation. To investigate the action of isothiafludine (NZ-4), a derivative of bis-heterocycle tandem pairs from the natural product leucamide A, on the replication cycle of hepatitis B virus (HBV) in vitro and in vivo.', 24487969),
('Benzenesulfonyl matrinane, 35d', 'Promising anti-enteroviral candidate for the treatment of various diseases infected with coxsackieviruses.', 'The optimized 35d showed the broad-spectrum anti-coxsackieviruse effects, an excellent pharmacokinetics and a good safety profile.', 'SAR evolution and discovery of benzenesulfonyl matrinanes as a novel class of potential coxsakievirus inhibitors.Fifty-one novel 12N-substituted matrinic acid derivatives were synthesized and evaluated for their anti-coxsackievirus B3 activities.', 26867658),
('THC19', 'THC19 acts at a relatively early stage of the viral lifecycle.', 'This compound had no cytotoxic effects and did not disrupt cell cycle progression or induce apoptosis in MDCK cells as confirmed by WST-1 assays, flow cytometry analysis, and caspase-3 assays.', 'Taken together, these results suggest that influenza virus PA protein is a potential target for, and may aid the development of, novel compounds that inhibit influenza A virus replication.', 22441116),
('R1479', 'Potent and highly selective inhibitor of nonstructural protein 5B-directed hepatitis C virus (HCV) replication in vitro.', 'No resistance to R1479 was observed after 14 days of treatment with R1626.', 'Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis C. The nucleoside analog R1479 is a potent and highly selective inhibitor of nonstructural protein 5B-directed hepatitis C virus (HCV) replication in vitro.', 18553458),
('Cyanovirin-N (CV-N)', 'CV-N and related homologs showed highly potent antiviral activity against almost all strains of influenza A and B virus, including clinical isolates and a neuraminidase inhibitor-resistant strain (EC(50) = 0.004 to 0.04 micro g/ml).', '', 'Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin. . The novel antiviral protein cyanovirin-N (CV-N) was initially discovered based on its potent activity against the human immunodeficiency virus (HIV).', 12878514),
('TTP-8307', 'A potent inhibitor of the replication of several rhino- and enteroviruses.', '', 'Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor T A novel compound, TTP-8307, was identified as a potent inhibitor of the replication of several rhino- and enteroviruses.', 19237651),
('VRX-480773', 'Inhibits viruses from efavirenz-resistant molecular clones and most NNRTI-resistant clinical HIV-1 isolates tested', '', 'In this study, we report a novel and potent NNRTI, VRX-480773, that inhibits viruses from efavirenz-resistant molecular clones and most NNRTI-resistant clinical HIV-1 isolates tested.', 17116677),
('Obatoclax', 'Active against alphaviruses, like chikungunya virus (50% effective concentration [EC50] = 0.03 microM) and Semliki Forest virus (SFV; EC50 = 0.11 microM).', '', 'In conclusion, obatoclax is a novel inhibitor of endosomal acidification that prevents viral fusion and that could be pursued as a potential broad-spectrum antiviral candidate.', 27993855),
('Benzodiazepine derivative (compound 7)', 'Compound 7 was validated as an inhibitor of infectious EBOV and Marburg virus (MARV) in cell-based assays, with 50% inhibitory concentrations (IC(50)s) of 10 microM and 12 microM, respectively.', '', 'In summary, we have identified a novel series of benzodiazepine compounds that are suitable for optimization as potential inhibitors of filoviral infection.', 21270170),
('2-(2-benzimidazolyl)-5-[4-(2-imidazolino)phenyl]furan dihydrochloride (DB772)', 'Serum concentrations of DB772 sufficient to inhibit viral replication in calves PI with BVDV types 1 and 2', 'No adverse effects of DB772 administration were detected', 'The purpose of this research was to initiate evaluation of the pharmacokinetic and safety data of a novel antiviral agent in BVDV-free calves and to assess the antiviral efficacy of the same agent in PI calves.', 22182713),
('4-guanidino-Neu5Ac2en, neuraminidase (NA)-specific inhibitor', 'The lowest resistance in cell culture was seen to zanamivir', '', 'The search for compounds with altered pharmacological properties has led to the identification of a novel series of influenza virus NA inhibitors in which the triol group of zanamivir has been replaced by a hydrophobic group linked by a carboxamide at the 6 position (6-carboxamide).', 9499107),
('SC93305', 'Highly effective not only against different HSV-1 and HSV-2 strains but also towards ACV- and multi-resistant HSV-1 and HSV-2 isolates', '', 'In the current study we present SC93305 as a novel potent antiviral substance that proved to be highly effective not only against different HSV-1 and HSV-2 strains but also towards ACV- and multi-resistant HSV-1 and HSV-2 isolates.', 29155164),
('GS-9160', 'GS-9160 has potent and selective antiviral activity in primary human T lymphocytes producing a 50% effective concentration (EC(50)) of approximately 2 nM, with a selectivity index (50% cytotoxic concentration/EC(50)) of approximately 2,000. The antiviral potency of GS-9160 decreased by 6- to 10-fold in the presence of human serum.', '', 'Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase. GS-9160 is a novel and potent inhibitor of human immunodeficiency virus type 1 (HIV-1) integrase (IN) that specifically targets the process of strand transfer. It is an authentic inhibitor of HIV-1 integration, since treatment of infected cells results in an elevation of two-long terminal repeat circles and a decrease of integration junctions.', 19104010),
('GS-9451', 'GS-9451 200 mg/day or 400 mg/day demonstrated potent antiviral activity in both HCV genotype 1a- and 1b-infected patients.', 'No resistance mutations were detected with GS-9451 60 mg/day.', 'A Phase I, randomized, placebo-controlled, 3-day, ascending-dose study of GS-9451, an NS3/4A protease inhibitor, in genotype 1 hepatitis C patients. GS-9451 is a novel inhibitor of the HCV NS3/4A protease and demonstrates potent in vitro suppression of HCV genotype 1 replicons.', 23047118),
('A-315675', 'Influenza virus neuraminidase (NA) inhibitor that has potent enzyme activity and is highly active in cell culture against a variety of strains of influenza A and B viruses.', '', 'A-315675 is a novel influenza virus NA inhibitor that has potent enzyme activity and is highly active in cell culture against a variety of strains of influenza A and B viruses.', 11991966),
('(1S,2S,3R,4R)-3-[(1S)-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-h ydroxy-cyclopentanecarboxylic acid (RWJ-270201, BCX-1812)', 'The 50% effective concentration (EC(50)) values for RWJ-270201 against wild-type and resistant viruses, determined by using a cytopathic effect inhibition assay, were 0.007 and 23 microM, respectively.', '', 'Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.', 11675142),
('RD4-2217, thiadiazole (TDA) derivatives', 'It inhibited replication of the HTLV-IIIB strain in MT-4 cells at a concentration of 6 nM.', '', 'In an attempt to develop more effective and pharmacologically favorable compounds, novel TDA derivatives have been synthesized and examined for their anti-HIV-1 activity in vitro.', 9159403),
('KU-55933', 'Inhibitor of ATM kinase activity, capable of suppressing the replication of both wild-type and drug-resistant HIV-1', '', 'Here we show that the activity of HIV-1 integrase stimulates an ataxia-telangiectasia-mutated (ATM)-dependent DNA damage response, and that a deficiency of this ATM kinase sensitizes cells to retrovirus-induced cell death. Consistent with these observations, we demonstrate that a novel and specific small molecule inhibitor of ATM kinase activity, KU-55933, is capable of suppressing the replication of both wild-type and drug-resistant HIV-1.', 15834407),
('Cyclic urea amide, SD146', 'IC90 is 5.1 nM', '', 'Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV. Cyclic urea amides, a novel series of HIV-1 protease (HIV PR) inhibitors, have increased activity against drug-resistant mutants of the HIV PR.', 9003516),
('EDP-239', 'A single 100-mg dose of EDP-239 resulted in reductions in HCV genotype 1a viral RNA of >3 log10 IU/ml within the first 48 h after dosing and reductions in genotype 1b viral RNA of >4-log10 IU/ml within 96 h', '', 'Preclinical Profile and Clinical Efficacy of a Novel Hepatitis C Virus NS5A Inhibitor, EDP-239. EDP-239, a novel hepatitis C virus (HCV) inhibitor targeting nonstructural protein 5A (NS5A), has been investigated in vitro and in vivo EDP-239 is a potent, selective inhibitor with potency at picomolar to nanomolar concentrations against HCV genotypes 1 through 6.', 27503640),
('Benzimidazole Derivative (B5)', 'Inhibits the HCV life cycle by blocking virus entry', '', 'In conclusion, B5 is a novel interesting anti-HCV molecule that could be used to decipher the early steps of the HCV life cycle.IMPORTANCE: In the last 4 years, HCV therapy has been profoundly improved with the approval of direct-acting antivirals in clinical practice.', 27412600),
('Cyclosporin A (CsA) analog, CPI-431-32', 'As a single agent or in combination with DAAs, to inhibit both HCV and HIV-1 infections.', '', 'Using this co-culture model, we demonstrate that cyclophilin inhibitors (CypI), including a novel cyclosporin A (CsA) analog, CPI-431-32, simultaneously inhibits replication of both HCV and HIV-1 when added pre- and post-infection.', 26263487),
('SCH 900518 (narlaprevir)', 'EC(90)) of 40 nM', '', 'Preclinical characterization of the antiviral activity of SCH 900518 (narlaprevir), a novel mechanism-based inhibitor of hepatitis C virus NS3 protease. Small-molecule hepatitis C virus (HCV) NS3 protease inhibitors such as boceprevir (SCH 503034) have been shown to have antiviral activity when they are used as monotherapy and in combination with pegylated alpha interferon and ribavirin in clinical trials.', 20308381),
('N-(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives', 'EC50 is 0.228 microM', '', 'Viral infectivity factor (Vif) is protective against APOBEC3G (A3G)-mediated viral cDNA hypermutations, and development of molecules that inhibit Vif mediated A3G degradation is a novel strategy for blocking HIV-1 replication.', 28235704),
('Piperidinylamino-diarylpyrimidine (pDAPY) derivatives', 'EC50 = 0.047 and 4.6 microM against both wild-type and drug-resistant mutant virus strains (K103N+Y181C RT) of HIV-1', '', 'Exploring these hybrid molecules with dual binding conformations might provide optional chemical scaffolds as novel HIV-1 reverse transcriptase inhibitors (HIV-1 NNRTIs).', 24239481),
('Pleconaril, guanidine-HCl, and oxoglaucine (PGO)', 'Decreased infectious virus content', '', 'The most important achievement of our previous studies was the development of a novel scheme for in vivo application of a triple combination of EV inhibitors with different modes of action against Coxsackievirus B (CVB) infections in mice.', 26196747),
('Pyrrolobenzoxazepinones (PBOs) derivatives', 'Potent against the most common mutant enzymes, including the highly resistant K103N mutant strain.', '', 'Molecular modeling studies based on the X-ray structures of HIV-1 RT prompted the synthesis of novel analogues which were tested as anti-HIV agents.', 16279773),
('8-hydroxyquinoline tetracyclic lactam', 'Antiviral activity against HIV-1', '', 'A novel series of HIV-1 integrase strand transfer inhibitors were designed using the venerable two-metal binding pharmacophore model and incorporating structural elements from two different literature scaffolds.', 27092410),
('Calix[4]arene-based ?-diketo derivatives', 'Inhibit strand transfer (ST) with IC50 values between 5.9 and 21.2 microM', '', 'Docking studies revealed the predominant binding modes that were distinct from the binding modes of raltegravir, which suggests a novel binding region in the IN active site.', 25682937),
('TMC114', 'EC50s of <10 nM', '', 'TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates. The purpose of this study was to characterize the antiviral activity, cytotoxicity, and mechanism of action of TMC114, a novel human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI).', 15917527),
('Leflunomide', 'Inhibits the production of multiple clinical CMV isolates (including multi-drug-resistant virus) in both human fibroblasts and endothelial cells.', '', 'These findings imply that leflunomide, an effective immunosuppressive agent, shows potential to concurrently attenuate a major complication of immunosuppression, CMV disease, by a novel mechanism of antiviral activity.', 10702725),
('AIC246 (Letermovir)', 'AIC246 blocks viral replication without inhibiting the synthesis of progeny HCMV DNA or viral proteins', '', 'The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.', 21752907),
('ACH-806', 'This compound was synergistic with NS3 protease inhibitors and NS5B nucleoside and nonnucleoside polymerase inhibitors.', '', 'ACH-806 is a hepatitis C virus NS4A inhibitor with a novel mechanism of action and resistance pathway.', 18332167),
('Alpha-hydroxy-glycineamide (alpha-HGA)', 'Inhibits the replication of clinical HIV-1 isolates with acquired resistance to reverse transcriptase and protease inhibitors', '', 'As an antiviral compound, alpha-HGA has an unusually simple structure, a pronounced antiviral specificity, and a novel mechanism of antiviral action.', 18644965),
('GRL-0739, a novel nonpeptidic HIV-1 protease inhibitor containing tricycle (cyclohexyl-bis-tetrahydrofuranylurethane [THF]) and a sulfonamide isostere', 'Highly active against laboratory HIV-1 strains and primary clinical isolates (50% effective concentration [EC50], 0.0019 to 0.0036 microM)', 'M, with minimal cytotoxicity (50% cytotoxic concentration [CC50], 21.0 microM)', 'A novel tricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor, GRL-0739, effectively inhibits the replication of multidrug-resistant HIV-1 variants and has a desirable central nervous system penetration property in vitro', 25691652),
('Pradimicin A (PRM-A)', 'It invariably inhibits representative virus strains of a variety of HIV-1 clades with X4 and R5 tropisms at nontoxic concentrations.', '', 'PRM-A represents the first prototype compound of a nonpeptidic CBA lead and, together with peptide-based lectins, belongs to a conceptually novel type of potential therapeutics for which drug pressure results in the selection of glycan deletions in the HIV gp120 envelope.', 17050611),
('GS-9451', 'In multiple GT1a and GT1b replicon cell lines, GS-9451 had mean 50% effective concentrations (EC50s) of 13 and 5.4 nM, respectively, with minimal cytotoxicity', '', 'Preclinical characterization of the novel hepatitis C virus NS3 protease inhibitor GS-9451. GS-9451 is a selective hepatitis C virus (HCV) NS3 protease inhibitor in development for the treatment of genotype 1 (GT1) HCV infection.', 23939899),
('MK-4519', '(EC(50)) of 1.8 nM and MK-4519 is highly active against genotype 1b HCV', '', 'Pharmacodynamic analysis of a serine protease inhibitor, MK-4519, against hepatitis C virus using a novel in vitro pharmacodynamic systemThe development of new antiviral compounds active against hepatitis C virus (HCV) has surged in recent years.', 22155837),
('2'',3''-Didehydro-3''-deoxy-4''-ethynylthymidine (4''-Ed4T)', 'The purified RT of mutants with the P119S/M184V and T165A/M184V mutations were inhibited by 4''-Ed4TTP with 8- to 13-fold less efficiency than wild-type RT.', '', 'Impact of novel human immunodeficiency virus type 1 reverse transcriptase mutations P119S and T165A on 4''-ethynylthymidine analog resistance profile.2'',3''-Didehydro-3''-deoxy-4''-ethynylthymidine (4''-Ed4T), a derivative of stavudine (d4T), has potent activity against human immunodeficiency virus and is much less inhibitory to mitochondrial DNA synthesis and cell growth than its progenitor, d4T.', 19704131),
('Samatasvir (IDX719)', 'EC50s falling within a tight range of 2 to 24 pM in genotype 1 through 5 replicon. The EC90/EC50 ratio was low (2.6). A 50% cytotoxic concentration (CC50) of >100 microM provided a selectivity index of >5 ? 10(7)', '', 'In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus. The hepatitis C virus (HCV) nonstructural 5A (NS5A) protein is a clinically validated target for drugs designed to treat chronic HCV infection.', 24867983),
('H1PVAT', 'Inhibitor of poliovirus replication that targets VP1', '', 'A novel small molecule, H1PVAT, was identified as a potent and selective inhibitor of the in vitro replication of all three poliovirus serotypes, whereas no activity was observed against other enteroviruses.', 25043639),
('Azvudine', 'Highly potent inhibition on HIV-1 (EC(50)s ranging from 0.03 to 6.92 nanoM), HIV-2 (EC(50)s ranging from 0.018 to 0.025 nanoM) and NRTI-resistant strains (L74V and T69N).', '', 'Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro. Azvudine is a novel nucleoside reverse transcriptase inhibitor with antiviral activity on human immunodeficiency virus, hepatitis B virus and hepatitis C virus.', 25144636),
('BPR2-D2', 'BPR2-D2 exhibited an excellent antiviral efficacy for the oseltamivir-resistant virus (EC(50) ranging from 0.021 to 0.040 microM', '', 'BPR2-D2 was identified as a novel inhibitor against influenza virus from a hit obtained from high throughput screening of 20 000 or more compounds.', 19892833),
('SC29EK', 'SC29EK blocked the replication of T-20-resistant HIV-1 strains and maintained antiviral activity even in the presence of high serum concentrations (up to 50%).', '', 'We have developed a novel HIV fusion inhibitor, SC34EK, which is a gp41-derived 34-amino-acid peptide with glutamate (E) and lysine (K) substitutions on its solvent-accessible site that stabilize its alpha-helicity.', 19114674),
('DMP 450 (bis-methanesulfonic acid salt)', 'A plasmid-based, in vivo assay model suggests that maintenance of plasma levels of DMP 450 near the antiviral IC90 suppresses HIV protease activity in the animal.', '', 'RESULTS: We have synthesized DMP 450 (bis-methanesulfonic acid salt), a water-soluble cyclic urea compound and a potent inhibitor of HIV replication in cell culture that also inhibits variants of HIV with single amino acid substitutions in the protease.', 8807858),
('Cyclo-D4G', 'Possessed anti-HIV activity', '', 'Novel use of a guanosine prodrug approach to convert 2'',3''-didehydro-2'',3''-dideoxyguanosine into a viable antiviral agent. Transient kinetic studies with human immunodeficiency virus (HIV) type 1 reverse transcriptase suggest that nucleotide analogs containing the 2'',3''-didehydro-2'',3''-dideoxy ribose ring structure present in D4T (stavudine) triphosphate are among the most effective alternative substrates.', 11850281),
('GRL-057-14, GRL-058-14, and GRL-059-14, all of which contain a P2-amino-substituted-bis-tetrahydrofuranylurethane (bis-THF) and a P2''-cyclopropyl-amino-benzothiazole (Cp-Abt).', 'These PIs not only potently inhibit the replication of wild-type HIV-1 (50% effective concentration [EC50], 0.22 nM to 10.4 nM) but also inhibit multi-PI-resistant HIV-1 variants, including highly DRV-resistant HIVDRV R P51 (EC50, 1.6 nM to 30.7 nM).', '', 'Combination antiretroviral therapy has achieved dramatic reductions in the mortality and morbidity in people with HIV-1 infection.', 31085520),
('tenofovir alafenamide (TAF) and OBP-601(2,3-didehydro-3-deoxy-4-ethynylthymidine)', 'TAF and OBP-601 inhibited the replication of almost all isolates at a median EC50 of 0.27 nM and 6.83 nM, respectively.', '', 'New antiretroviral drugs are needed to treat HIV-2 infected patients failing therapy.', 30391482),
('dihydrofuro[3,4- d]pyrimidine derivatives 13c2 and 13c4', 'Against a wide range of HIV-1 strains carrying single NNRTI-resistant mutations (EC50 = 0.9-8.4 nM), which were remarkably superior to that of etravirine (ETV)', '', 'the small molecule inhibited HBsAg production and hepatitis B virion secretion (10 ?M) at low micromolar concentrations and was also efficacious against a HBV quadruple mutant (CYEI mutant) resistant to tenofovir.', 30624934),
('2,4,5-Trisubstituted Pyrimidines', 'EC50 = 24.4 nM', '', 'Furthermore, 16c demonstrated favorable pharmacokinetic and safety properties, suggesting the potential of 16c as a promising anti-HIV-1 drug candidate.', 33734714),
('ZINC20451377', 'KD of 65.3 nM', '', 'Prolonged therapy with nucleoside/nucleotide analogues targeting the HBV-polymerase may lead to resistance and rarely results in the loss of HBsAg.', 34083665),
('Novel Boron-Containing N-Substituted Oseltamivir Derivatives- 4-(3-boronic acid benzyloxy)benzyl group (2c)', 'OSC showed a greater inhibitory potency toward wild-type NAs with IC50 values of 1.1 ', 'low cytotoxicity in vitro and no acute toxicity at the dose of 1000 mg/kg in mice', '4-(3-boronic acid benzyloxy)benzyl group was employed to provide a possible explanation for Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant', 36234966),
('Baloxavir acid (BXA), the active compound in baloxavir marboxil (BXM),', 'reduces the propagation of influenza A and B viruses by inhibiting the cap-dependent endonuclease activity of the polymerase acidic (PA) subunit.', '', 'The IC50 of BXA toward influenza A viruses containing PA E198K increased approximately 2- to 6-fold. These findings help to understand the mechanism by which PA substitutions reduce susceptibility to BXA.', 35511288),
('Dibenz[a,h]acridine, dibenz[a, i]acridine, NSC114903, dibenz[c,h]acridine, benzo[ a]acridine and their derivatives', 'The binding energy of the modified ligands of HIV-1 subtype C proteases increased, including the poorest-performing molecules.', '', 'Conclusion: Dibenz[a,h]acridine, dibenz[a, i]acridine, NSC114903, dibenz[c,h]acridine, benzo[ a]acridine and their derivatives might be considered as promising HIV-1 subtype C protease inhibitors. This could be confirmed through synthesis and subsequent in vitro assays.', 35114926),
('brequinar and homoharringtonine', 'potent HEV inhibitors, which are also effective against the ribavirin resistance variant harboring G1634R mutation', '', 'Thus, successful recapitulation of HEV infection in liver-derived organoids shall facilitate the study of virus-host interactions and development of antiviral therapies.', 35044825),
('6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives', 'new lead compound 13e, which exhibited an EC50 value of 4.50 MicroM against H1N1 influenza virus in MDCK cells', '', 'Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PAN inhibitors', 34700269),
('polyionenes containing quaternary ammoniums and varying hydrophobic components', 'The polyionenes with optimal compositions inactivates mouse hepatitis virus (MHV) completely in 30 s. More importantly, the polyionenes are effective in inhibiting SARS-CoV-2 by >99.999% within 30 s.', 'do not cause damage to the skin and have a high oral lethal dose', 'Overall, these polyionenes are promising active ingredients for disinfection and prevention of viral and microbial infections.', 34694749);

-- --------------------------------------------------------

--
-- Table structure for table `parasite_np`
--

CREATE TABLE IF NOT EXISTS `parasite_np` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

-- --------------------------------------------------------

--
-- Table structure for table `pathogen`
--

CREATE TABLE IF NOT EXISTS `pathogen` (
  `Bacteria` varchar(1000) NOT NULL,
  `Virus` varchar(1000) NOT NULL,
  `Fungi` varchar(1000) NOT NULL,
  `Parasite` varchar(1000) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `pathogen`
--

INSERT INTO `pathogen` (`Bacteria`, `Virus`, `Fungi`, `Parasite`) VALUES
('A. invadans', 'Antipicornavirus', 'Alternaria longipes', 'Babesia bigemina'),
('A. salmonicida', 'Avian H5n1 Flu Strains', 'Alternaria solani?', 'Babesia bovis'),
('Actinobacillus pleuropneumoniae.', 'Bovine Viral Diarrhoea Virus (Bvdv)', 'Aspergillus calidoustus', 'Babesia caballi'),
('Actinomyces naeslundii', 'Chikungunya Virus (Chikv)', 'Aspergillus clavatus', 'Giardia lamblia'),
('Ames Bacillus anthracis', 'Coxsackie B5 Virus', 'Aspergillus flavus', 'Leishmania'),
('AmpC beta-lactamase', 'Coxsackie Virus A16, A21, A24', 'Aspergillus fumigatus', 'Leishmania amastigotes'),
('Arcanobacterium pyogenes', 'Coxsackie Virus B3', 'Aspergillus nidulans', 'Leishmania amazonensis'),
('B. abortus 2308', 'Coxsackievirus', 'Aspergillus niger', 'Leishmania braziliensis'),
('B. anthracis', 'Coxsackievirus B3', 'Aspergillus oryzae', 'Leishmania chagasi'),
('B. cenocepacia K56-2', 'Dengue Fiver Virus', 'Aspergillus tubingensis', 'Leishmania donovani'),
('Bacillus anthracis acetohydroxyacid synthase', 'D-Peptide HIV', 'Blastomyces', 'Leishmania infantum'),
('Bacillus cereus', 'Duckling Hepatitis B Virus Dna ', 'Botrytis cinerea', 'Leishmania major'),
('Bacillus subtilis', 'Ebola Virus (Ebov)', 'Candida albicans', 'Plasmodium falciparum'),
('Bacteroides fragilis', 'Ebov', 'Candida glabrata', 'promastigotes'),
('Branhamella catarrhalis', 'Echovirus 9', 'Candida Guilliermondii', 'Theileria equi '),
('C. difficile', 'Enfuvirtide-Resistant Virus', 'Candida krusei', 'Trichomonas vaginalis'),
('C. neoformans', 'Enterovirus', 'Candida lusitaniae', 'Trypanosoma brucei'),
('C. trachomatis and C. pneumoniae', 'Enterovirus 71 (Ev71)', 'Candida parapsilosis', 'Trypanosoma cruzi'),
('Campylobacter jejuni', 'Equine Herpesvirus 1', 'Candida utilis', ''),
('Candida albicans', 'Fluv A', 'Candida yeasts', ''),
('Chlamydia pneumoniae', 'Gammaherpesvirus', 'Candida zeylanoides', ''),
('Coagulase-negative staphylococci (CoNS)', 'Ganciclovir (Gcv) Resistant Hcmvs?', 'Candida?tropicalis', ''),
('Cronobacter spp.', 'H1n1 Influenza', 'Cercospora beticola', ''),
('doxycycline-resistant MRSA', 'H1N1 Virus', 'Coccidioides', ''),
('Enterobacter aerogenes', 'H275y Virus?', 'Colletotrichum falcatum', ''),
('Enterobacteriaceae', 'H5n1 (Rg14)', 'Cryptococcus gattii', ''),
('Enterococcus faecalis', 'Hcv Ns5b Polymerase', 'Cryptococcus neoformans', ''),
('Enterococcus faecium', 'Hepatitis B Virus', 'F. avenaceum', ''),
('Escherichia coli', 'Hepatitis B Virus Surface Antigen (Hbsag)', 'F. keratoplasticum', ''),
('Fusobacterium nucleatum ATCC 10953', 'Hepatitis C Virus', 'F. moniliforme', ''),
('H. pylori', 'Hepatitis C Virus (HCV)', 'Fusarium oxysporum', ''),
('Haemophilus influenzae ', 'Hepatitis C Virus (Hcv) Ns5a', 'Histoplasma', ''),
('heterogeneous vancomycin-intermediate S. aureus (hVISA)', 'Hepatitis C Virus Ns4b Protein', 'Histoplasma capsulatum', ''),
('Legionella spp. ', 'Herpes Infection', 'M. slooffiae', ''),
('marine pathogen Tenacibaculum maritimum', 'Herpes Simplex Type 2 (Hsv-2) And Adenovirus Type 5 (Ad-5)', 'Malassezia sympodialis', ''),
('MDR Acinetobacter spp.', 'Herpesvirus Polymerases', 'Microsporum canis', ''),
('MDR strain of S. aureus and E. coli', 'Herpesviruses ', 'Microsporum gypseum', ''),
('Moraxella catarrhalis', 'HIV', 'Neurospora crassa', ''),
('MRSA', 'HIV-1', 'Paecilomyces variotii', ''),
('MRSA S186', 'HIV-1 (Iiib)', 'Paracoccidioides brasiliensis', ''),
('MSSA 29213   ', 'HIV-1 (Rtmdr-1) Strains', 'pathogenic yeasts', ''),
('Mycobacterium abscessus', 'HIV-1 Integrase And Rnase H', 'Phycomyces blakesleeanus', ''),
('Mycobacterium avium', 'HIV-1 Maturation Inhibitor', 'Pyrenophora teres', ''),
('Mycobacterium bovis  ', 'HIV-1 Protease', 'Pyrenophora tritici-repentis', ''),
('Mycobacterium smegmatis', 'HIV-1 Reverse Transcriptase', 'Ramularia collo-cygni', ''),
('Mycobacterium smegmatis ', 'HIV-1 Rt', 'Rhizoctonia solani', ''),
('Mycobacterium tuberculosis', 'HIV-1(Iiib-R)', 'Rhizopus oryzae', ''),
('Mycoplasma pneumoniae ', 'HIV-1, Ec(50)', 'Saccharomyces cerevisiae', ''),
('N. gonorrhoeae.', 'HIV-1, Ic(50)', 'Scopulariopsis brevicaulis', ''),
('Neisseria meningitidis', 'HIV-1lai', 'Sporothrix schenckii', ''),
('P. gingivalis', 'HIV-1mn', 'Trichoderma viride', ''),
('P. intermedia', 'HIV-1rf ', 'Trichophyton interdigitale', ''),
('P. mirabilis', 'HIV-2', 'Trichophyton mentagrophytes', ''),
('penicillin-resistant Streptococcus pneumoniae', 'HIV-2rod', 'Trichophyton rubrum', ''),
('polymyxin-resistant P. aeruginosa', 'HIVa02', 'Trichophyton tonsurans', ''),
('Prevotella melaninogenica', 'HSV-1', 'Trichosporon asahii', ''),
('propionibacteria', 'HSV-2', 'Zygosaccharomyces bailii', ''),
('Propionibacterium acnes', 'Htlv-Iiib Strain', 'Zymoseptoria tritici', ''),
('Proteus sp', 'Human Cytomegalovirus', '', ''),
('Pseudomonas aeruginosa', 'Human Cytomegalovirus (Hcmv)', '', ''),
('Pseudomonas spp.', 'Human Cytomegalovirus (Hcmv) ', '', ''),
('quinolone-resistant A. Baumannii', 'Human Cytomegalovirus (Hcmv) And Varicella Zoster Virus (Vzv)', '', ''),
('S. aureus Newman', 'Human Cytomegalovirus Ul97', '', ''),
('S. cerevesiae  ', 'Human Hbv ', '', ''),
('S. epidermidis', 'Human Herpes Simplex Virus( Hsv-2)', '', ''),
('S. intermedius', 'Influenza A And B Virus And Respiratory Syncytial Virus (Rsv)', '', ''),
('S. maltophilia', 'Influenza A Virus (Iav)', '', ''),
('S. marcescens ', 'Influenza A Virus Strains?', '', ''),
('S. pyogenes ', 'Influenza A Viruses', '', ''),
('S. salivarius', 'Influenza A Viruses ', '', ''),
('SA-1199B strain', 'Listeria', '', ''),
('Salmonella typhimurium ', 'Marburg Virus (Marv)', '', ''),
('Salmonella typhimurium  ', 'Multidrug-Resistant Hiv-1 Variants', '', ''),
('Serratia marcescens', 'Multiple-Drug-Resistant (Mdr) Tb?', '', ''),
('serum pantetheinase', 'Murine Norovirus (Mnv) ', '', ''),
('Shigella flexneri', 'Norovirus', '', ''),
('Shigella flexneri ', 'P2009 Influenza A', '', ''),
('Staphylococcus aureus', 'Parainfluenza Virus (Pfluv) Type 2', '', ''),
('Staphylococcus pseudintermedius', 'Respiratory Syncytial Virus', '', ''),
('Staphylococcus spp.', 'Respiratory Syncytial Virus (Rsv)', '', ''),
('Streptococcus agalactiae ', 'Rhinovirus', '', ''),
('Streptococcus mitis', 'Rilpivirine-Resistant Mutant Virus', '', ''),
('Streptococcus pneumoniae ', 'Sars Coronavirus In Vitro', '', ''),
('Streptococcus pyogenes', 'Semliki Forest Virus', '', ''),
('Streptococcus suis', 'SIV', '', ''),
('V. vulnificus', 'Specific Hiv-1 Protease?', '', ''),
('vancomycin-intermediate S. aureus (VISA)  ', 'Varicella Zoster Virus (Vzv)', '', ''),
('vancomycin-resistant S. aureus (VRSA)', 'Varicella-Zoster Virus (Vzv)', '', ''),
('Vibrio fischeri', 'Wild-Type Hiv', '', ''),
('Y. ruckeri', 'Wild-Type Hiv Protease', '', '');

-- --------------------------------------------------------

--
-- Table structure for table `related_database`
--

CREATE TABLE IF NOT EXISTS `related_database` (
  `CATEGORY` varchar(200) NOT NULL,
  `NAME` varchar(50) NOT NULL,
  `DATABASE FOCUS` varchar(1000) NOT NULL,
  `LINK` varchar(500) CHARACTER SET ascii COLLATE ascii_bin NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `related_database`
--

INSERT INTO `related_database` (`CATEGORY`, `NAME`, `DATABASE FOCUS`, `LINK`, `PMID`) VALUES
('Antimicrobial peptide database', 'PhytAMP', 'Antimicrobial plant peptides', 'https://webs.iiitd.edu.in/raghava/satpdb/catalogs/phytamp/', 18836196),
('Antimicrobial peptide database', 'DBAASP', 'Chemical, 3D structure  and activity for experimentally evaluated antimicrobial peptides', 'https://dbaasp.org/', 24888447),
('Antimicrobial peptide database', 'APD', 'Antibacterial, antifungal, antiviral and antitumor peptides', 'https://aps.unmc.edu/', 14681488),
('Antimicrobial peptide database', 'CAMPR3', 'Sequences, structures and signatures of antimicrobial peptides', 'http://www.camp.bicnirrh.res.in/', 26467475),
('Antimicrobial peptide database', 'DRAMP', 'Repository of  general AMPs,  patented sequences and peptides in drug development', 'http://dramp.cpu-bioinfor.org/', 27075512),
('Antimicrobial peptide database', 'AntiTbPdb', 'Experimentally validated anti-tubercular peptides compiled from literature', 'https://webs.iiitd.edu.in/raghava/antitbpdb/', 29688365),
('Antimicrobial peptide database', 'AVPdb', 'Experimentally validated antiviral peptides', 'https://webs.iiitd.edu.in/raghava/satpdb/catalogs/avpdb/', 24285301),
('Antimicrobial peptide database', 'ParaPep', 'Experimentally validated antiparasitic peptide sequences and their structures', 'https://webs.iiitd.edu.in/raghava/parapep/help.php', 24923818),
('Antimicrobial peptide database', 'DADP', 'Manually curated database of antimicrobial and other defense peptides from frog', 'http://split4.pmfst.hr/dadp/', 22467909),
('Antimicrobial peptide database', 'BaAMPs', 'Biofilm-active antimicrobial peptides', 'http://www.baamps.it/', 25760404),
('Antimicrobial peptide database', 'LAMP', 'Antimicrobial peptide with information about their antimicrobial activity and cytotoxicity', 'http://biotechlab.fudan.edu.cn/database/lamp/', 23825543),
('Antimicrobial peptide database', 'BACTIBASE', 'Bacteriocins with activity against various human and animal pathogens', 'http://bactibase.hammamilab.org/main.php', 17941971),
('Antimicrobial peptide database', 'THPdb', 'FDA-approved peptide and protein therapeutics', 'https://webs.iiitd.edu.in/raghava/thpdb/keyword.php', 28759605),
('Antimicrobial peptide database', 'PlantAFP', 'Plant-origin antifungal peptides', 'http://bioinformatics.cimap.res.in/sharma/PlantAFP/', 31612325),
('Antimicrobial peptide database', 'MimoDB', 'Pepository for therapeutic peptides', 'https://dbpedia.org/page/MimoDB', 21079566),
('Antimicrobial peptide database', 'YADAMP', 'Antimicrobial peptides from all biological sources active against bacteria.', 'https://webs.iiitd.edu.in/raghava/satpdb/catalogs/yadamp/', 22325123),
('Molecule', 'AntibioticDB', 'Clinically relevent antibacterial compounds', 'https://antibioticdb.com/', 29897476),
('Molecule', 'ChemDB', 'Database of small molecules and related chemoinformatics resources', 'http://chemdb.ics.uci.edu/', 16174682),
('Molecule', 'ASDCD', 'Antifungal synergistic drug combination', 'http://asdcd.amss.ac.cn/', 24475134),
('Molecule', 'DenvInD', 'Dengue virus inhibitors database', 'https://webs.iiitd.edu.in/raghava/denvind/', 32510549),
('Drug Target', 'TDD', 'Known therapeutic protein and nucleic acid targets described in the literature', 'http://db.idrblab.net/ttd/', 11752352),
('Drug Target', 'PfalDB', 'Drug target and chemical database for Plasmodium falciparum', 'http://indirag.org/database/3', 25198774),
('Drug Target', 'Clostridium-DTDB', 'Rotential drug targets with their structural information from Clostridium difficile', 'http://clostridium.bicpu.edu.in/', 23415847),
('Drug Target', 'sc-PDB', 'Three-dimensional structures of druggable binding sites', 'http://bioinfo-pharma.u-strasbg.fr/scPDB/', 16563002),
('Gene/ Sequence', 'CARD', 'Database of resistance genes, their products and associated phenotypes', 'https://card.mcmaster.ca/', 23650175),
('Gene/ Sequence', 'MEGARes', 'High-Throughput Sequencing database', 'https://megares.meglab.org/', 27899569),
('Gene/ Sequence', 'VFDB', 'Database of virulence factors of bacterial pathogens', 'http://www.mgc.ac.cn/VFs/', 15608208),
('Gene/ Sequence', 'PATRIC', 'Consistent annotations across all sequenced bacterial species ', 'https://www.patricbrc.org/', 24225323),
('Gene/ Sequence', 'Mustard', 'Antimicrobial resistance genes and AR Determinants', 'http://mgps.eu/Mustard/', 30478291),
('Gene/ Sequence', 'BacMet', 'antibacterial biocide and metal resistance genes', 'http://bacmet.biomedicine.gu.se/', 24304895),
('Gene/ Sequence', 'MARDy', 'Database of antifungal drug resistance mechanisms, including amino acid substitutions, tandem repeat sequences and genome ploidy', 'http://www.mardy.net/', 29897419),
('Gene/ Sequence', 'FARME DB', 'Functional metagenomic antibiotic resistance (AR) gene elements', 'http://staff.washington.edu/jwallace/farme/', 28077567),
('Gene/ Sequence', 'u-CARE', 'Antibiotics with reported resistance, 107 genes, transcription factors and single nucleotide polymorphism (SNPs) involved in multiple drug resistance', 'http://www.e-bioinformatics.net/ucare/', 25935546),
('Gene/ Sequence', 'ARDB', 'Annotation of gene and resistance type', 'https://ardb.cbcb.umd.edu/', 18832362);

-- --------------------------------------------------------

--
-- Table structure for table `related_link`
--

CREATE TABLE IF NOT EXISTS `related_link` (
  `NAME` varchar(100) NOT NULL,
  `DATABASE FOCUS` varchar(500) NOT NULL,
  `LINK` varchar(200) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `related_link`
--

INSERT INTO `related_link` (`NAME`, `DATABASE FOCUS`, `LINK`, `PMID`) VALUES
('CARD', 'Database of resistance genes, their products and associated phenotypes', 'https://card.mcmaster.ca/', 23650175),
('MEGARes', 'High-Throughput Sequencing database', 'https://megares.meglab.org/', 27899569),
('VFDB', 'Database of virulence factors of bacterial pathogens', 'http://www.mgc.ac.cn/VFs/', 15608208),
('PATRIC', 'Consistent annotations across all sequenced bacterial species ', 'https://www.patricbrc.org/', 24225323),
('Mustard', 'Antimicrobial resistance genes and AR Determinants', 'http://mgps.eu/Mustard/', 30478291),
('BacMet', 'antibacterial biocide and metal resistance genes', 'http://bacmet.biomedicine.gu.se/', 24304895),
('MARDy', 'Database of antifungal drug resistance mechanisms, including amino acid substitutions, tandem repeat sequences and genome ploidy', 'http://www.mardy.net/', 29897419),
('FARME DB', 'Functional metagenomic antibiotic resistance (AR) gene elements', 'http://staff.washington.edu/jwallace/farme/', 28077567),
('u-CARE', 'Antibiotics with reported resistance, 107 genes, transcription factors and single nucleotide polymorphism (SNPs) involved in multiple drug resistance', 'http://www.e-bioinformatics.net/ucare/', 25935546),
('ARDB', 'Annotation of gene and resistance type', 'https://ardb.cbcb.umd.edu/', 18832362);

-- --------------------------------------------------------

--
-- Table structure for table `table 30`
--

CREATE TABLE IF NOT EXISTS `table 30` (
  `COL 1` varchar(378) DEFAULT NULL,
  `COL 2` varchar(1327) DEFAULT NULL,
  `COL 3` varchar(385) DEFAULT NULL,
  `COL 4` varchar(619) DEFAULT NULL,
  `COL 5` varchar(8) DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `table 30`
--

INSERT INTO `table 30` (`COL 1`, `COL 2`, `COL 3`, `COL 4`, `COL 5`) VALUES
('Antimicrobial peptide KLKLLLLLKLK-NH2 and its D-enantiomer', 'Significant chemotherapeutic activity in MRSA-infected mice', '', 'Chemotherapeutic activity of synthetic antimicrobial peptides: correlation between chemotherapeutic activity and neutrophil-activating activity', '9326370'),
('Protegrin-1', '', '', 'CONCLUSIONS: This study shows that protegrin-1 potentially may be used as an alternative or adjunct therapy to standard agents used to treat wound infections.', '11445704'),
('Brevinin-2 peptides from the skin of the Hokkaido frog, Rana pirica', 'The most abundant peptide, brevinin-2PRa (680 nmol/g weight of dry skin) showed high potency [minimal inhibitory concentration (MIC) values between 6 and 12 microM] against a range of clinical isolates of P. aeruginosa.', '', 'A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Nine peptides displaying varying degrees of antimicrobial activity were extracted from the skin of the Hokkaido frog, Rana pirica.', '15003829'),
('Antimicrobial peptide, human lactoferrin 1-11 (hLF1-11)', '', '', 'The hLF1-11-treated group also had a significantly lower radiological score compared to the gentamicin-treated group. This study demonstrates the efficacy of hLF1-11 incorporated into Ca-P bone cement as a possible therapeutic strategy for the treatment of osteomyelitis, showing efficacy comparable to that of gentamicin.', '15917544'),
('[fMLF]PMBN and [fMLF]PMEN', '', '', 'Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria', '16048913'),
('Phenothiazinium', 'We used MDR-deficient mutants of Staphylococcus aureus (NorA), Escherichia coli (TolC), and Pseudomonas aeruginosa (MexAB) and found 2 to 4 logs more killing than seen with wild-type strains by use of three different phenothiazinium PSs and red light.: Mutants that overexpress MDRs were protected from killing compared to the wild type.', 'Antimicrobial photodynamic therapy (PDT) combines a nontoxic photoactivatable dye, or photosensitizer (PS), with harmless visible light to generate singlet oxygen and free radicals that kill microbial cells.', 'Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrobial photodynamic therapy (PDT) combines a nontoxic photoactivatable dye, or photosensitizer (PS), with harmless visible light to generate singlet oxygen and free radicals that kill microbial cells.', '16377686'),
('Natural toxins and animal venoms (snakes, scorpions and honey bee venoms)', 'Antimicrobial activity against Burkholderia pseudomallei', '', 'In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei', '16784542'),
('Antimicrobial peptides (AMPs), UBI 1-59 and synthetic fragments comprising amino acids 31-38', 'In vitro killing of MRSA by synthetic peptides derived from the alpha-helix or beta-sheet domains of the human cationic peptide ubiquicidin (UBI 1-59), allowed selection of AMPs for possible treatment of MRSA infections. The strongest antibacterial activity was observed for the entire peptide UBI 1-59 and for synthetic fragments comprising amino acids 31-38.', '', 'The availability, chemical synthesis opportunities, and size of these small peptides, combined with their strong antimicrobial activity towards MRSA make these compounds promising candidates for antimicrobial therapy and detection of infections in man. ', '16814900'),
('Hyaluronic acid binding peptides', 'Effective in experimental surgical wound infections caused by S. aureus', '', 'Treatment with these peptides was highly efficacious in reducing the number of S. aureus cells at the wound site and ameliorated the inflammatory host response associated with these infections.', '17065624'),
('Defr1, covalent dimer species of beta-defensin', 'Antimicrobial activity against Pseudomonas aeruginosa PAO1 and an extended panel of multidrug-resistant nosocomial pathogens', '', 'Covalent dimer species of beta-defensin Defr1 display potent antimicrobial activity against multidrug-resistant bacterial pathogens. Beta defensins comprise a family of cationic, cysteine-rich antimicrobial peptides, predominantly expressed at epithelial surfaces.', '17353239'),
('Lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin', 'Vancomycin combined to Pal-Lys-Lys-NH(2) exerted the strongest anti-staphylococcal efficacies. The in vitro studies showed, that MIC and MBC values for vancomycin were lower in presence of lipopeptides. They reduce the bacterial load and to enhance the effect of vancomycin in the prevention of vascular graft staphylococcal infections.', '', 'The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.', '17537542'),
('Antimicrobial peptide thionin Thi2.1', 'Growth inhibition of S. aureus isolates was dose-dependent, showing a total inhibition at concentrations higher than 3.12 microg/ml.', '', 'Antibacterial activity of thionin Thi2.1 from Arabidopsis thaliana expressed by bovine endothelial cells against Staphylococcus aureus isolates from bovine mastitis. Bovine mastitis is mainly caused by Staphylococcus aureus and antimicrobial therapy, commonly used for its control, has resulted in an increase in the frequency of resistant staphylococci in recent years.', '17961938'),
('AP-CECT7121 (an antimicrobial peptide isolated from an environmental strain of Enterococcus faecalis CECT7121)', 'Activity against Enterococcus faecium, Enterococcus faecalis,Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Clostridium perfringens and Clostridium difficile', '', 'CONCLUSIONS: AP-CECT7121 may provide a novel strategy for treating potentially fatal clinical infections in hospitalized patients.', '19494489'),
('Arminin', 'Minimal bactericidal concentration, 0.4 microM to 0.8 microM against multiresistant human pathogenic strains, such as methicillin-resistant Staphylococcus aureus (MRSA) strains', '', 'Activity of the novel peptide arminin against multiresistant human pathogens shows the considerable potential of phylogenetically ancient organisms as drug sources', '19770277'),
('Laterocidin and its analogues [3 (Asp(1)-->Asn(1), Phe(4)-->Tyr(4) and d-Tyr(6)-->d-Phe(6))]', 'Antimicrobial properties, against clinical Methicillin-resistant Staphylococcus aureus (L-MRSA) and the gram-negative extended-spectrum beta-lactamases-producing Escherichia coli (ESBLs E. coli) and L-E.coli.', '', 'Solid-phase synthesis and antibiotic activities of cyclodecapeptides on the scaffold of naturally occurring Laterocidin', '19932962'),
('longicornsin', 'Strong antimicrobial ability against drug-resistant microorganisms and Helicobacter pylori', '', 'A novel defensin-like peptide from salivary glands of the hard tick, Haemaphysalis longicornis', '20027626'),
('Alyteserin-1c (GLKEIFKAGLGSLVKGIAAHVAS?NH(2)) and its analogues', 'Alyteserin-1c displayed MIC=5-10 micro M; minimum bactericidal concentration, MBC=5-10 microM), increasing the cationicity of alyteserin-1c by the substitution Glu(4)->Lys enhanced the potency (MIC=1.25-5 micro M; MBC=1.25-5 micro M) against MDRAB', 'alyteserin-1c (LD(50)=220 ?M)and its catonic analogues (HC(50)>400 ?M) has low hemolytic activity against human erythrocytes , and.', 'Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii', '20603168'),
('Hominicin (DmIle-Dhb-Pro-Ala-Dhb-Pro-Phe-Dhb-Pro-Ala-Ile-Thr-Glu-Ile-Dhb-Ala-Ala-Val-Ile-Ala -Dmp)', 'Potent activity against Staphylococcus aureus ATCC 25923, methicillin-resistant S. aureus (MRSA) ATCC 11435 and vancomycin-intermediate S. aureus (VISA) CCARM 3501', '', 'Characterization and structure identification of an antimicrobial peptide, hominicin, produced by Staphylococcus hominis MBBL 2-9.', '20654578'),
('Acyldepsipeptide 4 (ADEP 4) analog in which the pipecolate was replaced by 4-methyl pipecolate', 'in vitro antibacterial activity against Enterococci that was fourfold higher than the parent compound ADEP 4', '', 'Diversity-oriented synthesis of cyclic acyldepsipeptides leads to the discovery of a potent antibacterial agent.', '20833054'),
('PTP-7, lytic peptide', 'Anti-biofilm activity, potent to Gram-positive bacteria and is able to kill antibiotic sensitive and resistant Staphylococcus aureus', '', 'The activity of a small lytic peptide PTP-7 on Staphylococcus aureus biofilms', '21887652'),
('C(12)K-2?(12), oligo-acyl-lysyl (OAK) antimicrobial peptidomimetic', 'A dual mode of action against the H. pylori membrane and cytoplasmic components', '', 'The oligo-acyl lysyl antimicrobial peptide C(12)K-2?(12) exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori', '22064541'),
('Epidermicin NI01', 'Potent antimicrobial activity toward a wide range of pathogenic Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA), enterococci, and biofilm-forming S. epidermidis strains', '', 'Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci.', '22155816'),
('CPF-AM1, PGLa-AM1, B2RP-ERa, [E4K]alyteserin-1c, [D4K]B2RP and [G4K]XT-7', 'Overall colistin-susceptibleminimum inhibitory concentration against colistin-susceptible (MIC) ? 2 micro g/mL] and colistin-resistant (MIC ? 64 micro g/mL) clinical isolates of multidrug-resistant strains of Acinetobacter baumannii and Acinetobacter nosocomialis, with most potent peptides being [D4K]B2RP and [E4K]alyteserin-1c (MIC=4-16 micro g/mL)', 'low haemolytic activity against human erythrocytes.', 'Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group', '22326566'),
('OH-CATH30 and its analog OH-CM6', 'The MICs of OH-CATH30 and OH-CM6 ranged from 1.56 to 12.5 micro g/ml against drug-resistant clinical isolates of several pathogenic species, including Escherichia coli, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus.', 'relatively low toxicity and potent efficacy in mouse models', 'Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models.', '22491685'),
('Dimeric PpIX-YI13WF (photosensitizer protophophyrin IX - YI13WF (YVLWKRKRKFCFI-Amide)) conjugate', '(MIC) values of dimeric PpIX-YI13WF conjugate itself observed for E. coli DH5a (~4 times), S. enterica (~8 times), and other Gram-negative strains including antibiotic-resistant E. coli BL21 (~8 times) and K. pneumoniae (~16 times).', 'Dimeric PpIX-YI13WF conjugate could selectively recognize bacterial strains over mammalian cells and generate less photo damage to mammalian cells.', 'Lipopolysaccharide neutralizing peptide-porphyrin conjugates for effective photoinactivation and intracellular imaging of gram-negative bacteria strains. A simple and specific strategy based on the bioconjugation of a photosensitizer protophophyrin IX (PpIX) with a lipopolysaccharide (LPS) binding antimicrobial peptide YI13WF (YVLWKRKRKFCFI-Amide) has been developed for the effective fluorescent imaging and photodynamic inactivation of Gram-negative bacterial strains.', '22769015'),
('Peptide conjugated phosphorodiamidate morpholino oligomers', 'Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis. ', '', 'Targeting bacterial essential genes using antisense phosphorodiamidate morpholino oligomers (PMOs) represents an important strategy in the development of novel antibacterial therapeutics.', '22978365'),
('PEP6R (VKVRVRVRV(D)PPTRVRVRVKV)', 'High potency against bacteria', 'cytocompatible toward human erythrocytes as well as mammalian mesenchymal stem cells', 'Arginine-rich self-assembling peptides as potent antibacterial gels.', '22995710'),
('PXL150', 'In vitro a broad spectrum microbicidal action against both Gram-positive and Gram-negative bacteria, including resistant strains', '', 'The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections.', '23053090'),
('NK-18', 'Two targets, acts on bacterial membrane and DNA in the cytoplasm', '', 'The double targets of NK-18 make it difficult for bacteria to generate resistance, which may present a new strategy to defend against multidrug-resistant bacteria and provide a new lead in the design of potent antimicrobial peptides with therapeutic application in the presence of increasing resistance to conventional antibiotics.', '23089755'),
('LL-37', 'Effective in killing extracellular S. aureus at nanomolar concentrations', '', 'Therefore, LL-37 was shown to be very potent and prompt in eliminating both extra- and intracellular S. aureus and was more effective in killing extra- and intracellular S. aureus than commonly used conventional antibiotics.', '23274662'),
('TSG-8-1, WWSYVRRWRSR-amide', 'Antimicrobial activity against E. coli and S. aureus', 'Very little hemolytic activity in human erythrocytes t high dose level', 'Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide', '23570790'),
('S-thanatin', 'High activity of S-thanatin against K. pneumoniae in vitro with MIC between 4 and 8 micro g/ml.?', '', 'All above implied that S-thanatin, as an alternative, may provide a novel strategy for treating K. pneumoniae infection and other infections due to multidrug-resistant bacteria.', '23643614'),
('Peptidomimetics (Short histidine-derived antimicrobial peptides (SAMPs))', 'High antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA)', 'No hemolytic activity', 'Non hemolytic short peptidomimetics as a new class of potent and broad-spectrum antimicrobial agents.', '23816372'),
('R-thanatin', 'Potent in vitro activity against coagulase-negative staphylococci, such as S. epidermidis, S. haemolyticus, and S. hominis, and inhibited biofilm formation at subinhibitory concentrations', '', 'R-thanatin inhibits growth and biofilm formation of methicillin-resistant Staphylococcus epidermidis in vivo and in vitro', '23917310'),
('C5a-derived immunobiotic peptide EP67', 'EP67 inhibits GBS growth in vitro and in vivo and that antibacterial activity was specific to Streptococcus species.', '', 'We have employed a host-directed immunomodulatory therapy using a novel peptide, known as EP67, derived from the C-terminal region of human complement component C5a.', '23979760'),
('Hymenochirin-1B (IKLSPETKDN(10)LKKVLKGAIK(20)GAIAVAKMV.NH2) analogue in which the Pro(5), Glu(6) and Asp(9) on the hydrophilic face of the ?-helix are substituted by one or more l-lysine or d-lysine residues', '[E6k,D9k]hymenochirin-1B has MIC in the range 0.8-3.1 micro M against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) and a range of Gram-negative bacteria, including multidrug-resistant strains of Acinetobacter baumannii and Stenotrophomonas maltophilia, MIC in the range 3.1-6.25 micro M against NDM-1 carbapenemase-producing clinical isolates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae and Citrobacter freundii.,', 'low hemolytic activity (LC50=302 ?M) of [E6k,D9k]hymenochirin-1B', 'An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties', '24172540'),
('BmKn2 scorpion venom peptide and its derivatives', 'Bactericidal, potent activity against N. gonorrhoeae with MIC50 values of 6.9-27.6 ?M', '', 'Potent and rapid antigonococcal activity of the venom peptide BmKn2 and its derivatives against different Maldi biotype of multidrug-resistant Neisseria gonorrhoeae.', '24184420'),
('His-derived antimicrobial peptides (HDAMPs)', 'Promising dual antimicrobial and anti-inflammatory activities, as well as anti-methicillin-resistant Staphylococcus aureus (MRSA) activity', '', 'CONCLUSION/SIGNIFICANCE: The combination of the ultra-short size, high-prokaryotic selectivity, potent anti-MRSA activity, anti-inflammatory activity, and proteolytic resistance of the designed HDAMP-1, -3, -5, and -6 makes these molecules promising candidates for future antimicrobial therapeutics.', '24302996'),
('Temporin-SHa (FLSGIVGMLGKLF amide)', 'Broad-spectrum activity against Gram-positive and Gram-negative bacteria, yeasts and parasites', '', 'Temporin-SHa (FLSGIVGMLGKLF amide) is a small hydrophobic and low cationic antimicrobial peptide with potent and very broad-spectrum activity against Gram-positive and Gram-negative bacteria, yeasts and parasites.', '24919960'),
('Pandinin 2 variants', 'Antimicrobial activity against E. coli, S. aureus, and M. tuberculosis', 'Pin2 [14] presented only 25% of hemolysis toward human erythrocytes at concentrations as high as 100 ?M, while the peptide Pin2 [17] did not show any hemolytic effect at the same concentration', 'Therefore, Pin2 [14] and Pin2 [17] have the potential to be used as an alternative antibiotics and anti-tuberculosis agents with reduced hemolytic effects.', '25019413'),
('Peptides human beta-defensin-3 (hBD-3) and cathelicidin (LL-37)', 'Non-cytotoxic concentrations of hBD-3 (10 and 20 micro M) and LL-37 (0.1 and 0.2 micro M)', '', 'This combination of antimicrobial peptides thus shows promising potential as an adjunctive therapy for treating inflammatory periodontitis.', '25187958'),
('l isomer of lycosin-I (l-lycosin-I), d isomer of lycosin-I (d-lycosin-I), l- and d-amino acid residues of RKGWFKAMKSIAKFIAKEKLKEHL', 'The MICs of the three isomers of lycosin-I and several other clinical drugs were determined through the broth microdilution method in accordance with the CLSI protocol', '', 'These two compounds displayed high antibacterial activities and rapid bactericidal effects against MDRAB. Moreover, the compounds retained their activity even at high salt (Mg(2+) or Ca(2+)) concentrations.', '25199777'),
('G(IIKK)(3)I-NH(2)', 'Effective against ESBL-producing bacterial infection', 'multidrug resistant ESBL-producing bacteria do not develop resistance and low toxicity toward mammalian hosts', 'High cell selectivity and low-level antibacterial resistance of designed amphiphilic peptide G(IIKK)(3)I-NH(2). On the basis of cell cultures involving bacterial strains (Escherichia coli 5? and Bacillus subtilis 168) and a mammalian cell line (NIH 3T3), the potent antibacterial activity and distinct selectivity from designed amphiphilic peptides G(IIKK)nI-NH2 (n = 2-4) have been demonstrated.', '25210781'),
('Antimicrobial peptides (AMPs) GPPPQGGRPQG and RFGYGYGPYQPVPEQPLYPQ', 'Antibacterial effect in S. aureus', '', 'These showed to exert an antibacterial effect in Staphylococcus aureus. This report validates the prospection of mammal''s saliva to find new alternatives to antibiotics.BIOLOGICAL SIGNIFICANCE: With the growing problem of antibiotic resistance, the identification of new routes in antibiotic therapy is on the scientific agenda worldwide.', '25534884'),
('VRV-PL-V (Vipera russellii venom phospholipase A2 fraction V) of Daboia russellii pulchella venom', 'Antibacterial activity with MIC values ranging from 13 to 24 micro g/ml', '', 'VRV-PL-V demonstrated a potent antibacterial activity against all the human pathogenic strains tested.', '25540009'),
('Tilapia piscidin antimicrobial peptides TP3 (H-FIHHIIGGLFSVGKHIHSLIHGH-OH), TP4 (H-FIHHIIGGLFSAGKAIHRLIRRRRR-OH)', 'TP4 MIC against K. pneumonia and A. baumannii in the range < 1.56 microg/mL - 3.125 microg/mL. TP3 MIC against K. pneumonia and A. baumannii in the range < 1.56 microg/mL - 25 microg/mL', '', 'TP3 and TP4 are able at potentiate anti-Acinetobacter baumannii or anti-Klebsiella pneumonia drug activity, reduce bacterial load, and prevent drug resistance, indicating their potential for use in combating multidrug-resistant bacteria.', '25874924'),
('VG16KRKP', 'Antimicrobial activity against Gram-negative E. coli and plant pathogens X. oryzae and X. campestris, as well as against human fungal pathogens C. albicans and C. grubii.', '', 'The de novo design of VG16KRKP provides valuable insights into the development of more potent antibacterial and antiendotoxic peptides for the treatment of human and plant infections.', '26144972'),
('Synthetic peptides based on LF11( LF11-215 (FWRIRIRR), LF11-227 (FWRRFWRR), DI-MB-LF11-322 (2,2-dimethylbutanoyl-PFWRIRIRR) and DI-MB-LF11-215)', 'Potent anti-biofilm activity against Pseudomonas aeruginosa', '', 'Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms', '26149536'),
('NLF20 (NLFRKLTHRLFRRNFGYTLR)', 'Potent antimicrobial effects against the Gram-negative bacteria Escherichia coli and P. aeruginosa, the Gram-positive Bacillus subtilis and Staphylococcus aureus and the fungi Candida albicans and Candida parapsilosis', '', 'NLF20: an antimicrobial peptide with therapeutic potential against invasive Pseudomonas aeruginosa infection', '26503666'),
('K1K8: an Hp1404-derived antibacterial peptide', 'Decreased methicillin-resistant Staphylococcus aureus (MRSA) bacterial counts in the wounded region in a mouse skin infection model', 'Low hemolytic activity', 'K1K8: an Hp1404-derived antibacterial peptide. As an alternative class of antimicrobial agents used to overcome drug-resistant infections, antimicrobial peptides (AMPs) have recently gained significant attention.', '26952110'),
('D-L91 (SEFAYGSFVRTVSLPVGADE)', 'Enhancement of IFN-gamma(+)TNF-alpha(+) polyfunctional Th1 cells and IL-17A(+)IFN-gamma(+) Th17 cells, enduring memory CD4 T cells and downregulation of PD-1', '', 'The adjunct therapy using drugs and L91 (D-L91) significantly declined the bacterial load in Mtb infected animals.', '27052185'),
('CSpK14 , antimicrobial peptide', 'MICs reduced by 8- to 64-fold and 2- to 16-fold in combination wth oxacillin and ampicillin respectively', '', 'CSpK14 was simple to purify, had low molecular mass, was stable over a wide pH range or tested chemicals, had broad inhibitory spectrum, and possessed potent synergistic antimicrobial-antibiofilm properties.', '27787755'),
('Series of side-chain hybrid dimer peptides J-AA (Anoplin-Anoplin), J-RR (RW-RW), and J-AR (Anoplin-RW) based on the wasp peptide Anoplin and the arginine- and tryptophan-rich hexapeptide', '', '', 'Design of novel antimicrobial peptide dimer analogues with enhanced antimicrobial activity in vitro and in vivo by intermolecular triazole bridge strategy.', '28040477'),
('Thiazomycin, nocathiacin and analogs', 'Activity against drug resistant Mycobacterium tuberculosis with different MICs', '', 'Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis. Thiazolyl peptides are a class of natural products with potent Gram-positive antibacterial activities.', '28096545'),
('Heterofunctionalized poly(ethylene glycol) with different lengths (methacrylate-PEGn-tosyl, n=10/45/90) conjugated with polypeptides to form diblock amphiphiles', 'Antimicrobial activity against several pathogenic bacteria like Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and effectively prevent biofilm formation', '', 'Thus, this facilely synthesized PEGylated AMP bottlebrush coating is a feasible method to prevent biomedical devices-associated infections.', '28131941'),
('[K3]SHa', '[K3]SHa emerged as a highly potent compound active against a wide range of bacteria, yeasts/fungi, and trypanosomatids (Leishmania and Trypanosoma), with leishmanicidal intramacrophagic activity and efficiency toward antibiotic-resistant strains of S. aureus and antimony-resistant L. infantum.', '', 'To improve activity, we designed analogs of SHa and compared the antibacterial and antiparasitic mechanisms. [K3]SHa emerged as a highly potent compound active against a wide range of bacteria, yeasts/fungi, and trypanosomatids (Leishmania and Trypanosoma), with leishmanicidal intramacrophagic activity and efficiency toward antibiotic-resistant strains of S. aureus and antimony-resistant L. infantum.', '28319176'),
('Cecropin A2', 'Synergistic Efficacy in combination with Tetracycline against Pseudomonas aeruginosa', '', 'Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa.', '28483966'),
('Sph12-38', 'MIC 3 micro M against Staphylococcus aureus, Corynebacterium glutamicum, Micrococcus lysodeikticus Fleming, Bacillus subtilis, Pseudomonas fluorescens, Aeromonas hydrophila and A. sobria', '', 'Taken together, the synthetic peptide of Sph12-38 had a potent antimicrobial activity against bacteria.', '28600196'),
('Free or anchored antimicrobial peptides like  the cathelicidins BMAP-27 and BMAP-28, their (1-18) fragments and the rationally designed, artificial P19(9/G7) peptide', 'Effective at micromolar concentrations against 22 Staphylococcus and Streptococcus isolates from orthopaedic infections,  BMAP-28 and to a lesser extent BMAP-27 were active against Enterococcus faecalis', 'Negligible toxicity towards osteoblasts', 'Alpha-helical antimicrobial peptides (AMPs) may be promising candidates in this respect due to their potent and broad-spectrum antimicrobial activity, their low tendency to elicit resistance and possible retention of efficacy in the immobilized state.', '28707817'),
('NZ2114 and MP1102', 'The minimal inhibitory concentration and minimal bactericidal concentration of NZ2114 and MP1102 against resistant C. perfringens type A strain CVCC 46 were 0.91 micro M', '', 'Mode of action of plectasin-derived peptides against gas gangrene-associated Clostridium perfringens type A. .', '28934314'),
('Antimicrobial peptide Brevinin-2Ta (GILDTLKNLAKTAGKGILKSLVNTASCKLSGQC)', 'MIC of B-2Ta against S. aureus 64 mg/L, E. coli 32 mg/L, C. albicans 64 mg/L.', '', 'Assessment of antimicrobial and wound healing effects of Brevinin-2Ta against the bacterium Klebsiella pneumoniae in dermally-wounded rats. Antimicrobial peptides (AMPs) are regarded as promising alternatives for antibiotics due to their inherent capacity to prevent microbial drug resistance. Amphibians are rich source of bioactive molecules, which provide numerous AMPs with various structures as drug candidates.', '29340060'),
('Histone H5 purified from chicken erythrocytes', 'Active against Gram-positive and Gram-negative planktonic bacteria (MIC range: 1.9 +- 1.8 to 4.9 +- 1.5 micro g/mL)', '', 'Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides. Modern medicine is challenged continuously by the increasing prevalence of antibiotic resistant bacteria.', '29402952'),
('OH-CATH30 (L and D)', 'highest bactericidal activity against Acinetobacter spp., including multi-drug-resistant Acinetobacter baumannii (MRAB) and methicillin-resistant Staphylococcus aureus (MRSA)', '', 'King cobra peptide OH-CATH30 as a potential candidate drug through clinic drug-resistant isolates. Cationic antimicrobial peptides (AMPs) are considered as important candidate therapeutic agents, which exert potent microbicidal properties against bacteria, fungi and some viruses.', '29515090'),
('Pituitary adenylate cyclase-activating polypeptide (PACAP)', 'Antimicrobial activity against Escherichia coli and Staphylococcus aureus', '', 'Pituitary adenylate cyclase-activating polypeptide (PACAP) is a naturally occurring cationic peptide with potent immunosuppressant and cytoprotective activities.', '29654809'),
('Myristoylation of Human alpha-Defensin 5', '', '', 'Our strategy involves the myristoylation of human alpha-defensin 5 (HD5) as a therapeutic target and subsequent self-assembly in aqueous media in the absence of exogenous excipients.', '29856606'),
('Antimicrobial peptide N10 and NB2', 'Both peptides were effective against A. baumannii and showed antibacterial activities (minimum inhibitory concentration (MIC) 500 micro g/ml). In the biofilm inhibition assay, NB2 reduced biofilm more efficiently (75%) than N10 (50%).', '', 'The selected peptides showed significant binding to A. baumannii rather than to the human cell line Caco-2. Both peptides were effective against A. baumannii and showed antibacterial activities', '29859290'),
('Marcin-18 (FFGHLFKLATKIIPSLFR), Meucin-18 (FFGHLFKLATKIIPSLFQ) and Megicin-18 (FFGALFKLATKIIPSLFR)', 'Showed highly potent inhibitory activity against Gram-positive bacteria (MIC 1.5 to > 48.3 microM), including some clinical antibiotic-resistant strains. Importantly, in a mouse acute peritonitis model, these peptides significantly decreased the bacterial load in ascites and rescued nearly all mice heavily infected with clinical methicillin-resistant Staphylococcus aureus from lethal bacteremia.', '', 'In vitro, chemically synthetic marcin-18 and its homologs (meucin-18 and megicin-18) showed highly potent inhibitory activity against Gram-positive bacteria, including some clinical antibiotic-resistant strains.', '29896190'),
('Oligo-lipidated arginyl peptide (OLAP11)', 'antimicrobial actions against MRSA infections', 'low in vitro toxicity', 'Our results showed that OLAP-11 exhibits potent antimicrobial activity against Gram-positive bacteria with improved physico-chemical activity in various physiological conditions.', '30066172'),
('LTX21', 'Role on host-pathogen interplay,', '', 'Targeting bacterial virulence or the human host immune system to increase host defence are important strategies in the search for novel antimicrobial drugs.', '30916807'),
('Melittin', 'Potency in eradication of extensively drug-resistant (XDR) Acinetobacter spp., killed all examined XDR isolates at 4 microg/mL up to 3 h, significant activity at the minimum dose of 0.062 microg/m', 'No toxixity observed on injured or healthy derma, as well as circulating Red Blood Cells (RBCs) in the examined mice', 'Potent promising antibacterial activity of melittin and the lack of toxicity at the therapeutic dose can clarify that melittin can be implemented as a topical drug lead in a preclinical trial of third degree burn infections.', '30513367'),
('MAP-0403 (J-1, J-2, and J-3)', 'MIC reported as, J-1: 5 microM, J-2 : 2.5 microM, J-3: 10 microM', 'J-2 showed significantly reduced hemolytic effect (3.4%), while J-1 and J-3 showed slightly decreased hemolytic effect (46.2%, 55.6%, respectively', 'Design, synthesis, and antimicrobial activities of novel functional peptides against Gram-positive and Gram-negative bacteria', '31059203'),
('N-terminal fatty acid modified-antimicrobial peptide', 'Displayed synergistic effects when used together with the antibiotics rifampicin and polymyxin B, had strong membrane permeabilization and depolarization, could damage the integrity of the bacterial membrane and could bind to bacterial DNA', '', 'Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.', '31466017'),
('Sphaeropsidin A', 'MIC= 6.25 microgram/mL to 12.5 microgram/mL, methicillin-resistant S. aureus (MRSA)', '', 'Sphaeropsidin A activity appears noteworthy for its ability to inhibit biofilm formation, preventing a growth mode that results in particular resistance to antibiotic treatment.', '32650496'),
('Anoplin analogues: Ano-1beta and Ano-8beta', 'Multidrug-resistant P. aeruginosa', '', 'The new peptides Ano-1beta and Ano-8beta might be promising antimicrobial candidates in combating the increasing antibiotic-resistant bacteria.', '32654770'),
('Tridecaptin M', 'Tridecaptin M reduced the MIC of vancomycin and rifampicin against A. baumannii by 16-fold', 'Tridecaptin M and rifampicin combination killed the bacteria completely in 4 h in an ex vivo blood infection model and was superior to rifampicin monotherapy', 'This study reports the in vitro potential of an antimicrobial peptide tridecaptin M in combination with other antibiotics against different strains of A. baumannii.', '32708842'),
('cCATH-2 (a chicken-derived antimicrobial peptide)', 'All tested concentrations of cCATH-2 (1/32-1/2MIC) significantly reduced the biomass at the biofilm formation stage', '', 'Inhibitory effect of a novel chicken-derived anti-biofilm peptide on P. aeruginosa biofilms and virulence factors.', '32976967'),
('PBDM1: YKWFAHLIKGLC and PBDM2: YKWFRHLIKKLC', 'The MIC value of PBDM1 was found to be as 10 microgram/mL against S. aureus, MRSA, and E. coli. Whereas, in case of E. faecalis, VRSA and VRE the MIC was found to be 30, 15, and 20 microgram/mL. But, the MIC value for PBDM2 was 10 microgram/mL when tested against S. aureus, MRSA, VRSA, VRE, and E. coli. Whereas, in case of E. faecalis the MIC was found to be 20 microgram/mL', 'in vitro study with human epithelial cells showed no significant cytotoxic effects with high biocompatibility and good hemocompatibility', 'In conclusion, PBDM peptides displayed significant antibacterial activity against certain drug resistant bacteria which cause infections in human beings', '32983007'),
('L1G, L7A, and L1GA5K : Mastoparan-C (MP-C) analogs', 'The newly designed peptides showed synergy or additive effects against Gram-negative bacteria, when they combined with conventional antibiotics gentamicin, rifampin, and polymyxin B.', '', 'Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.', '33285267'),
('Astucin from A. tubingensis A01.', 'The MIC of the purified polypeptide was 32 m/L and 128 microgram/mL and the MBIC was 2 and 8 microgram/mL against Staphylococcus aureus and MRSA, respectively', 'The results demonstrated that the antimicrobial and antibiofilm activity of astucin, together with its lack of cytotoxicity, makes it an alternative for application in medicine.', 'This protein shows antimicrobial and antibiofilm activity against S. aureus.', '33309927'),
('F12, Lysostaphin', 'F12 possesses high potency and rapid onset of action, it has narrow selectivity against pathogenic staphylococci, and it manifests synergy with numerous SOC antibiotics.', '', 'These results suggest that combinations of F12 and SOC antibiotics are a promising new approach to treating refractory S. aureus infections.', '33318001'),
('Nisin and P10', 'Nisin + colistin and P10+ceftazidime/doripenem were effective on XDR A. baumannii . The MIC value of Nisin and P10 against studied pathogens were 64-256 and 8-32 microgram/ml, respectively.', '', 'Combination therapy and using antimicrobial peptides are two strategies with high potential to solve this issue.', '33346078'),
('C14-R1 (C14-RWW-NH2) and C12-R2 (C12-RRW-NH2)', 'C14-R1 and C12-R2 showed high antimicrobial potential for gram-positive bacteria.', 'Among them, the new lipopeptides C14-R1 (C14-RWW-NH2) and C12-R2 (C12-RRW-NH2) presented higher selectivity to bacterial membranes over mammalian membranes and low cytotoxicity, which also maintained better antimicrobial activity in the presence of physiological salts or serum.', 'Most of the new lipopeptides exhibited preferable antimicrobial potential against gram-positive bacteria, including MRSA clinical isolates.', '33422980'),
('Fungal peptide, NZX', 'We further observed that this peptide was effective against nontuberculous mycobacteria (NTM), such as M. avium and M. abscessus, and several Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus.', 'In vivo, the peptide remained stable in circulation and preserved lung structure better than ethambutol alone', 'Alternative ways to prevent and treat infectious diseases are needed.', '33603037'),
('Peptide-Based Antibiotics', 'In both cases, optimization of the N-terminal lipid tails led to the identification of analogues with potent activity toward Escherichia coli and Pseudomonas aeruginosa.', '', 'Peptide natural products stand as promising candidates to meet this need as bacterial resistance is typically slow in response to their unique modes of action.', '33750106'),
('Dilipid ultrashort cationic lipopeptides (dUSCLs)', 'Can indirectly disrupt active efflux of chloramphenicol in P. aeruginosa', '', 'Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria', '30392097'),
('Microencapsulated-Host Defense Peptides (HDP ) ;Ub2-MS, K4-MS, and Aurein1.2-MS', 'HDP-MS exhibited up to ?3.02 and ?3.41-log decrease in Mycobacterium tuberculosis CFU as compared to blank-MS (drug free) and untreated control group in 96 h', '', 'Mycobactericidal activity of some micro-encapsulated synthetic Host Defense Peptides (HDP) by expediting the permeation of antibiotic: A new paradigm of drug delivery for tuberculosis.', '30630076'),
('Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles', 'The most potent, broad-spectrum peptidomimetic showed activity against Gram-positive (methicillin-resistant Staphylococcus aureus - MIC = 2 microg/mL) and Gram-negative (Escherichia coli - MIC = 4 microg/mL) pathogenic bacteria.', '', 'Synthetic small molecular antimicrobial peptidomimetics represent a promising new class of potential antibiotics due to their membrane-disrupting ability and their decreased propensity for bacterial resistance.', '30831407'),
('alpha-Peptide/beta-Peptoid Lysine-Based Peptidomimetics', 'High potency against clinical drug-resistant P. aeruginosa strains', '', 'Emergence of bacterial resistance renders existing antibiotics inefficient, and therefore discovery of new antimicrobial agents is highly warranted.', '30842761'),
('Cationic Antimicrobial Peptides (CAMPs) : LL-37: human cathelicidin, CAMA: cecropin(1-7)-melittin A(2-9) amide, magainin-II and nisin', 'activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa', '', 'This study showed the potent and rapid antibacterial activity of CAMPs on both laboratory and clinical isolates of S. aureus and P. aeruginosa either susceptible or resistant to antibiotics.', '30849936'),
('Peptide dendrimers G3KL and TNS18', 'Can destroy the Pseudomonas aeruginosa biofilm morphological structure and thickness', '', 'Potent activity on planktonic cells and biofilms of P. aeruginosa suggests that peptide dendrimers G3KL and TNS18 are promising candidates of clinical development for treating infections.', '31101943'),
('Hybrid antimicrobial peptide (B1) from helical parts taken from the parent peptides: LL-37 and BMAP-27', 'Broad-spectrum activities, the concentration against planktonic cells ranged between 10 and 20 microM, 40-60 microM were needed to eradicate the biofilm', 'Reduced toxicity toward mammalian cells with minimal hemolysis risk', 'Results: The new peptide B1 exhibited broad-spectrum activities against all tested strains.', '31118709'),
('Bac1, Bac2 and Bac3', 'Inhibit the growth of Leuconostoc mesenteroides and affect sperm motility', '', 'Bacteriocins, which are bacterially-derived antimicrobial peptides, may fulfill some of the criteria for these new agents.', '31244418'),
('vancomycin derivatives carrying LPS binding peptides, vancomycin-LPS binding peptide conjugates (VPCs).', 'were screened against VISA/VRE and Gram-negative strains', '', 'VPCs exhibited enhanced activity against vancomycin resistant bacteria and obtained the activity against Gram-negative bacteria in vitro, providing a novel strategy for vancomycin modification and glycopeptide antibiotics synthesis.', '34015504'),
('Activated caseinolytic protease P (ClpP)', 'an antibacterial assessment demonstrated that ONC212 displays excellent activity against Xoo and prevents rice bacterial leaf blight in vivo.', '', 'Additionally, an antibacterial assessment demonstrated that ONC212 displays excellent activity against Xoo and prevents rice bacterial leaf blight in vivo.', '34218658'),
('a chimeric peptide-G6, a N6NH2 analog', 'Showed MIC value: 16 microgram/mL and could curb N6NH2-resistant mutants by stronger inhibition of biofilm formation, stronger affinity with LPS, and stronger membrane permeability and depolarization than that of N6NH2.', '', 'Antimicrobial peptides (AMPs) are regarded as the potentially effective therapy.', '34889983'),
('AMPR-22 (antimicrobial peptide derived from Romo1)', 'It showed broad-spectrum antimicrobial activity against 17 sepsis-causing bacteria, including MDR strains, by inducing membrane permeabilization.', 'Moreover, treatment with AMPR-22 enabled a remarkable survival rate in mice injected with MDR bacteria in a murine model of sepsis.', 'Based on these results, we suggest that AMPR-22 could be prescribed as a first-line therapy (prior to bacterial identification) for patients diagnosed with sepsis.', '34361008'),
('glucose-dependent insulinotropic polypeptide (GIP)', 'While GIP was devoid of direct antimicrobial activity, it has a potent membrane depolarizing effect, and at low concentrations, it significantly potentiated the activity of eight antibiotics and bile salt by reducing MICs by 4-8-fold in E. coli TG1 and 4-20-fold in E. amylovora 1189.', '', 'GIP can thus be regarded as an antimicrobial adjuvant with potential for augmenting the available antibiotic arsenal. © 2020 Walter de Gruyter GmbH, Berlin/Boston.', '33938181'),
('beta-defensin-derived peptide', 'The MIC values ranged from 2 to 4?8 microM for all the microorganisms tested, with the exception of the P. aeruginosa MDR strain 1 and A. baumannii strain 1 that are resistant up to a concentration of 32?64 microM of both peptide forms', 'it has great stability in human serum thereby enhancing its antibacterial presence and activity without cytotoxicity in human cells.', 'Currently, the race is on to identify pharmaceutical molecules or combinations of molecules able to prevent or reduce the insurgence and/or progression of infectivity.', '34818435'),
('PHNX peptides', 'PHNX-1 demonstrated antibacterial activity (under high and low-salt conditions) against antibiotic resistant and susceptible strains of Gram-positive and Gram-negative bacteria and PHNX-4 to -8 demonstrated low-salt antibacterial activity only.', '', 'Development of new antibiotics has slowed in recent years and novel therapeutics (like AMPs) with a focus against Gram-negative bacteria are needed.', '34867843'),
('cationic antimicrobial peptides (AMPs)', 'In contrast, it showed minimum inhibitory concentration values (MICs) lower than reported for several AMPs and other synthetic cationic compounds on Acinetobacter genus (3.2-12.7 microM).', '', 'New therapeutic possibilities are, therefore, urgently needed to circumvent this important problem.', '34298891'),
('Synthetic beta-hairpin antimicrobial peptides', 'mutations of only 2 to 4 amino acids at the turn region could impart a wide range of antimicrobial profiles among synthetic beta-hairpin AMPs. BTT2-4 and BTT6 displayed selective potency against Gram-negative bacteria, with minimum inhibitory concentrations (MICs) of 4-8 microM.', 'Our peptides were also determined to be non-cytotoxic against a human cell line.', 'Synthetic β-hairpin antimicrobial peptides (AMPs) offer a useful source for the development of novel antimicrobial agents. β-hairpin peptides generally consist of two side strands bridged by a reverse turn.', '34506975'),
('dipicolylamine-containing carbazole amphiphiles with strong Zn2+', 'antimicrobial candidate. 16 combined with 12.5 microgram/mL Zn2+ exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria (MICs = 0.78-3.125 microgram/mL), weak hemolytic activity, and low cytotoxicity.', 'antimicrobial candidate. 16 combined with 12.5 microgram/mL Zn2+ exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria (MICs = 0.78-3.125 microgram/mL), weak hemolytic activity, and low cytotoxicity.', 'Effective broad-spectrum 16 combined with 12.5 μg/mL Zn2+ was identified as the most promising antimicrobial candidate. 16 combined with 12.5 μg/mL Zn2+ exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria (MICs = 0.78-3.125 μg/mL), weak hemolytic activity, and low cytotoxicity.', '34235929'),
('cathelicidin-related (CR-) peptides- PepBiotics', 'A relatively small number of PepBiotics remained highly antibacterial against CF-related respiratory pathogens Pseudomonas aeruginosa and Staphylococcus aureus, at high ionic strength and low pH. I', 'Finally, interaction of CR-163 with bacterial-type anionic membranes but not with mammalian-type (zwitterionic lipid) membranes was confirmed using ITC and 31P solid state NMR.', 'Interestingly, these PepBiotics also prevented LPS/LTA induced activation of macrophages and was shown to be non-toxic to primary human nasal epithelial cells.', '34147544'),
('Temporin A and the short lipopeptides (C10)2-KKKK-NH2 and (C12)2-KKKK-NH2', '', '', 'The results of the performed experiments suggest that the potential application of peptides as adjuvant agents in the treatment of biofilm-associated infections should be studied further.', '32887236'),
('CB6-C', 'effective antimicrobial activity against gram-positive bacteria (in particular, the MIC for MRSA was 16 Microgram/mL)', '', 'In conclusion, this protein CB6-C is a newly discovered antibacterial protein and has the potential to become an effective antibacterial agent due to its high therapeutic index, safety, nontoxicity and great stability.', '34983528'),
('Lactoferricin B-Mutant (M4)', 'Among the potent AMP mutants, a Lactoferricin B-Mutant (M4) possessed uniformly high affinity with SHV1, OXA48, NDM1, and AmpC having energies -842.0Kcal/mol, -774.8Kcal/mol, -1103.3Kcal/mol, and -858.8Kcal/mol respectively. Highest affinity of Lactoferricin B_M4 was found with NDM1 due to H-bonds, salt-bridges, and hydrophobic interactions with the metallo-?-lactamase domain including crucial active-site residue Asp124.', '', 'Molecular dynamics simulation further confirmed the stability of Lactoferricin B_M4-NDM1 complex having low residue-level root-mean square deviations (RMSD), atomic-level fluctuations, and radius of gyration (Rg). The study encourages experimental validations and similar methods to identify potential AMPs against drug-resistant pathogens.', '35188617'),
('PaP1', 'TSP showed lytic spectrum of ~ 75%, suggesting its activity against various MRSA and MSSA isolates from different clinical samples. The phage efficiently inhibited bacterial growth for up to 12 h at MOI of 1 and 10. TSP phage showed activity against various isolates of MRSA and MSSA, isolated from different clinical samples, with variable antibiotic susceptibility patterns.', '', 'Despite the necessity for additional preclinical drug development, the collective data from our study support PaP1 as a potential broad-spectrum monotherapy or adjunctive therapy for the topical treatment of polymicrobial infections and provide a foundation for engineering future lysin-derived peptides with improved antibacterial properties.', '35369520'),
('two-peptide lantibiotic produced by Vagococcus fluvialis LMGT 4216', 'The combination of the two peptides resulted in a 1,200-fold increase in potency, confirming the two-peptide nature of the bacteriocin, named vagococcin T. The bacteriocin was demonstrated to kill sensitive cells by the formation of pores in the cell membrane, and its inhibition spectrum covers most Gram-positive bacteria, including multiresistant pathogens.', '', 'The novel lantibiotic showed a broad spectrum of inhibition of Gram-positive strains, including vancomycin-resistant Enterococcus faecium, demonstrating its therapeutic potential.', '35730941'),
('two CAMPs (LL-37 and CAMA)', 'We observed a greater bactericidal effect when IB3-1 cells were pretreated with sub-minimum bactericidal concentrations (Sub-MBCs) of the CAMPs prior to infection. These findings suggest that CAMPs induce the production of factors by IB3-1 cells that improve their bactericidal action. LL-37 induced a weak inflammatory response in the cells without being toxic.', 'The two CAMPs exerted different effects on PA survival depending on the timing of their administration. However, we observed no bactericidal effect when supra-minimum bactericidal concentrations (Supra-MBCs) of the CAMPs were added to IB3-1 cells at the same time or after infection.', 'In conclusion, our findings suggest a potential prophylactic action of CAMPs. The bactericidal effects were low when the CAMPs were added after cell infection, likely due to degradation of CAMPs by bacterial or epithelial cell proteases and/or due to adherence of CAMPs to cells becoming less available for direct bacterial killing.', '34954126'),
('series of AMPs with linear and star-shape (using n-hexylamine and amine-terminated polyamidoamine dendrimers (Gx-PAMAM, x = 1-2) as initiators)', 'the star-shaped AMPs exhibited enhanced bactericidal activity against Gram-negative E. coli and similar bactericidal activity against Gram-positive S. aureus when compared with the linear AMPs. It is worth mentioning that star-shaped AMPs demonstrated a significantly faster bactericidal efficiency (completely killed bacteria within 5 min at a concentration of 2 ? MIC for S. aureus) than their linear analogues (took 15 min to achieve the same effect). However, when the AMPs were immobilized to the surface, they similarly exhibited superior antibacterial activity and fast bactericidal efficiency towards S. aureus and E. coli in the case of the same surface grafting amount.', '', 'In addition, both the surfaces grafted with AMPs of different topologies demonstrated favorable biocompatibility in vitro.', '35005755');
INSERT INTO `table 30` (`COL 1`, `COL 2`, `COL 3`, `COL 4`, `COL 5`) VALUES
('metronidazole (MDZ), clindamycin (CLI), and PM-477', 'Determination of the MIC indicated that 60% of a panel of 22 Gardnerella isolates of four different species were resistant to MDZ, while all strains were highly susceptible to CLI and to the endolysin PM-477. All strains were susceptible to PM-477 when grown as preformed biofilms, at minimum biofilm eradication concentrations (MBECs) in the range of 1 to 4 ?g/mL.', '', 'Therefore, the high efficacy of PM-477 in eliminating Gardnerella in in vitro biofilms, as well as its high resilience to resistance formation, makes PM-477 a promising potential alternative for the treatment of bacterial vaginosis, especially in patients with frequent recurrence.', '35416708'),
('cationic antimicrobial peptides (CAMPs)', 'In this study, the interaction of a CAMP derived from cecropin D-like (?M2) with model membranes mimicking bacterial biomembranes of wild-type (WTPa) strains of P. aeruginosa and CRPa was evaluated through in vitro and in silico approaches.', '', 'This work provides clues for elucidating the membrane-associated mechanism of action of ?M2 against colistin-susceptible and -resistant strains of Pseudomonas aeruginosa. Accordingly, cationic antimicrobial peptides (CAMPs) have emerged as promising alternatives to control resistant bacteria.', '35745820'),
('Temporin-PKE', 'Temporin-PKE is a novel peptide extracted from the skin secretion of Pelophylax kl. esculentus and it displays a strong activity against Gram-positive bacteria, with an extreme cytotoxicity. The transformation of the chirality of Ile could reduce haemolytic activity, and an analogue with appropriate D-isoforms could maintain antimicrobial activity and stability. The substitution of hydrophobic residues could bring about more potent and broad-spectrum antimicrobial activities.', 'The analogues with Lys were less harmful to the normal cells and their stabilities remained at similarly high levels compared to temporin-PKE.', 'Temporin-PKE-3K exerted dually efficient functions includingstrong antimicrobial and anticancer activity. This analogue showed a reduced possibility for inducing resistance in MRSA and Klebsiella pneumoniae, a rather strong antimicrobial activity in vivo, and it exhibited the highest therapeutic index such that temporin-PKE-3K has the potential to be developed as a clinical drug.', '35740884'),
('Pediocin-like bacteriocins (class IIa bacteriocins)', 'They act on the cytoplasmic membrane of Gram-positive cells by dissipating the transmembrane electrical potential through pore formation with the mannose phosphotransferase system (man-PTS) as the target/receptor. Bacteriocin-producing strains also synthesize a cognate immunity protein that protects them against their own bacteriocins.', 'Pediocin-like bacteriocins, ribosomally synthesized antimicrobial peptides, are generally co-expressed with cognate immunity proteins to protect the bacteriocin-producing strain from its own bacteriocin.', 'Bacteriocins are considered potential alternatives to conventional antibiotics in the context of the bacterial resistance crisis, but the immunity mechanism is unclear. This study uncovered the mechanisms of action and immunity of class IIa bacteriocins.', '35703550'),
('Antimicrobial Peptides CATH-1, CATH-3, and PMAP-36 With Erythromycin', 'The results showed that the minimum bactericidal concentration (MBC) of CATH-1,-3 and PMAP-36 was lower than 10 ?M, indicating that these three AMPs had good bacterial activity against S. aureus, S. enteritidis, and E. coli. The results showed that the FBCI of AMPs (CATH-1,-3 and PMAP-36) and erythromycin was lower than 0.5 against bacterial pathogens, demonstrating that they had a synergistic bactericidal effect. Furthermore, the time-killing kinetics of AMPs (CATH-1,-3 and PMAP-36) in combination with erythromycin showed that they had a continuous killing effect on bacteria within 3 h. Notably, the combination showed lower hemolytic activity and cytotoxicity to mammal cells compared to erythromycin and peptide alone treatment. In addition, the antibacterial mechanism of CATH-1 and erythromycin combination against E. coli was studied. The results of the scanning electron microscope showed that CATH-1 enhanced the antibacterial activity of erythromycin by increasing the permeability of bacterial cell membrane. Moreover, the results of bacterial migration movement showed that the combination of CATH-1 and erythromycin significantly inhibits the migration of E. coli. Finally, drug resistance analysis was performed and the results showed that CATH-1 delayed the emergence of E. coli resistance to erythromycin.', '', 'In conclusion, the combination of CATH-1 and erythromycin has synergistic antibacterial activity and reduces the emergence of bacterial drug resistance. Our study provides valuable information to develop AMPs as potential substitutes or adjuvants for traditional antibiotics.', '35910608'),
('?-Hairpin Peptide Z-d14CFR or recombinant Zophobas atratus (Z. atratus) defensin', 'Our results showed that Z-d14CFR (RGCRCNSKSFCVCR-NH2) exhibited a broad-spectrum antimicrobial activity to both Gram-positive bacteria and Gram-negative bacteria, including multidrug-resistant bacteria.', 'It possessed less than 5% hemolysis and 10% cytotoxicity, even at a high concentration of 1 mg/mL.', 'Our findings suggest that Z-d14CFR could be a promising candidate against multidrug-resistant bacteria.', '35563007'),
('cell-penetrating peptide fused endolysin', 'Bacteriophage encoded endolysin as an alternative antibiotics is a peptidoglycan degrading enzyme with a low rate of resistance. This engineered endolysin, DS-PA90, completely killed A. baumannii at 0.25 ?M, at which concentration PA90 could only eliminate less than one log in CFU/ml. Additionally, DS-PA90 has tolerance to NaCl, where the ?50% of activity could be maintained in the presence of 150 mM NaCl, and stable activity was also observed with changes in pH or temperature. Even MDR A. baumannii strains were highly susceptible to DS-PA90 treatment: five out of nine strains were entirely killed and four strains were reduced by 3-4 log in CFU/ml. Consequently, DS-PA90 could protect waxworm from A. baumannii-induced death by ?70% for ATCC 17978 or ?44% for MDR strain 1656-2 infection.', '', 'Collectively, our data suggest that CPP-fused endolysin can be an effective antibacterial agent against Gram-negative pathogens regardless of antibiotics resistance mechanisms.', '35614377'),
('tetrameric cell penetrating antimicrobial peptoids', 'short tetrameric Rhodamine B-labeled peptoids composed of a balance of aromatic and lipophilic residues have potent selective antimicrobial activity against a range of microorganisms. The most potent candidates were active against drug-resistant S. aureus isolates as well as mycobacterial strains, with cell penetrating capabilities reported in HeLa and RAW 264.7 macrophage cells.', '', 'Conclusions: These data suggest that peptoids with novel dual functionalities may potentially be an interesting class of therapeutics and/or molecular delivery agents for anti-infective purposes.', '35227007'),
('Human neutrophil peptide-1 (HNP-1)', 'HNP-1 induces bacterial apoptosis and prevents its SOS repair pathway from binding to the RecA protein, which may be a new antibacterial mechanism. In addition, we showed that HNP-1 encapsulated in liposomes inhibits the growth of methicillin-resistant Staphylococcus aureus (MRSA) and meropenem-resistant Pseudomonas aeruginosa (MRPA).', '', 'These results indicated that recombinant protein expression may be a simple and cost-effective solution to produce HNP-1 and that RecA inhibition via HNP-1 may serve as an alternative strategy to counteract antibiotic resistance.', '35019682'),
('RPMs : FK20 (L-Phenylalanine-L-Lysine, 20-mer), FdK (L-Phenylalanine-D-Lysine, 20-mer), dFdK (D-Phenylalanine-D-Lysine, 20-mer), and LK20 (L-Leucine-L-Lysine, 20-mer)', 'RPMs rapidly and efficiently kill different strains of A. baumannii, inhibit biofilm formation, and disrupt mature biofilms. Importantly, RPMs attenuated bacterial burden in mouse models of acute pneumonia and soft tissue infection and significantly reduced mouse mortality during sepsis.', '', 'Collectively, our results demonstrate RPMs have the potential to be used as powerful therapeutics against antibiotic-resistant A. baumannii.', '35326876'),
('?-hairpin structure with the template (XY)2RRRF(YX)2-NH2 (X: hydrophobic amino acids; Y: cationic amino acids)', 'almost all of the new peptides have strong antibacterial activity and negligible hemolytic toxicity. Particularly, the therapeutic index (TI) values of F(RI)2R and F(KW)2K reached up to 115.9 and 70.7, respectively. In addition, they did not show induced drug resistance and inhibited the development of antibiotic resistance when combined and used with traditional antibiotics.', '', 'Moreover, the new peptides F(RI)2R and F(KW)2K showed excellent performance in the pulmonary bacterial infection model and low toxicity in mice. In conclusion, F(RI)2R and F(KW)2K are considered new antimicrobial alternatives to address the antimicrobial-resistance crisis.', '35311294'),
('Black Soldier Fly ( Hermetia Illucens) : Hill-Cec1 and Hill-Cec10', 'Hill-Cec1 and Hill-Cec10 also showed high activity against other bacterial species, including Klebsiella pneumoniae and multi-drug resistant P. aeruginosa. Both AMPs are bactericidal and have a rapid onset of action with membrane-permeabilizing effects.', 'Hill-Cec1 and Hill-Cec10 were also able to prevent P. aeruginosa biofilm formation, but no relevant effect was seen on biofilm eradication.', 'Overall, Hill-Cec1 and Hill-Cec10 are promising leads for new antimicrobial development to treat critical infections caused by Gram-negative pathogens such as P. aeruginosa.', '34985302'),
('Cathelicidin-Mimetic Antimicrobial Peptoids', 'These peptoids also show efficient and fast (<30 min) killing of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) at low micromolar concentrations without having apparent cytotoxic side effects in vivo. One cationic 12mer, Peptoid 1, shows great promise, as it could prevent formation of and detach biofilms at concentrations as low as 1.6 ?M.', 'The use of a bioluminescent S. aureus murine incision wound model demonstrated clearance of infection in peptoid-treated mice within 8 days, conveying another advantage these peptoids have over conventional antibiotics.', 'These results provide clear evidence of the potential for antimicrobial peptoids for the treatment of S. aureus wound infections.', '35467395'),
('cell adhesion peptide (CAPs) nanocoatings', 'The two leading nanocoatings upregulated integrin-mediated hemidesmosomes, selectively increased keratinocyte proliferation compared to fibroblasts, which cannot form hemidesmosomes, and expression of junctional epithelium adhesive markers. CAP nanocoatings displayed marked durability under simulated clinical conditions and the top performer CAP nanocoating was validated in a percutaneous implant murine model. Basement membrane CAP nanocoatings, inspired by the tooth and junctional epithelium, may provide an alternative anti-infective strategy for percutaneous devices to mitigate the worldwide threat of antimicrobial resistance.', '', 'Application of cell adhesion peptide nanocoatings may provide an alternative to preventing, rather that necessarily treating, medical device infection across a range of device indications, like dental implants.', '34971784'),
('Peptides ASU2056, ASU2060', 'Overall, six peptides inhibited the M. abscessus smooth morphotype (IC50 = 1.7 ?M for all peptides) and had reduced activity against the M. abscessus rough morphotype (IC50 range: 13-82 ?M). Peptides ASU2056 and ASU2060 had minimum inhibitory concentration values of 32 and 8 ?M, respectively, against the M. abscessus smooth morphotype. Additionally, ASU2060 (8 ?M) was active against Escherichia coli, including multidrug-resistant E. coli clinical isolates, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus. ASU2056 and ASU2060 exhibited no significant hemolytic activity at biologically relevant concentrations, further supporting these peptides as promising therapeutic candidates. Moreover, ASU2060 retained antibacterial activity after preincubation in human serum for 24 h.', '', 'With antimicrobial resistance on the rise, methods such as those presented here will streamline the peptide discovery process for targeted antimicrobial peptides.', '35847280'),
('Purified arasin-likeSp', 'the ELP-intein self-cleavage system was used to produce antimicrobial peptide arasin-likeSp in Escherichia coli. The final yield of arasin-likeSp was about 3.56 mg/L. Purified arasin-likeSp exhibited significant antibacterial activities against the Gram-positive Bacillus subtilis and Gram-negative Vibrio harveyi bacteria.', '', 'Collectively, these data suggest that arasin-likeSp is a candidate AMP for effective inhibition of Vibrio harveyi, a significant bacterial pathogen infecting marine fish and invertebrates. The ELP-intein self-cleavage system described here is a low-cost, simple and potential method for producing antimicrobial peptides, which lays foundations for the large-scale production of antimicrobial peptides in the future.', '35240202'),
('hepcidin gene from the fish, Catla catla (Cc-Hep)', 'Sequence analysis revealed that Cc-Hep shared sequence similarity with hepcidin from Sorsogona tuberculata. Sequence analysis revealed that Cc-Hep shared sequence similarity with hepcidin from Sorsogona tuberculata.', '', 'Conclusion: Functional characterization predicted antibacterial, antioxidant, and anticancer potential of Cc-Hep, which can be explored in aquaculture or human health care.', '35344090'),
('d,l-K6L9 peptides', 'd,l-K6L9 peptides are stable and resistant to degradation by CF sputum proteases and maintain their activity in a CF sputum environment. Additionally, the d,l-K6L9 peptides do not induce bacterial resistance.', '', 'Overall, these findings should assist in the future development of alternative treatments against resistant bacterial biofilms.', '35759644'),
('Lycosin-II isolated from spiders Lycosa singoriensis', 'Lycosin-II showed strong antibacterial activity and biofilm inhibition effects against gram-positive and gram-negative bacteria including oxacillin-resistant Staphylococcus aureus (S. aureus) and meropenem-resistant Pseudomonas aeruginosa (P. aeruginosa) isolated from patients.', 'Lycosin-II was not cytotoxic against human foreskin fibroblast Hs27 or hemolytic against sheep red blood cells at the concentration of which exerted antibacterial activity.', 'Moreover, Lycosin-II showed anti-inflammatory effects by inhibiting the expression of pro-inflammatory cytokines that are increased during bacterial infection in Hs27 cells. These results suggest that Lycosin-II can serve as a therapeutic agent against infections with multidrug-resistant strains.', '34506798'),
('WLBU2 (also known as PLG0206)', 'Populations that survived WLBU2 treatment acquired a minimum of two mutations, making the acquisition of resistance more difficult than for most antibiotics, which can be tolerated by mutation of a single target. Major targets of resistance to WLBU2 included the orfN and pmrB genes, previously described to confer resistance to other cationic peptides. More surprisingly, mutations that increase aggregation such as the wsp pathway were also selected despite the ability of WLBU2 to kill cells growing in a biofilm.', '', 'Conclusions and implications: The results show how experimental evolution and WGS can identify genetic targets and actions of new antimicrobial compounds and predict pathways to resistance of new antibiotics in clinical practice.', '35712084'),
('insect metallopeptidase inhibitor (IMPI)', 'designed a cohort of 12 single and multiple point mutants, the best of which (I57F) inhibited aureolysin with an estimated inhibition constant (K i) of 346 nM.', '', 'Given that animals lack thermolysins, our strategy may facilitate the development of safe TPs against staphylococcal infections, including strains resistant to conventional antibiotics.', '35465156'),
('LcC CL28-25 (Larimichthys crocea), Derived from Piscine Chemokine', 'lcCCL28-25 was capable of rapidly destroying the integrity and permeability of the bacterial cell membrane', '', 'Additionally, the efficacy of lcCCL28-25 in in vivo antibacterial activity in a mammalian model revealed that this compound could be a promising agent for the development of peptide-based antibacterial therapeutics. The novel peptide lcCCL28-25 may prove to be an effective antibacterial agent.', '35616397'),
('anti-inhA peptide nucleic acids (PNAs)', 'The antibacterial efficacy of anti-inhA PNA is enhanced when it is combined with permeabilizing drugs, particularly ethambutol. This indicates that the addition of even small concentrations of anti-inhA PNA to the current TB regimen could potentiate their therapeutic efficiency. We hypothesize that this system would also overcome isoniazid resistance, since the resistance mutations lie outside the designed anti-inhA PNA target site.', '', 'We therefore propose that anti-inhA PNA could improve therapy even when applied in minute doses as an addition to the current anti-tuberculosis drug regimen.', '35171048'),
('pH-responsive antimicrobial peptides (F5: FLEHLIPHVIHGLVHAIHH-NH2)', 'efficient bacterial killing activity at pH 6.5 and inactivity at pH 7.4. Among the peptides, F5 exhibited outstanding pH-responsive antimicrobial activity and low toxicity. Fluorescence spectroscopy and electron microscopy illustrated that F5 killed bacteria via a membrane-disruptive mechanism at acidic pH values.', 'Mouse cutaneous abscesses revealed that F5 was equipped with excellent therapeutic ability to reduce the bacterial load and cytokines without causing skin toxicity.', 'In summary, this study reveals a strategy for selectively killing bacteria under the pathologic conditions of abscess sites while avoiding the elimination of commensal bacteria under normal physiological pH levels.', '35294199'),
('BF15-a1 (lysine-stapled CAMPs)', 'CAMPs with a better amphiphilic structure were inclined to exhibit improved antimicrobial activity, protease stability, and biocompatibility after lysine-stapling. One of the stapled analogues of BF15-a1 was found to have extended half-life in plasma, enhanced antimicrobial activity against clinically isolated MDR ESKAPE pathogens, and remained highly effective in combating MRSA infection in a mouse model.', '', 'Cationic antimicrobial peptides (CAMPs) are promising for treatment of multidrug-resistant (MDR) bacteria-caused infections.', '34968054'),
('ZN-5 and ZN-6 (Oreoch-2 analogues)', 'were identified to be broad-spectrum effective analogues, which were superior to their parent peptide Oreoch-2. good stability to the physiological environment, and much higher selectivity to bacterial cells than to mammalian cells. Were typical bactericidal agents and quickly eliminated bacteria in a bactericidal mode by disrupting bacterial cell membrane. Moreover, ZN-5 and ZN-6 could inhibit biofilm formation of Staphylococcus aureus ATCC25923.', 'Compared with their parent peptide Oreoch-2, ZN-5 and ZN-6 not only possessed shortened peptide chains, but also showed slightly improved antibacterial activity and greatly reduced hemolysis.', 'This indicates that they are ideal lead compounds of antimicrobial peptides, which can be developed as substitutes for traditional antibiotics.', '34971943'),
('human ApoB-derived antimicrobial peptide r(P)ApoBLAla in combination with low concentrations of conventional antibiotics', 'to treat ureteral catheter-colonizing bacterial communities on clinically isolated bacteria', '', 'The results suggest that combinations of conventional antibiotics and human antimicrobial peptides might synergistically counteract biofilm growth on ureteral catheters, suggesting novel avenues for preventing catheter-associated infections in patients who have undergone radical cystectomy and ureterocutaneostomy.', '35743833'),
('P-MtrE1', 'Cotreatment of bacteria with subinhibitory concentrations of the peptide led to 2- to 64-fold increases in susceptibility to erythromycin, azithromycin, ciprofloxacin, and/or ceftriaxone in N. gonorrhoeae strains FA1090, WHO K, WHO P, and WHO X. The cotreatment experiments with peptides P-MtrC1 and P-MtrE1 resulted in increased susceptibilities of WHO P and WHO X to azithromycin, ciprofloxacin, and ceftriaxone that were of the same magnitude seen in MtrCDE mutants.', '', 'Data presented here demonstrate that these peptides may be developed for use as a dual treatment with existing antibiotics to treat multidrug-resistant gonococcal infections.', '34633841'),
('caposomes', 'capsosomes selectively deliver their cargo in the presence of bacteria, producing a bactericidal effect to protect the host organism', '', 'Thus, the capsosomes serve as a versatile multidrug, subcompartmentalized microparticle system for preventing antibiotic-resistant bacterial infections, with potential applications to protect wounds or medical device implants from infections.', '35481905'),
('DCD-1L', 'The bacterial adhesion and biofilm formation in all A. baumannii isolates were inhibited at 2 ? , 4 ? , and 8 ? MIC of DCD-1L, while only 8 ? MIC of DCD-1L was able to destroy the pre-formed biofilm in vitro.', '', 'Results of this study demonstrated that DCD-1L can inhibit bacterial attachment and biofilm formation and prevent the onset of infection. Taking these properties together, DCD-1L appears as a promising candidate for antimicrobial and anti-biofilm drug development.', '35026999'),
('RWWWR (central motif) plus arginine (R) end-tagging', 'great potential in combating Escherichia coli bacteremia and the Staphylococcus aureus skin burn infection model, which induces a 62-90% reduction in bacterial burden, Pep 6 exhibited robust biofilm-inhibiting activity and eliminated 61.33% of the mature methicillin-resistant Staphylococcus aureus (MRSA) biofilm', '', 'These results suggest that the RWWWR motif and binding of arginine end-tagging could be harnessed as a new agent for combating multidrug-resistant bacteria.', '34964342'),
('R23F, R23DI, and R23EI hybrid peptides', 'against Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Pseudomonas aeruginosa, Escherichia coli, and Bacillus cereus', '', 'R23F, R23DI, and R23EI can be used as antimicrobial peptides against Gram-positive and Gram-negative bacteria resistant to traditional antibiotics.', '35008951'),
('Temporin-1CEc analogs 2K2L and 2K4L', 'against sensitive and multidrug-resistant bacteria, effectively killing the tested multidrug resistant strain Staphylococcus epidermidis (MRSE1208), inhibited the formation of MRSE1208 biofilms at concentrations below its MIC value', '', 'Collectively, these results suggest that 2K2L and 2K4L could be effective antibiotics against multidrug-resistant bacterial strains.', '34953322'),
('PEP-38 and PEP-137 peptides', 'active in vitro against carbapenem-resistant isolates of Klebsiella aerogenes and K. pneumoniae. PEP-137 was also active against Pseudomonas aeruginosa.', '', 'The data obtained can be used to develop new antibacterial peptide drugs to combat antibiotic resistance.', '35326874'),
('VicBac (Proline-Rich Cathelicidin from the Alpaca Vicugna pacos)', 'Potency to Combat Antibiotic-Resistant Bacteria', '', 'The pronounced antibacterial activity of VicBac, along with its moderate adverse effects on mammalian cells, make this molecule a promising scaffold for the development of peptide antibiotics.', '35629841'),
('NZX and P2, fungal defensin-derived peptides', 'MIC values (NZX: 0.11 MicroM, P2: 0.91 MicroM) and MPC (NZX: 1.82 MicroM) against Streptococcus agalactiae', '', 'Conclusion: NZX and P2 are promising antimicrobial agents for streptococcicosis treatment.', '35630326'),
('WAM-1', 'MICs of 2-4 mg/L and MBCs of 4-8 mg/L against carbapenem-resistant Klebsiella pneumoniae', '', 'Conclusions: WAM-1 has good antibacterial effect and potential anti-inflammatory effect on infection caused by CRKP.', '35474013'),
('RP557 alone or in combination with several clinically effective antibiotics, including clarithromycin, amikacin, cefoxitin and imipenem', 'increases the antibiotic sensitivity of Mycobacterium abscessus by inhibiting biofilm formation', '', 'As such, RP557 is a potential candidate to include in novel strategies to treat M. abscessus infections.', '34813807'),
('hyaluronic-acid-based hydrogel', 'The peptidomimetic was found to exhibit antimicrobial and anti-biofilm properties at concentration values ranging from 2.5 to 20 ?mol L-1, to be biocompatible toward human skin cell lines, and to protect human keratinocytes from bacterial infections being able to induce a reduction of bacterial units by two or even four orders of magnitude with respect to untreated samples.', '', 'The developed hydrogel-based system represents a promising, effective therapeutic option by combining the mechanical properties of the hyaluronic acid polymer with the anti-infective activity of the antimicrobial peptidomimetic, thus opening novel perspectives in the treatment of skin infections.', '35740323'),
('CHRG01, KSR, and KLR', 'active against gram positive as well as gram negative bacteria and kill bacteria by forming membrane pores', '', 'Understanding the molecular level interaction of individual amino acids with the lipid bilayer will greatly help in the design of more efficient antimicrobial peptides.', '34838874'),
('guanidinium-functionalized poly(l-lysine) (PLL22 -Gua)', 'kills MRSA with low resistance frequency (<3.3 ? 10-8 ). In an MRSA-caused wound infection mouse model, two-day treatment (twice daily) with 10, 20, or 40 mg per kg of PLL22 -Gua shows up to 99.5% bacterial removal.', '', 'These promising results show the excellent potential of PLL22 -Gua as an antimicrobial agent against multidrug-resistant infection in vivo.', '34846807'),
('peptidomimetic antibiotic 10 (human alpha-defensin 5)', 'potent killing of multiple drug-resistant gram-negative bacteria isolated from patients', '', 'By engaging multiple bacterial targets, the lead compound is efficacious in vitro and in vivo against bacteria with highly inducible antibiotic resistance, promising a useful therapeutic agent for the treatment of infections caused by antibiotic-resistant bacteria.', '35238683'),
('Anisaxins', 'potent bactericidal agents in vitro, selectively active against Gram-negative bacteria, including multi-drug resistant strains, at sub-micromolar concentrations', '', 'This membranolytic antibacterial activity does not translate to cytotoxicity towards human peripheral blood mononuclear cells (HPBMCs), which was minimal at well above bactericidal concentrations, making anisaxins promising candidates for further drug development.', '35470073'),
('Epinecidin-1 and Beta-Defesin-3', 'showed antibacterial activity in vitro in a concentration of 2 to 32 mg/L', '', 'For K. pneumoniae-sepsis, hBD-3 was shown to be a promising option in overcoming the resistance of Klebsiella spp. to carbapenems, though more research is needed. In the P. aeruginosa-sepsis model, the addition of Epi-1 to hBD-3 was found to have a slightly reduced mortality rate compared to hBD-3 monotherapy.', '35052952'),
('Alpha-MSH (melanocyte stimulating hormone) based cationic peptides', 'most cationic analogue, KKK-MSH with a + 5 charge, demonstrated successful eradication of 105 CFU/mL of E. coli cells within 15 min at a concentration as low as 1 MicroM', '', 'Here, we propose ?-MSH based cationic peptides as promising future agents with broad-spectrum antibacterial efficacy against both Gram-negative and Gram-positive pathogens.', '35132082'),
('Nigrocin-PN (Pelophylax nigromaculatus)', 'Nigrocin-PN and ampicillin could delay Staphylococcus aureus antibiotic resistance acquisition', '', 'Conclusions: A broad-spectrum antimicrobial peptide Nigrocin-PN was discovered from the skin secretion of Pelophylax nigromaculatus. Structurally, "Rana box" played a crucial role in reducing toxicities without compromising antibacterial abilities, and Nigrocin-PN could be a desired therapeutic candidate.', '35606468'),
('GHaR6R, GHaR7R, GHaR8R and GHaR9W', 'show potent antimicrobial activities against methicillin-resistant (MRSA)', 'GHaR6R, GHaR8R and GHaR9W show less toxicity toward normal cells HL-7702 and hFOB1.19.', 'These results suggest that the GHa-derived peptides may be promising antimicrobial candidates against MRSA infections.', '35538042'),
('combination of hydrocarbon stapled to L8 (KRIVQRIKKWLR) and L6 (RRLFRRILRWL) peptides and antibiotics (Vancomycin)', 'different hydrocarbon staples to two previously described peptides shown to act on the outer membrane, L6 and L8, and tested their activity in a zebrafish embryo infection model using a clinical isolate of Acinetobacter baumannii as a pathogen improves its in vivo potentiating activity on antibiotic treatment, without increasing its in vivo antimicrobial activity, toxicity or hemolytic activity', '', 'We show here that combinations of stapled peptide L8S1 and vancomycin may provide an attractive novel therapeutic strategy against nosocomial A. baumannii infection.', '35203875'),
('lichenicidin', 'presence of the two mature peptides, Bli? and Bli?, is necessary for full activity against target bacteria, both peptides exhibit synergistic activity in their interaction with the target membranes', '', 'Based on this information, we propose a mechanism of action of lichenicidin.', '34973602'),
('"Picturins" (PTR) and "Pictuseptins" (PTS)', 'PTR displayed moderate activity against Escherichia coli (MIC 24.80 to 48.95 MicroM), while PTS showed a broad antimicrobial and antifungal effect. PTS-1 was the most active peptide against E. coli (6.8 microM) followed by PTS-3 (11.7 MicroM) and PTS-2 (14.24 MicroM).', '', 'Overall, new unique non-hemolytic and cationic peptide sequences were characterized that could be valuable for the next-generation of anti-infective drugs. Future functional studies should explore the pharmacological potential of Boanins to include them as antimicrobial scaffolds.', '35640793'),
('Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin', 'against Cystic Fibrosis Pseudomonas aeruginosa', '', 'Our findings demonstrate that glatiramer acetate is a strong candidate for repurposing as an antibiotic resistance breaker of pathogenic P. aeruginosa.', '35727066'),
('h-Lf1-11, MSI-78, LL-37 and magainin-2', 'against Escherichia coli, methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, carbapenem-resistant Klebsiella pneumoniae, and Acinetobacter baumannii. The MSI-78 showed potent bactericidal activity with MIC range of 1.25-40 mg/L against all bacterial strains. The h-Lf1-11, magainin-2, and LL-37 exhibited moderate activity (MIC range of 40-160, 80-160, and 40-160 mg/L, respectively)', '', 'These results revealed that MSI-78, h-Lf1-11, magainin-2, and LL-37 have great potential as antibacterial agents and their activity deserves to be more explored in further studies for the treatment of antibiotic-resistant bacteria.', '34735710'),
('temporin B and temporin L with the addition of buforin II, a histone H2A fragment', 'less potent temporin B enhances the cooperativity of the in vitro antibacterial activity of the more potent temporin L against EMRSA-15 and that this may be associated with an altered interaction with the bacterial plasma membrane, a feature critical for the antibacterial activity of most AMPs. Addition of buforin II, a histone H2A fragment, can further increase the cooperativity.', '', 'Exploration of the mechanism of synergy between AMPs isolated from the same organism may therefore yield antibiotic combinations with advantageous pharmacodynamic properties.', '35609188'),
('amyloid-? inspired biocompatible short peptide amphiphile (sPA) molecule-AgNPs', 'potential therapeutic value for the treatment of microbiota triggered progression of neurodegenerative diseases', '', 'Such sPA-AgNPs hybrid structures can be further used to develop antibacterial materials to combat emerging bacterial resistance.', '35684988'),
('brevinin-2KP', 'weakly active towards the tested Gram-positive and Gram-negative bacteria as well as fungi due to its membranolytic action', 'brevinin-2KP inhibits the proliferation of several mammal cells with IC50 values ranging from 3.27 to 59.75 ?M', 'Conclusion: This is the first report on AMP identified from the skin of K. pulchra. Brevinin-2KP adopts a typical amphipathic ?-helix conformation in membrane mimic environment and shows antimicrobial and antitumor activities by potential membranolytic mechanism. In addition, brevinin-2KP can promote degranulation and histamine release of mast cells. Brevinin-2KP is expected to become a good drug temple molecule.', '35249479'),
('L-Chg10-Teixobactin', 'The MIC and MBC values of L-Chg10-teixobactin against both strains of Enterococcus faecalis were 0.8 Microg/mL.', '', 'Conclusions:L-Chg10-teixobactin demonstrated potent antibacterial and antibiofilm effects against E. faecalis, suggesting its potential role an effective antibacterial and antibiofilm agent in endodontic treatment.', '35744616'),
('r(P)ApoBLPro, r(P)ApoBSPro, and r(P)ApoBLAla derived from the human apolipoprotein B (residues 887-922)', 'exhibited potent antimicrobial activity against drug-resistant Klebsiella pneumoniae, Acinetobacter baumannii, and Staphylococci both in vitro and in an animal model', '', 'Our results provide a link between human plasma and innate immunity and point to the blood as a source of much-needed antimicrobials.', '35112568'),
('Star-Peptide Polymers', 'preferentially target and kill Gram-positive pathogens including MRSA', '', 'These results highlight the potential utility of peptide/polymers to fabricate materials for therapeutic development against MDR Gram-positive bacterial infections.', '35500245'),
('Human Cryptic Host Defence Peptide GVF27', 'Exhibits Anti-Infective Properties against Biofilm Forming Members of the Burkholderia multivorans and Burkholderia cenocepacia', '', 'Overall, all these findings contribute to the elucidation of the main features that a good therapeutic agent directed against these extremely leathery biofilm-forming bacteria should possess.', '35215373'),
('Liposome-Encapsulated Tobramycin and IDR-1018 Peptide', 'Biofilm Disruption and Enhanced Antimicrobial Activity against Pseudomonas aeruginosa, the biofilm formation was significantly reduced (p &lt; 0.05) at concentrations of ?4 Microg/mL and ?32 Microg/mL for PA01 and ?32 Microg/mL for MDR 7067 when loading tobramycin into liposomes, with or without the anti-biofilm peptide compared to the free antibiotic, empty liposomes, and IDR-1018-loaded liposomes', '', 'Tobramycin-loaded liposomes could be a potential candidate for treating lung-infected animal models owing to the high therapeutic efficacy and safety profile of this system compared to the free administration of the antibiotic.', '35631547'),
('cholic acid analogues 17c and 17d', 'analogues containing lysine-like residues showed the highest antibacterial potency against Gram-positive S. aureus. All di-substituted analogues possess high antimicrobial activity against both Gram-positive S. aureus as well as Gram-negative E. coli and P. aeruginosa.', '', 'These compounds were able to depolarise the bacterial membrane, suggesting that they are potential antimicrobial pore forming agents.', '35563014'),
('Mucosal pentraxin 2 (Mptx2)', 'against peritoneal infection by methicillin-resistant staphylococcus aureus', '', 'Mptx2 has bactericidal activity against MRSA both in vitro and in vivo, which may shed light on the discovery and development of novel strategies for MRSA-infected peritonitis.', '35609377'),
('symbah-1', 'macrocyclic ?-hairpin peptide antibiotic', '', 'The method of discovery and subsequent characterization of symbah-1 suggests large synthetic peptide libraries bias toward macrocyclic ?-hairpin structure could be designed and screened to rapidly expand and better understand this rare peptide antibiotic class.', '35005555'),
('isolate (WUL10) in the Brevibacillus genus', 'MIC of the purified substance was 1 ?g/mL against S. aureus TISTR 517 and MRSA strains. This substance showed the bactericidal effect at the concentration of 1-2 Microg/mL against these bacterial indicators.', '', 'This novel AMP would provide an advantage for further development of anti-MRSA substances to manage the situation of antibiotic resistance.', '35736972'),
('(SAAP)-148 and Halicin', 'equally effective against antimicrobial-resistant (AMR) Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus bacteria residing in immature and mature biofilms', '', 'Together, combinations of these two novel antimicrobial agents hold promise as an innovative treatment for infections not effectively treatable with current antibiotics.', '35625317'),
('Chicken cathelicidins CATH-1(RVKRVWPLVIRTVIAGYNLYAIKKK,), CATH-3(RVKRFWPLVPVAINTVAAGINLYKAIRRK, ) and porcine; PMAP-36(GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG) in combination with conventional antibiotics containing ampicillin tetracycline, gentamicin, and erythromycin', 'FBCIs of only CATH-1 + tetracycline were higher than 0.5 against S. aureus, FBCIs of other combinations (CATH-1,?3 and PMAP-36 with ampicillin, tetracycline, gentamicin, and erythromycin) were lower 0.5. FBCIs of CATH-1,?3 and PMAP-36 combination with erythromycin were lower 0.5 against S. enteritidis and E. coli . FBCIs of other combinations (CATH-1,?3 and PMAP-36 with ampicillin, tetracycline, and gentamicin) were higher than 0.5 or even higher than 1.0 against S. enteritidis and E. coli.', 'mice erythrocytes and macrophages and PK-15 cells were used to determine hemolytic activity and cytotoxicity, respectively. The results showed that CATH-1,?3 and PMAP-36 alone at MBC showed low hemolysis (<20%), and erythromycin alone at MBC showed high hemolysis (>95%). However, AMPs (CATH-1,?3 and PMAP-36) combined with erythromycin at sub-MBC showed lower hemolytic activity (<3%)', 'Hence result show that the combination of CATH-1 and erythromycin has synergistic antibacterial activity and reduces the emergence of bacterial drug resistance.', '35910608'),
('TAT-RasGAP317-326 peptide with antibiotics', 'synergistic combinations towards all three bacteria and demonstrated that these combinations had an increased bactericidal effect compared to individual drugs.', '', 'combination of TAT-RasGAP317-326 and meropenem had a promising antibiofilm effect towards A. baumannii.', '36270448'),
('The antimicrobial peptide GL13K was derived from the salivary protein BPIFA2.', 'Klebsiella pneumoniae (MICs 16-32 microgram/ml) and Acinetobacter baumannii (MICs 8-32 microgram/ml).', '', 'DGL13K displayed in vitro activity against extended-spectrum beta-lactamase (ESBL)-producing and Klebsiella pneumoniae carbapenemase, P. aeruginosa and Acinetobacter baumannii carrying metallo-beta-lactamases. P. aeruginosa showed low inherent resistance to DGL13K', '36006947'),
('Antimicrobial Peptides SAAP-148 and OP-145', 'The concentration of the peptides necessary to kill 99.9% of E. coli and E. hirae cells within 5 min of incubation period was found to be 1.6 ?M and 0.4 ?M for SAAP-148 and 6.4 ?M versus 3.2 ?M for OP-145 when tested in NaPi buffer for 1 ? 106 CFU/mL bacteria', 'The 99.9% lethal concentration (LC99.9%) implies antimicrobial activity and constitutes the lowest peptide concentration that killed ?99.9% of bacteria', 'these peptides immediately bind to negatively charged components and neutralize the surface of Gram-negative bacteria. Then, they insert into the fatty acyl chain region of the outer membrane, inducing higher outer membrane permeability. The increased membrane permeability for small ions will be sufficient to result in cell death.', '36139091'),
('Novel antimicrobial peptide Intestinalin (P30), which is derived from the LysC enzyme of Clostridium intestinale strain URNW', 'Intestinalin showed MIC values ranging from 7.8 to >124 ?M. The highest MICs (> 124 ?M) were observed for S. aureus KPD 740, S. aureus KPD 425, E. cloacae KPD 297, E. coli KPD 217, and K. pneumoniae KPD 298. The lowest MICs (7.8 ?M) were against three of four A. baumannii strains tested, as well as for S. hominis KPD 910 and S. pettenkoferi KPD 741.', 'The results showed that Intestinalin was not toxic to HaCaT cells at concentrations up to 100 ?M', 'Experimental data showed that Intestinalin interacts with negatively charged lipoteichoic acid (logK based on isothermal titration calorimetry, 7.45 ? 0.44), causes membrane depolarization, and affects membrane integrity by forming large pores, all of which result in loss of bacterial viability', '36094301'),
('AMP human ?-defensin-2 (HBD-2)', 'the data showed an almost total reduction in the invasive ability of EIEC in transfected cells (> 99%). Enteroinvasive E. coli (EIEC) that is responsible for the bacillary dysentery that causes severe diarrheal symptoms in both children and adults.', '', 'The results showed that HBD-2 is able to significantly reduce the expression of the proinflammatory cytokines by intestinal epithelial cells, the invasiveness ability of enteroinvasive E. coli (EIEC) and the expression of invasion-associated genes.', '36310877'),
('Phage Lysin-Derived Peptide P87', 'The MIC values for P88 (20?50 ?M) seem coherent with previously reported MICs of lysin-derived AMPs,', 'One of the drawbacks usually adduced for the therapeutic application of AMPs is their possible cytotoxic effect against eukaryotic cells.', 'A peptide, P87 from phage lysin Pae87 has been tested as a source for efficient, alternative antimicrobials. To improve its antimicrobial efficacy, a derivative peptide, termed P88, with increased hydrophobic moment and net charge has been designed and proven to possess an enhanced bactericidal and antibiofilm activity.', '36290106'),
('new lipopeptide-like pentamer, decanoyl-bis.diaminobutyrate-aminododecanoyl-diaminobutyrate-amide (C10BBc12B)', 'minimal inhibitory concentrations (MIC ? 50 ?M) against E.coli, P. aeroginosa, K. pneumoniae, A. baumanni', 'no cytotoxicity towards cell-lines was observed at-least up to 50 ?M.', 'action mechanism implicating the pentamer''s de-facto capacity to hijack bacterial efflux pumps for boosting its adjuvant activity through repetitive steps including outer-membrane adhesion, translocation and subsequent expulsion.', '36271103'),
('two peptides LP-23 and SA4, as well as their mimetic peptoids DP-23 and SPO were selected. Synergistic effects of short peptides and antibiotics', 'Based on the fraction inhibitory concentration: FICI ? 0.5 synergistic value , LP-23, DP-23, and SPO demonstrated synergy in combination with gentamicin against a gentamicin-resistant clinical isolate of Escherichia coli. For Staphylococcus aureus, Escherichia coli, and Salmonella typhimurium, seven combinations exhibited synergistic effects between peptide/peptoids and the tested antibiotics.', 'These peptides were also evaluated for its cytotoxicity against human embryonic normal kidney cells (HEK 293) and pancreatic cancer cells (MIA PaCa-2) using MTT assay. The average cell survival rate for all peptides in HEK cells was 90% at 100 ?g ml?1 and 68% at 500 ?g ml?1. In MIA PaCa-2, about 15% cells was compromised at high concentration of 500 ?g ml?1', 'Synergy obtained between LP-23, SA4 and their mimetic peptoids DP-23 and SPO with antibiotics have the potential to be used as a combination therapy against microbial infections. These combinations may be helpful in lowering the drug dose and creating better results, which can be applied in future against various MDR strains.', '35931657'),
('pentapeptide-4" (PP4, with amino acid sequence KTTKS)', 'peptide effective against Gram-positive (S. aureus, Enterococcus faecalis) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa) bacteria.', '', 'These constructs have potent wide-spectrum antimicrobial action, including against multidrug-resistant Gram-positive and Gram-negative bacteria, and fungi.', '35950860'),
('Novel Alligator Cathelicidin As-CATH8', 'MIC of As-CATH8 for S. aureus (0.5 ?M) and A. baumannii (0.25 ?M) respectively. As-CATH8 demonstrated strong antibacterial effects in a murine abscess model of high-density bacterial infections against clinical isolates of S. aureus and Acinetobacter baumannii,', 'As-CATH8 were moderately cytotoxic against human bronchial epithelial (HBE) cells and peripheral blood mononuclear cells', 'Result declare that As-CATH8 peptide, which has substantial therapeutic promise for treatment of S. aureus and A. baumannii skin infections, two of the most prevalent bacterial species causing SSTIs worldwide.', '36421248'),
('designed the (WRX)n hydrophobic tryptophan (W) residues and hydrophilic charged arginine (R) (where X = hydrophilic uncharged amino residues; n = number of repeat units) series engineered peptides with high cell selectivity by introducing hydrophilic uncharged threonine (T), serine (S), glutamine (Q) or asparagine (N) residues into the minimalist design of W- and R-rich AMPs.', 'T6 exhibited potent antibacterial and antiinflammatory capabilities in vivo in a mouse peritonitis-sepsis model infected with Escherichia coli.', '', 'The results showed that the introduction of these hydrophilic uncharged amino residues, especially T residues, significantly improved the cell selectivity of the W- and R-rich engineered peptides. It has potent antibacterial activity, good biocompatibility, high selectivity index, strong tolerance, rapid and efficient time-kill kinetics, and no tendency of resistance. Studies on antibacterial mechanism show that T6 exert antibacterial activity mainly by disrupting bacterial cell membrane and inducing the accumulation of reactive oxygen species in bacterial cells.', '36115654'),
('two designed, cationic antimicrobial-derived peptides: Mt6, and its dextroisomer D-Mt6, belonging to the analogs of MAF-1, which is isolated from the instar larvae of houseflies.', 'Mt6 and D-Mt6 showed different degrees of inhibitory activity against Gram-positive bacteria (S. aureus and B. subtilis) and Gram-negative bacteria (E. coli, K. pneumoniae, P. aeruginosa, A. baumannii).', '', 'Both Mt6 and D-Mt6 showed broad-spectrum antimicrobial activity, especially against A. baumannii, by damaging membrane integrity. Moreover, D-Mt6 showed better immunoregulatory activity against LPS induced inflammation through its LPS-neutralizing and suppression on MAPK signaling. This study suggested that D-Mt6 is a promising candidate drug as a derived peptide against A. baumannii.', '36190276'),
('rhamnolipid and linezolid', 'Four S.aureus (One ATCC 29213 strain and three methicillin-resistant strains) were used in the study. The minimum inhibitory concentration of the resistant strain decreased from 16 to 4 ?g/mL with a four-fold decrease.', '', 'The G.mellonella larval model demonstrated that combined therapy was more effective than monotherapy by survival function tests and CFU determination. RML/LNZ combination improved survival compared to monotherapy and decreased the bacterial burden.', '36526037'),
('Teixobactin type of peptide', '', 'Teixobactin damages only membranes that contain lipid II, which is absent in eukaryotes, elegantly resolving the toxicity problem.', 'Teixobactin targets lipid II, a precursor of peptidoglycan, destroy cell membrane of bacteria. The two-pronged action against cell wall synthesis and cytoplasmic membrane produces a highly effective compound targeting the bacterial cell envelope. Structural knowledge of the mechanism of teixobactin will enable the rational design of improved drug candidates.', ''),
('antimicrobial peptides (AMPs)', 'Anti-microbial Peptides against Methicillin-resistant Staphylococcus aureus', '', 'Anti-microbial peptides could be the next-generation solution to combat drug resistance among Superbugs. New approaches like antimicrobial peptides (AMPs) play a vital role and are more efficacious, economical, time, and energy saviours.', '36529917'),
('Innate defense regulator (IDR) peptides', 'he minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of KSL Peptide for C. albicans was determined at the level of 0.78 ?g/mL. he MIC of KSL for Staphylococcus aureus and Pseudomonas aeruginosa was 0.78 ?g/mL and 1.56 ?g/mL, respectively. Bac2A peptide derivative show MICs between 2 and 32 ?g/mL for Gram-negative bacteria, and between 0.25 and 16 ?g/mL for Gram-positive bacteria. other peptide drive fro naturally occurring molecules as cNK-2, Clavanin-MO, Ac-ApoE, KSLW, SET-M33, GW-A2, AWRK6', '', 'Many studies have shown that the activity of AMPs is mostly associated with bacterial membrane destabilization. However, their activity expressed as MIC is often much lower than that of conventional antibiotics', '36009931');
INSERT INTO `table 30` (`COL 1`, `COL 2`, `COL 3`, `COL 4`, `COL 5`) VALUES
('novel strategy that combines the human antimicrobial peptide (AMP) LL37 with different antibiotics( vancomycin, azithromycin, polymyxin B, and colistin)', 'For PA103, the MIC of polymyxin B, colistin, and gentamicin decreased twofold to fourfold, but the MIC of vancomycin and azithromycin was still >512 ?g/ml, which was the highest concentration tested. The antibacterial inhibitive effects of Ca2+ and Mg2+ ions were also observed for colistin; our preliminary data showed that the MIC of colistin is 0.5 ?g/ml when PAO1 was cultured in the MHB medium, but it increased to 1 ?g/ml in a cation-adjusted MHB medium.', '', 'Zeta potentials for P. aeruginosa strains PAO1 and PA103 were -40.9 and -10.9 mV, respectively. With the addition of LL37, negative zeta potentials were gradually neutralized. this process of neutralization is believed to have contributed to the increase in outer membrane permeability help to uptake of antibiotics. LL37-vancomycin combination showed a synergistic inhibitory effect to PAO1, as well as a synergistic bactericidal effect to both PAO1 and PA103. Vancomycin can target lipid II, which is embedded in the inner membrane and is also an important molecule needed for the synthesis of the bacterial cell wall', '35922283'),
('Antimicrobial peptide named P4 with sequence RTKLWEMLVELGNMDKAVKLWRKLKR that was constructed from influenza virus protein M1 and containing two cholesterol-recognizing amino-acid consensus (CRAC) motifs.', 'peptide P4 inhibits the growth of E. coli and B. subtilis strains at concentrations that are significantly lower than the cytotoxic concentration that was found for macrophages. The half-maximal inhibitory concentration (IC50) for B. subtilis and E. coli cells were 0.07 ? 0.01 ?M and 1.9 ? 0.4 ?M, respectively.', '', 'the toxic action of peptide P4 is based on membrane permeabilization through the interaction of the peptide cationic domain and anionic lipids of the bacterial membrane. They report antimicrobial activity of the peptide P4 against the representatives of Gram-positive (B. subtilis) and Gram-negative (E. coli) bacteria.', '36013956'),
('Synthetic antimicrobial peptide', 'This 6 peptides (ASU2001, ASU2009, ASU2019, ASU2056, ASU2059, and ASU2060) inhibited the M. abscessus smooth morphotype (IC50 = 1.7 ?M for all peptides) and had reduced activity against the M. abscessus rough morphotype (IC50 range: 13-82 ?M). Peptides ASU2056 and ASU2060 had minimum inhibitory concentration values of 32 and 8 ?M, respectively, against the M. abscessus smooth morphotype. Additionally, ASU2060 (8 ?M) was active against Escherichia coli, including multidrug-resistant E. coli clinical isolates, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus.', 'The two most potent peptides, ASU2056 and ASU2060, were tested for red blood cell toxicity and neither exhibited significant hRBC hemolytic activity even after prolonged incubation (18 h). ASU2060 was tested for serum stability and retained antibacterial activity after preincubation in human serum for 24 h.', 'The peptides (ASU2001, ASU2009, ASU2019, ASU2056, ASU2059, and ASU2060) were further screened against both Mabs smooth and rough morphotypes to determine the impact of cell wall glycopeptidolipids (GPLs) on activity. All six peptides displayed increased activity against the Mabs smooth morphotype, suggesting that interactions with cell wall GPLs are important for antibacterial activity. Additionally, all peptides exhibited increased inhibition in the presence of EDTA, further suggesting that sequestering divalent metal cations enhances peptide interactions with Mabs.', '35847280'),
('Temporins modeified version of brevinin-1GHa (BR-1GHa) from frog skin peptide', 'BR-1GHa-3, in which two alanine residues in the truncated version of BR-1GHa were replaced with leucine, exhibited significantly improved antimicrobial activity against Gram-positive bacterial strains (e.g., S. aureus ATCC 29213 and E. casseliflavus ATCC 700327) with lower hemolytic activity compared to the BR-1GHa peptide. BR-1GHa-4 analogue, in which Gly3 was replaced with Pro, did not show any hemolytic activity except for highest (128 ?M) concentration tested and have a strong antimicrobial effect on Gram-positive bacteria (e.g., E. faecalis ATCC 51299 and B. cereus ATCC 13061).', '', 'To enhance the antimicrobial activity of this peptide and to reduce its hemolytic activity, they designed five new temporin like analogues and examined their bioactivities. Temporins are another class of frog skin peptides without hemolytic activity and shorter than brevinins. This show antimicrobial activity', '35852614'),
('designed PLP-3, a novel synthetic (protegrin-1 ) PG-1-like peptide', 'Antimicrobial activity screening showed MIC90 values of 2 mg/L for A. baumannii, 16 mg/L for K. pneumoniae and 8 mg/L for P. aeruginosa. The haemolysis IC50 value was 48.53 mg/L', 'Cytotoxicity against human HeLa and A549 cells showed values of ca. 200 mg/L in both cell lines resulting in a 100-fold selectivity window for bacterial over human cells.', 'PLP-3 has potent antimicrobial activity, especially against A. baumannii, while maintaining low haemolysis and toxicity against human cell lines at antimicrobial concentrations. These characteristics make PLP-3 a promising peptide with an interesting therapeutic window.', '35972429'),
('plantaricin A an antimicrobial peptide derived from Lactobacillus plantarum, had a synergistic effect with ciprofloxacin (CIP)', 'lantaricin A (PlnA), reducing the IC90 of CIP by eight times and kill Multidrug-resistant Staphylococcus aureus', 'which has low cytotoxicity and haemolysis and powerful inhibitory activity on efflux pumps.', 'The present study showed a new efflux pump inhibitors EPI (plantaricin A) produced by Lactobacillus plantarum, changes in membrane permeability, membrane potential, and reactive oxygen species (ROS) were determined. Therefore, it helps the design of new EPIs and controls the infection of multidrug-resistant Staphylococcus aureus', '36254863'),
('Lugdunin (cyclic peptide-1), a nonribosomal cyclic peptide', 'cyclic peptide-1 and its analogues cyclic peptide-11 and cyclic peptide-14 have the ability to disperse mature Methicillin-resistant Staphylococcus aureus (MRSA) biofilms and show anti-clinical MRSA activity, including MRSA persister cells', 'these three cyclic peptide compounds have non-toxicity, lower hemolytic activity and lack of resistance development.', 'Our results indicate that cyclic peptide-1, cyclic peptide-11, and cyclic peptide-14 have great potential as new antimicrobial drug candidates for the treatment of clinical Methicillin-resistant Staphylococcus aureus (MRSA) infections.', '35887376'),
('a series of Temporin-PE (T-PE) analogues were designed and synthesized by glutamic acid', '', 'E11K4K10 exhibited slight toxicity to the spleen with slight edema observed in the spleen, but its toxicity was less severe than that of polymyxin B.', 'E11K4K10, the optimized T-PE and the relatively safe AMP, could overcome drug resistance which was expected to be a new antimicrobial agent against clinical resistant bacteria.', '36148510'),
('Nv-CATH peptide from the skin of the frog Nanorana ventripunctata', 'S. haemolyticus 13A13770 displayed the highest sensitivity to Nv-CATH (MIC = 3.125 ?g/mL), followed by S. aureus ATCC25923 and A. junii 13A15578 (MIC = 12.5 ?g/mL).', '100 ?g/mL Nv-CATH did not exhibit cytotoxicity toward mouse peritoneal macrophage (MPMs) and bone-marrow-derived neutrophils (BMDNs), and 300 ?g/mL Nv-CATH also had no hemolytic activity on rabbit erythrocytes.', 'Nv-CATH inhibited bacterial invasion of target organs via direct bactericidal ability. Nv-CATH selectively promoted CCL and CXCL chemokines? production, which modulated monocytes/macrophages? and neutrophils? trafficking to the infection site, and augmented immunocyte-mediated bacterial killing by modestly promoting neutrophil phagocytosis. Nv-CATH shows promise as a new antimicrobial agent, especially in the treatment of S. aureus infections', '36378028'),
('human ?-defensin 130 (hBD130)', 'hBD130 demonstrated efficient antimicrobial activities, with MICs ranging from 10 to 45 ?g/mL. Of note, hBD130 exhibited significant growth inhibition effects against E. coli ATCC 25,922 (10 ?g/mL), ETEC BNCC 125,783 (10 ?g/mL), L. monocytogenes ATCC 221,633 (25 ?g/mL), and S. typhimurium ATCC 14,028 (15 ?g/mL). The MICs for hBD130 against gram-negative bacteria, including E. coli and S. typhimurium, were 10?15 ?g/mL, which were lower than those against gram-positive bacteria, including L. monocytogenes, B. subtilis and S. aureus.', 'hBD130 showed a low hemolytic effect and nearly no cytotoxicity to mammalian cells with a dosage of 400 ?g/Ml', 'bactericidal effect of hBD130 showed that hBD130 is a promising antimicrobial agent to treat foodborne bacterial infections and inflammation.', '35720462'),
('develop chimeric peptides with dual cell-penetrating and antimicrobial functions by conjugating Cell-penetrating peptides with AMPs', '', '', 'AMPs are regarded as an ideal alternative to antibiotics due to their powerful antimicrobial potential, rapid killing effects, and low propensity to develop resistance. the combination of CPP and AMP gives it a dual function of cell penetration and antimicrobial activity, which may be a feasible method to treat intracellular infections.', '36503077'),
('Three novel peptide families ?Picturins? (PTR), ?Pictuseptins? (PTS), and ?Boanins? (BNS). were identified from Boana picturata skin secretion.', 'PTR displayed moderate activity against Escherichia coli (MIC 24.80 to 48.95 ?M), TS-1 was the most active peptide against E. coli (6.8 ?M) followed by PTS-3 (11.7 ?M) and PTS-2 (14.24 ?M)', '', 'Hence, Frog skin peptides are excellent examples of the biomedical potential of naturally evolved molecules for specific targets, including multi-resistant bacteria.', '35640793'),
('Peptide PN5 derived from Pinus densiflora (pine needle)', 'PN5 displayed antimicrobial activity against both Gram-negative and Gram-positive bacteria, with MICs of 2 to 16 ?M (2.65 to 21.22 ?g mL?1)', '', 'PN5 showed immunomodulatory properties of neutralizing LPS in a mouse septic model. These results indicate that PN5 could be a new and promising therapeutic agent for bacterial infectious disease caused by antibiotic-resistant strains.', '36129300'),
('Antimicrobial peptide (AMP) IDR-1018 derived D-amino acids substitution peptides (D1018 and D1018M) were synthesized', 'MIC of IDR-1018, 1018M and D1018 against E. coli ATCC25922 was 8 ?g/ mL while that of D1018M was 4 ?g/ mL. D1018M owned stronger potential antibacterial activity against E. coli ATCC25922. However, the antimicrobial activity of peptides was not so good as that of polymyxin (MIC = 1.56 ?g/mL).', 'he results indicated that peptides IDR-1018, 1018M and 1018M basically had no cytotoxicity against murine macrophage cells, when the concentration was up to 16 times of MIC. However, for D1018M, the safe concentration of murine macrophage cells was only 4 times of MIC.', 'This peptides could interact with E. coli cell wall and cytoplasmic membrane, penetrate the membrane, cause leakage of contents, and disrupt genomic DNA. Among them, D1018 is the most prominent one. these data demonstrate that D1018 is a promising peptide candidate for the treatment of E. coli infection.', '36532445'),
('peptide Spgillcin177-189 derived from the amino acid sequence of Spgillcin', 'Spgillcin177-189 also showed rapid bactericidal kinetics for S. aureus and Pseudomonas aeruginosand maintained its antimicrobial activity in different conditions with a range of minimum inhibitory concentrations from 1.5 to 48 ?M.', 'did not display any cytotoxicity to mammalian cells( human hepatic cell line (L02), mouse liver cell line (AML12), hepatocellular carcinoma cell line (Hep G2), and non-small-cell lung carcinoma (NSCLC) cell line (NCI-H460)', 'Spgillcin177-189 was mainly involved in the disruption of cell membrane integrity and cause the accumulation of intracellular reactive oxygen species. Spgillcin177-189 exerted a strong anti-biofilm activity by inhibiting biofilm formation and was also effective at killing extracellular S. aureus in the cultural supernatant of RAW 264.7 cells. Taken together, Spgillcin177-189 has strong potential as a substitute for antibiotics in future aquaculture and medical applications.', '36061863'),
('Antisense peptide nucleic acids (PNAs)', 'Concentration-dependent bactericidal activity was investigated by treatment of S. pneumoniae TIGR4 in a CPP-antisense PNA conjugate concentration range of 2.5 to 20 ?M', '', 'CPP-antisense PNA treatment increased the survival rate of infected Galleria mellonella larvae in vivo. Based on these results, we believe that efficient antisense PNAs can be developed for the treatment of S. pneumoniae infections.', '36321914'),
('hydrogel scaffold containing genipin crosslinked HF-18 peptide', 'It was observed that HF-18-loaded OPT (P-OPT) was able to release HF-18 peptide both in acidic and neutral conditions. Antimicrobial activity assessments demonstrated that P-OPT was effectively bactericidal on Staphylococcus aureus and methicillin-resistant S. aureus.', '', 'the optimized scaffold has a composition of 90 mg Ch, 0.25 mg HA, and 0.25 mg CS and is crosslinked with 0.5 mg genipin. This scaffold was found to have highly interconnected pores and high bactericidal activity. It was claimed that HF-18 showed a strong bactericidal effect on MRSA and biocompatibility against L929 cells. As a novel approach, for the first time, HF-18 loaded polymeric scaffold was tested for wound healing. the scaffold OPT was considered a suitable and promising polymeric carrier for AMPs in terms of wound healing.', '36377395'),
('novel synthetic antimicrobial peptide, GK-19, derived fromAndroctonus amoreuxi Antimicrobial Peptide 1 ( AamAP1 ) and its derivatives', 'GK-19 exhibited potent antibacterial activity against three Gram-positive and two Gram-negative bacteria with much lower minimal inhibitory concentration (MIC) values ranging between 3 and 10 ?M (E. coli (3 ?M), K. pneumoniae (5 ?M), P. aeruginosa (5 ?M), E. faecalis (3 ?M), and MRSA (5 ?M)) in comparison to that of AamAP1 (>20 ?M).', 'GK-19 showed negligible toxicity to mammalian cells, low hemolytic activity and high stability in plasma.', 'GK-19 showed significant antimicrobial and healing effects. Overall, it was demonstrated that GK-19 might be a promising drug candidate in the battle against drug-resistant bacterial and fungal infections.', '36145681'),
('Two novel antibacterial peptides were isolated from Alcalase-hydrolyzed chicken plasma', 'VSDH inhibited both S. aureus and B. cereus, while CCCPKAF only showed antibacterial activity toward B. cereus. The MIC values of VSDH and CCCPKAF against B. cereus were 0.5 mM and 0.25 mM, respectively. In addition, the MIC of VSDH against S. aureus was 0.5 mM. Both peptides showed weak inhibition towards S. typhimirium and L. monocytogenes with MIC > 8 mM. They did not inhibit E. coli.', '', '', '36429156'),
('scorpion venom peptide ctry2459 was modified to CT-K3K7', 'It can kill S. aureus strain MIC= 2.64 Micro Mol and P. aeruginosa strain PA01 MIC = 10.56 Micro Mol and P. aeruginosa strain ATCC9027 rapidly, and reduce the production of biofilm', 'lower hemolytic activity', 'peptide ctry2459 was modified to CT-K3K7 by lysine substitutions at the 3rd and 7th positions to increase the cationic properties. We discovered that the modified peptides CT-K3K7 had improved antibacterial activity, higher thermal stability, as well as lower hemolytic activity. CT-K3K7 has also been demonstrated to decrease bacterial counts. Hence, the modified peptide CT-K3K7 can be a novel antimicrobial agent candidate for the treatment of infections by S. aureus and P. aeruginosa.', '36113685'),
('lead peptide LI14', 'LI14 showed broad-spectrum and strong antibacterial activity against all MDR pathogens with MIC values ranging from 1 to 64 ?g/mL, involving methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), carbapenem-resistant Enterobacteriaceae (CRE), MCR-positive E. coli (MCRPEC) and tigecycline-resistant pathogen, which was comparable to that of some antibiotics used clinically.', '', 'In animal models of infection, LI14 or combined with antibiotics are effective against drug-resistant pathogens. These findings suggest that LI14 is a promising antibiotic candidate to tackle MDR bacterial infections.', '36071151'),
('antimicrobial peptide conjugated poly (glycolic acid-co-caprolactone) (PGCL) sutures', '(PGCL) sutures were investigated against P. aeruginosa and methicillin-resistant S. aureus (MRSA) strains by using antimicrobial peptide sequences of KRFRIRVRV-NH2, RWRWRWRW-NH2 and their dual combination (1:1)', '', 'Our results indicated that antimicrobial peptide modified sutures could be a potential novel medical device to overcome surgical site infections by the superior acceleration of wound healing.', '36510770'),
('Synergistic effect of - Synthetic antimicrobial peptides (SAMPs-Mo-CBP3-PepI, Mo-CBP3-PepII, Mo-CBP3-PepIII, RcAlb-PepI, RcAlb-PepII, RcAlb-PepIII, PepGAT ,and Pep KAA ) with antibiotics', 'combination made by Mo-CBP3-PepIII (6.2 ?g mL?1) and ciprofloxacin (0.2 ?g mL?1) induced pore formation of biofilm cells of S. aureus. combination with RcAlb-PepI (0.04 ?g mL?1) and ciprofloxacin (25 ?g mL?1) was it possible to induce pore formation on the membrane of S. aureus in biofilm and RcAlb-PepIII alone at 50 ?g mL?1 induce biofilm.', 'synthetic peptides are not toxic to human red blood cells (HRBC). Additionally, it has been shown that during synergistic action, peptides, besides enhancing drugs? effects, also reduce their toxicity to HRBC. iprofloxacin in combination with peptide RcAlb-PepI at 0.04 ?g mL?1 did not present any toxicity to HRBC.', 'The mechanism of the combined effect is possible by increasing the cytoplasmatic concentration of ciprofloxacin supported by pores on the membrane of S. aureus cells. Additionally, peptides reduced the toxicity of ciprofloxacin to HRBC. Considering all these findings, it is possible to suggest that the peptides studied are a considerable option to surpass the resistance of S. aureus strains to antibiotics such as ciprofloxacin.', '36145427'),
('antimicrobial peptides (AMPs) from marine parasites, Anisakis spp', 'These peptides are potent bactericidal agents in vitro, selectively active against Gram-negative bacteria, including multi-drug resistant strains, at sub-micromolar concentrations.', 'Their toxicity towards host cells is negligible,', 'Anisaxins are membrane-active peptides essential for future design of such biomaterials.', '35470073'),
('antimicrobial peptides centered on "RRR" labeled with hydrophobic amino acids at both ends- LWWR (LWWRRRWWL-NH2)', 'Show bactericidal activity against E. coli and S. aureus', '', 'LWWR (LWWRRRWWL-NH2) presented broad-spectrum antibacterial activity both in vitro and in vivo due to its multiple mechanisms and good stability. The findings of this study will provide some inspiration for the design and development of potential antibacterial agents, and contribute to the elimination of bacterial infections worldwide as soon as possible.', '36241015'),
('The Antimicrobial Peptide 1018-K6', 'this AMP was seen to be able to kill resistant Gram-positive and Gram-negative microorganisms (5 ? 105 cfu/mL) at concentrations ? 20 ?M mostly against three prokaryotic species studied: Salmonella Typhimurium2GN, Escherichia coli3GN, and Staphylococcus aureus3', '', 'The AMP 1018-K6 is a candidate to prevent (food preservation) or treat (antibiotic use) infections caused by certain pathogenic bacteria, especially some that are resistant to current antibiotics for three prokaryotic species studied: Salmonella Typhimurium2GN, Escherichia coli3GN, and Staphylococcus aureus3', '36293249'),
('Temporin-GHa (GHa) obtained from Hylarana guenther Derived Peptide - GHa4R', 'peptide GHa4R had stronger antibacterial activity and bactericidal efficacy against S. aureus. GHa4R presented antibacterial activity against methicillin-resistant S. aureus (MRSA).', '', 'It was barely affected by temperature, pH, and storage period, showing high stability. it increased the permeability of the cell membrane and damaged the membrane integrity, leading to cell death. The mentioned characteristics make GHa4R a promising candidate for the treatment of S. aureus infections.', '36476441'),
('PEGylation at the C-terminal of T9W (CT9W1000) peptide', 'CT9W1000 micelles exhibited good biocompatibility in vitro and in vivo, resulting in highly effective treatment in a mouse acute lung injury model induced by P. aeruginosa PAO1 without drug resistance.', '', 'These advances may profoundly accelerate the clinical transformation of T9W and promote the development of a combination of peptide-based antibiotics and PEGylated nanotechnology.', '36577517'),
('lipopeptide', 'against Multidrug-Resistant Pseudomonas aeruginosa', '', 'discovery of lipopeptides against bacterial "superbugs"', '35786900'),
('HAZ, a novel peptide', 'HAZ revealed significant antimicrobial activity, with MIC values of 15 ? 20 ?M against tested bacterial strains.', 'HAZ efficacy was accompanied with minimal hemolytic toxicity on human erythrocytes.', 'HAZ-antibiotics combinations exhibited a synergistic action mode that led to dramatic decrease in the MIC values for both HAZ peptide and the antibiotic. HAZ peptide is a broad-spectrum AMP, and a promising candidate for antimicrobial and anticancer drug development.', '36465844'),
('synthetic peptide CD4-PP', 'CD4-PP was active against both clinical and type strains in low concentrations between 0.78 and 1.56 ?M. The MIC for E. coli CFT073 and the ESBL strain (CCUG 55971) were 0.78 ?M. Klebsiella pneumoniae (ATCC 25955), MDR K. pneumoniae (CCUG 58547), Pseudomonas aeruginosa (ATCC 27853) had MICs of 1.56 ?M.', '', 'By developing a peptide with a cyclic backbone, they intended to increase the proteolytic stability and antimicrobial activity of the novel synthetic AMP. they observed that CD4-PP displayed enhanced stability against bacterial protease. CD4-PP was tested against a range of the most clinically important uropathogens indicating a promising clinical application.', '35821354'),
('cell-penetrating peptide (CPP) fused endolysin PA90', 'This engineered endolysin, DS-PA90, completely killed A. baumannii at 0.25 ?M,', '', 'Hence concluded MDR A. baumannii strains were highly susceptible to DS-PA90 treatment: five out of nine strains were entirely killed and four strains were reduced by 3?4 log in CFU/ml. Collectively, our data suggest that CPP-fused endolysin can be an effective antibacterial agent against Gram-negative pathogens', '35614377'),
('Modified the antimicrobial peptide Cec4 (41 amino acids) and obtained the derived peptide C9 (16 amino acids)', 'Derived peptide C9 (16 amino acids) showing better antimicrobial activity against S. epidermidis with an MIC value of 8 ?g/mL.', 'The median lethal dose of C9 in mice was more than 128 mg/kg, and the intraperitoneal administration of 64 mg/kg was less toxic to the liver and kidneys of mice.', 'C9 peptide has rapid bactericidal activity without detectable high-level resistance, showing certain inhibition and eradication ability on S. epidermidis biofilms. In addition, C9 altered the S. epidermidis cell membrane permeability, depolarization levels, fluidity, and reactive oxygen species (ROS) accumulation and possessed the ability to bind genomic DNA.', '36453944'),
('melittin-pexiganan combination, combination of temporin-pexiganan, temporin-melittin combination peptides', 'result found that S. aureus went extinct more rapidly when treated with a mixture of two antimicrobial peptides?pexiganan and melittin?compared to single AMP treatments. Pexiganan combinations result in the most effective combinations, as the MIC value toward pexiganan drops from an average of 9-fold change to 3-fold change in the combinations.', '', 'These results are consistent with the fact that AMP combinations that contain pexiganan were more effective for delaying resistance evolution', '35862981'),
('Novel D-form of hybrid peptide (D-AP19)', 'Geometric mean (MIC) of gram negative : GMb (Gr.? strains) = 7.16 ?g/ml and geometric mean for gram positive GMd (Gr. + strains) = 5.86 ?g/ml', 'AP-19 show minimal hemolytic and cytotoxic activities in mammalian cells.', 'D-AP19 displayed rapid killing via membrane disruption and leakage of intracellular contents. Additionally, it showed a low tendency to induce bacterial resistance. Among the peptides, AP19 demonstrated the best combination of broad-spectrum antibacterial activity including toward Acinetobacter baumannii', '36151303'),
('Host defense peptides (HDPs)- design the amphiphilic peptoid polymers', 'The optimal cyclic peptoid polymer, poly(Naeg0.7Npfbg0.3)20, displays strong antibacterial activities against drug-resistant bacteria.', 'low hemolysis and cytotoxicity', 'we design the amphiphilic peptoid polymers by mimicking the positively charged and hydrophobic structures of HDPs and synthesize a series of cyclic peptoid polymers efficiently via the polymerization on ?-amino acid N-substituted glycine N-carboxyanhydrides (?-NNCAs) using 1,8-diazabicycloundec-7-ene (DBU) as the initiator.', '35788576'),
('AMP called Pleurocidin (Ple) and its C-terminal-amidated derivative Pleurocidin-amide (Ple-a)', 'Our results indicated that both Ple and Ple-a exhibited significant antibacterial activity against a broad spectrum of Gram-positive and Gram-negative bacteria, especially marine pathogens, with MIC values ranging from 0.25 to 32 ?g/mL.', 'Ple and Ple-a also showed notable cytotoxicity toward various cancer cell lines, with IC50 values ranging from 11 to 340 ?M, while normal mouse fibroblast 3T3 cells were less susceptible to these peptides.', 'Our results indicated that both Ple and Ple-a exhibited significant antibacterial activity against a broad spectrum of Gram-positive and Gram-negative bacteria, especially marine pathogens. Our findings provided support for the future application of Ple-a as potential therapeutic agent for bacterial infections.', '36005521'),
('ApoE mimetic peptide, COG1410', 'In the case of Gram-positive strains, COG1410 inhibited the growth of Bacillus subtilis, vancomycin-resistant Enterococcus faecalis and Enterococcus faecium, and Mycobacterium smegmatis with MICs ranging from 1 to 32 ?g/ml. As for Gram-negative bacteria, COG1410 showed antimicrobial activity against Enterobacter cloacae, Escherichia coli, Citrobacter freundii, and even anaerobe, Porphyromonas gingivalis, with MICs ranging from 16 to 64 ?g/ml.', 'The minimal concentration that caused the lysis of half of the red blood cells (EC50) was 441 ?g/ml. COG1410 exhibited low hemolytic activity and medium cytotoxicity.', 'COG1410 easily entered bacterial cytoplasm and bound to DNA nonspecifically, the major mechanism of COG1410 killing was to disrupt the integrity of cell membrane and lead to leakage of cytoplasmic contents', '36081797'),
('Natural Peptide from Vespa mandarinia Venom and Its Synthetic Analogues', 'VM-3K produced a 90% survival of S. aureus-infected waxworms at a concentration of 5.656 mg/kg, at which concentration the natural template peptide only achieved 50% survival. VM-3G also displayed anti-microbial ability against Gram-negative bacteria and had bactericidal effects on E. coli and P. aeruginosa but not on K. pneumoniae', 'VM-3W exhibited haemolysis at a low concentration.', 'peptide VM-3K could be a promising broad-spectrum antimicrobial candidate for addressing the current antibiotic-resistant infection crisis. It is worth mentioning that this investigation on the relationship between peptide structure and mechanism of action could become an important aspect of drug research on short peptides.', '36138742'),
('KDEON WK-11: A short antipseudomonal peptide', 'identified its most potent effect, against Pseudomonas aeruginosa with an MIC value of 3.12 ?M', '', 'KDEON WK-11 had a broad range of antimicrobial activity and specific capabilities to fight Pseudomonas aeruginosa with low in vitro cytotoxicity and promising potential to express anti-lipopolysaccharide qualities, which could be exploited to expand its properties into an anti-sepsis agent.', '36465859'),
('Amino Acid-Rich Antimicrobial Peptides', 'found 138 Leu-rich AMPs active against Staphylococcus aureus and 81 against Escherichia coli. Likewise, there were 39 Pro-rich peptides against E. coli and 15 against S. aureus in the current database.', '', 'no natural AMPs are simultaneously rich in leucine and lysine, while proline, tryptophan, and cysteine-rich peptides can simultaneously be rich in arginine. These findings can be utilized to guide peptide design. Since multiple candidates are potent against antibiotic-resistant bacteria, rich AMPs stand out as promising future antibiotics.', '36361660'),
('tachplesin I analogue peptide (TP11A) and tachplesin I', 'Both inhibited C. albicans monomicrobial, S. aureus monomicrobial, and C. albicans-S. aureus polymicrobial biofilms quite well. TP11A suppressed the biofilm- and virulence-related genes of C. albicans (hwp 1) and S. aureus (ica A, fnb B, agr A, hla, nor A, and sig B) in the mixed biofilm,', '', '', '35998684'),
('antimicrobial peptidomimetics called peptoids (sequence-specific oligo-N-substituted glycines) the sequence-specific pentamer TM5', 'the MIC values for TM5 against Pseudomonas aeruginosa (PAO1) and Staphylococcus aureus (SA25923) are 8 ?g/mL and 16 ?g/mL, respectively.', 'determined the cytotoxicity of TM5 against A549 lung epithelial cells to identify a non-cytotoxic concentration. A549 cell exposure to 50 ?g/mL of TM5 for 24 h exposure did not cause cytotoxicity . TM5 has been shown to be safe on 3D human primary cultures of epithelial cells', 'demonstrated that TM5 is a multi-functional platform that can be used to eradicate biofilms and mitigate LPS-induced cytokine production. Future studies will explore the in vivo anti-persister cell activity of TM5 using a chronic biofilm infection animal model. Furthermore, the antimicrobial molecular mechanisms of TM5 seems to prevent resistance development. Although our resistance study showed that resistance development against TM5 is unlikely.', '36018039'),
('arenicins, antimicrobial peptides from the lugworm Arenicola marina', 'Peptide AA139, like other arenicins, exhibited an inhibitory effect on complement at a concentration of 160 ?g/Ml', '', 'our results suggest that the effect on the complement system should be taken into account in the development of antibiotics based on arenicins.', '36286436'),
('Stable isotope analysis with antimicrobial random peptide mixtures (RPMs). The RPMs used in this study consisted of 20-mer peptide composed of either L-phenylalanine and L-lysine (FK20) or phenylalanine with D-lysine (FdK20) in 1:1 molar ratio', 'FK20 induced a reduction of the MIC of four bacteria (i.e. X. campestris, X. perforans, C. michiganensis and P. syringae) to between 4 and 21% of the corresponding untreated control samples (> 200 ?g/mL). Two pathogenic bacteria, S. scabies and A. citrulli, were not affected by the treatment with FK20. Effects of FdK20 on the bacteria were very similar with the exception of P. syringae which was not affected by FdK20', '', 'Stable carbon isotope analysis invariably verified the changes in the FA groups of bacteria caused by treatment with FK20 and FdK20. Also, growth inhibition of bacteria by FK20 and FdK20 was generally associated with changes in the FA groups except for FdK20 in the case of C. michiganensis. The approach used in this study could be helpful in the search not only of novel antimicrobial RPMs but also other antibiotics such as polymyxin B.', '35789165'),
('Antimicrobial potential of a ponericin-like peptide', 'Results showed that Bm-ponericin-L1, at 4 ppm, inhibited biofilm formation by > 85% (P. aeruginosa) and > 90% (K. pneumoniae), after 24 h of incubation', '', 'Study revealed that infection with P. aeruginosa triggers the humoral response in B. mori larvae. The purified peptide fraction screened from the infected silkoworm found to be active against E. faecium , S. aureus , K. pneumoniae, A. baumannii , P. aeruginosa, and E. agglomerans, belonging to the ESKAPE group. This is the first report regarding the production and isolation of a ponericin in B. mori hemolymph upon P. aeruginosa infection. Bm-ponericin-L1was found to be highly specific towards bacterial cells suggesting its cell selectivity.', '36109567'),
('cross-linked lyotropic liquid crystals, formed by the self-assembly of the block copolymer Pluronic F-127.', 'The liquid crystal particles were shown to have antibacterial effect corresponding to a 4 log reduction against Staphylococcus aureus.', '', 'The bonding to the particles gave the AMPs improved stability in serum, as they retained almost all of the antibacterial potency for 2 days compared to free AMPs, which lost all of its antibacterial potency within a day.', '36152992'),
('florfenicol-polyarginine conjugates', 'These conjugates also showed excellent activity against drug-resistant strains such as methicillin-resistant S. aureus (MRSA) and florfenicol resistant Escherichia coli strains (2017XJ30, 2019XJ20), one of which as E6 had a minimum inhibitory concentration of 12.5 ?mol/L.', '', 'Polyarginine peptides are widely used as CPPs and shown to inhibit bacteria by entering certain microbial cell membranes. This suggested that conjugating arginine to florfenicol succinate effectively modulated the properties of prodrugs. These new conjugates may provide useful insights for expanding the pool of antibiotics.', '35844651'),
('three peptides (LS-AMP-E1, LS-AMP-F1, and LS-AMP-G1) from Chinese Wolf Spider Lycosa sinensis', 'LS-AMP-E1 and LS-AMP-F1 exhibited similar antibacterial effects towards tested microbes. The MIC values of LS-AMP-E1 and LS-AMP-F1 against 6 tested strands ranged between 50 and 6.25 ?M, except for P. vulgaris and S. aureus (not detected within 50 ?M). LS-AMP-G1, on the other hand, had no discernible effect on the growth of any one of the reference strains. (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species)', '', '. In terms of antimicrobial mechanisms, LS-AMP-E1 and LS-AMP-F1 destroyed the integrity of bacterial cell membranes in a short period of time and completely inhibited bacterial growth within 10 min of action. Meanwhile, high concentrations of Mg2+ effectively reduced the antibacterial activity of LS-AMP-E1 and LS-AMP-F1. Together, it suggested that the two peptides interact directly on bacterial cell membranes.', '36432731'),
('Parietin (PTN) or physcion', 'Complexation of PTN increased the aqueous solubility 28-fold and the photostability compared to free PTN. PTN/HP-?-CD complexes reduce the bacterial viability of Staphylococcus saprophyticus and Escherichia coli by > 4.8 log and > 1.0 log after irradiation, respectively.', '', 'As an alternative therapeutic option, antimicrobial photodynamic therapy (aPDT) can successfully eradicate antibiotic-resistant bacteria with a lower probability of developing resistance or systemic toxicity commonly associated with the standard antibiotic treatment.', '35214089');

-- --------------------------------------------------------

--
-- Table structure for table `table 31`
--

CREATE TABLE IF NOT EXISTS `table 31` (
  `COL 1` varchar(378) DEFAULT NULL,
  `COL 2` varchar(1327) DEFAULT NULL,
  `COL 3` varchar(385) DEFAULT NULL,
  `COL 4` varchar(619) DEFAULT NULL,
  `COL 5` int(8) DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `table 31`
--

INSERT INTO `table 31` (`COL 1`, `COL 2`, `COL 3`, `COL 4`, `COL 5`) VALUES
('Antimicrobial peptide KLKLLLLLKLK-NH2 and its D-enantiomer', 'Significant chemotherapeutic activity in MRSA-infected mice', '', 'Chemotherapeutic activity of synthetic antimicrobial peptides: correlation between chemotherapeutic activity and neutrophil-activating activity', 9326370),
('Protegrin-1', '', '', 'CONCLUSIONS: This study shows that protegrin-1 potentially may be used as an alternative or adjunct therapy to standard agents used to treat wound infections.', 11445704),
('Brevinin-2 peptides from the skin of the Hokkaido frog, Rana pirica', 'The most abundant peptide, brevinin-2PRa (680 nmol/g weight of dry skin) showed high potency [minimal inhibitory concentration (MIC) values between 6 and 12 microM] against a range of clinical isolates of P. aeruginosa.', '', 'A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Nine peptides displaying varying degrees of antimicrobial activity were extracted from the skin of the Hokkaido frog, Rana pirica.', 15003829),
('Antimicrobial peptide, human lactoferrin 1-11 (hLF1-11)', '', '', 'The hLF1-11-treated group also had a significantly lower radiological score compared to the gentamicin-treated group. This study demonstrates the efficacy of hLF1-11 incorporated into Ca-P bone cement as a possible therapeutic strategy for the treatment of osteomyelitis, showing efficacy comparable to that of gentamicin.', 15917544),
('[fMLF]PMBN and [fMLF]PMEN', '', '', 'Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria', 16048913),
('Phenothiazinium', 'We used MDR-deficient mutants of Staphylococcus aureus (NorA), Escherichia coli (TolC), and Pseudomonas aeruginosa (MexAB) and found 2 to 4 logs more killing than seen with wild-type strains by use of three different phenothiazinium PSs and red light.: Mutants that overexpress MDRs were protected from killing compared to the wild type.', 'Antimicrobial photodynamic therapy (PDT) combines a nontoxic photoactivatable dye, or photosensitizer (PS), with harmless visible light to generate singlet oxygen and free radicals that kill microbial cells.', 'Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrobial photodynamic therapy (PDT) combines a nontoxic photoactivatable dye, or photosensitizer (PS), with harmless visible light to generate singlet oxygen and free radicals that kill microbial cells.', 16377686),
('Natural toxins and animal venoms (snakes, scorpions and honey bee venoms)', 'Antimicrobial activity against Burkholderia pseudomallei', '', 'In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei', 16784542),
('Antimicrobial peptides (AMPs), UBI 1-59 and synthetic fragments comprising amino acids 31-38', 'In vitro killing of MRSA by synthetic peptides derived from the alpha-helix or beta-sheet domains of the human cationic peptide ubiquicidin (UBI 1-59), allowed selection of AMPs for possible treatment of MRSA infections. The strongest antibacterial activity was observed for the entire peptide UBI 1-59 and for synthetic fragments comprising amino acids 31-38.', '', 'The availability, chemical synthesis opportunities, and size of these small peptides, combined with their strong antimicrobial activity towards MRSA make these compounds promising candidates for antimicrobial therapy and detection of infections in man. ', 16814900),
('Hyaluronic acid binding peptides', 'Effective in experimental surgical wound infections caused by S. aureus', '', 'Treatment with these peptides was highly efficacious in reducing the number of S. aureus cells at the wound site and ameliorated the inflammatory host response associated with these infections.', 17065624),
('Defr1, covalent dimer species of beta-defensin', 'Antimicrobial activity against Pseudomonas aeruginosa PAO1 and an extended panel of multidrug-resistant nosocomial pathogens', '', 'Covalent dimer species of beta-defensin Defr1 display potent antimicrobial activity against multidrug-resistant bacterial pathogens. Beta defensins comprise a family of cationic, cysteine-rich antimicrobial peptides, predominantly expressed at epithelial surfaces.', 17353239),
('Lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin', 'Vancomycin combined to Pal-Lys-Lys-NH(2) exerted the strongest anti-staphylococcal efficacies. The in vitro studies showed, that MIC and MBC values for vancomycin were lower in presence of lipopeptides. They reduce the bacterial load and to enhance the effect of vancomycin in the prevention of vascular graft staphylococcal infections.', '', 'The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.', 17537542),
('Antimicrobial peptide thionin Thi2.1', 'Growth inhibition of S. aureus isolates was dose-dependent, showing a total inhibition at concentrations higher than 3.12 microg/ml.', '', 'Antibacterial activity of thionin Thi2.1 from Arabidopsis thaliana expressed by bovine endothelial cells against Staphylococcus aureus isolates from bovine mastitis. Bovine mastitis is mainly caused by Staphylococcus aureus and antimicrobial therapy, commonly used for its control, has resulted in an increase in the frequency of resistant staphylococci in recent years.', 17961938),
('AP-CECT7121 (an antimicrobial peptide isolated from an environmental strain of Enterococcus faecalis CECT7121)', 'Activity against Enterococcus faecium, Enterococcus faecalis,Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Clostridium perfringens and Clostridium difficile', '', 'CONCLUSIONS: AP-CECT7121 may provide a novel strategy for treating potentially fatal clinical infections in hospitalized patients.', 19494489),
('Arminin', 'Minimal bactericidal concentration, 0.4 microM to 0.8 microM against multiresistant human pathogenic strains, such as methicillin-resistant Staphylococcus aureus (MRSA) strains', '', 'Activity of the novel peptide arminin against multiresistant human pathogens shows the considerable potential of phylogenetically ancient organisms as drug sources', 19770277),
('Laterocidin and its analogues [3 (Asp(1)-->Asn(1), Phe(4)-->Tyr(4) and d-Tyr(6)-->d-Phe(6))]', 'Antimicrobial properties, against clinical Methicillin-resistant Staphylococcus aureus (L-MRSA) and the gram-negative extended-spectrum beta-lactamases-producing Escherichia coli (ESBLs E. coli) and L-E.coli.', '', 'Solid-phase synthesis and antibiotic activities of cyclodecapeptides on the scaffold of naturally occurring Laterocidin', 19932962),
('longicornsin', 'Strong antimicrobial ability against drug-resistant microorganisms and Helicobacter pylori', '', 'A novel defensin-like peptide from salivary glands of the hard tick, Haemaphysalis longicornis', 20027626),
('Alyteserin-1c (GLKEIFKAGLGSLVKGIAAHVAS?NH(2)) and its analogues', 'Alyteserin-1c displayed MIC=5-10 micro M; minimum bactericidal concentration, MBC=5-10 microM), increasing the cationicity of alyteserin-1c by the substitution Glu(4)->Lys enhanced the potency (MIC=1.25-5 micro M; MBC=1.25-5 micro M) against MDRAB', 'alyteserin-1c (LD(50)=220 ?M)and its catonic analogues (HC(50)>400 ?M) has low hemolytic activity against human erythrocytes , and.', 'Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii', 20603168),
('Hominicin (DmIle-Dhb-Pro-Ala-Dhb-Pro-Phe-Dhb-Pro-Ala-Ile-Thr-Glu-Ile-Dhb-Ala-Ala-Val-Ile-Ala -Dmp)', 'Potent activity against Staphylococcus aureus ATCC 25923, methicillin-resistant S. aureus (MRSA) ATCC 11435 and vancomycin-intermediate S. aureus (VISA) CCARM 3501', '', 'Characterization and structure identification of an antimicrobial peptide, hominicin, produced by Staphylococcus hominis MBBL 2-9.', 20654578),
('Acyldepsipeptide 4 (ADEP 4) analog in which the pipecolate was replaced by 4-methyl pipecolate', 'in vitro antibacterial activity against Enterococci that was fourfold higher than the parent compound ADEP 4', '', 'Diversity-oriented synthesis of cyclic acyldepsipeptides leads to the discovery of a potent antibacterial agent.', 20833054),
('PTP-7, lytic peptide', 'Anti-biofilm activity, potent to Gram-positive bacteria and is able to kill antibiotic sensitive and resistant Staphylococcus aureus', '', 'The activity of a small lytic peptide PTP-7 on Staphylococcus aureus biofilms', 21887652),
('C(12)K-2?(12), oligo-acyl-lysyl (OAK) antimicrobial peptidomimetic', 'A dual mode of action against the H. pylori membrane and cytoplasmic components', '', 'The oligo-acyl lysyl antimicrobial peptide C(12)K-2?(12) exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori', 22064541),
('Epidermicin NI01', 'Potent antimicrobial activity toward a wide range of pathogenic Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA), enterococci, and biofilm-forming S. epidermidis strains', '', 'Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci.', 22155816),
('CPF-AM1, PGLa-AM1, B2RP-ERa, [E4K]alyteserin-1c, [D4K]B2RP and [G4K]XT-7', 'Overall colistin-susceptibleminimum inhibitory concentration against colistin-susceptible (MIC) ? 2 micro g/mL] and colistin-resistant (MIC ? 64 micro g/mL) clinical isolates of multidrug-resistant strains of Acinetobacter baumannii and Acinetobacter nosocomialis, with most potent peptides being [D4K]B2RP and [E4K]alyteserin-1c (MIC=4-16 micro g/mL)', 'low haemolytic activity against human erythrocytes.', 'Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group', 22326566),
('OH-CATH30 and its analog OH-CM6', 'The MICs of OH-CATH30 and OH-CM6 ranged from 1.56 to 12.5 micro g/ml against drug-resistant clinical isolates of several pathogenic species, including Escherichia coli, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus.', 'relatively low toxicity and potent efficacy in mouse models', 'Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models.', 22491685),
('Dimeric PpIX-YI13WF (photosensitizer protophophyrin IX - YI13WF (YVLWKRKRKFCFI-Amide)) conjugate', '(MIC) values of dimeric PpIX-YI13WF conjugate itself observed for E. coli DH5a (~4 times), S. enterica (~8 times), and other Gram-negative strains including antibiotic-resistant E. coli BL21 (~8 times) and K. pneumoniae (~16 times).', 'Dimeric PpIX-YI13WF conjugate could selectively recognize bacterial strains over mammalian cells and generate less photo damage to mammalian cells.', 'Lipopolysaccharide neutralizing peptide-porphyrin conjugates for effective photoinactivation and intracellular imaging of gram-negative bacteria strains. A simple and specific strategy based on the bioconjugation of a photosensitizer protophophyrin IX (PpIX) with a lipopolysaccharide (LPS) binding antimicrobial peptide YI13WF (YVLWKRKRKFCFI-Amide) has been developed for the effective fluorescent imaging and photodynamic inactivation of Gram-negative bacterial strains.', 22769015),
('Peptide conjugated phosphorodiamidate morpholino oligomers', 'Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis. ', '', 'Targeting bacterial essential genes using antisense phosphorodiamidate morpholino oligomers (PMOs) represents an important strategy in the development of novel antibacterial therapeutics.', 22978365),
('PEP6R (VKVRVRVRV(D)PPTRVRVRVKV)', 'High potency against bacteria', 'cytocompatible toward human erythrocytes as well as mammalian mesenchymal stem cells', 'Arginine-rich self-assembling peptides as potent antibacterial gels.', 22995710),
('PXL150', 'In vitro a broad spectrum microbicidal action against both Gram-positive and Gram-negative bacteria, including resistant strains', '', 'The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections.', 23053090),
('NK-18', 'Two targets, acts on bacterial membrane and DNA in the cytoplasm', '', 'The double targets of NK-18 make it difficult for bacteria to generate resistance, which may present a new strategy to defend against multidrug-resistant bacteria and provide a new lead in the design of potent antimicrobial peptides with therapeutic application in the presence of increasing resistance to conventional antibiotics.', 23089755),
('LL-37', 'Effective in killing extracellular S. aureus at nanomolar concentrations', '', 'Therefore, LL-37 was shown to be very potent and prompt in eliminating both extra- and intracellular S. aureus and was more effective in killing extra- and intracellular S. aureus than commonly used conventional antibiotics.', 23274662),
('TSG-8-1, WWSYVRRWRSR-amide', 'Antimicrobial activity against E. coli and S. aureus', 'Very little hemolytic activity in human erythrocytes t high dose level', 'Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide', 23570790),
('S-thanatin', 'High activity of S-thanatin against K. pneumoniae in vitro with MIC between 4 and 8 micro g/ml.?', '', 'All above implied that S-thanatin, as an alternative, may provide a novel strategy for treating K. pneumoniae infection and other infections due to multidrug-resistant bacteria.', 23643614),
('Peptidomimetics (Short histidine-derived antimicrobial peptides (SAMPs))', 'High antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA)', 'No hemolytic activity', 'Non hemolytic short peptidomimetics as a new class of potent and broad-spectrum antimicrobial agents.', 23816372),
('R-thanatin', 'Potent in vitro activity against coagulase-negative staphylococci, such as S. epidermidis, S. haemolyticus, and S. hominis, and inhibited biofilm formation at subinhibitory concentrations', '', 'R-thanatin inhibits growth and biofilm formation of methicillin-resistant Staphylococcus epidermidis in vivo and in vitro', 23917310),
('C5a-derived immunobiotic peptide EP67', 'EP67 inhibits GBS growth in vitro and in vivo and that antibacterial activity was specific to Streptococcus species.', '', 'We have employed a host-directed immunomodulatory therapy using a novel peptide, known as EP67, derived from the C-terminal region of human complement component C5a.', 23979760),
('Hymenochirin-1B (IKLSPETKDN(10)LKKVLKGAIK(20)GAIAVAKMV.NH2) analogue in which the Pro(5), Glu(6) and Asp(9) on the hydrophilic face of the ?-helix are substituted by one or more l-lysine or d-lysine residues', '[E6k,D9k]hymenochirin-1B has MIC in the range 0.8-3.1 micro M against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) and a range of Gram-negative bacteria, including multidrug-resistant strains of Acinetobacter baumannii and Stenotrophomonas maltophilia, MIC in the range 3.1-6.25 micro M against NDM-1 carbapenemase-producing clinical isolates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae and Citrobacter freundii.,', 'low hemolytic activity (LC50=302 ?M) of [E6k,D9k]hymenochirin-1B', 'An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties', 24172540),
('BmKn2 scorpion venom peptide and its derivatives', 'Bactericidal, potent activity against N. gonorrhoeae with MIC50 values of 6.9-27.6 ?M', '', 'Potent and rapid antigonococcal activity of the venom peptide BmKn2 and its derivatives against different Maldi biotype of multidrug-resistant Neisseria gonorrhoeae.', 24184420),
('His-derived antimicrobial peptides (HDAMPs)', 'Promising dual antimicrobial and anti-inflammatory activities, as well as anti-methicillin-resistant Staphylococcus aureus (MRSA) activity', '', 'CONCLUSION/SIGNIFICANCE: The combination of the ultra-short size, high-prokaryotic selectivity, potent anti-MRSA activity, anti-inflammatory activity, and proteolytic resistance of the designed HDAMP-1, -3, -5, and -6 makes these molecules promising candidates for future antimicrobial therapeutics.', 24302996),
('Temporin-SHa (FLSGIVGMLGKLF amide)', 'Broad-spectrum activity against Gram-positive and Gram-negative bacteria, yeasts and parasites', '', 'Temporin-SHa (FLSGIVGMLGKLF amide) is a small hydrophobic and low cationic antimicrobial peptide with potent and very broad-spectrum activity against Gram-positive and Gram-negative bacteria, yeasts and parasites.', 24919960),
('Pandinin 2 variants', 'Antimicrobial activity against E. coli, S. aureus, and M. tuberculosis', 'Pin2 [14] presented only 25% of hemolysis toward human erythrocytes at concentrations as high as 100 ?M, while the peptide Pin2 [17] did not show any hemolytic effect at the same concentration', 'Therefore, Pin2 [14] and Pin2 [17] have the potential to be used as an alternative antibiotics and anti-tuberculosis agents with reduced hemolytic effects.', 25019413),
('Peptides human beta-defensin-3 (hBD-3) and cathelicidin (LL-37)', 'Non-cytotoxic concentrations of hBD-3 (10 and 20 micro M) and LL-37 (0.1 and 0.2 micro M)', '', 'This combination of antimicrobial peptides thus shows promising potential as an adjunctive therapy for treating inflammatory periodontitis.', 25187958),
('l isomer of lycosin-I (l-lycosin-I), d isomer of lycosin-I (d-lycosin-I), l- and d-amino acid residues of RKGWFKAMKSIAKFIAKEKLKEHL', 'The MICs of the three isomers of lycosin-I and several other clinical drugs were determined through the broth microdilution method in accordance with the CLSI protocol', '', 'These two compounds displayed high antibacterial activities and rapid bactericidal effects against MDRAB. Moreover, the compounds retained their activity even at high salt (Mg(2+) or Ca(2+)) concentrations.', 25199777),
('G(IIKK)(3)I-NH(2)', 'Effective against ESBL-producing bacterial infection', 'multidrug resistant ESBL-producing bacteria do not develop resistance and low toxicity toward mammalian hosts', 'High cell selectivity and low-level antibacterial resistance of designed amphiphilic peptide G(IIKK)(3)I-NH(2). On the basis of cell cultures involving bacterial strains (Escherichia coli 5? and Bacillus subtilis 168) and a mammalian cell line (NIH 3T3), the potent antibacterial activity and distinct selectivity from designed amphiphilic peptides G(IIKK)nI-NH2 (n = 2-4) have been demonstrated.', 25210781),
('Antimicrobial peptides (AMPs) GPPPQGGRPQG and RFGYGYGPYQPVPEQPLYPQ', 'Antibacterial effect in S. aureus', '', 'These showed to exert an antibacterial effect in Staphylococcus aureus. This report validates the prospection of mammal''s saliva to find new alternatives to antibiotics.BIOLOGICAL SIGNIFICANCE: With the growing problem of antibiotic resistance, the identification of new routes in antibiotic therapy is on the scientific agenda worldwide.', 25534884),
('VRV-PL-V (Vipera russellii venom phospholipase A2 fraction V) of Daboia russellii pulchella venom', 'Antibacterial activity with MIC values ranging from 13 to 24 micro g/ml', '', 'VRV-PL-V demonstrated a potent antibacterial activity against all the human pathogenic strains tested.', 25540009),
('Tilapia piscidin antimicrobial peptides TP3 (H-FIHHIIGGLFSVGKHIHSLIHGH-OH), TP4 (H-FIHHIIGGLFSAGKAIHRLIRRRRR-OH)', 'TP4 MIC against K. pneumonia and A. baumannii in the range < 1.56 microg/mL - 3.125 microg/mL. TP3 MIC against K. pneumonia and A. baumannii in the range < 1.56 microg/mL - 25 microg/mL', '', 'TP3 and TP4 are able at potentiate anti-Acinetobacter baumannii or anti-Klebsiella pneumonia drug activity, reduce bacterial load, and prevent drug resistance, indicating their potential for use in combating multidrug-resistant bacteria.', 25874924),
('VG16KRKP', 'Antimicrobial activity against Gram-negative E. coli and plant pathogens X. oryzae and X. campestris, as well as against human fungal pathogens C. albicans and C. grubii.', '', 'The de novo design of VG16KRKP provides valuable insights into the development of more potent antibacterial and antiendotoxic peptides for the treatment of human and plant infections.', 26144972),
('Synthetic peptides based on LF11( LF11-215 (FWRIRIRR), LF11-227 (FWRRFWRR), DI-MB-LF11-322 (2,2-dimethylbutanoyl-PFWRIRIRR) and DI-MB-LF11-215)', 'Potent anti-biofilm activity against Pseudomonas aeruginosa', '', 'Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms', 26149536),
('NLF20 (NLFRKLTHRLFRRNFGYTLR)', 'Potent antimicrobial effects against the Gram-negative bacteria Escherichia coli and P. aeruginosa, the Gram-positive Bacillus subtilis and Staphylococcus aureus and the fungi Candida albicans and Candida parapsilosis', '', 'NLF20: an antimicrobial peptide with therapeutic potential against invasive Pseudomonas aeruginosa infection', 26503666),
('K1K8: an Hp1404-derived antibacterial peptide', 'Decreased methicillin-resistant Staphylococcus aureus (MRSA) bacterial counts in the wounded region in a mouse skin infection model', 'Low hemolytic activity', 'K1K8: an Hp1404-derived antibacterial peptide. As an alternative class of antimicrobial agents used to overcome drug-resistant infections, antimicrobial peptides (AMPs) have recently gained significant attention.', 26952110),
('D-L91 (SEFAYGSFVRTVSLPVGADE)', 'Enhancement of IFN-gamma(+)TNF-alpha(+) polyfunctional Th1 cells and IL-17A(+)IFN-gamma(+) Th17 cells, enduring memory CD4 T cells and downregulation of PD-1', '', 'The adjunct therapy using drugs and L91 (D-L91) significantly declined the bacterial load in Mtb infected animals.', 27052185),
('CSpK14 , antimicrobial peptide', 'MICs reduced by 8- to 64-fold and 2- to 16-fold in combination wth oxacillin and ampicillin respectively', '', 'CSpK14 was simple to purify, had low molecular mass, was stable over a wide pH range or tested chemicals, had broad inhibitory spectrum, and possessed potent synergistic antimicrobial-antibiofilm properties.', 27787755),
('Series of side-chain hybrid dimer peptides J-AA (Anoplin-Anoplin), J-RR (RW-RW), and J-AR (Anoplin-RW) based on the wasp peptide Anoplin and the arginine- and tryptophan-rich hexapeptide', '', '', 'Design of novel antimicrobial peptide dimer analogues with enhanced antimicrobial activity in vitro and in vivo by intermolecular triazole bridge strategy.', 28040477),
('Thiazomycin, nocathiacin and analogs', 'Activity against drug resistant Mycobacterium tuberculosis with different MICs', '', 'Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis. Thiazolyl peptides are a class of natural products with potent Gram-positive antibacterial activities.', 28096545),
('Heterofunctionalized poly(ethylene glycol) with different lengths (methacrylate-PEGn-tosyl, n=10/45/90) conjugated with polypeptides to form diblock amphiphiles', 'Antimicrobial activity against several pathogenic bacteria like Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and effectively prevent biofilm formation', '', 'Thus, this facilely synthesized PEGylated AMP bottlebrush coating is a feasible method to prevent biomedical devices-associated infections.', 28131941),
('[K3]SHa', '[K3]SHa emerged as a highly potent compound active against a wide range of bacteria, yeasts/fungi, and trypanosomatids (Leishmania and Trypanosoma), with leishmanicidal intramacrophagic activity and efficiency toward antibiotic-resistant strains of S. aureus and antimony-resistant L. infantum.', '', 'To improve activity, we designed analogs of SHa and compared the antibacterial and antiparasitic mechanisms. [K3]SHa emerged as a highly potent compound active against a wide range of bacteria, yeasts/fungi, and trypanosomatids (Leishmania and Trypanosoma), with leishmanicidal intramacrophagic activity and efficiency toward antibiotic-resistant strains of S. aureus and antimony-resistant L. infantum.', 28319176),
('Cecropin A2', 'Synergistic Efficacy in combination with Tetracycline against Pseudomonas aeruginosa', '', 'Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa.', 28483966),
('Sph12-38', 'MIC 3 micro M against Staphylococcus aureus, Corynebacterium glutamicum, Micrococcus lysodeikticus Fleming, Bacillus subtilis, Pseudomonas fluorescens, Aeromonas hydrophila and A. sobria', '', 'Taken together, the synthetic peptide of Sph12-38 had a potent antimicrobial activity against bacteria.', 28600196),
('Free or anchored antimicrobial peptides like  the cathelicidins BMAP-27 and BMAP-28, their (1-18) fragments and the rationally designed, artificial P19(9/G7) peptide', 'Effective at micromolar concentrations against 22 Staphylococcus and Streptococcus isolates from orthopaedic infections,  BMAP-28 and to a lesser extent BMAP-27 were active against Enterococcus faecalis', 'Negligible toxicity towards osteoblasts', 'Alpha-helical antimicrobial peptides (AMPs) may be promising candidates in this respect due to their potent and broad-spectrum antimicrobial activity, their low tendency to elicit resistance and possible retention of efficacy in the immobilized state.', 28707817),
('NZ2114 and MP1102', 'The minimal inhibitory concentration and minimal bactericidal concentration of NZ2114 and MP1102 against resistant C. perfringens type A strain CVCC 46 were 0.91 micro M', '', 'Mode of action of plectasin-derived peptides against gas gangrene-associated Clostridium perfringens type A. .', 28934314),
('Antimicrobial peptide Brevinin-2Ta (GILDTLKNLAKTAGKGILKSLVNTASCKLSGQC)', 'MIC of B-2Ta against S. aureus 64 mg/L, E. coli 32 mg/L, C. albicans 64 mg/L.', '', 'Assessment of antimicrobial and wound healing effects of Brevinin-2Ta against the bacterium Klebsiella pneumoniae in dermally-wounded rats. Antimicrobial peptides (AMPs) are regarded as promising alternatives for antibiotics due to their inherent capacity to prevent microbial drug resistance. Amphibians are rich source of bioactive molecules, which provide numerous AMPs with various structures as drug candidates.', 29340060),
('Histone H5 purified from chicken erythrocytes', 'Active against Gram-positive and Gram-negative planktonic bacteria (MIC range: 1.9 +- 1.8 to 4.9 +- 1.5 micro g/mL)', '', 'Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides. Modern medicine is challenged continuously by the increasing prevalence of antibiotic resistant bacteria.', 29402952),
('OH-CATH30 (L and D)', 'highest bactericidal activity against Acinetobacter spp., including multi-drug-resistant Acinetobacter baumannii (MRAB) and methicillin-resistant Staphylococcus aureus (MRSA)', '', 'King cobra peptide OH-CATH30 as a potential candidate drug through clinic drug-resistant isolates. Cationic antimicrobial peptides (AMPs) are considered as important candidate therapeutic agents, which exert potent microbicidal properties against bacteria, fungi and some viruses.', 29515090),
('Pituitary adenylate cyclase-activating polypeptide (PACAP)', 'Antimicrobial activity against Escherichia coli and Staphylococcus aureus', '', 'Pituitary adenylate cyclase-activating polypeptide (PACAP) is a naturally occurring cationic peptide with potent immunosuppressant and cytoprotective activities.', 29654809),
('Myristoylation of Human alpha-Defensin 5', '', '', 'Our strategy involves the myristoylation of human alpha-defensin 5 (HD5) as a therapeutic target and subsequent self-assembly in aqueous media in the absence of exogenous excipients.', 29856606),
('Antimicrobial peptide N10 and NB2', 'Both peptides were effective against A. baumannii and showed antibacterial activities (minimum inhibitory concentration (MIC) 500 micro g/ml). In the biofilm inhibition assay, NB2 reduced biofilm more efficiently (75%) than N10 (50%).', '', 'The selected peptides showed significant binding to A. baumannii rather than to the human cell line Caco-2. Both peptides were effective against A. baumannii and showed antibacterial activities', 29859290),
('Marcin-18 (FFGHLFKLATKIIPSLFR), Meucin-18 (FFGHLFKLATKIIPSLFQ) and Megicin-18 (FFGALFKLATKIIPSLFR)', 'Showed highly potent inhibitory activity against Gram-positive bacteria (MIC 1.5 to > 48.3 microM), including some clinical antibiotic-resistant strains. Importantly, in a mouse acute peritonitis model, these peptides significantly decreased the bacterial load in ascites and rescued nearly all mice heavily infected with clinical methicillin-resistant Staphylococcus aureus from lethal bacteremia.', '', 'In vitro, chemically synthetic marcin-18 and its homologs (meucin-18 and megicin-18) showed highly potent inhibitory activity against Gram-positive bacteria, including some clinical antibiotic-resistant strains.', 29896190),
('Oligo-lipidated arginyl peptide (OLAP11)', 'antimicrobial actions against MRSA infections', 'low in vitro toxicity', 'Our results showed that OLAP-11 exhibits potent antimicrobial activity against Gram-positive bacteria with improved physico-chemical activity in various physiological conditions.', 30066172),
('LTX21', 'Role on host-pathogen interplay,', '', 'Targeting bacterial virulence or the human host immune system to increase host defence are important strategies in the search for novel antimicrobial drugs.', 30916807),
('Melittin', 'Potency in eradication of extensively drug-resistant (XDR) Acinetobacter spp., killed all examined XDR isolates at 4 microg/mL up to 3 h, significant activity at the minimum dose of 0.062 microg/m', 'No toxixity observed on injured or healthy derma, as well as circulating Red Blood Cells (RBCs) in the examined mice', 'Potent promising antibacterial activity of melittin and the lack of toxicity at the therapeutic dose can clarify that melittin can be implemented as a topical drug lead in a preclinical trial of third degree burn infections.', 30513367),
('MAP-0403 (J-1, J-2, and J-3)', 'MIC reported as, J-1: 5 microM, J-2 : 2.5 microM, J-3: 10 microM', 'J-2 showed significantly reduced hemolytic effect (3.4%), while J-1 and J-3 showed slightly decreased hemolytic effect (46.2%, 55.6%, respectively', 'Design, synthesis, and antimicrobial activities of novel functional peptides against Gram-positive and Gram-negative bacteria', 31059203),
('N-terminal fatty acid modified-antimicrobial peptide', 'Displayed synergistic effects when used together with the antibiotics rifampicin and polymyxin B, had strong membrane permeabilization and depolarization, could damage the integrity of the bacterial membrane and could bind to bacterial DNA', '', 'Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.', 31466017),
('Sphaeropsidin A', 'MIC= 6.25 microgram/mL to 12.5 microgram/mL, methicillin-resistant S. aureus (MRSA)', '', 'Sphaeropsidin A activity appears noteworthy for its ability to inhibit biofilm formation, preventing a growth mode that results in particular resistance to antibiotic treatment.', 32650496),
('Anoplin analogues: Ano-1beta and Ano-8beta', 'Multidrug-resistant P. aeruginosa', '', 'The new peptides Ano-1beta and Ano-8beta might be promising antimicrobial candidates in combating the increasing antibiotic-resistant bacteria.', 32654770),
('Tridecaptin M', 'Tridecaptin M reduced the MIC of vancomycin and rifampicin against A. baumannii by 16-fold', 'Tridecaptin M and rifampicin combination killed the bacteria completely in 4 h in an ex vivo blood infection model and was superior to rifampicin monotherapy', 'This study reports the in vitro potential of an antimicrobial peptide tridecaptin M in combination with other antibiotics against different strains of A. baumannii.', 32708842),
('cCATH-2 (a chicken-derived antimicrobial peptide)', 'All tested concentrations of cCATH-2 (1/32-1/2MIC) significantly reduced the biomass at the biofilm formation stage', '', 'Inhibitory effect of a novel chicken-derived anti-biofilm peptide on P. aeruginosa biofilms and virulence factors.', 32976967),
('PBDM1: YKWFAHLIKGLC and PBDM2: YKWFRHLIKKLC', 'The MIC value of PBDM1 was found to be as 10 microgram/mL against S. aureus, MRSA, and E. coli. Whereas, in case of E. faecalis, VRSA and VRE the MIC was found to be 30, 15, and 20 microgram/mL. But, the MIC value for PBDM2 was 10 microgram/mL when tested against S. aureus, MRSA, VRSA, VRE, and E. coli. Whereas, in case of E. faecalis the MIC was found to be 20 microgram/mL', 'in vitro study with human epithelial cells showed no significant cytotoxic effects with high biocompatibility and good hemocompatibility', 'In conclusion, PBDM peptides displayed significant antibacterial activity against certain drug resistant bacteria which cause infections in human beings', 32983007),
('L1G, L7A, and L1GA5K : Mastoparan-C (MP-C) analogs', 'The newly designed peptides showed synergy or additive effects against Gram-negative bacteria, when they combined with conventional antibiotics gentamicin, rifampin, and polymyxin B.', '', 'Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.', 33285267),
('Astucin from A. tubingensis A01.', 'The MIC of the purified polypeptide was 32 m/L and 128 microgram/mL and the MBIC was 2 and 8 microgram/mL against Staphylococcus aureus and MRSA, respectively', 'The results demonstrated that the antimicrobial and antibiofilm activity of astucin, together with its lack of cytotoxicity, makes it an alternative for application in medicine.', 'This protein shows antimicrobial and antibiofilm activity against S. aureus.', 33309927),
('F12, Lysostaphin', 'F12 possesses high potency and rapid onset of action, it has narrow selectivity against pathogenic staphylococci, and it manifests synergy with numerous SOC antibiotics.', '', 'These results suggest that combinations of F12 and SOC antibiotics are a promising new approach to treating refractory S. aureus infections.', 33318001),
('Nisin and P10', 'Nisin + colistin and P10+ceftazidime/doripenem were effective on XDR A. baumannii . The MIC value of Nisin and P10 against studied pathogens were 64-256 and 8-32 microgram/ml, respectively.', '', 'Combination therapy and using antimicrobial peptides are two strategies with high potential to solve this issue.', 33346078),
('C14-R1 (C14-RWW-NH2) and C12-R2 (C12-RRW-NH2)', 'C14-R1 and C12-R2 showed high antimicrobial potential for gram-positive bacteria.', 'Among them, the new lipopeptides C14-R1 (C14-RWW-NH2) and C12-R2 (C12-RRW-NH2) presented higher selectivity to bacterial membranes over mammalian membranes and low cytotoxicity, which also maintained better antimicrobial activity in the presence of physiological salts or serum.', 'Most of the new lipopeptides exhibited preferable antimicrobial potential against gram-positive bacteria, including MRSA clinical isolates.', 33422980),
('Fungal peptide, NZX', 'We further observed that this peptide was effective against nontuberculous mycobacteria (NTM), such as M. avium and M. abscessus, and several Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus.', 'In vivo, the peptide remained stable in circulation and preserved lung structure better than ethambutol alone', 'Alternative ways to prevent and treat infectious diseases are needed.', 33603037),
('Peptide-Based Antibiotics', 'In both cases, optimization of the N-terminal lipid tails led to the identification of analogues with potent activity toward Escherichia coli and Pseudomonas aeruginosa.', '', 'Peptide natural products stand as promising candidates to meet this need as bacterial resistance is typically slow in response to their unique modes of action.', 33750106),
('Dilipid ultrashort cationic lipopeptides (dUSCLs)', 'Can indirectly disrupt active efflux of chloramphenicol in P. aeruginosa', '', 'Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria', 30392097),
('Microencapsulated-Host Defense Peptides (HDP ) ;Ub2-MS, K4-MS, and Aurein1.2-MS', 'HDP-MS exhibited up to ?3.02 and ?3.41-log decrease in Mycobacterium tuberculosis CFU as compared to blank-MS (drug free) and untreated control group in 96 h', '', 'Mycobactericidal activity of some micro-encapsulated synthetic Host Defense Peptides (HDP) by expediting the permeation of antibiotic: A new paradigm of drug delivery for tuberculosis.', 30630076),
('Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles', 'The most potent, broad-spectrum peptidomimetic showed activity against Gram-positive (methicillin-resistant Staphylococcus aureus - MIC = 2 microg/mL) and Gram-negative (Escherichia coli - MIC = 4 microg/mL) pathogenic bacteria.', '', 'Synthetic small molecular antimicrobial peptidomimetics represent a promising new class of potential antibiotics due to their membrane-disrupting ability and their decreased propensity for bacterial resistance.', 30831407),
('alpha-Peptide/beta-Peptoid Lysine-Based Peptidomimetics', 'High potency against clinical drug-resistant P. aeruginosa strains', '', 'Emergence of bacterial resistance renders existing antibiotics inefficient, and therefore discovery of new antimicrobial agents is highly warranted.', 30842761),
('Cationic Antimicrobial Peptides (CAMPs) : LL-37: human cathelicidin, CAMA: cecropin(1-7)-melittin A(2-9) amide, magainin-II and nisin', 'activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa', '', 'This study showed the potent and rapid antibacterial activity of CAMPs on both laboratory and clinical isolates of S. aureus and P. aeruginosa either susceptible or resistant to antibiotics.', 30849936),
('Peptide dendrimers G3KL and TNS18', 'Can destroy the Pseudomonas aeruginosa biofilm morphological structure and thickness', '', 'Potent activity on planktonic cells and biofilms of P. aeruginosa suggests that peptide dendrimers G3KL and TNS18 are promising candidates of clinical development for treating infections.', 31101943),
('Hybrid antimicrobial peptide (B1) from helical parts taken from the parent peptides: LL-37 and BMAP-27', 'Broad-spectrum activities, the concentration against planktonic cells ranged between 10 and 20 microM, 40-60 microM were needed to eradicate the biofilm', 'Reduced toxicity toward mammalian cells with minimal hemolysis risk', 'Results: The new peptide B1 exhibited broad-spectrum activities against all tested strains.', 31118709),
('Bac1, Bac2 and Bac3', 'Inhibit the growth of Leuconostoc mesenteroides and affect sperm motility', '', 'Bacteriocins, which are bacterially-derived antimicrobial peptides, may fulfill some of the criteria for these new agents.', 31244418),
('vancomycin derivatives carrying LPS binding peptides, vancomycin-LPS binding peptide conjugates (VPCs).', 'were screened against VISA/VRE and Gram-negative strains', '', 'VPCs exhibited enhanced activity against vancomycin resistant bacteria and obtained the activity against Gram-negative bacteria in vitro, providing a novel strategy for vancomycin modification and glycopeptide antibiotics synthesis.', 34015504),
('Activated caseinolytic protease P (ClpP)', 'an antibacterial assessment demonstrated that ONC212 displays excellent activity against Xoo and prevents rice bacterial leaf blight in vivo.', '', 'Additionally, an antibacterial assessment demonstrated that ONC212 displays excellent activity against Xoo and prevents rice bacterial leaf blight in vivo.', 34218658),
('a chimeric peptide-G6, a N6NH2 analog', 'Showed MIC value: 16 microgram/mL and could curb N6NH2-resistant mutants by stronger inhibition of biofilm formation, stronger affinity with LPS, and stronger membrane permeability and depolarization than that of N6NH2.', '', 'Antimicrobial peptides (AMPs) are regarded as the potentially effective therapy.', 34889983),
('AMPR-22 (antimicrobial peptide derived from Romo1)', 'It showed broad-spectrum antimicrobial activity against 17 sepsis-causing bacteria, including MDR strains, by inducing membrane permeabilization.', 'Moreover, treatment with AMPR-22 enabled a remarkable survival rate in mice injected with MDR bacteria in a murine model of sepsis.', 'Based on these results, we suggest that AMPR-22 could be prescribed as a first-line therapy (prior to bacterial identification) for patients diagnosed with sepsis.', 34361008),
('glucose-dependent insulinotropic polypeptide (GIP)', 'While GIP was devoid of direct antimicrobial activity, it has a potent membrane depolarizing effect, and at low concentrations, it significantly potentiated the activity of eight antibiotics and bile salt by reducing MICs by 4-8-fold in E. coli TG1 and 4-20-fold in E. amylovora 1189.', '', 'GIP can thus be regarded as an antimicrobial adjuvant with potential for augmenting the available antibiotic arsenal. © 2020 Walter de Gruyter GmbH, Berlin/Boston.', 33938181),
('beta-defensin-derived peptide', 'The MIC values ranged from 2 to 4?8 microM for all the microorganisms tested, with the exception of the P. aeruginosa MDR strain 1 and A. baumannii strain 1 that are resistant up to a concentration of 32?64 microM of both peptide forms', 'it has great stability in human serum thereby enhancing its antibacterial presence and activity without cytotoxicity in human cells.', 'Currently, the race is on to identify pharmaceutical molecules or combinations of molecules able to prevent or reduce the insurgence and/or progression of infectivity.', 34818435),
('PHNX peptides', 'PHNX-1 demonstrated antibacterial activity (under high and low-salt conditions) against antibiotic resistant and susceptible strains of Gram-positive and Gram-negative bacteria and PHNX-4 to -8 demonstrated low-salt antibacterial activity only.', '', 'Development of new antibiotics has slowed in recent years and novel therapeutics (like AMPs) with a focus against Gram-negative bacteria are needed.', 34867843),
('cationic antimicrobial peptides (AMPs)', 'In contrast, it showed minimum inhibitory concentration values (MICs) lower than reported for several AMPs and other synthetic cationic compounds on Acinetobacter genus (3.2-12.7 microM).', '', 'New therapeutic possibilities are, therefore, urgently needed to circumvent this important problem.', 34298891),
('Synthetic beta-hairpin antimicrobial peptides', 'mutations of only 2 to 4 amino acids at the turn region could impart a wide range of antimicrobial profiles among synthetic beta-hairpin AMPs. BTT2-4 and BTT6 displayed selective potency against Gram-negative bacteria, with minimum inhibitory concentrations (MICs) of 4-8 microM.', 'Our peptides were also determined to be non-cytotoxic against a human cell line.', 'Synthetic β-hairpin antimicrobial peptides (AMPs) offer a useful source for the development of novel antimicrobial agents. β-hairpin peptides generally consist of two side strands bridged by a reverse turn.', 34506975),
('dipicolylamine-containing carbazole amphiphiles with strong Zn2+', 'antimicrobial candidate. 16 combined with 12.5 microgram/mL Zn2+ exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria (MICs = 0.78-3.125 microgram/mL), weak hemolytic activity, and low cytotoxicity.', 'antimicrobial candidate. 16 combined with 12.5 microgram/mL Zn2+ exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria (MICs = 0.78-3.125 microgram/mL), weak hemolytic activity, and low cytotoxicity.', 'Effective broad-spectrum 16 combined with 12.5 μg/mL Zn2+ was identified as the most promising antimicrobial candidate. 16 combined with 12.5 μg/mL Zn2+ exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria (MICs = 0.78-3.125 μg/mL), weak hemolytic activity, and low cytotoxicity.', 34235929),
('cathelicidin-related (CR-) peptides- PepBiotics', 'A relatively small number of PepBiotics remained highly antibacterial against CF-related respiratory pathogens Pseudomonas aeruginosa and Staphylococcus aureus, at high ionic strength and low pH. I', 'Finally, interaction of CR-163 with bacterial-type anionic membranes but not with mammalian-type (zwitterionic lipid) membranes was confirmed using ITC and 31P solid state NMR.', 'Interestingly, these PepBiotics also prevented LPS/LTA induced activation of macrophages and was shown to be non-toxic to primary human nasal epithelial cells.', 34147544),
('Temporin A and the short lipopeptides (C10)2-KKKK-NH2 and (C12)2-KKKK-NH2', '', '', 'The results of the performed experiments suggest that the potential application of peptides as adjuvant agents in the treatment of biofilm-associated infections should be studied further.', 32887236),
('CB6-C', 'effective antimicrobial activity against gram-positive bacteria (in particular, the MIC for MRSA was 16 Microgram/mL)', '', 'In conclusion, this protein CB6-C is a newly discovered antibacterial protein and has the potential to become an effective antibacterial agent due to its high therapeutic index, safety, nontoxicity and great stability.', 34983528),
('Lactoferricin B-Mutant (M4)', 'Among the potent AMP mutants, a Lactoferricin B-Mutant (M4) possessed uniformly high affinity with SHV1, OXA48, NDM1, and AmpC having energies -842.0Kcal/mol, -774.8Kcal/mol, -1103.3Kcal/mol, and -858.8Kcal/mol respectively. Highest affinity of Lactoferricin B_M4 was found with NDM1 due to H-bonds, salt-bridges, and hydrophobic interactions with the metallo-?-lactamase domain including crucial active-site residue Asp124.', '', 'Molecular dynamics simulation further confirmed the stability of Lactoferricin B_M4-NDM1 complex having low residue-level root-mean square deviations (RMSD), atomic-level fluctuations, and radius of gyration (Rg). The study encourages experimental validations and similar methods to identify potential AMPs against drug-resistant pathogens.', 35188617),
('PaP1', 'TSP showed lytic spectrum of ~ 75%, suggesting its activity against various MRSA and MSSA isolates from different clinical samples. The phage efficiently inhibited bacterial growth for up to 12 h at MOI of 1 and 10. TSP phage showed activity against various isolates of MRSA and MSSA, isolated from different clinical samples, with variable antibiotic susceptibility patterns.', '', 'Despite the necessity for additional preclinical drug development, the collective data from our study support PaP1 as a potential broad-spectrum monotherapy or adjunctive therapy for the topical treatment of polymicrobial infections and provide a foundation for engineering future lysin-derived peptides with improved antibacterial properties.', 35369520),
('two-peptide lantibiotic produced by Vagococcus fluvialis LMGT 4216', 'The combination of the two peptides resulted in a 1,200-fold increase in potency, confirming the two-peptide nature of the bacteriocin, named vagococcin T. The bacteriocin was demonstrated to kill sensitive cells by the formation of pores in the cell membrane, and its inhibition spectrum covers most Gram-positive bacteria, including multiresistant pathogens.', '', 'The novel lantibiotic showed a broad spectrum of inhibition of Gram-positive strains, including vancomycin-resistant Enterococcus faecium, demonstrating its therapeutic potential.', 35730941),
('two CAMPs (LL-37 and CAMA)', 'We observed a greater bactericidal effect when IB3-1 cells were pretreated with sub-minimum bactericidal concentrations (Sub-MBCs) of the CAMPs prior to infection. These findings suggest that CAMPs induce the production of factors by IB3-1 cells that improve their bactericidal action. LL-37 induced a weak inflammatory response in the cells without being toxic.', 'The two CAMPs exerted different effects on PA survival depending on the timing of their administration. However, we observed no bactericidal effect when supra-minimum bactericidal concentrations (Supra-MBCs) of the CAMPs were added to IB3-1 cells at the same time or after infection.', 'In conclusion, our findings suggest a potential prophylactic action of CAMPs. The bactericidal effects were low when the CAMPs were added after cell infection, likely due to degradation of CAMPs by bacterial or epithelial cell proteases and/or due to adherence of CAMPs to cells becoming less available for direct bacterial killing.', 34954126),
('series of AMPs with linear and star-shape (using n-hexylamine and amine-terminated polyamidoamine dendrimers (Gx-PAMAM, x = 1-2) as initiators)', 'the star-shaped AMPs exhibited enhanced bactericidal activity against Gram-negative E. coli and similar bactericidal activity against Gram-positive S. aureus when compared with the linear AMPs. It is worth mentioning that star-shaped AMPs demonstrated a significantly faster bactericidal efficiency (completely killed bacteria within 5 min at a concentration of 2 ? MIC for S. aureus) than their linear analogues (took 15 min to achieve the same effect). However, when the AMPs were immobilized to the surface, they similarly exhibited superior antibacterial activity and fast bactericidal efficiency towards S. aureus and E. coli in the case of the same surface grafting amount.', '', 'In addition, both the surfaces grafted with AMPs of different topologies demonstrated favorable biocompatibility in vitro.', 35005755);
INSERT INTO `table 31` (`COL 1`, `COL 2`, `COL 3`, `COL 4`, `COL 5`) VALUES
('metronidazole (MDZ), clindamycin (CLI), and PM-477', 'Determination of the MIC indicated that 60% of a panel of 22 Gardnerella isolates of four different species were resistant to MDZ, while all strains were highly susceptible to CLI and to the endolysin PM-477. All strains were susceptible to PM-477 when grown as preformed biofilms, at minimum biofilm eradication concentrations (MBECs) in the range of 1 to 4 ?g/mL.', '', 'Therefore, the high efficacy of PM-477 in eliminating Gardnerella in in vitro biofilms, as well as its high resilience to resistance formation, makes PM-477 a promising potential alternative for the treatment of bacterial vaginosis, especially in patients with frequent recurrence.', 35416708),
('cationic antimicrobial peptides (CAMPs)', 'In this study, the interaction of a CAMP derived from cecropin D-like (?M2) with model membranes mimicking bacterial biomembranes of wild-type (WTPa) strains of P. aeruginosa and CRPa was evaluated through in vitro and in silico approaches.', '', 'This work provides clues for elucidating the membrane-associated mechanism of action of ?M2 against colistin-susceptible and -resistant strains of Pseudomonas aeruginosa. Accordingly, cationic antimicrobial peptides (CAMPs) have emerged as promising alternatives to control resistant bacteria.', 35745820),
('Temporin-PKE', 'Temporin-PKE is a novel peptide extracted from the skin secretion of Pelophylax kl. esculentus and it displays a strong activity against Gram-positive bacteria, with an extreme cytotoxicity. The transformation of the chirality of Ile could reduce haemolytic activity, and an analogue with appropriate D-isoforms could maintain antimicrobial activity and stability. The substitution of hydrophobic residues could bring about more potent and broad-spectrum antimicrobial activities.', 'The analogues with Lys were less harmful to the normal cells and their stabilities remained at similarly high levels compared to temporin-PKE.', 'Temporin-PKE-3K exerted dually efficient functions includingstrong antimicrobial and anticancer activity. This analogue showed a reduced possibility for inducing resistance in MRSA and Klebsiella pneumoniae, a rather strong antimicrobial activity in vivo, and it exhibited the highest therapeutic index such that temporin-PKE-3K has the potential to be developed as a clinical drug.', 35740884),
('Pediocin-like bacteriocins (class IIa bacteriocins)', 'They act on the cytoplasmic membrane of Gram-positive cells by dissipating the transmembrane electrical potential through pore formation with the mannose phosphotransferase system (man-PTS) as the target/receptor. Bacteriocin-producing strains also synthesize a cognate immunity protein that protects them against their own bacteriocins.', 'Pediocin-like bacteriocins, ribosomally synthesized antimicrobial peptides, are generally co-expressed with cognate immunity proteins to protect the bacteriocin-producing strain from its own bacteriocin.', 'Bacteriocins are considered potential alternatives to conventional antibiotics in the context of the bacterial resistance crisis, but the immunity mechanism is unclear. This study uncovered the mechanisms of action and immunity of class IIa bacteriocins.', 35703550),
('Antimicrobial Peptides CATH-1, CATH-3, and PMAP-36 With Erythromycin', 'The results showed that the minimum bactericidal concentration (MBC) of CATH-1,-3 and PMAP-36 was lower than 10 ?M, indicating that these three AMPs had good bacterial activity against S. aureus, S. enteritidis, and E. coli. The results showed that the FBCI of AMPs (CATH-1,-3 and PMAP-36) and erythromycin was lower than 0.5 against bacterial pathogens, demonstrating that they had a synergistic bactericidal effect. Furthermore, the time-killing kinetics of AMPs (CATH-1,-3 and PMAP-36) in combination with erythromycin showed that they had a continuous killing effect on bacteria within 3 h. Notably, the combination showed lower hemolytic activity and cytotoxicity to mammal cells compared to erythromycin and peptide alone treatment. In addition, the antibacterial mechanism of CATH-1 and erythromycin combination against E. coli was studied. The results of the scanning electron microscope showed that CATH-1 enhanced the antibacterial activity of erythromycin by increasing the permeability of bacterial cell membrane. Moreover, the results of bacterial migration movement showed that the combination of CATH-1 and erythromycin significantly inhibits the migration of E. coli. Finally, drug resistance analysis was performed and the results showed that CATH-1 delayed the emergence of E. coli resistance to erythromycin.', '', 'In conclusion, the combination of CATH-1 and erythromycin has synergistic antibacterial activity and reduces the emergence of bacterial drug resistance. Our study provides valuable information to develop AMPs as potential substitutes or adjuvants for traditional antibiotics.', 35910608),
('?-Hairpin Peptide Z-d14CFR or recombinant Zophobas atratus (Z. atratus) defensin', 'Our results showed that Z-d14CFR (RGCRCNSKSFCVCR-NH2) exhibited a broad-spectrum antimicrobial activity to both Gram-positive bacteria and Gram-negative bacteria, including multidrug-resistant bacteria.', 'It possessed less than 5% hemolysis and 10% cytotoxicity, even at a high concentration of 1 mg/mL.', 'Our findings suggest that Z-d14CFR could be a promising candidate against multidrug-resistant bacteria.', 35563007),
('cell-penetrating peptide fused endolysin', 'Bacteriophage encoded endolysin as an alternative antibiotics is a peptidoglycan degrading enzyme with a low rate of resistance. This engineered endolysin, DS-PA90, completely killed A. baumannii at 0.25 ?M, at which concentration PA90 could only eliminate less than one log in CFU/ml. Additionally, DS-PA90 has tolerance to NaCl, where the ?50% of activity could be maintained in the presence of 150 mM NaCl, and stable activity was also observed with changes in pH or temperature. Even MDR A. baumannii strains were highly susceptible to DS-PA90 treatment: five out of nine strains were entirely killed and four strains were reduced by 3-4 log in CFU/ml. Consequently, DS-PA90 could protect waxworm from A. baumannii-induced death by ?70% for ATCC 17978 or ?44% for MDR strain 1656-2 infection.', '', 'Collectively, our data suggest that CPP-fused endolysin can be an effective antibacterial agent against Gram-negative pathogens regardless of antibiotics resistance mechanisms.', 35614377),
('tetrameric cell penetrating antimicrobial peptoids', 'short tetrameric Rhodamine B-labeled peptoids composed of a balance of aromatic and lipophilic residues have potent selective antimicrobial activity against a range of microorganisms. The most potent candidates were active against drug-resistant S. aureus isolates as well as mycobacterial strains, with cell penetrating capabilities reported in HeLa and RAW 264.7 macrophage cells.', '', 'Conclusions: These data suggest that peptoids with novel dual functionalities may potentially be an interesting class of therapeutics and/or molecular delivery agents for anti-infective purposes.', 35227007),
('Human neutrophil peptide-1 (HNP-1)', 'HNP-1 induces bacterial apoptosis and prevents its SOS repair pathway from binding to the RecA protein, which may be a new antibacterial mechanism. In addition, we showed that HNP-1 encapsulated in liposomes inhibits the growth of methicillin-resistant Staphylococcus aureus (MRSA) and meropenem-resistant Pseudomonas aeruginosa (MRPA).', '', 'These results indicated that recombinant protein expression may be a simple and cost-effective solution to produce HNP-1 and that RecA inhibition via HNP-1 may serve as an alternative strategy to counteract antibiotic resistance.', 35019682),
('RPMs : FK20 (L-Phenylalanine-L-Lysine, 20-mer), FdK (L-Phenylalanine-D-Lysine, 20-mer), dFdK (D-Phenylalanine-D-Lysine, 20-mer), and LK20 (L-Leucine-L-Lysine, 20-mer)', 'RPMs rapidly and efficiently kill different strains of A. baumannii, inhibit biofilm formation, and disrupt mature biofilms. Importantly, RPMs attenuated bacterial burden in mouse models of acute pneumonia and soft tissue infection and significantly reduced mouse mortality during sepsis.', '', 'Collectively, our results demonstrate RPMs have the potential to be used as powerful therapeutics against antibiotic-resistant A. baumannii.', 35326876),
('?-hairpin structure with the template (XY)2RRRF(YX)2-NH2 (X: hydrophobic amino acids; Y: cationic amino acids)', 'almost all of the new peptides have strong antibacterial activity and negligible hemolytic toxicity. Particularly, the therapeutic index (TI) values of F(RI)2R and F(KW)2K reached up to 115.9 and 70.7, respectively. In addition, they did not show induced drug resistance and inhibited the development of antibiotic resistance when combined and used with traditional antibiotics.', '', 'Moreover, the new peptides F(RI)2R and F(KW)2K showed excellent performance in the pulmonary bacterial infection model and low toxicity in mice. In conclusion, F(RI)2R and F(KW)2K are considered new antimicrobial alternatives to address the antimicrobial-resistance crisis.', 35311294),
('Black Soldier Fly ( Hermetia Illucens) : Hill-Cec1 and Hill-Cec10', 'Hill-Cec1 and Hill-Cec10 also showed high activity against other bacterial species, including Klebsiella pneumoniae and multi-drug resistant P. aeruginosa. Both AMPs are bactericidal and have a rapid onset of action with membrane-permeabilizing effects.', 'Hill-Cec1 and Hill-Cec10 were also able to prevent P. aeruginosa biofilm formation, but no relevant effect was seen on biofilm eradication.', 'Overall, Hill-Cec1 and Hill-Cec10 are promising leads for new antimicrobial development to treat critical infections caused by Gram-negative pathogens such as P. aeruginosa.', 34985302),
('Cathelicidin-Mimetic Antimicrobial Peptoids', 'These peptoids also show efficient and fast (<30 min) killing of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) at low micromolar concentrations without having apparent cytotoxic side effects in vivo. One cationic 12mer, Peptoid 1, shows great promise, as it could prevent formation of and detach biofilms at concentrations as low as 1.6 ?M.', 'The use of a bioluminescent S. aureus murine incision wound model demonstrated clearance of infection in peptoid-treated mice within 8 days, conveying another advantage these peptoids have over conventional antibiotics.', 'These results provide clear evidence of the potential for antimicrobial peptoids for the treatment of S. aureus wound infections.', 35467395),
('cell adhesion peptide (CAPs) nanocoatings', 'The two leading nanocoatings upregulated integrin-mediated hemidesmosomes, selectively increased keratinocyte proliferation compared to fibroblasts, which cannot form hemidesmosomes, and expression of junctional epithelium adhesive markers. CAP nanocoatings displayed marked durability under simulated clinical conditions and the top performer CAP nanocoating was validated in a percutaneous implant murine model. Basement membrane CAP nanocoatings, inspired by the tooth and junctional epithelium, may provide an alternative anti-infective strategy for percutaneous devices to mitigate the worldwide threat of antimicrobial resistance.', '', 'Application of cell adhesion peptide nanocoatings may provide an alternative to preventing, rather that necessarily treating, medical device infection across a range of device indications, like dental implants.', 34971784),
('Peptides ASU2056, ASU2060', 'Overall, six peptides inhibited the M. abscessus smooth morphotype (IC50 = 1.7 ?M for all peptides) and had reduced activity against the M. abscessus rough morphotype (IC50 range: 13-82 ?M). Peptides ASU2056 and ASU2060 had minimum inhibitory concentration values of 32 and 8 ?M, respectively, against the M. abscessus smooth morphotype. Additionally, ASU2060 (8 ?M) was active against Escherichia coli, including multidrug-resistant E. coli clinical isolates, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus. ASU2056 and ASU2060 exhibited no significant hemolytic activity at biologically relevant concentrations, further supporting these peptides as promising therapeutic candidates. Moreover, ASU2060 retained antibacterial activity after preincubation in human serum for 24 h.', '', 'With antimicrobial resistance on the rise, methods such as those presented here will streamline the peptide discovery process for targeted antimicrobial peptides.', 35847280),
('Purified arasin-likeSp', 'the ELP-intein self-cleavage system was used to produce antimicrobial peptide arasin-likeSp in Escherichia coli. The final yield of arasin-likeSp was about 3.56 mg/L. Purified arasin-likeSp exhibited significant antibacterial activities against the Gram-positive Bacillus subtilis and Gram-negative Vibrio harveyi bacteria.', '', 'Collectively, these data suggest that arasin-likeSp is a candidate AMP for effective inhibition of Vibrio harveyi, a significant bacterial pathogen infecting marine fish and invertebrates. The ELP-intein self-cleavage system described here is a low-cost, simple and potential method for producing antimicrobial peptides, which lays foundations for the large-scale production of antimicrobial peptides in the future.', 35240202),
('hepcidin gene from the fish, Catla catla (Cc-Hep)', 'Sequence analysis revealed that Cc-Hep shared sequence similarity with hepcidin from Sorsogona tuberculata. Sequence analysis revealed that Cc-Hep shared sequence similarity with hepcidin from Sorsogona tuberculata.', '', 'Conclusion: Functional characterization predicted antibacterial, antioxidant, and anticancer potential of Cc-Hep, which can be explored in aquaculture or human health care.', 35344090),
('d,l-K6L9 peptides', 'd,l-K6L9 peptides are stable and resistant to degradation by CF sputum proteases and maintain their activity in a CF sputum environment. Additionally, the d,l-K6L9 peptides do not induce bacterial resistance.', '', 'Overall, these findings should assist in the future development of alternative treatments against resistant bacterial biofilms.', 35759644),
('Lycosin-II isolated from spiders Lycosa singoriensis', 'Lycosin-II showed strong antibacterial activity and biofilm inhibition effects against gram-positive and gram-negative bacteria including oxacillin-resistant Staphylococcus aureus (S. aureus) and meropenem-resistant Pseudomonas aeruginosa (P. aeruginosa) isolated from patients.', 'Lycosin-II was not cytotoxic against human foreskin fibroblast Hs27 or hemolytic against sheep red blood cells at the concentration of which exerted antibacterial activity.', 'Moreover, Lycosin-II showed anti-inflammatory effects by inhibiting the expression of pro-inflammatory cytokines that are increased during bacterial infection in Hs27 cells. These results suggest that Lycosin-II can serve as a therapeutic agent against infections with multidrug-resistant strains.', 34506798),
('WLBU2 (also known as PLG0206)', 'Populations that survived WLBU2 treatment acquired a minimum of two mutations, making the acquisition of resistance more difficult than for most antibiotics, which can be tolerated by mutation of a single target. Major targets of resistance to WLBU2 included the orfN and pmrB genes, previously described to confer resistance to other cationic peptides. More surprisingly, mutations that increase aggregation such as the wsp pathway were also selected despite the ability of WLBU2 to kill cells growing in a biofilm.', '', 'Conclusions and implications: The results show how experimental evolution and WGS can identify genetic targets and actions of new antimicrobial compounds and predict pathways to resistance of new antibiotics in clinical practice.', 35712084),
('insect metallopeptidase inhibitor (IMPI)', 'designed a cohort of 12 single and multiple point mutants, the best of which (I57F) inhibited aureolysin with an estimated inhibition constant (K i) of 346 nM.', '', 'Given that animals lack thermolysins, our strategy may facilitate the development of safe TPs against staphylococcal infections, including strains resistant to conventional antibiotics.', 35465156),
('LcC CL28-25 (Larimichthys crocea), Derived from Piscine Chemokine', 'lcCCL28-25 was capable of rapidly destroying the integrity and permeability of the bacterial cell membrane', '', 'Additionally, the efficacy of lcCCL28-25 in in vivo antibacterial activity in a mammalian model revealed that this compound could be a promising agent for the development of peptide-based antibacterial therapeutics. The novel peptide lcCCL28-25 may prove to be an effective antibacterial agent.', 35616397),
('anti-inhA peptide nucleic acids (PNAs)', 'The antibacterial efficacy of anti-inhA PNA is enhanced when it is combined with permeabilizing drugs, particularly ethambutol. This indicates that the addition of even small concentrations of anti-inhA PNA to the current TB regimen could potentiate their therapeutic efficiency. We hypothesize that this system would also overcome isoniazid resistance, since the resistance mutations lie outside the designed anti-inhA PNA target site.', '', 'We therefore propose that anti-inhA PNA could improve therapy even when applied in minute doses as an addition to the current anti-tuberculosis drug regimen.', 35171048),
('pH-responsive antimicrobial peptides (F5: FLEHLIPHVIHGLVHAIHH-NH2)', 'efficient bacterial killing activity at pH 6.5 and inactivity at pH 7.4. Among the peptides, F5 exhibited outstanding pH-responsive antimicrobial activity and low toxicity. Fluorescence spectroscopy and electron microscopy illustrated that F5 killed bacteria via a membrane-disruptive mechanism at acidic pH values.', 'Mouse cutaneous abscesses revealed that F5 was equipped with excellent therapeutic ability to reduce the bacterial load and cytokines without causing skin toxicity.', 'In summary, this study reveals a strategy for selectively killing bacteria under the pathologic conditions of abscess sites while avoiding the elimination of commensal bacteria under normal physiological pH levels.', 35294199),
('BF15-a1 (lysine-stapled CAMPs)', 'CAMPs with a better amphiphilic structure were inclined to exhibit improved antimicrobial activity, protease stability, and biocompatibility after lysine-stapling. One of the stapled analogues of BF15-a1 was found to have extended half-life in plasma, enhanced antimicrobial activity against clinically isolated MDR ESKAPE pathogens, and remained highly effective in combating MRSA infection in a mouse model.', '', 'Cationic antimicrobial peptides (CAMPs) are promising for treatment of multidrug-resistant (MDR) bacteria-caused infections.', 34968054),
('ZN-5 and ZN-6 (Oreoch-2 analogues)', 'were identified to be broad-spectrum effective analogues, which were superior to their parent peptide Oreoch-2. good stability to the physiological environment, and much higher selectivity to bacterial cells than to mammalian cells. Were typical bactericidal agents and quickly eliminated bacteria in a bactericidal mode by disrupting bacterial cell membrane. Moreover, ZN-5 and ZN-6 could inhibit biofilm formation of Staphylococcus aureus ATCC25923.', 'Compared with their parent peptide Oreoch-2, ZN-5 and ZN-6 not only possessed shortened peptide chains, but also showed slightly improved antibacterial activity and greatly reduced hemolysis.', 'This indicates that they are ideal lead compounds of antimicrobial peptides, which can be developed as substitutes for traditional antibiotics.', 34971943),
('human ApoB-derived antimicrobial peptide r(P)ApoBLAla in combination with low concentrations of conventional antibiotics', 'to treat ureteral catheter-colonizing bacterial communities on clinically isolated bacteria', '', 'The results suggest that combinations of conventional antibiotics and human antimicrobial peptides might synergistically counteract biofilm growth on ureteral catheters, suggesting novel avenues for preventing catheter-associated infections in patients who have undergone radical cystectomy and ureterocutaneostomy.', 35743833),
('P-MtrE1', 'Cotreatment of bacteria with subinhibitory concentrations of the peptide led to 2- to 64-fold increases in susceptibility to erythromycin, azithromycin, ciprofloxacin, and/or ceftriaxone in N. gonorrhoeae strains FA1090, WHO K, WHO P, and WHO X. The cotreatment experiments with peptides P-MtrC1 and P-MtrE1 resulted in increased susceptibilities of WHO P and WHO X to azithromycin, ciprofloxacin, and ceftriaxone that were of the same magnitude seen in MtrCDE mutants.', '', 'Data presented here demonstrate that these peptides may be developed for use as a dual treatment with existing antibiotics to treat multidrug-resistant gonococcal infections.', 34633841),
('caposomes', 'capsosomes selectively deliver their cargo in the presence of bacteria, producing a bactericidal effect to protect the host organism', '', 'Thus, the capsosomes serve as a versatile multidrug, subcompartmentalized microparticle system for preventing antibiotic-resistant bacterial infections, with potential applications to protect wounds or medical device implants from infections.', 35481905),
('DCD-1L', 'The bacterial adhesion and biofilm formation in all A. baumannii isolates were inhibited at 2 ? , 4 ? , and 8 ? MIC of DCD-1L, while only 8 ? MIC of DCD-1L was able to destroy the pre-formed biofilm in vitro.', '', 'Results of this study demonstrated that DCD-1L can inhibit bacterial attachment and biofilm formation and prevent the onset of infection. Taking these properties together, DCD-1L appears as a promising candidate for antimicrobial and anti-biofilm drug development.', 35026999),
('RWWWR (central motif) plus arginine (R) end-tagging', 'great potential in combating Escherichia coli bacteremia and the Staphylococcus aureus skin burn infection model, which induces a 62-90% reduction in bacterial burden, Pep 6 exhibited robust biofilm-inhibiting activity and eliminated 61.33% of the mature methicillin-resistant Staphylococcus aureus (MRSA) biofilm', '', 'These results suggest that the RWWWR motif and binding of arginine end-tagging could be harnessed as a new agent for combating multidrug-resistant bacteria.', 34964342),
('R23F, R23DI, and R23EI hybrid peptides', 'against Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Pseudomonas aeruginosa, Escherichia coli, and Bacillus cereus', '', 'R23F, R23DI, and R23EI can be used as antimicrobial peptides against Gram-positive and Gram-negative bacteria resistant to traditional antibiotics.', 35008951),
('Temporin-1CEc analogs 2K2L and 2K4L', 'against sensitive and multidrug-resistant bacteria, effectively killing the tested multidrug resistant strain Staphylococcus epidermidis (MRSE1208), inhibited the formation of MRSE1208 biofilms at concentrations below its MIC value', '', 'Collectively, these results suggest that 2K2L and 2K4L could be effective antibiotics against multidrug-resistant bacterial strains.', 34953322),
('PEP-38 and PEP-137 peptides', 'active in vitro against carbapenem-resistant isolates of Klebsiella aerogenes and K. pneumoniae. PEP-137 was also active against Pseudomonas aeruginosa.', '', 'The data obtained can be used to develop new antibacterial peptide drugs to combat antibiotic resistance.', 35326874),
('VicBac (Proline-Rich Cathelicidin from the Alpaca Vicugna pacos)', 'Potency to Combat Antibiotic-Resistant Bacteria', '', 'The pronounced antibacterial activity of VicBac, along with its moderate adverse effects on mammalian cells, make this molecule a promising scaffold for the development of peptide antibiotics.', 35629841),
('NZX and P2, fungal defensin-derived peptides', 'MIC values (NZX: 0.11 MicroM, P2: 0.91 MicroM) and MPC (NZX: 1.82 MicroM) against Streptococcus agalactiae', '', 'Conclusion: NZX and P2 are promising antimicrobial agents for streptococcicosis treatment.', 35630326),
('WAM-1', 'MICs of 2-4 mg/L and MBCs of 4-8 mg/L against carbapenem-resistant Klebsiella pneumoniae', '', 'Conclusions: WAM-1 has good antibacterial effect and potential anti-inflammatory effect on infection caused by CRKP.', 35474013),
('RP557 alone or in combination with several clinically effective antibiotics, including clarithromycin, amikacin, cefoxitin and imipenem', 'increases the antibiotic sensitivity of Mycobacterium abscessus by inhibiting biofilm formation', '', 'As such, RP557 is a potential candidate to include in novel strategies to treat M. abscessus infections.', 34813807),
('hyaluronic-acid-based hydrogel', 'The peptidomimetic was found to exhibit antimicrobial and anti-biofilm properties at concentration values ranging from 2.5 to 20 ?mol L-1, to be biocompatible toward human skin cell lines, and to protect human keratinocytes from bacterial infections being able to induce a reduction of bacterial units by two or even four orders of magnitude with respect to untreated samples.', '', 'The developed hydrogel-based system represents a promising, effective therapeutic option by combining the mechanical properties of the hyaluronic acid polymer with the anti-infective activity of the antimicrobial peptidomimetic, thus opening novel perspectives in the treatment of skin infections.', 35740323),
('CHRG01, KSR, and KLR', 'active against gram positive as well as gram negative bacteria and kill bacteria by forming membrane pores', '', 'Understanding the molecular level interaction of individual amino acids with the lipid bilayer will greatly help in the design of more efficient antimicrobial peptides.', 34838874),
('guanidinium-functionalized poly(l-lysine) (PLL22 -Gua)', 'kills MRSA with low resistance frequency (<3.3 ? 10-8 ). In an MRSA-caused wound infection mouse model, two-day treatment (twice daily) with 10, 20, or 40 mg per kg of PLL22 -Gua shows up to 99.5% bacterial removal.', '', 'These promising results show the excellent potential of PLL22 -Gua as an antimicrobial agent against multidrug-resistant infection in vivo.', 34846807),
('peptidomimetic antibiotic 10 (human alpha-defensin 5)', 'potent killing of multiple drug-resistant gram-negative bacteria isolated from patients', '', 'By engaging multiple bacterial targets, the lead compound is efficacious in vitro and in vivo against bacteria with highly inducible antibiotic resistance, promising a useful therapeutic agent for the treatment of infections caused by antibiotic-resistant bacteria.', 35238683),
('Anisaxins', 'potent bactericidal agents in vitro, selectively active against Gram-negative bacteria, including multi-drug resistant strains, at sub-micromolar concentrations', '', 'This membranolytic antibacterial activity does not translate to cytotoxicity towards human peripheral blood mononuclear cells (HPBMCs), which was minimal at well above bactericidal concentrations, making anisaxins promising candidates for further drug development.', 35470073),
('Epinecidin-1 and Beta-Defesin-3', 'showed antibacterial activity in vitro in a concentration of 2 to 32 mg/L', '', 'For K. pneumoniae-sepsis, hBD-3 was shown to be a promising option in overcoming the resistance of Klebsiella spp. to carbapenems, though more research is needed. In the P. aeruginosa-sepsis model, the addition of Epi-1 to hBD-3 was found to have a slightly reduced mortality rate compared to hBD-3 monotherapy.', 35052952),
('Alpha-MSH (melanocyte stimulating hormone) based cationic peptides', 'most cationic analogue, KKK-MSH with a + 5 charge, demonstrated successful eradication of 105 CFU/mL of E. coli cells within 15 min at a concentration as low as 1 MicroM', '', 'Here, we propose ?-MSH based cationic peptides as promising future agents with broad-spectrum antibacterial efficacy against both Gram-negative and Gram-positive pathogens.', 35132082),
('Nigrocin-PN (Pelophylax nigromaculatus)', 'Nigrocin-PN and ampicillin could delay Staphylococcus aureus antibiotic resistance acquisition', '', 'Conclusions: A broad-spectrum antimicrobial peptide Nigrocin-PN was discovered from the skin secretion of Pelophylax nigromaculatus. Structurally, "Rana box" played a crucial role in reducing toxicities without compromising antibacterial abilities, and Nigrocin-PN could be a desired therapeutic candidate.', 35606468),
('GHaR6R, GHaR7R, GHaR8R and GHaR9W', 'show potent antimicrobial activities against methicillin-resistant (MRSA)', 'GHaR6R, GHaR8R and GHaR9W show less toxicity toward normal cells HL-7702 and hFOB1.19.', 'These results suggest that the GHa-derived peptides may be promising antimicrobial candidates against MRSA infections.', 35538042),
('combination of hydrocarbon stapled to L8 (KRIVQRIKKWLR) and L6 (RRLFRRILRWL) peptides and antibiotics (Vancomycin)', 'different hydrocarbon staples to two previously described peptides shown to act on the outer membrane, L6 and L8, and tested their activity in a zebrafish embryo infection model using a clinical isolate of Acinetobacter baumannii as a pathogen improves its in vivo potentiating activity on antibiotic treatment, without increasing its in vivo antimicrobial activity, toxicity or hemolytic activity', '', 'We show here that combinations of stapled peptide L8S1 and vancomycin may provide an attractive novel therapeutic strategy against nosocomial A. baumannii infection.', 35203875),
('lichenicidin', 'presence of the two mature peptides, Bli? and Bli?, is necessary for full activity against target bacteria, both peptides exhibit synergistic activity in their interaction with the target membranes', '', 'Based on this information, we propose a mechanism of action of lichenicidin.', 34973602),
('"Picturins" (PTR) and "Pictuseptins" (PTS)', 'PTR displayed moderate activity against Escherichia coli (MIC 24.80 to 48.95 MicroM), while PTS showed a broad antimicrobial and antifungal effect. PTS-1 was the most active peptide against E. coli (6.8 microM) followed by PTS-3 (11.7 MicroM) and PTS-2 (14.24 MicroM).', '', 'Overall, new unique non-hemolytic and cationic peptide sequences were characterized that could be valuable for the next-generation of anti-infective drugs. Future functional studies should explore the pharmacological potential of Boanins to include them as antimicrobial scaffolds.', 35640793),
('Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin', 'against Cystic Fibrosis Pseudomonas aeruginosa', '', 'Our findings demonstrate that glatiramer acetate is a strong candidate for repurposing as an antibiotic resistance breaker of pathogenic P. aeruginosa.', 35727066),
('h-Lf1-11, MSI-78, LL-37 and magainin-2', 'against Escherichia coli, methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, carbapenem-resistant Klebsiella pneumoniae, and Acinetobacter baumannii. The MSI-78 showed potent bactericidal activity with MIC range of 1.25-40 mg/L against all bacterial strains. The h-Lf1-11, magainin-2, and LL-37 exhibited moderate activity (MIC range of 40-160, 80-160, and 40-160 mg/L, respectively)', '', 'These results revealed that MSI-78, h-Lf1-11, magainin-2, and LL-37 have great potential as antibacterial agents and their activity deserves to be more explored in further studies for the treatment of antibiotic-resistant bacteria.', 34735710),
('temporin B and temporin L with the addition of buforin II, a histone H2A fragment', 'less potent temporin B enhances the cooperativity of the in vitro antibacterial activity of the more potent temporin L against EMRSA-15 and that this may be associated with an altered interaction with the bacterial plasma membrane, a feature critical for the antibacterial activity of most AMPs. Addition of buforin II, a histone H2A fragment, can further increase the cooperativity.', '', 'Exploration of the mechanism of synergy between AMPs isolated from the same organism may therefore yield antibiotic combinations with advantageous pharmacodynamic properties.', 35609188),
('amyloid-? inspired biocompatible short peptide amphiphile (sPA) molecule-AgNPs', 'potential therapeutic value for the treatment of microbiota triggered progression of neurodegenerative diseases', '', 'Such sPA-AgNPs hybrid structures can be further used to develop antibacterial materials to combat emerging bacterial resistance.', 35684988),
('brevinin-2KP', 'weakly active towards the tested Gram-positive and Gram-negative bacteria as well as fungi due to its membranolytic action', 'brevinin-2KP inhibits the proliferation of several mammal cells with IC50 values ranging from 3.27 to 59.75 ?M', 'Conclusion: This is the first report on AMP identified from the skin of K. pulchra. Brevinin-2KP adopts a typical amphipathic ?-helix conformation in membrane mimic environment and shows antimicrobial and antitumor activities by potential membranolytic mechanism. In addition, brevinin-2KP can promote degranulation and histamine release of mast cells. Brevinin-2KP is expected to become a good drug temple molecule.', 35249479),
('L-Chg10-Teixobactin', 'The MIC and MBC values of L-Chg10-teixobactin against both strains of Enterococcus faecalis were 0.8 Microg/mL.', '', 'Conclusions:L-Chg10-teixobactin demonstrated potent antibacterial and antibiofilm effects against E. faecalis, suggesting its potential role an effective antibacterial and antibiofilm agent in endodontic treatment.', 35744616),
('r(P)ApoBLPro, r(P)ApoBSPro, and r(P)ApoBLAla derived from the human apolipoprotein B (residues 887-922)', 'exhibited potent antimicrobial activity against drug-resistant Klebsiella pneumoniae, Acinetobacter baumannii, and Staphylococci both in vitro and in an animal model', '', 'Our results provide a link between human plasma and innate immunity and point to the blood as a source of much-needed antimicrobials.', 35112568),
('Star-Peptide Polymers', 'preferentially target and kill Gram-positive pathogens including MRSA', '', 'These results highlight the potential utility of peptide/polymers to fabricate materials for therapeutic development against MDR Gram-positive bacterial infections.', 35500245),
('Human Cryptic Host Defence Peptide GVF27', 'Exhibits Anti-Infective Properties against Biofilm Forming Members of the Burkholderia multivorans and Burkholderia cenocepacia', '', 'Overall, all these findings contribute to the elucidation of the main features that a good therapeutic agent directed against these extremely leathery biofilm-forming bacteria should possess.', 35215373),
('Liposome-Encapsulated Tobramycin and IDR-1018 Peptide', 'Biofilm Disruption and Enhanced Antimicrobial Activity against Pseudomonas aeruginosa, the biofilm formation was significantly reduced (p &lt; 0.05) at concentrations of ?4 Microg/mL and ?32 Microg/mL for PA01 and ?32 Microg/mL for MDR 7067 when loading tobramycin into liposomes, with or without the anti-biofilm peptide compared to the free antibiotic, empty liposomes, and IDR-1018-loaded liposomes', '', 'Tobramycin-loaded liposomes could be a potential candidate for treating lung-infected animal models owing to the high therapeutic efficacy and safety profile of this system compared to the free administration of the antibiotic.', 35631547),
('cholic acid analogues 17c and 17d', 'analogues containing lysine-like residues showed the highest antibacterial potency against Gram-positive S. aureus. All di-substituted analogues possess high antimicrobial activity against both Gram-positive S. aureus as well as Gram-negative E. coli and P. aeruginosa.', '', 'These compounds were able to depolarise the bacterial membrane, suggesting that they are potential antimicrobial pore forming agents.', 35563014),
('Mucosal pentraxin 2 (Mptx2)', 'against peritoneal infection by methicillin-resistant staphylococcus aureus', '', 'Mptx2 has bactericidal activity against MRSA both in vitro and in vivo, which may shed light on the discovery and development of novel strategies for MRSA-infected peritonitis.', 35609377),
('symbah-1', 'macrocyclic ?-hairpin peptide antibiotic', '', 'The method of discovery and subsequent characterization of symbah-1 suggests large synthetic peptide libraries bias toward macrocyclic ?-hairpin structure could be designed and screened to rapidly expand and better understand this rare peptide antibiotic class.', 35005555),
('isolate (WUL10) in the Brevibacillus genus', 'MIC of the purified substance was 1 ?g/mL against S. aureus TISTR 517 and MRSA strains. This substance showed the bactericidal effect at the concentration of 1-2 Microg/mL against these bacterial indicators.', '', 'This novel AMP would provide an advantage for further development of anti-MRSA substances to manage the situation of antibiotic resistance.', 35736972),
('(SAAP)-148 and Halicin', 'equally effective against antimicrobial-resistant (AMR) Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus bacteria residing in immature and mature biofilms', '', 'Together, combinations of these two novel antimicrobial agents hold promise as an innovative treatment for infections not effectively treatable with current antibiotics.', 35625317),
('Chicken cathelicidins CATH-1(RVKRVWPLVIRTVIAGYNLYAIKKK,), CATH-3(RVKRFWPLVPVAINTVAAGINLYKAIRRK, ) and porcine; PMAP-36(GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG) in combination with conventional antibiotics containing ampicillin tetracycline, gentamicin, and erythromycin', 'FBCIs of only CATH-1 + tetracycline were higher than 0.5 against S. aureus, FBCIs of other combinations (CATH-1,?3 and PMAP-36 with ampicillin, tetracycline, gentamicin, and erythromycin) were lower 0.5. FBCIs of CATH-1,?3 and PMAP-36 combination with erythromycin were lower 0.5 against S. enteritidis and E. coli . FBCIs of other combinations (CATH-1,?3 and PMAP-36 with ampicillin, tetracycline, and gentamicin) were higher than 0.5 or even higher than 1.0 against S. enteritidis and E. coli.', 'mice erythrocytes and macrophages and PK-15 cells were used to determine hemolytic activity and cytotoxicity, respectively. The results showed that CATH-1,?3 and PMAP-36 alone at MBC showed low hemolysis (<20%), and erythromycin alone at MBC showed high hemolysis (>95%). However, AMPs (CATH-1,?3 and PMAP-36) combined with erythromycin at sub-MBC showed lower hemolytic activity (<3%)', 'Hence result show that the combination of CATH-1 and erythromycin has synergistic antibacterial activity and reduces the emergence of bacterial drug resistance.', 35910608),
('TAT-RasGAP317-326 peptide with antibiotics', 'synergistic combinations towards all three bacteria and demonstrated that these combinations had an increased bactericidal effect compared to individual drugs.', '', 'combination of TAT-RasGAP317-326 and meropenem had a promising antibiofilm effect towards A. baumannii.', 36270448),
('The antimicrobial peptide GL13K was derived from the salivary protein BPIFA2.', 'Klebsiella pneumoniae (MICs 16-32 microgram/ml) and Acinetobacter baumannii (MICs 8-32 microgram/ml).', '', 'DGL13K displayed in vitro activity against extended-spectrum beta-lactamase (ESBL)-producing and Klebsiella pneumoniae carbapenemase, P. aeruginosa and Acinetobacter baumannii carrying metallo-beta-lactamases. P. aeruginosa showed low inherent resistance to DGL13K', 36006947),
('Antimicrobial Peptides SAAP-148 and OP-145', 'The concentration of the peptides necessary to kill 99.9% of E. coli and E. hirae cells within 5 min of incubation period was found to be 1.6 ?M and 0.4 ?M for SAAP-148 and 6.4 ?M versus 3.2 ?M for OP-145 when tested in NaPi buffer for 1 ? 106 CFU/mL bacteria', 'The 99.9% lethal concentration (LC99.9%) implies antimicrobial activity and constitutes the lowest peptide concentration that killed ?99.9% of bacteria', 'these peptides immediately bind to negatively charged components and neutralize the surface of Gram-negative bacteria. Then, they insert into the fatty acyl chain region of the outer membrane, inducing higher outer membrane permeability. The increased membrane permeability for small ions will be sufficient to result in cell death.', 36139091),
('Novel antimicrobial peptide Intestinalin (P30), which is derived from the LysC enzyme of Clostridium intestinale strain URNW', 'Intestinalin showed MIC values ranging from 7.8 to >124 ?M. The highest MICs (> 124 ?M) were observed for S. aureus KPD 740, S. aureus KPD 425, E. cloacae KPD 297, E. coli KPD 217, and K. pneumoniae KPD 298. The lowest MICs (7.8 ?M) were against three of four A. baumannii strains tested, as well as for S. hominis KPD 910 and S. pettenkoferi KPD 741.', 'The results showed that Intestinalin was not toxic to HaCaT cells at concentrations up to 100 ?M', 'Experimental data showed that Intestinalin interacts with negatively charged lipoteichoic acid (logK based on isothermal titration calorimetry, 7.45 ? 0.44), causes membrane depolarization, and affects membrane integrity by forming large pores, all of which result in loss of bacterial viability', 36094301),
('AMP human ?-defensin-2 (HBD-2)', 'the data showed an almost total reduction in the invasive ability of EIEC in transfected cells (> 99%). Enteroinvasive E. coli (EIEC) that is responsible for the bacillary dysentery that causes severe diarrheal symptoms in both children and adults.', '', 'The results showed that HBD-2 is able to significantly reduce the expression of the proinflammatory cytokines by intestinal epithelial cells, the invasiveness ability of enteroinvasive E. coli (EIEC) and the expression of invasion-associated genes.', 36310877),
('Phage Lysin-Derived Peptide P87', 'The MIC values for P88 (20?50 ?M) seem coherent with previously reported MICs of lysin-derived AMPs,', 'One of the drawbacks usually adduced for the therapeutic application of AMPs is their possible cytotoxic effect against eukaryotic cells.', 'A peptide, P87 from phage lysin Pae87 has been tested as a source for efficient, alternative antimicrobials. To improve its antimicrobial efficacy, a derivative peptide, termed P88, with increased hydrophobic moment and net charge has been designed and proven to possess an enhanced bactericidal and antibiofilm activity.', 36290106),
('new lipopeptide-like pentamer, decanoyl-bis.diaminobutyrate-aminododecanoyl-diaminobutyrate-amide (C10BBc12B)', 'minimal inhibitory concentrations (MIC ? 50 ?M) against E.coli, P. aeroginosa, K. pneumoniae, A. baumanni', 'no cytotoxicity towards cell-lines was observed at-least up to 50 ?M.', 'action mechanism implicating the pentamer''s de-facto capacity to hijack bacterial efflux pumps for boosting its adjuvant activity through repetitive steps including outer-membrane adhesion, translocation and subsequent expulsion.', 36271103),
('two peptides LP-23 and SA4, as well as their mimetic peptoids DP-23 and SPO were selected. Synergistic effects of short peptides and antibiotics', 'Based on the fraction inhibitory concentration: FICI ? 0.5 synergistic value , LP-23, DP-23, and SPO demonstrated synergy in combination with gentamicin against a gentamicin-resistant clinical isolate of Escherichia coli. For Staphylococcus aureus, Escherichia coli, and Salmonella typhimurium, seven combinations exhibited synergistic effects between peptide/peptoids and the tested antibiotics.', 'These peptides were also evaluated for its cytotoxicity against human embryonic normal kidney cells (HEK 293) and pancreatic cancer cells (MIA PaCa-2) using MTT assay. The average cell survival rate for all peptides in HEK cells was 90% at 100 ?g ml?1 and 68% at 500 ?g ml?1. In MIA PaCa-2, about 15% cells was compromised at high concentration of 500 ?g ml?1', 'Synergy obtained between LP-23, SA4 and their mimetic peptoids DP-23 and SPO with antibiotics have the potential to be used as a combination therapy against microbial infections. These combinations may be helpful in lowering the drug dose and creating better results, which can be applied in future against various MDR strains.', 35931657),
('pentapeptide-4" (PP4, with amino acid sequence KTTKS)', 'peptide effective against Gram-positive (S. aureus, Enterococcus faecalis) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa) bacteria.', '', 'These constructs have potent wide-spectrum antimicrobial action, including against multidrug-resistant Gram-positive and Gram-negative bacteria, and fungi.', 35950860),
('Novel Alligator Cathelicidin As-CATH8', 'MIC of As-CATH8 for S. aureus (0.5 ?M) and A. baumannii (0.25 ?M) respectively. As-CATH8 demonstrated strong antibacterial effects in a murine abscess model of high-density bacterial infections against clinical isolates of S. aureus and Acinetobacter baumannii,', 'As-CATH8 were moderately cytotoxic against human bronchial epithelial (HBE) cells and peripheral blood mononuclear cells', 'Result declare that As-CATH8 peptide, which has substantial therapeutic promise for treatment of S. aureus and A. baumannii skin infections, two of the most prevalent bacterial species causing SSTIs worldwide.', 36421248),
('designed the (WRX)n hydrophobic tryptophan (W) residues and hydrophilic charged arginine (R) (where X = hydrophilic uncharged amino residues; n = number of repeat units) series engineered peptides with high cell selectivity by introducing hydrophilic uncharged threonine (T), serine (S), glutamine (Q) or asparagine (N) residues into the minimalist design of W- and R-rich AMPs.', 'T6 exhibited potent antibacterial and antiinflammatory capabilities in vivo in a mouse peritonitis-sepsis model infected with Escherichia coli.', '', 'The results showed that the introduction of these hydrophilic uncharged amino residues, especially T residues, significantly improved the cell selectivity of the W- and R-rich engineered peptides. It has potent antibacterial activity, good biocompatibility, high selectivity index, strong tolerance, rapid and efficient time-kill kinetics, and no tendency of resistance. Studies on antibacterial mechanism show that T6 exert antibacterial activity mainly by disrupting bacterial cell membrane and inducing the accumulation of reactive oxygen species in bacterial cells.', 36115654),
('two designed, cationic antimicrobial-derived peptides: Mt6, and its dextroisomer D-Mt6, belonging to the analogs of MAF-1, which is isolated from the instar larvae of houseflies.', 'Mt6 and D-Mt6 showed different degrees of inhibitory activity against Gram-positive bacteria (S. aureus and B. subtilis) and Gram-negative bacteria (E. coli, K. pneumoniae, P. aeruginosa, A. baumannii).', '', 'Both Mt6 and D-Mt6 showed broad-spectrum antimicrobial activity, especially against A. baumannii, by damaging membrane integrity. Moreover, D-Mt6 showed better immunoregulatory activity against LPS induced inflammation through its LPS-neutralizing and suppression on MAPK signaling. This study suggested that D-Mt6 is a promising candidate drug as a derived peptide against A. baumannii.', 36190276),
('rhamnolipid and linezolid', 'Four S.aureus (One ATCC 29213 strain and three methicillin-resistant strains) were used in the study. The minimum inhibitory concentration of the resistant strain decreased from 16 to 4 ?g/mL with a four-fold decrease.', '', 'The G.mellonella larval model demonstrated that combined therapy was more effective than monotherapy by survival function tests and CFU determination. RML/LNZ combination improved survival compared to monotherapy and decreased the bacterial burden.', 36526037),
('antimicrobial peptides (AMPs)', 'Anti-microbial Peptides against Methicillin-resistant Staphylococcus aureus', '', 'Anti-microbial peptides could be the next-generation solution to combat drug resistance among Superbugs. New approaches like antimicrobial peptides (AMPs) play a vital role and are more efficacious, economical, time, and energy saviours.', 36529917),
('Innate defense regulator (IDR) peptides', 'he minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of KSL Peptide for C. albicans was determined at the level of 0.78 ?g/mL. he MIC of KSL for Staphylococcus aureus and Pseudomonas aeruginosa was 0.78 ?g/mL and 1.56 ?g/mL, respectively. Bac2A peptide derivative show MICs between 2 and 32 ?g/mL for Gram-negative bacteria, and between 0.25 and 16 ?g/mL for Gram-positive bacteria. other peptide drive fro naturally occurring molecules as cNK-2, Clavanin-MO, Ac-ApoE, KSLW, SET-M33, GW-A2, AWRK6', '', 'Many studies have shown that the activity of AMPs is mostly associated with bacterial membrane destabilization. However, their activity expressed as MIC is often much lower than that of conventional antibiotics', 36009931),
('novel strategy that combines the human antimicrobial peptide (AMP) LL37 with different antibiotics( vancomycin, azithromycin, polymyxin B, and colistin)', 'For PA103, the MIC of polymyxin B, colistin, and gentamicin decreased twofold to fourfold, but the MIC of vancomycin and azithromycin was still >512 ?g/ml, which was the highest concentration tested. The antibacterial inhibitive effects of Ca2+ and Mg2+ ions were also observed for colistin; our preliminary data showed that the MIC of colistin is 0.5 ?g/ml when PAO1 was cultured in the MHB medium, but it increased to 1 ?g/ml in a cation-adjusted MHB medium.', '', 'Zeta potentials for P. aeruginosa strains PAO1 and PA103 were -40.9 and -10.9 mV, respectively. With the addition of LL37, negative zeta potentials were gradually neutralized. this process of neutralization is believed to have contributed to the increase in outer membrane permeability help to uptake of antibiotics. LL37-vancomycin combination showed a synergistic inhibitory effect to PAO1, as well as a synergistic bactericidal effect to both PAO1 and PA103. Vancomycin can target lipid II, which is embedded in the inner membrane and is also an important molecule needed for the synthesis of the bacterial cell wall', 35922283);
INSERT INTO `table 31` (`COL 1`, `COL 2`, `COL 3`, `COL 4`, `COL 5`) VALUES
('Antimicrobial peptide named P4 with sequence RTKLWEMLVELGNMDKAVKLWRKLKR that was constructed from influenza virus protein M1 and containing two cholesterol-recognizing amino-acid consensus (CRAC) motifs.', 'peptide P4 inhibits the growth of E. coli and B. subtilis strains at concentrations that are significantly lower than the cytotoxic concentration that was found for macrophages. The half-maximal inhibitory concentration (IC50) for B. subtilis and E. coli cells were 0.07 ? 0.01 ?M and 1.9 ? 0.4 ?M, respectively.', '', 'the toxic action of peptide P4 is based on membrane permeabilization through the interaction of the peptide cationic domain and anionic lipids of the bacterial membrane. They report antimicrobial activity of the peptide P4 against the representatives of Gram-positive (B. subtilis) and Gram-negative (E. coli) bacteria.', 36013956),
('Synthetic antimicrobial peptide', 'This 6 peptides (ASU2001, ASU2009, ASU2019, ASU2056, ASU2059, and ASU2060) inhibited the M. abscessus smooth morphotype (IC50 = 1.7 ?M for all peptides) and had reduced activity against the M. abscessus rough morphotype (IC50 range: 13-82 ?M). Peptides ASU2056 and ASU2060 had minimum inhibitory concentration values of 32 and 8 ?M, respectively, against the M. abscessus smooth morphotype. Additionally, ASU2060 (8 ?M) was active against Escherichia coli, including multidrug-resistant E. coli clinical isolates, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus.', 'The two most potent peptides, ASU2056 and ASU2060, were tested for red blood cell toxicity and neither exhibited significant hRBC hemolytic activity even after prolonged incubation (18 h). ASU2060 was tested for serum stability and retained antibacterial activity after preincubation in human serum for 24 h.', 'The peptides (ASU2001, ASU2009, ASU2019, ASU2056, ASU2059, and ASU2060) were further screened against both Mabs smooth and rough morphotypes to determine the impact of cell wall glycopeptidolipids (GPLs) on activity. All six peptides displayed increased activity against the Mabs smooth morphotype, suggesting that interactions with cell wall GPLs are important for antibacterial activity. Additionally, all peptides exhibited increased inhibition in the presence of EDTA, further suggesting that sequestering divalent metal cations enhances peptide interactions with Mabs.', 35847280),
('Temporins modeified version of brevinin-1GHa (BR-1GHa) from frog skin peptide', 'BR-1GHa-3, in which two alanine residues in the truncated version of BR-1GHa were replaced with leucine, exhibited significantly improved antimicrobial activity against Gram-positive bacterial strains (e.g., S. aureus ATCC 29213 and E. casseliflavus ATCC 700327) with lower hemolytic activity compared to the BR-1GHa peptide. BR-1GHa-4 analogue, in which Gly3 was replaced with Pro, did not show any hemolytic activity except for highest (128 ?M) concentration tested and have a strong antimicrobial effect on Gram-positive bacteria (e.g., E. faecalis ATCC 51299 and B. cereus ATCC 13061).', '', 'To enhance the antimicrobial activity of this peptide and to reduce its hemolytic activity, they designed five new temporin like analogues and examined their bioactivities. Temporins are another class of frog skin peptides without hemolytic activity and shorter than brevinins. This show antimicrobial activity', 35852614),
('designed PLP-3, a novel synthetic (protegrin-1 ) PG-1-like peptide', 'Antimicrobial activity screening showed MIC90 values of 2 mg/L for A. baumannii, 16 mg/L for K. pneumoniae and 8 mg/L for P. aeruginosa. The haemolysis IC50 value was 48.53 mg/L', 'Cytotoxicity against human HeLa and A549 cells showed values of ca. 200 mg/L in both cell lines resulting in a 100-fold selectivity window for bacterial over human cells.', 'PLP-3 has potent antimicrobial activity, especially against A. baumannii, while maintaining low haemolysis and toxicity against human cell lines at antimicrobial concentrations. These characteristics make PLP-3 a promising peptide with an interesting therapeutic window.', 35972429),
('plantaricin A an antimicrobial peptide derived from Lactobacillus plantarum, had a synergistic effect with ciprofloxacin (CIP)', 'lantaricin A (PlnA), reducing the IC90 of CIP by eight times and kill Multidrug-resistant Staphylococcus aureus', 'which has low cytotoxicity and haemolysis and powerful inhibitory activity on efflux pumps.', 'The present study showed a new efflux pump inhibitors EPI (plantaricin A) produced by Lactobacillus plantarum, changes in membrane permeability, membrane potential, and reactive oxygen species (ROS) were determined. Therefore, it helps the design of new EPIs and controls the infection of multidrug-resistant Staphylococcus aureus', 36254863),
('Lugdunin (cyclic peptide-1), a nonribosomal cyclic peptide', 'cyclic peptide-1 and its analogues cyclic peptide-11 and cyclic peptide-14 have the ability to disperse mature Methicillin-resistant Staphylococcus aureus (MRSA) biofilms and show anti-clinical MRSA activity, including MRSA persister cells', 'these three cyclic peptide compounds have non-toxicity, lower hemolytic activity and lack of resistance development.', 'Our results indicate that cyclic peptide-1, cyclic peptide-11, and cyclic peptide-14 have great potential as new antimicrobial drug candidates for the treatment of clinical Methicillin-resistant Staphylococcus aureus (MRSA) infections.', 35887376),
('a series of Temporin-PE (T-PE) analogues were designed and synthesized by glutamic acid', '', 'E11K4K10 exhibited slight toxicity to the spleen with slight edema observed in the spleen, but its toxicity was less severe than that of polymyxin B.', 'E11K4K10, the optimized T-PE and the relatively safe AMP, could overcome drug resistance which was expected to be a new antimicrobial agent against clinical resistant bacteria.', 36148510),
('Nv-CATH peptide from the skin of the frog Nanorana ventripunctata', 'S. haemolyticus 13A13770 displayed the highest sensitivity to Nv-CATH (MIC = 3.125 ?g/mL), followed by S. aureus ATCC25923 and A. junii 13A15578 (MIC = 12.5 ?g/mL).', '100 ?g/mL Nv-CATH did not exhibit cytotoxicity toward mouse peritoneal macrophage (MPMs) and bone-marrow-derived neutrophils (BMDNs), and 300 ?g/mL Nv-CATH also had no hemolytic activity on rabbit erythrocytes.', 'Nv-CATH inhibited bacterial invasion of target organs via direct bactericidal ability. Nv-CATH selectively promoted CCL and CXCL chemokines? production, which modulated monocytes/macrophages? and neutrophils? trafficking to the infection site, and augmented immunocyte-mediated bacterial killing by modestly promoting neutrophil phagocytosis. Nv-CATH shows promise as a new antimicrobial agent, especially in the treatment of S. aureus infections', 36378028),
('human ?-defensin 130 (hBD130)', 'hBD130 demonstrated efficient antimicrobial activities, with MICs ranging from 10 to 45 ?g/mL. Of note, hBD130 exhibited significant growth inhibition effects against E. coli ATCC 25,922 (10 ?g/mL), ETEC BNCC 125,783 (10 ?g/mL), L. monocytogenes ATCC 221,633 (25 ?g/mL), and S. typhimurium ATCC 14,028 (15 ?g/mL). The MICs for hBD130 against gram-negative bacteria, including E. coli and S. typhimurium, were 10?15 ?g/mL, which were lower than those against gram-positive bacteria, including L. monocytogenes, B. subtilis and S. aureus.', 'hBD130 showed a low hemolytic effect and nearly no cytotoxicity to mammalian cells with a dosage of 400 ?g/Ml', 'bactericidal effect of hBD130 showed that hBD130 is a promising antimicrobial agent to treat foodborne bacterial infections and inflammation.', 35720462),
('develop chimeric peptides with dual cell-penetrating and antimicrobial functions by conjugating Cell-penetrating peptides with AMPs', '', '', 'AMPs are regarded as an ideal alternative to antibiotics due to their powerful antimicrobial potential, rapid killing effects, and low propensity to develop resistance. the combination of CPP and AMP gives it a dual function of cell penetration and antimicrobial activity, which may be a feasible method to treat intracellular infections.', 36503077),
('Three novel peptide families ?Picturins? (PTR), ?Pictuseptins? (PTS), and ?Boanins? (BNS). were identified from Boana picturata skin secretion.', 'PTR displayed moderate activity against Escherichia coli (MIC 24.80 to 48.95 ?M), TS-1 was the most active peptide against E. coli (6.8 ?M) followed by PTS-3 (11.7 ?M) and PTS-2 (14.24 ?M)', '', 'Hence, Frog skin peptides are excellent examples of the biomedical potential of naturally evolved molecules for specific targets, including multi-resistant bacteria.', 35640793),
('Peptide PN5 derived from Pinus densiflora (pine needle)', 'PN5 displayed antimicrobial activity against both Gram-negative and Gram-positive bacteria, with MICs of 2 to 16 ?M (2.65 to 21.22 ?g mL?1)', '', 'PN5 showed immunomodulatory properties of neutralizing LPS in a mouse septic model. These results indicate that PN5 could be a new and promising therapeutic agent for bacterial infectious disease caused by antibiotic-resistant strains.', 36129300),
('Antimicrobial peptide (AMP) IDR-1018 derived D-amino acids substitution peptides (D1018 and D1018M) were synthesized', 'MIC of IDR-1018, 1018M and D1018 against E. coli ATCC25922 was 8 ?g/ mL while that of D1018M was 4 ?g/ mL. D1018M owned stronger potential antibacterial activity against E. coli ATCC25922. However, the antimicrobial activity of peptides was not so good as that of polymyxin (MIC = 1.56 ?g/mL).', 'he results indicated that peptides IDR-1018, 1018M and 1018M basically had no cytotoxicity against murine macrophage cells, when the concentration was up to 16 times of MIC. However, for D1018M, the safe concentration of murine macrophage cells was only 4 times of MIC.', 'This peptides could interact with E. coli cell wall and cytoplasmic membrane, penetrate the membrane, cause leakage of contents, and disrupt genomic DNA. Among them, D1018 is the most prominent one. these data demonstrate that D1018 is a promising peptide candidate for the treatment of E. coli infection.', 36532445),
('peptide Spgillcin177-189 derived from the amino acid sequence of Spgillcin', 'Spgillcin177-189 also showed rapid bactericidal kinetics for S. aureus and Pseudomonas aeruginosand maintained its antimicrobial activity in different conditions with a range of minimum inhibitory concentrations from 1.5 to 48 ?M.', 'did not display any cytotoxicity to mammalian cells( human hepatic cell line (L02), mouse liver cell line (AML12), hepatocellular carcinoma cell line (Hep G2), and non-small-cell lung carcinoma (NSCLC) cell line (NCI-H460)', 'Spgillcin177-189 was mainly involved in the disruption of cell membrane integrity and cause the accumulation of intracellular reactive oxygen species. Spgillcin177-189 exerted a strong anti-biofilm activity by inhibiting biofilm formation and was also effective at killing extracellular S. aureus in the cultural supernatant of RAW 264.7 cells. Taken together, Spgillcin177-189 has strong potential as a substitute for antibiotics in future aquaculture and medical applications.', 36061863),
('Antisense peptide nucleic acids (PNAs)', 'Concentration-dependent bactericidal activity was investigated by treatment of S. pneumoniae TIGR4 in a CPP-antisense PNA conjugate concentration range of 2.5 to 20 ?M', '', 'CPP-antisense PNA treatment increased the survival rate of infected Galleria mellonella larvae in vivo. Based on these results, we believe that efficient antisense PNAs can be developed for the treatment of S. pneumoniae infections.', 36321914),
('hydrogel scaffold containing genipin crosslinked HF-18 peptide', 'It was observed that HF-18-loaded OPT (P-OPT) was able to release HF-18 peptide both in acidic and neutral conditions. Antimicrobial activity assessments demonstrated that P-OPT was effectively bactericidal on Staphylococcus aureus and methicillin-resistant S. aureus.', '', 'the optimized scaffold has a composition of 90 mg Ch, 0.25 mg HA, and 0.25 mg CS and is crosslinked with 0.5 mg genipin. This scaffold was found to have highly interconnected pores and high bactericidal activity. It was claimed that HF-18 showed a strong bactericidal effect on MRSA and biocompatibility against L929 cells. As a novel approach, for the first time, HF-18 loaded polymeric scaffold was tested for wound healing. the scaffold OPT was considered a suitable and promising polymeric carrier for AMPs in terms of wound healing.', 36377395),
('novel synthetic antimicrobial peptide, GK-19, derived fromAndroctonus amoreuxi Antimicrobial Peptide 1 ( AamAP1 ) and its derivatives', 'GK-19 exhibited potent antibacterial activity against three Gram-positive and two Gram-negative bacteria with much lower minimal inhibitory concentration (MIC) values ranging between 3 and 10 ?M (E. coli (3 ?M), K. pneumoniae (5 ?M), P. aeruginosa (5 ?M), E. faecalis (3 ?M), and MRSA (5 ?M)) in comparison to that of AamAP1 (>20 ?M).', 'GK-19 showed negligible toxicity to mammalian cells, low hemolytic activity and high stability in plasma.', 'GK-19 showed significant antimicrobial and healing effects. Overall, it was demonstrated that GK-19 might be a promising drug candidate in the battle against drug-resistant bacterial and fungal infections.', 36145681),
('Two novel antibacterial peptides were isolated from Alcalase-hydrolyzed chicken plasma', 'VSDH inhibited both S. aureus and B. cereus, while CCCPKAF only showed antibacterial activity toward B. cereus. The MIC values of VSDH and CCCPKAF against B. cereus were 0.5 mM and 0.25 mM, respectively. In addition, the MIC of VSDH against S. aureus was 0.5 mM. Both peptides showed weak inhibition towards S. typhimirium and L. monocytogenes with MIC > 8 mM. They did not inhibit E. coli.', '', '', 36429156),
('scorpion venom peptide ctry2459 was modified to CT-K3K7', 'It can kill S. aureus strain MIC= 2.64 Micro Mol and P. aeruginosa strain PA01 MIC = 10.56 Micro Mol and P. aeruginosa strain ATCC9027 rapidly, and reduce the production of biofilm', 'lower hemolytic activity', 'peptide ctry2459 was modified to CT-K3K7 by lysine substitutions at the 3rd and 7th positions to increase the cationic properties. We discovered that the modified peptides CT-K3K7 had improved antibacterial activity, higher thermal stability, as well as lower hemolytic activity. CT-K3K7 has also been demonstrated to decrease bacterial counts. Hence, the modified peptide CT-K3K7 can be a novel antimicrobial agent candidate for the treatment of infections by S. aureus and P. aeruginosa.', 36113685),
('lead peptide LI14', 'LI14 showed broad-spectrum and strong antibacterial activity against all MDR pathogens with MIC values ranging from 1 to 64 ?g/mL, involving methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), carbapenem-resistant Enterobacteriaceae (CRE), MCR-positive E. coli (MCRPEC) and tigecycline-resistant pathogen, which was comparable to that of some antibiotics used clinically.', '', 'In animal models of infection, LI14 or combined with antibiotics are effective against drug-resistant pathogens. These findings suggest that LI14 is a promising antibiotic candidate to tackle MDR bacterial infections.', 36071151),
('antimicrobial peptide conjugated poly (glycolic acid-co-caprolactone) (PGCL) sutures', '(PGCL) sutures were investigated against P. aeruginosa and methicillin-resistant S. aureus (MRSA) strains by using antimicrobial peptide sequences of KRFRIRVRV-NH2, RWRWRWRW-NH2 and their dual combination (1:1)', '', 'Our results indicated that antimicrobial peptide modified sutures could be a potential novel medical device to overcome surgical site infections by the superior acceleration of wound healing.', 36510770),
('Synergistic effect of - Synthetic antimicrobial peptides (SAMPs-Mo-CBP3-PepI, Mo-CBP3-PepII, Mo-CBP3-PepIII, RcAlb-PepI, RcAlb-PepII, RcAlb-PepIII, PepGAT ,and Pep KAA ) with antibiotics', 'combination made by Mo-CBP3-PepIII (6.2 ?g mL?1) and ciprofloxacin (0.2 ?g mL?1) induced pore formation of biofilm cells of S. aureus. combination with RcAlb-PepI (0.04 ?g mL?1) and ciprofloxacin (25 ?g mL?1) was it possible to induce pore formation on the membrane of S. aureus in biofilm and RcAlb-PepIII alone at 50 ?g mL?1 induce biofilm.', 'synthetic peptides are not toxic to human red blood cells (HRBC). Additionally, it has been shown that during synergistic action, peptides, besides enhancing drugs? effects, also reduce their toxicity to HRBC. iprofloxacin in combination with peptide RcAlb-PepI at 0.04 ?g mL?1 did not present any toxicity to HRBC.', 'The mechanism of the combined effect is possible by increasing the cytoplasmatic concentration of ciprofloxacin supported by pores on the membrane of S. aureus cells. Additionally, peptides reduced the toxicity of ciprofloxacin to HRBC. Considering all these findings, it is possible to suggest that the peptides studied are a considerable option to surpass the resistance of S. aureus strains to antibiotics such as ciprofloxacin.', 36145427),
('antimicrobial peptides (AMPs) from marine parasites, Anisakis spp', 'These peptides are potent bactericidal agents in vitro, selectively active against Gram-negative bacteria, including multi-drug resistant strains, at sub-micromolar concentrations.', 'Their toxicity towards host cells is negligible,', 'Anisaxins are membrane-active peptides essential for future design of such biomaterials.', 35470073),
('antimicrobial peptides centered on "RRR" labeled with hydrophobic amino acids at both ends- LWWR (LWWRRRWWL-NH2)', 'Show bactericidal activity against E. coli and S. aureus', '', 'LWWR (LWWRRRWWL-NH2) presented broad-spectrum antibacterial activity both in vitro and in vivo due to its multiple mechanisms and good stability. The findings of this study will provide some inspiration for the design and development of potential antibacterial agents, and contribute to the elimination of bacterial infections worldwide as soon as possible.', 36241015),
('The Antimicrobial Peptide 1018-K6', 'this AMP was seen to be able to kill resistant Gram-positive and Gram-negative microorganisms (5 ? 105 cfu/mL) at concentrations ? 20 ?M mostly against three prokaryotic species studied: Salmonella Typhimurium2GN, Escherichia coli3GN, and Staphylococcus aureus3', '', 'The AMP 1018-K6 is a candidate to prevent (food preservation) or treat (antibiotic use) infections caused by certain pathogenic bacteria, especially some that are resistant to current antibiotics for three prokaryotic species studied: Salmonella Typhimurium2GN, Escherichia coli3GN, and Staphylococcus aureus3', 36293249),
('Temporin-GHa (GHa) obtained from Hylarana guenther Derived Peptide - GHa4R', 'peptide GHa4R had stronger antibacterial activity and bactericidal efficacy against S. aureus. GHa4R presented antibacterial activity against methicillin-resistant S. aureus (MRSA).', '', 'It was barely affected by temperature, pH, and storage period, showing high stability. it increased the permeability of the cell membrane and damaged the membrane integrity, leading to cell death. The mentioned characteristics make GHa4R a promising candidate for the treatment of S. aureus infections.', 36476441),
('PEGylation at the C-terminal of T9W (CT9W1000) peptide', 'CT9W1000 micelles exhibited good biocompatibility in vitro and in vivo, resulting in highly effective treatment in a mouse acute lung injury model induced by P. aeruginosa PAO1 without drug resistance.', '', 'These advances may profoundly accelerate the clinical transformation of T9W and promote the development of a combination of peptide-based antibiotics and PEGylated nanotechnology.', 36577517),
('lipopeptide', 'against Multidrug-Resistant Pseudomonas aeruginosa', '', 'discovery of lipopeptides against bacterial "superbugs"', 35786900),
('HAZ, a novel peptide', 'HAZ revealed significant antimicrobial activity, with MIC values of 15 ? 20 ?M against tested bacterial strains.', 'HAZ efficacy was accompanied with minimal hemolytic toxicity on human erythrocytes.', 'HAZ-antibiotics combinations exhibited a synergistic action mode that led to dramatic decrease in the MIC values for both HAZ peptide and the antibiotic. HAZ peptide is a broad-spectrum AMP, and a promising candidate for antimicrobial and anticancer drug development.', 36465844),
('synthetic peptide CD4-PP', 'CD4-PP was active against both clinical and type strains in low concentrations between 0.78 and 1.56 ?M. The MIC for E. coli CFT073 and the ESBL strain (CCUG 55971) were 0.78 ?M. Klebsiella pneumoniae (ATCC 25955), MDR K. pneumoniae (CCUG 58547), Pseudomonas aeruginosa (ATCC 27853) had MICs of 1.56 ?M.', '', 'By developing a peptide with a cyclic backbone, they intended to increase the proteolytic stability and antimicrobial activity of the novel synthetic AMP. they observed that CD4-PP displayed enhanced stability against bacterial protease. CD4-PP was tested against a range of the most clinically important uropathogens indicating a promising clinical application.', 35821354),
('cell-penetrating peptide (CPP) fused endolysin PA90', 'This engineered endolysin, DS-PA90, completely killed A. baumannii at 0.25 ?M,', '', 'Hence concluded MDR A. baumannii strains were highly susceptible to DS-PA90 treatment: five out of nine strains were entirely killed and four strains were reduced by 3?4 log in CFU/ml. Collectively, our data suggest that CPP-fused endolysin can be an effective antibacterial agent against Gram-negative pathogens', 35614377),
('Modified the antimicrobial peptide Cec4 (41 amino acids) and obtained the derived peptide C9 (16 amino acids)', 'Derived peptide C9 (16 amino acids) showing better antimicrobial activity against S. epidermidis with an MIC value of 8 ?g/mL.', 'The median lethal dose of C9 in mice was more than 128 mg/kg, and the intraperitoneal administration of 64 mg/kg was less toxic to the liver and kidneys of mice.', 'C9 peptide has rapid bactericidal activity without detectable high-level resistance, showing certain inhibition and eradication ability on S. epidermidis biofilms. In addition, C9 altered the S. epidermidis cell membrane permeability, depolarization levels, fluidity, and reactive oxygen species (ROS) accumulation and possessed the ability to bind genomic DNA.', 36453944),
('melittin-pexiganan combination, combination of temporin-pexiganan, temporin-melittin combination peptides', 'result found that S. aureus went extinct more rapidly when treated with a mixture of two antimicrobial peptides?pexiganan and melittin?compared to single AMP treatments. Pexiganan combinations result in the most effective combinations, as the MIC value toward pexiganan drops from an average of 9-fold change to 3-fold change in the combinations.', '', 'These results are consistent with the fact that AMP combinations that contain pexiganan were more effective for delaying resistance evolution', 35862981),
('Novel D-form of hybrid peptide (D-AP19)', 'Geometric mean (MIC) of gram negative : GMb (Gr.? strains) = 7.16 ?g/ml and geometric mean for gram positive GMd (Gr. + strains) = 5.86 ?g/ml', 'AP-19 show minimal hemolytic and cytotoxic activities in mammalian cells.', 'D-AP19 displayed rapid killing via membrane disruption and leakage of intracellular contents. Additionally, it showed a low tendency to induce bacterial resistance. Among the peptides, AP19 demonstrated the best combination of broad-spectrum antibacterial activity including toward Acinetobacter baumannii', 36151303),
('Host defense peptides (HDPs)- design the amphiphilic peptoid polymers', 'The optimal cyclic peptoid polymer, poly(Naeg0.7Npfbg0.3)20, displays strong antibacterial activities against drug-resistant bacteria.', 'low hemolysis and cytotoxicity', 'we design the amphiphilic peptoid polymers by mimicking the positively charged and hydrophobic structures of HDPs and synthesize a series of cyclic peptoid polymers efficiently via the polymerization on ?-amino acid N-substituted glycine N-carboxyanhydrides (?-NNCAs) using 1,8-diazabicycloundec-7-ene (DBU) as the initiator.', 35788576),
('AMP called Pleurocidin (Ple) and its C-terminal-amidated derivative Pleurocidin-amide (Ple-a)', 'Our results indicated that both Ple and Ple-a exhibited significant antibacterial activity against a broad spectrum of Gram-positive and Gram-negative bacteria, especially marine pathogens, with MIC values ranging from 0.25 to 32 ?g/mL.', 'Ple and Ple-a also showed notable cytotoxicity toward various cancer cell lines, with IC50 values ranging from 11 to 340 ?M, while normal mouse fibroblast 3T3 cells were less susceptible to these peptides.', 'Our results indicated that both Ple and Ple-a exhibited significant antibacterial activity against a broad spectrum of Gram-positive and Gram-negative bacteria, especially marine pathogens. Our findings provided support for the future application of Ple-a as potential therapeutic agent for bacterial infections.', 36005521),
('ApoE mimetic peptide, COG1410', 'In the case of Gram-positive strains, COG1410 inhibited the growth of Bacillus subtilis, vancomycin-resistant Enterococcus faecalis and Enterococcus faecium, and Mycobacterium smegmatis with MICs ranging from 1 to 32 ?g/ml. As for Gram-negative bacteria, COG1410 showed antimicrobial activity against Enterobacter cloacae, Escherichia coli, Citrobacter freundii, and even anaerobe, Porphyromonas gingivalis, with MICs ranging from 16 to 64 ?g/ml.', 'The minimal concentration that caused the lysis of half of the red blood cells (EC50) was 441 ?g/ml. COG1410 exhibited low hemolytic activity and medium cytotoxicity.', 'COG1410 easily entered bacterial cytoplasm and bound to DNA nonspecifically, the major mechanism of COG1410 killing was to disrupt the integrity of cell membrane and lead to leakage of cytoplasmic contents', 36081797),
('Natural Peptide from Vespa mandarinia Venom and Its Synthetic Analogues', 'VM-3K produced a 90% survival of S. aureus-infected waxworms at a concentration of 5.656 mg/kg, at which concentration the natural template peptide only achieved 50% survival. VM-3G also displayed anti-microbial ability against Gram-negative bacteria and had bactericidal effects on E. coli and P. aeruginosa but not on K. pneumoniae', 'VM-3W exhibited haemolysis at a low concentration.', 'peptide VM-3K could be a promising broad-spectrum antimicrobial candidate for addressing the current antibiotic-resistant infection crisis. It is worth mentioning that this investigation on the relationship between peptide structure and mechanism of action could become an important aspect of drug research on short peptides.', 36138742),
('KDEON WK-11: A short antipseudomonal peptide', 'identified its most potent effect, against Pseudomonas aeruginosa with an MIC value of 3.12 ?M', '', 'KDEON WK-11 had a broad range of antimicrobial activity and specific capabilities to fight Pseudomonas aeruginosa with low in vitro cytotoxicity and promising potential to express anti-lipopolysaccharide qualities, which could be exploited to expand its properties into an anti-sepsis agent.', 36465859),
('Amino Acid-Rich Antimicrobial Peptides', 'found 138 Leu-rich AMPs active against Staphylococcus aureus and 81 against Escherichia coli. Likewise, there were 39 Pro-rich peptides against E. coli and 15 against S. aureus in the current database.', '', 'no natural AMPs are simultaneously rich in leucine and lysine, while proline, tryptophan, and cysteine-rich peptides can simultaneously be rich in arginine. These findings can be utilized to guide peptide design. Since multiple candidates are potent against antibiotic-resistant bacteria, rich AMPs stand out as promising future antibiotics.', 36361660),
('tachplesin I analogue peptide (TP11A) and tachplesin I', 'Both inhibited C. albicans monomicrobial, S. aureus monomicrobial, and C. albicans-S. aureus polymicrobial biofilms quite well. TP11A suppressed the biofilm- and virulence-related genes of C. albicans (hwp 1) and S. aureus (ica A, fnb B, agr A, hla, nor A, and sig B) in the mixed biofilm,', '', '', 35998684),
('antimicrobial peptidomimetics called peptoids (sequence-specific oligo-N-substituted glycines) the sequence-specific pentamer TM5', 'the MIC values for TM5 against Pseudomonas aeruginosa (PAO1) and Staphylococcus aureus (SA25923) are 8 ?g/mL and 16 ?g/mL, respectively.', 'determined the cytotoxicity of TM5 against A549 lung epithelial cells to identify a non-cytotoxic concentration. A549 cell exposure to 50 ?g/mL of TM5 for 24 h exposure did not cause cytotoxicity . TM5 has been shown to be safe on 3D human primary cultures of epithelial cells', 'demonstrated that TM5 is a multi-functional platform that can be used to eradicate biofilms and mitigate LPS-induced cytokine production. Future studies will explore the in vivo anti-persister cell activity of TM5 using a chronic biofilm infection animal model. Furthermore, the antimicrobial molecular mechanisms of TM5 seems to prevent resistance development. Although our resistance study showed that resistance development against TM5 is unlikely.', 36018039),
('arenicins, antimicrobial peptides from the lugworm Arenicola marina', 'Peptide AA139, like other arenicins, exhibited an inhibitory effect on complement at a concentration of 160 ?g/Ml', '', 'our results suggest that the effect on the complement system should be taken into account in the development of antibiotics based on arenicins.', 36286436),
('Stable isotope analysis with antimicrobial random peptide mixtures (RPMs). The RPMs used in this study consisted of 20-mer peptide composed of either L-phenylalanine and L-lysine (FK20) or phenylalanine with D-lysine (FdK20) in 1:1 molar ratio', 'FK20 induced a reduction of the MIC of four bacteria (i.e. X. campestris, X. perforans, C. michiganensis and P. syringae) to between 4 and 21% of the corresponding untreated control samples (> 200 ?g/mL). Two pathogenic bacteria, S. scabies and A. citrulli, were not affected by the treatment with FK20. Effects of FdK20 on the bacteria were very similar with the exception of P. syringae which was not affected by FdK20', '', 'Stable carbon isotope analysis invariably verified the changes in the FA groups of bacteria caused by treatment with FK20 and FdK20. Also, growth inhibition of bacteria by FK20 and FdK20 was generally associated with changes in the FA groups except for FdK20 in the case of C. michiganensis. The approach used in this study could be helpful in the search not only of novel antimicrobial RPMs but also other antibiotics such as polymyxin B.', 35789165),
('Antimicrobial potential of a ponericin-like peptide', 'Results showed that Bm-ponericin-L1, at 4 ppm, inhibited biofilm formation by > 85% (P. aeruginosa) and > 90% (K. pneumoniae), after 24 h of incubation', '', 'Study revealed that infection with P. aeruginosa triggers the humoral response in B. mori larvae. The purified peptide fraction screened from the infected silkoworm found to be active against E. faecium , S. aureus , K. pneumoniae, A. baumannii , P. aeruginosa, and E. agglomerans, belonging to the ESKAPE group. This is the first report regarding the production and isolation of a ponericin in B. mori hemolymph upon P. aeruginosa infection. Bm-ponericin-L1was found to be highly specific towards bacterial cells suggesting its cell selectivity.', 36109567),
('cross-linked lyotropic liquid crystals, formed by the self-assembly of the block copolymer Pluronic F-127.', 'The liquid crystal particles were shown to have antibacterial effect corresponding to a 4 log reduction against Staphylococcus aureus.', '', 'The bonding to the particles gave the AMPs improved stability in serum, as they retained almost all of the antibacterial potency for 2 days compared to free AMPs, which lost all of its antibacterial potency within a day.', 36152992),
('florfenicol-polyarginine conjugates', 'These conjugates also showed excellent activity against drug-resistant strains such as methicillin-resistant S. aureus (MRSA) and florfenicol resistant Escherichia coli strains (2017XJ30, 2019XJ20), one of which as E6 had a minimum inhibitory concentration of 12.5 ?mol/L.', '', 'Polyarginine peptides are widely used as CPPs and shown to inhibit bacteria by entering certain microbial cell membranes. This suggested that conjugating arginine to florfenicol succinate effectively modulated the properties of prodrugs. These new conjugates may provide useful insights for expanding the pool of antibiotics.', 35844651),
('three peptides (LS-AMP-E1, LS-AMP-F1, and LS-AMP-G1) from Chinese Wolf Spider Lycosa sinensis', 'LS-AMP-E1 and LS-AMP-F1 exhibited similar antibacterial effects towards tested microbes. The MIC values of LS-AMP-E1 and LS-AMP-F1 against 6 tested strands ranged between 50 and 6.25 ?M, except for P. vulgaris and S. aureus (not detected within 50 ?M). LS-AMP-G1, on the other hand, had no discernible effect on the growth of any one of the reference strains. (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species)', '', '. In terms of antimicrobial mechanisms, LS-AMP-E1 and LS-AMP-F1 destroyed the integrity of bacterial cell membranes in a short period of time and completely inhibited bacterial growth within 10 min of action. Meanwhile, high concentrations of Mg2+ effectively reduced the antibacterial activity of LS-AMP-E1 and LS-AMP-F1. Together, it suggested that the two peptides interact directly on bacterial cell membranes.', 36432731),
('Parietin (PTN) or physcion', 'Complexation of PTN increased the aqueous solubility 28-fold and the photostability compared to free PTN. PTN/HP-?-CD complexes reduce the bacterial viability of Staphylococcus saprophyticus and Escherichia coli by > 4.8 log and > 1.0 log after irradiation, respectively.', '', 'As an alternative therapeutic option, antimicrobial photodynamic therapy (aPDT) can successfully eradicate antibiotic-resistant bacteria with a lower probability of developing resistance or systemic toxicity commonly associated with the standard antibiotic treatment.', 35214089);

-- --------------------------------------------------------

--
-- Table structure for table `table 32`
--

CREATE TABLE IF NOT EXISTS `table 32` (
  `COL 1` varchar(378) DEFAULT NULL,
  `COL 2` varchar(1331) DEFAULT NULL,
  `COL 3` varchar(385) DEFAULT NULL,
  `COL 4` varchar(619) DEFAULT NULL,
  `COL 5` int(8) DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `table 32`
--

INSERT INTO `table 32` (`COL 1`, `COL 2`, `COL 3`, `COL 4`, `COL 5`) VALUES
('Antimicrobial peptide KLKLLLLLKLK-NH2 and its D-enantiomer', 'Significant chemotherapeutic activity in MRSA-infected mice', '', 'Chemotherapeutic activity of synthetic antimicrobial peptides: correlation between chemotherapeutic activity and neutrophil-activating activity', 9326370),
('Protegrin-1', '', '', 'CONCLUSIONS: This study shows that protegrin-1 potentially may be used as an alternative or adjunct therapy to standard agents used to treat wound infections.', 11445704),
('Brevinin-2 peptides from the skin of the Hokkaido frog, Rana pirica', 'The most abundant peptide, brevinin-2PRa (680 nmol/g weight of dry skin) showed high potency [minimal inhibitory concentration (MIC) values between 6 and 12 microM] against a range of clinical isolates of P. aeruginosa.', '', 'A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica. Nine peptides displaying varying degrees of antimicrobial activity were extracted from the skin of the Hokkaido frog, Rana pirica.', 15003829),
('Antimicrobial peptide, human lactoferrin 1-11 (hLF1-11)', '', '', 'The hLF1-11-treated group also had a significantly lower radiological score compared to the gentamicin-treated group. This study demonstrates the efficacy of hLF1-11 incorporated into Ca-P bone cement as a possible therapeutic strategy for the treatment of osteomyelitis, showing efficacy comparable to that of gentamicin.', 15917544),
('[fMLF]PMBN and [fMLF]PMEN', '', '', 'Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria', 16048913),
('Phenothiazinium', 'We used MDR-deficient mutants of Staphylococcus aureus (NorA), Escherichia coli (TolC), and Pseudomonas aeruginosa (MexAB) and found 2 to 4 logs more killing than seen with wild-type strains by use of three different phenothiazinium PSs and red light.: Mutants that overexpress MDRs were protected from killing compared to the wild type.', 'Antimicrobial photodynamic therapy (PDT) combines a nontoxic photoactivatable dye, or photosensitizer (PS), with harmless visible light to generate singlet oxygen and free radicals that kill microbial cells.', 'Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrobial photodynamic therapy (PDT) combines a nontoxic photoactivatable dye, or photosensitizer (PS), with harmless visible light to generate singlet oxygen and free radicals that kill microbial cells.', 16377686),
('Natural toxins and animal venoms (snakes, scorpions and honey bee venoms)', 'Antimicrobial activity against Burkholderia pseudomallei', '', 'In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei', 16784542),
('Antimicrobial peptides (AMPs), UBI 1-59 and synthetic fragments comprising amino acids 31-38', 'In vitro killing of MRSA by synthetic peptides derived from the alpha-helix or beta-sheet domains of the human cationic peptide ubiquicidin (UBI 1-59), allowed selection of AMPs for possible treatment of MRSA infections. The strongest antibacterial activity was observed for the entire peptide UBI 1-59 and for synthetic fragments comprising amino acids 31-38.', '', 'The availability, chemical synthesis opportunities, and size of these small peptides, combined with their strong antimicrobial activity towards MRSA make these compounds promising candidates for antimicrobial therapy and detection of infections in man. ', 16814900),
('Hyaluronic acid binding peptides', 'Effective in experimental surgical wound infections caused by S. aureus', '', 'Treatment with these peptides was highly efficacious in reducing the number of S. aureus cells at the wound site and ameliorated the inflammatory host response associated with these infections.', 17065624),
('Defr1, covalent dimer species of beta-defensin', 'Antimicrobial activity against Pseudomonas aeruginosa PAO1 and an extended panel of multidrug-resistant nosocomial pathogens', '', 'Covalent dimer species of beta-defensin Defr1 display potent antimicrobial activity against multidrug-resistant bacterial pathogens. Beta defensins comprise a family of cationic, cysteine-rich antimicrobial peptides, predominantly expressed at epithelial surfaces.', 17353239),
('Lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin', 'Vancomycin combined to Pal-Lys-Lys-NH(2) exerted the strongest anti-staphylococcal efficacies. The in vitro studies showed, that MIC and MBC values for vancomycin were lower in presence of lipopeptides. They reduce the bacterial load and to enhance the effect of vancomycin in the prevention of vascular graft staphylococcal infections.', '', 'The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection.', 17537542),
('Antimicrobial peptide thionin Thi2.1', 'Growth inhibition of S. aureus isolates was dose-dependent, showing a total inhibition at concentrations higher than 3.12 microg/ml.', '', 'Antibacterial activity of thionin Thi2.1 from Arabidopsis thaliana expressed by bovine endothelial cells against Staphylococcus aureus isolates from bovine mastitis. Bovine mastitis is mainly caused by Staphylococcus aureus and antimicrobial therapy, commonly used for its control, has resulted in an increase in the frequency of resistant staphylococci in recent years.', 17961938),
('AP-CECT7121 (an antimicrobial peptide isolated from an environmental strain of Enterococcus faecalis CECT7121)', 'Activity against Enterococcus faecium, Enterococcus faecalis,Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Clostridium perfringens and Clostridium difficile', '', 'CONCLUSIONS: AP-CECT7121 may provide a novel strategy for treating potentially fatal clinical infections in hospitalized patients.', 19494489),
('Arminin', 'Minimal bactericidal concentration, 0.4 microM to 0.8 microM against multiresistant human pathogenic strains, such as methicillin-resistant Staphylococcus aureus (MRSA) strains', '', 'Activity of the novel peptide arminin against multiresistant human pathogens shows the considerable potential of phylogenetically ancient organisms as drug sources', 19770277),
('Laterocidin and its analogues [3 (Asp(1)-->Asn(1), Phe(4)-->Tyr(4) and d-Tyr(6)-->d-Phe(6))]', 'Antimicrobial properties, against clinical Methicillin-resistant Staphylococcus aureus (L-MRSA) and the gram-negative extended-spectrum beta-lactamases-producing Escherichia coli (ESBLs E. coli) and L-E.coli.', '', 'Solid-phase synthesis and antibiotic activities of cyclodecapeptides on the scaffold of naturally occurring Laterocidin', 19932962),
('longicornsin', 'Strong antimicrobial ability against drug-resistant microorganisms and Helicobacter pylori', '', 'A novel defensin-like peptide from salivary glands of the hard tick, Haemaphysalis longicornis', 20027626),
('Alyteserin-1c (GLKEIFKAGLGSLVKGIAAHVAS?NH(2)) and its analogues', 'Alyteserin-1c displayed MIC=5-10 micro M; minimum bactericidal concentration, MBC=5-10 microM), increasing the cationicity of alyteserin-1c by the substitution Glu(4)->Lys enhanced the potency (MIC=1.25-5 micro M; MBC=1.25-5 micro M) against MDRAB', 'alyteserin-1c (LD(50)=220 ?M)and its catonic analogues (HC(50)>400 ?M) has low hemolytic activity against human erythrocytes , and.', 'Potent and rapid bactericidal action of alyteserin-1c and its [E4K] analog against multidrug-resistant strains of Acinetobacter baumannii', 20603168),
('Hominicin (DmIle-Dhb-Pro-Ala-Dhb-Pro-Phe-Dhb-Pro-Ala-Ile-Thr-Glu-Ile-Dhb-Ala-Ala-Val-Ile-Ala -Dmp)', 'Potent activity against Staphylococcus aureus ATCC 25923, methicillin-resistant S. aureus (MRSA) ATCC 11435 and vancomycin-intermediate S. aureus (VISA) CCARM 3501', '', 'Characterization and structure identification of an antimicrobial peptide, hominicin, produced by Staphylococcus hominis MBBL 2-9.', 20654578),
('Acyldepsipeptide 4 (ADEP 4) analog in which the pipecolate was replaced by 4-methyl pipecolate', 'in vitro antibacterial activity against Enterococci that was fourfold higher than the parent compound ADEP 4', '', 'Diversity-oriented synthesis of cyclic acyldepsipeptides leads to the discovery of a potent antibacterial agent.', 20833054),
('PTP-7, lytic peptide', 'Anti-biofilm activity, potent to Gram-positive bacteria and is able to kill antibiotic sensitive and resistant Staphylococcus aureus', '', 'The activity of a small lytic peptide PTP-7 on Staphylococcus aureus biofilms', 21887652),
('C(12)K-2?(12), oligo-acyl-lysyl (OAK) antimicrobial peptidomimetic', 'A dual mode of action against the H. pylori membrane and cytoplasmic components', '', 'The oligo-acyl lysyl antimicrobial peptide C(12)K-2?(12) exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori', 22064541),
('Epidermicin NI01', 'Potent antimicrobial activity toward a wide range of pathogenic Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA), enterococci, and biofilm-forming S. epidermidis strains', '', 'Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci.', 22155816),
('CPF-AM1, PGLa-AM1, B2RP-ERa, [E4K]alyteserin-1c, [D4K]B2RP and [G4K]XT-7', 'Overall colistin-susceptibleminimum inhibitory concentration against colistin-susceptible (MIC) ? 2 micro g/mL] and colistin-resistant (MIC ? 64 micro g/mL) clinical isolates of multidrug-resistant strains of Acinetobacter baumannii and Acinetobacter nosocomialis, with most potent peptides being [D4K]B2RP and [E4K]alyteserin-1c (MIC=4-16 micro g/mL)', 'low haemolytic activity against human erythrocytes.', 'Efficacy of six frog skin-derived antimicrobial peptides against colistin-resistant strains of the Acinetobacter baumannii group', 22326566),
('OH-CATH30 and its analog OH-CM6', 'The MICs of OH-CATH30 and OH-CM6 ranged from 1.56 to 12.5 micro g/ml against drug-resistant clinical isolates of several pathogenic species, including Escherichia coli, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus.', 'relatively low toxicity and potent efficacy in mouse models', 'Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models.', 22491685),
('Dimeric PpIX-YI13WF (photosensitizer protophophyrin IX - YI13WF (YVLWKRKRKFCFI-Amide)) conjugate', '(MIC) values of dimeric PpIX-YI13WF conjugate itself observed for E. coli DH5a (~4 times), S. enterica (~8 times), and other Gram-negative strains including antibiotic-resistant E. coli BL21 (~8 times) and K. pneumoniae (~16 times).', 'Dimeric PpIX-YI13WF conjugate could selectively recognize bacterial strains over mammalian cells and generate less photo damage to mammalian cells.', 'Lipopolysaccharide neutralizing peptide-porphyrin conjugates for effective photoinactivation and intracellular imaging of gram-negative bacteria strains. A simple and specific strategy based on the bioconjugation of a photosensitizer protophophyrin IX (PpIX) with a lipopolysaccharide (LPS) binding antimicrobial peptide YI13WF (YVLWKRKRKFCFI-Amide) has been developed for the effective fluorescent imaging and photodynamic inactivation of Gram-negative bacterial strains.', 22769015),
('Peptide conjugated phosphorodiamidate morpholino oligomers', 'Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis. ', '', 'Targeting bacterial essential genes using antisense phosphorodiamidate morpholino oligomers (PMOs) represents an important strategy in the development of novel antibacterial therapeutics.', 22978365),
('PEP6R (VKVRVRVRV(D)PPTRVRVRVKV)', 'High potency against bacteria', 'cytocompatible toward human erythrocytes as well as mammalian mesenchymal stem cells', 'Arginine-rich self-assembling peptides as potent antibacterial gels.', 22995710),
('PXL150', 'In vitro a broad spectrum microbicidal action against both Gram-positive and Gram-negative bacteria, including resistant strains', '', 'The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections.', 23053090),
('NK-18', 'Two targets, acts on bacterial membrane and DNA in the cytoplasm', '', 'The double targets of NK-18 make it difficult for bacteria to generate resistance, which may present a new strategy to defend against multidrug-resistant bacteria and provide a new lead in the design of potent antimicrobial peptides with therapeutic application in the presence of increasing resistance to conventional antibiotics.', 23089755),
('LL-37', 'Effective in killing extracellular S. aureus at nanomolar concentrations', '', 'Therefore, LL-37 was shown to be very potent and prompt in eliminating both extra- and intracellular S. aureus and was more effective in killing extra- and intracellular S. aureus than commonly used conventional antibiotics.', 23274662),
('TSG-8-1, WWSYVRRWRSR-amide', 'Antimicrobial activity against E. coli and S. aureus', 'Very little hemolytic activity in human erythrocytes t high dose level', 'Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide', 23570790),
('S-thanatin', 'High activity of S-thanatin against K. pneumoniae in vitro with MIC between 4 and 8 micro g/ml.?', '', 'All above implied that S-thanatin, as an alternative, may provide a novel strategy for treating K. pneumoniae infection and other infections due to multidrug-resistant bacteria.', 23643614),
('Peptidomimetics (Short histidine-derived antimicrobial peptides (SAMPs))', 'High antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA)', 'No hemolytic activity', 'Non hemolytic short peptidomimetics as a new class of potent and broad-spectrum antimicrobial agents.', 23816372),
('R-thanatin', 'Potent in vitro activity against coagulase-negative staphylococci, such as S. epidermidis, S. haemolyticus, and S. hominis, and inhibited biofilm formation at subinhibitory concentrations', '', 'R-thanatin inhibits growth and biofilm formation of methicillin-resistant Staphylococcus epidermidis in vivo and in vitro', 23917310),
('C5a-derived immunobiotic peptide EP67', 'EP67 inhibits GBS growth in vitro and in vivo and that antibacterial activity was specific to Streptococcus species.', '', 'We have employed a host-directed immunomodulatory therapy using a novel peptide, known as EP67, derived from the C-terminal region of human complement component C5a.', 23979760),
('Hymenochirin-1B (IKLSPETKDN(10)LKKVLKGAIK(20)GAIAVAKMV.NH2) analogue in which the Pro(5), Glu(6) and Asp(9) on the hydrophilic face of the ?-helix are substituted by one or more l-lysine or d-lysine residues', '[E6k,D9k]hymenochirin-1B has MIC in the range 0.8-3.1 micro M against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) and a range of Gram-negative bacteria, including multidrug-resistant strains of Acinetobacter baumannii and Stenotrophomonas maltophilia, MIC in the range 3.1-6.25 micro M against NDM-1 carbapenemase-producing clinical isolates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae and Citrobacter freundii.,', 'low hemolytic activity (LC50=302 ?M) of [E6k,D9k]hymenochirin-1B', 'An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties', 24172540),
('BmKn2 scorpion venom peptide and its derivatives', 'Bactericidal, potent activity against N. gonorrhoeae with MIC50 values of 6.9-27.6 ?M', '', 'Potent and rapid antigonococcal activity of the venom peptide BmKn2 and its derivatives against different Maldi biotype of multidrug-resistant Neisseria gonorrhoeae.', 24184420),
('His-derived antimicrobial peptides (HDAMPs)', 'Promising dual antimicrobial and anti-inflammatory activities, as well as anti-methicillin-resistant Staphylococcus aureus (MRSA) activity', '', 'CONCLUSION/SIGNIFICANCE: The combination of the ultra-short size, high-prokaryotic selectivity, potent anti-MRSA activity, anti-inflammatory activity, and proteolytic resistance of the designed HDAMP-1, -3, -5, and -6 makes these molecules promising candidates for future antimicrobial therapeutics.', 24302996),
('Temporin-SHa (FLSGIVGMLGKLF amide)', 'Broad-spectrum activity against Gram-positive and Gram-negative bacteria, yeasts and parasites', '', 'Temporin-SHa (FLSGIVGMLGKLF amide) is a small hydrophobic and low cationic antimicrobial peptide with potent and very broad-spectrum activity against Gram-positive and Gram-negative bacteria, yeasts and parasites.', 24919960),
('Pandinin 2 variants', 'Antimicrobial activity against E. coli, S. aureus, and M. tuberculosis', 'Pin2 [14] presented only 25% of hemolysis toward human erythrocytes at concentrations as high as 100 ?M, while the peptide Pin2 [17] did not show any hemolytic effect at the same concentration', 'Therefore, Pin2 [14] and Pin2 [17] have the potential to be used as an alternative antibiotics and anti-tuberculosis agents with reduced hemolytic effects.', 25019413),
('Peptides human beta-defensin-3 (hBD-3) and cathelicidin (LL-37)', 'Non-cytotoxic concentrations of hBD-3 (10 and 20 micro M) and LL-37 (0.1 and 0.2 micro M)', '', 'This combination of antimicrobial peptides thus shows promising potential as an adjunctive therapy for treating inflammatory periodontitis.', 25187958),
('l isomer of lycosin-I (l-lycosin-I), d isomer of lycosin-I (d-lycosin-I), l- and d-amino acid residues of RKGWFKAMKSIAKFIAKEKLKEHL', 'The MICs of the three isomers of lycosin-I and several other clinical drugs were determined through the broth microdilution method in accordance with the CLSI protocol', '', 'These two compounds displayed high antibacterial activities and rapid bactericidal effects against MDRAB. Moreover, the compounds retained their activity even at high salt (Mg(2+) or Ca(2+)) concentrations.', 25199777),
('G(IIKK)(3)I-NH(2)', 'Effective against ESBL-producing bacterial infection', 'multidrug resistant ESBL-producing bacteria do not develop resistance and low toxicity toward mammalian hosts', 'High cell selectivity and low-level antibacterial resistance of designed amphiphilic peptide G(IIKK)(3)I-NH(2). On the basis of cell cultures involving bacterial strains (Escherichia coli 5? and Bacillus subtilis 168) and a mammalian cell line (NIH 3T3), the potent antibacterial activity and distinct selectivity from designed amphiphilic peptides G(IIKK)nI-NH2 (n = 2-4) have been demonstrated.', 25210781),
('Antimicrobial peptides (AMPs) GPPPQGGRPQG and RFGYGYGPYQPVPEQPLYPQ', 'Antibacterial effect in S. aureus', '', 'These showed to exert an antibacterial effect in Staphylococcus aureus. This report validates the prospection of mammal''s saliva to find new alternatives to antibiotics.BIOLOGICAL SIGNIFICANCE: With the growing problem of antibiotic resistance, the identification of new routes in antibiotic therapy is on the scientific agenda worldwide.', 25534884),
('VRV-PL-V (Vipera russellii venom phospholipase A2 fraction V) of Daboia russellii pulchella venom', 'Antibacterial activity with MIC values ranging from 13 to 24 micro g/ml', '', 'VRV-PL-V demonstrated a potent antibacterial activity against all the human pathogenic strains tested.', 25540009),
('Tilapia piscidin antimicrobial peptides TP3 (H-FIHHIIGGLFSVGKHIHSLIHGH-OH), TP4 (H-FIHHIIGGLFSAGKAIHRLIRRRRR-OH)', 'TP4 MIC against K. pneumonia and A. baumannii in the range < 1.56 microg/mL - 3.125 microg/mL. TP3 MIC against K. pneumonia and A. baumannii in the range < 1.56 microg/mL - 25 microg/mL', '', 'TP3 and TP4 are able at potentiate anti-Acinetobacter baumannii or anti-Klebsiella pneumonia drug activity, reduce bacterial load, and prevent drug resistance, indicating their potential for use in combating multidrug-resistant bacteria.', 25874924),
('VG16KRKP', 'Antimicrobial activity against Gram-negative E. coli and plant pathogens X. oryzae and X. campestris, as well as against human fungal pathogens C. albicans and C. grubii.', '', 'The de novo design of VG16KRKP provides valuable insights into the development of more potent antibacterial and antiendotoxic peptides for the treatment of human and plant infections.', 26144972),
('Synthetic peptides based on LF11( LF11-215 (FWRIRIRR), LF11-227 (FWRRFWRR), DI-MB-LF11-322 (2,2-dimethylbutanoyl-PFWRIRIRR) and DI-MB-LF11-215)', 'Potent anti-biofilm activity against Pseudomonas aeruginosa', '', 'Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms', 26149536),
('NLF20 (NLFRKLTHRLFRRNFGYTLR)', 'Potent antimicrobial effects against the Gram-negative bacteria Escherichia coli and P. aeruginosa, the Gram-positive Bacillus subtilis and Staphylococcus aureus and the fungi Candida albicans and Candida parapsilosis', '', 'NLF20: an antimicrobial peptide with therapeutic potential against invasive Pseudomonas aeruginosa infection', 26503666),
('K1K8: an Hp1404-derived antibacterial peptide', 'Decreased methicillin-resistant Staphylococcus aureus (MRSA) bacterial counts in the wounded region in a mouse skin infection model', 'Low hemolytic activity', 'K1K8: an Hp1404-derived antibacterial peptide. As an alternative class of antimicrobial agents used to overcome drug-resistant infections, antimicrobial peptides (AMPs) have recently gained significant attention.', 26952110),
('D-L91 (SEFAYGSFVRTVSLPVGADE)', 'Enhancement of IFN-gamma(+)TNF-alpha(+) polyfunctional Th1 cells and IL-17A(+)IFN-gamma(+) Th17 cells, enduring memory CD4 T cells and downregulation of PD-1', '', 'The adjunct therapy using drugs and L91 (D-L91) significantly declined the bacterial load in Mtb infected animals.', 27052185),
('CSpK14 , antimicrobial peptide', 'MICs reduced by 8- to 64-fold and 2- to 16-fold in combination wth oxacillin and ampicillin respectively', '', 'CSpK14 was simple to purify, had low molecular mass, was stable over a wide pH range or tested chemicals, had broad inhibitory spectrum, and possessed potent synergistic antimicrobial-antibiofilm properties.', 27787755),
('Series of side-chain hybrid dimer peptides J-AA (Anoplin-Anoplin), J-RR (RW-RW), and J-AR (Anoplin-RW) based on the wasp peptide Anoplin and the arginine- and tryptophan-rich hexapeptide', '', '', 'Design of novel antimicrobial peptide dimer analogues with enhanced antimicrobial activity in vitro and in vivo by intermolecular triazole bridge strategy.', 28040477),
('Thiazomycin, nocathiacin and analogs', 'Activity against drug resistant Mycobacterium tuberculosis with different MICs', '', 'Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis. Thiazolyl peptides are a class of natural products with potent Gram-positive antibacterial activities.', 28096545),
('Heterofunctionalized poly(ethylene glycol) with different lengths (methacrylate-PEGn-tosyl, n=10/45/90) conjugated with polypeptides to form diblock amphiphiles', 'Antimicrobial activity against several pathogenic bacteria like Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and effectively prevent biofilm formation', '', 'Thus, this facilely synthesized PEGylated AMP bottlebrush coating is a feasible method to prevent biomedical devices-associated infections.', 28131941),
('[K3]SHa', '[K3]SHa emerged as a highly potent compound active against a wide range of bacteria, yeasts/fungi, and trypanosomatids (Leishmania and Trypanosoma), with leishmanicidal intramacrophagic activity and efficiency toward antibiotic-resistant strains of S. aureus and antimony-resistant L. infantum.', '', 'To improve activity, we designed analogs of SHa and compared the antibacterial and antiparasitic mechanisms. [K3]SHa emerged as a highly potent compound active against a wide range of bacteria, yeasts/fungi, and trypanosomatids (Leishmania and Trypanosoma), with leishmanicidal intramacrophagic activity and efficiency toward antibiotic-resistant strains of S. aureus and antimony-resistant L. infantum.', 28319176),
('Cecropin A2', 'Synergistic Efficacy in combination with Tetracycline against Pseudomonas aeruginosa', '', 'Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa.', 28483966),
('Sph12-38', 'MIC 3 micro M against Staphylococcus aureus, Corynebacterium glutamicum, Micrococcus lysodeikticus Fleming, Bacillus subtilis, Pseudomonas fluorescens, Aeromonas hydrophila and A. sobria', '', 'Taken together, the synthetic peptide of Sph12-38 had a potent antimicrobial activity against bacteria.', 28600196),
('Free or anchored antimicrobial peptides like  the cathelicidins BMAP-27 and BMAP-28, their (1-18) fragments and the rationally designed, artificial P19(9/G7) peptide', 'Effective at micromolar concentrations against 22 Staphylococcus and Streptococcus isolates from orthopaedic infections,  BMAP-28 and to a lesser extent BMAP-27 were active against Enterococcus faecalis', 'Negligible toxicity towards osteoblasts', 'Alpha-helical antimicrobial peptides (AMPs) may be promising candidates in this respect due to their potent and broad-spectrum antimicrobial activity, their low tendency to elicit resistance and possible retention of efficacy in the immobilized state.', 28707817),
('NZ2114 and MP1102', 'The minimal inhibitory concentration and minimal bactericidal concentration of NZ2114 and MP1102 against resistant C. perfringens type A strain CVCC 46 were 0.91 micro M', '', 'Mode of action of plectasin-derived peptides against gas gangrene-associated Clostridium perfringens type A. .', 28934314),
('Antimicrobial peptide Brevinin-2Ta (GILDTLKNLAKTAGKGILKSLVNTASCKLSGQC)', 'MIC of B-2Ta against S. aureus 64 mg/L, E. coli 32 mg/L, C. albicans 64 mg/L.', '', 'Assessment of antimicrobial and wound healing effects of Brevinin-2Ta against the bacterium Klebsiella pneumoniae in dermally-wounded rats. Antimicrobial peptides (AMPs) are regarded as promising alternatives for antibiotics due to their inherent capacity to prevent microbial drug resistance. Amphibians are rich source of bioactive molecules, which provide numerous AMPs with various structures as drug candidates.', 29340060),
('Histone H5 purified from chicken erythrocytes', 'Active against Gram-positive and Gram-negative planktonic bacteria (MIC range: 1.9 +- 1.8 to 4.9 +- 1.5 micro g/mL)', '', 'Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides. Modern medicine is challenged continuously by the increasing prevalence of antibiotic resistant bacteria.', 29402952),
('OH-CATH30 (L and D)', 'highest bactericidal activity against Acinetobacter spp., including multi-drug-resistant Acinetobacter baumannii (MRAB) and methicillin-resistant Staphylococcus aureus (MRSA)', '', 'King cobra peptide OH-CATH30 as a potential candidate drug through clinic drug-resistant isolates. Cationic antimicrobial peptides (AMPs) are considered as important candidate therapeutic agents, which exert potent microbicidal properties against bacteria, fungi and some viruses.', 29515090),
('Pituitary adenylate cyclase-activating polypeptide (PACAP)', 'Antimicrobial activity against Escherichia coli and Staphylococcus aureus', '', 'Pituitary adenylate cyclase-activating polypeptide (PACAP) is a naturally occurring cationic peptide with potent immunosuppressant and cytoprotective activities.', 29654809),
('Myristoylation of Human alpha-Defensin 5', '', '', 'Our strategy involves the myristoylation of human alpha-defensin 5 (HD5) as a therapeutic target and subsequent self-assembly in aqueous media in the absence of exogenous excipients.', 29856606),
('Antimicrobial peptide N10 and NB2', 'Both peptides were effective against A. baumannii and showed antibacterial activities (minimum inhibitory concentration (MIC) 500 micro g/ml). In the biofilm inhibition assay, NB2 reduced biofilm more efficiently (75%) than N10 (50%).', '', 'The selected peptides showed significant binding to A. baumannii rather than to the human cell line Caco-2. Both peptides were effective against A. baumannii and showed antibacterial activities', 29859290),
('Marcin-18 (FFGHLFKLATKIIPSLFR), Meucin-18 (FFGHLFKLATKIIPSLFQ) and Megicin-18 (FFGALFKLATKIIPSLFR)', 'Showed highly potent inhibitory activity against Gram-positive bacteria (MIC 1.5 to > 48.3 microM), including some clinical antibiotic-resistant strains. Importantly, in a mouse acute peritonitis model, these peptides significantly decreased the bacterial load in ascites and rescued nearly all mice heavily infected with clinical methicillin-resistant Staphylococcus aureus from lethal bacteremia.', '', 'In vitro, chemically synthetic marcin-18 and its homologs (meucin-18 and megicin-18) showed highly potent inhibitory activity against Gram-positive bacteria, including some clinical antibiotic-resistant strains.', 29896190),
('Oligo-lipidated arginyl peptide (OLAP11)', 'antimicrobial actions against MRSA infections', 'low in vitro toxicity', 'Our results showed that OLAP-11 exhibits potent antimicrobial activity against Gram-positive bacteria with improved physico-chemical activity in various physiological conditions.', 30066172),
('LTX21', 'Role on host-pathogen interplay,', '', 'Targeting bacterial virulence or the human host immune system to increase host defence are important strategies in the search for novel antimicrobial drugs.', 30916807),
('Melittin', 'Potency in eradication of extensively drug-resistant (XDR) Acinetobacter spp., killed all examined XDR isolates at 4 microg/mL up to 3 h, significant activity at the minimum dose of 0.062 microg/m', 'No toxixity observed on injured or healthy derma, as well as circulating Red Blood Cells (RBCs) in the examined mice', 'Potent promising antibacterial activity of melittin and the lack of toxicity at the therapeutic dose can clarify that melittin can be implemented as a topical drug lead in a preclinical trial of third degree burn infections.', 30513367),
('MAP-0403 (J-1, J-2, and J-3)', 'MIC reported as, J-1: 5 microM, J-2 : 2.5 microM, J-3: 10 microM', 'J-2 showed significantly reduced hemolytic effect (3.4%), while J-1 and J-3 showed slightly decreased hemolytic effect (46.2%, 55.6%, respectively', 'Design, synthesis, and antimicrobial activities of novel functional peptides against Gram-positive and Gram-negative bacteria', 31059203),
('N-terminal fatty acid modified-antimicrobial peptide', 'Displayed synergistic effects when used together with the antibiotics rifampicin and polymyxin B, had strong membrane permeabilization and depolarization, could damage the integrity of the bacterial membrane and could bind to bacterial DNA', '', 'Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity.', 31466017),
('Sphaeropsidin A', 'MIC= 6.25 microgram/mL to 12.5 microgram/mL, methicillin-resistant S. aureus (MRSA)', '', 'Sphaeropsidin A activity appears noteworthy for its ability to inhibit biofilm formation, preventing a growth mode that results in particular resistance to antibiotic treatment.', 32650496),
('Anoplin analogues: Ano-1beta and Ano-8beta', 'Multidrug-resistant P. aeruginosa', '', 'The new peptides Ano-1beta and Ano-8beta might be promising antimicrobial candidates in combating the increasing antibiotic-resistant bacteria.', 32654770),
('Tridecaptin M', 'Tridecaptin M reduced the MIC of vancomycin and rifampicin against A. baumannii by 16-fold', 'Tridecaptin M and rifampicin combination killed the bacteria completely in 4 h in an ex vivo blood infection model and was superior to rifampicin monotherapy', 'This study reports the in vitro potential of an antimicrobial peptide tridecaptin M in combination with other antibiotics against different strains of A. baumannii.', 32708842),
('cCATH-2 (a chicken-derived antimicrobial peptide)', 'All tested concentrations of cCATH-2 (1/32-1/2MIC) significantly reduced the biomass at the biofilm formation stage', '', 'Inhibitory effect of a novel chicken-derived anti-biofilm peptide on P. aeruginosa biofilms and virulence factors.', 32976967),
('PBDM1: YKWFAHLIKGLC and PBDM2: YKWFRHLIKKLC', 'The MIC value of PBDM1 was found to be as 10 microgram/mL against S. aureus, MRSA, and E. coli. Whereas, in case of E. faecalis, VRSA and VRE the MIC was found to be 30, 15, and 20 microgram/mL. But, the MIC value for PBDM2 was 10 microgram/mL when tested against S. aureus, MRSA, VRSA, VRE, and E. coli. Whereas, in case of E. faecalis the MIC was found to be 20 microgram/mL', 'in vitro study with human epithelial cells showed no significant cytotoxic effects with high biocompatibility and good hemocompatibility', 'In conclusion, PBDM peptides displayed significant antibacterial activity against certain drug resistant bacteria which cause infections in human beings', 32983007),
('L1G, L7A, and L1GA5K : Mastoparan-C (MP-C) analogs', 'The newly designed peptides showed synergy or additive effects against Gram-negative bacteria, when they combined with conventional antibiotics gentamicin, rifampin, and polymyxin B.', '', 'Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.', 33285267),
('Astucin from A. tubingensis A01.', 'The MIC of the purified polypeptide was 32 m/L and 128 microgram/mL and the MBIC was 2 and 8 microgram/mL against Staphylococcus aureus and MRSA, respectively', 'The results demonstrated that the antimicrobial and antibiofilm activity of astucin, together with its lack of cytotoxicity, makes it an alternative for application in medicine.', 'This protein shows antimicrobial and antibiofilm activity against S. aureus.', 33309927),
('F12, Lysostaphin', 'F12 possesses high potency and rapid onset of action, it has narrow selectivity against pathogenic staphylococci, and it manifests synergy with numerous SOC antibiotics.', '', 'These results suggest that combinations of F12 and SOC antibiotics are a promising new approach to treating refractory S. aureus infections.', 33318001),
('Nisin and P10', 'Nisin + colistin and P10+ceftazidime/doripenem were effective on XDR A. baumannii . The MIC value of Nisin and P10 against studied pathogens were 64-256 and 8-32 microgram/ml, respectively.', '', 'Combination therapy and using antimicrobial peptides are two strategies with high potential to solve this issue.', 33346078),
('C14-R1 (C14-RWW-NH2) and C12-R2 (C12-RRW-NH2)', 'C14-R1 and C12-R2 showed high antimicrobial potential for gram-positive bacteria.', 'Among them, the new lipopeptides C14-R1 (C14-RWW-NH2) and C12-R2 (C12-RRW-NH2) presented higher selectivity to bacterial membranes over mammalian membranes and low cytotoxicity, which also maintained better antimicrobial activity in the presence of physiological salts or serum.', 'Most of the new lipopeptides exhibited preferable antimicrobial potential against gram-positive bacteria, including MRSA clinical isolates.', 33422980),
('Fungal peptide, NZX', 'We further observed that this peptide was effective against nontuberculous mycobacteria (NTM), such as M. avium and M. abscessus, and several Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus.', 'In vivo, the peptide remained stable in circulation and preserved lung structure better than ethambutol alone', 'Alternative ways to prevent and treat infectious diseases are needed.', 33603037),
('Peptide-Based Antibiotics', 'In both cases, optimization of the N-terminal lipid tails led to the identification of analogues with potent activity toward Escherichia coli and Pseudomonas aeruginosa.', '', 'Peptide natural products stand as promising candidates to meet this need as bacterial resistance is typically slow in response to their unique modes of action.', 33750106),
('Dilipid ultrashort cationic lipopeptides (dUSCLs)', 'Can indirectly disrupt active efflux of chloramphenicol in P. aeruginosa', '', 'Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria', 30392097),
('Microencapsulated-Host Defense Peptides (HDP ) ;Ub2-MS, K4-MS, and Aurein1.2-MS', 'HDP-MS exhibited up to ?3.02 and ?3.41-log decrease in Mycobacterium tuberculosis CFU as compared to blank-MS (drug free) and untreated control group in 96 h', '', 'Mycobactericidal activity of some micro-encapsulated synthetic Host Defense Peptides (HDP) by expediting the permeation of antibiotic: A new paradigm of drug delivery for tuberculosis.', 30630076),
('Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles', 'The most potent, broad-spectrum peptidomimetic showed activity against Gram-positive (methicillin-resistant Staphylococcus aureus - MIC = 2 microg/mL) and Gram-negative (Escherichia coli - MIC = 4 microg/mL) pathogenic bacteria.', '', 'Synthetic small molecular antimicrobial peptidomimetics represent a promising new class of potential antibiotics due to their membrane-disrupting ability and their decreased propensity for bacterial resistance.', 30831407),
('alpha-Peptide/beta-Peptoid Lysine-Based Peptidomimetics', 'High potency against clinical drug-resistant P. aeruginosa strains', '', 'Emergence of bacterial resistance renders existing antibiotics inefficient, and therefore discovery of new antimicrobial agents is highly warranted.', 30842761),
('Cationic Antimicrobial Peptides (CAMPs) : LL-37: human cathelicidin, CAMA: cecropin(1-7)-melittin A(2-9) amide, magainin-II and nisin', 'activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa', '', 'This study showed the potent and rapid antibacterial activity of CAMPs on both laboratory and clinical isolates of S. aureus and P. aeruginosa either susceptible or resistant to antibiotics.', 30849936),
('Peptide dendrimers G3KL and TNS18', 'Can destroy the Pseudomonas aeruginosa biofilm morphological structure and thickness', '', 'Potent activity on planktonic cells and biofilms of P. aeruginosa suggests that peptide dendrimers G3KL and TNS18 are promising candidates of clinical development for treating infections.', 31101943),
('Hybrid antimicrobial peptide (B1) from helical parts taken from the parent peptides: LL-37 and BMAP-27', 'Broad-spectrum activities, the concentration against planktonic cells ranged between 10 and 20 microM, 40-60 microM were needed to eradicate the biofilm', 'Reduced toxicity toward mammalian cells with minimal hemolysis risk', 'Results: The new peptide B1 exhibited broad-spectrum activities against all tested strains.', 31118709),
('Bac1, Bac2 and Bac3', 'Inhibit the growth of Leuconostoc mesenteroides and affect sperm motility', '', 'Bacteriocins, which are bacterially-derived antimicrobial peptides, may fulfill some of the criteria for these new agents.', 31244418),
('vancomycin derivatives carrying LPS binding peptides, vancomycin-LPS binding peptide conjugates (VPCs).', 'were screened against VISA/VRE and Gram-negative strains', '', 'VPCs exhibited enhanced activity against vancomycin resistant bacteria and obtained the activity against Gram-negative bacteria in vitro, providing a novel strategy for vancomycin modification and glycopeptide antibiotics synthesis.', 34015504),
('Activated caseinolytic protease P (ClpP)', 'an antibacterial assessment demonstrated that ONC212 displays excellent activity against Xoo and prevents rice bacterial leaf blight in vivo.', '', 'Additionally, an antibacterial assessment demonstrated that ONC212 displays excellent activity against Xoo and prevents rice bacterial leaf blight in vivo.', 34218658),
('a chimeric peptide-G6, a N6NH2 analog', 'Showed MIC value: 16 microgram/mL and could curb N6NH2-resistant mutants by stronger inhibition of biofilm formation, stronger affinity with LPS, and stronger membrane permeability and depolarization than that of N6NH2.', '', 'Antimicrobial peptides (AMPs) are regarded as the potentially effective therapy.', 34889983),
('AMPR-22 (antimicrobial peptide derived from Romo1)', 'It showed broad-spectrum antimicrobial activity against 17 sepsis-causing bacteria, including MDR strains, by inducing membrane permeabilization.', 'Moreover, treatment with AMPR-22 enabled a remarkable survival rate in mice injected with MDR bacteria in a murine model of sepsis.', 'Based on these results, we suggest that AMPR-22 could be prescribed as a first-line therapy (prior to bacterial identification) for patients diagnosed with sepsis.', 34361008),
('glucose-dependent insulinotropic polypeptide (GIP)', 'While GIP was devoid of direct antimicrobial activity, it has a potent membrane depolarizing effect, and at low concentrations, it significantly potentiated the activity of eight antibiotics and bile salt by reducing MICs by 4-8-fold in E. coli TG1 and 4-20-fold in E. amylovora 1189.', '', 'GIP can thus be regarded as an antimicrobial adjuvant with potential for augmenting the available antibiotic arsenal. © 2020 Walter de Gruyter GmbH, Berlin/Boston.', 33938181),
('beta-defensin-derived peptide', 'The MIC values ranged from 2 to 4?8 microM for all the microorganisms tested, with the exception of the P. aeruginosa MDR strain 1 and A. baumannii strain 1 that are resistant up to a concentration of 32?64 microM of both peptide forms', 'it has great stability in human serum thereby enhancing its antibacterial presence and activity without cytotoxicity in human cells.', 'Currently, the race is on to identify pharmaceutical molecules or combinations of molecules able to prevent or reduce the insurgence and/or progression of infectivity.', 34818435),
('PHNX peptides', 'PHNX-1 demonstrated antibacterial activity (under high and low-salt conditions) against antibiotic resistant and susceptible strains of Gram-positive and Gram-negative bacteria and PHNX-4 to -8 demonstrated low-salt antibacterial activity only.', '', 'Development of new antibiotics has slowed in recent years and novel therapeutics (like AMPs) with a focus against Gram-negative bacteria are needed.', 34867843),
('cationic antimicrobial peptides (AMPs)', 'In contrast, it showed minimum inhibitory concentration values (MICs) lower than reported for several AMPs and other synthetic cationic compounds on Acinetobacter genus (3.2-12.7 microM).', '', 'New therapeutic possibilities are, therefore, urgently needed to circumvent this important problem.', 34298891),
('Synthetic beta-hairpin antimicrobial peptides', 'mutations of only 2 to 4 amino acids at the turn region could impart a wide range of antimicrobial profiles among synthetic beta-hairpin AMPs. BTT2-4 and BTT6 displayed selective potency against Gram-negative bacteria, with minimum inhibitory concentrations (MICs) of 4-8 microM.', 'Our peptides were also determined to be non-cytotoxic against a human cell line.', 'Synthetic β-hairpin antimicrobial peptides (AMPs) offer a useful source for the development of novel antimicrobial agents. β-hairpin peptides generally consist of two side strands bridged by a reverse turn.', 34506975),
('dipicolylamine-containing carbazole amphiphiles with strong Zn2+', 'antimicrobial candidate. 16 combined with 12.5 microgram/mL Zn2+ exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria (MICs = 0.78-3.125 microgram/mL), weak hemolytic activity, and low cytotoxicity.', 'antimicrobial candidate. 16 combined with 12.5 microgram/mL Zn2+ exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria (MICs = 0.78-3.125 microgram/mL), weak hemolytic activity, and low cytotoxicity.', 'Effective broad-spectrum 16 combined with 12.5 μg/mL Zn2+ was identified as the most promising antimicrobial candidate. 16 combined with 12.5 μg/mL Zn2+ exhibited excellent antimicrobial activity against both Gram-positive and Gram-negative bacteria (MICs = 0.78-3.125 μg/mL), weak hemolytic activity, and low cytotoxicity.', 34235929),
('cathelicidin-related (CR-) peptides- PepBiotics', 'A relatively small number of PepBiotics remained highly antibacterial against CF-related respiratory pathogens Pseudomonas aeruginosa and Staphylococcus aureus, at high ionic strength and low pH. I', 'Finally, interaction of CR-163 with bacterial-type anionic membranes but not with mammalian-type (zwitterionic lipid) membranes was confirmed using ITC and 31P solid state NMR.', 'Interestingly, these PepBiotics also prevented LPS/LTA induced activation of macrophages and was shown to be non-toxic to primary human nasal epithelial cells.', 34147544),
('Temporin A and the short lipopeptides (C10)2-KKKK-NH2 and (C12)2-KKKK-NH2', '', '', 'The results of the performed experiments suggest that the potential application of peptides as adjuvant agents in the treatment of biofilm-associated infections should be studied further.', 32887236),
('CB6-C', 'effective antimicrobial activity against gram-positive bacteria (in particular, the MIC for MRSA was 16 Microgram/mL)', '', 'In conclusion, this protein CB6-C is a newly discovered antibacterial protein and has the potential to become an effective antibacterial agent due to its high therapeutic index, safety, nontoxicity and great stability.', 34983528),
('Lactoferricin B-Mutant (M4)', 'Among the potent AMP mutants, a Lactoferricin B-Mutant (M4) possessed uniformly high affinity with SHV1, OXA48, NDM1, and AmpC having energies -842.0Kcal/mol, -774.8Kcal/mol, -1103.3Kcal/mol, and -858.8Kcal/mol respectively. Highest affinity of Lactoferricin B_M4 was found with NDM1 due to H-bonds, salt-bridges, and hydrophobic interactions with the metallo-beta-lactamase domain including crucial active-site residue Asp124.', '', 'Molecular dynamics simulation further confirmed the stability of Lactoferricin B_M4-NDM1 complex having low residue-level root-mean square deviations (RMSD), atomic-level fluctuations, and radius of gyration (Rg). The study encourages experimental validations and similar methods to identify potential AMPs against drug-resistant pathogens.', 35188617),
('PaP1', 'TSP showed lytic spectrum of ~ 75%, suggesting its activity against various MRSA and MSSA isolates from different clinical samples. The phage efficiently inhibited bacterial growth for up to 12 h at MOI of 1 and 10. TSP phage showed activity against various isolates of MRSA and MSSA, isolated from different clinical samples, with variable antibiotic susceptibility patterns.', '', 'Despite the necessity for additional preclinical drug development, the collective data from our study support PaP1 as a potential broad-spectrum monotherapy or adjunctive therapy for the topical treatment of polymicrobial infections and provide a foundation for engineering future lysin-derived peptides with improved antibacterial properties.', 35369520),
('two-peptide lantibiotic produced by Vagococcus fluvialis LMGT 4216', 'The combination of the two peptides resulted in a 1,200-fold increase in potency, confirming the two-peptide nature of the bacteriocin, named vagococcin T. The bacteriocin was demonstrated to kill sensitive cells by the formation of pores in the cell membrane, and its inhibition spectrum covers most Gram-positive bacteria, including multiresistant pathogens.', '', 'The novel lantibiotic showed a broad spectrum of inhibition of Gram-positive strains, including vancomycin-resistant Enterococcus faecium, demonstrating its therapeutic potential.', 35730941),
('two CAMPs (LL-37 and CAMA)', 'We observed a greater bactericidal effect when IB3-1 cells were pretreated with sub-minimum bactericidal concentrations (Sub-MBCs) of the CAMPs prior to infection. These findings suggest that CAMPs induce the production of factors by IB3-1 cells that improve their bactericidal action. LL-37 induced a weak inflammatory response in the cells without being toxic.', 'The two CAMPs exerted different effects on PA survival depending on the timing of their administration. However, we observed no bactericidal effect when supra-minimum bactericidal concentrations (Supra-MBCs) of the CAMPs were added to IB3-1 cells at the same time or after infection.', 'In conclusion, our findings suggest a potential prophylactic action of CAMPs. The bactericidal effects were low when the CAMPs were added after cell infection, likely due to degradation of CAMPs by bacterial or epithelial cell proteases and/or due to adherence of CAMPs to cells becoming less available for direct bacterial killing.', 34954126),
('series of AMPs with linear and star-shape (using n-hexylamine and amine-terminated polyamidoamine dendrimers (Gx-PAMAM, x = 1-2) as initiators)', 'The star-shaped AMPs exhibited enhanced bactericidal activity against Gram-negative E. coli and similar bactericidal activity against Gram-positive S. aureus when compared with the linear AMPs. It is worth mentioning that star-shaped AMPs demonstrated a significantly faster bactericidal efficiency (completely killed bacteria within 5 min at a concentration of 2 ? MIC for S. aureus) than their linear analogues (took 15 min to achieve the same effect). However, when the AMPs were immobilized to the surface, they similarly exhibited superior antibacterial activity and fast bactericidal efficiency towards S. aureus and E. coli in the case of the same surface grafting amount.', '', 'In addition, both the surfaces grafted with AMPs of different topologies demonstrated favorable biocompatibility in vitro.', 35005755);
INSERT INTO `table 32` (`COL 1`, `COL 2`, `COL 3`, `COL 4`, `COL 5`) VALUES
('metronidazole (MDZ), clindamycin (CLI), and PM-477', 'Determination of the MIC indicated that 60% of a panel of 22 Gardnerella isolates of four different species were resistant to MDZ, while all strains were highly susceptible to CLI and to the endolysin PM-477. All strains were susceptible to PM-477 when grown as preformed biofilms, at minimum biofilm eradication concentrations (MBECs) in the range of 1 to 4 microg/mL.', '', 'Therefore, the high efficacy of PM-477 in eliminating Gardnerella in in vitro biofilms, as well as its high resilience to resistance formation, makes PM-477 a promising potential alternative for the treatment of bacterial vaginosis, especially in patients with frequent recurrence.', 35416708),
('cationic antimicrobial peptides (CAMPs)', 'In this study, the interaction of a CAMP derived from cecropin D-like (?M2) with model membranes mimicking bacterial biomembranes of wild-type (WTPa) strains of P. aeruginosa and CRPa was evaluated through in vitro and in silico approaches.', '', 'This work provides clues for elucidating the membrane-associated mechanism of action of ?M2 against colistin-susceptible and -resistant strains of Pseudomonas aeruginosa. Accordingly, cationic antimicrobial peptides (CAMPs) have emerged as promising alternatives to control resistant bacteria.', 35745820),
('Temporin-PKE', 'Temporin-PKE is a novel peptide extracted from the skin secretion of Pelophylax kl. esculentus and it displays a strong activity against Gram-positive bacteria, with an extreme cytotoxicity. The transformation of the chirality of Ile could reduce haemolytic activity, and an analogue with appropriate D-isoforms could maintain antimicrobial activity and stability. The substitution of hydrophobic residues could bring about more potent and broad-spectrum antimicrobial activities.', 'The analogues with Lys were less harmful to the normal cells and their stabilities remained at similarly high levels compared to temporin-PKE.', 'Temporin-PKE-3K exerted dually efficient functions includingstrong antimicrobial and anticancer activity. This analogue showed a reduced possibility for inducing resistance in MRSA and Klebsiella pneumoniae, a rather strong antimicrobial activity in vivo, and it exhibited the highest therapeutic index such that temporin-PKE-3K has the potential to be developed as a clinical drug.', 35740884),
('Pediocin-like bacteriocins (class IIa bacteriocins)', 'They act on the cytoplasmic membrane of Gram-positive cells by dissipating the transmembrane electrical potential through pore formation with the mannose phosphotransferase system (man-PTS) as the target/receptor. Bacteriocin-producing strains also synthesize a cognate immunity protein that protects them against their own bacteriocins.', 'Pediocin-like bacteriocins, ribosomally synthesized antimicrobial peptides, are generally co-expressed with cognate immunity proteins to protect the bacteriocin-producing strain from its own bacteriocin.', 'Bacteriocins are considered potential alternatives to conventional antibiotics in the context of the bacterial resistance crisis, but the immunity mechanism is unclear. This study uncovered the mechanisms of action and immunity of class IIa bacteriocins.', 35703550),
('Antimicrobial Peptides CATH-1, CATH-3, and PMAP-36 With Erythromycin', 'The results showed that the minimum bactericidal concentration (MBC) of CATH-1,-3 and PMAP-36 was lower than 10 microM, indicating that these three AMPs had good bacterial activity against S. aureus, S. enteritidis, and E. coli. The results showed that the FBCI of AMPs (CATH-1,-3 and PMAP-36) and erythromycin was lower than 0.5 against bacterial pathogens, demonstrating that they had a synergistic bactericidal effect. Furthermore, the time-killing kinetics of AMPs (CATH-1,-3 and PMAP-36) in combination with erythromycin showed that they had a continuous killing effect on bacteria within 3 h. Notably, the combination showed lower hemolytic activity and cytotoxicity to mammal cells compared to erythromycin and peptide alone treatment. In addition, the antibacterial mechanism of CATH-1 and erythromycin combination against E. coli was studied. The results of the scanning electron microscope showed that CATH-1 enhanced the antibacterial activity of erythromycin by increasing the permeability of bacterial cell membrane. Moreover, the results of bacterial migration movement showed that the combination of CATH-1 and erythromycin significantly inhibits the migration of E. coli. Finally, drug resistance analysis was performed and the results showed that CATH-1 delayed the emergence of E. coli resistance to erythromycin.', '', 'In conclusion, the combination of CATH-1 and erythromycin has synergistic antibacterial activity and reduces the emergence of bacterial drug resistance. Our study provides valuable information to develop AMPs as potential substitutes or adjuvants for traditional antibiotics.', 35910608),
('beta-Hairpin Peptide Z-d14CFR or recombinant Zophobas atratus (Z. atratus) defensin', 'Our results showed that Z-d14CFR (RGCRCNSKSFCVCR-NH2) exhibited a broad-spectrum antimicrobial activity to both Gram-positive bacteria and Gram-negative bacteria, including multidrug-resistant bacteria.', 'It possessed less than 5% hemolysis and 10% cytotoxicity, even at a high concentration of 1 mg/mL.', 'Our findings suggest that Z-d14CFR could be a promising candidate against multidrug-resistant bacteria.', 35563007),
('cell-penetrating peptide fused endolysin', 'Bacteriophage encoded endolysin as an alternative antibiotics is a peptidoglycan degrading enzyme with a low rate of resistance. This engineered endolysin, DS-PA90, completely killed A. baumannii at 0.25 microM, at which concentration PA90 could only eliminate less than one log in CFU/ml. Additionally, DS-PA90 has tolerance to NaCl, where the ?50% of activity could be maintained in the presence of 150 mM NaCl, and stable activity was also observed with changes in pH or temperature. Even MDR A. baumannii strains were highly susceptible to DS-PA90 treatment: five out of nine strains were entirely killed and four strains were reduced by 3-4 log in CFU/ml. Consequently, DS-PA90 could protect waxworm from A. baumannii-induced death by ?70% for ATCC 17978 or ?44% for MDR strain 1656-2 infection.', '', 'Collectively, our data suggest that CPP-fused endolysin can be an effective antibacterial agent against Gram-negative pathogens regardless of antibiotics resistance mechanisms.', 35614377),
('tetrameric cell penetrating antimicrobial peptoids', 'Short tetrameric Rhodamine B-labeled peptoids composed of a balance of aromatic and lipophilic residues have potent selective antimicrobial activity against a range of microorganisms. The most potent candidates were active against drug-resistant S. aureus isolates as well as mycobacterial strains, with cell penetrating capabilities reported in HeLa and RAW 264.7 macrophage cells.', '', 'Conclusions: These data suggest that peptoids with novel dual functionalities may potentially be an interesting class of therapeutics and/or molecular delivery agents for anti-infective purposes.', 35227007),
('Human neutrophil peptide-1 (HNP-1)', 'HNP-1 induces bacterial apoptosis and prevents its SOS repair pathway from binding to the RecA protein, which may be a new antibacterial mechanism. In addition, we showed that HNP-1 encapsulated in liposomes inhibits the growth of methicillin-resistant Staphylococcus aureus (MRSA) and meropenem-resistant Pseudomonas aeruginosa (MRPA).', '', 'These results indicated that recombinant protein expression may be a simple and cost-effective solution to produce HNP-1 and that RecA inhibition via HNP-1 may serve as an alternative strategy to counteract antibiotic resistance.', 35019682),
('RPMs : FK20 (L-Phenylalanine-L-Lysine, 20-mer), FdK (L-Phenylalanine-D-Lysine, 20-mer), dFdK (D-Phenylalanine-D-Lysine, 20-mer), and LK20 (L-Leucine-L-Lysine, 20-mer)', 'RPMs rapidly and efficiently kill different strains of A. baumannii, inhibit biofilm formation, and disrupt mature biofilms. Importantly, RPMs attenuated bacterial burden in mouse models of acute pneumonia and soft tissue infection and significantly reduced mouse mortality during sepsis.', '', 'Collectively, our results demonstrate RPMs have the potential to be used as powerful therapeutics against antibiotic-resistant A. baumannii.', 35326876),
('beta-hairpin structure with the template (XY)2RRRF(YX)2-NH2 (X: hydrophobic amino acids; Y: cationic amino acids)', 'Almost all of the new peptides have strong antibacterial activity and negligible hemolytic toxicity. Particularly, the therapeutic index (TI) values of F(RI)2R and F(KW)2K reached up to 115.9 and 70.7, respectively. In addition, they did not show induced drug resistance and inhibited the development of antibiotic resistance when combined and used with traditional antibiotics.', '', 'Moreover, the new peptides F(RI)2R and F(KW)2K showed excellent performance in the pulmonary bacterial infection model and low toxicity in mice. In conclusion, F(RI)2R and F(KW)2K are considered new antimicrobial alternatives to address the antimicrobial-resistance crisis.', 35311294),
('Black Soldier Fly ( Hermetia Illucens) : Hill-Cec1 and Hill-Cec10', 'Hill-Cec1 and Hill-Cec10 also showed high activity against other bacterial species, including Klebsiella pneumoniae and multi-drug resistant P. aeruginosa. Both AMPs are bactericidal and have a rapid onset of action with membrane-permeabilizing effects.', 'Hill-Cec1 and Hill-Cec10 were also able to prevent P. aeruginosa biofilm formation, but no relevant effect was seen on biofilm eradication.', 'Overall, Hill-Cec1 and Hill-Cec10 are promising leads for new antimicrobial development to treat critical infections caused by Gram-negative pathogens such as P. aeruginosa.', 34985302),
('Cathelicidin-Mimetic Antimicrobial Peptoids', 'These peptoids also show efficient and fast (<30 min) killing of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) at low micromolar concentrations without having apparent cytotoxic side effects in vivo. One cationic 12mer, Peptoid 1, shows great promise, as it could prevent formation of and detach biofilms at concentrations as low as 1.6 microM.', 'The use of a bioluminescent S. aureus murine incision wound model demonstrated clearance of infection in peptoid-treated mice within 8 days, conveying another advantage these peptoids have over conventional antibiotics.', 'These results provide clear evidence of the potential for antimicrobial peptoids for the treatment of S. aureus wound infections.', 35467395),
('cell adhesion peptide (CAPs) nanocoatings', 'The two leading nanocoatings upregulated integrin-mediated hemidesmosomes, selectively increased keratinocyte proliferation compared to fibroblasts, which cannot form hemidesmosomes, and expression of junctional epithelium adhesive markers. CAP nanocoatings displayed marked durability under simulated clinical conditions and the top performer CAP nanocoating was validated in a percutaneous implant murine model. Basement membrane CAP nanocoatings, inspired by the tooth and junctional epithelium, may provide an alternative anti-infective strategy for percutaneous devices to mitigate the worldwide threat of antimicrobial resistance.', '', 'Application of cell adhesion peptide nanocoatings may provide an alternative to preventing, rather that necessarily treating, medical device infection across a range of device indications, like dental implants.', 34971784),
('Peptides ASU2056, ASU2060', 'Overall, six peptides inhibited the M. abscessus smooth morphotype (IC50 = 1.7 microM for all peptides) and had reduced activity against the M. abscessus rough morphotype (IC50 range: 13-82 microM). Peptides ASU2056 and ASU2060 had minimum inhibitory concentration values of 32 and 8 microM, respectively, against the M. abscessus smooth morphotype. Additionally, ASU2060 (8 microM) was active against Escherichia coli, including multidrug-resistant E. coli clinical isolates, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus. ASU2056 and ASU2060 exhibited no significant hemolytic activity at biologically relevant concentrations, further supporting these peptides as promising therapeutic candidates. Moreover, ASU2060 retained antibacterial activity after preincubation in human serum for 24 h.', '', 'With antimicrobial resistance on the rise, methods such as those presented here will streamline the peptide discovery process for targeted antimicrobial peptides.', 35847280),
('Purified arasin-likeSp', 'The ELP-intein self-cleavage system was used to produce antimicrobial peptide arasin-likeSp in Escherichia coli. The final yield of arasin-likeSp was about 3.56 mg/L. Purified arasin-likeSp exhibited significant antibacterial activities against the Gram-positive Bacillus subtilis and Gram-negative Vibrio harveyi bacteria.', '', 'Collectively, these data suggest that arasin-likeSp is a candidate AMP for effective inhibition of Vibrio harveyi, a significant bacterial pathogen infecting marine fish and invertebrates. The ELP-intein self-cleavage system described here is a low-cost, simple and potential method for producing antimicrobial peptides, which lays foundations for the large-scale production of antimicrobial peptides in the future.', 35240202),
('hepcidin gene from the fish, Catla catla (Cc-Hep)', 'Sequence analysis revealed that Cc-Hep shared sequence similarity with hepcidin from Sorsogona tuberculata. Sequence analysis revealed that Cc-Hep shared sequence similarity with hepcidin from Sorsogona tuberculata.', '', 'Conclusion: Functional characterization predicted antibacterial, antioxidant, and anticancer potential of Cc-Hep, which can be explored in aquaculture or human health care.', 35344090),
('d,l-K6L9 peptides', 'd,l-K6L9 peptides are stable and resistant to degradation by CF sputum proteases and maintain their activity in a CF sputum environment. Additionally, the d,l-K6L9 peptides do not induce bacterial resistance.', '', 'Overall, these findings should assist in the future development of alternative treatments against resistant bacterial biofilms.', 35759644),
('Lycosin-II isolated from spiders Lycosa singoriensis', 'Lycosin-II showed strong antibacterial activity and biofilm inhibition effects against gram-positive and gram-negative bacteria including oxacillin-resistant Staphylococcus aureus (S. aureus) and meropenem-resistant Pseudomonas aeruginosa (P. aeruginosa) isolated from patients.', 'Lycosin-II was not cytotoxic against human foreskin fibroblast Hs27 or hemolytic against sheep red blood cells at the concentration of which exerted antibacterial activity.', 'Moreover, Lycosin-II showed anti-inflammatory effects by inhibiting the expression of pro-inflammatory cytokines that are increased during bacterial infection in Hs27 cells. These results suggest that Lycosin-II can serve as a therapeutic agent against infections with multidrug-resistant strains.', 34506798),
('WLBU2 (also known as PLG0206)', 'Populations that survived WLBU2 treatment acquired a minimum of two mutations, making the acquisition of resistance more difficult than for most antibiotics, which can be tolerated by mutation of a single target. Major targets of resistance to WLBU2 included the orfN and pmrB genes, previously described to confer resistance to other cationic peptides. More surprisingly, mutations that increase aggregation such as the wsp pathway were also selected despite the ability of WLBU2 to kill cells growing in a biofilm.', '', 'Conclusions and implications: The results show how experimental evolution and WGS can identify genetic targets and actions of new antimicrobial compounds and predict pathways to resistance of new antibiotics in clinical practice.', 35712084),
('insect metallopeptidase inhibitor (IMPI)', 'designed a cohort of 12 single and multiple point mutants, the best of which (I57F) inhibited aureolysin with an estimated inhibition constant (K i) of 346 nM.', '', 'Given that animals lack thermolysins, our strategy may facilitate the development of safe TPs against staphylococcal infections, including strains resistant to conventional antibiotics.', 35465156),
('LcC CL28-25 (Larimichthys crocea), Derived from Piscine Chemokine', 'lcCCL28-25 was capable of rapidly destroying the integrity and permeability of the bacterial cell membrane', '', 'Additionally, the efficacy of lcCCL28-25 in in vivo antibacterial activity in a mammalian model revealed that this compound could be a promising agent for the development of peptide-based antibacterial therapeutics. The novel peptide lcCCL28-25 may prove to be an effective antibacterial agent.', 35616397),
('anti-inhA peptide nucleic acids (PNAs)', 'The antibacterial efficacy of anti-inhA PNA is enhanced when it is combined with permeabilizing drugs, particularly ethambutol. This indicates that the addition of even small concentrations of anti-inhA PNA to the current TB regimen could potentiate their therapeutic efficiency. We hypothesize that this system would also overcome isoniazid resistance, since the resistance mutations lie outside the designed anti-inhA PNA target site.', '', 'We therefore propose that anti-inhA PNA could improve therapy even when applied in minute doses as an addition to the current anti-tuberculosis drug regimen.', 35171048),
('pH-responsive antimicrobial peptides (F5: FLEHLIPHVIHGLVHAIHH-NH2)', 'efficient bacterial killing activity at pH 6.5 and inactivity at pH 7.4. Among the peptides, F5 exhibited outstanding pH-responsive antimicrobial activity and low toxicity. Fluorescence spectroscopy and electron microscopy illustrated that F5 killed bacteria via a membrane-disruptive mechanism at acidic pH values.', 'Mouse cutaneous abscesses revealed that F5 was equipped with excellent therapeutic ability to reduce the bacterial load and cytokines without causing skin toxicity.', 'In summary, this study reveals a strategy for selectively killing bacteria under the pathologic conditions of abscess sites while avoiding the elimination of commensal bacteria under normal physiological pH levels.', 35294199),
('BF15-a1 (lysine-stapled CAMPs)', 'CAMPs with a better amphiphilic structure were inclined to exhibit improved antimicrobial activity, protease stability, and biocompatibility after lysine-stapling. One of the stapled analogues of BF15-a1 was found to have extended half-life in plasma, enhanced antimicrobial activity against clinically isolated MDR ESKAPE pathogens, and remained highly effective in combating MRSA infection in a mouse model.', '', 'Cationic antimicrobial peptides (CAMPs) are promising for treatment of multidrug-resistant (MDR) bacteria-caused infections.', 34968054),
('ZN-5 and ZN-6 (Oreoch-2 analogues)', 'were identified to be broad-spectrum effective analogues, which were superior to their parent peptide Oreoch-2. good stability to the physiological environment, and much higher selectivity to bacterial cells than to mammalian cells. Were typical bactericidal agents and quickly eliminated bacteria in a bactericidal mode by disrupting bacterial cell membrane. Moreover, ZN-5 and ZN-6 could inhibit biofilm formation of Staphylococcus aureus ATCC25923.', 'Compared with their parent peptide Oreoch-2, ZN-5 and ZN-6 not only possessed shortened peptide chains, but also showed slightly improved antibacterial activity and greatly reduced hemolysis.', 'This indicates that they are ideal lead compounds of antimicrobial peptides, which can be developed as substitutes for traditional antibiotics.', 34971943),
('human ApoB-derived antimicrobial peptide r(P)ApoBLAla in combination with low concentrations of conventional antibiotics', 'to treat ureteral catheter-colonizing bacterial communities on clinically isolated bacteria', '', 'The results suggest that combinations of conventional antibiotics and human antimicrobial peptides might synergistically counteract biofilm growth on ureteral catheters, suggesting novel avenues for preventing catheter-associated infections in patients who have undergone radical cystectomy and ureterocutaneostomy.', 35743833),
('P-MtrE1', 'Cotreatment of bacteria with subinhibitory concentrations of the peptide led to 2- to 64-fold increases in susceptibility to erythromycin, azithromycin, ciprofloxacin, and/or ceftriaxone in N. gonorrhoeae strains FA1090, WHO K, WHO P, and WHO X. The cotreatment experiments with peptides P-MtrC1 and P-MtrE1 resulted in increased susceptibilities of WHO P and WHO X to azithromycin, ciprofloxacin, and ceftriaxone that were of the same magnitude seen in MtrCDE mutants.', '', 'Data presented here demonstrate that these peptides may be developed for use as a dual treatment with existing antibiotics to treat multidrug-resistant gonococcal infections.', 34633841),
('caposomes', 'capsosomes selectively deliver their cargo in the presence of bacteria, producing a bactericidal effect to protect the host organism', '', 'Thus, the capsosomes serve as a versatile multidrug, subcompartmentalized microparticle system for preventing antibiotic-resistant bacterial infections, with potential applications to protect wounds or medical device implants from infections.', 35481905),
('DCD-1L', 'The bacterial adhesion and biofilm formation in all A. baumannii isolates were inhibited at 2 ? , 4 ? , and 8 ? MIC of DCD-1L, while only 8 ? MIC of DCD-1L was able to destroy the pre-formed biofilm in vitro.', '', 'Results of this study demonstrated that DCD-1L can inhibit bacterial attachment and biofilm formation and prevent the onset of infection. Taking these properties together, DCD-1L appears as a promising candidate for antimicrobial and anti-biofilm drug development.', 35026999),
('RWWWR (central motif) plus arginine (R) end-tagging', 'great potential in combating Escherichia coli bacteremia and the Staphylococcus aureus skin burn infection model, which induces a 62-90% reduction in bacterial burden, Pep 6 exhibited robust biofilm-inhibiting activity and eliminated 61.33% of the mature methicillin-resistant Staphylococcus aureus (MRSA) biofilm', '', 'These results suggest that the RWWWR motif and binding of arginine end-tagging could be harnessed as a new agent for combating multidrug-resistant bacteria.', 34964342),
('R23F, R23DI, and R23EI hybrid peptides', 'against Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Pseudomonas aeruginosa, Escherichia coli, and Bacillus cereus', '', 'R23F, R23DI, and R23EI can be used as antimicrobial peptides against Gram-positive and Gram-negative bacteria resistant to traditional antibiotics.', 35008951),
('Temporin-1CEc analogs 2K2L and 2K4L', 'against sensitive and multidrug-resistant bacteria, effectively killing the tested multidrug resistant strain Staphylococcus epidermidis (MRSE1208), inhibited the formation of MRSE1208 biofilms at concentrations below its MIC value', '', 'Collectively, these results suggest that 2K2L and 2K4L could be effective antibiotics against multidrug-resistant bacterial strains.', 34953322),
('PEP-38 and PEP-137 peptides', 'active in vitro against carbapenem-resistant isolates of Klebsiella aerogenes and K. pneumoniae. PEP-137 was also active against Pseudomonas aeruginosa.', '', 'The data obtained can be used to develop new antibacterial peptide drugs to combat antibiotic resistance.', 35326874),
('VicBac (Proline-Rich Cathelicidin from the Alpaca Vicugna pacos)', 'Potency to Combat Antibiotic-Resistant Bacteria', '', 'The pronounced antibacterial activity of VicBac, along with its moderate adverse effects on mammalian cells, make this molecule a promising scaffold for the development of peptide antibiotics.', 35629841),
('NZX and P2, fungal defensin-derived peptides', 'MIC values (NZX: 0.11 MicroM, P2: 0.91 MicroM) and MPC (NZX: 1.82 MicroM) against Streptococcus agalactiae', '', 'Conclusion: NZX and P2 are promising antimicrobial agents for streptococcicosis treatment.', 35630326),
('WAM-1', 'MICs of 2-4 mg/L and MBCs of 4-8 mg/L against carbapenem-resistant Klebsiella pneumoniae', '', 'Conclusions: WAM-1 has good antibacterial effect and potential anti-inflammatory effect on infection caused by CRKP.', 35474013),
('RP557 alone or in combination with several clinically effective antibiotics, including clarithromycin, amikacin, cefoxitin and imipenem', 'increases the antibiotic sensitivity of Mycobacterium abscessus by inhibiting biofilm formation', '', 'As such, RP557 is a potential candidate to include in novel strategies to treat M. abscessus infections.', 34813807),
('hyaluronic-acid-based hydrogel', 'The peptidomimetic was found to exhibit antimicrobial and anti-biofilm properties at concentration values ranging from 2.5 to 20 micromol L-1, to be biocompatible toward human skin cell lines, and to protect human keratinocytes from bacterial infections being able to induce a reduction of bacterial units by two or even four orders of magnitude with respect to untreated samples.', '', 'The developed hydrogel-based system represents a promising, effective therapeutic option by combining the mechanical properties of the hyaluronic acid polymer with the anti-infective activity of the antimicrobial peptidomimetic, thus opening novel perspectives in the treatment of skin infections.', 35740323),
('CHRG01, KSR, and KLR', 'active against gram positive as well as gram negative bacteria and kill bacteria by forming membrane pores', '', 'Understanding the molecular level interaction of individual amino acids with the lipid bilayer will greatly help in the design of more efficient antimicrobial peptides.', 34838874),
('guanidinium-functionalized poly(l-lysine) (PLL22 -Gua)', 'kills MRSA with low resistance frequency (<3.3 ? 10-8 ). In an MRSA-caused wound infection mouse model, two-day treatment (twice daily) with 10, 20, or 40 mg per kg of PLL22 -Gua shows up to 99.5% bacterial removal.', '', 'These promising results show the excellent potential of PLL22 -Gua as an antimicrobial agent against multidrug-resistant infection in vivo.', 34846807),
('peptidomimetic antibiotic 10 (human alpha-defensin 5)', 'potent killing of multiple drug-resistant gram-negative bacteria isolated from patients', '', 'By engaging multiple bacterial targets, the lead compound is efficacious in vitro and in vivo against bacteria with highly inducible antibiotic resistance, promising a useful therapeutic agent for the treatment of infections caused by antibiotic-resistant bacteria.', 35238683),
('Anisaxins', 'potent bactericidal agents in vitro, selectively active against Gram-negative bacteria, including multi-drug resistant strains, at sub-micromolar concentrations', '', 'This membranolytic antibacterial activity does not translate to cytotoxicity towards human peripheral blood mononuclear cells (HPBMCs), which was minimal at well above bactericidal concentrations, making anisaxins promising candidates for further drug development.', 35470073),
('Epinecidin-1 and Beta-Defesin-3', 'showed antibacterial activity in vitro in a concentration of 2 to 32 mg/L', '', 'For K. pneumoniae-sepsis, hBD-3 was shown to be a promising option in overcoming the resistance of Klebsiella spp. to carbapenems, though more research is needed. In the P. aeruginosa-sepsis model, the addition of Epi-1 to hBD-3 was found to have a slightly reduced mortality rate compared to hBD-3 monotherapy.', 35052952),
('Alpha-MSH (melanocyte stimulating hormone) based cationic peptides', 'most cationic analogue, KKK-MSH with a + 5 charge, demonstrated successful eradication of 105 CFU/mL of E. coli cells within 15 min at a concentration as low as 1 MicroM', '', 'Here, we propose alpha-MSH based cationic peptides as promising future agents with broad-spectrum antibacterial efficacy against both Gram-negative and Gram-positive pathogens.', 35132082),
('Nigrocin-PN (Pelophylax nigromaculatus)', 'Nigrocin-PN and ampicillin could delay Staphylococcus aureus antibiotic resistance acquisition', '', 'Conclusions: A broad-spectrum antimicrobial peptide Nigrocin-PN was discovered from the skin secretion of Pelophylax nigromaculatus. Structurally, "Rana box" played a crucial role in reducing toxicities without compromising antibacterial abilities, and Nigrocin-PN could be a desired therapeutic candidate.', 35606468),
('GHaR6R, GHaR7R, GHaR8R and GHaR9W', 'show potent antimicrobial activities against methicillin-resistant (MRSA)', 'GHaR6R, GHaR8R and GHaR9W show less toxicity toward normal cells HL-7702 and hFOB1.19.', 'These results suggest that the GHa-derived peptides may be promising antimicrobial candidates against MRSA infections.', 35538042),
('combination of hydrocarbon stapled to L8 (KRIVQRIKKWLR) and L6 (RRLFRRILRWL) peptides and antibiotics (Vancomycin)', 'different hydrocarbon staples to two previously described peptides shown to act on the outer membrane, L6 and L8, and tested their activity in a zebrafish embryo infection model using a clinical isolate of Acinetobacter baumannii as a pathogen improves its in vivo potentiating activity on antibiotic treatment, without increasing its in vivo antimicrobial activity, toxicity or hemolytic activity', '', 'We show here that combinations of stapled peptide L8S1 and vancomycin may provide an attractive novel therapeutic strategy against nosocomial A. baumannii infection.', 35203875),
('lichenicidin', 'presence of the two mature peptides, Blialpha and Blibeta, is necessary for full activity against target bacteria, both peptides exhibit synergistic activity in their interaction with the target membranes', '', 'Based on this information, we propose a mechanism of action of lichenicidin.', 34973602),
('"Picturins" (PTR) and "Pictuseptins" (PTS)', 'PTR displayed moderate activity against Escherichia coli (MIC 24.80 to 48.95 MicroM), while PTS showed a broad antimicrobial and antifungal effect. PTS-1 was the most active peptide against E. coli (6.8 microM) followed by PTS-3 (11.7 MicroM) and PTS-2 (14.24 MicroM).', '', 'Overall, new unique non-hemolytic and cationic peptide sequences were characterized that could be valuable for the next-generation of anti-infective drugs. Future functional studies should explore the pharmacological potential of Boanins to include them as antimicrobial scaffolds.', 35640793),
('Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin', 'against Cystic Fibrosis Pseudomonas aeruginosa', '', 'Our findings demonstrate that glatiramer acetate is a strong candidate for repurposing as an antibiotic resistance breaker of pathogenic P. aeruginosa.', 35727066),
('h-Lf1-11, MSI-78, LL-37 and magainin-2', 'against Escherichia coli, methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, carbapenem-resistant Klebsiella pneumoniae, and Acinetobacter baumannii. The MSI-78 showed potent bactericidal activity with MIC range of 1.25-40 mg/L against all bacterial strains. The h-Lf1-11, magainin-2, and LL-37 exhibited moderate activity (MIC range of 40-160, 80-160, and 40-160 mg/L, respectively)', '', 'These results revealed that MSI-78, h-Lf1-11, magainin-2, and LL-37 have great potential as antibacterial agents and their activity deserves to be more explored in further studies for the treatment of antibiotic-resistant bacteria.', 34735710),
('temporin B and temporin L with the addition of buforin II, a histone H2A fragment', 'less potent temporin B enhances the cooperativity of the in vitro antibacterial activity of the more potent temporin L against EMRSA-15 and that this may be associated with an altered interaction with the bacterial plasma membrane, a feature critical for the antibacterial activity of most AMPs. Addition of buforin II, a histone H2A fragment, can further increase the cooperativity.', '', 'Exploration of the mechanism of synergy between AMPs isolated from the same organism may therefore yield antibiotic combinations with advantageous pharmacodynamic properties.', 35609188),
('amyloid-beta inspired biocompatible short peptide amphiphile (sPA) molecule-AgNPs', 'potential therapeutic value for the treatment of microbiota triggered progression of neurodegenerative diseases', '', 'Such sPA-AgNPs hybrid structures can be further used to develop antibacterial materials to combat emerging bacterial resistance.', 35684988),
('brevinin-2KP', 'weakly active towards the tested Gram-positive and Gram-negative bacteria as well as fungi due to its membranolytic action', 'brevinin-2KP inhibits the proliferation of several mammal cells with IC50 values ranging from 3.27 to 59.75 microM', 'Conclusion: This is the first report on AMP identified from the skin of K. pulchra. Brevinin-2KP adopts a typical amphipathic alpha-helix conformation in membrane mimic environment and shows antimicrobial and antitumor activities by potential membranolytic mechanism. In addition, brevinin-2KP can promote degranulation and histamine release of mast cells. Brevinin-2KP is expected to become a good drug temple molecule.', 35249479),
('L-Chg10-Teixobactin', 'The MIC and MBC values of L-Chg10-teixobactin against both strains of Enterococcus faecalis were 0.8 Microg/mL.', '', 'Conclusions:L-Chg10-teixobactin demonstrated potent antibacterial and antibiofilm effects against E. faecalis, suggesting its potential role an effective antibacterial and antibiofilm agent in endodontic treatment.', 35744616),
('r(P)ApoBLPro, r(P)ApoBSPro, and r(P)ApoBLAla derived from the human apolipoprotein B (residues 887-922)', 'exhibited potent antimicrobial activity against drug-resistant Klebsiella pneumoniae, Acinetobacter baumannii, and Staphylococci both in vitro and in an animal model', '', 'Our results provide a link between human plasma and innate immunity and point to the blood as a source of much-needed antimicrobials.', 35112568),
('Star-Peptide Polymers', 'preferentially target and kill Gram-positive pathogens including MRSA', '', 'These results highlight the potential utility of peptide/polymers to fabricate materials for therapeutic development against MDR Gram-positive bacterial infections.', 35500245),
('Human Cryptic Host Defence Peptide GVF27', 'Exhibits Anti-Infective Properties against Biofilm Forming Members of the Burkholderia multivorans and Burkholderia cenocepacia', '', 'Overall, all these findings contribute to the elucidation of the main features that a good therapeutic agent directed against these extremely leathery biofilm-forming bacteria should possess.', 35215373),
('Liposome-Encapsulated Tobramycin and IDR-1018 Peptide', 'Biofilm Disruption and Enhanced Antimicrobial Activity against Pseudomonas aeruginosa, the biofilm formation was significantly reduced (p &lt; 0.05) at concentrations of ?4 Microg/mL and ?32 Microg/mL for PA01 and ?32 Microg/mL for MDR 7067 when loading tobramycin into liposomes, with or without the anti-biofilm peptide compared to the free antibiotic, empty liposomes, and IDR-1018-loaded liposomes', '', 'Tobramycin-loaded liposomes could be a potential candidate for treating lung-infected animal models owing to the high therapeutic efficacy and safety profile of this system compared to the free administration of the antibiotic.', 35631547),
('cholic acid analogues 17c and 17d', 'analogues containing lysine-like residues showed the highest antibacterial potency against Gram-positive S. aureus. All di-substituted analogues possess high antimicrobial activity against both Gram-positive S. aureus as well as Gram-negative E. coli and P. aeruginosa.', '', 'These compounds were able to depolarise the bacterial membrane, suggesting that they are potential antimicrobial pore forming agents.', 35563014),
('Mucosal pentraxin 2 (Mptx2)', 'against peritoneal infection by methicillin-resistant staphylococcus aureus', '', 'Mptx2 has bactericidal activity against MRSA both in vitro and in vivo, which may shed light on the discovery and development of novel strategies for MRSA-infected peritonitis.', 35609377),
('symbah-1', 'macrocyclic beta-hairpin peptide antibiotic', '', 'The method of discovery and subsequent characterization of symbah-1 suggests large synthetic peptide libraries bias toward macrocyclic beta-hairpin structure could be designed and screened to rapidly expand and better understand this rare peptide antibiotic class.', 35005555),
('isolate (WUL10) in the Brevibacillus genus', 'MIC of the purified substance was 1 microg/mL against S. aureus TISTR 517 and MRSA strains. This substance showed the bactericidal effect at the concentration of 1-2 Microg/mL against these bacterial indicators.', '', 'This novel AMP would provide an advantage for further development of anti-MRSA substances to manage the situation of antibiotic resistance.', 35736972),
('(SAAP)-148 and Halicin', 'equally effective against antimicrobial-resistant (AMR) Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus bacteria residing in immature and mature biofilms', '', 'Together, combinations of these two novel antimicrobial agents hold promise as an innovative treatment for infections not effectively treatable with current antibiotics.', 35625317),
('Chicken cathelicidins CATH-1(RVKRVWPLVIRTVIAGYNLYAIKKK,), CATH-3(RVKRFWPLVPVAINTVAAGINLYKAIRRK, ) and porcine; PMAP-36(GRFRRLRKKTRKRLKKIGKVLKWIPPIVGSIPLGCG) in combination with conventional antibiotics containing ampicillin tetracycline, gentamicin, and erythromycin', 'FBCIs of only CATH-1 + tetracycline were higher than 0.5 against S. aureus, FBCIs of other combinations (CATH-1,?3 and PMAP-36 with ampicillin, tetracycline, gentamicin, and erythromycin) were lower 0.5. FBCIs of CATH-1,?3 and PMAP-36 combination with erythromycin were lower 0.5 against S. enteritidis and E. coli . FBCIs of other combinations (CATH-1,?3 and PMAP-36 with ampicillin, tetracycline, and gentamicin) were higher than 0.5 or even higher than 1.0 against S. enteritidis and E. coli.', 'mice erythrocytes and macrophages and PK-15 cells were used to determine hemolytic activity and cytotoxicity, respectively. The results showed that CATH-1,?3 and PMAP-36 alone at MBC showed low hemolysis (<20%), and erythromycin alone at MBC showed high hemolysis (>95%). However, AMPs (CATH-1,?3 and PMAP-36) combined with erythromycin at sub-MBC showed lower hemolytic activity (<3%)', 'Hence result show that the combination of CATH-1 and erythromycin has synergistic antibacterial activity and reduces the emergence of bacterial drug resistance.', 35910608),
('TAT-RasGAP317-326 peptide with antibiotics', 'synergistic combinations towards all three bacteria and demonstrated that these combinations had an increased bactericidal effect compared to individual drugs.', '', 'combination of TAT-RasGAP317-326 and meropenem had a promising antibiofilm effect towards A. baumannii.', 36270448),
('The antimicrobial peptide GL13K was derived from the salivary protein BPIFA2.', 'Klebsiella pneumoniae (MICs 16-32 microgram/ml) and Acinetobacter baumannii (MICs 8-32 microgram/ml).', '', 'DGL13K displayed in vitro activity against extended-spectrum beta-lactamase (ESBL)-producing and Klebsiella pneumoniae carbapenemase, P. aeruginosa and Acinetobacter baumannii carrying metallo-beta-lactamases. P. aeruginosa showed low inherent resistance to DGL13K', 36006947),
('Antimicrobial Peptides SAAP-148 and OP-145', 'The concentration of the peptides necessary to kill 99.9% of E. coli and E. hirae cells within 5 min of incubation period was found to be 1.6 microM and 0.4 microM for SAAP-148 and 6.4 microM versus 3.2 microM for OP-145 when tested in NaPi buffer for 1 ? 106 CFU/mL bacteria', 'The 99.9% lethal concentration (LC99.9%) implies antimicrobial activity and constitutes the lowest peptide concentration that killed ?99.9% of bacteria', 'these peptides immediately bind to negatively charged components and neutralize the surface of Gram-negative bacteria. Then, they insert into the fatty acyl chain region of the outer membrane, inducing higher outer membrane permeability. The increased membrane permeability for small ions will be sufficient to result in cell death.', 36139091),
('Novel antimicrobial peptide Intestinalin (P30), which is derived from the LysC enzyme of Clostridium intestinale strain URNW', 'Intestinalin showed MIC values ranging from 7.8 to >124 microM. The highest MICs (> 124 microM) were observed for S. aureus KPD 740, S. aureus KPD 425, E. cloacae KPD 297, E. coli KPD 217, and K. pneumoniae KPD 298. The lowest MICs (7.8 microM) were against three of four A. baumannii strains tested, as well as for S. hominis KPD 910 and S. pettenkoferi KPD 741.', 'The results showed that Intestinalin was not toxic to HaCaT cells at concentrations up to 100 microM', 'Experimental data showed that Intestinalin interacts with negatively charged lipoteichoic acid (logK based on isothermal titration calorimetry, 7.45 ? 0.44), causes membrane depolarization, and affects membrane integrity by forming large pores, all of which result in loss of bacterial viability', 36094301),
('AMP human beta-defensin-2 (HBD-2)', 'the data showed an almost total reduction in the invasive ability of EIEC in transfected cells (> 99%). Enteroinvasive E. coli (EIEC) that is responsible for the bacillary dysentery that causes severe diarrheal symptoms in both children and adults.', '', 'The results showed that HBD-2 is able to significantly reduce the expression of the proinflammatory cytokines by intestinal epithelial cells, the invasiveness ability of enteroinvasive E. coli (EIEC) and the expression of invasion-associated genes.', 36310877),
('Phage Lysin-Derived Peptide P87', 'The MIC values for P88 (20?50 microM) seem coherent with previously reported MICs of lysin-derived AMPs,', 'One of the drawbacks usually adduced for the therapeutic application of AMPs is their possible cytotoxic effect against eukaryotic cells.', 'A peptide, P87 from phage lysin Pae87 has been tested as a source for efficient, alternative antimicrobials. To improve its antimicrobial efficacy, a derivative peptide, termed P88, with increased hydrophobic moment and net charge has been designed and proven to possess an enhanced bactericidal and antibiofilm activity.', 36290106),
('new lipopeptide-like pentamer, decanoyl-bis.diaminobutyrate-aminododecanoyl-diaminobutyrate-amide (C10BBc12B)', 'minimal inhibitory concentrations (MIC ? 50 microM) against E.coli, P. aeroginosa, K. pneumoniae, A. baumanni', 'no cytotoxicity towards cell-lines was observed at-least up to 50 microM.', 'action mechanism implicating the pentamer''s de-facto capacity to hijack bacterial efflux pumps for boosting its adjuvant activity through repetitive steps including outer-membrane adhesion, translocation and subsequent expulsion.', 36271103),
('two peptides LP-23 and SA4, as well as their mimetic peptoids DP-23 and SPO were selected. Synergistic effects of short peptides and antibiotics', 'Based on the fraction inhibitory concentration: FICI ? 0.5 synergistic value , LP-23, DP-23, and SPO demonstrated synergy in combination with gentamicin against a gentamicin-resistant clinical isolate of Escherichia coli. For Staphylococcus aureus, Escherichia coli, and Salmonella typhimurium, seven combinations exhibited synergistic effects between peptide/peptoids and the tested antibiotics.', 'These peptides were also evaluated for its cytotoxicity against human embryonic normal kidney cells (HEK 293) and pancreatic cancer cells (MIA PaCa-2) using MTT assay. The average cell survival rate for all peptides in HEK cells was 90% at 100 microg ml?1 and 68% at 500 microg ml?1. In MIA PaCa-2, about 15% cells was compromised at high concentration of 500 microg ml?1', 'Synergy obtained between LP-23, SA4 and their mimetic peptoids DP-23 and SPO with antibiotics have the potential to be used as a combination therapy against microbial infections. These combinations may be helpful in lowering the drug dose and creating better results, which can be applied in future against various MDR strains.', 35931657),
('pentapeptide-4" (PP4, with amino acid sequence KTTKS)', 'peptide effective against Gram-positive (S. aureus, Enterococcus faecalis) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa) bacteria.', '', 'These constructs have potent wide-spectrum antimicrobial action, including against multidrug-resistant Gram-positive and Gram-negative bacteria, and fungi.', 35950860),
('Novel Alligator Cathelicidin As-CATH8', 'MIC of As-CATH8 for S. aureus (0.5 microM) and A. baumannii (0.25 microM) respectively. As-CATH8 demonstrated strong antibacterial effects in a murine abscess model of high-density bacterial infections against clinical isolates of S. aureus and Acinetobacter baumannii,', 'As-CATH8 were moderately cytotoxic against human bronchial epithelial (HBE) cells and peripheral blood mononuclear cells', 'Result declare that As-CATH8 peptide, which has substantial therapeutic promise for treatment of S. aureus and A. baumannii skin infections, two of the most prevalent bacterial species causing SSTIs worldwide.', 36421248),
('designed the (WRX)n hydrophobic tryptophan (W) residues and hydrophilic charged arginine (R) (where X = hydrophilic uncharged amino residues; n = number of repeat units) series engineered peptides with high cell selectivity by introducing hydrophilic uncharged threonine (T), serine (S), glutamine (Q) or asparagine (N) residues into the minimalist design of W- and R-rich AMPs.', 'T6 exhibited potent antibacterial and antiinflammatory capabilities in vivo in a mouse peritonitis-sepsis model infected with Escherichia coli.', '', 'The results showed that the introduction of these hydrophilic uncharged amino residues, especially T residues, significantly improved the cell selectivity of the W- and R-rich engineered peptides. It has potent antibacterial activity, good biocompatibility, high selectivity index, strong tolerance, rapid and efficient time-kill kinetics, and no tendency of resistance. Studies on antibacterial mechanism show that T6 exert antibacterial activity mainly by disrupting bacterial cell membrane and inducing the accumulation of reactive oxygen species in bacterial cells.', 36115654),
('two designed, cationic antimicrobial-derived peptides: Mt6, and its dextroisomer D-Mt6, belonging to the analogs of MAF-1, which is isolated from the instar larvae of houseflies.', 'Mt6 and D-Mt6 showed different degrees of inhibitory activity against Gram-positive bacteria (S. aureus and B. subtilis) and Gram-negative bacteria (E. coli, K. pneumoniae, P. aeruginosa, A. baumannii).', '', 'Both Mt6 and D-Mt6 showed broad-spectrum antimicrobial activity, especially against A. baumannii, by damaging membrane integrity. Moreover, D-Mt6 showed better immunoregulatory activity against LPS induced inflammation through its LPS-neutralizing and suppression on MAPK signaling. This study suggested that D-Mt6 is a promising candidate drug as a derived peptide against A. baumannii.', 36190276),
('rhamnolipid and linezolid', 'Four S.aureus (One ATCC 29213 strain and three methicillin-resistant strains) were used in the study. The minimum inhibitory concentration of the resistant strain decreased from 16 to 4 microg/mL with a four-fold decrease.', '', 'The G.mellonella larval model demonstrated that combined therapy was more effective than monotherapy by survival function tests and CFU determination. RML/LNZ combination improved survival compared to monotherapy and decreased the bacterial burden.', 36526037),
('antimicrobial peptides (AMPs)', 'Anti-microbial Peptides against Methicillin-resistant Staphylococcus aureus', '', 'Anti-microbial peptides could be the next-generation solution to combat drug resistance among Superbugs. New approaches like antimicrobial peptides (AMPs) play a vital role and are more efficacious, economical, time, and energy saviours.', 36529917),
('Innate defense regulator (IDR) peptides', 'he minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of KSL Peptide for C. albicans was determined at the level of 0.78 microg/mL. he MIC of KSL for Staphylococcus aureus and Pseudomonas aeruginosa was 0.78 microg/mL and 1.56 microg/mL, respectively. Bac2A peptide derivative show MICs between 2 and 32 microg/mL for Gram-negative bacteria, and between 0.25 and 16 microg/mL for Gram-positive bacteria. other peptide drive fro naturally occurring molecules as cNK-2, Clavanin-MO, Ac-ApoE, KSLW, SET-M33, GW-A2, AWRK6', '', 'Many studies have shown that the activity of AMPs is mostly associated with bacterial membrane destabilization. However, their activity expressed as MIC is often much lower than that of conventional antibiotics', 36009931),
('novel strategy that combines the human antimicrobial peptide (AMP) LL37 with different antibiotics( vancomycin, azithromycin, polymyxin B, and colistin)', 'For PA103, the MIC of polymyxin B, colistin, and gentamicin decreased twofold to fourfold, but the MIC of vancomycin and azithromycin was still >512 microg/ml, which was the highest concentration tested. The antibacterial inhibitive effects of Ca2+ and Mg2+ ions were also observed for colistin; our preliminary data showed that the MIC of colistin is 0.5 microg/ml when PAO1 was cultured in the MHB medium, but it increased to 1 microg/ml in a cation-adjusted MHB medium.', '', 'Zeta potentials for P. aeruginosa strains PAO1 and PA103 were -40.9 and -10.9 mV, respectively. With the addition of LL37, negative zeta potentials were gradually neutralized. this process of neutralization is believed to have contributed to the increase in outer membrane permeability help to uptake of antibiotics. LL37-vancomycin combination showed a synergistic inhibitory effect to PAO1, as well as a synergistic bactericidal effect to both PAO1 and PA103. Vancomycin can target lipid II, which is embedded in the inner membrane and is also an important molecule needed for the synthesis of the bacterial cell wall', 35922283);
INSERT INTO `table 32` (`COL 1`, `COL 2`, `COL 3`, `COL 4`, `COL 5`) VALUES
('Antimicrobial peptide named P4 with sequence RTKLWEMLVELGNMDKAVKLWRKLKR that was constructed from influenza virus protein M1 and containing two cholesterol-recognizing amino-acid consensus (CRAC) motifs.', 'peptide P4 inhibits the growth of E. coli and B. subtilis strains at concentrations that are significantly lower than the cytotoxic concentration that was found for macrophages. The half-maximal inhibitory concentration (IC50) for B. subtilis and E. coli cells were 0.07 ? 0.01 microM and 1.9 ? 0.4 microM, respectively.', '', 'the toxic action of peptide P4 is based on membrane permeabilization through the interaction of the peptide cationic domain and anionic lipids of the bacterial membrane. They report antimicrobial activity of the peptide P4 against the representatives of Gram-positive (B. subtilis) and Gram-negative (E. coli) bacteria.', 36013956),
('Synthetic antimicrobial peptide', 'This 6 peptides (ASU2001, ASU2009, ASU2019, ASU2056, ASU2059, and ASU2060) inhibited the M. abscessus smooth morphotype (IC50 = 1.7 microM for all peptides) and had reduced activity against the M. abscessus rough morphotype (IC50 range: 13-82 microM). Peptides ASU2056 and ASU2060 had minimum inhibitory concentration values of 32 and 8 microM, respectively, against the M. abscessus smooth morphotype. Additionally, ASU2060 (8 microM) was active against Escherichia coli, including multidrug-resistant E. coli clinical isolates, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus.', 'The two most potent peptides, ASU2056 and ASU2060, were tested for red blood cell toxicity and neither exhibited significant hRBC hemolytic activity even after prolonged incubation (18 h). ASU2060 was tested for serum stability and retained antibacterial activity after preincubation in human serum for 24 h.', 'The peptides (ASU2001, ASU2009, ASU2019, ASU2056, ASU2059, and ASU2060) were further screened against both Mabs smooth and rough morphotypes to determine the impact of cell wall glycopeptidolipids (GPLs) on activity. All six peptides displayed increased activity against the Mabs smooth morphotype, suggesting that interactions with cell wall GPLs are important for antibacterial activity. Additionally, all peptides exhibited increased inhibition in the presence of EDTA, further suggesting that sequestering divalent metal cations enhances peptide interactions with Mabs.', 35847280),
('Temporins modeified version of brevinin-1GHa (BR-1GHa) from frog skin peptide', 'BR-1GHa-3, in which two alanine residues in the truncated version of BR-1GHa were replaced with leucine, exhibited significantly improved antimicrobial activity against Gram-positive bacterial strains (e.g., S. aureus ATCC 29213 and E. casseliflavus ATCC 700327) with lower hemolytic activity compared to the BR-1GHa peptide. BR-1GHa-4 analogue, in which Gly3 was replaced with Pro, did not show any hemolytic activity except for highest (128 microM) concentration tested and have a strong antimicrobial effect on Gram-positive bacteria (e.g., E. faecalis ATCC 51299 and B. cereus ATCC 13061).', '', 'To enhance the antimicrobial activity of this peptide and to reduce its hemolytic activity, they designed five new temporin like analogues and examined their bioactivities. Temporins are another class of frog skin peptides without hemolytic activity and shorter than brevinins. This show antimicrobial activity', 35852614),
('designed PLP-3, a novel synthetic (protegrin-1 ) PG-1-like peptide', 'Antimicrobial activity screening showed MIC90 values of 2 mg/L for A. baumannii, 16 mg/L for K. pneumoniae and 8 mg/L for P. aeruginosa. The haemolysis IC50 value was 48.53 mg/L', 'Cytotoxicity against human HeLa and A549 cells showed values of ca. 200 mg/L in both cell lines resulting in a 100-fold selectivity window for bacterial over human cells.', 'PLP-3 has potent antimicrobial activity, especially against A. baumannii, while maintaining low haemolysis and toxicity against human cell lines at antimicrobial concentrations. These characteristics make PLP-3 a promising peptide with an interesting therapeutic window.', 35972429),
('plantaricin A an antimicrobial peptide derived from Lactobacillus plantarum, had a synergistic effect with ciprofloxacin (CIP)', 'lantaricin A (PlnA), reducing the IC90 of CIP by eight times and kill Multidrug-resistant Staphylococcus aureus', 'which has low cytotoxicity and haemolysis and powerful inhibitory activity on efflux pumps.', 'The present study showed a new efflux pump inhibitors EPI (plantaricin A) produced by Lactobacillus plantarum, changes in membrane permeability, membrane potential, and reactive oxygen species (ROS) were determined. Therefore, it helps the design of new EPIs and controls the infection of multidrug-resistant Staphylococcus aureus', 36254863),
('Lugdunin (cyclic peptide-1), a nonribosomal cyclic peptide', 'cyclic peptide-1 and its analogues cyclic peptide-11 and cyclic peptide-14 have the ability to disperse mature Methicillin-resistant Staphylococcus aureus (MRSA) biofilms and show anti-clinical MRSA activity, including MRSA persister cells', 'these three cyclic peptide compounds have non-toxicity, lower hemolytic activity and lack of resistance development.', 'Our results indicate that cyclic peptide-1, cyclic peptide-11, and cyclic peptide-14 have great potential as new antimicrobial drug candidates for the treatment of clinical Methicillin-resistant Staphylococcus aureus (MRSA) infections.', 35887376),
('a series of Temporin-PE (T-PE) analogues were designed and synthesized by glutamic acid', '', 'E11K4K10 exhibited slight toxicity to the spleen with slight edema observed in the spleen, but its toxicity was less severe than that of polymyxin B.', 'E11K4K10, the optimized T-PE and the relatively safe AMP, could overcome drug resistance which was expected to be a new antimicrobial agent against clinical resistant bacteria.', 36148510),
('Nv-CATH peptide from the skin of the frog Nanorana ventripunctata', 'S. haemolyticus 13A13770 displayed the highest sensitivity to Nv-CATH (MIC = 3.125 microg/mL), followed by S. aureus ATCC25923 and A. junii 13A15578 (MIC = 12.5 microg/mL).', '100 microg/mL Nv-CATH did not exhibit cytotoxicity toward mouse peritoneal macrophage (MPMs) and bone-marrow-derived neutrophils (BMDNs), and 300 microg/mL Nv-CATH also had no hemolytic activity on rabbit erythrocytes.', 'Nv-CATH inhibited bacterial invasion of target organs via direct bactericidal ability. Nv-CATH selectively promoted CCL and CXCL chemokines? production, which modulated monocytes/macrophages? and neutrophils? trafficking to the infection site, and augmented immunocyte-mediated bacterial killing by modestly promoting neutrophil phagocytosis. Nv-CATH shows promise as a new antimicrobial agent, especially in the treatment of S. aureus infections', 36378028),
('human beta-defensin 130 (hBD130)', 'hBD130 demonstrated efficient antimicrobial activities, with MICs ranging from 10 to 45 microg/mL. Of note, hBD130 exhibited significant growth inhibition effects against E. coli ATCC 25,922 (10 microg/mL), ETEC BNCC 125,783 (10 microg/mL), L. monocytogenes ATCC 221,633 (25 microg/mL), and S. typhimurium ATCC 14,028 (15 microg/mL). The MICs for hBD130 against gram-negative bacteria, including E. coli and S. typhimurium, were 10?15 microg/mL, which were lower than those against gram-positive bacteria, including L. monocytogenes, B. subtilis and S. aureus.', 'hBD130 showed a low hemolytic effect and nearly no cytotoxicity to mammalian cells with a dosage of 400 microg/Ml', 'bactericidal effect of hBD130 showed that hBD130 is a promising antimicrobial agent to treat foodborne bacterial infections and inflammation.', 35720462),
('develop chimeric peptides with dual cell-penetrating and antimicrobial functions by conjugating Cell-penetrating peptides with AMPs', '', '', 'AMPs are regarded as an ideal alternative to antibiotics due to their powerful antimicrobial potential, rapid killing effects, and low propensity to develop resistance. the combination of CPP and AMP gives it a dual function of cell penetration and antimicrobial activity, which may be a feasible method to treat intracellular infections.', 36503077),
('Three novel peptide families ?Picturins? (PTR), ?Pictuseptins? (PTS), and ?Boanins? (BNS). were identified from Boana picturata skin secretion.', 'PTR displayed moderate activity against Escherichia coli (MIC 24.80 to 48.95 microM), TS-1 was the most active peptide against E. coli (6.8 microM) followed by PTS-3 (11.7 microM) and PTS-2 (14.24 microM)', '', 'Hence, Frog skin peptides are excellent examples of the biomedical potential of naturally evolved molecules for specific targets, including multi-resistant bacteria.', 35640793),
('Peptide PN5 derived from Pinus densiflora (pine needle)', 'PN5 displayed antimicrobial activity against both Gram-negative and Gram-positive bacteria, with MICs of 2 to 16 microM (2.65 to 21.22 microg mL?1)', '', 'PN5 showed immunomodulatory properties of neutralizing LPS in a mouse septic model. These results indicate that PN5 could be a new and promising therapeutic agent for bacterial infectious disease caused by antibiotic-resistant strains.', 36129300),
('Antimicrobial peptide (AMP) IDR-1018 derived D-amino acids substitution peptides (D1018 and D1018M) were synthesized', 'MIC of IDR-1018, 1018M and D1018 against E. coli ATCC25922 was 8 microg/ mL while that of D1018M was 4 microg/ mL. D1018M owned stronger potential antibacterial activity against E. coli ATCC25922. However, the antimicrobial activity of peptides was not so good as that of polymyxin (MIC = 1.56 microg/mL).', 'he results indicated that peptides IDR-1018, 1018M and 1018M basically had no cytotoxicity against murine macrophage cells, when the concentration was up to 16 times of MIC. However, for D1018M, the safe concentration of murine macrophage cells was only 4 times of MIC.', 'This peptides could interact with E. coli cell wall and cytoplasmic membrane, penetrate the membrane, cause leakage of contents, and disrupt genomic DNA. Among them, D1018 is the most prominent one. these data demonstrate that D1018 is a promising peptide candidate for the treatment of E. coli infection.', 36532445),
('peptide Spgillcin177-189 derived from the amino acid sequence of Spgillcin', 'Spgillcin177-189 also showed rapid bactericidal kinetics for S. aureus and Pseudomonas aeruginosand maintained its antimicrobial activity in different conditions with a range of minimum inhibitory concentrations from 1.5 to 48 microM.', 'did not display any cytotoxicity to mammalian cells( human hepatic cell line (L02), mouse liver cell line (AML12), hepatocellular carcinoma cell line (Hep G2), and non-small-cell lung carcinoma (NSCLC) cell line (NCI-H460)', 'Spgillcin177-189 was mainly involved in the disruption of cell membrane integrity and cause the accumulation of intracellular reactive oxygen species. Spgillcin177-189 exerted a strong anti-biofilm activity by inhibiting biofilm formation and was also effective at killing extracellular S. aureus in the cultural supernatant of RAW 264.7 cells. Taken together, Spgillcin177-189 has strong potential as a substitute for antibiotics in future aquaculture and medical applications.', 36061863),
('Antisense peptide nucleic acids (PNAs)', 'Concentration-dependent bactericidal activity was investigated by treatment of S. pneumoniae TIGR4 in a CPP-antisense PNA conjugate concentration range of 2.5 to 20 microM', '', 'CPP-antisense PNA treatment increased the survival rate of infected Galleria mellonella larvae in vivo. Based on these results, we believe that efficient antisense PNAs can be developed for the treatment of S. pneumoniae infections.', 36321914),
('hydrogel scaffold containing genipin crosslinked HF-18 peptide', 'It was observed that HF-18-loaded OPT (P-OPT) was able to release HF-18 peptide both in acidic and neutral conditions. Antimicrobial activity assessments demonstrated that P-OPT was effectively bactericidal on Staphylococcus aureus and methicillin-resistant S. aureus.', '', 'the optimized scaffold has a composition of 90 mg Ch, 0.25 mg HA, and 0.25 mg CS and is crosslinked with 0.5 mg genipin. This scaffold was found to have highly interconnected pores and high bactericidal activity. It was claimed that HF-18 showed a strong bactericidal effect on MRSA and biocompatibility against L929 cells. As a novel approach, for the first time, HF-18 loaded polymeric scaffold was tested for wound healing. the scaffold OPT was considered a suitable and promising polymeric carrier for AMPs in terms of wound healing.', 36377395),
('novel synthetic antimicrobial peptide, GK-19, derived fromAndroctonus amoreuxi Antimicrobial Peptide 1 ( AamAP1 ) and its derivatives', 'GK-19 exhibited potent antibacterial activity against three Gram-positive and two Gram-negative bacteria with much lower minimal inhibitory concentration (MIC) values ranging between 3 and 10 microM (E. coli (3 microM), K. pneumoniae (5 microM), P. aeruginosa (5 microM), E. faecalis (3 microM), and MRSA (5 microM)) in comparison to that of AamAP1 (>20 microM).', 'GK-19 showed negligible toxicity to mammalian cells, low hemolytic activity and high stability in plasma.', 'GK-19 showed significant antimicrobial and healing effects. Overall, it was demonstrated that GK-19 might be a promising drug candidate in the battle against drug-resistant bacterial and fungal infections.', 36145681),
('Two novel antibacterial peptides were isolated from Alcalase-hydrolyzed chicken plasma', 'VSDH inhibited both S. aureus and B. cereus, while CCCPKAF only showed antibacterial activity toward B. cereus. The MIC values of VSDH and CCCPKAF against B. cereus were 0.5 mM and 0.25 mM, respectively. In addition, the MIC of VSDH against S. aureus was 0.5 mM. Both peptides showed weak inhibition towards S. typhimirium and L. monocytogenes with MIC > 8 mM. They did not inhibit E. coli.', '', '', 36429156),
('scorpion venom peptide ctry2459 was modified to CT-K3K7', 'It can kill S. aureus strain MIC= 2.64 Micro Mol and P. aeruginosa strain PA01 MIC = 10.56 Micro Mol and P. aeruginosa strain ATCC9027 rapidly, and reduce the production of biofilm', 'lower hemolytic activity', 'peptide ctry2459 was modified to CT-K3K7 by lysine substitutions at the 3rd and 7th positions to increase the cationic properties. We discovered that the modified peptides CT-K3K7 had improved antibacterial activity, higher thermal stability, as well as lower hemolytic activity. CT-K3K7 has also been demonstrated to decrease bacterial counts. Hence, the modified peptide CT-K3K7 can be a novel antimicrobial agent candidate for the treatment of infections by S. aureus and P. aeruginosa.', 36113685),
('lead peptide LI14', 'LI14 showed broad-spectrum and strong antibacterial activity against all MDR pathogens with MIC values ranging from 1 to 64 microg/mL, involving methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), carbapenem-resistant Enterobacteriaceae (CRE), MCR-positive E. coli (MCRPEC) and tigecycline-resistant pathogen, which was comparable to that of some antibiotics used clinically.', '', 'In animal models of infection, LI14 or combined with antibiotics are effective against drug-resistant pathogens. These findings suggest that LI14 is a promising antibiotic candidate to tackle MDR bacterial infections.', 36071151),
('antimicrobial peptide conjugated poly (glycolic acid-co-caprolactone) (PGCL) sutures', '(PGCL) sutures were investigated against P. aeruginosa and methicillin-resistant S. aureus (MRSA) strains by using antimicrobial peptide sequences of KRFRIRVRV-NH2, RWRWRWRW-NH2 and their dual combination (1:1)', '', 'Our results indicated that antimicrobial peptide modified sutures could be a potential novel medical device to overcome surgical site infections by the superior acceleration of wound healing.', 36510770),
('Synergistic effect of - Synthetic antimicrobial peptides (SAMPs-Mo-CBP3-PepI, Mo-CBP3-PepII, Mo-CBP3-PepIII, RcAlb-PepI, RcAlb-PepII, RcAlb-PepIII, PepGAT ,and Pep KAA ) with antibiotics', 'combination made by Mo-CBP3-PepIII (6.2 microg mL?1) and ciprofloxacin (0.2 microg mL?1) induced pore formation of biofilm cells of S. aureus. combination with RcAlb-PepI (0.04 microg mL?1) and ciprofloxacin (25 microg mL?1) was it possible to induce pore formation on the membrane of S. aureus in biofilm and RcAlb-PepIII alone at 50 microg mL?1 induce biofilm.', 'synthetic peptides are not toxic to human red blood cells (HRBC). Additionally, it has been shown that during synergistic action, peptides, besides enhancing drugs? effects, also reduce their toxicity to HRBC. iprofloxacin in combination with peptide RcAlb-PepI at 0.04 microg mL?1 did not present any toxicity to HRBC.', 'The mechanism of the combined effect is possible by increasing the cytoplasmatic concentration of ciprofloxacin supported by pores on the membrane of S. aureus cells. Additionally, peptides reduced the toxicity of ciprofloxacin to HRBC. Considering all these findings, it is possible to suggest that the peptides studied are a considerable option to surpass the resistance of S. aureus strains to antibiotics such as ciprofloxacin.', 36145427),
('antimicrobial peptides (AMPs) from marine parasites, Anisakis spp', 'These peptides are potent bactericidal agents in vitro, selectively active against Gram-negative bacteria, including multi-drug resistant strains, at sub-micromolar concentrations.', 'Their toxicity towards host cells is negligible,', 'Anisaxins are membrane-active peptides essential for future design of such biomaterials.', 35470073),
('antimicrobial peptides centered on "RRR" labeled with hydrophobic amino acids at both ends- LWWR (LWWRRRWWL-NH2)', 'Show bactericidal activity against E. coli and S. aureus', '', 'LWWR (LWWRRRWWL-NH2) presented broad-spectrum antibacterial activity both in vitro and in vivo due to its multiple mechanisms and good stability. The findings of this study will provide some inspiration for the design and development of potential antibacterial agents, and contribute to the elimination of bacterial infections worldwide as soon as possible.', 36241015),
('The Antimicrobial Peptide 1018-K6', 'this AMP was seen to be able to kill resistant Gram-positive and Gram-negative microorganisms (5 ? 105 cfu/mL) at concentrations ? 20 microM mostly against three prokaryotic species studied: Salmonella Typhimurium2GN, Escherichia coli3GN, and Staphylococcus aureus3', '', 'The AMP 1018-K6 is a candidate to prevent (food preservation) or treat (antibiotic use) infections caused by certain pathogenic bacteria, especially some that are resistant to current antibiotics for three prokaryotic species studied: Salmonella Typhimurium2GN, Escherichia coli3GN, and Staphylococcus aureus3', 36293249),
('Temporin-GHa (GHa) obtained from Hylarana guenther Derived Peptide - GHa4R', 'peptide GHa4R had stronger antibacterial activity and bactericidal efficacy against S. aureus. GHa4R presented antibacterial activity against methicillin-resistant S. aureus (MRSA).', '', 'It was barely affected by temperature, pH, and storage period, showing high stability. it increased the permeability of the cell membrane and damaged the membrane integrity, leading to cell death. The mentioned characteristics make GHa4R a promising candidate for the treatment of S. aureus infections.', 36476441),
('PEGylation at the C-terminal of T9W (CT9W1000) peptide', 'CT9W1000 micelles exhibited good biocompatibility in vitro and in vivo, resulting in highly effective treatment in a mouse acute lung injury model induced by P. aeruginosa PAO1 without drug resistance.', '', 'These advances may profoundly accelerate the clinical transformation of T9W and promote the development of a combination of peptide-based antibiotics and PEGylated nanotechnology.', 36577517),
('lipopeptide', 'against Multidrug-Resistant Pseudomonas aeruginosa', '', 'discovery of lipopeptides against bacterial "superbugs"', 35786900),
('HAZ, a novel peptide', 'HAZ revealed significant antimicrobial activity, with MIC values of 15 ? 20 microM against tested bacterial strains.', 'HAZ efficacy was accompanied with minimal hemolytic toxicity on human erythrocytes.', 'HAZ-antibiotics combinations exhibited a synergistic action mode that led to dramatic decrease in the MIC values for both HAZ peptide and the antibiotic. HAZ peptide is a broad-spectrum AMP, and a promising candidate for antimicrobial and anticancer drug development.', 36465844),
('synthetic peptide CD4-PP', 'CD4-PP was active against both clinical and type strains in low concentrations between 0.78 and 1.56 microM. The MIC for E. coli CFT073 and the ESBL strain (CCUG 55971) were 0.78 microM. Klebsiella pneumoniae (ATCC 25955), MDR K. pneumoniae (CCUG 58547), Pseudomonas aeruginosa (ATCC 27853) had MICs of 1.56 microM.', '', 'By developing a peptide with a cyclic backbone, they intended to increase the proteolytic stability and antimicrobial activity of the novel synthetic AMP. they observed that CD4-PP displayed enhanced stability against bacterial protease. CD4-PP was tested against a range of the most clinically important uropathogens indicating a promising clinical application.', 35821354),
('cell-penetrating peptide (CPP) fused endolysin PA90', 'This engineered endolysin, DS-PA90, completely killed A. baumannii at 0.25 microM,', '', 'Hence concluded MDR A. baumannii strains were highly susceptible to DS-PA90 treatment: five out of nine strains were entirely killed and four strains were reduced by 3?4 log in CFU/ml. Collectively, our data suggest that CPP-fused endolysin can be an effective antibacterial agent against Gram-negative pathogens', 35614377),
('Modified the antimicrobial peptide Cec4 (41 amino acids) and obtained the derived peptide C9 (16 amino acids)', 'Derived peptide C9 (16 amino acids) showing better antimicrobial activity against S. epidermidis with an MIC value of 8 microg/mL.', 'The median lethal dose of C9 in mice was more than 128 mg/kg, and the intraperitoneal administration of 64 mg/kg was less toxic to the liver and kidneys of mice.', 'C9 peptide has rapid bactericidal activity without detectable high-level resistance, showing certain inhibition and eradication ability on S. epidermidis biofilms. In addition, C9 altered the S. epidermidis cell membrane permeability, depolarization levels, fluidity, and reactive oxygen species (ROS) accumulation and possessed the ability to bind genomic DNA.', 36453944),
('melittin-pexiganan combination, combination of temporin-pexiganan, temporin-melittin combination peptides', 'result found that S. aureus went extinct more rapidly when treated with a mixture of two antimicrobial peptides?pexiganan and melittin?compared to single AMP treatments. Pexiganan combinations result in the most effective combinations, as the MIC value toward pexiganan drops from an average of 9-fold change to 3-fold change in the combinations.', '', 'These results are consistent with the fact that AMP combinations that contain pexiganan were more effective for delaying resistance evolution', 35862981),
('Novel D-form of hybrid peptide (D-AP19)', 'Geometric mean (MIC) of gram negative : GMb (Gr.? strains) = 7.16 microg/ml and geometric mean for gram positive GMd (Gr. + strains) = 5.86 microg/ml', 'AP-19 show minimal hemolytic and cytotoxic activities in mammalian cells.', 'D-AP19 displayed rapid killing via membrane disruption and leakage of intracellular contents. Additionally, it showed a low tendency to induce bacterial resistance. Among the peptides, AP19 demonstrated the best combination of broad-spectrum antibacterial activity including toward Acinetobacter baumannii', 36151303),
('Host defense peptides (HDPs)- design the amphiphilic peptoid polymers', 'The optimal cyclic peptoid polymer, poly(Naeg0.7Npfbg0.3)20, displays strong antibacterial activities against drug-resistant bacteria.', 'low hemolysis and cytotoxicity', 'we design the amphiphilic peptoid polymers by mimicking the positively charged and hydrophobic structures of HDPs and synthesize a series of cyclic peptoid polymers efficiently via the polymerization on alpha-amino acid N-substituted glycine N-carboxyanhydrides (alpha-NNCAs) using 1,8-diazabicycloundec-7-ene (DBU) as the initiator.', 35788576),
('AMP called Pleurocidin (Ple) and its C-terminal-amidated derivative Pleurocidin-amide (Ple-a)', 'Our results indicated that both Ple and Ple-a exhibited significant antibacterial activity against a broad spectrum of Gram-positive and Gram-negative bacteria, especially marine pathogens, with MIC values ranging from 0.25 to 32 microg/mL.', 'Ple and Ple-a also showed notable cytotoxicity toward various cancer cell lines, with IC50 values ranging from 11 to 340 microM, while normal mouse fibroblast 3T3 cells were less susceptible to these peptides.', 'Our results indicated that both Ple and Ple-a exhibited significant antibacterial activity against a broad spectrum of Gram-positive and Gram-negative bacteria, especially marine pathogens. Our findings provided support for the future application of Ple-a as potential therapeutic agent for bacterial infections.', 36005521),
('ApoE mimetic peptide, COG1410', 'In the case of Gram-positive strains, COG1410 inhibited the growth of Bacillus subtilis, vancomycin-resistant Enterococcus faecalis and Enterococcus faecium, and Mycobacterium smegmatis with MICs ranging from 1 to 32 microg/ml. As for Gram-negative bacteria, COG1410 showed antimicrobial activity against Enterobacter cloacae, Escherichia coli, Citrobacter freundii, and even anaerobe, Porphyromonas gingivalis, with MICs ranging from 16 to 64 microg/ml.', 'The minimal concentration that caused the lysis of half of the red blood cells (EC50) was 441 microg/ml. COG1410 exhibited low hemolytic activity and medium cytotoxicity.', 'COG1410 easily entered bacterial cytoplasm and bound to DNA nonspecifically, the major mechanism of COG1410 killing was to disrupt the integrity of cell membrane and lead to leakage of cytoplasmic contents', 36081797),
('Natural Peptide from Vespa mandarinia Venom and Its Synthetic Analogues', 'VM-3K produced a 90% survival of S. aureus-infected waxworms at a concentration of 5.656 mg/kg, at which concentration the natural template peptide only achieved 50% survival. VM-3G also displayed anti-microbial ability against Gram-negative bacteria and had bactericidal effects on E. coli and P. aeruginosa but not on K. pneumoniae', 'VM-3W exhibited haemolysis at a low concentration.', 'peptide VM-3K could be a promising broad-spectrum antimicrobial candidate for addressing the current antibiotic-resistant infection crisis. It is worth mentioning that this investigation on the relationship between peptide structure and mechanism of action could become an important aspect of drug research on short peptides.', 36138742),
('KDEON WK-11: A short antipseudomonal peptide', 'identified its most potent effect, against Pseudomonas aeruginosa with an MIC value of 3.12 microM', '', 'KDEON WK-11 had a broad range of antimicrobial activity and specific capabilities to fight Pseudomonas aeruginosa with low in vitro cytotoxicity and promising potential to express anti-lipopolysaccharide qualities, which could be exploited to expand its properties into an anti-sepsis agent.', 36465859),
('Amino Acid-Rich Antimicrobial Peptides', 'found 138 Leu-rich AMPs active against Staphylococcus aureus and 81 against Escherichia coli. Likewise, there were 39 Pro-rich peptides against E. coli and 15 against S. aureus in the current database.', '', 'no natural AMPs are simultaneously rich in leucine and lysine, while proline, tryptophan, and cysteine-rich peptides can simultaneously be rich in arginine. These findings can be utilized to guide peptide design. Since multiple candidates are potent against antibiotic-resistant bacteria, rich AMPs stand out as promising future antibiotics.', 36361660),
('tachplesin I analogue peptide (TP11A) and tachplesin I', 'Both inhibited C. albicans monomicrobial, S. aureus monomicrobial, and C. albicans-S. aureus polymicrobial biofilms quite well. TP11A suppressed the biofilm- and virulence-related genes of C. albicans (hwp 1) and S. aureus (ica A, fnb B, agr A, hla, nor A, and sig B) in the mixed biofilm,', '', '', 35998684),
('antimicrobial peptidomimetics called peptoids (sequence-specific oligo-N-substituted glycines) the sequence-specific pentamer TM5', 'the MIC values for TM5 against Pseudomonas aeruginosa (PAO1) and Staphylococcus aureus (SA25923) are 8 microg/mL and 16 microg/mL, respectively.', 'determined the cytotoxicity of TM5 against A549 lung epithelial cells to identify a non-cytotoxic concentration. A549 cell exposure to 50 microg/mL of TM5 for 24 h exposure did not cause cytotoxicity . TM5 has been shown to be safe on 3D human primary cultures of epithelial cells', 'demonstrated that TM5 is a multi-functional platform that can be used to eradicate biofilms and mitigate LPS-induced cytokine production. Future studies will explore the in vivo anti-persister cell activity of TM5 using a chronic biofilm infection animal model. Furthermore, the antimicrobial molecular mechanisms of TM5 seems to prevent resistance development. Although our resistance study showed that resistance development against TM5 is unlikely.', 36018039),
('arenicins, antimicrobial peptides from the lugworm Arenicola marina', 'Peptide AA139, like other arenicins, exhibited an inhibitory effect on complement at a concentration of 160 microg/Ml', '', 'our results suggest that the effect on the complement system should be taken into account in the development of antibiotics based on arenicins.', 36286436),
('Stable isotope analysis with antimicrobial random peptide mixtures (RPMs). The RPMs used in this study consisted of 20-mer peptide composed of either L-phenylalanine and L-lysine (FK20) or phenylalanine with D-lysine (FdK20) in 1:1 molar ratio', 'FK20 induced a reduction of the MIC of four bacteria (i.e. X. campestris, X. perforans, C. michiganensis and P. syringae) to between 4 and 21% of the corresponding untreated control samples (> 200 microg/mL). Two pathogenic bacteria, S. scabies and A. citrulli, were not affected by the treatment with FK20. Effects of FdK20 on the bacteria were very similar with the exception of P. syringae which was not affected by FdK20', '', 'Stable carbon isotope analysis invariably verified the changes in the FA groups of bacteria caused by treatment with FK20 and FdK20. Also, growth inhibition of bacteria by FK20 and FdK20 was generally associated with changes in the FA groups except for FdK20 in the case of C. michiganensis. The approach used in this study could be helpful in the search not only of novel antimicrobial RPMs but also other antibiotics such as polymyxin B.', 35789165),
('Antimicrobial potential of a ponericin-like peptide', 'Results showed that Bm-ponericin-L1, at 4 ppm, inhibited biofilm formation by > 85% (P. aeruginosa) and > 90% (K. pneumoniae), after 24 h of incubation', '', 'Study revealed that infection with P. aeruginosa triggers the humoral response in B. mori larvae. The purified peptide fraction screened from the infected silkoworm found to be active against E. faecium , S. aureus , K. pneumoniae, A. baumannii , P. aeruginosa, and E. agglomerans, belonging to the ESKAPE group. This is the first report regarding the production and isolation of a ponericin in B. mori hemolymph upon P. aeruginosa infection. Bm-ponericin-L1was found to be highly specific towards bacterial cells suggesting its cell selectivity.', 36109567),
('cross-linked lyotropic liquid crystals, formed by the self-assembly of the block copolymer Pluronic F-127.', 'The liquid crystal particles were shown to have antibacterial effect corresponding to a 4 log reduction against Staphylococcus aureus.', '', 'The bonding to the particles gave the AMPs improved stability in serum, as they retained almost all of the antibacterial potency for 2 days compared to free AMPs, which lost all of its antibacterial potency within a day.', 36152992),
('florfenicol-polyarginine conjugates', 'These conjugates also showed excellent activity against drug-resistant strains such as methicillin-resistant S. aureus (MRSA) and florfenicol resistant Escherichia coli strains (2017XJ30, 2019XJ20), one of which as E6 had a minimum inhibitory concentration of 12.5 micromol/L.', '', 'Polyarginine peptides are widely used as CPPs and shown to inhibit bacteria by entering certain microbial cell membranes. This suggested that conjugating arginine to florfenicol succinate effectively modulated the properties of prodrugs. These new conjugates may provide useful insights for expanding the pool of antibiotics.', 35844651),
('three peptides (LS-AMP-E1, LS-AMP-F1, and LS-AMP-G1) from Chinese Wolf Spider Lycosa sinensis', 'LS-AMP-E1 and LS-AMP-F1 exhibited similar antibacterial effects towards tested microbes. The MIC values of LS-AMP-E1 and LS-AMP-F1 against 6 tested strands ranged between 50 and 6.25 microM, except for P. vulgaris and S. aureus (not detected within 50 microM). LS-AMP-G1, on the other hand, had no discernible effect on the growth of any one of the reference strains. (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species)', '', 'In terms of antimicrobial mechanisms, LS-AMP-E1 and LS-AMP-F1 destroyed the integrity of bacterial cell membranes in a short period of time and completely inhibited bacterial growth within 10 min of action. Meanwhile, high concentrations of Mg2+ effectively reduced the antibacterial activity of LS-AMP-E1 and LS-AMP-F1. Together, it suggested that the two peptides interact directly on bacterial cell membranes.', 36432731),
('Parietin (PTN) or physcion', 'Complexation of PTN increased the aqueous solubility 28-fold and the photostability compared to free PTN. PTN/HP-beta-CD complexes reduce the bacterial viability of Staphylococcus saprophyticus and Escherichia coli by > 4.8 log and > 1.0 log after irradiation, respectively.', '', 'As an alternative therapeutic option, antimicrobial photodynamic therapy (aPDT) can successfully eradicate antibiotic-resistant bacteria with a lower probability of developing resistance or systemic toxicity commonly associated with the standard antibiotic treatment.', 35214089);

-- --------------------------------------------------------

--
-- Table structure for table `virus_amp`
--

CREATE TABLE IF NOT EXISTS `virus_amp` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` varchar(5000) NOT NULL,
  `SAFETY_INFORMATION` varchar(2000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `virus_amp`
--

INSERT INTO `virus_amp` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('C20-Jp-Hp, Antiviral peptides generated by conjugating two known short antiviral peptides: part-1 (named Jp with the sequence of ARLPR) and part-2 (named Hp with the sequence of KKWK)', 'The anti-IAV screening results identified that C20-Jp-Hp was the most potent peptide with IC50 value of 0.53 microM against A/Puerto Rico/8/34 (H1N1) strain.', '', 'Herein, we show a new class of antiviral peptides generated by conjugating two known short antiviral peptides: part-1 (named Jp with the sequence of ARLPR) and part-2 (named Hp with the sequence of KKWK).', 26952867),
('Tripeptide GPG-NH2', 'Inhibits the replication of HIV-1, 50% inhibitory concentrations values were 2.7 to 37 microM', '', 'CONCLUSIONS: The tripeptide GPG-NH2 is a nontoxic compound that inhibits the replication of HIV-1 by an apparently new mode of action. Glycyl-prolyl-glycine-NH2 might prove useful by itself or as a lead compound for the treatment of drug-resistant HIV-1.', 11213928),
('P-1946', 'Specific HIV-1 protease inhibitor that has potent and selective in vitro antiviral activity (EC50 152 nM) against a range of isolates resistant to commercially available protease inhibitors.', '', 'Antiviral activity and cross-resistance profile of P-1946, a novel human immunodeficiency virus type 1 protease inhibitor. The HIV protease inhibitor P-1946 is a member of a novel family of l-Lysine derivatives.', 16473417),
('T-20EK - T-20 (enfuvirtide) through engineered electrostatic interactions between glutamic acid (E) and lysine (K) substitutions.', 'Anti-HIV-1', '', 'HIV-1 resistance mechanism to an electrostatically constrained peptide fusion inhibitor that is active against T-20-resistant strains. T-20EK is a novel fusion inhibitor designed to have enhanced ?-helicity over T-20 (enfuvirtide) through engineered electrostatic interactions between glutamic acid (E) and lysine (K) substitutions.', 23689710),
('King cobra cathelicidin (OH-CATH)', 'Both L- and D-OH-CATH30 showed higher efficacy against (toward) Gram-positive bacteria and stronger antibacterial activity against nearly all Gram-negative bacteria tested compare with antibiotics.', '', 'King cobra peptide OH-CATH30 as a potential candidate drug through clinic drug-resistant isolates. Cationic antimicrobial peptides (AMPs) are considered as important candidate therapeutic agents, which exert potent microbicidal properties against bacteria, fungi and some viruses.', 29515090),
('PIE12-trimer', 'First D-peptide HIV entry inhibitor with the breadth and potency required for clinical use.', '', 'D-peptides (peptides composed of D-amino acids) are promising therapeutic agents due to their insensitivity to protease degradation. PIE12-trimer was designed using structure-guided mirror-image phage display and linker optimization and is the first D-peptide HIV entry inhibitor with the breadth and potency required for clinical use.', 20719956),
('Series of oligomeric HR2 peptides with increased helical structure and with exceptionally high HR1/HR2 bundle stability', 'The engineered peptides are found to be as much as 3,600-fold more active than ENF against viruses that are resistant to the HR2 peptides ENF, T-1249, or T-651.', '', 'Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus. Enfuvirtide (ENF), the first approved fusion inhibitor (FI) for HIV, is a 36-aa peptide that acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus-cell fusion.', 17640899),
('Muramyl dipeptide (MDP)', 'MDP exhibited an inhibitory activity against HIV infection of CD4+ H9 lymphocytes and U937 monocytoid cells.', '', 'Muramyl dipeptide inhibits replication of human immunodeficiency virus in vitro. An inhibitor of viral reverse transcriptase, 2'', 3''-dideoxyadenosine, produced potent inhibition in cultures which were similarly infected with HIV.', 2111159),
('SC34EK', 'Demonstrates remarkably potent inhibition of membrane fusion by the resistant HIV-1 variants as well as wild-type viruses.', '', 'Electrostatically constrained alpha-helical peptide inhibits replication of HIV-1 resistant to enfuvirtide. In particular, the modified peptide, SC34EK, demonstrates remarkably potent inhibition of membrane fusion by the resistant HIV-1 variants as well as wild-type viruses.', 18834950),
('Fatty acid-conjugated lipopeptide named LP-11', 'Showed potent and broad inhibitory activity against diverse primary HIV-1 isolates and clinically drug-resistant mutants, and it had dramatically increased ex-vivo antiviral activity and extended half-life.', '', 'DESIGN: On the basis of the M-T hook structure, we recently developed a short-peptide named HP23, which mainly targets the deep pocket site of gp41 and possesses highly potent antiviral activity.', 26919736),
('Aza-dipeptide analogues [8 aza-dipeptide analogues carrying N-(bis-aryl-methyl) substituents on the (hydroxethyl)hydrazine moiety]', 'Potent and orally absorbed HIV-1 protease inhibitors, candidates for clinical development', '', 'New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors: candidates for clinical development.', 9719591),
('Albuvirtide (ABT), a 3-maleimimidopropionic acid-modified peptide fusion inhibitor', 'ABT had potent inhibitory activity against the subtypes A, B and C that predominate the worldwide AIDS epidemics, and subtype B'', CRF07_BC and CRF01_AE recombinants that are currently circulating in China.', '', 'The results showed that ABT had potent inhibitory activity against the subtypes A, B and C that predominate the worldwide AIDS epidemics, and subtype B'', CRF07_BC and CRF01_AE recombinants that are currently circulating in China.', 22403678),
('Ancestral peptide (named P3)', 'mean IC50, 63.8 nmol/l', '', 'CONCLUSION: P3 is an HIV-2/SIV ancestral peptide with low antigenicity, high stability, and potent activity against both HIV-1, including variants resistant to T-20, and HIV-2.', 23324659),
('Artificial peptides containing four heptad repeats (m4HR) conjugated with a pocket-specific small molecule (pssm) or pssm and cholesterol (chol) [pssm-m4HR or pssm-m4HR-chol]', 'pssm-m4HR conjugates exhibited promising inhibitory activity against HIV-1 Env-mediated cell-cell fusion and laboratory-adapted HIV-1 replication with IC50 values at the low micromolar level, whereas the pssm-m4HR-chol conjugates exhibited dramatically increased anti-HIV-1 activities with IC50 values at the low nanomolar level. Some of the pssm-m4HR-chol conjugates (e.g. 5a and 5b) showed highly potent antiviral activity against infection by primary HIV-1 isolates and enfuvirtide-resistant HIV-1 strains.', 'No or low cytotoxicity towards MT-2 cells', 'These results suggest this scaffold design is a promising strategy for developing novel peptide conjugates with improved antiviral activity against a broad spectrum of HIV-1 strains, including those highly resistant to enfuvirtide.', 24500189),
('p5RD(D-form of heparan sulfate binding peptide)', 'Reduce HCMV infectivity in vitro including GCV resistant HCMVs and MCMV infection', '', 'In an effort to develop novel CMV treatments, we tested the effectiveness of the D-form of a novel heparan sulfate binding peptide, p5RD, at reducing infection of ganciclovir (GCV) resistant HCMVs in vitro and MCMV in vivo.', 27678155),
('SK&F 107647', 'Increase natural host resistance to infections caused by both gram-negative and gram-positive bacteria.', '', 'Treatment of experimental gram-negative and gram-positive bacterial sepsis with the hematoregulatory peptide SK&F 107647. SK&F 107647, a novel synthetic low-molecular-weight peptide, has demonstrated potent antiinfective activities in murine models of fungal and viral infection.', 8537660),
('P3 and an arginine-substituted analog, JH-3', 'Potent antimicrobial activities against drug-resistant strains by disrupting and penetrating the bacterial cytoplasmic membrane', '', 'P3, a novel hemoglobin peptide derived from bovine erythrocytes, exhibited modest antimicrobial activity in vitro.', 25753638),
('Labyrinthopeptin A1 (LabyA1)', 'LabyA1 exhibited a consistent and broad anti-HIV activity (EC50s: 0.70-3.3 microM) and anti-HSV activity (EC50s: 0.29-2.8 microM) in cell cultures. LabyA1 also inhibited viral cell-cell transmission between persistently HIV-infected T cells and uninfected CD4(+) T cells (EC50?2.5 microM) and inhibited the transmission of HIV captured by DC-SIGN(+)-cells to uninfected CD4(+) T cells (EC50?4.1 microM).', '', 'LabyA1 can be considered as a novel lead peptide as it had profound antiviral activity against HIV and HSV.', 23724015),
('Peptide (6a)', 'Among the peptides synthesized and evaluated, a lead peptide (6a) with potent activity (IC50: 4.4nM) was identified against the MDR769 HIV-1 protease.', '', 'Design, synthesis and evaluation of a potent substrate analog inhibitor identified by scanning Ala/Phe mutagenesis, mimicking substrate co-evolution, against multidrug-resistant HIV-1 protease.', 23921229),
('antimicrobial peptide conjugated poly (glycolic acid-co-caprolactone) (PGCL) sutures', 'against P. aeruginosa, methicillin-resistant S. aureus (MRSA) strains and viruses by using antimicrobial peptide sequences of KRFRIRVRV-NH2, RWRWRWRW-NH2 and their dual combination (1:1).', 'without any cytotoxic effect to combat surgical site infections is vital.', '', 36510770);

-- --------------------------------------------------------

--
-- Table structure for table `virus_light`
--

CREATE TABLE IF NOT EXISTS `virus_light` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `virus_light`
--

INSERT INTO `virus_light` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('photoimmuno-antimicrobial strategy (PIAS)', 'PIAS acts on a broad range of microbes, including the bacterial pathogen Staphylococcus aureus, fungal pathogen Candida albicans, including their drug-resistant strains, and viral pathogen SARS-CoV-2, the causative agent of COVID-19.', 'PIAS protects mice from fatal infections without damaging the non-targeted host microbiota and tissues.', 'This study may contribute to the development of next-generation anti-infective therapies. Conjugates, 0.1 microg/mL; near-infra-red light (NIR) illumination, 10 J/cm2 used against SARS-CoV-2.', 35788695);

-- --------------------------------------------------------

--
-- Table structure for table `virus_naturalproduct`
--

CREATE TABLE IF NOT EXISTS `virus_naturalproduct` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `virus_naturalproduct`
--

INSERT INTO `virus_naturalproduct` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('S. chinensis fruit lignans, Schisandrin B and Deoxyschizandrin', 'HIV-1 inhibitor', '', 'From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors. We purified 6 lignans from Schisandra chinensis fruits and assayed their effects on HIV-1 RT and viral replication. Among the S. chinensis fruit lignans, Schisandrin B and Deoxyschizandrin selectively inhibited the HIV-1 RT-associated DNA polymerase activity', 25740376),
('Pomegranate rind extract and punicalagin coadministered zinc (II)', 'Herpes simplex virus (HSV)', '', 'Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV. BACKGROUND: There is a clinical need for new therapeutic products against Herpes simplex virus (HSV).', 28665969),
('Licochalcone G (1) and seven known (2-8) chalcones', 'Activity influenza viral strains, H1N1, H9N2, novel H1N1 (WT), and oseltamivir-resistant novel H1N1 (H274Y)', '', 'Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata. During our course of an anti-influenza screening program on natural products, one new licochalcone G (1) and seven known (2-8) chalcones were isolated as active principles from the acetone extract of Glycyrrhiza inflata.', 21123068),
('Calanolides A (1) and B (4)', 'Against HIV-1', '', 'The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. Eight new coumarin compounds (1-8) were isolated by anti-HIV bioassay-guided fractionation of an extract of Calophyllum lanigerum.', 1379639),
('LADANIA067 from the leaves of the wild black currant (Ribes nigrum folium)', 'Anti influenza A viruses (IAV)', '', 'A plant extract of Ribes nigrum folium possesses anti-influenza virus activity in vitro and in vivo by preventing virus entry to host cells. In conclusion, an extract from the leaves of the wild black currant might be a promising source for the development of new antiviral compounds to fight IAV infections.', 23717460),
('N-acetylglucosamine-binding protein from Urtica dioica (UDA)', 'Prevents HIV entry', '', 'Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV GP120: a new therapeutic concept to hit the achilles heel of HIV. Mannose-binding proteins derived from several plants (i.e.', 16183648),
('Cajanine derivatives Cajanus cajan L.', 'Cajanine was identified as a potent HCV inhibitor with EC50?= 3.17 ? 0.75 microM', '', 'Design and Synthesis of Cajanine Analogues against Hepatitis C Virus through Down-Regulating Host Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1. There still remains a need to develop new anti-HCV agents with distinct mechanism of action (MOA) due to the occurrence of resistance to direct-acting antiviral agents (DAAs).', 27783522),
('Melissa extract', 'Free viral particles of two acyclovir-resistant HSV strains at low IC50 values of 0.13 and 0.23 microg/mL', 'Melissa extract exhibits low toxicity and affects attachment and penetration of acyclovir-sensitive and acyclovir-resistant HSVs in vitro.', 'Attachment and penetration of acyclovir-resistant herpes simplex virus are inhibited by Melissa officinalis extract. Medicinal plants are increasingly of interest as novel source of drugs for antiherpetic agents, because herpes simplex virus (HSV) might develop resistance to commonly used antiviral drugs.', 24817544),
('Nordihydroguaiaretic acid (6)', 'HIV-1 Nucleocapsid Protein Inhibitors', '', 'Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains. Here, using a multidisciplinary approach combining in silico screening, fluorescence-based molecular assays, and cellular antiviral assays, we identified nordihydroguaiaretic acid (6), as a novel natural product inhibitor of NC.', 29235845),
('Cistus incanus (Ci) extracts', 'Ci extracts show potent and broad in vitro antiviral activity against viruses that cause life-threatening diseases in humans and are promising sources of agents that target virus particles.', '', 'Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins. These results demonstrate that Ci extracts show potent and broad in vitro antiviral activity against viruses that cause life-threatening diseases in humans and are promising sources of agents that target virus particles.', 26833261),
('Brazilian flora [natural alkaloid isolated from Maytrenus ilicifolia, and the lignans from Peperomia blanda]', 'The compounds APS (EC50=2.3microM), a natural alkaloid isolated from Maytrenus ilicifolia, and the lignans 3(?)43 (EC50=4.0microM), 3(?)20 (EC50=8.2microM) and 5(?)362 (EC50=38.9microM) from Peperomia blanda dramatically inhibited HCV replication as judged by reductions in luciferase activity and HCV protein expression in both the subgenomic and infectious systems.', '', 'Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitro.', 25557602),
('Chinese medicinal formula Liangcha', 'Chinese medicinal formula Liangcha, inhibition rate more than 50% at the concentration of 5.3 microg/mL.', 'it was not significantly cytotoxic in several T lymphocytes cell lines with CC50 range 564.79 - 1699.22 microg/mL.', 'RESULTS: The extracts from Chinese medicinal formula Liangcha exhibited potent and broad-spectrum anti-HIV-1 activity on different HIV-1 strains with EC50 range 12.74 -116.87 microg/mL, but weakly inhibited HIV-2 replication.', 21243774),
('MeOH extract of Symphyocladia latiuscula', '2,3,6-tribromo-4,5-dihydroxybenzyl methyl ether (TDB) of a CH(2)Cl(2)-soluble fraction was active against wild type HSV-1, as well as AP(r) HSV-1 and TK(-) HSV-1 (IC(50) values of 5.48, 4.81 and 23.3 microg/ml, respectively)', '', 'Antiviral activity of the marine alga Symphyocladia latiuscula against herpes simplex virus (HSV-1) in vitro and its therapeutic efficacy against HSV-1 infection in mice', 16327161),
('Acacia catechu extracts', 'The aqueous and 50% ethanolic extracts of A. catechu showed IC50 values of 1.8 ? 0.18 ?g/ml and 3.6 ? 0.31 ?g/ml, respectively in cell-free virus based assay using TZM-bl cells and HIV-1NL4.3 (X-4 tropic), The n-butanol fraction demonstrates a potent inhibitory activity against the viral protease (IC50 = 12.9 microg/ml), but not reverse transcriptase or integrase.', '', 'Extracts from Acacia catechu suppress HIV-1 replication by inhibiting the activities of the viral protease and Tat', 25228267),
('Polyphenol rich extract (CYSTUS052) from the Mediterranean plant Cistus incanus', 'Effective dose of 50 microg/ml', '', 'Here we demonstrate that a polyphenol rich extract (CYSTUS052) from the Mediterranean plant Cistus incanus exerts a potent anti-influenza virus activity in A549 or MDCK cell cultures infected with prototype avian and human influenza strains of different subtypes.', 17572513),
('Micrococcin P1', 'Inhibiting HCV entry with an EC50 range of 0.1-0.5 microM.', '', 'Accordingly, our study aimed to identify affordable novel HCV inhibitors by screening of natural product compound libraries.', 27387825),
('Phyllanthus extract', 'Inhibited HBV DNA synthesis', '', 'Inhibitory effect of Phyllanthus urinaria L. extract on the replication of lamivudine-resistant hepatitis B virus in vitro. These data indicate that Phyllanthus extract may be useful as an alternative therapeutic agent for the treatment of drug-resistant CHB patients.', 26220282),
('irisolidone', 'anti-inflammatory, antiangiogenic, anti-cancer, anti-platelet, anti-oxidant, anti-hyperlipidemic, immunomodulating, hepatoprotective and estrogenic potential', '', 'Conclusion: Present work signified the biological importance and therapeutic potential of irisolidone in medicine.', 35249525),
('Pistacia lentiscus bark methanol extract', 'extract of P. lentiscus bark could be a beneficial source for novel flavonoid glycosides inhibitors against SARS-CoV-2 infection', '', 'Taken together, this study highlights the Pistacia lentiscus bark methanol extract as a promising antimicrobial and antiviral agent.', 35624793);

-- --------------------------------------------------------

--
-- Table structure for table `virus_novelagent`
--

CREATE TABLE IF NOT EXISTS `virus_novelagent` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `virus_novelagent`
--

INSERT INTO `virus_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('2-alkyl-2-aminoadamantane derivatives with sufficient adducts', 'Activity against p2009 influenza A', '', 'The results indicate that 2-alkyl-2-aminoadamantane derivatives with sufficient adducts can persistently block p2009 influenza A in vitro through an alternative mechanism.', 24793875),
('Naphthyridone 3 (HM13N)', 'Inhibit the HIV-1', '', 'A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication. The emergence of multidrug resistant HIV-1 strains and the inability of the HAART to eradicate HIV-1 virus from infected patients demand new drugs able to interfere with an alternative step of the replicative cycle.', 19958026),
('Conjugation of D4T with 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (MKC-442, emivirine)', 'Anti-HIV activity', '', 'Conjugation of D4T with 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (MKC-442, emivirine)-type reverse transcriptase inhibitors via the SATE prodrug approach. This paper reports the synthesis and the antiviral activities of new double-prodrugs against HIV based on the known mixed SATE (S-acyl-2-thioethyl) prodrug approach.', 15715487),
('2-cyano-3-acrylamide small-molecule', 'Activity against murine norovirus (MNV) and Listeria', '', 'Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens. Due to the rise of antibiotic resistance and the small number of effective antiviral drugs, new approaches for treating infectious diseases are urgently needed.', 27139470),
('2,4-diarylaniline analogs (DAANs) derivatives 9a-9e', 'HIV-1 reverse transcriptase inhibitors, compound 9e not exhibited extremely high potency against wild-type virus (EC(50) 0.53 nM) and several resistant viral strains (EC(50) 0.36-3.9 nM)', '', 'Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors. The current optimization of 2,4-diarylaniline analogs (DAANs) on the central phenyl ring provided a series of new active DAAN derivatives 9a-9e, indicating an accessible modification approach that could improve anti-HIV potency against wild-type and resistant strains, aqueous solubility, and metabolic stability.', 22406117),
('UC 38, analog of oxathiin carboxanilide', 'Anti-HIV activity', '', 'Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor. UC 38, a simple analog of oxathiin carboxanilide, UC 84, lacking the oxathiin ring, was found to be a potent inhibitor of human immunodeficiency virus (HIV)-1-induced cell killing and HIV replication in a variety of human cell lines, as well as in human peripheral blood lymphocytes and macrophages.', 8558446),
('Pyridazinone derivative, compound 3711', 'Inhibits hepatitis B virus', '', 'Pyridazinone derivative 3711, a novel chemical entity and HBV inhibitor, may provide a new opportunity to combat chronic HBV infection.', 26349829),
('1,1,3-trioxo-2H,4H-thieno[3,4-e] [1,2,4]thiadiazine (TTD) derivatives, i.e., 2-(3-fluorobenzyl)-4-cyanomethylen-l,1,3-trioxo-2H,4H- thieno [3,4-e] [1,2,4] thiadiazine) (QM96639)', 'Inhibit human immunodeficiency virus (HIV) type 1 [HIV-1 (IIIB)] at concentration 0.09 microM', '', '1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity. We report the development of a new group of nonnucleoside reverse transcriptase inhibitors (NNRTIs).', 9517942),
('BAY 57-1293', 'Against HSV infection', '', 'Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293. BAY 57-1293 belongs to a new class of antiviral compounds and inhibits replication of herpes simplex virus (HSV) type 1 and type 2 in the nanomolar range in vitro by abrogating the enzymatic activity of the viral primase-helicase complex.', 12019088),
('Urea-PETT (phenylethylthiazolylthiourea)', 'HIV-1 inhibitor', '', 'Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues. The further development of allosteric HIV-1 RT inhibitors in the urea analogue series of PETT (phenylethylthiazolylthiourea) derivatives is described here. The series includes derivatives with an ethyl linker (1-5) and racemic (6-16) and enantiomeric (17-20) cis-cyclopropane compounds.', 10514285),
('Diphenyl heterocyclic compounds(R706)', 'hepatitis C virus (HCV)', '', 'We conclude that R803 and related heterocyclic compounds constitute a new class of HCV-specific inhibitors that could potentially be developed as a treatment for HCV infection.', 18227176),
('Crown-Like Oxotricyclic Core as the P2-Ligand', 'HIV-1 inhibitor', '', 'Design and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants. Design, synthesis, and evaluation of a new class of exceptionally potent HIV-1 protease inhibitors are reported.', 28418652),
('Neoechinulin B and its analogues', 'Activity against H1N1 virus', '', 'A class of prenylated indole diketopiperazine alkaloids including 15 new compounds namely rubrumlines A-O obtained from marine-derived fungus Eurotium rubrum, were tested against influenza A/WSN/33 virus. Neoechinulin B (18) exerted potent inhibition against H1N1 virus infected in MDCK cells, and is able to inhibit a panel of influenza virus strains including amantadine- and oseltamivir-resistant clinical isolates.', 25681711),
('Meso-tetrakis-(3,5-dicarboxy-4,4''-biphenyl) porphyrin', 'Activity against hepatitis C virus (HCV)', '', 'A novel class of meso-tetrakis-porphyrin derivatives exhibits potent activities against hepatitis C virus genotype 1b replicons in vitro. Recent years have seen the rapid advancement of new therapeutic agents against hepatitis C virus (HCV) in response to the need for treatment that is unmet by interferon (IFN)-based therapies.', 19901090),
('Combination of the (R)-(hydroxyethylamino)sulfonamide isostere and the cyclic urea component of lopinavir', 'HIV-1 inhibitor', '', 'Discovery of imidazolidine-2,4-dione-linked HIV protease inhibitors with activity against lopinavir-resistant mutant HIV. A new series of HIV protease inhibitors has been designed and synthesized based on the combination of the (R)-(hydroxyethylamino)sulfonamide isostere and the cyclic urea component of lopinavir.', 16828558),
('PTC725', 'Targets the hepatitis C Virus NS4B protein', '', 'Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B protein. While new direct-acting antiviral agents for the treatment of chronic hepatitis C virus (HCV) infection have been approved, there is a continued need for novel antiviral agents that act on new targets and can be used in combination with current therapies to enhance efficacy and to restrict the emergence of drug-resistant viral variants.', 23629699),
('Acridone derivatives, obtained by reaction of acridone-4-carboxylic acid derivatives with aromatic amines', 'NS3 helicase of hepatitis C virus (HCV) with IC(50) range from 1.5 to 20 microM', '', 'Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication. A new goup of acridone derivatives, obtained by reaction of acridone-4-carboxylic acid derivatives with aromatic amines, was tested to determine the inhibitory properties toward the NS3 helicase of hepatitis C virus (HCV).', 20337460),
('Novel compounds generated by merging pharmacophores of salicylate and catechol [2,3-dihydroxybenzamide (5a), structural modifications on the 5a scaffold with carboxamide and the piperidin-1-ylsulfonyl substituted at the phenyl ring to generate (5p), N-(cyclohexylmethyl)-2,3-dihydroxy-5-(piperidin-1-ylsulfonyl) benzamide (5u)]', 'HIV-1 inhibitor, 5p, IC(50)=5 microM, 5u IC(50) value of 8 microM', '', 'Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups. By merging the pharmacophores of salicylate and catechol, the 2,3-dihydroxybenzamide (5a) was identified as a new scaffold to inhibit the strand transfer reaction efficiently.', 21778063),
('Bicyclic hydroxy-1H-pyrrolopyridine-triones', 'HIV-1 integrase inhibitors', '', 'Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors. We report herein bicyclic hydroxy-1H-pyrrolopyridine-triones as a new family of HIV-1 integrase inhibitors that were efficiently prepared using a key ''Pummerer cyclization deprotonation cycloaddition'' cascade of imidosulfoxides.', 22107736),
('N-(2-phenylethyl)-N''-(2-thiazolyl)thiourea (LY73497)', 'Inhibit HIV-1 but not HIV-2', '', 'The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. To identify the minimal structural elements necessary for biological activity, the rigid tricyclic nucleus of the known human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) inhibitor tetrahydroimidazobenzodiazepinthione was subjected to systematic bond disconnection to obtain simpler structures.', 7574525),
('1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils', 'HIV-1 non-nucleoside reverse transcriptase inhibitors', '', 'Design, synthesis, and biological evaluation of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as potent HIV-1 non-nucleoside reverse transcriptase inhibitors with an improved drug resistance profile. Because the emergence of drug-resistant mutants has limited the efficacy of non-nucleoside reverse transcriptase inhibitors (NNRTIs), it is essential to develop new antivirals with better drug resistance and pharmacokinetic profiles. Here we designed and synthesized a series of 1-[(2-benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils, the HEPT analogues, and evaluated their biological activity using nevirapine and 18 (TNK-651) as reference compounds.', 22283377),
('Amidine 6 and guanidine 7', 'Activity against oseltamivir-resistant influenza viruses', '', 'Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A. With the emergence of oseltamivir-resistant influenza viruses and in view of a highly pathogenic flu pandemic, it is important to develop new anti-influenza agents. Several 5-guanidino- and 5-amidino-based oseltamivir derivatives were synthesized and profiled for their anti-influenza activity and in vitro and in vivo PK properties. Amidine 6 and guanidine 7 were comparably effective against a panel of different A/H1N1 and A/H3N2 strains and also inhibited mutant A/H1N1 neuraminidase. Among different prodrug strategies pursued, a simple amidoxime ethyl ester (9) exhibited a superior PK profile with an oral bioavailability of 31% (rats), which is comparable to oseltamivir (36%). Thus, bioisosteric replacement of the 5-guanidine with an acetamidine-in the form of its N-hydroxy prodrug-successfully tackled the two key limitations of currently used NA inhibitors, as exemplified with oseltamivir.', 24422530),
('PL-100', 'Potent inhibition of HIV-1 protease and viral replication in vitro (K(i), approximately 36 pM, and 50% effective concentration [EC(50)], approximately 16 nM, respectively)', '', 'In vitro antiviral activity and cross-resistance profile of PL-100, a novel protease inhibitor of human immunodeficiency virus type 1. Despite the success of highly active antiretroviral therapy, the current emergence and spread of drug-resistant variants of human immunodeficiency virus (HIV) stress the need for new inhibitors with distinct properties.', 17638694),
('1H-1,2,3-triazole-4-carboxamide derivative 3b', 'Anti-influenza A viruses, H5N1 (RG14), amantidine-resistant A/WSN/33 (H1N1), and oseltamivir-resistant A/WSN/1933 (H1N1, 274Y) virus strains', '', 'Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein. The influenza virus nucleoprotein (NP) is an emerging target for anti-influenza drug development.', 22332894),
('3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides', 'Inhibit HIV-1 Integrase and RNase H', '', '3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H. On the basis of our previously reported 3-hydroxypyrimidine-2,4-dione (HPD) core, we have designed and synthesized a new integrase strand transfer (INST) inhibitor type featuring a 5-N-benzylcarboxamide moiety. Significantly, the 6-alkylamino variant of this new chemotype consistently conferred low nanomolar inhibitory activity against HIV-1.', 27283261),
('4-Benzyloxy-gamma-sultone (4- and 5-substituted-5H-1,2-oxathiole-2,2-dioxide derivatives ) derivatives', 'Against human cytomegalovirus (HCMV) and varicella zoster virus (VZV)', '', '4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus. We report the synthesis and antiviral activity of a new family of non-nucleoside antivirals, derived from the 4-keto-1,2-oxathiole-2,2-dioxide (beta-keto-gamma-sultone) heterocyclic system.', 19226140),
('(3aS,4S,7aR)-hexahydro-2H-furo[2,3-b]pyran-4-ol, (-)-7', 'Activity against multidrug-resistant HIV-1 variants', '', 'Design and synthesis of potent HIV-1 protease inhibitors incorporating hexahydrofuropyranol-derived high affinity P(2) ligands: structure-activity studies and biological evaluation. The design, synthesis, and evaluation of a new series of hexahydrofuropyranol-derived HIV-1 protease inhibitors are described.', 21194227),
('New series of fused heteroaromatic sulfonamides', 'Against HIV-1', '', 'Design of HIV-1 protease inhibitors active on multidrug-resistant virus. On the basis of structural data gathered during our ongoing HIV-1 protease inhibitors program, from which our clinical candidate TMC114 9 was selected, we have discovered new series of fused heteroaromatic sulfonamides.', 15771440),
('4-substituted 1,5-diarylanilines( three most promising compounds 14e, 14h, and 15h)', 'Activity against HIV-1, EC(50) values ranging from 0.2 to 10 nM', '', 'Design, synthesis, and preclinical evaluations of novel 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidates. Twenty-one new 4-substituted diarylaniline compounds (DAANs) (series 13, 14, and 15) were designed, synthesized, and evaluated against wild-type and drug resistant HIV-1 viral strains.', 22856541),
('MP-134 and MP-167', 'Inhibitors of HIV type 1 protease', '', 'Design, synthesis, and resistance patterns of MP-134 and MP-167, two novel inhibitors of HIV type 1 protease. Inhibitors of HIV-1 protease represent a new class of antiretroviral compounds.', 8825619),
('1-aryl-4,6-diamino-1,2-dihydrotriazine derivatives', 'Inhibitors of influenza A and B virus and respiratory syncytial virus (RSV) via targeting of the host dihydrofolate reductase (DHFR) enzyme. best compounds (11, 13, 14 and 16) even reached the sub-micromolar potency of zanamivir (EC50 = 0.060 ?M)', '', 'We have identified a series of 1-aryl-4,6-diamino-1,2-dihydrotriazines, structurally related to the antimalarial drug cycloguanil, as new inhibitors of influenza A and B virus and respiratory syncytial virus (RSV) via targeting of the host dihydrofolate reductase (DHFR) enzyme.', 28477572),
('1H-benzo[de]isoquinoline-1,3(2H)-diones', 'Inhibitors of HCV NS5B polymerase.', '', 'Herein, we present 1H-benzo[de]isoquinoline-1,3(2H)-diones as a new series of selective inhibitors of HCV NS5B polymerase.', 19877603),
('Imide derivatives of 3-nitro-1.8-naphthalic acid', 'Activity against herpes simplex type 2 (HSV-2) and adenovirus type 5 (Ad-5)', '', 'Imide derivatives of 3-nitro-1.8-naphthalic acid: their inhibitory activity against DNA viruses. The antiviral action of a new drug, 5-amino-2-(dimethylaminoethyl)-benzo-[de]-isoquinolin-1.3-dione has been studied against herpes simplex type 2 (HSV-2) and adenovirus type 5 (Ad-5) grown in Vero cells.', 6299235),
('SPD754 (also known as AVX-754)', 'Activity against HIV-1 and HIV-2 in vitro and against recombinant viruses containing thymidine analogue mutations (TAMs)', '', 'In vitro activity of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor (NRTI), against 215 HIV-1 isolates resistant to other NRTIs.', 16245645),
('9-phenylcyclohepta[d]pyrimidinedione derivatives', 'Inhibit HIV-1 replication', '', 'Inhibitory activity of 9-phenylcyclohepta[d]pyrimidinedione derivatives against different strains of HIV-1 as non-nucleoside reverse transcriptase inhibitors. BACKGROUND: The non-nucleoside reverse transcriptase inhibitor (NNRTI), as a major component of the highly active antiretroviral therapy (HAART) to HIV-1 (human immunodeficiency virus type 1) infected patients, required the development of new NNRTIs with improved resistance profile and decreased toxicity.', 21569631),
('New diarylaniline (DAAN) analogues', 'Anti-HIV potency, especially against the E138K', '', 'Three series (6, 13, and 14) of new diarylaniline (DAAN) analogues were designed, synthesized, and evaluated for anti-HIV potency, especially against the E138K viral strain with a major mutation conferring resistance to the new-generation non-nucleoside reverse transcriptase inhibitor drug rilpivirine (1b).', 27070547),
('Pyrrolidine-3,4-bis-N-benzyl-sulfonamides', 'The most promising candidate exhibited a K(i) of 74 nM towards a wild-type HIV protease', '', 'Recently, symmetric pyrrolidine-3,4-bis-N-benzyl-sulfonamides have been developed as a new class of HIV-1 protease inhibitors.', 18692068),
('Compounds HIV-1 protease inhibitors with the hydroxyethylamine core and different phenyloxazolidinone P2 ligands?', 'HIV-1 protease inhibitors', '', 'Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones. A series of new HIV-1 protease inhibitors with the hydroxyethylamine core and different phenyloxazolidinone P2 ligands were designed and synthesized.', 20958050),
('Diarylpyrimidine (DAPY)', 'Nonnucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-1', '', 'Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1. This paper reports the synthesis and the antiviral properties of new diarylpyrimidine (DAPY) compounds as nonnucleoside reverse transcriptase inhibitors (NNRTIs).', 15771449),
('2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4(3H)-one (S-DABO) derivatives', 'Target at the non-nucleoside reverse transcriptase inhibitors resistant HIV-1 strain', '', 'The anti-HIV activity of three 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4 (3H)-one derivatives acting as non-nucleoside reverse transcriptase inhibitor in vitro. It was recently shown that several new synthetic 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4(3H)-one (S-DABO) derivatives demonstrated anti-HIV-1 activity.', 21348416),
('Lactoside compounds', 'Against HIV-1', '', 'Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection. Despite significant improvements, antiretroviral therapies against HIV-1 are plagued by a high frequency of therapeutic failures that have been associated with acquisition of drug resistance.', 22064534),
('New derivative of bevirimat', 'HIV-1 maturation inhibitor', '', 'Synthesis and biological evaluation of a new derivative of bevirimat that targets the Gag CA-SP1 cleavage site. Bevirimat (2), the first-in-class HIV-1 maturation inhibitor, shows a low efficacy due essentially to the natural polymorphism of its target, the CA-SP1 junction.', 23399723),
('Alizarine analogues K-49 and KNA-53', 'Inhibitors of the HIV-1,  IC(50) values for both RT-associated functions of ? 10 microm', '', 'Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases. HIV-1 reverse transcriptase (RT) has two associated activities, DNA polymerase and RNase H, both essential for viral replication and validated drug targets.', 21348941),
('Proteasome inhibitor VL-01', 'Reduction of influenza virus', '', 'Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses. The appearance of highly pathogenic avian influenza A viruses of the H5N1 subtype being able to infect humans and the 2009 H1N1 pandemic reveals the urgent need for new and efficient countermeasures against these viruses.', 21777621),
('2-phenylimidazopyridines', 'Herpes infection', '', '2-phenylimidazopyridines, a new series of Golgi compounds with potent antiviral activity. Drugs targeted to viral proteins are highly vulnerable to the development of resistant strains.', 17973358),
('9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-guanine (BIOLF-62)', 'Activity against herpes simplex virus types 1 and 2', '', 'A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2. A novel nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-guanine (BIOLF-62), was found to have potent antiviral activity against herpes simplex virus types 1 and 2 at concentrations well below cytotoxic levels.', 6289741),
('1-(omega-phenoxyalkyl)uracils bearing acetanilide fragment in 3 position of pyrimidine ring', 'Inhibitors of Hepatitis C Virus replication', '', 'Here, we describe new 1-(?-phenoxyalkyl)uracils bearing acetanilide fragment in 3 position of pyrimidine ring as potential antiviral drugs against HCV. A detailed structure-activity relationship revealed that the most active compounds were the N(3)-substituted uracil derivatives containing 6-(4-bromophenoxy)hexyl or 8-(4-bromophenoxy)octyl fragment at N(1) position.', 27406141),
('Indolyl aryl sulfones bearing the 4,5-difluoro (10) or 5-chloro-4-fluoro (16) substitution pattern at the indole ring ', 'HIV-1 non-nucleoside reverse transcriptase inhibitors', '', 'Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity.', 17803291),
('2-acetyl-3-methyl-5-(p-tolyl)indeno[1,2-d]thiazolo[3,2- a]pyrimidin-6(5H)-one (9b) and ethyl 3-methyl-6-oxo-5-(p-tolyl)-5,6-dihydroindeno[1,2-d]thiazolo- [3,2-a]pyrimidine-2-carboxylate (9c),', 'Anti-HSV-1', '', 'Merged pyrimidine derivatives were designed by one pot synthesis of pyrimidinethione derivative with halogenated compounds. Amongst the tested compounds 2-acetyl-3-methyl-5-(p-tolyl)indeno[1,2-d]thiazolo[3,2- a]pyrimidin-6(5H)-one (9b) and ethyl 3-methyl-6-oxo-5-(p-tolyl)-5,6-dihydroindeno[1,2-d]thiazolo- [3,2-a]pyrimidine-2-carboxylate (9c), caused viral inhibition over 90%. . CONCLUSION: We succeeded in this context to synthesize a new series of potent fused pyrimidine derivatives as anti-HSV-1.', 29219053),
('5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines', 'Anti-human immunodeficiency virus (HIV)', '', 'Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines. OBJECTIVES: To discover new potent and selective anti-human immunodeficiency virus (HIV) acyclic nucleoside phosphonate (ANP) drugs with in vivo antiretroviral activity.', 17124193),
('SJ-3366', 'Inhibited the entry of both HIV-1 and HIV-2', '', 'SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2. We have identified and characterized a potent new nonnucleoside reverse transcriptase (RT) inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1) that also is active against HIV-2 and which interferes with virus replication by two distinct mechanisms. 1-(3-Cyclopenten-1-yl)methyl-6-(3,5-dimethylbenzoyl)-5-ethyl-2,4-pyrimidinedione (SJ-3366) inhibits HIV-1 replication at concentrations of approximately 1 nM, with a therapeutic index of greater than 4 x 10(6).', 11158731),
('Benzamide derivative N-[1-(7-tert-Butyl-1H-indol-3-ylmethyl)-2-(4-cyclopropanecarbonyl-3-methyl-piperazin-1-yl)-2-oxo-ethyl]-4-nitro-benzamide (SP-10)', 'Reduces HIV-1 infectivity (IC50 = 0.036 nM)', '', 'We investigated the in vitro efficacy, safety and mechanism of action of the benzamide derivative N-[1-(7-tert-Butyl-1H-indol-3-ylmethyl)-2-(4-cyclopropanecarbonyl-3-methyl-pipera zin-1-yl)-2-oxo-ethyl]-4-nitro-benzamide (SP-10), a potential new HIV treatment. When HIV-1-responsive engineered HeLa cells were pre-incubated for 48 h with either SP-10 or zidovudine (AZT), SP-10 was able to inhibit viral replication at much lower concentrations (IC50 = 0.036 nM) than AZT (IC50 = 27.4 nM).', 17249247),
('1,3-oxazinan-2-one, piperidine-2,4-dione, piperidine-2-one and piperidine', 'Activity against Influenza A virus strains (IC50 = 7.7 microM)', '', 'A series of (R)- and (S)-isomers of new adamantane-substituted heterocycles (1,3-oxazinan-2-one, piperidine-2,4-dione, piperidine-2-one and piperidine) with potent activity against rimantadine-resistant strains of influenza A virus were synthesized through the transformation of adamantyl-substituted N-Boc-homoallylamines 8 into piperidine-2,4-diones 11 through the cyclic bromourethanes 9 and key intermediate enol esters 10.', 28338150),
('Thiophene[3,2-d]pyrimidine Derivatives', 'HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors', '', 'Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants. In the present study, we designed, synthesized, and biologically tested several series of new derivatives in order to investigate previously unexplored chemical space. Some of the synthesized compounds displayed single-digit nanomolar anti-HIV potencies against wild-type (WT) virus and a panel of NNRTI-resistant mutant viruses in MT-4 cells. Compound 25a was exceptionally potent against the whole viral panel, affording 3-4-fold enhancement of in vitro antiviral potency against WT, L100I, K103N, Y181C, Y188L, E138K, and K103N+Y181C and 10-fold enhancement against F227L+V106A relative to the reference drug etravirine (ETV) in the same cellular assay. Overall, the results indicate that 25a is a promising new drug candidate for treatment of HIV-1 infection.', 28481112),
('Triazolo[4,5-g]quinoline derivatives (compounds 1-6). 4,9-Dihydrotriazolo[4,5-g]quinoline-1-oxide (1)', 'Activity against NNRTI-resistant HIV-1 mutants', '', 'Activity and molecular modeling of a new small molecule active against NNRTI-resistant HIV-1 mutants. In this preliminary study we report the antiviral screening of triazolo[4,5-g]quinoline derivatives (compounds 1-6). 4,9-Dihydrotriazolo[4,5-g]quinoline-1-oxide (1) stood out as a new, small molecule endowed with a selective, promising activity in cell-based assays against HIV-1wt and clinically relevant NNRTI resistant mutants.', 19775780),
('PHA767491', 'Activity against human herpes simplex virus(both HSV-1 and HSV-2)', '', 'PHA767491 potently blocked the proliferation of HSV in cells, as well as HSV induced cell death. Further, we found that PHA767491 strongly inhibited HSV infection post viral entry. Moreover, PHA767491 reduced the expression of viral genes required for DNA synthesis including UL30/42 DNA polymerase and UL5/8/52 helicase-primase complex. Thus, PHA767491 could be a promising agent for the development of new anti-HSV therapy.', 28320320),
('Alternariol 5-O-Methyl Ether', 'Inhibits HIV-1 Integration by Blocking Nuclear', '', 'Microbial Natural Product Alternariol 5-O-Methyl Ether Inhibits HIV-1 Integration by Blocking Nuclear Import of the Pre-Integration Complex. While Highly Active Antiretroviral Therapy (HAART) has significantly decreased the mortality of human immunodeficiency virus (HIV)-infected patients, emerging drug resistance to approved HIV-1 integrase inhibitors highlights the need to develop new antivirals with novel mechanisms of action.', 28489061),
('5,6-dimethylxanthenone-4-acetic acid (DMXAA)', 'Activity against H1N1 influenza', '', 'The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-beta-mediated antiviral activity in vitro and in vivo. The 2009 outbreak of pandemic H1N1 influenza, increased drug resistance, and the significant delay in obtaining adequate numbers of vaccine doses have heightened awareness of the need to develop new antiviral drugs that can be used prophylactically or therapeutically.', 21084628),
('2,3-dihydrobenzofuran derivatives', 'Hepatitis C Virus (HCV) NS5A Inhibitors', '', 'Discovery of Chromane Containing Hepatitis C Virus (HCV) NS5A Inhibitors with Improved Potency against Resistance-Associated Variants. This effort, incorporating the C-1 fluoro substitution at the tetracyclic indole core, led to the discovery of a new series of NS5A inhibitors, such as compounds 14 and 25-28, with significantly improved potency against resistance-associated variants, such as GT2b, GT1a Y93H, and GT1a L31V.', 27792320),
('Moronic acid and other triterpene derivatives', 'Moronic acid derivatives 19, 20, and 21 showed significant activity in HIV-1 infected H9 lymphocytes. Compound 20 showed potent anti-HIV activity with EC50 values of 0.0085 microM against NL4-3, 0.021 microM against PI-R (a multiple protease inhibitor resistant strain), and 0.13 microM against FHR-2 (an HIV strain resistant to 8)', '', 'Moronic acid and other triterpene derivatives as novel potent anti-HIV agents.', 16942019),
('n-benzenesulphony 1-2 (2 or 3-pyridylethyl) benzimidazole derivatives', 'Coxsackie B5 virus', 'Cytotoxicity tests show that many of these substances are well tolerated by the VERO cells.', 'The antiviral and antiproliferative activity of new compounds having n-benzenesulphony 1-2 (2 or 3-pyridylethyl) benzimidazole as a base structure were studied in vitro. The antiviral and antiproliferative activity of new compounds having n-benzenesulphony 1-2 (2 or 3-pyridylethyl) benzimidazole as a base structure were studied in vitro. Only compound 7a, with the presence of both the pyridyl moiety bound at the ethylenic bridge in C-2 of benzimidazole and the nitro-group in the benzene ring, displays a selective antiproliferative effect against certain leukaemia cells and a good antiviral activity especially towards the Coxsackie B5 virus.', 11169164),
('TLT35', 'HIV-1 infection prevention', '', 'Here we reported the design of a novel chimera protein-based fusion inhibitor targeting gp41, TLT35, that uses a flexible 35-mer linker to couple T20 and T1144, the first and next generation HIV-1 fusion inhibitors, respectively.', 21690094),
('Benzophenone template compounds 70h (GW678248)', '70h has in vitro antiviral assay IC(50) values of 0.5 nM against wild-type HIV, 1 nM against the K103N mutant associated with clinical resistance to efavirenz, and 0.7 nM against the Y181C mutant associated with clinical resistance to nevirapine', '', 'Structure-activity relationship studies of novel benzophenones leading to the discovery of a potent, next generation HIV nonnucleoside reverse transcriptase inhibitor. These potent inhibitors include 70h (GW678248), which has in vitro antiviral assay IC(50) values of 0.5 nM against wild-type HIV, 1 nM against the K103N mutant associated with clinical resistance to efavirenz, and 0.7 nM against the Y181C mutant associated with clinical resistance to nevirapine. Compound 70h has also demonstrated relatively low clearance in intravenous pharmacokinetic studies in three species, and it is the active component of a drug candidate which has progressed to phase 2 clinical studies..', 16420058),
('Thiazolidenebenzenesulfonamides', 'Activity against nevirapine-resistant virus, HIV-1(IIIB-R)', '', 'Studies of nonnucleoside HIV-1 reverse transcriptase inhibitors.', 15519161),
('SA-2, the ethyl 4-(2-hydroxymethyl-5-oxopyrrolidin-1-yl)-3-[3-(3-methylbenzoyl)-thioureido] benzoate', 'Activity against influenza A virus', '', 'A target-free and cell-based approach was applied to evaluate the anti-influenza properties of six newly synthesized benzoic acid derivatives. SA-2, the ethyl 4-(2-hydroxymethyl-5-oxopyrrolidin-1-yl)-3-[3-(3-methylbenzoyl)-thioureido] benzoate (compound 2) was screened as a potential drug candidate. Based on these favourable findings, SA-2, a novel anti-influenza agent, with its potent anti-influenza activity in vitro and in vivo, could be a promising antiviral for the treatment of infection of influenza A viruses, including oseltamivir-resistant mutants.', 26802558),
('JTK-853', 'Nonnucleoside inhibitor of hepatitis C virus (HCV) RNA-dependent RNA polymerase.', '', 'Collectively, these data demonstrate that JTK-853 is a potent and novel nonnucleoside palm site-binding HCV polymerase inhibitor, suggesting JTK-853 as a potentially useful agent in combination with other DAAs for treatment of HCV infections.', 22615294),
('1R,2R-dicamphanoyl-3,3-dimethydihydropyrano[2,3-c]xanthen-7(1H)-one (DCX)', 'Reverse transcriptase (RT) inhibitor-resistant HIV-1 (RTMDR-1) strains.', '', 'Design, synthesis, and evaluation of 1R,2R-dicamphanoyl-3,3-dimethyldihydropyrano-[2,3-c]xanthen-7(1H)-one (DCX) derivatives as novel anti-HIV agents. In this study, 1R,2R-dicamphanoyl-3,3-dimethydihydropyrano[2,3-c]xanthen-7(1H)-one (DCX) derivatives were designed and synthesized as novel anti-HIV agents against both wild-type and non-nucleoside reverse transcriptase (RT) inhibitor-resistant HIV-1 (RTMDR-1) strains.', 22063755),
('Benzimidazole-related compound', 'To prevent chikungunya virus (CHIKV) infection', '', 'Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus. Screening of chemical compound libraries were performed and one candidate, a benzimidazole-related compound designated Compound-A was found to inhibit infection by several CHIKV strains and a Sindbis virus strain at nanomolar concentrations.', 28236746),
('141W94 (VX-478) in combination with other antiretroviral agents', 'HIV-1 protease inhibitor with an IC50 of 0.08 microM against HIV-1 (strain IIIB) and a mean IC50 of 0.012 microM against six HIV clinical isolates.', '', 'In vitro antiviral activity of 141W94 (VX-478) in combination with other antiretroviral agents. 141W94 (VX-478) is a novel HIV-1 protease inhibitor with an IC50 of 0.08 microM against HIV-1 (strain IIIB) and a mean IC50 of 0.012 microM against six HIV clinical isolates. 141W94 was synergistic on the basis of isobologram analysis with each of the following reverse transcriptase inhibitors: AZT, 935U83, 524W91, 1592U89 and ddl, 141W94 was also synergistic with saquinavir and additive with either indinavir or ritonavir.', 8721545),
('Alkylamidophospholipid analogues', 'Anti-human immunodeficiency virus type 1 agents', '', 'In vitro evaluation and characterization of newly designed alkylamidophospholipid analogues as anti-human immunodeficiency virus type 1 agents. Our laboratories first reported two novel classes of complex synthetic lipids, including alkylamidophosphocholines (PC lipid; CP-51) and alkylamidophosphate ester-linked lipid-AZT conjugates (lipid-AZT conjugates; CP-92), with selective and potent activity against human immunodeficiency virus type 1 (HIV-1).', 9875387),
('6-{4-[(biphenyl-2-ylcarbonyl) amino]benzoyl}-N-cyclopropyl-5,6-dihydro-4H-thieno[3,2-d][1]benzazepine-2-carboxamide (YM-53403).', 'The EC(50) value 0.20 microM, was about 100-fold more potent than ribavirin.', '', 'YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action', 15708639),
('Stavudine-5''-(p-bromophenyl methoxyalaninyl phosphate) (stampidine)', 'Anti-HIV activity', '', 'We have evaluated the clinical potential of stavudine-5''-(p-bromophenyl methoxyalaninyl phosphate(stampidine [STAMP]), a novel aryl phosphate derivative of stavudine, as a new anti-human immunodeficiency virus (anti-HIV) agent, by examining its acute, subacute, and chronic toxicity profile in mice as well as by testing its antiviral activity in a surrogate human peripheral blood lymphocyte (Hu-PBL)-SCID mouse model of human AIDS.', 12384347),
('Alkenyldiarylmethanes( most potent of these proved to be 3'',3"-dibromo-4'',4"-dimethoxy-5''5"-bis(methoxycarbonyl)-1,1-diphenyl-1-+ ++heptene)', 'Anti-HIV-1 activity', '', 'Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors. Several novel alkenyldiarylmethane (ADAM) non-nucleoside HIV-1 reverse transcriptase inhibitors were synthesized.', 8759644),
('17-amino-17-demethoxygeldanamycin derivatives', 'Inhibited duckling hepatitis B virus DNA replication', '', 'The 17-amino-17-demethoxygeldanamycin derivatives could be novel agents with potential antiviral activity.', 20710066),
('6-methyl-7-substituted-7-deaza purine analogues', 'Compounds 5x (IC50 = 5.88 microM and 6.95 microM for H1N1 and H3N2, respectively) and 5z (IC50 = 3.95 microM and 3.61 microM for H1N1 and H3N2, respectively) demonstrated potent anti-influenza A activity.', '', 'Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents.', 26802557),
('1592U89, (-)-(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclo pentene-1-methanol', 'Average 50% inhibitory concentration [IC50], 0.26 microM for 1592U89', '', '1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity.', 9145874),
('Cytidine analogue, FNC (2''-deoxy-2''-?-fluoro-4''-azidocytidine)', 'Strongly inhibit human HBV and duck HBV (DHBV) replication in vitro and in vivo, respectively.', '', 'A novel cytidine analogue, FNC (2''-deoxy-2''-?-fluoro-4''-azidocytidine), was recently shown to strongly inhibit human HBV and duck HBV (DHBV) replication in vitro and in vivo, respectively.', 22910281),
('2''-deoxy-3''-thiacytidine (BCH-189)', 'Activity against five different strains of human immunodeficiency virus type 1 (HIV-1) (mean 50% inhibitory dose, 0.73 microM)', 'less toxic than AZT in cell culture', 'Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2''-deoxy-3''-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog. We describe a novel nucleoside analog, 2''-deoxy-3''-thiacytidine (BCH-189), in which the 3'' carbon of the ribose ring of 2''-deoxycytidine has been replaced by a sulfur atom.', 1929298),
('2'',3''-didehydro-3''-deoxy-4''-ethynylthymidine', 'Activity anti-human immunodeficiency virus type 1 (HIV-1)', 'Weak cytotoxicity in cell cultures', 'Anti-human immunodeficiency virus type 1 activity and resistance profile of 2'',3''-didehydro-3''-deoxy-4''-ethynylthymidine in vitro. 2'',3''-Didehydro-3''-deoxy-4''-ethynylthymidine (4''-Ed4T) has been identified as a novel nucleoside analog with potent and selective anti-human immunodeficiency virus type 1 (HIV-1) activity and weak cytotoxicity in cell cultures. 4''-Ed4T proved to be 5- to 10-fold more active than its structurally related compound, stavudine (d4T).', 16048947),
('GS-9148 [(5-(6-amino-purin-9-yl)-4-fluoro-2,5-dihydro-furan-2-yloxymethyl)phosphonic acid]', 'Activity against nucleoside-resistant variants of human immunodeficiency virus type 1', '', 'Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131. GS-9148 [(5-(6-amino-purin-9-yl)-4-fluoro-2,5-dihydro-furan-2-yloxymethyl)phosphonic acid] is a novel ribose-modified human immunodeficiency virus type 1 (HIV-1) nucleotide reverse transcriptase (RT) inhibitor (NRTI) selected from a series of nucleoside phosphonate analogs for its favorable in vitro biological properties including (i) a low potential for mitochondrial toxicity, (ii) a minimal cytotoxicity in renal proximal tubule cells and other cell types, (iii) synergy in combination with other antiretrovirals, and (iv) a unique resistance profile against multiple NRTI-resistant HIV-1 strains.', 18056282),
('2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine', 'Activity against multidrug-resistant hepatitis B virus mutants', '', 'In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants. The susceptibilities of drug-resistant hepatitis B virus (HBV) mutants to lamivudine, adefovir, tenofovir, entecavir, and 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine (PMEO-DAPym), a novel acyclic pyrimidine analogue, were assessed in vitro.', 17371827),
('Pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring', 'Activity against pleconaril-resistant coxsackievirus B3', '', 'New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3. In the present study, novel analogues with different substitutions in the central phenoxy group were synthesized to study their influence on anti-CVB3 activity with the aim to overcome pleconaril resistance.', 18840470),
('6-(3-trifluoromethylbenzyl) and 6-(fluorobenzyl)', 'Activity against HIV-1 wild type and mutants resistant to non-nucleoside RT inhibitors', '', 'Synthesis and antiviral evaluation of 6-(trifluoromethylbenzyl) and 6-(fluorobenzyl) analogues of HIV drugs emivirine and GCA-186. The present study describes the synthesis and antiviral evaluation of a series of novel 6-(3-trifluoromethylbenzyl) and 6-(fluorobenzyl) analogues of the HIV drugs emivirine and GCA-186.', 18161905),
('2-amino thiazole [T157602 and its analogs]', 'Inhibitor of herpes simplex virus (HSV) DNA replication', '', 'T157602 and its analogs represent a novel class of specific and reversible anti-HSV agents eliciting their inhibitory effects on HSV replication by interacting with the UL5 helicase.', 9696789),
('4-[1-hydroxy-2-(4,5-dimethoxy-2-nitrophenyl)ethyl]benzonitrile (LPCRW_0005)', 'Inhibits rhinovirus replication', '', 'A novel benzonitrile analogue inhibits rhinovirus replication.', 24948704),
('6-PMEO 2,4-diaminopyrimidine and 6-PMPO 2,4-diaminopyrimidine derivatives', 'Potent activity against human immunodeficiency virus (HIV) in the laboratory', '', 'Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates. A novel class of acyclic nucleoside phosphonates has been discovered in which the base consists of a pyrimidine preferably containing an amino group at C-2 and C-4 and a 2-(phosphonomethoxy)ethoxy (PMEO) or a 2-(phosphonomethoxy)propoxy (PMPO) group at C-6.', 12069973),
('3-Biphenylimidazo[1,2-a]pyridines or [1,2-b]pyridazines and analogues', 'Activity against bovine viral diarrhoea virus (BVDV) and hepatitis C virus (HCV)', '', '3-Biphenylimidazo[1,2-a]pyridines or [1,2-b]pyridazines and analogues, novel Flaviviridae inhibitors. Using Ttou 84 as starting point, a novel class of biphenyl derivatives of imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine was designed to optimize the inhibitory properties on the replication of the bovine viral diarrhoea virus (BVDV) and hepatitis C virus (HCV).', 23665801),
('Beta-d-2''-deoxy-2''-?-fluoro-2''-beta-C-methyluridine nucleotide prodrug (PSI-7977)', 'Inhibitors of the HCV NS5B polymerase', '', 'Discovery of a Beta-d-2''-deoxy-2''-?-fluoro-2''-beta-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus. Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease.', 20845908),
('BAY 38-4766', 'Inhibitor of human cytomegalovirus (HCMV)', '', 'Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action. As a representative of a novel inhibitory approach, the non-nucleosidic BAY 38-4766 was identified as a highly selective inhibitor of human cytomegalovirus (HCMV).', 11733458),
('Elaidic acid ganciclovir (E-GCV)', 'Activity against laboratory and clinical strains of herpes simplex type 1 (HSV-1) and type 2 (HSV-2), varicella-zoster virus (VZV) and human cytomegalovirus (HCMV) in human embryonic lung fibroblasts, IC(50) value of E-GCV for HSV-1 strain KOS being 0.07 nM', '', 'Antiviral activity of ganciclovir elaidic acid ester against herpesviruses', 10771080),
('Brecanavir, a novel tyrosyl-based arylsulfonamide', 'Anti-HIV activity', '', 'Brecanavir, a novel tyrosyl-based arylsulfonamide, high-affinity, human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI), has been evaluated for anti-HIV activity in several in vitro assays.', 17620375),
('GW678248', 'Anti-human immunodeficiency virus type 1', '', 'GW678248, a novel nonnucleoside reverse transcriptase inhibitor, has been evaluated for anti-human immunodeficiency virus activity in a variety of in vitro assays against laboratory strains and clinical isolates.', 16251284),
('PD0084430', 'Non-nucleoside inhibitor of human cytomegalovirus replication', '', 'PD0084430: a non-nucleoside inhibitor of human cytomegalovirus replication in vitro. A novel, non-nucleoside inhibitor of HCMV replication, PD0084430, was identified in a screening assay using the HCMV beta-galactosidase recombinant RC256.', 11675146),
('Naphthyridinone GSK364735', 'Potently inhibited recombinant human immunodeficiency virus type 1 (HIV-1) integrase in a strand transfer assay (mean 50% inhibitory concentration +/- standard deviation, 8 +/- 2 nM).', '', 'The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.', 18160521),
('6-(indol-2-yl)pyridine-3-sulfonamides', 'Inhibit HCV RNA replication in the HCV replicon cell culture assay', '', 'Discovery of novel HCV inhibitors: synthesis and biological activity of 6-(indol-2-yl)pyridine-3-sulfonamides targeting hepatitis C virus NS4B.', 23683597),
('GRL-02031', 'Effective against laboratory HIV-1 strains and primary clinical isolates, including subtypes A, B, C, and E (50% effective concentration [EC(50)] range, 0.015 to 0.038 microM)', 'Minimal cytotoxicity (50% cytotoxic concentration, >100 microM in CD4(+) MT-2 cells)', 'GRL-02031, a novel nonpeptidic protease inhibitor (PI) containing a stereochemically defined fused cyclopentanyltetrahydrofuran potent against multi-PI-resistant human immunodeficiency virus type 1 in vitro.', 18955518),
('Benzo[4,5]furo[3,2,d]pyrimidin-2-one NcRTI chemical series', 'Compound A inhibited HIV-1 RT in a primer extension assay (50% inhibitory concentration, 2.6 nM) but had no measurable activity against human DNA polymerase ? at 10 microM. It potently inhibited HIV-1 replication in vitro (50% effective concentration, 1.5 nM)', '', 'Identification and characterization of a novel HIV-1 nucleotide-competing reverse transcriptase inhibitor series', 23545531),
('Phosphonylmethoxyalkyl derivatives of adenine', 'Equine herpesvirus 1', '', 'Effective chemotherapy of equine herpesvirus 1 by phosphonylmethoxyalkyl derivatives of adenine demonstrated in a novel murine model for the disease.', 2163242),
('Substituted N-phenylbenzenesulphonamides', 'Non-nucleoside hepatitis C virus polymerase inhibitors with IC(50) values up to 40 nM', '', 'Here we describe a novel non-nucleoside inhibitor (NNI) chemotype identified by screening: The substituted N-phenylbenzenesulphonamides (SPBS) which showed reversible inhibition of NS5B from HCV genotype 1b with IC(50) values up to 40 nM.', 22580131),
('Pyridinioalkanoyl thioesters (PATEs)', 'Anti-HIV agents, EC(50) < 10 microM', 'Non toxic', 'Synthesis and biological properties of amino acid amide ligand-based pyridinioalkanoyl thioesters as anti-HIV agents.', 11886789),
('9-Arylpurines', 'These compounds elicit activity against a variety of enteroviruses in the low microM range including Coxsackie virus A16, A21, A24, Coxsackie virus B3, and echovirus 9.', '', '9-Arylpurines as a novel class of enterovirus inhibitors. Here we report on a novel class of enterovirus inhibitors that can be structurally described as 9-arylpurines.', 19924996),
('Tricyclic nucleosides [9-benzylamino-3-(?-D-ribofuranosyl)-3H-imidazo[4'',5'':5,6]pyrido[2,3-b]pyrazine (15d)]', 'Inhibited non-structural protein 5A (NS5A) of hepatitis C virus (HCV)', '', 'Novel nucleoside analogues targeting HCV replication through an NS5A-dependent inhibition mechanism', 28245093),
('4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol (IsoddA)', 'Inhibitor of HIV-1', '', 'Antiviral, metabolic, and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol.', 8540705),
('PNU-183792, a 4-oxo-dihydroquinoline', 'Activity against human and animal herpesviruses, specifically inhibit herpesvirus polymerases', '', 'Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses.', 11888654),
('Cyclohexyl carboxylic acid analogues [VX-787]', 'Strong potency versus multiple influenza A strains, including pandemic 2009 H1N1 and avian H5N1 flu strains', '', 'Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.', 25019388),
('FP-21399 of bis(disulfonaphthalene) dimethoxybenzene class', 'Inhibitor of HIV-1', '', 'FP-21399 is a novel compound of the bis(disulfonaphthalene) dimethoxybenzene class that blocks entry of HIV into CD4+ cells and blocks fusion of infected and noninfected CD4+ cells.', 9094135);
INSERT INTO `virus_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Pirodavir (R 77975), a phenoxy-pyridazinamine', 'Broad-spectrum antipicornaviral activity', '', 'In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity. Pirodavir (R 77975) is the prototype of a novel class of broad-spectrum antipicornavirus compounds.', 1317142),
('1,5-diphenylpyrazole', 'Nonnucleoside HIV-1 reverse transcriptase inhibitors', '', 'Novel 1,5-diphenylpyrazole nonnucleoside HIV-1 reverse transcriptase inhibitors with enhanced activity versus the delavirdine-resistant P236L mutant: lead identification and SAR of 3- and 4-substituted derivatives. Through computationally directed broad screening, a novel 1, 5-diphenylpyrazole (DPP) class of HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs) has been discovered.', 10715167),
('SB 9200', 'SB 9200 has broad-spectrum antiviral activity against RNA viruses including hepatitis C virus (HCV), norovirus, respiratory syncytial virus, and influenza and has demonstrated activity against hepatitis B virus (HBV) in vitro and in vivo.', '', 'SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants. SB 9200 is a novel, first-in-class oral modulator of innate immunity that is believed to act via the activation of the RIG-I and NOD2 pathways.', 28303593),
('2,4,5-Trisubstituted thiazole derivatives', 'Tested on seven NNRTI-resistant HIV-1 strains, and all exhibited inhibitory effects with fold changes in IC50 ranging from 2.6 to 111', '', '2,4,5-Trisubstituted thiazole derivatives: a novel and potent class of non-nucleoside inhibitors of wild type and mutant HIV-1 reverse transcriptase.', 25072874),
('2,6-Bis(benzimidazol-2-yl)pyridine (BBP/CSFA-0)', 'BBP/CSFA-0 inhibits the in vitro replication of the classical swine fever virus (CSFV) with an EC50 of 0.330 +/-.25microM. BBP/CSFA-0 proved in vitro inactive against the hepatitis C virus, that belongs like BVDV and CSFV to the family of Flaviviridae.', '', 'Substituted 2,6-bis(benzimidazol-2-yl)pyridines: a novel chemical class of pestivirus inhibitors that targets a hot spot for inhibition of pestivirus replication in the RNA-dependent RNA polymerase.', 24680957),
('Bictegravir (GS-9883)', 'Anti-HIV-1, specifically targets IN strand transfer activity (50% inhibitory concentration [IC50] of 7.5 ? 0.3 nM) and HIV-1 integration in cells', 'BIC exhibits potent and selective in vitro antiretroviral activity in both T-cell lines and primary human T lymphocytes, with 50% effective concentrations ranging from 1.5 to 2.4 nM and selectivity indices up to 8,700 relative to cytotoxicity.', 'Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile.', 27645238),
('6-substituted 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives', 'Active in human immunodeficiency virus type 1 (HIV-1) infection', '', 'Anti-human immunodeficiency virus type 1 activity of novel 6-substituted 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives. Nonnucleoside reverse transcriptase (RT) inhibitors (NNRTIs) are important components of current combination therapies for human immunodeficiency virus type 1 (HIV-1) infection.', 22290950),
('ASP2151', 'Activity aginst varicella-zoster virus and herpes simplex virus types 1 and 2', '', 'ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2. OBJECTIVES: To evaluate and describe the anti-herpesvirus effect of ASP2151, amenamevir, a novel non-nucleoside oxadiazolylphenyl-containing herpesvirus helicase-primase complex inhibitor.', 20534624),
('F18', 'F18 displayed distinct profiles against 17 NNRTI-resistant pseudoviruses, with an excellent potency especially against one of the most prevalent strains with the Y181C mutation (50% effective concentration, 1.0 nM)', '', 'F18, a novel small-molecule nonnucleoside reverse transcriptase inhibitor, inhibits HIV-1 replication using distinct binding motifs as demonstrated by resistance selection and docking analysis. Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are one of the key components of antiretroviral therapy drug regimen against human immunodeficiency virus type 1 (HIV-1) replication.', 22037848),
('6-(tert-butyl)-4-phenyl-4-(trifluoromethyl)-1H,3H-1,3,5-triazin-2-one', 'In in vitro assays, HIV-1 reverse transcriptase (RT) activity was inhibited by compound 1 with an EC50 of 4.3 microm', '', 'A Triazinone Derivative Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity. A novel HIV-1 inhibitor, 6-(tert-butyl)-4-phenyl-4-(trifluoromethyl)-1H,3H-1,3,5-triazin-2-one (compound 1), was identified from a compound library screened for the ability to inhibit HIV-1 replication.', 27634404),
('GW678248 is a novel benzophenone', 'Preclinical assessment of GW678248 indicates that this compound potently inhibits wild-type (WT) and mutant human immunodeficiency virus type 1 (HIV-1) reverse transcriptase in biochemical assays, with 50% inhibitory concentrations (IC(50)s) between 0.8 and 6.8 nM.', 'Cytotoxicity studies with GW678248 indicate that the 50% cytotoxicity concentration is greater than the level of compound solubility and provides a selectivity index of >2,500-fold for WT, Y181C, or K103N HIV-1.', 'Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitor. The compound GW678248 is a novel benzophenone nonnucleoside reverse transcriptase inhibitor (NNRTI).', 16189079),
('UK-201844', 'UK-201844 exhibited antiviral activity against HIV-1 NL4-3 in MT-2 and PM1 cells, with 50% effective concentrations of 1.3 and 2.7 microM, respectively, but did not exhibit measurable antiviral activity against the closely related HIV-1 IIIB laboratory strain.', '', 'Identification and characterization of UK-201844, a novel inhibitor that interferes with human immunodeficiency virus type 1 gp160 processing.', 17646410),
('3-fluoro-2-(phosphonomethoxy)propyl (FPMP) {(S)-FPMPA amidate}', 'Activity against hepatitis B virus (HBV) and varicella-zoster virus (VZV)', '', 'The derivatization of the phosphonic acid functionality of FPMPs with a diamyl aspartate phenoxyamidate group led to a novel generation of compounds that not only demonstrate drastically improved antiretroviral potency but also are characterized by an expanded spectrum of activity that also covers hepatitis B and herpes viruses.', 28682067),
('Enviroxime-like compound, AN-12-H5', 'Anti-enterovirus', '', 'These results suggest that AN-12-H5 is a bifunctional anti-enterovirus compound that belongs to a novel class of enviroxime-like compounds and targets both a replication step and an early stage of EV71 infection.', 20660150),
('RO-7', 'Inhibited influenza A viruses (seasonal and 2009 pandemic H1N1 and seasonal H3N2) and B viruses (Yamagata and Victoria lineages), zoonotic viruses (H5N1, H7N9, and H9N2), and NAI-resistant variants', '', 'A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In Vitro. Here, we characterized a novel compound, RO-7, identified as a putative PA endonuclease inhibitor.', 27381402),
('BIT225', 'BIT225, blocks Vpu ion channel activity and also shows anti-HIV-1 activity, with a 50% effective concentration of 2.25+/-0.23 microM (mean+/-the standard error)', 'minimal in vitro toxicity (50% toxic concentration, 284 microM) in infected MDM, resulting in a selectivity index of 126', 'Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages.', 19995924),
('4-Oxo-4,7-dihydrothieno[2,3-b]pyridines', 'Inhibitors of human cytomegalovirus and related herpesvirus polymerases', '', '4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases. A novel series of 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides have been identified as potential antivirals against human herpesvirus infections resulting from human cytomegalovirus (HCMV), herpes simplex virus type 1 (HSV-1), and varicella-zoster virus (VZV).', 16134946),
('4-(5-(2,6-difluorobenzyl)-1-(2-fluorobenzyl)-2-oxo-1,2-dihydropyridin-3-yl)-4-hydroxy-2-oxo-N-(2-oxopyrrolidin-1-yl)but-3-enamide', 'Exhibits low nM antiviral activity against a diverse set of HIV-1 isolates, and against HIV-2 and the simian immunodeficiency virus (SIV).', '', 'A novel anti-HIV active integrase inhibitor with a favorable in vitro cytochrome P450 and uridine 5''-diphospho-glucuronosyltransferase metabolism profile.', 23602851),
('Bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065', 'Active against wide spectrum of HIV isolates', '', 'A novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065, is potent against multiple-PI-resistant human immunodeficiency virus in vitro. We designed, synthesized, and identified GRL-98065, a novel nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) containing the structure-based designed privileged cyclic ether-derived nonpeptide P2 ligand, 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane (bis-THF), and a sulfonamide isostere, which is highly potent against laboratory HIV-1 strains and primary clinical isolates (50% effective concentration [EC(50)], 0.0002 to 0.0005 microM) with minimal cytotoxicity (50% cytotoxicity, 35.7 microM in CD4(+) MT-2 cells).', 17371811),
('compound 7f (A-98881)', 'HIV-1 protease inhibition assay and the in vitro MT-4 cell culture assay (Ki = approximately 5 pM and EC50 = 0.002 microM).', '', 'A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease. The design, synthesis, and molecular modeling studies of a novel series of azacyclic ureas, which are inhibitors of human immunodeficiency virus type 1 (HIV-1) protease that incorporate different ligands for the S1'', S2, and S2'' substrate-binding sites of HIV-1 protease are described.', 8558507),
('Benzophenone derivatives', 'inhibitors of HIV-1 reverse transcriptase (RT) and the growth of HIV-1 in MT-4 cells.', '', 'Benzophenone derivatives: a novel series of potent and selective inhibitors of human immunodeficiency virus type 1 reverse transcriptase. A series of benzophenone derivatives has been synthesized and evaluated as inhibitors of HIV-1 reverse transcriptase (RT) and the growth of HIV-1 in MT-4 cells.', 7538590),
('Nonpeptidic macrocyclic HIV protease inhibitors', 'Exerted potent activity against multidrug-resistant HIV-1 variants', '', 'Design, synthesis, protein-ligand X-ray structure, and biological evaluation of a series of novel macrocyclic human immunodeficiency virus-1 protease inhibitors to combat drug resistance. The structure-based design, synthesis, and biological evaluation of a series of nonpeptidic macrocyclic HIV protease inhibitors are described. The inhibitors are designed to effectively fill in the hydrophobic pocket in the S1''-S2'' subsites and retain all major hydrogen bonding interactions with the protein backbone similar to darunavir (1) or inhibitor 2. The ring size, the effect of methyl substitution, and unsaturation within the macrocyclic ring structure were assessed. In general, cyclic inhibitors were significantly more potent than their acyclic homologues, saturated rings were less active than their unsaturated analogues and a preference for 10- and 13-membered macrocylic rings was revealed. The addition of methyl substituents resulted in a reduction of potency. Both inhibitors 14b and 14c exhibited marked enzyme inhibitory and antiviral activity, and they exerted potent activity against multidrug-resistant HIV-1 variants.', 19746963),
('Dihydroxythiophenes', 'HIV-1', '', 'Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore. We have identified dihydroxythiophenes (DHT) as a novel series of human immunodeficiency virus type 1 (HIV-1) integrase inhibitors with broad antiviral activities against different HIV isolates in vitro.', 16809294),
('ABT-378', 'Human immunodeficiency virus type 1 (HIV-1) protease inhibitor', '', 'In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor. ABT-378, a new human immunodeficiency virus type 1 (HIV-1) protease inhibitor which is significantly more active than ritonavir in cell culture, is currently under investigation for the treatment of AIDS.', 9696850),
('2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs)', 'Anti-HIV-1', '', 'Investigation of a novel series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as human immunodeficiency virus type 1 integrase inhibitors. We report herein further insight into the biological activities displayed by a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs).', 24793360),
('8-substituted dipyridodiazepinone', 'Activity against wild type human immunodeficiency virus (HIV-1) and the clinically prevalent K103N/Y181C mutant virus', '', 'Novel 8-substituted dipyridodiazepinone inhibitors with a broad-spectrum of activity against HIV-1 strains resistant to non-nucleoside reverse transcriptase inhibitors. A series of novel 8-substituted dipyridodiazepinone-based inhibitors were investigated for their antiviral activity against wild type human immunodeficiency virus (HIV-1) and the clinically prevalent K103N/Y181C mutant virus.', 16107158),
('UIC-94017 (containing a 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane (bis-THF) and a sulfonamide isostere)', 'Activity against laboratory HIV-1 strains and primary clinical isolates (50% inhibitory concentration [IC(50)], approximately 0.003 micro M; IC(90), approximately 0.009 micro M)', 'minimal cytotoxicity (50% cytotoxic concentration for CD4(+) MT-2 cells, 74 micro M)', 'Novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitro. We designed, synthesized, and identified UIC-94017 (TMC114), a novel nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) containing a 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane (bis-THF) and a sulfonamide isostere which is extremely potent against laboratory HIV-1 strains and primary clinical isolates (50% inhibitory concentration [IC(50)], approximately 0.003 micro M; IC(90), approximately 0.009 micro M) with minimal cytotoxicity (50% cytotoxic concentration for CD4(+) MT-2 cells, 74 micro M).', 14506019),
('Novel pyridine oxide derivatives', '(HIV-1) and HIV-2 strains', '', 'Novel human immunodeficiency virus (HIV) inhibitors that have a dual mode of anti-HIV action. We have found that novel pyridine oxide derivatives are inhibitors of a wide range of human immunodeficiency virus (HIV) type 1 (HIV-1) and HIV-2 strains in CEM cell cultures.', 14506017),
('Stavudine-5''-(p-bromophenyl methoxyalaninyl phosphate) (stampidine [STAMP]), a novel aryl phosphate derivative of stavudine', 'HIV-1', '', 'We report the antiretroviral activity of stavudine-5''-(p-bromophenyl methoxyalaninyl phosphate) (stampidine [STAMP]), a novel aryl phosphate derivative of stavudine, against primary clinical human immunodeficiency virus type 1 (HIV-1) isolates.', 12384373),
('Pyrido [1,2a] indole derivatives', 'Inhibitory effect against purified HIV-1 reverse transcriptase (RT) in an in vitro assay', '', 'Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1. Pyrido [1,2a] indole derivatives were identified as potent inhibitors of human immunodeficiency virus type 1 (HIV-1) replication during a random screening programme.', 10335402),
('1-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-4-methylbenzimida zole (35)', 'an IC50 = 200 nM against HIV-1 WT RT in an in vitro enzyme assay', '', 'Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles. The development of new nonnucleoside inhibitors of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) active against the drug-induced mutations in RT continues to be a very important goal of AIDS research.', 9435891),
('MK-4965', 'MK-4965 is also highly potent against the WT virus and two most prevalent NNRTI-resistant viruses (viruses that harbor the K103N or the Y181C mutation), against which it had 95% effective concentrations (EC(95)s) of <30 nM in the presence of 10% fetal bovine serum. The antiviral EC(95) of MK-4965 was reduced approximately four- to sixfold when it was tested in 50% human serum.', '', 'Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor. Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are the mainstays of therapy for the treatment of human immunodeficiency virus type 1 (HIV-1) infections.', 19289522),
('TMC310911', 'TMC310911 has potent activity against wild-type (WT) HIV-1 (median 50% effective concentration [EC(50)], 14 nM) and a wide spectrum of recombinant HIV-1 clinical isolates, including multiple-PI-resistant strains with decreased susceptibility to currently approved PIs (fold change [FC] in EC(50), >10).', '', 'TMC310911, a novel human immunodeficiency virus type 1 protease inhibitor, shows in vitro an improved resistance profile and higher genetic barrier to resistance compared with current protease inhibitors. TMC310911 is a novel human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) structurally closely related to darunavir (DRV) but with improved virological characteristics.', 21896904),
('GRL-04810 and GRL-05010, containing the structure-based designed privileged cyclic ether-derived nonpeptide P2 ligand, bis-tetrahydrofuranylurethane (bis-THF), and a difluoride moiety', 'Active against the laboratory strain HIV-1LAI (50% effective concentrations [EC50s], 0.0008 and 0.003 microM, respectively)', 'GRL-04810 and GRL-05010 have minimal cytotoxicity (50% cytotoxic concentrations [CC50s], 17.5 and 37.0 microM, respectively', 'GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration.', 24080647),
('GRL008 and DRV', '[EC50s], 0.029 and 0.002 microM, respectively) against a multidrug-resistant clinical isolate of HIV-1 (HIVA02)', '', 'A conserved hydrogen-bonding network of P2 bis-tetrahydrofuran-containing HIV-1 protease inhibitors (PIs) with a protease active-site amino acid backbone aids in their activity against PI-resistant HIV.', 24752271),
('Thiothymidine derivatives, KAY-2-41 and KAH-39-149', 'Active against herpes simplex virus, varicella-zoster virus (VZV), and particularly against Epstein-Barr virus', '', 'Antiherpesvirus activities of two novel 4''-thiothymidine derivatives, KAY-2-41 and KAH-39-149, are dependent on viral and cellular thymidine kinases. The emergence of drug-resistant herpesviruses represents a significant problem in clinical practice, primarily in immunocompromised patients.', 24820089),
('A-790742', '(HIV-1) protease inhibitor, with 50% effective concentrations ranging from 2 to 7 nM against wild-type HIV-1', '', 'Characterization of a novel human immunodeficiency virus type 1 protease inhibitor, A-790742 is a potent human immunodeficiency virus type 1 (HIV-1) protease inhibitor, with 50% effective concentrations ranging from 2 to 7 nM against wild-type HIV-1.', 18212102),
('Compounds derived from scaffolds containing a thiazole replacement of the exocyclic amide with modification at position 7 and/or 9 of the bicyclic pyrimidinone core', 'HIV integrase inhibitors', '', 'Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses. A series of novel HIV integrase inhibitors active against rategravir resistant strains are reported.', 20685117),
('AIC292, diarylpyrazole-[imidazolidinone]-carboxamides', 'HIV-1', '', 'In vitro and in vivo activities of AIC292, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.', 23959304),
('ACH-806 (GS-9132)', 'Inhibits hepatitis C virus (HCV) replication', '', 'Selection of replicon variants resistant to ACH-806, a novel hepatitis C virus inhibitor with no cross-resistance to NS3 protease and NS5B polymerase inhibitors. We have discovered a novel class of compounds active against hepatitis C virus (HCV), using a surrogate cellular system, HCV replicon cells.', 18411324),
('C3-substituted cyclopentyltetrahydrofuranyl (Cp-THF)', 'HIV-1 protease inhibitors', '', 'Substituent effects on P2-cyclopentyltetrahydrofuranyl urethanes: design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors. The design, synthesis, and biological evaluation of novel C3-substituted cyclopentyltetrahydrofuranyl (Cp-THF)-derived HIV-1 protease inhibitors are described.', 22364812),
('Dexlansoprazole', 'Human immunodeficiency virus (HIV)-1 integrase (IN) inhibitor', '', 'A novel assay for screening inhibitors targeting HIV-1 integrase dimerization based on Ni-NTA magnetic agarose beads. Human immunodeficiency virus (HIV)-1 integrase (IN), which mediates integration of viral cDNA into the cellular chromosome, is a validated antiviral drug target.', 27137477),
('Combination of boceprevir with a nucleoside analog or a non-nucleoside HCV NS5B polymerase inhibitor', 'Effective against hepatitis C virus (HCV)', '', 'A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors. Boceprevir (SCH 503034) is an orally active novel inhibitor of the hepatitis C virus (HCV) NS3 protease currently in clinical development for the treatment of hepatitis C.', 19747948),
('EI-1, HCV pseudoparticles (HCVpp)', 'Agianst hepatitis C virus (HCV)', '', 'A novel small molecule inhibitor of hepatitis C virus entry. Small molecule inhibitors of hepatitis C virus (HCV) are being developed to complement or replace treatments with pegylated interferons and ribavirin, which have poor response rates and significant side effects.', 20838466),
('5-[(4-bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine (BPIP)', 'The 50% effective concentration (EC50) for inhibition of bovine viral diarrhea virus (BVDV)-induced cytopathic effect formation was 0.04 +/- 0.01 microM', '', 'A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase. We report on the highly potent and selective antipestivirus activity of 5-[(4-bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine (BPIP).', 16352539),
('R165481 and R221239', 'Inhibit wild-type HIV-1 RT and drug-resistant variants, including Tyr181Cys and Lys103Asn RT', '', 'An acrylonitrile substituent on R165481 substantially improves the activity of the compound against wild-type RT (and several mutants) and provides a way to generate novel inhibitors that could interact with conserved elements of HIV-1 RT at the polymerase catalytic site.', 16302798),
('NS3/4A proteinase inhibitors screened from Developmental Therapeutics Program (NCI/NIH)', 'Hepatitis C virus (HCV)', '', 'As a result, we identified several novel, previously uncharacterized, nanomolar range inhibitory scaffolds, which suppressed of the NS3/4A activity in vitro and replication of a sub-genomic HCV RNA replicon with a luciferase reporter in human hepatocarcinoma cells.', 22768327),
('Sodium (+)-isolaricireinol-2 alpha-sulfate, sodium 3,4-dihydroxy-5-methoxybenzoic acid methyl ester-4-sulfate, sodium (E)-7-hydroxy-1,7-bis(4-hydroxyphenyl)hept-5-ene-3S-sulfonate, and 3-methoxytyramine-betaxanthin', 'Activity against H1N1 influenza viruses', '', 'Based on virtual screening, MD simulation, and interaction energy evaluation, TCM candidates demonstrate good potential as novel H1 inhibitors.', 22012120),
('methyl ((S)-1-((S)-2-(4-(4-(6-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)quinoxalin-2-yl)phenyl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate', 'Activity against hepatitis C virus (HCV)', '', 'By varying the biphenyl-imidazole unit of daclatasvir, novel inhibitors of HCV NS5A were identified with an improved resistance profile against mutant strains of the virus while retaining the picomolar potency of daclatasvir.', 24729513),
('GS-5885', 'Hepatitis C virus (HCV) NS5A inhibitor', '', 'Characterization of Hepatitis C virus resistance from a multiple-dose clinical trial of the novel NS5A inhibitor GS-5885. GS-5885 is a novel hepatitis C virus (HCV) NS5A inhibitor.', 23877691),
('3''-Azidothymidine (AZT)', 'HIV', '', 'Clicking 3''-azidothymidine into novel potent inhibitors of human immunodeficiency virus. 3''-Azidothymidine (AZT) was the first approved antiviral for the treatment of human immunodeficiency virus (HIV).', 24102161),
('Cationic N,N-Dimethyl[70]fulleropyrrolidinium Iodide Derivatives', 'Anti-HIV-1', '', 'Collectively, our studies indicate fullerene derivatives 2a-c as potent and novel HIV-1 maturation inhibitors.', 28002960),
('EMT-305 and EMT-104', 'Activity against Influenza A virus', '', 'Computational and experimental screening of extensive and water soluble compounds identified novel influenza virus inhibitors that can reduce influenza virus infection without detectable toxic effects on host cells.', 28713784),
('Inhibitors designed by incorporating N-phenyloxazolidinone-5-carboxamides into the hydroxyethylene and (hydroxyethyl)hydrazine dipeptide isosteres as P2 and P2'' ligands.', 'HIV-1 protease inhibitor', '', 'Design and synthesis of HIV-1 protease inhibitors incorporating oxazolidinones as P2/P2'' ligands in pseudosymmetric dipeptide isosteres. A series of novel HIV-1 protease inhibitors based on two pseudosymmetric dipeptide isosteres have been synthesized and evaluated.', 17696512),
('3,5-diamino-N-aryl-1H-pyrazole-4-carbothioamide and 4-amino-5-benzoyl-N-phenyl-2-(substituted-amino)-1H-pyrrole-3-carbothioamide derivatives', 'Anti-HIV-1', '', 'Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions.', 28859311),
('Triazolo-pyrimidine derivatives', 'Inhibitors of hepatitis B virus surface antigen (HBsAg) secretion', '', 'Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion. The high levels of hepatitis B virus (HBV) surface antigen (HBsAg)-bearing subviral particles in the serum of chronically infected individuals play an important role in suppressing HBV-specific immune response and are only mildly affected by the current small molecule therapies.', 21786803),
('Osalmid and its derivative 4-cyclopropyl-2-fluoro-N-(4-hydroxyphenyl) benzamide (YZ51)', 'HBV', '', 'Furthermore, 4-cyclopropyl-2-fluoro-N-(4-hydroxyphenyl) benzamide (YZ51), a novel derivative of osalmid, showed higher efficacy than osalmid with more potent RR inhibitory activity.', 26774458),
('GRL-0519, a novel nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) containing tris-tetrahydrofuranylurethane (tris-THF) and a sulfonamide isostere', 'Activity against laboratory HIV-1 strains and primary clinical isolates (50% effective concentration [EC50], 0.0005 to 0.0007 microM)', 'minimal cytotoxicity (50% cytotoxic concentration [CC50], 44.6 microM)', 'GRL-0519, a novel oxatricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor (PI), potently suppresses replication of a wide spectrum of multi-PI-resistant HIV-1 variants in vitroWe report that GRL-0519, a novel nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI) containing tris-tetrahydrofuranylurethane (tris-THF) and a sulfonamide isostere, is highly potent against laboratory HIV-1 strains and primary clinical isolates (50% effective concentration [EC50], 0.0005 to 0.0007 microM) with minimal cytotoxicity (50% cytotoxic concentration [CC50], 44.6 microM).', 23403426),
('Novel inhibitors of RSV including the P13 fusion inhibitor, and the PG545 virucide', 'Respiratory syncytial virus (RSV)', '', 'Here we describe the cell culture-based methods used in our laboratory in identification of novel inhibitors of RSV including the P13 fusion inhibitor, and the PG545 virucide.', 23821281),
('FA-583 and FA-617', 'Influenza A Virus', '', 'Here we identify and characterize two structurally different novel fusion inhibitors of the influenza A virus group 1 hemagglutinin (HA), FA-583 and FA-617, with low nanomolar activities.', 26676787),
('cpd 1, 2, and 3', 'Respiratory Syncytial Virus (RSV)', '', 'Here we report the characterization of three novel classes of RSV replication inhibitors identified through a high throughput RSV replicon screen of ?1million compounds in the AstraZeneca compound collection.', 25542974),
('GRL-142, containing an unprecedented 6-5-5-ring-fused crown-like tetrahydropyranofuran', 'Potent activity against all HIV-1 strains examined with IC50 values of attomolar-to-picomolar concentrations', '', 'Here, we report GRL-142, a novel HIV-1 protease inhibitor containing an unprecedented 6-5-5-ring-fused crown-like tetrahydropyranofuran, which has extremely potent activity against all HIV-1 strains examined with IC50 values of attomolar-to-picomolar concentrations, virtually no effects on cellular growth, extremely high genetic barrier against the emergence of drug-resistant variants, and favorable intracellular and central nervous system penetration.', 29039736),
('4''-C-cyano-2-amino-2''-deoxyadenosine (CAdA)', 'Activity against hepatitis B virus (HBV), half maximal inhibitory concentration [IC50 ] = 0.4 nM) and HIV-1 (IC50 = 0.4 nM', '', '4''-modified nucleoside analogs: potent inhibitors active against entecavir-resistant hepatitis B virus', 26122273),
('GLS4 (ethyl 4-[2-bromo-4-fluorophenyl]-6-[morpholino-methyl]-2-[2-thiazolyl]-1,4-dihydro-pyrimidine-5-carboxylate)', 'GLS4 demonstrated potent inhibitory activities in HBV HepG2.2.15 cell assay with an EC50 value of 1nM, and it also exhibited high potency against various drug-resistant HBV viral strains with EC50 values in the range of 10-20nM', '', 'Herein we described our lead optimization studies including the synthesis, molecular docking studies and structure-activity relationship (SAR) studies of a series of novel heteroaryldihydropyrimidine (HAP) inhibitors of HBV capsid assembly inhibitors, and the discovery of a potent inhibitor of HBV capsid assembly of GLS4 (ethyl 4-[2-bromo-4-fluorophenyl]-6-[morpholino-methyl]-2-[2-thiazolyl]-1,4-dihydro-pyri midine-5-carboxylate) which is now in clinical phase 2.', 28082068),
('Pyridone-based compound PF-46396', 'Anti-HIV-1', '', 'HIV-1 maturation inhibitors are novel as they target the Gag protein, specifically by inhibiting CA-SP1 proteolytic cleavage.', 27384665),
('Cytidine analogue D-d4FC (DPC817, Reverset)', 'Anti-HIV-1', '', 'HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2'',3''-dideoxy-2'',3''-didehydro-5-fluorocytidine (Reverset). Nucleoside reverse transcriptase inhibitors (NRTIs) represent the cornerstone of highly active antiretroviral therapy when combined with non-nucleoside reverse transcriptase inhibitors (NNRTIs) or HIV-1 protease inhibitors (PIs).', 12790516),
('Three-ring oxadiazole compounds', 'Anti-HIV-1', '', 'Identification of novel bifunctional HIV-1 reverse transcriptase inhibitors. The increasing prevalence of mutations in HIV-1 reverse transcriptase (RT) that confer resistance to existing NRTIs and NNRTIs underscores the need to develop RT inhibitors with novel mode-of-inhibition and distinct resistance profiles.', 29029095),
('A series of 1,3,5-triazine compounds', 'Anti-HCV', '', 'Importantly, I719, the most relevant natural polymorphism, did not significantly alter the susceptibility of HCV to the triazine compounds. The preclinical properties of these triazine compounds support further investigation of entry inhibitors as a potential novel therapy for HCV infection.', 22545104),
('D4GTP (the planar 2'',3''-unsaturated deoxyribose guanosine analogue that is complementary to D4TTP)', 'Anti-HIV-1', '', 'In contrast to CBVTP, D4GTP was found to be an excellent substrate for RT(WT) and no resistance was conferred by the M184V mutation, thus providing novel insight into structure-activity relationships for nucleoside-based inhibitors.', 11955063),
('Bromocriptine (BRC)', 'Dengue virus (DENV) half maximal effective concentration [EC50], 0.8-1.6 microM', 'Half maximal cytotoxicity concentration [CC50], 53.6 microM)', 'In summary, BRC was found to be a novel DENV inhibitor and a potential candidate for the treatment of DENV infectious disease.', 27181378),
('2,2''-diselenobisbenzamides (DISeBAs)', 'Anti-HIV', '', 'In this manuscript, we have identified a series of 2,2''-diselenobisbenzamides (DISeBAs) as novel HIV retroviral nucleocapsid protein 7 (NCp7) inhibitors.', 26613134),
('VRX-329747 and VRX-413638', 'Anti-HIV-1', '', 'In this study, we report a novel series of nonnucleoside inhibitors of HIV-1, exemplified by VRX-329747 and VRX-413638, which inhibit both NNRTI- and NRTI-resistant HIV-1 isolates.', 16870771),
('GSK2485852 (referred to here as GSK5852)', 'Hepatitis C virus (HCV) NS5B polymerase inhibitor with 50% effective concentrations (EC50s)', '', 'In vitro characterization of GSK2485852, a novel hepatitis C virus polymerase inhibitor. GSK2485852 (referred to here as GSK5852) is a hepatitis C virus (HCV) NS5B polymerase inhibitor with 50% effective concentrations (EC50s) in the low nanomolar range in the genotype 1 and 2 subgenomic replicon system as well as the infectious HCV cell culture system.', 23939896),
('3-hydroxypyrimidine-2,4-diones', 'Activity against human immunodeficiency virus (HIV)', '', 'Inhibitors with a novel structure core are essential for combating resistance associated with known IN inhibitors (INIs).', 21381765),
('JTK-853', 'hepatitis C virus (HCV)', '', 'JTK-853, a novel non-nucleoside hepatitis C virus polymerase inhibitor, demonstrates a high genetic barrier to resistance in vitro. JTK-853 is a novel, non-nucleoside, palm site-binding hepatitis C virus (HCV) polymerase inhibitor that has demonstrated antiviral activity in HCV-infected patients during 3 days of treatment.', 24008863),
('1, 4-dihydro-2H-3, 1-benzoxazin-2-ones', 'The compound was a potent inhibitor of the wild-type HIV-1 RT (Ki = 2.93 nM) and exhibited a 95% inhibitory concentration of 1.5 nM for the inhibition of HIV-1 replicative spread in cell culture.', '', 'L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase. The clinical benefit of the human immunodeficiency virus type 1 (HIV-1) nonnucleoside reverse transcriptase (RT) inhibitors (NNRTIs) is limited by the rapid selection of inhibitor-resistant viral variants.', 8592986),
('2-Hydroxyisoquinoline-1,3(2H,4H)-dione', 'Anti-HIV-1', '', 'Magnesium chelating 2-hydroxyisoquinoline-1,3(2H,4H)-diones, as inhibitors of HIV-1 integrase and/or the HIV-1 reverse transcriptase ribonuclease H domain: discovery of a novel selective inhibitor of the ribonuclease H function. 2-Hydroxyisoquinoline-1,3(2H,4H)-dione was recently discovered as a scaffold for the inhibition of HIV-1 integrase and the ribonuclease H function of HIV-1 reverse transcriptase.', 21366258),
('Artocarpin', 'H1N1 IC(50) values, determined in chemiluminescence-based NA inhibition assays, are in the range of 0.18-17 microM', '', 'In particular, artocarpin exhibits high affinity toward three H1N1 oseltamivir-sensitive influenza A viruses. It also inhibits the NA of an oseltamivir-resistant H1N1 isolate.', 21452980),
('Sifuvirtide (SFT)', 'Anti-HIV', '', 'Our data present important information for developing SFT for clinical use and for designing novel HIV fusion inhibitors.', 22228771),
('Protease inhibitors (PI''s) bearing 1,3,4-oxadiazoles at the P1'' position', 'Anti-HIV-1', '', 'P1'' oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1. HIV-1 protease inhibitors (PI''s) bearing 1,3,4-oxadiazoles at the P1'' position were prepared by a novel method involving the diastereoselective installation of a carboxylic acid and conversion to the P1'' heterocycle.', 15324882),
('BPR0Z-194, one of the pyridyl imidazolidinones', 'Enterovirus 71', '', 'Pyridyl imidazolidinone is a novel class of potent and selective human enterovirus 71 inhibitor.', 15328120),
('RSV604, a novel benzodiazepine', 'Respiratory syncytial virus (RSV)', '', 'RSV604, a novel inhibitor of respiratory syncytial virus replication. Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infections worldwide, ye+B11t no effective vaccine or antiviral treatment is available.', 17576833),
('GSK2248761', '[EC(50)] = 36.9 ng/ml) against HIV-1', '', 'Safety and efficacy of GSK2248761, a next-generation nonnucleoside reverse transcriptase inhibitor, in treatment-naive HIV-1-infected subjects. GSK2248761 is a novel, once-daily (QD), next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) with activity against efavirenz-resistant strains.', 22314532),
('A series of novel N-alkoxy-arylsulfonamide', 'HIV protease inhibitors', '', 'Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors. A series of novel N-alkoxy-arylsulfonamide HIV protease inhibitors with low picomolar enzyme activity and single digit nanomolar antiviral activity is disclosed. DOI: 10.1016/j.bmcl.2005.05.101', 15975788),
('3-aryl-phospho-indole (API)', 'Anti-HIV-1', '', 'Synthesis and biological evaluation of aryl-phospho-indole as novel HIV-1 non-nucleoside reverse transcriptase inhibitors. A novel series of 3-aryl-phospho-indole (API) non-nucleoside reverse transcriptase inhibitors of HIV-1 was developed.', 21142105),
('Replacement of the pyridylmethyl moiety in indinavir with a pyridyl oxazole yielded HIV-1 protease inhibitors (PI)', 'Anti-HIV-1', '', 'The design, synthesis and evaluation of novel HIV-1 protease inhibitors with high potency against PI-resistant viral strains. Replacement of the pyridylmethyl moiety in indinavir with a pyridyl oxazole yielded HIV-1 protease inhibitors (PI) with greatly improved potency against PI-resistant HIV-1 strains.', 12852969),
('Bicyclams', 'Human immunodeficiency virus type 1 (HIV-1) and HIV-2 inhibitor', '', 'The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication. Bicyclams are a novel class of antiviral compounds which act as potent and selective inhibitors of the replication of human immunodeficiency virus type 1 (HIV-1) and HIV-2.', 8551604),
('CP32M', 'Inhibit a large panel of diverse HIV-1 variants, including subtype B'', CRF07_BC, and CRF01_AE recombinants and naturally occurring or induced T20-resistant viruses.', '', 'Therefore, our data present important information for developing novel HIV-1 fusion inhibitors for clinical use.', 22679024),
('AZ-27', 'Respiratory syncytial virus (RSV) inhibitors', '', 'This novel and broad-spectrum RSV L polymerase inhibitor may pave the way toward an efficacious RSV therapeutic and provide a new tool for interrogation of the L protein function.', 24777090),
('Alkyl Amine Bevirimat Derivatives', 'Anti-HIV-1', '', 'To overcome the loss of BVM activity induced by polymorphisms in SP1, we carried out an extensive medicinal chemistry campaign to develop novel maturation inhibitors.', 26482309),
('Protease inhibitor SG85', 'enterovirus 71 (EV71)', '', 'We demonstrate that the novel enteroviral protease inhibitor (PI) SG85 and capsid binder (CB) vapendavir efficiently inhibit the in vitro replication of 21 EV71 strains/isolates that are representative of the different genogroups A, B, and C.', 25199773),
('Bisheteroarylpiperazine, U-90152 [1-(5-methanesulfonamido-1H-indol-2-yl-carbonyl)-4-[3-(1-methyl eth yl-amino)pyridinyl]piperazine]', 'Inhibited recombinant HIV-1 RT at a 50% inhibitory concentration (IC50) of 0.26 microM (compared with IC50s of > 440 microM for DNA polymerases alpha and delta)', '', 'We describe a novel bisheteroarylpiperazine, U-90152 [1-(5-methanesulfonamido-1H-indol-2-yl-carbonyl)-4-[3-(1-methyl eth yl-amino)pyridinyl]piperazine], which inhibited recombinant HIV-1 RT at a 50% inhibitory concentration (IC50) of 0.26 microM (compared with IC50s of > 440 microM for DNA polymerases alpha and delta).', 7685995),
('ABT-450', 'Inhibitor of HCV NS3/4A protease, with 50% effective concentration values of 1.0, 0.21, 5.3, 19, 0.09, and 0.69 nM against stable HCV replicons with NS3 protease from genotypes 1a, 1b, 2a, 3a, 4a, and 6a, respectively.', '', 'In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450. The development of direct-acting antiviral agents is a promising therapeutic advance in the treatment of hepatitis C virus (HCV) infection. ABT-450 is an efficacious inhibitor of HCV NS3/4A protease, with 50% effective concentration values of 1.0, 0.21, 5.3, 19, 0.09, and 0.69 nM against stable HCV replicons with NS3 protease from genotypes 1a, 1b, 2a, 3a, 4a, and 6a, respectively.', 25451053),
('GLS4', 'The IC(50) of GLS4 was 0.012 microM, which is significantly lower than that of lamivudine (0.325 microM).', '', 'CONCLUSIONS: GLS4 is a new and unique potential anti-HBV agent that possesses a different mechanism of action than existing therapeutic drugs.', 22668794),
('2-phenylbenzimidazole derivatives', 'Selectively and potently active against the bovine viral diarrhea virus (BVDV)', '', 'Pharmacophore modeling, resistant mutant isolation, docking, and MM-PBSA analysis: Combined experimental/computer-assisted approaches to identify new inhibitors of the bovine viral diarrhea virus (BVDV). Starting from a series of our new 2-phenylbenzimidazole derivatives, shown to be selectively and potently active against the bovine viral diarrhea virus (BVDV), we developed a hierarchical combined experimental/molecular modeling strategy to explore the drug leads for the BVDV RNA-dependent RNA-polymerase.', 20189812),
('Arylazoenamine derivatives', 'Selectively and potently active against the bovine viral diarrhea virus (BVDV), we developed a hierarchical combined experimental/molecular modeling strategy to explore the drug leads for the BVDV RNA-dependent RNA polymerase.', '', 'Synergistic experimental/computational studies on arylazoenamine derivatives that target the bovine viral diarrhea virus RNA-dependent RNA polymerase. Starting from a series of arylazoenamine derivatives, shown to be selectively and potently active against the bovine viral diarrhea virus (BVDV), we developed a hierarchical combined experimental/molecular modeling strategy to explore the drug leads for the BVDV RNA-dependent RNA polymerase.', 20638852),
('Compound 27, piperidine-substituted thiophene[3,2-d]pyrimidine scaffold', 'Compound 27 was the most potent; compared with ETV, its antiviral efficacy was 3-fold greater against WT, 5-7-fold greater against Y181C, Y188L, E138K, and F227L+V106A, and nearly equipotent against L100I and K103N, though somewhat weaker against K103N+Y181C.', '27 has lower cytotoxicity (CC50 > 227 microM) and a huge selectivity index (SI) value (ratio of CC50/EC50) of >159101', 'We designed and synthesized a series of human immunodeficiency virus type 1 (HIV-1) non-nucleoside reverse transcriptase inhibitors (NNRTIs) with a piperidine-substituted thiophene[3,2-d]pyrimidine scaffold, employing a strategy of structure-based molecular hybridization and substituent decorating.', 27541578),
('Remazol Brilliant Blue R', 'Remazol Brilliant Blue R (RB19, an anthraquinone dye), which inhibited WT NA and MDR NA with IC(50) values of 3.4 and 4.5 microM, respectively.', '', 'Using this strategy, we identified a new inhibitor, Remazol Brilliant Blue R (RB19, an anthraquinone dye), which inhibited WT NA and MDR NA with IC(50) values of 3.4 and 4.5 microM, respectively.', 23437217),
('Macrocyclic acylsulfonamide', 'Potent inhibitor of the NS3-NS4A proteases of all hepatitis C virus genotypes and of a panel of genotype 1-resistant variants.', '', 'This work describes our rational approach toward the identification of a macrocyclic acylsulfonamide that is a potent inhibitor of the NS3-NS4A proteases of all hepatitis C virus genotypes and of a panel of genotype 1-resistant variants.', 23271737),
('Chebulagic acid (CHLA) and punicalagin (PUG)', 'Could prevent binding, penetration, and cell-to-cell spread, as well as secondary infection.', 'inhibit HSV-1 entry at noncytotoxic doses in A549 human lung cells.', 'Experiments revealed that both tannins targeted and inactivated HSV-1 viral particles and could prevent binding, penetration, and cell-to-cell spread, as well as secondary infection.', 21307190),
('Nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781', '25 microM UC781 provided essentially equivalent microbicidal activity against NNRTI-resistant and wt virus', '', 'In vitro microbicidal activity of the nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 against NNRTI-resistant human immunodeficiency virus type 1. The nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 is under development as a microbicide to prevent sexual transmission of the human immunodeficiency virus type 1 (HIV-1).', 16611904),
('Stilbene 1,2-diamines', 'Compounds selectively block the initiation of replication of incoming HCV RNA but have no impact on viral entry, primary translation, or ongoing HCV RNA replication, nor do they suppress persistent HCV infection.', 'prevent HCV infection at nontoxic, low micromolar concentrations in cell culture.', 'Using a cell-based colorimetric screening assay to interrogate a 1,200-compound chemical library for anti-HCV activity, we identified a family of 1,2-diamines derived from trans-stilbene oxide that prevent HCV infection at nontoxic, low micromolar concentrations in cell culture.', 21430055),
('Distamycin analogue, 2,2''-[4, 4''-[[aminocarbonyl]amino]bis[N,4''-di[pryrrole-2-carboxamide- 1, 1''-dimethyl]]-6,8-naphthalenedisulfonic acid]hexasodium salt (NSC 651016)', 'NSC 651016 inhibited in vitro replication of a wide range of HIV-1 isolates, as well as HIV-2 and SIV, and exhibited in vivo anti-HIV-1 activity in a murine model.', '', 'NSC 651016 represents an attractive candidate for the chemotherapeutic treatment of HIV-1 infection and as a microbicide to prevent the sexual transmisssion of HIV-1.', 9632350),
('D- and L-(beta)-deoxy- and -dideoxynucleoside triphosphate analogues', 'L-(beta)-enantiomers of nucleoside RT inhibitors were synergistic when combined with nonnucleoside RT inhibitors', '', 'Potentiation of inhibition of wild-type and mutant human immunodeficiency virus type 1 reverse transcriptases by combinations of nonnucleoside inhibitors and d- and L-(beta)-dideoxynucleoside triphosphate analogs. Combinations of reverse transcriptase (RT) inhibitors are currently used in anti-human immunodeficiency virus therapy in order to prevent or delay the emergence of resistant virus and to improve the efficacy against viral enzymes carrying resistance mutations.', 11257034),
('N-Butyldeoxynojirimycin (NB-DNJ)', 'When encapsulated inside liposomes, NB-DNJ inhibited HIV-1 with final concentrations in the nmol/l range (IC50 = 4 nmol/l), a 100 000-fold enhancement in IC50 relative to free NB-DNJ.', '', 'N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery. NB-DNJ CD4 liposomes demonstrated additional antiviral effects, reducing viral secretion by 81% and effectively neutralizing free viral particles to prevent further infections.', 18753929),
('CDG (carbocyclic 2''-deoxyguanosine) and abacavir ([1S,4R]-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol)', 'Drug assays indicated that the lamivudine-resistant virus exhibited reduced sensitivity to penciclovir [9-(4-hydroxy-3-hydroxymethyl-but-1-yl) guanine] but was still inhibited by the nucleoside analogues CDG (carbocyclic 2''-deoxyguanosine) and abacavir ([1S,4R]-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol).', '', 'Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening. Lamivudine [beta-L-(-)-2'',3''-dideoxy-3''-thiacytidine] is a potent inhibitor of hepadnavirus replication and is used both to treat chronic hepatitis B virus (HBV) infections and to prevent reinfection of transplanted livers.', 12760870),
('Boceprevir-S isomer (SCH 534128)', 'Median concentration in patients with breakthrough was 48.3 ng/mL (interquartile range 43-58 ng/mL); in others, it was significantly (p 0.019) higher: 151 ng/mL.', '', 'Boceprevir-S isomer (SCH 534128) median concentration in patients with breakthrough was 48.3 ng/mL (interquartile range 43-58 ng/mL); in others, it was significantly (p 0.019) higher: 151 ng/mL. Low boceprevir plasma concentration can lead to virologic resistance; therapeutic drug monitoring should be used to prevent the onset of viral breakthrough during triple-regimen therapy with boceprevir. Copyright ? 2014 European Society of Clinical Microbiology and Infectious Diseases.', 25658567);
INSERT INTO `virus_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('4-oxo-4H-1-benzopyran-8-carbaldehydes 11a-11g', 'Most promising, and they demonstrated better activities and selectivities comparable to those the reference ribarivin, a nucleoside antiviral agent.', '', 'A series of novel isoflavonoids were synthesized based on structural modifications of daidzein, an active ingredient of traditional Chinese medicine (TCM) and evaluated for their anti-influenza activity, in vitro, against H1N1 Tamiflu-resistant (H1N1 TR) virus in the MDCK cell line. Among them, 4-oxo-4H-1-benzopyran-8-carbaldehydes 11a-11g were most promising, and they demonstrated better activities and selectivities comparable to those the reference ribarivin, a nucleoside antiviral agent. 3-(4-Bromophenyl)-7-hydroxy-4-oxo-4H-1-benzopyran-8-carboxaldehyde (11c) displayed the best inhibitory activity (EC50 , 29.0 microM) and selectivity index (SI>10.3).', 25879510),
('Carraguard-based formulation', 'PC-817 appeared no more effective than Carraguard in vivo, due to the limited activity of a single dose of MIV-150 and the dominant barrier effect of Carraguard.', '', 'Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity. Anti-HIV microbicides are being investigated in clinical trials and understanding how promising strategies work, coincident with demonstrating efficacy in vivo, is central to advancing new generation microbicides.', 18776937),
('4''-methoxyflavone and 2''-hydroxy-4-methoxychalcone', 'In-silico study, binders of the 150-cavity of neuraminidase (NA)', '', 'A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1.', 27412704),
('Diphenyl ether', 'Non-nucleoside reverse transcriptase inhibitors with excellent potency against resistant mutant viruses and promising pharmacokinetic properties', '', 'Diphenyl ether non-nucleoside reverse transcriptase inhibitors with excellent potency against resistant mutant viruses and promising pharmacokinetic properties. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are part of the preferred treatment regimens for individuals infected with HIV.', 19006142),
('Indolylarylsulfones (IASs), halo- and nitro-substituted IAS derivatives', 'Exhibited high selectivity to the mutant RT in complex with its substrates, behaving as uncompetitive inhibitors.', '', 'Mechanism of interaction of novel indolylarylsulfone derivatives with K103N and Y181I mutant HIV-1 reverse transcriptase in complex with its substrates. BACKGROUND: Novel indolylarylsulfones (IASs), designed through rational structure-based molecular modelling and docking approaches, have been recently characterized as effective inhibitors of the wild-type and drug-resistant mutant HIV-1 reverse transcriptase (RT).', 22095519),
('Icosahedral metallacarboranes', 'Potent and specific competitive inhibitors of drug-resistant HIV PRs prepared either by site-directed mutagenesis or cloned from HIV-positive patients.', '', 'Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance. HIV protease (PR) is a prime target for rational anti-HIV drug design.', 18598016),
('Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol)', 'Active against ganciclovir- and foscarnet-resistant human cytomegalovirus UL97 mutants', '', 'The Z-isomers of 2-hydroxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol) were previously shown to be potent inhibitors of AD169 and Towne HCMV reference strains and postulated to share a common phosphorylation pathway with ganciclovir (GCV) possibly involving the UL97-encoded phosphotransferase.', 12406510),
('R1626 plus peginterferon Alfa-2a', 'Potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin', '', 'R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin. R1626, a prodrug of the hepatitis C virus (HCV) RNA polymerase inhibitor R1479, showed time-dependent and dose-dependent reduction of HCV RNA levels in a previous study.', 18570306),
('Benzothiadiazine-substituted tetramic acids', 'Potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase', '', 'An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids is reported.', 16455253),
('KNI-227 and KNI-272', 'the 50% inhibitory concentrations of KNI-227 against HIV type 1 LAI (HIV-1LAI), HIV-1RF, HIV-1MN, and HIV-2ROD were 0.1, 0.02, 0.03, and 0.1 microM, respectively, while those of KNI-272 were 0.1, 0.02, 0.04, and 0.1 microM, respectively.', 'The ratios of 50% cytotoxic concentrations to 50% inhibitory concentrations for KNI-227 and KNI-272 were approximately 2,500 and > 4,000, respectively, as assessed in peripheral blood mononuclear cells.', 'In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine. Two compounds, KNI-227 and KNI-272, which were highly potent against HIV protease with little inhibition of other aspartic proteases, showed the most potent activity against the infectivity and cytopathic effect of a wide spectrum of HIV strains.', 8494379),
('2''-deoxy-4''-C-ethynyl-2-fluoroadenosine and 2''-deoxy-4''-C-ethynyl-2-chloroadenosine', 'Have supremely high activity against all human immunodeficiency viruses including multidrug-resistant HIV and low toxicity.', 'low toxicity.', 'Development of modified nucleosides that have supremely high anti-HIV activity and low toxicity and prevent the emergence of resistant HIV mutants. An idea to use 4''-C-substituted-2''-deoxynucleoside derivatives was proposed based on a working hypothesis to solve the problems of existing acquired immune deficiency syndrome chemotherapy (highly active antiretroviral therapy).', 21422739),
('GRL-1388 and -1398', 'GRL-1388 was as potent as darunavir (DRV) against various drug-resistant HIV-1 laboratory strains with 50% effective concentration (EC(50)s) of 2.6 to 32.6 nM. GRL-1398 was significantly more potent against such variants than DRV with EC(50)s of 0.1 to 5.7 nM. GRL-1388 and -1398 were also potent against multiple-PI-resistant clinical HIV-1 variants ((CL)HIV-1(MDR)) with EC(50)s ranging from 2.7 to 21.3 nM and from 0.3 to 4.8 nM, respectively.', '', 'Novel HIV-1 protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran, that are potent against multi-PI-resistant HIV-1 variants. We identified GRL-1388 and -1398, potent nonpeptidic human immunodeficiency virus type 1 (HIV-1) protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran (Tp-THF).', 21282450),
('MK-1439', 'Treatment of HIV infection.', '', 'Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses.', 24412110),
('GRL-5010A and GRL-4410A', 'More effective than darunavir in inhibiting mature PR20 and show promise for further development of antiviral agents targeting highly resistant PR mutants.', '', 'Substituted Bis-THF Protease Inhibitors with Improved Potency against Highly Resistant Mature HIV-1 Protease PR20. An extremely drug resistant mutant of HIV-1 protease (PR) bearing 20 mutations (PR20) has been studied with two potent antiviral investigational inhibitors.', 26010498),
('TMC647055 (TMC)', 'A novel and potent non-nucleoside inhibitor of the HCV NS5B polymerase.', '', 'TMC647055 (TMC) is a novel and potent non-nucleoside inhibitor of the HCV NS5B polymerase. However, mutations that result in drug resistance to TMC have been reported.', 26836778),
('EDP-239', 'Hepatitis C Virus NS5A Inhibitor', '', 'EDP-239, a potent and selective hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor developed for the treatment of HCV infection, has been investigated in vitro and in vivo', 27503644),
('Three amide-DAANs 8e, 4a, and 4b', 'High potency against wild-type and rilpivirine-resistant viral strains and multiple desirable drug-like properties.', '', 'Drug-like property-driven optimization of 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against rilpivirine-resistant mutant virus.', 28465101),
('TMC125-R165335 (etravirine)', 'TMC125-R165335 and related anti-AIDS drug candidates can bind the enzyme RT in multiple conformations and thereby escape the effects of drug-resistance mutations.', '', 'Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. Anti-AIDS drug candidate and non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC125-R165335 (etravirine) caused an initial drop in viral load similar to that observed with a five-drug combination in na?ve patients and retains potency in patients infected with NNRTI-resistant HIV-1 variants.', 15115397),
('7-Deaza-2''-C-methyl-adenosine', 'Potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties', '', 'A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties. Improved treatments for chronic hepatitis C virus (HCV) infection are needed due to the suboptimal response rates and deleterious side effects associated with current treatment options.', 15388457),
('Aurintricarboxylic acid', 'Potent inhibitor of influenza A and B virus neuraminidases', '', 'Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases. BACKGROUND: Influenza viruses cause serious infections that can be prevented or treated using vaccines or antiviral agents, respectively.', 20020057),
('2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236)', 'PHI-236 displayed high-binding affinity (Ludi K(i) = 0.07 microM) for HIV-1 RT and robust anti-HIV activity against the wild type (IC50 = <0.001 microM) as well as primary clinical isolates (IC50 = 0.009-0.04 microM) carrying multiple RT gene mutations associated with NRTI and NNRTI resistance.', '', 'Discovery of 2,5-dimethoxy-substituted 5-bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human immunodeficiency virus microbicide.', 16254003),
('beta-L-2'',3''-Dideoxycytidine (beta-L-ddC) and beta-L-5-fluoro-2'',3''-dideoxycytidine (5-F-beta-L-ddC)', 'The beta-L-dideoxycytidine nucleosides had similar anti-HIV-1 activities, significantly greater anti-HBV activities', 'decreased toxicities to a B-cell line, T-cell lines, and human bone marrow progenitor cells.', 'Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides. beta-L-2'',3''-Dideoxycytidine (beta-L-ddC) and beta-L-5-fluoro-2'',3''-dideoxycytidine (5-F-beta-L-ddC) were prepared and shown to have potent activity against human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV).', 7518218),
('[tetrahydroimidazo[4,5,1-jk] [1,4]benzodiazepin-2(1H)-one and -thione (TIBO), 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine, nevirapine, pyridinone, bis(heteroaryl)piperazine, etc.]', 'Potent inhibitors of HIV-1 replication in cell culture.', '', 'Kinetics of different human immunodeficiency virus type 1 reverse transcriptases resistant to human immunodeficiency virus type 1-specific reverse transcriptase inhibitors. The human immunodeficiency virus type 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors [tetrahydroimidazo[4,5,1-jk] [1,4]benzodiazepin-2(1H)-one and -thione (TIBO), 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine, nevirapine, pyridinone, bis(heteroaryl)piperazine, etc.] are potent inhibitors of HIV-1 replication in cell culture.', 7682649),
('N-[2-(1-cyclohexenyl)ethyl]-N''-[2-(5-bromopyridyl)]-thiourea and N''-[2-(1-cyclohexenyl)ethyl]-N''-[2-(5-chloropyridyl)]-thiourea', 'HIV-1 inhibition assays was: HI-445 = HI-346 (IC50 = 3 nM) > MKC-442 (IC50 = 4 nM) = AZT (IC50 = 4 nM) > trovirdine (IC50 = 7 nM) > delavirdine (IC50 = 9 nM) > nevirapine (IC50 = 34 nM).', '', 'N-[2-(1-cyclohexenyl)ethyl]-N''-[2-(5-bromopyridyl)]-thiourea and N''-[2-(1-cyclohexenyl)ethyl]-N''-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1.', 10509923),
('MKC-442 (6-benzyl-1-ethoxymethyl-5-isopropyluracil or I-EBU)', 'The 50 and 90% effective concentrations for HIV-1 (HTLV-IIIB strain) replication in MT-4 cells were 15 and 98 nM, respectively.', '', 'Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro. MKC-442 (6-benzyl-1-ethoxymethyl-5-isopropyluracil or I-EBU) has recently been identified as a highly potent and specific inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.', 7518216),
('5-Fluorouracil, 5-fluorouridine (FUrd), 5-fluoro-2''-deoxyuridine (FdUrd), 5-fluorocytidine (FCyd), 5-fluoro-2''-deoxycytidine (FdCyd), 5-trifluoro-2''-deoxythymidine (F3dThd), and the 5''-monophosphates and 3'',5''-cyclic monophosphates', 'Activity against thymidine kinase-deficient (TK-) herpes simplex virus', '', 'Potent activity of 5-fluoro-2''-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase. Other 5-substituted 2''-deoxyuridines that have previously been recognized as potent thymidylate synthase inhibitors behaved in a similar fashion.', 3039343),
('(S,S)-1,2-bis(5-methoxy-2-benzimidazolyl)-1,2-ethanediol', 'Potent inhibitors of rhinoviruses', '', 'Antiviral activity in tissue culture systems of bis-benzimidazoles, potent inhibitors of rhinoviruses.', 4333892),
('Pyridinone derivatives', 'Potent and specific inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) and HIV-1 replication in cell culture.', '', 'L-702,019 was also a potent inhibitor of the replication of mutant HIV-1 containing the individual mutations at amino acid 103 or 181 as well as of clinical isolates resistant to L-697,661 and L-696,229.', 7685996),
('PNU-140690 (sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrone)', 'A potent, nonpeptidic inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease currently under clinical evaluation.', '', 'In vitro combination of PNU-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and -resistant clinical isolates. PNU-140690 (sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrone) is a potent, nonpeptidic inhibitor of the human immunodeficiency virus type 1 (HIV-1) protease currently under clinical evaluation.', 9371335),
('(-)-beta-D-2, 6-diaminopurine-dioxolane', 'Suppressive effects of the K65R and L74V mutations on AZT resistance.', '', 'In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3''-azido-3''-deoxythymidine. Human immunodeficiency virus type 1 (HIV-1) isolates resistant to (-)-beta-D-dioxolane-guanosine (DXG), a potent and selective nucleoside analog HIV-1 reverse transcriptase (RT) inhibitor, were selected by serial passage of HIV-1(LAI) in increasing drug concentrations (maximum concentration, 30 microM). Two independent selection experiments were performed.', 10858331),
('2'',3''-dideoxy-3''-thiacytidine (3TC)', 'A potent inhibitor of wild-type human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT).', '', 'Wild-type and YMDD mutant murine leukemia virus reverse transcriptases are resistant to 2'',3''-dideoxy-3''-thiacytidine. The antiretroviral nucleoside analog 2'',3''-dideoxy-3''-thiacytidine (3TC) is a potent inhibitor of wild-type human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT).', 10864683),
('L-chicoric acid', 'A potent and selective inhibitor of HIV-1 integrase that also inhibits HIV-1 replication in cell culture.', '', 'L-chicoric acid is a potent and selective inhibitor of HIV-1 integrase that also inhibits HIV-1 replication in cell culture.', 10867160),
('DPC 817, 2'',3''-didehydro-2'',3''-dideoxy-5-fluorocytidine (PSI 5582 D-D4FC)', 'A cytidine nucleoside analog with activity against zidovudine- and lamivudine-resistant viral variants', '', 'DPC 817, 2'',3''-didehydro-2'',3''-dideoxy-5-fluorocytidine (PSI 5582 D-D4FC) is a potent inhibitor of HIV type 1 replication in vitro.', 11959574),
('1263W94', '1263W94 inhibited viral replication in a dose-dependent manner, with a mean 50% inhibitory concentration (IC(50)) of 0.12 +/- 0.01 microM', '', 'Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. enzimidazole nucleosides have been shown to be potent inhibitors of human cytomegalovirus (HCMV) replication in vitro.', 12121906),
('Imidazole-linked pinanamine derivatives (compound 33)', 'Inhibited the amantadine-resistant virus (IC50 = 3.4 microM) and its activity increased by almost 24-fold compared to initial compound, with its action mechanism being not M2 channel mediated.', '', 'Imidazole-based pinanamine derivatives: Discovery of dual inhibitors of the wild-type and drug-resistant mutant of the influenza A virus. We previously reported potent hit compound 4 inhibiting the wild-type influenza A virus A/HK/68 (H3N2) and A/M2-S31N mutant viruses A/WS/33 (H1N1), with its latter activity quite weak.', 26722757),
('Benzodithiin compound (RD3-0028)', 'RD3-0028 inhibits RSV replication by interfering with intracellular processing of the RSV fusion protein, or a step immediately thereafter, leading to loss of infectivity.', '', 'Mechanism of selective inhibition of respiratory syncytial virus by a benzodithiin compound (RD3-0028). RD3-0028, a compound with a benzodithiin structure, was found to be a potent inhibitor of respiratory syncytial virus (RSV) replication.', 11529559),
('Methyl 3'',3"-dichloro-4'',4"-dimethoxy-5'', 5"-bis(methoxycarbonyl)-6,6-diphenyl-5-hexenoate (ADAM II)', 'ADAM II inhibited HIV-1 reverse transcriptase with an IC50 of 0.3 microM but was inactive as an inhibitor of HIV-1 attachment/fusion to cells, protease, integrase, and the nucleocapsid protein.', '', 'New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors. The most potent compound proved to be methyl 3'',3"-dichloro-4'',4"-dimethoxy-5'', 5"-bis(methoxycarbonyl)-6,6-diphenyl-5-hexenoate (ADAM II), which displayed an EC50 of 13 nM for inhibition of the cytopathic effect of HIV-1RF in CEM-SS cells.', 9622549),
('2-fluoroadenosine analogue 32', '2-fluoroadenosine analogue 32 showed antiviral potency as well as high cytotoxicity (IC(50) 1.5, 1.1, and 7.6 microM for PBM, CEM, and Vero, respectively) whereas no other compound showed cytotoxicity up to 100 microM.', '', 'Stereoselective synthesis and antiviral activity of D-2'',3''-didehydro-2'',3''-dideoxy-2''-fluoro-4''-thionucleosides. The antiviral activity of the synthesized compounds were evaluated against HIV-1 in human peripheral blood mononuclear (PBM) cells, among which cytidine 17, 5-fluorocytidine 18, adenosine 24, and 2-fluoroadenosine 32 showed moderate to potent anti-HIV activities (EC(50) 1.3, 11.6, 8.1, and 1.2 microM, respectively).', 12383014),
('Cytosine 17, 5-fluorocytosine 18, and adenine 27 derivatives', 'Showed potent anti-HIV activities (EC(50) = 0.12, 0.15, and 1.74 microM, respectively) without significant cytotoxicity up to 100 microM in human PBM, CEM, and Vero cells.', '', 'Synthesis, anti-HIV activity, and molecular mechanism of drug resistance of L-2'',3''-didehydro-2'',3''-dideoxy-2''-fluoro-4''-thionucleosides. The antiviral activity of the newly synthesized compounds was evaluated against HIV-1 in human peripheral blood mononuclear (PBM) cells, among which the cytosine 17, 5-fluorocytosine 18, and adenine 27 derivatives showed potent anti-HIV activities (EC(50) = 0.12, 0.15, and 1.74 microM, respectively) without significant cytotoxicity up to 100 microM in human PBM, CEM, and Vero cells.', 12540238),
('Diketo acid compound L-742,001', 'Two- to 3-fold resistance was seen for the T20A, L42T, and V122T mutants, and the R124Q and Y130A mutants were 3-fold more sensitive to L-742,001.', '', 'The diketo acid compound L-742,001 was previously identified as a potent inhibitor of the influenza virus endonuclease reaction, but information on its precise binding mode to PA or potential resistance profile is limited.', 23824822),
('DPC 681 and DPC 684', 'A panel of chimeric viruses constructed from clinical samples from patients who failed PI-containing regimens and containing 5 to 11 mutations, including positions 10, 32, 46, 47, 50, 54, 63, 71, 82, 84, and 90 had mean IC(50) values of <20 nM for DPC 681 and DPC 681, respectively', '', 'DPC 681 and DPC 684: potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variants. Two compounds resulting from our studies, designated DPC 681 and DPC 684, are potent and selective inhibitors of HIV protease with IC(90)s for wild-type HIV-1 of 4 to 40 nM.', 11600351),
('N-[2-(2,5-dimethoxyphenylethyl)]-N''-[2-(5-bromopyridyl)]-thi ourea (HI-236)', 'The activity of HI-236 against RT-MDR was superior to that of other anti-HIV agents tested, in the following order, from high to low activity; HI-236 (IC50 5 nM), HI-240 (IC50 6 nM), trovirdine (IC50 20 nM), zidovudine (IC50 150 nM), MKC-442 (IC50 300 nM), delavirdine (IC50 400 nM) and nevirapine (IC50 5 microM).', '', 'Our lead compound, N-[2-(2,5-dimethoxyphenylethyl)]-N''-[2-(5-bromopyridyl)]-thi ourea (HI-236) was tested against clinically observed non-nucleoside inhibitor (NNI)-resistant mutated strains of HIV.. HI-236 was more potent than trovirdine, MKC-442 and zidovudine against the drug-sensitive HIV-1 strain IIIB, 50-100 times more effective than delavirdine or nevirapine and twice as effective as our recently reported lead compound N-[2-(2-fluorophenethyl)]-N''-[2-(5-bromopyridyl)]-thiourea (HI-240) against the NNI-resistant Y181C mutant HIV-1 strain A17.', 10574178),
('Lignosulfonic acid (LA)', 'LA demonstrated potent inhibitory activity of HIV replication against a wide range of R5 and X4 HIV strains and prevented the uptake of HIV by bystander CD4+ T cells from persistently infected T cells in vitro (IC50: 0.07 - 0.34 microM). LA also inhibited HSV-2 replication in vitro in different cell types (IC50: 0.42 - 1.1 microM) and in rodents in vivo.', '', 'The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications. ', 26132818),
('4"-Benzoylureido-TSAO derivatives', 'A stringent structure-antiviral activity relationship was observed for the 4"-benzoylureido- TSAO derivatives for which the concomitant presence of a highly lipophilic substituent at both 2''- and 5''-positions was required to fully preserve the antihuman cytomegalovirus efficacy.', '', '4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors.', 18707089),
('2''-deoxy-3''-oxa-4''-thiocytidine (dOTC)', 'The mean 50% inhibitory concentration of dOTC for drug-naive isolates was 1.76 microM, rising to only 2.53 and 2.5 microM for viruses resistant to 3TC and viruses resistant to 3TC and AZT, respectively.', '', 'Both 5''-triphosphate (TP) derivatives of dOTC were more potent than 3TC-TP at inhibiting HIV-1 reverse transcriptase (RT) in vitro.', 10428900),
('Pyromeconic acid and derivatives', 'This approach ultimately resulted in the development of a lead compound with an IC50 value of 14 nM, which displayed an EC50 value of 2.1 microM against H1N1 influenza virus in MDCK cells.', '', 'Fragment-Based Identification of Influenza Endonuclease Inhibitors. Herein we report the development of inhibitors of influenza PA endonuclease derived from lead compounds identified from a metal-binding pharmacophore (MBP) library screen. Pyromeconic acid and derivatives thereof were found to be potent inhibitors of endonuclease.', 27291165),
('JM3100, bicyclam derivative', 'JM3100, in which the cyclam moieties are tethered by an aromatic bridge [i.e., phenylenebis(methylene)], inhibits the replication of various HIV-1 and HIV-2 strains in various cell lines at a 50% effective concentration (EC50) of 1 to 10 ng/ml, which is about 100-fold lower than the concentration required for JM2763 to inhibit HIV replication and at least 100,000-fold lower than the cytotoxic concentration (> 500 micrograms/ml).', '', 'Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Bicyclams, in which the cyclam (1,4,8,11-tetraazacyclotetradecane) moieties are tethered via an aliphatic bridge (i.e., propylene, as in JM2763) are potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) (E.', 7913308),
('MRL-1237', 'MRL-1237 inhibited poliovirus-specific RNA synthesis in HeLa cells infected with a wild strain but not with an F164Y mutant.', '', 'Mutations in the 2C region of poliovirus responsible for altered sensitivity to benzimidazole derivatives. MRL-1237, [1-(4-fluorophenyl)-2-(4-imino-1,4-dihydropyridin-1-yl) methylbenzimidazole hydrochloride], is a potent and selective inhibitor of the replication of enteroviruses.', 10756027),
('AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2'',3''-dideoxy-3''-thiacytidine', 'The potency of AT-61 was not affected by one of the mutations responsible for (-)-beta-L-2'', 3''-dideoxy-3'' thiacytidine (3TC) resistance in HBV, and AT-61 acted synergistic with 3TC to inhibit HBV replication.', 'AT-61 (81 microM) was not cytotoxic or antiproliferative to several cell lines and had no antiviral effect on woodchuck or duck HBV, human immunodeficiency virus type 1, herpes simplex virus type 1, vesicular stomatitis virus, or Newcastle disease virus.', 'AT-61, a member of a novel class of phenylpropenamide derivatives, was found to be a highly selective and potent inhibitor of human hepatitis B virus (HBV) replication in four different human hepatoblastoma cell lines which support the replication of HBV (i.e., HepAD38, HepAD79, 2.2.15, and transiently transfected HepG2 cells).', 9835512),
('2-(quinolin-3-yl)acetic acid derivatives', 'HIV-1 integrase inhibitors', '', 'We have rationally designed a series of 2-(quinolin-3-yl)acetic acid derivatives (LEDGINs) that act as potent inhibitors of the LEDGF/p75-integrase interaction and HIV-1 replication at submicromolar concentration by blocking the integration step.', 20473303),
('Novel fluorine-containing DAPY', 'Activities against wild-type (WT) HIV-1 and NNRTI-resistant strains', '', 'Novel fluorine-containing DAPY derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2014072419.', 26415039),
('Organosilanes', 'Potent antiviral activity against a panel of human clinical isolates of influenza A viruses, including viruses that are resistant to amantadine, oseltamivir, or both.', '', 'Design and expeditious synthesis of organosilanes as potent antivirals targeting multidrug-resistant influenza A viruses. In this study we report the design and synthesis of the first class of organosilanes that have potent antiviral activity against a panel of human clinical isolates of influenza A viruses, including viruses that are resistant to amantadine, oseltamivir, or both.', 28433777),
('Amino-bis-tetrahydrofuran Derivative [25f, 25i, and 25j]', '25f, 25i, and 25j were evaluated against a number of highly-PI-resistant HIV-1 strains, and they exhibited improved antiviral activity over darunavir.', '', 'Design of HIV-1 Protease Inhibitors with Amino-bis-tetrahydrofuran Derivatives as P2-Ligands to Enhance Backbone-Binding Interactions: Synthesis, Biological Evaluation, and Protein-Ligand X-ray Studies. Structure-based design, synthesis, and biological evaluation of a series of very potent HIV-1 protease inhibitors are described.', 26306007),
('Benzamide derivative named AH0109', 'Exhibits potent anti-HIV-1 activity at an 50% effective concentration of 0.7 microM in HIV-1-susceptible CD4(+) C8166 T cells.', '', 'In this study, we have identified a benzamide derivative named AH0109 that exhibits potent anti-HIV-1 activity at an 50% effective concentration of 0.7 microM in HIV-1-susceptible CD4(+) C8166 T cells.', 23669388),
('4''-ethynyl-2-fluoro-2''-deoxyadenosine (EFdA)', 'Similar to WT RT, the N348I RT is inhibited by EFdA mainly at the point of incorporation through decreased translocation.', '', 'Bond Life Sciences Center and Department of Molecular Microbiology & Immunology, School of Medicine, University of Missouri, Columbia, MO 65211, USA. 4''-ethynyl-2-fluoro-2''-deoxyadenosine (EFdA) is a highly potent inhibitor of HIV-1 reverse transcriptase (RT).', 23273211),
('NVP018', 'A potent inhibitor of hepatitis B virus, hepatitis C virus (HCV), and HIV-1 replication, shows minimal inhibition of major drug transporters, and has a high barrier to generation of both HCV and HIV-1 resistance', '', 'NVP018 is a potent inhibitor of hepatitis B virus, hepatitis C virus (HCV), and HIV-1 replication, shows minimal inhibition of major drug transporters, and has a high barrier to generation of both HCV and HIV-1 resistance.', 25619934),
('5-[(4-bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine (BPIP)', 'The compound resulted in a dose-dependent antiviral effect in PK(15) cells with a 50% effective concentration (EC(50)) for the inhibition of CSFV Alfort(187) (subgroup 1.1) of 1.6+/-0.4 microM and for CSFV Wingene (subgroup 2.3) 0.8+/-0.2 microM.', '', 'We here report that 5-[(4-bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine (BPIP) is a highly potent inhibitor of the in vitro replication of CSFV.', 17997169),
('Phosphonoformate (foscarnet; PFA)', 'Except for an HIV-1 variant encoding the K65R mutation in RT that exhibited 3.3- to 8.2-fold resistance, the nucleoside-resistant viruses included in the panel were sensitive to the PFA prodrugs (<3-fold increase in 50% inhibitory concentration)', 'its use for the treatment of HIV-1 infection is limited by toxicity and the lack of an orally bioavailable formulation.', 'Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance. Phosphonoformate (foscarnet; PFA) is a potent inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT), but its use for the treatment of HIV-1 infection is limited by toxicity and the lack of an orally bioavailable formulation.', 11353603),
('BI-RG-587', '50% inhibitory concentration of 84 nM against HIV-1 reverse transcriptase activity.', '', 'BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine. A series of dipyridodiazepinones have been shown to be potent inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.', 1708976),
('Compounds bearing a 3-isopropyl and 3-iodine group', 'The most potent inhibitors with EC50 of 4 nM', '', 'Novel pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors (NNRTIs) with high potency against NNRTI-resistant HIV-1 strains. Most of the compounds, especially 26 and 22, bearing a 3-isopropyl and 3-iodine group, respectively, exhibited highly potent activity against wild-type HIV-1 strains and those resistant to reverse transcriptase inhibitors (RTIs).', 23540737),
('S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (HPMPC)', 'Potent in vitro and in vivo activity against a broad range of herpesviruses, including acyclovir-resistant herpes simplex virus (HSV)', '', 'Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS.', 8077713),
('2''-deoxy-5-ethyl-beta-4''-thiouridine (4''-S-EtdU)', 'Shown to be a more potent inhibitor of gammaherpesvirus infection than acyclovir.', '', '2''-Deoxy-5-ethyl-beta-4''-thiouridine inhibits replication of murine gammaherpesvirus and delays the onset of virus latency.', 10628807),
('BP008', 'The compound reduced the reporter expression of the HCV1b replicon with a 50% effective concentration (EC(50)) and selective index value of 4.1 ? 0.7 nM and >12,195, respectively.', '', 'Resistance analysis and characterization of a thiazole analogue, BP008, as a potent hepatitis C virus NS5A inhibitor. Hepatitis C virus (HCV) is a global health problem, affecting approximately 3% of the world''s population.', 22006008),
('2,6-difluoro analogue (4r)', 'With potent antiviral activity (IC50 = 0.087 ? 0.002 microM)', 'Low cytotoxicity (CC50 = 90.6 ? 2.06 microM)', 'Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation. The subsequent SAR study and drug-like optimization resulted in the discovery of the lead candidate 4r, with potent antiviral activity (IC50 = 0.087 ? 0.002 microM), low cytotoxicity (CC50 = 90.6 ? 2.06 microM), sensitivity to nucleoside analogue-resistant HBV mutants, and synergistic effect with nucleoside analogues in HepG2.2.15 cells.', 27989113),
('4-{[4-({(3R)-1-Butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5dioxo-1,4,9-triazaspiro [5.5]undec-9-yl}methyl)phenyl]oxy}benzoic acid hydrochloride (873140)', 'A potent allosteric noncompetitive HIV entry inhibitor', '', 'The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor.', 15644495),
('Furanyl-containing analog UC10, UC040, UC82, and UC781', 'The most potent inhibitor of human immunodeficiency virus type 1 (HIV-1) replication and a promising candidate for further development.', '', 'From these studies, the furanyl-containing analog UC10 was identified as the most potent inhibitor of human immunodeficiency virus type 1 (HIV-1) replication and a promising candidate for further development.', 9087499),
('Dihydrotriazolopyrimidine derivative, hybrid molecules 36 and 37', 'Compound 36 that emerged as the most potent PA-PB1 interaction inhibitor (IC50 = 1.1 microM) among all the small molecules reported so far.', '', 'A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits. Very interesting results were obtained with the hybrid molecules 36 and 37, designed by merging some peculiar structural features known to impart PA-PB1 interaction inhibition, with compound 36 that emerged as the most potent PA-PB1 interaction inhibitor (IC50 = 1.1 microM) among all the small molecules reported so far.', 25856229),
('Inhibitors (compounds 1 and 2) of malarial aspartyl protease, plasmepsin-II', 'compounds 1 and 2 show promising inhibitory activity against HIV-1 protease variants and hence are good candidates for further development to enhance their potency against NL4-3 as well as MDR HIV-1 protease variants.', '', 'Two potent inhibitors (compounds 1 and 2) of malarial aspartyl protease, plasmepsin-II, were evaluated against wild type (NL4-3) and multidrug-resistant clinical isolate 769 (MDR) variants of human immunodeficiency virus type-1 (HIV-1) aspartyl protease.', 22469467),
('5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide analogues', 'These compounds satisfy two structural requirements known for potent inhibition of HIV-1 IN catalysis: a metal chelating moiety and a hydrophobic functionality necessary for selectivity against the strand transfer reaction.', '', 'Design and discovery of 5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide inhibitors of HIV-1 integrase. Most of the new compounds described herein are potent and selective for the strand transfer reaction and show antiviral activity in cell-based assays.', 25150089),
('UV-4 or N-(9-methoxynonyl)-1-deoxynojirimycin', 'UV-4, and its hydrochloride salt known as UV-4B, is highly potent against dengue virus in vitro and promotes complete survival in a lethal dengue virus mouse model.', 'UV-4 treatment did not affect the development of protective antibody responses after either influenza infection or vaccination', 'In vivo therapeutic protection against influenza A (H1N1) oseltamivir-sensitive and resistant viruses by the iminosugar UV-4. Our lead iminosugar analog called UV-4 or N-(9-methoxynonyl)-1-deoxynojirimycin inhibits activity of endoplasmic reticulum (ER) ?-glucosidases I and II and is a potent, host-targeted antiviral candidate.', 25786028),
('Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine', 'Alkoxyalkyl esters of (S)-HPMPA were 6 to 20 times more active than unmodified (S)-HPMPA on the basis of their 50% effective concentrations in 2.2.15 cells.', '', 'Alkoxyalkyl esters of 9-(s)-(3-hydroxy-2-phosphonomethoxypropyl) adenine are potent and selective inhibitors of hepatitis B virus (HBV) replication in vitro and in HBV transgenic mice in vivo. Alkoxyalkyl esters of acyclic nucleoside phosphonates have previously been shown to have increased antiviral activity when they are administered orally in animal models of viral diseases, including lethal infections with vaccinia virus, cowpox virus, ectromelia virus, murine cytomegalovirus, and adenovirus. 9-(S)-(3-Hydroxy-2-phosphonomethoxypropyl)adenine [(S)-HPMPA] was previously shown to have activity against hepatitis B virus (HBV) in vitro.', 19398648),
('S/GSK1349572', 'Inhibited HIV replication with low-nanomolar or subnanomolar potency and with a selectivity index of 9,400.', '', 'In Vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitor. S/GSK1349572 is a next-generation HIV integrase (IN) inhibitor designed to deliver potent antiviral activity with a low-milligram once-daily dose requiring no pharmacokinetic (PK) booster.', 21115794),
('BMS-790052', 'Inhibits hybrid replicons containing HCV genotype-4 NS5A genes with 50% effective concentrations (EC(50)s) ranging from 7 to 13 pM.', '', 'In vitro activity of BMS-790052 on hepatitis C virus genotype 4 NS5A. The antiviral profile of BMS-790052, a potent hepatitis C virus (HCV) replication complex inhibitor targeting nonstructural protein NS5A, is well characterized for HCV genotype-1.', 22203595),
('PSI-352938', 'The effective concentration required to achieve 50% inhibition for PSI-352938, determined using genotype 1a-, 1b-, and 2a-derived replicons stably expressed in the Lunet cell line, were 0.20, 0.13, and 0.14 microM, respectively.', '', 'Inhibition of hepatitis C virus replicon RNA synthesis by PSI-352938, a cyclic phosphate prodrug of ?-D-2''-deoxy-2''-?-fluoro-2''-?-C-methylguanosine. PSI-352938 is a novel cyclic phosphate prodrug of ?-D-2''-deoxy-2''-?-fluoro-2''-?-C-methylguanosine 5''-monophosphate that has potent activity against hepatitis C virus (HCV) in vitro.', 21444700),
('Cepharanthine hydrochloride (CH)', 'CH inhibited replication and HBeAg production by either wild-type or lamivudine-resistant HBV clinical isolates in a dose-dependent manner', '', 'In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates. Cepharanthine hydrochloride (CH), a natural alkaloid-derived compound, has been reported to possess potent activity against various viruses.', 22387093),
('TMC125', 'In high-MOI experiments, 1 muM TMC125 completely inhibited the breakthrough of resistant virus from wild-type and NNRTI-resistant HIV-1, in contrast to efavirenz and nevirapine.', '', 'TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments. TMC125 is a potent new investigational nonnucleoside reverse transcriptase inhibitor (NNRTI) that is active against human immunodeficiency virus type 1 (HIV-1) with resistance to currently licensed NNRTIs.', 16188980),
('BI 207127', 'Rapid virological response (RVR; HCV RNA <15 IU/ml) at day 28 occurred in 11/19 TN and 4/30 TE patients treated with BI 207127.', 'BI 207127 in combination with PegIFN/RBV demonstrated strong antiviral activity with a favourable safety and tolerability profile. The best benefit/risk ratio was observed at 600 mg.', 'Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin. BACKGROUND & AIMS: BI 207127 is a potent non-nucleoside hepatitis C virus (HCV) NS5B polymerase inhibitor in vitro.', 22414766),
('1-[2-(2-Benzoyl- and 2-benzylphenoxy)ethyl]uracils', 'The candidate compounds can be regarded as potential lead compounds against the wild-type virus and drug-resistant forms.', '', '1-[2-(2-Benzoyl- and 2-benzylphenoxy)ethyl]uracils as potent anti-HIV-1 agents. Non-nucleoside reverse transcriptase inhibitors (NNRTI) are key components in highly active antiretroviral therapy for treating HIV-1.', 21903401),
('PSI-353661, a phosphoramidate prodrug of 2''-deoxy-2''-fluoro-2''-C-methylguanosine-5''-monophosphate', 'PSI-352666 is equally active against wild-type NS5B and NS5B containing the S282T amino acid alteration.', '', 'Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661.', 21600932),
('Spiroadamantane amine (3)', 'Inhibits both the M2-WT and M2-V27A mutant with IC50 values of 18.7 and 0.3 microM, respectively', '', 'An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses. Adamantanes such as amantadine (1) and rimantadine (2) are FDA-approved anti-influenza drugs that act by inhibiting the wild-type M2 proton channel from influenza A viruses, thereby inhibiting the uncoating of the virus.', 28087313),
('N-[4-Chloro-3-(3-methyl-2-butenyloxy)phenyl]-2-methyl-3-furanca rbothioamide (UC781)', '1:1 molar combination of UC781 and 3''-azido-3''-deoxythymidine (AZT) showed high-level synergy in inhibiting the replication of AZT-resistant virus, implying that UC781 can restore antiviral activity to AZT against AZT-resistant HIV-1.', '', 'The thiocarboxanilide nonnucleoside inhibitor UC781 restores antiviral activity of 3''-azido-3''-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus type 1. N-[4-Chloro-3-(3-methyl-2-butenyloxy)phenyl]-2-methyl-3-furanca rbothioamide (UC781) is an exceptionally potent nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.', 9925515),
('Analogues of the dicaffeoylquinic acids (DCQAs) and dicaffeoyltartaric acids (DCTAs) [D-chicoric acid, meso-chicoric acid, bis(3,4-dihydroxydihydrocinnamoyl)-L-tartaric acid, digalloyl-L-tartaric acid, bis(3,4-dihydroxybenzoyl)-L-tartaric acid, dicaffeoylglyceric acid, and bis(3, 4-dihydroxyphenylacetyl)-L-tartaric acid]', 'Seventeen of the 34 analogues had potent activity against HIV-1 integrase ranging from 0. 07 to >10 microM.', '', 'Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.', 9986720),
('N-acyl azacyclic ureas (II)', 'The extensive SAR study has yielded a series of N-acyl azacyclic ureas (II), which are highly potent against both wild-type and multiple PI-resistant viral strains.', '', 'Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strains. As part of our efforts to identify potent HIV-1 protease inhibitors that are active against resistant viral strains, structural modification of the azacyclic urea (I) was undertaken by incorporating acyl groups as P(1)'' ligands.', 16203141),
('Benzylpyridinones Compounds 14, 19, and 27', 'IC(50) values ranging from 0.2 to 6 nM', '', 'Synthesis and antiviral activity of 4-benzyl pyridinone derivatives as potent and selective non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors. Several 4-benzyl analogues of 5-ethyl-6-methyl-4-(phenylthio)pyridin-2(1H)-ones were synthesized and evaluated for their anti-HIV-l activities.', 11052800),
('Monosubstituted 5''-O-fatty acyl derivatives of 3TC', 'The monosubstituted 5''-O-fatty acyl derivatives of 3TC (EC(50) = 0.2-2.3 microM) were more potent than the corresponding monosubstituted N(4)-fatty acyl (EC(50) = 0.4-29.4 microM) and 5''-O-N(4)-disubstituted (EC(50) = 72.6 to >154.0 microM) derivatives of the nucleoside. 5''-O-Myristoyl (16) and 5''-O-12-azidododecanoyl derivatives (17) were found to be the most potent compounds (EC(50) = 0.2-0.9 microM) exhibiting at least 16-36-fold higher anti-HIV activity against cell-free virus than 1 (EC(50) = 11.4-32.7 microM).', '', 'Synthesis and biological evaluation of fatty acyl ester derivatives of (-)-2'',3''-dideoxy-3''-thiacytidine. A number of fatty acyl derivatives of (-)-2'',3''-dideoxy-3''-thiacytidine (lamivudine, 3TC, 1) were synthesized and evaluated for their anti-HIV activity. ', 22533850),
('Beta-d-3''-fluoro-2'',3''-unsaturated nucleosides', 'd-3''-fluoro-2'',3''-unsaturated nucleosides against HIV-1 in human peripheral blood mononuclear cells, from which we found that the cytosine derivative 26 was the most potent among the synthesized compounds.', '', 'Synthesis, structure-activity relationships, and drug resistance of beta-d-3''-fluoro-2'',3''-unsaturated nucleosides as anti-HIV Agents. Our recent studies demonstrated that d- and l-2''-fluoro-2'',3''-unsaturated nucleosides (d- and l-2''-F-d4Ns) display moderate to potent antiviral activities against HIV-1 and HBV.', 15189036),
('T-1249', 'Antiretroviral activity, as measured by levels of HIV-1 RNA, was not predicted by baseline susceptibility to T-1249 or to ENF; genotypic substitutions that emerged during T-1249 treatment were identified in virus from some patients', '', 'T-1249 retains potent antiretroviral activity in patients who had experienced virological failure while on an enfuvirtide-containing treatment regimen. BACKGROUND: T-1249 is a 39-amino acid synthetic peptide fusion inhibitor (FI) shown to preserve antiretroviral activity in vitro against human immunodeficiency virus (HIV) isolates that have decreased susceptibility to enfuvirtide (ENF).', 15747252),
('Peramivir conjugates 8 and 9', 'Thus, conjugates 8 and 9 offer better effect to protect MDCK cells from infection of H275Y virus with low EC50 value (?17 nM)', '', 'The C2-OH group of peramivir is elaborated to link with caffeate derivatives, giving the desired conjugates 8 and 9 that possess potent NA inhibitory activity against both wild-type and H275Y viruses with the IC50 values in nanomolar range.', 29324342),
('BMS-986001', 'BMS-986001 inhibited HIV-2 isolates from treatment-naive individuals, with 50% effective concentrations (EC50s) ranging from 30 to 81 nM', '', 'The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1.', 26392486),
('(E)-5-(2-bromovinyl)-2''-deoxyuridine (BVDU)', 'The phosphoramidate derivatives of BVDU that contain L-alanine exhibited potent anti herpes simplex virus type 1 and varicella-zoster virus activity but lost marked activity against thymidine kinase-deficient virus strains.', '', 'The phosphoramidate derivatives of BVDU that contain L-alanine exhibited potent anti herpes simplex virus type 1 and varicella-zoster virus activity but lost marked activity against thymidine kinase-deficient virus strains.', 11900348),
('PF-00868554', 'EC(50) of 0.059 microM', '', 'Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase. Our results indicate that PF-00868554 has potent in vitro antiviral activity against a majority (95.8%) of genotype 1a and 1b replicons, with an overall mean EC(50) of 0.059 microM.', 19307358),
('Betulinic acid derivative IC9564', 'IC9564 blocked HIV type 1 (HIV-1) envelope-mediated membrane fusion.', '', 'Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564. The betulinic acid derivative IC9564 is a potent anti-human immunodeficiency virus (anti-HIV) compound that can inhibit both HIV primary isolates and laboratory-adapted strains.', 11120945),
('Several 3-(2-methylfuranyl)- and 3-(2-methylthienyl)-thiocarboxanilide ester, (thio)ether, and oxime ether derivatives UC-82', '50% effective concentration, 0.009 to 0.021 microM and 0.015 to 0.021 microM respectively', '', 'Several 3-(2-methylfuranyl)- and 3-(2-methylthienyl)-thiocarboxanilide ester, (thio)ether, and oxime ether derivatives showed exquisitely potent antiviral activity against wild-type HIV-1 (50% effective concentration, 0.009 to 0.021 microM).', 8726019),
('Spirodiketopiperazine (SDP) derivative, AK602/ONO4128/GW873140', '50% inhibitory concentration values of 0.1 to 0.6 nM', '', 'Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro. ', 15280474);
INSERT INTO `virus_novelagent` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('2-chloro-8-phenylthiomethyl analogue 37', 'Displayed sub-100 nM activity against all HIV-1 RT enzymes tested.', '', 'Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 8. 8-Aryloxymethyl- and 8-arylthiomethyldipyridodiazepinones. The most potent compound was 2-chloro-8-phenylthiomethyl analogue 37 which displayed sub-100 nM activity against all HIV-1 RT enzymes tested.', 9685236),
('1,2,3-Triazole; 4-Oxoquinoline', 'Oxoquinoline derivative 1i with an EC50 of 0.2 microM', '', 'Oxoquinoline derivative 1i was the most potent compound within this series, inhibiting 94% of wild-type (WT) influenza neuraminidase (NA) activity.', 26643220),
('BMS-232632', '50% effective concentration [EC(50)], 2.6 to 5.3 nM; EC(90), 9 to 15 nM', '', 'In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632.', 10952574),
('5-chloro- or 5-bromo-3-[(3,5-dimethylphenyl)sulfonyl]indole-2-carboxyamide', 'Very potent and selective anti-HIV-1 activity against some mutants carrying NNRTI resistant mutations at positions 103 and 181 of the reverse transcriptase.', '', 'Indolyl aryl sulfones (IASs): development of highly potent NNRTIs active against wt-HIV-1 and clinically relevant drug resistant mutants.', 16305512),
('NITD008', 'In cell culture, the compound inhibits EV71 at a 50% effective concentration of 0.67 microM and a 50% cytotoxic concentration of 119.97 microM.', '', 'Inhibition of enterovirus 71 by adenosine analog NITD008. Here we report that NITD008 has potent antiviral activity against EV71.', 25100827),
('Tetra-O-glycyl-NDGA (G(4)N)', 'In yield reduction assays, G(4)N inhibited replication of laboratory and clinical strains of wild type HSV-1 and ACV-resistant (HSV-1(R)) strains of HSV-1 in a dose-dependent manner, with average IC(50) values of 4.7 and 3.2 microM against wild-type and HSV-1(R) strains, respectively.', '', 'Inhibition of HSV-1 replication and reactivation by the mutation-insensitive transcription inhibitor tetra-O-glycyl-nordihydroguaiaretic acid. Methylated derivatives of nordihydroguaiaretic acid (NDGA)were previously shown to be potent mutation-resistant inhibitors of herpes simplex virus type 1 (HSV-1) which target Sp1 protein binding to critical viral promoters.', 12719005),
('Maraviroc (UK-427,857)', 'Maraviroc was active against 200 clinically derived HIV-1 envelope-recombinant pseudoviruses, 100 of which were derived from viruses resistant to existing drug classes.', '', 'Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Maraviroc (UK-427,857) is a selective CCR5 antagonist with potent anti-human immunodeficiency virus type 1 (HIV-1) activity and favorable pharmacological properties.', 16251317),
('(-)-Beta-D-1'',3''-Dioxolane guanosine (DXG) and 2,6-diaminopurine (DAPD) dioxolanyl nucleoside', 'In cellular toxicity analyses, DXG and DAPD had 50% cytotoxic concentrations of greater than 500 microM when tested in peripheral blood mononuclear cells and a variety of human tumor and normal cell lines', '', 'Mechanism of action and in vitro activity of 1'',3''-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants. (-)-Beta-D-1'',3''-Dioxolane guanosine (DXG) and 2,6-diaminopurine (DAPD) dioxolanyl nucleoside analogues have been reported to be potent inhibitors of human immunodeficiency virus type 1 (HIV-1).', 10508010),
('(-)-(2R,4R)-1-(2-Hydroxymethyl-1,3-dioxolan-4yl)thymine (DOT)', 'Has potent in vitro activity against wild-type and nucleoside reverse transcriptase inhibitor (NRTI)-resistant HIV.', '', 'Mechanism of action of (-)-(2R,4R)-1-(2-hydroxymethyl-1,3-dioxolan-4-yl) thymine as an anti-HIV agent. (-)-(2R,4R)-1-(2-Hydroxymethyl-1,3-dioxolan-4yl)thymine (DOT) is a thymidine analogue that has potent in vitro activity against wild-type and nucleoside reverse transcriptase inhibitor (NRTI)-resistant HIV.', 17542153),
('MIV-150 with zinc acetate (ZA)', 'While less potent than NNRTIs, ZA was shown to be active in primary cells against laboratory-adapted and primary HIV-1 isolates and HIV-1 isolates/clones with NNRTI and RT resistance mutations, with EC50 values between 20 and 110 microM.', '', 'MIV-150 and zinc acetate combination provides potent and broad activity against HIV-1. We previously showed that the combination of the non-nucleoside reverse transcriptase inhibitor (NNRTI) MIV-150 with zinc acetate (ZA) formulated in a carrageenan (CG; MZC) gel provided macaques significant protection against vaginal simian-human immunodeficiency virus-RT (SHIV-RT) challenge, better than either MIV-150/CG or ZA/CG.', 28812250),
('GS-5806', '[EC50] = 0.43 nM', '', 'In summary, GS-5806 is a potent and selective RSV fusion inhibitor with antiviral activity against a diverse set of RSV clinical isolates.', 26666922),
('ca603', 'ca603 inhibits rhinovirus replication by interaction with the VP1 protein and, by this, allows to further expand the chemical diversity of capsid-binding molecules.', '', 'In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses. BACKGROUND: Rhinovirus infections do not only cause common colds, but may also trigger severe exacerbations of asthma and chronic obstructive pulmonary disease (COPD). It is confirmed that ca603 inhibits rhinovirus replication by interaction with the VP1 protein and, by this, allows to further expand the chemical diversity of capsid-binding molecules.', 26169596),
('D- and L-2'',3''-didehydro-2'',3''-dideoxy-3''-fluoro-carbocyclic nucleosides', 'Among the synthesized L-series nucleosides, compounds 18, 19, 26 and 28 exhibited moderate antiviral activity (EC50 7.1 microM, 6.4 microM, 10.3 microM, and 20.7 microM, respectively), while among the D-series, the guanosine analogue (35, D-3''-F-C-d4G) exhibited the most potent anti-HIV activity (EC50 0.4 microM, EC90 2.8 microM)', '', 'Among the synthesized L-series nucleosides, compounds 18, 19, 26 and 28 exhibited moderate antiviral activity (EC50 7.1 microM, 6.4 microM, 10.3 microM, and 20.7 microM, respectively), while among the D-series, the guanosine analogue (35, D-3''-F-C-d4G) exhibited the most potent anti-HIV activity (EC50 0.4 microM, EC90 2.8 microM).', 17373782),
('3''-fluoro-3''-deoxythymidine (FLT)', 'IC(50) values for FLT of 0.0014-0.0168 microM', '', 'Anti-HIV type 1 activity of 3''-fluoro-3''-deoxythymidine for several different multidrug-resistant mutants. The objective of this work was to test the antiviral activity of a potent nucleoside reverse transcriptase inhibitor, 3''-fluoro-3''-deoxythymidine (FLT), on both a wild-type human immunodeficiency virus (HIV-1) isolate and multidrug-resistant HIV-1 patient isolates.', 11282008),
('Bicyclam derivative JM3100', 'JM3100 exhibits anti-HIV potency at concentrations ranging from 0.001 to 0.01 micrograms/ml', '', 'Antiviral activity of the bicyclam derivative JM3100 against drug-resistant strains of human immunodeficiency virus type 1. Bicyclams have recently been identified as potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) replication.', 8739608),
('BMS-955176', 'BMS-955176 exhibits potent activity (50% effective concentration [EC50], 3.9 +/- 3.4 nM ) toward a library (n = 87) of gag/pr recombinant viruses representing 96.5% of subtype B polymorphic Gag diversity near the CA/SP1 cleavage site.', '', 'BMS-955176 exhibits potent activity (50% effective concentration [EC50], 3.9 ? 3.4 nM [mean ? standard deviation]) toward a library (n = 87) of gag/pr recombinant viruses representing 96.5% of subtype B polymorphic Gag diversity near the CA/SP1 cleavage site.', 27090171),
('CGP 53437', 'The replication of HIV-1/LAV, HIV-1/Z-84, and HIV-1/pLAI was inhibited with a 90% effective dose of 0.1 microM in acutely infected MT-2 cells.', 'The 50% cytotoxic dose was 100 microM.', 'CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity. CGP 53437 is a peptidomimetic inhibitor of human immunodeficiency virus type 1 (HIV-1) protease containing a hydroxyethylene isostere.', 8257128),
('hexadecyloxypropyl-(S)-HPMPA [HDP-(S)-HPMPA] and octadecyloxyethyl-(S)-HPMPA [ODE-(S)-HPMPA]', 'Ec50 is 0.4 to 0.7 nanomolar, active against HIV variants', '', 'Alkoxyalkyl esters of (S)-9-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine are potent inhibitors of the replication of wild-type and drug-resistant human immunodeficiency virus type 1 in vitro.', 16870786),
('A titanium containing polyoxotungstate, PM-523 and vanadium substituted polyoxotungstate, PM-1001', 'PM-523 exhibited potent anti-influenza virus (FluV) A and anti-respiratory syncytial virus (RSV). PM-1001 has antiviral activity against FluV A, RSV, parainfluenza virus (PfluV) type 2, Dengue fiver virus, HIV-1 and SARS coronavirus in vitro.', '', 'A titanium containing polyoxotungstate, PM-523 exhibited potent anti-influenza virus (FluV) A and anti-respiratory syncytial virus (RSV) activities in vitro.', 16737794),
('Compound-13 (P1-substituted HIV PIs)', 'Compound 13 demonstrated the best balance of potency against drug resistant strains of HIV', '', 'A series of HIV protease inhibitors (PIs) with potent activity against both wild-type (WT) virus and drug-resistant strains of HIV was designed and synthesized.', 21899332),
('Compound 2, a copper(I)-catalyzed 1,2,3-triazole derivative', 'IC 50 = 6.0 nM and 15.7 nM against wild -type protease and ultidrug-resistant 6X protease mutant respectively.', '', 'A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant. Treatment with HIV-1 protease inhibitors, a component of highly active antiretroviral therapy (HAART), often results in viral resistance.', 18823110),
('2''-deoxy-4''-C-ethynyl-2-fluoroadenosine', 'Potent to all human immunodeficiency viruses type 1 (HIV-1s) including multidrug-resistant HIV-1 and has a low toxicity', '', '2''-deoxy-4''-C-ethynyl-2-fluoroadenosine, a nucleoside reverse transcriptase inhibitor, is highly potent against all human immunodeficiency viruses type 1 and has low toxicity. An idea to use 4''-C-substituted-2''-deoxynucleoside derivatives was proposed based on a working hypothesis to solve the problems of existing acquired immune deficiency syndrome chemotherapy (highly active antiretroviral therapy).', 16795005),
('\nNcRTIs (compound A)', 'Treatment of infections with K65R substitution-containing HIV-1 viruses', '', 'Subtype-specific analysis of the K65R substitution in HIV-1 that confers hypersusceptibility to a novel nucleotide-competing reverse transcriptase inhibitor. Compound A is a novel nucleotide-competing HIV-1 reverse transcriptase (RT) inhibitor (NcRTI) that selects for a unique W153L substitution that confers hypersusceptibility to tenofovir, while the K65R substitution in RT confers resistance against tenofovir and enhances susceptibility to NcRTIs.', 25779585),
('Apricitabine (ATC)', 'Promising antiviral activity and effective treatment-experienced patients with M184V', '', 'Antiviral activity of apricitabine in treatment-experienced HIV-1-infected patients with M184V who are failing combination therapy. Apricitabine (ATC) is a novel deoxycytidine analogue nucleoside reverse transcriptase inhibitor (NRTI) with significant antiviral activity in vitro, including activity against HIV-1 with reverse transcriptase mutations that confer resistance to other NRTIs.', 21054750),
('Calanolide A, costatolide, and dihydrocostatolide', 'Anti-HIV', '', 'The calanolide isomers represent a novel and distinct subgroup of the NNRTI family, and these data suggest that a compound of the calanolide A series, such as costatolide, should be evaluated further for therapeutic use in combination with other anti-HIV agents.', 10428899),
('WPR-6 : 1-[(benzyloxy)methyl]-6-(3,5-dimethylbenzyl)-5-iodopyrimidine-2,4(1H,3H)-dione', 'EC50 of 2 to 4nM against laboratory-adapted HIV-1 strain SF33 and an EC50 of 7 to 14 nM against nucleoside reverse transcriptase inhibitor-resistant HIV-1 strain 7391.', '', 'The HEPT Analogue WPR-6 Is Active against a Broad Spectrum of Nonnucleoside Reverse Transcriptase Drug-Resistant HIV-1 Strains of Different Serotypes', 26055365),
('Pleconaril variants with F, Cl, Br, CH3, OH and aromatic ring substitutions', 'Pleconaril variants with F, Cl, Br, CH3, OH and aromatic ring substitutions were shown to be effective alternatives to Oseltamivir as anti influenza drugs.', '', 'In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain. Neuraminidase (NA) is a prominent surface antigen of Influenza viruses, which helps in release of viruses from the host cells after replication.', 22340192),
('PF-00868554, non-nucleoside inhibitor (NNI)', 'Activity against hepatitis C virus', '', 'The obtained computational results will have important value for the rational design of novel non-nucleoside inhibitors targeting HCV NS5B polymerase.', 24452008),
('TBZE-029 {1-(2,6-difluorophenyl)-6-trifluoromethyl-1H,3H-thiazolo[3,4-a]benzimidazole}', 'Inhibits enterovirus replication', '', 'The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C.', 18337578),
('Morus alba germin-like protein', 'Silkworm fecal matter is considered one of the richest sources of antimicrobial and antiviral protein (substances)', '', 'Molecular cloning and characterization of novel Morus alba germin-like protein gene which encodes for a silkworm gut digestion-resistant antimicrobial protein. Silkworm fecal matter is considered one of the richest sources of antimicrobial and antiviral protein (substances) and such economically feasible and eco-friendly proteins acting as secondary metabolites from the insect system can be explored for their practical utility in conferring broad spectrum disease resistance against pathogenic microbial specimens.', 23284650),
('BP13944', 'BP13944 reduced the expression of the DENV replicon reporter in cells, showing a 50% effective concentration (EC50) of 1.03 +/- 0.09 microM.', '', 'A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease. Dengue virus (DENV) causes disease globally, resulting in an estimated 25 to 100 million new infections per year.', 24145533),
('Arylthio isopropyl pyridinylmethylpyrrolemethanols (AThPs)', 'Docking experiments of the potent inhibitors 4k (IC(50) = 0.24 microM, SI = 167) and 5e (IC(50) = 0.11 microM, SI > 1667) of wild-type RT prompted the synthesis and biological evaluation of novel AThP derivatives featuring a number of polar groups in position 3 of the pyrrole ring and larger and more hydrophobic alicyclic substituents in place of the isopropyl group at position 4.', '', 'Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies', 17089434),
('KINK-20, a synthetic phosphocholine lipid-AZT conjugate', 'EC50 values were 0.01 and 0.03 microM for INK-20 and 0.0005 and 0.33 microM for AZT, respectively.', '', 'Synthesis and evaluation of a novel synthetic phosphocholine lipid-AZT conjugate that double-targets wild-type and drug resistant variants of HIV.', 15043162),
('N(4)-octyl-6,6-dimethyl-N(2)-(4-methylbenzyl)-1,6-dihydro-1,3,5-triazine-2,4-diamine (HM-242)', 'Potent virucidal activity against enveloped viruses such as influenza virus and herpes simplex virus.', '', 'The antimicrobial activities of N(4)-octyl-6,6-dimethyl-N(2)-(4-methylbenzyl)-1,6-dihydro-1,3,5-triazine-2,4-diam ine (HM-242), a novel synthetic compound, were compared with those of chlorhexidine gluconate (CHG).', 19575042),
('Alcian Blue (AB)', 'Novel synthetic nonpeptidic antiviral drugs targeting the glycans of the envelope of HIV.', '', 'These data suggest that AB is likely endowed with carbohydrate-binding properties and can be considered an important lead compound in the development of novel synthetic nonpeptidic antiviral drugs targeting the glycans of the envelope of HIV.', 19721061),
('Indolocarbazole compounds, G?6976 and NGIC-I', 'Indolocarbazole compounds are potent pUL97 inhibitors and, therefore, represent novel candidates for antiviral drugs that target viral protein kinase functions', '', 'Based on the phosphorylation of ganciclovir (GCV), a novel quantification system for pUL97 kinase activity was established: the phosphorylated form of GCV exerts an easily quantifiable cytotoxic effect in transfected cells.', 11369889),
('Sho-seiryu-to (SST)', 'SST is a novel compund with potential as an anti-HCMV.', '', 'These results suggest that SST is a novel compund with potential as an anti-HCMV.', 16542001),
('lersivirine (UK-453,061)', 'Binds the RT enzyme in a novel way (resulting in a unique resistance profile), inhibits over 60% of viruses bearing key RT mutations, with 50% effective concentrations (EC(50)s) within 10-fold of those for wt viruses, and has excellent selectivity against a range of human targets.', '', 'The emerging candidate, lersivirine (UK-453,061), binds the RT enzyme in a novel way (resulting in a unique resistance profile), inhibits over 60% of viruses bearing key RT mutations, with 50% effective concentrations (EC(50)s) within 10-fold of those for wt viruses, and has excellent selectivity against a range of human targets.', 20660667),
('Raoulic acid', 'raoulic acid was found to possess broad-spectrum antiviral activity against six HRVs with a 50% inhibition concentration of less than 9.5 microg/mL', '', 'Collectively, the results demonstrate that raoulic acid is a novel therapeutic candidate for two different groups of human rhinovirus.', 20412019),
('Isothiafludine (NZ-4)', 'NZ-4 suppressed intracellular HBV replication in HepG2.2.15 cells with an IC?? value of 1.33 micromol/L, whereas the compound inhibited the cell viability with an IC?? value of 50.4 micromol/L.', '', 'Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation. To investigate the action of isothiafludine (NZ-4), a derivative of bis-heterocycle tandem pairs from the natural product leucamide A, on the replication cycle of hepatitis B virus (HBV) in vitro and in vivo.', 24487969),
('Benzenesulfonyl matrinane, 35d', 'Promising anti-enteroviral candidate for the treatment of various diseases infected with coxsackieviruses.', 'The optimized 35d showed the broad-spectrum anti-coxsackieviruse effects, an excellent pharmacokinetics and a good safety profile.', 'SAR evolution and discovery of benzenesulfonyl matrinanes as a novel class of potential coxsakievirus inhibitors.Fifty-one novel 12N-substituted matrinic acid derivatives were synthesized and evaluated for their anti-coxsackievirus B3 activities.', 26867658),
('THC19', 'THC19 acts at a relatively early stage of the viral lifecycle.', 'This compound had no cytotoxic effects and did not disrupt cell cycle progression or induce apoptosis in MDCK cells as confirmed by WST-1 assays, flow cytometry analysis, and caspase-3 assays.', 'Taken together, these results suggest that influenza virus PA protein is a potential target for, and may aid the development of, novel compounds that inhibit influenza A virus replication.', 22441116),
('R1479', 'Potent and highly selective inhibitor of nonstructural protein 5B-directed hepatitis C virus (HCV) replication in vitro.', 'No resistance to R1479 was observed after 14 days of treatment with R1626.', 'Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis C. The nucleoside analog R1479 is a potent and highly selective inhibitor of nonstructural protein 5B-directed hepatitis C virus (HCV) replication in vitro.', 18553458),
('Cyanovirin-N (CV-N)', 'CV-N and related homologs showed highly potent antiviral activity against almost all strains of influenza A and B virus, including clinical isolates and a neuraminidase inhibitor-resistant strain (EC(50) = 0.004 to 0.04 micro g/ml).', '', 'Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin. . The novel antiviral protein cyanovirin-N (CV-N) was initially discovered based on its potent activity against the human immunodeficiency virus (HIV).', 12878514),
('TTP-8307', 'A potent inhibitor of the replication of several rhino- and enteroviruses.', '', 'Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor T A novel compound, TTP-8307, was identified as a potent inhibitor of the replication of several rhino- and enteroviruses.', 19237651),
('VRX-480773', 'Inhibits viruses from efavirenz-resistant molecular clones and most NNRTI-resistant clinical HIV-1 isolates tested', '', 'In this study, we report a novel and potent NNRTI, VRX-480773, that inhibits viruses from efavirenz-resistant molecular clones and most NNRTI-resistant clinical HIV-1 isolates tested.', 17116677),
('Obatoclax', 'Active against alphaviruses, like chikungunya virus (50% effective concentration [EC50] = 0.03 microM) and Semliki Forest virus (SFV; EC50 = 0.11 microM).', '', 'In conclusion, obatoclax is a novel inhibitor of endosomal acidification that prevents viral fusion and that could be pursued as a potential broad-spectrum antiviral candidate.', 27993855),
('Benzodiazepine derivative (compound 7)', 'Compound 7 was validated as an inhibitor of infectious EBOV and Marburg virus (MARV) in cell-based assays, with 50% inhibitory concentrations (IC(50)s) of 10 microM and 12 microM, respectively.', '', 'In summary, we have identified a novel series of benzodiazepine compounds that are suitable for optimization as potential inhibitors of filoviral infection.', 21270170),
('2-(2-benzimidazolyl)-5-[4-(2-imidazolino)phenyl]furan dihydrochloride (DB772)', 'Serum concentrations of DB772 sufficient to inhibit viral replication in calves PI with BVDV types 1 and 2', 'No adverse effects of DB772 administration were detected', 'The purpose of this research was to initiate evaluation of the pharmacokinetic and safety data of a novel antiviral agent in BVDV-free calves and to assess the antiviral efficacy of the same agent in PI calves.', 22182713),
('4-guanidino-Neu5Ac2en, neuraminidase (NA)-specific inhibitor', 'The lowest resistance in cell culture was seen to zanamivir', '', 'The search for compounds with altered pharmacological properties has led to the identification of a novel series of influenza virus NA inhibitors in which the triol group of zanamivir has been replaced by a hydrophobic group linked by a carboxamide at the 6 position (6-carboxamide).', 9499107),
('SC93305', 'Highly effective not only against different HSV-1 and HSV-2 strains but also towards ACV- and multi-resistant HSV-1 and HSV-2 isolates', '', 'In the current study we present SC93305 as a novel potent antiviral substance that proved to be highly effective not only against different HSV-1 and HSV-2 strains but also towards ACV- and multi-resistant HSV-1 and HSV-2 isolates.', 29155164),
('GS-9160', 'GS-9160 has potent and selective antiviral activity in primary human T lymphocytes producing a 50% effective concentration (EC(50)) of approximately 2 nM, with a selectivity index (50% cytotoxic concentration/EC(50)) of approximately 2,000. The antiviral potency of GS-9160 decreased by 6- to 10-fold in the presence of human serum.', '', 'Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase. GS-9160 is a novel and potent inhibitor of human immunodeficiency virus type 1 (HIV-1) integrase (IN) that specifically targets the process of strand transfer. It is an authentic inhibitor of HIV-1 integration, since treatment of infected cells results in an elevation of two-long terminal repeat circles and a decrease of integration junctions.', 19104010),
('GS-9451', 'GS-9451 200 mg/day or 400 mg/day demonstrated potent antiviral activity in both HCV genotype 1a- and 1b-infected patients.', 'No resistance mutations were detected with GS-9451 60 mg/day.', 'A Phase I, randomized, placebo-controlled, 3-day, ascending-dose study of GS-9451, an NS3/4A protease inhibitor, in genotype 1 hepatitis C patients. GS-9451 is a novel inhibitor of the HCV NS3/4A protease and demonstrates potent in vitro suppression of HCV genotype 1 replicons.', 23047118),
('A-315675', 'Influenza virus neuraminidase (NA) inhibitor that has potent enzyme activity and is highly active in cell culture against a variety of strains of influenza A and B viruses.', '', 'A-315675 is a novel influenza virus NA inhibitor that has potent enzyme activity and is highly active in cell culture against a variety of strains of influenza A and B viruses.', 11991966),
('(1S,2S,3R,4R)-3-[(1S)-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-h ydroxy-cyclopentanecarboxylic acid (RWJ-270201, BCX-1812)', 'The 50% effective concentration (EC(50)) values for RWJ-270201 against wild-type and resistant viruses, determined by using a cytopathic effect inhibition assay, were 0.007 and 23 microM, respectively.', '', 'Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.', 11675142),
('RD4-2217, thiadiazole (TDA) derivatives', 'It inhibited replication of the HTLV-IIIB strain in MT-4 cells at a concentration of 6 nM.', '', 'In an attempt to develop more effective and pharmacologically favorable compounds, novel TDA derivatives have been synthesized and examined for their anti-HIV-1 activity in vitro.', 9159403),
('KU-55933', 'Inhibitor of ATM kinase activity, capable of suppressing the replication of both wild-type and drug-resistant HIV-1', '', 'Here we show that the activity of HIV-1 integrase stimulates an ataxia-telangiectasia-mutated (ATM)-dependent DNA damage response, and that a deficiency of this ATM kinase sensitizes cells to retrovirus-induced cell death. Consistent with these observations, we demonstrate that a novel and specific small molecule inhibitor of ATM kinase activity, KU-55933, is capable of suppressing the replication of both wild-type and drug-resistant HIV-1.', 15834407),
('Cyclic urea amide, SD146', 'IC90 is 5.1 nM', '', 'Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV. Cyclic urea amides, a novel series of HIV-1 protease (HIV PR) inhibitors, have increased activity against drug-resistant mutants of the HIV PR.', 9003516),
('EDP-239', 'A single 100-mg dose of EDP-239 resulted in reductions in HCV genotype 1a viral RNA of >3 log10 IU/ml within the first 48 h after dosing and reductions in genotype 1b viral RNA of >4-log10 IU/ml within 96 h', '', 'Preclinical Profile and Clinical Efficacy of a Novel Hepatitis C Virus NS5A Inhibitor, EDP-239. EDP-239, a novel hepatitis C virus (HCV) inhibitor targeting nonstructural protein 5A (NS5A), has been investigated in vitro and in vivo EDP-239 is a potent, selective inhibitor with potency at picomolar to nanomolar concentrations against HCV genotypes 1 through 6.', 27503640),
('Benzimidazole Derivative (B5)', 'Inhibits the HCV life cycle by blocking virus entry', '', 'In conclusion, B5 is a novel interesting anti-HCV molecule that could be used to decipher the early steps of the HCV life cycle.IMPORTANCE: In the last 4 years, HCV therapy has been profoundly improved with the approval of direct-acting antivirals in clinical practice.', 27412600),
('Cyclosporin A (CsA) analog, CPI-431-32', 'As a single agent or in combination with DAAs, to inhibit both HCV and HIV-1 infections.', '', 'Using this co-culture model, we demonstrate that cyclophilin inhibitors (CypI), including a novel cyclosporin A (CsA) analog, CPI-431-32, simultaneously inhibits replication of both HCV and HIV-1 when added pre- and post-infection.', 26263487),
('SCH 900518 (narlaprevir)', 'EC(90)) of 40 nM', '', 'Preclinical characterization of the antiviral activity of SCH 900518 (narlaprevir), a novel mechanism-based inhibitor of hepatitis C virus NS3 protease. Small-molecule hepatitis C virus (HCV) NS3 protease inhibitors such as boceprevir (SCH 503034) have been shown to have antiviral activity when they are used as monotherapy and in combination with pegylated alpha interferon and ribavirin in clinical trials.', 20308381),
('N-(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives', 'EC50 is 0.228 microM', '', 'Viral infectivity factor (Vif) is protective against APOBEC3G (A3G)-mediated viral cDNA hypermutations, and development of molecules that inhibit Vif mediated A3G degradation is a novel strategy for blocking HIV-1 replication.', 28235704),
('Piperidinylamino-diarylpyrimidine (pDAPY) derivatives', 'EC50 = 0.047 and 4.6 microM against both wild-type and drug-resistant mutant virus strains (K103N+Y181C RT) of HIV-1', '', 'Exploring these hybrid molecules with dual binding conformations might provide optional chemical scaffolds as novel HIV-1 reverse transcriptase inhibitors (HIV-1 NNRTIs).', 24239481),
('Pleconaril, guanidine-HCl, and oxoglaucine (PGO)', 'Decreased infectious virus content', '', 'The most important achievement of our previous studies was the development of a novel scheme for in vivo application of a triple combination of EV inhibitors with different modes of action against Coxsackievirus B (CVB) infections in mice.', 26196747),
('Pyrrolobenzoxazepinones (PBOs) derivatives', 'Potent against the most common mutant enzymes, including the highly resistant K103N mutant strain.', '', 'Molecular modeling studies based on the X-ray structures of HIV-1 RT prompted the synthesis of novel analogues which were tested as anti-HIV agents.', 16279773),
('8-hydroxyquinoline tetracyclic lactam', 'Antiviral activity against HIV-1', '', 'A novel series of HIV-1 integrase strand transfer inhibitors were designed using the venerable two-metal binding pharmacophore model and incorporating structural elements from two different literature scaffolds.', 27092410),
('Calix[4]arene-based ?-diketo derivatives', 'Inhibit strand transfer (ST) with IC50 values between 5.9 and 21.2 microM', '', 'Docking studies revealed the predominant binding modes that were distinct from the binding modes of raltegravir, which suggests a novel binding region in the IN active site.', 25682937),
('TMC114', 'EC50s of <10 nM', '', 'TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates. The purpose of this study was to characterize the antiviral activity, cytotoxicity, and mechanism of action of TMC114, a novel human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PI).', 15917527),
('Leflunomide', 'Inhibits the production of multiple clinical CMV isolates (including multi-drug-resistant virus) in both human fibroblasts and endothelial cells.', '', 'These findings imply that leflunomide, an effective immunosuppressive agent, shows potential to concurrently attenuate a major complication of immunosuppression, CMV disease, by a novel mechanism of antiviral activity.', 10702725),
('AIC246 (Letermovir)', 'AIC246 blocks viral replication without inhibiting the synthesis of progeny HCMV DNA or viral proteins', '', 'The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.', 21752907),
('ACH-806', 'This compound was synergistic with NS3 protease inhibitors and NS5B nucleoside and nonnucleoside polymerase inhibitors.', '', 'ACH-806 is a hepatitis C virus NS4A inhibitor with a novel mechanism of action and resistance pathway.', 18332167),
('Alpha-hydroxy-glycineamide (alpha-HGA)', 'Inhibits the replication of clinical HIV-1 isolates with acquired resistance to reverse transcriptase and protease inhibitors', '', 'As an antiviral compound, alpha-HGA has an unusually simple structure, a pronounced antiviral specificity, and a novel mechanism of antiviral action.', 18644965),
('GRL-0739, a novel nonpeptidic HIV-1 protease inhibitor containing tricycle (cyclohexyl-bis-tetrahydrofuranylurethane [THF]) and a sulfonamide isostere', 'Highly active against laboratory HIV-1 strains and primary clinical isolates (50% effective concentration [EC50], 0.0019 to 0.0036 microM)', 'M, with minimal cytotoxicity (50% cytotoxic concentration [CC50], 21.0 microM)', 'A novel tricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor, GRL-0739, effectively inhibits the replication of multidrug-resistant HIV-1 variants and has a desirable central nervous system penetration property in vitro', 25691652),
('Pradimicin A (PRM-A)', 'It invariably inhibits representative virus strains of a variety of HIV-1 clades with X4 and R5 tropisms at nontoxic concentrations.', '', 'PRM-A represents the first prototype compound of a nonpeptidic CBA lead and, together with peptide-based lectins, belongs to a conceptually novel type of potential therapeutics for which drug pressure results in the selection of glycan deletions in the HIV gp120 envelope.', 17050611),
('GS-9451', 'In multiple GT1a and GT1b replicon cell lines, GS-9451 had mean 50% effective concentrations (EC50s) of 13 and 5.4 nM, respectively, with minimal cytotoxicity', '', 'Preclinical characterization of the novel hepatitis C virus NS3 protease inhibitor GS-9451. GS-9451 is a selective hepatitis C virus (HCV) NS3 protease inhibitor in development for the treatment of genotype 1 (GT1) HCV infection.', 23939899),
('MK-4519', '(EC(50)) of 1.8 nM and MK-4519 is highly active against genotype 1b HCV', '', 'Pharmacodynamic analysis of a serine protease inhibitor, MK-4519, against hepatitis C virus using a novel in vitro pharmacodynamic systemThe development of new antiviral compounds active against hepatitis C virus (HCV) has surged in recent years.', 22155837),
('2'',3''-Didehydro-3''-deoxy-4''-ethynylthymidine (4''-Ed4T)', 'The purified RT of mutants with the P119S/M184V and T165A/M184V mutations were inhibited by 4''-Ed4TTP with 8- to 13-fold less efficiency than wild-type RT.', '', 'Impact of novel human immunodeficiency virus type 1 reverse transcriptase mutations P119S and T165A on 4''-ethynylthymidine analog resistance profile.2'',3''-Didehydro-3''-deoxy-4''-ethynylthymidine (4''-Ed4T), a derivative of stavudine (d4T), has potent activity against human immunodeficiency virus and is much less inhibitory to mitochondrial DNA synthesis and cell growth than its progenitor, d4T.', 19704131),
('Samatasvir (IDX719)', 'EC50s falling within a tight range of 2 to 24 pM in genotype 1 through 5 replicon. The EC90/EC50 ratio was low (2.6). A 50% cytotoxic concentration (CC50) of >100 microM provided a selectivity index of >5 ? 10(7)', '', 'In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus. The hepatitis C virus (HCV) nonstructural 5A (NS5A) protein is a clinically validated target for drugs designed to treat chronic HCV infection.', 24867983),
('H1PVAT', 'Inhibitor of poliovirus replication that targets VP1', '', 'A novel small molecule, H1PVAT, was identified as a potent and selective inhibitor of the in vitro replication of all three poliovirus serotypes, whereas no activity was observed against other enteroviruses.', 25043639),
('Azvudine', 'Highly potent inhibition on HIV-1 (EC(50)s ranging from 0.03 to 6.92 nanoM), HIV-2 (EC(50)s ranging from 0.018 to 0.025 nanoM) and NRTI-resistant strains (L74V and T69N).', '', 'Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro. Azvudine is a novel nucleoside reverse transcriptase inhibitor with antiviral activity on human immunodeficiency virus, hepatitis B virus and hepatitis C virus.', 25144636),
('BPR2-D2', 'BPR2-D2 exhibited an excellent antiviral efficacy for the oseltamivir-resistant virus (EC(50) ranging from 0.021 to 0.040 microM', '', 'BPR2-D2 was identified as a novel inhibitor against influenza virus from a hit obtained from high throughput screening of 20 000 or more compounds.', 19892833),
('SC29EK', 'SC29EK blocked the replication of T-20-resistant HIV-1 strains and maintained antiviral activity even in the presence of high serum concentrations (up to 50%).', '', 'We have developed a novel HIV fusion inhibitor, SC34EK, which is a gp41-derived 34-amino-acid peptide with glutamate (E) and lysine (K) substitutions on its solvent-accessible site that stabilize its alpha-helicity.', 19114674),
('DMP 450 (bis-methanesulfonic acid salt)', 'A plasmid-based, in vivo assay model suggests that maintenance of plasma levels of DMP 450 near the antiviral IC90 suppresses HIV protease activity in the animal.', '', 'RESULTS: We have synthesized DMP 450 (bis-methanesulfonic acid salt), a water-soluble cyclic urea compound and a potent inhibitor of HIV replication in cell culture that also inhibits variants of HIV with single amino acid substitutions in the protease.', 8807858),
('Cyclo-D4G', 'Possessed anti-HIV activity', '', 'Novel use of a guanosine prodrug approach to convert 2'',3''-didehydro-2'',3''-dideoxyguanosine into a viable antiviral agent. Transient kinetic studies with human immunodeficiency virus (HIV) type 1 reverse transcriptase suggest that nucleotide analogs containing the 2'',3''-didehydro-2'',3''-dideoxy ribose ring structure present in D4T (stavudine) triphosphate are among the most effective alternative substrates.', 11850281),
('GRL-057-14, GRL-058-14, and GRL-059-14, all of which contain a P2-amino-substituted-bis-tetrahydrofuranylurethane (bis-THF) and a P2''-cyclopropyl-amino-benzothiazole (Cp-Abt).', 'These PIs not only potently inhibit the replication of wild-type HIV-1 (50% effective concentration [EC50], 0.22 nM to 10.4 nM) but also inhibit multi-PI-resistant HIV-1 variants, including highly DRV-resistant HIVDRV R P51 (EC50, 1.6 nM to 30.7 nM).', '', 'Combination antiretroviral therapy has achieved dramatic reductions in the mortality and morbidity in people with HIV-1 infection.', 31085520),
('tenofovir alafenamide (TAF) and OBP-601(2,3-didehydro-3-deoxy-4-ethynylthymidine)', 'TAF and OBP-601 inhibited the replication of almost all isolates at a median EC50 of 0.27 nM and 6.83 nM, respectively.', '', 'New antiretroviral drugs are needed to treat HIV-2 infected patients failing therapy.', 30391482),
('dihydrofuro[3,4- d]pyrimidine derivatives 13c2 and 13c4', 'Against a wide range of HIV-1 strains carrying single NNRTI-resistant mutations (EC50 = 0.9-8.4 nM), which were remarkably superior to that of etravirine (ETV)', '', 'the small molecule inhibited HBsAg production and hepatitis B virion secretion (10 ?M) at low micromolar concentrations and was also efficacious against a HBV quadruple mutant (CYEI mutant) resistant to tenofovir.', 30624934),
('2,4,5-Trisubstituted Pyrimidines', 'EC50 = 24.4 nM', '', 'Furthermore, 16c demonstrated favorable pharmacokinetic and safety properties, suggesting the potential of 16c as a promising anti-HIV-1 drug candidate.', 33734714),
('ZINC20451377', 'KD of 65.3 nM', '', 'Prolonged therapy with nucleoside/nucleotide analogues targeting the HBV-polymerase may lead to resistance and rarely results in the loss of HBsAg.', 34083665),
('Novel Boron-Containing N-Substituted Oseltamivir Derivatives- 4-(3-boronic acid benzyloxy)benzyl group (2c)', 'OSC showed a greater inhibitory potency toward wild-type NAs with IC50 values of 1.1 ', 'low cytotoxicity in vitro and no acute toxicity at the dose of 1000 mg/kg in mice', '4-(3-boronic acid benzyloxy)benzyl group was employed to provide a possible explanation for Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant', 36234966),
('Baloxavir acid (BXA), the active compound in baloxavir marboxil (BXM),', 'reduces the propagation of influenza A and B viruses by inhibiting the cap-dependent endonuclease activity of the polymerase acidic (PA) subunit.', '', 'The IC50 of BXA toward influenza A viruses containing PA E198K increased approximately 2- to 6-fold. These findings help to understand the mechanism by which PA substitutions reduce susceptibility to BXA.', 35511288),
('Dibenz[a,h]acridine, dibenz[a, i]acridine, NSC114903, dibenz[c,h]acridine, benzo[ a]acridine and their derivatives', 'The binding energy of the modified ligands of HIV-1 subtype C proteases increased, including the poorest-performing molecules.', '', 'Conclusion: Dibenz[a,h]acridine, dibenz[a, i]acridine, NSC114903, dibenz[c,h]acridine, benzo[ a]acridine and their derivatives might be considered as promising HIV-1 subtype C protease inhibitors. This could be confirmed through synthesis and subsequent in vitro assays.', 35114926),
('brequinar and homoharringtonine', 'potent HEV inhibitors, which are also effective against the ribavirin resistance variant harboring G1634R mutation', '', 'Thus, successful recapitulation of HEV infection in liver-derived organoids shall facilitate the study of virus-host interactions and development of antiviral therapies.', 35044825),
('6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives', 'new lead compound 13e, which exhibited an EC50 value of 4.50 MicroM against H1N1 influenza virus in MDCK cells', '', 'Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PAN inhibitors', 34700269),
('polyionenes containing quaternary ammoniums and varying hydrophobic components', 'The polyionenes with optimal compositions inactivates mouse hepatitis virus (MHV) completely in 30 s. More importantly, the polyionenes are effective in inhibiting SARS-CoV-2 by >99.999% within 30 s.', 'do not cause damage to the skin and have a high oral lethal dose', 'Overall, these polyionenes are promising active ingredients for disinfection and prevention of viral and microbial infections.', 34694749);

-- --------------------------------------------------------

--
-- Table structure for table `virus_np`
--

CREATE TABLE IF NOT EXISTS `virus_np` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY_INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `virus_np`
--

INSERT INTO `virus_np` (`ENTITY`, `POTENCY`, `SAFETY_INFORMATION`, `EVIDENCE`, `PMID`) VALUES
('Multivalent Glycosylated Nanostructures', 'Ebola virus (EBOV) infection', '', 'However, new tridecafullerenes-in which the central alkyne scaffold of [60]fullerene is connected to 12 sugar-containing [60]fullerene units (total 120 mannoses)-exhibit an outstanding antiviral activity with IC50 in the sub-nanomolar range! The multivalent presentation of specific carbohydrates by using 3D fullerenes as controlled biocompatible carbon scaffolds represents a real advance, being currently the most efficient molecules in vitro against EBOV infection.', 28394600),
('Metal oxide microspheres', 'An antiviral activity higher than 2 log of reduction was also observed on H1N1 and HSV-1 viruses', '', 'Antimicrobial activity of metal oxide microspheres: an innovative process for homogeneous incorporation into materials.', 29502354),
('BSA-nano-Ag', 'Potent anti-TB drug', '', 'Nature-inspired novel drug design paradigm using nanosilver: efficacy on multi-drug-resistant clinical isolates of tuberculosis.', 20936471),
('15 N [Cobalt Ferrite (0.3 CoFe2O4) + Silver chromite (0.7 Ag0.5Cr2.5O4)]', 'The inhibitory activity of the tested sample against the hepatitis A virus was detected under these experimental conditions with a 50% effective concentration (EC50) = 408.14 ', '', 'The tested compound showed weak antiviral activity.', 35624524),
('Farnesol-Containing Nanoparticles  (NPs) loaded with the natural bactericide farnesol (FSL NPs)', 'the engineered nano-entities demonstrated strong antiviral properties and inhibited the spike proteins of SARS-CoV-2 by up to 83%.', 'The novel FSL NPs did not cause skin tissue irritation and did not induce the secretion of anti-inflammatory cytokines in a 3D skin tissue model.', 'These results support the potential of these bio-based nano-actives to replace the existing antibiotics and they may be used for the development of topical pharmaceutic products as Antibacterial, Antibiofilm, and Antiviral', 35886883);

-- --------------------------------------------------------

--
-- Table structure for table `virus_phage`
--

CREATE TABLE IF NOT EXISTS `virus_phage` (
  `ENTITY` varchar(1000) NOT NULL,
  `POTENCY` varchar(2000) NOT NULL,
  `SAFETY INFORMATION` varchar(1000) NOT NULL,
  `EVIDENCE` varchar(5000) NOT NULL,
  `PMID` int(50) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
